PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Milne, GL; Yin, HY; Morrow, JD				Milne, Ginger L.; Yin, Huiyong; Morrow, Jason D.			Human biochemistry of the isoprostane pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							POLYUNSATURATED FATTY-ACIDS; PROSTAGLANDIN F-2 ALPHA; IN-VIVO; LIPID-PEROXIDATION; OXIDATIVE STRESS; VITAMIN-E; 8-ISO-PROSTAGLANDIN F2-ALPHA; CYCLOPENTENONE ISOPROSTANES; PLATELET ACTIVATION; DIABETES-MELLITUS		Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Morrow, JD (corresponding author), Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Sch Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	jason.morrow@vanderbilt.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X; yin, hui yong/0000-0001-7049-1560	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48831] Funding Source: Medline; NIEHS NIH HHS [ES00267, ES13125] Funding Source: Medline; NIGMS NIH HHS [GM15431] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P319, DOI 10.1016/S0952-3278(98)90042-4; Bohnstedt KC, 2003, J CHROMATOGR B, V796, P11, DOI 10.1016/S1570-0232(03)00600-7; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Davi G, 2003, CIRCULATION, V107, P3199, DOI 10.1161/01.CIR.0000074205.17807.D0; Davi G, 1999, CIRCULATION, V99, P224; Fam SS, 2003, CURR MED CHEM, V10, P1723, DOI 10.2174/0929867033457115; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kunapuli P, 1997, J BIOL CHEM, V272, P27147, DOI 10.1074/jbc.272.43.27147; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Liang YL, 2003, FREE RADICAL BIO MED, V34, P409, DOI 10.1016/S0891-5849(02)01018-3; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Milne GL, 2005, J BIOL CHEM, V280, P25178, DOI 10.1074/jbc.M502891200; Milne GL, 2004, CHEM RES TOXICOL, V17, P17, DOI 10.1021/tx034213o; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Montine TJ, 2003, BIOCHEM PHARMACOL, V65, P611, DOI 10.1016/S0006-2952(02)01607-6; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Morrow JD, 2006, CURR PHARM DESIGN, V12, P895, DOI 10.2174/138161206776055985; MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7; Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; Musiek ES, 2006, J NEUROCHEM, V97, P1301, DOI 10.1111/j.1471-4159.2006.03797.x; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Pratico D, 1998, P NATL ACAD SCI USA, V95, P3449, DOI 10.1073/pnas.95.7.3449; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; PRYOR WA, 1976, LIPIDS, V11, P370, DOI 10.1007/BF02532843; Roberts LJ, 2007, FREE RADICAL BIO MED, V43, P1388, DOI 10.1016/j.freeradbiomed.2007.06.019; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P853, DOI 10.1016/S0090-6980(97)00184-6; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sethi S, 1996, J LAB CLIN MED, V128, P27, DOI 10.1016/S0022-2143(96)90111-0; Taber DF, 1997, PROSTAGLANDINS, V53, P63, DOI 10.1016/S0090-6980(97)00005-1; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; Taylor AW, 2006, ANAL BIOCHEM, V350, P41, DOI 10.1016/j.ab.2005.12.003; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Yin HY, 2007, J BIOL CHEM, V282, P329, DOI 10.1074/jbc.M608975200; Yin HY, 2005, J BIOL CHEM, V280, P26600, DOI 10.1074/jbc.M503088200; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200	46	162	164	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15533	15537		10.1074/jbc.R700047200	http://dx.doi.org/10.1074/jbc.R700047200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18285331	Green Published, hybrid			2022-12-27	WOS:000256332500005
J	Nakatsubo, T; Mizutani, M; Suzuki, S; Hattori, T; Umezawa, T				Nakatsubo, Tomoyuki; Mizutani, Masaharu; Suzuki, Shiro; Hattori, Takefumi; Umezawa, Toshiaki			Characterization of Arabidopsis thaliana pinoresinol reductase, a new type of enzyme involved in lignan biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARICIRESINOL REDUCTASES	A lignan, lariciresinol, was isolated from Arabidopsis thaliana, the most widely used model plant in plant bioscience sectors, for the first time. In the A. thaliana genome database, there are two genes (At1g32100 and At4g13660) that are annotated as pinoresinol/lariciresinol reductase (PLR). The recombinant AtPLRs showed strict substrate preference toward pinoresinol but only weak or no activity toward lariciresinol, which is in sharp contrast to conventional PLRs of other plants that can reduce both pinoresinol and lariciresinol efficiently to lariciresinol and secoisolariciresinol, respectively. Therefore, we renamed AtPLRs as A. thaliana pinoresinol reductases (AtPrRs). The recombinant AtPrR2 encoded by At4g13660 reduced only (-)-pinoresinol to (-)-lariciresinol and not (+)-pinoresinol in the presence of NADPH. This enantiomeric selectivity accords with that of other PLRs of other plants so far reported, which can reduce one of the enantiomers selectively, whatever the preferential enantiomer. In sharp contrast, AtPrR1 encoded by At1g32100 reduced both (+)-and (-)-pinoresinols to (+)-and (-)-lariciresinols efficiently with comparative k(cat)/K-m values. Analysis of lignans and spatio-temporal expression of AtPrR1 and AtPrR2 in their functionally deficient A. thaliana mutants and wild type indicated that both genes are involved in lariciresinol biosynthesis. In addition, the analysis of the enantiomeric compositions of lariciresinol isolated from the mutants and wild type showed that PrRs together with a dirigent protein(s) are involved in the enantiomeric control in lignan biosynthesis. Furthermore, it was demonstrated conclusively for the first time that differential expression of PrR isoforms that have distinct selectivities of substrate enantiomers can determine enantiomeric compositions of the product, lariciresinol.	[Mizutani, Masaharu] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Suzuki, Shiro; Umezawa, Toshiaki] Kyoto Univ, Inst Sustainabil Sci, Kyoto 6110011, Japan; [Nakatsubo, Tomoyuki; Hattori, Takefumi; Umezawa, Toshiaki] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6110011, Japan	Kyoto University; Kyoto University; Kyoto University		tumezawa@rish.kyoto-u.ac.jp	Suzuki, Shiro/P-5830-2019	Mizutani, Masaharu/0000-0002-4321-0644				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davin Laurence B., 2003, Phytochemistry Reviews, V2, P257, DOI 10.1023/B:PHYT.0000046175.83729.b5; DINCOVAKOSTOVA AT, 1996, J BIOL CHEM, V271, P29473; Fujita M, 1999, J BIOL CHEM, V274, P618, DOI 10.1074/jbc.274.2.618; Hemmati S, 2007, FEBS LETT, V581, P603, DOI 10.1016/j.febslet.2007.01.018; Kai K, 2006, PHYTOCHEMISTRY, V67, P379, DOI 10.1016/j.phytochem.2005.11.006; Li LG, 2001, PLANT CELL, V13, P1567, DOI 10.1105/tpc.13.7.1567; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MACRAE WD, 1984, PHYTOCHEMISTRY, V23, P1207, DOI 10.1016/S0031-9422(00)80428-8; Moss GP, 2000, PURE APPL CHEM, V72, P1493, DOI 10.1351/pac200072081493; Okunishi T, 2000, J WOOD SCI, V46, P234, DOI 10.1007/BF00776455; Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Sakakibara N, 2007, ORG BIOMOL CHEM, V5, P802, DOI 10.1039/b616705e; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Suzuki S, 2007, J WOOD SCI, V53, P273, DOI 10.1007/s10086-007-0892-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Umezawa T., 2001, Regulation of Plant Growth & Development, V36, P57; Umezawa T., 1997, Wood Research, P62; UMEZAWA T, 1994, BIOSCI BIOTECH BIOCH, V58, P230, DOI 10.1271/bbb.58.230; Umezawa Toshiaki, 2003, Wood Research, P27; Umezawa Toshiaki, 2003, Phytochemistry Reviews, V2, P371, DOI 10.1023/B:PHYT.0000045487.02836.32; von Heimendahl CBI, 2005, PHYTOCHEMISTRY, V66, P1254, DOI 10.1016/j.phytochem.2005.04.026	23	91	96	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15550	15557		10.1074/jbc.M801131200	http://dx.doi.org/10.1074/jbc.M801131200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18347017	Green Published, hybrid			2022-12-27	WOS:000256332500008
J	Shen, WH; Chen, Z; Shi, S; Chen, HY; Zhu, WQ; Penner, A; Bu, GX; Li, W; Boyle, DW; Rubart, M; Field, LJ; Abraham, R; Liechty, EA; Shou, WN				Shen, Wei-Hua; Chen, Zhuang; Shi, Shu; Chen, Hanying; Zhu, Wuqiang; Penner, Anne; Bu, Guixue; Li, Wei; Boyle, David W.; Rubart, Michael; Field, Loren J.; Abraham, Robert; Liechty, Edward A.; Shou, Weinian			Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CARDIOMYOCYTE DNA-SYNTHESIS; S6 KINASE; PROTEIN-SYNTHESIS; IN-VIVO; HYPERTROPHY; ACTIVATION; INSULIN; GROWTH; MICE	Mammalian target of rapamycin (mTOR) is a key regulator for cell growth through modulating components of the translation machinery. Previously, numerous pharmacological studies using rapamycin suggested that mTOR has an important role in regulating cardiac hypertrophic growth. To further investigate this assumption, we have generated two lines of cardiac specific mTOR transgenic mice, kinase-dead (kd) mTOR and constitutively active (ca) mTOR, using alpha-myosin heavy chain promoter. alpha-Myosin heavy chain (alpha MHC)-mTOR(kd) mice had a near complete inhibition of p70 S6k and 4E-BP1 phosphorylation, whereas alpha MHC-mTOR(ca) had a significant increase in p70 S6k and 4E-BP1 phosphorylation. Although the cardiac function of alpha MHC-mTOR(kd) mice was significantly altered, the cardiac morphology of these transgenic mice was normal. The cardiac hypertrophic growth in response to physiological and pathological stimuli was not different in alpha MHC-mTOR(kd) and alpha MHC-mTOR(ca) transgenic mice when compared with that of nontransgenic litter-mates. These findings suggest that the mTOR-mediated signaling pathway is not essential to cardiac hypertrophic growth but is involved in regulating cardiac function. Additional analysis of cardiac responses to fasting-refeeding or acute insulin administration indicated that alpha MHC-mTOR(kd) mice had a largely impaired physiological response to nutrient energy supply and insulin stimulation.	[Shen, Wei-Hua; Chen, Zhuang; Shi, Shu; Chen, Hanying; Zhu, Wuqiang; Penner, Anne; Li, Wei; Boyle, David W.; Rubart, Michael; Field, Loren J.; Liechty, Edward A.; Shou, Weinian] Indiana Univ, Sch Med, Dept Pediat,Herman B Wells Ctr Pediat Res, Div Pediat Cardiol & Neonatol, Indianapolis, IN 46202 USA; [Abraham, Robert] Dept Oncol Discovery, Pearl River, NY 10965 USA; [Bu, Guixue] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liechty, EA (corresponding author), Indiana Univ, Sch Med, Dept Pediat,Herman B Wells Ctr Pediat Res, Div Pediat Cardiol & Neonatol, Indianapolis, IN 46202 USA.	eliecht@iupui.edu; wshou@iupui.edu	Liechty, Edward A/AGN-4710-2022; Bu, Guixue/E-8291-2010; Bu, Guixue/B-1957-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092, R01HL075165, P01HL085098] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL085098-01A10003, R01 HL081092, P01 HL085098, R01 HL075165-03, R01 HL081092-01A2, R01 HL075165] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gerdes A M, 1998, J Card Fail, V4, P343, DOI 10.1016/S1071-9164(98)90240-8; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GULICK J, 1991, J BIOL CHEM, V266, P9180; Ha TZ, 2005, FREE RADICAL BIO MED, V39, P1570, DOI 10.1016/j.freeradbiomed.2005.08.002; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shen WH, 2005, J ENDOCRINOL, V185, P275, DOI 10.1677/joe.1.06080; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SOONPAA MH, 1994, AM J PHYSIOL, V266, pH1439, DOI 10.1152/ajpheart.1994.266.4.H1439; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	35	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13842	13849		10.1074/jbc.M801510200	http://dx.doi.org/10.1074/jbc.M801510200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326485	hybrid, Green Published			2022-12-27	WOS:000255728200037
J	Barbone, D; Yang, TM; Morgan, JR; Gaudino, G; Broaddus, VC				Barbone, Dario; Yang, Tsung-Ming; Morgan, Jeffrey R.; Gaudino, Giovanni; Broaddus, V. Courtney			Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; IN-VITRO; TUMOR; MTOR; AKT; AKT/PKB; KINASE; PATHWAY; INSULIN; STRESS	When grown as three-dimensional structures, tumor cells can acquire an additional multicellular resistance to apoptosis that may mimic the chemoresistance found in solid tumors. We developed a multicellular spheroid model of malignant mesothelioma to investigate molecular mechanisms of acquired apoptotic resistance. We found that mesothelioma cell lines, when grown as multicellular spheroids, acquired resistance to a variety of apoptotic stimuli, including combinations of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL), ribotoxic stressors, histone deacetylase, and proteasome inhibitors, that were highly effective against mesothelioma cells when grown as monolayers. Inhibitors of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin ( mTOR) pathway, particularly rapamycin, blocked much of the acquired resistance of the spheroids, suggesting a key role for mTOR. Knockdown by small interference RNA of S6K, a major downstream target of mTOR, reproduced the effect of rapamycin, thereby confirming the role of mTOR and of S6K in the acquired resistance of three-dimensional spheroids. Rapamycin or S6K knockdown increased TRAIL-induced caspase-8 cleavage in spheroids, suggesting initially that mTOR inhibited apoptosis by actions at the death receptor pathway; however, isolation of the apoptotic pathways by means of Bid knockdown ablated this effect showing that mTOR actually controls a step distal to Bid, probably at the level of the mitochondria. In sum, mTOR and S6K contribute to the apoptotic resistance of mesothelioma cells in three-dimensional, not in two-dimensional, cultures. The three-dimensional model may reflect a more clinically relevant in vitro setting in which mTOR exhibits anti-apoptotic properties.	[Barbone, Dario; Yang, Tsung-Ming; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94110 USA; [Gaudino, Giovanni] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Chim Alimentari Farmaceut & Farm, I-28100 Novara, Italy; [Morgan, Jeffrey R.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Eastern Piedmont Amedeo Avogadro; Brown University	Broaddus, VC (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, 1001 Potrero Ave,Bldg 1,Rm 150, San Francisco, CA 94110 USA.	cbroaddus@medsfgh.ucsf.edu		Morgan, Jeffrey/0000-0002-7546-3443	NCI NIH HHS [R01 CA95671] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095671] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Broaddus VC, 1996, J CLIN INVEST, V98, P2050, DOI 10.1172/JCI119010; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Edinger AL, 2003, CANCER RES, V63, P8451; Emanuele S, 2004, EUR J CANCER, V40, P1441, DOI 10.1016/j.ejca.2004.01.039; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Fracasso G, 2000, CRIT REV ONCOL HEMAT, V36, P159, DOI 10.1016/S1040-8428(00)00084-6; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kim KL, 2005, AM J RESP CELL MOL, V33, P541, DOI 10.1165/rcmb.2004-0355OC; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Liu WH, 2001, AM J RESP CELL MOL, V25, P111, DOI 10.1165/ajrcmb.25.1.4472; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MANSBRIDGE JN, 1992, J CELL PHYSIOL, V151, P433, DOI 10.1002/jcp.1041510302; Michael CW, 1997, DIAGN CYTOPATHOL, V17, P272, DOI 10.1002/(SICI)1097-0339(199710)17:4<272::AID-DC7>3.0.CO;2-E; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Neuzil H, 2004, BIOCHEM BIOPH RES CO, V314, P186, DOI 10.1016/j.bbrc.2003.12.074; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Reddy RM, 2007, APOPTOSIS, V12, P55, DOI 10.1007/s10495-006-0484-z; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Shen CX, 2007, MOL CELL BIOL, V27, P7007, DOI 10.1128/MCB.00290-07; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Steele JPC, 2005, ANN ONCOL, V16, P345, DOI 10.1093/annonc/mdi094; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; TORRES IP, 1994, P NATL ACAD SCI USA, V91, P2081, DOI 10.1073/pnas.91.6.2081; Vivo C, 2003, J BIOL CHEM, V278, P25461, DOI 10.1074/jbc.M302161200; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, CELL CYCLE, V3, P847; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; WHITAKER D, 1977, ACTA CYTOL, V21, P236	65	115	118	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13021	13030		10.1074/jbc.M709698200	http://dx.doi.org/10.1074/jbc.M709698200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18339627	hybrid, Green Published			2022-12-27	WOS:000255499800039
J	Riefler, GM; Dent, SYR; Schumacher, JM				Riefler, Gary M.; Dent, Sharon Y. R.; Schumacher, Jill M.			Tousled-mediated activation of Aurora B kinase does not require Tousled kinase activity in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; CHROMATIN ASSEMBLY FACTORS; HISTONE CHAPERONE ASF1; RNA-POLYMERASE-II; CHROMOSOME SEGREGATION; CELL-DIVISION; SERINE/THREONINE KINASE; DNA-DAMAGE; YEAST; PHOSPHORYLATION	The Aurora kinases comprise an evolutionarily conserved protein family that is required for a variety of cell division events, including spindle assembly, chromosome segregation, and cytokinesis. Emerging evidence suggests that once phosphorylated, a subset of Aurora substrates can enhance Aurora kinase activity. Our previous work revealed that the Caenorhabditis elegans Tousled-like kinase TLK-1 is a substrate and activator of the AIR-2 Aurora B kinase in vitro and that partial loss of TLK-1 enhances the mitotic defects of an air-2 mutant. However, given that these experiments were performed in vitro and with partial loss of function alleles in vivo, a necessary step forward in our understanding of the relationship between the Aurora B and Tousled kinases is to prove that TLK-1 expression is sufficient for Aurora B activation in vivo. Here, we report that heterologous expression of wild-type and kinase-inactive forms of TLK-1 suppresses the lethality of temperature-sensitive mutants of the yeast Aurora B kinase Ip11. Moreover, kinase-dead TLK-1 associates with and augments the activity of Ip11 in vivo. Together, these results provide critical and compelling evidence that Tousled has a bona fide kinase-independent role in the activation of Aurora B kinases in vivo.	[Riefler, Gary M.; Schumacher, Jill M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; [Dent, Sharon Y. R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Program Genes & Dev, Houston, TX 77030 USA; [Riefler, Gary M.; Dent, Sharon Y. R.; Schumacher, Jill M.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr Excellence Epigenet Res, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Schumacher, JM (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd,Unit 1006, Houston, TX 77030 USA.	jschumac@mdanderson.org	Dent, Sharon YR/F-1746-2011; Schumacher, Jill/B-2932-2012	Dent, Sharon YR/0000-0002-4824-3269; 	NCI NIH HHS [T32 CA009299 29, CA-16672] Funding Source: Medline; NICHD NIH HHS [T32 HD007325 21] Funding Source: Medline; NIGMS NIH HHS [R01 GM62181-06] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; CHAN CSM, 1993, GENETICS, V135, P677; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Ehsan H, 2004, PLANT PHYSIOL, V134, P1488, DOI 10.1104/pp.103.038117; Eissenberg JC, 2006, CURR OPIN GENET DEV, V16, P184, DOI 10.1016/j.gde.2006.02.004; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015; Han ZB, 2005, CURR BIOL, V15, P894, DOI 10.1016/j.cub.2005.04.019; Han ZB, 2003, CURR BIOL, V13, P1921, DOI 10.1016/j.cub.2003.10.035; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006; Li Y, 2001, ONCOGENE, V20, P726, DOI 10.1038/sj.onc.1204147; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Nguyen HG, 2006, J CELL PHYSIOL, V208, P12, DOI 10.1002/jcp.20565; Pascreau G, 2005, J BIOL CHEM, V280, P13415, DOI 10.1074/jbc.M410584200; Petersen J, 2001, J CELL SCI, V114, P4371; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Roe JL, 1997, PLANT CELL, V9, P335, DOI 10.1105/tpc.9.3.335; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	46	10	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12763	12768		10.1074/jbc.M709034200	http://dx.doi.org/10.1074/jbc.M709034200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334486	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000255499800012
J	Chen, H; He, XJ; Wang, Z; Wu, D; Zhang, HY; Xu, CP; He, HB; Cui, LX; Ba, DN; He, W				Chen, Hui; He, Xiaojuan; Wang, Zhun; Wu, Di; Zhang, Huiyuan; Xu, Chunping; He, Hongbin; Cui, Lianxian; Ba, Denian; He, Wei			Identification of human T cell receptor gamma delta-recognized epitopes/proteins via CDR3 delta peptide-based immunobiochemical strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; TUMOR-CELLS; NK CYTOTOXICITY; CANCER; HMSH2; PROTEINS; HEAT-SHOCK-PROTEIN-70; INVOLVEMENT; EXPRESSION; INDUCTION	Human T lymphocytes, bearing T cell receptor (TCR) gamma delta, play an important role in anti-tumor/microbe immune responses. However, few tumor antigens recognized by TCR gamma delta have been defined so far. To investigate antigenic epitopes/proteins recognized by gamma delta T cells, we have established a new immunobiochemical strategy that uses complementarity-determining region 3 of TCR delta chain (CDR3 delta) peptide-mediated epitope/protein-binding assays. CDR3 delta peptides synthesized using the CDR3 region in TCR V delta 2 chain were validated for their binding specificity to target cells or tissues. These CDR3 delta peptides were then employed as probes to pan putative epitopes in a 12-mer random peptide phage-displayed library and to identify putative protein ligands within tumor protein extracts by affinity chromatography and liquid chromatography/electrospray ionizationtandem mass spectrometry analysis. As a result, we have identified nine peptides and two proteins for TCR gamma delta, including human mutS homolog 2 ( hMSH2) and heat shock protein (HSP) 60. All nine tested epitope peptides not only bind to gamma delta T cells but also functionally activate gamma delta T cells in vitro. Identification of HSP60 confirms the validity of this method as HSP60 is an identified ligand for TCR gamma delta. We show that hMSH2 is expressed on the surface of SKOV3 tumor cells, and cytotoxicity of V delta 2 gamma delta T cells to SKOV3 cells was blocked by anti-hMSH2 antibody, suggesting that hMSH2 may be a new ligand for TCR gamma delta. Taken together, our findings provide a novel immunobiochemical strategy to identify epitopes/proteins recognized by gamma delta T cells.	[He, Wei] Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, Beijing 100005, Peoples R China; Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	He, W (corresponding author), Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	heweiimu@public.bta.net.cn	Zhang, Huiyuan/J-2784-2016					Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Cao W, 2004, IMMUNOBIOLOGY, V209, P283, DOI 10.1016/j.imbio.2004.04.008; Cao W, 2007, J BIOL CHEM, V282, P18922, DOI 10.1074/jbc.M702504200; Chen Y, 2001, CANCER RES, V61, P4112; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Dangles-Marie V, 2003, CANCER RES, V63, P3682; Davies A, 2004, J IMMUNOL, V172, P6828, DOI 10.4049/jimmunol.172.11.6828; Davis MM, 1997, CIBA F SYMP, V204, P94; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; Jung CY, 2006, CANCER EPIDEM BIOMAR, V15, P762, DOI 10.1158/1055-9965.EPI-05-0834; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; KAKEDA K, 1991, J BIOCHEM, V110, P583, DOI 10.1093/oxfordjournals.jbchem.a123623; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kunzmann V, 2000, BLOOD, V96, P384; Laad AD, 1999, INT J CANCER, V80, P709, DOI 10.1002/(SICI)1097-0215(19990301)80:5<709::AID-IJC14>3.3.CO;2-I; Maeurer MJ, 1996, J EXP MED, V183, P1681, DOI 10.1084/jem.183.4.1681; Mitchell RJ, 2002, AM J EPIDEMIOL, V156, P885, DOI 10.1093/aje/kwf139; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Rakheja D, 2005, PEDIATR DEVEL PATHOL, V8, P615, DOI 10.1007/s10024-005-0148-y; Samimi G, 2000, CLIN CANCER RES, V6, P1415; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Seifert M, 2006, J MOL HISTOL, V37, P301, DOI 10.1007/s10735-006-9062-5; Spagnoletti I, 2004, ONCOL REP, V11, P845; Srivastava P K, 1991, Semin Immunol, V3, P57; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Thomas ML, 2000, CANCER IMMUNOL IMMUN, V48, P653, DOI 10.1007/s002620050014; Todryk SM, 2003, IMMUNOLOGY, V110, P1, DOI 10.1046/j.1365-2567.2003.01725.x; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; Wei YQ, 1996, CANCER RES, V56, P1104; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Zhang HY, 2005, IMMUNOL INVEST, V34, P453, DOI 10.1080/08820130500265349; Zhao JP, 2006, BIOCHEM BIOPH RES CO, V339, P232, DOI 10.1016/j.bbrc.2005.10.198	36	53	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12528	12537		10.1074/jbc.M708067200	http://dx.doi.org/10.1074/jbc.M708067200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321859	hybrid			2022-12-27	WOS:000255340000069
J	Zhang, B; Dong, YL; Zhang, GH; Moir, RD; Xia, WM; Yue, Y; Tian, M; Culley, DJ; Crosby, G; Tanzi, RE; Xie, ZC				Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Moir, Robert D.; Xia, Weiming; Yue, Yun; Tian, Ming; Culley, Deborah J.; Crosby, Gregory; Tanzi, Rudolph E.; Xie, Zhongcong			The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SECRETASE ACTIVITY; APOPTOSIS; PRESENILIN; PEPTIDE; GAMMA; ISOFLURANE; CLEAVAGE	Perioperative factors including hypoxia, hypocapnia, and certain anesthetics have been suggested to contribute to Alzheimer disease (AD) neuropathogenesis. Desflurane is one of the most commonly used inhalation anesthetics. However, the effects of desflurane on AD neuropathogenesis have not been previously determined. Here, we set out to assess the effects of desflurane and hypoxia on caspase activation, amyloid precursor protein (APP) processing, and amyloid beta-protein (A beta) generation in H4 human neuroglioma cells (H4 naive cells) as well as those over-expressing APP (H4-APP cells). Neither 12% desflurane nor hypoxia (18% O-2) alone affected caspase-3 activation, APP-processing, and A beta generation. However, treatment with a combination of 12% desflurane and hypoxia (18% O-2) (desflurane/hypoxia) for 6 h induced caspase-3 activation, altered APP processing, and increased A beta generation in H4-APP cells. Desflurane/hypoxia also increased levels of beta-site APP-cleaving enzyme in H-4-APP cells. In addition, desflurane/hypoxia-induced A beta generation could be reduced by the broad caspase inhibitor benzyloxycarbonyl- VAD. Finally, the A beta aggregation inhibitor clioquinol and gamma-secretase inhibitor L-685,458 attenuated caspase-3 activation induced by desflurane/ hypoxia. In summary, desflurane can induce A beta production and caspase activation, but only in the presence of hypoxia. Pending in vivo confirmation, these data may have profound implications for anesthesia care in elderly patients, and especially those with AD.	[Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Yue, Yun; Tanzi, Rudolph E.; Xie, Zhongcong] Harvard Univ, Sch Med, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Genet & Aging Res Unit,Dept Neurol, Charlestown, MA 02129 USA; [Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Xie, Zhongcong] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Xie, Zhongcong] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Zhang, Bin; Tian, Ming] Capital Med Univ, Dept Anesthesia, Beijing Friendship Hosp, Beijing 100050, Peoples R China; [Zhang, Guohua] China Med Univ, Fac Forens Med, Dept Forens Pathol, Shenyang 110001, Peoples R China; [Xia, Weiming; Culley, Deborah J.; Crosby, Gregory] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Xia, Weiming] Harvard Inst Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Yue, Yun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesia, Beijing 100050, Peoples R China; [Culley, Deborah J.; Crosby, Gregory] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Capital Medical University; China Medical University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Capital Medical University; Harvard University; Brigham & Women's Hospital	Tanzi, RE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Genet & Aging Res Unit,Dept Neurol, 114 16th St,C3009, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu; zxie@partners.org	Tanzi, Rudolph/AAE-9622-2019; Crosby, Gregory/N-6578-2019; xia, weiming/E-5465-2016; Moir, Robert D./M-7612-2017	Tanzi, Rudolph/0000-0002-7032-1454; xia, weiming/0000-0002-7463-3295; Moir, Robert D./0000-0001-5431-3553; Dong, Yuanlin/0000-0002-4760-0519	NIGMS NIH HHS [R01 GM088801] Funding Source: Medline; NIMH NIH HHS [R37MH60009] Funding Source: Medline; NINDS NIH HHS [K08 NS048140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048140] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOHNEN N, 1994, INT J NEUROSCI, V77, P181, DOI 10.3109/00207459408986029; BOHNEN NILJ, 1994, J AM GERIATR SOC, V42, P198, DOI 10.1111/j.1532-5415.1994.tb04952.x; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Galli C, 1998, P NATL ACAD SCI USA, V95, P1247, DOI 10.1073/pnas.95.3.1247; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Grace EA, 2002, NEUROSCIENCE, V114, P265, DOI 10.1016/S0306-4522(02)00241-5; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Guo Q, 1997, J NEUROSCI, V17, P4212; Jendroska K, 1997, Ann N Y Acad Sci, V826, P401, DOI 10.1111/j.1749-6632.1997.tb48492.x; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Masliah E, 1998, J NEUROPATH EXP NEUR, V57, P1041, DOI 10.1097/00005072-199811000-00007; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; MURAVCHICK S, 1995, ANESTHESIOLOGY, V82, P305, DOI 10.1097/00000542-199501000-00039; Nagy Z, 1997, J NEUROPATH EXP NEUR, V56, P165, DOI 10.1097/00005072-199702000-00007; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pillot T, 1999, J NEUROCHEM, V73, P1626, DOI 10.1046/j.1471-4159.1999.0731626.x; Raina AK, 2003, PROG NEURO-PSYCHOPH, V27, P251, DOI 10.1016/S0278-5846(03)00020-4; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Sponne I, 2003, J BIOL CHEM, V278, P3437, DOI 10.1074/jbc.M206745200; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2005, J MOL NEUROSCI, V25, P67, DOI 10.1385/JMN:25:1:067; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2004, NEURODEGENER DIS, V1, P29, DOI 10.1159/000076667; Yang FS, 1998, AM J PATHOL, V152, P379; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	58	78	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11866	11875		10.1074/jbc.M800199200	http://dx.doi.org/10.1074/jbc.M800199200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326038	Green Published, hybrid			2022-12-27	WOS:000255340000002
J	Cheong, JK; Gunaratnam, L; Hsu, SIH				Cheong, Jit Kong; Gunaratnam, Lakshman; Hsu, Stephen I-Hong			CRM1-mediated nuclear export is required for 26 S proteasome-dependent degradation of the TRIP-Br2 proto-oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; BR FAMILY; IN-VIVO; CYCLIN; SIGNAL; E2F; UBIQUITIN; DOMAIN; LOCALIZATION; PROTEINS	Overexpression of the proto-oncogene TRIP-Br2 (SERTAD2) has been shown to induce E2F activity and promote tumorigenesis, whereas ablation of TRIP-Br2 arrests cell proliferation. Timely degradation of many cell cycle regulators is fundamental to the maintenance of proper cell cycle progression. Here we report novel mechanism(s) that govern the tight regulation of TRIP-Br2 levels during cell cycle progression. TRIP-Br2 was observed to be a short-lived protein in which the expression level peaks at the G(1)/S boundary. TRIP-Br2 accumulated in cells treated with 26 S proteasome inhibitors. Co-immunoprecipitation studies revealed that TRIP-Br2 forms ubiquitin conjugates. In silico analysis identified a putative leucine-rich nuclear export signal (NES) motif that overlaps with the PHD-Bromo interaction domain in the acidic C-terminal transactivation domain (TAD) of TRIP-Br2. This NES motif is highly conserved in widely divergent species and in all TRIP-Br family members. TRIP-Br2 was shown to be stabilized in G(2)/M phase cells through nuclear entrapment, either by deletion of the acidic C-terminal TAD, which includes the NES motif, or by leptomycin B-mediated inhibition of the CRM1-dependent nuclear export machinery. Mutation of leucine residue 238 of this NES motif abolished the interaction between CRM1 and TRIP-Br2, as well as the nuclear export of TRIP- Br2 and its subsequent 26 S proteasome-dependent degradation. These data suggest that CRM1-mediated nuclear export may be required for the proper execution of ubiquitin-proteasome-dependent degradation of TRIP- Br2.	[Cheong, Jit Kong; Hsu, Stephen I-Hong] Univ Florida, Coll Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA; [Cheong, Jit Kong; Gunaratnam, Lakshman; Hsu, Stephen I-Hong] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Cheong, Jit Kong; Gunaratnam, Lakshman; Hsu, Stephen I-Hong] Harvard Univ, Sch Med, Boston, MA 02115 USA	State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hsu, SIH (corresponding author), Univ Florida, Coll Med, Div Nephrol Hypertens & Transplantat, 1600 SW Archer Rd,Rm NG-4A,POB 100224, Gainesville, FL 32610 USA.	Stephen.Hsu@medicine.ufl.edu	Gunaratnam, Lakshman/G-3299-2011	Gunaratnam, Lakshman/0000-0002-8845-1126				BARINAGA M, 1995, SCIENCE, V269, P631, DOI 10.1126/science.7624789; BARRETT AJ, 1992, ANN NY ACAD SCI, V674, P1; Bennetts JS, 2006, GENE, V374, P153, DOI 10.1016/j.gene.2006.01.027; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Calgaro S, 2002, GENETICS, V160, P547; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Darwish H, 2007, ONCOGENE, V26, P4319, DOI 10.1038/sj.onc.1210195; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Heerklotz D, 2001, MOL CELL BIOL, V21, P1759, DOI 10.1128/MCB.21.5.1759-1768.2001; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Kobayashi T, 2001, J VIROL, V75, P3404, DOI 10.1128/JVI.75.7.3404-3412.2001; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Lai IL, 2007, GENE, V388, P102, DOI 10.1016/j.gene.2006.10.008; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Sim KG, 2004, CELL CYCLE, V3, P1296, DOI 10.4161/cc.3.10.1157; Sim KG, 2006, CELL CYCLE, V5, P1111, DOI 10.4161/cc.5.10.2797; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Watanabe-Fukunaga R, 2005, GENES CELLS, V10, P851, DOI 10.1111/j.1365-2443.2005.00881.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Zang ZJ, 2007, CANCER BIOL THER, V6, P712, DOI 10.4161/cbt.6.5.3964	41	9	13	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11661	11676		10.1074/jbc.M708365200	http://dx.doi.org/10.1074/jbc.M708365200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18316374	hybrid			2022-12-27	WOS:000255067400067
J	Deudero, JJP; Caramelo, C; Castellanos, MC; Neria, F; Fernandez-Sanchez, R; Calabia, O; Penate, S; Gonzalez-Pacheco, FR				Deudero, Juan Jose P.; Caramelo, Carlos; Castellanos, Maria Carmen; Neria, Fernando; Fernandez-Sanchez, Ruth; Calabia, Olalla; Penate, Silvia; Gonzalez-Pacheco, Francisco Roman			Induction of hypoxia-inducible factor 1 alpha gene expression by vascular endothelial growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE-OXYGEN; NAD(P)H OXIDASE; FACTOR-I; DEPENDENT REGULATION; MAP KINASE; CELLS; PATHWAY; TRANSCRIPTION; ANGIOGENESIS; MODULATION	Transcriptional regulation of vascular endothelial growth factor (VEGF) is critically dependent on hypoxia-inducible factor 1 (HIF-1). However, not only hypoxia, but selected growth factors can induce HIF-1. High levels of both VEGF and HIF-1 coexist in certain conditions, e. g. tumors. Nonetheless, the possibility that the stimulatory relationship between HIF-1 and VEGF may be bi-directional has not been addressed up to date. The present study in endothelial cells analyzed whether HIF-1 is regulated by a product of its own transcriptionally activated genes, namely, VEGF. As a main finding, VEGF-A165 induced the increase of HIF-1 alpha mRNA and HIF-1 alpha protein and nuclear translocation. Autologous endothelial cell VEGF mRNA and protein were also increased upon exposure to exogenous VEGF. The signaling implication of reactive oxygen species was examined by comparison with H2O2 and hypoxanthine/xanthine oxidase and by the superoxide dismutase mimetic, MnTMPyP, the Rac1-NAD(P) H oxidase complex inhibitor, apocynin, transfection of a dominant negative Rac1 mutant, and transfection of a p67phox antisense oligonucleotide. Superoxide anion, largely dependent on Rac1-NAD(P) H oxidase complex activity, was the critical signaling element. The transductional functionality of the pathway was confirmed by means of a reporter gene flanked by a transcription site-related VEGF sequence and by quantitative PCR. In summary, the present results reveal a previously undescribed action of VEGF on the expression of its own transcription factor, HIF-1, and on VEGF itself. This effect is principally mediated by superoxide anion, therefore identifying a new, potentially relevant role of reactive oxygen species in VEGF signaling.	[Deudero, Juan Jose P.; Caramelo, Carlos; Neria, Fernando; Fernandez-Sanchez, Ruth; Calabia, Olalla; Penate, Silvia; Gonzalez-Pacheco, Francisco Roman] Univ Autonoma Madrid, Lab Nefrol Hipertens, Fdn Jimenez Diaz Capio, Madrid 28040, Spain; [Castellanos, Maria Carmen] Univ Autonoma Madrid, Serv Inmunol, Hosp Princesa, Madrid 28040, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Hospital de La Princesa	Gonzalez-Pacheco, FR (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super,Tarry Bldg 4-750-752, Chicago, IL 60611 USA.	fromanglez@gmail.com	Deudero, Juan/E-4345-2010; Gonzalez-Pacheco, Francisco/A-2934-2009	Gonzalez-Pacheco, Francisco/0000-0002-6243-5814; Pena Deudero, Juan Jose/0000-0002-0203-2247				Abdelrahman M, 2005, SHOCK, V23, P107, DOI 10.1097/01.shk.0000151028.15377.f7; Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Arroyo MVA, 2002, TRANSPLANTATION, V74, P1618, DOI 10.1097/01.TP.0000041449.31360.16; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Castilla MA, 1999, CIRC RES, V85, P1132; Chatterjee PK, 2005, LANCET, V365, P1890, DOI 10.1016/S0140-6736(05)66622-6; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Feldser D, 1999, CANCER RES, V59, P3915; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fisher JW, 2003, EXP BIOL MED, V228, P1; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gonzalez-Pacheco FR, 2002, NEPHROL DIAL TRANSPL, V17, P392, DOI 10.1093/ndt/17.3.392; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lu Q, 2007, J CELL PHYSIOL, V212, P827, DOI 10.1002/jcp.21079; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P805, DOI 10.1089/152308602760598963; Maxwell P, 2004, CANCER BIOL THER, V3, P29, DOI 10.4161/cbt.3.1.547; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Millar TM, 2007, FREE RADICAL BIO MED, V42, P1165, DOI 10.1016/j.freeradbiomed.2007.01.015; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Naranjo-Suarez S, 2003, J BIOL CHEM, V278, P31895, DOI 10.1074/jbc.M304079200; Richard DE, 2000, J BIOL CHEM, V275, P26765; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Suda O, 2005, ARTERIOSCL THROM VAS, V25, P506, DOI 10.1161/01.ATV.0000153284.81572.f0; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tacchini L, 2001, CARCINOGENESIS, V22, P1363, DOI 10.1093/carcin/22.9.1363; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Victoria M, 1998, J AM SOC NEPHROL, V9, P1998; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	49	39	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11435	11444		10.1074/jbc.M703875200	http://dx.doi.org/10.1074/jbc.M703875200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305118	hybrid			2022-12-27	WOS:000255067400041
J	Gilberthorpe, NJ; Poole, RK				Gilberthorpe, Nicola J.; Poole, Robert K.			Nitric oxide homeostasis in Salmonella typhimurium - Roles of respiratory nitrate reductase and flavohemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; COLI FLAVOHAEMOGLOBIN HMP; ESCHERICHIA-COLI; NITROSATIVE STRESS; GENE-EXPRESSION; CYTOCHROME BD; IN-VITRO; FNR; BACTERIAL; SYNTHASE	Nitric oxide (NO) is generated in biological systems primarily via the activity of NO synthases and nitrate and nitrite reductases. Here we show that Salmonella enterica serovar Typhimurium (S. typhimurium) grown anaerobically with nitrate is capable of generating polarographically detectable NO after nitrite (NO2-) addition. NO accumulation is sensitive to the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide. Neither an fnr mutant nor an fnr hmp double mutant produces NO, indicating the involvement in NO evolution from NO2- of protein(s) positively regulated by FNR. Contrary to previous findings in Escherichia coli, we demonstrate that neither the periplasmic nitrite reductase (NrfA) nor the cytoplasmic nitrite reductase (NirB) is involved in NO production in S. typhimurium. However, mutant cells lacking the membrane-bound nitrate reductase, NarGHI, and membranes derived from these cells are unable to produce NO, demonstrating that, in wild-type S. typhimurium, this enzyme is responsible for NO production. Membrane terminal oxidases cannot account for the NO levels measured. The nitrate reductase inhibitor, azide, abrogates NO evolution by Salmonella, and production of NO occurs only in the absence from the assays of nitrate; both features reveal a marked similarity between the NO-generating activities of this bacterium and plants. Unlike the situation in E. coli, an S. typhimurium hmp mutant produces NO both aerobically and anaerobically. Under aerobic conditions, when a functional flavohemoglobin is present, no NO is detectable. We propose a homeostatic mechanism in S. typhimurium, in which NO produced from NO2- by nitrate reductase derepresses Hmp expression (via FNR and NsrR) and NorV expression (via NorR) and thus limits NO toxicity.	[Gilberthorpe, Nicola J.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk			Biotechnology and Biological Sciences Research Council [BB/E015883/1] Funding Source: Medline; BBSRC [BB/E015883/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Borisov VB, 2004, FEBS LETT, V576, P201, DOI 10.1016/j.febslet.2004.09.013; Borisov VB, 2001, J BIOL CHEM, V276, P22095, DOI 10.1074/jbc.M011542200; Browning DF, 2000, MOL MICROBIOL, V37, P1258, DOI 10.1046/j.1365-2958.2000.02087.x; Browning DF, 2002, MOL MICROBIOL, V43, P687, DOI 10.1046/j.1365-2958.2002.02776.x; CALMELS S, 1988, J GEN MICROBIOL, V134, P221; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; CHEN YJ, 1994, BIOCHEM BIOPH RES CO, V203, P1251, DOI 10.1006/bbrc.1994.2317; Choi WS, 1997, BIOCHEM BIOPH RES CO, V237, P554, DOI 10.1006/bbrc.1997.7189; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; COSTA C, 1990, FEBS LETT, V276, P67, DOI 10.1016/0014-5793(90)80508-G; Crawford MJ, 1998, J BIOL CHEM, V273, P12543, DOI 10.1074/jbc.273.20.12543; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; DARWIN AJ, 1995, J MOL BIOL, V251, P15, DOI 10.1006/jmbi.1995.0412; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; GENNIS RB, 1999, RESP ESCHERICHIA COL; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Gonzalez PJ, 2006, J INORG BIOCHEM, V100, P1015, DOI 10.1016/j.jinorgbio.2005.11.024; HADDOCK BA, 1976, BIOCHEM J, V154, P285, DOI 10.1042/bj1540285; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; HOCHSTEIN LI, 1988, ANNU REV MICROBIOL, V42, P231, DOI 10.1146/annurev.mi.42.100188.001311; JI XB, 1988, BIOCHEM BIOPH RES CO, V157, P106, DOI 10.1016/S0006-291X(88)80018-4; JI XB, 1988, APPL ENVIRON MICROB, V54, P1791, DOI 10.1128/AEM.54.7.1791-1794.1988; Kalnenieks U, 1998, FEMS MICROBIOL LETT, V168, P91; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; KITA K, 1986, METHOD ENZYMOL, V126, P94; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Maloy SR., 1996, GENETIC ANAL PATHOGE; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Martin MJ, 2001, CURR PHARM DESIGN, V7, P881, DOI 10.2174/1381612013397645; McKnight GM, 1997, GUT, V40, P211, DOI 10.1136/gut.40.2.211; Metheringham R, 1997, MICROBIOL-UK, V143, P2647, DOI 10.1099/00221287-143-8-2647; Mills CE, 2001, BIOCHEM J, V353, P207, DOI 10.1042/0264-6021:3530207; Mills PC, 2005, BIOCHEM SOC T, V33, P198, DOI 10.1042/BST0330198; Modolo LV, 2005, FEBS LETT, V579, P3814, DOI 10.1016/j.febslet.2005.05.078; Morozkina EV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1151, DOI 10.1134/S0006297907100124; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Poock SR, 2002, J BIOL CHEM, V277, P23664, DOI 10.1074/jbc.M200731200; POOLE RK, 1977, J GEN MICROBIOL, V99, P369, DOI 10.1099/00221287-99-2-369; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; POOLE RK, 1979, BIOCHEM J, V184, P379, DOI 10.1042/bj1840379; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; RALT D, 1988, J BACTERIOL, V170, P359, DOI 10.1128/jb.170.1.359-364.1988; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Sobko T, 2006, FREE RADICAL BIO MED, V41, P985, DOI 10.1016/j.freeradbiomed.2006.06.020; Spector MP, 1999, MICROBIOL-SGM, V145, P3035, DOI 10.1099/00221287-145-11-3035; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Stachura J, 1996, J PHYSIOL PHARMACOL, V47, P131; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; STEWART V, 1993, MOL MICROBIOL, V9, P425, DOI 10.1111/j.1365-2958.1993.tb01704.x; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Yamasaki H, 2000, FEBS LETT, V468, P89, DOI 10.1016/S0014-5793(00)01203-5; Yamasaki H, 1999, TRENDS PLANT SCI, V4, P128, DOI 10.1016/S1360-1385(99)01393-X; Yamasaki H, 2000, PHILOS T R SOC B, V355, P1477, DOI 10.1098/rstb.2000.0708; Zhao ZW, 2003, BIOCHEMISTRY-US, V42, P14225, DOI 10.1021/bi0350856; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	75	101	101	5	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11146	11154		10.1074/jbc.M708019200	http://dx.doi.org/10.1074/jbc.M708019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18285340	hybrid			2022-12-27	WOS:000255067400010
J	Kihara, A; Sakuraba, H; Ikeda, M; Denpoh, A; Igarashi, Y				Kihara, Akio; Sakuraba, Hiroko; Ikeda, Mika; Denpoh, Aki; Igarashi, Yasuyuki			Membrane topology and essential amino acid residues of Phs1, a 3-hydroxyacyl-CoA dehydratase involved in very long-chain fatty acid elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MYOTUBULAR MYOPATHY; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CERAMIDE SYNTHASE; YEAST; GENE; IDENTIFICATION; TRAFFICKING; EXPLORATION; DISRUPTION	Yeast Phs1 is the 3-hydroxyacyl-CoA dehydratase that catalyzes the third reaction of the four-step cycle in the elongation of very long-chain fatty acids (VLCFAs). In yeast, the hydrophobic backbone of sphingolipids, ceramide, consists of a long-chain base and an amide-linked C26 VLCFA. Therefore, defects in VLCFA synthesis would be expected to greatly affect sphingolipid synthesis. In fact, in this study we found that reduced Phs1 levels result in significant impairment of the conversion of ceramide to inositol phosphorylceramide. Phs1 proteins are conserved among eukaryotes, constituting a novel protein family. Phs1 family members exhibit no sequence similarity to other dehydratase families, so their active site sequence and catalytic mechanism have been completely unknown. Here, by mutating 22 residues conserved among Phs1 family members, we identified six amino acid residues important in Phs1 function, two of which (Tyr-149 and Glu-156) are indispensable. We also examined the membrane topology of Phs1 using an N-glycosylation reporter assay. Our results suggest that Phs1 is a membrane-spanning protein that traverses the membrane six times and has an N terminus and C terminus facing the cytosol. The important amino acids are concentrated in or near two of the six proposed transmembrane regions. Thus, we also propose a catalytic mechanism for Phs1 that is not unlike mechanisms used by other hydratases active in lipid synthesis.	[Kihara, Akio; Sakuraba, Hiroko; Ikeda, Mika; Denpoh, Aki; Igarashi, Yasuyuki] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lab Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Kita 12 Jo,Nishi 6 Choume, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788				Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Brachmann CB, 1998, YEAST, V14, P115; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Farwanah H, 2005, ANAL BIOANAL CHEM, V383, P632, DOI 10.1007/s00216-005-0044-3; FUJITA M, 2008, IN PRESS BIOCH BIOPH; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hakomori S, 2004, AN ACAD BRAS CIENC, V76, P553, DOI 10.1590/S0001-37652004000300010; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kvam E, 2005, MOL BIOL CELL, V16, P3987, DOI 10.1091/mbc.e05-04-0290; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Li DX, 2000, GENE, V256, P237, DOI 10.1016/S0378-1119(00)00347-4; Liu YJ, 1997, BIOCHEMISTRY-US, V36, P10675, DOI 10.1021/bi970430a; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; OSEI P, 1989, J BIOL CHEM, V264, P6844; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Ponec M, 2003, J INVEST DERMATOL, V120, P581, DOI 10.1046/j.1523-1747.2003.12103.x; POULOS A, 1987, BIOCHEM J, V248, P961, DOI 10.1042/bj2480961; REVARDEL E, 1995, BBA-GENE STRUCT EXPR, V1263, P261, DOI 10.1016/0167-4781(95)00124-Y; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rossler H, 2003, MOL GENET GENOMICS, V269, P290, DOI 10.1007/s00438-003-0836-0; Sandhoff R, 2005, J BIOL CHEM, V280, P27310, DOI 10.1074/jbc.M502775200; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Uemura S, 2007, J BIOL CHEM, V282, P8613, DOI 10.1074/jbc.M606649200; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524	49	49	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11199	11209		10.1074/jbc.M708993200	http://dx.doi.org/10.1074/jbc.M708993200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18272525	hybrid			2022-12-27	WOS:000255067400015
J	Leskovar, A; Wegele, H; Werbeck, ND; Buchner, J; Reinstein, J				Leskovar, Adriane; Wegele, Harald; Werbeck, Nicolas D.; Buchner, Johannes; Reinstein, Jochen			The ATPase cycle of the mitochondrial Hsp90 analog trap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; IN-VIVO; ESSENTIAL PROTEIN; BINDING; COMPLEX; HSP70; INHIBITION; RECEPTOR	Hsp90 is an ATP-dependent molecular chaperone whose mechanism is not yet understood in detail. Here, we present the first ATPase cycle for the mitochondrial member of the Hsp90 family called Trap1 (tumor necrosis factor receptor-associated protein 1). Using biochemical, thermodynamic, and rapid kinetic methods we dissected the kinetics of the nucleotide-regulated rearrangements between the open and the closed conformations. Surprisingly, upon ATP binding, Trap1 shifts predominantly to the closed conformation (70%), but, unlike cytosolic Hsp90 from yeast, this process is rather slow at 0.076 s(-1). Because reopening (0.034 s(-1)) is about ten times faster than hydrolysis (k(hyd) = 0.0039 s(-1)), which is the rate-limiting step, Trap1 is not able to commit ATP to hydrolysis. The proposed ATPase cycle was further scrutinized by a global fitting procedure that utilizes all relevant experimental data simultaneously. This analysis corroborates our model of a two-step binding mechanism of ATP followed by irreversible ATP hydrolysis and a one-step product ( ADP) release.	[Leskovar, Adriane; Werbeck, Nicolas D.; Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Wegele, Harald; Buchner, Johannes] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Max Planck Society; Technical University of Munich	Reinstein, J (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	Jochen.Reinstein@mpimf-heidelberg.mpg.de	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737				Adam H., 1962, METHODEN ENZYMATISCH, P573; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; BERNASCONI CF, 1976, RELAXATION KINETICS, P20; Birnby DA, 2000, GENETICS, V155, P85; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Chen CF, 1996, MOL CELL BIOL, V16, P4691; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; EHRESMAN.B, 1973, ANAL BIOCHEM, V54, P454, DOI 10.1016/0003-2697(73)90374-6; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Morita T, 2004, J CELL SCI, V117, P5759, DOI 10.1242/jcs.01499; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; RICHTER K, 2005, PROTEIN FOLDING HDB, P768; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Scheibel T, 1999, MOL MICROBIOL, V34, P701, DOI 10.1046/j.1365-2958.1999.01632.x; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; SCHLEE S, 2004, PROTEIN FOLDING HDB, P105; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Simmons AD, 1999, HUM MOL GENET, V8, P2155, DOI 10.1093/hmg/8.12.2155; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WU XM, 1992, BIOCHEMISTRY-US, V31, P2123, DOI 10.1021/bi00122a033; Yamaguchi H, 2005, EXP CELL RES, V303, P415, DOI 10.1016/j.yexcr.2004.10.005; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yue L, 1999, GENETICS, V151, P1065	55	81	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11677	11688		10.1074/jbc.M709516200	http://dx.doi.org/10.1074/jbc.M709516200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18287101	hybrid, Green Published			2022-12-27	WOS:000255067400068
J	Runge, S; Thogersen, H; Madsen, K; Lau, J; Rudolph, R				Runge, Steffen; Thogersen, Henning; Madsen, Kjeld; Lau, Jesper; Rudolph, Rainer			Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; N-TERMINAL DOMAIN; GLP-1 RECEPTOR; SPATIAL APPROXIMATION; AMINO-TERMINUS; MID-REGION; AGONIST; BINDING; SECRETIN; EXENDIN-4	The glucagon-like peptide-1 receptor (GLP-1R) belongs to Family B1 of the seven-transmembrane G protein-coupled receptors, and its natural agonist ligand is the peptide hormone glucagon-like peptide-1 (GLP-1). GLP-1 is involved in glucose homeostasis, and activation of GLP-1R in the plasma membrane of pancreatic beta-cells potentiates glucose-dependent insulin secretion. The N-terminal extracellular domain (nGLP-1R) is an important ligand binding domain that binds GLP-1 and the homologous peptide Exendin-4 with differential affinity. Exendin-4 has a C-terminal extension of nine amino acid residues known as the "Trp cage", which is absent in GLP-1. The Trp cage was believed to interact with nGLP-1R and thereby explain the superior affinity of Exendin-4. However, the molecular details that govern ligand binding and specificity of nGLP-1R remain undefined. Here we report the crystal structure of human nGLP-1R in complex with the antagonist Exendin-4(9 39) solved by the multiwavelength anomalous dispersion method to 2.2 A resolution. The structure reveals that Exendin-4(9-39) is an amphipathic alpha-helix forming both hydrophobic and hydrophilic interactions with nGLP-1R. The Trp cage of Exendin-4 is not involved in binding to nGLP-1R. The hydrophobic binding site of nGLP-1R is defined by discontinuous segments including primarily a well defined alpha-helix in the N terminus of nGLP-1R and a loop between two antiparallel beta-strands. The structure provides for the first time detailed molecular insight into ligand binding of the human GLP-1 receptor, an established target for treatment of type 2 diabetes.	[Runge, Steffen; Thogersen, Henning] Novo Nordisk, Dept Struct & Biophys Chem, DK-2760 Malov, Denmark; [Madsen, Kjeld; Lau, Jesper] Novo Nordisk, Dept Prot & Peptide Chem, DK-2760 Malov, Denmark; [Rudolph, Rainer] Univ Halle Wittenberg, Inst Biotechnol, D-06120 Halle, Germany	Novo Nordisk; Novo Nordisk; Martin Luther University Halle Wittenberg	Runge, S (corresponding author), Nov Nordisk Pk G8S439, DK-2760 Malov, Denmark.	sffr@novonordisk.com	Lau, Jesper/G-3834-2011					ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Andersen NH, 2002, BIOORGAN MED CHEM, V10, P79, DOI 10.1016/S0968-0896(01)00263-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; CARRUTHERS CJL, 1994, J BIOL CHEM, V269, P29321; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; Dong MQ, 2006, MOL PHARMACOL, V70, P206, DOI 10.1124/mol.105.021840; Dong MQ, 2005, MOL ENDOCRINOL, V19, P1821, DOI 10.1210/me.2004-0421; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 2003, J BIOL CHEM, V278, P48300, DOI 10.1074/jbc.M309166200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lisenbee CS, 2005, J BIOL CHEM, V280, P12330, DOI 10.1074/jbc.M414016200; MATURANA RL, 2004, PROTEIN PEPTIDE LETT, V11, P15; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; PARTHIER C, 2007, P NATL ACAD SCI USA; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2003, J BIOL CHEM, V278, P28005, DOI 10.1074/jbc.M301085200; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Tibaduiza EC, 2001, J BIOL CHEM, V276, P37787; VAN EB, 1996, PEPTIDES, V17, P565; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wilmen A, 1997, PEPTIDES, V18, P301, DOI 10.1016/S0196-9781(96)00321-X; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a	40	244	271	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11340	11347		10.1074/jbc.M708740200	http://dx.doi.org/10.1074/jbc.M708740200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18287102	hybrid			2022-12-27	WOS:000255067400030
J	Soeda, A; Inagaki, A; Oka, N; Ikegame, Y; Aoki, H; Yoshimura, SI; Nakashima, S; Kunisada, T; Iwama, T				Soeda, Akio; Inagaki, Akihito; Oka, Naoki; Ikegame, Yuka; Aoki, Hitomi; Yoshimura, Shin-ichi; Nakashima, Shigeru; Kunisada, Takahiro; Iwama, Toru			Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-RECEPTOR; NEURAL PROGENITORS; IN-VITRO; CANCER; KINASE; EGF; INHIBITION; APOPTOSIS; AKT; IDENTIFICATION	A cancer stem cell population in malignant brain tumors takes an essential part in brain tumor initiation, growth, and recurrence. Growth factors, such as epidermal growth factor, fibroblast growth factor-2, vascular endothelial growth factor, platelet-derived growth factor, and hepatocyte growth factor, are shown to support the proliferation of neural stem cells and also may play key roles in gliomagenesis. However, the responsible growth factor(s), which controls maintenance of brain tumor stem cells, is not yet uncovered. We have established three cancer stem cell lines from human gliomas. These cells were immunoreactive with the neuronal progenitor markers, nestin and CD133, and established tumors that closely resembled the features of original tumor upon transplantation into mouse brain. Three cell lines retained their self-renewal ability and proliferation only in the presence of epidermal growth factor (>2.5 ng/ml). In sharp contrast, other growth factors, including fibroblast growth factor-2, failed to support maintenance of these cells. The tyrosine kinase inhibitors of epidermal growth factor signaling (AG1478 and gefitinib) suppressed the proliferation and self-renewal of these cells. Gefitinib inhibited phosphorylation of epidermal growth factor receptor as well as Akt kinase and extracellular signal-regulated kinase 1/2. Flow cytometric analysis revealed that epidermal growth factor concentration-dependently increased the population of CD133-positive cells. Gefitinib significantly reduced CD133-positive fractions and also induced their apoptosis. These results indicate that maintenance of human brain tumor stem cells absolutely requires epidermal growth factor and that tyrosine kinase inhibitors of epidermal growth factor signaling potentially inhibit proliferation and induce apoptosis of these cells.	[Soeda, Akio; Oka, Naoki; Ikegame, Yuka; Yoshimura, Shin-ichi; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu 5011194, Japan; [Inagaki, Akihito; Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev Regenerat & Adv Med Sch, Gifu 5011194, Japan; [Nakashima, Shigeru] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu 5011194, Japan	Gifu University; Gifu University; Gifu University	Soeda, A (corresponding author), Univ Pittsburgh, Pittsburgh Canc Inst, Dept Med, Div Hematol Oncol, Res Pavil Hillman Canc Ctr,Suite G1,5150 Ave, Pittsburgh, PA 15232 USA.	akio.soeda@gmail.com	Ikegame, Yuka/AAU-8880-2020	Iwama, Toru/0000-0002-9426-284X; Ikegame, Yuka/0000-0002-8932-9798				Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Andrae J, 2001, MOL CELL NEUROSCI, V17, P1001, DOI 10.1006/mcne.2001.0989; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dowlati A, 2004, MOL CANCER THER, V3, P459; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gibson S, 1999, J BIOL CHEM, V274, P17612, DOI 10.1074/jbc.274.25.17612; Gritti A, 1999, J NEUROSCI, V19, P3287; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; HOPEWELL JW, 1975, J PATHOL, V117, P101, DOI 10.1002/path.1711170208; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Inagaki A, 2007, BIOCHEM BIOPH RES CO, V361, P586, DOI 10.1016/j.bbrc.2007.07.037; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kari C, 2003, CANCER RES, V63, P1; Kokuzawa J, 2003, MOL CELL NEUROSCI, V24, P190, DOI 10.1016/S1044-7431(03)00160-X; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Nunes M, 2004, MOL CANCER THER, V3, P21; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oka N, 2007, BIOCHEM BIOPH RES CO, V360, P553, DOI 10.1016/j.bbrc.2007.06.094; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ono M, 2004, MOL CANCER THER, V3, P465; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SCHLEGEL J, 1994, INT J CANCER, V56, P72; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; vanderValk P, 1997, ANN ONCOL, V8, P1023, DOI 10.1023/A:1008265905505; Wakeling AE, 2002, CANCER RES, V62, P5749; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Yoshimura S, 1997, MOL BRAIN RES, V45, P90, DOI 10.1016/S0169-328X(96)00239-2; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhou YH, 2003, CLIN CANCER RES, V9, P3369	51	138	144	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10958	10966		10.1074/jbc.M704205200	http://dx.doi.org/10.1074/jbc.M704205200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18292095	hybrid			2022-12-27	WOS:000254894700077
J	Buggia-Prevot, V; Sevalle, J; Rossner, S; Checler, F				Buggia-Prevot, Virginie; Sevalle, Jean; Rossner, Steffen; Checler, Frederic			NF kappa B-dependent control of BACE1 promoter transactivation by A beta 42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; DEGRADING ENZYME NEPRILYSIN; ALZHEIMERS BETA-SECRETASE; APP INTRACELLULAR DOMAIN; GAMMA-SECRETASE; TRANSCRIPTIONAL CONTROL; NUCLEAR TRANSLOCATION; ASPARTYL PROTEASE; ALPHA-SECRETASE; CELL-SURVIVAL	beta-Amyloid (A beta) peptides that accumulate in Alzheimer disease are generated from the beta-amyloid precursor protein (beta APP) by cleavages by beta-secretase BACE1 and by presenilin-dependent beta-secretase activities. Very few data document a putative cross-talk between these proteases and the regulatory mechanisms underlying such interaction. We show that presenilin deficiency lowers BACE1 maturation and affects both BACE1 activity and promoter transactivation. The specific beta-secretase inhibitor DFK167 triggers the decrease of BACE1 activity in wild-type but not in presenilin-deficient fibroblasts. This decrease is also elicited by catalytically inactive beta-secretase. The overexpression of APP intracellular domain (AICD), the gamma/epsilon-secretase-derived C-terminal product of beta-amyloid precursor protein, does not modulate BACE1 activity or promoter transactivation in fibroblasts and does not alter BACE1 expression in AICD transgenic brains of mice. A DFK167-sensitive increase of BACE1 activity is observed in cells overexpressing APP epsilon (the N-terminal product of beta APP generated by epsilon-secretase cleavage harboring the A domain but lacking the AICD sequence), suggesting that the production of A beta could account for the modulation of BACE1. Accordingly, we show that HEK293 cells overexpressing wild-type beta APP exhibit a DFK167-sensitive increase in BACE1 promoter transactivation that is increased by the A beta-potentiating Swedish mutation. This effect was mimicked by exogenous application of A beta 42 but not A beta 40 or by transient transfection of cDNA encoding A beta 42 sequence. The I kappa B kinase inhibitor BMS345541 prevents A beta-induced BACE1 promoter transactivation suggesting that NF kappa B could mediate this A beta-associated phenotype. Accordingly, the overexpression of wild-type or Swedish mutated beta APP does not modify the transactivation of BACE1 promoter constructs lacking NF kappa B-responsive element. Furthermore, APP/beta-amyloid precursor protein-like protein deficiency does not affect BACE1 activity and expression. Overall, these data suggest that physiological levels of endogenous A beta are not sufficient per se to modulate BACE1 promoter transactivation but that exacerbated A beta production linked to wild-type or Swedish mutated beta APP overexpression modulates BACE1 promoter transactivation and activity via an NF kappa B-dependent pathway.	[Buggia-Prevot, Virginie; Sevalle, Jean; Checler, Frederic] CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee Fondat Rech Med, UMR6097 UNSA, F-06560 Valbonne, France; [Rossner, Steffen] Univ Leipzig, Dept Neurochem, D-04109 Leipzig, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Leipzig University	Checler, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee Fondat Rech Med, UMR6097 UNSA, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Rossner, Steffen/A-5184-2017; Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750				ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Andrau D, 2003, J BIOL CHEM, V278, P25859, DOI 10.1074/jbc.M302622200; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Armogida M, 2001, NAT CELL BIOL, V3, P1030, DOI 10.1038/ncb1101-1030; Arvanitis DN, 2007, J NEUROCHEM, V103, P216, DOI 10.1111/j.1471-4159.2007.04704.x; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Checler F, 1999, IUBMB LIFE, V48, P33, DOI 10.1080/152165499307396; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chevallier N, 1997, BRIT J PHARMACOL, V121, P556, DOI 10.1038/sj.bjp.0701151; Cisse MA, 2006, BIOCHEM BIOPH RES CO, V347, P254, DOI 10.1016/j.bbrc.2006.06.065; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; Ge YW, 2004, FASEB J, V18, P1037, DOI 10.1096/fj.03-1379fje; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heber S, 2000, J NEUROSCI, V20, P7951; Hebert SS, 2003, NEUROBIOL DIS, V13, P238, DOI 10.1016/S0969-9961(03)00035-4; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hersh LB, 2003, CURR PHARM DESIGN, V9, P449, DOI 10.2174/1381612033391676; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kume H, 2004, INT J MOL MED, V13, P121; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Lai MT, 2006, J NEUROCHEM, V96, P118, DOI 10.1111/j.1471-4159.2005.03528.x; Lange-Dohna C, 2003, J NEUROSCI RES, V73, P73, DOI 10.1002/jnr.10639; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Lefranc-Jullien S, 2005, BRIT J PHARMACOL, V145, P228, DOI 10.1038/sj.bjp.0706183; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MALONEY B, 2006, SOC NEUR ANN M ATL G; McCarthy JV, 2005, BIOCHEM SOC T, V33, P568, DOI 10.1042/BST0330568; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2007, NEURON, V53, P483, DOI 10.1016/j.neuron.2007.01.024; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Popescu BO, 2004, J ALZHEIMERS DIS, V6, P123; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Thinakaran G, 2004, PHARMACOL RES, V50, P411, DOI 10.1016/j.phrs.2003.12.026; Uemura K, 2003, J NEUROSCI RES, V74, P184, DOI 10.1002/jnr.10753; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wilson CA, 2003, J NEUROSCI RES, V74, P361, DOI 10.1002/jnr.10776; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	79	113	118	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10037	10047		10.1074/jbc.M706579200	http://dx.doi.org/10.1074/jbc.M706579200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18263584	hybrid			2022-12-27	WOS:000254671600058
J	Neptune, ER; Podowski, M; Calvi, C; Cho, JH; Garcia, JGN; Tuder, R; Linnoila, RI; Tsai, MJ; Dietz, HC				Neptune, Enid R.; Podowski, Megan; Calvi, Carla; Cho, Jang-Hyeon; Garcia, Joe G. N.; Tuder, Rubin; Linnoila, R. Ilona; Tsai, Ming-Jer; Dietz, Harry C.			Targeted disruption of NeuroD, a proneural basic helix-loop-helix factor, impairs distal lung formation and neuroendocrine morphology in the neonatal lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROEPITHELIAL BODIES; AIRWAY EPITHELIUM; MOUSE MODEL; DIFFERENTIATION; CELLS; PROLIFERATION; PATHOGENESIS; GROWTH; MICE; LOCALIZATION	Despite the importance of airspace integrity in vertebrate gas exchange, the molecular pathways that instruct distal lung formation are poorly understood. Recently, we found that fibrillin-1 deficiency in mice impairs alveolar formation and recapitulates the pulmonary features of human Marfan syndrome. To further elucidate effectors involved in distal lung formation, we performed expression profiling analysis comparing the fibrillin1-deficient and wild-type developing lung. NeuroD, a basic helix-loop-helix transcription factor, fulfilled the expression criteria for a candidate mediator of distal lung development. We investigated its role in murine lung development using genetically targeted NeuroD-deficient mice. We found that NeuroD deficiency results in both impaired alveolar septation and altered morphology of the pulmonary neuroendocrine cells. NeuroD-deficient mice had enlarged alveoli associated with reduced epithelial proliferation in the airway and airspace compartments during development. Additionally, the neuroendocrine compartment in these mice manifested an increased number of neuroepithelial bodies but a reduced number of solitary pulmonary neuroendocrine cells in the neonatal lung. Overexpression of NeuroD in a murine lung epithelial cell line conferred a neuroendocrine phenotype characterized by the induction of neuroendocrine markers as well as increased proliferation. These results support an unanticipated role for NeuroD in the regulation of pulmonary neuroendocrine and alveolar morphogenesis and suggest an intimate connection between the neuroendocrine compartment and distal lung development.	[Neptune, Enid R.; Podowski, Megan; Calvi, Carla; Garcia, Joe G. N.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Neptune, Enid R.; Dietz, Harry C.] Johns Hopkins Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Tuder, Rubin] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Linnoila, R. Ilona] NCI, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA; [Cho, Jang-Hyeon; Tsai, Ming-Jer] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine	Neptune, ER (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Rm 547, Baltimore, MD 21205 USA.	eneptune@jhmi.edu; hdietz@jhmi.edu	Garcia, Joe GN/E-8862-2010		Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL 69340, K08 HL 067980, R01 HL 66554, U01 HL 66583] Funding Source: Medline; NIAMS NIH HHS [AR 41135] Funding Source: Medline; NICHD NIH HHS [HD 17379] Funding Source: Medline; NIDDK NIH HHS [DK 45641] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017379, R37HD017379] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC000167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066554, K08HL067980, R01HL069340, U01HL066583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045641, R37DK045641] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ball DW, 2004, CANCER LETT, V204, P159, DOI 10.1016/S0304-3835(03)00452-X; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Castro CM, 2000, LAB INVEST, V80, P1533, DOI 10.1038/labinvest.3780163; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Chu K, 2001, RECENT PROG HORM RES, V56, P23, DOI 10.1210/rp.56.1.23; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; CUTZ E, 1982, EXP LUNG RES, V3, P185, DOI 10.3109/01902148209069653; Dakhama A, 2004, CURR OPIN PHARMACOL, V4, P215, DOI 10.1016/j.coph.2004.01.006; DIFIGLIA M, 1989, J NEUROSCI, V9, P4158; EBINA M, 1993, ANAT REC, V236, P226, DOI 10.1002/ar.1092360127; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hiroshima K, 2006, MODERN PATHOL, V19, P1358, DOI 10.1038/modpathol.3800659; HOYT RF, 1991, AM J PHYSIOL, V260, pL234, DOI 10.1152/ajplung.1991.260.4.L234; HOYT RF, 1993, ANAT REC, V236, P15, DOI 10.1002/ar.1092360106; Itkin-Ansari P, 2005, DEV DYNAM, V233, P946, DOI 10.1002/dvdy.20443; Ito T, 2000, DEVELOPMENT, V127, P3913; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kazanjian A, 2004, CANCER RES, V64, P6874, DOI 10.1158/0008-5472.CAN-04-0633; Kim WY, 2001, DEVELOPMENT, V128, P417; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Linnoila RI, 2007, LAB INVEST, V87, P336, DOI 10.1038/labinvest.3700527; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; MCDOWELL EM, 1994, CELL TISSUE RES, V275, P157, DOI 10.1007/BF00305383; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Morrow EM, 1999, DEVELOPMENT, V126, P23; Mutoh H, 1997, P NATL ACAD SCI USA, V94, P3560, DOI 10.1073/pnas.94.8.3560; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pan J, 2006, AM J RESP CELL MOL, V35, P320, DOI 10.1165/rcmb.2005-0468OC; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Sunday ME, 1998, J CLIN INVEST, V102, P584, DOI 10.1172/JCI2329; SUNDAY ME, 1990, AM J RESP CELL MOL, V3, P199, DOI 10.1165/ajrcmb/3.3.199; Sunday ME, 2000, CONT ENDOCRINOL, P299; Van Lommel A, 2001, Paediatr Respir Rev, V2, P171, DOI 10.1053/prrv.2000.0126; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; WHITE SR, 1993, AM J RESP CELL MOL, V8, P592, DOI 10.1165/ajrcmb/8.6.592; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; YEI SP, 1994, AM J RESP CELL MOL, V11, P329, DOI 10.1165/ajrcmb.11.3.8086169	45	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21160	21169		10.1074/jbc.M708692200	http://dx.doi.org/10.1074/jbc.M708692200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18339630	hybrid, Green Published			2022-12-27	WOS:000257746100058
J	Cadieux, C; Harada, R; Paquet, M; Cote, O; Trudel, M; Nepveu, A; Bouchard, M				Cadieux, Chantal; Harada, Ryoko; Paquet, Marilene; Cote, Olivier; Trudel, Marie; Nepveu, Alain; Bouchard, Maxime			Polycystic kidneys caused by sustained expression of Cux1 isoform p75	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HINF-D; CCAAT DISPLACEMENT PROTEIN; CELL TYPE SPECIFICATION; CDP/CUX TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE-TRANSCRIPTION; HISTONE GENE; S-PHASE; CUT HOMEODOMAIN; DNA-BINDING	The transcriptional regulator Cux1 (CDP, Cutl1) is aberrantly expressed in mouse models for polycystic kidney disease. Here we show that p75-Cux1, the shortest isoform of Cux1, transcribed from an alternative promoter within intron 20, is also deregulated in polycystic kidneys derived from Pkd1 mutant embryos. To determine the role of the p75-Cux1 isoform in cystogenesis, we generated transgenic mice expressing p75-CUX1 in the kidneys and other tissues. Strikingly, these animals developed polycystic kidneys at variable penetrance and severity, correlating with transgene expression levels. Histological and marker analysis of p75-CUX1-derived polycystic kidneys revealed renal cysts derived from the tubular nephron, supporting a model of autosomal dominant polycystic kidney disease. Transgenic p75-CUX1 kidneys additionally showed an up-regulation of the protooncogene c-myc and a down-regulation of the cyclin-dependent kinase inhibitor p27. Chromatin affinity purification experiments confirmed the direct interaction of Cux1 with the c-myc and p27 promoters. These molecular alterations were accompanied by an increase in cilia length and in the proliferative index of epithelial cells lining the cysts. Together, these results identify an important role for the short isoform of CUX1 in polycystic kidney disease development.	[Cadieux, Chantal; Nepveu, Alain; Bouchard, Maxime] McGill Univ, McGill Univ Hlth Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Cadieux, Chantal; Harada, Ryoko; Paquet, Marilene; Nepveu, Alain; Bouchard, Maxime] McGill Univ, McGill Univ Hlth Ctr, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; [Cadieux, Chantal; Harada, Ryoko; Nepveu, Alain] McGill Univ, McGill Univ Hlth Ctr, Mol Oncol Grp, Montreal, PQ H3G 1Y6, Canada; [Cote, Olivier; Trudel, Marie] Univ Montreal, Fac Med, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	McGill University; McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Bouchard, M (corresponding author), McGill Univ, McGill Univ Hlth Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	maxime.bouchard@mcgill.ca	/AAB-8315-2020; Paquet, Marilene/L-3414-2019	Paquet, Marilene/0000-0002-3562-4636; Bouchard, Maxime/0000-0002-7619-9680; Trudel, Marie/0000-0003-0057-2669				BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Brantley JG, 2003, KIDNEY INT, V63, P1240, DOI 10.1046/j.1523-1755.2003.00889.x; Cadieux C, 2006, CANCER RES, V66, P9492, DOI 10.1158/0008-5472.CAN-05-4230; Cai HN, 1997, EMBO J, V16, P1732, DOI 10.1093/emboj/16.7.1732; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; DUFORT D, 1994, MOL CELL BIOL, V14, P4251, DOI 10.1128/MCB.14.6.4251; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2002, CANCER RES, V62, P6625; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gupta S, 2003, J CELL PHYSIOL, V196, P541, DOI 10.1002/jcp.10335; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Heuvel GBV, 1996, KIDNEY INT, V50, P453, DOI 10.1038/ki.1996.336; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; JACK J, 1991, DEVELOPMENT, V113, P735; JACK J, 1995, GENETICS, V139, P1689; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lanoix J, 1996, ONCOGENE, V13, P1153; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Ledford AW, 2002, DEV BIOL, V245, P157, DOI 10.1006/dbio.2002.0636; Li KJ, 2005, KIDNEY INT, V67, P1710, DOI 10.1111/j.1523-1755.2005.00268.x; LIEVENS PMJ, 1995, J BIOL CHEM, V270, P12745, DOI 10.1074/jbc.270.21.12745; LIU S, 1992, DEV BIOL, V150, P133, DOI 10.1016/0012-1606(92)90013-7; LIU S, 1991, GENETICS, V127, P151; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; MODOLELL J, 1983, P NATL ACAD SCI-BIOL, V80, P1678, DOI 10.1073/pnas.80.6.1678; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Nirodi C, 2001, J BIOL CHEM, V276, P26122, DOI 10.1074/jbc.M102872200; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Sharma M, 2005, KIDNEY INT, V67, P432, DOI 10.1111/j.1523-1755.2005.67099.x; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; STOCKLIN E, 1993, J CELL BIOL, V122, P199, DOI 10.1083/jcb.122.1.199; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tufarelli C, 1998, DEV BIOL, V200, P69, DOI 10.1006/dbio.1998.8950; VANWIJNEN AJ, 1989, J BIOL CHEM, V264, P15034; vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516; VANWIJNEN AJ, 1991, P NATL ACAD SCI USA, V88, P2573, DOI 10.1073/pnas.88.6.2573; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WRIGHT KL, 1992, BIOCHEMISTRY-US, V31, P2812, DOI 10.1021/bi00125a023; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhu Q, 2004, MOL CELL BIOL, V24, P4810, DOI 10.1128/MCB.24.11.4810-4823.2004	63	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13817	13824		10.1074/jbc.M709332200	http://dx.doi.org/10.1074/jbc.M709332200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18356167	hybrid			2022-12-27	WOS:000255728200034
J	Canaff, L; Zhou, X; Hendy, GN				Canaff, Lucie; Zhou, Xiang; Hendy, Geoffrey N.			The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; AUTOSOMAL-DOMINANT HYPOCALCEMIA; NEONATAL SEVERE HYPERPARATHYROIDISM; PARATHYROID-HORMONE SECRETION; CRITICALLY-ILL; BURN INJURY; CASR; EXPRESSION; MUTATIONS; PROMOTER	Increased expression of the calcium-sensing receptor ( CASR), which controls blood calcium homeostasis, leads to a decrease in the extracellular calcium set-point, thereby reducing parathyroid hormone secretion and renal calcium reabsorption and increasing calcitonin secretion resulting in reduced circulating calcium levels. Critically ill patients with elevated proinflammatory cytokine levels commonly have hypocalcemia, although the mechanism is not known. After intraperitoneal injection of interleukin (IL)-6 in the rat, circulating levels of parathyroid hormone, 1,25-dihydroxyvitamin D, and calcium fell within hours and remained low at 24 h. Expression of CASR ( mRNA and protein) increased within hours in parathyroid, thyroid, and kidney and remained elevated at 24 h. The CASR gene has two promoters (P1 and P2) yielding transcripts having alternative 5'-untranslated regions but encoding the same receptor protein. Activities of P1 and P2 promoter/luciferase reporter constructs were stimulated similar to 2-3-fold by IL-6 in proximal tubule HKC cells and TT thyroid C-cells. Studies with P1 deleted and mutated promoter-reporter and Stat1 and/or Stat3 dominant-negative constructs showed that a Stat1/3 element downstream of the P1 start site accounted for the IL-6 induction. There are no Stat elements in the P2 promoter, but Sp1/3 elements are clustered at the transcription start site. A series of transfection P2 promoter-reporter analyses showed that Sp1 together with Stat1/3 was critical for IL-6 responsiveness of P2. By oligonucleotide precipitation assay, IL-6 rapidly promoted a complex containing both Sp1/3 and Stat1/3 on the Sp1/3 elements. In conclusion, Stat1/3 directly controls promoter P1, and the Stats indirectly regulate promoter P2 via Sp1/3 in response to IL-6. By this mechanism, the cytokine likely contributes to altered extracellular calcium homeostasis.	[Hendy, Geoffrey N.] Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University	Hendy, GN (corresponding author), Royal Victoria Hosp, Calcium Res Lab, Rm H4-67,687 Pine Ave, Montreal, PQ H3A 1A1, Canada.	geoffrey.hendy@mcgill.ca						Caldwell F. T. Jr., 1997, Journal of Burn Care and Rehabilitation, V18, P525, DOI 10.1097/00004630-199711000-00010; Canaff L, 2005, J BIOL CHEM, V280, P14177, DOI 10.1074/jbc.M408587200; Canaff L, 2002, J BIOL CHEM, V277, P30337, DOI 10.1074/jbc.M201804200; Canaff L, 2001, J BIOL CHEM, V276, P4070, DOI 10.1074/jbc.M009317200; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Carlstedt E, 1999, BIOSCIENCE REP, V19, P35, DOI 10.1023/A:1020146023812; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chikatsu N, 2000, J BIOL CHEM, V275, P7553, DOI 10.1074/jbc.275.11.7553; D'Souza-Li L, 2002, J CLIN ENDOCR METAB, V87, P1309, DOI 10.1210/jc.87.3.1309; D'Souza-Li L, 2001, HUM MUTAT, V18, P411, DOI 10.1002/humu.1212; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; GUO Y, 1990, CLIN IMMUNOL IMMUNOP, V54, P361, DOI 10.1016/0090-1229(90)90050-Z; Haan S, 2005, CELL SIGNAL, V17, P1542, DOI 10.1016/j.cellsig.2005.03.010; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; KLEIN GL, 1995, BONE, V17, P455, DOI 10.1016/8756-3282(95)00279-1; KOWALVERN A, 1994, J AM COLL SURGEONS, V178, P357; Lepage R, 1999, J CLIN ENDOCR METAB, V84, P2654, DOI 10.1210/jc.84.8.2654; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Lind L, 2000, CRIT CARE MED, V28, P93, DOI 10.1097/00003246-200001000-00015; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; MOULAND AJ, 1991, ENDOCRINOLOGY, V128, P441, DOI 10.1210/endo-128-1-441; Muller B, 2000, EUR J CLIN INVEST, V30, P823; Murphey ED, 2000, CRIT CARE MED, V28, P3885, DOI 10.1097/00003246-200012000-00024; NIJSTEN MWN, 1991, SURGERY, V109, P761; OHZATO H, 1993, BIOCHEM BIOPH RES CO, V197, P1556, DOI 10.1006/bbrc.1993.2655; Pidasheva S, 2006, HUM MOL GENET, V15, P2200, DOI 10.1093/hmg/ddl145; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; SCHLUTER B, 1991, J TRAUMA, V31, P1663, DOI 10.1097/00005373-199112000-00017; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Yamada Y, 1996, BURNS, V22, P587, DOI 10.1016/S0305-4179(96)00052-6; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	39	91	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13586	13600		10.1074/jbc.M708087200	http://dx.doi.org/10.1074/jbc.M708087200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348986	hybrid			2022-12-27	WOS:000255728200012
J	Izumi, N; Fumoto, K; Izumi, S; Kikuchi, A				Izumi, Nanae; Fumoto, Katsumi; Izumi, Shunsuke; Kikuchi, Akira			GSK-3 beta regulates proper mitotic spindle formation in cooperation with a component of the gamma-tubulin ring complex, GCP5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ADENOMATOUS POLYPOSIS-COLI; MICROTUBULE NUCLEATION; BICAUDAL-D; BETA-CATENIN; CENTROSOME; PROTEIN; DYNEIN; RECRUITMENT; PHOSPHORYLATION	Glycogen synthase kinase-3 beta (GSK-3 beta) is known to play a role in the regulation of the dynamics of microtubule networks in cells. Here we show the role of GSK-3 beta in the proper formation of the mitotic spindles through an interaction with GCP5, a component of the gamma-tubulin ring complex (gamma TuRC). GCP5 bound directly to GSK-3 beta in vitro, and their interaction was also observed in intact cells at endogenous levels. Depletion of GCP5 dramatically reduced the GCP2 and gamma-tubulin in the gamma TuRC fraction of sucrose density gradients and disrupted gamma-tubulin localization to the spindle poles in mitotic cells. GCP5 appears to be required for the formation or stability of gamma TuRC and the recruitment of gamma-tubulin to the spindle poles. AGSK-3 inhibitor not only led to the accumulation of gamma-tubulin and GCP5 at the spindle poles but also enhanced microtubule nucleation activity at the spindle poles. Depletion of GCP5 rescued this disrupted organization of spindle poles observed in cells treated with the GSK-3 inhibitor. Furthermore, the inhibition of GSK-3 enhanced the binding of gamma TuRC to the centrosome isolated from mitotic cells in vitro. Our findings suggest that GSK-3 beta regulates the localization of gamma TuRC, including GCP5, to the spindle poles, thereby controlling the formation of proper mitotic spindles.	[Izumi, Nanae; Fumoto, Katsumi; Kikuchi, Akira] Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; [Izumi, Shunsuke] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University; Hiroshima University	Kikuchi, A (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	akikuchi@hiroshima-u.ac.jp						Andoh T, 2000, MOL CELL BIOL, V20, P6712, DOI 10.1128/MCB.20.18.6712-6720.2000; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hirata Y, 2003, MOL BIOL CELL, V14, P302, DOI 10.1091/mbc.E02-05-0247; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vogt N, 2006, DEVELOPMENT, V133, P3963, DOI 10.1242/dev.02570; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wiese C, 1999, CURR OPIN STRUC BIOL, V9, P250, DOI 10.1016/S0959-440X(99)80035-9; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Zhang LJ, 2000, J CELL BIOL, V151, P1525, DOI 10.1083/jcb.151.7.1525; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	37	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12981	12991		10.1074/jbc.M710282200	http://dx.doi.org/10.1074/jbc.M710282200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316369	hybrid			2022-12-27	WOS:000255499800035
J	Loch, S; Klauschies, F; Scholz, C; Verweij, MC; Wiertz, EJHJ; Koch, J; Tampe, R				Loch, Sandra; Klauschies, Florian; Schoelz, Christian; Verweij, Marieke C.; Wiertz, Emmanuel J. H. J.; Koch, Joachim; Tampe, Robert			Signaling of a varicelloviral factor across the endoplasmic reticulum membrane induces destruction of the peptide-loading complex and immune evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANTIGEN-PROCESSING TAP; TRANSPORTER TAP; FLUORESCENCE COMPLEMENTATION; GLYCOPROTEIN-M; HOMOLOG GENE; INSECT CELLS; PROTEIN; VIRUS; BINDING	Cytotoxic T lymphocytes eliminate infected cells upon surface display of antigenic peptides on major histocompatibility complex I molecules. To promote immune evasion, UL49.5 of several varicelloviruses interferes with the pathway of major histocompatibility complex I antigen processing. However, the inhibition mechanism has not been elucidated yet. Within the macromolecular peptide-loading complex we identified the transporter associated with antigen processing (TAP1 and TAP2) as the prime target of UL49.5. Moreover, we determined the active oligomeric state and crucial elements of the viral factor. Remarkably, the last two residues of the cytosolic tail of UL49.5 are essential for endoplasmic reticulum (ER)associated proteasomal degradation of TAP. However, this process strictly requires additional signaling of an upstream regulatory element in the ER lumenal domain of UL49.5. Within this new immune evasion mechanism, we show for the first time that additive elements of a small viral factor and their signaling across the ER membrane are essential for targeted degradation of a multi-subunit membrane complex.	[Loch, Sandra; Klauschies, Florian; Schoelz, Christian; Koch, Joachim; Tampe, Robert] Univ Frankfurt, Dept Biochem, Bioctr, D-60438 Frankfurt, Germany; [Verweij, Marieke C.; Wiertz, Emmanuel J. H. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands	Goethe University Frankfurt; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Koch, J (corresponding author), Univ Frankfurt, Dept Biochem, Bioctr, D-60438 Frankfurt, Germany.	joachim.koch@em.uni-frankfurt.de; tampe@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015; Schölz, Christian/K-2855-2014; Schölz, Christian/F-1261-2010	Tampé, Robert/0000-0002-0403-2160; Schölz, Christian/0000-0002-1633-2072; 				Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; BARNETT BC, 1992, J GEN VIROL, V73, P2167, DOI 10.1099/0022-1317-73-8-2167; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Koch J, 2006, CELL MOL LIFE SCI, V63, P653, DOI 10.1007/s00018-005-5462-z; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2003, ARCH VIROL, V148, P2023, DOI 10.1007/s00705-003-0142-5; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Lauvau G, 1999, J BIOL CHEM, V274, P31349, DOI 10.1074/jbc.274.44.31349; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; LIANG XP, 1995, J VIROL, V69, P3863, DOI 10.1128/JVI.69.6.3863-3867.1995; Liang XP, 1996, J VIROL, V70, P1448, DOI 10.1128/JVI.70.3.1448-1454.1996; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lipinska AD, 2006, J VIROL, V80, P5822, DOI 10.1128/JVI.02707-05; Loch S, 2005, PFLUG ARCH EUR J PHY, V451, P409, DOI 10.1007/s00424-005-1420-8; Lybarger L, 2005, CURR OPIN IMMUNOL, V17, P71, DOI 10.1016/j.coi.2004.11.009; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Noriega VM, 2008, J BIOL CHEM, V283, P4031, DOI 10.1074/jbc.M706283200; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; Rufer E, 2007, J IMMUNOL, V179, P5717, DOI 10.4049/jimmunol.179.9.5717; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; Schreiner A, 2007, MOL BIOL CELL, V18, P1272, DOI 10.1091/mbc.E06-07-0637; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Wolters JC, 2005, J BIOL CHEM, V280, P23631, DOI 10.1074/jbc.M503231200; Wu SX, 1998, J VIROL, V72, P3029, DOI 10.1128/JVI.72.4.3029-3036.1998; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	40	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13428	13436		10.1074/jbc.M800226200	http://dx.doi.org/10.1074/jbc.M800226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321854	hybrid			2022-12-27	WOS:000255499800082
J	Sayer, JM; Liu, FL; Ishima, R; Weber, IT; Louis, JM				Sayer, Jane M.; Liu, Fengling; Ishima, Rieko; Weber, Irene T.; Louis, John M.			Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESOLUTION CRYSTAL-STRUCTURES; DRUG-RESISTANCE; RETROVIRAL PROTEASES; SUBSTRATE COMPLEX; VIRAL INFECTIVITY; DIMER STABILITY; INHIBITION; MUTANTS; MONOMER	All aspartic proteases, including retroviral proteases, share the triplet DTG critical for the active site geometry and catalytic function. These residues interact closely in the active, dimeric structure of HIV-1 protease (PR). We have systematically assessed the effect of the D25N mutation on the structure and stability of the mature PR monomer and dimer. The D25N mutation (PRD25N) increases the equilibrium dimer dissociation constant by a factor > 100-fold (1.3 +/- 0.09 mu M) relative to PR. In the absence of inhibitor, NMR studies reveal clear structural differences between PR and PRD25N in the relatively mobile P1 loop (residues 79-83) and flap regions, and differential scanning calorimetric analyses show that the mutation lowers the stabilities of both the monomer and dimer folds by 5 and 7.3 C, respectively. Only minimal differences are observed in high resolution crystal structures of PRD25N complexed to darunavir (DRV), a potent clinical inhibitor, or a non-hydrolyzable substrate analogue, Ac-Thr-Ile-Nle-r-Nle-Gln-Arg-NH2 (RPB), as compared with PR center dot DRV and PR center dot RPB complexes. Although complexation with RPB stabilizes both dimers, the effect on their T-m is smaller for PRD25N (6.2 degrees C) than for PR (8.7 degrees C). The Tm of PRD25N center dot DRV increases by only 3 C relative to free PRD25N, as compared with a 22 degrees C increase for PR center dot DRV, and the mutation increases the ligand dissociation constant of PRD25N . DRV by a factor of similar to 10(6) relative to PR center dot DRV. These results suggest that interactions mediated by the catalytic Asp residues make a major contribution to the tight binding of DRV to PR.	[Sayer, Jane M.; Louis, John M.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Liu, Fengling; Weber, Irene T.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Ishima, Rieko] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; Georgia State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Louis, JM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm B2-29, Bethesda, MD 20892 USA.	johnl@intra.niddk.nih.gov		Louis, John M/0000-0002-0052-1899	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062920] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 DK999999] Funding Source: Medline; NIGMS NIH HHS [R01 GM062920-10, R01 GM062920-09, GM62920, R01 GM062920] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABE LM, 1995, P NATL ACAD SCI USA, V92, P10069, DOI 10.1073/pnas.92.22.10069; Beissinger M, 1996, EUR J BIOCHEM, V237, P383, DOI 10.1111/j.1432-1033.1996.0383k.x; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Erickson JW, 1996, ANNU REV PHARMACOL, V36, P545, DOI 10.1146/annurev.pa.36.040196.002553; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; Ishima R, 2001, J BIOL CHEM, V276, P49110, DOI 10.1074/jbc.M108136200; Ishima R, 2001, J MOL BIOL, V305, P515, DOI 10.1006/jmbi.2000.4321; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAPLAN AH, 1994, J VIROL, V68, P6782, DOI 10.1128/JVI.68.10.6782-6786.1994; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Katoh E, 2003, PROTEIN SCI, V12, P1376, DOI 10.1110/ps.0300703; King NM, 2004, J VIROL, V78, P12012, DOI 10.1128/JVI.78.21.12012-12021.2004; Klei HE, 2007, J VIROL, V81, P9525, DOI 10.1128/JVI.02503-05; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Kovalevsky AY, 2006, J MOL BIOL, V363, P161, DOI 10.1016/j.jmb.2006.08.007; KRAUSSLICH HG, 1991, P NATL ACAD SCI USA, V88, P3213, DOI 10.1073/pnas.88.8.3213; Liu FL, 2006, J MOL BIOL, V358, P1191, DOI 10.1016/j.jmb.2006.02.076; Liu FL, 2005, J MOL BIOL, V354, P789, DOI 10.1016/j.jmb.2005.09.095; Louis J M, 2000, Adv Pharmacol, V49, P111; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Mahalingam B, 2004, EUR J BIOCHEM, V271, P1516, DOI 10.1111/j.1432-1033.2004.04060.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OROSZLAN S, 1990, CURR TOP MICROBIOL, V157, P153; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; Prabu-Jeyabalan M, 2000, J MOL BIOL, V301, P1207, DOI 10.1006/jmbi.2000.4018; RODRIGUEZ EJ, 1993, BIOCHEMISTRY-US, V32, P12380, DOI 10.1021/bi00097a015; Rodriguez-Barrios F, 2004, CURR TOP MED CHEM, V4, P991, DOI 10.2174/1568026043388529; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHRAKE A, 1992, BIOPOLYMERS, V32, P925, DOI 10.1002/bip.360320804; Sluis-Cremer N, 2002, EUR J BIOCHEM, V269, P5103, DOI 10.1046/j.1432-1033.2002.03216.x; Stoll V, 2002, BIOORGAN MED CHEM, V10, P2803, DOI 10.1016/S0968-0896(02)00051-2; Strisovsky K, 2000, PROTEIN SCI, V9, P1631, DOI 10.1110/ps.9.9.1631; Temesgen Z, 2006, EXPERT OPIN PHARMACO, V7, P1541, DOI 10.1517/14656566.7.12.1541; Tie YF, 2005, FEBS J, V272, P5265, DOI 10.1111/j.1742-4658.2005.04923.x; Tie YF, 2004, J MOL BIOL, V338, P341, DOI 10.1016/j.jmb.2004.02.052; WEBER IT, 1990, J BIOL CHEM, V265, P10492; WEBER IT, 2007, FRONTIERS DRUG DESIG, V3, P45; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Wondrak EM, 1996, BIOCHEMISTRY-US, V35, P12957, DOI 10.1021/bi960984y; Xie D, 1999, PROTEIN SCI, V8, P1702, DOI 10.1110/ps.8.8.1702	46	66	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13459	13470		10.1074/jbc.M708506200	http://dx.doi.org/10.1074/jbc.M708506200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18281688	Green Published, hybrid			2022-12-27	WOS:000255499800085
J	Belcheva, A; Golemi-Kotra, D				Belcheva, Antoaneta; Golemi-Kotra, Dasantila			A close-up view of the VraSR two-component system - A mediator of staphylococcus aureus response to cell wall damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; HISTIDINE KINASES; ENVELOPE STRESS; PROTEIN-KINASE; BINDING; PHOSPHORYLATION; RESISTANCE; REGULATOR	Staphylococcus aureus remains a clinical scourge. Recent studies have revealed that S. aureus is capable of mounting a response to antibiotics that target cell wall peptidoglycan biosynthesis, such as beta-lactams and vancomycin. A phosphotransfer-mediated signaling pathway composed of a histidine protein kinase, VraS, and a response regulator protein, VraR, has been linked to the coordination of this response. Herein, we report for the first time on the signal transduction mechanism of the VraSR system. We found that VraS is capable of undergoing autophosphorylation in vitro and its phosphoryl group is rapidly transferred to VraR. In addition, phosphorylated VraR undergoes rapid dephosphorylation by VraS. Evidence is presented that VraR has adopted a novel strategy in regulating the output response of the VraSR-mediated signaling pathway. The VraR effector domain inhibits formation of inactive VraR dimers and, in doing so, it holds the regulatory domain into an intermediate active state. Weshow that only phosphorylation induces formation of the biological active VraR-dimer species. Furthermore, we propose that damage inflicted to cell wall peptidoglycan could be the main source of the stimuli that VraR responds to due to the tight control that VraS has on the phosphorylation state of VraR. Our findings provide for the first time insights into the molecular basis for the proposed role of VraSR as a "sentinel" system capable of rapidly sensing cell wall peptidoglycan damage and coordinating a response that enhances the resistance phenotype in S. aureus.	[Belcheva, Antoaneta; Golemi-Kotra, Dasantila] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Golemi-Kotra, Dasantila] York Univ, Dept Chem, N York, ON M3J 1P3, Canada	York University - Canada; York University - Canada	Golemi-Kotra, D (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	dgkotra@yorku.ca	/N-6611-2013	/0000-0003-1299-6987; Belcheva, Antoaneta/0000-0001-5061-7533				AIBA H, 1989, J BIOCHEM-TOKYO, V106, P5, DOI 10.1093/oxfordjournals.jbchem.a122817; Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Bergstrom LC, 1998, GENES CELLS, V3, P777, DOI 10.1046/j.1365-2443.1998.00228.x; Birck C, 2002, J MOL BIOL, V321, P447, DOI 10.1016/S0022-2836(02)00651-4; Birkey SM, 1998, MOL MICROBIOL, V30, P943, DOI 10.1046/j.1365-2958.1998.01122.x; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; Darwin AJ, 1996, MOL MICROBIOL, V20, P621, DOI 10.1046/j.1365-2958.1996.5491074.x; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Eldridge AM, 2002, BIOCHEMISTRY-US, V41, P15173, DOI 10.1021/bi026254+; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; GALINIER A, 1994, J BIOL CHEM, V269, P23784; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Green David W, 2002, Expert Opin Ther Targets, V6, P1, DOI 10.1517/14728222.6.1.1; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Kato Y, 2008, INT J ANTIMICROB AG, V31, P64, DOI 10.1016/j.ijantimicag.2007.08.012; KENNEY LJ, 1995, P NATL ACAD SCI USA, V92, P8866, DOI 10.1073/pnas.92.19.8866; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2000, BIOCHEM BIOPH RES CO, V269, P485, DOI 10.1006/bbrc.2000.2277; LUKAT GS, 1993, J CELL BIOCHEM, V51, P41, DOI 10.1002/jcb.240510109; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; MCCLEARY WR, 1993, J BACTERIOL, V175, P2793, DOI 10.1128/JB.175.10.2793-2798.1993; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Okada A, 2007, METHOD ENZYMOL, V422, P386, DOI 10.1016/S0076-6879(06)22019-6; Qin L, 2001, P NATL ACAD SCI USA, V98, P908, DOI 10.1073/pnas.031383098; Raivio TL, 1997, J BACTERIOL, V179, P7724, DOI 10.1128/jb.179.24.7724-7733.1997; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; ROGGIANI M, 1993, J BACTERIOL, V175, P3182, DOI 10.1128/JB.175.10.3182-3187.1993; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Sobral RG, 2007, J BACTERIOL, V189, P2376, DOI 10.1128/JB.01439-06; Stephenson K., 2002, Current Drug Targets - Infectious Disorders, V2, P235, DOI 10.2174/1568005023342443; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Ulijasz AT, 2000, BIOCHEMISTRY-US, V39, P11417, DOI 10.1021/bi0012888; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WRIGHT GD, 1993, BIOCHEMISTRY-US, V32, P5057, DOI 10.1021/bi00070a013; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhang JH, 2003, BIOCHEMISTRY-US, V42, P2552, DOI 10.1021/bi0272205	45	86	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12354	12364		10.1074/jbc.M710010200	http://dx.doi.org/10.1074/jbc.M710010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326495	hybrid			2022-12-27	WOS:000255340000052
J	Carvalho, CML; Chew, EH; Hashemy, SI; Lu, J; Holmgren, A				Carvalho, Cristina M. L.; Chew, Eng-Hui; Hashemy, Seyed Isaac; Lu, Jun; Holmgren, Arne			Inhibition of the human thioredoxin system - A molecular mechanism of mercury toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL MERCURY; NUTRITIONAL FACTORS; HUMAN GLUTAREDOXIN; ESCHERICHIA-COLI; OXIDATIVE STRESS; METHYLMERCURY; REDUCTASE; RAT; GLUTATHIONE; SELENIUM	Mercury toxicity mediated by different forms of mercury is a major health problem; however, the molecular mechanisms underlying toxicity remain elusive. We analyzed the effects of mercuric chloride (HgCl2) and monomethylmercury (MeHg) on the proteins of the mammalian thioredoxin system, thioredoxin reductase (TrxR) and thioredoxin (Trx), and of the glutaredoxin system, glutathione reductase (GR) and glutaredoxin (Grx). HgCl2 and MeHg inhibited recombinant rat TrxR with IC50 values of 7.2 and 19.7 nM, respectively. Fully reduced human Trx1 bound mercury and lost all five free thiols and activity after incubation with HgCl2 or MeHg, but only HgCl2 generated dimers. Mass spectra analysis demonstrated binding of 2.5 mol of Hg2+ and 5 mol of MeHg+/mol of Trx1 with the very strong Hg2+ complexes involving active site and structural disulfides. Inhibition of both TrxR and Trx activity was observed in HeLa and HEK 293 cells treated with HgCl2 or MeHg. GR was inhibited by HgCl2 and MeHg in vitro, but no decrease in GR activity was detected in cell extracts treated with mercurials. Human Grx1 showed similar reactivity as Trx1 with both mercurial compounds, with the loss of all free thiols and Grx dimerization in the presence of HgCl2, but no inhibition of Grx activity was observed in lysates of HeLa cells exposed to mercury. Overall, mercury inhibition was selective toward the thioredoxin system. In particular, the remarkable potency of the mercury compounds to bind to the selenol-thiol in the active site of TrxR should be a major molecular mechanism of mercury toxicity.	[Carvalho, Cristina M. L.; Chew, Eng-Hui; Hashemy, Seyed Isaac; Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden; [Carvalho, Cristina M. L.] Univ Lisbon, Fac Pharm, P-1649003 Lisbon, Portugal	Karolinska Institutet; Universidade de Lisboa	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Hashemy, Seyed Isaac/A-2693-2017; Lu, Jun/E-9701-2017; Chew, Eng Hui/D-8975-2016; Carvalho, Cristina/E-3379-2014; iMed.ULisboa, CBT/B-4215-2014	Hashemy, Seyed Isaac/0000-0002-1323-5250; Lu, Jun/0000-0002-1699-8835; Chew, Eng Hui/0000-0002-2615-8987; Carvalho, Cristina/0000-0002-1097-7910; 				Almagro X, 2001, J ORGANOMET CHEM, V623, P137, DOI 10.1016/S0022-328X(00)00672-0; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; ARNER ESJ, 2000, CURR PROTOCOL TOXI S, V5; Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Bando I, 2005, J BIOCHEM MOL TOXIC, V19, P154, DOI 10.1002/jbt.20067; Boelsterli UA, 2003, MECH TOXICOLOGY; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; CAMPOS EST, 2003, TOXICOL LETT S1, V144, P142; Carvalho CML, 2006, METAL IONS BIOL MED, V9, P381; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; Chapman L, 2000, ENVIRON HEALTH PERSP, V108, P29, DOI [10.2307/3454631, 10.2307/3454292]; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Clarkson TW, 2003, J NUTR, V133, p1539S, DOI 10.1093/jn/133.5.1539S; CLARKSON TW, 1993, ANNU REV PHARMACOL, V33, P545, DOI 10.1146/annurev.pa.33.040193.002553; CUVINARALAR MLA, 1991, ECOTOX ENVIRON SAFE, V21, P348, DOI 10.1016/0147-6513(91)90074-Y; DANCE I, 1992, METALLOTHIONEINS, P284; DAVIS LE, 1994, ANN NEUROL, V35, P680, DOI 10.1002/ana.410350608; dos Santos APM, 2007, TOXICOL LETT, V169, P121, DOI 10.1016/j.toxlet.2006.12.007; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Farina M, 2004, TOXICOL LETT, V146, P227, DOI 10.1016/j.toxlet.2003.10.001; Frisk P, 2000, BIOMETALS, V13, P101, DOI 10.1023/A:1009222625616; GANTHER HE, 1972, SCIENCE, V175, P1122, DOI 10.1126/science.175.4026.1122; GHILARDI CA, 1993, J CHEM SOC DALTON, P3117, DOI 10.1039/dt9930003117; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; Grandjean P, 2005, ENVIRON HEALTH PERSP, V113, P905, DOI 10.1289/ehp.7842; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Heinz GH, 1998, ENVIRON TOXICOL CHEM, V17, P139; HIROTA Y, 1980, TOXICOL APPL PHARM, V53, P174, DOI 10.1016/0041-008X(80)90394-4; Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Hylander LD, 2006, SCI TOTAL ENVIRON, V368, P352, DOI 10.1016/j.scitotenv.2005.11.029; Kaur P, 2007, TOXICOLOGY, V230, P164, DOI 10.1016/j.tox.2006.11.058; KERPER LE, 1992, AM J PHYSIOL, V262, pR761, DOI 10.1152/ajpregu.1992.262.5.R761; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Mann RA, 1999, OPER TECHN SPORT MED, V7, P2, DOI 10.1016/S1060-1872(99)80033-1; Naganuma A, 1998, LIFE SCI, V62, pPL157, DOI 10.1016/S0024-3205(98)00037-X; PADILLA CA, 1995, EUR J BIOCHEM, V227, P27, DOI 10.1111/j.1432-1033.1995.tb20356.x; Parran DK, 2001, TOXICOL SCI, V59, P278, DOI 10.1093/toxsci/59.2.278; POTAMITOUFERNAN.A, 2004, ANTIOXID REDOX SIGN, V6, P63; POTTER S, 1974, J NUTR, V104, P638, DOI 10.1093/jn/104.5.638; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Rooney JPK, 2007, TOXICOLOGY, V234, P145, DOI 10.1016/j.tox.2007.02.016; ROZELL B, 1985, EUR J CELL BIOL, V38, P79; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; SARAFIAN T, 1991, INT J DEV NEUROSCI, V9, P147, DOI 10.1016/0736-5748(91)90005-7; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; STEMME S, 1985, BRAIN RES, V359, P140, DOI 10.1016/0006-8993(85)91421-0; VAHTER ME, 1995, TOXICOL APPL PHARM, V134, P273, DOI 10.1006/taap.1995.1193; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; WATAHA JC, 2007, IN PRESS DENTAL MAT; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; WHO, 2000, AIR QUAL GUID; *WHO, 2003, SUMM CONCL 61 M JECF; WHO World Health Organization, 1989, MERC ENV ASP; Woods JS, 2005, TOXICOL APPL PHARM, V206, P113, DOI 10.1016/j.taap.2004.12.016; WRIGHT JG, 1990, PROG INORG CHEM, V38, P323; Zalups RZ., 2000, MOL BIOL TOXICOLOGY; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	67	357	367	4	82	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11913	11923		10.1074/jbc.M710133200	http://dx.doi.org/10.1074/jbc.M710133200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321861	hybrid			2022-12-27	WOS:000255340000007
J	Hoffmann, E; Ashouri, J; Wolter, S; Doerrie, A; Dittrich-Breiholz, O; Schneider, H; Wagner, EF; Troppmair, J; Mackman, N; Kracht, M				Hoffmann, Elke; Ashouri, Judith; Wolter, Sabine; Doerrie, Anneke; Dittrich-Breiholz, Oliver; Schneider, Heike; Wagner, Erwin F.; Troppmair, Jakob; Mackman, Nigel; Kracht, Michael			Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAYS; NECROSIS-FACTOR-ALPHA; GROWTH-RESPONSE FACTOR-1; HUMAN MONOCYTIC CELLS; C-JUN; GENE-EXPRESSION; INFLAMMATORY CYTOKINES; 3T3 FIBROBLASTS	The proinflammatory cytokine interleukin (IL)-1 activates several hundred genes within the same cell. This occurs in part by activation of the MKK7-JNK-c-Jun signaling pathway whose precise role in the regulation of individual inflammatory genes is still incompletely understood. To identify the genes that are under specific control of activated JNK, we used a JNK-MKK7 fusion protein. Genome-wide microarray analysis revealed EGR-1 as the transcript that was most strongly induced by JNK-MKK7. IL-1-stimulated EGR-1 mRNA and protein expression were impaired in cells lacking JNK or c-Jun. Transcriptional activation of the EGR-1 promoter by JNK-MKK7 or by IL-1 required a single upstream AP-1 site and three distal serum-response elements (SRE). Reconstitution experiments in c-Jun-deficient cells revealed that c-Jun is required for EGR-1 transcription through both the AP-1 site and the distal SREs. By chromatin immunoprecipitation analysis, we found IL-1-inducible recruitment of c-Jun to the AP-1 site and to the region containing the three distal SREs. These experiments suggest that c-Jun plays a dual role in EGR-1 transcription. It directly binds to the AP-1 element, and at the same time it is essential for promoter activation through the three distal SREs by an indirect unknown mechanism. As predicted by TRANSFAC analysis and verified by ChIP experiments, IL-1-induced EGR-1 protein binds to the promoter regions of inflammatory mediators such as IL-6, IL-8, and CCL2. Furthermore, short interfering RNA-mediated suppression of EGR-1 partially suppresses IL-1-inducible transcription of IL-8, IL-6, and CCL2. In summary, we provide novel evidence for a complex c-Jun-mediated mechanism that is essential for inducible EGR-1 expression. We identify this pathway as a previously unrecognized part of a multistep gene regulatory network that controls cytokine and chemokine expression via the IL-1-MKK7-JNK- c-Jun-EGR-1 pathway.	[Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmakol, D-35392 Giessen, Germany; [Hoffmann, Elke; Ashouri, Judith; Wolter, Sabine; Doerrie, Anneke; Dittrich-Breiholz, Oliver; Schneider, Heike; Kracht, Michael] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany; [Wagner, Erwin F.] Inst Mol Pathol, A-1030 Vienna, Austria; [Troppmair, Jakob] Innsbruck Med Univ, Dept Gen & Transplant Surg, Daniel Swarovski Res Lab, A-6020 Innsbruck, Austria; [Mackman, Nigel] Scripps Res Inst, La Jolla, CA 92037 USA	Justus Liebig University Giessen; Hannover Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Innsbruck; Scripps Research Institute	Kracht, M (corresponding author), Univ Giessen, Rudolf Buchheim Inst Pharmakol, Frankfurter Str 107, D-35392 Giessen, Germany.	Michael.Kracht@pharma.med.uni-giessen.de		Hoffmann-Lucke, Elke/0000-0002-2437-0140; Ashouri, Judith/0000-0001-8405-7503; Troppmair, Jakob/0000-0002-0611-3837; Kracht, Michael/0000-0002-8501-043X; Wagner, Erwin F/0000-0001-7872-0196	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048872] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL048872, R01 HL048872-08] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Giri RK, 2003, J IMMUNOL, V170, P5281, DOI 10.4049/jimmunol.170.10.5281; Granet C, 2004, CYTOKINE, V26, P169, DOI 10.1016/j.cyto.2004.03.002; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han SY, 2002, J BIOL CHEM, V277, P47167, DOI 10.1074/jbc.M204270200; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; ISSHIKI H, 1990, MOL CELL BIOL, V10, P2757, DOI 10.1128/MCB.10.6.2757; Janknecht R, 1997, J BIOL CHEM, V272, P4219, DOI 10.1074/jbc.272.7.4219; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Khachigian LM, 1998, J MOL MED-JMM, V76, P613, DOI 10.1007/s001090050258; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Krause A, 1998, J BIOL CHEM, V273, P23681, DOI 10.1074/jbc.273.37.23681; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Kumar SN, 2000, MOL IMMUNOL, V37, P623, DOI 10.1016/S0161-5890(00)00097-3; Maltzman JS, 1996, J EXP MED, V183, P1747, DOI 10.1084/jem.183.4.1747; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Okada M, 2001, FASEB J, V15, P2757, DOI 10.1096/fj.01-0490fje; Pawlinski R, 2003, BLOOD, V101, P3940, DOI 10.1182/blood-2002-07-2303; Rennefahrt U, 2004, CANCER LETT, V215, P113, DOI 10.1016/j.canlet.2004.05.015; Rennefahrt UEE, 2002, J BIOL CHEM, V277, P29510, DOI 10.1074/jbc.M203010200; Rolli-Derkinderen M, 2003, J BIOL CHEM, V278, P18859, DOI 10.1074/jbc.M211696200; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shin SY, 2006, EXP MOL MED, V38, P677, DOI 10.1038/emm.2006.80; Silverman ES, 2001, AM J RESP CRIT CARE, V163, P778, DOI 10.1164/ajrccm.163.3.2003123; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Thiefes A, 2005, J BIOL CHEM, V280, P27728, DOI 10.1074/jbc.M411657200; Thiefes A, 2006, EMBO REP, V7, P838, DOI 10.1038/sj.embor.7400754; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wolter S, 2002, J BIOL CHEM, V277, P3576, DOI 10.1074/jbc.M105800200; WORLEY PF, 1991, P NATL ACAD SCI USA, V88, P5106, DOI 10.1073/pnas.88.12.5106; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966; ZINCK R, 1995, MOL CELL BIOL, V15, P4930	60	63	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12120	12128		10.1074/jbc.M800583200	http://dx.doi.org/10.1074/jbc.M800583200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18281687	hybrid			2022-12-27	WOS:000255340000028
J	Keshwani, MM; Harris, TK				Keshwani, Malik M.; Harris, Thomas K.			Kinetic mechanism of fully activated S6K1 protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; WATER; MTOR; TOR	S6K1 is a member of the AGC subfamily of serine-threonine protein kinases, whereby catalytic activation requires dual phosphorylation of critical residues in the conserved T-loop (Thr-229) and hydrophobic motif (Thr-389). Previously, we described production of the fully activated catalytic kinase domain construct, His6-S6K1 alpha II(Delta AID)-T389E. Now, we report its kinetic mechanism for catalyzing phosphorylation of a model peptide substrate (Tide, RRRLSSLRA). First, two-substrate steady-state kinetics and product inhibition patterns indicated a Steady-State Ordered Bi Bi mechanism, whereby initial high affinity binding of ATP (K-d(ATP) = 5-6 mu M) was followed by low affinity binding of Tide (K-d(Tide) = 180 mu M), and values of K-m(ATP) = 5-6 mu M and K-m(Tide) = 4-5 mu M were expressed in the active ternary complex. Global curve-fitting analysis of ATP, Tide, and ADP titrations of pre-steady-state burst kinetics yielded microscopic rate constants for substrate binding, rapid chemical phosphorylation, and rate-limiting product release. Catalytic trapping experiments confirmed rate-limiting steps involving release of ADP. Pre-steady-state kinetic and catalytic trapping experiments showed osmotic pressure to increase the rate of ADP release; and direct binding experiments showed osmotic pressure to correspondingly weaken the affinity of the enzyme for both ADP and ATP, indicating a less hydrated conformational form of the free enzyme.	[Keshwani, Malik M.; Harris, Thomas K.] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA; [Harris, Thomas K.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33136 USA	University of Miami; University of Miami	Harris, TK (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA.	tkharris@miami.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069868] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM69868] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Aubol BE, 2004, J BIOL CHEM, V279, P30182, DOI 10.1074/jbc.M402797200; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LEISER SA, 2005, BIOCHIM BIOPHYS ACTA, V1754, P191; LiCata VJ, 1998, METHOD ENZYMOL, V295, P42; Lieser SA, 2005, J BIOL CHEM, V280, P7769, DOI 10.1074/jbc.M411736200; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; PARSEGIAN VA, 1994, ADV CHEM SER, V235, P177; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Robinson CR, 1995, METHOD ENZYMOL, V259, P395; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435	21	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11972	11980		10.1074/jbc.M800114200	http://dx.doi.org/10.1074/jbc.M800114200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326039	hybrid, Green Published			2022-12-27	WOS:000255340000013
J	Choi, SH; Czifra, G; Kedei, N; Lewin, NE; Lazar, J; Pu, YM; Marquez, VE; Blumberg, PM				Choi, Sung Hee; Czifra, Gabriella; Kedei, Noemi; Lewin, Nancy E.; Lazar, Jozsef; Pu, Yongmei; Marquez, Victor E.; Blumberg, Peter M.			Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; DIACYLGLYCEROL KINASES; PKC-ALPHA; ACTIVATION; RECEPTORS; MECHANISM; EFFECTORS; CALCIUM; SIGNALS; DELTA	C1 domains mediate the recognition and subsequent signaling response to diacylglycerol and phorbol esters by protein kinase C (PKC) and by several other families of signal-transducing proteins such as the chimerins or RasGRP. MRCK(myotonic dystrophy kinase-related Cdc42 binding kinase), a member of the dystrophia myotonica protein kinase family that functions downstream of Cdc42, contains a C1 domain with substantial homology to that of the diacylglycerol/phorbol ester-responsive C1 domains and has been reported to bind phorbol ester. We have characterized here the interaction of the C1 domains of the two MRCK isoforms alpha and beta with phorbol ester. The MRCK C1 domains bind [20-H-3] phorbol 12,13-dibutyrate with K-d values of 10 and 17 nM, respectively, reflecting 60-90-fold weaker affinity compared with the protein kinase C delta C1b domain. In contrast to binding by the C1b domain of PKC delta, the binding by the C1 domains of MRCK alpha and beta was fully dependent on the presence of phosphatidylserine. Comparison of ligand binding selectivity showed resemblance to that by the C1b domain of PKC alpha and marked contrast to that of the C1b domain of PKC delta. In intact cells, as in the binding assays, the MRCK C1 domains required 50-100-fold higher concentrations of phorbol ester for induction of membrane translocation. We conclude that additional structural elements within the MRCK structure are necessary if the C1 domains of MRCK are to respond to phorbol ester at concentrations comparable with those that modulate PKC.	[Choi, Sung Hee; Czifra, Gabriella; Kedei, Noemi; Lewin, Nancy E.; Lazar, Jozsef; Pu, Yongmei; Blumberg, Peter M.] NCI, Lab Canc Biol & genet, Natl Inst Hlth, Bethesda, MD 20892 USA; [Marquez, Victor E.] NCI, Med Chem Lab, Ctr Canc Res, Natl Inst Hlth, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumberg, PM (corresponding author), NCI, Lab Canc Biol & genet, Natl Inst Hlth, Bldg 37 Rm 4048B 37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	blumberg@dc37a.nci.nih.gov	Marquez, Victor/AAP-3549-2021		Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC005270, Z01BC010942, ZIABC005270, ZIABC010942] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARECES LB, 1994, J BIOL CHEM, V269, P19553; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; DRIEDGER PE, 1977, CANCER RES, V37, P3257; Garcia P, 2006, FASEB J, V20, P1142, DOI 10.1096/fj.05-5262com; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Hurley JH, 1997, PROTEIN SCI, V6, P477; Irie K, 2004, BIOORGAN MED CHEM, V12, P4575, DOI 10.1016/j.bmc.2004.07.008; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; KONIG B, 1985, J CELL BIOCHEM, V29, P37, DOI 10.1002/jcb.240290105; Lambert QT, 2006, METHOD ENZYMOL, V407, P82, DOI 10.1016/S0076-6879(05)07008-4; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Lewin Nancy E, 2003, Methods Mol Biol, V233, P129; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oliva JL, 2005, GROWTH FACTORS, V23, P245, DOI 10.1080/08977190500366043; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Silinsky EM, 2003, BRIT J PHARMACOL, V138, P1191, DOI 10.1038/sj.bjp.0705213; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Wakelam MJO, 1998, BBA-MOL CELL BIOL L, V1436, P117, DOI 10.1016/S0005-2760(98)00123-4; Wang H, 2006, BIOCHEM SOC T, V34, P855, DOI 10.1042/BST0340855; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	31	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10543	10549		10.1074/jbc.M707463200	http://dx.doi.org/10.1074/jbc.M707463200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18263588	Green Published, hybrid			2022-12-27	WOS:000254894700036
J	Gara, SK; Grumati, P; Urciuolo, A; Bonaldo, P; Kobbe, B; Koch, M; Paulsson, M; Wagener, R				Gara, Sudheer Kumar; Grumati, Paolo; Urciuolo, Anna; Bonaldo, Paolo; Kobbe, Birgit; Koch, Manuel; Paulsson, Mats; Wagener, Raimund			Three novel collagen VI chains with high homology to the alpha 3 chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; AMINO-ACID-SEQUENCE; ALPHA-3(VI) CHAIN; SUSCEPTIBILITY LOCI; BETHLEM MYOPATHY; A-DOMAIN; MITOCHONDRIAL DYSFUNCTION; MICROFIBRIL FORMATION; VONWILLEBRAND-FACTOR; SWEDISH POPULATION	Here we describe three novel collagen VI chains, alpha 4, alpha 5, and alpha 6. The corresponding genes are arranged in tandem on mouse chromosome 9. The new chains structurally resemble the collagen VI alpha 3 chain. Each chain consists of sevenvon Willebrand factor A domains followed by a collagenous domain, two C-terminal von Willebrand factor A domains, and a unique domain. In addition, the collagen VI alpha 4 chain carries a Kunitz domain at the C terminus, whereas the collagen VI alpha 5 chain contains an additional von Willebrand factor A domain and a unique domain. The size of the collagenous domains and the position of the structurally important cysteine residues within these domains are identical between the collagen VI alpha 3, alpha 4, alpha 5, and alpha 6 chains. In mouse, the new chains are found in or close to basement membranes. Collagen VI alpha 1 chain-deficient mice lack expression of the new collagen VI chains implicating that the new chains may substitute for the alpha 3 chain, probably forming alpha 1 alpha 2 alpha 4, alpha 1 alpha 2 alpha 5, or alpha 1 alpha 2 alpha 6 heterotrimers. Due to a large scale pericentric inversion, the human COL6A4 gene on chromosome 3 was broken into two pieces and became a non-processed pseudogene. Recently COL6A5 was linked to atopic dermatitis and designated COL29A1. The identification of novel collagen VI chains carries implications for the etiology of atopic dermatitis as well as Bethlem myopathy and Ullrich congenital muscular dystrophy.	[Gara, Sudheer Kumar; Kobbe, Birgit; Koch, Manuel; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Inst Biochem 2, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Ctr Mol Med, D-50931 Cologne, Germany; [Koch, Manuel] Univ Cologne, Fac Med, Dept Dermatol, D-50931 Cologne, Germany; [Grumati, Paolo; Urciuolo, Anna; Bonaldo, Paolo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy	University of Cologne; University of Cologne; University of Cologne; University of Padua	Wagener, R (corresponding author), Univ Cologne, Inst Biochem 2, Fac Med, Ctr Biochem, Stelzmann Str 52, D-50931 Cologne, Germany.	raimund.wagener@uni-koeln.de	Gara, Sudheer Kumar/E-8084-2016; Grumati, Paolo/AAA-5787-2019; Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814; Bonaldo, Paolo/0000-0002-9571-8140; Urciuolo, Anna/0000-0001-7571-9747	Fondazione Telethon Funding Source: Custom; Telethon [GGP04113] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Ball S, 2003, J BIOL CHEM, V278, P15326, DOI 10.1074/jbc.M209977200; Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Bischof JM, 2006, HUM MUTAT, V27, P545, DOI 10.1002/humu.20335; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; Bradley M, 2002, HUM MOL GENET, V11, P1539, DOI 10.1093/hmg/11.13.1539; BROWN JC, 1994, MATRIX BIOL, V14, P287, DOI 10.1016/0945-053X(94)90194-5; Bu LM, 2006, ALLERGY, V61, P617, DOI 10.1111/j.1398-9995.2006.01072.x; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; COLOMBATTI A, 1987, J BIOL CHEM, V262, P14454; COLOMBATTI A, 1989, MATRIX, V9, P177, DOI 10.1016/S0934-8832(89)80048-4; Dziadek M, 2002, MATRIX BIOL, V21, P227, DOI 10.1016/S0945-053X(02)00009-4; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; Finnis ML, 1997, J BIOL CHEM, V272, P22817, DOI 10.1074/jbc.272.36.22817; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Knupp C, 2001, EMBO J, V20, P372, DOI 10.1093/emboj/20.3.372; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lamande SR, 1998, J BIOL CHEM, V273, P7423, DOI 10.1074/jbc.273.13.7423; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lampe AK, 2005, J MED GENET, V42, P108, DOI 10.1136/jmg.2004.023754; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lucioli S, 2005, NEUROLOGY, V64, P1931, DOI 10.1212/01.WNL.0000163990.00057.66; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; Muzny DM, 2006, NATURE, V440, P1194, DOI 10.1038/nature04728; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; PERKINS SJ, 1994, J MOL BIOL, V238, P104, DOI 10.1006/jmbi.1994.1271; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; Sengle G, 2003, J BIOL CHEM, V278, P50240, DOI 10.1074/jbc.M307794200; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200	44	117	124	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10658	10670		10.1074/jbc.M709540200	http://dx.doi.org/10.1074/jbc.M709540200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18276594	hybrid			2022-12-27	WOS:000254894700048
J	Chung, RS; Penkowa, M; Dittmann, J; King, CE; Bartlett, C; Asmussen, JW; Hidalgo, J; Carrasco, J; Leung, YKJ; Walker, AK; Fung, SJ; Dunlop, SA; Fitzgerald, M; Beazley, LD; Chuah, MI; Vickers, JC; West, AK				Chung, Roger S.; Penkowa, Milena; Dittmann, Justin; King, Carolyn E.; Bartlett, Carole; Asmussen, Johanne W.; Hidalgo, Juan; Carrasco, Javier; Leung, Yee Kee J.; Walker, Adam K.; Fung, Samantha J.; Dunlop, Sarah A.; Fitzgerald, Melinda; Beazley, Lyn D.; Chuah, Meng I.; Vickers, James C.; West, Adrian K.			Redefining the role of metallothionein within the injured brain - Extracellular metallothioneins play an important role in the astrocyte-neuron response to injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; II-DEFICIENT MICE; GENE-EXPRESSION; PROTECTIVE ROLE; NEURITE GROWTH; CNS; SURVIVAL; BINDING; DIFFERENTIATION; REGENERATION	A number of intracellular proteins that are protective after brain injury are classically thought to exert their effect within the expressing cell. The astrocytic metallothioneins (MT) are one example and are thought to act via intracellular free radical scavenging and heavy metal regulation, and in particular zinc. Indeed, we have previously established that astrocytic MTs are required for successful brain healing. Here we provide evidence for a fundamentally different mode of action relying upon intercellular transfer from astrocytes to neurons, which in turn leads to uptake-dependent axonal regeneration. First, we show that NIT can be detected within the extracellular fluid of the injured brain, and that cultured astrocytes are capable of actively secreting NIT in a regulatable manner. Second, we identify a receptor, megalin, that mediates NIT transport into neurons. Third, we directly demonstrate for the first time the transfer of NIT from astrocytes to neurons over a specific time course in vitro. Finally, we show that NIT is rapidly internalized via the cell bodies of retinal ganglion cells in vivo and is a powerful promoter of axonal regeneration through the inhibitory environment of the completely severed mature optic nerve. Our work suggests that the protective functions of NIT in the central nervous system should be widened from a purely astrocytic focus to include extracellular and intra-neuronal roles. This unsuspected action of NIT represents a novel paradigm of astrocyte-neuronal interaction after injury and may have implications for the development of MT-based therapeutic agents.	[Chung, Roger S.; Dittmann, Justin; Leung, Yee Kee J.; Walker, Adam K.; Fung, Samantha J.; Chuah, Meng I.; Vickers, James C.; West, Adrian K.] Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas 7001, Australia; [Penkowa, Milena; Asmussen, Johanne W.] Univ Copenhagen, Fac Hlth Sci, Sect Neuroprotect, DK-2200 Copenhagen, Denmark; [King, Carolyn E.; Bartlett, Carole; Hidalgo, Juan; Carrasco, Javier; Dunlop, Sarah A.; Fitzgerald, Melinda; Beazley, Lyn D.] Univ Western Australia, Sch Anim Biol, Nedlands, WA 6907, Australia; [Hidalgo, Juan; Carrasco, Javier] Autonomous Univ Barcelona, Inst Neurosci, Barcelona 08193, Spain; [Hidalgo, Juan; Carrasco, Javier] Autonomous Univ Barcelona, Fac Sci, Dept Cell Biol Physiol & Immunol, Anim Physiol Unit, Barcelona 08193, Spain	University of Tasmania; Menzies Institute for Medical Research; University of Copenhagen; University of Western Australia; Autonomous University of Barcelona; Autonomous University of Barcelona	Chung, RS (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Private Bag 58, Hobart, Tas 7001, Australia.	rschung@utas.edu.au	Fung, Samantha/C-9660-2011; Hidalgo, Juan/C-9082-2011; Chung, Roger/ABF-8395-2020; Vickers, James C/J-7464-2014; Dunlop, Sarah A/G-9357-2013; Fitzgerald, Melinda/C-4235-2011; Chuah, Meng Inn/J-7671-2014; Walker, Adam Keith/B-7418-2009; West, Adrian/AAR-8857-2021; Carrasco, Javier/C-9732-2011	Hidalgo, Juan/0000-0003-0921-1122; Vickers, James C/0000-0001-5671-4879; Fitzgerald, Melinda/0000-0002-4823-8179; Walker, Adam Keith/0000-0001-7954-5801; Carrasco, Javier/0000-0001-6436-0863; Chung, Roger/0000-0002-9286-947X; Dunlop, Sarah/0000-0002-1306-3962; King, Carolyn/0000-0001-5097-8064				Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Ceballos D, 2003, CELL MOL LIFE SCI, V60, P1209, DOI 10.1007/s00018-003-3047-2; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2002, BIOCHEM J, V365, P323, DOI 10.1042/BJ20011751; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fitzgerald M, 2007, EXP BRAIN RES, V183, P171, DOI 10.1007/s00221-007-1032-y; GASULL T, 1993, J IMMUNOASSAY, V14, P209, DOI 10.1080/15321819308019851; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; HIDALGO J, 1994, CHEM-BIOL INTERACT, V93, P197, DOI 10.1016/0009-2797(94)90020-5; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; KIKUCHI Y, 1993, FEBS LETT, V317, P22, DOI 10.1016/0014-5793(93)81483-G; King CE, 1997, NEUROREPORT, V8, P1663; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Klassen RB, 2004, AM J PHYSIOL-RENAL, V287, pF393, DOI 10.1152/ajprenal.00233.2003; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Pedersen MV, 2004, J NEUROSCI RES, V75, P55, DOI 10.1002/jnr.10812; Penkowa M, 2006, J NEUROSCI RES, V83, P974, DOI 10.1002/jnr.20790; Penkowa M, 2001, EXP NEUROL, V170, P1, DOI 10.1006/exnr.2001.7675; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2001, J NEUROIMMUNOL, V119, P248, DOI 10.1016/S0165-5728(01)00357-5; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Schousboe A., 1989, DISSECTION TISSUE CU, P203; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Trayhurn P, 2000, AM J PHYSIOL-REG I, V279, pR2329, DOI 10.1152/ajpregu.2000.279.6.R2329; Trayhurn P, 2000, HORM METAB RES, V32, P542, DOI 10.1055/s-2007-978683; Uchida Y, 2002, J BIOL CHEM, V277, P32353, DOI 10.1074/jbc.M111263200; Vincent AJ, 2005, GLIA, V51, P132, DOI 10.1002/glia.20195; West AK, 2004, REV NEUROSCIENCE, V15, P157; Wolff NA, 2006, J PHARMACOL EXP THER, V318, P782, DOI 10.1124/jpet.106.102574; Xie T, 2004, J NEUROSCI, V24, P7043, DOI 10.1523/JNEUROSCI.1626-04.2004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	38	121	126	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15349	15358		10.1074/jbc.M708446200	http://dx.doi.org/10.1074/jbc.M708446200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18334482	hybrid, Green Published			2022-12-27	WOS:000256232000053
J	Sakaki, K; Wu, J; Kaufman, RJ				Sakaki, Kenjiro; Wu, Jun; Kaufman, Randal J.			Protein kinase C theta is required for autophagy in response to stress in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-THETA; ER STRESS; INSULIN-RESISTANCE; CELL-DEATH; ACTIVATION LOOP; APOPTOSIS; SURVIVAL; OBESITY; ROLES; BETA	Autophagy is an evolutionally conserved process for the bulk degradation of cytoplasmic proteins and organelles. Recent observations indicate that autophagy is induced in response to cellular insults that result in the accumulation of misfolded proteins in the lumen of the endoplasmic reticulum (ER). However, the signaling mechanisms that activate autophagy under these conditions are not understood. Here, we report that ER stress-induced autophagy requires the activation of protein kinase C theta (PKC theta), a member of the novel-type PKC family. Induction of ER stress by treatment with either thapsigargin or tunicamycin activated autophagy in immortalized hepatocytes as monitored by the conversion LC3-I to LC3-II, clustering of LC3 into dot-like cytoplasmic structures, and electron microscopic detection of autophago-somes. Pharmacological inhibition of PKC theta or small interfering RNA-mediated knockdown of PKC theta prevented the autophagic response to ER stress. Treatment with ER stressors induced PKC theta phosphorylation within the activation loop and localization of phospho-PKC theta to LC3-containing dot structures in the cytoplasm. However, signaling through the known unfolded protein response sensors was not required for PKC theta activation. PKC theta activation and stress-induced autophagy were blocked by chelation of intracellular Ca2+ with BAPTA-AM. PKC theta was not activated or required for autophagy in response to amino acid starvation. These observations indicate that Ca2+-dependent PKC theta activation is specifically required for autophagy in response to ER stress but not in response to amino acid starvation.	[Kaufman, Randal J.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Sakaki, Kenjiro; Wu, Jun] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kaufman, RJ (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, 4570 MSRB II,1150 W Med Ctr, Ann Arbor, MI 48109 USA.	kaufmanr@umich.edu			NHLBI NIH HHS [P01 HL 057346, R01 HL 052173] Funding Source: Medline; NIDDK NIH HHS [R01 DK 042934] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173, P01HL057346] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Altman A, 2002, J BIOCHEM, V132, P841, DOI 10.1093/oxfordjournals.jbchem.a003295; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; BERRY MN, 1991, ISOLATED HEPATOCYTES, P59; Choi EY, 2007, LIFE SCI, V80, P436, DOI 10.1016/j.lfs.2006.09.044; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Ferrari D, 2002, CELL CALCIUM, V32, P413, DOI 10.1016/S0143416002002014; Fujita M, 2007, J BIOL CHEM, V282, P5736, DOI 10.1074/jbc.M606175200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Haasch D, 2006, BIOCHEM BIOPH RES CO, V343, P361, DOI 10.1016/j.bbrc.2006.02.177; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; He CC, 2006, ACS CHEM BIOL, V1, P211, DOI 10.1021/cb600182h; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lee W, 2005, APOPTOSIS, V10, P407, DOI 10.1007/s10495-005-0814-6; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nagai K, 2006, J NUTR BIOCHEM, V17, P525, DOI 10.1016/j.jnutbio.2005.09.007; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sousa M, 1996, MOL HUM REPROD, V2, P967, DOI 10.1093/molehr/2.12.967; Sparatore B, 2003, FEBS LETT, V554, P35, DOI 10.1016/S0014-5793(03)01073-1; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	62	144	150	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15370	15380		10.1074/jbc.M710209200	http://dx.doi.org/10.1074/jbc.M710209200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18356160	Green Published, hybrid			2022-12-27	WOS:000256232000055
J	Galmiche, A; Fueller, J; Santel, A; Krohne, G; Wittig, I; Doye, A; Rolando, M; Flatau, G; Lemichez, E; Rapp, UR				Galmiche, Antoine; Fueller, Jochen; Santel, Ansgar; Krohne, Georg; Wittig, Ilka; Doye, Anne; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel; Rapp, Ulf R.			Isoform-specific interaction of C-RAF with mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP-KINASE-KINASE; B-RAF; PLASMA-MEMBRANE; A-RAF; LOCALIZATION; PROTEINS; PHOSPHORYLATION; PROLIFERATION; FRAGMENTATION; INACTIVATION	The proteins of the RAF family (A-RAF, B-RAF, and C-RAF) are serine/threonine kinases that play important roles in development, mature cell regulation, and cancer. Although it is widely held that their localization on membranes is an important aspect of their function, there are few data that address this aspect of their mode of action. Here, we report that each member of the RAF family exhibits a specific distribution at the level of cellular membranes and that C-RAF is the only isoform that directly targets mitochondria. We found that the RAF kinases exhibit intrinsic differences in terms of mitochondrial affinity and that C-RAF is the only isoform that binds this organelle efficiently. This affinity is conferred by the C-RAF amino-terminal domain and does not depend on the presence of RAS GTPases on the surface of mitochondria. Finally, we analyzed the consequences of C-RAF activation on mitochondria and observed that this event dramatically changes their morphology and their subcellular distribution. Our observations indicate that: (i) RAF kinases exhibit different localizations at the level of cellular membranes; (ii) C-RAF is the only isoform that directly binds mitochondria; and (iii) through its functional coupling with MEK, C-RAF regulates the shape and the cellular distribution of mitochondria.	[Galmiche, Antoine; Fueller, Jochen; Rapp, Ulf R.] Univ Wurzburg, Inst Med Strahlenkunde & Zellforschung, D-97078 Wurzburg, Germany; [Santel, Ansgar] Silence Therapeut AG, D-13125 Berlin, Germany; [Krohne, Georg] Univ Wurzburg, Bioctr, Div Elect Microscopy, D-97074 Wurzburg, Germany; [Wittig, Ilka] Univ Frankfurt Klinikum, Zentrum Biol Chem Mol Bioenerget, D-60590 Frankfurt, Germany; [Doye, Anne; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel] INSERM, U895, Ctr Mediterraneen Med Mol C3M, F-06204 Nice 3, France; [Doye, Anne; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel] Univ Nice Sophia Antipolis, UFR Med, F-06204 Nice, France; [Lemichez, Emmanuel] Univ Nice, Ctr Hosp, Serv Bacteriol, Hop Archet 2, F-06204 Nice, France	University of Wurzburg; University of Wurzburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Galmiche, A (corresponding author), Univ Wurzburg, Inst Med Strahlenkunde & Zellforschung, Versbacher Str 5, D-97078 Wurzburg, Germany.	antoine.galmiche@mail.uni-wuerzburg.de	Lemichez, Emmanuel/G-3559-2013	Lemichez, Emmanuel/0000-0001-9080-7761; Rolando, Monica/0000-0002-3710-0115				Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Colanzi A, 2003, J CELL BIOL, V161, P27, DOI 10.1083/jcb.200208099; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Galmiche A, 2007, BBA-MOL CELL RES, V1773, P1256, DOI 10.1016/j.bbamcr.2006.10.012; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hindley A, 2002, J CELL SCI, V115, P1575; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Santel A, 2006, BBA-MOL CELL RES, V1763, P490, DOI 10.1016/j.bbamcr.2006.02.004; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Wang G, 2006, MOL CELL BIOL, V26, P3243, DOI 10.1128/MCB.26.8.3243-3255.2006; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Yuryev A, 2000, MOL CELL BIOL, V20, P4870, DOI 10.1128/MCB.20.13.4870-4878.2000	42	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14857	14866		10.1074/jbc.M709098200	http://dx.doi.org/10.1074/jbc.M709098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356164	hybrid			2022-12-27	WOS:000255941400073
J	Gomez-Quiroz, LE; Factor, VM; Kaposi-Novak, P; Coulouarn, C; Conner, EA; Thorgeirsson, SS				Gomez-Quiroz, Luis E.; Factor, Valentina M.; Kaposi-Novak, Pal; Coulouarn, Cedric; Conner, Elizabeth A.; Thorgeirsson, Snorri S.			Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-RAT HEPATOCYTES; NF-KAPPA-B; GROWTH-FACTOR; OXIDATIVE STRESS; REACTIVE OXYGEN; SIGNALING PATHWAY; CELL-DEATH; ACTIVATION; EXPRESSION; PROTECTS	The hepatocyte growth factor and its receptor c-Met direct a pleiotropic signal transduction pathway that controls cell survival. We previously demonstrated that mice lacking c-Met (Met-KO) in hepatocytes were hypersensitive to Fas-induced liver injury. In this study, we used primary hepatocytes isolated from Met-KO and control (Cre-Ctrl) mice to address more directly the protective effects of c-Met signaling. Loss of c-Met function increased sensitivity to Fas-mediated apoptosis. Hepatocyte growth factor suppressed apoptosis in Cre-Ctrl but not Met-KO hepatocytes concurrently with up-regulation of NF-kappa B and major antiapoptotic proteins Bcl-2 and Bcl-xL. Intriguingly, Met-KO hepatocytes exhibited intrinsic activation of NF-kappa B as well as Bcl-2 and Bcl-xL. Furthermore, unchallenged Met-KO cells displayed oxidative stress as evidenced by overproduction of reactive oxygen species, which was associated with greater NADPH and Rac1 activities, was blocked by the known NADPH oxidase inhibitors, and was paralleled by increased lipid peroxidation and reduced glutathione (GSH) content. N-Acetylcysteine, an antioxidant and GSH precursor, significantly reduced Jo2-induced cell death. Conversely, the GSH-depleting agent buthionine sulfoximine completely abolished the protective effects of N-acetylcysteine in Met-KO hepatocytes. In conclusion, genetic inactivation of c-Met in mouse hepatocytes caused defects in redox regulation, which may account for the increased sensitivity to Fas-induced apoptosis and adaptive up-regulation of NF-kappa B survival signaling. These data provide evidence that intact c-Met signaling is a critical factor in the protection against excessive generation of endogenous reactive oxygen species.	[Gomez-Quiroz, Luis E.; Factor, Valentina M.; Kaposi-Novak, Pal; Coulouarn, Cedric; Conner, Elizabeth A.; Thorgeirsson, Snorri S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thorgeirsson, SS (corresponding author), 37 Convent Dr,Bldg 37,Rm 4146A, Bethesda, MD 20892 USA.	snorri_s_thorgeirsson@nih.gov	Coulouarn, Cedric/E-5472-2011; Gomez-Quiroz, Luis/L-8415-2013	Coulouarn, Cedric/0000-0002-5692-9586; Gomez-Quiroz, Luis Enrique/0000-0002-5704-5985	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010638] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson ME, 1998, SEMIN LIVER DIS, V18, P415, DOI 10.1055/s-2007-1007174; Arena S, 2007, P NATL ACAD SCI USA, V104, P11412, DOI 10.1073/pnas.0703205104; Buege J A, 1978, Methods Enzymol, V52, P302; Carmona-Cuenca I, 2006, J CELL PHYSIOL, V207, P322, DOI 10.1002/jcp.20568; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Comoglio PM, 2001, NAT CELL BIOL, V3, pE161, DOI 10.1038/35083116; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Devadas S, 2003, FREE RADICAL BIO MED, V35, P648, DOI 10.1016/S0891-5849(03)00391-5; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Fan SJ, 2005, ONCOGENE, V24, P1749, DOI 10.1038/sj.onc.1208327; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Fornoni A, 2001, AM J PATHOL, V158, P275, DOI 10.1016/S0002-9440(10)63966-1; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kannan R, 2004, FREE RADICAL BIO MED, V37, P166, DOI 10.1016/j.freeradbiomed.2004.04.011; Kao CY, 1996, BIOCHEM BIOPH RES CO, V222, P64, DOI 10.1006/bbrc.1996.0698; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Morante M, 2005, FREE RADICAL RES, V39, P1127, DOI 10.1080/10715760500193820; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Nakagawa T, 1996, MUTAT RES-ENVIR MUTA, V360, P181, DOI 10.1016/S0165-1161(96)90015-1; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Sanchez A, 2004, HEPATOLOGY, V40, P590, DOI 10.1002/hep.20363; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Santangelo C, 2007, J MOL ENDOCRINOL, V38, P147, DOI 10.1677/jme.1.02133; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Shiba D, 1999, FREE RADICAL BIO MED, V27, P1019, DOI 10.1016/S0891-5849(99)00150-1; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tripathi P, 2004, APOPTOSIS, V9, P515, DOI 10.1023/B:APPT.0000038033.14925.02; Tsuboi S, 1999, J BIOCHEM-TOKYO, V126, P815, DOI 10.1093/oxfordjournals.jbchem.a022521; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898	46	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14581	14589		10.1074/jbc.M707733200	http://dx.doi.org/10.1074/jbc.M707733200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18348981	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000255941400046
J	Yamakoshi, Y; Lu, Y; Hu, JCC; Kim, JW; Iwata, T; Kobayashi, K; Nagano, T; Yamakoshi, F; Hu, Y; Fukae, M; Simmer, JP				Yamakoshi, Yasuo; Lu, Yuhe; Hu, Jan C. -C.; Kim, Jung-Wook; Iwata, Takanori; Kobayashi, Kazuyuki; Nagano, Takatoshi; Yamakoshi, Fumiko; Hu, Yuanyuan; Fukae, Makoto; Simmer, James P.			Porcine dentin sialophosphoprotein - Length polymorphisms, glycosylation, phosphorylation, and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPERFECTA TYPE-II; DENTINOGENESIS IMPERFECTA; SEQUENCE DETERMINATION; MATRIX PROTEINS; IN-VITRO; DSPP; PHOSPHOPROTEIN; PHOSPHOPHORYN; SIALOPROTEIN; GENE	Dentin sialophosphoprotein (DSPP) is critical for proper mineralization of tooth dentin, and mutations in DSPP cause inherited dentin defects. Dentin phosphoprotein (DPP) is the C-terminal cleavage product of DSPP that binds collagen and induces intrafibrillar mineralization. We isolated DPP from individual pigs and determined that its N-terminal and C-terminal domains are glycosylated and that DPP averages 155 phosphates per molecule. Porcine DPP is unstable at low pH and high temperatures, and complexing with collagen improves its stability. Surprisingly, we observed DPP size variations on SDS-PAGE for DPP isolated from individual pigs. These variations are not caused by differences in proteolytic processing or degrees of phosphorylation or glycosylation, but rather to allelic variations in Dspp. Characterization of the DPP coding region identified 4 allelic variants. Among the 4 alleles, 27 sequence variations were identified, including 16 length polymorphisms ranging from 3 to 63 nucleotides. None of the length variations shifted the reading frame, and all localized to the highly redundant region of the DPP code. The 4 alleles encode DPP domains having 551, 575, 589, or 594 amino acids and completely explain the DPP size variations. DPP length variations are polymorphic and are not associated with dentin defects.	[Yamakoshi, Yasuo; Nagano, Takatoshi; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA; [Hu, Yuanyuan] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48108 USA; [Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul 110768, South Korea; [Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110768, South Korea; [Nagano, Takatoshi] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; [Kobayashi, Kazuyuki; Nagano, Takatoshi] Tsurumi Univ, Sch Dent Med, Dept Periodont & Endodont, Yokohama, Kanagawa 2308501, Japan; [Fukae, Makoto] Tsurumi Univ, Sch Dent Med, Dept Biochem, Yokohama, Kanagawa 2308501, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seoul National University (SNU); Seoul National University (SNU); Tokyo Women's Medical University; Tsurumi University; Tsurumi University	Simmer, JP (corresponding author), Univ Michigan, Dent Res Lab, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA.	jsimmer@umich.edu	Hu, Jan C-C./F-5679-2015; Iwata, Takanori/AAT-3219-2020	Hu, Jan C-C./0000-0002-9294-0248; Iwata, Takanori/0000-0002-5461-7298	NIDCR NIH HHS [R01 DE011301, DE 15846, R01 DE015846, R01 DE015846-05, R29 DE011301, R56 DE011301, DE 11301] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011301, R01DE011301, R29DE011301] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BUTLER WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P178, DOI 10.1016/0003-9861(83)90021-8; BUTLER WT, 1981, COLLAGEN REL RES, V1, P187; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; Chang SR, 1996, CALCIFIED TISSUE INT, V59, P149, DOI 10.1007/s002239900101; Cross KJ, 2005, J PEPT RES, V66, P59, DOI 10.1111/j.1399-3011.2005.00273.x; Dong J, 2005, AM J MED GENET A, V132A, P305, DOI 10.1002/ajmg.a.30460; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hart PS, 2007, CELLS TISSUES ORGANS, V186, P70, DOI 10.1159/000102682; Holappa H, 2006, EUR J ORAL SCI, V114, P381, DOI 10.1111/j.1600-0722.2006.00391.x; Huq NL, 2000, J DENT RES, V79, P1914, DOI 10.1177/00220345000790111701; IBARAKI K, 1991, MATRIX, V11, P115, DOI 10.1016/S0934-8832(11)80215-5; JONSSON M, 1978, J CHROMATOGR, V157, P234; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2005, HUM GENET, V116, P186, DOI 10.1007/s00439-004-1223-6; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Malmgren B, 2004, HUM GENET, V114, P491, DOI 10.1007/s00439-004-1084-z; Patel PI, 2001, NAT GENET, V27, P129, DOI 10.1038/84728; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; RITCHIE HH, 1994, J BIOL CHEM, V269, P3698; Song YL, 2006, ORAL SURG ORAL MED O, V102, P360, DOI 10.1016/j.tripleo.2005.06.020; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; TERMINE JD, 1980, J BIOL CHEM, V255, P9769; Thomas LJ, 2004, GLYCOBIOLOGY, V14, P883, DOI 10.1093/glycob/cwh112; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2005, J BIOL CHEM, V280, P1552, DOI 10.1074/jbc.M409606200; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamakoshi Y, 2003, EUR J ORAL SCI, V111, P60, DOI 10.1034/j.1600-0722.2003.00009.x; YAMAKOSHI Y, 2008, IN PRESS J ORAL BIOS; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Zhang XQ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-52	34	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14835	14844		10.1074/jbc.M800633200	http://dx.doi.org/10.1074/jbc.M800633200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18359767	Green Published, hybrid			2022-12-27	WOS:000255941400071
J	Hanley, KP; Oakley, F; Sugden, S; Wilson, DI; Mann, DA; Hanley, NA				Hanley, Karen Piper; Oakley, Fiona; Sugden, Sarah; Wilson, David I.; Mann, Derek A.; Hanley, Neil A.			Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITOR; HUMAN PANCREAS DEVELOPMENT; TRANSCRIPTION FACTOR SOX9; NEURAL CREST DEVELOPMENT; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; MESENCHYMAL TRANSITION; LIVER FIBROSIS; INTESTINAL EPITHELIUM	Appropriate temporospatial expression of the transcription factor SOX9 is important for normal development of a wide range of organs. Here, we show that when SOX9 is expressed ectopically, target genes become expressed that are associated with disease. Histone deacetylase inhibitors in clinical trials for cancer therapy induced SOX9 expression via enhanced recruitment of nuclear factor Y (NF-Y) to CCAAT elements in the SOX9 proximal promoter. The effect of histone deacetylase inhibitors could be elicited in cells that normally lack SOX9, such as hepatocytes. In human fetal hepatocytes, this aberrant induction of SOX9 protein caused ectopic expression of COL2A1 and COMP1 that encode extracellular matrix (ECM) components normally associated with chondrogenesis. Previously, ectopic expression of this "chondrogenic" profile has been implicated in vascular calcification. More broadly, inappropriate ECM deposition is a hallmark of fibrosis. We demonstrated that induction of SOX9 expression also occurred during activation of fibrogenic cells from the adult liver when the transcription factor was responsible for expression of the major component of fibrotic ECM, type 1 collagen. These combined data identify new aspects in the regulation of SOX9 expression. They support a role for SOX9 beyond normal development as a transcriptional regulator in the pathology of fibrosis.	[Hanley, Karen Piper; Sugden, Sarah; Wilson, David I.; Hanley, Neil A.] Univ Southampton, Southampton Gen Hosp, Div Human Genet, Southampton SO16 6YD, Hants, England; [Hanley, Karen Piper; Sugden, Sarah; Wilson, David I.; Hanley, Neil A.] Univ Southampton, Southampton Gen Hosp, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England; [Oakley, Fiona; Mann, Derek A.] Newcastle Univ, Inst Cellular Med, Liver Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Southampton; University of Southampton; Newcastle University - UK	Hanley, KP (corresponding author), Univ Southampton, Southampton Gen Hosp, Div Human Genet, Duthie Bldg,Mailpoint 808,Tremona Rd, Southampton SO16 6YD, Hants, England.	k.piper@soton.ac.uk; n.a.hanley@soton.ac.uk	Piper Hanley, Karen/O-8676-2015; Wilson, David/A-6264-2010	Piper Hanley, Karen/0000-0001-9473-9647; Wilson, David/0000-0001-8779-2060; Sugden, Sarah/0000-0003-2071-4038; Hanley, Neil/0000-0003-3234-4038; Mann, Derek/0000-0003-0950-243X	Medical Research Council [G0401643] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0401643] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Colter DC, 2005, MATRIX BIOL, V24, P185, DOI 10.1016/j.matbio.2005.04.001; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Deutsch G, 2001, DEVELOPMENT, V128, P871; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Friedman SL, 2006, J GASTROEN HEPATOL, V21, pS79, DOI 10.1111/j.1440-1746.2006.04585.x; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Hanley NA, 2000, MECH DEVELOP, V91, P403, DOI 10.1016/S0925-4773(99)00307-X; Hanley NA, 2001, MOL ENDOCRINOL, V15, P57, DOI 10.1210/me.15.1.57; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007; Kent J, 1996, DEVELOPMENT, V122, P2813; Kypriotou M, 2007, J BIOL CHEM, V282, P32000, DOI 10.1074/jbc.M705197200; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Liu CJ, 2007, FRONT BIOSCI, V12, P3899, DOI 10.2741/2359; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Naitoh M, 2005, GENES CELLS, V10, P1081, DOI 10.1111/j.1365-2443.2005.00902.x; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Piera-Velazquez S, 2007, EXP CELL RES, V313, P1069, DOI 10.1016/j.yexcr.2007.01.001; Piper K, 2002, MECH DEVELOP, V116, P223, DOI 10.1016/S0925-4773(02)00145-4; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; Rombouts K, 2002, EXP CELL RES, V278, P184, DOI 10.1006/excr.2002.5577; Schaefer JF, 2003, OSTEOARTHR CARTILAGE, V11, P233, DOI 10.1016/S1063-4584(02)00354-0; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Smart DE, 2006, HEPATOLOGY, V44, P1432, DOI 10.1002/hep.21436; Spokony RF, 2002, DEVELOPMENT, V129, P421; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Ylostalo J, 2006, STEM CELLS, V24, P642, DOI 10.1634/stemcells.2005-0270; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	51	88	93	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14063	14071		10.1074/jbc.M707390200	http://dx.doi.org/10.1074/jbc.M707390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18296708	hybrid			2022-12-27	WOS:000255728200060
J	Saito, T; Nishi, M; Lim, MI; Wu, B; Maeda, T; Hashimoto, H; Takeuchi, T; Roos, DS; Asai, T				Saito, Tomoya; Nishi, Manami; Lim, Muoy I.; Wu, Bo; Maeda, Takuya; Hashimoto, Hisayuki; Takeuchi, Tsutomu; Roos, David S.; Asai, Takashi			A novel GDP-dependent pyruvate kinase isozyme from Toxoplasma gondii localizes to both the apicoplast and the mitochondrion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PLASMODIUM-FALCIPARUM; NUCLEOSIDE TRIPHOSPHATE HYDROLASE; ESCHERICHIA-COLI; SUBCELLULAR-LOCALIZATION; ALLOSTERIC TRANSITION; REGULATORY PROPERTIES; SIGNAL PEPTIDES; ORTHOLOG GROUPS; CLEAVAGE SITES; METABOLIC MAPS	We previously reported a cytosolic pyruvate kinase (EC 2.7.1.40) from Toxoplasma gondii (TgPyKI) that differs from most eukaryotic pyruvate kinases in being regulated by glucose 6-phosphate rather than fructose 1,6-diphosphate. Another putative pyruvate kinase (TgPyKII) was identified from parasite genome, which exhibits 32% amino acid sequence identity to TgPyKI and retains pyruvate kinase signature motifs and amino acids essential for substrate binding and catalysis. Whereas TgPyKI is most closely related to plant/algal enzymes, phylogenetic analysis suggests a proteobacterial origin for TgPyKII. Enzymatic characterization of recombinant TgPyKII shows a high pH optimum at 8.5, and a preference for GDP as a phosphate recipient. Catalytic activity is independent of K+, and no allosteric or regulatory effects were observed in the presence of fructose 1,6-diphosphate, fructose 2,6-diphosphate, glucose 6-phosphate, ribose 5-phosphate, AMP, or ATP. Unlike TgPyKI, native TgPyKII activity was exclusively associated with the membranous fraction of a T. gondii tachyzoite lysate. TgPyKII possesses a long N-terminal extension containing five putative start codons before the conserved region and localizes to both apicoplast and mitochondrion by immunofluorescence assay using native antibody and fluorescent protein fusion to the N-terminal extension. Further deletional and site-directed mutagenesis suggests that a translation product from 1st Met is responsible for the localization to the apicoplast, whereas one from 3rd Met is for the mitochondrion. This is the first study of a potential mitochondrial pyruvate kinase in any system.	[Saito, Tomoya; Maeda, Takuya; Hashimoto, Hisayuki; Takeuchi, Tsutomu; Asai, Takashi] Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan; [Nishi, Manami; Lim, Muoy I.; Wu, Bo; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Keio University; University of Pennsylvania	Asai, T (corresponding author), Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	asait@sc.itc.keio.ac.jp	Hashimoto, Hisayuki/AAS-1938-2020	Hashimoto, Hisayuki/0000-0001-7367-4805; Roos, David Siker/0000-0001-6725-4089; Maeda, Takuya/0000-0003-0912-4643; Saito, Tomoya/0000-0001-6250-4464				ABBE K, 1982, J BACTERIOL, V149, P299, DOI 10.1128/JB.149.1.299-305.1982; ASAI T, 1990, FEMS MICROBIOL LETT, V72, P89, DOI 10.1111/j.1574-6968.1990.tb03867.x; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOYER PD, 1962, ENZYMES, P95; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Coombs GH, 1997, ADV PARASIT, V39, P141, DOI 10.1016/S0065-308X(08)60046-9; Crawford MJ, 2006, EMBO J, V25, P3214, DOI 10.1038/sj.emboj.7601189; CROW VL, 1982, METHOD ENZYMOL, V90, P165, DOI 10.1016/S0076-6879(82)90122-7; Denton H, 1996, MOL BIOCHEM PARASIT, V76, P23, DOI 10.1016/0166-6851(95)02527-8; Denton H, 1996, FEMS MICROBIOL LETT, V137, P103, DOI 10.1111/j.1574-6968.1996.tb08090.x; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Dubey J., 1993, PARASITIC PROTOZOA, P5; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Esposito S, 2001, PLANTA, V212, P627, DOI 10.1007/s004250000443; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Fulton J. D., 1960, Experimental Parasitology, V9, P293, DOI 10.1016/0014-4894(60)90037-0; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Hattori J, 1995, BIOCHEM SYST ECOL, V23, P773, DOI 10.1016/0305-1978(95)00061-5; Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; IRELAND RJ, 1979, PLANT PHYSIOL, V63, P903, DOI 10.1104/pp.63.5.903; IRELAND RJ, 1980, PLANT PHYSIOL, V65, P1188, DOI 10.1104/pp.65.6.1188; JAULT JM, 1991, J BIOL CHEM, V266, P8073; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KAHN A, 1982, METHOD ENZYMOL, V90, P131; KAPOOR R, 1981, BIOCHEM J, V193, P435, DOI 10.1042/bj1930435; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; KROGH A, 1998, P 6 INT C INT SYST M, P122; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; Laughlin LT, 1997, ARCH BIOCHEM BIOPHYS, V348, P262, DOI 10.1006/abbi.1997.0448; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maeda T, 2003, PARASITOL RES, V89, P259, DOI 10.1007/s00436-002-0739-8; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Melo EJL, 2000, J STRUCT BIOL, V130, P27, DOI 10.1006/jsbi.2000.4228; MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NISHI M, 2006, THESIS U PENNSYLVANI; Olejnik K, 2007, FEBS J, V274, P4877, DOI 10.1111/j.1742-4658.2007.06009.x; Oria-Hernandez J, 2006, J BIOL CHEM, V281, P30717, DOI 10.1074/jbc.M605310200; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; PENG ZY, 1992, MOL BIOCHEM PARASIT, V54, P223, DOI 10.1016/0166-6851(92)90114-Y; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; PLOWMAN KM, 1965, BIOCHEMISTRY-US, V4, P2809, DOI 10.1021/bi00888a035; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Saavedra E, 2004, EXP PARASITOL, V106, P11, DOI 10.1016/j.exppara.2004.01.009; Saito T, 2002, INT J PARASITOL, V32, P961, DOI 10.1016/S0020-7519(02)00059-0; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; SIMCOX PD, 1978, PLANT PHYSIOL, V61, P871, DOI 10.1104/pp.61.6.871; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WAYGOOD EB, 1974, J BIOL CHEM, V249, P265; WAYGOOD EB, 1975, CAN J BIOCHEM CELL B, V53, P444, DOI 10.1139/o75-061; Wiesner J, 2005, EXPERT OPIN THER TAR, V9, P23, DOI 10.1517/14728222.9.1.23; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	73	39	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14041	14052		10.1074/jbc.M709015200	http://dx.doi.org/10.1074/jbc.M709015200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326043	Green Published, hybrid			2022-12-27	WOS:000255728200058
J	Boutilier, J; Ceni, C; Pagdala, PC; Forgie, A; Neet, KE; Barker, PA				Boutilier, Jacqueline; Ceni, Claire; Pagdala, Promila C.; Forgie, Alison; Neet, Kenneth E.; Barker, Philip A.			Proneurotrophins require endocytosis and intracellular proteolysis to induce TrkA activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; SIGNALING ENDOSOME; ALZHEIMERS-DISEASE; PRO-PEPTIDE; CELL-DEATH; PROTEIN; BRAIN; FURIN; NGF	The uncleaved, pro-form of nerve growth factor (proNGF) functions as a pro-apoptotic ligand for the p75 neurotrophin receptor (p75NTR). However, some reports have indicated that proneurotrophins bind and activate Trk receptors. In this study, we have examined proneurotrophin receptor binding and activation properties in an attempt to reconcile these findings. We show that proNGF readily binds p75NTR expressed in HEK293T cells but does not interact with TrkA expressed under similar circumstances. Importantly, proNGF activates TrkA tyrosine phosphorylation, induces Erk and Akt activation, and causes PC12 cell differentiation. We show that inhibiting endocytosis or furin activity reduced TrkA activation induced by proNGF but not that induced by mature NGF and that proNGF123, a mutant form of NGF lacking dibasic cleavage sites in the prodomain, does not induce TrkA phosphorylation in PC12 cells. Therefore, endocytosis and cleavage appear to be prerequisites for proNGF-induced TrkA activity. We also found that proBDNF induces activation of TrkB in cerebellar granule neurons and that proBDNF cleavage by furin and metalloproteases facilitates this effect. Taken together, these data indicate that under physiological conditions, proneurotrophins do not directly bind or activate Trk receptors. However, endocytosis and cleavage of proneurotrophins produce processed forms of neurotrophins that are capable of inducing Trk activation.	McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Boutilier, Jacqueline; Ceni, Claire; Barker, Philip A.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; [Forgie, Alison] Rinat Neurosci, San Francisco, CA 94080 USA	McGill University; Rosalind Franklin University Medical & Science	Barker, PA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	phil.barker@mcgill.ca			NINDS NIH HHS [NS24380] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Althaus HH, 2006, J NEUROCHEM, V98, P506, DOI 10.1111/j.1471-4159.2006.03891.x; Band AM, 2001, FEBS LETT, V505, P118, DOI 10.1016/S0014-5793(01)02798-3; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bierl MA, 2005, NEUROSCI LETT, V380, P133, DOI 10.1016/j.neulet.2005.01.029; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen CD, 2001, EMBO J, V20, P6277, DOI 10.1093/emboj/20.22.6277; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hasan W, 2003, J NEUROBIOL, V57, P38, DOI 10.1002/neu.10250; Hauburger A, 2007, FEBS LETT, V581, P4159, DOI 10.1016/j.febslet.2007.07.063; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; JEANNETEAU F, 2006, NOVART FDN SYMP, V276, P189; JEANNETEAU F, 2006, NOVART FDN SYMP, V276, P187; Jeanneteau Freddy, 2006, Novartis Found Symp, V276, P181; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Paoletti F, 2006, BIOCHEM SOC T, V34, P605, DOI 10.1042/BST0340605; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Peters EMJ, 2006, J HISTOCHEM CYTOCHEM, V54, P275, DOI 10.1369/jhc.4A6585.2005; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Scott GK, 2003, EMBO J, V22, P6234, DOI 10.1093/emboj/cdg596; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	40	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12709	12716		10.1074/jbc.M710018200	http://dx.doi.org/10.1074/jbc.M710018200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18299325	hybrid, Green Published			2022-12-27	WOS:000255499800006
J	Cheng, KT; Liu, XB; Ong, HL; Ambudkar, IS				Cheng, Kwong Tai; Liu, Xibao; Ong, Hwei Ling; Ambudkar, Indu S.			Functional requirement for Orai1 in store-operated TRPC1-STIM1 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CALCIUM-CHANNELS; SALIVARY-GLAND CELLS; CRAC CHANNEL; CA2+ INFLUX; TRPC CHANNELS; PORE SUBUNIT; ENTRY; STIM1; PROTEIN; MICE	Orai1 and TRPC1 have been proposed as core components of store-operated calcium release-activated calcium ( CRAC) and store-operated calcium (SOC) channels, respectively. STIM1, a Ca2+ sensor protein in the endoplasmic reticulum, interacts with and mediates store-dependent regulation of both channels. We have previously reported that dynamic association of Orai1, TRPC1, and STIM1 is involved in activation of store-operated Ca2+ entry ( SOCE) in salivary gland cells. In this study, we have assessed the molecular basis of TRPC1-SOC channels in HEK293 cells. We report that TRPC1+STIM1-dependent SOCE requires functional Orai1. Thapsigargin stimulation of cells expressing Orai1 + STIM1 increased Ca2+ entry and activated typical I-CRAC current. STIM1 alone did not affect SOCE, whereas expression of Orai1 induced a decrease. Expression of TRPC1 induced a small increase in SOCE, which was greatly enhanced by co-expression of STIM1. Thapsigargin stimulation of cells expressing TRPC1 + STIM1 activated a non-selective cation current, I-SOC, that was blocked by 1 mu M Gd3+ and 2-APB. Knockdown of Orai1 decreased endogenous SOCE as well as SOCE with TRPC1 alone. siOrai1 also significantly reduced SOCE and ISOC in cells expressing TRPC1 + STIM1. Expression of R91WOrai1 or E106QOrai1 induced similar attenuation of TRPC1 + STIM1-dependent SOCE and ISOC, whereas expression of Orai1 with TRPC1 + STIM1 resulted in SOCE that was larger than that with Orai1 + STIM1 or TRPC1 + STIM1 but not additive. Additionally, Orai1, E106QOrai1, and R91WOrai1 co-immunoprecipitated with similar levels of TRPC1 and STIM1 from HEK293 cells, and endogenous TRPC1, STIM1, and Orai1 were co-immunoprecipitated from salivary glands. Together, these data demonstrate a functional requirement for Orai1 in TRPC1 + STIM1-dependent SOCE.	[Cheng, Kwong Tai; Liu, Xibao; Ong, Hwei Ling; Ambudkar, Indu S.] NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ambudkar, IS (corresponding author), NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bldg 10,Rm 1N-113, Bethesda, MD 20892 USA.	indu.ambudkar@nih.gov		Ong, Hwei Ling/0000-0002-7551-6883	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000438] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Bolotina Victoria M, 2004, Sci STKE, V2004, ppe34, DOI 10.1126/stke.2432004pe34; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu X, 2004, J MEMBRANE BIOL, V200, P93, DOI 10.1007/s00232-004-0698-3; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Mori Y, 2001, JPN J PHARMACOL, V87, P245, DOI 10.1254/jjp.87.245; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tseng PH, 2004, BIOCHEMISTRY-US, V43, P11701, DOI 10.1021/bi049349f; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Wissenbach U, 2007, CELL CALCIUM, V42, P439, DOI 10.1016/j.ceca.2007.05.014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	36	172	179	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12935	12940		10.1074/jbc.C800008200	http://dx.doi.org/10.1074/jbc.C800008200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326500	Green Published, hybrid			2022-12-27	WOS:000255499800030
J	Parker, MD; Musa-Aziz, R; Rojas, JD; Choi, I; Daly, CM; Boron, WF				Parker, Mark D.; Musa-Aziz, Raif; Rojas, Jose D.; Choi, Inyeong; Daly, Christopher M.; Boron, Walter F.			Characterization of human SLC4A10 as an electroneutral Na/HCO3 cotransporter (NBCn2) with Cl- self-exchange activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROGENIC NA+-HCO3-COTRANSPORTER; INTRACELLULAR PH TRANSIENTS; SQUID GIANT-AXONS; FUNCTIONAL-CHARACTERIZATION; XENOPUS OOCYTES; TISSUE DISTRIBUTION; CHLORIDE TRANSPORT; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; FIBER LOBE	The SLC4A10 gene product, commonly known as NCBE, is highly expressed in rodent brain and has been characterized by others as a Na+-driven Cl-HCO3 exchanger. However, some of the earlier data are not consistent with Na+-driven Cl-HCO3 exchange activity. In the present study, northern blot analysis showed that, also in humans, NCBE transcripts are predominantly expressed in brain. In some human NCBE transcripts, splice cassettes A and/or B, originally reported in rats and mice, are spliced out. In brain cDNA, we found evidence of a unique partial splice of cassette B that is predicted to produce an NCBE protein with a novel C terminus containing a protein kinase C phosphorylation site. We used pH-sensitive microelectrodes to study the molecular physiology of human NCBE expressed in Xenopus oocytes. In agreement with others we found that NCBE mediates the 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid-sensitive, Na+-dependent transport of HCO3-. For the first time, we demonstrated that this transport process is electroneutral. Using Cl--sensitive microelectrodes positioned at the oocyte surface, we found that, unlike both human and squid Na+-driven Cl-HCO3 exchangers, human NCBE does not normally couple the net influx of HCO3-to a net efflux of Cl-. Moreover we found that that the Cl-36 efflux from NCBE-expressing oocytes, interpreted by others to be coupled to the influx of Na+ and HCO3-, actually represents a CO2/HCO3-stimulated Cl-self-exchange not coupled to either Na+ or net HCO3-transport. We propose to rename NCBE as the second electroneutral Na/HCO3 cotransporter, NBCn2.	[Parker, Mark D.; Musa-Aziz, Raif; Rojas, Jose D.; Choi, Inyeong; Daly, Christopher M.; Boron, Walter F.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Boron, WF (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	wfb2@case.edu	Musa-Aziz, Raif/F-3434-2013; Boron, Walter/ABI-1564-2020; Parker, Mark/AAH-5575-2020; choi, inyeong/AAM-4826-2021	Musa-Aziz, Raif/0000-0002-0386-4248; Boron, Walter/0000-0003-4741-7287	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018400] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK030344, R37 DK030344-28] Funding Source: Medline; NINDS NIH HHS [NS18400, R01 NS018400-19A2, R01 NS018400] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BORON WF, 1977, AM J PHYSIOL, V233, pC61, DOI 10.1152/ajpcell.1977.233.3.C61; BORON WF, 1983, J GEN PHYSIOL, V81, P373, DOI 10.1085/jgp.81.3.373; Bourgeois S, 2002, AM J PHYSIOL-RENAL, V282, pF655, DOI 10.1152/ajprenal.00220.2000; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; Chen LM, 2008, NEUROSCIENCE, V151, P374, DOI 10.1016/j.neuroscience.2007.10.015; Choi I, 2002, FASEB J, V16, pA796; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; DALMARK M, 1976, J GEN PHYSIOL, V67, P223, DOI 10.1085/jgp.67.2.223; Doughty JM, 2001, J PHYSIOL-LONDON, V534, P753, DOI 10.1111/j.1469-7793.2001.t01-1-00753.x; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Grichtchenko II, 2001, J BIOL CHEM, V276, P8358, DOI 10.1074/jbc.C000716200; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Hubner CA, 2004, GENE EXPR PATTERNS, V5, P219, DOI 10.1016/j.modgep.2004.08.002; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; JAROLIMEK W, 1990, PFLUG ARCH EUR J PHY, V416, P247, DOI 10.1007/BF00392060; KIETZ D, 1991, BIOCHIM BIOPHYS ACTA, V1064, P81, DOI 10.1016/0005-2736(91)90414-4; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Lu J, 2007, AM J PHYSIOL-CELL PH, V292, pC1787, DOI 10.1152/ajpcell.00267.2006; Odgaard E, 2004, J PHYSIOL-LONDON, V555, P205, DOI 10.1113/jphysiol.2003.046474; OKUBO K, 1994, J BIOL CHEM, V269, P1918; PARKER MD, 2007, SELDIN GIEBISCHS KID, P1481; Pasternack M, 1996, NEUROPHARMACOLOGY, V35, P1279, DOI 10.1016/S0028-3908(96)00075-5; Piermarini PM, 2007, AM J PHYSIOL-CELL PH, V292, pC2032, DOI 10.1152/ajpcell.00544.2006; Praetorius J, 2004, AM J PHYSIOL-CELL PH, V286, pC601, DOI 10.1152/ajpcell.00240.2003; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; RANSOM BR, 1992, PROG BRAIN RES, V94, P37; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; RUSSELL JM, 1976, NATURE, V264, P73, DOI 10.1038/264073a0; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; THOMAS RC, 1977, J PHYSIOL-LONDON, V273, P317, DOI 10.1113/jphysiol.1977.sp012096; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; Virkki LV, 2003, AM J PHYSIOL-CELL PH, V285, pC771, DOI 10.1152/ajpcell.00439.2002; Virkki LV, 2002, AM J PHYSIOL-CELL PH, V282, pC1278, DOI 10.1152/ajpcell.00589.2001; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200	43	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12777	12788		10.1074/jbc.M707829200	http://dx.doi.org/10.1074/jbc.M707829200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319254	hybrid, Green Published			2022-12-27	WOS:000255499800014
J	Sheoran, A; Sharma, G; First, EA				Sheoran, Anita; Sharma, Gyanesh; first, Eric A.			Activation of D-tyrosine by Bacillus stearothermophilus tyrosyl-tRNA synthetase - 1. Pre-steady-state kinetic analysis reveals the mechanistic basis for the recognition of D-tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; TRANSITION-STATE; BINDING-ENERGY; GENETIC-CODE; MOBILE LOOP; POSITION 51	Tyrosyl-tRNA synthetase (TyrRS) is able to catalyze the transfer of both L-and D-tyrosine to the 3' end of tRNATyr. Activation of either stereoisomer by ATP results in formation of an enzyme-bound tyrosyl-adenylate intermediate and is accompanied by a blue shift in the intrinsic fluorescence of the protein. Single turnover kinetics for the aminoacylation of tRNATyr by D-tyrosine were monitored using stopped-flow fluorescence spectroscopy. Bacillus stearothermophilus tyrosyl-tRNA synthetase binds D-tyrosine with an 8.5-fold lower affinity than that of L-tyrosine (K-d (D-Tyr) = 102 mu M) and exhibits a 3-fold decrease in the forward rate constant for the activation reaction (k(3)(D-Tyr) = 13 s(-1)). Furthermore, as is the case for L-tyrosine, tyrosyl-tRNA synthetase exhibits "half-of-the-sites" reactivity with respect to the binding and activation of D-tyrosine. Surprisingly, pyrophosphate binds to the TyrRS.D-Tyr-AMP intermediate with a 14-fold higher affinity than it binds to the TyrRS.L-TyrAMP intermediate (K-d(PPi) = 0.043 for TyrRS.D-Tyr-AMP.PPi). tRNATyr binds with a slightly (2.3-fold) lower affinity to the TyrRS.D-Tyr-AMP intermediate than it does to the TyrRS.LTyr-AMP intermediate. The observation that the K-d(Tyr) and k(3) values are similar for L- and D-tyrosine suggests that their side chains bind to tyrosyl-tRNA synthetase in similar orientations and that at least one of the carboxylate oxygen atoms in D-tyrosine is properly positioned for attack on the alpha-phosphate of ATP.	[Sheoran, Anita; Sharma, Gyanesh; first, Eric A.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	First, EA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	efirst@lsuhsc.edu	Sharma, Gyanesh/G-1210-2012		NIGMS NIH HHS [GM68070, R01 GM068070] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068070] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; AVIS JM, 1993, BIOCHEMISTRY-US, V32, P5312, DOI 10.1021/bi00071a005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1967, J MOL BIOL, V26, P39, DOI 10.1016/0022-2836(67)90259-8; CLARKE AR, 1996, ENZYMOLOGY LABFAX, P201; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELANO WL, 2002, PYMOL MOL GRAPHICS; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1985, BIOCHEMISTRY-US, V24, P5858, DOI 10.1021/bi00342a025; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13644, DOI 10.1021/bi00212a032; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13658, DOI 10.1021/bi00212a034; Gibson T., 1984, THESIS U CAMBRIDGE C; HO CK, 1986, BIOCHEMISTRY-US, V25, P1891, DOI 10.1021/bi00356a009; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JONES DH, 1985, BIOCHEMISTRY-US, V24, P5852, DOI 10.1021/bi00342a024; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; LIN SX, 1983, BIOCHEMISTRY-US, V22, P681, DOI 10.1021/bi00272a024; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; SANTI DV, 1971, FEBS LETT, V13, P157, DOI 10.1016/0014-5793(71)80224-7; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sheoran A, 2008, J BIOL CHEM, V283, P12971, DOI 10.1074/jbc.M801650200; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Soutourina O, 2004, J BIOL CHEM, V279, P42560, DOI 10.1074/jbc.M402931200; Thompson D, 2007, J BIOL CHEM, V282, P30856, DOI 10.1074/jbc.M704788200; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Xin Y, 2000, BIOCHEMISTRY-US, V39, P340, DOI 10.1021/bi991675l	45	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12960	12970		10.1074/jbc.M801649200	http://dx.doi.org/10.1074/jbc.M801649200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319247	Green Published, hybrid			2022-12-27	WOS:000255499800033
J	Tornaletti, S; Park-Snyder, S; Hanawalt, PC				Tornaletti, Silvia; Park-Snyder, Shaun; Hanawalt, Philip C.			G4-forming sequences in the non-transcribed DNA strand pose blocks to T7 RNA polymerase and mammalian RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SWITCH REGIONS; G4 DNA; TRANSCRIPTION ELONGATION; TEMPLATE DNA; RAT-LIVER; PURIFICATION; GENE; TRANSLOCATION; HYPERMUTATION; COMPLEXES	DNA sequences rich in runs of guanine have the potential to form G4 DNA, a four-stranded non-canonical DNA structure stabilized by formation and stacking of G quartets, planar arrays of four hydrogen-bonded guanines. It was reported recently that G4 DNA can be generated in Escherichia coli during transcription of plasmids containing G-rich sequences in the non-transcribed strand. In addition, a stable RNA/DNA hybrid is formed with the transcribed strand. These novel structures, termed G loops, are suppressed in recQ(+) strains, suggesting that their persistence may generate genomic instability and that the RecQ helicase may be involved in their dissolution. However, little is known about how such non-canonical DNA structures are processed when encountered by an elongating polymerase. To assess whether G4-forming sequences interfere with transcription, we studied their effect on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II. We used a reconstituted transcription system in vitro with purified polymerase and initiation factors and with substrates containing G-rich sequences in either the transcribed or non-transcribed strand downstream of the T7 promoter or the adenovirus major late promoter. We report that G-rich sequences located in the transcribed strand do not affect transcription by either polymerase, but when the sequences are located in the non-transcribed strand, they partially arrest both polymerases. The efficiency of arrest increases with negative supercoiling and also with multiple rounds of transcription compared with single events.	[Tornaletti, Silvia] Univ Florida, Dept Anat & Cell Biol, Coll Med, Gainesville, FL 32610 USA; [Tornaletti, Silvia; Park-Snyder, Shaun; Hanawalt, Philip C.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	State University System of Florida; University of Florida; Stanford University	Tornaletti, S (corresponding author), Univ Florida, Dept Anat & Cell Biol, Coll Med, Gainesville, FL 32610 USA.	silviat@ufl.edu			NCI NIH HHS [R01 CA077712, CA-77712] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077712, R56CA077712] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; CONAWAY JW, 1987, J BIOL CHEM, V262, P8293; Conaway RC, 1996, METHOD ENZYMOL, V273, P194; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; GRABCZYK E, 1995, J BIOL CHEM, V270, P1791, DOI 10.1074/jbc.270.4.1791; GU WG, 1993, J BIOL CHEM, V268, P25604; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Larson ED, 2005, CURR BIOL, V15, P470, DOI 10.1016/j.cub.2004.12.077; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; REINES D, 1991, ANAL BIOCHEM, V196, P367, DOI 10.1016/0003-2697(91)90480-H; REINES D, 1987, J MOL BIOL, V196, P299, DOI 10.1016/0022-2836(87)90691-7; Scicchitano DA, 2004, DNA REPAIR, V3, P1537, DOI 10.1016/j.dnarep.2004.06.004; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Sun H, 2001, P NATL ACAD SCI USA, V98, P12444, DOI 10.1073/pnas.231479198; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; Tornaletti S, 2003, J BIOL CHEM, V278, P35791, DOI 10.1074/jbc.M305394200; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Wright BE, 2004, GENES IMMUN, V5, P176, DOI 10.1038/sj.gene.6364053	33	56	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12756	12762		10.1074/jbc.M705003200	http://dx.doi.org/10.1074/jbc.M705003200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18292094	Green Published, hybrid			2022-12-27	WOS:000255499800011
J	Wang, Y; Lee, ATC; Ma, JZI; Wang, JB; Ren, JW; Yang, YC; Tantoso, E; Li, KB; Ooi, LLPJ; Tan, P; Lee, CGL				Wang, Yu; Lee, Alvin T. C.; Ma, Joel Z. I.; Wang, Jingbo; Ren, Jianwei; Yang, Yuchen; Tantoso, Erwin; Li, Kuo-Bin; Ooi, London L. P. J.; Tan, Patrick; Lee, Caroline G. L.			Profiling MicroRNA expression in hepatocellular carcinoma reveals MicroRNA-224 up-regulation and apoptosis inhibitor-5 as a MicroRNA-224-specific target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG CANCERS; IDENTIFICATION; SIGNATURE; AAC-11; GENES; CELLS; PCR; RNA; MYC	Like other cancers, aberrant gene regulation features significantly in hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) were recently found to regulate gene expression at the post-transcriptional/ translational levels. The expression profiles of 157 miRNAs were examined in 19 HCC patients, and 19 up-regulated and 3 down-regulated miRNAs were found to be associated with HCC. Putative gene targets of these 22 miRNAs were predicted in silico and were significantly enriched in 34 biological pathways, most of which are frequently dysregulated during carcinogenesis. Further characterization of microRNA-224 (miR-224), the most significantly upregulated miRNA in HCC patients, revealed that miR-224 increases apoptotic cell death as well as proliferation and targets apoptosis inhibitor-5 (API-5) to inhibit API-5 transcript expression. Significantly, miR-224 expression was found to be inversely correlated with API-5 expression in HCC patients (p < 0.05). Hence, our findings define a true in vivo target of miR-224 and reaffirm the important role of miRNAs in the dysregulation of cellular processes that may ultimately lead to tumorigenesis.	[Lee, Alvin T. C.; Ren, Jianwei; Ooi, London L. P. J.; Lee, Caroline G. L.] Natl Canc Ctr, Div Med Sci, Dept Surg Oncol, Singapore 169610, Singapore; [Wang, Yu; Ma, Joel Z. I.; Wang, Jingbo; Lee, Caroline G. L.] Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore; [Yang, Yuchen; Tantoso, Erwin; Li, Kuo-Bin] Bioinformat Inst, Singapore 138671, Singapore; [Ooi, London L. P. J.] Singapore Gen Hosp, Dept Surg, Singapore 169608, Singapore; [Tan, Patrick; Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore 169547, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Singapore General Hospital; National University of Singapore	Lee, CGL (corresponding author), Natl Canc Ctr, Div Med Sci, Dept Surg Oncol, Level 6,Lab 5,11 Hosp Dr, Singapore 169610, Singapore.	bchleec@nus.edu.sg	Yang, Yuchen/GZK-6062-2022; Ooi, London Lucien/AGK-1395-2022; Lee, Caroline G/M-8918-2019	Lee, Caroline G/0000-0002-4323-3635; Tantoso, Erwin/0000-0002-7946-6297; Ma, Joel/0000-0002-0448-6744				Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dragan YP, 2001, TOXICOL SCI, V61, P6, DOI 10.1093/toxsci/61.1.6; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Kim JW, 2000, LAB INVEST, V80, P587, DOI 10.1038/labinvest.3780063; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Polakis P, 2000, GENE DEV, V14, P1837; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tewari M, 1997, CANCER RES, V57, P4063; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	54	303	338	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13205	13215		10.1074/jbc.M707629200	http://dx.doi.org/10.1074/jbc.M707629200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319255	hybrid			2022-12-27	WOS:000255499800060
J	Zaks-Zilberman, M; Harrington, AE; Ishino, T; Chaiken, IM				Zaks-Zilberman, Meirav; Harrington, Adrian E.; Ishino, Tetsuya; Chaiken, Irwin M.			Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; HIGH-AFFINITY BINDING; COMMON BETA-CHAIN; GROWTH-HORMONE RECEPTOR; GM-CSF RECEPTOR; IL-5 RECEPTORS; ALPHA-SUBUNIT; ERYTHROPOIETIN RECEPTOR; EXTRACELLULAR DOMAIN; CYTOKINE RECOGNITION	Interleukin (IL)-5 exerts hematopoietic functions through binding to the IL-5 receptor subunits, alpha and beta c. Specific assembly steps of full-length subunits as they occur in cell membranes, ultimately leading to receptor activation, are not well understood. We tracked the oligomerization of IL-5 receptor subunits using fluorescence resonance energy transfer ( FRET) imaging. Full-length IL-5R alpha and beta c were expressed in Phoenix cells as chimeric proteins fused to enhanced cyan or yellow fluorescent protein (CFP or YFP, respectively). A time-and dose-dependent increase in FRET signal between IL-5R alpha-CFP and beta c-YFP was observed in response to IL-5, indicative of heteromeric receptor alpha-beta c subunit interaction. This response was inhibited by AF17121, a peptide antagonist of IL-5R alpha. Substantial FRET signals with beta c-CFP and beta c-YFP co-expressed in the absence of IL-5R alpha demonstrated that beta c subunits exist as preformed homo-oligomers. IL-5 had no effect on this beta c-alone FRET signal. Interestingly, the addition of IL-5 to cells co-expressing beta c-CFP, beta c-YFP, and nontagged IL-5R alpha led to further increase in FRET efficiency. Observation of preformed beta c oligomers fits with the view that this form can lead to rapid cellular responses upon IL-5 stimulation. The IL-5-induced effects on beta c assembly in the presence of nontagged IL-5R alpha provide direct evidence that IL-5 can cause higher order rearrangements of beta c homo-oligomers. These results suggest that IL-5 and perhaps other beta c cytokines (IL-3 and granulocyte/macrophage colony-stimulating factor) trigger cellular responses by the sequential binding of cytokine ligand to the specificity receptor ( subunit alpha), followed by binding of the ligand-subunit alpha complex to, and consequent rearrangement of, a ground state form of beta c oligomers.	[Zaks-Zilberman, Meirav; Harrington, Adrian E.; Ishino, Tetsuya; Chaiken, Irwin M.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Chaiken, IM (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 11102 New Coll Bldg,245 N 15th St, Philadelphia, PA 19102 USA.	ichaiken@drexelmed.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055648] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 40462] Funding Source: Medline; NIGMS NIH HHS [R01 GM55648] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Carr PD, 2006, ACTA CRYSTALLOGR F, V62, P509, DOI 10.1107/S1744309106016812; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DEVOS R, 1991, EMBO J, V10, P2133, DOI 10.1002/j.1460-2075.1991.tb07747.x; DEVOS R, 1993, J BIOL CHEM, V268, P6581; England BP, 2000, P NATL ACAD SCI USA, V97, P6862, DOI 10.1073/pnas.110053997; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GOODALL GJ, 1993, GROWTH FACTORS, V8, P87, DOI 10.3109/08977199309046929; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hibbs AR, 2004, CONFOCAL MICROSCOPY; Ishino T, 2005, VITAM HORM, V71, P321, DOI 10.1016/S0083-6729(05)71011-6; Ishino T, 2004, J BIOL CHEM, V279, P9547, DOI 10.1074/jbc.M309327200; Ishino T, 2005, J BIOL CHEM, V280, P22951, DOI 10.1074/jbc.M502341200; JOHANSON K, 1995, J BIOL CHEM, V270, P9459, DOI 10.1074/jbc.270.16.9459; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; Krause CD, 2006, BIOCHEM BIOPH RES CO, V340, P377, DOI 10.1016/j.bbrc.2005.11.182; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Le F, 2000, J BIOL CHEM, V275, P5124, DOI 10.1074/jbc.275.7.5124; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; LOCK P, 1994, P NATL ACAD SCI USA, V91, P252, DOI 10.1073/pnas.91.1.252; LOPEZ AF, 1991, J BIOL CHEM, V266, P24741; LOPEZ AF, 1992, EMBO J, V11, P909, DOI 10.1002/j.1460-2075.1992.tb05129.x; LOPEZ AF, 1992, IMMUNOL TODAY, V13, P495, DOI 10.1016/0167-5699(92)90025-3; Majoul Irina, 2002, J Biotechnol, V82, P267; McClure BJ, 2003, BLOOD, V101, P1308, DOI 10.1182/blood-2002-06-1903; MIGITA M, 1991, CELL IMMUNOL, V133, P484, DOI 10.1016/0008-8749(91)90120-Z; MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; Murray EW, 1996, J BIOL CHEM, V271, P15330, DOI 10.1074/jbc.271.26.15330; Muto A, 1995, J ALLERGY CLIN IMMUN, V96, P1100, DOI 10.1016/S0091-6749(95)70195-8; Muto A, 1996, J EXP MED, V183, P1911, DOI 10.1084/jem.183.4.1911; Ogata N, 1998, BLOOD, V91, P2264, DOI 10.1182/blood.V91.7.2264.2264_2264_2271; PLAETINCK G, 1990, J EXP MED, V172, P683, DOI 10.1084/jem.172.3.683; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Sanderson C J, 2000, Curr Opin Investig Drugs, V1, P435; Scibek JJ, 2002, ANAL BIOCHEM, V307, P258, DOI 10.1016/S0003-2697(02)00043-X; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SHANAFELT AB, 1991, EMBO J, V10, P4105, DOI 10.1002/j.1460-2075.1991.tb04987.x; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Stirling RG, 2001, AM J RESP CRIT CARE, V164, P1403, DOI 10.1164/ajrccm.164.8.2010002; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Stomski FC, 1996, MOL CELL BIOL, V16, P3035; TAVERNIER J, 1992, P NATL ACAD SCI USA, V89, P7041, DOI 10.1073/pnas.89.15.7041; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1997, BLOOD, V90, P3005, DOI 10.1182/blood.V90.8.3005; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Yang XK, 2006, ANAL BIOCHEM, V351, P158, DOI 10.1016/j.ab.2005.12.004; Yi L, 2006, J BIOL CHEM, V281, P35446, DOI 10.1074/jbc.M607302200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13398	13406		10.1074/jbc.M710230200	http://dx.doi.org/10.1074/jbc.M710230200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326494	Green Published, hybrid			2022-12-27	WOS:000255499800079
J	Iriyama, A; Fujiki, R; Inoue, Y; Takahashi, H; Tamaki, Y; Takezawa, S; Takeyama, K; Jang, WD; Kato, S; Yanagi, Y				Iriyama, Aya; Fujiki, Ryoji; Inoue, Yuji; Takahashi, Hidenori; Tamaki, Yasuhiro; Takezawa, Shinichiro; Takeyama, Kenichi; Jang, Woo-Dong; Kato, Shigeaki; Yanagi, Yasuo			A2E, a pigment of the lipofuscin of retinal pigment epithelial cells, is an endogenous ligand for retinoic acid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; NUCLEAR RECEPTORS; IN-VITRO; ANGIOGENESIS; ACTIVATION; EXPRESSION; VEGF; PATHOGENESIS; INHIBITION	Lipofuscin contains fluorophores, which represent a biomarker for cellular aging. Although it remains unsubstantiated clinically, experimental results support that the accumulation of lipofuscin is related to an increased risk of choroidal neovascularization due to age-related macular degeneration, a leading cause of legal blindness. Here, we report that a major lipofuscin component, A2E, activates the retinoic acid receptor (RAR). In vitro experiments using luciferase reporter assay, competitional binding assay, analysis of target genes, and chromatin immunoprecipitation (ChIP) assay strongly suggest that A2E is a bona fide ligand for RAR and induces sustained activation of RAR target genes. A2E-induced vascular endothelial growth factor (VEGF) expression in a human retinal pigment epithelial cell line (ARPE-19) and RAR antagonist blocked the up-regulation of VEGF. The conditioned medium of A2E-treated ARPE-19 cells induced tube formation in human umbilical vascular endothelial cells, which was blocked by the RAR antagonist and anti-VEGF antibody. These results suggest that A2E accumulation results in the phenotypic alteration of retinal pigment epithelial cells, predisposing the environment to choroidal neovascularization development. This is mediated through the agonistic function of A2E, at least in part. The results of this study provide a novel potential therapeutic target for this incurable condition.	[Iriyama, Aya; Inoue, Yuji; Takahashi, Hidenori; Tamaki, Yasuhiro; Yanagi, Yasuo] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan; [Fujiki, Ryoji; Takezawa, Shinichiro; Takeyama, Kenichi; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Jang, Woo-Dong] Yonsei Univ, Coll Sci, Dept Chem, Seoul 120749, South Korea	University of Tokyo; University of Tokyo; Yonsei University	Yanagi, Y (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	yanagi-tky@umin.ac.jp	Jang, Woo-Dong/I-7186-2019; Yanagi, Yasuo/AAF-2670-2020; Yanagi, Yasuo/AAA-5441-2022; Takahashi, Hidenori/H-2945-2019	Jang, Woo-Dong/0000-0002-1281-6037; Takahashi, Hidenori/0000-0001-5331-4730; Yanagi, Yasuo/0000-0002-0362-7285				Akiyama H, 2002, INVEST OPHTH VIS SCI, V43, P1367; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; Dafer Rima M, 2007, Semin Ophthalmol, V22, P201, DOI 10.1080/08820530701543024; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; ELDRED GE, 1982, SCIENCE, V216, P757, DOI 10.1126/science.7079738; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gaetano C, 2001, CIRC RES, V88, pE38; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; MAJEWSKI S, 1993, CANCER LETT, V75, P35, DOI 10.1016/0304-3835(93)90204-M; Moshfeghi AA, 2006, OPHTHALMOLOGY, V113, P2002, DOI 10.1016/j.ophtha.2006.05.070; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PEPPER MS, 1994, J CELL BIOCHEM, V55, P419, DOI 10.1002/jcb.240550403; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Saito A, 2007, ENDOCRINOLOGY, V148, P1412, DOI 10.1210/en.2006-0900; Samuel W, 2001, J BIOL CHEM, V276, P28744, DOI 10.1074/jbc.M103587200; SARKS SH, 2001, RETINA, P1064; Schwesinger C, 2001, AM J PATHOL, V158, P1161, DOI 10.1016/S0002-9440(10)64063-1; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; WORMALD R, 2000, COCHRANE DB SYST REV, V2; Yanagi Y, 1999, J BIOL CHEM, V274, P12971, DOI 10.1074/jbc.274.19.12971; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	34	43	53	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11947	11953		10.1074/jbc.M708989200	http://dx.doi.org/10.1074/jbc.M708989200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326047	hybrid			2022-12-27	WOS:000255340000010
J	Sun, XX; Dai, MS; Lu, H				Sun, Xiao-Xin; Dai, Mu-Shui; Lu, Hua			Mycophenolic acid activation of p53 requires ribosomal proteins l5 and l11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE DEPLETION; INOSINE MONOPHOSPHATE DEHYDROGENASE; CELL-CYCLE ARREST; MULTIPLE-MYELOMA CELLS; IMP DEHYDROGENASE; LEUKEMIA-CELLS; T-LYMPHOCYTES; DNA-SYNTHESIS; INHIBITION; APOPTOSIS	Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase ( IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G(1) cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.	[Sun, Xiao-Xin; Dai, Mu-Shui; Lu, Hua] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Sun, Xiao-Xin; Dai, Mu-Shui; Lu, Hua] Simon Canc Ctr, Indianapolis, IN 46202 USA; [Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University	Lu, H (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu			NCI NIH HHS [K99 CA127134-01, R00 CA127134, K99 CA127134] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K99CA127134, R00CA127134] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison A C, 1977, Ciba Found Symp, P207; Allison AC, 2005, TRANSPLANTATION, V80, pS181, DOI 10.1097/01.tp.0000186390.10150.66; Allison AC, 2005, LUPUS, V14, pS2, DOI 10.1191/0961203305lu2109oa; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; CARR SF, 1993, J BIOL CHEM, V268, P27286; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; DUAN DS, 1988, BIOCHEM J, V255, P1045, DOI 10.1042/bj2551045; GHAREHBAGHI K, 1994, LEUKEMIA, V8, P1257; Gu JJ, 2003, BLOOD, V101, P4958, DOI 10.1182/blood-2002-08-2547; Heinschink A, 2000, CLIN CHIM ACTA, V300, P23, DOI 10.1016/S0009-8981(00)00297-7; Inai K, 1998, ADV EXP MED BIOL, V431, P549; Inai K, 2000, LEUKEMIA RES, V24, P761, DOI 10.1016/S0145-2126(00)00045-X; Ishitsuka K, 2005, ONCOGENE, V24, P5888, DOI 10.1038/sj.onc.1208739; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Laliberte J, 1998, BLOOD, V91, P2896, DOI 10.1182/blood.V91.8.2896.2896_2896_2904; Li GD, 1998, ENDOCRINOLOGY, V139, P3752, DOI 10.1210/en.139.9.3752; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Messina E, 2005, NEUROSCI LETT, V375, P97, DOI 10.1016/j.neulet.2004.10.076; Messina E, 2004, NUCLEOS NUCLEOT NUCL, V23, P1545, DOI 10.1081/NCN-200027770; Messina E, 2004, INT J CANCER, V108, P812, DOI 10.1002/ijc.11642; NAGAI M, 1991, CANCER RES, V51, P3886; NAGAI M, 1992, CANCER RES, V52, P258; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; NGUYEN BT, 1986, BIOCHEM J, V234, P263, DOI 10.1042/bj2340263; Panic L, 2007, CELL CYCLE, V6, P20, DOI 10.4161/cc.6.1.3666; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Takebe N, 2006, MOL CANCER THER, V5, P457, DOI 10.1158/1535-7163.MCT-05-0340; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weigel G, 2001, CLIN PHARMACOL THER, V69, P137, DOI 10.1067/mcp.2001.114166; WILSON BS, 1989, J IMMUNOL, V143, P259; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	42	82	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12387	12392		10.1074/jbc.M801387200	http://dx.doi.org/10.1074/jbc.M801387200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18305114	Green Published, hybrid			2022-12-27	WOS:000255340000055
J	Sbia, M; Parnell, EJ; Yu, Y; Olsen, AE; Kretschmann, KL; Voth, WP; Stillman, DJ				Sbia, Mohammed; Parnell, Emily J.; Yu, Yaxin; Olsen, Aileen E.; Kretschmann, Kelsi L.; Voth, Warren P.; Stillman, David J.			Regulation of the yeast Ace2 transcription factor during the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; FORKHEAD GENES; MITOTIC EXIT; HO PROMOTER; DNA-BINDING; KINASE; SWI5; MORPHOGENESIS; NETWORK	Previous studies have revealed many parallels in the cell cycle regulation of the Ace2 and Swi5 transcription factors. Although both proteins begin entry into the nucleus near the start of mitosis, here we show that Ace2 accumulates in the nucleus and binds DNA about 10 min later in the cell cycle than Swi5. We used chimeric fusions to identify the N-terminal region of Ace2 as responsible for the delay, and this same region of Ace2 was required for interaction with Cbk1, a kinase necessary for both transcriptional activation by Ace2 and asymmetric distribution of Ace2. Ace2 and Swi5 also showed differences in prevalence during the cell cycle. Swi5 is apparently degraded soon after nuclear entry, whereas constant Ace2 levels throughout the cell cycle suggest Ace2 is exported from the nucleus. Our work suggests that the precise timing of Ace2 accumulation in the nucleus involves both a nuclear export sequence and a nuclear localization signal, whose activities are regulated by phosphorylation.	[Sbia, Mohammed; Parnell, Emily J.; Yu, Yaxin; Olsen, Aileen E.; Kretschmann, Kelsi L.; Voth, Warren P.; Stillman, David J.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Stillman, DJ (corresponding author), Univ Utah, Dept Pathol, 15 N Med Dr E, Salt Lake City, UT 84112 USA.	david.stillman@utah.edu		Stillman, David/0000-0002-5268-2416	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32-DK007115] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bhoite LT, 1998, MOL CELL BIOL, V18, P6436, DOI 10.1128/MCB.18.11.6436; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Burke D., 2000, METHODS YEAST GENETI; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Dohrmann PR, 1996, MOL CELL BIOL, V16, P1746; Eriksson P, 2004, MOL CELL BIOL, V24, P6419, DOI 10.1128/MCB.24.14.6419-6429.2004; Hollenhorst PC, 2000, GENETICS, V154, P1533; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Jensen TH, 2000, MOL CELL BIOL, V20, P8047, DOI 10.1128/MCB.20.21.8047-8058.2000; Kasten MM, 1996, MOL CELL BIOL, V16, P4215; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; McBride HJ, 1997, MOL CELL BIOL, V17, P2669, DOI 10.1128/MCB.17.5.2669; Measday V, 2000, MOL MICROBIOL, V35, P825, DOI 10.1046/j.1365-2958.2000.01754.x; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; NASMYTH K, 1987, CELL, V49, P549, DOI 10.1016/0092-8674(87)90457-0; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; TEBB G, 1993, GENE DEV, V7, P517, DOI 10.1101/gad.7.3.517; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Voth WP, 2007, EMBO J, V26, P4324, DOI 10.1038/sj.emboj.7601859; Voth WP, 2005, EUKARYOT CELL, V4, P1018, DOI 10.1128/EC.4.6.1018-1028.2005; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	39	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11135	11145		10.1074/jbc.M800196200	http://dx.doi.org/10.1074/jbc.M800196200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18292088	hybrid, Green Published			2022-12-27	WOS:000255067400009
J	Messick, TE; Russell, NS; Iwata, AJ; Sarachan, KL; Shiekhattar, R; Shanks, JR; Reyes-Turcu, FE; Wilkinson, KD; Marmorstein, R				Messick, Troy Eugene; Russell, Nathaniel Scott; Iwata, Ayaka Jennifer; Sarachan, Kathryn Lorenz; Shiekhattar, Ramin; Shanks, John R.; Reyes-Turcu, Francisca E.; Wilkinson, Keith D.; Marmorstein, Ronen			Structural basis for ubiquitin recognition by the OTU1 ovarian tumor domain protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME; CRYSTAL-STRUCTURE; CYSTEINE PROTEASES; REVEALS; DEGRADATION; MECHANISMS; GENERATION; FAMILY; GENE	Ubiquitination of proteins modifies protein function by either altering their activities, promoting their degradation, or altering their subcellular localization. Deubiquitinating enzymes are proteases that reverse this ubiquitination. Previous studies demonstrate that proteins that contain an ovarian tumor (OTU) domain possess deubiquitinating activity. This domain of similar to 130 amino acids is weakly similar to the papain family of proteases and is highly conserved from yeast to mammals. Here we report structural and functional studies on the OTU domain-containing protein from yeast, Otu1. We show that Otu1 binds polyubiquitin chain analogs more tightly than monoubiquitin and preferentially hydrolyzes longer polyubiquitin chains with Lys(48) linkages, having little or no activity on Lys(63)- and Lys(29)-linked chains. We also show that Otu1 interacts with Cdc48, a regulator of the ER-associated degradation pathway. We also report the x-ray crystal structure of the OTU domain of Otu1 covalently complexed with ubiquitin and carry out structure-guided mutagenesis revealing a novel mode of ubiquitin recognition and a variation on the papain protease catalytic site configuration that appears to be conserved within the OTU family of ubiquitin hydrolases. Together, these studies provide new insights into ubiquitin binding and hydrolysis by yeast Otu1 and other OTU domain-containing proteins.	[Messick, Troy Eugene; Iwata, Ayaka Jennifer; Sarachan, Kathryn Lorenz; Shiekhattar, Ramin; Marmorstein, Ronen] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Iwata, Ayaka Jennifer; Sarachan, Kathryn Lorenz; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Iwata, Ayaka Jennifer; Sarachan, Kathryn Lorenz; Marmorstein, Ronen] Univ Penn, Grad Div Mol Biophys & Biochem, Philadelphia, PA 19104 USA; [Russell, Nathaniel Scott; Shanks, John R.; Reyes-Turcu, Francisca E.; Wilkinson, Keith D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Russell, Nathaniel Scott; Shanks, John R.; Wilkinson, Keith D.] Emory Univ, Sch Med, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; Emory University; Emory University	Marmorstein, R (corresponding author), 3601 Spruce St, Philadelphia, PA USA.	marmor@wistar.org		Messick, Troy/0000-0001-7914-1524; Sarachan, Kathryn/0000-0003-2511-1404	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030308, T32GM008275] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30308, T32 GM008275] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Glenn LE, 2001, MECH DEVELOP, V102, P181, DOI 10.1016/S0925-4773(01)00314-8; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reinstein E, 2006, ANN INTERN MED, V145, P676, DOI 10.7326/0003-4819-145-9-200611070-00010; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; RODESCH C, 1995, GENETICS, V141, P191; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; RUSSELL NS, 2005, THESIS EMORY U ATLAN; SASS GL, 1995, DEV BIOL, V167, P201, DOI 10.1006/dbio.1995.1017; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	38	83	85	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					11038	11049		10.1074/jbc.M704398200	http://dx.doi.org/10.1074/jbc.M704398200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18270205	Green Published, hybrid			2022-12-27	WOS:000254894700084
J	Tong, Q; Hirschler-Laszkiewicz, I; Zhang, W; Conrad, K; Neagley, DW; Barber, DL; Cheung, JY; Miller, BA				Tong, Qin; Hirschler-Laszkiewicz, Iwona; Zhang, Wenyi; Conrad, Kathleen; Neagley, David W.; Barber, Dwayne L.; Cheung, Joseph Y.; Miller, Barbara A.			TRPC3 is the erythropoietin-regulated calcium channel in human erythroid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; OPERATED CA2+ CHANNELS; PLASMA-MEMBRANE; SIGNAL-TRANSDUCTION; HUMAN ERYTHROBLASTS; CATION CHANNELS; PHOSPHOLIPASE C-GAMMA-1; MOLECULAR MECHANISMS; FURA RED; RECEPTOR	Erythropoietin (Epo) stimulates a significant increase in the intracellular calcium concentration ([Ca2+](i)) through activation of the murine transient receptor potential channel TRPC2, but TRPC2 is a pseudogene in humans. TRPC3 expression increases on normal human erythroid progenitors during differentiation. Here, we determined that erythropoietin regulates calcium influx through TRPC3. Epo stimulation of HEK 293T cells transfected with Epo receptor and TRPC3 resulted in a dose-dependent increase in [Ca2+](i), which required extracellular calcium influx. Treatment with the phospholipase C (PLC) inhibitor U-73122 or down-regulation of PLC gamma 1 by RNA interference inhibited the Epo-stimulated increase in [Ca2+](i) in TRPC3-transfected HEK 293T cells and in primary human erythroid precursors, demonstrating a requirement for PLC. TRPC3 associated with PLC gamma, and substitution of predicted PLC gamma Src homology 2 binding sites (Y226F, Y555F, Y648F, and Y674F) on TRPC3 reduced the interaction of TRPC3 with PLC gamma and inhibited the rise in [Ca2+](i). Substitution of Tyr(226) alone with phenylalanine significantly reduced the Epo-stimulated increase in [Ca2+](i) but not the association of PLC gamma with TRPC3. PLC activation results in production of inositol 1,4,5-trisphosphate (IP3). To determine whether IP3 is involved in Epo activation of TRPC3, TRPC3 mutants were prepared with substitution or deletion of COOH-terminal IP3 receptor (IP3R) binding domains. In cells expressing TRPC3 with mutant IP3R binding sites and Epo receptor, interaction of IP3R with TRPC3 was abolished, and Epo-modulated increase in [Ca2+](i) was reduced. Our data demonstrate that Epo modulates TRPC3 activation through a PLC gamma-mediated process that requires interaction of PLC gamma and IP3R with TRPC3. They also show that TRPC3 Tyr(226) is critical in Epo-dependent activation of TRPC3. These data demonstrate a redundancy of TRPC channel activation mechanisms by widely different agonists.	[Miller, Barbara A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Tong, Qin; Hirschler-Laszkiewicz, Iwona; Zhang, Wenyi; Conrad, Kathleen; Neagley, David W.; Miller, Barbara A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, Hershey, PA 17033 USA; [Barber, Dwayne L.] Ontario Canc Inst, Div Stem Cells & Dev Biol, Toronto, ON M5G 2M9, Canada; [Cheung, Joseph Y.] Thomas Jefferson Univ, Div Nephrol, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Jefferson University	Miller, BA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, Coll Med, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu		Barber, Dwayne/0000-0001-5528-8150	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074854, R01HL058672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL58672, R01 HL74854] Funding Source: Medline; NIDDK NIH HHS [R01 DK46778] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bony V, 1999, BRIT J HAEMATOL, V107, P263, DOI 10.1046/j.1365-2141.1999.01721.x; Boudot C, 1999, J BIOL CHEM, V274, P33966, DOI 10.1074/jbc.274.48.33966; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; CHEUNG JY, 1992, J CLIN INVEST, V90, P1850, DOI 10.1172/JCI116061; Cheung JY, 2001, NEPHRON, V87, P215, DOI 10.1159/000045918; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chu X, 2004, J BIOL CHEM, V279, P10514, DOI 10.1074/jbc.M308478200; Chu X, 2002, J BIOL CHEM, V277, P34375, DOI 10.1074/jbc.M205541200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Di Giacomo V, 2005, J CELL PHYSIOL, V202, P831, DOI 10.1002/jcp.20179; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GILLO B, 1993, BLOOD, V81, P783; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gudermann Thomas, 2004, Novartis Found Symp, V258, P103; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HENSOLD JO, 1991, BLOOD, V77, P1362; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; Kawasaki BT, 2006, P NATL ACAD SCI USA, V103, P335, DOI 10.1073/pnas.0508030102; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; KUREBAYASHI N, 1993, BIOPHYS J, V64, P1934, DOI 10.1016/S0006-3495(93)81564-9; Kwon YK, 2003, J CELL BIOL, V163, P375, DOI 10.1083/jcb.200301131; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; Marrero MB, 1998, KIDNEY INT, V53, P1259, DOI 10.1046/j.1523-1755.1998.00887.x; MASONGARCIA M, 1992, AM J PHYSIOL, V262, pC1197; MASUDA S, 1993, J BIOL CHEM, V268, P11208; MILLER BA, 1989, BLOOD, V73, P1188; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; MILLER BA, 1988, J CLIN INVEST, V82, P309, DOI 10.1172/JCI113588; MISITI J, 1979, J CLIN INVEST, V64, P1573, DOI 10.1172/JCI109618; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ogilvie M, 2000, J BIOL CHEM, V275, P39754, DOI 10.1074/jbc.M004999200; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Ramos-Franco J, 2000, BIOPHYS J, V79, P1388, DOI 10.1016/S0006-3495(00)76391-0; REN HY, 1994, J BIOL CHEM, V269, P19633; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tong Q, 2004, AM J PHYSIOL-CELL PH, V287, pC1667, DOI 10.1152/ajpcell.00265.2004; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Vazquez G, 2003, J BIOL CHEM, V278, P21649, DOI 10.1074/jbc.M302162200; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Wu YM, 1997, AM J PHYSIOL-HEART C, V273, pH2161, DOI 10.1152/ajpheart.1997.273.5.H2161; Zhang MY, 1998, BLOOD, V92, P1225, DOI 10.1182/blood.V92.4.1225.416k20_1225_1234	59	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10385	10395		10.1074/jbc.M710231200	http://dx.doi.org/10.1074/jbc.M710231200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18276585	Green Published, hybrid			2022-12-27	WOS:000254894700019
J	Ariga, M; Nedachi, T; Katagiri, H; Kanzaki, M				Ariga, Miyako; Nedachi, Taku; Katagiri, Hideki; Kanzaki, Makoto			Functional role of sortilin in myogenesis and development of insulin-responsive glucose transport system in C2C12 myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; L6 MUSCLE-CELLS; STIMULATED GLUT4 TRANSLOCATION; AFFINITY RECEPTOR P75(NTR); P75 NEUROTROPHIN RECEPTOR; SKELETAL-MUSCLE; 3T3-L1 ADIPOCYTES; SORTILIN/NEUROTENSIN RECEPTOR-3; GLUT4-CONTAINING VESICLES; STORAGE COMPARTMENT	Sortilin has been implicated in the formation of insulin-responsive GLUT4 storage vesicles in adipocytes by regulating sorting events between the trans-Golgi-network and endosomes. We herein show that sortilin serves as a potent myogenic differentiation stimulator for C2C12 myocytes by cooperatively functioning with p75NTR, which subsequently further contributes to development of the insulin-responsive glucose transport system in C2C12 myotubes. Sortilin expression was up-regulated upon C2C12 differentiation, and overexpression of sortilin in C2C12 cells significantly stimulated myogenic differentiation, a response that was completely abolished by either anti-p75NTR- or anti-nerve growth factor (NGF)-neutralizing antibodies. Importantly, small interference RNA-mediated suppression of endogenous sortilin significantly inhibited C2C12 differentiation, indicating the physiological significance of sortilin expression in the process of myogenesis. Although sortilin overexpression in C2C12 myotubes improved insulin-induced 2-deoxyglucose uptake, as previously reported, this effect apparently resulted from a decrease in the cellular content of GLUT1 and an increase in GLUT4 via differentiation dependent alterations at both the gene transcriptional and the post-translational level. In addition, cellular contents of Ubc9 and SUMO-modified proteins appeared to be increased by sortilin overexpression. Taken together, these data demonstrate that sortilin is involved not only in development of the insulin-responsive glucose transport system in myocytes, but is also directly involved in muscle differentiation via modulation of proNGF-p75NTR.	[Ariga, Miyako; Nedachi, Taku; Kanzaki, Makoto] Tohoku Univ, Div Biomat Biomed Engn Re Org, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ariga, Miyako; Katagiri, Hideki] Tohoku Univ, Grad Sch Pharmaceut Sci, 21st Century COE Program Cpmprehens Res, Sendai, Miyagi 9808575, Japan; [Ariga, Miyako; Katagiri, Hideki] Tohoku Univ, Grad Sch Pharmaceut Sci, Educ Ctr Planning Drug Dev & Clin Evaluat, Sendai, Miyagi 9808575, Japan; [Ariga, Miyako; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Div Adv Therapeut Metab Dis, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kanzaki, M (corresponding author), Tohoku Univ, Div Biomat Biomed Engn Re Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kanzakimakoto@mac.com	Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955; Nedachi, Taku/0000-0003-4462-0618				Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bronfman FC, 2004, EMBO REP, V5, P867, DOI 10.1038/sj.embor.7400219; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Charrasse S, 2002, J CELL BIOL, V158, P953, DOI 10.1083/jcb.200202034; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DEHERREROS AG, 1989, J BIOL CHEM, V264, P9885; Erck C, 1998, J CELL PHYSIOL, V176, P22, DOI 10.1002/(SICI)1097-4652(199807)176:1<22::AID-JCP3>3.0.CO;2-A; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Kanzaki M, 2001, J BIOL CHEM, V276, P42436, DOI 10.1074/jbc.M108297200; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kanzaki M, 2006, ENDOCR J, V53, P267, DOI 10.1507/endocrj.KR-65; Koistinen HA, 2002, ANN MED, V34, P410, DOI 10.1080/078538902321012351; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; MUECKLER M, 1990, DIABETES, V39, P6, DOI 10.2337/diabetes.39.1.6; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nishiyama T, 2004, J BIOL CHEM, V279, P47311, DOI 10.1074/jbc.M403546200; NUUTILA P, 1994, AM J PHYSIOL-ENDOC M, V267, pE941, DOI 10.1152/ajpendo.1994.267.6.E941; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Onishi M, 1996, EXP HEMATOL, V24, P324; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Peters EMJ, 2006, AM J PATHOL, V168, P221, DOI 10.2353/ajpath.2006.050163; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Ralston E, 1996, J CELL SCI, V109, P2967; RALSTON E, 1993, J CELL BIOL, V120, P399, DOI 10.1083/jcb.120.2.399; Reddypalli S, 2005, J CELL PHYSIOL, V204, P819, DOI 10.1002/jcp.20330; Rende M, 2000, INT J DEV NEUROSCI, V18, P869, DOI 10.1016/S0736-5748(00)00041-1; Riquelme C, 2006, EXP CELL RES, V312, P2132, DOI 10.1016/j.yexcr.2006.03.016; RODNICK KJ, 1992, J BIOL CHEM, V267, P6278; Rudich A, 2003, ACTA PHYSIOL SCAND, V178, P297, DOI 10.1046/j.1365-201X.2003.01163.x; SANTALUCIA T, 1992, ENDOCRINOLOGY, V130, P837, DOI 10.1210/en.130.2.837; Seidl K, 1998, J CELL PHYSIOL, V176, P10, DOI 10.1002/(SICI)1097-4652(199807)176:1<10::AID-JCP2>3.0.CO;2-B; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; SHIBATA H, 1995, J BIOL CHEM, V270, P11489, DOI 10.1074/jbc.270.19.11489; Shibata H, 1996, J BIOL CHEM, V271, P9704, DOI 10.1074/jbc.271.16.9704; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V246, P287, DOI 10.1006/bbrc.1998.8600; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tortorella LL, 2002, AM J PHYSIOL-ENDOC M, V283, pE514, DOI 10.1152/ajpendo.00092.2002; WALKER PS, 1990, J BIOL CHEM, V265, P1516; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Zeng JB, 2004, MOL REPROD DEV, V68, P469, DOI 10.1002/mrd.20097	65	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10208	10220		10.1074/jbc.M710604200	http://dx.doi.org/10.1074/jbc.M710604200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18258592	hybrid			2022-12-27	WOS:000254671600073
J	Zhang, JW; Li, LH				Zhang, Jiwang; Li, Linheng			Stem cell niche: Microenvironment and beyond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MARROW VASCULAR NICHE; HEMATOPOIETIC-STEM; BONE-MARROW; SELF-RENEWAL; PROGENITOR CELLS; EXTRAMEDULLARY HEMATOPOIESIS; CXCR4 EXPRESSION; GERMLINE; MAINTENANCE; RECEPTOR		[Zhang, Jiwang] Loyola Univ, Med Ctr, Dept Pathol, Inst Oncol, Chicago, IL 60153 USA; [Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Linheng] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Loyola University Chicago; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Zhang, JW (corresponding author), Loyola Univ, Med Ctr, Dept Pathol, Inst Oncol, Chicago, IL 60153 USA.	jzhang@lumc.edu	Zhang, Jiwang/AAG-2706-2021	Li, Linheng/0000-0001-9963-430X				Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Abud HE, 2004, GASTROENTEROLOGY, V126, P1779, DOI 10.1053/j.gastro.2004.03.006; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2005, TRENDS CARDIOVAS MED, V15, P75, DOI 10.1016/j.tcm.2005.03.002; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asai R, 2005, DEV GROWTH DIFFER, V47, P501, DOI 10.1111/j.1440-169X.2005.00825.x; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Basto D, 2005, ACTA NEUROPATHOL, V109, P207, DOI 10.1007/s00401-004-0936-x; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; Benovic JL, 2004, CANCER CELL, V6, P429, DOI 10.1016/j.ccr.2004.10.017; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Christiano AM, 2004, CELL, V118, P530, DOI 10.1016/j.cell.2004.08.024; Conover JC, 2008, CELL TISSUE RES, V331, P211, DOI 10.1007/s00441-007-0503-6; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; El-Badri NS, 1998, EXP HEMATOL, V26, P110; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Goichberg P, 2006, BLOOD, V107, P870, DOI 10.1182/blood-2005-03-0941; GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; King FJ, 1999, DEVELOPMENT, V126, P1833; King FJ, 2001, MOL CELL, V7, P497, DOI 10.1016/S1097-2765(01)00197-6; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; LORD BI, 1975, BLOOD, V46, P65; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; MALONEY MA, 1975, P SOC EXP BIOL MED, V149, P94; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Moore KA, 2004, CURR OPIN HEMATOL, V11, P107, DOI 10.1097/01.moh.0000133652.06863.47; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; NILSSON SK, 1994, EXP HEMATOL, V22, P377; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Ohneda O, 1998, BLOOD, V92, P908; Ohshima H, 2005, ARCH ORAL BIOL, V50, P153, DOI 10.1016/j.archoralbio.2004.09.008; Parisi M J, 1998, Cell Res, V8, P15; PATT HM, 1972, P SOC EXP BIOL MED, V140, P205; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rafii S, 1997, LEUKEMIA LYMPHOMA, V27, P375, DOI 10.3109/10428199709058305; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tavian M, 2005, EXP HEMATOL, V33, P1062, DOI 10.1016/j.exphem.2005.06.025; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	101	89	94	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9499	9503		10.1074/jbc.R700043200	http://dx.doi.org/10.1074/jbc.R700043200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18272517	hybrid			2022-12-27	WOS:000254671600001
J	Dillon, TM; Ricci, MS; Vezina, C; Flynn, GC; Liu, YD; Rehder, DS; Plant, M; Henkle, B; Li, Y; Deechongkit, S; Varnum, B; Wypych, J; Balland, A; Bondarenko, PV				Dillon, Thomas M.; Ricci, Margaret Speed; Vezina, Chris; Flynn, Gregory C.; Liu, Yaoqing Diana; Rehder, Douglas S.; Plant, Matthew; Henkle, Brad; Li, Yu; Deechongkit, Songpon; Varnum, Brian; Wypych, Jette; Balland, Alain; Bondarenko, Pavel V.			Structural and functional characterization of disulfide isoforms of the human IgG2 subclass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT ANTIBODIES; SPECTROMETRY METHOD; MASS-SPECTROMETRY; IMMUNOGLOBULIN-G; PROTEINS; PERFORMANCE; STABILITY; HETEROGENEITY; INFECTION; CYTOKINES	In the accompanying report ( Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., Bondarenko, P. V., Ricci, M. S., Dillon, T. M., and Balland, A. (2008) J. Biol. Chem. 283, 16194 -16205), we have identified that the human IgG2 subclass exists as an ensemble of distinct isoforms, designated IgG2-A, -B, and -A/ B, which differ by the disulfide connectivity at the hinge region. In this report, we studied the structural and functional properties of the IgG2 disulfide isoforms and compared them to IgG1. Human monoclonal IgG1 and IgG2 antibodies were designed with identical antigen binding regions, specific to interleukin-1 cell surface receptor type 1. In vitro biological activity measurements showed an increased activity of the IgG1 relative to the IgG2 in blocking interleukin-1 beta ligand from binding to the receptor, suggesting that some of the IgG2 isoforms had lower activity. Under reduction-oxidation conditions, the IgG2 disulfide isoforms converted to IgG2-A when 1M guanidine was used, whereas IgG2-B was enriched in the absence of guanidine. The relative potency of the antibodies in cell-based assays was: IgG1 > IgG2-A > IgG2 >> IgG2-B. This difference correlated with an increased hydrodynamic radius of IgG2-A relative to IgG2-B, as shown by biophysical characterization. The enrichment of disulfide isoforms and activity studies were extended to additional IgG2 monoclonal antibodies with various antigen targets. All IgG2 antibodies displayed the same disulfide conversion, but only a subset showed activity differences between IgG2-A and IgG2-B. Additionally, the distribution of isoforms was influenced by the light chain type, with IgG2 lambda composed mostly of IgG2-A. Based on crystal structure analysis, we propose that IgG2 disulfide exchange is caused by the close proximity of several cysteine residues at the hinge and the reactivity of tandem cysteines within the hinge. Furthermore, the IgG2 isoforms were shown to interconvert in whole blood or a "blood-like" environment, thereby suggesting that the in vivo activity of isoforms.	[Dillon, Thomas M.; Ricci, Margaret Speed; Rehder, Douglas S.; Deechongkit, Songpon; Bondarenko, Pavel V.] Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA; [Vezina, Chris; Plant, Matthew; Henkle, Brad; Li, Yu; Varnum, Brian] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA; [Flynn, Gregory C.; Liu, Yaoqing Diana; Wypych, Jette; Balland, Alain] Amgen Inc, Dept Analyt Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Dillon, TM (corresponding author), Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA.	Tdillon@Amgen.com; Pavel.Bondarenko@Amgen.com	Liu, Y Diana/AAU-4624-2021					Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Banks DD, 2008, J PHARM SCI-US, V97, P775, DOI 10.1002/jps.21014; Beenhouwer DO, 2007, INFECT IMMUN, V75, P1424, DOI 10.1128/IAI.01161-06; BREKKE OH, 1993, MOL IMMUNOL, V30, P1419, DOI 10.1016/0161-5890(93)90103-I; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Chaderjian WB, 2005, BIOTECHNOL PROGR, V21, P550, DOI 10.1021/bp0497029; CHOWDHURY SK, 1990, J AM CHEM SOC, V112, P9012, DOI 10.1021/ja00180a074; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; Dillon TM, 2004, J CHROMATOGR A, V1053, P299, DOI 10.1016/j.chroma.2004.08.058; FRANGIONE B, 1969, NATURE, V221, P145, DOI 10.1038/221145a0; Gorgani NN, 1999, J BIOL CHEM, V274, P29633, DOI 10.1074/jbc.274.42.29633; GUERNE PA, 1990, J IMMUNOL, V144, P499; Harris RJ, 2005, DEV BIOLOGICALS, V122, P117; Hildebrandt W, 2002, MECH AGEING DEV, V123, P1269, DOI 10.1016/S0047-6374(02)00013-1; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9; LIU H, 2008, J PHARM SCI IN PRESS; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mills BJ, 2000, J LAB CLIN MED, V135, P396, DOI 10.1067/mlc.2000.105976; Montano RF, 2002, J IMMUNOL, V168, P224, DOI 10.4049/jimmunol.168.1.224; Naisbitt DJ, 2000, AIDS RES HUM RETROV, V16, P1929, DOI 10.1089/088922200750054657; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SASSENFELD HM, 2002, Patent No. 02068455; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; SRINIVASAN N, 1990, INT J PEPT PROT RES, V36, P147; Teerinen T, 2006, J MOL BIOL, V361, P687, DOI 10.1016/j.jmb.2006.06.073; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200	35	206	255	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16206	16215		10.1074/jbc.M709988200	http://dx.doi.org/10.1074/jbc.M709988200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18339626	Green Published, hybrid			2022-12-27	WOS:000256332500079
J	Smith, WL; Murphy, RC				Smith, William L.; Murphy, Robert C.			Oxidized lipids formed non-enzymatically by reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Smith, William L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48108 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	University of Michigan System; University of Michigan; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, WL (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48108 USA.	smithww@umich.edu; robert.murphy@uchsc.edu	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515					0	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15513	15514		10.1074/jbc.R800006200	http://dx.doi.org/10.1074/jbc.R800006200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18285325	Green Published, hybrid			2022-12-27	WOS:000256332500001
J	Lee, S; Kim, MH; Kang, BS; Kim, JS; Kim, GH; Kim, YG; Kim, KJ				Lee, Sujin; Kim, Myung Hee; Kang, Beom Sik; Kim, Jeong-Sun; Kim, Ghyung-Hwa; Kim, Yeon-Gil; Kim, Kyung Jin			Crystal structure of Escherichia coli MazG, the regulator of nutritional stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; PYROPHOSPHATE SYNTHASE; BACTERIAL; MECHANISM; (P)PPGPP; COMPLEX; MODULE; MODEL; HISE	MazG is a nucleoside triphosphate pyrophosphohydrolase that hydrolyzes all canonical nucleoside triphosphates. The mazG gene located downstream from the chromosomal mazEF "addiction module," that mediated programmed cell death in Escherichia coli. MazG activity is inhibited by the MazEF complex both in vivo and in vitro. Enzymatic activity of MazG in vivo affects the cellular level of guanosine 3', 5'-bispyrophosphate (ppGpp), synthesized by RelA under amino acid starvation. The reduction of ppGpp, caused by MazG, may extend the period of cell survival under nutritional stress. Here we describe the first crystal structure of active MazG from E. coli, which is composed of two similarly folded globular domains in tandem. Among the two putative catalytic domains, only the C-terminal domain has well ordered active sites and exhibits an NTPase activity. The MazG-ATP complex structure and subsequent mutagenesis studies explain the peculiar active site environment accommodating all eight canonical NTPs as substrates. In vivo nutrient starvation experiments show that the C terminus NTPase activity is responsible for the regulation of bacterial cell survival under nutritional stress.	[Lee, Sujin; Kim, Ghyung-Hwa; Kim, Yeon-Gil; Kim, Kyung Jin] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea; [Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305600, South Korea; [Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Kwangju 500757, South Korea	Pohang University of Science & Technology (POSTECH); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; Chonnam National University	Kim, KJ (corresponding author), Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea.	kkj@postech.ac.kr						Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; GAFNY R, 1988, NUCLEIC ACIDS RES, V16, P61, DOI 10.1093/nar/16.1.61; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Guo RT, 2004, J BIOL CHEM, V279, P4903, DOI 10.1074/jbc.M310161200; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kwon JH, 2000, CAN J MICROBIOL, V46, P848, DOI 10.1139/cjm-46-9-848; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Moroz OV, 2004, J MOL BIOL, V342, P1583, DOI 10.1016/j.jmb.2004.07.050; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; SMITH DWE, 1965, J BIOL CHEM, V240, P3056; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wu BL, 2007, J MOL BIOL, V367, P1405, DOI 10.1016/j.jmb.2007.01.057; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	34	19	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15232	15240		10.1074/jbc.M800479200	http://dx.doi.org/10.1074/jbc.M800479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18353782	Green Published, hybrid			2022-12-27	WOS:000256232000041
J	Chen, L; Zhang, JL; Huang, XY				Chen, Lin; Zhang, Jillian; Huang, Xin-Yun			CAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN KINASES; SMOOTH-MUSCLE; PHOSPHORYLATION; CONTRACTION; ACTIVATION; ENA/VASP; MOTILITY; SIGNALS; CSK	Cell migration is critical for animal development and physiological as well as pathological responses. One important step during cell migration is the formation of lamellipodia at the leading edge of migrating cells. Here we report that the second messenger cAMP inhibits the migration of mouse embryonic fibroblast cells and mouse breast tumor cells. cAMP acts downstream of the small GTPase Rac and interferes with the formation of lamellipodia. Moreover, cAMP decreases the phosphorylation of the myosin light chain at the leading edge of cells and increases the phosphorylation of the vasodilator-stimulated phosphoprotein. Together with our previous report of a positive role of another second messenger, cGMP, in lamellipodium formation, our data indicate that cAMP and cGMP play opposite roles in modulating lamellipodium formation.	[Chen, Lin; Zhang, Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	Cornell University	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	xyhuang@med.cornell.edu			NATIONAL INSTITUTE ON AGING [R01AG023202] Funding Source: NIH RePORTER; NIA NIH HHS [AG23202] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bakre MM, 2002, NAT MED, V8, P995, DOI 10.1038/nm753; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gomez TM, 2004, NEURON, V42, P1, DOI 10.1016/S0896-6273(04)00188-6; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hirakawa M, 2007, J PHARMACOL EXP THER, V321, P1102, DOI 10.1124/jpet.106.118042; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; McGarrigle D, 2006, J BIOL CHEM, V281, P10583, DOI 10.1074/jbc.M513002200; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8429; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sandulache VC, 2007, WOUND REPAIR REGEN, V15, P122, DOI 10.1111/j.1524-475X.2006.00193.x; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; SPUDICH JA, 1989, CELL REGUL, V1, P1; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200	39	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13799	13805		10.1074/jbc.M800555200	http://dx.doi.org/10.1074/jbc.M800555200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353776	hybrid, Green Published			2022-12-27	WOS:000255728200032
J	Kim, MK; Kang, MR; Nam, HW; Bae, YS; Kim, YS; Chung, IK				Kim, Mi Kyung; Kang, Mi Ran; Nam, Hyung Wook; Bae, Young-Seuk; Kim, Yu Sam; Chung, In Kwon			Regulation of telomeric repeat binding factor 1 binding to telomeres by casein kinase 2-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; ATAXIA-TELANGIECTASIA; HUMAN-CELLS; IMMORTAL CELLS; LENGTH CONTROL; TRF1; DNA; DEGRADATION; INHIBITION; END	Telomere maintenance is essential for continued cell proliferation and chromosome stability. Telomeres are maintained by telomerase and a collection of associated proteins. The telomeric protein telomeric repeat binding factor 1 (TRF1) negatively regulates telomere length by inhibiting access of telomerase at telomere termini. Here we report that TRF1 interacts with the beta subunit of casein kinase 2 (CK2) and serves as a substrate for CK2. CK2-mediated phosphorylation is required for the efficient telomere binding of TRF1 in vitro and in vivo. Inhibition of CK2 by the CK2 inhibitor 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole decreased the ability of TRF1 to bind telomeric DNA. The resulting telomere-unbound form of TRF1 was then ubiquitinated and degraded by the proteasome. Partial knockdown of CK2 by small interfering RNA resulted in removal of TRF1 from telomeres and subsequent degradation of TRF1. Mapping of the CK2 target site identified threonine 122 as a substrate in TRF1. A threonine to alanine change at this position led to a diminished DNA binding due to reduced dimerization of TRF1. In addition, phosphorylation of threonine 122 seemed critical for TRF1-mediated telomere length control. Our findings suggest that CK2-mediated phosphorylation of TRF1 plays an important role in modulating telomere length homeostasis by determining the levels of TRF1 at telomeres.	[Kim, Mi Kyung; Kang, Mi Ran; Chung, In Kwon] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Kim, Mi Kyung; Kang, Mi Ran; Chung, In Kwon] Yonsei Univ, Mol Aging Res Ctr, Seoul 120749, South Korea; [Nam, Hyung Wook; Kim, Yu Sam] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Nam, Hyung Wook; Kim, Yu Sam; Chung, In Kwon] Yonsei Univ, Prot Network Res Ctr, Seoul 120749, South Korea; [Bae, Young-Seuk] Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Kyungpook National University	Chung, IK (corresponding author), Yonsei Univ, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	topoviro@yonsei.ac.kr						Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Ford HL, 2000, J BIOL CHEM, V275, P22245, DOI 10.1074/jbc.M002446200; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Harrington L, 2005, CHROMOSOME RES, V13, P493, DOI 10.1007/s10577-005-0994-5; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim YS, 2003, J BIOL CHEM, V278, P28462, DOI 10.1074/jbc.M302584200; Kishi S, 2002, J BIOL CHEM, V277, P7420, DOI 10.1074/jbc.M111365200; Kwon C, 2004, J BIOL CHEM, V279, P12812, DOI 10.1074/jbc.M312011200; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Nam HW, 2005, J CHROMATOGR B, V826, P91, DOI 10.1016/j.jchromb.2005.07.039; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Son MY, 1999, BIOCHEM BIOPH RES CO, V263, P743, DOI 10.1006/bbrc.1999.1460; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	48	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14144	14152		10.1074/jbc.M710065200	http://dx.doi.org/10.1074/jbc.M710065200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347021	hybrid			2022-12-27	WOS:000255728200068
J	Ma, QL; Yang, FS; Calon, F; Ubeda, OJ; Hansen, JE; Weisbart, RH; Beech, W; Frautschy, SA; Cole, GM				Ma, Qiu-Lan; Yang, Fusheng; Calon, Frederic; Ubeda, Oliver J.; Hansen, James E.; Weisbart, Richard H.; Beech, Walter; Frautschy, Sally A.; Cole, Greg M.			p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; AMYLOID-BETA OLIGOMERS; LONG-TERM POTENTIATION; IN-VIVO; A-BETA; MENTAL-RETARDATION; RHO-GTPASES; DENDRITIC SPINES; NMDA RECEPTOR; MICE	Defects in dendritic spines and synapses contribute to cognitive deficits in mental retardation syndromes and, potentially, Alzheimer disease. p21-activated kinases (PAKs) regulate actin filaments and morphogenesis of dendritic spines regulated by the Rho family GTPases Rac and Cdc42. We previously reported that active PAK was markedly reduced in Alzheimer disease cytosol, accompanied by downstream loss of the spine actin-regulatory protein Drebrin. beta-Amyloid (A beta) oligomer was implicated in PAK defects. Here we demonstrate that PAK is aberrantly activated and translocated from cytosol to membrane in Alzheimer disease brain and in 22-month-old Tg2576 transgenic mice with Alzheimer disease. This active PAK co-immunoprecipitated with the small GTPase Rac and both translocated to granules. A beta(42) oligomer treatment of cultured hippocampal neurons induced similar effects, accompanied by reduction of dendrites that were protected by kinase-active but not kinase-dead PAK. A beta(42) oligomer treatment also significantly reduced N-methyl-D-aspartic acid receptor subunit NR2B phosphotyrosine labeling. The Src family tyrosine kinase inhibitor PP2 significantly blocked the PAK/Rac translocation but not the loss of p-NR2B in A beta(42) oligomer-treated neurons. Src family kinases are known to phosphorylate the Rac activator Tiam1, which has recently been shown to be A beta-responsive. In addition, anti-oligomer curcumin comparatively suppressed PAK translocation in aged Tg2576 transgenic mice with Alzheimer amyloid pathology and in A beta(42) oligomer-treated cultured hippocampal neurons. Our results implicate aberrant PAK in A beta oligomer-induced signaling and synaptic deficits in Alzheimer disease.	[Ma, Qiu-Lan; Yang, Fusheng; Ubeda, Oliver J.; Hansen, James E.; Weisbart, Richard H.; Beech, Walter; Frautschy, Sally A.; Cole, Greg M.] Vet Affairs Med Ctr, Greater Los Angeles Vet Affairs Healthcare Syst, Geriatr Res & Clin Ctr, North Hills, CA 91343 USA; [Ma, Qiu-Lan; Yang, Fusheng; Ubeda, Oliver J.; Hansen, James E.; Weisbart, Richard H.; Beech, Walter; Frautschy, Sally A.; Cole, Greg M.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Frautschy, Sally A.; Cole, Greg M.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Calon, Frederic] Univ Laval, Med Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Laval University; Laval University	Cole, GM (corresponding author), Vet Affairs Med Ctr, Greater Los Angeles Vet Affairs Healthcare Syst, Geriatr Res & Clin Ctr, Alzheimer Res 151,Bldg 7,Rm A102, North Hills, CA 91343 USA.	gmcole@ucla.edu	Calon, Frederic/AAF-4390-2020	Frautschy, Sally A./0000-0003-0194-0363; Calon, Frederic/0000-0002-4203-0887	NCCIH NIH HHS [AT003008, R01 AT003008-03, R01 AT003008, R01 AT003008-02, R01 AT003008-01] Funding Source: Medline; NIA NIH HHS [R01 AG021975-02, P50 AG016570-090005, U01 AG028583-03, R01 AG021975, R01 AG021975-01A2, R01 AG013741-05, P50 AG016570, AG13471, P50 AG016570-060005, AG16570, U01 AG028583, P50 AG016570-070005, R01 AG021975-04, P50 AG016570-080005, P50 AG016570-040001, R01 AG013741-06, AG021975, R01 AG021975-03, R01 AG013741, R01 AG013741-07A2, R01 AG013741-08, P50 AG016570-100005, P50 AG005142] Funding Source: Medline; PHS HHS [U0128583] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013741, P50AG005142, P50AG016570, R01AG021975, U01AG028583] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Buttini M, 2000, NEUROSCIENCE, V97, P207, DOI 10.1016/S0306-4522(00)00069-5; Buttini M, 2002, J NEUROSCI, V22, P10539; Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Frasca G, 2008, J NEUROSCI RES, V86, P350, DOI 10.1002/jnr.21487; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	53	93	103	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14132	14143		10.1074/jbc.M708034200	http://dx.doi.org/10.1074/jbc.M708034200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347024	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000255728200067
J	Eichberger, T; Kaser, A; Pixner, C; Schmid, C; Klingler, S; Winklmayr, M; Hauser-Kronberger, C; Aberger, F; Frischauf, AM				Eichberger, Thomas; Kaser, Alexandra; Pixner, Claudia; Schmid, Carmen; Klingler, Stefan; Winklmayr, Martina; Hauser-Kronberger, Cornelia; Aberger, Fritz; Frischauf, Anna-Maria			GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE DEVELOPMENT; EPITHELIAL STEM-CELLS; SONIC HEDGEHOG; HUMAN KERATINOCYTES; CARCINOMA PROLIFERATION; CUBITUS INTERRUPTUS; SKIN DEVELOPMENT; DNA METHYLATION; BINDING PROTEIN; GENE-EXPRESSION	Hedgehog (HH) signaling in the epidermis is primarily mediated by the zinc finger transcription factors GLI1 and GLI2. Exquisite regulation of HH/GLI signaling is crucial for proper specification of the epidermal lineage and development of its derivatives, whereas dysregulation of HH/GLI signaling disrupts tissue homeostasis and causes basal cell carcinoma (BCC). Similarly, bone morphogenetic proteins (BMPs) and activins have been described as key signaling factors in the complex regulation of epidermal fate decisions, although their precise interplay with HH/GLI is largely elusive. Here we show that, in human epidermal cells, expression of the activin/BMP antagonist follistatin (FST) is predominantly up-regulated by the HH effector GLI2. Consistently, we found strong FST expression in the outer root sheath of human hair follicles and BCC. Detailed promoter analysis showed that two sequences with homology to the GLI consensus binding site are required for GLI2-mediated activation. Interestingly, activation of the FST promoter is highly GLI2-specific, because neither GLI1 nor GLI3 can significantly increase FST transcription. GLI2 specificity requires the presence of a 518-bp fragment in the proximal FST promoter region. On the protein level, sequences C-terminal to the zinc finger are responsible for GLI2-specific activation of FST transcription, pointing to the existence of GLI-interacting cofactors that modulate GLI target specificity. Our results reveal a key role of GLI2 in activation of the activin/BMP antagonist FST in response to HH signaling and provide new evidence for a regulatory interaction between HH and activin/BMP signaling in hair follicle development and BCC.	[Eichberger, Thomas; Kaser, Alexandra; Pixner, Claudia; Schmid, Carmen; Klingler, Stefan; Winklmayr, Martina; Aberger, Fritz; Frischauf, Anna-Maria] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Hauser-Kronberger, Cornelia] Paracelsus Med Univ, St Johanns Hosp, Dept Pathol, A-5020 Salzburg, Austria	Salzburg University; Paracelsus Private Medical University	Frischauf, AM (corresponding author), Salzburg Univ, Dept Mol Biol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	annemarie.frischauf@sbg.ac.at	Aberger, Fritz/B-6357-2012	Aberger, Fritz/0000-0003-2009-6305; Kaser-Eichberger, Alexandra/0000-0002-6115-5036	Austrian Science Fund FWF [P 16518] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Alvarez-Salas LM, 2005, INT J ONCOL, V26, P259; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Callahan CA, 2001, CURR OPIN GENET DEV, V11, P541, DOI 10.1016/S0959-437X(00)00230-6; Chen Y, 2000, MOL CELL BIOL, V20, P1616, DOI 10.1128/MCB.20.5.1616-1625.2000; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Ding Q, 1998, DEVELOPMENT, V125, P2533; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Gomes WA, 2001, DEV BIOL, V237, P212, DOI 10.1006/dbio.2001.0344; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Matise MP, 1998, DEVELOPMENT, V125, P2759; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mo R, 1997, DEVELOPMENT, V124, P113; Morita K, 2006, J DERMATOL SCI, V44, P11, DOI 10.1016/j.jdermsci.2006.06.001; Nakamura M, 2003, FASEB J, V17, P497, DOI 10.1096/fj.02-0247fje; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; NUMOTO M, 1993, NUCLEIC ACIDS RES, V21, P3767, DOI 10.1093/nar/21.16.3767; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Ohyama M, 2007, J DERMATOL SCI, V46, P81, DOI 10.1016/j.jdermsci.2006.12.002; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Park HL, 2000, DEVELOPMENT, V127, P1593; Patel K, 1999, MECH DEVELOP, V86, P51, DOI 10.1016/S0925-4773(99)00107-0; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Seishima M, 1999, J INVEST DERMATOL, V112, P432, DOI 10.1046/j.1523-1747.1999.00558.x; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Utriainen P, 2006, J ENDOCRINOL, V188, P305, DOI 10.1677/joe.1.06392; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Werner S, 2001, ONCOGENE, V20, P7494, DOI 10.1038/sj.onc.1204937; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu XZ, 2004, J INVEST DERMATOL, V123, P1120, DOI 10.1111/j.0022-202X.2004.23492.x; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496	83	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12426	12437		10.1074/jbc.M707117200	http://dx.doi.org/10.1074/jbc.M707117200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319260	Green Published, hybrid			2022-12-27	WOS:000255340000059
J	Fukui, K; Nishida, M; Nakagawa, N; Masui, R; Kuramitsu, S				Fukui, Kenji; Nishida, Masami; Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki			Bound nucleotide controls the endonuclease activity of mismatch repair enzyme MutL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS; RECA PROTEIN; DNA-REPAIR; GENES; ALPHA; CANCER; ATPASE; TRANSFORMATION; RECOMBINATION; RECOGNITION	DNA mismatch repair corrects mismatched base pairs mainly caused by replication error. Recent studies revealed that human MutL endonuclease, hPMS2, plays an essential role in the repair. However, there has been little biochemical analysis of the MutL endonuclease. In particular, it is unknown for what the MutL utilizes ATP binding and hydrolyzing activity. Here we report the detailed functional analysis of Thermus thermophilus MutL (ttMutL). ttMutL exhibited an endonuclease activity that decreased on alteration of Asp364 in ttMutL to Asn. The biochemical characteristics of ttMutL were significantly affected on ATP binding, which suppressed nonspecific DNA digestion and promoted the mismatch-and MutS-dependent DNA binding. The inactivation of the cysteinyl residues in the C-terminal domain resulted in the perturbation in ATP-dependent regulation of the endonuclease activity, although the ATP-binding motif is located in the N-terminal domain. Complementation experiments revealed that the endonuclease activity of ttMutL and its regulation by ATP binding are necessary for DNA repair in vivo.	[Fukui, Kenji; Nishida, Masami; Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki] RIKEN, SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Osaka University	Kuramitsu, S (corresponding author), RIKEN, SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	kuramitu@bio.sci.osaka-u.ac.jp		Fukui, Kenji/0000-0003-2463-7578				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; de Grado M, 1999, PLASMID, V42, P241, DOI 10.1006/plas.1999.1427; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; FANG WH, 1993, J BIOL CHEM, V268, P11838; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiang JJ, 2005, MOL CELL, V20, P771, DOI 10.1016/j.molcel.2005.10.014; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; KONDO N, 2007, THERMOPHILES, V12, P217; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KURAMITSU S, 1981, J BIOCHEM-TOKYO, V90, P1033, DOI 10.1093/oxfordjournals.jbchem.a133555; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; Luria SE, 1943, GENETICS, V28, P491; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakagawa N, 1997, J BIOL CHEM, V272, P22703, DOI 10.1074/jbc.272.36.22703; PUGH BF, 1988, J BIOL CHEM, V263, P76; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; SUNG P, 1993, J BIOL CHEM, V268, P26391; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021	35	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12136	12145		10.1074/jbc.M800110200	http://dx.doi.org/10.1074/jbc.M800110200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310077	hybrid			2022-12-27	WOS:000255340000030
J	Zhang, Z; Gameiro, A; Grewer, C				Zhang, Zhou; Gameiro, Armanda; Grewer, Christof			Highly conserved asparagine 82 controls the interaction of Na+ with the sodium-coupled neutral amino acid transporter SNAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE EXPRESSION PATTERN; PANCREATIC ACINAR-CELLS; SYSTEM N; FUNCTIONAL-CHARACTERISTICS; ELECTROGENIC PROPERTIES; ALANINE COTRANSPORTER; SUBTYPE; CLONING; IDENTIFICATION; METABOLISM	The neutral amino acid transporter 2 (SNAT2), which belongs to the SLC38 family of solute transporters, couples the transport of amino acid to the cotransport of one Na+ ion into the cell. Several polar amino acids are highly conserved within the SLC38 family. Here, we mutated three of these conserved amino acids, Asn(82) in the predicted transmembrane domain 1 (TMD1), Tyr(337) in TMD7, and Arg(374) in TMD8; and we studied the functional consequences of these modifications. The mutation of N82A virtually eliminated the alanine-induced transport current, as well as amino acid uptake by SNAT2. In contrast, the mutations Y337A and R374Q did not abolish amino acid transport. The K-m of SNAT2 for its interaction with Na+, K-Na(+), was dramatically reduced by the N82A mutation, whereas the more conservative mutation N82S resulted in a K-Na(+) that was in between SNAT2(N82A) and SNAT2(WT). These results were interpreted as a reduction of Na+ affinity caused by the Asn(82) mutations, suggesting that these mutations interfere with the interaction of SNAT2 with the sodium ion. As a consequence of this dramatic reduction in Na+ affinity, the apparent K-m of SNAT2(N82A) for alanine was increased 27-fold compared with that of SNAT2(WT). Our results demonstrate a direct or indirect involvement of Asn(82) in Na+ coordination by SNAT2. Therefore, we predict that TMD1 is crucial for the function of SLC38 transporters and that of related families.	[Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Zhang, Zhou; Gameiro, Armanda; Grewer, Christof] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Zhang, Zhou] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Miami; Shanghai Normal University	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu	Albers, Thomas/A-9082-2012		NINDS NIH HHS [R01 NS049335, R01-NS049335-02, R01 NS049335-04] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JAUCH P, 1986, J MEMBRANE BIOL, V94, P99, DOI 10.1007/BF01871191; JAUCH P, 1986, J MEMBRANE BIOL, V94, P117, DOI 10.1007/BF01871192; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Ortiz-Lopez A, 2000, BBA-BIOMEMBRANES, V1465, P275, DOI 10.1016/S0005-2736(00)00144-9; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pi J, 2002, J BACTERIOL, V184, P5842, DOI 10.1128/JB.184.21.5842-5847.2002; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wang HP, 2000, BIOCHEM BIOPH RES CO, V273, P1175, DOI 10.1006/bbrc.2000.3061; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Young VR, 2001, J NUTR, V131, p2449S, DOI 10.1093/jn/131.9.2449S; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200	36	22	24	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12284	12292		10.1074/jbc.M706774200	http://dx.doi.org/10.1074/jbc.M706774200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319257	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000255340000045
J	Yang, L; Reece, JM; Cho, J; Bortner, CD; Shears, SB				Yang, Ling; Reece, Jeff M.; Cho, Jaiesoon; Bortner, Carl D.; Shears, Stephen B.			The nucleolus exhibits an osmotically regulated gatekeeping activity that controls the spatial dynamics and functions of nucleolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIS-DIPHOSPHOINOSITOL TETRAKISPHOSPHATE; INOSITOL POLYPHOSPHATE PHOSPHATASE; REPLICATION PROTEIN-A; HYPEROSMOTIC STRESS; COMPLEX-FORMATION; DNA-REPLICATION; CELL-DEATH; PYROPHOSPHATES; HEXAKISPHOSPHATE; PENTAKISPHOSPHATE	We demonstrate that physiologically relevant perturbations in the osmotic environment rheostatically regulate a gatekeeping function for the nucleolus that controls the spatial dynamics and functions of nucleolin. HeLa cells and U2-OS osteosarcoma cells were osmotically challenged with 100-200 mM sorbitol, and the intranuclear distribution of nucleolin was monitored by confocal microscopy. Nucleolin that normally resides in the innermost fibrillar core of the nucleolus, where it assists rDNA transcription and replication, was expelled within 30 min of sorbitol addition. The nucleolin was transferred into the nucleoplasm, but it distributed there non-uniformly; locally high levels accumulated in 4',6-diamidino-2-phenylindole-negative zones containing euchromatic (transcriptionally active) DNA. Inositol pyrophosphates also responded within 30 min of hyperosmotic stress: levels of bisdiphosphoinositol tetrakisphosphate increased 6-fold, and this was matched by decreased levels of its precursor, diphosphoinositol pentakisphosphate. Such fluctuations in inositol pyrophosphate levels are of considerable interest, because, according to previously published in vitro data, they regulate the degree of phosphorylation of nucleolin through a novel kinase-independent phosphotransferase reaction (Saiardi, A., Bhandari, A., Resnick, R., Cain, A., Snowman, A. M., and Snyder, S. H. (2004) Science 306, 2101-2105). However, by pharmacologically intervening in inositol pyrophosphate metabolism, we found that it did not supervise the osmotically driven switch in the biological activities of nucleolin in vivo.	[Yang, Ling; Cho, Jaiesoon; Shears, Stephen B.] NIEHS, Inositol Signaling Grp, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Bortner, Carl D.] NIEHS, Mol Endocrinol Grp, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Reece, Jeff M.] Reecent Technol LLC, Durham, NC 27713 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Shears, SB (corresponding author), NIEHS, Inositol Signaling Grp, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	Shears@niehs.nih.gov	Shears, Stephen B/C-6335-2019	Shears, Stephen B/0000-0001-7309-8916	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102486, ZICES102486, Z01ES080046, ZIAES080046] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Barker CJ, 2004, BIOCHEM J, V380, P465, DOI 10.1042/BJ20031872; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Bourque CW, 1997, ANNU REV PHYSIOL, V59, P601, DOI 10.1146/annurev.physiol.59.1.601; Brehm MA, 2007, BIOCHEM J, V408, P335, DOI 10.1042/BJ20070382; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caffrey JJ, 1999, FEBS LETT, V442, P99, DOI 10.1016/S0014-5793(98)01636-6; Cho J, 2006, J BIOTECHNOL, V126, P248, DOI 10.1016/j.jbiotec.2006.04.028; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Craxton A, 1997, BIOCHEM J, V328, P75, DOI 10.1042/bj3280075; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Darrow DC, 1935, J CLIN INVEST, V14, P266, DOI 10.1172/JCI100674; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Ginisty H, 1999, J CELL SCI, V112, P761; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Kultz D, 2001, COMP BIOCHEM PHYS A, V130, P421, DOI 10.1016/S1095-6433(01)00440-8; Kultz D, 1998, J EXP BIOL, V201, P3015; Laussmann T, 1997, BIOCHEM J, V322, P31, DOI 10.1042/bj3220031; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Maeno E, 2006, FEBS LETT, V580, P6513, DOI 10.1016/j.febslet.2006.10.074; MAJERUS PW, 2007, SCI STKE, pPE72; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Pesesse X, 2005, BIOCHEM BIOPH RES CO, V336, P157, DOI 10.1016/j.bbrc.2005.08.049; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Raboy Victor, 2006, V39, P71; Safrany ST, 2004, MOL PHARMACOL, V66, P1585, DOI 10.1124/mol.104.002667; Safrany ST, 1998, EMBO J, V17, P1710, DOI 10.1093/emboj/17.6.1710; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Schliess F, 2002, BIOL CHEM, V383, P577, DOI 10.1515/BC.2002.059; SHEARS SB, 1995, J BIOL CHEM, V270, P10489, DOI 10.1074/jbc.270.18.10489; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Shears SB, 2007, BIOCHEM SOC SYMP, V74, P211, DOI 10.1042/BSS2007c18; Song YL, 2001, J GEN PHYSIOL, V117, P573, DOI 10.1085/jgp.117.6.573; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Thiry M, 2005, TRENDS CELL BIOL, V15, P194, DOI 10.1016/j.tcb.2005.02.007; URBAN JPG, 1993, J CELL PHYSIOL, V154, P262, DOI 10.1002/jcp.1041540208; Valdez BC, 1995, MOL IMMUNOL, V32, P1207, DOI 10.1016/0161-5890(95)00093-3; Verbsky J, 2005, J BIOL CHEM, V280, P29263, DOI 10.1074/jbc.M503366200; Verbsky J, 2005, P NATL ACAD SCI USA, V102, P8448, DOI 10.1073/pnas.0503656102; Verbsky JW, 2005, J BIOL CHEM, V280, P1911, DOI 10.1074/jbc.M411528200; VOMDAHL S, 1991, BIOCHEM J, V280, P105, DOI 10.1042/bj2800105; Wang YZ, 2001, J BIOL CHEM, V276, P20579, DOI 10.1074/jbc.M100874200; York JD, 2004, SCIENCE, V306, P2053, DOI 10.1126/science.1107225	54	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11823	11831		10.1074/jbc.M800308200	http://dx.doi.org/10.1074/jbc.M800308200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299322	hybrid, Green Published			2022-12-27	WOS:000255067400081
J	Desilets, A; Beliveau, F; Vandal, G; McDuff, FO; Lavigne, P; Leduc, R				Desilets, Antoine; Beliveau, Francois; Vandal, Guillaume; McDuff, Francois-Olivier; Lavigne, Pierre; Leduc, Richard			Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ACTIVATOR INHIBITOR-1; EPIDERMAL BARRIER FUNCTION; SERINE-PROTEASE; GROWTH; DOMAIN; EXPRESSION; RELEASE; ROLES; SITES; ST14	Matriptase is a member of the novel family of type II transmembrane serine proteases. It was recently shown that a rare genetic disorder, autosomal recessive ichthyosis with hypotrichosis, is caused by a mutation in the coding region of matriptase. However, the biochemical and functional consequences of the G827R mutation in the catalytic domain of the enzyme have not been reported. Here we expressed the G827R-matriptase mutant in bacterial cells and found that it did not undergo autocatalytic cleavage from its zymogen to its active form as did the wild-type matriptase. Enzymatic activity measurements showed that the G827R mutant was catalytically inactive. When expressed in HEK293 cells, G827R-matriptase remained inactive but was shed as a soluble form, suggesting that another protease cleaved the full-length mature form of matriptase. Molecular modeling based on the crystal structure of matriptase showed that replacing Gly(827) by Arg blocks access to the binding/catalytic cleft of the enzyme thereby preventing autocatalysis of the zymogen form. Our study, thus, provides direct evidence that the G827R mutation in patients with autosomal recessive ichthyosis with hypotrichosis leads to the expression of an inactive protease.	[Desilets, Antoine; Beliveau, Francois; Vandal, Guillaume; McDuff, Francois-Olivier; Lavigne, Pierre; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Leduc, R (corresponding author), 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	richard.leduc@usherbrooke.ca		Beliveau, Francois/0000-0001-6324-2363; Desilets, Antoine/0000-0001-5081-5564				Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Forbs D, 2005, INT J ONCOL, V27, P1061; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Kang JY, 2003, CANCER RES, V63, P1101; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; Qiu D, 2007, BIOCHEM SOC T, V35, P583, DOI 10.1042/BST0350583; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; STEVEN AC, 1994, J CELL SCI, V107, P693; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639	30	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10535	10542		10.1074/jbc.M707012200	http://dx.doi.org/10.1074/jbc.M707012200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18263585	hybrid, Green Published			2022-12-27	WOS:000254894700035
J	Tsuchiya, H; Oka, T; Nakamura, K; Ichikawa, A; Saper, CB; Sugimoto, Y				Tsuchiya, Hiroyoshi; Oka, Takakazu; Nakamura, Kazuhiro; Ichikawa, Atsushi; Saper, Clifford B.; Sugimoto, Yukihiko			Prostaglandin E-2 attenuates preoptic expression of GABA(A) receptors via EP3 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEBRILE RESPONSE; SUBTYPE EP3; RAT HYPOTHALAMUS; NERVOUS-SYSTEM; MESSENGER-RNA; AREA; FEVER; LOCALIZATION; NUCLEUS; NEURONS	Prostaglandin E-2 (PGE(2)) has been shown to produce fever by acting on EP3 receptors within the preoptic area of the brain. However, there is little information about the molecular events downstream of EP3 activation in preoptic neurons. As a first step toward this issue, we examined PGE(2)-induced gene expression changes at single-cell resolution in preoptic neurons expressing EP3. Brain sections of the preoptic area from PGE(2)- or saline-injected rats were stained with an anti-EP3 antibody, and the cell bodies of EP3-positive neurons were dissected and subjected to RNA amplification procedures. Microarray analysis of the amplified products demonstrated the possibility that gene expression of gamma-aminobutyric acid type A (GABA(A)) receptor subunits is decreased upon PGE(2) injection. Indeed, we found that most EP3-positive neurons in the mouse preoptic area are positive for the alpha 2 or gamma 2 GABA(A) receptor subunit. Moreover, PGE(2) decreased the preoptic gene expression of these GABA(A) subunits via an EP3-dependent and pertussis toxin-sensitive pathway. PGE(2) also attenuated the preoptic protein expression of the alpha 2 subunit in wild-type but not in EP3-deficient mice. These results indicate that PGE(2)-EP3 signaling elicits G(i/o) activation in preoptic thermocenter neurons, and we propose the possibility that a rapid decrease in preoptic GABA(A) expression may be involved in PGE(2)-induced fever.	[Tsuchiya, Hiroyoshi; Ichikawa, Atsushi; Sugimoto, Yukihiko] Kyoto Univ, Dept Physiol Chem, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Nakamura, Kazuhiro] Kyoto Univ, Mol Neurobiol Lab, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Oka, Takakazu; Saper, Clifford B.] Harvard Univ, Sch Med, Dept Neurol & Program Nerosci, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Oka, Takakazu] Univ Occupat & Environm Hlth, Dept Neurol, Div Psychosomat Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan	Kyoto University; Kyoto University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Occupational & Environmental Health - Japan	Sugimoto, Y (corresponding author), Kyoto Univ, Dept Physiol Chem, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	ysugimot@pharm.kyoto-u.ac.jp	Nakamura, Kazuhiro/A-5431-2008; Sugimoto, Yukihiko/AAV-6470-2021; Saper, Clifford/L-3815-2019	Nakamura, Kazuhiro/0000-0002-6095-8996; Sugimoto, Yukihiko/0000-0001-6973-932X; 				Crino PB, 1996, P NATL ACAD SCI USA, V93, P14152, DOI 10.1073/pnas.93.24.14152; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Fujimoto S, 2006, NEUROBIOL DIS, V22, P130, DOI 10.1016/j.nbd.2005.10.008; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12, DOI 10.1111/j.1476-5381.1957.tb01354.x; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; KLUGER MJ, 1991, PHYSIOL REV, V71, P93, DOI 10.1152/physrev.1991.71.1.93; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; MILTON AS, 1971, J PHYSIOL-LONDON, V218, P325, DOI 10.1113/jphysiol.1971.sp009620; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 2002, J NEUROSCI, V22, P4600, DOI 10.1523/JNEUROSCI.22-11-04600.2002; Nakamura K, 1999, NEUROSCI LETT, V260, P117, DOI 10.1016/S0304-3940(98)00962-8; NEGISHI M, 1993, BIOCHIM BIOPHYS ACTA, V1175, P343, DOI 10.1016/0167-4889(93)90227-G; OKA T, 2003, J PHYSL, V55, P1945; Osaka T, 2004, AM J PHYSIOL-REG I, V287, pR306, DOI 10.1152/ajpregu.00003.2004; OSBORNE PG, 1994, BRAIN RES, V661, P237, DOI 10.1016/0006-8993(94)91200-9; Ranels HJ, 2003, BRAIN RES, V964, P42, DOI 10.1016/S0006-8993(02)04063-5; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; SAPER CB, 1994, NEW ENGL J MED, V330, P1880; STITT JT, 1986, YALE J BIOL MED, V59, P137; SUGIMOTO Y, 1994, NEUROSCIENCE, V62, P919, DOI 10.1016/0306-4522(94)90483-9; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; Sugimoto Y, 2005, J IMMUNOL, V175, P2606, DOI 10.4049/jimmunol.175.4.2606; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanaka S, 1998, J BIOL CHEM, V273, P8177, DOI 10.1074/jbc.273.14.8177; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; WISDEN W, 1992, J NEUROSCI, V12, P1040; Yoshida K, 2003, EUR J NEUROSCI, V18, P1848, DOI 10.1046/j.1460-9568.2003.02919.x	31	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					11064	11071		10.1074/jbc.M801359200	http://dx.doi.org/10.1074/jbc.M801359200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18292084	hybrid			2022-12-27	WOS:000254894700086
J	Liu, K; Gualano, RC; Hibbs, ML; Anderson, GP; Bozinovski, S				Liu, Kenneth; Gualano, Rosa C.; Hibbs, Margaret L.; Anderson, Gary P.; Bozinovski, Steven			Epidermal growth factor receptor signaling to Erk1/2 and STATs control the intensity of the epithelial inflammatory responses to rhinovirus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; INNATE IMMUNE-RESPONSES; C-ERBB RECEPTORS; VIRAL-INFECTIONS; BRONCHIAL EPITHELIUM; RESPIRATORY VIRUSES; NEGATIVE REGULATION; CIGARETTE-SMOKE; GM-CSF	Rhinovirus infection is the most common cause of acute exacerbations of inflammatory lung diseases, such as asthma and chronic obstructive pulmonary disease, where it provokes steroid refractory and abnormally intense neutrophilic inflammation that can be life threatening. Epidermal growth factor receptor (EGFR) expression correlates with disease severity and neutrophil infiltration in these conditions. However, the role of EGFR signaling in rhinovirus infection is unknown. We measured the key determinants of neutrophilic inflammation interleukin (IL)-8 and ICAM-1 in rhinovirus (RV16 serotype)- infected bronchial epithelial cells, BEAS-2B. RV16 infection stimulated IL-8 and ICAM-1 expression, which was further elevated (2-fold) by transient up-regulation of EGFR levels. Detection of viral RNA by quantitative real time PCR confirmed that enhanced expression was not associated with increased viral replication. EGFR ligands (epiregulin, amphiregulin, and heparin-binding epidermal growth factor) were induced by RV16 infection, and inhibition of metalloproteases responsible for ligand shedding partially suppressed this response. The EGFR inhibitor AG1478, completely blocked IL-8 and ICAM-1 expression to basal levels, as did the specific Erk1/2 inhibitor U0126. The p38 mitogen-activated protein kinase inhibitor SB203580 blocked IL-8 secretion but not ICAM-1 expression, whereas the PI3K inhibitor wortmannin was ineffective in both responses. Kinase inactive K721R EGFR, which is selectively deficient in STAT signaling, reversed RV16 responses associated with EGFR overexpression. In conclusion, RV16 infection rapidly promotes induction of EGFR ligands and utilizes EGFR signaling to increase IL-8 and ICAM-1 levels. These results suggest that targeting EGFR may provide a selective therapy that dampens neutrophil-driven inflammation without compromising essential antiviral pathways mediated by pathogen recognition receptors such as TLR3.	[Liu, Kenneth; Gualano, Rosa C.; Anderson, Gary P.; Bozinovski, Steven] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Hibbs, Margaret L.] Ludwig Inst Canc Res, Melbourne Branch, Parkville, Vic, Australia; [Anderson, Gary P.] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia	University of Melbourne; Ludwig Institute for Cancer Research; University of Melbourne	Bozinovski, S (corresponding author), Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia.	bozis@unimelb.edu.au	Liu, Kenneth W/G-7973-2012; Hibbs, Margaret L/D-7013-2011	Hibbs, Margaret L/0000-0002-3751-6751; Bozinovski, Steven/0000-0001-6533-8641; Anderson, Gary/0000-0001-6580-3398				Anderson GP, 2003, TRENDS PHARMACOL SCI, V24, P71, DOI 10.1016/S0165-6147(02)00052-4; ARRUDA E, 1995, J INFECT DIS, V171, P1329, DOI 10.1093/infdis/171.5.1329; Atmar RL, 1998, ARCH INTERN MED, V158, P2453, DOI 10.1001/archinte.158.22.2453; Barsky SH, 1998, JNCI-J NATL CANCER I, V90, P1198, DOI 10.1093/jnci/90.16.1198; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; Bozinovski S, 2002, J BIOL CHEM, V277, P42808, DOI 10.1074/jbc.M207840200; CHEUNG D, 1995, AM J RESP CRIT CARE, V152, P1490, DOI 10.1164/ajrccm.152.5.7582282; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Dagher H, 2004, J VIROL METHODS, V117, P113, DOI 10.1016/j.jviromet.2004.01.003; de Boer WI, 2006, AM J CLIN PATHOL, V125, P184, DOI 10.1039/W1AXKGT7UA37X257; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Griego SD, 2000, J IMMUNOL, V165, P5211, DOI 10.4049/jimmunol.165.9.5211; Grunberg K, 1999, AM J RESP CRIT CARE, V160, P1375; Grunberg K, 1997, AM J RESP CRIT CARE, V156, P609; Grunberg K, 1997, CLIN EXP ALLERGY, V27, P36, DOI 10.1111/j.1365-2222.1997.tb00670.x; Hamilton LM, 2003, CLIN EXP ALLERGY, V33, P233, DOI 10.1046/j.1365-2222.2003.01593.x; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Holgate ST, 2000, CLIN EXP ALLERGY, V30, P1; HUCTHINSON AF, 2007, RESP MED, V101, P2472; Huguenel ED, 1997, AM J RESP CRIT CARE, V155, P1206, DOI 10.1164/ajrccm.155.4.9105055; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Johnston NW, 2006, THORAX, V61, P722, DOI 10.1136/thx.2005.045161; Johnston Sebastian L, 2005, Proc Am Thorac Soc, V2, P150, DOI 10.1513/pats.200502-018AW; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; LANNAN S, 1994, AM J PHYSIOL, V266, pL92, DOI 10.1152/ajplung.1994.266.1.L92; MacNee W, 2003, THORAX, V58, P261, DOI 10.1136/thorax.58.3.261; Mallia P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-116; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Nadel Jay A., 2001, Current Opinion in Pharmacology, V1, P254, DOI 10.1016/S1471-4892(01)00045-5; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Nakanaga T, 2007, AM J PHYSIOL-LUNG C, V292, pL1289, DOI 10.1152/ajplung.00356.2006; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Ozes ON, 1999, NATURE, V401, P82; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Polosa R, 2002, J ALLERGY CLIN IMMUN, V109, P75, DOI 10.1067/mai.2002.120274; Polosa R, 1999, AM J RESP CELL MOL, V20, P914, DOI 10.1165/ajrcmb.20.5.3308; Proud D, 2006, AM J RESP CELL MOL, V35, P513, DOI 10.1165/rcmb.2006-0199TR; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Robbins CS, 2004, AM J RESP CELL MOL, V30, P202, DOI 10.1165/rcmb.2003-0259OC; Rohde G, 2003, THORAX, V58, P37, DOI 10.1136/thorax.58.1.37; Sanders SP, 2001, J ALLERGY CLIN IMMUN, V107, P235, DOI 10.1067/mai.2001.112028; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Walker F, 1998, MOL CELL BIOL, V18, P7192, DOI 10.1128/MCB.18.12.7192; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Yu YM, 2003, AM J PHYSIOL-GASTR L, V285, pG282, DOI 10.1152/ajpgi.00503.2002	63	78	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9977	9985		10.1074/jbc.M710257200	http://dx.doi.org/10.1074/jbc.M710257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18276593	hybrid			2022-12-27	WOS:000254671600054
J	Csutora, P; Peter, K; Kilic, H; Park, KM; Zarayskiy, V; Gwozdz, T; Bolotina, VM				Csutora, Peter; Peter, Krisztina; Kilic, Helena; Park, Kristen M.; Zarayskiy, Vladislav; Gwozdz, Tomasz; Bolotina, Victoria M.			Novel role for STIM1 as a trigger for calcium influx factor production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; CA2+-INDEPENDENT PHOSPHOLIPASE A(2); CRAC CHANNELS; STORE DEPLETION; ACTIVATION; ORAI1; SENSOR; MECHANISM; CURRENTS; CELLS	STIM1 has been recently identified as a Ca2+ sensor in endoplasmic reticulum (ER) and an initiator of the store-operated Ca2+ entry (SOCE) pathway, but the mechanism of SOCE activation remains controversial. Here we focus on the early ER-delimited steps of the SOCE pathway and demonstrate that STIM1 is critically involved in initiating of production of calcium influx factor (CIF), a diffusible messenger that can deliver the signal from the stores to plasma membrane and activate SOCE. We discovered that CIF production is tightly coupled with STIM1 expression and requires functional integrity of its intraluminal sterile alpha-motif (SAM) domain. We demonstrate that 1) molecular knockdown or overexpression of STIM1 results in corresponding impairment or amplification of CIF production and 2) inherent deficiency in the ER-delimited CIF production and SOCE activation in some cell types can be a result of their deficiency in STIM1 protein; expression of a wildtype STIM1 in such cells was sufficient to fully rescue their ability to produce CIF and SOCE. We found that glycosylation sites in the ER-resident SAM domain of STIM1 are essential for initiation of CIF production. We propose that after STIM1 loses Ca2+ from EF hand, its intraluminal SAM domain may change conformation, and via glycosylation sites it can interact with and activate CIF-producing machinery. Thus, CIF production appears to be one of the earliest STIM-dependent events in the ER lumen, and impairment of this process results in impaired SOCE response.	[Csutora, Peter; Peter, Krisztina; Kilic, Helena; Park, Kristen M.; Zarayskiy, Vladislav; Gwozdz, Tomasz; Bolotina, Victoria M.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Bolotina, VM (corresponding author), EBRC, Ion Channel & Calcium Signaling Unit, X-704,650 Albany St, Boston, MA 02118 USA.	bolotina@bu.edu		Bolotina, Victoria/0000-0001-5862-181X	NHLBI NIH HHS [HL 007224, R01 HL054150, R21 HL097569, R01 HL071793, R01 HL 71793, R01 HL 54150, HL 007969] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071793, T32HL007969, R01HL054150, R21HL097569, T32HL007224] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009; Bose DD, 2005, BIOCHEM J, V386, P291, DOI 10.1042/BJ20040900; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Chen PY, 1998, DIABETES, V47, P874, DOI 10.2337/diabetes.47.6.874; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Csutora P, 2006, J BIOL CHEM, V281, P34926, DOI 10.1074/jbc.M606504200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HISATSUNE C, 2005, SCI STKE, pE53; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; KIM HY, 1995, J BIOL CHEM, V270, P9706, DOI 10.1074/jbc.270.17.9706; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; LO TM, 1993, AM J PHYSIOL, V264, pC641, DOI 10.1152/ajpcell.1993.264.3.C641; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Martinez J, 2005, BIOCHEM PHARMACOL, V70, P733, DOI 10.1016/j.bcp.2005.04.045; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peel SE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-119; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ross K, 2007, J CELL PHYSIOL, V211, P569, DOI 10.1002/jcp.20993; Shin KJ, 2002, TOXICOL APPL PHARM, V178, P37, DOI 10.1006/taap.2001.9317; Shuttleworth TJ, 2007, CELL CALCIUM, V42, P183, DOI 10.1016/j.ceca.2007.01.012; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; THOMAS D, 1995, J BIOL CHEM, V270, P6429, DOI 10.1074/jbc.270.12.6429; Thomas D, 1996, BIOCHEM J, V318, P649, DOI 10.1042/bj3180649; Trepakova ES, 2000, J BIOL CHEM, V275, P26158, DOI 10.1074/jbc.M004666200; Trepakova ES, 2002, BIOL MEMBRANY, V19, P49; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zablocki K, 2000, ACTA BIOCHIM POL, V47, P591; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	49	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14524	14531		10.1074/jbc.M709575200	http://dx.doi.org/10.1074/jbc.M709575200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18337241	Green Published, hybrid			2022-12-27	WOS:000255941400040
J	Mccoy, CE; Carpenter, S; Palsson-McDermott, EM; Gearing, LJ; O'Neill, LAJ				McCoy, Claire E.; Carpenter, Susan; Palsson-McDermott, Eva M.; Gearing, Linden J.; O'Neill, Luke A. J.			Glucocorticoids inhibit IRF3 phosphorylation in response to toll-like receptor-3 and-4 by targeting TBK1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-3; DOUBLE-STRANDED-RNA; NF-KAPPA-B; TANK-BINDING KINASE-1; ANTIVIRAL RESPONSE; GENE-EXPRESSION; VIRAL-INFECTION; VIRUS-INFECTION; PROTEIN-KINASE; IKK-EPSILON	Phosphorylation of the transcription factor interferon regulatory factor 3 ( IRF3) is essential for the induction of promoters which contain the interferon-stimulated response element ( ISRE). IRF3 can be activated by Toll-like receptor 3 ( TLR3) in response to the double-stranded RNA mimic poly( I-C) and by TLR4 in response to lipopolysaccharide ( LPS). Here we have analyzed the effect of the glucocorticoid dexamethasone on this response. Dexamethasone inhibited the induction of the ISRE-dependent gene RANTES ( regulated on activation normal T cell expressed and secreted) in both U373-CD14 cells and human peripheral blood mononuclear cells and also an ISRE luciferase construct, activated by either TLR3 or TLR4. It also inhibited increased phosphorylation of IRF3 in its N terminus in response to LPS and in its C terminus on Ser-396 in response to either poly( I-C) or LPS. Several dexamethasone-induced phosphatases were tested for possible involvement in these effects; MKP1 did not appear to be involved, although MKP2 and MKP5 both partially inhibited induction of the ISRE, pointing to their possible involvement in the effect of dexamethasone. Importantly, we found that dexamethasone could inhibit TBK1 kinase activity and TBK1 phosphorylation on Ser-172, both of which are required for IRF3 phosphorylation downstream of TLR3 and TLR4 stimulation. Our study, therefore, demonstrates that TBK1 is a target for dexamethasone, common to both TLR3 and TLR4 signaling.	[McCoy, Claire E.; Carpenter, Susan; Palsson-McDermott, Eva M.; Gearing, Linden J.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Mccoy, CE (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	cmccoy@tcd.ie		O'Neill, Luke/0000-0002-4333-2748; McCoy, Claire/0000-0001-8710-896X; Gearing, Linden/0000-0003-3508-3056				Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chinenov Y, 2007, MOL CELL ENDOCRINOL, V275, P30, DOI 10.1016/j.mce.2007.04.014; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lowe EL, 2006, J ENDOTOXIN RES, V12, P337, DOI 10.1179/096805106X118915; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Reily MM, 2006, EMBO J, V25, P108, DOI 10.1038/sj.emboj.7600919; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sing A, 2000, INFECT IMMUN, V68, P1600, DOI 10.1128/IAI.68.3.1600-1607.2000; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	34	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14277	14285		10.1074/jbc.M709731200	http://dx.doi.org/10.1074/jbc.M709731200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356163	hybrid, Green Published			2022-12-27	WOS:000255941400014
J	Zabolotny, JM; Kim, YB; Welsh, LA; Kershaw, EE; Neel, BG; Kahn, BB				Zabolotny, Janice M.; Kim, Young-Bum; Welsh, Laura A.; Kershaw, Erin E.; Neel, Benjamin G.; Kahn, Barbara B.			Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; DIET-INDUCED OBESITY; KAPPA-B ACTIVATION; SKELETAL-MUSCLE; ADIPOSE-TISSUE; TNF-ALPHA; RECEPTOR SUBSTRATE-1; GLUCOSE-HOMEOSTASIS	Protein-tyrosine phosphatase 1B (PTP1B) is a major negative regulator of insulin and leptin sensitivity. PTP1B overexpression in adipose tissue and skeletal muscle of humans and rodents may contribute to insulin resistance and obesity. The mechanisms mediating PTP1B overexpression in obese and diabetic states have been unclear. We find that adipose tissue inflammation and the pro-inflammatory cytokine tumor necrosis factor alpha (TNF alpha) regulate PTP1B expression in vivo. High fat feeding of mice increased PTP1B expression 1.5- to 7-fold in adipose tissue, liver, skeletal muscle, and arcuate nucleus of hypothalamus. PTP1B overexpression in high fat-fed mice coincided with increased adipose tissue expression of the macrophage marker CD68 and TNF alpha, which is implicated in causing obesity-induced insulin resistance. TNF alpha increased PTP1B mRNA and protein levels by 2- to 5-fold in a dose-and time-dependent manner in adipocyte and hepatocyte cell lines. TNF alpha administration in mice increased PTP1B mRNA1.4- to 4-fold in adipose tissue, liver, skeletal muscle, and hypothalamic arcuate nucleus and PTP1B protein 2- fold in liver. Actinomycin D treatment blocked, and high dose salicylate treatment inhibited by 80%, TNF alpha-induced PTP1B expression in adipocyte cell lines, suggesting TNF alpha may induce PTP1B transcription via nuclear factor kappa B ( NF kappa B) activation. Chromatin immunoprecipitation from adipocyte cell lines and liver of mice demonstrated TNF alpha-induced recruitment of NF kappa B subunit p65 to the PTP1B promoter in vitro and in vivo. In mice with diet-induced obesity, TNF alpha deficiency also partly blocked PTP1B overexpression in adipose tissue. Our data suggest that PTP1B overexpression in multiple tissues in obesity is regulated by inflammation and that PTP1B may be a target of anti-inflammatory therapies.	[Zabolotny, Janice M.; Kim, Young-Bum; Welsh, Laura A.; Kershaw, Erin E.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Neel, Benjamin G.] Beth Israel Deaconess Med Ctr, Dept Med, Canc Biol Program, Div Hematol Oncol, Boston, MA 02215 USA; [Neel, Benjamin G.] Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Zabolotny, JM (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, N 325A,330 Brookline Ave, Boston, MA 02215 USA.	jzabolot@bidmc.harvard.edu	Kershaw, Erin E/G-9587-2013; Welsh, Laura/AAW-8481-2020	Kershaw, Erin E/0000-0002-3887-4868; Welsh, Laura/0000-0002-3987-2186	NATIONAL CANCER INSTITUTE [R01CA049152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060838, R21DK073530, R01DK060839, P30DK057521, K01DK062212, K08DK065833, P30DK046200] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 049152] Funding Source: Medline; NIDDK NIH HHS [K08 DK 065833, R21 DK 073530, K08 DK065833-05, R01 DK 060838, R01 DK 060839, P30 DK 046200, P30 DK 057521, K08 DK065833, K01 DK 062212] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad F, 1997, METABOLISM, V46, P1140, DOI 10.1016/S0026-0495(97)90206-7; Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; AHMAD F, 1995, AM J PHYSIOL-ENDOC M, V268, pE932, DOI 10.1152/ajpendo.1995.268.5.E932; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; Ahmad F, 1997, J CELL BIOCHEM, V64, P117, DOI 10.1002/(SICI)1097-4644(199701)64:1<117::AID-JCB14>3.0.CO;2-I; Ameloot P, 2002, EUR J IMMUNOL, V32, P2759, DOI 10.1002/1521-4141(2002010)32:10<2759::AID-IMMU2759>3.0.CO;2-L; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berg AH, 2004, AM J PHYSIOL-ENDOC M, V287, pE1178, DOI 10.1152/ajpendo.00002.2004; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cheung A, 1999, J LAB CLIN MED, V134, P115, DOI 10.1016/S0022-2143(99)90115-4; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Dadke SS, 2000, BIOCHEM BIOPH RES CO, V274, P583, DOI 10.1006/bbrc.2000.3188; DeFronzo RA, 1997, DIABETES REV, V5, P177; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; FLICK DA, 1986, J IMMUNOPHARMACOL, V8, P89; FLINT AJ, 1993, EMBO J, V12, P1937, DOI 10.1002/j.1460-2075.1993.tb05843.x; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Gouni-Berthold I, 2005, J INTERN MED, V257, P272, DOI 10.1111/j.1365-2796.2004.01446.x; Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kipfer-Coudreau S, 2004, DIABETOLOGIA, V47, P1278, DOI 10.1007/s00125-004-1432-5; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; KUSARI J, 1994, J CLIN INVEST, V93, P1156, DOI 10.1172/JCI117068; Lam NT, 2004, MOL ENDOCRINOL, V18, P1333, DOI 10.1210/me.2002-0193; Lam NT, 2006, J MOL ENDOCRINOL, V36, P163, DOI 10.1677/jme.1.01937; Lu T, 2004, ONCOGENE, V23, P2138, DOI 10.1038/sj.onc.1207332; Lukic M L, 1998, Dev Immunol, V6, P119, DOI 10.1155/1998/92198; Mantzoros C S, 1995, Adv Endocrinol Metab, V6, P193; Mensah-Brown EPK, 2002, MOL IMMUNOL, V38, P941, DOI 10.1016/S0161-5890(02)00021-4; Nieto-Vazquez I, 2007, DIABETES, V56, P404, DOI 10.2337/db06-0989; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Obata T, 1998, J BIOCHEM-TOKYO, V123, P813; PANG XP, 1991, LYMPHOKINE CYTOK RES, V10, P301; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Qi C, 2000, P SOC EXP BIOL MED, V223, P128, DOI 10.1046/j.1525-1373.2000.22318.x; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.3.CO;2-M; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Santaniemi M, 2004, J INTERN MED, V256, P48, DOI 10.1111/j.1365-2796.2004.01339.x; SCHIEVELLA AR, 1993, CELL GROWTH DIFFER, V4, P239; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Shao J, 1998, Zhonghua Yi Xue Za Zhi, V78, P753; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Sykiotis GP, 2001, MOL ENDOCRINOL, V15, P1864, DOI 10.1210/me.15.11.1864; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Thomas CR, 1998, BIOCHEM PHARMACOL, V56, P1145, DOI 10.1016/S0006-2952(98)00151-8; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Worm D, 1999, DIABETOLOGIA, V42, P1146; Wu Y, 2005, BRIT J PHARMACOL, V146, P234, DOI 10.1038/sj.bjp.0706306; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zabolotny JM, 2004, J BIOL CHEM, V279, P24844, DOI 10.1074/jbc.M310688200; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	76	291	299	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14230	14241		10.1074/jbc.M800061200	http://dx.doi.org/10.1074/jbc.M800061200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18281274	hybrid, Green Published			2022-12-27	WOS:000255941400009
J	Kumar, V; Jong, YJI; O'Malley, KL				Kumar, Vikas; Jong, Yuh-Jiin I.; O'Malley, Karen L.			Activated nuclear metabotropic glutamate receptor mGlu5 couples to nuclear G(q/11) proteins to generate inositol 1,4,5-trisphosphate-mediated nuclear Ca2+ release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PTDINS(4,5)P-2; HETEROTRIMERIC G-PROTEINS; SIGNAL-TRANSDUCTION; LIVING CELLS; NUCLEOPLASMIC RETICULUM; CEREBELLAR PURKINJE; RYANODINE RECEPTORS; FLUORESCENT PROTEIN; CALCIUM TRANSIENTS; CYTOSOLIC CALCIUM	Recently we have shown that the metabotropic glutamate 5 (mGlu5) receptor can be expressed on nuclear membranes of heterologous cells or endogenously on striatal neurons where it can mediate nuclear Ca2+ changes. Here, pharmacological, optical, and genetic techniques were used to show that upon activation, nuclear mGlu5 receptors generate nuclear inositol 1,4,5-trisphosphate (IP3) in situ. Specifically, expression of an mGlu5 F767S mutant in HEK293 cells that blocks G(q/11) coupling or introduction of a dominant negative G alpha(q) construct in striatal neurons prevented nuclear Ca2+ changes following receptor activation. These data indicate that nuclear mGlu5 receptors couple to G(q/11) to mobilize nuclear Ca2+. Nuclear mGlu5-mediated Ca2+ responses could also be blocked by the phospholipase C (PLC) inhibitor, U73122, the phosphatidylinositol (PI) PLC inhibitor 1-O-octadecyl-2-O-methyl-sn-glycero-3- phosphorylcholine (ET-18-OCH3), or by using small interfering RNA targeted against PLC beta 1 demonstrating that PI-PLC is involved. Direct assessment of inositol phosphate production using a PIP2/IP3 "biosensor" revealed for the first time that IP3 can be generated in the nucleus following activation of nuclear mGlu5 receptors. Finally, both IP3 and ryanodine receptor blockers prevented nuclear mGlu5-mediated increases in intranuclear Ca2+. Collectively, this study shows that like plasma membrane receptors, activated nuclear mGlu5 receptors couple to G(q/11) and PLC to generate IP3-mediated release of Ca2+ from Ca2+-release channels in the nucleus. Thus the nucleus can function as an autonomous organelle independent of signals originating in the cytoplasm, and nuclear mGlu5 receptors play a dynamic role in mobilizing Ca2+ in a specific, localized fashion.	[Kumar, Vikas; Jong, Yuh-Jiin I.; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), 660 S Euclid Ave, St Louis, MO 63110 USA.	omalleyk@pcg.wustl.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069646, R01MH057817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NIMH NIH HHS [MH69646, MH57817] Funding Source: Medline; NINDS NIH HHS [NS057105] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Bolsover S, 2001, BIOCHEM J, V356, P345, DOI 10.1042/0264-6021:3560345; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; D'Santos C, 2000, EUR J HISTOCHEM, V44, P51; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Gerasimenko O, 2005, CELL CALCIUM, V38, P201, DOI 10.1016/j.ceca.2005.06.025; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Halet G, 2002, J CELL SCI, V115, P2139; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Ibarra C, 2004, J BIOL CHEM, V279, P7554, DOI 10.1074/jbc.M311604200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2007, J NEUROCHEM, V101, P458, DOI 10.1111/j.1471-4159.2006.04382.x; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim YH, 2006, J CELL PHYSIOL, V207, P689, DOI 10.1002/jcp.20609; Kingston AE, 2002, NEUROSCI LETT, V330, P127, DOI 10.1016/S0304-3940(02)00751-6; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; Marchenko SM, 2006, CEREBELLUM, V5, P36, DOI 10.1080/14734220600554438; Marchenko SM, 2005, J PHYSIOL-LONDON, V565, P897, DOI 10.1113/jphysiol.2004.081299; Marius P, 2006, CELL CALCIUM, V39, P65, DOI 10.1016/j.ceca.2005.09.010; Martelli AM, 2005, HISTOL HISTOPATHOL, V20, P1251, DOI 10.14670/HH-20.1251; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Muhlemann AM, 2005, BRIT J PHARMACOL, V144, P1118, DOI 10.1038/sj.bjp.0706152; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Oka T, 2002, BRIT J PHARMACOL, V135, P1959, DOI 10.1038/sj.bjp.0704662; Power JM, 2002, J NEUROSCI, V22, P3454; Quesada I, 2005, BIOPHYS J, V88, P3946, DOI 10.1529/biophysj.105.061390; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Romano C, 2001, MOL PHARMACOL, V59, P46, DOI 10.1124/mol.59.1.46; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SORENSEN AM, 1995, J CELL BIOCHEM, V58, P15, DOI 10.1002/jcb.240580104; Spitzer NC, 2000, BIOESSAYS, V22, P811; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Ventura C, 2001, CRIT REV EUKAR GENE, V11, P243; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Willard FS, 2000, IMMUNOL CELL BIOL, V78, P387, DOI 10.1046/j.1440-1711.2000.00927.x; Yagisawa H, 2006, J CELL BIOCHEM, V97, P233, DOI 10.1002/jcb.20677; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	68	72	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14072	14083		10.1074/jbc.M708551200	http://dx.doi.org/10.1074/jbc.M708551200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337251	hybrid, Green Published			2022-12-27	WOS:000255728200061
J	Malay, AD; Umehara, T; Matsubara-Malay, K; Padmanabhan, B; Yokoyama, S				Malay, Ali D.; Umehara, Takashi; Matsubara-Malay, Kazuko; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki			Crystal structures of fission yeast histone chaperone Asf1 complexed with the Hip1 B-domain or the Cac2 C terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN; PROTEIN; NUCLEOSOME; IDENTIFICATION; DEPOSITION; REPLICATION; CIA/ASF1; PARTICLE; CAF-1; RAD53	The assembly of core histones onto eukaryotic DNA is modulated by several histone chaperone complexes, including Asf1, CAF-1, and HIRA. Asf1 is a unique histone chaperone that participates in both the replication-dependent and replication-independent pathways. Here we report the crystal structures of the apo-form of fission yeast Asf1/Cia1 (SpAsf1N; residues 1-161) as well as its complexes with the B-domain of the fission yeast HIRA orthologue Hip1 (Hip1B) and the C-terminal region of the Cac2 subunit of CAF-1 (Cac2C). The mode of the fission yeast Asf1N-Hip1B recognition is similar to that of the human Asf1-HIRA recognition, suggesting that Asf1N recognition of Hip1B/HIRA is conserved from yeast to mammals. Interestingly, Hip1B and Cac2C show remarkably similar interaction modes with Asf1. The binding between Asf1N and Hip1B was almost completely abolished by the D37A and L60A/V62A mutations in Asf1N, indicating the critical role of salt bridge and van der Waals contacts in the complex formation. Consistently, both of the aforementioned Asf1 mutations also drastically reduced the binding to Cac2C. These results provide a structural basis for a mutually exclusive Asf1-binding model of CAF-1 and HIRA/Hip1, in which Asf1 and CAF-1 assemble histones H3/H4 (H3.1/H4 in vertebrates) in a replication-dependent pathway, whereas Asf1 and HIRA/Hip1 assemble histones H3/H4 (H3.3/H4 in vertebrates) in a replication-independent pathway.	[Malay, Ali D.; Umehara, Takashi; Matsubara-Malay, Kazuko; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki] RIKEN, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Padmanabhan, B (corresponding author), Aptuit Laurus Private Ltd, ICICI Knowledge Pk, Hyderabad 500078, Andhra Pradesh, India.	paddy.b@aptuitlaurus.com; yokoyama@biochem.s.u-tokyo.ac.jp	Malay, Ali/N-9136-2015; Yokoyama, Shigeyuki/N-6911-2015; Umehara, Takashi/N-5683-2015; Umehara, Takashi/AHB-1730-2022	Malay, Ali/0000-0003-0885-5524; Yokoyama, Shigeyuki/0000-0003-3133-7338; Umehara, Takashi/0000-0003-3464-2960; Umehara, Takashi/0000-0003-3464-2960				Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chimura T, 2002, P NATL ACAD SCI USA, V99, P9334, DOI 10.1073/pnas.142627899; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2005, J BIOCHEM, V138, P821, DOI 10.1093/jb/mvi182; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Singer MS, 1998, GENETICS, V150, P613; Sutton A, 2001, GENETICS, V158, P587; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tamburini BA, 2005, EUKARYOT CELL, V4, P1583, DOI 10.1128/EC.4.9.1583-1590.2005; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Umehara T, 2005, ACTA CRYSTALLOGR F, V61, P971, DOI 10.1107/S1744309105030927; Umehara T, 2003, J BIOL CHEM, V278, P35660, DOI 10.1074/jbc.M303549200; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	41	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14022	14031		10.1074/jbc.M800594200	http://dx.doi.org/10.1074/jbc.M800594200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18334479	hybrid			2022-12-27	WOS:000255728200056
J	Sansom, FM; Riedmaier, P; Newton, HJ; Dunstone, MA; Muller, CE; Stephan, H; Byres, E; Beddoe, T; Rossjohn, J; Cowan, PJ; d'Apice, AJF; Robson, SC; Hartland, EL				Sansom, Fiona M.; Riedmaier, Patrice; Newton, Hayley J.; Dunstone, Michelle A.; Mueller, Christa E.; Stephan, Holger; Byres, Emma; Beddoe, Travis; Rossjohn, Jamie; Cowan, Peter J.; d'Apice, Anthony J. F.; Robson, Simon C.; Hartland, Elizabeth L.			Enzymatic properties of an ecto-nucleoside triphosphate diphosphohydrolase from Legionella pneumophila - Substrate specificity and requirement for virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; E-TYPE ATPASES; ATP-DIPHOSPHOHYDROLASE; SCHISTOSOMA-MANSONI; INTRACELLULAR MULTIPLICATION; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; LEISHMANIA-AMAZONENSIS; ENDOPLASMIC-RETICULUM; TOXOPLASMA-GONDII	Legionella pneumophila is the predominant cause of Legionnaires disease, a severe and potentially fatal form of pneumonia. Recently, we identified an ecto-nucleoside triphosphate diphosphohydrolase ( NTPDase) from L. pneumophila, termed Lpg1905, which enhances intracellular replication of L. pneumophila in eukaryotic cells. Lpg1905 is the first prokaryotic member of the CD39/NTPDase1 family of enzymes, which are characterized by the presence of five apyrase conserved regions and the ability to hydrolyze nucleoside tri- and diphosphates. Here we examined the substrate specificity of Lpg1905 and showed that apart from ATP and ADP, the enzyme catalyzed the hydrolysis of GTP and GDP but had limited activity against CTP, CDP, UTP, and UDP. Based on amino acid residues conserved in the apyrase conserved regions of eukaryotic NTPDases, we generated five site-directed mutants, Lpg1905E159A, R122A, N168A, Q193A, and W384A. Although the mutations E159A, R122A, Q193A, and W384A abrogated activity completely, N168A resulted in decreased activity caused by reduced affinity for nucleotides. When introduced into the lpg1905 mutant strain of L. pneumophila, only N168A partially restored the ability of L. pneumophila to replicate in THP-1 macrophages. Following intratracheal inoculation of A/J mice, none of the Lpg1905 mutants was able to restore virulence to an lpg1905 mutant during lung infection, thereby demonstrating the importance of NTPDase activity to L. pneumophila infection. Overall, the kinetic studies undertaken here demonstrated important differences to mammalian NTPDases and different sensitivities to NTPDase inhibitors that may reflect underlying structural variations.	[Sansom, Fiona M.; Newton, Hayley J.; Hartland, Elizabeth L.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Cowan, Peter J.; d'Apice, Anthony J. F.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [Sansom, Fiona M.; Riedmaier, Patrice; Newton, Hayley J.; Dunstone, Michelle A.; Hartland, Elizabeth L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Dunstone, Michelle A.; Byres, Emma; Beddoe, Travis; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Mueller, Christa E.] Univ Bonn, Inst Pharmacol, D-53121 Bonn, Germany; [Stephan, Holger] Res Ctr Dresden Rossendorf, Inst Radiopharm, D-01314 Dresden, Germany; [d'Apice, Anthony J. F.] St Vincents Hosp, Immunol Res Ctr, Fitzroy, Vic 3065, Australia; [Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	University of Melbourne; University of Melbourne; Monash University; Monash University; University of Bonn; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); St Vincent's Hospital Melbourne; Harvard University; Beth Israel Deaconess Medical Center	Hartland, EL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	hartland@unimelb.edu.au	Sansom, Fiona M/W-8445-2019; Cowan, Peter J/B-8730-2013; Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013; Robson, Simon C./AAA-8537-2021; Cowan, Peter/AAH-7218-2020; Müller, Christa Elisabeth/C-7748-2014; Stephan, Holger/F-9789-2014; Hartland, Elizabeth/O-2569-2014; Dunstone, Michelle/I-2895-2014	Cowan, Peter J/0000-0001-9016-4954; Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Müller, Christa Elisabeth/0000-0002-0013-6624; Stephan, Holger/0000-0002-2972-2803; Hartland, Elizabeth/0000-0003-4254-2863; Newton, Hayley/0000-0002-9240-2001; Sansom, Fiona/0000-0002-9433-2545; Dunstone, Michelle/0000-0002-6026-648X	NHLBI NIH HHS [HL63972, HL57307, HL076540] Funding Source: Medline; NIAID NIH HHS [U01 AI066331-01, U01 AI066331-02, U01 AI066331] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540, R01HL057307, R01HL063972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066331] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASAI T, 1983, J BIOL CHEM, V258, P6816; Asai T, 1998, EXP PARASITOL, V90, P277, DOI 10.1006/expr.1998.4346; ASAI T, 1995, J BIOL CHEM, V270, P11391, DOI 10.1074/jbc.270.19.11391; ASAI T, 1987, ZBL BAKT-INT J MED M, V264, P464; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; BERMUDES D, 1994, J BIOL CHEM, V269, P29252; Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; BRIELAND J, 1994, AM J PATHOL, V145, P1537; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen DQ, 2006, MICROBIOL RES, V161, P246, DOI 10.1016/j.micres.2005.09.001; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; de Jesus JB, 2002, Z NATURFORSCH C, V57, P890; Leite MDS, 2007, EXP PARASITOL, V115, P315, DOI 10.1016/j.exppara.2006.09.002; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DeMarco R, 2003, BIOCHEM BIOPH RES CO, V307, P831, DOI 10.1016/S0006-291X(03)01268-3; Drosopoulos JHF, 2000, BIOCHEMISTRY-US, V39, P6936, DOI 10.1021/bi992581e; Drosopoulos JHF, 2002, ARCH BIOCHEM BIOPHYS, V406, P85, DOI 10.1016/S0003-9861(02)00414-9; ENGLEBERG NC, 1984, INFECT IMMUN, V44, P222, DOI 10.1128/IAI.44.2.222-227.1984; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Esch JSA, 1999, BIOCHEMISTRY-US, V38, P2248, DOI 10.1021/bi982426k; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Faria-Pinto P, 2004, PARASITOLOGY, V129, P51, DOI 10.1017/S0031182004005244; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fietto JLR, 2004, BIOCHEM BIOPH RES CO, V316, P454, DOI 10.1016/j.bbrc.2004.02.071; Fonseca FV, 2006, EXP PARASITOL, V112, P76, DOI 10.1016/j.exppara.2005.09.005; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Grinthal A, 2000, BIOCHEMISTRY-US, V39, P9, DOI 10.1021/bi991751k; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Hardy CL, 2003, AM J RESP CRIT CARE, V167, P1393, DOI 10.1164/rccm.200209-1002OC; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Jesus JB, 2002, VET PARASITOL, V103, P29, DOI 10.1016/S0304-4017(01)00576-3; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kirley TL, 2001, ARCH BIOCHEM BIOPHYS, V395, P94, DOI 10.1006/abbi.2001.2570; Knowles AF, 2006, BIOCHEMISTRY-US, V45, P7323, DOI 10.1021/bi052268e; Kusner DJ, 2001, J IMMUNOL, V167, P3308, DOI 10.4049/jimmunol.167.6.3308; Langston HP, 2003, J IMMUNOL, V170, P2962, DOI 10.4049/jimmunol.170.6.2962; Levano-Garcia J, 2007, BIOCHEM BIOPH RES CO, V352, P384, DOI 10.1016/j.bbrc.2006.11.023; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Matos JAD, 2001, INT J PARASITOL, V31, P770, DOI 10.1016/S0020-7519(01)00191-6; Menze MA, 2005, AM J PHYSIOL-REG I, V288, pR501, DOI 10.1152/ajpregu.00490.2004; Meyer-Fernandes JR, 2004, PARASITOL RES, V93, P567, DOI 10.1007/s00436-003-1066-4; MeyerFernandes JR, 1997, ARCH BIOCHEM BIOPHYS, V341, P40, DOI 10.1006/abbi.1997.9933; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Mundy R, 2003, MOL MICROBIOL, V48, P795, DOI 10.1046/j.1365-2958.2003.03470.x; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; Penido MLO, 2007, EUR J PHARMACOL, V570, P10, DOI 10.1016/j.ejphar.2007.05.028; PINE L, 1986, J CLIN MICROBIOL, V23, P163, DOI 10.1128/JCM.23.1.163-169.1986; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Segal G, 1998, MOL MICROBIOL, V30, P197, DOI 10.1046/j.1365-2958.1998.01054.x; Smith TM, 1999, BIOCHEMISTRY-US, V38, P5849, DOI 10.1021/bi990171k; Smith TM, 1999, BIOCHEMISTRY-US, V38, P321, DOI 10.1021/bi9820457; Stroppolo ME, 2001, CELL MOL LIFE SCI, V58, P1451, DOI 10.1007/PL00000788; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tasca T, 2005, PARASITOLOGY, V131, P71, DOI 10.1017/S0031182005007377; Torres CR, 1998, EUR J BIOCHEM, V251, P516, DOI 10.1046/j.1432-1327.1998.2510516.x; Vasconcelos EG, 1996, J BIOL CHEM, V271, P22139, DOI 10.1074/jbc.271.36.22139; VASCONCELOS EG, 1993, MOL BIOCHEM PARASIT, V58, P205, DOI 10.1016/0166-6851(93)90042-V; Yang F, 2001, BIOCHEMISTRY-US, V40, P3943, DOI 10.1021/bi002711f; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Zimmermann H, 2001, DRUG DEVELOP RES, V52, P44, DOI 10.1002/ddr.1097	81	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12909	12918		10.1074/jbc.M801006200	http://dx.doi.org/10.1074/jbc.M801006200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337253	Green Published, hybrid			2022-12-27	WOS:000255499800027
J	Wainszelbaum, MJ; Charron, AJ; Kong, C; Kirkpatrick, DS; Srikanth, P; Barbieri, MA; Gygi, SP; Stahl, PD				Wainszelbaum, Marisa J.; Charron, Audra J.; Kong, Chen; Kirkpatrick, Donald S.; Srikanth, Priya; Barbieri, M. Alejandro; Gygi, Steven P.; Stahl, Philip D.			The hominoid-specific oncogene TBC1D3 activates ras and modulates epidermal growth factor receptor signaling and trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASES; LUNG-CANCER; ENDOCYTOSIS; PROTEIN; UBIQUITINATION; UBIQUITYLATION; TRANSDUCTION; MUTATIONS; DOMAIN; RAB5	Hominoid- and human-specific genes may have evolved to modulate signaling pathways of a higher order of complexity. TBC1D3 is a hominoid-specific oncogene encoded by a cluster of eight paralogs on chromosome 17. Initial work indicates that TBC1D3 is widely expressed in human tissues (Hodzic, D., Kong, C., Wainszelbaum, M. J., Charron, A. J., Su, X., and Stahl, P. D. ( 2006) Genomics 88, 731-736). In this study, we show that TBC1D3 expression has a powerful effect on cell proliferation that is further enhanced by epidermal growth factor (EGF) in both human and mouse cell lines. EGF activation of the Erk and protein kinase B/Akt pathways is enhanced, both in amplitude and duration, by TBC1D3 expression, whereas RNA interference silencing of TBC1D3 suppresses the activation. Light microscopy and Western blot experiments demonstrate that increased signaling in response to EGF is coupled with a significant delay in EGF receptor (EGFR) trafficking and degradation, which significantly extends the life span of EGFR. Moreover, TBC1D3 suppresses polyubiquitination of the EGFR and the recruitment of c-Cbl. Using the Ras binding domain of Raf1 to monitor GTP-Ras we show that TBC1D3 expression enhances Ras activation in quiescent cells, which is further increased by EGF treatment. We speculate that TBC1D3 may alter Ras GTP loading. We conclude that the expression of TBC1D3 generates a delay in EGFR degradation, a decrease in ubiquitination, and a failure to recruit adapter proteins that ultimately dysregulate EGFR signal transduction and enhance cell proliferation. Altered growth factor receptor trafficking and GTP-Ras turnover may be sites where recently evolved genes such as TBC1D3 selectively modulate signaling in hominoids and humans.	[Wainszelbaum, Marisa J.; Charron, Audra J.; Kong, Chen; Srikanth, Priya; Barbieri, M. Alejandro; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Kirkpatrick, Donald S.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Washington University (WUSTL); Harvard University; Harvard Medical School	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid, St Louis, MO 63110 USA.	pstahl@wustl.edu	Stahl, Philip/D-6315-2012; Barbieri, Marco/J-2597-2014	Kirkpatrick, Donald/0000-0003-3091-2804; Srikanth, Priya/0000-0002-9669-0434	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259, R01GM067945] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM67945, R01 GM42259] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Bizimungu C, 2007, BIOTECHNOL LETT, V29, P1927, DOI 10.1007/s10529-007-9475-6; BOS JL, 1989, CANCER RES, V49, P4682; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Crosetto N, 2005, FEBS LETT, V579, P3231, DOI 10.1016/j.febslet.2005.03.029; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; FRITTOLI E, 2008, MOL BIOL CELL   0116; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pei L, 2002, CANCER RES, V62, P5420; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; SORKIN A, 1991, J BIOL CHEM, V266, P8355; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	37	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13233	13242		10.1074/jbc.M800234200	http://dx.doi.org/10.1074/jbc.M800234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319245	Green Published, hybrid			2022-12-27	WOS:000255499800063
J	Kelly, EM; Hou, ZJ; Bossuyt, J; Bers, DM; Robia, SL				Kelly, Eileen M.; Hou, Zhanjia; Bossuyt, Julie; Bers, Donald M.; Robia, Seth L.			Phospholamban oligomerization, quaternary structure, and sarco(endo) plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; CARDIAC SARCOPLASMIC-RETICULUM; LIPID-BILAYERS; MONOMERIC PHOSPHOLAMBAN; CA2+ PUMP; PROTEIN; MEMBRANES; DYNAMICS; INHIBITION; PENTAMER	Phospholamban (PLB) oligomerization, quaternary structure, and sarco(endo) plasmic reticulum calcium ATPase(SERCA) binding were quantified by fluorescence resonance energy transfer (FRET) in an intact cellular environment. FRET between cyan fluorescent protein-PLB and yellow fluorescent protein-PLB in AAV-293 cells showed hyperbolic dependence on protein concentration, with a maximum efficiency of 45.1 +/- 1.3%. The observed FRET corresponds to a probe separation distance of 58.7 +/- 0.5 angstrom, according to a computational model of intrapentameric FRET. This is consistent with models of the PLB pentamer in which cytoplasmic domains fan out from the central bundle of transmembrane helices. An I40A mutation of PLB did not alter pentamer conformation but increased the concentration of half-maximal FRET (K-D) by >4-fold. This is consistent with the previous observation that this putatively monomeric mutant still oligomerizes in intact membranes but forms more dynamic pentamers than wild type PLB. PLB association with SERCA, measured by FRET between cyan fluorescent protein-SERCA and yellow fluorescent protein-PLB, was increased by the I40A mutation without any detectable change in probe separation distance. The data indicate that the regulatory complex conformation is not altered by the I40A mutation. A naturally occurring human mutation (L39Stop) greatly reduced PLB oligomerization and SERCA binding and caused mislocalization of PLB to the cytoplasm and nucleus. Overall, the data suggest that the PLB pentamer adopts a "pinwheel" shape in cell membranes, as opposed to a more compact "bellflower" conformation. I40A mutation decreases oligomerization and increases PLB binding to SERCA. Truncation of the transmembrane domain by L39Stop mutation prevents anchoring of the protein in the membrane, greatly reducing PLB binding to itself or its regulatory target, SERCA.	[Kelly, Eileen M.; Hou, Zhanjia; Bossuyt, Julie; Bers, Donald M.; Robia, Seth L.] Loyola Univ, Dept Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ, Dept Physiol, 102-5609,2160 S 1st Ave, Maywood, IL 60153 USA.	srobia@lumc.edu	Bers, Donald M/C-4507-2012	Bossuyt, Julie/0000-0001-8874-4765; Bers, Donald/0000-0002-2237-9483	NHLBI NIH HHS [R01 HL092321, R01 HL106189] Funding Source: Medline; NIBIB NIH HHS [EB006061, K01 EB006061-02, K01 EB006061] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321, R01HL106189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abu-Baker S, 2007, PROTEIN SCI, V16, P2345, DOI 10.1110/ps.072977707; Abu-Baker S, 2006, BIOCHEMISTRY-US, V45, P13312, DOI 10.1021/bi0614028; ARKIN IT, 1995, J MOL BIOL, V248, P824, DOI 10.1006/jmbi.1995.0263; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Clayton JC, 2005, BIOCHEMISTRY-US, V44, P17016, DOI 10.1021/bi0511383; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; Ha KN, 2007, J BIOL CHEM, V282, P37205, DOI 10.1074/jbc.M704056200; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hughes E, 2005, BIOCHEMISTRY-US, V44, P4055, DOI 10.1021/bi0482351; INUI M, 1986, J BIOL CHEM, V261, P1794; Kang MS, 2005, J MOL CELL CARDIOL, V38, P753, DOI 10.1016/j.yjmcc.2005.02.017; Karim CB, 1998, BIOCHEMISTRY-US, V37, P12074, DOI 10.1021/bi980642n; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; KUBITSCHECK U, 1991, BIOPHYS J, V60, P307, DOI 10.1016/S0006-3495(91)82055-0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mascioni A, 2002, J AM CHEM SOC, V124, P9392, DOI 10.1021/ja026507m; Merzlyakov M, 2006, J MOL BIOL, V358, P1, DOI 10.1016/j.jmb.2006.01.086; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Nesmelov YE, 2007, BIOPHYS J, V93, P2805, DOI 10.1529/biophysj.107.108910; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pollesello P, 1999, BIOPHYS J, V76, P1784, DOI 10.1016/S0006-3495(99)77339-X; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Waggoner JR, 2004, PROTEIN EXPRES PURIF, V34, P56, DOI 10.1016/j.pep.2003.11.005; YOUNG RM, 1994, BIOPHYS J, V67, P881, DOI 10.1016/S0006-3495(94)80549-1; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5; Zhai J, 2000, J BIOL CHEM, V275, P10538, DOI 10.1074/jbc.275.14.10538	47	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12202	12211		10.1074/jbc.M707590200	http://dx.doi.org/10.1074/jbc.M707590200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18287099	Green Published, hybrid			2022-12-27	WOS:000255340000036
J	Dang, Y; Siew, LM; Wang, XJ; Han, YX; Lampen, R; Zheng, YH				Dang, Ying; Siew, Lai Mun; Wang, Xiaojun; Han, Yanxing; Lampen, Russell; Zheng, Yong-Hui			Human cytidine deaminase APOBEC3H restricts HIV-1 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VIF; ANTIVIRAL ACTIVITY; REVERSE TRANSCRIPTION; ANTIRETROVIRAL FACTOR; LTR-RETROTRANSPOSON; POTENT INHIBITOR; ENZYME APOBEC3G; DNA; HYPERMUTATION; DEGRADATION	The human genome encodes seven APOBEC3 (A3) cytidine deaminases with potential antiretroviral activity: A3A, A3B, A3C, A3DE, A3F, A3G, and A3H. A3G was the first identified to block replication of human immunodeficiency virus type 1 (HIV-1) and many other retroviruses. A3F, A3B, and A3DE were shown later to have similar activities. HIV-1 produces a protein called Vif that is able to neutralize the antiretroviral activities of A3DE, A3F, and A3G, but not A3B. Only the antiretroviral activity of A3H remains to be defined due to its poor expression in cell culture. Here, we studied the mechanism impairing A3H expression. When primate A3H sequences were compared, a premature termination codon was identified on the fifth exon of the human and chimpanzee A3H genes, which significantly decreased their protein expression. It causes a 29-residue deletion from the C terminus, and this truncation did not reduce human A3H protein stability. However, the mRNA levels of the truncated gene were significantly decreased. Human A3H protein expression could be restored to a normal level either by repairing this truncation or through expression from a vector containing an intron from human cytomegalovirus. Once expression was optimized, human A3H could reduce HIV-1 infectivity up to 150-fold. Importantly, HIV-1 Vif failed to neutralize A3H activity. Nevertheless, extensive sequence analysis could not detect any significant levels of G-to-A mutation in the HIV-1 genome by human A3H. Thus, A3H inhibits HIV-1 replication potently by a cytidine deamination-independent mechanism, and optimizing A3H expression in vivo should represent a novel therapeutic strategy for HIV-1 treatment.	[Dang, Ying; Siew, Lai Mun; Wang, Xiaojun; Han, Yanxing; Zheng, Yong-Hui] Michigan State Univ, Coll Osteopath Med, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lampen, Russell] Michigan State Univ, Coll Osteopath Med, Div Infect Dis, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University; Michigan State University College of Osteopathic Medicine	Zheng, YH (corresponding author), Michigan State Univ, Coll Osteopath Med, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Han, Yanxing/GRO-5138-2022; Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385; Wang, Xiaojun/0000-0003-4521-4099	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063944, R01AI063944, K02AI080225] Funding Source: NIH RePORTER; NIAID NIH HHS [AI063944, K02 AI080225, R01 AI063944-02, R01 AI063944] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hartikka J, 1996, HUM GENE THER, V7, P1205, DOI 10.1089/hum.1996.7.10-1205; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Opi S, 2007, J VIROL, V81, P8236, DOI 10.1128/JVI.02694-06; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	35	95	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11606	11614		10.1074/jbc.M707586200	http://dx.doi.org/10.1074/jbc.M707586200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299330	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000255067400061
J	Oram, JF; Wolfbauer, G; Tang, C; Davidson, WS; Albers, JJ				Oram, John F.; Wolfbauer, Gertrud; Tang, Chongren; Davidson, W. Sean; Albers, John J.			An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; CASSETTE TRANSPORTER A1; SURFACE BINDING-SITES; LIPID EFFLUX; APOLIPOPROTEIN AI; DEFICIENT MICE; HDL FORMATION; KINASE-C; ABCA1; MACROPHAGES	Phospholipid lipid transfer protein (PLTP) mimics high-density lipoprotein apolipoproteins in removing cholesterol and phospholipids from cells through the ATP-binding cassette transporter A1 (ABCA1). Because amphipathic alpha-helices are the structural determinants for ABCA1 interactions, we examined the ability of synthetic peptides corresponding to helices in PLTP to remove cellular cholesterol by the ABCA1 pathway. Of the seven helices tested, only one containing PLTP residues 144-163 (p144), located at the tip of the N-terminal barrel, promoted ABCA1-dependent cholesterol efflux and stabilized ABCA1 protein. Mutating methionine 159 (Met-159) in this helix in PLTP to aspartate (M159D) or glutamate (M159E) nearly abolished the ability of PLTP to remove cellular cholesterol and dramatically reduced PLTP binding to phospholipid vesicles and its phospholipid transfer activity. These mutations impaired PLTP binding to ABCA1-generated lipid domains and PLTP-mediated stabilization of ABCA1 but increased PLTP binding to ABCA1. PLTP interactions with ABCA1 also mimicked apolipoproteins in activating Janus kinase 2; however, the M159D/E mutants were also able to activate this kinase. Structural analyses showed that the M159D/E mutations had only minor effects on PLTP conformation. These findings indicate that PLTP helix 144-163 is critical for removing lipid domains formed by ABCA1, stabilizing ABCA1 protein, interacting with phospholipids, and promoting phospholipid transfer. Direct interactions with ABCA1 and activation of signaling pathways likely involve other structural determinants of PLTP.	[Oram, John F.; Wolfbauer, Gertrud; Tang, Chongren; Albers, John J.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA; [Davidson, W. Sean] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	University of Washington; University of Washington Seattle; University System of Ohio; University of Cincinnati	Albers, JJ (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Box 356426, Seattle, WA 98195 USA.	jja@u.washington.edu		Davidson, William/0000-0003-2756-2989	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055362, R01HL062542, P01HL030086, R01HL085437] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01HL030086, R01HL055362, R01HL085437, R01HL62542] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiello RJ, 2003, ARTERIOSCL THROM VAS, V23, P972, DOI 10.1161/01.ATV.0000054661.21499.FB; ALBERS JJ, 1995, BBA-LIPID LIPID MET, V1258, P27, DOI 10.1016/0005-2760(95)00091-P; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Cheung MC, 1996, BBA-LIPID LIPID MET, V1303, P103, DOI 10.1016/0005-2760(96)00082-3; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Davidson WS, 2006, J LIPID RES, V47, P440, DOI 10.1194/jlr.D500034-JLR200; DAY JR, 1994, J BIOL CHEM, V269, P9388; Desrumaux C, 2001, J BIOL CHEM, V276, P5908, DOI 10.1074/jbc.M008420200; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Hailman E, 1996, J BIOL CHEM, V271, P12172, DOI 10.1074/jbc.271.21.12172; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Huuskonen J, 1999, J LIPID RES, V40, P1123; Huuskonen J, 2000, CURR OPIN LIPIDOL, V11, P285, DOI 10.1097/00041433-200006000-00009; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; JIANG XC, 1995, J BIOL CHEM, V270, P17133, DOI 10.1074/jbc.270.29.17133; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Jiang XC, 1996, J CLIN INVEST, V98, P2373, DOI 10.1172/JCI119050; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Lee-Rueckert M, 2006, J LIPID RES, V47, P1725, DOI 10.1194/jlr.M600051-JLR200; Liu RJ, 2007, ARTERIOSCL THROM VAS, V27, P190, DOI 10.1161/01.ATV.0000249721.96666.e5; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; Mendez AJ, 1997, BBA-LIPID LIPID MET, V1346, P285, DOI 10.1016/S0005-2760(97)00031-3; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; O'Brien KD, 2003, CIRCULATION, V108, P270, DOI 10.1161/01.CIR.0000079163.97653.CD; Ogier N, 2007, ARTERIOSCL THROM VAS, V27, P2407, DOI 10.1161/ATVBAHA.107.151753; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Setala NL, 2007, BIOCHEMISTRY-US, V46, P1312, DOI 10.1021/bi0621866; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Tang CR, 2006, J LIPID RES, V47, P107, DOI 10.1194/jlr.M500240-JLR200; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; TU AY, 1993, J BIOL CHEM, V268, P23098; Valenta DT, 2008, J LIPID RES, V49, P24, DOI 10.1194/jlr.M700228-JLR200; Valenta DT, 2006, ARTERIOSCL THROM VAS, V26, P1572, DOI 10.1161/01.ATV.0000225700.43836.ae; van Haperen R, 2002, J BIOL CHEM, V277, P48938, DOI 10.1074/jbc.M209128200; van Tol A, 2002, CURR OPIN LIPIDOL, V13, P135, DOI 10.1097/00041433-200204000-00004; Vaughan AM, 2003, J LIPID RES, V44, P1373, DOI 10.1194/jlr.M300078-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vedhachalam C, 2007, ARTERIOSCL THROM VAS, V27, P1603, DOI 10.1161/ATVBAHA.107.145789; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wolfbauer G, 1999, BBA-MOL CELL BIOL L, V1439, P65, DOI 10.1016/S1388-1981(99)00077-3; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200	56	43	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11541	11549		10.1074/jbc.M800117200	http://dx.doi.org/10.1074/jbc.M800117200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18287097	Green Published, hybrid			2022-12-27	WOS:000255067400054
J	Sikora, B; Chen, Y; Lichti, CF; Harrison, MK; Jennings, TA; Tang, Y; Tackett, AJ; Jordan, JB; Sakon, J; Cameron, CE; Raney, KD				Sikora, Bartek; Chen, Yingfeng; Lichti, Cheryl F.; Harrison, Melody K.; Jennings, Thomas A.; Tang, Yong; Tackett, Alan J.; Jordan, John B.; Sakon, Joshua; Cameron, Craig E.; Raney, Kevin D.			Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEASE DOMAIN; COLI UVRD; TRANSLOCATION; REPLICATION; MECHANISM; DUPLEX; MOLECULES; OLIGONUCLEOTIDE; DISPLACEMENT	HCV NS3 helicase exhibits activity toward DNA and RNA substrates. The DNA helicase activity of NS3 has been proposed to be optimal when multiple NS3 molecules are bound to the same substrate molecule. NS3 catalyzes little or no measurable DNA unwinding under single cycle conditions in which the concentration of substrate exceeds the concentration of enzyme by 5-fold. However, when NS3 (100 nM) is equimolar with the substrate, a small burst amplitude of similar to 8 nM is observed. The burst amplitude increases as the enzyme concentration increases, consistent with the idea that multiple molecules are needed for optimal unwinding. Protein-protein interactions may facilitate optimal activity, so the oligomeric properties of the enzyme were investigated. Chemical cross-linking indicates that full-length NS3 forms higher order oligomers much more readily than the NS3 helicase domain. Dynamic light scattering indicates that full-length NS3 exists as an oligomer, whereas NS3 helicase domain exists in a monomeric form in solution. Size exclusion chromatography also indicates that full-length NS3 behaves as an oligomer in solution, whereas the NS3 helicase domain behaves as a monomer. When NS3 was passed through a small pore filter capable of removing protein aggregates, greater than 95% of the protein and the DNA unwinding activity was removed from solution. In contrast, only similar to 10% of NS3 helicase domain and similar to 20% of the associated DNA unwinding activity was removed from solution after passage through the small pore filter. The results indicate that the optimally active form of full-length NS3 is part of an oligomeric species in vitro.	[Sikora, Bartek; Chen, Yingfeng; Lichti, Cheryl F.; Harrison, Melody K.; Jennings, Thomas A.; Tang, Yong; Tackett, Alan J.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Jordan, John B.; Sakon, Joshua] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Fayetteville; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	raneykevind@uams.edu	Lichti, Cheryl/C-6359-2013; Sakon, Joshua/N-2289-2014	Sakon, Joshua/0000-0002-8373-969X; Lichti, Cheryl/0000-0003-4099-4954	NCRR NIH HHS [P20 RR015569-096068, P20 RR15569, P20RR016460, P20 RR015569] Funding Source: Medline; NIAID NIH HHS [AI060563, R56 AI060563, R01 AI060563] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569, P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060563, R56AI060563] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; CHOO QL, 1990, BRIT MED BULL, V46, P423, DOI 10.1093/oxfordjournals.bmb.a072408; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; Eoff RL, 2005, BIOCHEMISTRY-US, V44, P666, DOI 10.1021/bi0484926; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Frick DN, 2003, DRUG NEWS PERSPECT, V16, P355, DOI 10.1358/dnp.2003.16.6.829307; Gwack Y, 1997, EUR J BIOCHEM, V250, P47, DOI 10.1111/j.1432-1033.1997.00047.x; Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Kang LW, 1998, ACTA CRYSTALLOGR D, V54, P121, DOI 10.1107/S0907444997008883; Khu YL, 2001, J VIROL, V75, P205, DOI 10.1128/JVI.75.1.205-214.2001; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; McHutchison JG, 2004, AM J MANAG CARE, V10, pS21; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nanduri B, 2002, P NATL ACAD SCI USA, V99, P14722, DOI 10.1073/pnas.232401899; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pearlman BL, 2004, SOUTH MED J, V97, P365, DOI 10.1097/01.SMJ.0000118903.35704.30; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Porter DJT, 1998, J BIOL CHEM, V273, P18906, DOI 10.1074/jbc.273.30.18906; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rajagopal V, 2008, J MOL BIOL, V376, P69, DOI 10.1016/j.jmb.2007.10.070; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P4128, DOI 10.1021/bi00066a039; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	53	35	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11516	11525		10.1074/jbc.M708125200	http://dx.doi.org/10.1074/jbc.M708125200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18283103	hybrid, Green Published			2022-12-27	WOS:000255067400051
J	Thom, SR; Bhopale, VM; Mancini, DJ; Milovanova, TN				Thom, Stephen R.; Bhopale, Veena M.; Mancini, D. Joshua; Milovanova, Tatyana N.			Actin S-nitrosylation inhibits neutrophil beta(2) integrin function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HYPERBARIC-OXYGEN THERAPY; DEPENDENT PROTEIN-KINASE; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; PEPTIDE-STIMULATED NEUTROPHILS; INTEGRIN-MEDIATED ADHESION; MYOCARDIAL-INFARCTION; TYROSINE NITRATION; CHEMOTACTIC FACTOR; B-2 INTEGRINS	The focus of this work was to elucidate the mechanism for inhibition of neutrophil beta(2) integrin adhesion molecules by hyperoxia. Results demonstrate that exposure to high oxygen partial pressures increases synthesis of reactive species derived from type 2 nitric-oxide synthase and myeloperoxidase, leading to excessive S-nitrosylation of beta-actin and possibly profilin. Hyperoxia causes S-nitrosylation of the four cysteine moieties closest to the carboxyl-terminal end of actin, which results in formation of short actin filaments. This alters actin polymerization, network formation, and intracellular distribution, as well as inhibits beta(2) integrin clustering. If neutrophils are exposed to ultraviolet light to reverse S-nitrosylation, or are incubated with N-formyl-methionyl-leucine-phenylalanine to trigger "inside-out" activation, the effects of hyperoxia are reversed. We conclude that cytoskeletal changes triggered by hyperoxia inhibit beta(2) integrin-dependent neutrophil adhesion.	[Thom, Stephen R.; Bhopale, Veena M.; Mancini, D. Joshua; Milovanova, Tatyana N.] Univ Penn, Med Ctr, Inst Environm Med, Philadelphia, PA 19104 USA; [Thom, Stephen R.] Univ Penn, Med Ctr, Dept Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thom, SR (corresponding author), Univ Penn, Med Ctr, Inst Environm Med, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	sthom@mail.med.upenn.edu						Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P6876, DOI 10.1021/bi010066m; Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Andoh T, 2003, J BIOL CHEM, V278, P885, DOI 10.1074/jbc.M209914200; Aslan M, 2003, J BIOL CHEM, V278, P4194, DOI 10.1074/jbc.M208916200; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Banick PD, 1997, J CELL PHYSIOL, V172, P12, DOI 10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO;2-G; BATH PMW, 1991, ARTERIOSCLER THROMB, V11, P254, DOI 10.1161/01.ATV.11.2.254; Bengtsson T, 2006, CELL BIOL INT, V30, P154, DOI 10.1016/j.cellbi.2005.10.017; Blystone SD, 2004, BBA-MOL CELL RES, V1692, P47, DOI 10.1016/j.bbamcr.2004.04.011; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Chen QP, 1996, J PHARMACOL EXP THER, V276, P929; Clements MK, 2003, J LEUKOCYTE BIOL, V73, P344, DOI 10.1189/jlb.0802401; CRUZ EDL, 1994, BIOCHEMISTRY-US, V33, P14387; Dalle-Donne I, 2000, J MUSCLE RES CELL M, V21, P171, DOI 10.1023/A:1005671319604; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Esue O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.048301; Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553; Fekete Z, 2001, SHOCK, V16, P15, DOI 10.1097/00024382-200116010-00003; Galijasevic S, 2003, P NATL ACAD SCI USA, V100, P14766, DOI 10.1073/pnas.2435008100; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Heijnen HFG, 2006, FREE RADICAL BIO MED, V40, P1903, DOI 10.1016/j.freeradbiomed.2005.09.006; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; JAMIESON D, 1963, J APPL PHYSIOL, V18, P869, DOI 10.1152/jappl.1963.18.5.869; JOHNSON G, 1991, CRIT CARE MED, V19, P244, DOI 10.1097/00003246-199102000-00021; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; Kerkhoff E, 2006, TRENDS CELL BIOL, V16, P477, DOI 10.1016/j.tcb.2006.07.005; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; Lakshmi VM, 2005, J BIOL CHEM, V280, P1746, DOI 10.1074/jbc.M411263200; Lee SY, 2003, FASEB J, V17, P947, DOI 10.1096/fj.02-0807fje; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Machesky Laura M., 1993, Trends in Cell Biology, V3, P381, DOI 10.1016/0962-8924(93)90087-H; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MACLEANFLETCHER SD, 1980, J CELL BIOL, V85, P414, DOI 10.1083/jcb.85.2.414; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; MILESKI WJ, 1990, SURGERY, V108, P206; MILESKI WJ, 1993, J SURG RES, V54, P349, DOI 10.1006/jsre.1993.1056; Niggli V, 1999, EXP CELL RES, V250, P558, DOI 10.1006/excr.1999.4548; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; PRYZWANSKY KB, 1990, BLOOD, V76, P612; PYSZNIAK AM, 1994, J IMMUNOL, V152, P5241; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; ROSS RM, 1965, LANCET, V1, P579; RuchaudSparagano MH, 1997, BRIT J HAEMATOL, V98, P612, DOI 10.1046/j.1365-2141.1997.2523070.x; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Schoenenberger CA, 1999, MICROSC RES TECHNIQ, V47, P38, DOI 10.1002/(SICI)1097-0029(19991001)47:1<38::AID-JEMT4>3.0.CO;2-5; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; SHAAFI RI, 1988, PROG ALLERGY, V42, P1; Shandling AH, 1997, AM HEART J, V134, P544, DOI 10.1016/S0002-8703(97)70093-0; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Sharifi Mohsen, 2002, Cardiovasc Radiat Med, V3, P124, DOI 10.1016/S1522-1865(03)00104-5; Sheikh S, 1997, BIOCHEM BIOPH RES CO, V238, P910, DOI 10.1006/bbrc.1997.7407; SHETERLINE P, 1994, ACTIN STRUCTURE PROT, P1; Stavitsky Y, 1998, CARDIOLOGY, V90, P131, DOI 10.1159/000006832; Tahepold P, 2003, J THORAC CARDIOV SUR, V125, P650, DOI 10.1067/mtc.2003.36; Tahepold P, 2001, LIFE SCI, V68, P1629, DOI 10.1016/S0024-3205(01)00964-X; TAIT JF, 1982, BIOCHEMISTRY-US, V21, P6046, DOI 10.1021/bi00267a004; Teubner A, 1996, BBA-PROTEIN STRUCT M, V1297, P214, DOI 10.1016/S0167-4838(96)00111-2; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Thom SR, 2004, P NATL ACAD SCI USA, V101, P13660, DOI 10.1073/pnas.0405642101; Thom SR, 2003, AM J PHYSIOL-HEART C, V284, pH1230, DOI 10.1152/ajpheart.01043.2002; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; Thom SR, 1997, AM J PHYSIOL-CELL PH, V272, pC770, DOI 10.1152/ajpcell.1997.272.3.C770; Thom SR, 2002, J NEUROBIOL, V51, P85, DOI 10.1002/neu.10044; THOM SR, 1986, J INFECT DIS, V154, P504, DOI 10.1093/infdis/154.3.504; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; WATTS RG, 1993, BLOOD, V81, P2750; WATTS RG, 1992, CELL MOTIL CYTOSKEL, V21, P25, DOI 10.1002/cm.970210104; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; WHITE JR, 1983, J BIOL CHEM, V258, P4041; Wong Howard P., 1996, Surgical Forum, V47, P705; WYATT TA, 1991, J BIOL CHEM, V266, P21274; Yan SR, 1998, J LEUKOCYTE BIOL, V64, P401, DOI 10.1002/jlb.64.3.401; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; ZAFFRAN Y, 1993, J CELL SCI, V105, P675; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; Zamir E, 2001, J CELL SCI, V114, P3583; Zhou JH, 2003, J IMMUNOL, V170, P3331, DOI 10.4049/jimmunol.170.6.3331	91	72	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10822	10834		10.1074/jbc.M709200200	http://dx.doi.org/10.1074/jbc.M709200200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18283105	hybrid			2022-12-27	WOS:000254894700065
J	Olson, LJ; Hindsgaul, O; Dahms, NM; Kim, JJP				Olson, Linda J.; Hindsgaul, Ole; Dahms, Nancy M.; Kim, Jung-Ja P.			Structural insights into the mechanism of pH-dependent ligand binding and release by the cation-dependent mannose 6-phosphate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION; LYSOSOMAL-ENZYMES; INSECT CELLS; PROTEIN; RESIDUES; SITE; OLIGOSACCHARIDES; IDENTIFICATION; REFINEMENT; TRANSPORT	The cation-dependent mannose 6-phosphate receptor (CD-MPR) is a key component of the lysosomal enzyme targeting system that binds newly synthesized mannose 6-phosphate (Man-6-P)-containing acid hydrolases and transports them to endosomal compartments. The interaction between the MPRs and its ligands is pH-dependent; the homodimeric CD-MPR binds lysosomal enzymes optimally in the pH environment of the trans Golgi network (pH similar to 6.5) and releases its cargo in acidic endosomal compartments (< pH 5.5) and at the cell surface. In addition, CD-MPR binding affinities are modulated by divalent cations. Our previous crystallographic studies have shown that at pH 6.5, the CD-MPR bound to Man-6-P adopts a significantly different quaternary conformation than the CD-MPR in a ligand-unbound state, a feature unique among known lectin structures. To determine whether different pH conditions elicit conformational changes in the receptor that alters ligand binding affinities, we have obtained additional crystal structures representative of the various environments encountered by the receptor including: 1) the CD-MPR bound at pH 6.5 (i.e. trans Golgi network) to a high affinity ligand (the terminally phosphorylated trisaccharide P-Man(alpha 1,2) Man(alpha 1,2) Man-O-(CH2)(8)COOMe), 2) the CD-MPR at pH 4.8 in an unbound state (i.e. endosome), and 3) the CD-MPR at pH 7.4 (i.e. cell surface). A detailed comparison of the available CD-MPR structures reveals the positional invariability of specific binding pocket residues and implicates intermonomer contact(s), as well as the protonation state of Man-6-P, as regulators of pH-dependent carbohydrate binding.	[Olson, Linda J.; Dahms, Nancy M.; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Hindsgaul, Ole] Carlsberg Lab, DK-2500 Copenhagen, Denmark	Medical College of Wisconsin	Dahms, NM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown plank Rd, Milwaukee, WI 53226 USA.	ndahms@mcw.edu; jjkim@mcw.edu			NCRR NIH HHS [P41 RR007707, RR 07707] Funding Source: Medline; NIDDK NIH HHS [R01 DK 42667, R01 DK042667] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*ACC INC, 1995, INSIGHT 2 MOL MOD PR; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; DISTLER JJ, 1987, ANAL BIOCHEM, V166, P65, DOI 10.1016/0003-2697(87)90546-X; DISTLER JJ, 1991, J BIOL CHEM, V266, P21687; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; IMORT M, 1983, BIOCHEM J, V214, P671, DOI 10.1042/bj2140671; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4; Marron-Terada PG, 1998, BIOCHEMISTRY-US, V37, P17223, DOI 10.1021/bi981883y; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Olson LJ, 2002, J BIOL CHEM, V277, P10156, DOI 10.1074/jbc.M112230200; Olson LJ, 1999, J BIOL CHEM, V274, P29889, DOI 10.1074/jbc.274.42.29889; Olson LJ, 1999, J BIOL CHEM, V274, P36905, DOI 10.1074/jbc.274.52.36905; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; Olson LJ, 2004, EMBO J, V23, P2019, DOI 10.1038/sj.emboj.7600215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; ROUSSEL A, 1994, TURBO FRODO SOFTWARE; SRIVASTAVA OP, 1987, CARBOHYD RES, V161, P195, DOI 10.1016/S0008-6215(00)90077-6; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; Sun GJ, 2005, GLYCOBIOLOGY, V15, P1136, DOI 10.1093/glycob/cwi098; TONG PY, 1989, J BIOL CHEM, V264, P7962; TONG PY, 1989, J BIOL CHEM, V264, P7970; VARKI A, 1980, J BIOL CHEM, V255, P847; WATANABE H, 1990, P NATL ACAD SCI USA, V87, P8036, DOI 10.1073/pnas.87.20.8036; WESTCOTT KR, 1987, J BIOL CHEM, V262, P6101; ZHANG Y, 1993, BIOCHEM J, V295, P841, DOI 10.1042/bj2950841	36	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10124	10134		10.1074/jbc.M708994200	http://dx.doi.org/10.1074/jbc.M708994200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18272523	hybrid, Green Published			2022-12-27	WOS:000254671600066
J	Soto, A; Carman, GM				Soto, Anibal; Carman, George M.			Regulation of the Saccharomyces cerevisiae CKI1-encoded choline kinase by zinc depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYTOPIC MEMBRANE-PROTEIN; DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; PHOSPHOLIPID BIOSYNTHESIS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; TOPOLOGICAL ORGANIZATION; TRANSPORTER PROTEIN; NEGATIVE REGULATOR; CKI GENE; YEAST	In the yeast Saccharomyces cerevisiae, the CKI1-encoded choline kinase catalyzes the committed step in the synthesis of phosphatidylcholine via the CDP-choline branch of the Kennedy pathway. Analysis of a PCKI1-lacZ reporter gene revealed that CKI1 expression was regulated by intracellular levels of the essential mineral zinc. Zinc depletion resulted in a concentration-dependent induction of CKI1 expression. This regulation was mediated by the zinc-sensing and zinc-inducible transcriptional activator Zap1p. A purified Zap1p probe interacted with two putative UASZRE sequences (ZRE1 and ZRE2) in the CKI1 promoter. Mutations of ZRE1 and ZRE2 to a nonconsensus UASZRE attenuated the induction of CKI1 expression in response to zinc depletion. A UAS(INO) element in the CKI1 promoter was responsible for stimulating CKI1 expression, but this element was not involved with the regulation by zinc depletion. The induction of CKI1 expression in zinc-depleted cells translated into increased choline kinase activity in vitro and in vivo, and an increase in phosphatidylcholine synthesis via the Kennedy pathway.	[Soto, Anibal; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Soto, Anibal; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dubley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			NIGMS NIH HHS [R01 GM028140, GM 75378, R01 GM028140-25, GM 28140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075378, R37GM028140, R01GM028140] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBROZIAK J, 1994, J BIOL CHEM, V269, P15344; Anderson MS, 1996, J BIOL CHEM, V271, P26596, DOI 10.1074/jbc.271.43.26596; BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980; Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CHEN CC, 1984, J BIOL CHEM, V259, P150; Choi MG, 2005, J BIOL CHEM, V280, P26105, DOI 10.1074/jbc.M503551200; CULBERTSON MR, 1975, GENETICS, V80, P23; Devirgiliis C, 2004, BIOCHEM BIOPH RES CO, V323, P58, DOI 10.1016/j.bbrc.2004.08.051; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Eide DJ, 2003, J NUTR, V133, p1532S, DOI 10.1093/jn/133.5.1532S; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Greenberg ML, 1996, MICROBIOL REV, V60, P1; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Han SH, 2005, J BIOL CHEM, V280, P29017, DOI 10.1074/jbc.M505881200; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Hernandez-Alcoceba R, 1999, CANCER RES, V59, P3112; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; HOSAKA K, 1990, J BACTERIOL, V172, P2005, DOI 10.1128/jb.172.4.2005-2012.1990; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kersting MC, 2006, J BIOL CHEM, V281, P13110, DOI 10.1074/jbc.M601612200; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; LAMPING E, 1994, GENETICS, V137, P55; LESTER RL, 1993, ADV LIPID RES, V26, P253; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MENON AK, 1992, J BIOL CHEM, V267, P15277; Miyabe S, 2000, BIOCHEM BIOPH RES CO, V276, P879, DOI 10.1006/bbrc.2000.3580; Miyabe S, 2001, BIOCHEM BIOPH RES CO, V282, P79, DOI 10.1006/bbrc.2001.4522; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nakagami K, 1999, JPN J CANCER RES, V90, P1212, DOI 10.1111/j.1349-7006.1999.tb00698.x; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; NIKAWA J, 1993, MOL MICROBIOL, V10, P955, DOI 10.1111/j.1365-2958.1993.tb00967.x; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PORTER TJ, 1992, METHOD ENZYMOL, V209, P134; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; WHITE MJ, 1991, J BIOL CHEM, V266, P863; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Yu Y, 2002, J BIOL CHEM, V277, P34978, DOI 10.1074/jbc.M205316200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	79	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10079	10088		10.1074/jbc.M800502200	http://dx.doi.org/10.1074/jbc.M800502200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18276583	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000254671600062
J	Pala, D; Kapoor, M; Woods, A; Kennedy, L; Liu, SX; Chen, S; Bursell, L; Lyons, KM; Carter, DE; Beier, F; Leask, A				Pala, Daphne; Kapoor, Mohit; Woods, Anita; Kennedy, Laura; Liu, Shangxi; Chen, Shioqiong; Bursell, Laura; Lyons, Karen M.; Carter, David E.; Beier, Frank; Leask, Andrew			Focal adhesion kinase/Src suppresses early chondrogenesis - Central role of CCN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR CTGF; REGULATES CHONDROGENESIS; DIFFERENTIATION; EXPRESSION; GENE; CELLS; CYR61; SOX9; CONDENSATION; CHONDROCYTES	Adhesive signaling plays a key role in cellular differentiation, including in chondrogenesis. Herein, we probe the contribution to early chondrogenesis of two key modulators of adhesion, namely focal adhesion kinase ( FAK)/Src and CCN2 ( connective tissue growth factor, CTGF). We use the micromass model of chondrogenesis to show that FAK/Src signaling, which mediates cell/matrix attachment, suppresses early chondrogenesis, including the induction of Ccn2, Agc, and Sox6. The FAK/Src inhibitor PP2 elevates Ccn2, Agc, and Sox6 expression in wildtype mesenchymal cells in micromass culture, but not in cells lacking CCN2. Our results suggest a reduction in FAK/Src signaling is a critical feature permitting chondrogenic differentiation and that CCN2 operates downstream of this loss to promote chondrogenesis.	[Pala, Daphne; Woods, Anita; Kennedy, Laura; Bursell, Laura; Beier, Frank; Leask, Andrew] Univ Western Ontario, Schulich Sch Med & Dent, Canadian Inst Hlth Res, Dept Physiol & Pharmacol,Grp Skeletal Dev & Remod, London, ON N6A 5C1, Canada; [Kapoor, Mohit; Liu, Shangxi; Chen, Shioqiong; Leask, Andrew] Univ Western Ontario, Schulich Sch Med & Dent, Canadian Inst Hlth Res, Div Oral Biol,Grp Skeletal Dev & Remodeling, London, ON N6A 5C1, Canada; [Lyons, Karen M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Lyons, Karen M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Carter, David E.] London Reg Gen Ctr, London, ON N6A 5C1, Canada	Institute for Work & Health; Western University (University of Western Ontario); Institute for Work & Health; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Leask, A (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Canadian Inst Hlth Res, Dept Physiol & Pharmacol,Grp Skeletal Dev & Remod, London, ON N6A 5C1, Canada.	Andrew.Leask@schulich.uwo.ca	Leask, Andy/ABH-9433-2020; Leask, Andrew/G-5217-2015; Beier, Frank/T-4734-2019; Beier, Frank/G-4595-2013	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537	NIAMS NIH HHS [R01 AR052686] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052686] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P522, DOI 10.1006/bbrc.2000.3831; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Carlberg AL, 2001, DIFFERENTIATION, V67, P128, DOI 10.1046/j.1432-0436.2001.670405.x; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Friedrichsen S, 2003, CELL TISSUE RES, V312, P175, DOI 10.1007/s00441-003-0712-6; FURUTA Y, 1995, ONCOGENE, V11, P1989; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Gomes RR, 2003, CONNECT TISSUE RES, V44, P196, DOI 10.1080/03008200390181645; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; ILLC D, 1995, NATURE, V377, P539; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kawai J, 1999, EUR J CELL BIOL, V78, P707, DOI 10.1016/S0171-9335(99)80039-9; Kennedy L, 2007, EXP CELL RES, V313, P952, DOI 10.1016/j.yexcr.2006.12.006; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P678, DOI 10.1006/bbrc.2001.4379; Nicoll SB, 2002, BIOCHEM BIOPH RES CO, V292, P819, DOI 10.1006/bbrc.2002.6697; Okazaki K, 2004, CLIN ORTHOP RELAT R, pS123, DOI 10.1097/01.blo.0000144478.51284.f3; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Seghatoleslami MR, 2003, J CELL BIOCHEM, V88, P1129, DOI 10.1002/jcb.10458; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Takigawa M, 2003, DRUG NEWS PERSPECT, V16, P11, DOI 10.1358/dnp.2003.16.1.829302; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659	50	43	44	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9239	9247		10.1074/jbc.M705175200	http://dx.doi.org/10.1074/jbc.M705175200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18276598	hybrid, Green Published			2022-12-27	WOS:000254465800054
J	Qiao, LP; Zou, CH; Shao, P; Schaack, J; Johnson, PF; Shao, JH				Qiao, Liping; Zou, Chenhui; Shao, Peng; Schaack, Jerome; Johnson, Peter F.; Shao, Jianhua			Transcriptional regulation of fatty acid Translocase/CD36 expression by CCAAT/Enhancer-binding protein alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN GENE-EXPRESSION; SKELETAL-MUSCLE; C/EBP-BETA; SARCOLEMMAL FAT/CD36; ADIPOSE-TISSUE; NULL MUTATION; CD36; TRANSPORT; INSULIN; GLUCOSE	Fatty acid translocase (FAT/CD36) plays an important role in facilitating long chain fatty acid transport. FAT/CD36 gene deletion protects mice from high fat diet-induced obesity. In this study we have investigated the regulatory mechanism of FAT/CD36 expression at the transcription level. FAT/CD36 expression was activated during 3T3-L1 adipocyte differentiation, and FAT/CD36 protein levels were positively correlated with CCAAT/enhancer-binding protein alpha(C/EBP alpha) and peroxisome proliferator-activated receptor gamma. However, a negative correlation was detected between FAT/CD36 and C/EBP ss. Overexpression of C/EBP alpha or C/EBP ss increased FAT/CD36 mRNAand protein levels in several types of cells. Restoration of C/EBP alpha or C/EBP ss expression in C/EBP alpha- or C/EBP ss-deficient mouse embryonic fibroblasts increased FAT/CD36 expression. However, in mouse embryonic fibroblasts C/EBP alpha was a more potent activator of FAT/CD36 expression than was C/EBP alpha. Expression of C/EBP ss robustly increased FAT/CD36 proximal promoter- directed luciferase expression in human embryonic kidney 293 cells. A C/EBP-responsive element was identified in the FAT/CD36 promoter by using 5 ' and specific site mutations. The binding of C/EBP alpha in the FAT/CD36 promoter was detected by chromatin immunoprecipitation in 3T3-L1 adipocytes. These results demonstrated that C/EBP alpha regulates FAT/CD36 gene expression at the transcriptional level.	[Qiao, Liping; Zou, Chenhui; Shao, Peng; Shao, Jianhua] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Schaack, Jerome] Univ Colorado Denver, Dept Microbiol, Aurora, CO 80045 USA; [Schaack, Jerome] Hlth Sci Ctr, Aurora, CO 80045 USA; [Johnson, Peter F.] NCI Frederick, Natl Inst Hlth, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA	University of Kentucky; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Shao, JH (corresponding author), Univ Kentucky, Grad Ctr Nutr Sci, 900 S Limestone, Lexington, KY 40536 USA.	JianhuaShao@uky.edu	Johnson, Peter/A-1940-2012	Johnson, Peter/0000-0002-4145-4725	NATIONAL CANCER INSTITUTE [ZIABC010328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077643] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [R DK 077643 A] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Armesilla AL, 1996, J BIOL CHEM, V271, P7781, DOI 10.1074/jbc.271.13.7781; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118; Chabowski A, 2004, AM J PHYSIOL-ENDOC M, V287, pE781, DOI 10.1152/ajpendo.00573.2003; Chabowski A, 2006, AM J PHYSIOL-ENDOC M, V291, pE675, DOI 10.1152/ajpendo.00096.2006; Chen SS, 2000, MOL CELL BIOL, V20, P7292, DOI 10.1128/MCB.20.19.7292-7299.2000; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; McKnight SL, 2001, CELL, V107, P259, DOI 10.1016/S0092-8674(01)00543-8; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Orlicky DJ, 2001, J LIPID RES, V42, P910; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Sampson MJ, 2003, ATHEROSCLEROSIS, V167, P129, DOI 10.1016/S0021-9150(02)00421-5; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Sfeir Z, 1999, MOL CELL BIOCHEM, V192, P3, DOI 10.1023/A:1006811300125; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; WAGATSUMA A, MOL CELL BIOCH, V304, P25	37	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8788	8795		10.1074/jbc.M800055200	http://dx.doi.org/10.1074/jbc.M800055200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18263877	Green Published, hybrid			2022-12-27	WOS:000254465800004
J	Grou, CP; Carvalho, AF; Pinto, MP; Wiese, S; Piechura, H; Meyer, HE; Warscheid, B; Sa-Miranda, C; Azevedo, JE				Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Wiese, Sebastian; Piechura, Heike; Meyer, Helmut E.; Warscheid, Bettina; Sa-Miranda, Clara; Azevedo, Jorge E.			Members of the E2D (UbcH5) family mediate the ubiquitination of the conserved cysteine of Pex5p, the peroxisomal import receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME PEX4P; SIGNAL TYPE-1 RECEPTOR; MATRIX PROTEIN IMPORT; CYCLING RECEPTOR; RAT-LIVER; FUNCTIONAL-CHARACTERIZATION; MASS-SPECTROMETRY; PICHIA-PASTORIS; PTS1 RECEPTOR; IDENTIFICATION	According to current models of peroxisomal biogenesis, newly synthesized peroxisomal matrix proteins are transported into the organelle by Pex5p. Pex5p recognizes these proteins in the cytosol, mediates their membrane translocation, and is exported back into the cytosol in an ATP-dependent manner. We have previously shown that export of Pex5p is preceded by ( and requires) monoubiquitination of a conserved cysteine residue present at its N terminus. In yeasts, and probably also in plants, ubiquitination of Pex5p is mediated by a specialized ubiquitin-conjugating enzyme, Pex4p. In mammals, the identity of this enzyme has remained unknown for many years. Here, we provide evidence suggesting that E2D1/2/3 (UbcH5a/b/c) are the mammalian functional counterparts of yeast/plant Pex4p. The mechanistic implications of these findings are discussed.	[Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, IBMC, P-4150180 Oporto, Portugal; [Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4009003 Oporto, Portugal; [Wiese, Sebastian; Piechura, Heike; Meyer, Helmut E.; Warscheid, Bettina] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany	Universidade do Porto; Universidade do Porto; Ruhr University Bochum	Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	sá Miranda, Maria Clara/K-3920-2013; Carvalho, Andreia/J-9013-2015; Azevedo, Jorge E/A-4113-2008; Lima, Marta T/C-7042-2009; Grou, Claudia P/K-5472-2013; Pinto, Manuel/K-6425-2013	sá Miranda, Maria Clara/0000-0003-0123-5525; Carvalho, Andreia/0000-0001-8781-5680; Azevedo, Jorge E/0000-0001-7714-5302; Grou, Claudia P/0000-0001-5197-2270; Pinto, Manuel/0000-0001-9778-2093; Warscheid, Bettina/0000-0001-5096-1975; Wiese, Heike/0000-0002-8941-3762				Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; Baker A, 2005, CURR OPIN PLANT BIOL, V8, P640, DOI 10.1016/j.pbi.2005.09.009; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; CRANE DI, 1994, J BIOL CHEM, V269, P21835; Eckert JH, 2003, J CELL SCI, V116, P3623, DOI 10.1242/jcs.00678; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Okamoto Y, 2003, CANCER RES, V63, P4167; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rajapurohitam V, 2002, AM J PHYSIOL-ENDOC M, V282, pE739, DOI 10.1152/ajpendo.00511.2001; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Schaefer H, 2004, PROTEOMICS, V4, P2541, DOI 10.1002/pmic.200300801; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; van der Klei IJ, 1998, EMBO J, V17, P3608, DOI 10.1093/emboj/17.13.3608; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	59	96	102	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14190	14197		10.1074/jbc.M800402200	http://dx.doi.org/10.1074/jbc.M800402200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18359941	hybrid			2022-12-27	WOS:000255941400004
J	Jansen, M; Pietiarinen, VM; Polonen, H; Rasilainen, L; Koivusalo, M; Ruotsalainen, U; Jokitalo, E; Ikonen, E				Jansen, Maurice; Pietiarinen, Vilja M.; Polonen, Harri; Rasilainen, Laura; Koivusalo, Mirkka; Ruotsalainen, Ulla; Jokitalo, Eija; Ikonen, Elina			Cholesterol substitution increases the structural heterogeneity of caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ENDOCYTIC TRAFFICKING; LIPID RAFTS; IN-VITRO; CELLS; PROTEIN; KINASE; GLYCOSPHINGOLIPIDS; PHOSPHORYLATION; SIMIAN-VIRUS-40	Caveolin-1 binds cholesterol and caveola formation involves caveolin-1 oligomerization and cholesterol association. The role of cholesterol in caveolae has so far been addressed by methods that compromise membrane integrity and abolish caveolar invaginations. To study the importance of sterol specificity for the structure and function of caveolae, we replaced cholesterol in mammalian cells with its immediate precursor desmosterol by inhibiting 24-dehydrocholesterol reductase. Desmosterol could substitute for cholesterol in maintaining cell growth, membrane integrity, and preserving caveolar invaginations. However, in desmosterol cells the affinity of caveolin-1 for sterol and the stability of caveolin oligomers were decreased. Moreover, caveolar invaginations became more heterogeneous in dimensions and in the number of caveolin-1 molecules per caveola. Despite the altered caveolar structure, caveolar ligand uptake was only moderately inhibited. We found that in desmosterol cells, Src kinase phosphorylated Cav1 at Tyr14 more avidly than in cholesterol cells. Taken the role of Cav1 Tyr14 phosphorylation in caveolar endocytosis, this may help to preserve caveolar uptake in desmosterol cells. We conclude that a sterol C24 double bond interferes with caveolin-sterol interaction and perturbs caveolar morphology but facilitates Cav1 Src phosphorylation and allows caveolar endocytosis. More generally, substitution of cholesterol by a structurally closely related sterol provides a method to selectively modify membrane protein-sterol affinity, structure and function of cholesterol-dependent domains without compromising membrane integrity.	[Jansen, Maurice; Pietiarinen, Vilja M.; Koivusalo, Mirkka; Ikonen, Elina] Univ Helsinki, Inst Biomed Anat, FIN-00140 Helsinki, Finland; [Rasilainen, Laura; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, FIN-00140 Helsinki, Finland; [Polonen, Harri; Ruotsalainen, Ulla] Tampere Univ Technol, Inst Signal Proc, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; Tampere University	Ikonen, E (corresponding author), Univ Helsinki, Inst Biomed Anat, Haartmaninkatu 8, FIN-00140 Helsinki, Finland.	elina.ikonen@helsinki.fi	Jokitalo, Eija/C-8375-2009; Ruotsalainen, Ulla/J-5678-2014	Jokitalo, Eija/0000-0002-4159-6934; Ruotsalainen, Ulla/0000-0001-7775-3412; Ikonen, Elina/0000-0001-8382-1135; , Harri/0000-0002-3270-2897; Pietiainen, Vilja/0000-0003-3125-2406				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom TS, 2003, HUM MOL GENET, V12, P257, DOI 10.1093/hmg/ddg025; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Gaylor JL, 2002, BIOCHEM BIOPH RES CO, V292, P1139, DOI 10.1006/bbrc.2001.2008; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; KUHRY JG, 1985, BIOCHIM BIOPHYS ACTA, V845, P60, DOI 10.1016/0167-4889(85)90055-2; Lu XL, 2006, ENDOCRINOLOGY, V147, P3123, DOI 10.1210/en.2005-1426; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NAOI M, 1974, ANAL BIOCHEM, V58, P571, DOI 10.1016/0003-2697(74)90226-7; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Oh P, 1999, J BIOL CHEM, V274, P23144, DOI 10.1074/jbc.274.33.23144; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Radel C, 2007, BIOCHEM BIOPH RES CO, V358, P626, DOI 10.1016/j.bbrc.2007.04.179; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Ruan BF, 1997, J LIPID RES, V38, P2615; Salonen A, 2003, J VIROL, V77, P1691, DOI 10.1128/JVI.77.3.1691-1702.2003; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Tohka J, 2007, IEEE T MED IMAGING, V26, P696, DOI 10.1109/TMI.2007.895453; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Vainio S, 2006, J BIOL CHEM, V281, P348, DOI 10.1074/jbc.M509530200; WEISS JF, 1976, ARCH NEUROL-CHICAGO, V33, P180, DOI 10.1001/archneur.1976.00500030036007	53	33	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14610	14618		10.1074/jbc.M710355200	http://dx.doi.org/10.1074/jbc.M710355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353778	hybrid			2022-12-27	WOS:000255941400049
J	Rogemond, V; Auger, C; Giraudon, P; Becchi, M; Auvergnon, N; Belin, MF; Honnorat, J; Moradi-Ameli, M				Rogemond, Veronique; Auger, Carole; Giraudon, Pascale; Becchi, Michel; Auvergnon, Nathalie; Belin, Marie-Francoise; Honnorat, Jerome; Moradi-Ameli, Mahnaz			Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE MEDIATOR PROTEIN-2; GROWTH-CONE COLLAPSE; SIGNALING PATHWAYS; MOUSE-BRAIN; RHO-KINASE; NEURONS; PHOSPHORYLATION; RAT; EXPRESSION; COMPLEX	Collapsin response mediator proteins (CRMPs) are believed to play a crucial role in neuronal differentiation and axonal outgrowth. Among them, CRMP2 mediates axonal guidance by collapsing growth cones during development. This activity is correlated with the reorganization of cytoskeletal proteins. CRMP2 is implicated in the regulation of several intracellular signaling pathways. Two subtypes, A and B, and multiple cytosolic isoforms of CRMP2B with apparent masses between 62 and 66 kDa have previously been reported. Here, we show a new short isoform of 58 kDa, expressed during brain development, derived from C-terminal processing of the CRMP2B subtype. Although full-length CRMP2 is restricted to the cytoplasm, using transfection experiments, we demonstrate that a part of the short isoform is found in the nucleus. Interestingly, at the tissue level, this short CRMP2 is also found in a nuclear fraction of brain extract. By mutational analysis, we demonstrate, for the first time, that nuclear translocation occurs via nuclear localization signal (NLS) within residues Arg(471)-Lys(472) in CRMP2 sequence. The NLS may be unmasked after C-terminal processing; thereby, this motif may be surface-exposed. This short CRMP2 induces neurite outgrowth inhibition in neuroblastoma cells and suppressed axonal growth in cultured cortical neurons, whereas full-length CRMP2 promotes neurite elongation. The NLS-mutated short isoform, restricted to the cytoplasm, abrogates both neurite outgrowth and axon growth inhibition, indicating that short nuclear CRMP2 acts as a dominant signal. Therefore, post-transcriptional processing of CRMP2 together with its nuclear localization may be an important key in the regulation of neurite outgrowth in brain development.	[Rogemond, Veronique; Auger, Carole; Giraudon, Pascale; Auvergnon, Nathalie; Belin, Marie-Francoise; Honnorat, Jerome; Moradi-Ameli, Mahnaz] Univ Lyon 1, Fac Med Laennec, INSERM, U Neurooncol & Neuroinflammat 842, F-69372 Lyon, France; [Becchi, Michel] CNRS, UMR 5086, Inst Biol & Chim Proteins, F-69367 Lyon, France; [Rogemond, Veronique; Honnorat, Jerome] Hosp Civil Lyon, F-69677 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon	Honnorat, J (corresponding author), Univ Lyon 1, Fac Med Laennec, INSERM, U Neurooncol & Neuroinflammat 842, Rue Guilaume Paradin, F-69372 Lyon, France.	jerome.honnorat@chu-layon.fr	Rogemond, Veronique/J-4824-2017; Honnorat, jerome/G-6394-2017	Rogemond, Veronique/0000-0003-2098-920X; Honnorat, jerome/0000-0002-4721-5952				Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; Bradley KJ, 2007, ONCOGENE, V26, P1213, DOI 10.1038/sj.onc.1209893; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Buck KB, 2002, J NEUROSCI, V22, P9358; Bulliard C, 1997, BIOCHEM J, V324, P555, DOI 10.1042/bj3240555; Chung MA, 2005, NEUROREPORT, V16, P1647, DOI 10.1097/01.wnr.0000176520.49841.e6; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Katano T, 2006, PROTEOMICS, V6, P6085, DOI 10.1002/pmic.200600300; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Lee S, 2002, J BIOL CHEM, V277, P6542, DOI 10.1074/jbc.M108047200; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Suzuki Y, 2003, J NEUROCHEM, V86, P1042, DOI 10.1046/j.1471-4159.2003.01920.x; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278	43	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14751	14761		10.1074/jbc.M708480200	http://dx.doi.org/10.1074/jbc.M708480200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332147	hybrid, Green Submitted			2022-12-27	WOS:000255941400063
J	Arikketh, D; Nelson, R; Vance, JE				Arikketh, Devi; Nelson, Randy; Vance, Jean E.			Defining the importance of phosphatidylserine synthase-1 (PSS1) - Unexpected viability of PSS1-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; PICK C1-DEFICIENT NEURONS; SACCHAROMYCES-CEREVISIAE; LIPOPROTEIN SECRETION; DISTAL AXONS; RAT-LIVER; GENE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS; MEMBRANE	Phosphatidylserine (PS) is a quantitatively minor, but physiologically important, phospholipid in mammalian cells. PS is synthesized by two distinct base-exchange enzymes, PS synthase-1 (PSS1) and PS synthase-2 (PSS2), that are encoded by different genes. PSS1 exchanges serine for choline of phosphatidylcholine, whereas PSS2 exchanges ethanolamine of phosphatidylethanolamine for serine. We previously generated mice lacking PSS2 (Bergo, M. O., Gavino, B. J., Steenbergen, R., Sturbois, B., Parlow, A. F., Sanan, D. A., Skarnes, W. C., Vance, J. E., and Young, S. G. (2002) J. Biol. Chem. 277, 47701-47708) and found that PSS2 is not required for mouse viability. We have now generated PSS1-deficient mice. In light of the markedly impaired survival of Chinese hamster ovary cells lacking PSS1 we were surprised that PSS1-deficient mice were viable, fertile, and had a normal life span. Total serine-exchange activity (contributed by PSS1 and PSS2) in tissues of Pss1(-/-) mice was reduced by up to 85%, but except in liver, the PS content was unaltered. Despite the presumed importance of PS in the nervous system, the rate of axonal extension of PSS1-deficient neurons was normal. Intercrosses of Pss1(-/-) mice and Pss2(-/-) mice yielded mice with three disrupted Pss alleles but no double knockout mice. In Pss1(-/-)/Pss2(-/-) and Pss1(-/-)/Pss2(-/-) mice, serine-exchange activity was reduced by 65-91%, and the tissue content of PS and phosphatidylethanolamine was also decreased. We conclude that (i) elimination of either PSS1 or PSS2, but not both, is compatible with mouse viability, (ii) mice can tolerate as little as 10% of normal total serine-exchange activity, and (iii) mice survive with significantly reduced PS and phosphatidylethanolamine content.	[Arikketh, Devi; Vance, Jean E.] Univ Alberta, Dept Med, Heritage Med Res Ctr 328, Edmonton, AB T6G 2S2, Canada; [Arikketh, Devi; Nelson, Randy; Vance, Jean E.] Univ Alberta, Grp Mol & Cel Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Nelson, Randy] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Dept Med, Heritage Med Res Ctr 328, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca	A, Devi/ABE-6011-2021	ARIKKETH, DEVI/0000-0002-8542-3760				ATKINSON K, 1980, J BIOL CHEM, V255, P6653; AXELROD J, 1953, J BIOL CHEM, V204, P903; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Grandmaison PA, 2004, BBA-MOL CELL BIOL L, V1636, P1, DOI 10.1016/j.bbalip.2003.11.004; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Hayashi H, 2002, NEUROREPORT, V13, P383, DOI 10.1097/00001756-200203250-00004; Hicks AM, 2006, BBA-MOL CELL BIOL L, V1761, P1022, DOI 10.1016/j.bbalip.2006.05.010; Jackson SN, 2007, J AM SOC MASS SPECTR, V18, P17, DOI 10.1016/j.jasms.2006.08.015; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Karten B, 2003, J BIOL CHEM, V278, P4168, DOI 10.1074/jbc.M205406200; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; KUGE O, 1986, J BIOL CHEM, V261, P5790; Kuge O, 1997, J BIOL CHEM, V272, P19133, DOI 10.1074/jbc.272.31.19133; Matsuo Y, 2007, EUKARYOT CELL, V6, P2092, DOI 10.1128/EC.00300-07; PERCY AK, 1983, ARCH BIOCHEM BIOPHYS, V223, P484, DOI 10.1016/0003-9861(83)90613-6; PERRY TL, 1975, J NEUROCHEM, V24, P587, DOI 10.1111/j.1471-4159.1975.tb07680.x; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Saito K, 1996, FEBS LETT, V395, P262, DOI 10.1016/0014-5793(96)01049-6; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 1999, BIOCHEM J, V342, P57, DOI 10.1042/0264-6021:3420057; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; Sturbois-Balcerzak B, 2001, J BIOL CHEM, V276, P8205, DOI 10.1074/jbc.M009776200; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANCE JE, 1988, BIOCHIM BIOPHYS ACTA, V963, P70, DOI 10.1016/0005-2760(88)90339-6; VANCE JE, 2008, IN PRESS J LIPID RES; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; VOELKER DR, 1986, J BIOL CHEM, V261, P1002; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7	39	55	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12888	12897		10.1074/jbc.M800714200	http://dx.doi.org/10.1074/jbc.M800714200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343815	hybrid			2022-12-27	WOS:000255499800025
J	Chang, YG; Yan, XZ; Xie, YY; Gao, XC; Song, AX; Zhang, DE; Hu, HY				Chang, Yong-Gang; Yan, Xian-Zhong; Xie, Yuan-Yuan; Gao, Xue-Chao; Song, Ai-Xin; Zhang, Dong-Er; Hu, Hong-Yu			Different roles for two ubiquitin-like domains of ISG15 in protein modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MOLECULE; STIMULATED GENE-15; HUMAN-CELLS; E3 LIGASE; INTERFERON; CONJUGATION; INFLUENZA; TARGETS; ENZYME; E2	ISG15 (interferon-stimulated gene 15) is a novel ubiquitin-like (UbL) modifier with two UbL domains in its architecture. We investigated different roles for the two UbL domains in protein modification by ISG15 (ISGylation) and the impact of Influenza B virus NS1 protein (NS1B) on regulation of the pathway. The results show that, although the C-terminal domain is sufficient to link ISG15 to UBE1L and UbcH8, the N-terminal domain is dispensable in the activation and transthiolation steps but required for efficient E3-mediated transfer of ISG15 from UbcH8 to its substrates. NS1B specifically binds to the N-terminal domain of ISG15 but does not affect ISG15 linkage via a thioester bond to its activating and conjugating enzymes. However, it does inhibit the formation of cellular ISG15 conjugates upon interferon treatment. We propose that the N-terminal UbL domain of ISG15 mainly functions in the ligation step and NS1B inhibits ISGylation by competing with E3 ligases for binding to the N-terminal domain.	[Chang, Yong-Gang; Xie, Yuan-Yuan; Gao, Xue-Chao; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Yan, Xian-Zhong] Natl Ctr Biomed Anal, NMR Lab, Beijing 100850, Peoples R China; [Chang, Yong-Gang; Xie, Yuan-Yuan; Gao, Xue-Chao] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Xie, Yuanyuan/F-1974-2017; Hu, Hong-Yu/AAQ-2633-2020					Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; KNIGHT E, 1988, J BIOL CHEM, V263, P4520; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Takeuchi T, 2006, FEBS LETT, V580, P4521, DOI 10.1016/j.febslet.2006.07.032; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	30	42	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13370	13377		10.1074/jbc.M800162200	http://dx.doi.org/10.1074/jbc.M800162200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18356159	hybrid			2022-12-27	WOS:000255499800076
J	Cheung, WD; Hart, GW				Cheung, Win D.; Hart, Gerald W.			AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; GLCNAC MODIFICATION; NUCLEOCYTOPLASMIC PROTEINS; SIGNAL-TRANSDUCTION; NEUROFILAMENT SUBUNIT; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; X-CHROMOSOME; BRAIN-INJURY; PHOSPHORYLATION	We have demonstrated previously that a wide array of stress signals induces O-GlcNAc transferase ( OGT) expression and increases O-GlcNAcylation of many intracellular proteins, a response that is critical for cell survival. Here, we describe a mechanism by which glucose deprivation induces OGT expression and activity in Neuro-2a neuroblastoma cells. Glucose deprivation increases OGT mRNA and protein expression in an AMP-activated protein kinase-dependent manner, whereas OGT enzymatic activity is regulated in a p38 MAPK-dependent manner. OGT is not phosphorylated by p38, but rather it interacts directly with p38 through its C terminus; this interaction increases with p38 activation during glucose deprivation. Surprisingly, the catalytic activity of OGT, as measured toward peptide substrates, is not altered by glucose deprivation. Instead, p38 regulates OGT activity within the cell by recruiting it to specific targets, including neurofilament H. Neurofilament H is O-GlcNAcylated during glucose deprivation in a p38-dependent manner. Interestingly, neurofilament H solubility is increased by glucose deprivation in an O-GlcNAc-dependent manner, suggesting that O-GlcNAcylation of neurofilament H regulates its disassembly from filaments. Not only do these data help to reveal how OGT is regulated by stress, but these findings also describe a possible mechanism by which defective brain glucose metabolism, as found in aging and ischemia, may directly affect axonal structure.	[Cheung, Win D.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD013563, R01HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA042486-25, CA42486, R01 CA042486] Funding Source: Medline; NICHD NIH HHS [R37 HD013563-30, R01 HD13563, R37 HD013563] Funding Source: Medline; NIDDK NIH HHS [R01 DK061671] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; BRAIDMAN I, 1974, FEBS LETT, V41, P181, DOI 10.1016/0014-5793(74)81206-8; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Fehm HL, 2006, PROG BRAIN RES, V153, P129, DOI 10.1016/S0079-6123(06)53007-9; FUKUYAMA H, 1994, J NUCL MED, V35, P1; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GOLD PE, 2005, NEUROBIOL AGING S1, V28, P60; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Hoyer S, 1998, J NEURAL TRANSM-SUPP, P187; Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; LaManna JC, 1997, NEUROSURG CLIN N AM, V8, P145; Lehmann R, 2000, ELECTROPHORESIS, V21, P3010, DOI 10.1002/1522-2683(20000801)21:14<3010::AID-ELPS3010>3.0.CO;2-C; Leys D, 2000, J NEURAL TRANSM-SUPP, P31; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Ludemann N, 2005, J BIOL CHEM, V280, P31648, DOI 10.1074/jbc.M504395200; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; SCOTT CW, 1991, J NEUROSCI RES, V30, P154, DOI 10.1002/jnr.490300116; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; SHEA TB, 1994, FEBS LETT, V343, P131, DOI 10.1016/0014-5793(94)80304-8; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; TAKMAN R, 2004, J MOL NEUROSCI, V22, P237; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; WATSON DF, 1989, J NEUROCHEM, V53, P1818, DOI 10.1111/j.1471-4159.1989.tb09248.x; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; White L, 2006, ALZ DIS ASSOC DIS, V20, pS79, DOI 10.1097/00002093-200607001-00012; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	72	169	175	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13009	13020		10.1074/jbc.M801222200	http://dx.doi.org/10.1074/jbc.M801222200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18353774	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000255499800038
J	Huveneers, S; Arslan, S; van de Water, B; Sonnenberg, A; Danen, EHJ				Huveneers, Stephan; Arslan, Serdar; van de Water, Bob; Sonnenberg, Arnoud; Danen, Erik H. J.			Integrins uncouple src-induced morphological and oncogenic transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; FAMILY KINASES; V-SRC; CELL-TRANSFORMATION; HUMAN-MELANOMA; ACTIVATED SRC; HUMAN CANCER; E-CADHERIN; EXPRESSION; ADHESION	Expression of activated mutants of c-Src in epithelial cells can induce tumorigenicity. In addition to such oncogenic transformation, the cells undergo a dramatic morphological transformation: cell-cell contacts are disrupted, spreading on extracellular matrix proteins is suppressed, actin stress fibers and focal contacts are lost, and podosomes are formed. We have previously shown that integrin alpha v beta 3 strongly supports Src-mediated oncogenic transformation through an interaction at the beta 3 cytoplasmic tail. Our current findings demonstrate that this interaction does not affect Src-mediated morphological alterations, thus separating oncogenic from morphological transformation. Moreover, beta 1 and beta 3 integrins differently affect the various aspects of Src-induced morphological transformation. High levels of beta 3, but not beta 1, integrins can prevent Src-induced cell rounding although stress fiber disassembly and podosome formation still occur. Studies using chimeric integrin subunits demonstrate that this protection requires the beta 3 extracellular domain. Finally, like tumor formation, podosome assembly occurs independent of beta 3 phosphorylation. Instead, phosphorylation of beta 1 is required to suppress Rho-mediated contractility in order to assemble podosomes. Thus, integrins regulate Src-mediated oncogenic transformation and various aspects of morphological transformation through dissociable pathways.	[Huveneers, Stephan; Arslan, Serdar; van de Water, Bob; Danen, Erik H. J.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, NL-2300 RA Leiden, Netherlands; [Huveneers, Stephan; Sonnenberg, Arnoud; Danen, Erik H. J.] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Netherlands Cancer Institute	Danen, EHJ (corresponding author), Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Einsteinweg 55,POB 9502, NL-2300 RA Leiden, Netherlands.	e.danen@lacdr.leidenuniv.nl		Huveneers, Stephan/0000-0002-1091-475X; danen, erik/0000-0002-0491-6345				ALBELDA SM, 1990, CANCER RES, V50, P6757; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Danen EHJ, 1996, BIOCHEM BIOPH RES CO, V226, P75, DOI 10.1006/bbrc.1996.1313; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Datta A, 2001, MOL CELL BIOL, V21, P7295, DOI 10.1128/MCB.21.21.7295-7306.2001; Fincham VJ, 1999, J CELL SCI, V112, P947; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Huveneers S, 2007, CANCER RES, V67, P2693, DOI 10.1158/0008-5472.CAN-06-3654; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; JOVE R, 1986, J VIROL, V60, P840, DOI 10.1128/JVI.60.3.840-848.1986; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Matsumoto T, 2003, CANCER RES, V63, P4819; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WARREN SL, 1987, MOL CELL BIOL, V7, P1326, DOI 10.1128/MCB.7.4.1326; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	34	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13243	13251		10.1074/jbc.M800927200	http://dx.doi.org/10.1074/jbc.M800927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326486	Green Published, hybrid			2022-12-27	WOS:000255499800064
J	Oliveira, V; Romanow, WJ; Geisen, C; Otterness, DM; Mercurio, F; Wang, HG; Dalton, WS; Abraham, RT				Oliveira, Vasco; Romanow, William J.; Geisen, Christoph; Otterness, Diane M.; Mercurio, Frank; Wang, Hong Gang; Dalton, William S.; Abraham, Robert T.			A protective role for the human SMG-1 kinase against tumor necrosis factor-alpha-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; INDUCED CELL-DEATH; NF-KAPPA-B; SURVEILLANCE PROTEIN; SIGNALING PATHWAYS; STRESS; UPF1; PHOSPHORYLATION; SUPERFAMILY; ACTIVATION	The human suppressor of morphogenesis in genitalia-1 (hSMG-1) protein kinase plays dual roles in mRNA surveillance and genotoxic stress response pathways in human cells. Here, we report that small interfering RNA-mediated depletion of hSMG-1, but not ATM, ATR, hUpf1, or hUpf2, in human U2OS osteosarcoma cells markedly increases the magnitude and accelerates the rate of apoptosis induced by tumor necrosis factor-alpha(TNF alpha) stimulation. The increase in TNF alpha-mediated cell killing observed in hSMG-1-depleted cells is not related to the suppression of nonsense-mediated mRNA decay or to the inhibition of TNF alpha-induced NF-kappa B activation. Rather, we observed that loss of hSMG-1 accelerates the degradation of the long form of the FLICE-inhibitory protein (FLIPL), an inhibitor of death-inducing signaling complex-mediated caspase-8 activation, in TNF alpha-treated cells. These results suggest that hSMG-1 plays an important role in cell survival during TNF alpha-induced stress.	[Oliveira, Vasco; Wang, Hong Gang; Dalton, William S.] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Expt Therapeut & Interdisciplinary Oncol, Tampa, FL 33612 USA; [Romanow, William J.; Mercurio, Frank] Signal Pharmaceut LLC, Discovery Biol Grp, San Diego, CA 92121 USA; [Geisen, Christoph] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Otterness, Diane M.] Burnham Inst Med Res, La Jolla, CA 92038 USA	State University System of Florida; University of South Florida; Harvard University; Dana-Farber Cancer Institute; Sanford Burnham Prebys Medical Discovery Institute	Dalton, WS (corresponding author), Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Expt Therapeut & Interdisciplinary Oncol, 12902 Magnolla Dr, Tampa, FL 33612 USA.	william.dalton@moffitt.org		Romanow, William/0000-0002-3808-6482	NATIONAL CANCER INSTITUTE [P30CA076292, R01CA097950] Funding Source: NIH RePORTER; NCI NIH HHS [CA97950, CA2 P30 CA076292-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2004, DNA REPAIR, V3, P919, DOI 10.1016/j.dnarep.2004.04.003; Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; LLOBET D, 2007, ONCOGENE; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Saklatvala J, 1996, PHILOS T ROY SOC B, V351, P151, DOI 10.1098/rstb.1996.0011; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002	28	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13174	13184		10.1074/jbc.M708008200	http://dx.doi.org/10.1074/jbc.M708008200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326048	Green Published, hybrid			2022-12-27	WOS:000255499800057
J	Buffone, MG; Zhuang, T; Ord, TS; Hui, L; Moss, SB; Gerton, GL				Buffone, Mariano G.; Zhuang, Tiangang; Ord, Teri S.; Hui, Ling; Moss, Stuart B.; Gerton, George L.			Recombinant mouse sperm ZP3-binding protein (ZP3R/sp56) forms a high order oligomer that binds eggs and inhibits mouse fertilization in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA GLYCOPROTEIN; ACROSOME REACTION; DIFFERENTIAL RELEASE; EXTRACELLULAR-MATRIX; AMINO-ACIDS; SP56; SPERMATOZOA; COMPLEMENT; ACTIVATION; EXOCYTOSIS	Many candidates have been proposed as zona pellucida-binding proteins. Without precluding a role for any of those candidates, we focused on mouse sperm protein ZP3R/sp56, which is localized in the acrosomal matrix. The objective of this study was to analyze the role of ZP3R/sp56 in mouse fertilization. We expressed recombinant ZP3R/sp56 as a secreted protein in HEK293 cells and purified it from serum-free, conditioned medium. In the presence of reducing agents, the recombinant ZP3R/sp56 exhibited a molecular weight similar to that observed for the native ZP3R/sp56. Reminiscent of the native protein, recombinant ZP3R/sp56 formed a high molecular weight, disulfide cross-linked oligomer consisting of six or more monomers under non-reducing conditions. Recombinant ZP3R/sp56 bound to the zona pellucida of unfertilized eggs but not to 2-cell embryos, indicating that the changes that take place in the zona pellucida at fertilization affected the interaction of this protein with the zona pellucida. The extent of in vitro fertilization was reduced in a dose-dependent manner when unfertilized eggs were preincubated with recombinant ZP3R/sp56 (74% drop at the maximum concentrations assayed). Eggs incubated with the recombinant protein showed an absence of or very few sperm in the perivitelline space, suggesting that the reduction in the fertilization rate is caused by the inhibition of sperm binding and/or penetration through the zona pellucida. These results indicate that sperm ZP3R/sp56 is important for sperm-zona interactions during fertilization and support the concept that the acrosomal matrix plays an essential role in mediating the binding of sperm to the zona pellucida.	[Buffone, Mariano G.; Zhuang, Tiangang; Ord, Teri S.; Hui, Ling; Moss, Stuart B.; Gerton, George L.] Univ Penn, Sch Med, Dept Obstet & Gynecol, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Gerton, GL (corresponding author), Univ Penn, Sch Med, Dept Obstet & Gynecol, Ctr Res Reprod & Womens Hlth, 421 Curie Blvd,1311 BRB 2-3, Philadelphia, PA 19104 USA.	gerton@mail.med.upenn.edu	Gerton, George L/A-1039-2007	Gerton, George L/0000-0001-9894-5640	FIC NIH HHS [5D43TW000671] Funding Source: Medline; NICHD NIH HHS [HD-41552] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041552] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000671] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		BABA T, 1994, J BIOL CHEM, V269, P31845; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; BLEIL JD, 1990, P NATL ACAD SCI USA, V87, P5563, DOI 10.1073/pnas.87.14.5563; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; BLEIL JD, 1983, DEV BIOL, V95, P317, DOI 10.1016/0012-1606(83)90032-5; Blom AM, 2002, BIOCHEM SOC T, V30, P978, DOI 10.1042/bst0300978; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; BRADEN AWH, 1954, AUST J BIOL SCI, V7, P391, DOI 10.1071/BI9540391; Chemes HE, 2003, HUM REPROD UPDATE, V9, P405, DOI 10.1093/humupd/dmg034; CHENG A, 1994, J CELL BIOL, V125, P867, DOI 10.1083/jcb.125.4.867; Cohen N, 2001, INT J DEV BIOL, V45, P569; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Ducibella T, 1996, HUM REPROD UPDATE, V2, P29, DOI 10.1093/humupd/2.1.29; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Foster JA, 1997, J BIOL CHEM, V272, P12714, DOI 10.1074/jbc.272.19.12714; Gao Z, 1998, J BIOL CHEM, V273, P3415, DOI 10.1074/jbc.273.6.3415; Gerton G L., 2002, FERTILIZATION, P265; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kim KS, 2001, BIOL REPROD, V64, P148, DOI 10.1095/biolreprod64.1.148; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MA, 1986, BIOL REPROD, V34, P349, DOI 10.1095/biolreprod34.2.349; Lu QX, 1997, DEVELOPMENT, V124, P4121; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; MILLER DJ, 1993, DEVELOPMENT, V118, P1279; Murayama Yoshinobu, 2006, Hum Cell, V19, P119, DOI 10.1111/j.1749-0774.2006.00019.x; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nixon B, 2001, CELLS TISSUES ORGANS, V168, P46, DOI 10.1159/000016805; PERKINS SJ, 1986, BIOCHEM J, V233, P799, DOI 10.1042/bj2330799; Rockwell PL, 2000, MOL REPROD DEV, V55, P335, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;335::AID-MRD12&gt;3.0.CO;2-5; Rodriguez-Martinez H, 1998, REPROD FERT DEVELOP, V10, P491, DOI 10.1071/RD98111; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHILL WB, 1991, HUM REPROD, V6, P969, DOI 10.1093/oxfordjournals.humrep.a137471; SCHROEDER AC, 1990, BIOL REPROD, V43, P891, DOI 10.1095/biolreprod43.5.891; SOTOMAYOR RE, 1986, BIOL REPROD, V34, P171, DOI 10.1095/biolreprod34.1.171; Summers MC, 2000, HUM REPROD, V15, P1791, DOI 10.1093/humrep/15.8.1791; Tang N, 2004, MASS SPECTROM REV, V23, P34, DOI 10.1002/mas.10066; Tanphaichitr N, 2007, FRONT BIOSCI-LANDMRK, V12, P1748, DOI 10.2741/2186; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD CR, 1994, J BIOL CHEM, V269, P13254; WARD CR, 1992, J BIOL CHEM, V267, P14061; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291; YANAGIMACHI R, 1979, FERTIL STERIL, V31, P562; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	48	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12438	12445		10.1074/jbc.M706421200	http://dx.doi.org/10.1074/jbc.M706421200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316377	hybrid, Green Published			2022-12-27	WOS:000255340000060
J	Dolniak, B; Katsoulidis, E; Carayol, N; Altman, JK; Redig, AJ; Tallman, MS; Ueda, T; Watanabe-Fukunaga, R; Fukunaga, R; Platanias, LC				Dolniak, Blazej; Katsoulidis, Efstratios; Carayol, Nathalie; Altman, Jessica K.; Redig, Amanda J.; Tallman, Martin S.; Ueda, Takeshi; Watanabe-Fukunaga, Rie; Fukunaga, Rikiro; Platanias, Leonidas C.			Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; ABL-EXPRESSING CELLS; CAP-BINDING PROTEIN; NF-KAPPA-B; HEMATOPOIETIC-CELLS; INDUCED APOPTOSIS; MYELOID-LEUKEMIA; INTERFERON-ALPHA	Arsenic trioxide (As2O3) is a potent inducer of apoptosis of malignant cells in vitro and in vivo, but the precise mechanisms by which it mediates such effects are not well defined. We provide evidence that As2O3 induces phosphorylation/ activation of the MAPK signal-integrating kinases (Mnks) 1 and 2 in leukemia cell lines. Such activation is defective in cells with targeted disruption of the p38 alpha MAPK gene, indicating that it requires upstream engagement of the p38 MAPK pathway. Studies using Mnk1(-/-) or Mnk2(-/-), or double Mnk1(-/-) Mnk2(-/-) knock-out cells, establish that activation of Mnk1 and Mnk2 by arsenic trioxide regulates downstream phosphorylation of the eukaryotic initiation factor 4E at Ser-209. Importantly, arsenic-induced apoptosis is enhanced in cells with targeted disruption of the Mnk1 and/or Mnk2 genes, suggesting that these kinases are activated in a negative-feedback regulatory manner, to control generation of arsenic trioxide responses. Consistent with this, pharmacological inhibition of Mnk activity enhances the suppressive effects of arsenic trioxide on primary leukemic progenitors from patients with acute leukemias. Taken together, these findings indicate an important role for Mnk kinases, acting as negative regulators for signals that control generation of arsenic trioxide-dependent apoptosis and antileukemic responses.	[Dolniak, Blazej; Katsoulidis, Efstratios; Carayol, Nathalie; Altman, Jessica K.; Redig, Amanda J.; Tallman, Martin S.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Dolniak, Blazej; Katsoulidis, Efstratios; Carayol, Nathalie; Altman, Jessica K.; Redig, Amanda J.; Tallman, Martin S.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA; [Dolniak, Blazej; Katsoulidis, Efstratios; Carayol, Nathalie; Altman, Jessica K.; Redig, Amanda J.; Tallman, Martin S.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Ueda, Takeshi; Watanabe-Fukunaga, Rie; Fukunaga, Rikiro] Osaka Univ, Genet Lab, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Osaka University	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Superior St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Fukunaga, Rikiro/CAG-2891-2022	Ueda, Takeshi/0000-0001-9823-6764	NCI NIH HHS [CA77816, CA121192, CA100579] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA100579, R01CA077816] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Ahmad S, 1997, J BIOL CHEM, V272, P29991, DOI 10.1074/jbc.272.48.29991; Akao Y, 1998, BRIT J HAEMATOL, V102, P1055, DOI 10.1046/j.1365-2141.1998.00869.x; Beretta L, 1998, J IMMUNOL, V160, P3269; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Chen GQ, 1996, BLOOD, V88, P1052; Chen Z, 2002, SEMIN HEMATOL, V39, P22, DOI 10.1053/shem.2002.33611; Chrestensen CA, 2007, GENES CELLS, V12, P1133, DOI 10.1111/j.1365-2443.2007.01122.x; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Evens AM, 2004, LEUKEMIA RES, V28, P891, DOI 10.1016/j.leukres.2004.01.011; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Jauch R, 2006, EMBO J, V25, P4020, DOI 10.1038/sj.emboj.7601285; Jing Y, 2007, CURR TOP MICROBIOL, V313, P245; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kandel EV, 1937, ARCH INTERN MED, V60, P846, DOI 10.1001/archinte.1937.00180050113008; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kerbauy DMB, 2005, BLOOD, V106, P3917, DOI 10.1182/blood-2005-04-1424; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; List A, 2003, LEUKEMIA, V17, P1499, DOI 10.1038/sj.leu.2403021; Mathas S, 2003, BLOOD, V102, P1028, DOI 10.1182/blood-2002-04-1154; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P2890, DOI 10.1128/MCB.24.7.2890-2904.2004; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Nervi C, 1998, BLOOD, V92, P2244; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Novick SC, 2000, SEMIN ONCOL, V27, P495; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Ramos AM, 2005, BLOOD, V105, P4013, DOI 10.1182/blood-2004-07-2802; Reiling JH, 2005, CURR BIOL, V15, P24, DOI 10.1016/j.cub.2004.12.034; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Shenberger JS, 2007, INT J BIOCHEM CELL B, V39, P1828, DOI 10.1016/j.biocel.2007.05.001; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Tallman MS, 2001, BLOOD REV, V15, P133, DOI 10.1054/blre.2001.0160; Tschopp C., 2000, Molecular Cell Biology Research Communications, V3, P205, DOI 10.1006/mcbr.2000.0217; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Uddin S, 1997, BLOOD, V90, P2574; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wei LH, 2005, ONCOGENE, V24, P390, DOI 10.1038/sj.onc.1208192; Worch J, 2004, ONCOGENE, V23, P9162, DOI 10.1038/sj.onc.1208164; Yoon P, 2006, MOL CANCER THER, V5, P2815, DOI 10.1158/1535-7163.MCT-06-0263	60	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12034	12042		10.1074/jbc.M708816200	http://dx.doi.org/10.1074/jbc.M708816200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18299328	Green Published, hybrid			2022-12-27	WOS:000255340000019
J	Jacquet, S; Nishino, Y; Kumphune, S; Sicard, P; Clark, JE; Kobayashi, KS; Flavell, RA; Eickhoff, J; Cotten, M; Marber, MS				Jacquet, Sebastien; Nishino, Yasuhiro; Kumphune, Sarawut; Sicard, Pierre; Clark, James E.; Kobayashi, Koichi S.; Flavell, Richard A.; Eickhoff, Jan; Cotten, Matt; Marber, Michael S.			The role of RIP2 in p38 MAPK activation in the stressed heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVATION; INDEPENDENT ACTIVATION; SIMULATED ISCHEMIA; INHIBITION; P38-ALPHA; MECHANISMS; PATHWAY; BINDING; AUTOPHOSPHORYLATION; EXPRESSION	The activation of p38 MAPK by dual phosphorylation aggravates myocardial ischemic injury and depresses cardiac contractile function. SB203580, an ATP-competitive inhibitor of p38 MAPK and other kinases, prevents this dual phosphorylation during ischemia. Studies in non-cardiac tissue have shown receptor-interacting protein 2 (RIP2) lies upstream of p38 MAPK, is SB203580-sensitive and ischemia-responsive, and aggravates ischemic injury. We therefore examined the RIP2-p38 MAPK signaling axis in the heart. Adenovirus-driven expression of wild-type RIP2 in adult rat ventricular myocytes caused robust, SB203580-sensitive dual phosphorylation of p38 MAPK associated with activation of p38 MAPK kinases MKK3, MKK4, and MKK6. The effect of SB203580 was recapitulated by unrelated inhibitors of RIP2 or the downstream MAPK kinase kinase, TAK1. However, overexpression of wild-type, kinase-dead, caspase recruitment domain-deleted, or kinase-dead and caspase recruitment domain-deleted forms of RIP2 had no effect on the activating dual phosphorylation of p38 MAPK during simulated ischemia. Similarly, p38 MAPK activation and myocardial infarction size in response to true ischemia did not differ between hearts from wild-type and RIP2 null mice. However, both p38 MAPK activation and the contractile depression caused by the endotoxin component muramyl dipeptide were attenuated by SB203580 and in RIP2 null hearts. Although RIP2 can cause myocardial p38 MAPK dual phosphorylation in the heart under some circumstances, it is not responsible for the SB203580-sensitive pattern of activation during ischemia.	[Jacquet, Sebastien; Nishino, Yasuhiro; Kumphune, Sarawut; Sicard, Pierre; Clark, James E.; Marber, Michael S.] Kings Coll London, Rayne Inst, St Thomas Hosp, Div Cardiovasc, London SE1 7EH, England; [Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA; [Eickhoff, Jan] GBC Biotech, D-82152 Munich, Germany; [Cotten, Matt] MRC Labs, Banjul, Gambia	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Yale University; MRC Laboratory Molecular Biology	Marber, MS (corresponding author), Kings Coll London, Rayne Inst, St Thomas Hosp, Div Cardiovasc, London SE1 7EH, England.	mike.marber@kcl.ac.uk	Sicard, Pierre/N-7310-2018; Sicard, Pierre/B-1637-2010; marber, michael/AAW-7916-2021; Clark, James/H-7786-2019; Kumphune, Sarawut/AAH-9060-2019; KUMPHUNE, SARAWUT/AAA-9278-2021	Sicard, Pierre/0000-0001-5837-3916; Sicard, Pierre/0000-0001-8100-9792; KUMPHUNE, SARAWUT/0000-0003-4940-7103; Cotten, Matthew/0000-0002-3361-3351; Marber, Michael/0000-0002-3463-7128; Clark, James/0000-0001-7574-2162; Kobayashi, Koichi/0000-0003-2930-0114	British Heart Foundation [07/073/23432] Funding Source: Medline; NIDDK NIH HHS [R01 DK074738, R01 DK074738-05] Funding Source: Medline; Wellcome Trust [074653] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleshin A, 2004, EUR J CARDIO-THORAC, V26, P974, DOI 10.1016/j.ejcts.2004.06.021; Argast GM, 2005, MOL CELL BIOCHEM, V268, P129, DOI 10.1007/s11010-005-3701-0; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; Clanachan AS, 2003, TRANSPLANTATION, V75, P173, DOI 10.1097/01.TP.0000040429.40245.3A; Clark JE, 2007, PHARMACOL THERAPEUT, V116, P192, DOI 10.1016/j.pharmthera.2007.06.013; Dorsch M, 2006, CELL SIGNAL, V18, P2223, DOI 10.1016/j.cellsig.2006.05.005; Eickhoff J, 2004, J BIOL CHEM, V279, P9642, DOI 10.1074/jbc.M312893200; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gorog DA, 2004, CARDIOVASC RES, V61, P123, DOI 10.1016/j.cardiores.2003.09.034; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; House SL, 2005, AM J PHYSIOL-HEART C, V289, pH2167, DOI 10.1152/ajpheart.00392.2005; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Iwanaga Y, 2003, INFLAMM RES, V52, P272, DOI 10.1007/s00011-003-1170-z; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lau JMC, 2007, MOL CELL BIOL, V27, P1455, DOI 10.1128/MCB.01369-06; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; Marber MS, 2000, CIRC RES, V86, P926, DOI 10.1161/01.RES.86.9.926; Maulik N, 1998, AM J PHYSIOL-HEART C, V275, pH1857, DOI 10.1152/ajpheart.1998.275.5.H1857; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; MURCH O, 2008, IN PRESS SHOCK; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; Wang MJ, 2005, ANN THORAC SURG, V80, P2235, DOI 10.1016/j.athoracsur.2005.05.070; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Yada M, 2004, J THORAC CARDIOV SUR, V128, P588, DOI 10.1016/j.jtcvs.2004.02.007; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100	44	28	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11964	11971		10.1074/jbc.M707750200	http://dx.doi.org/10.1074/jbc.M707750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310079	Green Published, hybrid			2022-12-27	WOS:000255340000012
J	Nyman, T; Stenmark, P; Flodin, S; Johansson, I; Hammarstrom, M; Nordlund, P				Nyman, Tomas; Stenmark, Pal; Flodin, Susanne; Johansson, Ida; Hammarstroem, Martin; Nordlund, Paer			The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; TIR-DOMAIN; ADAPTER PROTEIN; BB LOOPS; MYD88; FAMILY; GENE; TRANSDUCTION; DIMERIZATION; INHIBITION	The Toll/interleukin-1 receptor (TIR) domain is a highly conserved signaling domain found in the intracellular regions of Toll-like receptors (TLRs), in interleukin-1 receptors, and in several cytoplasmic adaptor proteins. TIR domains mediate receptor signal transduction through recruitment of adaptor proteins and play critical roles in the innate immune response and inflammation. This work presents the 2.2 angstrom crystal structure of the TIR domain of human TLR10, revealing a symmetric dimer in the asymmetric unit. The dimer interaction surface contains residues from the BB-loop, DD- loop, and alpha C-helix, which have previously been identified as important structural motifs for signaling in homologous TLR receptors. The interaction surface is extensive, containing a central hydrophobic patch surrounded by polar residues. The BB-loop forms a tight interaction, where a range of consecutive residues binds in a pocket formed by the reciprocal BB-loop and alpha C-helix. This pocket appears to be well suited for binding peptide substrates, which is consistent with the notion that peptides and peptide mimetics of the BB-loop are inhibitors for TLR signaling. The TLR10 structure is in good agreement with available biochemical data on TLR receptors and is likely to provide a good model for the physiological dimer.	[Nyman, Tomas; Stenmark, Pal; Flodin, Susanne; Johansson, Ida; Hammarstroem, Martin; Nordlund, Paer] Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Nordlund, Paer] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Nordlund, P (corresponding author), Nobels Vag 5, S-17177 Stockholm, Sweden.	par.nordlund@ki.se		Stenmark, Pal/0000-0003-4777-3417				Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; DeLano W.L, PYMOL MOL GRAPHICS S; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Heine H, 2003, INT ARCH ALLERGY IMM, V130, P180, DOI 10.1159/000069517; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MEDZHITOV R, 1997, NATURE, V388, P397; MIGUEL RN, 2008, PLOS 1, V2, pE788; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	33	158	163	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11861	11865		10.1074/jbc.C800001200	http://dx.doi.org/10.1074/jbc.C800001200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332149	hybrid			2022-12-27	WOS:000255340000001
J	Frese, MA; Schulz, S; Dierks, T				Frese, Marc-Andre; Schulz, Stefanie; Dierks, Thomas			Arylsulfatase G, a novel lysosomal sulfatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; FORMYLGLYCINE; GENE; DEFICIENCY; EXPRESSION; MUTATIONS; MECHANISM; TRANSPORT; PROTEINS; BINDING	The sulfatases constitute a conserved family of enzymes that specifically hydrolyze sulfate esters in a wide variety of substrates such as glycosaminoglycans, steroid sulfates, or sulfolipids. By modifying the sulfation state of their substrates, sulfatases play a key role in the control of physiological processes, including cellular degradation, cell signaling, and hormone regulation. The loss of sulfatase activity has been linked with various severe pathophysiological conditions such as lysosomal storage disorders, developmental abnormalities, or cancer. A novel member of this family, arylsulfatase G (ASG), was initially described as an enzyme lacking in vitro arylsulfatase activity and localizing to the endoplasmic reticulum. Contrary to these results, we demonstrate here that ASG does indeed have arylsulfatase activity toward different pseudosubstrates like p-nitrocatechol sulfate and 4-methylumbelliferyl sulfate. The activity of ASG depends on the Cys-84 residue that is predicted to be post-translationally converted to the critical active site C-alpha-formylglycine. Phosphate acts as a strong, competitive ASG inhibitor. ASG is active as an unprocessed 63-kDa monomer and shows an acidic pH optimum as typically seen for lysosomal sulfatases. In transfected cells, ASG accumulates within lysosomes as indicated by indirect immunofluorescence microscopy. Furthermore, ASG is a glycoprotein that binds specifically to mannose 6-phosphate receptors, corroborating its lysosomal localization. ARSG mRNA expression was found to be tissue-specific with highest expression in liver, kidney, and pancreas, suggesting a metabolic role of ASG that might be associated with a so far non-classified lysosomal storage disorder.	[Frese, Marc-Andre; Dierks, Thomas] Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany; [Schulz, Stefanie] Univ Gottingen, Biochem Abt 2, D-37073 Gottingen, Germany	University of Bielefeld; University of Gottingen	Dierks, T (corresponding author), Univ Bielefeld, Fak Chem, Univ Str 25, D-33615 Bielefeld, Germany.	dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012; Schupke, Stefanie/G-8382-2016	Dierks, Thomas/0000-0001-6426-1339; Schupke, Stefanie/0000-0002-0294-2283				Ahmed S, 2002, CURR MED CHEM, V9, P263, DOI 10.2174/0929867023371210; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; CHATTARAJ S, 1992, ANALYST, V117, P413, DOI 10.1039/an9921700413; Chruszcz M, 2003, J INORG BIOCHEM, V96, P386, DOI 10.1016/S0162-0134(03)00176-4; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Ferrante P, 2002, EUR J HUM GENET, V10, P813, DOI 10.1038/sj.ejhg.5200887; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; HOPWOOD JJ, 2001, METABOLIC MOL BASES, V3, P3725; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; KOSTER A, 1993, EMBO J, V12, P5219, DOI 10.1002/j.1460-2075.1993.tb06217.x; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lefrancois S, 2002, J BIOL CHEM, V277, P17188, DOI 10.1074/jbc.M200343200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P429, DOI 10.1074/mcp.M300140-MCP200; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; PISONI RL, 1991, J BIOL CHEM, V266, P979; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Sleat DE, 2005, PROTEOMICS, V5, P1520, DOI 10.1002/pmic.200401054; STECKEL F, 1983, J BIOL CHEM, V258, P4322; STEIN C, 1989, J BIOL CHEM, V264, P13865; STEIN C, 1989, J BIOL CHEM, V264, P1252; Via LE, 1998, J CELL SCI, V111, P897; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; von Bulow R, 2002, J BIOL CHEM, V277, P9455, DOI 10.1074/jbc.M111993200; Waldow A, 1999, J BIOL CHEM, V274, P12284, DOI 10.1074/jbc.274.18.12284; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101	39	38	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11388	11395		10.1074/jbc.M709917200	http://dx.doi.org/10.1074/jbc.M709917200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18283100	hybrid			2022-12-27	WOS:000255067400036
J	Babenko, AP				Babenko, Andrey P.			A novel ABCC8(SUR1)-dependent mechanism of metabolism excitation uncoupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; NEONATAL DIABETES-MELLITUS; MULTIDRUG ABC TRANSPORTER; PANCREATIC BETA-CELLS; SULFONYLUREA RECEPTOR; INSULIN-SECRETION; TOLBUTAMIDE SITE; SUR1; REGULATOR	ATP/ADP-sensing ( sulfonylurea receptor ( SUR)/K(IR)6)(4) K-ATP channels regulate the excitability of our insulin secreting and other vital cells via the differential MgATP/ADP-dependent stimulatory actions of their tissue-specific ATP-binding cassette regulatory subunits ( sulfonylurea receptors), which counterbalance the nearly constant inhibitory action of ATP on the K+ inwardly rectifying pore. Mutations in SUR1 that abolish its stimulation have been found in infants persistently releasing insulin. Activating mutations in SUR1 have been shown to cause neonatal diabetes. Here, analyses of K(IR)6.2-based channels with diabetogenic receptors reveal that MgATP-dependent hyper-stimulation of mutant SUR can compromise the ability of KATP channels to function as metabolic sensors. I demonstrate that the channel hyperactivity rises exponentially with the number of hyperstimulating subunits, so small subpopulations of channels with more than two mutant SUR can dominate hyperpolarizing currents in heterozygous patients. I uncovered an attenuated tolbutamide inhibition of the hyperstimulated mutant, which is normally sensitive to the drug under non-stimulatory conditions. These findings show the key role of SUR in sensing the metabolic index in humans and urge others to ( re) test mutant SUR/K(IR)6 channels from probands in physiologic MgATP.	[Babenko, Andrey P.] Pacific NW Res Inst, Seattle, WA 98122 USA		Babenko, AP (corresponding author), 720 Broadway, Seattle, WA USA.	ababenko@pnri.org						AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 1999, FEBS LETT, V445, P131, DOI 10.1016/S0014-5793(99)00102-7; Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Babenko AP, 1999, FEBS LETT, V459, P367, DOI 10.1016/S0014-5793(99)01215-6; Christesen H. B. T., 2005, HORM RES, V64, P135; COOK DL, 1988, DIABETES, V37, P495, DOI 10.2337/diabetes.37.5.495; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Sperling MA, 2006, NEW ENGL J MED, V355, P507, DOI 10.1056/NEJMe068142; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268	26	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8778	8782		10.1074/jbc.C700243200	http://dx.doi.org/10.1074/jbc.C700243200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18281290	Green Published, hybrid			2022-12-27	WOS:000254465800002
J	Hayashi, C; Ono, Y; Doi, N; Kitamura, F; Tagami, M; Mineki, R; Arai, T; Taguchi, H; Yanagida, M; Hirner, S; Labeit, D; Labeit, S; Sorimachi, H				Hayashi, Chikako; Ono, Yasuko; Doi, Naoko; Kitamura, Fujiko; Tagami, Mai; Mineki, Reiko; Arai, Takao; Taguchi, Hayao; Yanagida, Mitsuaki; Hirner, Stephanie; Labeit, Dietmar; Labeit, Siegfried; Sorimachi, Hiroyuki			Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-REPEAT PROTEIN; DYSTROPHY TYPE 2A; MYOGENIC REGULATORY FACTORS; SPINAL MUSCULAR-ATROPHY; IN-VIVO; CONGENITAL MYOPATHY; ELASTIC PROTEIN; CALPAIN SYSTEM; MYOSITIS MDM; TITIN	p94/calpain 3 is a skeletal muscle-specific Ca2+-regulated cysteine protease (calpain), and genetic loss of p94 protease activity causes muscular dystrophy (calpainopathy). In addition, a small in-frame deletion in the N2A region of connectin/titin that impairs p94-connectin interaction causes a severe muscular dystrophy (mdm) in mice. Since p94 via its interaction with the N2A and M-line regions of connectin becomes part of the connectin filament system that serves as a molecular scaffold for the myofibril, it has been proposed that structural and functional integrity of the p94-connectin complex is essential for health and maintenance of myocytes. In this study, we have surveyed the interactions made by p94 and connectin N2A inside COS7 cells. This revealed that p94 binds to connectin at multiple sites, including newly identified loci in the N2A and PEVK regions of connectin. Functionally, p94-N2A interactions suppress p94 autolysis and protected connectin from proteolysis. The connectin N2A region also contains a binding site for the muscle ankyrin repeat proteins (MARPs), a protein family involved in the cellular stress responses. MARP2/Ankrd2 competed with p94 for binding to connectin and was also proteolyzed by p94. Intriguingly, a connectin N2A fragment with the mdm deletion possessed enhanced resistance to proteases, including p94, and its interaction with MARPs was weakened. Our data support a model in which MARP2-p94 signaling converges within the N2A connectin segment and the mdm deletion disrupts their coordination. These results also implicate the dynamic nature of connectin molecule as a regulatory scaffold of p94 functions.	[Hayashi, Chikako; Ono, Yasuko; Doi, Naoko; Kitamura, Fujiko; Tagami, Mai; Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci, Dept Enzymat Regulat Cell Funct, Calpain Project, Bunkyo Ku, Tokyo 1138613, Japan; [Hayashi, Chikako; Arai, Takao; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba 2788570, Japan; [Doi, Naoko] Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan; [Mineki, Reiko] Juntendo Univ, Grad Sch Med, Ctr Biomed Res, Chiba 2790021, Japan; [Hirner, Stephanie; Labeit, Dietmar; Labeit, Siegfried] Univ Klinikum Mannheim, Inst Anasthesiol & Operat Intensivmed, D-68167 Mannheim, Germany; [Yanagida, Mitsuaki] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Chiba 2790021, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo University of Science; Japan Science & Technology Agency (JST); Juntendo University; Ruprecht Karls University Heidelberg; Juntendo University	Ono, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Enzymat Regulat Cell Funct, Calpain Project, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	yakoono@rinshoken.or.jp	Sorimachi, Hiroyuki/C-6448-2009; Sorimachi, Hiroyuki/Q-6956-2017	Sorimachi, Hiroyuki/0000-0001-9509-6727; Sorimachi, Hiroyuki/0000-0001-9509-6727; Taguchi, Hayao/0000-0001-5270-581X				Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Bassaglia Y, 2005, EXP CELL RES, V302, P221, DOI 10.1016/j.yexcr.2004.08.038; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; Centner T, 2000, ADV EXP MED BIOL, V481, P35; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Dedieu S, 2003, J MOL BIOL, V326, P453, DOI 10.1016/S0022-2836(02)01310-4; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Heimann P, 1996, CELL TISSUE RES, V283, P435, DOI 10.1007/s004410050554; Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619; Hentzen ER, 2006, J PHYSIOL-LONDON, V570, P157, DOI 10.1113/jphysiol.2005.093005; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kinbara K, 1997, ARCH BIOCHEM BIOPHYS, V342, P99, DOI 10.1006/abbi.1997.0108; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Laval M, 2002, BBA-GEN SUBJECTS, V1570, P121, DOI 10.1016/S0304-4165(02)00184-8; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; MARUYAMA K, 1976, J BIOCHEM-TOKYO, V80, P405, DOI 10.1093/oxfordjournals.jbchem.a131291; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; Nakada C, 2003, PATHOL INT, V53, P653, DOI 10.1046/j.1440-1827.2003.01541.x; Nakamura K, 2002, PATHOBIOLOGY, V70, P197, DOI 10.1159/000069329; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2008, FEBS LETT, V582, P691, DOI 10.1016/j.febslet.2008.01.044; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Raynaud F, 2005, FEBS J, V272, P2578, DOI 10.1111/j.1742-4658.2005.04683.x; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; SUGITA H, 1980, MUSCLE NERVE, V3, P335, DOI 10.1002/mus.880030410; Suzuki A, 1996, ADV BIOPHYS, V33, P53; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tagawa K, 2000, HUM MOL GENET, V9, P1393, DOI 10.1093/hmg/9.9.1393; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Taylor RG, 1997, J MUSCLE RES CELL M, V18, P285, DOI 10.1023/A:1018665924412; TOKUYASU KT, 1987, J CELL BIOL, V105, P2795, DOI 10.1083/jcb.105.6.2795; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tsukamoto Y, 2002, LAB INVEST, V82, P645, DOI 10.1038/labinvest.3780459; Witt SH, 2005, J MUSCLE RES CELL M, V26, P401, DOI 10.1007/s10974-005-9022-9; Wittt CC, 2004, J MOL BIOL, V336, P145, DOI 10.1016/j.jmb.2003.12.021; ZAK R, 1977, J BIOL CHEM, V252, P3430; Zou YM, 1997, DEVELOPMENT, V124, P793	65	84	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14801	14814		10.1074/jbc.M708262200	http://dx.doi.org/10.1074/jbc.M708262200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18310072	hybrid			2022-12-27	WOS:000255941400068
J	Parsons, JB; Dinesh, SD; Deery, E; Leech, HK; Brindley, AA; Heldt, D; Frank, S; Smales, CM; Lunsdorf, H; Rambach, A; Gass, MH; Bleloch, A; McClean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ; Prentice, MB				Parsons, Joshua B.; Dinesh, Sriramulu D.; Deery, Evelyne; Leech, Helen K.; Brindley, Amanda A.; Heldt, Dana; Frank, Steffanie; Smales, C. Mark; Luensdorf, Heinrich; Rambach, Alain; Gass, Mhairi H.; Bleloch, Andrew; McClean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.; Prentice, Michael B.			Biochemical and structural insights into bacterial organelle form and biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME B-12-DEPENDENT DEGRADATION; SALMONELLA-ENTERICA; GENOME SEQUENCE; CARBOXYSOMES; TYPHIMURIUM; 1,2-PROPANEDIOL; EVOLUTION; PROTEIN; GENES; SHELL	Many heterotrophic bacteria have the ability to make polyhedral structures containing metabolic enzymes that are bounded by a unilamellar protein shell (metabolosomes or enterosomes). These bacterial organelles contain enzymes associated with a specific metabolic process ( e. g. 1,2-propanediol or ethanolamine utilization). We show that the 21 gene regulon specifying the pdu organelle and propanediol utilization enzymes from Citrobacter freundii is fully functional when cloned in Escherichia coli, both producing metabolosomes and allowing propanediol utilization. Genetic manipulation of the level of specific shell proteins resulted in the formation of aberrantly shaped metabolosomes, providing evidence for their involvement as delimiting entities in the organelle. This is the first demonstration of complete recombinant metabolosome activity transferred in a single step and supports phylogenetic evidence that the pdu genes are readily horizontally transmissible. One of the predicted shell proteins ( PduT) was found to have a novel Fe-S center formed between four protein subunits. The recombinant model will facilitate future experiments establishing the structure and assembly of these multiprotein assemblages and their fate when the specific metabolic function is no longer required.	[Parsons, Joshua B.; Deery, Evelyne; Leech, Helen K.; Brindley, Amanda A.; Heldt, Dana; Frank, Steffanie; Smales, C. Mark; Warren, Martin J.] Univ Kent, Dept Biochem, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England; [Dinesh, Sriramulu D.; Prentice, Michael B.] Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland; [Dinesh, Sriramulu D.; Prentice, Michael B.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, Dept Vaccinol, D-38124 Braunschweig, Germany; [Rambach, Alain] CHROMagar, F-75006 Paris, France; [Gass, Mhairi H.; Bleloch, Andrew] SERC, Daresbury Lab, SuperSTEM Facil, Warrington WA4 4AD, Cheshire, England; [McClean, Kirsty J.; Munro, Andrew W.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Rigby, Stephen E. J.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Kent; University College Cork; University College Cork; Helmholtz Association; Helmholtz-Center for Infection Research; STFC Daresbury Laboratory; University of Manchester; University of London	Warren, MJ (corresponding author), Univ Kent, Dept Biochem, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk; m.prentice@ucc.ie	Bleloch, Andrew/A-1350-2009; Prentice, Michael/AAE-7246-2019; Munro, Andrew/G-5639-2019	Prentice, Michael/0000-0003-1117-2388; Munro, Andrew/0000-0002-4642-180X; Parsons, Joshua/0000-0002-0589-3587; Frank, Stefanie/0000-0003-3153-6417; Smales, Christopher Mark/0000-0002-2762-4724; Warren, Martin/0000-0002-6028-6456	BBSRC [BB/E010563/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010563/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056; ALHASHIMI A, 2002, OMICS, V6, P305; ALLEN LN, 1985, J BACTERIOL, V161, P955, DOI 10.1128/JB.161.3.955-962.1985; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Forouhar Farhad, 2007, Journal of Structural and Functional Genomics, V8, P37, DOI 10.1007/s10969-007-9018-3; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Lawrence JG, 1996, GENETICS, V142, P11; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Prentice MB, 2003, ADV EXP MED BIOL, V529, P43; Raux E, 1996, J BACTERIOL, V178, P753, DOI 10.1128/jb.178.3.753-767.1996; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; Sauvageot N, 2002, FEMS MICROBIOL LETT, V209, P69, DOI 10.1111/j.1574-6968.2002.tb11111.x; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Shively JM, 2001, CURR OPIN MICROBIOL, V4, P301, DOI 10.1016/S1369-5274(00)00207-1; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; TORAYA T, 1979, J BACTERIOL, V139, P39, DOI 10.1128/JB.139.1.39-47.1979; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144	33	109	137	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14366	14375		10.1074/jbc.M709214200	http://dx.doi.org/10.1074/jbc.M709214200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332146	hybrid			2022-12-27	WOS:000255941400023
J	Schobel, S; Neumann, S; Hertweck, M; Dislich, B; Kuhn, PH; Kremmer, E; Seed, B; Baumeister, R; Haass, C; Lichtenthaler, SF				Schoebel, Susanne; Neumann, Stephanie; Hertweck, Maren; Dislich, Bastian; Kuhn, Peer-Hendrik; Kremmer, Elisabeth; Seed, Brian; Baumeister, Ralf; Haass, Christian; Lichtenthaler, Stefan F.			A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MARIE-TOOTH DISEASE; ALZHEIMERS-DISEASE; BETA-SECRETASE; GAMMA-SECRETASE; C-ELEGANS; DOMAIN PROTEINS; MUTATION CAUSES; DYNAMIN; ECTODOMAIN	Ectodomain shedding of the amyloid precursor protein (APP) by the two proteases alpha- and beta-secretase is a key regulatory event in the generation of the Alzheimer disease amyloid beta peptide (A beta). beta-Secretase catalyzes the first step in A beta generation, whereas alpha-secretase cleaves within the A beta domain, prevents A beta generation, and generates a secreted form of APP with neuroprotective properties. At present, little is known about the cellular mechanisms that control APP alpha-secretase cleavage and A beta generation. To explore the contributory pathways, we carried out an expression cloning screen. We identified a novel member of the sorting nexin (SNX) family of endosomal trafficking proteins, called SNX33, as a new activator of APP alpha-secretase cleavage. SNX33 is a homolog of SNX9 and was found to be a ubiquitously expressed phosphoprotein. Exogenous expression of SNX33 in cultured cells increased APP alpha-secretase cleavage 4- fold but surprisingly had little effect on beta-secretase cleavage. This effect was similar to the expression of the dominant negative dynamin-1 mutant K44A. SNX33 bound the endocytic GTPase dynamin and reduced the rate of APP endocytosis in a dynamin-dependent manner. This led to an increase of APP at the plasma membrane, where alpha-secretase cleavage mostly occurs. In summary, our study identifies SNX33 as a new endocytic protein, which modulates APP endocytosis and APP alpha-secretase cleavage, and demonstrates that the rate of APP endocytosis is a major control factor for APP alpha-secretase cleavage.	[Schoebel, Susanne; Neumann, Stephanie; Dislich, Bastian; Kuhn, Peer-Hendrik; Haass, Christian; Lichtenthaler, Stefan F.] Univ Munich, Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Schoebel, Susanne; Neumann, Stephanie; Dislich, Bastian; Kuhn, Peer-Hendrik; Haass, Christian; Lichtenthaler, Stefan F.] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Hertweck, Maren; Baumeister, Ralf] Univ Freiburg, Ctr Biochem & Mol Cell Res, ZBMZ, Fac Med,Fac Biol,Inst Biol 3, D-79104 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Ctr Syst Biol, ZBSA, D-79104 Freiburg, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany; [Seed, Brian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA	University of Munich; University of Munich; University of Freiburg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lichtenthaler, SF (corresponding author), Univ Munich, Ctr Integrated Prot Sci, Schillerstr 44, D-80336 Munich, Germany.	Stefan.Lichtenthaler@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575; Kuhn, Peer-Hendrik/0000-0001-7891-5102				Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Childress C, 2006, BIOCHEM J, V394, P693, DOI 10.1042/BJ20050576; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 2006, NEURODEGENER DIS, V3, P262, DOI 10.1159/000095265; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Schobel S, 2006, INT J DEV NEUROSCI, V24, P141, DOI 10.1016/j.ijdevneu.2005.11.003; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shin N, 2007, J BIOL CHEM, V282, P28939, DOI 10.1074/jbc.M700283200; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	55	66	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14257	14268		10.1074/jbc.M801531200	http://dx.doi.org/10.1074/jbc.M801531200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353773	hybrid			2022-12-27	WOS:000255941400012
J	Caughey, GH; Beauchamp, J; Schlatter, D; Raymond, WW; Trivedi, NN; Banner, D; Mauser, H; Fingerle, J				Caughey, George H.; Beauchamp, Jeremy; Schlatter, Daniel; Raymond, Wilfred W.; Trivedi, Neil N.; Banner, David; Mauser, Harald; Fingerle, Juergen			Guinea pig chymase is leucine-specific - A novel example of functional plasticity in the chymase/granzyme family of serine peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL CHYMASE; EXTENDED SUBSTRATE-SPECIFICITY; ANGIOTENSIN-II GENERATION; RODENT ALPHA-CHYMASES; HUMAN CATHEPSIN-G; IN-VIVO; MAMMALIAN EVOLUTION; BETA-CHYMASES; PROTEASE; INHIBITOR	To explore guinea pigs as models of chymase biology, we cloned and expressed the guinea pig ortholog of human chymase. In contrast to rats and mice, guinea pigs appear to express just one chymase, which belongs to the alpha clade, like primate chymases and mouse mast cell protease-5. The guinea pig enzyme autolyzes at Leu residues in the loop where human chymase autolyzes at Phe. In addition, guinea pig alpha-chymase selects P1 Leu in a combinatorial peptide library and cleaves Ala-Ala-Pro-Leu-4-nitroanilide but has negligible activity toward substrates with P1 Phe and does not cleave angiotensin I. This contrasts with human chymase, which cleaves after Phe or Tyr, prefers P1 Phe in peptidyl 4-nitroanilides, and avidly hydrolyzes angiotensin I at Phe(8) to generate bioactive angiotensin II. The guinea pig enzyme also is inactivated more effectively by alpha(1)-antichymotrypsin, which features P1 Leu in the reactive loop. Unlike mouse, rat, and hamster alpha-chymases, guinea pig chymase lacks elastase-like preference for P1 Val or Ala. Partially humanized A216G guinea pig chymase acquires human-like P1 Phe- and angiotensin-cleaving capacity. Molecular models suggest that the wild type active site is crowded by the Ala(216) side chain, which potentially blocks access by bulky P1 aromatic residues. On the other hand, the guinea pig pocket is deeper than in Val-selective chymases, explaining the preference for the longer aliphatic side chain of Leu. These findings are evidence that chymase-like peptidase specificity is sensitive to small changes in structure and provide the first example of a vertebrate Leu-selective peptidase.	[Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Caughey, George H.] Vet Hlth Res Inst, San Francisco, CA 94121 USA; [Caughey, George H.; Raymond, Wilfred W.; Trivedi, Neil N.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Caughey, George H.; Trivedi, Neil N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Beauchamp, Jeremy; Schlatter, Daniel; Banner, David; Mauser, Harald; Fingerle, Juergen] F Hoffmann La Roche Ltd, Preclin Pharm Res Basel, CH-4070 Basel, Switzerland	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding	Caughey, GH (corresponding author), Vet Affairs Med Ctr, 111-D,4150 Clement St, San Francisco, CA 94121 USA.	george.caughey@ucsf.edu			NHLBI NIH HHS [P01 HL024136, HL024136] Funding Source: Medline; PHS HHS [T32 07185] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abonia JP, 2005, J IMMUNOL, V174, P7285, DOI 10.4049/jimmunol.174.11.7285; Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Caughey GH, 2006, CURR RESPIR MED REV, V2, P263, DOI 10.2174/157339806778019024; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; DELMAR EG, 1980, BIOCHEMISTRY-US, V19, P468, DOI 10.1021/bi00544a011; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Edwards HM, 1999, J BIOL CHEM, V274, P30468, DOI 10.1074/jbc.274.43.30468; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; Greco MN, 2007, J MED CHEM, V50, P1727, DOI 10.1021/jm0700619; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Ju HS, 2001, P NATL ACAD SCI USA, V98, P7469, DOI 10.1073/pnas.131147598; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2008, J BIOL CHEM, V283, P427, DOI 10.1074/jbc.M707157200; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P364; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Mellon MB, 2002, J IMMUNOL, V168, P290, DOI 10.4049/jimmunol.168.1.290; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Muilenburg DJ, 2002, BBA-PROTEIN STRUCT M, V1596, P346, DOI 10.1016/S0167-4838(02)00224-8; Nishimoto M, 2001, CIRCULATION, V104, P1274, DOI 10.1161/hc3601.094304; Pemberton AD, 2003, CLIN EXP ALLERGY, V33, P1005, DOI 10.1046/j.1365-2222.2003.01720.x; Pereira PJB, 1999, J MOL BIOL, V286, P163, DOI 10.1006/jmbi.1998.2462; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Plotnick MI, 1997, BIOCHEMISTRY-US, V36, P14601, DOI 10.1021/bi971530j; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; POWERS JC, 1985, BIOCHEMISTRY-US, V24, P2048, DOI 10.1021/bi00329a037; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Raymond WW, 2003, J BIOL CHEM, V278, P34517, DOI 10.1074/jbc.M304087200; Sakaguchi M, 2004, EUR J PHARMACOL, V493, P173, DOI 10.1016/j.ejphar.2004.04.024; SCHECHTER NM, 1993, J BIOL CHEM, V268, P23626; SMYTH MJ, 1992, J BIOL CHEM, V267, P24418; Smyth MJ, 1996, J IMMUNOL, V156, P4174; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; URATA H, 1990, J BIOL CHEM, V265, P22348; Wang ZM, 1998, BIOL CHEM, V379, P167, DOI 10.1515/bchm.1998.379.2.167; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; YOSHIDA N, 1980, BIOCHEMISTRY-US, V19, P5799, DOI 10.1021/bi00566a021; ZAMOLODCHIKOVA TS, 1995, EUR J BIOCHEM, V227, P866, DOI 10.1111/j.1432-1033.1995.tb20212.x	55	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13943	13951		10.1074/jbc.M710502200	http://dx.doi.org/10.1074/jbc.M710502200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353771	Green Published, hybrid			2022-12-27	WOS:000255728200048
J	Raychaudhuri, N; Raychaudhuri, S; Thamotharan, M; Devaskar, SU				Raychaudhuri, Nupur; Raychaudhuri, Santanu; Thamotharan, Manikkavasagar; Devaskar, Sherin U.			Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER ISOFORM-3 GENE; MEF2 TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; GLUCOSE TRANSPORTERS; DNA METHYLATION; GLUT4; PROTEIN; ENHANCER; DIFFERENTIATION; ACTIVATION	We examined transcriptional and epigenetic mechanism(s) behind diminished skeletal muscle GLUT4 mRNA in intrauterine growth-restricted (IUGR) female rat offspring. An increase in MEF2D (inhibitor) with a decline in MEF2A (activator) and MyoD (co-activator) binding to the glut4 promoter in IUGR versus control was observed. The functional role of MEF2/MyoD-binding sites and neighboring three CpG clusters in glut4 gene transcription was confirmed in C2C12 muscle cells. No differential methylation of these three and other CpG clusters in the glut4 promoter occurred. DNA methyltransferase 1 (DNMT1) in postnatal, DNMT3a, and DNMT3b in adult was differentially recruited with increased MeCP2 ( methyl CpG-binding protein) concentrations to bind the IUGR glut4 gene. Covalent modifications of the histone (H) code consisted of H3.K14 de-acetylation by recruitment of histone deacetylase (HDAC) 1 and enhanced association of HDAC4 enzymes. This set the stage for Suv39H1 methylase-mediated di-methylation of H3.K9 and increased recruitment of heterochromatin protein 1 alpha, which partially inactivates postnatal and adult IUGR glut4 gene transcription. Further increased interactions in the adult IUGR between DNMT3a/DNMT3b and HDAC1 and MEF2D and HDAC1/HDAC4 and decreased association between MyoD and MEF2A existed. We conclude that epigenetic mechanisms consisting of histone code modifications repress skeletal muscle glut4 transcription in the postnatal period and persist in the adult female IUGR offspring.	[Raychaudhuri, Nupur; Raychaudhuri, Santanu; Thamotharan, Manikkavasagar; Devaskar, Sherin U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Neonatol & Dev Biol, Los Angeles, CA 90095 USA; [Raychaudhuri, Nupur; Raychaudhuri, Santanu; Thamotharan, Manikkavasagar; Devaskar, Sherin U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Neonatal Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Devaskar, SU (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Neonatol & Dev Biol, 10833 Le Conte Ave,MDCC-B2-375, Los Angeles, CA 90095 USA.	sdevaskar@mednet.ucla.edu			NICHD NIH HHS [HD 25024, HD 33997, HD 46979, HD 41230] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041230] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD025024, R01HD033997, R01HD025024, R01HD046979] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agote M, 2001, AM J PHYSIOL-ENDOC M, V281, pE1101, DOI 10.1152/ajpendo.2001.281.5.E1101; BALY DL, 1988, BIOCHIM BIOPHYS ACTA, V947, P571, DOI 10.1016/0304-4157(88)90008-1; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGDE GC, 2007, BR J NUTR, V97, P435; Carretero MV, 1998, FEBS LETT, V439, P55, DOI 10.1016/S0014-5793(98)01335-0; Chamson-Reig A, 2006, J ENDOCRINOL, V191, P83, DOI 10.1677/joe.1.06754; Cox DM, 2003, J BIOL CHEM, V278, P15297, DOI 10.1074/jbc.M211312200; Devaskar SU, 2007, PEDIATR RES, V61, p1R, DOI 10.1203/pdr.0b013e31805cdbd8; DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445; Dolinoy DC, 2007, PEDIATR RES, V61, p30R, DOI 10.1203/pdr.0b013e31804575f7; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Fu Yutao, 2005, Genome Inform, V16, P68; Fueger PT, 2005, J PHYSIOL-LONDON, V562, P925, DOI 10.1113/jphysiol.2004.076158; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Garg M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1218, DOI 10.1152/ajpendo.00474.2005; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Holemans K, 1996, J SOC GYNECOL INVEST, V3, P71, DOI 10.1016/1071-5576(95)00046-1; Huang EY, 2000, GENE DEV, V14, P45; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Ling JQ, 2007, PEDIATR RES, V61, p11R, DOI 10.1203/pdr.0b013e31804575db; LIU ML, 1994, J BIOL CHEM, V269, P28514; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Martin-Gronert MS, 2007, J INTERN MED, V261, P437, DOI 10.1111/j.1365-2796.2007.01800.x; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Moreno H, 2003, J BIOL CHEM, V278, P40557, DOI 10.1074/jbc.M306609200; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; Oak SA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1321, DOI 10.1152/ajpendo.00437.2005; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Pattyn F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-496; Poirier LA, 2001, METABOLISM, V50, P1014, DOI 10.1053/meta.2001.25655; Rajakumar A, 2004, J BIOL CHEM, V279, P26768, DOI 10.1074/jbc.M402735200; Rajakumar RA, 1998, J BIOL CHEM, V273, P27474, DOI 10.1074/jbc.273.42.27474; Rees WD, 2000, J NUTR, V130, P1821, DOI 10.1093/jn/130.7.1821; RICHARDSON JM, 1993, J BIOL CHEM, V268, P21021; Sadiq HF, 1999, BRAIN RES, V823, P96, DOI 10.1016/S0006-8993(99)01145-2; Santalucia T, 2001, J MOL BIOL, V314, P195, DOI 10.1006/jmbi.2001.5091; SANTALUCIA T, 2005, ACTA PHYSL SCAND, V183, P43; Steinmetz KL, 1998, CARCINOGENESIS, V19, P1487, DOI 10.1093/carcin/19.8.1487; TAKAI D, 2003, SILICO BIOL, V2, P35; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Thamotharan M, 2005, AM J PHYSIOL-ENDOC M, V288, pE935, DOI 10.1152/ajpendo.00342.2004; Thamotharan M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1270, DOI 10.1152/ajpendo.00462.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wallberg-Henriksson H, 2001, MOL MEMBR BIOL, V18, P205; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Yokomori N, 1999, DIABETES, V48, P685, DOI 10.2337/diabetes.48.4.685; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	68	158	169	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13611	13626		10.1074/jbc.M800128200	http://dx.doi.org/10.1074/jbc.M800128200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326493	Green Published, hybrid			2022-12-27	WOS:000255728200014
J	He, LS; Hou, ZB; Qi, RZ				He, Lisheng; Hou, Zhibo; Qi, Robert Z.			Calmodulin binding and cdk5 phosphorylation of p35 regulate its effect on microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURONAL-SPECIFIC ACTIVATOR; TARGET RECOGNITION; PROTEIN ACTIVATOR; STOP PROTEINS; TAU; IDENTIFICATION; P25; CLEAVAGE; CALPAIN	In the nervous system, Cdk5 and its neuronal activator p35 are involved in the control of various activities, including neuronal differentiation and migration. Recently, we have reported that p35 is a microtubule-associated protein that regulates microtubule dynamics (Hou, Z., Li, Q., He, L., Lim, H. Y., Fu, X., Cheung, N. S., Qi, D. X., and Qi, R. Z. ( 2007) J. Biol. Chem. 282, 18666 18670). Here we present two regulatory modes of p35 function as a microtubule-associated protein. First, p35 is Ca2+-dependent calmodulin (CaM)-binding protein. The CaM- and microtubule binding domains are localized to overlapping regions at the N terminus of p35. Within the CaM- binding region, Ala substitution for Trp-52 abolishes the CaM- binding activity, corroborating specific CaM- binding of p35. Furthermore, CaM blocks p35 association with microtubules in a Ca2+- specific manner, suggesting that p35 may be involved in the Ca2+/CaM-mediated inhibition of microtubule assembly. Second, p35 phosphorylation by Cdk5 interferes with the microtubule-binding and polymerizing activities of p35. Using a mutational approach, we found that only phosphorylation at Thr-138, one of the two residues primarily phosphorylated in vivo, inhibits the polymerizing activity. In PC12 cells, expression of p35 promotes nerve growth factor-induced neurite outgrowth under a Cdk5 inhibitory condition. Such p35 activity is impaired by the phosphomimetic mutation of Thr-138. These data suggest that Thr-138 phosphorylation plays a critical role in the control of the p35 functions in microtubule assembly and neurite outgrowth.	[He, Lisheng; Hou, Zhibo; Qi, Robert Z.] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		Qi, Robert Zhong/0000-0001-5596-8172				BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; HULEN D, 1991, CELL MOTIL CYTOSKEL, V18, P113, DOI 10.1002/cm.970180206; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Johnson K, 2005, J NEUROCHEM, V93, P538, DOI 10.1111/j.1471-4159.2004.03004.x; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEE YC, 1984, J BIOL CHEM, V259, P8041; LEE YC, 1982, J BIOL CHEM, V257, P6306; LEE YC, 1984, J BIOL CHEM, V259, P1226; Li CJ, 1999, J CELL SCI, V112, P1567; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Paglini G, 1998, J NEUROSCI, V18, P9858; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pigino G, 1997, J CELL SCI, V110, P257; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; SANCHEZ C, 1995, BIOCHEM J, V306, P481, DOI 10.1042/bj3060481; SOBUE K, 1981, FEBS LETT, V132, P137, DOI 10.1016/0014-5793(81)80447-4; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; TEO TS, 1973, J BIOL CHEM, V248, P5950	44	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13252	13260		10.1074/jbc.M706937200	http://dx.doi.org/10.1074/jbc.M706937200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326489	hybrid			2022-12-27	WOS:000255499800065
J	Kao, YY; Gianni, D; Bohl, B; Taylor, RM; Bokoch, GM				Kao, Yu-Ya; Gianni, Davide; Bohl, Benjamin; Taylor, Ross M.; Bokoch, Gary M.			Identification of a conserved Rac-binding site on NADPH oxidases supports a direct GTPase regulatory mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; MOLECULAR-BASIS; HUMAN-NEUTROPHILS; ACTIVATION; GENERATION; FLAVOCYTOCHROME; P67(PHOX); P47(PHOX); COMPONENT	The NADPH oxidases (Noxs) are a family of superoxide-generating enzymes implicated in a variety of biological processes. Full activity of Nox1, -2, and -3 requires the action of a Rac GTPase. A direct regulatory interaction of Rac with Nox2 has been proposed as part of a two-step mechanism for regulating electron transfer during superoxide formation. Using truncation analysis of Rac binding to the cytoplasmic tail of Nox2, along with peptides derived from this region in cell-free assays, we identify a Rac interaction site within amino acids 419 -430 of Nox2. This region is required for binding Rac2 but not p47(phox) or p67(phox) cytosolic regulatory factors. A cell-permeant version of the peptide encompassing amino acids 419 -430 specifically inhibits NADPH oxidase activation in intact human neutrophils. Mutational analysis of the putative Rac-binding site revealed specific residues, particularly Lys-421, Tyr-425, and Lys-426, individually required for Rac-dependent NADPH oxidase activity that are conserved in the Rac-regulated Nox1, Nox2, and Nox3 enzymes but not in Nox4 or Nox5. Mutation of the conserved residues in the Rac-binding site of Nox1 also result in the loss of Rac-dependent activity. Our data identify a functional Rac interaction site conserved in Rac-dependent Noxs and support a direct regulatory interaction of Rac GTPases to promote activation of these NADPH oxidases.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Scripps Research Institute; Scripps Research Institute; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Bokoch, GM (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Bokoch@scripps.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48008] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Burritt JB, 2003, J IMMUNOL, V170, P6082, DOI 10.4049/jimmunol.170.12.6082; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Fortemaison N, 2005, EUR J ENDOCRINOL, V152, P127, DOI 10.1530/eje.1.01815; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Kamiguti AS, 2005, J IMMUNOL, V175, P8424, DOI 10.4049/jimmunol.175.12.8424; Kaneda M, 1999, BLOOD, V93, P2098, DOI 10.1182/blood.V93.6.2098.406k09_2098_2104; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Martyn KD, 2005, BLOOD, V106, P3962, DOI 10.1182/blood-2005-03-0859; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; NAKAMURA M, 1987, BLOOD, V69, P1404; NAKAMURA M, 1988, Acta Paediatrica Hungarica, V29, P179; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Roos D, 1996, IMMUNOL TODAY, V17, P517; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SMITH RM, 1991, BLOOD, V77, P673; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vocero-Akbani A, 2001, METHOD ENZYMOL, V332, P36; Zhao TM, 2003, J CLIN INVEST, V112, P1732, DOI 10.1172/JCI200319108; Zhao XX, 2003, J BIOL CHEM, V278, P40788, DOI 10.1074/jbc.M302208200	54	56	56	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12736	12746		10.1074/jbc.M801010200	http://dx.doi.org/10.1074/jbc.M801010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18347018	Green Published, hybrid			2022-12-27	WOS:000255499800009
J	Murphy, KL; Zhang, XD; Gainetdinov, RR; Beaulieu, JM; Caron, MG				Murphy, Karen L.; Zhang, Xiaodong; Gainetdinov, Raul R.; Beaulieu, Jean-Martin; Caron, Marc G.			A regulatory domain in the n terminus of tryptophan hydroxylase 2 controls enzyme expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN HYDROXYLASE-2 GENE; ISOFORM TPH2 GENE; TYROSINE-HYDROXYLASE; TRANSMISSION DISEQUILIBRIUM; FUNCTIONAL POLYMORPHISMS; HAPLOTYPE ANALYSIS; SEROTONIN; VARIANTS; PHOSPHORYLATION; ACID	Serotonin is involved in a variety of physiological processes in the central nervous system and the periphery. As the rate-limiting enzyme in serotonin synthesis, tryptophan hydroxylase plays an important role in modulating these processes. Of the two variants of tryptophan hydroxylase, tryptophan hydroxylase 2 (TPH2) is expressed predominantly in the central nervous system, whereas tryptophan hydroxylase 1 (TPH1) is expressed mostly in peripheral tissues. Although the two enzymes share considerable sequence homology, the regulatory domain of TPH2 contains an additional 41 amino acids at the N terminus that TPH1 lacks. Here we show that the extended TPH2 N-terminal domain contains a unique sequence involved in the regulation of enzyme expression. When expressed in cultured mammalian cells, TPH2 is synthesized less efficiently and is also less stable than TPH1. Removal of the unique portion of the N terminus of TPH2 results in expression of the enzyme at a level similar to that of TPH1, whereas protein chimeras containing this fragment are expressed at lower levels than their wild-type counterparts. We identify a region centered on amino acids 10-20 that mediates the bulk of this effect. Wealso demonstrate that phosphorylation of serine 19, a protein kinase A consensus site located in this N-terminal domain, results in increased TPH2 stability and consequent increases in enzyme output in cell culture systems. Because this domain is unique to TPH2, these data provide evidence for selective regulation of brain serotonin synthesis.	[Zhang, Xiaodong; Gainetdinov, Raul R.; Beaulieu, Jean-Martin; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Murphy, Karen L.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287,487 CARL Bldg, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Gainetdinov, Raul R/G-5875-2011	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Murphy, Karen/0000-0002-3726-0928	NIMH NIH HHS [MH-40159, MH-79201] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH040159, R01MH079201, P50MH040159] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson GM, 2004, INT J DEV NEUROSCI, V22, P397, DOI 10.1016/j.ijdevneu.2004.06.006; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Blier P, 2001, J PSYCHIATR NEUROSCI, V26, P37; Breidenthal SE, 2004, PSYCHIAT GENET, V14, P69, DOI 10.1097/01.ypg.0000107929.32051.58; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; Chaube R, 2005, GEN COMP ENDOCR, V141, P116, DOI 10.1016/j.ygcen.2004.12.010; Courtet P, 2005, AM J MED GENET C, V133C, P25, DOI 10.1002/ajmg.c.30043; De Luca V, 2005, PSYCHIAT RES, V134, P195, DOI 10.1016/j.psychres.2005.01.005; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FERNSTROM JD, 1983, PHYSIOL REV, V63, P484, DOI 10.1152/physrev.1983.63.2.484; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Jiang GCT, 2000, J MOL BIOL, V302, P1005, DOI 10.1006/jmbi.2000.4097; JOHANSEN PA, 1995, J NEUROCHEM, V65, P882; Kinney GG, 2000, MOL NEUROBIOL, V21, P137, DOI 10.1385/MN:21:3:137; Kleppe R, 2004, FEBS LETT, V565, P155, DOI 10.1016/j.febslet.2004.03.092; Kuhn DM, 2007, J NEUROCHEM, V103, P1567, DOI 10.1111/j.1471-4159.2007.04855.x; Kumar GK, 2003, J APPL PHYSIOL, V95, P536, DOI 10.1152/japplphysiol.00186.2003; Kumer SC, 1997, J NEUROCHEM, V69, P1738; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lin YMJ, 2007, ARCH GEN PSYCHIAT, V64, P1015, DOI 10.1001/archpsyc.64.9.1015; Ma FY, 2004, J NEUROCHEM, V90, P431, DOI 10.1111/j.1471-4159.2004.02492.x; Martinez A, 2001, CURR MED CHEM, V8, P1077, DOI 10.2174/0929867013372616; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKinney J, 2005, J NEUROCHEM, V92, P311, DOI 10.1111/j.1471-4159.2004.02850.x; Mossner R, 2006, INT J NEUROPSYCHOPH, V9, P437, DOI 10.1017/S1461145705005997; Nielsen DA, 2008, BEHAV GENET, V38, P133, DOI 10.1007/s10519-007-9187-7; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Perriquet O, 2003, BIOINFORMATICS, V19, P108, DOI 10.1093/bioinformatics/19.1.108; PICKEL VM, 1977, BRAIN RES, V131, P197, DOI 10.1016/0006-8993(77)90515-7; Sakowski SA, 2006, J NEUROCHEM, V96, P758, DOI 10.1111/j.1471-4159.2005.03604.x; Sheehan K, 2005, MOL PSYCHIATR, V10, P944, DOI 10.1038/sj.mp.4001698; Stenfors C, 2002, J NEURAL TRANSM, V109, P1353, DOI 10.1007/s00702-002-0732-5; Tenner K, 2007, J NEUROCHEM, V102, P1887, DOI 10.1111/j.1471-4159.2007.04664.x; Touzet H, 2004, NUCLEIC ACIDS RES, V32, pW142, DOI 10.1093/nar/gkh415; Walitza S, 2005, MOL PSYCHIATR, V10, P1126, DOI 10.1038/sj.mp.4001734; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Winge I, 2008, BIOCHEM J, V410, P195, DOI 10.1042/BJ20071033; Winge I, 2007, J NEUROCHEM, V100, P1648, DOI 10.1111/j.1471-4159.2006.04290.x; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Zhang X, 2006, CELL MOL LIFE SCI, V63, P6, DOI 10.1007/s00018-005-5417-4; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhou ZF, 2005, ARCH GEN PSYCHIAT, V62, P1109, DOI 10.1001/archpsyc.62.10.1109; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525; Zill P, 2004, BIOL PSYCHIAT, V56, P581, DOI 10.1016/j.biopsych.2004.07.015; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	28	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13216	13224		10.1074/jbc.M706749200	http://dx.doi.org/10.1074/jbc.M706749200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18339632	Green Published, hybrid			2022-12-27	WOS:000255499800061
J	Karim, ZA; Choi, WS; Whiteheart, SW				Karim, Zubair A.; Choi, Wangsun; Whiteheart, Sidney W.			Primary platelet signaling cascades and integrin-mediated signaling control ADP-ribosylation factor (Arf) 6-GTP levels during platelet activation and aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DENSE GRANULE SECRETION; BINDING-PROTEIN; P21-ACTIVATED KINASE; RAP1 ACTIVATION; CELL-ADHESION; THROMBIN; COLLAGEN; GPVI; MECHANISM	Previous studies showed that ADP-ribosylation factor 6 (Arf6) is important for platelet function; however, little is known about which signaling events regulate this small GTP-binding protein. Arf6-GTP was monitored in platelets stimulated with a number of agonists (TRAP, thrombin, convulxin, collagen, PMA, thapsigargin, or A23187) and all led to a time-dependent decrease in Arf6-GTP. ADP and U46619 were without effect. Using inhibitors, it was shown that the decrease of Arf6-GTP is a direct consequence of known signaling cascades. Upon stimulation via PAR receptors, Arf6-GTP loss could be blocked by treatment with U-73122, BAPTA/AM, Ro-31-8220, or Go6976, indicating requirements for phospholipase C, calcium, and protein kinase C (PKC) alpha/beta, respectively. The Arf6-GTP decrease in convulxin- stimulated platelets showed similar requirements and was also sensitive to piceatannol, wortmannin, and LY294002, indicating additional requirements for Syk and phosphatidylinositol 3-kinase. The convulxin- induced decrease was sensitive to both PKC alpha/beta and delta inhibitors. Outside-in signaling, potentially via integrin engagement, caused a second wave of signaling that affected Arf6. Inclusion of RGDS peptides or EGTA, during activation, led to a biphasic response; Arf6-GTP levels partially recovered upon continued incubation. A similar response was seen in beta 3 integrin-null platelets. These data show that Arf6-GTP decreases in response to known signaling pathways associated with PAR and GPVI. They further reveal a second, aggregation-dependent, process that dampens Arf6-GTP recovery. This study demonstrates that the nucleotide state of Arf6 in platelets is regulated during the initial phases of activation and during the later stages of aggregation.	[Karim, Zubair A.; Choi, Wangsun; Whiteheart, Sidney W.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Whiteheart, SW (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, 741 S Limestone,Biomed Biol Sci Res Bldg, Lexington, KY 40536 USA.	whitehe@uky.edu		Whiteheart, Sidney/0000-0001-5577-0473	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091893, R01HL056652] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056652, HL56652, R01 HL091893] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Clough RR, 2002, J BIOL CHEM, V277, P28972, DOI 10.1074/jbc.M201504200; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Danielewski O, 2005, THROMB HAEMOSTASIS, V93, P319, DOI 10.1160/TH04-09-0582; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Elrod JW, 2003, PLATELETS, V14, P247, DOI 10.1080/0953710031000118894; Fitzgerald ML, 1999, BIOCHEM J, V342, P353, DOI 10.1042/0264-6021:3420353; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; HUGHAN SC, 2007, THROMB VASC BIOL, V27, P422; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Jung SM, 2006, THROMB RES, V118, P509, DOI 10.1016/j.thromres.2005.11.002; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Prevost N, 2003, J THROMB HAEMOST, V1, P1613, DOI 10.1046/j.1538-7836.2003.00327.x; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; RANDAZZO PA, SCI STKE 2000, pRE1; Riondino S, 2005, J BIOL CHEM, V280, P6504, DOI 10.1074/jbc.M407854200; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sato H, 2008, BIOCHEM BIOPH RES CO, V368, P157, DOI 10.1016/j.bbrc.2008.01.064; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Suzuki-Inoue K, 2001, BLOOD, V98, P3708, DOI 10.1182/blood.V98.13.3708; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; WHITE TE, 1990, P NATL ACAD SCI USA, V87, P758, DOI 10.1073/pnas.87.2.758; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008	51	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11995	12003		10.1074/jbc.M800146200	http://dx.doi.org/10.1074/jbc.M800146200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326492	Green Published, hybrid			2022-12-27	WOS:000255340000015
J	Kingsbury, JS; Laue, TM; Klimtchuk, ES; Theberge, R; Costello, CE; Connors, LH				Kingsbury, Jonathan S.; Laue, Thomas M.; Klimtchuk, Elena S.; Theberge, Roger; Costello, Catherine E.; Connors, Lawreen H.			The modulation of transthyretin tetramer stability by cysteine 10 adducts and the drug diflunisal - Direct analysis by fluorescence-detected analytical ultracentrifugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY DATA; SENILE SYSTEMIC AMYLOIDOSIS; CLINICAL-SIGNIFICANCE; CARDIAC AMYLOIDOSIS; MASS-SPECTROMETRY; ACIDIC CONDITIONS; SELF-ASSOCIATION; WEIGHT AVERAGE; LAMM EQUATION; NATIVE-STATE	Transthyretin (TTR) is normally a stable plasma protein. However, in cases of familial TTR-related amyloidosis and senile systemic amyloidosis (SSA), TTR is deposited as amyloid fibrils, leading to organ dysfunction and possibly death. The mechanism by which TTR undergoes the transition from stable, soluble precursor to insoluble amyloid fibril and the factors that promote this process are largely undetermined. Most models involve the dissociation of the native TTR tetramer as the initial step. It is largely accepted that the TTR gene mutations associated with TTR-related amyloidosis lead to the expression of variant proteins that are intrinsically unstable and prone to aggregation. It has been suggested that amyloidogenicity may be conferred to wild-type TTR (the form deposited in SSA) by chemical modification of the lone cysteine residue (Cys(10)) through mixed disulfide bonds. S-Sulfonation and S-cysteinylation are prevalent TTR modifications physiologically, and studies have suggested their ability to modulate the structure of TTR under denaturing conditions. In the present study, we have used fluorescence-detected sedimentation velocity to determine the effect of S-sulfonate and S-cysteine on the quaternary structural stability of fluorophore-conjugated recombinant TTR under nondenaturing conditions. We determined that S-sulfonation stabilized TTR tetramer stability by a factor of 7, whereas S-cysteinylation enhanced dissociation by 2-fold with respect to the unmodified form. In addition, we report the direct observation of tetramer stabilization by the potential therapeutic compound diflunisal. Finally, as proof of concept, we report the sedimentation of TTR in serum and the qualitative assessment of the resulting data.	[Kingsbury, Jonathan S.; Costello, Catherine E.; Connors, Lawreen H.] Boston Univ, Sch Med, Amyloid Treatment & Res Program, Dept Biochem, Boston, MA 02118 USA; [Kingsbury, Jonathan S.; Klimtchuk, Elena S.; Theberge, Roger; Costello, Catherine E.; Connors, Lawreen H.] Boston Univ, Sch Med, Alan & Sandra Gerry Amyloid Res Lab, Boston, MA 02118 USA; [Theberge, Roger; Costello, Catherine E.] Boston Univ, Sch Med, Ctr Biol Mass Spectrometry, Boston, MA 02118 USA; [Laue, Thomas M.] Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA	Boston University; Boston University; Boston University; University System Of New Hampshire; University of New Hampshire	Connors, LH (corresponding author), Boston Univ, Sch Med, Amyloid Treatment & Res Program, Dept Biochem, K-507,715 Albany St, Boston, MA 02118 USA.	lconnors@bu.edu	Laue, Tom/AAI-5136-2020	Laue, Tom/0000-0003-3571-9368; Kingsbury, Jonathan/0000-0003-1851-3325; Costello, Catherine/0000-0003-1594-5122; Connors, Lawreen/0000-0002-4672-4296	NCRR NIH HHS [S10RR020946, P41 RR10888, S10RR10493] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888, S10RR020946, S10RR010493] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Benson MD, 1996, AMYLOID, V3, P44, DOI 10.3109/13506129609014354; CANN JR, 1970, INTERACTING MACROMOL, P133; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Correia JJ, 2000, METHOD ENZYMOL, V321, P81; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; Demeler B, 1998, BIOPHYS J, V74, P444, DOI 10.1016/S0006-3495(98)77802-6; Falk R H, 2000, Adv Intern Med, V45, P107; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; HODKINSON HM, 1977, Q J MED, V46, P381; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; JOHNSTON JP, 1946, T FARADAY SOC, V42, P789, DOI 10.1039/tf9464200789; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kingsbury JS, 2007, PROTEIN EXPRES PURIF, V53, P370, DOI 10.1016/j.pep.2007.01.004; KROE RA, 2005, APPL FLUORESCENCE DE; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lim A, 2003, J BIOL CHEM, V278, P49707, DOI 10.1074/jbc.M306748200; Lim A, 2002, ANAL CHEM, V74, P741, DOI 10.1021/ac010780+; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; MANN M, 1989, ANAL CHEM, V61, P1702, DOI 10.1021/ac00190a023; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Ng B, 2005, ARCH INTERN MED, V165, P1425, DOI 10.1001/archinte.165.12.1425; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; RAZ A, 1969, J BIOL CHEM, V244, P3230; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; SCHACHMAN HK, 1959, ULTRACENTRIFUGATION, P157; Schnaible V, 1999, BIOCONJUGATE CHEM, V10, P861, DOI 10.1021/bc990039x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SMITH TJ, 1984, MAYO CLIN PROC, V59, P547, DOI 10.1016/S0025-6196(12)61493-1; Sontag CA, 2004, BIOPHYS CHEM, V108, P215, DOI 10.1016/j.bpc.2003.10.029; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Suhr OB, 1999, AMYLOID, V6, P187, DOI 10.3109/13506129909007325; SVEDBERG T, 1940, ULTRACENTRIFUGE, P28; Teske CA, 2007, BIOTECHNOL BIOENG, V98, P193, DOI 10.1002/bit.21374; Theberge R, 1999, ANAL CHEM, V71, P452, DOI 10.1021/ac980531u; WALLEY VM, 1995, CARDIOVASC PATHOL, V4, P79, DOI 10.1016/1054-8807(95)90411-L; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; WRIGHT JR, 1975, J AM GERIATR SOC, V23, P97, DOI 10.1111/j.1532-5415.1975.tb00968.x; Zhang QH, 2003, BIOCHEMISTRY-US, V42, P8756, DOI 10.1021/bi030077a	51	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11887	11896		10.1074/jbc.M709638200	http://dx.doi.org/10.1074/jbc.M709638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326041	hybrid, Green Published			2022-12-27	WOS:000255340000004
J	Oh, J; Sohn, DH; Ko, M; Chung, H; Jeon, SH; Seong, RH				Oh, Jaehak; Sohn, Dong H.; Ko, Myunggon; Chung, Heekyoung; Jeon, Sung H.; Seong, Rho H.			BAF60a interacts with p53 to recruit the SWI/SNF complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TUMOR-SUPPRESSOR P53; NUCLEAR RECEPTORS; TRANSCRIPTIONAL REPRESSION; RETINOBLASTOMA PROTEIN; INDUCED APOPTOSIS; BREAST-CANCER; SRG3; BRG1; TRANSACTIVATION	To understand the tumor-suppressing mechanism of the SWI/SNF chromatin remodeling complex, we investigated its molecular relationship with p53. Using the pREP4-luc episomal reporter, we first demonstrated that p53 utilizes the chromatin remodeling activity of the SWI/SNF complex to initiate transcription from the chromatin-structured promoter. Among the components of the SWI/SNF complex, we identified BAF60a as a mediator of the interaction with p53 by the yeast two-hybrid assay. p53 directly interacted only with BAF60a, but not with other components of the SWI/SNF complex, such as BRG1, SRG3, SNF5, or BAF57. We found out that multiple residues at the amino acid 108-150 region of BAF60a were involved in the interaction with the tetramerization domain of p53. The N-terminal fragment of BAF60a containing the p53-interacting region as well as small interfering RNA for baf60a inhibited the SWI/SNF complex-mediated transcriptional activity of p53. The uncoupling of p53 with the SWI/SNF complex resulted in the repression of both p53-dependent apoptosis and cell cycle arrest by the regulation of target genes. These results suggest that the SWI/SNF chromatin remodeling complex is involved in the suppression of tumors by the interaction with p53.	[Oh, Jaehak; Sohn, Dong H.; Ko, Myunggon; Seong, Rho H.] Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet, Seoul 151742, South Korea; [Oh, Jaehak; Sohn, Dong H.; Ko, Myunggon; Seong, Rho H.] Seoul Natl Univ, Res Ctr Funct Cellulom, Seoul 151742, South Korea; [Chung, Heekyoung] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea; [Jeon, Sung H.] Hallym Univ, Dept Life Sci, Chunchon 200702, South Korea; [Jeon, Sung H.] Hallym Univ, Inst Biosci & Biotechnol, Chunchon 200702, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hallym University; Hallym University	Seong, RH (corresponding author), Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet Bldg 105, San 56-1, Seoul 151742, South Korea.	rhseong@snu.ac.kr		Ko, Myunggon/0000-0002-6007-2570; Seong, Rho/0000-0001-5699-0718				An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Bennett-Lovsey R, 2002, BIOINFORMATICS, V18, P626, DOI 10.1093/bioinformatics/18.4.626; Biegel JA, 1999, CANCER RES, V59, P74; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chien CY, 2003, FEBS LETT, V543, P55, DOI 10.1016/S0014-5793(03)00401-0; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; DRILLER L, 1990, MOL CELL BIOL, V10, P5772; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Han SM, 2001, J IMMUNOL, V167, P805, DOI 10.4049/jimmunol.167.2.805; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hong CY, 2005, MOL CELL BIOL, V25, P4841, DOI 10.1128/MCB.25.12.4841-4852.2005; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kim DS, 2002, IMMUNITY, V16, P9, DOI 10.1016/S1074-7613(02)00264-9; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kiskinis E, 2006, BREAST CANCER RES TR, V98, P191, DOI 10.1007/s10549-005-9149-9; Ko M, 2004, J BIOL CHEM, V279, P21916, DOI 10.1074/jbc.M402145200; Koszewski NJ, 2003, J STEROID BIOCHEM, V87, P223, DOI 10.1016/j.jsbmb.2003.09.006; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; MIYASHITA T, 1995, CELL, V80, P293; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; van der Vlag J, 2000, J BIOL CHEM, V275, P697, DOI 10.1074/jbc.275.1.697; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WANG W, 1996, EMBO J, V19, P5370; WANG W, 1996, GENE DEV, V17, P2117; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	45	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11924	11934		10.1074/jbc.M705401200	http://dx.doi.org/10.1074/jbc.M705401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303029	hybrid, Green Published			2022-12-27	WOS:000255340000008
J	Ma, YL; Taylor, SS				Ma, Yuliang; Taylor, Susan S.			A molecular switch for targeting between endoplasmic reticulum (ER) and mitochondria - Conversion of a mitochondria-targeting element into an ER-targeting signal in DAKAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; OUTER-MEMBRANE; MESSENGER-RNA; REGULATORY SUBUNITS; ANCHOR PROTEIN; CYCLIC-AMP; BINDING; PHOSPHORYLATION; SEQUENCE; IMPORT	DAKAP1 (AKAP121, S-AKAP84), a dual specificity PKA scaffold protein, exists in several forms designated as a, b, c, and d. Whether DAKAP1 targets to endoplasmic reticulum ( ER) or mitochondria depends on the presence of the N-terminal 33 amino acids (N1), and these N-terminal variants are generated by either alternative splicing and/or differential initiation of translation. The mitochondrial targeting motif, which is localized between residues 49 and 63, is comprised of a hydrophobic helix followed by positive charges (Ma, Y., and Taylor, S. ( 2002) J. Biol. Chem. 277, 27328-27336). DAKAP1 is located on the cytosolic surface of mitochondria outer membrane and both smooth and rough ER membrane. A single residue, Asp(31), within the first 33 residues of DAKAP1b is required for ER targeting. Asp(31), which functions as a separate motif from the mitochondrial targeting signal, converts the mitochondrial-targeting signal into a bipartite ER-targeting signal, without destroying the mitochondria-targeting signal. Therefore DAKAP1 possesses a single targeting element capable of targeting to both mitochondria and ER, with the ER signal overlapping the mitochondria signal. The specificity of ER or mitochondria targeting is determined and switched by the availability of the negatively charged residue, Asp(31).	[Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, 9500 Gilman Dr,MC 0654, La Jolla, CA 92093 USA.	staylor@ucsd.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK54441, P01 DK054441] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Alto N, 2002, DIABETES, V51, pS385, DOI 10.2337/diabetes.51.2007.S385; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Cardone L, 2002, J MOL BIOL, V320, P663, DOI 10.1016/S0022-2836(02)00479-5; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009; Furusawa M, 2001, J BIOL CHEM, V276, P36647, DOI 10.1074/jbc.M103885200; Ginsberg MD, 2003, J MOL BIOL, V327, P885, DOI 10.1016/S0022-2836(03)00173-6; Graf SA, 2004, J BIOL CHEM, V279, P42954, DOI 10.1074/jbc.M405040200; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Ma Y, 1999, CANCER RES, V59, P5341; Ma YL, 2002, J BIOL CHEM, V277, P27328, DOI 10.1074/jbc.M201421200; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Miyazaki E, 2005, MOL BIOL CELL, V16, P1788, DOI 10.1091/mbc.e04-08-0707; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pestov DG, 1999, BIOTECHNIQUES, V26, P102, DOI 10.2144/99261st04; Ranganathan G, 2002, J BIOL CHEM, V277, P43281, DOI 10.1074/jbc.M202560200; Rizzuto R, 1996, CURR BIOL, V6, P183, DOI 10.1016/S0960-9822(02)00451-7; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Scott JD, 2006, BIOCHEM SOC T, V34, P465, DOI 10.1042/BST0340465; SHARMA RN, 1978, J BIOL CHEM, V253, P2033; Smith FD, 2006, EUR J CELL BIOL, V85, P585, DOI 10.1016/j.ejcb.2006.01.011; Suzuki H, 2002, J CELL SCI, V115, P1895; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241	44	35	36	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11743	11751		10.1074/jbc.M710494200	http://dx.doi.org/10.1074/jbc.M710494200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18287098	Green Published, hybrid			2022-12-27	WOS:000255067400074
J	Tavalin, SJ				Tavalin, Steven J.			AKAP79 selectively enhances protein kinase C regulation of GluR1 at a Ca2+-calmodulin-dependent protein kinase II/protein kinase C site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RECEPTOR UNITARY CONDUCTANCE; GLUR2-LACKING AMPA RECEPTORS; CA1 PYRAMIDAL CELLS; GLUTAMATE-RECEPTOR; ANCHORING PROTEIN; SYNAPTIC-TRANSMISSION; PHOSPHORYLATION SITE; HIPPOCAMPAL-NEURONS; SIGNALING COMPLEXES	Enhancement of AMPA receptor activity in response to synaptic plasticity inducing stimuli may arise, in part, through phosphorylation of the GluR1 AMPA receptor subunit at Ser-831. This site is a substrate for both Ca2+-calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC). However, neuronal protein levels of CaMKII may exceed those of PKC by an order of magnitude. Thus, it is unclear how PKC could effectively regulate this common target site. The multivalent neuronal scaffold A-kinase-anchoring protein 79 (AKAP79) is known to bind PKC and is linked to GluR1 by synapse-associated protein 97 (SAP97). Here, biochemical studies demonstrate that AKAP79 localizes PKC activity near the receptor, thus accelerating Ser-831 phosphorylation. Complementary electrophysiological studies indicate that AKAP79 selectively shifts the dose-dependence for PKC modulation of GluR1 receptor currents similar to 20-fold, such that low concentrations of PKC are as effective as much higher CaMKII concentrations. By boosting PKC activity near a target substrate, AKAP79 provides a mechanism to overcome limitations in kinase abundance thereby ensuring faithful signal propagation and efficient modification of AMPA receptor-mediated responses.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Tavalin, SJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	stavalin@utmem.edu			NINDS NIH HHS [NS46661, R01 NS046661] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046661] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LU Y, 2007, EMBO J; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shukla K, 2007, J BIOL CHEM, V282, P18100, DOI 10.1074/jbc.M702906200; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tsui J, 2006, J BIOL CHEM, V281, P13794, DOI 10.1074/jbc.M600966200; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wikstrom MA, 2003, NEUROPHARMACOLOGY, V45, P828, DOI 10.1016/S0028-3908(03)00336-8; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	57	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11445	11452		10.1074/jbc.M709253200	http://dx.doi.org/10.1074/jbc.M709253200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305116	Green Published, hybrid			2022-12-27	WOS:000255067400042
J	Orfeo, T; Brummel-Ziedins, KE; Gissel, M; Butenas, S; Mann, KG				Orfeo, Thomas; Brummel-Ziedins, Kathleen E.; Gissel, Matthew; Butenas, Saulius; Mann, Kenneth G.			The nature of the stable blood clot procoagulant activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR ACTIVITY; CELL-DERIVED MICROPARTICLES; HEPARIN COFACTOR-II; BOVINE FACTOR-V; FACTOR-X; BOUND THROMBIN; ANTITHROMBIN-III; FACTOR-VIIA; HUMAN PLATELETS; WHOLE-BLOOD	The function of tissue factor (Tf)-initiated coagulation is hemorrhage control through the formation and maintenance of an impermeable platelet-fibrin barrier. The catalytic processes involved in the clot maintenance function are not well defined, although the rebleeding problems characteristic of individuals with hemophilias A and B suggest a link between specific defects in the Tf-initiated process and defects in the maintenance function. We have previously demonstrated, using a methodology of "flow replacement" (or resupply) of ongoing Tf-initiated reactions with fresh reactants, that procoagulant complexes are produced during Tf-initiated coagulation, which are capable of reinitiating coagulation without input from extrinsic factor Xase activity (Orfeo, T., Butenas, S., Brummel-Ziedins, K. E., and Mann, K. G. (2005) J. Biol. Chem. 280, 42887 - 42896). Here we used Tf-initiated reactions in normal and hemophilia blood or in their corresponding proteome mixtures as sources of procoagulant end products and then varied the resupplying material to determine the identity of the catalysts that drive the new cycle of thrombin formation. The central findings are as follows: 1) the prothrombinase complex (fVa-fXa-Ca2+-membrane) accumulated during the episode of Tf-initiated coagulation is the primary catalyst responsible for the observed pattern of prothrombin activation after resupply; 2) impairments in intrinsic factor Xase function, i.e. hemophilias A and B, result in an impaired capacity to mount a resupply response; and 3) in normal hemostasis the intrinsic factor Xase function contributes to the durability of the resupply response.	[Orfeo, Thomas; Brummel-Ziedins, Kathleen E.; Gissel, Matthew; Butenas, Saulius; Mann, Kenneth G.] Univ Vermont, Dept Biochem, Colchester, VT 05446 USA	University of Vermont	Mann, KG (corresponding author), 208 S Pk Dr,Rm T227, Colchester, VT 05446 USA.	kenneth.mann@uvm.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 46703] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHMAD SS, 1992, SEMIN THROMB HEMOST, V18, P311, DOI 10.1055/s-2007-1002570; BAJAJ SP, 1981, PREP BIOCHEM, V11, P397, DOI 10.1080/00327488108065531; Balasubramanian V, 2002, BLOOD, V100, P2787, DOI 10.1182/blood-2002-03-0902; BENDAYAN P, 1994, THROMB HAEMOSTASIS, V71, P576; Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Betz A, 1999, BIOCHEMISTRY-US, V38, P14582, DOI 10.1021/bi990958a; Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841; BRAND K, 1991, MOL CELL BIOL, V11, P4732, DOI 10.1128/MCB.11.9.4732; Brummel KE, 1999, J BIOL CHEM, V274, P22862, DOI 10.1074/jbc.274.32.22862; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Butenas S, 2005, BLOOD, V105, P2764, DOI 10.1182/blood-2004-09-3567; Butenas S, 1997, J BIOL CHEM, V272, P21527, DOI 10.1074/jbc.272.34.21527; Butenas S, 2003, ARTERIOSCL THROM VAS, V23, P123, DOI 10.1161/01.ATV.0000042081.57854.A2; Butenas S, 2002, BLOOD, V99, P923, DOI 10.1182/blood.V99.3.923; Camera M, 2003, ARTERIOSCL THROM VAS, V23, P1690, DOI 10.1161/01.ATV.0000085629.23209.AA; Cawthern KM, 1998, BLOOD, V91, P4581, DOI 10.1182/blood.V91.12.4581.412k12_4581_4592; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; CHURCH WR, 1988, BLOOD, V72, P1911; Day SM, 2005, BLOOD, V105, P192, DOI 10.1182/blood-2004-06-2225; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Diamant M, 2002, CIRCULATION, V106, P2442, DOI 10.1161/01.CIR.0000036596.59665.C6; DOOLITTLE RF, 1994, HAEMOSTASIS THROMBOS, P491; DRAKE TA, 1989, AM J PATHOL, V134, P1087; ELLIS V, 1982, BIOCHIM BIOPHYS ACTA, V701, P24; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; FRANCIS CW, 1983, J LAB CLIN MED, V102, P220; Fredenburgh JC, 2004, BIOPHYS CHEM, V112, P277, DOI 10.1016/j.bpc.2004.07.031; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; GITEL SN, 1984, J BIOL CHEM, V259, P6890; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; Hathcock JJ, 2004, BLOOD, V104, P123, DOI 10.1182/blood-2003-12-4352; HIBBARD LS, 1982, BIOCHEMISTRY-US, V21, P2285, DOI 10.1021/bi00539a003; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hoffman M, 2007, J THROMB HAEMOST, V5, P1403, DOI 10.1111/j.1538-7836.2007.02576.x; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoffman M, 2006, BLOOD, V108, P3053, DOI 10.1182/blood-2006-05-020495; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HOJIMA Y, 1980, THROMB RES, V20, P149, DOI 10.1016/0049-3848(80)90381-3; Jesty J, 2005, ARTERIOSCL THROM VAS, V25, P2463, DOI 10.1161/01.ATV.0000187463.91403.b2; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; Komatsu Y, 2000, BIOL PHARM BULL, V23, P502; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; KUMAR R, 1994, THROMB HAEMOSTASIS, V72, P713; KUMAR R, 1995, THROMB HAEMOSTASIS, V74, P962; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JH, 1994, J BIOL CHEM, V269, P23357; Lundblad R L, 1976, Methods Enzymol, V45, P156; MANN KG, 1992, SEMIN HEMATOL, V29, P213; MIHALYI E, 1988, BIOCHEMISTRY-US, V27, P976, DOI 10.1021/bi00403a021; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; NASKI MC, 1990, J BIOL CHEM, V265, P1401; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OKAMOTO S, 1993, METHOD ENZYMOL, V222, P328; Orfeo T, 2005, J BIOL CHEM, V280, P42887, DOI 10.1074/jbc.M505506200; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; Osterud B, 2001, SEMIN HEMATOL, V38, P2, DOI 10.1016/S0037-1963(01)90139-8; Panes O, 2007, BLOOD, V109, P5242, DOI 10.1182/blood-2006-06-030619; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Santucci RA, 2000, THROMB HAEMOSTASIS, V83, P445, DOI 10.1055/s-0037-1613835; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; SHAFER JA, 1988, CRIT REV CL LAB SCI, V26, P1; Siddiqui FA, 2002, PLATELETS, V13, P247, DOI 10.1080/09537100220146398; TAKAHASHI H, 1994, AM J HEMATOL, V46, P333, DOI 10.1002/ajh.2830460414; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; Wolberg AS, 2005, BRIT J HAEMATOL, V131, P645, DOI 10.1111/j.1365-2141.2005.05820.x; Zillmann A, 2001, BIOCHEM BIOPH RES CO, V281, P603, DOI 10.1006/bbrc.2001.4399	76	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9776	9786		10.1074/jbc.M707435200	http://dx.doi.org/10.1074/jbc.M707435200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18268016	hybrid, Green Published			2022-12-27	WOS:000254671600032
J	Li, Y; Wang, ZL; Furukawa, N; Escaron, P; Weiszmann, J; Lee, G; Lindstrom, M; Liu, JS; Liu, XH; Xu, HD; Plotnikova, O; Prasad, V; Walker, N; Learned, RM; Chen, JL				Li, Yang; Wang, Zhulun; Furukawa, Noboru; Escaron, Patrick; Weiszmann, Jennifer; Lee, Gary; Lindstrom, Michelle; Liu, Jinsong; Liu, Xiaohong; Xu, Haoda; Plotnikova, Olga; Prasad, Vidya; Walker, Nigel; Learned, R. Marc; Chen, Jin-Long			T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; LIGAND; NUCLEAR; THIAZOLIDINEDIONE; ANTAGONIST; SUBSTITUTION; SUMOYLATION; MECHANISMS; LXRS	The nuclear hormone receptor peroxisome proliferator-activated receptor gamma( PPAR gamma) plays central roles in adipogenesis and glucose homeostasis and is the molecular target for the thiazolidinedione (TZD) class of antidiabetic drugs. Activation of PPAR gamma by TZDs improves insulin sensitivity; however, this is accompanied by the induction of several undesirable side effects. We have identified a novel synthetic PPAR gamma ligand, T2384, to explore the biological activities associated with occupying different regions of the receptor ligand-binding pocket. X-ray crystallography studies revealed that T2384 can adopt two distinct binding modes, which we have termed "U" and "S", interacting with the ligand- binding pocket of PPAR gamma primarily via hydrophobic contacts that are distinct from full agonists. The different binding modes occupied by T2384 induced distinct patterns of coregulatory protein interaction with PPAR gamma in vitro and displayed unique receptor function in cell-based activity assays. We speculate that these unique biochemical and cellular activities may be responsible for the novel in vivo profile observed in animals treated systemically with T2384. When administered to diabetic KKAy mice, T2384 rapidly improved insulin sensitivity in the absence of weight gain, hemodilution, and anemia characteristics of treatment with rosiglitazone ( a TZD). Moreover, upon coadministration with rosiglitazone, T2384 was able to antagonize the side effects induced by rosiglitazone treatment alone while retaining robust effects on glucose disposal. These results are consistent with the hypothesis that interactions between ligands and specific regions of the receptor ligand- binding pocket might selectively trigger a subset of receptor-mediated biological responses leading to the improvement of insulin sensitivity, without eliciting less desirable responses associated with full activation of the receptor. We suggest that T2384 may represent a prototype for a novel class of PPAR gamma ligand and, furthermore, that molecules sharing some of these properties would be useful for treatment of type 2 diabetes.	[Li, Yang; Wang, Zhulun; Escaron, Patrick; Weiszmann, Jennifer; Lee, Gary; Lindstrom, Michelle; Liu, Jinsong; Liu, Xiaohong; Xu, Haoda; Plotnikova, Olga; Prasad, Vidya; Walker, Nigel; Learned, R. Marc; Chen, Jin-Long] Amgen Inc, San Francisco, CA 94080 USA; [Furukawa, Noboru] Japan Tobacco Inc, Tokyo 1058422, Japan	Amgen; Japan Tobacco Inc.	Li, Y (corresponding author), Amgen Inc, San Francisco, CA 94080 USA.	yangl@amgen.com						Argmann CA, 2005, EUR J CLIN INVEST, V35, P82, DOI 10.1111/j.1365-2362.2005.01456.x; Auwerx J, 1999, CELL, V97, P161; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Florez JC, 2004, J CLIN ENDOCR METAB, V89, P4234, DOI 10.1210/jc.2004-1402; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Masugi J, 2000, BIOCHEM BIOPH RES CO, V268, P178, DOI 10.1006/bbrc.2000.2096; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shimizu M, 2006, MOL CELL BIOCHEM, V286, P33, DOI 10.1007/s11010-005-9052-z; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Zelcer N, 2005, CELL METAB, V2, P273, DOI 10.1016/j.cmet.2005.10.004	33	59	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9168	9176		10.1074/jbc.M800104200	http://dx.doi.org/10.1074/jbc.M800104200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18263587	hybrid			2022-12-27	WOS:000254465800046
J	Hua, QX; Nakagawa, SH; Jia, W; Huang, K; Phillips, NB; Hu, SQ; Weiss, MA				Hua, Qing-Xin; Nakagawa, Satoe H.; Jia, Wenhua; Huang, Kun; Phillips, Nelson B.; Hu, Shi-quan; Weiss, Michael A.			Design of an active ultrastable single-chain insulin analog - Synthesis, structure, and therapeutic implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIABETES-ASSOCIATED MUTATIONS; RECEPTOR-BINDING SURFACE; PHOTO-CROSS-LINKING; A-CHAIN; GROWTH-FACTOR; SIDE-CHAIN; BIOLOGICAL-ACTIVITY; CHIRAL MUTAGENESIS; MINI-PROINSULIN; IN-VIVO	Single-chain insulin (SCI) analogs provide insight into the inter-relation of hormone structure, function, and dynamics. Although compatible with wild-type structure, short connecting segments (< 3 residues) prevent induced fit upon receptor binding and so are essentially without biological activity. Substantial but incomplete activity can be regained with increasing linker length. Here, we describe the design, structure, and function of a single-chain insulin analog (SCI-57) containing a 6-residue linker (GGGPRR). Native receptor-binding affinity (130 +/- 8% relative to the wild type) is achieved as hindrance by the linker is offset by favorable substitutions in the insulin moiety. The thermodynamic stability of SCI-57 is markedly increased (Delta Delta G(u) = 0.7 +/- 0.1 kcal/mol relative to the corresponding two-chain analog and 1.9 +/- 0.1 kcal/mol relative to wild-type insulin). Analysis of inter-residue nuclear Overhauser effects demonstrates that a native-like fold is maintained in solution. Surprisingly, the glycine-rich connecting segment folds against the insulin moiety: its central Pro contacts Val(A3) at the edge of the hydrophobic core, whereas the final Arg extends the A1-A8 alpha-helix. Comparison between SCI-57 and its parent two-chain analog reveals striking enhancement of multiple native-like nuclear Overhauser effects within the tethered protein. These contacts are consistent with wild-type crystal structures but are ordinarily attenuated in NMR spectra of two-chain analogs, presumably due to conformational fluctuations. Linker-specific damping of fluctuations provides evidence for the intrinsic flexibility of an insulin monomer. In addition to their biophysical interest, ultrastable SCIs may enhance the safety and efficacy of insulin replacement therapy in the developing world.	[Hua, Qing-Xin; Jia, Wenhua; Huang, Kun; Phillips, Nelson B.; Hu, Shi-quan; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Nakagawa, Satoe H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Case Western Reserve University; University of Chicago	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012		NIDDK NIH HHS [R01 DK040949, DK 040949] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bassili A, 2001, DIABETES RES CLIN PR, V53, P187, DOI 10.1016/S0168-8227(01)00264-9; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Bott RF, 2007, DRUG DEV IND PHARM, V33, P393, DOI 10.1080/03639040600975022; BRANDENBURG D, 1973, Z PHYSIOL CHEM, V354, P613; Brange I., 1987, GALENICS INSULIN PHY; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; BREMS DN, 1991, J BIOL CHEM, V266, P1611; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; BREMS DN, 1992, PROTEIN ENG, V5, P519, DOI 10.1093/protein/5.6.519; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; BRUCH MD, 1991, PROTEINS, V10, P130, DOI 10.1002/prot.340100206; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURKE GT, 1990, BIOCHEM BIOPH RES CO, V173, P982, DOI 10.1016/S0006-291X(05)80882-4; CARA JF, 1990, J BIOL CHEM, V265, P17820; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; Chance R. E., 1981, PEPTIDES SYNTHESIS S, P721; Chang SG, 1998, BIOCHEM J, V329, P631, DOI 10.1042/bj3290631; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; COSMATOS A, 1978, J BIOL CHEM, V253, P6586; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; FREYCHET P, 1974, DIABETOLOGIA, V10, P1, DOI 10.1007/BF00421406; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GLIEMANN J, 1974, DIABETOLOGIA, V10, P105, DOI 10.1007/BF01219665; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; Guthridge SL, 1996, AUST NZ J PUBL HEAL, V20, P657, DOI 10.1111/j.1467-842X.1996.tb01084.x; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUA QX, 1993, J MOL BIOL, V230, P387, DOI 10.1006/jmbi.1993.1156; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Huang YD, 2001, SCI CHINA SER C, V44, P593, DOI 10.1007/BF02879353; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KANG S, 1991, DIABETES CARE, V14, P571, DOI 10.2337/diacare.14.7.571; Keller Kelley J, 2003, S D J Med, V56, P303; KITAGAWA K, 1984, BIOCHEMISTRY-US, V23, P1405, DOI 10.1021/bi00302a011; Kjeldsen T, 2000, APPL MICROBIOL BIOT, V54, P277, DOI 10.1007/s002530000402; Kjeldsen T, 2002, J BIOL CHEM, V277, P18245, DOI 10.1074/jbc.C200137200; KOBAYASHI M, 1989, DIABETES RES CLIN PR, V7, P25, DOI 10.1016/0168-8227(89)90040-5; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Lefebvre Pierre, 2004, World Hosp Health Serv, V40, P37; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKUSSEN J, 1985, INT J PEPT PROT RES, V25, P431; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MARKUSSEN J, 1987, PEPTIDES 1986, P189, DOI DOI 10.1002/BIT.260460206; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; NICHOLSON H, 1991, BIOCHEMISTRY-US, V30, P9816, DOI 10.1021/bi00105a002; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Park YM, 2005, J GENE MED, V7, P621, DOI 10.1002/jgm.708; PEAVY DE, 1985, J BIOL CHEM, V260, P3989; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; PINGEL M, 1972, DIABETES, V21, P805, DOI 10.2337/diab.21.7.805; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; ROY M, 1989, J BIOL CHEM, V264, P19081; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SELDEN RF, 1987, NEW ENGL J MED, V317, P1067; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SMITH GD, 1984, P NATL ACAD SCI-BIOL, V81, P7093, DOI 10.1073/pnas.81.22.7093; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steiner DF, 2000, J PEDIATR ENDOCR MET, V13, P229; TIDOR B, 1994, J MOL BIOL, V238, P405, DOI 10.1006/jmbi.1994.1300; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1987, J MAGN RESON, V72, P324, DOI 10.1016/0022-2364(87)90294-0; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; WEISS MA, 2002, INSULIN RELATED PROT; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377	107	46	64	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14703	14716		10.1074/jbc.M800313200	http://dx.doi.org/10.1074/jbc.M800313200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332129	Green Published, hybrid			2022-12-27	WOS:000255941400059
J	Xiao, H; Qian, W; Staschke, K; Qian, Y; Cui, G; Deng, L; Ehsani, M; Wang, XL; Qian, YW; Chen, ZJJ; Gilmour, R; Jiang, ZF; Li, XX				Xiao, Hui; Qian, Wen; Staschke, Kirk; Qian, Youcun; Cui, Grace; Deng, Li; Ehsani, Mariam; Wang, Xiliang; Qian, Yue-Wei; Chen, Zhijian J.; Gilmour, Raymond; Jiang, Zhengfan; Li, Xiaoxia			Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NF kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; ADAPTER PROTEIN; IL-1; TAK1; BINDING; TAB2; POLYUBIQUITINATION; FAMILY; TRAF6; IRAK	IL-1 receptor-associated kinase (IRAK) is phosphorylated, ubiquitinated, and degraded upon interleukin-1 (IL-1) stimulation. In this study, we showed that IRAK can be ubiquitinated through both Lys-48- and Lys-63-linked polyubiquitin chains upon IL-1 induction. Pellino 3b is the RING-like motif ubiquitin protein ligase that promotes the Lys-63-linked polyubiquitination on IRAK. Pellino 3b-mediated Lys-63-linked IRAK polyubiquitination competed with Lys-48- linked IRAK polyubiquitination for the same ubiquitination site, Lys-134 of IRAK, thereby blocking IL-1-induced IRAK degradation. Importantly, the negative impact of Pellino 3b on IL-1-induced IRAK degradation correlated with the inhibitory effect of Pellino 3b on the IL-1-induced TAK1-dependent pathway, suggesting that a positive role of IRAK degradation in IL-1 induced TAK1 activation. Taken together, our results suggest that Pellino 3b acts as a negative regulator for IL-1 signaling by regulating IRAK degradation through its ubiquitin protein ligase activity.	[Xiao, Hui; Qian, Wen; Qian, Youcun; Cui, Grace; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Staschke, Kirk; Ehsani, Mariam; Wang, Xiliang; Qian, Yue-Wei; Gilmour, Raymond] Lilly Res Labs, Indianapolis, IN 46285 USA; [Deng, Li] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA	Cleveland Clinic Foundation; Eli Lilly; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn	Staschke, Kirk/HGC-5664-2022; Chen, Zhijian/C-6039-2012	Staschke, Kirk/0000-0001-8722-9585; Chen, Zhijian/0000-0002-8475-8251	NIGMS NIH HHS [R01 GM 060020-06] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Butler MP, 2005, J BIOL CHEM, V280, P27759, DOI 10.1074/jbc.M500756200; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jensen LE, 2003, J IMMUNOL, V171, P1500, DOI 10.4049/jimmunol.171.3.1500; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rich T, 2000, IMMUNOGENETICS, V52, P145, DOI 10.1007/s002510000249; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; XIA ZP, 2005, SCI STKE, V272, pPE7; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075	31	37	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14654	14664		10.1074/jbc.M706931200	http://dx.doi.org/10.1074/jbc.M706931200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18326498	hybrid, Green Published			2022-12-27	WOS:000255941400054
J	Belmont, PJ; Tadimalla, A; Chen, WQJ; Martindale, JJ; Thuerauf, DJ; Marcinko, M; Gude, N; Sussman, MA; Glembotski, CC				Belmont, Peter J.; Tadimalla, Archana; Chen, Wenqiong J.; Martindale, Joshua J.; Thuerauf, Donna J.; Marcinko, Marie; Gude, Natalie; Sussman, Mark A.; Glembotski, Christopher C.			Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE APOPTOSIS; MESSENGER-RNA; ER STRESS; TRANSCRIPTION FACTORS; DOWN-SYNDROME; CELL-GROWTH; IN-VITRO; ATF6	Exposing cells to conditions that modulate growth can impair endoplasmic reticulum (ER) protein folding, leading to ER stress and activation of the transcription factor, ATF6. ATF6 binds to ER stress response elements in target genes, inducing expression of proteins that enhance the ER protein folding capacity, which helps overcome the stress and foster survival. To examine the mechanism of ATF6-mediated survival in vivo, we developed a transgenic mouse model that expresses a novel conditionally activated form of ATF6. We previously showed that activating ATF6 protected the hearts of ATF6 transgenic mice from ER stresses. In the present study, transcript profiling identified modulatory calcineurin interacting protein-1 (MCIP1), also known as regulator of calcineurin 1 (RCAN1), as a novel ATF6-inducible gene that encodes a known regulator of calcineurin/nuclear factor of activated T cells (NFAT)mediated growth and development in many tissues. The ability of ATF6 to induce RCAN1 in vivo was replicated in cultured cardiac myocytes, where adenoviral (AdV)-mediated overexpression of activated ATF6 induced the RCAN1 promoter, up-regulated RCAN1 mRNA, inhibited calcineurin phosphatase activity, and exerted a striking growth modulating effect that was inhibited by RCAN1-targeted small interfering RNA. These results demonstrate that RCAN1 is a novel ATF6 target gene that may coordinate growth and ER stress signaling pathways. By modulating growth, RCAN1 may reduce the need for ER protein folding, thus helping to overcome the stress and enhance survival. Moreover, these results suggest that RCAN1 may also be a novel integrator of growth and ER stress signaling in many other tissues that depend on calcineurin/NFAT signaling for optimal growth and development.	San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), 5500 Campanile Dr, San Diego, CA 92182 USA.	cglembotski@sciences.sdsu.edu	Sussman, Mark/H-2284-2014	Sussman, Mark/0000-0002-0104-4799	NHLBI NIH HHS [HL-075573, HL-085577] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085577, R01HL075573] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ardehali H, 2005, CIRC RES, V97, P740, DOI 10.1161/01.RES.0000186277.12336.11; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Blobel G, 2000, BIOSCIENCE REP, V20, P303, DOI 10.1023/A:1010318832604; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; HANFORD DS, 1994, J BIOL CHEM, V269, P26227; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Leahy KP, 1999, ARCH BIOCHEM BIOPHYS, V368, P67, DOI 10.1006/abbi.1998.1059; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P449, DOI 10.1097/01.WCB.0000054216.21675.AC; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Rzymski T, 2007, CLIN CANCER RES, V13, P2537, DOI 10.1158/1078-0432.CCR-06-2126; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Shin SY, 2006, FEBS LETT, V580, P5965, DOI 10.1016/j.febslet.2006.09.064; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	46	79	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14012	14021		10.1074/jbc.M709776200	http://dx.doi.org/10.1074/jbc.M709776200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18319259	hybrid, Green Published			2022-12-27	WOS:000255728200055
J	Gong, P; Angelini, DJ; Yang, S; Xia, G; Cross, AS; Mann, D; Bannerman, DD; Vogel, SN; Goldblum, SE				Gong, Ping; Angelini, Daniel J.; Yang, Shiqi; Xia, Guanjun; Cross, Alan S.; Mann, Dean; Bannerman, Douglas D.; Vogel, Stefanie N.; Goldblum, Simeon E.			TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; FACTOR-KAPPA-B; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR; P120 CATENIN; C-SRC; BARRIER DYSFUNCTION; CYTOKINE PRODUCTION; ENDOTOXIN RELEASE; BINDING-PROTEIN	Bacterial lipopolysaccharide (LPS) is a key mediator in the vascular leak syndromes associated with Gram-negative bacterial infections. LPS opens the paracellular pathway in pulmonary vascular endothelia through protein tyrosine phosphorylation. We now have identified the protein-tyrosine kinases (PTKs) and their substrates required for LPS-induced protein tyrosine phosphorylation and opening of the paracellular pathway in human lung microvascular endothelial cells (HMVEC-Ls). LPS disrupted barrier integrity in a dose-and time-dependent manner, and prior broad spectrum PTK inhibition was protective. LPS increased tyrosine phosphorylation of zonula adherens proteins, VE-cadherin, gamma-catenin, and p120(ctn). Two SRC family PTK (SFK)-selective inhibitors, PP2 and SU6656, blocked LPS-induced increments in tyrosine phosphorylation of VE-cadherin and p120(ctn) and paracellular permeability. InHMVEC-Ls, c-SRC, YES, FYN, and LYN were expressed at both mRNA and protein levels. Selective small interfering RNA-induced knockdown of c-SRC, FYN, or YES diminished LPS-induced SRC Tyr(416) phosphorylation, tyrosine phosphorylation of VE-cadherin and p120(ctn), and barrier disruption, whereas knockdown of LYN did not. For VE-cadherin phosphorylation, knockdown of either c-SRC or FYN provided total protection, whereas YES knockdown was only partially protective. For p120(ctn) phosphorylation, knockdown of FYN, c-SRC, or YES each provided comparable but partial protection. Toll-like receptor 4 (TLR4) was expressed both on the surface and intracellular compartment of HMVEC-Ls. Prior knockdown of TLR4 blocked both LPS-induced SFK activation and barrier disruption. These data indicate that LPS recognition by TLR4 activates the SFKs, c-SRC, FYN, and YES, which, in turn, contribute to tyrosine phosphorylation of zonula adherens proteins to open the endothelial paracellular pathway.	[Gong, Ping; Angelini, Daniel J.; Yang, Shiqi; Goldblum, Simeon E.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Gong, Ping; Angelini, Daniel J.; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA; [Yang, Shiqi; Goldblum, Simeon E.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Xia, Guanjun] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Cross, Alan S.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Bannerman, Douglas D.] USDA, Bovine Funct Genom Lab, Beltsville, MD 20705 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Agriculture (USDA)	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,HSF 2-Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070155, R01HL084223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018797, R01AI018797, R56AI018797] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-84223, HL-70155] Funding Source: Medline; NIAID NIH HHS [AI-18797] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHEN MG, 1995, DIFFERENTIATION, V59, P15, DOI 10.1046/j.1432-0436.1995.5910015.x; Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bannerman DD, 1998, INFECT IMMUN, V66, P1400, DOI 10.1128/IAI.66.4.1400-1407.1998; Bannerman DD, 1997, AM J PHYSIOL-LUNG C, V273, pL217, DOI 10.1152/ajplung.1997.273.1.L217; BEEKHUIZEN H, 1991, J IMMUNOL, V147, P3761; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BONE RC, 1993, CLIN MICROBIOL REV, V6, P57, DOI 10.1128/CMR.6.1.57-68.1993; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; CHAOUAT G, 1994, CELL IMMUNOL, V157, P328, DOI 10.1006/cimm.1994.1231; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cross A, 1996, SHOCK, V6, pS71, DOI 10.1097/00024382-199610001-00013; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; DOFFERHOFF ASM, 1991, SCAND J INFECT DIS, V23, P745, DOI 10.3109/00365549109024303; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; FEINGOLD KR, 1995, INFECT IMMUN, V63, P2041, DOI 10.1128/IAI.63.5.2041-2046.1995; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Funakoshi-Tago M, 2003, EUR J BIOCHEM, V270, P1257, DOI 10.1046/j.1432-1033.2003.03487.x; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P522, DOI 10.1073/pnas.90.2.522; GOLDBLUM SE, 1993, J CELL PHYSIOL, V157, P13, DOI 10.1002/jcp.1041570103; Goldblum SE, 1999, MOL BIOL CELL, V10, P1537, DOI 10.1091/mbc.10.5.1537; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hamajima Y, 2007, AURIS NASUS LARYNX, V34, P49, DOI 10.1016/j.anl.2006.09.026; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; HENRICSON BE, 1995, MOL MED, V1, P428, DOI 10.1007/BF03401580; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jersmann HPA, 2001, INFECT IMMUN, V69, P479, DOI 10.1128/IAI.69.1.479-485.2001; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kanemitsu MY, 1997, J BIOL CHEM, V272, P22824, DOI 10.1074/jbc.272.36.22824; Kang JL, 2005, J TOXICOL ENV HEAL A, V68, P1643, DOI 10.1080/15287390500192114; Kang JL, 2001, AM J RESP CRIT CARE, V164, P2206, DOI 10.1164/ajrccm.164.12.2104017; Kox M, 2007, VASC PHARMACOL, V46, P195, DOI 10.1016/j.vph.2006.10.004; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Lidington D, 2002, J CELL PHYSIOL, V193, P373, DOI 10.1002/jcp.10179; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Loo LWM, 1999, MOL CARCINOGEN, V25, P187, DOI 10.1002/(SICI)1098-2744(199907)25:3<187::AID-MC5>3.3.CO;2-F; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Lu TT, 1997, J BIOL CHEM, V272, P14442, DOI 10.1074/jbc.272.22.14442; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Mukundan L, 2004, CELL SIGNAL, V16, P375, DOI 10.1016/j.cellsig.2003.08.008; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PRINS JM, 1995, J INFECT DIS, V172, P886, DOI 10.1093/infdis/172.3.886; Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Ruetten H, 1997, BRIT J PHARMACOL, V122, P59, DOI 10.1038/sj.bjp.0701345; SCHEIFELE DW, 1985, AM J CLIN PATHOL, V83, P227, DOI 10.1093/ajcp/83.2.227; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; Severgnini M, 2005, AM J RESP CRIT CARE, V171, P858, DOI 10.1164/rccm.200407-981OC; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Shen YM, 1998, AM J PHYSIOL-ENDOC M, V275, pE479, DOI 10.1152/ajpendo.1998.275.3.E479; Spitzer JH, 2002, EUR J IMMUNOL, V32, P1182, DOI 10.1002/1521-4141(200204)32:4<1182::AID-IMMU1182>3.0.CO;2-9; Stief TW, 2007, BLOOD COAGUL FIBRIN, V18, P179, DOI 10.1097/MBC.0b013e328040bf9a; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; ULEVITCH RJ, 1975, J EXP MED, V142, P1570, DOI 10.1084/jem.142.6.1570; Volk T, 2000, INFLAMM RES, V49, P185, DOI 10.1007/s000110050579; VONASMUTH EJU, 1993, IMMUNOLOGY, V80, P78; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; WU NZ, 1992, AM J PHYSIOL, V262, pH1238; Young BA, 1998, BIOCHEM BIOPH RES CO, V251, P320, DOI 10.1006/bbrc.1998.9475; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zhou YQ, 2002, J BIOL CHEM, V277, P38104, DOI 10.1074/jbc.M206167200	91	105	107	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13437	13449		10.1074/jbc.M707986200	http://dx.doi.org/10.1074/jbc.M707986200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326860	Green Published, hybrid			2022-12-27	WOS:000255499800083
J	Lange, A; Mills, RE; Devine, SE; Corbett, AH				Lange, Allison; Mills, Ryan E.; Devine, Scott E.; Corbett, Anita H.			A PY-NLS nuclear targeting signal is required for nuclear localization and function of the Saccharomyces cerevisiae mRNA-binding protein Hrp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTIN-BETA; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; YEAST; IDENTIFICATION; RECOGNITION; CYTOPLASM; STRAINS; RANGTP; EXPORT	Proteins destined for import into the nucleus contain nuclear localization signals (NLSs) that are recognized by import receptors termed karyopherins or importins. Until recently, the only nuclear import sequence that had been well defined and characterized was the classical NLS ( cNLS), which is recognized by importin alpha. However, Chook and coworkers ( Lee, B. J., Cansizoglu, A. E., Suel, K. E., Louis, T. H., Zhang, Z., and Chook, Y. M. ( 2006) Cell 126, 543 - 558) have provided new insight into nuclear targeting with their identification of a novel NLS, termed the PY-NLS, that is recognized by the human karyopherin beta 2/transportin (Kap beta 2) receptor. Here, we demonstrate that the PY-NLS is conserved in Saccharomyces cerevisiae and show for the first time that the PY-NLS is a functional nuclear targeting sequence in vivo. The apparent ortholog of Kap beta 2 in yeast, Kap104, has two known cargos, the mRNA-binding proteins Hrp1 and Nab2, which both contain putative PY-NLS- like sequences. We find that the PY-NLS- like sequence within Hrp1, which closely matches the PY-NLS consensus, is both necessary and sufficient for nuclear import and is also required for receptor binding and protein function. In contrast, the PY-NLS- like sequences in Nab2, which vary from the PY-NLS consensus, are not required for proper import or protein function, suggesting that Kap104 may interact with different cargos using multiple mechanisms. Dissection of the PY-NLS consensus reveals that the minimal PY-NLS in yeast consists of the C-terminal portion of the human consensus, R/H/KX2-5PY, with upstream basic or hydrophobic residues enhancing the targeting function. Finally, we apply this analysis to a bioinformatic search of the yeast proteome as a preliminary search for new potential Kap104 cargos.	[Lange, Allison; Mills, Ryan E.; Devine, Scott E.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Mills, Ryan/F-4225-2010; Corbett, Anita/AAH-6106-2021	Mills, Ryan/0000-0003-3425-6998; Corbett, Anita/0000-0002-0461-6895	NHGRI NIH HHS [R01 HG002898, R01 HG002898-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM058728] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams A, 1997, METHODS YEAST GENETI; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Allen TD, 2000, J CELL SCI, V113, P1651; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BONNER WM, 1978, PROTEIN MIGRATION AC; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Sambrook J, 2001, MOL CLONING A LAB MA, V3rd; SIKORSKI RS, 1989, GENETICS, V122, P19; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	32	36	36	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12926	12934		10.1074/jbc.M800898200	http://dx.doi.org/10.1074/jbc.M800898200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343812	Green Published, hybrid			2022-12-27	WOS:000255499800029
J	Elbaz, Y; Salomon, T; Schuldiner, S				Elbaz, Yael; Salomon, Tal; Schuldiner, Shimon			Identification of a glycine motif required for packing in EmrE, a multidrug transporter from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BRANCHED RESIDUES; GXXXG MOTIF; BINDING DOMAIN; TOPOLOGY; REVEALS; MUTAGENESIS; ANTIPORTER; PROTEINS; PARALLEL; H+	Glycine residues may play functional and structural roles in membrane proteins. In this work we studied the role of glycine residues in EmrE, a small multidrug transporter from Escherichia coli. EmrE extrudes various drugs across the plasma membrane in exchange with protons and, as a result, confers resistance against their toxic effects. Each of 12 glycine residues was replaced by site-directed mutagenesis. Four of the 12 glycine residues in EmrE are evolutionary conserved within the small multidrug resistance family of multidrug transporters. Our analysis reveals that only two (Gly-67 and Gly-97) of these four highly conserved residues are essential for transporter activity. Moreover, two glycine positions that are less conserved, Gly-17 and Gly-90, demonstrate also a nil phenotype when substituted. Our present results identifying Gly-17 and Gly-67 as irreplaceable reinforce the importance of previously defined functional clusters. Two essential glycine residues, Gly-90 and Gly-97, form a protein motif in which glycine residues are separated by six other residues (GG7). Upon substitution of glycine in these positions, the protein ability to form dimers is impaired as evaluated by cross-linking and pull-down experiments.	[Elbaz, Yael; Salomon, Tal; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012; Elbaz-Alon, Yael/AAW-5332-2021; Elbaz-Alon, Yael/AAB-7044-2019	Schuldiner, Shimon/0000-0002-4874-6237; Elbaz-Alon, Yael/0000-0002-6267-9800; Elbaz-Alon, Yael/0000-0002-6267-9800; Elbaz Alon, Yael/0000-0003-1763-4571	NINDS NIH HHS [NS16708] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Arbely E, 2006, BIOCHEMISTRY-US, V45, P11349, DOI 10.1021/bi060953v; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1997, P NATL ACAD SCI USA, V94, P13442, DOI 10.1073/pnas.94.25.13442; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holliday GL, 2007, J MOL BIOL, V372, P1261, DOI 10.1016/j.jmb.2007.07.034; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kim S, 2004, P NATL ACAD SCI USA, V101, P5988, DOI 10.1073/pnas.0308694101; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; Li Fusheng, 2002, Methods Mol Biol, V182, P19; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; Liu Y, 2002, GENOME BIOL, V3; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rath A, 2006, J BIOL CHEM, V281, P15546, DOI 10.1074/jbc.M600434200; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schuldiner S, 2001, J MOL MICROB BIOTECH, V3, P155; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Sharoni M, 2005, J BIOL CHEM, V280, P32849, DOI 10.1074/jbc.M504910200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Weinglass AB, 2001, BIOCHEMISTRY-US, V40, P769, DOI 10.1021/bi002171m; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200	45	31	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12276	12283		10.1074/jbc.M710338200	http://dx.doi.org/10.1074/jbc.M710338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321856	hybrid, Green Published			2022-12-27	WOS:000255340000044
J	Lu, M; Echeverri, F; Kalabat, D; Laita, B; Dahan, DS; Smith, RD; Xu, H; Staszewski, L; Yamamoto, J; Ling, J; Hwang, N; Kimmich, R; Li, P; Patron, E; Keung, W; Patron, A; Moyer, BD				Lu, Min; Echeverri, Fernando; Kalabat, Dalia; Laita, Bianca; Dahan, David S.; Smith, Raymond D.; Xu, Hong; Staszewski, Lena; Yamamoto, Jeff; Ling, Jing; Hwang, Nancy; Kimmich, Rachel; Li, Peter; Patron, Erika; Keung, Walter; Patron, Andrew; Moyer, Bryan D.			Small molecule activator of the human epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CONDUCTANCE; NA+ SELF-INHIBITION; ALPHA-SUBUNIT; DELTA-SUBUNIT; CYSTIC-FIBROSIS; FUNCTIONAL EXPRESSION; XENOPUS-OOCYTES; PSEUDOHYPOALDOSTERONISM TYPE-1; SURFACE EXPRESSION; GAMMA-SUBUNIT	The epithelial sodium channel (ENaC), a heterotrimeric complex composed of alpha, beta, and gamma subunits, belongs to the ENaC/degenerin family of ion channels and forms the principal route for apical Na+ entry in many reabsorbing epithelia. Although high affinity ENaC blockers, including amiloride and derivatives, have been described, potent and specific small molecule ENaC activators have not been reported. Here we describe compound S3969 that fully and reversibly activates human ENaC (hENaC) in an amiloride-sensitive and dose-dependent manner in heterologous cells. Mechanistically, S3969 increases hENaC open probability through interactions requiring the extracellular domain of the beta subunit. hENaC activation by S3969 did not require cleavage by the furin protease, indicating that nonproteolyzed channels can be opened. Function of alpha beta G37S gamma hENaC, a channel defective in gating that leads to the salt-wasting disease pseudohypoaldosteronism type I, was rescued by S3969. Small molecule activation of hENaC may find application in alleviating human disease, including pseudohypoaldosteronism type I, hypotension, and neonatal respiratory distress syndrome, when improved Na+ flux across epithelial membranes is clinically desirable.	[Lu, Min; Echeverri, Fernando; Kalabat, Dalia; Laita, Bianca; Dahan, David S.; Smith, Raymond D.; Xu, Hong; Staszewski, Lena; Yamamoto, Jeff; Ling, Jing; Hwang, Nancy; Kimmich, Rachel; Li, Peter; Patron, Erika; Keung, Walter; Patron, Andrew; Moyer, Bryan D.] Senomyx Inc, San Diego, CA 92121 USA		Moyer, BD (corresponding author), Senomyx Inc, 4767 Nexus Ctr Dr, San Diego, CA 92121 USA.	bryan.moyer@senomyx.com						Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Beene DL, 2004, J NEUROSCI, V24, P9097, DOI 10.1523/JNEUROSCI.2429-04.2004; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; Bonny O, 2002, PEDIATR NEPHROL, V17, P804, DOI 10.1007/s00467-002-0945-8; Bonny O, 1999, J CLIN INVEST, V104, P967, DOI 10.1172/JCI6821; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CALLAMARAS N, 2002, Patent No. 2002087306; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Chraibi A, 2001, J MEMBRANE BIOL, V183, P15, DOI 10.1007/s00232-001-0049-6; Chraibi A, 1999, J PHARMACOL EXP THER, V290, P341; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; DOGGRELL S, 1994, CLIN EXP PHARMACOL P, V21, P833, DOI 10.1111/j.1440-1681.1994.tb02454.x; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Giraldez T, 2007, J NEUROCHEM, V102, P1304, DOI 10.1111/j.1471-4159.2007.04622.x; Gribkoff VK, 2003, EXPERT OPIN THER TAR, V7, P737, DOI 10.1517/eott.7.6.737.22569; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Hewawasam P, 2003, J MED CHEM, V46, P2819, DOI 10.1021/jm030005h; Hirsh AJ, 2006, J MED CHEM, V49, P4098, DOI 10.1021/jm051134w; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Ji HL, 2004, J BIOL CHEM, V279, P8428, DOI 10.1074/jbc.M312012200; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; MACDONALD RL, 1995, EPILEPSIA, V36, P2; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; Papke RL, 2004, NEUROPHARMACOLOGY, V46, P1023, DOI 10.1016/j.neuropharm.2004.01.005; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; Randrianarison N, 2007, J PHYSIOL-LONDON, V582, P777, DOI 10.1113/jphysiol.2007.131078; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schnizler M, 2003, BBA-BIOMEMBRANES, V1609, P170, DOI 10.1016/S0005-2736(02)00684-3; Schnizler M, 2000, PFLUG ARCH EUR J PHY, V439, P579, DOI 10.1007/s004240050981; SERVANT G, 2005, Patent No. 2005014848; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Swift PA, 2004, ADV RENAL REPLACE TH, V11, P76, DOI 10.1053/j.arrt.2003.10.011; Takahashi A, 1996, AM J PHYSIOL-CELL PH, V271, pC1887, DOI 10.1152/ajpcell.1996.271.6.C1887; Thomas CP, 1998, AM J PHYSIOL-CELL PH, V274, pC1312, DOI 10.1152/ajpcell.1998.274.5.C1312; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wright T, 1998, HEART FAIL REV, V2, P173; Wu YJ, 2004, J MED CHEM, V47, P2887, DOI 10.1021/jm0305826; Yamamura H, 2005, MOL PHARMACOL, V68, P1142, DOI 10.1124/mol.104.010850; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yamamura H, 2004, J BIOL CHEM, V279, P12529, DOI 10.1074/jbc.M400274200; Yamamura H, 2006, BIOCHEM BIOPH RES CO, V349, P317, DOI 10.1016/j.bbrc.2006.08.043; Zennaro MC, 2004, TRENDS ENDOCRIN MET, V15, P264, DOI 10.1016/j.tem.2004.06.003	77	44	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11981	11994		10.1074/jbc.M708001200	http://dx.doi.org/10.1074/jbc.M708001200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326490	hybrid			2022-12-27	WOS:000255340000014
J	Sen, A; Heymann, JB; Cheng, NQ; Qiao, J; Mindich, L; Steven, AC				Sen, Anindito; Heymann, J. Bernard; Cheng, Naiqian; Qiao, Jian; Mindich, Leonard; Steven, Alasdair C.			Initial location of the RNA-dependent RNA polymerase in the bacteriophage Phi 6 procapsid determined by cryo-electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DSRNA BACTERIOPHAGE-PHI-6; PHI-6; COMPLEX; REPLICATION; SPECIFICITY; PARTICLES; PROTEINS; SEGMENTS; GENOME	The RNA-dependent RNA polymerases (RdRPs) of Cystoviridae bacteriophages, like those of eukaryotic viruses of the Reoviridae, function inside the inner capsid shell in both replication and transcription. In bacteriophage Phi 6, this inner shell is first assembled as an icosahedral procapsid with recessed 5-fold vertices that subsequently undergoes major structural changes during maturation. The tripartite genome is packaged as single-stranded RNA molecules via channels on the 5-fold vertices, and transcripts probably exit the mature capsid by the same route. The RdRP (protein P2) is assembled within the procapsid, and it was thought that it should be located on the 5-fold axes near the RNA entry and exit channels. To determine the initial location of the RdRP inside the procapsid of bacteriophage Phi 6, we performed cryo-electron microscopy of wild type and mutant procapsids and complemented these data with biochemical determinations of copy numbers. We observe ring-like densities on the 3-fold axes that are strong in a mutant that has similar to 10 copies of P2 per particle; faint in wild type, reflecting the lower copy number of similar to 3; and completely absent in a P2-null mutant. The dimensions and shapes of these densities match those of the known crystal structure of the P2 monomer. We propose that, during maturation, the P2 molecules rotate to occupy positions closer to adjacent 5-fold vertices where they conduct replication and transcription.	[Sen, Anindito; Heymann, J. Bernard; Cheng, Naiqian; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA; [Qiao, Jian; Mindich, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rutgers State University New Brunswick; Rutgers State University Medical Center	Heymann, JB (corresponding author), NIAMS, Struct Biol Lab, NIH, Bldg 50,Rm 1515,50 S Dr,MSC 8025, Bethesda, MD 20892 USA.	Bernard_Heymann@nih.gov	Heymann, Bernard/F-6825-2011; Heymann, Bernard/H-8265-2019	Heymann, Bernard/0000-0002-8872-5326	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM34352] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034352] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; DAY LA, 1980, VIROLOGY, V103, P376, DOI 10.1016/0042-6822(80)90196-8; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; GOTTLIEB P, 1994, VIROLOGY, V200, P42, DOI 10.1006/viro.1994.1160; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Huiskonen JT, 2007, J STRUCT BIOL, V158, P156, DOI 10.1016/j.jsb.2006.08.021; Ikonen T, 2003, J APPL CRYSTALLOGR, V36, P525, DOI 10.1107/S0021889803001857; JUUTI JT, 1995, J MOL BIOL, V249, P545, DOI 10.1006/jmbi.1995.0317; Juuti JT, 1997, J MOL BIOL, V266, P891, DOI 10.1006/jmbi.1996.0817; Mindich L, 2004, VIRUS RES, V101, P83, DOI 10.1016/j.virusres.2003.12.008; MINDICH L, 1994, VIROLOGY, V202, P258, DOI 10.1006/viro.1994.1341; MINDICH L, 1995, VIROLOGY, V212, P213, DOI 10.1006/viro.1995.1470; OLKKONEN VM, 1987, J VIROL, V61, P2362, DOI 10.1128/JVI.61.8.2362-2367.1987; Poranen MM, 2004, VIRUS RES, V101, P93, DOI 10.1016/j.virusres.2003.12.009; Qiao J, 2003, J BACTERIOL, V185, P4572, DOI 10.1128/JB.185.15.4572-4577.2003; Salgado PS, 2004, STRUCTURE, V12, P307, DOI 10.1016/j.str.2004.01.012; Taraporewala ZF, 2004, VIRUS RES, V101, P57, DOI 10.1016/j.virusres.2003.12.006; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009	20	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12227	12231		10.1074/jbc.M710508200	http://dx.doi.org/10.1074/jbc.M710508200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18287088	Green Published, hybrid			2022-12-27	WOS:000255340000038
J	Tu, CF; Yan, YT; Wu, SY; Djoko, B; Tsai, MT; Cheng, CJ; Yang, RB				Tu, Cheng-Fen; Yan, Yu-Ting; Wu, Szu-Yao; Djoko, Bambang; Tsai, Ming-Tzu; Cheng, Chien-Jui; Yang, Ruey-Bing			Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-RELATED GENE; CUB DOMAIN; NEURAL-TUBE; GROWTH; EXPRESSION; RECEPTOR; GLYCOSYLATION; NEURULATION; FAMILY; PAIR	SCUBE1 ((s) under bar ignal peptide-CUB-(E) under bar GF domain-containing protein 1) is a novel, secreted, cell surface glycoprotein expressed during early embryogenesis and found in platelet and endothelial cells. This protein is composed of an N-terminal signal peptide sequence followed by nine tandemly arranged epidermal growth factor (EGF)-like repeats, a spacer region, three cysteinerich repeat motifs, and one CUB domain at the C terminus. However, little is known about its domain and biological function. Here, we generated a comprehensive panel of domain deletion constructs and a new genetic mouse model with targeted disruption of Scube1 (Scube1(Delta cub/Delta cub)) to investigate the domain function and biological significance. A number of cell-based assays were utilized to define the critical role of the spacer region for membrane association and establish that the EGFlike repeats 7-9 are sufficient for the formation of SCUBE1-mediated homophilic adhesions in a calcium-dependent fashion. Biochemical and molecular analyses showed that the C-terminal cysteine-rich motifs and CUB domain could directly bind and antagonize the bone morphogenetic protein activity. Furthermore, genetic ablation of this C-terminal region resulted in brain malformation in the Scube1(Delta cub/Delta cub) embryos. Together, our results support the dual roles of SCUBE1 on brain morphogenesis and cell-cell adhesions through its distinct domain function.	[Tu, Cheng-Fen; Yan, Yu-Ting; Wu, Szu-Yao; Djoko, Bambang; Tsai, Ming-Tzu; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Cheng, Chien-Jui] Taipei Med Univ Hosp, Coll Med, Grad Inst Clin Med, Taipei 110, Taiwan; [Cheng, Chien-Jui] Taipei Med Univ Hosp, Coll Med, Dept Pathol, Taipei 110, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	rbyang@ibms.sinica.edu.tw	Thomson, Axel/A-7893-2013; Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714; Tu, Cheng-Fen/0000-0003-3624-7884				Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chen GP, 2006, J BIOL CHEM, V281, P27436, DOI 10.1074/jbc.M605525200; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Franzke CW, 2006, J BIOL CHEM, V281, P30260, DOI 10.1074/jbc.M604464200; Greene NDE, 2005, AM J MED GENET C, V135C, P31, DOI 10.1002/ajmg.c.30051; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Haworth K, 2007, GENE EXPR PATTERNS, V7, P630, DOI 10.1016/j.modgep.2006.12.004; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mishra VK, 1996, BIOCHEMISTRY-US, V35, P11210, DOI 10.1021/bi960760f; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Romero A, 1997, NAT STRUCT BIOL, V4, P783, DOI 10.1038/nsb1097-783; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Stottmann RW, 2006, DEV BIOL, V295, P647, DOI 10.1016/j.ydbio.2006.03.051; Su YC, 2007, GENE THER, V14, P565, DOI 10.1038/sj.gt.3302896; Tu CF, 2006, CARDIOVASC RES, V71, P486, DOI 10.1016/j.cardiores.2006.04.010; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	35	76	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12478	12488		10.1074/jbc.M705872200	http://dx.doi.org/10.1074/jbc.M705872200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303018	hybrid			2022-12-27	WOS:000255340000064
J	Grimm, MOW; Grimm, HS; Tomic, I; Beyreuther, K; Hartmann, T; Bergmann, C				Grimm, Marcus O. W.; Grimm, Heike S.; Tomic, Inge; Beyreuther, Konrad; Hartmann, Tobias; Bergmann, Christine			Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; RAT HIPPOCAMPAL-NEURONS; TRANSGENIC MOUSE MODEL; ENDOPLASMIC-RETICULUM; IN-VITRO; TRANSMEMBRANE DOMAIN; REDUCTASE INHIBITORS; PRIMARY CULTURES; APOLIPOPROTEIN-E; DISTINCT SITES	The major molecular risk factor for Alzheimer disease so far identified is the amyloidogenic peptide A beta(42). In addition, growing evidence suggests a role of cholesterol in Alzheimer disease pathology and A beta generation. However, the cellular mechanism of lipid-dependent A beta production remains unclear. Here we describe that the two enzymatic activities responsible for A beta production, beta-secretase and beta-secretase, are inhibited in parallel by cholesterol reduction. Importantly, our data indicate that cholesterol depletion within the cellular context inhibits both secretases additively and independently from each other. This is unexpected because the beta-secretase beta-site amyloid precursor protein cleaving enzyme and the presenilin-containing gamma-secretase complex are structurally different from each other, and these enzymes are apparently located in different subcellular compartments. The parallel and additive inhibition has obvious consequences for therapeutic research and may indicate an intrinsic cross-talk between Alzheimer disease-related amyloid precursor protein processing, amyloid precursor protein function, and lipid biology.	[Grimm, Marcus O. W.; Grimm, Heike S.; Tomic, Inge; Hartmann, Tobias; Bergmann, Christine] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany; [Grimm, Marcus O. W.; Grimm, Heike S.; Tomic, Inge; Hartmann, Tobias; Bergmann, Christine] Univ Saarland, Dept Neurobiol, D-66421 Homburg, Germany; [Beyreuther, Konrad] Heidelberg Univ, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Bergmann, Christine] Cent Inst Mental Hlth, Div Geriat Psychiat, D-68159 Mannheim, Germany	Saarland University; Saarland University; Ruprecht Karls University Heidelberg; Central Institute of Mental Health	Hartmann, T (corresponding author), Univ Saarland, Dept Neurobiol, Kirrbergerstr,Bldg 90, D-66421 Homburg, Germany.	tobias.hartmann@uniklinikum-saarland.de	Grimm, Marcus O. W./F-8134-2011; Hartmann, Tobias/AAB-8297-2022	Grimm, Marcus O. W./0000-0002-4160-6506; Hartmann, Tobias/0000-0001-7481-6430				BLOOM GS, 1989, J BIOL CHEM, V264, P16083; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bunnell WL, 1998, J BIOL CHEM, V273, P31947, DOI 10.1074/jbc.273.48.31947; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DYRKS T, 1994, FEBS LETT, V349, P210, DOI 10.1016/0014-5793(94)00671-7; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Evans RM, 2004, NEUROLOGY, V62, P1869, DOI 10.1212/01.WNL.0000125323.15458.3F; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Gouras GK, 1998, J NEUROCHEM, V71, P1920; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Grimm HS, 2003, J BIOL CHEM, V278, P13077, DOI 10.1074/jbc.M210380200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Grziwa B, 2003, J BIOL CHEM, V278, P6803, DOI 10.1074/jbc.M210047200; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1996, ACTA NEUROL SCAND, V93, P13; Hartmann T, 1999, EUR ARCH PSY CLIN N, V249, P291, DOI 10.1007/s004060050102; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hoglund K, 2005, DEMENT GERIATR COGN, V19, P256, DOI 10.1159/000084550; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jensen M, 2000, MOL MED, V6, P291, DOI 10.1007/BF03401938; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; LANGAN TJ, 1987, J NEUROCHEM, V49, P513, DOI 10.1111/j.1471-4159.1987.tb02894.x; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; NAGAMATSU S, 1992, J BIOL CHEM, V267, P467; OLKKONEN VM, 1993, J NEUROSCI RES, V35, P445, DOI 10.1002/jnr.490350412; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Simons M, 1996, J NEUROSCI, V16, P899; SLATER EE, 1988, DRUGS, V36, P72, DOI 10.2165/00003495-198800363-00016; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sudoh S, 1998, J NEUROCHEM, V71, P1535; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303	78	90	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11302	11311		10.1074/jbc.M801520200	http://dx.doi.org/10.1074/jbc.M801520200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308724	hybrid			2022-12-27	WOS:000255067400026
J	Rondou, P; Haegeman, G; Vanhoenacker, P; Van Craenenbroeck, K				Rondou, Pieter; Haegeman, Guy; Vanhoenacker, Peter; Van Craenenbroeck, Kathleen			BTB protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED UBIQUITINATION; SUBSTRATE ADAPTER PROTEIN; DELTA-OPIOID RECEPTORS; MEDIATES UBIQUITINATION; PROTEASOMAL DEGRADATION; DOWN-REGULATION; PATHWAY; KEAP1; NRF2; POLYMORPHISMS	Dopamine receptors belong to the superfamily of G-protein-coupled receptors and are subdivided into D1-type (D1 and D5) and D2-type (D2, D3, and D4) receptors. The D4 receptor has a remarkable polymorphism in its third intracellular loop, which is under intensive investigation and which has been associated with, among other conditions, attention deficit hyperactivity disorder. Here, we demonstrate that KLHL12, a BTB-Kelch protein, specifically binds to this polymorphic region of the D4 receptor through its Kelch domain. Moreover, we show that KLHL12 also interacts with Cullin3 and thereby functions as an adaptor to target the D4 receptor to an E3 ubiquitin ligase complex. By ubiquitination assays in eukaryotic cells, we further demonstrate that overexpression of KLHL12 strongly promotes ubiquitination of the D4 receptor. In addition, we show that also other dopamine receptor subtypes undergo basal ubiquitination, but this is not affected by KLHL12. These data are the first to show ubiquitination of dopamine receptors and the first to identify a protein specifically interacting with the D4 polymorphism, thereby building up an E3 ligase complex with substrate specificity toward the D4 receptor.	[Rondou, Pieter; Haegeman, Guy; Vanhoenacker, Peter; Van Craenenbroeck, Kathleen] Ghent Univ UGent, Lab Eukaryot Gene Express & Signal Transduct, Dept Mol Biol, B-9000 Ghent, Belgium	Ghent University	Van Craenenbroeck, K (corresponding author), Ghent Univ UGent, Lab Eukaryot Gene Express & Signal Transduct, Dept Mol Biol, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	Kathleen.VanCraenenbroeck@UGent.be						Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Ben Zion IZ, 2006, MOL PSYCHIATR, V11, P782, DOI 10.1038/sj.mp.4001832; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; De Martelaere K, 2007, CELL SIGNAL, V19, P278, DOI 10.1016/j.cellsig.2006.06.012; DeValck D, 1997, BIOCHEM BIOPH RES CO, V238, P590, DOI 10.1006/bbrc.1997.7343; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Helmeste DM, 2000, JPN J PHARMACOL, V82, P1; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Khan ZU, 1998, J COMP NEUROL, V402, P353, DOI 10.1002/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Krek W, 2003, NAT CELL BIOL, V5, P950, DOI 10.1038/ncb1103-950; Mai A, 2004, EXP CELL RES, V300, P72, DOI 10.1016/j.yexcr.2004.06.023; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Oldenhof J, 1998, BIOCHEMISTRY-US, V37, P15726, DOI 10.1021/bi981634+; Paterson AD, 1999, NEUROPSYCHOPHARMACOL, V21, P3, DOI 10.1016/S0893-133X(98)00115-8; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Van Craenenbroeck K, 2005, J BIOL CHEM, V280, P19350, DOI 10.1074/jbc.M414043200; VANTOL HHM, 1992, NATURE, V358, P149; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wong AHC, 2000, EUR J PHARMACOL, V410, P183; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	39	62	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11083	11096		10.1074/jbc.M708473200	http://dx.doi.org/10.1074/jbc.M708473200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303015	hybrid, Green Published			2022-12-27	WOS:000255067400004
J	Barroso, MMS; Freire, E; Limaverde, GSCS; Rocha, GM; Batista, EJO; Weissmuller, G; Andrade, LR; Coelho-Sampaio, T				Sant'Ana Barroso, Madalena Martins; Freire, Elisabete; Limaverde, Gabriel S. C. S.; Rocha, Gustavo Miranda; Batista, Evander J. O.; Weissmueller, Gilberto; Andrade, Leonardo Rodrigues; Coelho-Sampaio, Tatiana			Artificial laminin polymers assembled in acidic pH mimic basement membrane organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELLS; RAT-BRAIN; BINDING; SITES; NEURITOGENESIS; MATRICES; HEPARIN; NETWORK	Natural laminin matrices are formed on cell membranes by a cooperative process involving laminin self-polymerization and binding to cognate cellular receptors. In a cell-free system, laminin can self-polymerize, given that a minimal critical concentration is achieved. We have previously described that pH acidification renders self-polymerization independent of protein concentration. Here we studied the ultrastructure of acid-induced laminin polymers using electron and atomic force microscopies. Polymers presented the overall appearance of natural matrices and could be described as homogeneous polygonal sheets, presenting struts of 21 +/- 5 and 86 +/- 3 nm of height, which approximately correspond to the sizes of the short and the long arms of the molecule, respectively. The addition of fragment E3 ( the distal two domains of the long arm) did not affect the polymerization in solution nor the formation of adsorbed matrices. On the other hand, the addition of fragment E1', which contains two intact short arms, completely disrupted polymerization. These results indicate that acid-induced polymers, like natural ones, involve only interactions between the short arms. The electrostatic surface map of laminin alpha 1 LG4-5 shows that acidification renders the distal end in the long arms exclusively positive, precluding homophylic interactions between them. Therefore, acidification reproduces in vitro, and at a physiological protein concentration, what receptor interaction does in the cellular context, namely, it prevents the long arm from disturbing formation of the homogeneous matrix involving the short arms only. We propose that acid-induced polymers are the best tool to study cellular response to laminin in the future.	[Sant'Ana Barroso, Madalena Martins; Freire, Elisabete; Andrade, Leonardo Rodrigues; Coelho-Sampaio, Tatiana] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941590 Rio De Janeiro, Brazil; [Limaverde, Gabriel S. C. S.; Rocha, Gustavo Miranda; Batista, Evander J. O.; Weissmueller, Gilberto] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Coelho-Sampaio, T (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941590 Rio De Janeiro, Brazil.	tcsampaio@histo.ufrj.br	Andrade, Leonardo/C-9554-2011	Andrade, Leonardo/0000-0002-0004-5677				Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; DeLano W.L, PYMOL MOL GRAPHICS S; Freire E, 2004, J CELL SCI, V117, P4067, DOI 10.1242/jcs.01276; Freire E, 2002, J CELL SCI, V115, P4867, DOI 10.1242/jcs.00173; Freire E, 2000, J BIOL CHEM, V275, P817, DOI 10.1074/jbc.275.2.817; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; KALB E, 1991, J BIOL CHEM, V266, P19047; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; MORRIS VJ, 1999, ATOMIC FORCE MICROSC, P44; STICHEL CC, 1994, J NEUROCYTOL, V23, P615, DOI 10.1007/BF01191556; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Tsiper MV, 2002, J CELL SCI, V115, P1005; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119; YURCHENCO PD, 1985, J BIOL CHEM, V260, P7636; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; ZHOU FC, 1990, DEV BRAIN RES, V55, P191, DOI 10.1016/0165-3806(90)90200-I	22	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11714	11720		10.1074/jbc.M709301200	http://dx.doi.org/10.1074/jbc.M709301200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18276595	hybrid			2022-12-27	WOS:000255067400071
J	Sirijovski, N; Lundqvist, J; Rosenback, M; Elmlund, H; Al-Karadaghi, S; Willows, RD; Hansson, M				Sirijovski, Nickolche; Lundqvist, Joakim; Rosenback, Matilda; Elmlund, Hans; Al-Karadaghi, Salam; Willows, Robert D.; Hansson, Mats			Substrate-binding model of the chlorophyll biosynthetic magnesium chelatase BchH subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOPORPHYRIN IX CHELATASE; MG-CHELATASE; ATPASE ACTIVITY; H-SUBUNIT; SYNECHOCYSTIS PCC6803; ENZYME; RESOLUTION; PROTEINS; CHLI; RECONSTITUTION	Photosynthetic organisms require chlorophyll and bacteriochlorophyll to harness light energy and to transform water and carbon dioxide into carbohydrates and oxygen. The biosynthesis of these pigments is initiated by magnesium chelatase, an enzyme composed of BchI, BchD, and BchH proteins, which catalyzes the insertion of Mg2+ into protoporphyrin IX ( Proto) to produce Mg-protoporphyrin IX. BchI and BchD form an ATP-dependent AAA(+) complex that transiently interacts with the Proto-binding BchH subunit, at which point Mg2+ is chelated. In this study, controlled proteolysis, electron microscopy of negatively stained specimens, and single-particle three-dimensional reconstruction have been used to probe the structure and substrate-binding mechanism of the BchH subunit to a resolution of 25 angstrom. The apo structure contains three major lobeshaped domains connected at a single point with additional densities at the tip of two lobes termed the "thumb" and "finger." With the independent reconstruction of a substratebound BchH complex (BchH.Proto), we observed a distinct conformational change in the thumb and finger subdomains. Prolonged proteolysis of native apo-BchH produced a stable C-terminal fragment of 45 kDa, and Proto was shown to protect the full-length polypeptide from degradation. Fitting of a truncated BchH polypeptide reconstruction identified the Nand C-terminal domains. Our results show that the N- and C-terminal domains play crucial roles in the substrate-binding mechanism.	[Sirijovski, Nickolche; Rosenback, Matilda; Hansson, Mats] Lund Univ, Ctr Mol Prot Sci, Dept Biochem, SE-22100 Lund, Sweden; [Lundqvist, Joakim; Elmlund, Hans; Al-Karadaghi, Salam] Lund Univ, Ctr Mol Prot Sci, Dept Mol Biophys, SE-22100 Lund, Sweden; [Elmlund, Hans] Karolinska Inst, Dept Biosci & Nutr, SE-14187 Huddinge, Sweden; [Elmlund, Hans] Royal Inst Technol, Sch Technol & Hlth, SE-14187 Huddinge, Sweden; [Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW 2109, Australia	Lund University; Lund University; Karolinska Institutet; Royal Institute of Technology; Macquarie University	Hansson, M (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem, Box 124, SE-22100 Lund, Sweden.	mats.hansson@biochemistry.lu.se	ELMLUND, HANS/AAA-6625-2021; Willows, Robert/C-1537-2010; Al-karadaghi, Salam/F-1492-2011	Willows, Robert/0000-0002-0731-2950; Al-karadaghi, Salam/0000-0001-8608-0635; Elmlund, Hans/0000-0002-6992-0601; Hansson, Mats/0000-0002-0168-9968; Sirijovski, Nick/0000-0002-6191-3845				Ahrman E, 2007, PROTEIN SCI, V16, P1464, DOI 10.1110/ps.072831607; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; BOLLIVAR DW, 2003, TETRAPYRROLE HDB, V2, P49; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; DEBUSSCHE L, 1992, J BACTERIOL, V174, P7445, DOI 10.1128/jb.174.22.7445-7451.1992; Drapeau G R, 1976, Methods Enzymol, V45, P469; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; FALK JE, 1964, PORPHYRINS METALLOPO; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Hansson A, 2002, P NATL ACAD SCI USA, V99, P13944, DOI 10.1073/pnas.212504499; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; HUDSON A, 1993, EMBO J, V12, P3711, DOI 10.1002/j.1460-2075.1993.tb06048.x; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Lake V, 2004, EUR J BIOCHEM, V271, P2182, DOI 10.1111/j.1432-1033.2004.04143.x; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lebart L., 1984, MULTIVARIATE DESCRIP; Lecerof D, 2000, J MOL BIOL, V297, P221, DOI 10.1006/jmbi.2000.3569; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Moradian-Oldak J, 2001, BIOPOLYMERS, V58, P606, DOI 10.1002/1097-0282(200106)58:7<606::AID-BIP1034>3.0.CO;2-8; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Sirijovski N, 2006, BIOCHEM J, V400, P477, DOI 10.1042/BJ20061103; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; WALKER CJ, 1991, P NATL ACAD SCI USA, V88, P5789, DOI 10.1073/pnas.88.13.5789; WALKER CJ, 1991, PLANT PHYSIOL, V95, P1189, DOI 10.1104/pp.95.4.1189; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Willows RD, 1998, J BIOL CHEM, V273, P34206, DOI 10.1074/jbc.273.51.34206; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x; Willows RD, 2003, J BACTERIOL, V185, P3249, DOI 10.1128/JB.185.11.3249-3258.2003; WILLOWS RD, 2003, TETRAPYRROLE HDB, V2, P1; Yang SX, 2003, J STRUCT BIOL, V144, P162, DOI 10.1016/j.jsb.2003.09.016; ZSEBO KM, 1984, CELL, V37, P937, DOI 10.1016/0092-8674(84)90428-8	47	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11652	11660		10.1074/jbc.M709172200	http://dx.doi.org/10.1074/jbc.M709172200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18263581	hybrid			2022-12-27	WOS:000255067400066
J	Das, A; Davis, MA; Tomoda, H; Omura, S; Rudel, LL				Das, Akash; Davis, Matthew A.; Tomoda, Hiroshi; Omura, Satoshi; Rudel, Lawrence L.			Identification of the interaction site within acyl-CoA: Cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY ATHEROSCLEROSIS; MICE; ACAT2; PRIMATES; ENZYME; CELLS; LIVER; HYPERCHOLESTEROLEMIA; LIPOPROTEIN; MEMBRANE	Targeted deletion of acyl-CoA: cholesterol acyltransferase 2 (ACAT2) (A2), especially in the liver, protects hyperlipidemic mice from diet-induced hypercholesterolemia and atherosclerosis, whereas the deletion of ACAT1 (A1) is not as effective, suggesting ACAT2 may be the more appropriate target for treatment of atherosclerosis. Among the numerous ACAT inhibitors known, pyripyropene A (PPPA) is the only compound that has high selectivity (> 2000-fold) for inhibition of ACAT2 compared with ACAT1. In the present study we sought to determine the PPPA interaction site of ACAT2. To achieve this goal we made several chimeric proteins where parts of ACAT2 were replaced by the analogous region of ACAT1. Differences in the amino acid sequence and the membrane topology were utilized to design the chimeras. Among chimeras, A2: 1-428/A1:444-550 had 50% reduced PPPA selectivity, whereas C-terminal-truncated ACAT2 mutant A2:1-504 (C-terminal last 22 amino acids were deleted) remained selectively inhibited, indicating the PPPA-sensitive site is located within a region between amino acids 440 and 504. Three additional chimeras within this region helped narrow down the PPPA-sensitive site to a region containing amino acids 480-504, representing the fifth putative transmembrane domain of ACAT2. Subsequently, for this region we made single amino acid mutants where each amino acid in ACAT2 was individually changed to its ACAT1 counterpart. Mutation of Q492L, V493L, S494A resulted in only 30, 50, and 70% inhibition of the activity by PPPA, respectively (as opposed to greater than 95% with the wild type enzyme), suggesting these three residues are responsible for the selective inhibition by PPPA of ACAT2. Additionally, we found that PPPA non-covalently interacts with ACAT2 apparently without altering the oligomeric structure of the protein. The present study provides the first evidence for a unique motif in ACAT2 that can be utilized for making an ACAT2-specific drug.	[Davis, Matthew A.; Rudel, Lawrence L.] Wake Forest Univ, Dept Pathol, Sect Lipid Sci, Sch Med, Winston Salem, NC 27157 USA; [Das, Akash; Rudel, Lawrence L.] Wake Forest Univ, Dept Biochem, Sect Lipid Sci, Sch Med, Winston Salem, NC 27157 USA; [Tomoda, Hiroshi] Kitasato Univ, Sch Pharm, Tokyo 1088641, Japan; [Omura, Satoshi] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan; [Omura, Satoshi] Kitasato Univ, Grad Sch Infect Control Sci, Tokyo 1088641, Japan	Wake Forest University; Wake Forest University; Kitasato University; Kitasato University; Kitasato University	Rudel, LL (corresponding author), Wake Forest Univ, Dept Pathol, Sect Lipid Sci, Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	lrudel@wfubmc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373] Funding Source: NIH RePORTER; NHLBI NIH HHS [NIH-P01-HL49373] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; Buhman KF, 2000, BBA-MOL CELL BIOL L, V1529, P142, DOI 10.1016/S1388-1981(00)00144-X; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; CARR TP, 1992, ARTERIOSCLER THROMB, V12, P1274, DOI 10.1161/01.ATV.12.11.1274; DUGGLEBY RG, 1981, ANAL BIOCHEM, V110, P9, DOI 10.1016/0003-2697(81)90104-4; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Lee RG, 2000, J LIPID RES, V41, P1991; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Rudel LL, 2005, ARTERIOSCL THROM VAS, V25, P1112, DOI 10.1161/01.ATV.0000166548.65753.1e; Rudel LL, 1998, PROG LIPID RES, V37, P353, DOI 10.1016/S0163-7827(98)00015-0; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Sliskovic Drago R, 2002, Prog Med Chem, V39, P121, DOI 10.1016/S0079-6468(08)70070-5; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139	24	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10453	10460		10.1074/jbc.M709460200	http://dx.doi.org/10.1074/jbc.M709460200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18285335	Green Published, hybrid			2022-12-27	WOS:000254894700026
J	Perez, JC; Latifi, T; Groisman, EA				Perez, J. Christian; Latifi, Tammy; Groisman, Eduardo A.			Overcoming H-NS-mediated transcriptional silencing of horizontally acquired genes by the PhoP and SlyA proteins in Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; RNA-POLYMERASE; ANTIMICROBIAL PEPTIDES; REGULATORY NETWORK; FOREIGN DNA; EXPRESSION; RESISTANCE; VIRULENCE; TYPHIMURIUM; SYSTEM	The acquisition of new traits through horizontal gene transfer depends on the ability of the recipient organism to express the incorporated genes. However, foreign DNA appears to be silenced by the histone-like nucleoid-structuring protein (H-NS) in several enteric pathogens, raising the question of how this silencing is overcome and the acquired genes are expressed at the right time and place. To address this question, we investigated transcription of the horizontally acquired ugtL and pagC genes from Salmonella enterica, which is dependent on the regulatory DNA-binding proteins PhoP and SlyA. We reconstituted transcription of the ugtL and pagC genes in vitro and determined occupancy of their respective promoters by PhoP, H-NS, and RNA polymerase in vivo. The SlyA protein counteracted H-NS-promoted repression in vitro but could not promote gene transcription by itself. PhoP-promoted transcription required SlyA when H-NS was present but not in its absence. In vivo, H-NS remained bound to the ugtL and pagC promoters under inducing conditions that promoted RNA polymerase recruitment and transcription of the ugtL and pagC genes. Our results indicate that relief of H-NS repression and recruitment of RNA polymerase are controlled by different regulatory proteins that act in concert to express horizontally acquired genes.	[Perez, J. Christian] Washington Univ, Sch Med, Howard Hughes Med Inst, Program Mol Genet & Genom, St Louis, MO 63110 USA; [Latifi, Tammy; Groisman, Eduardo A.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu		Perez, J. Christian/0000-0001-5790-1481	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI049561, AI49561, R01 AI042236-10, R01 AI049561-16, R01 AI042236] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042236, R01AI049561] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Boyle EC, 2007, J BACTERIOL, V189, P1489, DOI 10.1128/JB.01730-06; Chamnongpol S, 2000, J MOL BIOL, V300, P291, DOI 10.1006/jmbi.2000.3848; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Corbett D, 2007, J BIOL CHEM, V282, P33326, DOI 10.1074/jbc.M703465200; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Kusano S, 1996, J BIOL CHEM, V271, P1998, DOI 10.1074/jbc.271.4.1998; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Nishio M, 2005, MICROBIOL-SGM, V151, P863, DOI 10.1099/mic.0.27654-0; Noom MC, 2007, CURR BIOL, V17, pR913, DOI 10.1016/j.cub.2007.09.005; Norte VA, 2003, J BACTERIOL, V185, P3508, DOI 10.1128/JB.185.12.3508-3514.2003; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Reusch RN, 2002, FEBS LETT, V527, P319, DOI 10.1016/S0014-5793(02)03236-2; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Shin D, 2005, J BIOL CHEM, V280, P4089, DOI 10.1074/jbc.M412741200; Shin D, 2006, SCIENCE, V314, P1607, DOI 10.1126/science.1134930; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; SNAVELY MD, 1991, J BIOL CHEM, V266, P824; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Sonnenfield JM, 2001, BIOCHIMIE, V83, P243, DOI 10.1016/S0300-9084(01)01232-9; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Turner EC, 2007, J BACTERIOL, V189, P3403, DOI 10.1128/JB.01813-06; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Winfield MD, 2005, J BIOL CHEM, V280, P14765, DOI 10.1074/jbc.M413900200; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004; Yamamoto K, 2002, MOL MICROBIOL, V45, P423, DOI 10.1046/j.1365-2958.2002.03017.x; Zwir I, 2005, BIOINFORMATICS, V21, P4073, DOI 10.1093/bioinformatics/bti672; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	49	77	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10773	10783		10.1074/jbc.M709843200	http://dx.doi.org/10.1074/jbc.M709843200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18270203	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000254894700060
J	Bhattacharyya, S; Kotlo, K; Shukla, S; Danziger, RS; Tobacman, JK				Bhattacharyya, Sumit; Kotlo, Kumar; Shukla, Sagar; Danziger, Robert S.; Tobacman, Joanne K.			Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYLSULFATASE-B; GROWTH-FACTOR; CELLS; SYNDECAN-1; ENDOCYTOSIS; DECORIN; HEPARIN; BINDING; PROTEOGLYCANS; CARCINOMA	The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B (ASB)) and galactose-6-sulfatase (GALNS) hydrolyze sulfate groups of CS. Deficiencies of ASB and GALNS are associated with the mucopolysaccharidoses. To determine if expression of ASB and GALNS impacts on glycosaminoglycans (GAGs) and proteoglycans beyond their association with the mucopolysaccharidoses, we modified the expression of ASB and GALNS by overexpression and by silencing with small interference RNA in MCF-7 cells. Content of total sulfated GAG (sGAG), chondroitin 4-sulfate (C4S), and total chondroitin sulfates (CSs) was measured following immunoprecipitation with C4S and CS antibodies and treatment with chondroitinase ABC. Following silencing of ASB or GALNS, total sGAG, C4S, and CS increased significantly. Following overexpression of ASB or GALNS, total sGAG, C4S, and CS declined significantly. Measurements following chondroitinase ABC treatment of the cell lysates demonstrated no change in the content of the other sGAG, including heparin, heparan sulfate, dermatan sulfate, and keratan sulfate. Following overexpression of ASB and immunoprecipitation with C4S antibody, virtually no sGAG was detectable. Total sGAG content increased to 23.39 (+/- 1.06) mu g/mg of protein from baseline of 12.47 (+/- 0.68) mu g/mg of protein following ASB silencing. mRNA expression of core proteins of the CS-containing proteoglycans, syndecan-1 and decorin, was significantly up-regulated following overexpression of ASB and GALNS. Soluble syndecan-1 protein increased following increases in ASB and GALNS and reduced following silencing, inversely to changes in CS. These findings demonstrate that modification of expression of the lysosomal sulfatases ASB and GALNS regulates the content of CSs.	[Bhattacharyya, Sumit; Kotlo, Kumar; Shukla, Sagar; Danziger, Robert S.; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Danziger, Robert S.; Tobacman, Joanne K.] Univ Illinois, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,M-C 718,CSN 440, Chicago, IL 60612 USA.	jkt@uic.edu						Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; Bhattacharyya S, 2007, CLIN CHIM ACTA, V380, P122, DOI 10.1016/j.cca.2007.01.021; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Burbach BJ, 2003, MATRIX BIOL, V22, P163, DOI 10.1016/S0945-053X(03)00009-X; Couchman JR, 2001, INT REV CYTOL, V207, P113; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Hausser H, 1998, ARCH BIOCHEM BIOPHYS, V349, P363, DOI 10.1006/abbi.1997.0471; HAUSSER H, 1991, J CELL BIOL, V114, P45, DOI 10.1083/jcb.114.1.45; HAUSSER H, 1992, J BIOL CHEM, V267, P11559; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Li J, 2002, J CELL SCI, V115, P1951; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Samiric T, 2004, EUR J BIOCHEM, V271, P3612, DOI 10.1111/j.0014-2956.2004.04307.x; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tsanou E, 2004, J EXP CLIN CANC RES, V23, P641; Wilson VA, 2002, GLYCOCONJUGATE J, V19, P347, DOI 10.1023/A:1025325222530; Winter AD, 2000, MATRIX BIOL, V19, P129, DOI 10.1016/S0945-053X(00)00054-8; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zimmermann P, 1999, FASEB J, V13, pS91	23	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9523	9530		10.1074/jbc.M707967200	http://dx.doi.org/10.1074/jbc.M707967200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18285341	hybrid			2022-12-27	WOS:000254671600005
J	Gee, P; Chua, PK; Gevorkyan, J; Klumpp, K; Najera, I; Swinney, DC; Deval, J				Gee, Peter; Chua, Pong Kian; Gevorkyan, Jirair; Klumpp, Klaus; Najera, Isabel; Swinney, David C.; Deval, Jerome			Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; ANTIVIRAL SIGNALING PROTEIN; INNATE IMMUNITY; NS3 HELICASE; NONSTRUCTURAL PROTEIN-3; ADAPTER PROTEIN; BOX HELICASES; RNA VIRUSES; KAPPA-B; ACTIVATION	Retinoic acid-inducible gene I (RIG-I) is a cytosolic receptor that recognizes viral RNA and activates the interferon-mediated innate antiviral response. To understand the mechanism of signal activation at the receptor level, we cloned, expressed, and purified human RIG-I containing the two caspase activation and recruitment domains (CARDs) followed by the C-terminal helicase domain. We found that recombinant RIG-I is a functional protein that interacts with double-stranded RNA with substantially higher affinity as compared with single-stranded RNA structures unless they contain a 5'-triphosphate group. Viral RNA binding to RIG-I stimulates the velocity of ATP hydrolysis by 33-fold, which at the cellular level translates into a 43-fold increase of interferon-beta expression. In contrast, the isolated ATPase/helicase domain is constitutively activated while also retaining its RNA ligand binding properties. These results support the recent model by which RIG-I signaling is autoinhibited in the absence of RNA by intra-molecular interactions between the CARDs and the C terminus. Based on pH profile and metal ion dependence experiments, we propose that the active site of RIG-I cannot efficiently accommodate divalent cations under the RNA-free repressed conformation. Overall, these results show a direct correlation between RNA binding and ATPase enzymatic function leading to signal transduction and suggest that a tight control of ATPase activity by the CARDs prevents RIG-I signaling in the absence of viral RNA.	[Gee, Peter; Chua, Pong Kian; Gevorkyan, Jirair; Klumpp, Klaus; Najera, Isabel; Swinney, David C.; Deval, Jerome] Roche Palo Alto LLC, Palo Alto, CA 94304 USA	Roche Holding	Deval, J (corresponding author), Roche Palo Alto LLC, Palo Alto, CA 94304 USA.	jerome.deval@roche.com	Gee, Peter/H-5681-2013					Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Du MX, 2002, BIOCHEM J, V363, P147, DOI 10.1042/0264-6021:3630147; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Frick DN, 2007, J MOL BIOL, V365, P1017, DOI 10.1016/j.jmb.2006.10.023; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Klumpp K, 2006, J BIOL CHEM, V281, P3793, DOI 10.1074/jbc.M510195200; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Manelyte L, 2006, NUCLEIC ACIDS RES, V34, P5270, DOI 10.1093/nar/gkl489; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; McKenna SA, 2007, J BIOL CHEM, V282, P11474, DOI 10.1074/jbc.M700301200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Wardell AD, 1999, J GEN VIROL, V80, P701, DOI 10.1099/0022-1317-80-3-701; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	40	57	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9488	9496		10.1074/jbc.M706777200	http://dx.doi.org/10.1074/jbc.M706777200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18268020	hybrid			2022-12-27	WOS:000254465800078
J	Kimura, Y; Hirano, Y; Yu, LJ; Suzuki, H; Kobayashi, M; Wang, ZY				Kimura, Yukihiro; Hirano, Yu; Yu, Long-Jiang; Suzuki, Hiroaki; Kobayashi, Masayuki; Wang, Zheng-Yu			Calcium ions are involved in the unusual red shift of the light-harvesting 1 Q(y) transition of the core complex in thermophilic purple sulfur bacterium Thermochromatium tepidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYNTHETIC REACTION-CENTER; BULLFROG SKELETAL-MUSCLE; RHODOBACTER-SPHAEROIDES; RHODOPSEUDOMONAS-VIRIDIS; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; HEAT-CAPACITY; CA2+ BINDING; TROPONIN-C	Thermophilic purple sulfur bacterium, Thermochromatium tepidum, can grow at temperatures up to 58 C and exhibits an unusual Q(y) absorption at 915 nm for the core light-harvesting complex (LH1), an similar to 35-nm red shift from those of its mesophilic counterparts. We demonstrate in this study, using a highly purified LH1-reaction center complex, that the LH1 Qy transition is strongly dependent on metal cations and Ca2+ is involved in the unusual red shift. Removal of the Ca2+ resulted in formation of a species with the LH1 Qy absorption at 880 nm, and addition of the Ca2+ to the 880-nm species recovered the native 915-nm form. Interchange between the two forms is fully reversible. Based on spectroscopic and isothermal titration calorimetry analyses, the Ca2+ binding to the LH1 complex was estimated to occur in a stoichiometric ratio of Ca2+/alpha beta-subunit = 1: 1 and the binding constant was in 10(5) M-1 order of magnitude, which is comparable with those for EF-hand Ca2+-binding proteins. Despite the high affinity, conformational changes in the LH1 complex upon Ca2+ binding were small and occurred slowly, with a typical time constant of similar to 6 min. Replacement of the Ca2+ with other metal cations caused blue shifts of the Qy bands depending on the property of the cations, indicating that the binding site is highly selective. Based on the amino acid sequences of the LH1 complex, possible Ca2+-binding sites are proposed that consist of several acidic amino acid residues near the membrane interfaces of the C-terminal region of the alpha-polypeptide and the N-terminal region of the beta-polypeptide.	[Kimura, Yukihiro; Hirano, Yu; Yu, Long-Jiang; Suzuki, Hiroaki; Wang, Zheng-Yu] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan; [Kobayashi, Masayuki] Ariake Natl Coll Technol, Fukuoka 8368585, Japan	Ibaraki University	Wang, ZY (corresponding author), Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan.	wang@mx.ibaraki.ac.jp	Kimura, Yukihiro/AAI-6300-2020					ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P5730, DOI 10.1073/pnas.84.16.5730; ALLEN JP, 1986, P NATL ACAD SCI USA, V83, P8589, DOI 10.1073/pnas.83.22.8589; CLAYTON RK, 1981, P NATL ACAD SCI-BIOL, V78, P5583, DOI 10.1073/pnas.78.9.5583; Cogdell RJ, 2002, PHOTOSYNTH RES, V74, P135, DOI 10.1023/A:1020995224156; COX JA, 1982, J BIOL CHEM, V257, P694; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; Dudev T, 2007, ACCOUNTS CHEM RES, V40, P85, DOI 10.1021/ar068181i; Fathir I, 1998, PHOTOSYNTH RES, V58, P193, DOI 10.1023/A:1006146713751; FOWLER GJS, 1992, NATURE, V355, P848, DOI 10.1038/355848a0; Georgakopoulou S, 2006, J PHYS CHEM B, V110, P3344, DOI 10.1021/jp051794c; Georgakopoulou S, 2006, J PHYS CHEM B, V110, P3354, DOI 10.1021/jp0517955; Glaeser J, 1999, ARCH MICROBIOL, V171, P405, DOI 10.1007/s002030050727; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; IMAIZUMI M, 1987, J BIOL CHEM, V262, P7963; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; Kobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P1130, DOI 10.1271/bbb.69.1130; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Kramer H, 1996, PHOTOSYNTH RES, V49, P237, DOI 10.1007/BF00034784; MADIGAN MT, 1984, SCIENCE, V225, P313, DOI 10.1126/science.225.4659.313; Madigan MT, 2003, PHOTOSYNTH RES, V76, P157, DOI 10.1023/A:1024998212684; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a; MILOS M, 1986, BIOCHEMISTRY-US, V25, P6279, DOI 10.1021/bi00368a067; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; NOZAWA T, 1986, BIOCHIM BIOPHYS ACTA, V852, P191, DOI 10.1016/0005-2728(86)90223-9; OGAWA Y, 1986, J BIOCHEM-TOKYO, V99, P81, DOI 10.1093/oxfordjournals.jbchem.a135482; OGAWA Y, 1984, J BIOCHEM-TOKYO, V95, P19, DOI 10.1093/oxfordjournals.jbchem.a134584; OLSEN JD, 1994, P NATL ACAD SCI USA, V91, P7124, DOI 10.1073/pnas.91.15.7124; Permentier HP, 2001, BIOCHEMISTRY-US, V40, P5573, DOI 10.1021/bi0024308; POTTER JD, 1977, J BIOL CHEM, V252, P2452; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; SCHWARZ FP, 1993, J BIOL CHEM, V268, P7668; STURGIS JN, 1995, BIOCHEMISTRY-US, V34, P517, DOI 10.1021/bi00002a016; Suzuki H, 2007, BBA-BIOENERGETICS, V1767, P1057, DOI 10.1016/j.bbabio.2007.06.002; TANOKURA M, 1993, J BIOL CHEM, V268, P7090; TANOKURA M, 1987, BIOCHEMISTRY-US, V26, P7668, DOI 10.1021/bi00398a020; TANOKURA M, 1986, FEBS LETT, V209, P77, DOI 10.1016/0014-5793(86)81087-0; TANOKURA M, 1984, J BIOCHEM-TOKYO, V95, P643, DOI 10.1093/oxfordjournals.jbchem.a134653; Tuschak C, 2004, PHOTOSYNTH RES, V81, P181, DOI 10.1023/B:PRES.0000035046.91126.bd; Wang ZY, 2003, PHOTOSYNTH RES, V78, P133, DOI 10.1023/B:PRES.0000004328.11219.79; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; YAMADA K, 1982, J BIOCHEM-TOKYO, V92, P1505, DOI 10.1093/oxfordjournals.jbchem.a134075; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b	49	54	56	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13867	13873		10.1074/jbc.M800256200	http://dx.doi.org/10.1074/jbc.M800256200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332135	hybrid			2022-12-27	WOS:000255728200040
J	Lee, DW; Ozturk, Y; Osyczka, A; Cooley, JW; Daldal, F				Lee, Dong-Woo; Ozturk, Yavuz; Osyczka, Artur; Cooley, Jason W.; Daldal, Fevzi			Cytochrome bc(1)-c(y) fusion complexes reveal the distance constraints for functional electron transfer between photosynthesis components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION Q(O) SITE; RHODOBACTER-CAPSULATUS; DOMAIN MOVEMENT; SPHAEROIDES; MEMBRANE; C(Y); SUPERCOMPLEXES; CHAIN; PROTEIN; GROWTH	Photosynthetic (Ps) growth of purple non-sulfur bacteria such as Rhodobacter capsulatus depends on the cyclic electron transfer (ET) between the ubihydroquinone (QH(2)): cytochrome (cyt) c oxidoreductases (cyt bc(1) complex), and the photochemical reaction centers (RC), mediated by either a membrane-bound (cyt c(y)) or a freely diffusible (cyt c(2)) electron carrier. Previously, we constructed a functional cyt bc(1)-c(y) fusion complex that supported Ps growth solely relying on membrane-confined ET (Lee, D.-W., Ozturk, Y., Mamedova, A., Osyczka, A., Cooley, J. W., and Daldal, F. (2006) Biochim. Biophys. Acta 1757, 346 352). In this work, we further characterized this cyt bc1-cy fusion complex, and used its derivatives with shorter cyt c(y) linkers as "molecular rulers" to probe the distances separating the Ps components. Comparison of the physicochemical properties of both membrane-embedded and purified cyt bc(1)-c(y) fusion complexes established that these enzymes were matured and assembled properly. Light-activated, time-resolved kinetic spectroscopy analyses revealed that their variants with shorter cyt c(y) linkers exhibited fast, native-like ET rates to the RC via the cyt bc(1). However, shortening the length of the cyt (c)y linker decreased drastically this electronic coupling between the cyt bc(1)-c(y) fusion complexes and the RC, thereby limiting Ps growth. The shortest and still functional cyt c(y) linker was about 45 amino acids long, showing that the minimal distance allowed between the cyt bc(1)-c(y) fusion complexes and the RC and their surrounding light harvesting proteins was very short. These findings support the notion that membrane-bound Ps components form large, active structural complexes that are "hardwired" for cyclic ET.	[Lee, Dong-Woo; Ozturk, Yavuz; Cooley, Jason W.; Daldal, Fevzi] Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; [Osyczka, Artur] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ozturk, Yavuz] TUBITAK Marmara Res Ctr, Genet Engn & Biotechnol Inst, TR-41470 Gebze, Kocaeli, Turkey	University of Pennsylvania; University of Pennsylvania; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)	Daldal, F (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu		Osyczka, Artur/0000-0002-1637-2365	NIGMS NIH HHS [GM38237, R01 GM038237] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Crofts AR, 2000, TRENDS MICROBIOL, V8, P105, DOI 10.1016/S0966-842X(99)01693-5; CROFTS AR, 1982, BIOCHEM SOC T, V10, P201, DOI 10.1042/bst0100201; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2004, PHOTOSYNTH RES, V79, P25, DOI 10.1023/B:PRES.0000011926.47778.4e; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DONOHUE TJ, 1988, BIOCHEMISTRY-US, V27, P1918, DOI 10.1021/bi00406a018; Dutton P L, 1978, Methods Enzymol, V54, P411; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; JENNEY FE, 1994, BIOCHEMISTRY-US, V33, P2496, DOI 10.1021/bi00175a019; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Jenney FE, 1996, BBA-BIOENERGETICS, V1273, P159, DOI 10.1016/0005-2728(95)00137-9; Joliot P, 2005, BBA-BIOENERGETICS, V1706, P204, DOI 10.1016/j.bbabio.2004.11.002; JOLIOT P, 1989, BIOCHIM BIOPHYS ACTA, V975, P336, DOI 10.1016/S0005-2728(89)80341-X; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DW, 2006, BBA-BIOENERGETICS, V1757, P346, DOI 10.1016/j.bbabio.2006.04.025; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Myllykallio H, 1998, BIOCHEMISTRY-US, V37, P5501, DOI 10.1021/bi973123d; Myllykallio H, 1997, J BACTERIOL, V179, P2623, DOI 10.1128/jb.179.8.2623-2631.1997; Ozturk Y, 2008, J BIOL CHEM, V283, P13964, DOI 10.1074/jbc.M800090200; ROBERTSON DE, 1993, BIOCHEMISTRY-US, V32, P1310, DOI 10.1021/bi00056a016; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schoepp-Cothenet B, 2001, FEBS LETT, V487, P372, DOI 10.1016/S0014-5793(00)02357-7; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; Vermeglio A, 1999, TRENDS MICROBIOL, V7, P435, DOI 10.1016/S0966-842X(99)01625-X; ZANNONI D, 1993, ARCH MICROBIOL, V160, P413, DOI 10.1007/BF00245301	38	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13973	13982		10.1074/jbc.M800091200	http://dx.doi.org/10.1074/jbc.M800091200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343816	Green Published, hybrid			2022-12-27	WOS:000255728200051
J	Planque, S; Escobar, MA; Smith, KC; Taguchi, H; Nishiyama, Y; Donnachie, E; Pratt, KP; Paul, S				Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Pratt, Kathleen P.; Paul, Sudhir			Covalent inactivation of factor VIII antibodies from hemophilia a patients by an electrophilic FVIII analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CRYSTAL-STRUCTURE; C2 DOMAIN; INHIBITOR; BINDING; IDENTIFICATION; COMPLEX; EPITOPE; DERIVATIVES; MECHANISMS	The antigen-binding sites of antibodies (Abs) can express enzyme-like nucleophiles that react covalently with electrophilic compounds. We examined the irreversible and specific inactivation of antibodies (Abs) to Factor VIII (FVIII) responsible for failure of FVIII replacement therapy in hemophilia A (HA) patients. Electrophilic analogs of FVIII (E-FVIII) and its C2 domain (E-C2) were prepared by placing the strongly electrophilic phosphonate groups at surface-exposed Lys side chains of diverse antigenic epitopes. IgG Abs to FVIII from HA patients formed stable immune complexes with E-FVIII and E-C2 that were refractory to dissociation by SDS treatment and boiling, procedures that dissociate noncovalent Ab-antigen complexes. The rate-limiting step in the reaction was formation of the initial noncovalent complexes. Conversion of the initial complexes to the irreversible state occurred rapidly. The antigenic epitopes of E-FVIII were largely intact, and most of the Abs were consumed covalently. E-FVIII expressed poor FVIII cofactor activity in clotting factor assays. Nonspecific interference by E-FVIII in clotting factor function was not evident. Treatment with E-FVIII, and to a lesser extent E-C2, irreversibly relieved the FVIII inhibitory effect of HA IgG in clotting factor assays. Small FVIII peptides did not display useful reactivity, highlighting the diverse epitope specificities of the Abs and the conformational character of FVIII epitopes. E-FVIII is a prototype reagent able to attain irreversible and specific inactivation of pathogenic Abs.	[Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Paul, Sudhir] Univ Texas Houston, Sch Med, Gulf States Hemophilia & Thrombophilia Ctr, Houston, TX 77030 USA; [Pratt, Kathleen P.] Univ Washington, Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Pratt, Kathleen P.] Univ Washington, Div Hematol, Seattle, WA 98104 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Paul, S (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol, Chem Immunol Res Ctr, 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Pratt, Kathleen P/E-9489-2019	Csencsits-Smith, Keri/0000-0002-8477-7903; Pratt, Kathleen/0000-0001-6837-6133	NIAID NIH HHS [AI31268] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031268, R21AI031268] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APPEL SH, 1975, NEW ENGL J MED, V293, P760, DOI 10.1056/NEJM197510092931508; Berntorp E, 2006, SEMIN THROMB HEMOST, V32, P22, DOI 10.1055/s-2006-946911; Bertrand JA, 1996, BIOCHEMISTRY-US, V35, P3147, DOI 10.1021/bi9520996; Bhopale GM, 2003, J BIOSCIENCES, V28, P783, DOI 10.1007/BF02708439; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Brackmann H H, 1984, Prog Clin Biol Res, V150, P181; BRACKMANN HH, 1977, LANCET, V2, P933; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Coopamah MD, 2003, TRANSFUS MED REV, V17, P69, DOI 10.1053/tmrv.2003.50004; Ettingshausen CE, 2006, HAEMOPHILIA, V12, P102, DOI 10.1111/j.1365-2516.2006.01373.x; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gilles JGG, 2004, BLOOD, V103, P2617, DOI 10.1182/blood-2003-07-2207; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HEALEY JF, 1995, J BIOL CHEM, V270, P14505, DOI 10.1074/jbc.270.24.14505; Jones ML, 2003, HAEMOPHILIA, V9, P464, DOI 10.1046/j.1365-2516.2003.00782.x; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P875, DOI 10.1055/s-0038-1651380; Kopecky EM, 2006, J IMMUNOL METHODS, V308, P90, DOI 10.1016/j.jim.2005.10.016; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Lavigne-Lissalde G, 2005, THROMB HAEMOSTASIS, V94, P760, DOI 10.1160/TH05-02-0118; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; Nogami K, 1999, BRIT J HAEMATOL, V107, P196, DOI 10.1046/j.1365-2141.1999.01673.x; Nossal GJV, 1997, CIBA F SYMP, V204, P220; OLEKSYSZYN J, 1994, METHOD ENZYMOL, V244, P423; PAUL S, 1991, J BIOL CHEM, V266, P16128; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; PAUL S, 1992, J BIOL CHEM, V267, P13142; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; PAUL S, 1989, J NEUROIMMUNOL, V23, P133, DOI 10.1016/0165-5728(89)90032-5; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Sahud MA, 2007, HAEMOPHILIA, V13, P317, DOI 10.1111/j.1365-2516.2007.01450.x; Scandella D, 1999, VOX SANG, V77, P17, DOI 10.1159/000056708; Schenone M, 2004, CURR OPIN HEMATOL, V11, P272, DOI 10.1097/01.moh.0000130308.37353.d4; Shetty S, 2003, HAEMOPHILIA, V9, P654, DOI 10.1046/j.1365-2516.2003.00810.x; Smith KC, 2007, J IMMUNOL, V178; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; ten Boekel E, 2007, THROMB RES, V121, P361, DOI 10.1016/j.thromres.2007.05.006; Tsao ML, 2005, CHEMBIOCHEM, V6, P2147, DOI 10.1002/cbic.200500314; van Dijk K, 2005, HAEMATOLOGICA, V90, P494; Villard S, 2003, BLOOD, V102, P949, DOI 10.1182/blood-2002-06-1886; Villard S, 2002, J BIOL CHEM, V277, P27232, DOI 10.1074/jbc.M203415200; WALTER J, 1983, H-S Z PHYSIOL CHEM, V364, P949, DOI 10.1515/bchm2.1983.364.2.949; Zhong DG, 1998, BLOOD, V92, P136, DOI 10.1182/blood.V92.1.136.413k35_136_142	50	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11876	11886		10.1074/jbc.M800589200	http://dx.doi.org/10.1074/jbc.M800589200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18337255	Green Published, hybrid			2022-12-27	WOS:000255340000003
J	Steed, PR; Fillingame, RH				Steed, P. Ryan; Fillingame, Robert H.			Subunit a facilitates aqueous access to a membrane-embedded region of subunit C in Escherichia coli F1F0 ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE PROTEIN COMPONENT; ENERGY-TRANSDUCING SYSTEM; CROSS-LINKING; ROTARY MOTOR; ROTOR RING; CHANNEL; SECTOR; DICYCLOHEXYLCARBODIIMIDE; STOICHIOMETRY; MECHANISM	Rotary catalysis in F1F0 ATP synthase is powered by proton translocation through the membrane-embedded F-0 sector. Proton binding and release occurs in the middle of the membrane at Asp-61 on transmembrane helix 2 of subunit c. Previously, the reactivity of cysteines substituted into F0 subunit a revealed two regions of aqueous access, one extending from the periplasm to the middle of the membrane and a second extending from the middle of the membrane to the cytoplasm. To further characterize aqueous accessibility at the subunit a-c interface, we have substituted Cys for residues on the cytoplasmic side of transmembrane helix 2 of subunit c and probed the accessibility to these substituted positions using thiolate-reactive reagents. The Cys substitutions tested were uniformly inhibited by Ag+ treatment, which suggested widespread aqueous access to this generally hydrophobic region. Sensitivity to N-ethylmaleimide (NEM) and methanethiosulfonate reagents was localized to a membrane-embedded pocket surrounding Asp-61. The cG58C substitution was profoundly inhibited by all the reagents tested, including membrane impermeant methanethiosulfonate reagents. Further studies of the highly reactive cG58C substitution revealed that NEM modification of a single c subunit in the oligomeric c-ring was sufficient to cause complete inhibition. In addition, NEMmodification of subunit c was dependent upon the presence of subunit a. The results described here provide further evidence for an aqueous-accessible region at the interface of subunits a and c extending from the middle of the membrane to the cytoplasm.	[Steed, P. Ryan; Fillingame, Robert H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; [Anonymous], 1973, CHEM BIOCH SULFHYDRY; Barik S, 1996, Methods Mol Biol, V57, P203; Bell RA, 1999, ENVIRON TOXICOL CHEM, V18, P9, DOI [10.1897/1551-5028(1999)018&lt;0009:SCAGOS&gt;2.3.CO;2, 10.1002/etc.5620180103]; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; FILLINGAME RH, 1976, J BIOL CHEM, V251, P6630; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FIMMEL AL, 1983, BIOCHEM J, V213, P451, DOI 10.1042/bj2130451; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, FEBS J, V272, P5474, DOI [10.1111/j.1742-4658.2005.04940.x, 10.1111/j.1742-4685.2005.04940.x]; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Vincent OD, 2007, J BIOL CHEM, V282, P33788, DOI 10.1074/jbc.M706904200; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	41	35	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12365	12372		10.1074/jbc.M800901200	http://dx.doi.org/10.1074/jbc.M800901200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332132	Green Published, hybrid			2022-12-27	WOS:000255340000053
J	Wakabayashi, H; Fay, PJ				Wakabayashi, Hironao; Fay, Philip J.			Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILD HEMOPHILIA-A; ONE-STAGE; SUBUNIT DISSOCIATION; FAMILIAL DISCREPANCY; A1/A3-C1-C2 DIMER; CA2+ BINDING; FACTOR-IXA; MUTATIONS; MODEL; SITE	Factor VIII circulates as a heterodimer composed of heavy (A1A2B domains) and light (A3C1C2 domains) chains, whereas the contiguous A1A2 domains are separate subunits in the active cofactor, factor VIIIa. Whereas the A1 subunit maintains a stable interaction with the A3C1C2 subunit, the A2 subunit is weakly associated in factor VIIIa and its dissociation accounts for the labile activity of the cofactor. In examining the ceruloplasmin-based factor VIII A domain model, potential hydrogen bonding based upon spatial separations of < 2.8 angstrom were found between side chains of 14 A2 domain residues and 7 and 9 residues in the A1 and A3 domains, respectively. These residues were individually replaced with Ala, except Tyr residues were replaced with Phe, and proteins stably expressed to examine the contribution of each residue to protein stability. Factor VIII stability at 55 degrees C and factor VIIIa activity were monitored using factor Xa generation assays. Fourteen of 30 factor VIII mutants showed > 2-fold increases in either or both decay rates compared with wild type; whereas, 7 mutants showed > 2-fold increased rates in factor VIIIa decay compared with factor VIII decay. These results suggested that multiple residues at the A1-A2 and A2-A3 domain interfaces contribute to stabilizing the protein. Furthermore, these data discriminate residues that stabilize interactions in the procofactor from those in the cofactor, where hydrogen bonding in the latter appears to contribute more significantly to stability. This observation is consistent with an altered conformation involving new inter-subunit interactions involving A2 domain following procofactor activation.	[Wakabayashi, Hironao; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), 601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			NHLBI NIH HHS [HL38199, HL76213] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076213, R01HL038199] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansong C, 2005, BIOCHEMISTRY-US, V44, P8850, DOI 10.1021/bi050145o; Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; DUNCAN EM, 1994, BRIT J HAEMATOL, V87, P846, DOI 10.1111/j.1365-2141.1994.tb06749.x; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakeos WH, 2002, THROMB HAEMOSTASIS, V88, P781, DOI 10.1055/s-0037-1613302; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1984, BLOOD, V63, P1303; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Parker ET, 2006, J BIOL CHEM, V281, P13922, DOI 10.1074/jbc.M513124200; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; Pipe SW, 2001, BLOOD, V97, P685, DOI 10.1182/blood.V97.3.685; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Rudzki Z, 1996, BRIT J HAEMATOL, V94, P400, DOI 10.1046/j.1365-2141.1996.d01-1792.x; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Thurlkill RL, 2006, J MOL BIOL, V362, P594, DOI 10.1016/j.jmb.2006.07.056; Wakabayashi H, 2007, J THROMB HAEMOST, V5, P996, DOI 10.1111/j.1538-7836.2007.02458.x; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051	32	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11645	11651		10.1074/jbc.M710252200	http://dx.doi.org/10.1074/jbc.M710252200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299331	hybrid, Green Published			2022-12-27	WOS:000255067400065
J	Lakowski, TM; Frankel, A				Lakowski, Ted M.; Frankel, Adam			A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; S-ADENOSYLMETHIONINE; N-METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; HISTONE H3; SYMMETRIC DIMETHYLARGININE; METHYLATION; RESIDUES; PURIFICATION; PRMT6	Human protein arginine N-methyltransferase 6 (PRMT6) transfers methyl groups from the co-substrate S-adenosyl-L-methionine to arginine residues within proteins, forming S-adenosyl-L-homocysteine as well as omega-N-G-monomethylarginine (MMA) and asymmetric dimethylarginine (aDMA) residues in the process. We have characterized the kinetic mechanism of recombinant His-tagged PRMT6 using a mass spectrometry method for monitoring the methylation of a series of peptides bearing a single arginine, MMA, or aDMA residue. We find that PRMT6 follows an ordered sequential mechanism in which S-adenosyl-L-methionine binds to the enzyme first and the methylated product is the first to dissociate. Furthermore, we find that the enzyme displays a preference for the monomethylated peptide substrate, exhibiting both lower K-m and higher V-max values than what are observed for the unmethylated peptide. This difference in substrate K-m and V-max, as well as the lack of detectable aDMA-containing product from the unmethylated substrate, suggest a distributive rather than processive mechanism for multiple methylations of a single arginine residue. In addition, we speculate that the increased catalytic efficiency of PRMT6 for methylated substrates combined with lower K-m values for native protein methyl acceptors may obscure this distributive mechanism to produce an apparently processive mechanism.	[Lakowski, Ted M.; Frankel, Adam] Univ British Columbia, Fac Pharmaceut Sci, Div Biomol & Pharmaceut Chem, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Frankel, A (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Div Biomol & Pharmaceut Chem, 2146 E Mall, Vancouver, BC V6T 1Z3, Canada.	afrankel@interchange.ubc.ca		Lakowski, Ted/0000-0002-6625-6717				Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Cheng X, 2000, S ADENOSYLMETHIONINE; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; DAWSON MC, 1986, DATA BIOCH RES, P1; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Duan P, 2007, J IMMUNOL METHODS, V320, P132, DOI 10.1016/j.jim.2007.01.006; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; FRANCIS DM, 1980, BIOCHEM J, V187, P819, DOI 10.1042/bj1870819; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gehrig PM, 2004, J AM SOC MASS SPECTR, V15, P142, DOI 10.1016/j.jasms.2003.10.002; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GITOMER WL, 1986, BIOCHEM J, V233, P669, DOI 10.1042/bj2330669; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Invernizzi CF, 2007, AIDS, V21, P795, DOI 10.1097/QAD.0b013e32803277ae; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Klein S, 2000, J BIOL CHEM, V275, P3150, DOI 10.1074/jbc.275.5.3150; KNOGGE W, 1984, EUR J BIOCHEM, V140, P113, DOI 10.1111/j.1432-1033.1984.tb08073.x; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE HW, 1977, BIOCHEMISTRY-US, V16, P78, DOI 10.1021/bi00620a013; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LISCHWE MA, 1985, J BIOL CHEM, V260, P14304; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Morris DP, 1995, J BIOL CHEM, V270, P30491, DOI 10.1074/jbc.270.51.30491; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; RAWAL N, 1995, BBA-PROTEIN STRUCT M, V1248, P11, DOI 10.1016/0167-4838(94)00213-Z; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; SEGEL IH, 1975, ENZYME KINETICS, P506; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Siebel CW, 1996, P NATL ACAD SCI USA, V93, P13641, DOI 10.1073/pnas.93.24.13641; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Spannhoff A, 2007, J MED CHEM, V50, P2319, DOI 10.1021/jm061250e; Spannhoff A, 2007, BIOORG MED CHEM LETT, V17, P4150, DOI 10.1016/j.bmcl.2007.05.088; STEWART DJ, 1984, J NEURO-ONCOL, V2, P53, DOI 10.1007/BF00165158; Tamanoi F, 2006, ENZYMES, V24, pXI; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; YOUNG PR, 1988, BIOCHEM J, V250, P221, DOI 10.1042/bj2500221; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	70	66	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					10015	10025		10.1074/jbc.M710176200	http://dx.doi.org/10.1074/jbc.M710176200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18263580	hybrid			2022-12-27	WOS:000254671600057
J	Ma, CL; Bower, KA; Chen, G; Shi, XL; Ke, ZJ; Luo, J				Ma, Cuiling; Bower, Kimberly A.; Chen, Gang; Shi, Xianglin; Ke, Zun-Ji; Luo, Jia			Interaction between ERK and GSK3 beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3-BETA; CISPLATIN-INDUCED APOPTOSIS; BETA-ARRESTIN; MAP KINASE; TAU PHOSPHORYLATION; GLIAL-CELLS; DEATH; SURVIVAL; FYN	The Ewing's sarcoma family of tumors ( ESFT) includes Ewing's sarcoma ( ES), Askin's tumor of the chest wall, and peripheral primitive neuroectodermal tumor. Basic fibroblast growth factor ( FGF2) suppresses the growth of ESFT cells and causes their apoptosis. The underlying mechanism is unclear. Using a human peripheral primitive neuroectodermal tumor cell line, SK-N-MC, we demonstrated FGF2 stimulated phosphorylation of ERK1 and ERK2 ( pERK1/2) and GSK3 beta ( pGSK3 beta( Tyr-216)), all of which were primarily retained in the cytoplasm. FGF2 promoted the association between ERK and pGSK3 beta( Tyr-216). Inhibitors for GSK3 beta( TDZD and LiCl) and ERK ( PD98059) protected cells from FGF2-induced apoptosis. On the other hand, inhibitors of GSK3 beta, but not PD98059 decreased ERK/pGSK3 beta( Tyr-216) association and caused a nuclear translocation of pERK1/2. Similarly, expression of a kinase-deficient ( K85R) GSK3 beta or GSK3 beta-small interfering RNA inhibited FGF2-regulated ERK/pGSK3 beta( Tyr-216) association and translocated pERK to the nucleus. Both K85R GSK3 beta and small interfering RNA offered protection against FGF2-induced cell death. In contrast, overexpression of wild-type GSK3 beta sensitized cells to FGF2 cytotoxicity. Hydrogen peroxide and ethanol enhanced FGF2-stimulated pGSK3 beta( Tyr-216), ERK/pGSK3 beta( Tyr-216) association, and cytoplasmic retention of pERK1/2. As a result, they potentiated FGF2-induced cell death. Taken together, our results suggested that FGF2-induced accumulation of pERK1/ 2 in the cytoplasm is toxic for SK-N-MC cells. The formation of an ERK center dot GSK3 beta complex retained pERK1/ 2 in the cytoplasm. In contrast, disruption of the ERK center dot GSK3 beta complex resulted in nuclear translocation of pERK1/ 2 and offered protection.	[Ma, Cuiling; Bower, Kimberly A.; Chen, Gang; Luo, Jia] W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Ma, Cuiling] Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Shi, Xianglin] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Ke, Zun-Ji; Luo, Jia] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	West Virginia University; Air Force Military Medical University; University of Kentucky; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, J (corresponding author), W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA.	jluo@hsc.wvu.edu	Luo, Jia/E-4674-2012; He, Liuge/E-6385-2010; Ke, Zunji/E-4822-2010; Shi, Xianglin/B-8588-2012; Ke, Zun-Ji/N-5689-2014	Luo, Jia/0000-0002-6968-3618; Ke, Zunji/0000-0003-4038-2456; Ke, Zun-Ji/0000-0003-4038-2456	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015407] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA015407-03, R01 AA015407, AA 015407] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Burchill SA, 2002, APOPTOSIS, V7, P5, DOI 10.1023/A:1013548426273; Cai GQ, 2007, INT J ONCOL, V31, P657; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Germain D, 2000, J BIOL CHEM, V275, P12074, DOI 10.1074/jbc.275.16.12074; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205; Hartigan JA, 1999, J BIOL CHEM, V274, P21395, DOI 10.1074/jbc.274.30.21395; Hochholdinger F, 1999, MOL CELL BIOL, V19, P8052; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim MS, 2004, J PATHOL, V202, P103, DOI 10.1002/path.1497; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; LANDGREN E, 1995, ONCOGENE, V10, P2027; Ledoux Dominique, 1992, Progress in Growth Factor Research, V4, P107, DOI 10.1016/0955-2235(92)90026-E; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Maloof P, 1999, BREAST CANCER RES TR, V56, P153; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Russo VC, 2004, J CELL PHYSIOL, V199, P371, DOI 10.1002/jcp.10416; Sahni M, 2001, DEVELOPMENT, V128, P2119; Scurr M, 2006, ONCOLOGIST, V11, P65, DOI 10.1634/theoncologist.11-1-65; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Sturla LM, 2000, CANCER RES, V60, P6160; Takahashi-Yanaga F, 2004, BIOCHEM BIOPH RES CO, V316, P411, DOI 10.1016/j.bbrc.2004.02.061; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Valencia A, 2004, FREE RADICAL BIO MED, V36, P1112, DOI 10.1016/j.freeradbiomed.2004.02.013; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang YM, 2006, J INFRARED MILLIM W, V25, P50; Williamson AJK, 2004, J BIOL CHEM, V279, P47912, DOI 10.1074/jbc.M409035200; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	49	21	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9248	9256		10.1074/jbc.M707316200	http://dx.doi.org/10.1074/jbc.M707316200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18263590	Green Published, hybrid			2022-12-27	WOS:000254465800055
J	Pang, T; Zhang, ZS; Gu, M; Qiu, BY; Yu, LF; Cao, PR; Shao, W; Su, MB; Li, JY; Nan, FJ; Li, J				Pang, Tao; Zhang, Zhen-Shan; Gu, Min; Qiu, Bei-Ying; Yu, Li-Fang; Cao, Peng-Rong; Shao, Wei; Su, Ming-Bo; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia			Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; GAMMA-SUBUNIT ISOFORMS; METABOLIC SYNDROME; CATALYTIC SUBUNIT; UPSTREAM KINASE; GLUCOSE-UPTAKE; RAT-LIVER; METFORMIN; MECHANISM; CASCADE	AMP-activated protein kinase (AMPK) serves as an energy sensor and is considered a promising drug target for treatment of type II diabetes and obesity. A previous report has shown that mammalian AMPK alpha 1 catalytic subunit including autoinhibitory domain was inactive. To test the hypothesis that small molecules can activate AMPK through antagonizing the autoinhibition in alpha subunits, we screened a chemical library with inactive human alpha 1(394) (alpha 1, residues 1-394) and found a novel small-molecule activator, PT1, which dose-dependently activated AMPK alpha 1(394), alpha 1(335), alpha 2(398), and even heterotrimer alpha 1 beta 1 gamma 1. Based on PT1-docked AMPK alpha 1 subunit structure model and different mutations, we found PT1 might interact with Glu-96 and Lys-156 residues near the autoinhibitory domain and directly relieve autoinhibition. Further studies using L6 myotubes showed that the phosphorylation of AMPK and its downstream substrate, acetyl-CoA carboxylase, were dose-dependently and time-dependently increased by PT1 without an increase in cellular AMP: ATP ratio. Moreover, in HeLa cells deficient in LKB1, PT1 enhanced AMPK phosphorylation, which can be inhibited by the calcium/calmodulin-dependent protein kinase kinases inhibitor STO-609 and AMPK inhibitor compound C. PT1 also lowered hepatic lipid content in a dose-dependent manner through AMPK activation in HepG2 cells, and this effect was diminished by compound C. Taken together, these data indicate that this small-molecule activator may directly activate AMPK via antagonizing the autoinhibition in vitro and in cells. This compound highlights the effort to discover novel AMPK activators and can be a useful tool for elucidating the mechanism responsible for conformational change and autoinhibitory regulation of AMPK.	[Pang, Tao; Gu, Min; Qiu, Bei-Ying; Yu, Li-Fang; Cao, Peng-Rong; Shao, Wei; Su, Ming-Bo; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China; [Zhang, Zhen-Shan] Roche R&D Ctr China Ltd, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Roche Holding	Nan, FJ (corresponding author), Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	fjnan@mail.shcnc.ac.cn; jli@mail.shcnc.ac.cn	Li, Jia/F-9116-2011; Zhang, zs/GXN-3521-2022; li, jia/GVT-7587-2022					BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Edelsbrunner H., 1995, Proceedings of the Twenty-Eighth Hawaii International Conference on System Sciences, P256, DOI 10.1109/HICSS.1995.375331; FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gao G, 1996, J BIOL CHEM, V271, P8675, DOI 10.1074/jbc.271.15.8675; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hamilton SR, 2002, BIOCHEM BIOPH RES CO, V293, P892, DOI 10.1016/S0006-291X(02)00312-1; Haque MS, 1999, DIABETES, V48, P1706, DOI 10.2337/diabetes.48.9.1706; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kosaka T, 2005, ANAL CHEM, V77, P2050, DOI 10.1021/ac0484631; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	56	132	150	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16051	16060		10.1074/jbc.M710114200	http://dx.doi.org/10.1074/jbc.M710114200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18321858	Green Published, hybrid			2022-12-27	WOS:000256332500063
J	Bentinger, M; Tekle, M; Brismar, K; Chojnacki, T; Swiezewska, E; Dallner, G				Bentinger, Magnus; Tekle, Michael; Brismar, Kerstin; Chojnacki, Tadeusz; Swiezewska, Ewa; Dallner, Gustav			Polyisoprenoid epoxides stimulate the biosynthesis of coenzyme Q and inhibit cholesterol synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN DYSFUNCTION; RAT-LIVER; 2,3-OXIDOSQUALENE CYCLASE; DOLICHYL-PHOSPHATE; METABOLISM; UBIQUINONE; Q(10); TISSUES; EPOXYUBIQUINONES; TOCOTRIENOLS	In our search for compounds that up-regulate the biosynthesis of coenzyme Q (CoQ), we discovered that irradiation of CoQ with ultraviolet light results in the formation of a number of compounds that influence the synthesis of mevalonate pathway lipids by HepG2 cells. Among the compounds that potently stimulated CoQ synthesis while inhibiting cholesterol synthesis, derivatives of CoQ containing 1-4 epoxide moieties in their polyisoprenoid side chains were identified. Subsequently, chemical epoxidation of all-trans-polyprenols of different lengths revealed that the shorter farnesol and geranylgeraniol derivatives were without effect, whereas the longer derivatives of solanesol enhanced CoQ and markedly reduced cholesterol biosynthesis. In contrast, none of the modified trans-trans-poly-cis-polyprenols exerted noticeable effects. Tocotrienol epoxides were especially potent in our system; those with one epoxide moiety in the side-chain generally up-regulated CoQ biosynthesis by 200-300%, whereas those with two such moieties also decreased cholesterol synthesis by 50-90%. Prolonged treatment of HepG2 cells with tocotrienol epoxides for 26 days elevated their content of CoQ by 30%. In addition, the levels of mRNA encoding enzymes involved in CoQ biosynthesis were also elevated by the tocotrienol epoxides. The site of inhibition of cholesterol synthesis was shown to be oxidosqualene cyclase. In conclusion, epoxide derivatives of certain all-trans-polyisoprenoids cause pronounced stimulation of CoQ synthesis and, in some cases, simultaneous reduction of cholesterol biosynthesis by HepG2 cells.	[Bentinger, Magnus; Tekle, Michael; Dallner, Gustav] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Bentinger, Magnus; Brismar, Kerstin; Dallner, Gustav] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Stockholm University; Karolinska Institutet; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Dallner, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	gustav.dallner@dbb.su.se		Swiezewska, Ewa/0000-0002-3439-8948; Brismar, Kerstin/0000-0002-5241-514X				ABERG F, 1994, CHEM-BIOL INTERACT, V91, P1, DOI 10.1016/0009-2797(94)90002-7; AITHAL HN, 1968, BIOCHIM BIOPHYS ACTA, V162, P66, DOI 10.1016/0005-2728(68)90214-4; Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; CATTEL L, 1995, LIPIDS, V30, P235, DOI 10.1007/BF02537827; CHOJNACKI T, 1984, ACTA BIOCHIM POL, V31, P115; Doring F, 2007, IUBMB LIFE, V59, P628, DOI 10.1080/15216540701545991; Downs SM, 2001, BIOL REPROD, V64, P80, DOI 10.1095/biolreprod64.1.80; Duitsman PK, 1999, INT J VITAM NUTR RES, V69, P303, DOI 10.1024/0300-9831.69.5.303; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; EKSTROM TJ, 1984, J BIOL CHEM, V259, P460; ERICSSON J, 1992, J BIOL CHEM, V267, P19730; ERICSSON J, 1993, J BIOL CHEM, V268, P832; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; FAUST JR, 1980, J BIOL CHEM, V255, P6546; ForsmarkAndree P, 1997, FREE RADICAL BIO MED, V22, P391, DOI 10.1016/S0891-5849(96)00330-9; FRIIS P, 1967, BIOCHEMISTRY-US, V6, P3618, DOI 10.1021/bi00863a037; Groneberg DA, 2005, INT J BIOCHEM CELL B, V37, P1208, DOI 10.1016/j.biocel.2004.11.017; Huff MW, 2005, TRENDS PHARMACOL SCI, V26, P335, DOI 10.1016/j.tips.2005.05.004; IKEDA S, 1984, HORM METAB RES, V16, P585, DOI 10.1055/s-2007-1014857; KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072; KELLER RK, 1986, J BIOL CHEM, V261, P2053; Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1; Liao JK, 2005, CURR OPIN LIPIDOL, V16, P624, DOI 10.1097/01.mol.0000191913.16321.60; Littarru G. P., 1996, HDB ANTIOXIDANTS, P203; Littarru GP, 2007, MITOCHONDRION, V7, pS168, DOI 10.1016/j.mito.2007.03.002; MANKOWSKI T, 1976, BIOCHEMISTRY-US, V15, P2125, DOI 10.1021/bi00655a015; Mark M, 1996, J LIPID RES, V37, P148; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Morand OH, 1997, J LIPID RES, V38, P373; MORIMOTO H, 1969, LIEBIGS ANN CHEM, V729, P158, DOI 10.1002/jlac.19697290120; Morimoto H, 1970, Justus Liebigs Ann Chem, V735, P65, DOI 10.1002/jlac.19707350111; Nakamura T, 1999, BIOFACTORS, V9, P111, DOI 10.1002/biof.5520090205; Podda M, 1998, FREE RADICAL BIO MED, V24, P55, DOI 10.1016/S0891-5849(97)00142-1; POPJAK G, 1962, J BIOL CHEM, V237, P56; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Rustin P, 2004, METHOD ENZYMOL, V382, P81; Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001; SEN SE, 1995, SYNTHESIS-STUTTGART, P756; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; SOTTOCAS.GL, 1965, BIOCHEMISTRY-US, V4, P305, DOI 10.1021/bi00878a019; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; THELIN A, 1994, BBA-LIPID LIPID MET, V1215, P245, DOI 10.1016/0005-2760(94)90049-3; THELIN A, 1992, FEBS LETT, V313, P118, DOI 10.1016/0014-5793(92)81425-L; TRZASKOS JM, 1986, J BIOL CHEM, V261, P6937; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Turunen M, 2000, J MOL BIOL, V297, P607, DOI 10.1006/jmbi.2000.3596; YOSHIDA H, 1992, J LIPID RES, V33, P343	48	28	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14645	14653		10.1074/jbc.M710202200	http://dx.doi.org/10.1074/jbc.M710202200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353784	hybrid			2022-12-27	WOS:000255941400053
J	Karch, CM; Borchelt, DR				Karch, Celeste M.; Borchelt, David R.			A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC SUPEROXIDE-DISMUTASE; MOLECULAR-WEIGHT COMPLEXES; MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; TRANSGENIC MICE; CU,ZN-SUPEROXIDE DISMUTASE; ATOMIC STRUCTURES; ALS; SUPEROXIDE-DISMUTASE-1; MUTATIONS	One of the mechanisms by which mutations in superoxide dismutase 1 (SOD1) cause familial amyotrophic lateral sclerosis (fALS) is proposed to involve the accumulation of detergent-insoluble, disulfide-cross-linked, mutant protein. Recent studies have implicated cysteine residues at positions 6 and 111 as critical in mediating disulfide cross-linking and promoting aggregation. In the present study, we used a panel of experimental and disease-linked mutations at cysteine residues of SOD1 (positions 6, 57, 111, and 146) in cell culture assays for aggregation to demonstrate that extensive disulfide cross-linking is not required for the formation of mutant SOD1 aggregates. Experimental mutants possessing only a single cysteine residue or lacking cysteine entirely were found to retain high potential to aggregate. Furthermore we demonstrate that aggregate structures in symptomatic SOD1-G93A mice can be dissociated such that they no longer sediment upon ultracentrifugation (i.e. appear soluble) under relatively mild conditions that leave disulfide bonds intact. Similar to other recent work, we found that cysteines 6 and 111, particularly the latter, play interesting roles in modulating the aggregation of human SOD1. However, we did not find that extensive disulfide cross-linking via these residues, or any other cysteine, is critical to aggregate structure. Instead we suggest that these residues participate in other features of the protein that, in some manner, modulate aggregation.	[Karch, Celeste M.; Borchelt, David R.] Univ Florida, SantaFe HealthCare Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, SantaFe HealthCare Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, 100 Newell Dr,Rm L1-100,POB 100244, Gainesville, FL 32611 USA.	borchelt@mbi.ufl.edu		Karch, Celeste/0000-0002-6854-5547	NINDS NIH HHS [P01 NS049134] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Guo JT, 2004, PROTEINS, V57, P357, DOI 10.1002/prot.20222; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; KELLER GA, 1991, P NATL ACAD SCI USA, V88, P7381, DOI 10.1073/pnas.88.16.7381; Krishnan U, 2006, MOL CELL BIOCHEM, V287, P201, DOI 10.1007/s11010-005-9112-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lyons TJ, 1999, MET IONS BIOL SYST, V36, P125; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morimoto A, 2002, BIOCHEM BIOPH RES CO, V295, P306, DOI 10.1016/S0006-291X(02)00670-8; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Ogawa Y, 1997, BIOCHEM BIOPH RES CO, V241, P251, DOI 10.1006/bbrc.1997.7804; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schinina ME, 1996, EUR J BIOCHEM, V237, P433, DOI 10.1111/j.1432-1033.1996.0433k.x; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stromer T, 2005, MICROSC RES TECHNIQ, V67, P210, DOI 10.1002/jemt.20190; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Watanabe Y, 2005, MOL BRAIN RES, V135, P12, DOI 10.1016/j.molbrainres.2004.11.019; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	48	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13528	13537		10.1074/jbc.M800564200	http://dx.doi.org/10.1074/jbc.M800564200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18316367	hybrid, Green Published			2022-12-27	WOS:000255728200006
J	Sakasai, R; Tibbetts, R				Sakasai, Ryo; Tibbetts, Randal			RNF8-dependent and RNF8-independent regulation of 53BP1 in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR PS-341; REPLICATION PROTEIN-A; CELL-CYCLE REGULATION; HISTONE H2AX; INDUCED PHOSPHORYLATION; ATR; REPAIR; MDC1; UBIQUITIN; MEDIATOR	The DNA damage surveillance network orchestrates cellular responses to DNA damage through the recruitment of DNA damage-signaling molecules to DNA damage sites and the concomitant activation of protein phosphorylation cascades controlled by the ATM (ataxia-telangiectasia-mutated) and ATR (ATM-Rad3-related) kinases. Activation of ATM/ATR triggers cell cycle checkpoint activation and adaptive responses to DNA damage. Recent studies suggest that protein ubiquitylation or degradation plays an important role in the DNA damage response. In this study, we examined the potential role of the proteasome in checkpoint activation and ATM/ATR signaling in response to UV light-induced DNA damage. HeLa cells treated with the proteasome inhibitor MG-132 showed delayed phosphorylation of ATM substrates in response to UV light. UV light-induced phosphorylation of 53BP1, as well as its recruitment to DNA damage foci, was strongly suppressed by proteasome inhibition, whereas the recruitment of upstream regulators of 53BP1, including MDC1 and H2AX, was unaffected. The ubiquitin-protein isopeptide ligase RNF8 was critical for 53BP1 focus targeting and phosphorylation in ionizing radiation-damaged cells, whereas UV light-induced 53BP1 phosphorylation and targeting exhibited partial dependence on RNF8 and the ubiquitin-conjugating enzyme UBC13. Suppression of RNF8 or UBC13 also led to subtle defects in UV light-induced G2/M checkpoint activation. These findings are consistent with a model in which RNF8 ubiquitylation pathways are essential for 53BP1 regulation in response to ionizing radiation, whereas RNF8-independent pathways contribute to 53BP1 targeting and phosphorylation in response to UV light and potentially other forms of DNA replication stress.	[Sakasai, Ryo; Tibbetts, Randal] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, R (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297; Sakasai, Ryo/0000-0002-4495-5437				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Berlanga O, 2000, BLOOD, V96, P2740; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hideshima T, 2001, CANCER RES, V61, P3071; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Liu QH, 2000, GENE DEV, V14, P1448; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maki CG, 1996, CANCER RES, V56, P2649; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; O'Connor Owen A, 2004, Curr Treat Options Oncol, V5, P269, DOI 10.1007/s11864-004-0018-2; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Yoo E, 2005, ONCOGENE, V24, P5423, DOI 10.1038/sj.onc.1208710; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	47	37	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13549	13555		10.1074/jbc.M710197200	http://dx.doi.org/10.1074/jbc.M710197200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337245	hybrid			2022-12-27	WOS:000255728200008
J	Li, Y; Zhang, XW; Polakiewicz, RD; Yao, TP; Comb, MJ				Li, Yu; Zhang, Xiaowu; Polakiewicz, Roberto D.; Yao, Tso-Pang; Comb, Michael J.			HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; ACETYLATION; ACTIVATION; PATHWAY; CANCER; RECEPTOR; APC	Nuclear translocation of beta-catenin is a hallmark of Wnt signaling and is associated with various cancers. In addition to the canonical Wnt pathway activated by Wnt ligands, growth factors such as epidermal growth factor (EGF) also induce beta-catenin dissociation from the adherens junction complex, translocation into the nucleus, and activation of target genes such as c-myc. Here we report that EGF-induced beta-catenin nuclear localization and activation of c-myc are dependent on the deacetylase HDAC6. We show that EGF induces HDAC6 translocation to the caveolae membrane and association with beta-catenin. HDAC6 deacetylates beta-catenin at lysine 49, a site frequently mutated in anaplastic thyroid cancer, and inhibits beta-catenin phosphorylation at serine 45. HDAC6 inactivation blocks EGF-induced beta-catenin nuclear localization and decreases c-Myc expression, leading to inhibition of tumor cell proliferation. These results suggest that EGF-induced nuclear localization of beta-catenin is regulated by HDAC6-dependent deacetylation and provide a new mechanism by which HDAC inhibitors prevent tumor growth.	[Li, Yu; Zhang, Xiaowu; Polakiewicz, Roberto D.; Comb, Michael J.] Cell Signaling Technol, Danvers, MA 01923 USA; [Yao, Tso-Pang] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Comb, MJ (corresponding author), Cell Signaling Technol, 3 Trask La, Danvers, MA 01923 USA.	mcomb@cellsignal.com			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054022, R01 NS054022-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COHEN T, 2004, SCI STKE, pPE42; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	22	134	143	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12686	12690		10.1074/jbc.C700185200	http://dx.doi.org/10.1074/jbc.C700185200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18356165	Green Published, hybrid			2022-12-27	WOS:000255499800003
J	Archer, CT; Delahodde, A; Gonzalez, F; Johnston, SA; Kodadek, T				Archer, Chase T.; Delahodde, Agnes; Gonzalez, Fernando; Johnston, Stephen Albert; Kodadek, Thomas			Activation domain-dependent monoubiquitylation of gal4 protein is essential for promoter binding in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; REGULATORY PARTICLE; 26S PROTEASOME; IDENTIFICATION; ASSOCIATION; ELONGATION; UBIQUITIN	The Saccharomyces cerevisiae Gal4 protein is a paradigmatic transcriptional activator containing a C-terminal acidic activation domain ( AD) of 34 amino acids. A mutation that results in the truncation of about two-thirds of the Gal4AD (gal4D) results in a crippled protein with only 3% the activity of the wild-type activator. Weshow here that although the Gal4D protein is not intrinsically deficient in DNA binding, it is nonetheless unable to stably occupy GAL promoters in vivo. This is because of the activity of the proteasomal ATPases, including Sug1/Rpt6, which bind to Gal4D via the remainder of the AD and strip it off of DNA. A mutation that suppressed the Gal4D "no growth on galactose" phenotype repressed the stripping activity of the ATPase complex but not other activities. We further demonstrate that Gal4D is hypersensitive to this stripping activity because of its failure to be monoubiquitylated efficiently in vivo and in vitro. Evidence is presented that the piece of the AD that is deleted in Gal4D protein is likely a recognition element for the E3 ubiquitin-protein ligase that modifies Gal4. These data argue that acidic ADs comprise at least two small peptide subdomains, one of which is responsible for activator monou-biquitylation and another that interacts with the proteasomal ATPases, coactivators and other transcription factors. This study validates the physiological importance of Gal4 monoubiquitylation and clarifies its major role as that of protecting the activator from being destabilized by the proteasomal ATPases.	[Archer, Chase T.; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dallas, TX 75390 USA; [Delahodde, Agnes; Gonzalez, Fernando; Johnston, Stephen Albert; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.Kodadek@utsouthwestern.edu		Kodadek, Thomas/0000-0003-1930-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 71833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BHAT KP, 2008, MOL IMMUNOL; Ding WV, 1997, MOL CELL BIOL, V17, P2538, DOI 10.1128/MCB.17.5.2538; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MATSUMOTO K, 1980, J BACTERIOL, V141, P508, DOI 10.1128/JB.141.2.508-527.1980; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SALMERON JM, 1990, GENETICS, V125, P21; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	28	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12614	12623		10.1074/jbc.M801050200	http://dx.doi.org/10.1074/jbc.M801050200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326036	Green Published, hybrid			2022-12-27	WOS:000255340000078
J	Brooks, JD; Milne, GL; Yin, HY; Sanchez, SC; Porter, NA; Morrow, JD				Brooks, Joshua D.; Milne, Ginger L.; Yin, Huiyong; Sanchez, Stephanie C.; Porter, Ned A.; Morrow, Jason D.			Formation of highly reactive cyclopentenone isoprostane compounds (A(3)/J(3)-isoprostanes) in vivo from eicosapentaenoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSPRAY MASS-SPECTROMETRY; POLYUNSATURATED FATTY-ACIDS; SUDDEN CARDIAC DEATH; FISH-OIL; LIPID-PEROXIDATION; OXIDIZED OMEGA-3-FATTY-ACIDS; D-RING; IDENTIFICATION; PRODUCTS; N-3	Omega-3 (omega-3) polyunsaturated fatty acids (PUFAs) found in marine fish oils are known to suppress inflammation associated with a wide variety of diseases. Eicosapentaenoic acid (EPA) is one of the most abundant omega-3 fatty acids in fish oil, but the mechanism(s) by which EPA exerts its beneficial effects is unknown. Recent studies, however, have demonstrated that oxidized EPA, rather than native EPA, possesses anti-atherosclerotic, anti-inflammatory, and anti-proliferative effects. Very few studies to date have investigated which EPA oxidation products are responsible for this bioactivity. Our research group has previously reported that anti-inflammatory prostaglandin A(2)-like and prostaglandin J(2)-like compounds, termed A(2)/J(2)-isoprostanes (IsoPs), are produced in vivo by the free radical-catalyzed peroxidation of arachidonic acid and represent one of the major products resulting from the oxidation of this PUFA. Based on these observations, we questioned whether cyclopentenone-IsoP compounds are formed from the oxidation of EPA in vivo. Herein, we report the formation of cyclopentenone-IsoP molecules, termed A(3)/J(3)-IsoPs, formed in abundance in vitro and in vivo from EPA peroxidation. Chemical approaches coupled with gas chromatography/ mass spectrometry (GC/MS) and liquid chromatography/ mass spectrometry (LC/MS) were used to structurally characterize these compounds as A(3)/J(3)-IsoPs. We found that levels of these molecules increase similar to 200-fold with oxidation of EPA in vitro from a basal level of 0.8 +/- 0.4 ng/mg EPA to 196 +/- 23 ng/mg EPA after 36 h. We also detected these compounds in significant amounts in fresh liver tissue from EPA-fed rats at basal levels of 19 +/- 2 ng/g tissue. Amounts increased to 102 +/- 15 ng/g tissue in vivo in settings of oxidative stress. These studies have, for the first time, definitively characterized novel, highly reactive A/J-ring IsoP compounds that form in abundance from the oxidation of EPA in vivo.	[Brooks, Joshua D.; Milne, Ginger L.; Yin, Huiyong; Sanchez, Stephanie C.; Morrow, Jason D.] Vanderbilt Univ, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA; [Brooks, Joshua D.; Milne, Ginger L.; Yin, Huiyong; Sanchez, Stephanie C.; Morrow, Jason D.] Vanderbilt Univ, Div Clin Pharmacol, Dept Pharmacol, Nashville, TN 37232 USA; [Porter, Ned A.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Morrow, JD (corresponding author), Vanderbilt Univ, Div Clin Pharmacol, Dept Med, 532 RRB,23rd Ave S & Pierce Ave, Nashville, TN 37232 USA.	jason.morrow@vanderbilt.edu	Milne, Ginger/D-7648-2014	Milne, Ginger/0000-0003-3890-151X	NIDDK NIH HHS [DK48831] Funding Source: Medline; NIEHS NIH HHS [ES13125] Funding Source: Medline; NIGMS NIH HHS [GM15431] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achard F, 1997, BIOCHEM BIOPH RES CO, V241, P513, DOI 10.1006/bbrc.1997.7848; Arita K, 2003, FREE RADICAL BIO MED, V35, P189, DOI 10.1016/S0891-5849(03)00310-1; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Calder PC, 2006, P NUTR SOC, V65, P264, DOI 10.1079/PNS2006500; Chaudhary A, 2004, NEPHRON EXP NEPHROL, V97, P136, DOI 10.1159/000079178; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Connor SL, 1997, AM J CLIN NUTR, V66, P1020; Das UN, 1999, PROSTAG LEUKOTR ESS, V61, P157, DOI 10.1054/plef.1999.0085; Davis TA, 2006, J AM CHEM SOC, V128, P14897, DOI 10.1021/ja064399o; Fam SS, 2002, J BIOL CHEM, V277, P36076, DOI 10.1074/jbc.M205638200; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gao L, 2006, J BIOL CHEM, V281, P14092, DOI 10.1074/jbc.M601035200; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kerwin JL, 1996, J MASS SPECTROM, V31, P184, DOI 10.1002/(SICI)1096-9888(199602)31:2<184::AID-JMS283>3.0.CO;2-2; Kerwin JL, 1996, ANAL BIOCHEM, V237, P56, DOI 10.1006/abio.1996.0200; KISERUD CE, 1995, THROMB RES, V80, P75, DOI 10.1016/0049-3848(95)00152-H; Kokura S, 2002, CANCER LETT, V185, P139, DOI 10.1016/S0304-3835(02)00262-8; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Milne GL, 2005, J LIPID RES, V46, P307, DOI 10.1194/jlr.M400311-JLR200; Milne GL, 2001, LIPIDS, V36, P1265, DOI 10.1007/s11745-001-0841-2; Mishra A, 2004, ARTERIOSCL THROM VAS, V24, P1621, DOI 10.1161/01.ATV.0000137191.02577.86; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1994, J BIOL CHEM, V269, P4317; Oliw EH, 1998, LIPIDS, V33, P843, DOI 10.1007/s11745-998-0280-0; PORTER NA, 1984, METHOD ENZYMOL, V105, P273; PORTER NA, 1981, J AM CHEM SOC, V103, P6447, DOI 10.1021/ja00411a032; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Reich EE, 2000, BIOCHEMISTRY-US, V39, P2376, DOI 10.1021/bi992000l; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2003, CHEM IMMUNOL, V83, P115; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sethi S, 1996, J LAB CLIN MED, V128, P27, DOI 10.1016/S0022-2143(96)90111-0; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Taber DF, 1997, PROSTAGLANDINS, V53, P63, DOI 10.1016/S0090-6980(97)00005-1; Uauy R, 1999, EUR J CLIN NUTR, V53, pS66, DOI 10.1038/sj.ejcn.1600745; Vallve JC, 2002, ATHEROSCLEROSIS, V164, P45, DOI 10.1016/S0021-9150(02)00046-1; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Waugh RJ, 1997, FREE RADICAL BIO MED, V23, P943, DOI 10.1016/S0891-5849(97)00133-0; Yang PY, 2004, J LIPID RES, V45, P1030, DOI 10.1194/jlr.M300455-JLR200; Yin HY, 2007, J BIOL CHEM, V282, P29890, DOI 10.1074/jbc.M703108200; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; ZIRROLLI JA, 1990, J AM SOC MASS SPECTR, V1, P325, DOI 10.1016/1044-0305(90)85009-B	55	64	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12043	12055		10.1074/jbc.M800122200	http://dx.doi.org/10.1074/jbc.M800122200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18263929	Green Published, hybrid			2022-12-27	WOS:000255340000020
J	Furukawa, Y; Umemoto, E; Jang, MH; Tohya, K; Miyasaka, M; Hirata, T				Furukawa, Yuko; Umemoto, Eiji; Jang, Myoung Ho; Tohya, Kazuo; Miyasaka, Masayuki; Hirata, Takako			Identification of novel isoforms of mouse L-selectin with different carboxyl-terminal tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE HOMING RECEPTOR; CYTOPLASMIC DOMAIN; CELL-ADHESION; ENDOTHELIUM; PROTEINS; INFLAMMATION; MECHANISMS; MOLECULE; SEQUENCE; REVEALS	The leukocyte adhesion molecule L-selectin mediates the recruitment of lymphocytes to secondary lymphoid organs and is involved in the accumulation of neutrophils at sites of inflammation. In this study, we report the identification of novel isoforms of the mouse L-selectin gene, termed L-selectin-v1 and L-selectin-v2. Sequence analysis revealed that these isoforms are generated by alternative splicing: the L-selectin-v2 transcript includes a previously unknown exon of 100 bp located between the 7th and 8th exons of the mouse L-selectin gene, while the L-selectin-v1 transcript contains the first 49-bp sequence of this new exon. The insertion of each new sequence adds a downstream reading frame, giving rise to predicted proteins that differ in their carboxyl-terminal tails. These splice variants were found in cells that express conventional L-selectin, termed L-selectin-c, including B and T lymphocytes and granulocytes. Functionally, like L-selectin-c, both L-selectin-v1 and L-selectin-v2 expressed in cultured cells underwent phorbol ester-induced shedding, although L-selectin-v1 and L-selectin-v2 were shed to a greater and lesser degree, respectively, than L-selectin-c. Under flow conditions, both L-selectin-v1 and L-selectin-v2 mediated faster cell rolling than did L-selectin-c. In addition, ligation of L-selectin-c and L-selectin-v1, but not L-selectin-v2, induced p38 mitogen-activated protein kinase phosphorylation. These results suggest that alternative splicing is one mechanism for generating functional diversity in L-selectin.	[Furukawa, Yuko; Hirata, Takako] Osaka Univ, Microbial Dis Res Inst, 21st Century Ctr Excellence Program, Suita, Osaka 5650871, Japan; [Jang, Myoung Ho] Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr, Lab Gastrointestinal Immunol, Suita, Osaka 5650871, Japan; [Furukawa, Yuko; Umemoto, Eiji; Miyasaka, Masayuki] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immunodynam, Suita, Osaka 5650871, Japan; [Tohya, Kazuo] Kansai Univ Hlth Sci, Dept Anat, Osaka 5900482, Japan	Osaka University; Osaka University; Osaka University	Hirata, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, 21st Century Ctr Excellence Program, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	thirata@biken.osaka-u.ac.jp	Jang, Myoung Ho/D-1714-2009; Umemoto, Eiji/AAX-6562-2021; Miyasaka, Masayuki/AAM-6343-2020	Jang, Myoung Ho/0000-0001-8909-4725; Hirata, Takako/0000-0002-1740-6168				Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; BILLUPS KL, 1995, J LAB CLIN MED, V126, P580; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Crockett-Torabi E, 1998, J LEUKOCYTE BIOL, V63, P1; CYBULSKY MI, 1991, AM J PATHOL, V138, P815; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Evans SS, 1999, J IMMUNOL, V162, P3615; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; KING PD, 1995, J IMMUNOL, V154, P6080; KIRSCHBAUM NE, 1994, BLOOD, V84, P4028, DOI 10.1182/blood.V84.12.4028.bloodjournal84124028; Kumar A, 1999, CIRCULATION, V99, P1363, DOI 10.1161/01.CIR.99.10.1363; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3	34	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12112	12119		10.1074/jbc.M801745200	http://dx.doi.org/10.1074/jbc.M801745200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332130	hybrid			2022-12-27	WOS:000255340000027
J	Means, CK; Miyamoto, S; Chun, J; Brown, JH				Means, Christopher Kable; Miyamoto, Shigeki; Chun, Jerold; Brown, Joan Heller			S1P(1) receptor localization confers selectivity for G(i)-mediated cAMP and contractile responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-GAMMA-SUBUNITS; HETEROTRIMERIC G-PROTEINS; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHOLIPID RECEPTOR; CARDIAC MYOCYTES; ADENYLYL-CYCLASE; KINASE PATHWAY; IN-VIVO; PLASMALEMMAL CAVEOLAE	Adult mouse ventricular myocytes express S1P(1), S1P(2), and S1P(3) receptors. S1P activates Akt and ERK in adult mouse ventricular myocytes through a pertussis toxin-sensitive (G(i/o)-mediated) pathway. Akt and ERK activation by S1P are reduced similar to 30% in S1P(3) and 60% in S1P(2) receptor knock- out myocytes. With combined S1P(2,3) receptor deletion, activation of Akt is abolished and ERK activation is reduced by nearly 90%. Thus the S1P(1) receptor, while present in S1P(2,3) receptor knock- out myocytes, is unable to mediate Akt or ERK activation. In contrast, S1P induces pertussis toxin-sensitive inhibition of isoproterenol-stimulated cAMP accumulation in both WT and S1P(2,3) receptor knock- out myocytes demonstrating that the S1P(1) receptor can functionally couple to G(i). An S1P(1) receptor selective agonist, SEW2871, also decreased cAMP accumulation but failed to activate ERK or Akt. To determine whether localization of the S1P(1) receptor mediates this signaling specificity, methyl-beta-cyclodextrin (M beta CD) treatment was used to disrupt caveolae. The S1P(1) receptor was concentrated in caveolar fractions, and associated with caveolin-3 and this localization was disrupted by M beta CD. S1P-mediated activation of ERK or Akt was not diminished but inhibition of cAMP accumulation by S1P and SEW2871 was abolished by M beta CD treatment. S1P inhibits the positive inotropic response to isoproterenol and this response is also mediated through the S1P(1) receptor and lost following caveolar disruption. Thus localization of S1P(1) receptors to caveolae is required for the ability of this receptor to inhibit adenylyl cyclase and contractility but compromises receptor coupling to Akt and ERK.	[Means, Christopher Kable] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Means, Christopher Kable; Miyamoto, Shigeki; Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Chun, Jerold] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Brown, JH (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Miyamoto, Shigeki/L-4004-2019; Chun, Jerold/Y-4670-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028143, R01HL028143, P01HL046345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019674] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28143, HL46345] Funding Source: Medline; NIDA NIH HHS [DA019674] Funding Source: Medline; NIGMS NIH HHS [T32 GM007752] Funding Source: Medline; NINDS NIH HHS [NS048478] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baudhuin LM, 2003, FASEB J, V17, P341, DOI 10.1096/fj.03-0302fje; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; BRODDE OE, 1988, AM J CARDIOL, V62, pC24, DOI 10.1016/S0002-9149(88)80063-8; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; FAURE M, 1994, J BIOL CHEM, V269, P7851; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Goparaju SK, 2005, MOL CELL BIOL, V25, P4237, DOI 10.1128/MCB.25.10.4237-4249.2005; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hilal-Dandan R, 2000, J MOL CELL CARDIOL, V32, P1211, DOI 10.1006/jmcc.2000.1156; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Means CK, 2007, AM J PHYSIOL-HEART C, V292, pH2944, DOI 10.1152/ajpheart.01331.2006; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Okamoto H, 1999, BIOCHEM BIOPH RES CO, V260, P203, DOI 10.1006/bbrc.1999.0886; Ostrom RS, 2000, MOL PHARMACOL, V57, P1075; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Rockman HA, 1996, J MOL MED-JMM, V74, P489, DOI 10.1007/BF00204974; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Serriere-Lanneau V, 2007, FASEB J, V21, P2005, DOI 10.1096/fj.06-6889com; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steinberg SF, 1999, CIRC RES, V85, P1101; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; THORBURN J, 1994, BIOCHEM BIOPH RES CO, V202, P1586, DOI 10.1006/bbrc.1994.2113; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; ZHANG J, 2007, AM J PHYSIOL, V292, pH3150; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	52	62	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11954	11963		10.1074/jbc.M707422200	http://dx.doi.org/10.1074/jbc.M707422200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18296752	hybrid, Green Published			2022-12-27	WOS:000255340000011
J	Seong, C; Sehorn, MG; Plate, I; Shi, I; Song, B; Chi, P; Mortensen, U; Sung, P; Krejci, L				Seong, Changhyun; Sehorn, Michael G.; Plate, Iben; Shi, Idina; Song, Binwei; Chi, Peter; Mortensen, Uffe; Sung, Patrick; Krejci, Lumir			Molecular anatomy of the recombination mediator function of Saccharomyces cerevisiae Rad52	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; YEAST RAD51; RAD51-INDEPENDENT RECOMBINATION; BINDING-PROTEIN; REPAIR; BRCA2; COMPLEX; RPA	A helical filament of Rad51 on single-strand DNA (ssDNA), called the presynaptic filament, catalyzes DNA joint formation during homologous recombination. Rad52 facilitates presynaptic filament assembly, and this recombination mediator activity is thought to rely on the interactions of Rad52 with Rad51, the ssDNA-binding protein RPA, and ssDNA. The N-terminal region of Rad52, which has DNA binding activity and an oligomeric structure, is thought to be crucial for mediator activity and recombination. Unexpectedly, we find that the C-terminal region of Rad52 also harbors a DNA binding function. Importantly, the Rad52 C-terminal portion alone can promote Rad51 presynaptic filament assembly. The middle portion of Rad52 associates with DNA-bound RPA and contributes to the recombination mediator activity. Accordingly, expression of a protein species that harbors the middle and C-terminal regions of Rad52 in the rad52 Delta 327 background enhances the association of Rad51 protein with a HO-made DNA double-strand break and partially complements the methyl-methane sulfonate sensitivity of the mutant cells. Our results provide a mechanistic framework for rationalizing the multi-faceted role of Rad52 in recombination and DNA repair.	[Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Seong, Changhyun; Sehorn, Michael G.; Shi, Idina; Chi, Peter; Sung, Patrick; Krejci, Lumir] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Plate, Iben; Mortensen, Uffe] Tech Univ Denmark, Ctr Microbial Biotechnol, Bioctr, DK-2800 Lyngby, Denmark; [Song, Binwei] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Song, Binwei] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA	Masaryk University Brno; Yale University; Technical University of Denmark; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Krejci, L (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Kamenice 5-A4, Brno 62500, Czech Republic.	lkrejci@chemi.muni.cz	Chi, Peter/AAI-1580-2019; Mortensen, Uffe/AAQ-1150-2021; Classen, Scott/AAY-8176-2020; Huang, Wenchi/F-3981-2010; Krejci, Lumir/B-7842-2009	Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; Krejci, Lumir/0000-0002-4732-1405	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA92584] Funding Source: Medline; NIEHS NIH HHS [R01ES07061] Funding Source: Medline; NIGMS NIH HHS [R01GM57814] Funding Source: Medline; Wellcome Trust [GR076476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Asleson EN, 1999, GENETICS, V153, P681; Bianco P R, 1998, Front Biosci, V3, pD570; BOUNDYMILLS KL, 1993, GENETICS, V133, P39; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; D'Andrea AD, 2003, GENE DEV, V17, P1933, DOI 10.1101/gad.1128303; Davis AP, 2003, DNA REPAIR, V2, P1127, DOI 10.1016/S1568-7864(03)00121-6; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Fortin GS, 2002, EMBO J, V21, P3160, DOI 10.1093/emboj/cdf293; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Moynahan ME, 2001, CANCER RES, V61, P4842; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tsukamoto M, 2003, GENETICS, V165, P1703; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	58	41	42	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12166	12174		10.1074/jbc.M800763200	http://dx.doi.org/10.1074/jbc.M800763200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310075	hybrid, Green Published			2022-12-27	WOS:000255340000033
J	Smith, AG; Luk, N; Newton, RA; Roberts, DW; Sturm, RA; Muscat, GEO				Smith, Aaron G.; Luk, Nicole; Newton, Richard A.; Roberts, Donald W.; Sturm, Richard A.; Muscat, George E. O.			Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MC1R VARIANT ALLELES; SKIN-CANCER RISK; SKELETAL-MUSCLE; ULTRAVIOLET-RADIATION; STIMULATING HORMONE; MELANOMA-CELLS; DNA-DAMAGE; RED HAIR; HUMAN PIGMENTATION; NGFI-B	The melanocortin-1 receptor (MCIR) is a G-protein-coupled receptor expressed primarily in melanocytes and is known to play a pivotal role in the regulation of pigmentation in mammals. In humans MC1R has been found to be highly polymorphic with several functional variants associated with the phenotype of red hair color and fair skin, cutaneous UV sensitivity, and increased risk of developing melanoma and non-melanoma skin cancer. Recent evidence suggests that MC1R plays a photo-protective role in melanocytes in response to UV irradiation. Relatively few genetic targets of MC1R signaling have been identified independent of the pigmentation pathway. Here we show that MC1R signaling in B16 mouse melanoma cells and primary human melanocytes rapidly, and transiently, induces the transcription of the NR4A subfamily of orphan nuclear receptors. Furthermore, primary human melanocytes harboring homozygous RHC variant MC1R alleles exhibited an impaired induction of NR4A genes in response to the potent MC1R agonist (Nle4, D-Phe7)-alpha-melanocyte-stimulating hormone. Using small interference RNA-mediated attenuation of NR4A1 and NR4A2 expression in melanocytes, the ability to remove cyclobutane pyrimidine dimers following UV irradiation appeared to be impaired in the context of MC1R signaling. These data identify the NR4A receptor family as potential mediators of an MC1R-coordinated DNA damage response to UV exposure in melanocytic cells.	[Smith, Aaron G.; Luk, Nicole; Newton, Richard A.; Roberts, Donald W.; Sturm, Richard A.; Muscat, George E. O.] Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, St Lucia, Qld 4072, Australia	University of Queensland	Smith, AG (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, St Lucia, Qld 4072, Australia.	a.smith@imb.uq.edu.au; r.sturm@imb.uq.edu.au; g.muscat@imb.uq.edu.au	Smith, Aaron/A-8329-2010; Sturm, Richard A/C-9943-2009; Muscat, George/A-6401-2017	Sturm, Richard A/0000-0003-1301-0294; Muscat, George/0000-0002-5829-5695; Smith, Aaron/0000-0003-2937-1713				April CS, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030009; April CS, 2006, PIGM CELL RES, V19, P194, DOI 10.1111/j.1600-0749.2006.00305.x; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Beaumont KA, 2005, HUM MOL GENET, V14, P2145, DOI 10.1093/hmg/ddi219; Beaumont KA, 2007, HUM MOL GENET, V16, P2249, DOI 10.1093/hmg/ddm177; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Hauser JE, 2006, PIGM CELL RES, V19, P303, DOI 10.1111/j.1600-0749.2006.00315.x; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Hsu Hui-Chen, 2004, Current Drug Targets - Inflammation and Allergy, V3, P413, DOI 10.2174/1568010042634523; Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Maira M, 1999, MOL CELL BIOL, V19, P7549; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Morita K, 2005, BIOCHEM PHARMACOL, V71, P98, DOI 10.1016/j.bcp.2005.10.017; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Newton RA, 2005, PEPTIDES, V26, P1818, DOI 10.1016/j.peptides.2004.11.031; Newton RA, 2007, PEPTIDES, V28, P2387, DOI 10.1016/j.peptides.2007.10.003; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; RANGNEKAR VV, 1992, J BIOL CHEM, V267, P6240; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Roberts DW, 2008, J CELL PHYSIOL, V215, P344, DOI 10.1002/jcp.21318; Rouzaud F, 2005, MUTAT RES-FUND MOL M, V571, P133, DOI 10.1016/j.mrfmmm.2004.09.014; Rusciano D, 1999, J CELL SCI, V112, P623; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Scott MC, 2002, J CELL SCI, V115, P2349; Smith AG, 2006, AM J PHYSIOL-CELL PH, V291, pC203, DOI 10.1152/ajpcell.00476.2005; Smith AG, 2005, INT J BIOCHEM CELL B, V37, P2047, DOI 10.1016/j.biocel.2005.03.002; Smith AG, 1998, MELANOMA RES, V8, P2, DOI 10.1097/00008390-199802000-00002; Sturm RA, 2003, PIGM CELL RES, V16, P266, DOI 10.1034/j.1600-0749.2003.00041.x; Sturm RA, 2003, ANN NY ACAD SCI, V994, P348, DOI 10.1111/j.1749-6632.2003.tb03199.x; Sturm RA, 2002, MELANOMA RES, V12, P405, DOI 10.1097/00008390-200209000-00001; Sturm RA, 2006, TRENDS GENET, V22, P464, DOI 10.1016/j.tig.2006.06.010; Tada A, 2002, J INVEST DERMATOL, V118, P316, DOI 10.1046/j.0022-202x.2001.01694.x; Wansa KDSA, 2005, J MOL ENDOCRINOL, V34, P835, DOI 10.1677/jme.1.01739; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Wong WS, 1996, INT J BIOCHEM CELL B, V28, P1223, DOI 10.1016/S1357-2725(96)00074-X; Yu H, 2007, CANCER BIOL THER, V6, P405, DOI 10.4161/cbt.6.3.3755	54	84	85	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12564	12570		10.1074/jbc.M800480200	http://dx.doi.org/10.1074/jbc.M800480200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18292087	hybrid			2022-12-27	WOS:000255340000073
J	Brown, JM; Bell, TA; Alger, HM; Sawyer, JK; Smith, TL; Kelley, K; Shah, R; Wilson, MD; Davis, MA; Lee, RG; Graham, MJ; Crooke, RM; Rudel, LL				Brown, J. Mark; Bell, Thomas A., III; Alger, Heather M.; Sawyer, Janet K.; Smith, Thomas L.; Kelley, Kathryn; Shah, Ramesh; Wilson, Martha D.; Davis, Matthew A.; Lee, Richard G.; Graham, Mark J.; Crooke, Rosanne M.; Rudel, Lawrence L.			Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; SMALL-INTESTINE; ACID SYNTHESIS; MICE; ACAT2; ABSORPTION; ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; SECRETION; EXCRETION	Deletion of acyl-CoA: cholesterol O-acyltransferase 2 (ACAT2) in mice results in resistance to diet-induced hypercholesterolemia and protection against atherosclerosis. Recently, our group has shown that liver-specific inhibition of ACAT2 via antisense oligonucleotide (ASO)-mediated targeting likewise limits atherosclerosis. However, whether this atheroprotective effect was mediated by: 1) prevention of packaging of cholesterol into apoB-containing lipoproteins, 2) augmentation of nascent HDL cholesterol secretion, or 3) increased hepatobiliary sterol secretion was not examined. Therefore, the purpose of these studies was to determine whether hepatic ACAT2 is rate-limiting in all three of these important routes of cholesterol homeostasis. Liver-specific depletion of ACAT2 resulted in reduced packaging of cholesterol into apoB-containing lipoproteins (very low density lipoprotein, intermediate density lipoprotein, and low density lipoprotein), whereas high density lipoprotein cholesterol levels remained unchanged. In the liver of ACAT2 ASO-treated mice, cholesterol ester accumulation was dramatically reduced, yet there was no reciprocal accumulation of unesterified cholesterol. Paradoxically, ASO-mediated depletion of hepatic ACAT2 promoted fecal neutral sterol excretion without altering biliary sterol secretion. Interestingly, during isolated liver perfusion, ACAT2 ASO-treated livers had augmented secretion rates of unesterified cholesterol and phospholipid. Furthermore, we demonstrate that liver-derived cholesterol from ACAT2 ASO-treated mice is preferentially delivered to the proximal small intestine as a precursor to fecal excretion. Collectively, these studies provide the first insight into the hepatic itinerary of cholesterol when cholesterol esterification is inhibited only in the liver, and provide evidence for a novel non-biliary route of fecal sterol loss.	[Brown, J. Mark; Sawyer, Janet K.; Kelley, Kathryn; Shah, Ramesh; Wilson, Martha D.; Davis, Matthew A.; Rudel, Lawrence L.] Wake Forest Univ, Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27157 USA; [Alger, Heather M.; Rudel, Lawrence L.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Smith, Thomas L.] Wake Forest Univ, Sch Med, Dept Orthoped Surg, Winston Salem, NC 27157 USA; [Bell, Thomas A., III] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Lee, Richard G.; Graham, Mark J.; Crooke, Rosanne M.] ISIS Pharmaceut Inc, Cardiovasc Grp, Antisense Drug Discovery, Carlsbad, CA 92008 USA	Wake Forest University; Wake Forest University; Wake Forest University; Scripps Research Institute; Isis Pharmaceuticals Inc	Rudel, LL (corresponding author), Wake Forest Univ, Sch Med, Dept Pathol, Sect Lipid Sci, Med Ctr Blvd, Winston Salem, NC 27157 USA.	lrudel@wfubmc.edu	Alger, Heather/AAK-1019-2020	Alger, Heather/0000-0003-1795-9675	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007115, P01HL049373, R00HL096166] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL07115-28, P01-HL49373, R00 HL096166] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bell TA, 2007, ARTERIOSCL THROM VAS, V27, P1396, DOI 10.1161/ATVBAHA.107.142802; Bell TA, 2006, ARTERIOSCL THROM VAS, V26, P1814, DOI 10.1161/01.ATV.0000225289.30767.06; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; Buhman KK, 2000, NAT MED, V6, P1341, DOI 10.1038/82153; Butler M, 1997, LAB INVEST, V77, P379; Chang CCY, 2000, J BIOL CHEM, V275, P28083; CHENG SH, 1959, P SOC EXP BIOL MED, V101, P223; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JOHNSON FL, 1983, J CLIN INVEST, V72, P221, DOI 10.1172/JCI110961; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Lee RG, 2000, J LIPID RES, V41, P1991; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; PERTSEMLIDIS D, 1973, J CLIN INVEST, V52, P2353, DOI 10.1172/JCI107424; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Repa JJ, 2004, HEPATOLOGY, V40, P1088, DOI 10.1002/hep.20439; Rudel LL, 1997, J CLIN INVEST, V100, P74, DOI 10.1172/JCI119524; Rudel LL, 2005, ARTERIOSCL THROM VAS, V25, P1112, DOI 10.1161/01.ATV.0000166548.65753.1e; Schwarz M, 1998, J LIPID RES, V39, P1833; SIMMONDS WJ, 1967, J CLIN INVEST, V46, P874, DOI 10.1172/JCI105587; SMITH JL, 1990, J LIPID RES, V31, P1993; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; TURLEY SD, 1979, J LIPID RES, V20, P923; Turley SD, 2003, CURR OPIN LIPIDOL, V14, P233, DOI 10.1097/00041433-200306000-00002; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100	32	92	96	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10522	10534		10.1074/jbc.M707659200	http://dx.doi.org/10.1074/jbc.M707659200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281279	Green Published, hybrid			2022-12-27	WOS:000254894700034
J	Keskiaho, K; Kukkola, L; Page, AP; Winter, AD; Vuoristo, J; Sormunen, R; Nissi, R; Riihimaa, P; Myllyharju, J				Keskiaho, Katriina; Kukkola, Liisa; Page, Antony P.; Winter, Alan D.; Vuoristo, Jussi; Sormunen, Raija; Nissi, Ritva; Riihimaa, Paeivi; Myllyharju, Johanna			Characterization of a novel Caenorhabditis elegans prolyl 4-hydroxylase with a unique substrate specificity and restricted expression in the pharynx and excretory duct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE-FACTOR; PROTEIN DISULFIDE-ISOMERASE; ALPHA-SUBUNIT ISOFORM; AMINO-ACID-SEQUENCE; GENE-EXPRESSION; BACULOVIRUS EXPRESSION; BINDING DOMAIN; BETA-SUBUNIT; ARABIDOPSIS-THALIANA; ENZYME TETRAMER	Collagen prolyl 4-hydroxylases (C-P4Hs) have a critical role in collagen synthesis, since 4-hydroxyproline residues are necessary for folding of the triple-helical molecules. Vertebrate C-P4Hs are alpha(2)beta(2) tetramers in which the beta subunit is identical to protein-disulfide isomerase (PDI). Three isoforms of the catalytic alpha subunit, PHY-1, PHY-2, and PHY-3, have been characterized from Caenorhabditis elegans, PHY-1 and PHY-2 being responsible for the hydroxylation of cuticle collagens, whereas PHY-3 is predicted to be involved in collagen synthesis in early embryos. We have characterized transcripts of two additional C. elegans alpha subunit-like genes, Y43F8B.4 and C14E2.4. Three transcripts were generated from Y43F8B.4, and a polypeptide encoded by one of them, named PHY-4.1, assembled into active (PHY-4.1)(2)/(PDI-2)(2) tetramers and PHY-4.1/PDI-2 dimers when coexpressed with C. elegans PDI-2 in insect cells. The C14E2.4 transcript was found to have a frameshift leading to the absence of codons for two residues critical for P4H catalytic activity. Thus, C. elegans has altogether four functional C-P4H alpha subunits, PHY-1, PHY-2, PHY-3, and PHY-4.1. The tetramers and dimers containing recombinant PHY-4.1 had a distinct substrate specificity from the other C-P4Hs in that they hydroxylated poly(L-proline) and certain other proline-rich peptides, including ones that are expressed in the pharynx, in addition to collagen-like peptides. These data and the observed restricted expression of the phy-4.1 transcript and PHY-4.1 polypeptide in the pharyngeal gland cells and the excretory duct suggest that in addition to collagens, PHY-4.1 may hydroxylate additional proline-rich proteins in vivo.	[Keskiaho, Katriina; Kukkola, Liisa; Nissi, Ritva; Riihimaa, Paeivi; Myllyharju, Johanna] Univ Oulu, Collagen Res Unit, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Keskiaho, Katriina; Kukkola, Liisa; Vuoristo, Jussi; Sormunen, Raija; Nissi, Ritva; Riihimaa, Paeivi; Myllyharju, Johanna] Univ Oulu, Bioctr, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland; [Page, Antony P.; Winter, Alan D.] Univ Glasgow, Fac Vet Med, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland	University of Oulu; University of Oulu; University of Oulu; University of Glasgow	Myllyharju, J (corresponding author), Univ Oulu, Collagen Res Unit, Dept Med Biochem & Mol Biol, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi			Medical Research Council [G117/476] Funding Source: Medline; MRC [G117/476] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Abrams EW, 2002, MECH DEVELOP, V112, P165, DOI 10.1016/S0925-4773(01)00636-0; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Annunen P, 1999, J BIOL CHEM, V274, P6790, DOI 10.1074/jbc.274.10.6790; Annunen P, 1998, J BIOL CHEM, V273, P5989, DOI 10.1074/jbc.273.11.5989; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; CROSSEN R, 1998, BACULOVIRUS EXPRESSI; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Eriksson M, 1999, J BIOL CHEM, V274, P22131, DOI 10.1074/jbc.274.32.22131; Eschenlauer SCP, 2003, J BIOL CHEM, V278, P4227, DOI 10.1074/jbc.M210510200; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Friedman L, 2000, P NATL ACAD SCI USA, V97, P4736, DOI 10.1073/pnas.97.9.4736; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; HELAAKOSKI T, 1989, P NATL ACAD SCI USA, V86, P4392, DOI 10.1073/pnas.86.12.4392; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hill KL, 2000, GENETICS, V155, P1139; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; JOHN DCA, 1994, BIOCHEMISTRY-US, V33, P14018, DOI 10.1021/bi00251a009; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; KESKIAHO K, 2007, J PLANT CELL, V19, P256; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; LAMBERG A, 1995, J BIOL CHEM, V270, P9926, DOI 10.1074/jbc.270.17.9926; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2002, J BIOL CHEM, V277, P29187, DOI 10.1074/jbc.M203824200; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Nissi R, 2001, J HISTOCHEM CYTOCHEM, V49, P1143, DOI 10.1177/002215540104900908; Nonet ML, 1997, J NEUROSCI, V17, P8061; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200; Riihimaa P, 2002, J BIOL CHEM, V277, P18238, DOI 10.1074/jbc.M200895200; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; Veijola J, 1996, BIOCHEM J, V317, P721, DOI 10.1042/bj3170721; VEIJOLA J, 1994, J BIOL CHEM, V269, P26746; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000; Winter AD, 2003, J BIOL CHEM, V278, P2554, DOI 10.1074/jbc.M210381200; Winter AD, 2007, MATRIX BIOL, V26, P382, DOI 10.1016/j.matbio.2007.01.008	61	6	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10679	10689		10.1074/jbc.M800972200	http://dx.doi.org/10.1074/jbc.M800972200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18276589	hybrid			2022-12-27	WOS:000254894700050
J	Paleologou, KE; Schmid, AW; Rospigliosi, CC; Kim, HY; Lamberto, GR; Fredenburg, RA; Lansbury, PT; Fernandez, CO; Eliezer, D; Zweckstetter, M; Lashuel, HA				Paleologou, Katerina E.; Schmid, Adrian W.; Rospigliosi, Carla C.; Kim, Hai-Young; Lamberto, Gonzalo R.; Fredenburg, Ross A.; Lansbury, Peter T., Jr.; Fernandez, Claudio O.; Eliezer, David; Zweckstetter, Markus; Lashuel, Hilal A.			Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTANTS; PARKINSONS-DISEASE; TAU PHOSPHORYLATION; INCLUSION FORMATION; NMR; DYNAMICS; BINDING; SYSTEM	alpha-Synuclein (alpha-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related alpha-synulceinopathies. However, whether phosphorylation promotes or inhibits alpha-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of alpha-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type alpha-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated alpha-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of alpha-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of alpha-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern alpha-syn aggregation and toxicity in PD and related alpha-synulceinopathies.	[Paleologou, Katerina E.; Schmid, Adrian W.; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, LMNN, CH-1015 Lausanne, Switzerland; [Rospigliosi, Carla C.; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Rospigliosi, Carla C.; Eliezer, David] Weill Cornell Med, Program Struct Biol, New York, NY 10021 USA; [Kim, Hai-Young; Zweckstetter, Markus] Deutsche Forsch Gemeinschaft Res ctr Mol Physiol, Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Lamberto, Gonzalo R.; Fernandez, Claudio O.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, Consejo Nacl Invest Cient & Tecn, RA-2000 Rosario, Argentina; [Fredenburg, Ross A.; Lansbury, Peter T., Jr.] Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Ctr Neurodegenerat & Repair, Cambridge, MA 02139 USA; [Fredenburg, Ross A.; Lansbury, Peter T., Jr.] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Cornell University; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Harvard University; Brigham & Women's Hospital; Harvard University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, LMNN, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Schmid, Adrien/CAG-1527-2022	Fernandez, Claudio Oscar/0000-0003-0454-7735; Zweckstetter, Markus/0000-0002-2536-6581; Schmid, Adrien W./0000-0001-6671-7950	NIA NIH HHS [R01 AG025440-03, AG019391, R01 AG019391-08, R01 AG019391, R37 AG019391, R01 AG025440] Funding Source: Medline; NIGMS NIH HHS [GM66354] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019391, R01AG025440, R37AG019391] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hirai Y, 2004, FEBS LETT, V572, P227, DOI 10.1016/j.febslet.2004.07.046; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kahle PJ, 2000, ANN NY ACAD SCI, V920, P33; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; KOSEN PA, 1986, BIOCHEMISTRY-US, V25, P2356, DOI 10.1021/bi00357a009; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Payton JE, 2004, J MOL BIOL, V337, P1001, DOI 10.1016/j.jmb.2004.02.014; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ryu MY, 2008, J NEUROL SCI, V266, P9, DOI 10.1016/j.jns.2007.08.027; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Tamamizu-Kato S, 2006, BIOCHEMISTRY-US, V45, P10947, DOI 10.1021/bi060939i; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q	44	247	252	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2008	283	24					16895	16905		10.1074/jbc.M800747200	http://dx.doi.org/10.1074/jbc.M800747200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	309YW	18343814	Green Published, hybrid			2022-12-27	WOS:000256497100067
J	Ha, CH; Wang, W; Jhun, BS; Wong, C; Hausser, A; Pfizenmaier, K; McKinsey, TA; Olson, EN; Jin, ZG				Ha, Chang Hoon; Wang, Weiye; Jhun, Bong Sook; Wong, Chelsea; Hausser, Angelika; Pfizenmaier, Klaus; McKinsey, Timothy A.; Olson, Eric N.; Jin, Zheng-Gen			Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY; NUR77 EXPRESSION; ACTIVATION; VEGF; CELLS; EMBRYOGENESIS; RECEPTORS; APOPTOSIS	Vascular endothelial growth factor (VEGF) is essential for normal and pathological angiogenesis. However, the signaling pathways linked to gene regulation in VEGF-induced angiogenesis are not fully understood. Here we demonstrate a critical role of protein kinaseD(PKD) and histone deacetylase 5 (HDAC5) in VEGF-induced gene expression and angiogenesis. We found that VEGF stimulated HDAC5 phosphorylation and nuclear export in endothelial cells through a VEGF receptor 2-phospholipase C gamma-protein kinase C-PKD-dependent pathway. We further showed that the PKD-HDAC5 pathway mediated myocyte enhancer factor-2 transcriptional activation and a specific subset of gene expression in response to VEGF, including NR4A1, an orphan nuclear receptor involved in angiogenesis. Specifically, inhibition of PKD by overexpression of the PKD kinase-negative mutant prevents VEGF-induced HDAC5 phosphorylation and nuclear export as well as NR4A1 induction. Moreover, a mutant of HDAC5 specifically deficient in PKD-dependent phosphorylation inhibited VEGF-mediated NR4A1 expression, endothelial cell migration, and in vitro angiogenesis. These findings suggest that the PKD-HDAC5 pathway plays an important role in VEGF regulation of gene transcription and angiogenesis.	[Ha, Chang Hoon; Wang, Weiye; Jhun, Bong Sook; Wong, Chelsea; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14586 USA; [Ha, Chang Hoon; Wang, Weiye; Jhun, Bong Sook; Wong, Chelsea; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14586 USA; [Hausser, Angelika; Pfizenmaier, Klaus] Univ Stuttgart, Inst Cell Biol & Immunol, D-70659 Stuttgart, Germany; [McKinsey, Timothy A.] Myogen Inc, Westminster, CO 80021 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Rochester; University of Rochester; University of Stuttgart; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jin, ZG (corresponding author), 211 Bailey Rd,W Henrietta, Rochester, NY 14586 USA.	zheng-gen_jin@urmc.rochester.edu	Hausser, Angelika/AAC-4531-2021; Ha, C/GZL-9046-2022	Ha, Chang Hoon/0000-0001-7606-4340; Jhun, Bong Sook/0000-0001-9916-9962	NHLBI NIH HHS [R01 HL080611-05, R01 HL 080611, R01 HL080611] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Claesson-Welsh L, 2003, BIOCHEM SOC T, V31, P20, DOI 10.1042/bst0310020; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lin Q, 1998, DEVELOPMENT, V125, P4565; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Pi XC, 2005, CIRC RES, V96, P1145, DOI 10.1161/01.RES.0000168802.43528.e1; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sucharov CC, 2006, AM J PHYSIOL-CELL PH, V291, pC1029, DOI 10.1152/ajpcell.00059.2006; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	32	140	146	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14590	14599		10.1074/jbc.M800264200	http://dx.doi.org/10.1074/jbc.M800264200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332134	Green Published, hybrid			2022-12-27	WOS:000255941400047
J	Wu, Y; Kantake, N; Sugiyama, T; Kowalczykowski, SC				Wu, Yun; Kantake, Noriko; Sugiyama, Tomohiko; Kowalczykowski, Stephen C.			Rad51 protein controls Rad52-mediated DNA annealing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; RAD51-INDEPENDENT RECOMBINATION; MITOTIC RECOMBINATION; INDUCED REPLICATION; MULTIPLE PATHWAYS; MISMATCH REPAIR; RECA PROTEIN; BINDING	In Saccharomyces cerevisiae, Rad52 protein plays an essential role in the repair of DNA double-stranded breaks (DSBs). Rad52 and its orthologs possess the unique capacity to anneal single-stranded DNA (ssDNA) complexed with its cognate ssDNA-binding protein, RPA. This annealing activity is used in multiple mechanisms of DSB repair: single-stranded annealing, synthesis-dependent strand annealing, and crossover formation. Here we report that the S. cerevisiae DNA strand exchange protein, Rad51, prevents Rad52-mediated annealing of complementary ssDNA. Efficient inhibition is ATP-dependent and involves a specific interaction between Rad51 and Rad52. Free Rad51 can limit DNA annealing by Rad52, but the Rad51 nucleoprotein filament is even more effective. We also discovered that the budding yeast Rad52 paralog, Rad59 protein, partially restores Rad52-dependent DNA annealing in the presence of Rad51, suggesting that Rad52 and Rad59 function coordinately to enhance recombinational DNA repair either by directing the processed DSBs to repair by DNA strand annealing or by promoting second end capture to form a double Holliday junction. This regulation of Rad52-mediated annealing suggests a control function for Rad51 in deciding the recombination path taken for a processed DNA break; the ssDNA can be directed to either Rad51-mediated DNA strand invasion or to Rad52-mediated DNA annealing. This channeling determines the nature of the subsequent repair process and is consistent with the observed competition between these pathways in vivo.	[Wu, Yun; Kowalczykowski, Stephen C.] Univ Calif Davis, Microbiol Sect & Mol & Cellular Biol, Davis, CA 95616 USA; [Kantake, Noriko; Sugiyama, Tomohiko] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University of California System; University of California Davis; University System of Ohio; Ohio University	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect & Mol & Cellular Biol, Briggs Hall 1 Shields Ave, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Sugiyama, Tomohiko/0000-0003-2942-3667	NIAID NIH HHS [AI 18987] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018987] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUILERA A, 1995, CURR GENET, V27, P298, DOI 10.1007/BF00352096; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bai Y, 1999, GENETICS, V153, P1117; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; BIANCO PR, 1998, FRONT BIOSCI, V570, pD570; BOUNDYMILLS KL, 1993, GENETICS, V133, P39; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Davis AP, 2003, DNA REPAIR, V2, P1127, DOI 10.1016/S1568-7864(03)00121-6; Davis AP, 2001, GENETICS, V159, P515; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Ivanov EL, 1996, GENETICS, V142, P693; Jablonovich Z, 1999, CURR GENET, V36, P13, DOI 10.1007/s002940050467; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kang LE, 2000, MOL CELL BIOL, V20, P9162, DOI 10.1128/MCB.20.24.9162-9172.2000; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kim HK, 2002, GENES CELLS, V7, P1125, DOI 10.1046/j.1365-2443.2002.00588.x; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; LEBOWITZ J, 1985, THESIS J HOPKINS U B; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; MCENTEE K, 1985, BIOCHEMISTRY-US, V24, P4345, DOI 10.1021/bi00337a014; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5937, DOI 10.1021/bi027232q; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Namsaraev EA, 1998, BIOCHEMISTRY-US, V37, P11932, DOI 10.1021/bi9810297; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; RATTRAY AJ, 1995, GENETICS, V139, P45; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Spell RM, 2003, GENETICS, V165, P1733; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Tsukamoto M, 2003, GENETICS, V165, P1703; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126; Wu XH, 1997, GENETICS, V147, P399; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	69	62	63	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14883	14892		10.1074/jbc.M801097200	http://dx.doi.org/10.1074/jbc.M801097200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18337252	Green Published, hybrid			2022-12-27	WOS:000255941400075
J	Barkefors, I; Le Jan, S; Jakobsson, L; Hejll, E; Carlson, G; Johansson, H; Jarvius, J; Park, JW; Jeon, NL; Kreuger, J				Barkefors, Irmeli; Le Jan, Sebastien; Jakobsson, Lars; Hejll, Eduar; Carlson, Gustav; Johansson, Henrik; Jarvius, Jonas; Park, Jeong Won; Jeon, Noo Li; Kreuger, Johan			Endothelial cell migration in stable gradients of vascular endothelial growth factor a and fibroblast growth factor 2 - Effects on chemotaxis and chemokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; FOCAL ADHESIONS; VEGF; ANGIOGENESIS; DIFFUSION; RECEPTOR; DIFFERENTIATION; PROLIFERATION; ACTIVATION; LETHALITY	Gradients of secreted signaling proteins guide growing blood vessels during both normal and pathological angiogenesis. However, the mechanisms by which endothelial cells integrate and respond to graded distributions of chemotactic factors are still poorly understood. We have in this study investigated endothelial cell migration in response to hill-shaped gradients of vascular endothelial growth factor A (VEGFA) and fibroblast growth factor 2 (FGF2) using a novel microfluidic chemotaxis chamber (MCC). Cell migration was scored at the level of individual cells using time-lapse microscopy. A stable gradient of VEGFA165 ranging from 0 to 50 ng/ml over a distance of 400 mu m was shown to strongly induce chemotaxis of endothelial cells of different vascular origin. VEGFA121, unable to bind proteoglycan and neuropilin coreceptors, was also shown to induce chemotaxis in this setup. Furthermore, a gradient of FGF2 was able to attract venular but not arterial endothelial cells, albeit less efficiently than VEGFA165. Notably, constant levels of VEGFA165, but not of FGF2, were shown to efficiently reduce chemokinesis. Systematic exploration of different gradient shapes led to the identification of a minimal gradient steepness required for efficient cell guidance. Finally, analysis of cell migration in different regions of the applied gradients showed that chemotaxis is reduced when cells reach the high end of the gradient. Our findings suggest that chemotactic growth factor gradients may instruct endothelial cells to shift toward a nonmigratory phenotype when approaching the growth factor source.	[Barkefors, Irmeli; Le Jan, Sebastien; Hejll, Eduar; Carlson, Gustav; Kreuger, Johan] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Jakobsson, Lars; Johansson, Henrik; Jarvius, Jonas] Uppsala Univ, Dept Genet & Pathol, SE-75123 Uppsala, Sweden; [Park, Jeong Won; Jeon, Noo Li] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	Uppsala University; Uppsala University; University of California System; University of California Irvine	Kreuger, J (corresponding author), Husargatan 3,Box 582, SE-75123 Uppsala, Sweden.	Johan.Kreuger@imbim.uu.se	LE JAN, Sébastien/AAH-3952-2019; Kreuger, Johan/HDM-1503-2022; Jakobsson, Lars/B-4200-2011	LE JAN, Sébastien/0000-0003-4027-2855; Jakobsson, Lars/0000-0001-7956-587X				ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chung BG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-60; Cox CM, 2000, DEV DYNAM, V218, P371, DOI 10.1002/(SICI)1097-0177(200006)218:2<371::AID-DVDY10>3.3.CO;2-Q; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Filion RJ, 2004, ANN BIOMED ENG, V32, P645, DOI 10.1023/B:ABME.0000030231.88326.78; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hsu S, 2005, BIOCHEM BIOPH RES CO, V337, P401, DOI 10.1016/j.bbrc.2005.08.272; Hufnagel L, 2006, DEV BIOL, V300, P512, DOI 10.1016/j.ydbio.2006.08.076; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kanda S, 2000, J BIOL CHEM, V275, P10105, DOI 10.1074/jbc.275.14.10105; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Poole TJ, 2001, DEV DYNAM, V220, P1, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1087>3.0.CO;2-2; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Senger DR, 1996, AM J PATHOL, V149, P293; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shono T, 2001, EXP CELL RES, V268, P169, DOI 10.1006/excr.2001.5276; Shono T, 2001, EXP CELL RES, V264, P275, DOI 10.1006/excr.2001.5154; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yamamoto M, 1999, J BIOACT COMPAT POL, V14, P474, DOI 10.1177/088391159901400603; Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	38	122	126	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13905	13912		10.1074/jbc.M704917200	http://dx.doi.org/10.1074/jbc.M704917200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347025	hybrid			2022-12-27	WOS:000255728200044
J	Stallings, JD; Zeng, YX; Narvaez, F; Rebecchi, MJ				Stallings, Jonathan D.; Zeng, Yue X.; Narvaez, Francisco; Rebecchi, Mario J.			Phospholipase C-delta(1) expression is linked to proliferation, DNA synthesis, and cyclin E levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PLECKSTRIN HOMOLOGY DOMAIN; CELL-CYCLE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MAMMALIAN-CELLS; KINASE-ACTIVITY; S-PHASE; C GENE; NUCLEAR; BINDING	We previously reported that phospholipase C-delta(1) (PLC-delta(1)) accumulates in the nucleus at the G(1)/S transition, which is largely dependent on its binding to phosphatidylinositol 4,5-bisphosphate (Stallings, J. D., Tall, E. G., Pentyala, S., and Rebecchi, M. J. (2005) J. Biol. Chem. 280, 22060-22069). Here, using small interfering RNA (siRNA) that specifically targets rat PLC-delta(1), we investigated whether this enzyme plays a role in cell cycle control. Inhibiting expression of PLC-delta(1) significantly decreased proliferation of rat C6 glioma cells and altered S phase progression. [H-3] Thymidine labeling and fluorescence-activated cell sorting analysis indicated that the rates of G(1)/S transition and DNA synthesis were enhanced. On the other hand, knockdown cultures released from the G(1)/S boundary were slower to reach full G(2)/M DNA content, consistent with a delay in S phase. The levels of cyclin E, a key regulator of the G(1)/S transition and DNA synthesis, were elevated in asynchronous cultures as well as those blocked at the G(1)/S boundary. Epifluorescence imaging showed that transient expression of human phospholipase C-delta(1), resistant to these siRNA, suppressed expression of cyclin E at the G(1)/S boundary despite treatment of cultures with rat-specific siRNA. Although whole cell levels of phosphatidylinositol 4,5-bisphosphate were unchanged, suppression of PLC-delta(1) led to a significant rise in the nuclear levels of this phospholipid at the G(1)/S boundary. These results support a role for PLC-delta(1) and nuclear phospholipid metabolism in regulating cell cycle progression.	[Zeng, Yue X.; Narvaez, Francisco; Rebecchi, Mario J.] SUNY Stony Brook, Dept Anesthesiol, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Stallings, Jonathan D.] Madigan Army Med Ctr, Dept Clin Invest, Tacoma, WA 98431 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Madigan Army Medical Center	Rebecchi, MJ (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Hlth Sci Ctr, Level 4,Rm 075, Stony Brook, NY 11794 USA.	mrebecchi@notes.cc.sunysb.edu	Stallings, Jonathan D/H-7779-2013	Stallings, Jonathan D/0000-0002-6430-5888				Albi E, 2003, J CELL PHYSIOL, V197, P181, DOI 10.1002/jcp.10292; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cocco L, 2006, BBA-MOL CELL BIOL L, V1761, P509, DOI 10.1016/j.bbalip.2006.03.001; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; Downes CP, 2007, ADV ENZYME REGUL, V47, P184, DOI 10.1016/j.advenzreg.2006.12.018; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Faenza I, 2000, J BIOL CHEM, V275, P30520, DOI 10.1074/jbc.M004630200; Faenza I, 2008, FRONT BIOSCI-LANDMRK, V13, P2452, DOI 10.2741/2858; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Flick JS, 1998, GENETICS, V148, P33; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Huppi K, 2005, MOL CELL, V17, P1, DOI 10.1016/j.molcel.2004.12.017; Hwang JI, 2005, BIOCHEM J, V389, P181, DOI 10.1042/BJ20041677; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ji GS, 1998, MOL BIOL CELL, V9, P749, DOI 10.1091/mbc.9.4.749; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Lee H, 2002, MOL VIS, V8, P17; Leone G, 1999, P NATL ACAD SCI USA, V96, P6626, DOI 10.1073/pnas.96.12.6626; Manzoli L, 2005, PROG LIPID RES, V44, P185, DOI 10.1016/j.plipres.2005.04.003; Martelli AM, 2004, PHARMACOL THERAPEUT, V101, P47, DOI 10.1016/j.pharmthera.2003.10.003; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakahara M, 2005, J BIOL CHEM, V280, P29128, DOI 10.1074/jbc.M503817200; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Nebigil CG, 1997, BIOCHEMISTRY-US, V36, P15949, DOI 10.1021/bi971721m; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Osborne SL, 2001, J CELL SCI, V114, P2501; Parrington J, 2002, REPRODUCTION, V123, P31, DOI 10.1530/rep.0.1230031; PAYNE WE, 1993, MOL CELL BIOL, V13, P4351, DOI 10.1128/MCB.13.7.4351; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; TUSCHL T, 2003, RNAI GUIDE GENE SILE, P280; Wang S, 1998, FEBS LETT, V441, P261, DOI 10.1016/S0014-5793(98)01518-X; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Winston JT, 1999, GENE DEV, V13, P2751, DOI 10.1101/gad.13.21.2751; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yagisawa H, 2006, J CELL BIOCHEM, V97, P233, DOI 10.1002/jcb.20677; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; Yu HY, 1998, EUR J BIOCHEM, V251, P281, DOI 10.1046/j.1432-1327.1998.2510281.x; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	60	22	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13992	14001		10.1074/jbc.M800752200	http://dx.doi.org/10.1074/jbc.M800752200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359940	hybrid			2022-12-27	WOS:000255728200053
J	Li, H; Gade, P; Nallar, SC; Raha, A; Roy, SK; Karra, S; Reddy, JK; Reddy, SP; Kalvakolanu, DV				Li, Hui; Gade, Padmaja; Nallar, Shreeram C.; Raha, Abhijit; Roy, Sanjit K.; Karra, Sreenivasu; Reddy, Janardan K.; Reddy, Sekhar P.; Kalvakolanu, Dhananjaya V.			The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-beta-driven transcription in response to interferon-gamma.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; THYROID-HORMONE RECEPTOR; C/EBP-BETA; GENE-EXPRESSION; COACTIVATOR COMPLEX; (PPAR)-BINDING PROTEIN; SIGNAL TRANSDUCER; TRAP220 COMPONENT; NUCLEAR RECEPTORS; PHOSPHORYLATION	Transcription factor CCAAT/enhancer-binding protein (C/EBP)-beta is crucial for regulating transcription of genes involved in a number of diverse cellular processes, including those involved in some cytokine-induced responses. However, the mechanisms that contribute to its diverse transcriptional activity are not yet fully understood. To gain an understanding into its mechanisms of action, we took a proteomic approach and identified cellular proteins that associate with C/EBP-beta in an interferon (IFN)-gamma-dependent manner. Transcriptional mediator ( Mediator) is a multisubunit protein complex that regulates signal-induced cellular gene transcription from enhancer-bound transcription factor(s). Here, we report that the Med1 subunit of the Mediator as a C/EBP-beta-interacting protein. Using gene knock-out cells and mutational and RNA interference approaches, we show that Med1 is critical for IFN-induced expression of certain genes. Med1 associates with C/EBP-beta through a domain located between amino acids 125 and 155 of its N terminus. We also show that the MAPK, ERK1/2, and an ERK phosphorylation site within regulatory domain 2, more specifically the Thr(189) residue, of C/EBP-beta are essential for it to bind to Med1. Last, an ERK- regulated site in Med1 protein is also essential for up-regulating IFN-induced transcription although not critical for binding to C/EBP-beta.	[Li, Hui; Gade, Padmaja; Nallar, Shreeram C.; Raha, Abhijit; Roy, Sanjit K.; Karra, Sreenivasu; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Greenbaum Canc Ctr, Baltimore, MD 21201 USA; [Reddy, Janardan K.] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Reddy, Sekhar P.] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Northwestern University; Johns Hopkins University	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Greenbaum Canc Ctr, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu			NATIONAL CANCER INSTITUTE [R01CA104578, R01CA078282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER; NCI NIH HHS [CA78282, CA104578] Funding Source: Medline; NIEHS NIH HHS [ES011863] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Chen XN, 1997, BLOOD, V90, P156; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Croniger C, 1997, J BIOL CHEM, V272, P26306, DOI 10.1074/jbc.272.42.26306; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Diehl AM, 1998, J BIOL CHEM, V273, P30843, DOI 10.1074/jbc.273.47.30843; Drane P, 1997, ONCOGENE, V15, P3013, DOI 10.1038/sj.onc.1201492; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frade R, 2000, CANCER RES, V60, P6585; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lau JF, 2003, MOL CELL BIOL, V23, P620, DOI 10.1128/MCB.23.2.620-628.2003; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Minucci S, 1997, MOL CELL BIOL, V17, P644, DOI 10.1128/MCB.17.2.644; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NATSUKA S, 1992, BLOOD, V79, P460; Nevado J, 2004, MOL CELL ENDOCRINOL, V222, P41, DOI 10.1016/j.mce.2004.05.003; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Park JM, 2003, MOL CELL BIOL, V23, P1358, DOI 10.1128/MCB.23.4.1358-1367.2003; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shui JW, 2004, GENESIS, V39, P217, DOI 10.1002/gene.20044; Simpson RJ, 2003, PROTEINS PROTEOMICS; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P103, DOI 10.1073/pnas.94.1.103; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	61	34	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13077	13086		10.1074/jbc.M800604200	http://dx.doi.org/10.1074/jbc.M800604200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18339625	Green Published, hybrid			2022-12-27	WOS:000255499800046
J	Adan, C; Matsushima, Y; Hernandez-Sierra, R; Marco-Ferreres, R; Fernandez-Moreno, MA; Gonzalez-Vioque, E; Calleja, M; Aragon, JJ; Kaguni, LS; Garesse, R				Adan, Cristina; Matsushima, Yuichi; Hernandez-Sierra, Rosana; Marco-Ferreres, Raquel; Fernandez-Moreno, Miguel Angel; Gonzalez-Vioque, Emiliano; Calleja, Manuel; Aragon, Juan J.; Kaguni, Laurie S.; Garesse, Rafael			Mitochondrial transcription factor B2 is essential for metabolic function in Drosophila melanogaster development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-GAMMA; RNA-POLYMERASE; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; SCHNEIDER CELLS; GENE-EXPRESSION; SIGMA-FACTORS; COPY NUMBER; SC-MTTFB	Characterization of the basal transcription machinery of mitochondrial DNA (mtDNA) is critical to understand mitochondrial pathophysiology. In mammalian in vitro systems, mtDNA transcription requires mtRNA polymerase, transcription factor A (TFAM), and either transcription factor B1 (TFB1M) or B2 (TFB2M). We have silenced the expression of TFB2M by RNA interference in Drosophila melanogaster. RNA interference knockdown of TF2BM causes lethality by arrest of larval development. Molecular analysis demonstrates that TF2BM is essential for mtDNA transcription during Drosophila development and is not redundant with TFB1M. The impairment of mtDNA transcription causes a dramatic decrease in oxidative phosphorylation and mitochondrial ATP synthesis in the long-lived larvae, and a metabolic shift to glycolysis, which partially restores ATP levels and elicits a compensatory response at the nuclear level that increases mitochondrial mass. At the cellular level, the mitochondrial dysfunction induced by TFB2M knockdown causes a severe reduction in cell proliferation without affecting cell growth, and increases the level of apoptosis. In contrast, cell differentiation and morphogenesis are largely unaffected. Our data demonstrate the essential role of TFB2M in mtDNA transcription in a multicellular organism, and reveal the complex cellular, biochemical, and molecular responses induced by impairment of oxidative phosphorylation during Drosophila development.	[Adan, Cristina; Hernandez-Sierra, Rosana; Marco-Ferreres, Raquel; Fernandez-Moreno, Miguel Angel; Gonzalez-Vioque, Emiliano; Aragon, Juan J.; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, CSIC,Dept Bioquim, CIBERER ISCIII,Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Calleja, Manuel] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Michigan State University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Garesse, R (corresponding author), Univ Autonoma Madrid, Fac Med, CSIC,Dept Bioquim, CIBERER ISCIII,Inst Invest Biomed Alberto Sols, C Arzobispo Morcillo 4, E-28029 Madrid, Spain.	rafael.garesse@uam.es	Marco-Ferreres, Raquel/J-7122-2012; Fernandez-Moreno, Miguel Angel/K-4425-2017; Garesse, Rafael/F-3836-2012	Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Gonzalez Vioque, Emiliano/0000-0001-7279-4311; Garesse, Rafael/0000-0002-0338-2281; Marco-Ferreres, Raquel/0000-0002-6109-3840	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERTHIER F, 1986, NUCLEIC ACIDS RES, V14, P4519, DOI 10.1093/nar/14.11.4519; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CLAYTON DA, 1992, J INHERIT METAB DIS, V15, P439, DOI 10.1007/BF01799602; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Garesse R, 2005, IUBMB LIFE, V57, P555, DOI 10.1080/15216540500215572; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; GONZALEZMATEOS F, 1993, J BIOL CHEM, V268, P7809; Iyengar B, 1999, GENETICS, V153, P1809; Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899; JANG SH, 1991, J BIOL CHEM, V266, P22671; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Marco-Ferreres R, 2005, MECH DEVELOP, V122, P681, DOI 10.1016/j.mod.2004.12.005; Marin MC, 2004, MOL BIOL CELL, V15, P1185, DOI 10.1091/mbc.E03-09-0663; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1; Toivonen JM, 2001, GENETICS, V159, P241; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	45	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12333	12342		10.1074/jbc.M801342200	http://dx.doi.org/10.1074/jbc.M801342200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18308726	hybrid, Green Published			2022-12-27	WOS:000255340000050
J	Abe, T; Hashimoto, Y; Hosaka, H; Tomita-Yokotani, K; Kobayashi, M				Abe, Tomoko; Hashimoto, Yoshiteru; Hosaka, Hideaki; Tomita-Yokotani, Kaori; Kobayashi, Michihiko			Discovery of amide (peptide) bond synthetic activity in Acyl-CoA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; PSEUDOMONAS-CHLORORAPHIS B23; RHODOCOCCUS-RHODOCHROUS J1; CRYSTAL-STRUCTURE; FIREFLY LUCIFERASE; NITRILE HYDRATASE; ACETYL-COENZYME; TRANSCRIPTIONAL REGULATION; ADENYLATION DOMAINS; STRUCTURAL BASIS	Acyl-CoA synthetase, which is one of the acid-thiol ligases (EC 6.2.1), plays key roles in metabolic and regulatory processes. This enzyme forms a carbon-sulfur bond in the presence of ATP and Mg2+, yielding acyl-CoA thioesters from the corresponding free acids and CoA. This enzyme belongs to the superfamily of adenylate-forming enzymes, whose three-dimensional structures are analogous to one another. We here discovered a new reaction while studying the short-chain acyl-CoA synthetase that we recently reported (Hashimoto, Y., Hosaka, H., Oinuma, K., Goda, M., Higashibata, H., and Kobayashi, M. (2005) J. Biol. Chem. 280, 8660-8667). When L-cysteine was used as a substrate instead of CoA, N-acyl-L-cysteine was surprisingly detected as a reaction product. This finding demonstrated that the enzyme formed a carbon-nitrogen bond (EC 6.3.1 acid-ammonia (or amide) ligase (amide synthase); EC 6.3.2 acid-amino acid ligase (peptide synthase)) comprising the amino group of the cysteine and the carboxyl group of the acid. N-Acyl-D-cysteine, N-acyl-DL-homocysteine, and N-acyl-L-cysteine methyl ester were also synthesized from the corresponding cysteine analog substrates by the enzyme. Furthermore, this unexpected enzyme activity was also observed for acetyl-CoA synthetase and firefly luciferase, indicating the generality of the new reaction in the superfamily of adenylate-forming enzymes.	Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Kobayashi, M (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.							BLACK PN, 1992, J BIOL CHEM, V267, P25513; BRUCKNER H, 1995, J CHROMATOGR A, V711, P201, DOI 10.1016/0021-9673(95)00158-J; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DIXON M, 1964, ENZYMES, P315; Ehmann DE, 2000, P NATL ACAD SCI USA, V97, P2509, DOI 10.1073/pnas.040572897; Endo I, 1999, TRENDS BIOTECHNOL, V17, P244, DOI 10.1016/S0167-7799(99)01303-7; Faergeman NJ, 1997, BIOCHEM J, V323, P1; GOULD SJ, 1988, ANAL BIOCHEM, V175, P5, DOI 10.1016/0003-2697(88)90353-3; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hann EC, 1999, BIOORGAN MED CHEM, V7, P2239, DOI 10.1016/S0968-0896(99)00157-1; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; Herai S, 2004, P NATL ACAD SCI USA, V101, P14031, DOI 10.1073/pnas.0406058101; HOSAKA K, 1981, METHOD ENZYMOL, V71, P325; Ingram-Smith C, 2006, BIOCHEMISTRY-US, V45, P11482, DOI 10.1021/bi061023e; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Kaneko M, 2003, J BACTERIOL, V185, P20, DOI 10.1128/JB.185.1.20-27.2003; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Komeda H, 1997, P NATL ACAD SCI USA, V94, P36, DOI 10.1073/pnas.94.1.36; Konishi K, 2006, P NATL ACAD SCI USA, V103, P564, DOI 10.1073/pnas.0505412103; Linne U, 2007, FEBS LETT, V581, P905, DOI 10.1016/j.febslet.2007.01.066; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; NAGASAWA T, 1987, EUR J BIOCHEM, V162, P691, DOI 10.1111/j.1432-1033.1987.tb10692.x; Nakamura M, 2005, BIOCHEM BIOPH RES CO, V331, P471, DOI 10.1016/j.bbrc.2005.03.202; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oba Y, 2003, FEBS LETT, V540, P251, DOI 10.1016/S0014-5793(03)00272-2; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; Samanta SK, 2005, MOL MICROBIOL, V55, P1151, DOI 10.1111/j.1365-2958.2004.04452.x; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; SHIMIZU S, 1981, BIOCHEM BIOPH RES CO, V103, P1231, DOI 10.1016/0006-291X(81)90254-0; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; TANAKA T, 1979, EUR J BIOCHEM, V98, P165, DOI 10.1111/j.1432-1033.1979.tb13173.x; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953	40	21	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11312	11321		10.1074/jbc.M709654200	http://dx.doi.org/10.1074/jbc.M709654200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305111	hybrid			2022-12-27	WOS:000255067400027
J	Izumikawa, T; Koike, T; Shiozawa, S; Sugahara, K; Tamura, JI; Kitagawa, H				Izumikawa, Tomomi; Koike, Toshiyasu; Shiozawa, Shoko; Sugahara, Kazuyuki; Tamura, Jun-Ichi; Kitagawa, Hiroshi			Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization - Chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; MOLECULAR-CLONING; HEPARAN-SULFATE; N-ACETYLGALACTOSAMINYLTRANSFERASE; DERMATAN SULFATE; GLUCURONIC-ACID; BIOSYNTHESIS; EXPRESSION; PROTEOGLYCANS; ELONGATION	Recently, we demonstrated that chondroitin polymerization is achieved by any two combinations of human chondroitin synthase-1 (ChSy-1), ChSy-2 (chondroitin sulfate synthase 3, CSS3), and chondroitin-polymerizing factor (ChPF). Although an additional ChSy family member, called chondroitin sulfate glucuronyltransferase (CSGlcA-T), has been identified, its involvement in chondroitin polymerization remains unclear because it possesses only glucuronyltransferase II activity responsible for the elongation of chondroitin sulfate (CS) chains. Herein, we report that CSGlcA-T exhibits polymerization activity on alpha-thrombomodulin bearing the truncated linkage region tetrasaccharide through its interaction with ChSy-1, ChSy-2 (CSS3), or ChPF, and the chain length of chondroitin formed by the co-expressed proteins in various combinations is different. In addition, ChSy family members co-expressed in various combinations exhibited distinct but overlapping acceptor substrate specificities toward the two synthetic acceptor substrates, GlcUA beta 1-3Gal beta 1-O-naphthalenemethanol and GlcUA beta 1-3Gal beta 1-O-C2H4NH-benzyloxycarbonyl, both of which share the disaccharide sequence with the glycosaminoglycan-protein linkage region tetrasaccharide. Moreover, overexpression of CSGlcA-T increased the amount of CS in HeLa cells, whereas the RNA interference of CSGlcA-T resulted in a reduction of the amount of CS in the cells. Furthermore, the analysis using the CSGlcA-T mutant that lacks any glycosyltransferase activity but interacts with other ChSy family members showed that the glycosyltransferase activity of CSGlcA-T plays an important role in chondroitin polymerization. Overall, these results suggest that chondroitin polymerization is achieved by multiple combinations of ChSy-1, ChSy-2, CSGlcA-T, and ChPF and that each combination may play a unique role in the biosynthesis of CS. Based on these results, we renamed CSGlcA-T chondroitin synthase-3 (ChSy-3).	[Izumikawa, Tomomi; Koike, Toshiyasu; Shiozawa, Shoko; Sugahara, Kazuyuki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Tamura, Jun-Ichi] Tottori Univ, Fac Reg Sci, Dept Reg Environm, Tottori 6808551, Japan	Kobe Pharmaceutical University; Tottori University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079				Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fernandez CJ, 1998, J BIOL CHEM, V273, P19030, DOI 10.1074/jbc.273.30.19030; GLEESON PA, 1994, GLYCOCONJUGATE J, V11, P381, DOI 10.1007/BF00731273; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P905, DOI 10.1093/glycob/7.7.905; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Prydz K, 2000, J CELL SCI, V113, P193; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; WATZELE G, 1990, NUCLEIC ACIDS RES, V18, P7174, DOI 10.1093/nar/18.23.7174; WIGGINS S, 1998, P NATL ACAD SCI USA, V95, P7845; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170	35	107	110	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11396	11406		10.1074/jbc.M707549200	http://dx.doi.org/10.1074/jbc.M707549200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18316376	hybrid			2022-12-27	WOS:000255067400037
J	Black, SA; Trackman, PC				Black, Samuel A., Jr.; Trackman, Philip C.			Transforming growth factor-beta 1 (TGF beta 1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism - Statins with forskolin block TGF beta 1-induced CCN2/CTGF expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE INHIBITORS; COA REDUCTASE INHIBITORS; ACTIN STRESS FIBERS; LYSOPHOSPHATIDIC ACID; FACTOR-BETA; ATHEROSCLEROTIC LESIONS; SCLERODERMA FIBROBLASTS; CELLULAR-RESPONSES; EPITHELIAL-CELLS; FACTOR CTGF/CCN2	Regulation of connective tissue growth factor (CCN2/CTGF) in gingival fibroblasts is unique and may provide therapeutic opportunities to treat oral fibrotic diseases. RhoA was previously implicated in mediating the expression of CCN2/CTGF. We now present evidence that Rho family GTPases Rac1 and Cdc42 are the principal mediators of the transforming growth factor-beta 1 (TGF beta 1)-stimulated expression of CCN2/CTGF in primary human gingival fibroblasts. TGF beta 1 does not stimulate RhoA activation in gingival fibroblasts, and the overexpression of dominant-negative RhoA does not reduce CCN2/CTGF expression in response to TGF beta 1. In contrast, the overexpression of dominant-negative forms of Cdc42 or Rac1 results in a dramatic reduction of CCN2/CTGF protein levels. Lovastatin and a geranylgeranyltransferase inhibitor reduce the TGF beta 1-stimulated levels of CCN2/CTGF protein by similar to 75 and 100%, respectively. We previously demonstrated that JNK1 phosphorylation by TGF beta 1 is also critical for TGF beta 1-induced CCN2/CTGF expression, and forskolin partially reduces levels of phosphorylated JNK1. Inhibition of geranylgeranyltransferase has no effect on levels of JNK phosphorylation in response to TGF beta 1 suggesting Rho-GTPases act independently of JNK1. The combination of lova-statin and forskolin results in a greater inhibitory effect than each agent alone and reduces CCN2/CTGF mRNA and protein expression by greater than 90%. This novel combination has additive inhibitory effects on the TGF beta 1-stimulated expression of CCN2/ CTGF in human gingival fibroblasts through the simultaneous disruption of Rho-and JNK1-mediated pathways, respectively. This combination of available therapeutic compounds may therefore be useful in designing treatment strategies for oral fibrotic conditions in which gingival CCN2/CTGF is elevated.	[Black, Samuel A., Jr.; Trackman, Philip C.] Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Div Oral Biol, Boston, MA 02118 USA	Boston University	Trackman, PC (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Div Oral Biol, 700 Albany St, Boston, MA 02118 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X	NCRR NIH HHS [M01 RR00533] Funding Source: Medline; NIDCR NIH HHS [R01 DE11004, K08 DE016609-03, R01 DE011004-12, K08DE016609, R01 DE011004] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011004, K08DE016609] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Allen JT, 1999, AM J RESP CELL MOL, V21, P693, DOI 10.1165/ajrcmb.21.6.3719; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Black SA, 2007, J BIOL CHEM, V282, P15416, DOI 10.1074/jbc.M610432200; Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192, DOI 10.1136/mp.54.3.192; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Dabbagh K, 1998, THROMB HAEMOSTASIS, V79, P405; Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; di Mola FF, 1999, ANN SURG, V230, P63, DOI 10.1097/00000658-199907000-00010; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Eberlein M, 2001, BRIT J PHARMACOL, V133, P1172, DOI 10.1038/sj.bjp.0704173; Essig M, 1998, J AM SOC NEPHROL, V9, P1377; Fischer DJ, 1998, MOL PHARMACOL, V54, P979, DOI 10.1124/mol.54.6.979; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GERRARD JM, 1989, BIOCHIM BIOPHYS ACTA, V1001, P282, DOI 10.1016/0005-2760(89)90112-4; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Goppelt-Struebe M, 2001, J CLIN PATHOL-MOL PA, V54, P176, DOI 10.1136/mp.54.3.176; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hall EE, 1997, CURR OPIN PERIODONT, V4, P59; Hassell T M, 1981, Monogr Oral Sci, V9, P1; HASSELL T M, 1991, Critical Reviews in Oral Biology and Medicine, V2, P103; Heusinger-Ribeiro J, 2001, J AM SOC NEPHROL, V12, P1853, DOI 10.1681/ASN.V1291853; Holmes A, 2003, J BIOL CHEM, V278, P41728, DOI 10.1074/jbc.M305019200; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Hong HH, 1999, LAB INVEST, V79, P1655; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jackson S M, 1997, Subcell Biochem, V28, P1; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kantarci A, 2006, J PATHOL, V210, P59, DOI 10.1002/path.2000; Kubota S, 2004, J BIOCHEM, V136, P279, DOI 10.1093/jb/mvh126; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lee EH, 1999, INVEST OPHTH VIS SCI, V40, P2025; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Lobell RB, 2001, CANCER RES, V61, P8758; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Oemar BS, 1997, CIRCULATION, V95, P831; Ohnishi H, 1998, J MOL CELL CARDIOL, V30, P2411, DOI 10.1006/jmcc.1998.0799; Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425; Pendurthi UR, 2000, J BIOL CHEM, V275, P14632, DOI 10.1074/jbc.275.19.14632; Querfeld C, 1999, J DERMATOL SCI, V21, P13, DOI 10.1016/S0923-1811(99)00008-0; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Sedlaczek N, 2001, AM J PATHOL, V158, P1239, DOI 10.1016/S0002-9440(10)64074-6; Tamatani T, 1998, BIOCHEM BIOPH RES CO, V251, P748, DOI 10.1006/bbrc.1998.9543; Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001; Ueberham U, 2003, NEUROSCIENCE, V116, P1, DOI 10.1016/S0306-4522(02)00670-X; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Watts KL, 2005, AM J RESP CELL MOL, V32, P290, DOI 10.1165/rcmb.2004-0127OC; Williams EJ, 2000, J HEPATOL, V32, P754, DOI 10.1016/S0168-8278(00)80244-5; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Xia Z, 2001, LEUKEMIA, V15, P1398, DOI 10.1038/sj.leu.2402196; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	73	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10835	10847		10.1074/jbc.M710363200	http://dx.doi.org/10.1074/jbc.M710363200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18287089	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000254894700066
J	Cooper, SK; Pandhare, J; Donald, SP; Phang, JM				Cooper, Sandra K.; Pandhare, Jui; Donald, Steven P.; Phang, James M.			Novel function for hydroxyproline oxidase in apoptosis through generation of reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOXORUBICIN-INDUCED APOPTOSIS; PROLINE-OXIDASE; CELL-DEATH; ENZYMATIC SYNTHESIS; DNA-DAMAGE; TUMOR-CELL; METABOLISM; DELTA-1-PYRROLINE-3-HYDROXY-5-CARBOXYLATE; EXPRESSION; PATHWAYS	Proline and hydroxyproline are metabolized by distinct pathways. Proline is important for protein synthesis, as a source of glutamate, arginine, and tricarboxylic acid cycle intermediates, and for participating in a metabolic cycle that shuttles redox equivalents between mitochondria and cytosol. Hydroxyproline, in contrast, is not reutilized for protein synthesis. The first steps in the degradation of proline and hydroxyproline are catalyzed by proline oxidase (POX) and hydroxyproline oxidase (OH-POX), respectively. Because it is well documented that POX is induced by p53 and plays a role in apoptosis, we considered whether OH-POX also participates in the response to cytotoxic stress. In LoVo and RKO cells, which respond to adriamycin with a p53-mediated induction of POX and generation of reactive oxygen species, we found that adriamycin also induced OH-POX gene expression and markedly increased OH-POX catalytic activity, and this increase in activity was not observed in the cell lines HT29 and HCT15, which do not have a functional p53. We also observed an increase in reactive oxygen species generation and activation of caspase-9 with adriamycin in a hydroxyproline-dependent manner. Therefore, we hypothesize that OH-POX plays a role analogous to POX in growth regulation, ROS generation, and activation of the apoptotic cascade.	[Pandhare, Jui; Donald, Steven P.; Phang, James M.] Natl Inst Hlth, Comparat Carcinogenesis Lab, NCI, CCR, Ft Detrick, MD 21702 USA; [Cooper, Sandra K.] NCI, Basic Res Program, SAIC Frederick Inc, Natl Inst Hlth, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Phang, JM (corresponding author), Natl Inst Hlth, Comparat Carcinogenesis Lab, NCI, CCR, Bldg 538 Rm 144, Ft Detrick, MD 21702 USA.	phang@ncifcrf.gov		Pandhare, Jui/0000-0002-0356-064X	NATIONAL CANCER INSTITUTE [Z01BC010743, ZIABC010746] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS E, 1960, J BIOL CHEM, V235, P3492; ADAMS E, 1960, J BIOL CHEM, V235, P3504; ADAMS E, 1960, J BIOL CHEM, V235, P3499; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Bhattacharjee A, 2005, IUBMB LIFE, V57, P161, DOI 10.1080/15216540500090710; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Donald SP, 2001, CANCER RES, V61, P1810; DOWNING SJ, 1977, J CELL PHYSIOL, V91, P369, DOI 10.1002/jcp.1040910306; Gewirtz DA, 2000, BREAST CANCER RES TR, V62, P223, DOI 10.1023/A:1006414422919; Green PS, 2002, BBA-MOL BASIS DIS, V1588, P94, DOI 10.1016/S0925-4439(02)00144-8; HAGEDORN CH, 1983, ARCH BIOCHEM BIOPHYS, V225, P95, DOI 10.1016/0003-9861(83)90010-3; Hoogendoorn B, 2004, HUM MUTAT, V24, P35, DOI 10.1002/humu.20061; Ii M, 2006, EXP BIOL MED, V231, P20; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kim SZ, 1997, J PEDIATR-US, V130, P437, DOI 10.1016/S0022-3476(97)70207-5; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Liu YM, 2005, CARCINOGENESIS, V26, P1335, DOI 10.1093/carcin/bgi083; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; Mizutani H, 2005, LIFE SCI, V76, P1439, DOI 10.1016/j.lfs.2004.05.040; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; PHANG JM, 1975, J LAB CLIN MED, V85, P312; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; VALLE D, 1979, J CLIN INVEST, V64, P1365, DOI 10.1172/JCI109593; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158	31	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10485	10492		10.1074/jbc.M702181200	http://dx.doi.org/10.1074/jbc.M702181200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18287100	hybrid, Green Published			2022-12-27	WOS:000254894700030
J	Harkewicz, R; Hartvigsen, K; Almazan, F; Dennis, EA; Witztum, JL; Miller, YI				Harkewicz, Richard; Hartvigsen, Karsten; Almazan, Felicidad; Dennis, Edward A.; Witztum, Joseph L.; Miller, Yury I.			Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-DEFICIENT MICE; LDL RECEPTOR-DEFICIENT; APOLIPOPROTEIN-E; APOPTOTIC CELLS; OVEREXPRESS 15-LIPOXYGENASE; MEDIATED MODIFICATION; SELECTIVE UPTAKE; IN-VIVO; 12/15-LIPOXYGENASE; ATHEROSCLEROSIS	Oxidation of low density lipoprotein (LDL) occurs in vivo and significantly contributes to the development of atherosclerosis. An important mechanism of LDL oxidation in vivo is its modification with 12/15-lipoxygenase (LO). We have developed a model of minimally oxidized LDL (mmLDL) in which native LDL is modified by cells expressing 12/15LO. This mm LDL activates macrophages inducing membrane ruffling and cell spreading, activation of ERK1/2 and Akt signaling, and secretion of proinflammatory cytokines. In this study, we found that many of the biological activities of mmLDL were associated with cholesteryl ester (CE) hydroperoxides and were diminished by ebselen, a reducing agent. Liquid chromatography coupled with mass spectroscopy demonstrated the presence of many mono-and polyoxygenated CE species in mmLDL but not in native LDL. Nonpolar lipid extracts of mmLDL activated macrophages, although to a lesser degree than intact mmLDL. The macrophage responses were also induced by LDL directly modified with immobilized 12/15LO, and the nonpolar lipids extracted from 12/15LO-modified LDL contained a similar set of oxidized CE. Cholesteryl arachidonate modified with 12/15LO also activated macrophages and contained a similar collection of oxidized CE molecules. Remarkably, many of these oxidized CE were found in the extracts of atherosclerotic lesions isolated from hyperlipidemic apoE(-/-) mice. These results suggest that CE hydroperoxides constitute a class of biologically active components of mmLDL that may be relevant to proinflammatory activation of macrophages in atherosclerotic lesions.	[Harkewicz, Richard; Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol Chem & Biochem, La Jolla, CA 92093 USA; [Hartvigsen, Karsten; Almazan, Felicidad; Witztum, Joseph L.; Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, YI (corresponding author), Univ Calif San Diego, Dept Pharmacol Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yumiller@ucsd.edu	Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140	NHLBI NIH HHS [R01 HL081862-03, R01 HL081862, HL081862] Funding Source: Medline; NIGMS NIH HHS [GM069338, U54 GM069338] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belkner J, 1998, J BIOL CHEM, V273, P23225, DOI 10.1074/jbc.273.36.23225; BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Boullier A, 2006, ARTERIOSCL THROM VAS, V26, P1169, DOI 10.1161/01.ATV.0000210279.97308.9a; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chen NG, 1999, BIOCHEM BIOPH RES CO, V263, P718, DOI 10.1006/bbrc.1999.1437; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Cyrus T, 2001, CIRCULATION, V103, P2277; EDENIUS C, 1991, EUR J BIOCHEM, V199, P401, DOI 10.1111/j.1432-1033.1991.tb16137.x; EZAKI M, 1995, J LIPID RES, V36, P1996; Fluiter K, 1999, J BIOL CHEM, V274, P8893, DOI 10.1074/jbc.274.13.8893; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; George J, 2001, CIRCULATION, V104, P1646, DOI 10.1161/hc3901.095772; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P581, DOI 10.1161/01.ATV.0000012782.59850.41; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Jedidi I, 2006, BIOCHEM BIOPH RES CO, V351, P733, DOI 10.1016/j.bbrc.2006.10.122; Leitinger Norbert, 2003, Molecular Aspects of Medicine, V24, P239, DOI 10.1016/S0098-2997(03)00019-0; Letters JM, 1999, J LIPID RES, V40, P1104; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2003, MOL BIOL CELL, V14, P4196, DOI 10.1091/mbc.E03-02-0063; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Miller YI, 2005, FUTUR CARDIOL, V1, P785, DOI 10.2217/14796678.1.6.785; MULLER A, 1984, BIOCHEM PHARMACOL, V33, P3235, DOI 10.1016/0006-2952(84)90083-2; Nigam S, 2004, J BIOL CHEM, V279, P29023, DOI 10.1074/jbc.M307576200; PARTHASARATHY S, 1990, EUR HEART J, V11, P83, DOI 10.1093/eurheartj/11.suppl_E.83; Pfister SL, 2003, ARCH BIOCHEM BIOPHYS, V420, P142, DOI 10.1016/j.abb.2003.09.026; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; Scheidegger KJ, 1997, J BIOL CHEM, V272, P21609, DOI 10.1074/jbc.272.34.21609; Sigari F, 1997, ARTERIOSCL THROM VAS, V17, P3639, DOI 10.1161/01.ATV.17.12.3639; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sultana C, 1996, J CELL PHYSIOL, V167, P477, DOI 10.1002/(SICI)1097-4652(199606)167:3<477::AID-JCP12>3.0.CO;2-1; Takahashi Y, 2005, BIOCHEM BIOPH RES CO, V338, P128, DOI 10.1016/j.bbrc.2005.07.182; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Upston JM, 2002, AM J PATHOL, V160, P701, DOI 10.1016/S0002-9440(10)64890-0; Upston JM, 1997, J BIOL CHEM, V272, P30067, DOI 10.1074/jbc.272.48.30067; Walton KA, 2003, J BIOL CHEM, V278, P29661, DOI 10.1074/jbc.M300738200; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200; Zhu H, 2003, J BIOL CHEM, V278, P13350, DOI 10.1074/jbc.M212104200	51	89	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10241	10251		10.1074/jbc.M709006200	http://dx.doi.org/10.1074/jbc.M709006200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18263582	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000254894700005
J	Meharenna, YT; Slessor, KE; Cavaignac, SM; Poulos, TL; De Voss, JJ				Meharenna, Yergalem T.; Slessor, Kate E.; Cavaignac, Sonia M.; Poulos, Thomas L.; De Voss, James J.			The critical role of substrate-protein hydrogen bonding in the control of regioselective hydroxylation in P450cin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN CYTOCHROME P4502B4; DIVINYL ETHER SYNTHASE; BINDING FREE-ENERGIES; CRYSTAL-STRUCTURE; HYDROPEROXIDE LYASE; DIOXYGEN COMPLEX; WILD-TYPE; MUTANT; ACTIVATION; RESOLUTION	Cytochrome P450cin (CYP176A1) is a bacterial P450 isolated from Citrobacter braakii that catalyzes the hydroxylation of cineole to (S)-6 beta-hydroxycineole. This initiates the biodegradation of cineole, enabling C. braakii to live on cineole as its sole source of carbon and energy. P450cin lacks the almost universally conserved threonine residue believed to be involved in dioxygen activation and instead contains an asparagine at this position (Asn-242). To investigate the role of Asn-242 in P450cin catalysis, it was converted to alanine, and the resultant mutant was characterized. The characteristic CO-bound spectrum and spectrally determined K-D for substrate binding were unchanged in the mutant. The x-ray crystal structures of the substrate-free and -bound N242A mutant were determined and show that the only significant change is in a reorientation of the substrate such that (R)-6 alpha-hydroxycineole should be a major product. Molecular dynamics simulations of both wild type and mutant are consistent with the change in regio- and stereoselectivity predicted from the crystal structure. The mutation has only a modest effect on enzyme activity and on the diversion of the NADPH-reducing equivalent toward unproductive peroxide formation. Product profile analysis shows that (R)-6 alpha-hydroxycineole is the main product, which is consistent with the crystal structure. These results demonstrate that Asn-242 is not a functional replacement for the conserved threonine in other P450s but, rather, is critical in controlling regioselective substrate oxidation.	[Meharenna, Yergalem T.; Poulos, Thomas L.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Meharenna, Yergalem T.; Poulos, Thomas L.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Meharenna, Yergalem T.; Poulos, Thomas L.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Slessor, Kate E.; Cavaignac, Sonia M.; De Voss, James J.] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Queensland	Poulos, TL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	poulos@uci.edu; j.devoss@uq.edu.au			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033688] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33688] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSEN JF, 1993, BIOCHEMISTRY-US, V32, P1905, DOI 10.1021/bi00059a004; ATKINS WM, 1988, J BIOL CHEM, V263, P18842; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPDEVILA JH, 1996, J BIOL CHEM, V271, P22633; CARMAN RM, 1984, AUST J CHEM, V37, P1117, DOI 10.1071/CH9841117; Cryle MJ, 2007, TETRAHEDRON-ASYMMETR, V18, P547, DOI 10.1016/j.tetasy.2007.01.034; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Deprez E, 2002, J INORG BIOCHEM, V91, P597, DOI 10.1016/S0162-0134(02)00467-1; DeVoss JJ, 1997, J AM CHEM SOC, V119, P5489, DOI 10.1021/ja970349v; Grechkin AN, 2002, PROSTAG OTH LIPID M, V68-9, P457, DOI 10.1016/S0090-6980(02)00048-5; Harris DL, 2004, PROTEINS, V55, P895, DOI 10.1002/prot.20062; Hawkes DB, 2002, J BIOL CHEM, V277, P27725, DOI 10.1074/jbc.M203382200; Hawkes DB, 2003, THESIS U QUEENSLAND; Hishiki T, 2000, J BIOCHEM, V128, P965, DOI 10.1093/oxfordjournals.jbchem.a022848; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, INT CCP4 ESF EACMB N, V26; Li H, 1996, BIOCHIMIE, V78, P695, DOI 10.1016/S0300-9084(97)82526-6; MARTINIS SA, 1989, J AM CHEM SOC, V111, P9252, DOI 10.1021/ja00208a031; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Matsui K, 1996, FEBS LETT, V394, P21, DOI 10.1016/0014-5793(96)00924-6; Meharenna YT, 2004, BIOCHEMISTRY-US, V43, P9487, DOI 10.1021/bi049293p; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; SALMON JA, 1982, METHOD ENZYMOL, V86, P91; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; STARKOVICH JA, 1969, J FOOD SCI, V34, P194, DOI 10.1111/j.1365-2621.1969.tb00917.x; Stumpe M, 2001, FEBS LETT, V507, P371, DOI 10.1016/S0014-5793(01)03019-8; Tijet N, 2002, PROSTAG OTH LIPID M, V68-9, P423, DOI 10.1016/S0090-6980(02)00046-1; Truan G, 1998, ARCH BIOCHEM BIOPHYS, V349, P53, DOI 10.1006/abbi.1997.0400; Xiang H, 2000, J BIOL CHEM, V275, P35999, DOI 10.1074/jbc.M005811200	39	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10804	10812		10.1074/jbc.M709722200	http://dx.doi.org/10.1074/jbc.M709722200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18270198	Green Published, hybrid			2022-12-27	WOS:000254894700063
J	Stridh, MH; Tranberg, M; Weber, SG; Blomstrand, F; Sandberg, M				Stridh, Malin H.; Tranberg, Mattias; Weber, Stephen G.; Blomstrand, Fredrik; Sandberg, Mats			Stimulated efflux of amino acids and glutathione from cultured hippocampal slices by omission of extracellular calcium - Likely involvement of connexin hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION HEMICHANNELS; P2X(7) RECEPTOR; GLUTAMATE RELEASE; ATP RELEASE; REGIONAL VULNERABILITY; PURINERGIC RECEPTORS; METABOLIC INHIBITION; N-ACETYLASPARTATE; MEDIATED RELEASE; RAT-BRAIN	Omission of extracellular Ca2+ for 15 min from the incubation medium of cultured hippocampal slices stimulated the efflux of glutathione, phosphoethanolamine, hypotaurine, and taurine. The efflux was reduced by several blockers of gap junctions, i.e. carbenoxolone, flufenamic acid, and endothelin-1, and by the connexin43 hemichannel blocking peptide Gap26 but was unchanged by the P2X(7) receptor inhibitor oxidized ATP, a pannexin1 hemichannel blocking peptide and an inactive analogue of carbenoxolone. Pretreatment of the slices with the neurotoxin N-methyl-D-aspartate left the efflux by Ca2+ omission unchanged, indicating that the stimulated efflux primarily originated from glia. Elevated glutamate efflux was detected when Ca2+ omission was combined with the glutamate uptake blocker L-trans-pyrrolidine-2,4-dicarboxylate and when both Ca2+ and Mg2+ were omitted from the medium. Omission of Ca2+ for 15 min alone did not induce delayed toxicity, but in combination with blocked glutamate uptake, significant cell death was observed 24 h later. Our results indicate that omission of extracellular Ca2+ stimulates efflux of glutathione and specific amino acids including glutamate via opening of glial hemichannels. This type of efflux may have protective functions via glutathione efflux but can aggravate toxicity in situations when glutamate reuptake is impaired, such as following a stroke.	[Sandberg, Mats] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden; [Stridh, Malin H.; Tranberg, Mattias; Blomstrand, Fredrik; Sandberg, Mats] Univ Gothenburg, Inst Neurosci & Physiol, SE-40530 Gothenburg, Sweden; [Weber, Stephen G.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Gothenburg; University of Gothenburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sandberg, M (corresponding author), Univ Gothenburg, Inst Biomed, Box 420, SE-40530 Gothenburg, Sweden.	mats.sandberg@anatcell.gu.se	Weber, Stephen G/AAJ-9255-2020	Weber, Stephen/0000-0002-7970-2632	NIGMS NIH HHS [GM 44842] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044842] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Blomstrand F, 2006, J NEUROSCI RES, V83, P996, DOI 10.1002/jnr.20801; Blomstrand F, 2004, EUR J NEUROSCI, V19, P1005, DOI 10.1111/j.0953-816X.2004.03197.x; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Chen HB, 2006, EUR J PHARMACOL, V550, P1, DOI 10.1016/j.ejphar.2006.08.039; Chessell IP, 1997, BRIT J PHARMACOL, V121, P1429, DOI 10.1038/sj.bjp.0701278; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Ebihara L, 2003, BIOPHYS J, V84, P277, DOI 10.1016/S0006-3495(03)74848-6; Egelman DM, 1999, BIOPHYS J, V76, P1856, DOI 10.1016/S0006-3495(99)77345-5; Ek-Vitorin JF, 2005, AM J PHYSIOL-CELL PH, V289, pC1535, DOI 10.1152/ajpcell.00182.2005; Eskandari S, 2002, J MEMBRANE BIOL, V185, P93, DOI 10.1007/s00232-001-0115-0; Fellin T, 2006, J BIOL CHEM, V281, P4274, DOI 10.1074/jbc.M510679200; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Henke W, 1998, BBA-BIOENERGETICS, V1363, P209, DOI 10.1016/S0005-2728(97)00103-5; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Martin ME, 2005, J NEUROSCI RES, V82, P93, DOI 10.1002/jnr.20613; Molchanova SM, 2005, NEUROCHEM INT, V47, P343, DOI 10.1016/j.neuint.2005.04.027; Muyderman H, 2004, J NEUROSCI, V24, P8019, DOI 10.1523/JNEUROSCI.1103-04.2004; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; OGITA K, 1995, J NEUROCHEM, V64, P1088; Paredes-Gamero EJ, 2004, J FLUORESC, V14, P711, DOI 10.1023/B:JOFL.0000047221.51493.e3; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pomper JK, 2001, DEV BRAIN RES, V126, P109, DOI 10.1016/S0165-3806(00)00132-2; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; Ranat S, 2007, NEUROSCI LETT, V415, P45, DOI 10.1016/j.neulet.2006.12.043; Regan RF, 1999, BRAIN RES, V817, P145, DOI 10.1016/S0006-8993(98)01252-9; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; SANDBERG M, 1986, J NEUROCHEM, V47, P178; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Tranberg M, 2005, ANAL BIOCHEM, V343, P179, DOI 10.1016/j.ab.2005.03.004; Tranberg M, 2004, NEUROCHEM INT, V45, P1195, DOI 10.1016/j.neuint.2004.06.005; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Vornov JJ, 1998, EXP NEUROL, V149, P109, DOI 10.1006/exnr.1997.6673; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Wallin C, 2003, NEUROCHEM RES, V28, P281, DOI 10.1023/A:1022381318126; Wallin C, 1999, J NEUROCHEM, V73, P1566, DOI 10.1046/j.1471-4159.1999.0731566.x; Wang CM, 2003, CELL SIGNAL, V15, P1129, DOI 10.1016/S0898-6568(03)00112-8; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	64	57	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10347	10356		10.1074/jbc.M704153200	http://dx.doi.org/10.1074/jbc.M704153200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18272524	Green Published, hybrid			2022-12-27	WOS:000254894700015
J	Antonson, P; Jakobsson, T; Almlof, T; Guldevall, K; Steffensen, KR; Gustafsson, JA				Antonson, Per; Jakobsson, Tomas; Almloef, Tova; Guldevall, Karolin; Steffensen, Knut R.; Gustafsson, Jan-Ake			RAP250 is a coactivator in the transforming growth factor beta signaling pathway that interacts with smad2 and smad3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATOR; CREB-BINDING PROTEIN; LIVER-X-RECEPTORS; LXXLL-MOTIF; TRANSCRIPTIONAL COACTIVATORS; COMPLEX; MICE; METABOLISM; ACTIVATION; GENE	RAP250 is a coactivator for nuclear receptors as well as other transcription factors. Recent studies have established RAP250 as an essential coactivator for many important biological processes, but its exact mechanism of action is not fully understood. To identify novel proteins that can associate with RAP250, we used a yeast two-hybrid system to screen cDNA libraries and identified the intracellular mediators of transforming growth factor-beta( TGF-beta) response Smad2 and Smad3 as direct interacting proteins. We show that the interaction between RAP250 and Smad2/3 is dependent upon the second LXXLL interaction motif in RAP250 and the MH2 domain in Smad2 and Smad3. Mouse embryonic fibroblasts lacking RAP250 have reduced expression of the TGF-beta target gene PAI-1 after stimulation by TGF-beta when compared with wild type cells. Furthermore, we demonstrate a cross-talk between TGF-beta and liver X receptors (LXR) signaling pathways and show that stimulation of cells with TGF-beta and LXR agonists have a synergistic effect on the expression of the LXR target gene ABCG1. Our data identify RAP250 as a new coactivator in the TGF-beta signaling pathway that binds Smad2 and Smad3. Our data also suggest that the interaction between RAP250, Smad2, and Smad3 constitutes an important bridging mechanism linking LXR and TGF-beta signaling pathways.	[Antonson, Per; Jakobsson, Tomas; Almloef, Tova; Guldevall, Karolin; Steffensen, Knut R.; Gustafsson, Jan-Ake] Karolinska Inst, Novum, Dept Biosci & Nutr, S-14157 Huddinge, Sweden	Karolinska Institutet	Antonson, P (corresponding author), Karolinska Inst, Novum, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.	per.antonson@biosci.ki.se		Steffensen, Knut/0000-0001-6093-2801; Guldevall, Karolin/0000-0003-1016-2460; Antonson, Per/0000-0001-9335-9941				Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Argmann CA, 2001, ARTERIOSCL THROM VAS, V21, P2011, DOI 10.1161/hq1201.099426; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kim SW, 2003, MOL CELL BIOL, V23, P3583, DOI 10.1128/MCB.23.10.3583-3592.2003; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kuang SQ, 2002, J BIOL CHEM, V277, P45356, DOI 10.1074/jbc.C200509200; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Li QT, 2007, MOL CELL BIOL, V27, P8073, DOI 10.1128/MCB.00451-07; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; Mahajan MA, 2004, MOL CELL BIOL, V24, P4994, DOI 10.1128/MCB.24.11.4994-5004.2004; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Moustakas A, 2001, J CELL SCI, V114, P4359; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Panousis CG, 2001, J LIPID RES, V42, P856; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Randall RA, 2002, EMBO J, V21, P145, DOI 10.1093/emboj/21.1.145; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh NN, 2006, ARTERIOSCL THROM VAS, V26, P1323, DOI 10.1161/01.ATV.0000220383.19192.55; Steffensen KR, 2006, FUTURE LIPIDOL, V1, P181, DOI 10.2217/17460875.1.2.181; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Zhu YJ, 2003, J BIOL CHEM, V278, P1986, DOI 10.1074/jbc.C200634200; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	44	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8995	9001		10.1074/jbc.M707203200	http://dx.doi.org/10.1074/jbc.M707203200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18263591	hybrid			2022-12-27	WOS:000254465800029
J	Ivarsson, Y; Travaglini-Allocatelli, C; Brunori, M; Gianni, S				Ivarsson, Ylva; Travaglini-Allocatelli, Carlo; Brunori, Maurizio; Gianni, Stefano			Folding and misfolding in a naturally occurring circularly permuted PDZ domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL PROCESSING PROTEASE; ON-PATHWAY INTERMEDIATE; TRANSITION-STATE; PHOTOSYSTEM-II; SCENEDESMUS-OBLIQUUS; CONTACT ORDER; D1; MECHANISM; KINETICS; PERMUTATIONS	One of the most extreme and fascinating examples of naturally occurring mutagenesis is represented by circular permutation. Circular permutations involve the linking of two chain ends and cleavage at another site. Here we report the first description of the folding mechanism of a naturally occurring circularly permuted protein, a PDZ domain from the green alga Scenedesmus obliquus. Data reveal that the folding of the permuted protein is characterized by the presence of a low energy off-pathway kinetic trap. This finding contrasts with what was previously observed for canonical PDZ domains that, although displaying a similar primary structure when structurally re-aligned, fold via an on-pathway productive intermediate. Although circular permutation of PDZ domains may be necessary for a correct orientation of their functional sites in multidomain protein scaffolds, such structural rearrangement may compromise their folding pathway. This study provides a straightforward example of the divergent demands of folding and function.	[Ivarsson, Ylva; Travaglini-Allocatelli, Carlo; Brunori, Maurizio; Gianni, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Ist Biol & Patol Mol, CNR, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Gianni, S (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Ist Biol & Patol Mol, CNR, P Le A More 5, I-00185 Rome, Italy.	stefano.gianni@uniroma1.it	gianni, stefano/C-8536-2009; Ivarsson, Ylva/HGE-0283-2022	Ivarsson, Ylva/0000-0002-7081-3846; Gianni, Stefano/0000-0003-1653-1925; Brunori, Maurizio/0000-0002-7795-1635; Travaglini-Allocatelli, Carlo/0000-0001-8735-1126				ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; DINER BA, 1988, J BIOL CHEM, V263, P8972; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; FERREIRO DU, 2000, P NATL ACAD SCI USA, P19819; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; FUJITA S, 1989, FEBS LETT, V255, P1, DOI 10.1016/0014-5793(89)81049-X; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2005, PROTEIN ENG DES SEL, V18, P389, DOI 10.1093/protein/gzi047; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Harris BZ, 2001, J CELL SCI, V114, P3219; Ivarsson Y, 2007, J BIOL CHEM, V282, P8568, DOI 10.1074/jbc.M611026200; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10436, DOI 10.1021/bi00107a011; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P9029, DOI 10.1073/pnas.92.20.9029; Li L, 2001, J MOL BIOL, V306, P121, DOI 10.1006/jmbi.2000.4375; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindberg MO, 2001, J MOL BIOL, V314, P891, DOI 10.1006/jmbi.2001.5186; Lindqvist Y, 1997, CURR OPIN STRUC BIOL, V7, P422, DOI 10.1016/S0959-440X(97)80061-9; Miller EJ, 2002, P NATL ACAD SCI USA, V99, P10359, DOI 10.1073/pnas.162219099; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Otzen DE, 1998, BIOCHEMISTRY-US, V37, P8139, DOI 10.1021/bi980250g; Pandya MJ, 1999, J BIOL CHEM, V274, P26828, DOI 10.1074/jbc.274.38.26828; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Trost JT, 1997, J BIOL CHEM, V272, P20348, DOI 10.1074/jbc.272.33.20348; Viguera AR, 1996, NAT STRUCT BIOL, V3, P874, DOI 10.1038/nsb1096-874; Vogel C, 2006, BIOESSAYS, V28, P973, DOI 10.1002/bies.20474; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005; Yamamoto Y, 2001, J BIOL CHEM, V276, P7518, DOI 10.1074/jbc.M008877200	35	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8954	8960		10.1074/jbc.M707424200	http://dx.doi.org/10.1074/jbc.M707424200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18263589	hybrid			2022-12-27	WOS:000254465800024
J	Song, DS; Lee, FS				Song, Daisheng; Lee, Frank S.			A role for IOP1 in mammalian cytosolic iron-sulfur protein biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FE-S CLUSTER; REGULATORY PROTEIN-1; RESPONSIVE ELEMENTS; MOLECULAR CONTROL; SCAFFOLD PROTEIN; HOMEOSTASIS; MITOCHONDRIA; TRANSLATION; DEGRADATION	The biogenesis of cytosolic iron-sulfur ( Fe-S) proteins in mammalian cells is poorly understood. In Saccharomyces cerevisiae, there is a pathway dedicated to cytosolic Fe-S protein maturation that involves several essential proteins. One of these is Nar1, which intriguingly is homologous to iron-only hydrogenases, ancient enzymes that catalyze the formation of hydrogen gas in anaerobic bacteria. There are two orthologues of Nar1 in mammalian cells, iron-only hydrogenase-like protein 1 ( IOP1) and IOP2 ( also known as nuclear prelamin A recognition factor). We examined IOP1 for a potential role in mammalian cytosolic Fe-Sproteinbiogenesis. We found that knockdown of IOP1 in both HeLa and Hep3B cells decreases the activity of cytosolic aconitase, an Fe-S protein, but not that of mitochondrial aconitase. Knockdown of IOP2, in contrast, had no effect on either. The decrease in aconitase activity upon IOP1 knockdown is rescued by expression of a small interference RNA-resistant version of IOP1. Upon loss of its Fe-S cluster, cytosolic aconitase is known to be converted to iron regulatory protein 1, and consistent with this, we found that IOP1 knockdown increases transferrin receptor 1 mRNA levels and decreases ferritin heavy chain protein levels. IOP1 knockdown also leads to a decrease in activity of xanthine oxidase, a distinct cytosolic Fe-S protein. Taken together, these results provide evidence that IOP1 is involved in mammalian cytosolic Fe-S protein maturation.	[Song, Daisheng; Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Lee, FS (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 605 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu		Lee, Frank/0000-0003-2511-1834	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071459] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071459, R01 GM 71459] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mueller S, 2002, METHOD ENZYMOL, V348, P324, DOI 10.1016/S0076-6879(02)48651-X; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SETCHENSKA MS, 1978, BIOCHEM J, V170, P193, DOI 10.1042/bj1700193; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Yu F, 2001, CANCER RES, V61, P4136	34	60	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9231	9238		10.1074/jbc.M708077200	http://dx.doi.org/10.1074/jbc.M708077200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18270200	hybrid, Green Published			2022-12-27	WOS:000254465800053
J	Minami, K; Okano, H; Okumachi, A; Seino, S				Minami, Kohtaro; Okano, Hirotoshi; Okumachi, Akinori; Seino, Susumu			Role of cadherin-mediated cell-cell adhesion in pancreatic exocrine-to-endocrine transdifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETING CELLS; BETA-CELLS; IN-VITRO; ADHERENS JUNCTIONS; PROGENITOR CELLS; ACINAR-CELLS; HUMAN ISLETS; MDCK CELLS; DIFFERENTIATION; REGENERATION	Although pancreatic exocrine acinar cells have the potential to transdifferentiate into pancreatic endocrine cells, the mechanisms are poorly understood. Here we report that intracellular signaling pathways, including those involving MAPK and phosphatidylinositol 3 (PI3)-kinase, are activated by enzymatic dissociation of pancreatic acinar cells and that spherical cell clusters are formed by cadherin-mediated cell-cell adhesion during transdifferentiation. Inhibition of PI3-kinase by LY294002 prevents spheroid formation by degrading E-cadherin and beta-catenin, blocking transdifferentiation into insulin-secreting cells. In addition, neutralizing antibody against E-cadherin suppresses the induction of genes characteristic of pancreatic beta-cells. We also show that loss of cadherin-mediated cell-cell adhesion induces and maintains a dedifferentiated state in isolated pancreatic acinar cells. Thus, disruption and remodeling of cadherin-mediated cell-cell adhesion is critical in pancreatic exocrine-to-endocrine transdifferentiation, in which the PI3-kinase pathway plays an essential role.	[Minami, Kohtaro; Okano, Hirotoshi; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan; [Minami, Kohtaro; Okumachi, Akinori; Seino, Susumu] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 6068507, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Div Endocrinol Diabet & Metab, Dept Internal Med,Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University; Kyoto University; Kobe University	Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan.	seino@med.kobe-u.ac.jp		Minami, Kohtaro/0000-0003-4698-6250				Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bouwens L, 1998, MICROSC RES TECHNIQ, V43, P332, DOI 10.1002/(SICI)1097-0029(19981115)43:4<332::AID-JEMT7>3.0.CO;2-1; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dabeva MD, 1997, P NATL ACAD SCI USA, V94, P7356, DOI 10.1073/pnas.94.14.7356; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ito K, 1999, ONCOGENE, V18, P7080, DOI 10.1038/sj.onc.1203191; KANNO Y, 1984, EXP CELL RES, V152, P270, DOI 10.1016/0014-4827(84)90253-2; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Okuno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE158, DOI 10.1152/ajpendo.00180.2006; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; RAO MS, 1988, BIOCHEM BIOPH RES CO, V156, P131, DOI 10.1016/S0006-291X(88)80814-3; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Somasiri A, 2000, DIFFERENTIATION, V66, P116, DOI 10.1046/j.1432-0436.2000.660206.x; Strobel O, 2007, P NATL ACAD SCI USA, V104, P4419, DOI 10.1073/pnas.0605248104; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; TSONIS PA, 1995, SEMIN CELL BIOL, V6, P127, DOI 10.1006/scel.1995.0018; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; YEUNG RS, 1993, CANCER, V72, P2124, DOI 10.1002/1097-0142(19931001)72:7<2124::AID-CNCR2820720711>3.0.CO;2-C	47	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13753	13761		10.1074/jbc.M710034200	http://dx.doi.org/10.1074/jbc.M710034200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332139	hybrid			2022-12-27	WOS:000255728200027
J	Wongsiriroj, N; Piantedosi, R; Palczewski, K; Goldberg, IJ; Johnston, TP; Li, E; Blaner, WS				Wongsiriroj, Nuttaporn; Piantedosi, Roseann; Palczewski, Krzysztof; Goldberg, Ira J.; Johnston, Thomas P.; Li, Ellen; Blaner, William S.			The molecular basis of retinoid absorption - A genetic dissection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; RAT-LIVER MICROSOMES; ACYL-COENZYME-A; BINDING-PROTEIN; VITAMIN-A; SMALL-INTESTINE; DIACYLGLYCEROL ACYLTRANSFERASE; ADIPOSE-TISSUE; ESTERIFICATION; LECITHIN	The intestine and other tissues are able to synthesize retinyl esters in an acyl-CoA-dependent manner involving an acyl-CoA: retinol acyltransferase (ARAT). However, the molecular identity of this ARAT has not been established. Recent studies of lecithin: retinol acyltransferase (LRAT)-deficient mice indicate that LRAT is responsible for the preponderance of retinyl ester synthesis in the body, aside from in the intestine and adipose tissue. Our present studies, employing a number of mutant mouse models, identify diacylglycerol acyltransferase 1 (DGAT1) as an important intestinal ARAT in vivo. The contribution that DGAT1 makes to intestinal retinyl ester synthesis becomes greater when a large pharmacologic dose of retinol is administered by gavage to mice. Moreover, when large retinol doses are administered another intestinal enzyme(s) with ARAT activity becomes apparent. Surprisingly, although DGAT1 is expressed in adipose tissue, DGAT1 does not catalyze retinyl ester synthesis in adipose tissue in vivo. Our data also establish that cellular retinol-binding protein, type II (CRBPII), which is expressed solely in the adult intestine, in vivo channels retinol to LRAT for retinyl ester synthesis. Contrary to what has been proposed in the literature based on in vitro studies, CRBPII does not directly prevent retinol from being acted upon by DGAT1 or other intestinal ARATs in vivo.	[Wongsiriroj, Nuttaporn; Piantedosi, Roseann; Goldberg, Ira J.; Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Wongsiriroj, Nuttaporn; Piantedosi, Roseann; Goldberg, Ira J.; Blaner, William S.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Case Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Johnston, Thomas P.] Univ Missouri, Sch Pharm, Kansas City, MO 64110 USA; [Li, Ellen] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Columbia University; Columbia University; Case Western Reserve University; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL)	Blaner, WS (corresponding author), Columbia Univ, Dept Med, Black Bldg,Rm 914, New York, NY 10032 USA.	wsb2@columbia.edu			NEI NIH HHS [R01 EY009339-19S1, R01 EY009339, R01 EY09339, R01 EY08123] Funding Source: Medline; NIDDK NIH HHS [R01 DK079221, R01 DK068437, R01 DK061310, P30 DK052574] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009339, R01EY008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, R01DK079221, P30DK052574, R01DK061310] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BELFRAGE P, 1977, FEBS LETT, V75, P259, DOI 10.1016/0014-5793(77)80099-9; Blaner William S., 1994, P229; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; CROW JA, 1985, P NATL ACAD SCI USA, V82, P4707, DOI 10.1073/pnas.82.14.4707; DEW SE, 1994, BIOCHEMISTRY-US, V33, P12340, DOI 10.1021/bi00206a042; E XP, 2002, J BIOL CHEM, V277, P36617, DOI 10.1074/jbc.M205519200; ECKHOFF C, 1991, TOXICOL APPL PHARM, V111, P116, DOI 10.1016/0041-008X(91)90140-A; ERIKSSON U, 1984, J BIOL CHEM, V259, P3464; GOODMAN DS, 1965, J LIPID RES, V6, P390; Gudas Lorraine J., 1994, P443; HELGERUD P, 1982, J LIPID RES, V23, P609; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; MOORE T, 1957, VITAMIN A, P1; NOY N, 1999, HDB EXPT PHARM BIOCH, P3; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OBYRNE SM, 2005, CAROTENOIDS RETINOID, P1; Ong David E., 1994, P283; ONG DE, 1987, J BIOL CHEM, V262, P2729; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; Palmer WK, 1998, ATHEROSCLEROSIS, V136, P115, DOI 10.1016/S0021-9150(97)00193-7; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; QUICK TC, 1990, BIOCHEMISTRY-US, V29, P11116, DOI 10.1021/bi00502a015; RANDOLPH RK, 1991, ARCH BIOCHEM BIOPHYS, V288, P500, DOI 10.1016/0003-9861(91)90227-A; ROSS AC, 1982, J BIOL CHEM, V257, P2453; ROSS AC, 1982, J LIPID RES, V23, P133; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wasan KM, 2003, J PHARM PHARM SCI, V6, P189; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; YEAMAN SJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P128, DOI 10.1016/0167-4889(90)90067-N; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; YOST RW, 1988, J BIOL CHEM, V263, P18693; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	47	87	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13510	13519		10.1074/jbc.M800777200	http://dx.doi.org/10.1074/jbc.M800777200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348983	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000255728200004
J	Jacamo, R; Sinnett-Smith, J; Rey, O; Waldron, RT; Rozengurt, E				Jacamo, Rodrigo; Sinnett-Smith, James; Rey, Osvaldo; Waldron, Richard T.; Rozengurt, Enrique			Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via G(q)-coupled receptors - Differential regulation of activation loop Ser(744) and Ser(748) phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; INTESTINAL EPITHELIAL-CELLS; POTENTIATES DNA-SYNTHESIS; CYSTEINE-RICH MOTIFS; PHORBOL ESTERS; LYSOPHOSPHATIDIC ACID; INTACT-CELLS; IN-VIVO	Protein kinase D (PKD) is a serine/threonine protein kinase rapidly activated by G protein-coupled receptor (GPCR) agonists via a protein kinase C(PKC)-dependent pathway. Recently, PKD has been implicated in the regulation of long term cellular activities, but little is known about the mechanism(s) of sustained PKD activation. Here, we show that cell treatment with the preferential PKC inhibitors GF 109203X or Go 6983 blocked rapid (1 -5-min) PKD activation induced by bombesin stimulation, but this inhibition was greatly diminished at later times of bombesin stimulation (e. g. 45 min). These results imply that GPCR-induced PKD activation is mediated by early PKC-dependent and late PKC-independent mechanisms. Western blot analysis with site-specific antibodies that detect the phosphorylated state of the activation loop residues Ser(744) and Ser(748) revealed striking PKC-independent phosphorylation of Ser748 as well as Ser744 phosphorylation that remained predominantly but not completely PKC-dependent at later times of bombesin or vasopressin stimulation (20-90 min). To determine the mechanisms involved, we examined activation loop phosphorylation in a set of PKD mutants, including kinase-deficient, constitutively activated, and PKD forms in which the activation loop residues were substituted for alanine. Our results show that PKC-dependent phosphorylation of the activation loop Ser744 and Ser748 is the primary mechanism involved in early phase PKD activation, whereas PKD autophosphorylation on Ser748 is a major mechanism contributing to the late phase of PKD activation occurring in cells stimulated by GPCR agonists. The present studies identify a novel mechanism induced by GPCR activation that leads to late, PKC-independent PKD activation.	Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis,CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002; Rey, Osvaldo/0000-0003-1575-9864	NATIONAL CANCER INSTITUTE [K22CA128883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK055003, R01DK056930, R21DK071783] Funding Source: NIH RePORTER; NCI NIH HHS [K22 CA 128883] Funding Source: Medline; NIDDK NIH HHS [R0-1 DK56930, P30 DK41301, R21 DK071783, R0-1 DK55003] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Guha S, 2002, CANCER RES, V62, P1632; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, FEBS LETT, V437, P19, DOI 10.1016/S0014-5793(98)01189-2; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Marais R, 1996, CANCER SURV, V27, P101; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Needham LK, 1998, J BIOL CHEM, V273, P14626, DOI 10.1074/jbc.273.23.14626; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; OLIVER AW, 2007, TRENDS BIOCH SCI; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 2007, BIOCHEM BIOPH RES CO, V356, P361, DOI 10.1016/j.bbrc.2007.02.142; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2003, MOL PHARMACOL, V64, P1342, DOI 10.1124/mol.64.6.1342; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	86	72	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12877	12887		10.1074/jbc.M800442200	http://dx.doi.org/10.1074/jbc.M800442200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337243	hybrid, Green Published			2022-12-27	WOS:000255499800024
J	Michalska, K; Hernandez-Santoyo, A; Jaskolski, M				Michalska, Karolina; Hernandez-Santoyo, Alejandra; Jaskolski, Mariusz			The mechanism of autocatalytic activation of plant-type L-asparaginases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL NUCLEOPHILE; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; PENICILLIN ACYLASE; REVEALS; ACID; GLYCOSYLASPARAGINASE; CONSTRAINTS; MATURATION; SEQUENCE	Plant L-asparaginases and their bacterial homologs, such as EcAIII found in Escherichia coli, form a subgroup of the N-terminal nucleophile (Ntn)-hydrolase family. In common with all Ntn-hydrolases, they are expressed as inactive precursors that undergo activation in an autocatalytic manner. The maturation process involves intramolecular hydrolysis of a single peptide bond, leading to the formation of two subunits (alpha and beta) folded as one structural domain, with the nucleophilic Thr residue located at the freed N terminus of subunit beta. The mechanism of the autocleavage reaction remains obscure. We have determined the crystal structure of an active site mutant of EcAIII, with the catalytic Thr residue substituted by Ala (T179A). The modification has led to a correctly folded but unprocessed molecule, revealing the geometry and molecular environment of the scissile peptide bond. The autocatalytic reaction is analyzed from the point of view of the Thr179 side chain rotation, identification of a potential general base residue, and the architecture of the oxyanion hole.	[Michalska, Karolina; Hernandez-Santoyo, Alejandra; Jaskolski, Mariusz] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, PL-60780 Poznan, Poland; [Jaskolski, Mariusz] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallograph Res, PL-61704 Poznan, Poland	Adam Mickiewicz University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Jaskolski, M (corresponding author), Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, Grunwaldzka 6, PL-60780 Poznan, Poland.	mariuszj@amu.edu.pl	Hernández-Santoyo, Alejandra H.S./C-7618-2015	Hernández-Santoyo, Alejandra H.S./0000-0001-8045-4157; Jaskolski, Mariusz/0000-0003-1587-6489				Borek D, 2000, ACTA CRYSTALLOGR D, V56, P1505, DOI 10.1107/S0907444900010076; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; Borek D, 2001, ACTA BIOCHIM POL, V48, P893; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans TC, 2002, CHEM REV, V102, P4869, DOI 10.1021/cr9601369; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Guo HC, 1998, J BIOL CHEM, V273, P20205, DOI 10.1074/jbc.273.32.20205; Hewitt L, 2000, J MOL BIOL, V302, P887, DOI 10.1006/jmbi.2000.4105; Ignatova Z, 2005, J MOL BIOL, V348, P999, DOI 10.1016/j.jmb.2005.03.005; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Kim JK, 2003, BIOCHEMISTRY-US, V42, P4084, DOI 10.1021/bi027181x; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Michalska K, 2008, ACTA CRYSTALLOGR D, V64, P309, DOI 10.1107/S0907444907068072; Michalska K, 2006, J MOL BIOL, V360, P105, DOI 10.1016/j.jmb.2006.04.066; Muller P, 2003, ACTA CRYSTALLOGR D, V59, P32, DOI 10.1107/S0907444902018000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Prahl A, 2004, ACTA CRYSTALLOGR D, V60, P1173, DOI 10.1107/S0907444904003403; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; Saarela J, 2004, BIOCHEM J, V378, P363, DOI 10.1042/BJ20031496; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Yoon J, 2004, J BIOL CHEM, V279, P341, DOI 10.1074/jbc.M309281200	47	40	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13388	13397		10.1074/jbc.M800746200	http://dx.doi.org/10.1074/jbc.M800746200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334484	hybrid			2022-12-27	WOS:000255499800078
J	Biswas, G; Tang, W; Sondheimer, N; Guha, M; Bansal, S; Avadhani, NG				Biswas, Gopa; Tang, Weigang; Sondheimer, Neal; Guha, Manti; Bansal, Seema; Avadhani, Narayan G.			A distinctive physiological role for I kappa B beta in the propagation of mitochondrial respiratory stress signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-FACTOR; CANCER-CELLS; OXIDATIVE-PHOSPHORYLATION; INDUCED RESISTANCE; TUMOR PROGRESSION; PROSTATE-CANCER; ACTIVATION; APOPTOSIS; ALPHA; PATHWAY	The NF kappa Bs regulate an array of physiological and pathological processes, including propagation of mitochondrial respiratory stress signaling in mammalian cells. We showed previously that mitochondrial stress activates NF kappa B using a novel calcineurin-requiring pathway that is different from canonical or non-canonical pathways. This study shows that I kappa B beta is essential for the propagation of mitochondrial stress signaling. Knock down of I kappa B beta, but not I kappa B alpha, mRNA reduced the mitochondrial stress-mediated activation and nuclear translocation of cRel:p50, inhibiting expression of nuclear target genes RyR1 and cathepsin L. I kappa B beta mRNA knock down also reduced resistance to staurosporine-induced apoptosis and decreased in vitro invasiveness. Induced receptor switching to insulin-like growth factor-1 receptor and increased glucose uptake are hallmarks of mitochondrial stress. I kappa B beta mRNA knock down selectively abrogated the receptor switch and altered tubulin cytoskeletal organization. These results show that mitochondrial stress signaling uses an I kappa B beta-initiated NF kappa B pathway that is distinct from the other known NF kappa B pathways. Furthermore, our results demonstrate the distinctive physiological roles of the two inhibitory proteins I kappa B beta and I kappa B alpha	[Biswas, Gopa; Tang, Weigang; Guha, Manti; Bansal, Seema; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Biswas, Gopa; Tang, Weigang; Guha, Manti; Bansal, Seema; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Sondheimer, Neal] Childrens Hosp Philadelphia, Sect Biochem Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Sondheimer, Neal/X-7846-2019	Sondheimer, Neal/0000-0001-9982-5712	NCI NIH HHS [CA-22762] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022762, R37CA022762] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553; Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104; BOETTIGER D, 1995, DEV BIOL, V169, P261, DOI 10.1006/dbio.1995.1142; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Coloff JL, 2006, J CELL BIOL, V175, P845, DOI 10.1083/jcb.200610119; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Duffey DC, 1999, CANCER RES, V59, P3468; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; GILOMRE TD, 2003, CANC TREAT RES, V115, P241; Girnita A, 2006, CLIN CANCER RES, V12, P1383, DOI 10.1158/1078-0432.CCR-05-1106; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; GRILLI M, 1993, INT REV CYTOL, V143, P1; Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Kang BPS, 2003, AM J PHYSIOL-RENAL, V285, pF1013, DOI 10.1152/ajprenal.00209.2003; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kim JY, 2002, ONCOGENE, V21, P3139, DOI 10.1038/sj.onc.1205406; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; May MJ, 2006, J IMMUNOL, V177, P7483, DOI 10.4049/jimmunol.177.11.7483; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Romieu-Mourez R, 2002, CANCER RES, V62, P6770; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Schoonbroodt S, 2000, J IMMUNOL, V164, P4292, DOI 10.4049/jimmunol.164.8.4292; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; SHIRADA Y, 2005, CANCER RES, V65, P1655; Srinivasan S, 2007, ANN NY ACAD SCI, V1117, P51, DOI 10.1196/annals.1402.067; Stromberg T, 2006, BLOOD, V107, P669, DOI 10.1182/blood-2005-01-0306; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	62	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12586	12594		10.1074/jbc.M710481200	http://dx.doi.org/10.1074/jbc.M710481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18272519	Green Published, hybrid			2022-12-27	WOS:000255340000075
J	Wei, CC; Wang, ZQ; Tejero, J; Yang, YP; Hemann, C; Hille, R; Stuehr, DJ				Wei, Chin-Chuan; Wang, Zhi-Qiang; Tejero, Jesus; Yang, Ya-Ping; Hemann, Craig; Hille, Russ; Stuehr, Dennis J.			Catalytic reduction of a tetrahydrobiopterin radical within nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL NO SYNTHASE; HEME-DIOXY REDUCTION; HYDROXY-L-ARGININE; ELECTRON-TRANSFER; OMEGA-HYDROXYARGININE; OXYGEN; BINDING; DOMAIN; PTERIN; CYTOCHROME-P450	Nitric-oxide synthases (NOS) are catalytically self-sufficient flavo-heme enzymes that generate NO from arginine (Arg) and display a novel utilization of their tetrahydrobiopterin (H4B) cofactor. During Arg hydroxylation, H4B acts as a one-electron donor and is then presumed to redox cycle (i.e. be reduced back to H4B) within NOS before further catalysis can proceed. Whereas H4B radical formation is well characterized, the subsequent presumed radical reduction has not been demonstrated, and its potential mechanisms are unknown. We investigated radical reduction during a single turnover Arg hydroxylation reaction catalyzed by neuronal NOS to document the process, determine its kinetics, and test for involvement of the NOS flavoprotein domain. We utilized a freeze-quench instrument, the biopterin analog 5-methyl-H4B, and a method that could separately quantify the flavin and pterin radicals that formed in NOS during the reaction. Our results establish that the NOS flavoprotein domain catalyzes reduction of the biopterin radical following Arg hydroxylation. The reduction is calmodulin-dependent and occurs at a rate that is similar to heme reduction and fast enough to explain H4B redox cycling in NOS. These results, in light of existing NOS crystal structures, suggest a "through-heme" mechanism may operate for H4B radical reduction in NOS.	[Wei, Chin-Chuan] So Illinois Univ, Dept Chem, Edwardsville, IL 62026 USA; [Wang, Zhi-Qiang; Tejero, Jesus; Yang, Ya-Ping; Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Wang, Zhi-Qiang] Kent State Univ Tuscarawas, Dept Chem, New Philadelphia, OH 44663 USA; [Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Hemann, Craig] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Southern Illinois University System; Southern Illinois University Edwardsville; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Tuscarawas; University of California System; University of California Riverside; University System of Ohio; Ohio State University	Wei, CC (corresponding author), So Illinois Univ, Dept Chem, Edwardsville, IL 62026 USA.	cwei@siue.edu; stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; Hemann, Craig/0000-0002-7380-4072; Wei, Chin-Chuan/0000-0001-6453-9409	NCI NIH HHS [CA53914] Funding Source: Medline; NHLBI NIH HHS [HL58883] Funding Source: Medline; NIEHS NIH HHS [ES012658] Funding Source: Medline; NIGMS NIH HHS [GM51491, GM075036] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491, R01GM075036] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; AbuSoud HM, 1997, BIOCHEMISTRY-US, V36, P10811, DOI 10.1021/bi971414g; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; Berka V, 2004, BIOCHEMISTRY-US, V43, P13137, DOI 10.1021/bi049026j; Berka V, 2004, J BIOL CHEM, V279, P32243, DOI 10.1074/jbc.M404044200; Buga GM, 1996, AM J PHYSIOL-HEART C, V271, pH1988, DOI 10.1152/ajpheart.1996.271.5.H1988; Capeillere-Blandin C, 2005, BIOCHEM J, V392, P583, DOI 10.1042/BJ20050437; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Galli C, 1996, BIOCHEMISTRY-US, V35, P2804, DOI 10.1021/bi9520444; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GIOVANELLI J, 1991, P NATL ACAD SCI USA, V88, P7091, DOI 10.1073/pnas.88.16.7091; Gorren ACF, 2001, NITRIC OXIDE-BIOL CH, V5, P176, DOI 10.1006/niox.2001.0332; Gorren ACF, 1996, BIOCHEMISTRY-US, V35, P16735, DOI 10.1021/bi961931j; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Hurshman AR, 2003, BIOCHEMISTRY-US, V42, P13287, DOI 10.1021/bi035491p; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Ost TWB, 2005, J BIOL CHEM, V280, P965, DOI 10.1074/jbc.M411191200; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Perry JM, 1998, CHEM BIOL, V5, P355, DOI 10.1016/S1074-5521(98)90069-2; Reif A, 1999, J BIOL CHEM, V274, P24921, DOI 10.1074/jbc.274.35.24921; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Schmidt PP, 2001, J BIOL INORG CHEM, V6, P151, DOI 10.1007/s007750000185; Shimanuki T, 1999, J BIOL CHEM, V274, P26956, DOI 10.1074/jbc.274.38.26956; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Wei CC, 2005, J BIOL CHEM, V280, P8929, DOI 10.1074/jbc.M409737200; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; Wei CC, 2003, BIOCHEMISTRY-US, V42, P1969, DOI 10.1021/bi026898h; Wei CC, 2001, J BIOL CHEM, V276, P315, DOI 10.1074/jbc.M008441200; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Witteveen CFB, 1996, J BIOL CHEM, V271, P4143; Witteveen CFB, 1999, J BIOL CHEM, V274, P29755, DOI 10.1074/jbc.274.42.29755	44	63	65	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11734	11742		10.1074/jbc.M709250200	http://dx.doi.org/10.1074/jbc.M709250200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18283102	Green Published, hybrid			2022-12-27	WOS:000255067400073
J	Xu, CY; Xu, WJ; Palmer, AE; Reed, JC				Xu, Chunyan; Xu, Wenjie; Palmer, Amy E.; Reed, John C.			BI-1 regulates endoplasmic reticulum Ca2+ Homeostasis downstream of bcl-2 family proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; MITOCHONDRIAL PERMEABILITY TRANSITION; BAX INHIBITOR-1; INOSITOL 1,4,5-TRISPHOSPHATE; FLUORESCENT INDICATORS; INDUCED APOPTOSIS; DOWN-REGULATION; PLANT HOMOLOG; MODULATION; STRESS	BI-1 (Bax inhibitor-1) is an evolutionarily conserved multi-transmembrane protein that resides in the endoplasmic reticulum (ER) and that has documented cytoprotective functions in both animals and plants. Recent studies indicate that BI-1 shares in common with Bcl-2/Bax family proteins the ability to regulate the amounts of Ca2+ that can be released from the ER by agents, such as the ER-Ca2+-ATPase (SERCA) inhibitor thapsigargin (TG). Using an ER-targeted, Ca2+ indicator (cameleon), with characteristics optimized for measuring ER Ca2+ ([Ca2+](er)), we studied the effects of BI-1 on [Ca2+](er) in resting and TG-treated cells. Similar to cells overexpressing antiapoptotic Bcl-2 or Bcl-XL, overexpression of BI-1 resulted in lower resting [Ca2+](er), with concomitantly less Ca2+ released into the cytosol upon stimulation by TG and with a higher rate of Ca2+ leakage from the ER. Co-expression of SERCA restored levels of [Ca2+](er) to normal, showing opposing actions of the ER-Ca2+ ATPase and BI-1 on ER Ca2+ homeostasis. Conversely, cells with deficient BI-1 have increased [Ca2+](er), and release more Ca2+ into the cytosol when challenged with TG. In BI-1-deficient cells, Bcl-XL fails to reduce [Ca2+](er), indicating that BI-1 functions downstream of Bcl-XL. In bax(-/-) bak(-/-) double knock-out cells, both BI-1 and Bcl-XL retained their ability to reduce [Ca2+](er), suggesting that BI-1 and Bcl-XL operate downstream of or parallel to Bax/Bak. The findings reveal a hierarchy of functional interactions of BI-1 with Bcl-2/Bax family proteins in regulating ER Ca2+ homeostasis.	[Xu, Chunyan; Xu, Wenjie; Reed, John C.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Palmer, Amy E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Reed, JC (corresponding author), Burnham Inst Med Res, Program Apoptosis & Cell Death Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@burnham.org	Xu, Wenjie/F-5453-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, F32NS047855, R01NS027177] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32-GM067488] Funding Source: Medline; NINDS NIH HHS [F32-NS047855, NS27177] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bolduc N, 2002, FEBS LETT, V532, P111, DOI 10.1016/S0014-5793(02)03650-5; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Dremina ES, 2006, BIOCHEMISTRY-US, V45, P175, DOI 10.1021/bi050800s; Dremina ES, 2004, BIOCHEM J, V383, P361, DOI 10.1042/BJ20040187; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Foyouzi-Youssefi R, 2000, P NATL ACAD SCI USA, V97, P5723, DOI 10.1073/pnas.97.11.5723; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Jones RG, 2007, IMMUNITY, V27, P268, DOI 10.1016/j.immuni.2007.05.023; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2000, J CELL BIOL, V148, P857, DOI 10.1083/jcb.148.5.857; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Vanden Abeele F, 2002, CANCER CELL, V1, P169; WALTER L, 1994, MAMM GENOME, V5, P216, DOI 10.1007/BF00360548; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	54	90	93	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11477	11484		10.1074/jbc.M708385200	http://dx.doi.org/10.1074/jbc.M708385200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299329	Green Published, hybrid			2022-12-27	WOS:000255067400046
J	Davis, MC; McColl, KS; Zhong, F; Wang, ZQ; Malone, MH; Distelhorst, CW				Davis, Michael C.; McColl, Karen S.; Zhong, Fei; Wang, Zhengqi; Malone, Michael H.; Distelhorst, Clark W.			Dexamethasone-induced inositol 1,4,5-trisphosphate receptor elevation in murine lymphoma cells is not required for dexamethasone-mediated calcium elevation and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-INDUCED APOPTOSIS; ACUTE LYMPHOBLASTIC-LEUKEMIA; ENDOGENOUS ENDONUCLEASE ACTIVATION; TRISPHOSPHATE RECEPTORS; OLIGONUCLEOTIDE ARRAYS; EXPRESSION PATTERNS; MESSENGER-RNA; PROTEIN BIM; RESISTANT; GENES	Glucocorticosteroid hormones, including dexamethasone, have diverse effects on immature lymphocyte function that ultimately lead to cell death. Previous studies established that glucocorticoid-induced alterations in intracellular calcium homeostasis promote apoptosis, but the mechanism by which glucocorticoids disrupt calcium homeostasis is unknown. Through gene expression array analysis, we found that dexamethasone induces a striking elevation of inositol 1,4,5-trisphosphate receptor (IP3R) levels in two murine lymphoma cell lines, WEHI7.2 and S49.A2.IP3R elevation was confirmed at both mRNA and protein levels. However, there was not a strong correlation between IP3R elevation and altered calcium homeostasis in terms of either kinetics or dose response. Moreover, IP3R knockdown, by either antisense or small interfering RNA, did not prevent either calcium disruption or apoptosis. Finally, DT40 lymphoma cells lacking all three IP3R isoforms were just as sensitive to dexamethasone-induced apoptosis as wild-type DT40 cells expressing all three IP3R isoforms. Thus, although alterations in intracellular calcium homeostasis contribute to glucocorticoid-induced apoptosis, these calcium alterations are not directly attributable to IP3R elevation.	[Davis, Michael C.; McColl, Karen S.; Zhong, Fei; Wang, Zhengqi; Malone, Michael H.; Distelhorst, Clark W.] Case Western Reserve Univ, Ctr Comprehens Canc, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA; [Davis, Michael C.; McColl, Karen S.; Zhong, Fei; Wang, Zhengqi; Malone, Michael H.; Distelhorst, Clark W.] Case Western Reserve Univ, Ctr Comprehens Canc, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Ctr Comprehens Canc, Dept Med, Div Hematol Oncol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	cwd@case.edu	Davis, Michael C/L-8920-2013	Davis, Michael C/0000-0003-2293-5694	NCI NIH HHS [R01 CA042755] Funding Source: Medline; NHLBI NIH HHS [T32 HL07147, T32 HL007147] Funding Source: Medline; NIGMS NIH HHS [T32 GM007250] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042755] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chauhan D, 2002, ONCOGENE, V21, P1346, DOI 10.1038/sj.onc.1205205; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; FERNANDEZ A, 1995, J IMMUNOL, V155, P5133; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Hirota J, 1998, BIOCHEM J, V333, P615, DOI 10.1042/bj3330615; Jayaraman T, 1997, MOL CELL BIOL, V17, P3005, DOI 10.1128/MCB.17.6.3005; Jondal M, 2004, TRENDS IMMUNOL, V25, P595, DOI 10.1016/j.it.2004.09.003; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; LAM M, 1993, MOL ENDOCRINOL, V7, P686, DOI 10.1210/me.7.5.686; Lencesova L, 2002, FEBS LETT, V531, P432, DOI 10.1016/S0014-5793(02)03579-2; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Malone MH, 2004, J BIOL CHEM, V279, P52850, DOI 10.1074/jbc.M408040200; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Mountian I, 1999, CELL CALCIUM, V25, P371, DOI 10.1054/ceca.1999.0034; Obexer P, 2001, ONCOGENE, V20, P4324, DOI 10.1038/sj.onc.1204573; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Roderick HL, 2003, BIOCHEM SOC T, V31, P950; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; SIBLEY CH, 1974, CELL, V2, P213, DOI 10.1016/0092-8674(74)90013-0; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Thompson E B, 1986, Adv Exp Med Biol, V196, P111; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Tome ME, 2001, CANCER RES, V61, P2766; Tonko M, 2001, FASEB J, V15, P693, DOI 10.1096/fj.00-0327com; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yoshida NL, 2002, BIOCHEM BIOPH RES CO, V293, P1254; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	48	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10357	10365		10.1074/jbc.M800269200	http://dx.doi.org/10.1074/jbc.M800269200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18272518	Green Published, hybrid			2022-12-27	WOS:000254894700016
J	Wypych, J; Li, M; Guo, A; Zhang, ZQ; Martinez, T; Allen, MJ; Fodor, S; Kelner, DN; Flynn, GC; Liu, YQD; Bondarenko, PV; Ricci, MS; Dillon, TM; Balland, A				Wypych, Jette; Li, Ming; Guo, Amy; Zhang, Zhongqi; Martinez, Theresa; Allen, Martin J.; Fodor, Szilan; Kelner, Drew N.; Flynn, Gregory C.; Liu, Yaoqing Diana; Bondarenko, Pavel V.; Ricci, Margaret Speed; Dillon, Thomas M.; Balland, Alain			Human IgG2 antibodies display disulfide-mediated structural isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; INDUCED DISSOCIATION SPECTRA; HINGE REGION; DISULPHIDE BRIDGES; IMMUNOGLOBULIN G; SPECTROMETRY METHOD; MASS-SPECTROMETRY; HEAVY CHAIN; PEPTIDES; PREDICTION	In this work, we present studies of the covalent structure of human IgG2 molecules. Detailed analysis showed that recombinant human IgG2 monoclonal antibody could be partially resolved into structurally distinct forms caused by multiple disulfide bond structures. In addition to the presently accepted structure for the human IgG2 subclass, we also found major structures that differ from those documented in the current literature. These novel structural isoforms are defined by the light chain constant domain (CL) and the heavy chain C(H)1 domain covalently linked via disulfide bonds to the hinge region of the molecule. Our results demonstrate the presence of three main types of structures within the human IgG2 subclass, and we have named these structures IgG2-A, -B, and -A/B. IgG2-A is the known classic structure for the IgG2 subclass defined by structurally independent Fab domains and hinge region. IgG2-B is a structure defined by a symmetrical arrangement of a (C(H)1-C-L-hinge) 2 complex with both Fab regions covalently linked to the hinge. IgG2-A/B represents an intermediate form, defined by an asymmetrical arrangement involving one Fab arm covalently linked to the hinge through disulfide bonds. The newly discovered structural isoforms are present in native human IgG2 antibodies isolated from myeloma plasma and from normal serum. Furthermore, the isoforms are present in native human IgG2 with either kappa or lambda light chains, although the ratios differ between the light chain classes. These findings indicate that disulfide structural heterogeneity is a naturally occurring feature of antibodies belonging to the human IgG2 subclass.	[Wypych, Jette; Li, Ming; Guo, Amy; Martinez, Theresa; Fodor, Szilan; Kelner, Drew N.; Flynn, Gregory C.; Liu, Yaoqing Diana; Balland, Alain] Amgen Inc, Dept Analyt Sci, Thousand Oaks, CA 91320 USA; [Zhang, Zhongqi] Amgen Inc, Dept Global Cellular & Analyt Resources, Thousand Oaks, CA 91320 USA; [Allen, Martin J.] Amgen Inc, Dept Cell Sci & Technol, Thousand Oaks, CA 91320 USA; [Bondarenko, Pavel V.; Ricci, Margaret Speed; Dillon, Thomas M.] Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Wypych, J (corresponding author), 1 Amgen Ctr Dr,Mail Stop 30E-1-C, Thousand Oaks, CA 91320 USA.	jwypych@amgen.com; ballanda@amgen.com	Liu, Y Diana/AAU-4624-2021					Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Bloom JW, 1997, PROTEIN SCI, V6, P407; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Buchner J, 2002, J MOL BIOL, V318, P829, DOI 10.1016/S0022-2836(02)00171-7; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Bures EJ, 1998, BIOCHEMISTRY-US, V37, P12172, DOI 10.1021/bi981082v; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Creighton CJ, 2001, J AM CHEM SOC, V123, P12664, DOI 10.1021/ja016505m; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; Dillon TM, 2004, J CHROMATOGR A, V1053, P299, DOI 10.1016/j.chroma.2004.08.058; DORRINGTON KJ, 1978, CAN J BIOCHEM CELL B, V56, P1087, DOI 10.1139/o78-172; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; FRANGION.B, 1968, BIOCHEM J, V106, P15, DOI 10.1042/bj1060015; FRANGIONE B., 1968, J MOL BIOL, V33, P893, DOI 10.1016/0022-2836(68)90326-4; FRANGIONE B, 1969, NATURE, V221, P145, DOI 10.1038/221145a0; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; LILIE H, 1995, J MOL BIOL, V248, P190, DOI 10.1006/jmbi.1995.0211; LU HS, 1986, MODERN METHODS PROTE, P493; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MILSTEIN C, 1971, BIOCHEM J, V121, P217, DOI 10.1042/bj1210217; PINK JRL, 1967, NATURE, V216, P941, DOI 10.1038/216941a0; PINK JRL, 1967, NATURE, V214, P92, DOI 10.1038/214092a0; Redpath S, 1998, HUM IMMUNOL, V59, P720, DOI 10.1016/S0198-8859(98)00075-5; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Yang J, 2007, J CHROMATOGR A, V1156, P174, DOI 10.1016/j.chroma.2007.01.140; Yen TY, 2002, J MASS SPECTROM, V37, P15, DOI 10.1002/jms.241; Yoo EM, 2003, J IMMUNOL, V170, P3134, DOI 10.4049/jimmunol.170.6.3134; ZHANG Y, 2003, BIO PROCESS J, V2, P37; Zhang ZQ, 2004, ANAL CHEM, V76, P3908, DOI 10.1021/ac049951b; Zhang ZQ, 2005, ANAL CHEM, V77, P6364, DOI 10.1021/ac050857k; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	37	213	246	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16194	16205		10.1074/jbc.M709987200	http://dx.doi.org/10.1074/jbc.M709987200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18339624	Green Published, hybrid			2022-12-27	WOS:000256332500078
J	Keller, P; Petrie, JT; De Rose, P; Gerin, I; Wright, WS; Chiang, SH; Nielsen, AR; Fischer, CP; Pedersen, BK; MacDougald, OA				Keller, Pernille; Petrie, John T.; De Rose, Paul; Gerin, Isabelle; Wright, Wendy S.; Chiang, Shian-Huey; Nielsen, Anders R.; Fischer, Christian P.; Pedersen, Bente K.; MacDougald, Ormond A.			Fat-specific protein 27 regulates storage of triacylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; LIPID DROPLET PROTEIN; GENE-EXPRESSION; ADIPOCYTE LIPOLYSIS; TRIGLYCERIDE LIPASE; LIVER STEATOSIS; RECEPTOR-ALPHA; DEFICIENT MICE; PERILIPIN-A; OBESITY	FSP27 ( fat-specific protein 27) is a member of the cell death-inducing DNA fragmentation factor-alpha-like effector ( CIDE) family. Although Cidea and Cideb were initially characterized as activators of apoptosis, recent studies have demonstrated important metabolic roles for these proteins. In this study, we investigated the function of another member of this family, FSP27 ( Cidec), in apoptosis and adipocyte metabolism. Although overexpression of FSP27 is sufficient to increase apoptosis of 293T and 3T3-L1 cells, more physiological levels of expression stimulate spontaneous lipid accumulation in several cell types without induction of adipocyte genes. Increased triacylglycerol is likely due to decreased beta-oxidation of nonesterified fatty acids. Altered flux of fatty acids into triacylglycerol may be a direct effect of FSP27 function, which is localized to lipid droplets in 293T cells and 3T3-L1 adipocytes. Stable knockdown of FSP27 during adipogenesis of 3T3-L1 cells substantially decreases lipid droplet size, increases mitochondrial and lipid droplet number, and modestly increases glucose uptake and lipolysis. Expression of FSP27 in subcutaneous adipose tissue of a human diabetes cohort decreases with total fat mass but is not associated with measures of insulin resistance ( e. g. homeostasis model assessment). Together, these data indicate that FSP27 binds to lipid droplets and regulates their enlargement.	[Keller, Pernille; Petrie, John T.; De Rose, Paul; Gerin, Isabelle; Wright, Wendy S.; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Chiang, Shian-Huey] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Nielsen, Anders R.; Fischer, Christian P.; Pedersen, Bente K.] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metabol, DK-2100 Copenhagen, Denmark	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rigshospitalet; University of Copenhagen	MacDougald, OA (corresponding author), 7620 Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	macdouga@umich.edu	Pedersen, Bente Klarlund/AGR-3217-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Fischer, Christian/0000-0002-0657-9143; MacDougald, Ormond/0000-0001-6907-7960; Rinnov, Anders Rasmussen/0000-0003-3859-3289; Hahn, Wendy/0000-0002-4374-5876	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062876, R01DK062876] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 62876] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Ceperuelo-Mallafre V, 2007, J CLIN ENDOCR METAB, V92, P3640, DOI 10.1210/jc.2007-0531; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Croce MA, 2007, DIABETES, V56, P2395, DOI 10.2337/db07-0480; Dahlman I, 2005, DIABETES, V54, P3032, DOI 10.2337/diabetes.54.10.3032; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; DANESCH U, 1992, J BIOL CHEM, V267, P7185; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Gummesson A, 2007, J CLIN ENDOCR METAB, V92, P4759, DOI 10.1210/jc.2007-1136; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Inohara N, 1999, J BIOL CHEM, V274, P270, DOI 10.1074/jbc.274.1.270; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; KELDER B, 2007, J COMP HEPATOL, V6, P4; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Preece A, 1972, MANUAL HIST TECHNICI; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Yu ST, 2001, J BIOL CHEM, V276, P42485, DOI 10.1074/jbc.M106480200; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	52	157	174	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14355	14365		10.1074/jbc.M708323200	http://dx.doi.org/10.1074/jbc.M708323200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18334488	hybrid, Green Published			2022-12-27	WOS:000255941400022
J	El-Yassimi, A; Hichami, A; Besnard, P; Khan, NA				El-Yassimi, Abdelghani; Hichami, Aziz; Besnard, Philippe; Khan, Naim Akhtar			Linoleic acid induces calcium signaling, Src kinase phosphorylation, and neurotransmitter release in mouse CD36-positive gustatory cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TASTE-BUDS; CIRCUMVALLATE PAPILLAE; TYROSINE KINASES; FATTY-ACIDS; TRANSDUCTION; SEROTONIN; CD36; LOCALIZATION; HYDROXYLASE; EXPRESSION	We have recently demonstrated that the cells expressing CD36, localized apically on the taste buds of mouse lingual circumvallate papillae, act as gustatory cells. In the present study we isolated these CD36- positive cells from mouse circumvallate papillae and investigated intracellular signaling events, triggered by a long-chain polyunsaturated fatty acid, i.e. linoleic acid ( LA). LA induced increases in free intracellular calcium concentrations, [ Ca2+](i), by recruiting calcium from endoplasmic reticulum pool via inositol 1,4,5-triphosphate production followed by calcium influx via opening of store-operated calcium (SOC) channels. LA also induced phosphorylation of Src-protein-tyrosine kinases ( Src-PTKs), particularly of Fyn(59) and Yes(62). LA-evoked phosphorylation of Fyn(59) and Yes(62) was implicated in the activation of SOC channels. Reverse transcription-quantitative PCR revealed that the CD36- positive gustatory cells possessed mRNA of enzymes like tryptophan hydroxylase-1, L-aromatic amino acid decarboxylase, tyrosine hydroxylase, and dopamine beta-hydroxylase, involved in the synthesis of monoamine neurotransmitters. Interestingly, the addition of LA to these cells induced the release of 5-hydroxytryptamine and noradrenalin to the extracellular environment. The LA-induced release of these neurotransmitters was curtailed by SOC channel blockers and Src-PTK inhibitors. These results altogether demonstrate that LA binds to mouse CD36- positive gustatory cells, induces Src-PTKs phosphorylation, triggers calcium signaling, and evokes the release of 5-hydroxytryptamine and noradrenalin, which in turn may be implicated in the downstream signaling to the afferent nerve fibers, thus transmitting the output signal from taste buds to the central nervous system.	[El-Yassimi, Abdelghani; Hichami, Aziz; Khan, Naim Akhtar] Fac Life Sci, Equipe Accueil 4183, Unite Propre Enseignment Super Lipides & Signalis, F-21000 Dijon, France; [Besnard, Philippe] Univ Burgundy, INSERM, Ecole Natl Super Biol Appl Nutr & Alimentat, UMR,U866, F-21000 Dijon, France	Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Khan, NA (corresponding author), Fac Life Sci, Equipe Accueil 4183, Unite Propre Enseignment Super Lipides & Signalis, Gabriel 6, F-21000 Dijon, France.	Naim.Khan@u-bourgogne.fr		hichami, aziz/0000-0003-4331-5152				Babnigg G, 1997, J BIOL CHEM, V272, P29434, DOI 10.1074/jbc.272.47.29434; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; FLEMING I, 1995, CIRC RES, V76, P522, DOI 10.1161/01.RES.76.4.522; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; GAILLARD D, 2007, IN PRESS FASEB J; Ganchrow JR, 2000, PHYSIOL BEHAV, V69, P29, DOI 10.1016/S0031-9384(00)00185-2; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; Gousset K, 2004, BBA-BIOMEMBRANES, V1660, P7, DOI 10.1016/j.bbamem.2003.09.009; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Haskew RE, 2002, J NEUROCHEM, V82, P903, DOI 10.1046/j.1471-4159.2002.01037.x; Herness S, 2002, J PHYSIOL-LONDON, V543, P601, DOI 10.1113/jphysiol.2002.020438; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Huang YJ, 2005, ARCH ITAL BIOL, V143, P87; Izikki M, 2007, AM J PHYSIOL-LUNG C, V293, pL1045, DOI 10.1152/ajplung.00082.2007; Kawai T, 2003, AM J PHYSIOL-REG I, V285, pR447, DOI 10.1152/ajpregu.00729.2002; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lee KM, 2006, EXP MOL MED, V38, P703, DOI 10.1038/emm.2006.83; Liman E. R., 2007, V179, P287; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Moret F, 2004, J COMP NEUROL, V468, P135, DOI 10.1002/cne.10965; Nagai T, 1996, CHEM SENSES, V21, P353, DOI 10.1093/chemse/21.3.353; NAGATSU T, 1991, NEUROSCI RES, V12, P315, DOI 10.1016/0168-0102(91)90001-F; Ortiz-Alvarado R, 2006, FEBS LETT, V580, P5371, DOI 10.1016/j.febslet.2006.08.078; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perez CA, 2003, CELL CALCIUM, V33, P541, DOI 10.1016/S0143-4160(03)00059-9; Ren Y, 1999, MOL BRAIN RES, V74, P221, DOI 10.1016/S0169-328X(99)00253-3; RIGGIN RM, 1977, ANAL CHEM, V49, P2109, DOI 10.1021/ac50021a052; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1504, DOI 10.1152/ajpregu.00364.2007; Seta Y, 2007, HISTOCHEM CELL BIOL, V127, P415, DOI 10.1007/s00418-006-0257-3; TAKEDA M, 1980, CELL TISSUE RES, V210, P71; Vazquez G, 1998, J BIOL CHEM, V273, P33954, DOI 10.1074/jbc.273.51.33954; Wang SJ, 2003, NEUROREPORT, V14, P1519, DOI 10.1097/00001756-200308060-00024; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F	39	139	144	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12949	12959		10.1074/jbc.M707478200	http://dx.doi.org/10.1074/jbc.M707478200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321850	hybrid			2022-12-27	WOS:000255499800032
J	Hase, M; Yokomizo, T; Shimizu, T; Nakamura, M				Hase, Momoko; Yokomizo, Takehiko; Shimizu, Takao; Nakamura, Motonao			Characterization of an orphan G protein-coupled receptor, GPR20, that constitutively activates G(i) proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CELL-PROLIFERATION; EXPRESSION; IDENTIFICATION; CYCLASE; EXHIBIT; CLONING; TDAG8; MOTIF; ACID	GPR20 was isolated as an orphan G protein-coupled receptor from genomic DNA by PCR amplification. Although GPR20 was closely related to nucleotide or lipid receptors, the functional role of this receptor, as well as its endogenous ligand, remains unclear. Here we demonstrate that GPR20 is constitutively active in the absence of ligand, leading to continuous activation of its coupled G proteins. When GPR20 was exogenously expressed in HEK293 cells, both the basal level and the prostaglandin E-2-induced production of cAMP were significantly decreased. A remarkable increase in [S-35] guanosine 5'-(gamma-thio) triphosphate (GTP gamma S) binding to membrane preparations was also observed in GPR20-expressing cells. These effects of GPR20 overexpression were diminished in cells treated with pertussis toxin, suggesting that the expression of GPR20 results in the activation of G(i/o) proteins. Involvement of GPR20 in the activation of G(i/o) proteins was also supported by evidence that the disruption of a conserved DRY motif in GPR20 attenuated both [ 35S] GTP gamma S incorporation and inhibition of the prostaglandin E2-induced cAMP production. Knockdown of GPR20 in PC12h cells resulted in an elevation of the basal cAMP level, suggesting that the endogenous GPR20 achieves a constitutively or spontaneously active conformation. Furthermore, enhancement of [H-3] thymidine incorporation was also observed in the GPR20-silencing cells, implying that the GPR20 expression seems to attenuate PC12h cell growth. Taken together, these data indicate that GPR20 constitutively activates G(i) proteins without ligand stimulation. The receptor may be involved in cellular processes, including control of intracellular cAMP levels and mitogenic signaling.	[Hase, Momoko; Yokomizo, Takehiko; Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 8128582, Japan	University of Tokyo; Kyushu University	Nakamura, M (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moto-nakamura@umin.net	Yokomizo, Takehiko/P-5673-2016; Shimizu, Takao/AAV-7052-2021	Yokomizo, Takehiko/0000-0002-5219-1553; 				Allander SV, 2001, CANCER RES, V61, P8624; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bates B, 2006, BRAIN RES, V1087, P1, DOI 10.1016/j.brainres.2006.02.123; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN TJ, 2003, Patent No. 0018989; Chen G, 2000, MOL PHARMACOL, V57, P125; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Dhanasekaran N, 1998, ONCOGENE, V17, P1383, DOI 10.1038/sj.onc.1202242; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; HUNT TW, 1994, J BIOL CHEM, V269, P29565; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Jones PG, 2007, BBA-GEN SUBJECTS, V1770, P890, DOI 10.1016/j.bbagen.2007.01.013; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; ODowd BF, 1997, GENE, V187, P75, DOI 10.1016/S0378-1119(96)00722-6; OKUNO T, 2008, IN PRESS J EXP MED; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wise A, 1997, BIOCHEM J, V321, P721, DOI 10.1042/bj3210721; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	35	21	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12747	12755		10.1074/jbc.M709487200	http://dx.doi.org/10.1074/jbc.M709487200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18347022	hybrid			2022-12-27	WOS:000255499800010
J	Pechkovsky, DV; Scaffidi, AK; Hackett, TL; Ballard, J; Shaheen, F; Thompson, PJ; Thannickal, VJ; Knight, DA				Pechkovsky, Dmitri V.; Scaffidi, Amelia K.; Hackett, Tillie L.; Ballard, Joanne; Shaheen, Furquan; Thompson, Philip J.; Thannickal, Victor J.; Knight, Darryl A.			Transforming growth factor beta 1 induces alpha v beta 3 integrin expression in human lung fibroblasts via a beta 3 integrin-, c-Src-, and p38 MAPK-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; FOCAL ADHESION KINASE; EPITHELIAL-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL CELLS; GENE-EXPRESSION; II RECEPTOR; P38 MAPK; ACTIVATION; SP1	In response to transforming growth factor beta 1 ( TGF beta) stimulation, fibroblasts modify their integrin repertoire and adhesive capabilities to certain extracellular matrix proteins. Although TGF beta has been shown to increase the expression of specific alpha v integrins, the mechanisms underlying this are unknown. In this study we demonstrate that TGF beta 1 increased both beta 3 integrin subunit mRNA and protein levels as well as surface expression of alpha v beta 3 in human lung fibroblasts. TGF beta 1-induced alpha v beta 3 expression was strongly adhesion-dependent and associated with increased focal adhesion kinase and c-Src kinase phosphorylation. Inhibition of beta 3 integrin activation by the Arg-Gly-Asp tripeptide motif-specific disintegrin echistatin or alpha v beta 3 blocking antibody prevented the increase in beta 3 but not beta 5 integrin expression. In addition, echistatin inhibited TGF beta 1-induced p38 MAPK but not Smad3 activation. Furthermore, inhibition of the Src family kinases, but not focal adhesion kinase, completely abrogated TGF beta 1-induced expression of alpha v beta 3 and p38 MAPK phosphorylation but not beta 5 integrin expression and Smad3 activation. The TGF beta 1-induced alpha v beta 3 expression was blocked by pharmacologic and genetic inhibition of p38 MAPK- but not Smad2/3-, Sp1-, ERK-, phosphatidylinositol 3-kinase, and NF-kappa B-dependent pathways. Our results demonstrate that TGF beta 1 induces alpha v beta 3 integrin expression via a beta 3 integrin-, c-Src-, and p38 MAPK-dependent pathway. These data identify a novel mechanism for TGF beta 1 signaling in human lung fibroblasts by which they may contribute to normal and pathological wound healing.	[Pechkovsky, Dmitri V.; Shaheen, Furquan; Knight, Darryl A.] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Resp Res, Vancouver, BC V6Z 1Y6, Canada; [Hackett, Tillie L.; Knight, Darryl A.] Univ British Columbia, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V6Z 1Y6, Canada; [Scaffidi, Amelia K.; Ballard, Joanne; Thompson, Philip J.] Univ Western Australia, Lung Inst W Australia, Nedlands, WA 6009, Australia; [Scaffidi, Amelia K.; Ballard, Joanne; Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Nedlands, WA 6009, Australia; [Thannickal, Victor J.] Univ Michigan, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	University of British Columbia; University of British Columbia; University of Western Australia; University of Western Australia; University of Michigan System; University of Michigan	Knight, DA (corresponding author), St Pauls Hosp, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	dknight@mrl.ubc.ca		Pechkovsky, Dmitri/0000-0001-8908-3444				Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Courter DL, 2005, J BIOL CHEM, V280, P12145, DOI 10.1074/jbc.M412555200; Della Morte R, 2000, EUR J BIOCHEM, V267, P5047, DOI 10.1046/j.1432-1327.2000.01561.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; JANAT MF, 1992, J CELL PHYSIOL, V151, P588, DOI 10.1002/jcp.1041510319; Jinnin M, 2004, ONCOGENE, V23, P1656, DOI 10.1038/sj.onc.1207064; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Larouche K, 2000, J BIOL CHEM, V275, P39182, DOI 10.1074/jbc.M002945200; Lu N, 2006, MATRIX BIOL, V25, P118, DOI 10.1016/j.matbio.2005.10.002; Maeda M, 2006, J BIOL CHEM, V281, P59, DOI 10.1074/jbc.M503304200; Marcinkiewicz C, 1997, BLOOD, V90, P1565, DOI 10.1182/blood.V90.4.1565.1565_1565_1575; McHugh KP, 2001, J CELL BIOCHEM, V81, P320, DOI 10.1002/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO;2-M; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyazono K, 2000, J CELL SCI, V113, P1101; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; NEHLS MC, 1993, J CLIN INVEST, V92, P2916, DOI 10.1172/JCI116914; Paine R, 1999, AM J MED, V107, P268, DOI 10.1016/S0002-9343(99)00226-0; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Scaffidi AK, 2001, J CELL SCI, V114, P3507; Schoppet M, 2002, LAB INVEST, V82, P37, DOI 10.1038/labinvest.3780393; Sekimoto H, 2005, MOL ENDOCRINOL, V19, P1859, DOI 10.1210/me.2004-0481; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; SHEPPARD D, 1992, J BIOL CHEM, V267, P17409; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Wilhide CC, 1997, BLOOD, V90, P3951, DOI 10.1182/blood.V90.10.3951; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	43	84	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12898	12908		10.1074/jbc.M708226200	http://dx.doi.org/10.1074/jbc.M708226200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18353785	hybrid			2022-12-27	WOS:000255499800026
J	Zhang, Q; Guo, RL; Lu, Y; Zhao, L; Zhou, Q; Schwarz, EM; Huang, J; Di, C; Jin, ZG; Boyce, BF; Xing, LP				Zhang, Qian; Guo, Ruolin; Lu, Yan; Zhao, Lan; Zhou, Quan; Schwarz, Edward M.; Huang, Jing; Chen, Di; Jin, Zheng-Gen; Boyce, Brendan F.; Xing, Lianping			VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COLONY-STIMULATING FACTOR; IN-VIVO; CELL-PROLIFERATION; MATURE OSTEOCLASTS; EXPRESSION; KINASE; MICE; SRC; DIFFERENTIATION	Osteoclasts are bone-resorbing cells, but they also secrete and respond to cytokines. Here, we test the hypothesis that osteoclasts secrete the lymphatic growth factor, VEGF-C, to increase their resorptive activity. Osteoclasts and osteoclast precursors were generated by culturing splenocytes with macrophage colony-stimulating factor and RANKL from wild-type, NF-kappa Bp50(-/-)/p52(-/-), and Src(-/-) mice. Expression of VEGFs was measured by real time reverse transcription-PCR, Western blotting, and immunostaining. The effect of VEGF-C signaling on osteoclast function was determined by osteoclastogenesis and pit assays. RANKL increased the expression of VEGF-C but not of other VEGFs in osteoclasts and their precursors. RANKL-induced VEGF-C expression was reduced in NF-kappa Bp50(-/-)/p52(-/-) precursors or wild- type cells treated with an NF-kappa B inhibitor. VEGF-C directly stimulated RANKL-mediated bone resorption, which was reduced by the VEGF-C-specific receptor blocker, VEGFR3:Fc. Osteoclasts express VEGFR3, and VEGF-C stimulated Src phosphorylation in osteoclasts. VEGF-C-mediated bone resorption was abolished in Src(-/-) osteoclasts or cells treated with an Src inhibitor. We conclude that RANKL stimulates osteoclasts and their precursors to release VEGF-C through an NF-kappa B-dependent mechanism, indicating that VEGF-C is a new RANKL target gene in osteoclasts and functions as an autocrine factor regulating osteoclast activity.	[Zhang, Qian; Guo, Ruolin; Lu, Yan; Zhao, Lan; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Schwarz, Edward M.; Huang, Jing; Chen, Di; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Jin, Zheng-Gen] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Xing, LP (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	Lianping_xing@urmc.rochester.edu			NHLBI NIH HHS [R01 HL080611-05, R01 HL080611] Funding Source: Medline; NIAMS NIH HHS [R01 AR054465, K02 AR052411, AR43510, R01 AR051189, AR48697, AR53586] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051189, K02AR052411, R01AR043510, R01AR048697, R01AR054465, R21AR053586] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ali N, 2005, J PHARMACOL SCI, V98, P130, DOI 10.1254/jphs.FP0040850; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyce BF, 2006, CLIN CANCER RES, V12, p6291S, DOI 10.1158/1078-0432.CCR-06-0991; Boyce BF, 2006, CURR OPIN RHEUMATOL, V18, P427, DOI 10.1097/01.bor.0000231913.32364.32; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Cha HS, 2007, J RHEUMATOL, V34, P16; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Hamrah P, 2003, AM J PATHOL, V163, P57, DOI 10.1016/S0002-9440(10)63630-9; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Matsumoto Y, 2002, J IMMUNOL, V168, P5824, DOI 10.4049/jimmunol.168.11.5824; Mills BG, 1997, CALCIFIED TISSUE INT, V61, P16, DOI 10.1007/s002239900285; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Pettit AR, 2006, RHEUMATOLOGY, V45, P1068, DOI 10.1093/rheumatology/kel045; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Sedivy R, 2004, CANCER DETECT PREV, V29, P8, DOI 10.1016/j.cdp.2004.10.006; Shakespeare WC, 2008, CHEM BIOL DRUG DES, V71, P97, DOI 10.1111/j.1747-0285.2007.00615.x; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Xing LP, 2001, GENE DEV, V15, P241, DOI 10.1101/gad.840301; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Zhang Q, 2005, ARTHRITIS RHEUM-US, V52, P2708, DOI 10.1002/art.21236; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326	48	60	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13491	13499		10.1074/jbc.M708055200	http://dx.doi.org/10.1074/jbc.M708055200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18359770	Green Published, hybrid			2022-12-27	WOS:000255499800088
J	Chuderland, D; Marmor, G; Shainskaya, A; Seger, R				Chuderland, Dana; Marmor, Goldie; Shainskaya, Alla; Seger, Rony			RETRACTED: Calcium-mediated interactions regulate the subcellular localization of extracellular signal-regulated kinases (Retracted article. See vol. 292, pg. 8850, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ACTIVATED PROTEIN-KINASE; GONADOTROPIN-RELEASING-HORMONE; NUCLEAR EXPORT SIGNAL; MAP KINASE; GROWTH-FACTOR; ERK; TRANSLOCATION; MECHANISM; CASCADE; PHOSPHORYLATION	The subcellular localization of ERKs in cells, which is important for proper signaling, may be regulated through protein-protein interactions. We found that inactive ERK2 interacts with a large number of proteins through its cytosolic retention sequence/common docking domain, whereas the phospho-ERK2 interacts with only few substrates. Varying calcium concentrations significantly modified the repertoire of ERK2-interacting proteins, of which many were identified. The effect of calcium on ERK interactions also influenced the localization of ERKs, as calcium chelators enhanced nuclear translocation, whereas elevated calcium levels prevented it. This effect of calcium was apparent upon lysophosphatidic acid stimulation, where ERKs translocation was delayed compared with that induced by EGF in a calcium-dependent manner. In vitro translocation assay revealed that high calcium concentrations affect ERK translocation by preventing the shuttling machinery through the nuclear envelope, probably due to higher binding to nuclear pore proteins. These results are consistent with a model in which ERKs in quiescent cells are bound to several cytoplasmic proteins. Upon stimulation, ERKs are phosphorylated and released from cytoplasmic anchors to allow shuttling toward the nucleus. This translocation is delayed when calcium levels are increased, and this modifies the localization of ERKs and, therefore, also their spatiotemporal regulation. Thus, calcium regulates ERK localization, which is important for the compartmentalization of ERKs with their proper substrates and thereby their signaling specificity.	[Chuderland, Dana; Marmor, Goldie; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Shainskaya, Alla] Weizmann Inst Sci, Mass Spectroscopy Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Seger, R (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	rony.seger@weizmann.ac.il						Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Cook SJ, 1996, BIOCHEM J, V320, P237, DOI 10.1042/bj3200237; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Erickson ES, 2006, CAN J PHYSIOL PHARM, V84, P309, DOI 10.1139/Y05-109; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Harris D, 2003, ENDOCRINOLOGY, V144, P612, DOI 10.1210/en.2002-220690; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Lee MA, 1998, CELL CALCIUM, V23, P91, DOI 10.1016/S0143-4160(98)90107-5; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Mulvaney JM, 1999, J BIOL CHEM, V274, P29796, DOI 10.1074/jbc.274.42.29796; Murasawa S, 1998, HYPERTENSION, V32, P668, DOI 10.1161/01.HYP.32.4.668; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; RAO VN, 1994, ONCOGENE, V9, P1855; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tanoue T, 2002, PHARMACOL THERAPEUT, V93, P193, DOI 10.1016/S0163-7258(02)00188-2; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Wolf I, 2001, J BIOL CHEM, V276, P24490, DOI 10.1074/jbc.M103352200; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	55	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11176	11188		10.1074/jbc.M709030200	http://dx.doi.org/10.1074/jbc.M709030200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18268018	Green Published, hybrid			2022-12-27	WOS:000255067400013
J	Coll, T; Eyre, E; Rodriguez-Calvo, R; Palomer, X; Sanchez, RM; Merlos, M; Laguna, JC; Vazquez-Carrera, M				Coll, Teresa; Eyre, Elena; Rodriguez-Calvo, Ricardo; Palomer, Xavier; Sanchez, Rosa M.; Merlos, Manuel; Laguna, Juan Carlos; Vazquez-Carrera, Manuel			Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; PROTEIN-KINASE-C; FACTOR-KAPPA-B; MONOUNSATURATED FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; TRIGLYCERIDE SYNTHESIS; CARNITINE PALMITOYLTRANSFERASE; GENE-TRANSCRIPTION; DIABETES-MELLITUS; ALPHA EXPRESSION	Here we report that in skeletal muscle cells the contribution to insulin resistance and inflammation of two common dietary long-chain fatty acids depends on the channeling of these lipids to distinct cellular metabolic fates. Exposure of cells to the saturated fatty acid palmitate led to enhanced diacylglycerol levels and the consequent activation of the protein kinase C theta/nuclear factor kappa B pathway, finally resulting in enhanced interleukin 6 secretion and down-regulation of the expression of genes involved in the control of the oxidative capacity of skeletal muscle (peroxisome proliferator-activated receptor (PPAR)gamma-coactivator 1 alpha) and triglyceride synthesis (acyl-coenzyme A: diacylglycerol acyltransferase 2). In contrast, exposure to the monounsaturated fatty acid oleate did not lead to these changes. Interestingly, co-incubation of cells with palmitate and oleate reversed both inflammation and impairment of insulin signaling by channeling palmitate into triglycerides and by up-regulating the expression of genes involved in mitochondrial beta-oxidation, thus reducing its incorporation into diacylglycerol. Our findings support a model of cellular lipid metabolism in which oleate protects against palmitate-induced inflammation and insulin resistance in skeletal muscle cells by promoting triglyceride accumulation and mitochondrial beta-oxidation through PPAR alpha- and protein kinase A-dependent mechanisms.	[Coll, Teresa; Eyre, Elena; Rodriguez-Calvo, Ricardo; Palomer, Xavier; Sanchez, Rosa M.; Merlos, Manuel; Laguna, Juan Carlos; Vazquez-Carrera, Manuel] Univ Barcelona, Fac Farm, Unitat Farmacol, Dept Pharmacol & Therapeut Chem, E-08028 Barcelona, Spain; [Coll, Teresa; Eyre, Elena; Rodriguez-Calvo, Ricardo; Palomer, Xavier; Sanchez, Rosa M.; Merlos, Manuel; Laguna, Juan Carlos; Vazquez-Carrera, Manuel] Inst Salud Carlos III, CIBERDEM, E-08028 Barcelona, Spain; [Coll, Teresa; Eyre, Elena; Rodriguez-Calvo, Ricardo; Palomer, Xavier; Sanchez, Rosa M.; Merlos, Manuel; Laguna, Juan Carlos; Vazquez-Carrera, Manuel] Inst Biomed UB, E-08028 Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Vazquez-Carrera, M (corresponding author), Univ Barcelona, Fac Farm, Unitat Farmacol, Dept Pharmacol & Therapeut Chem, Diagonal 643, E-08028 Barcelona, Spain.	mvazquezcarrera@ub.edu	Merlos, Manuel/AAC-3064-2021; Tarridas, Xavier Palomer/H-1494-2015; Rodriguez-Calvo, Ricardo/AAB-4054-2019; Vázquez-Carrera, Manuel/H-2612-2015; Laguna, JCLaguna - Juan C./C-5481-2017; Rodriguez-Calvo, Ricardo/R-6645-2018	Merlos, Manuel/0000-0002-8423-3033; Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Vázquez-Carrera, Manuel/0000-0001-7138-8207; Laguna, JCLaguna - Juan C./0000-0002-7082-0704; Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Eyre Sanchez, Elena/0000-0002-5858-9036				Berry EM, 1997, AM J CLIN NUTR, V66, P991; BODEN G, 1995, J CLIN INVEST, V96, P1261, DOI 10.1172/JCI118160; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BRADY PS, 1992, BIOCHEM J, V286, P779, DOI 10.1042/bj2860779; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chang CH, 2000, AM J PHYSIOL-GASTR L, V279, pG295, DOI 10.1152/ajpgi.2000.279.2.G295; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; COTRIGHT RN, 2000, AM J PHYSIOL-ENDOC M, V278, pE553; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Gorski J, 1998, MOL CELL BIOCHEM, V178, P113, DOI 10.1023/A:1006820907955; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Itani SI, 2000, DIABETES, V49, P1353, DOI 10.2337/diabetes.49.8.1353; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Krogsdam AM, 2002, BIOCHEM J, V363, P157, DOI 10.1042/0264-6021:3630157; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Low CC, 1996, DIABETES, V45, P569, DOI 10.2337/diabetes.45.5.569; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; PARILLO M, 1992, METABOLISM, V41, P1373, DOI 10.1016/0026-0495(92)90111-M; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ryan M, 2000, QJM-MON J ASSOC PHYS, V93, P85, DOI 10.1093/qjmed/93.2.85; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	61	258	272	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11107	11116		10.1074/jbc.M708700200	http://dx.doi.org/10.1074/jbc.M708700200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18281277	Green Published, hybrid			2022-12-27	WOS:000255067400006
J	Lazebnik, MB; Tussie-Luna, MI; Roy, AL				Lazebnik, Maria B.; Tussie-Luna, Maria Isabel; Roy, Ananda L.			Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL TRANSCRIPTION FACTOR-3; GENOMIC ORGANIZATION; CHROMOSOME 7Q11.23; PROMOTER ACTIVITY; EXPRESSION; GTF2IRD1; PROTEIN; IDENTIFICATION; SEQUENCES; RECEPTOR	The ubiquitously expressed TFII-I family of multifunctional transcription factors is involved in gene regulation as well as signaling. Despite the fact that they share significant sequence homology, these factors exhibit varied and distinct functions. The lack of knowledge about its binding sites and physiological target genes makes it more difficult to assign a definitive function for the TFII-I-related protein, BEN. We set out to determine its optimal binding site with the notion of predicting its physiological target genes. Here we report the identification of an optimal binding sequence for BEN by SELEX (systematic evolution of ligands by exponential enrichment) and confirm the relevance of this sequence by functional assays. We further performed a data base search to assign genes that have this consensus site(s) and validate several candidate genes by quantitative PCR upon stable silencing of BEN and by chromatin immunoprecipitation assay upon stable expression of BEN. Given that haploinsufficiency in BEN is causative to Williams-Beuren syndrome, these results may further lead to the identification of a set of physiologically relevant target genes for BEN and may help identify molecular determinants of Williams-Beuren syndrome.	[Lazebnik, Maria B.; Roy, Ananda L.] Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Program Immunol, Boston, MA 02111 USA; [Tussie-Luna, Maria Isabel; Roy, Ananda L.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Roy, AL (corresponding author), Tufts Univ, Sch Med, Genet Program, 150 Harrison Ave, Boston, MA 02111 USA.	ananda.roy@tufts.edu		Tussie-Luna, Maria Isabel/0000-0002-5033-408X	NICHD NIH HHS [HD04603] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bayarsaihan D, 2003, GENE EXPR PATTERNS, V3, P579, DOI 10.1016/S1567-133X(03)00118-2; Bayarsaihan D, 2002, GENOMICS, V79, P137, DOI 10.1006/geno.2001.6674; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; BLACKWELL TK, 1995, METHOD ENZYMOL, V254, P604; Burge CB, 1999, RNA WORLD, P525; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; Chimge NO, 2007, J EXP ZOOL PART B, V308B, P209, DOI 10.1002/jez.b.21129; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Franke Y, 1999, CYTOGENET CELL GENET, V86, P296, DOI 10.1159/000015322; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Hakre S, 2006, MOL CELL, V24, P301, DOI 10.1016/j.molcel.2006.09.005; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hoppe R, 2003, GENOME RES, V13, P2674, DOI 10.1101/gr.1372203; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Manuel M, 2002, EUR J BIOCHEM, V269, P2527, DOI 10.1046/j.1432-1033.2002.02917.x; McWhirter JR, 1997, DEVELOPMENT, V124, P3221; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Osborne LR, 1999, GENOMICS, V57, P279, DOI 10.1006/geno.1999.5784; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Schug J, 2003, CURRENT PROTOCOLS BI; Steinberger D, 1998, HUM GENET, V102, P145, DOI 10.1007/s004390050668; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 1999, EUR J HUM GENET, V7, P737, DOI 10.1038/sj.ejhg.5200396; Tay ESE, 2003, BIOCHEM J, V374, P359, DOI 10.1042/BJ20030189; Tussie-Luna MI, 2001, P NATL ACAD SCI USA, V98, P7789, DOI 10.1073/pnas.141222298; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; Vullhorst D, 2003, J BIOL CHEM, V278, P8370, DOI 10.1074/jbc.M209361200; Yan XM, 2000, BIOCHEM J, V345, P749, DOI 10.1042/0264-6021:3450749	33	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11078	11082		10.1074/jbc.C800049200	http://dx.doi.org/10.1074/jbc.C800049200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18326499	Green Published, hybrid			2022-12-27	WOS:000255067400003
J	Kelly, RM; Leemhuis, H; Gatjen, L; Dijkhuizen, L				Kelly, Ronan M.; Leemhuis, Hans; Gatjen, Linda; Dijkhuizen, Lubbert			Evolution toward small molecule inhibitor resistance affects native enzyme function and stability, generating acarbose-insensitive cyclodextrin glucanotransferase variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC-RESISTANCE; DRUG-RESISTANCE; DIRECTED EVOLUTION; BIOLOGICAL COST; ALPHA-AMYLASE; FITNESS COST; COMPENSATORY EVOLUTION; STAPHYLOCOCCUS-AUREUS; AMINOGLYCOSIDE ACTION; PROTEASE INHIBITORS	Small molecule inhibitors play an essential role in the selective inhibition of enzymes associated with human infection and metabolic disorders. Targeted enzymes may evolve toward inhibitor resistance through selective incorporation of mutations. Acquisition of insensitivity may, however, result in profound devolution of native enzyme function and stability. We therefore investigated the consequential effects on native function and stability by evolving a cyclodextrin glucanotransferase (CGTase) enzyme toward insensitivity to the small molecule inhibitor of the protein, acarbose. Error-prone PCR mutagenesis was applied to search the sequence space of CGTase for acarbose-insensitive variants. Our results show that all selected mutations were localized around the active site of the enzyme, and in particular, at the acceptor substrate binding sites, highlighting the regions importance in acarbose inhibition. Single mutations conferring increased resistance, K232E, F283L, and A230V, raised IC50 values for acarbose between 3,500- and 6,700-fold when compared with wild-type CGTase but at a significant cost to catalytic efficiency. In addition, the thermostability of these variants was significantly lowered. These results reveal not only the relative ease by which resistance may be acquired to small molecule inhibitors but also the considerable cost incurred to native enzyme function and stability, highlighting the subsequent constraints in the further evolutionary potential of inhibitor-resistant variants.	[Kelly, Ronan M.; Leemhuis, Hans; Gatjen, Linda; Dijkhuizen, Lubbert] Univ Groningen, Ctr Carbohydrate Bioproc, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	University of Groningen	Dijkhuizen, L (corresponding author), Univ Groningen, Ctr Carbohydrate Bioproc, Groningen Biomol Sci & Biotechnol Inst, Kerklaan 30, NL-9751 NN Haren, Netherlands.	L.Dijkhuizen@rug.nl	Dijkhuizen, Lubbert/K-3539-2019; Dijkhuizen, Lubbert/E-9454-2014	Dijkhuizen, Lubbert/0000-0003-2312-7162; 				Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; DeLano W.L, PYMOL MOL GRAPHICS S; Doyon L, 1996, J VIROL, V70, P3763, DOI 10.1128/JVI.70.6.3763-3769.1996; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Fernandez A, 2005, J BIOMOL STRUCT DYN, V22, P615, DOI 10.1080/07391102.2005.10531228; Fisher TS, 2002, J VIROL, V76, P4068, DOI 10.1128/JVI.76.8.4068-4072.2002; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Galan JC, 2003, ANTIMICROB AGENTS CH, V47, P2551, DOI 10.1128/AAC.47.8.2551-2557.2003; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Gough K, 2002, EUR J PHYCOL, V37, P419, DOI 10.1017/S0967026202003797; Gupta ML, 2003, P NATL ACAD SCI USA, V100, P6394, DOI 10.1073/pnas.1131967100; Jana S, 2006, APPL MICROBIOL BIOT, V70, P140, DOI 10.1007/s00253-005-0279-0; Janecek S, 2003, EUR J BIOCHEM, V270, P635, DOI 10.1046/j.1432-1033.2003.03404.x; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kanai R, 2004, PROTEIN SCI, V13, P457, DOI 10.1110/ps.03408504; Kaper T, 2002, BIOCHEM J, V368, P461, DOI 10.1042/BJ20020726; Kawate H, 2002, J BIOL CHEM, V277, P36304, DOI 10.1074/jbc.M204956200; Kelly RM, 2007, BIOCHEMISTRY-US, V46, P11216, DOI 10.1021/bi701160h; Kikuchi M, 1999, GENE, V236, P159, DOI 10.1016/S0378-1119(99)00240-1; KNEGTEL RMK, 1995, J BIOL CHEM, V270, P29256, DOI 10.1074/jbc.270.49.29256; Leach KL, 2007, MOL CELL, V26, P393, DOI 10.1016/j.molcel.2007.04.005; Leemhuis H, 2004, BIOCHEMISTRY-US, V43, P13204, DOI 10.1021/bi049015q; Leemhuis H, 2004, PROTEINS, V54, P128, DOI 10.1002/prot.10516; Leemhuis H, 2003, BIOCATAL BIOTRANSFOR, V21, P261, DOI 10.1080/10242420310001614333; Leemhuis H, 2003, BIOCHEMISTRY-US, V42, P7518, DOI 10.1021/bi034439q; Leemhuis H, 2003, EUR J BIOCHEM, V270, P155, DOI 10.1046/j.1432-1033.2003.03376.x; Leemhuis H, 2002, FEBS LETT, V514, P189, DOI 10.1016/S0014-5793(02)02362-1; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Liu FL, 2005, J MOL BIOL, V354, P789, DOI 10.1016/j.jmb.2005.09.095; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Mahalingam B, 1999, EUR J BIOCHEM, V263, P238, DOI 10.1046/j.1432-1327.1999.00514.x; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Maisnier-Patin S, 2007, J MOL BIOL, V366, P207, DOI 10.1016/j.jmb.2006.11.047; Marciano DC, 2007, GENETICS, V176, P2381, DOI 10.1534/genetics.106.069443; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; NAKAMURA A, 1993, BIOCHEMISTRY-US, V32, P6624, DOI 10.1021/bi00077a015; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Paulander W, 2007, MOL MICROBIOL, V64, P1038, DOI 10.1111/j.1365-2958.2007.05713.x; Poole K, 2001, CURR OPIN MICROBIOL, V4, P500, DOI 10.1016/S1369-5274(00)00242-3; Sanchez IE, 2006, J MOL BIOL, V363, P422, DOI 10.1016/j.jmb.2006.08.020; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Uitdehaag JCM, 1999, J BIOL CHEM, V274, P34868, DOI 10.1074/jbc.274.49.34868; van der Kaaij RA, 2007, EUKARYOT CELL, V6, P1178, DOI 10.1128/EC.00354-06; van der Veen BA, 2000, J MOL BIOL, V296, P1027, DOI 10.1006/jmbi.2000.3528; van der Veen BA, 2001, J BIOL CHEM, V276, P44557, DOI 10.1074/jbc.M107533200; VIKMON M, 1982, RAPID SIMPLE SPECTRO, P69; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wehmeier UF, 2004, APPL MICROBIOL BIOT, V63, P613, DOI 10.1007/s00253-003-1477-2; Wichelhaus TA, 2002, ANTIMICROB AGENTS CH, V46, P3381, DOI 10.1128/AAC.46.11.3381-3385.2002; Wicki J, 2007, J AM CHEM SOC, V129, P4530, DOI 10.1021/ja0707254; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Yin PD, 2006, CELL MOL LIFE SCI, V63, P1706, DOI 10.1007/s00018-006-6009-7	60	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10727	10734		10.1074/jbc.M709287200	http://dx.doi.org/10.1074/jbc.M709287200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18283101	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000254894700055
J	Kostka, M; Hogen, T; Danzer, KM; Levin, J; Habeck, M; Wirth, A; Wagner, R; Glabe, CG; Finger, S; Heinzelmann, U; Garidel, P; Duan, W; Ross, CA; Kretzschmar, H; Giese, A				Kostka, Marcus; Hoegen, Tobias; Danzer, Karin M.; Levin, Johannes; Habeck, Matthias; Wirth, Andreas; Wagner, Richard; Glabe, Charles G.; Finger, Sabine; Heinzelmann, Udo; Garidel, Patrick; Duan, Wenzhen; Ross, Christopher A.; Kretzschmar, Hans; Giese, Armin			Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTENSELY FLUORESCENT TARGETS; PROTEIN MISFOLDING DISEASES; SOLUBLE AMYLOID OLIGOMERS; PARKINSONS-DISEASE; COMMON MECHANISM; PRION PROTEIN; METAL-IONS; NEURODEGENERATIVE DISEASES; VESICLE PERMEABILIZATION; TRANSGENIC MICE	Aggregation of alpha-synuclein is a key event in several neurodegenerative diseases, including Parkinson disease. Recent findings suggest that oligomers represent the principal toxic aggregate species. Using confocal single-molecule fluorescence techniques, such as scanning for intensely fluorescent targets (SIFT) and atomic force microscopy, we monitored alpha-synuclein oligomer formation at the single particle level. Organic solvents were used to trigger aggregation, which resulted in small oligomers ("intermediate I"). Under these conditions, Fe3+ at low micromolar concentrations dramatically increased aggregation and induced formation of larger oligomers ("intermediate II"). Both oligomer species were on-pathway to amyloid fibrils and could seed amyloid formation. Notably, only Fe3+-induced oligomers were SDS-resistant and could form ion-permeable pores in a planar lipid bilayer, which were inhibited by the oligomer-specific A11 antibody. Moreover, baicalein and N'-benzylidenebenzohydrazide derivatives inhibited oligomer formation. Baicalein also inhibited alpha-synuclein-dependent toxicity in neuronal cells. Our results may provide a potential disease mechanism regarding the role of ferric iron and of toxic oligomer species in Parkinson diseases. Moreover, scanning for intensely fluorescent targets allows high throughput screening for aggregation inhibitors and may provide new approaches for drug development and therapy.	[Kostka, Marcus; Danzer, Karin M.; Finger, Sabine; Heinzelmann, Udo; Garidel, Patrick] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, D-88397 Biberach, Germany; [Hoegen, Tobias; Habeck, Matthias; Kretzschmar, Hans; Giese, Armin] Univ Munich, Zentrum Neuropathol & Prionforsch, D-81377 Munich, Germany; [Levin, Johannes] Univ Munich, Klinikum Grosshadern, Neurol Klin, D-81377 Munich, Germany; [Wirth, Andreas] Ionovat GmbH, D-49084 Osnabruck, Germany; [Wagner, Richard] Univ Osnabruck, Dept Biophys, D-49078 Osnabruck, Germany; [Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Duan, Wenzhen; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA	Boehringer Ingelheim; University of Munich; University of Munich; University Osnabruck; University of California System; University of California Irvine; Johns Hopkins University	Kostka, M (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Birkendorferstr 65, D-88397 Biberach, Germany.	Marcus.Kostka@boehringer-ingelheim.com; Armin.Giese@med.uni-muenchen.de	Giese, Armin/F-3271-2010; Ross, Christopher A/H-8395-2013; Levin, Johannes/E-4052-2010	Giese, Armin/0000-0002-8238-4102; Levin, Johannes/0000-0001-5092-4306	NINDS NIH HHS [R21 NS055971] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Ben Shachar D, 2004, NEUROPHARMACOLOGY, V46, P254, DOI 10.1016/j.neuropharm.2003.09.005; BENSHACHAR D, 1991, J NEUROCHEM, V56, P1441, DOI 10.1111/j.1471-4159.1991.tb11444.x; Berg D, 2007, NEUROCHEM RES, V32, P1646, DOI 10.1007/s11064-007-9346-5; Bertsch U, 2005, J VIROL, V79, P7785, DOI 10.1128/JVI.79.12.7785-7791.2005; Bieschke J, 2000, P NATL ACAD SCI USA, V97, P5468, DOI 10.1073/pnas.97.10.5468; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; COLTON RJ, 1997, PROCEDURES SCANNING; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Forman MS, 2005, NEURON, V47, P479, DOI 10.1016/j.neuron.2005.07.021; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; Giese A, 2005, BIOCHEM BIOPH RES CO, V333, P1202, DOI 10.1016/j.bbrc.2005.06.025; Giese A, 2004, BIOCHEM BIOPH RES CO, V320, P1240, DOI 10.1016/j.bbrc.2004.06.075; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Hasegawa T, 2004, BRAIN RES, V1013, P51, DOI 10.1016/j.brainres.2004.04.018; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kaur D, 2007, NEUROBIOL AGING, V28, P907, DOI 10.1016/j.neurobiolaging.2006.04.003; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Levin J, 2005, BIOCHEM BIOPH RES CO, V329, P1200, DOI 10.1016/j.bbrc.2005.02.094; Luibl V, 2006, J CLIN INVEST, V116, P378, DOI 10.1172/JCI25843; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Michaeli S, 2007, MOVEMENT DISORD, V22, P334, DOI 10.1002/mds.21227; Munishkina LA, 2003, BIOCHEMISTRY-US, V42, P2720, DOI 10.1021/bi027166s; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; Obata T, 2006, EUR J PHARMACOL, V539, P34, DOI 10.1016/j.ejphar.2006.03.071; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Schiffer NW, 2007, J BIOL CHEM, V282, P9195, DOI 10.1074/jbc.M607865200; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tofaris GK, 2007, ARCH NEUROL-CHICAGO, V64, P280, DOI 10.1001/archneur.64.2.280; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; WOODBURY DJ, 1988, BIOPHYS J, V54, P345, DOI 10.1016/S0006-3495(88)82965-5; Youdim MBH, 2004, ANN NY ACAD SCI, V1012, P306, DOI 10.1196/annals.1306.025; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; ZAYED J, 1990, CAN J NEUROL SCI, V17, P286, DOI 10.1017/S0317167100030584; Zhang X, 2005, BIOCHEM BIOPH RES CO, V333, P544, DOI 10.1016/j.bbrc.2005.05.150; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	64	189	198	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10992	11003		10.1074/jbc.M709634200	http://dx.doi.org/10.1074/jbc.M709634200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18258594	hybrid			2022-12-27	WOS:000254894700080
J	Dultz, E; Hildenbeutel, M; Martoglio, B; Hochman, J; Dobberstein, B; Kapp, K				Dultz, Elisa; Hildenbeutel, Markus; Martoglio, Bruno; Hochman, Jacob; Dobberstein, Bernhard; Kapp, Katja			The signal peptide of the mouse mammary tumor virus Rem protein is released from the endoplasmic reticulum membrane and accumulates in nucleoli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARENAVIRUS ENVELOPE GLYCOPROTEIN; T-CELL LYMPHOMAS; CORE PROTEIN; INTRAMEMBRANE PROTEOLYSIS; CLEAVAGE; B23; IDENTIFICATION; TRANSLOCATION; SEQUENCE; COMPLEX	N-terminal signal sequences mediate endoplasmic reticulum (ER) targeting and insertion of nascent secretory and membrane proteins and are, in most cases, cleaved off by signal peptidase. The mouse mammary tumor virus envelope protein and its alternative splice variant Rem have an unusually long signal sequence, which contains a nuclear localization signal. Although the envelope protein is targeted to the ER, inserted, and glycosylated, Rem has been described as a nuclear protein. Rem as well as a truncated version identical to the cleaved signal sequence have been shown to function as nuclear export factors for intron-containing transcripts. Using transiently transfected cells, we found that Rem is targeted to the ER, where the C-terminal portion is translocated and glycosylated. The signal sequence is cleaved off and accumulates in nucleoli. In a cell-free in vitro system, the generation of the Rem signal peptide depends on the presence of microsomal membranes. In vitro and in cells, the signal peptide initially accumulates in the membrane and is subsequently released into the cytosol. This release does not depend on processing by signal peptide peptidase, an intramembrane cleaving protease that can mediate the liberation of signal peptide fragments from the ER membrane. Our study suggests a novel pathway by which a signal peptide can be released from the ER membrane to fulfill a post-targeting function in a different compartment.	[Dultz, Elisa; Hildenbeutel, Markus; Dobberstein, Bernhard; Kapp, Katja] Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Martoglio, Bruno] Nova Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Hochman, Jacob] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel	Ruprecht Karls University Heidelberg; Novartis; Hebrew University of Jerusalem	Kapp, K (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany.	k.kapp@zmbh.uni-heidelberg.de	Dultz, Elisa/AAQ-1918-2021	Dultz, Elisa/0000-0003-1114-5523				Agnihothram SS, 2006, J VIROL, V80, P5189, DOI 10.1128/JVI.00208-06; Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Bar-Sinai A, 2005, CANCER RES, V65, P7223, DOI 10.1158/0008-5472.CAN-04-3879; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DICKSON C, 1980, J VIROL, V35, P349, DOI 10.1128/JVI.35.2.349-361.1980; EATON DL, 1986, BIOCHEMISTRY-US, V25, P8343, DOI 10.1021/bi00374a001; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eichler R, 2003, FEBS LETT, V538, P203, DOI 10.1016/S0014-5793(03)00160-1; Fineberg K, 2003, BIOCHEMISTRY-US, V42, P2625, DOI 10.1021/bi0206199; Froeschke M, 2003, J BIOL CHEM, V278, P41914, DOI 10.1074/jbc.M302343200; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hoch-Marchaim H, 1998, VIROLOGY, V242, P246, DOI 10.1006/viro.1997.8997; Hoch-Marchaim H, 2003, VIROLOGY, V313, P22, DOI 10.1016/S0042-6822(03)00236-8; Indik S, 2005, VIROLOGY, V337, P1, DOI 10.1016/j.virol.2005.03.040; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; LOWER R, 1995, J VIROL, V69, P141; LYKO F, 1995, J BIOL CHEM, V270, P19873, DOI 10.1074/jbc.270.34.19873; MACKALL J, 1979, ANAL BIOCHEM, V95, P270, DOI 10.1016/0003-2697(79)90216-1; Majeau N, 2005, J GEN VIROL, V86, P3055, DOI 10.1099/vir.0.81174-0; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mertz JA, 2005, J VIROL, V79, P14737, DOI 10.1128/JVI.79.23.14737-14747.2005; MICHALIDES R, 1982, J VIROL, V43, P819, DOI 10.1128/JVI.43.3.819-829.1982; RACEVSKIS J, 1982, J VIROL, V42, P804, DOI 10.1128/JVI.42.3.804-813.1982; REDMOND SMS, 1983, EMBO J, V2, P125, DOI 10.1002/j.1460-2075.1983.tb01393.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schrempf S, 2007, J VIROL, V81, P12515, DOI 10.1128/JVI.01481-07; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Szebeni A, 1999, PROTEIN SCI, V8, P905; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vauloup-Fellous C, 2006, J BIOL CHEM, V281, P27679, DOI 10.1074/jbc.M602587200; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06	41	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9966	9976		10.1074/jbc.M705712200	http://dx.doi.org/10.1074/jbc.M705712200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18270201	hybrid			2022-12-27	WOS:000254671600053
J	Kim, K; Choi, J; Heo, K; Kim, H; Levens, D; Kohno, K; Johnson, EM; Brock, HW; An, W				Kim, Kyunghwan; Choi, Jongkyu; Heo, Kyu; Kim, Hyunjung; Levens, David; Kohno, Kimitoshi; Johnson, Edward M.; Brock, Hugh W.; An, Woojin			Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKER HISTONE FUNCTION; GENE-EXPRESSION; IN-VIVO; PUR-ALPHA; CHROMATIN-STRUCTURE; DNA-BINDING; POLY(ADP-RIBOSE) POLYMERASE; NUCLEOSOME; PROTEIN; P53	Linker histone H1 has been generally viewed as a global repressor of transcription by preventing the access of transcription factors to sites in chromatin. However, recent studies suggest that H1 can interact with other regulatory factors for its action as a negative modulator of specific genes. To investigate these aspects, we established a human cell line expressing H1.2, one of the H1 subtypes, for the purification of H1-interacting proteins. Our results showed that H1.2 can stably associate with sets of cofactors and ribosomal proteins that can significantly repress p53-dependent, p300-mediated chromatin transcription. This repressive action of H1.2 complex involves direct interaction of H1.2 with p53, which in turn blocks p300-mediated acetylation of chromatin. YB1 and PUR alpha, two factors present in the H1.2 complex, together with H1.2 can closely recapitulate the repressive action of the entire H1.2 complex in transcription. Chromatin immunoprecipitation and RNA interference analyses further confirmed that the recruitment of YB1, PUR alpha, and H1.2 to the p53 target gene Bax is required for repression of p53-induced transcription. Therefore, these results reveal a previously unrecognized function of H1 as a transcriptional repressor as well as the underlying mechanism involving specific sets of factors in this repression process.	[Kim, Kyunghwan; Choi, Jongkyu; Heo, Kyu; Kim, Hyunjung; An, Woojin] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Levens, David] NCI, NIH, Pathol Lab, Bethesda, MD 20892 USA; [Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Dept Mol Biol, Fukuoka 8078555, Japan; [Johnson, Edward M.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Brock, Hugh W.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z3, Canada	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Occupational & Environmental Health - Japan; Eastern Virginia Medical School; University of British Columbia	An, W (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	woojinan@usc.edu	Levens, David/C-9216-2009	Levens, David/0000-0002-7616-922X; Heo, Kyu/0000-0001-8833-4731	NATIONAL CANCER INSTITUTE [Z01SC009144, ZIASC009144] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2004, METHOD ENZYMOL, V377, P460; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Angelov D, 2006, EMBO J, V25, P1669, DOI 10.1038/sj.emboj.7601046; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Barr SM, 2001, J CELL BIOCHEM, V81, P621, DOI 10.1002/jcb.1099; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Bauerle M, 2002, J BIOL CHEM, V277, P32480, DOI 10.1074/jbc.M202765200; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniel DC, 2004, DNA CELL BIOL, V23, P858, DOI 10.1089/1044549042729577; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; de Oca ROM, 2005, J BIOL CHEM, V280, P42252, DOI 10.1074/jbc.M509917200; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Georgel PT, 2001, BIOCHEM CELL BIOL, V79, P313, DOI 10.1139/bcb-79-3-313; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Heo K, 2007, J BIOL CHEM, V282, P15476, DOI 10.1074/jbc.M610270200; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Huang JY, 2006, NUCLEIC ACIDS RES, V34, P2398, DOI 10.1093/nar/gkl241; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Khochbin S, 2001, GENE, V271, P1, DOI 10.1016/S0378-1119(01)00495-4; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Knapp AM, 2006, J BIOL CHEM, V281, P7907, DOI 10.1074/jbc.M509682200; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lasham A, 2000, GENE, V252, P1, DOI 10.1016/S0378-1119(00)00220-1; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Li BM, 2004, J BIOL CHEM, V279, P13659, DOI 10.1074/jbc.M311606200; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Meergans T, 1998, EUR J BIOCHEM, V256, P436, DOI 10.1046/j.1432-1327.1998.2560436.x; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Paulson JR, 1996, J CELL SCI, V109, P1437; Ponte I, 2003, MOL BIOL EVOL, V20, P371, DOI 10.1093/molbev/msg041; Safak R, 1999, MOL CELL BIOL, V19, P2712; Samuel S, 2005, BIOCHEM J, V388, P921, DOI 10.1042/BJ20041497; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; van Holde K.E., 1988, CHROMATIN; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Wesierska-Gadek J, 2000, J CELL BIOCHEM, V80, P85; Widlak P, 2005, BIOCHEMISTRY-US, V44, P7871, DOI 10.1021/bi050100n; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	60	87	90	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9113	9126		10.1074/jbc.M708205200	http://dx.doi.org/10.1074/jbc.M708205200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18258596	Green Published, hybrid			2022-12-27	WOS:000254465800041
J	Arias-Moreno, X; Arolas, JL; Aviles, FX; Sancho, J; Ventura, S				Arias-Moreno, Xabier; Arolas, Joan L.; Aviles, Francesc X.; Sancho, Javier; Ventura, Salvador			Scrambled isomers as key intermediates in the oxidative folding of ligand binding module 5 of the low density lipoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS; CYSTEINE-RICH REPEAT; LDL-A MODULE; DISULFIDE-BOND; 3-DIMENSIONAL STRUCTURE; MOLECULAR-BASIS; PROTEINS; CALCIUM; MECHANISM; DETERMINANTS	The ligand binding module five (LA5) of the low density lipoprotein receptor is a small, single-domain protein of 40 residues and three disulfide bonds with a calcium binding motif that is essential for its structure and function. Several mutations in LA5 have been reported to cause familial hypercholesterolemia by impairing a proper folding of the module. The current study reports the oxidative folding and reductive unfolding pathways of wild type and mutant LA5 modules through kinetic and structural analysis of the trapped intermediates. Wild type LA5 folding involves an initial phase of nonspecific packing where the sequential oxidation of its cysteines gives rise to complex equilibrated populations of intermediates. In the presence of calcium, the attainment of a coordination-competent conformation becomes the rate-limiting step of folding while binding of the ion funnels both thermodynamically and kinetically the folding reaction toward the native state. In the absence of calcium, a scrambled isomer (termed Xa) constitutes the global free energy minimum of the folding process. Xa and the native form are stable, inter-convertible species whose relative populations at equilibrium appear displaced in disease-linked mutants toward the scrambled form. Because stable scrambled isomers such as Xa avoid the exposition of reactive cysteines in misfolded modules, they might constitute a strategy to prevent wrong interactions with other domains during folding of the receptor. Comparison of the folding pathways of wild type and mutant LA5 provides the molecular basis to understand how LA modules fold into a functional conformation or upon mutation misfold and lead to disease.	[Arolas, Joan L.; Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, E-08193 Barcelona, Spain; [Arolas, Joan L.; Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Zaragoza; University of Zaragoza	Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotechnol & Biomed, E-08193 Barcelona, Spain.	Salvador.Ventura@uab.es	MORENO, XABIER ARIAS/AAA-1176-2021; Sancho, javier/AAA-1225-2019; Ventura, Salvador/AAY-3170-2021; Aviles, Francesc Xavier/F-3482-2019; Ventura, Salvador/C-7021-2008; Avilés, Francesc Xavier/A-2664-2015	MORENO, XABIER ARIAS/0000-0001-8601-9092; Sancho, javier/0000-0002-2879-9200; Ventura, Salvador/0000-0002-9652-6351; Aviles, Francesc Xavier/0000-0002-1399-6789; Ventura, Salvador/0000-0002-9652-6351; Avilés, Francesc Xavier/0000-0002-1399-6789; Lopez Arolas, Joan/0000-0002-4198-5016				Abdul-Aziz D, 2005, BIOCHEMISTRY-US, V44, P5075, DOI 10.1021/bi047575j; Arolas JL, 2006, J BIOL CHEM, V281, P22906, DOI 10.1074/jbc.M602301200; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Chang JY, 2008, ANTIOXID REDOX SIGN, V10, P171, DOI 10.1089/ars.2007.1873; Chang JY, 2000, J BIOL CHEM, V275, P8287, DOI 10.1074/jbc.275.12.8287; Chang JY, 1997, J BIOL CHEM, V272, P69; Creighton TE, 1997, BIOL CHEM, V378, P731; Cuesta-Lopez S, 2007, PROTEINS, V66, P87, DOI 10.1002/prot.21181; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; English BP, 2002, J AM CHEM SOC, V124, P4995, DOI 10.1021/ja012634r; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Guo Y, 2004, J BIOL CHEM, V279, P16629, DOI 10.1074/jbc.M400157200; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Iwaoka M, 1998, BIOCHEMISTRY-US, V37, P4490, DOI 10.1021/bi9725327; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Lu BY, 2005, BIOCHEMISTRY-US, V44, P15032, DOI 10.1021/bi051399c; North CL, 2000, BIOCHEMISTRY-US, V39, P13127, DOI 10.1021/bi0015156; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Singh RR, 2004, BIOCHEM J, V377, P685, DOI 10.1042/BJ20030968; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798	38	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13627	13637		10.1074/jbc.M800755200	http://dx.doi.org/10.1074/jbc.M800755200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343813	hybrid			2022-12-27	WOS:000255728200015
J	Wang, XH; Urvalek, AM; Liu, JS; Zhao, JH				Wang, Xianhui; Urvalek, Alison M.; Liu, Jinsong; Zhao, Jihe			Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-8; GENE-EXPRESSION; ONCOGENIC TRANSFORMATION; CYCLE PROGRESSION; RECEPTOR GENE; GROWTH-FACTOR; SP1; FAK; INVASION; PROTEIN	KLF8 (Kruppel-like factor 8) is a transcription factor downstream of focal adhesion kinase (FAK) important in the regulation of the cell cycle and also plays a critical role in oncogenic transformation and epithelial to mesenchymal transition. Here we report the mechanisms by which FAK regulates KLF8 expression in human ovarian epithelial and cancer cells. We show that the overexpression of both KLF8 and FAK in the human ovarian cancer cells as compared with the normal human ovarian surface epithelial cells is critical for cell growth. Using promoter luciferase reporter assays, we demonstrate that exogenous FAK strongly promotes the activity of the KLF8 promoter, and knockdown of FAK inhibits it. KLF8 promoter activity and mRNA levels are induced by expression of constitutively active (CA) phosphatidylinositol 3-kinase (PI3K) or CA-Akt but are repressed by dominant negative Akt or the PI3K inhibitor LY294002. Disruption of an Sp1 binding site in the KLF8 promoter abolishes the FAK- or Sp1-mediated promoter activation. Sp1 knockdown prevents the KLF8 promoter from being activated by Sp1 or CA-Akt, and expression of CA-Akt enhances Sp1 expression in SKOV3ip1 cells. Chromatin immunoprecipitation and oligonucleotide precipitation results show that Sp1 binds to the KLF8 promoter. Taken together, our data suggest that FAK induces KLF8 expression in human ovarian cancer cells by activating the PI3K-Akt signaling pathway, leading to the activation of KLF8 promoter by Sp1.	[Wang, Xianhui; Urvalek, Alison M.; Zhao, Jihe] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Albany Medical College; University of Texas System; UTMD Anderson Cancer Center	Zhao, JH (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MS338,47 New Scotland Ave,MC-165, Albany, NY 12208 USA.	zhaojh@mail.amc.edu			NATIONAL CANCER INSTITUTE [R01CA131183, P50CA083639] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA083639, R01 CA131183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allgayer H, 1999, J BIOL CHEM, V274, P18428, DOI 10.1074/jbc.274.26.18428; Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Bennudez Y, 2007, GYNECOL ONCOL, V106, P526, DOI 10.1016/j.ygyno.2007.05.005; Bilsland AE, 2006, CANCER RES, V66, P1363, DOI 10.1158/0008-5472.CAN-05-1941; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Buczek-Thomas JA, 1998, CELL SIGNAL, V10, P55, DOI 10.1016/S0898-6568(97)00074-0; Chen CS, 2004, GENE, V330, P133, DOI 10.1016/j.gene.2004.01.014; Cheng JQ, 2002, DRUG RESIST UPDATE, V5, P131, DOI 10.1016/S1368-7646(02)00003-1; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Judson PL, 1999, CANCER, V86, P1551, DOI 10.1002/(SICI)1097-0142(19991015)86:6<1551::AID-CNCR23>3.0.CO;2-P; Kruk PA, 1999, GYNECOL ONCOL, V73, P229, DOI 10.1006/gyno.1999.5348; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Maor S, 2007, HORM METAB RES, V39, P179, DOI 10.1055/s-2007-970415; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Mitra SK, 2006, ONCOGENE, V25, P4429, DOI 10.1038/sj.onc.1209482; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHILDER RJ, 1990, INT J CANCER, V45, P416, DOI 10.1002/ijc.2910450306; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tomassetti A, 2003, CANCER RES, V63, P696; van Nimwegen MJ, 2005, CANCER RES, V65, P4698, DOI 10.1158/0008-5472.CAN-04-4126; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Volberg T, 2001, J CELL SCI, V114, P2279; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; YU DH, 1993, CANCER RES, V53, P891; Zhao JH, 2000, J CELL SCI, V113, P3063; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	50	69	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13934	13942		10.1074/jbc.M709300200	http://dx.doi.org/10.1074/jbc.M709300200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353772	hybrid			2022-12-27	WOS:000255728200047
J	Lemaire, S; Fuda, C; Van Bambeke, F; Tulkens, PM; Mobashery, S				Lemaire, Sandrine; Fuda, Cosimo; Van Bambeke, Francoise; Tulkens, Paul M.; Mobashery, Shahriar			Restoration of susceptibility of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics by acidic pH - Role of penicillin-binding protein PBP 2a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; INTRACELLULAR ACTIVITIES; VANCOMYCIN-INTERMEDIATE; THP-1 MACROPHAGES; MECHANISTIC BASIS; PREVALENCE; MRSA; IDENTIFICATION; PATHOGEN; ANIMALS	Methicillin-resistant Staphylococcus aureus (MRSA) is a global scourge, and treatment options are becoming limited. The MRSA phenotype reverts to that of beta-lactam-sensitive S. aureus when bacteria are grown at pH 5.0 in broth and, more importantly from a medical perspective (protracted, relapsing infections), after phagocytosis by macrophages, where the bacteria thrive in the acidic environment of phagolysosomes. The central factor for the MRSA phenotype is the function of the penicillin-binding protein (PBP) 2a, which maintains transpeptidase activity while being poorly inhibited by beta-lactams because of a closed conformation of its active site. We document herein by binding, acylation/deacylation kinetics, and circular dichroism spectroscopy with purified PBP 2a that at acidic pH (i) beta-lactams interact with PBP 2a more avidly; (ii) the non-covalent pre-acylation complex exhibits a lower dissociation constant and an increased rate of acyl-enzyme formation (first-order rate constant) without change in hydrolytic deacylation rate; and (iii) PBP 2a undergoes a conformational change in the presence of the antibiotic consistent with the opening of the active site from the closed conformation. These observations argue that PBP 2a most likely evolved for its physiological function at pH 7 or higher by adopting a closed conformation, which is not maintained at acidic pH. Although at the organism level the effect of acidic pH on other biological processes in MRSA could not be discounted, our report should provide the impetus for closer examination of the properties of PBP 2a at low pH and thereby identifying novel points of intervention in combating this problematic organism.	[Lemaire, Sandrine; Van Bambeke, Francoise; Tulkens, Paul M.] Catholic Univ Louvain, Unite Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium; [Fuda, Cosimo; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Universite Catholique Louvain; University of Notre Dame	Lemaire, S (corresponding author), Catholic Univ Louvain, Unite Pharmacol Cellulaire & Mol, 73-70 Ave E Mounier 73, B-1200 Brussels, Belgium.	sandrine.lemaire@facm.ucl.ac.be	Van Bambeke, Françoise/H-5934-2019; Tulkens, Paul/B-2087-2015	Van Bambeke, Françoise/0000-0002-0052-7991; Tulkens, Paul/0000-0002-7121-3623	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061629] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33170] Funding Source: Medline; NIGMS NIH HHS [GM61629] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Barcia-Macay M, 2006, ANTIMICROB AGENTS CH, V50, P841, DOI 10.1128/AAC.50.3.841-851.2006; Barcia-Macay M, 2006, J ANTIMICROB CHEMOTH, V58, P1177, DOI 10.1093/jac/dkl424; Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; BERGERBACHI B, 1986, EUR J CLIN MICROBIOL, V5, P697, DOI 10.1007/BF02013308; CHAMBERS HF, 1992, ANTIMICROB AGENTS CH, V36, P656, DOI 10.1128/AAC.36.3.656; Davies TA, 2007, ANTIMICROB AGENTS CH, V51, P2621, DOI 10.1128/AAC.00029-07; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; File Jr TM, 2007, CLEV CLIN J MED, V74, P6, DOI [DOI 10.3949/CCJM.74.SUPPL_4.S6, 10.3949/ccjm.74.Suppl_4.S6]; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fuda C, 2006, J BIOL CHEM, V281, P10035, DOI 10.1074/jbc.M508846200; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; GEORGOPAPADAKOU NH, 1982, ANTIMICROB AGENTS CH, V22, P172, DOI 10.1128/AAC.22.1.172; Gould IM, 2006, INT J ANTIMICROB AG, V28, P379, DOI 10.1016/j.ijantimicag.2006.09.001; Guignard B, 2005, CURR OPIN PHARMACOL, V5, P479, DOI 10.1016/j.coph.2005.06.002; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lee JH, 2003, APPL ENVIRON MICROB, V69, P6489, DOI 10.1128/AEM.69.11.6489-6494.2003; Lemaire S, 2007, ANTIMICROB AGENTS CH, V51, P1627, DOI 10.1128/AAC.01192-06; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Loveland-Cherry CJ, 2006, J FAM NURS, V12, P4, DOI 10.1177/1074840705285209; Lovering AL, 2006, PROTEIN SCI, V15, P1701, DOI 10.1110/ps.062112106; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Macheboeuf P, 2007, NAT CHEM BIOL, V3, P565, DOI 10.1038/nchembio.2007.21; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; MOELLERING RC, 2007, PRINCIPLES PRACTICE; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Normanno G, 2007, INT J FOOD MICROBIOL, V117, P219, DOI 10.1016/j.ijfoodmicro.2007.04.006; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Page MGP, 2007, EXPERT OPIN EMERG DR, V12, P511, DOI 10.1517/14728214.12.4.511; Pantosti A, 2007, FUTURE MICROBIOL, V2, P323, DOI 10.2217/17460913.2.3.323; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; PRESTON DA, 1990, ANTIMICROB AGENTS CH, V34, P718, DOI 10.1128/AAC.34.5.718; SABATH LD, 1972, ANTIMICROB AGENTS CH, V22, P350, DOI 10.1128/AAC.2.5.350; Weese JS, 2005, J AM ANIM HOSP ASSOC, V41, P150, DOI 10.5326/0410150; Wijaya L, 2006, ANN ACAD MED SINGAP, V35, P479; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	45	30	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12769	12776		10.1074/jbc.M800079200	http://dx.doi.org/10.1074/jbc.M800079200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337244	hybrid, Green Published			2022-12-27	WOS:000255499800013
J	Mao, C; Patterson, NM; Cherian, MT; Aninye, IO; Zhang, C; Montoya, JB; Cheng, J; Putt, KS; Hergenrother, PJ; Wilson, EM; Nardulli, AM; Nordeen, SK; Shapiro, DJ				Mao, Chengjian; Patterson, Nicole M.; Cherian, Milu T.; Aninye, Irene O.; Zhang, Chen; Montoya, Jamie Boney; Cheng, Jingwei; Putt, Karson S.; Hergenrother, Paul J.; Wilson, Elizabeth M.; Nardulli, Ann M.; Nordeen, Steven K.; Shapiro, David J.			A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; PROTEIN INTERACTIONS; ANDROGEN RECEPTOR; ENDOCRINE THERAPY; TARGET GENE; DNA-BINDING; IN-VIVO; EXPRESSION; MECHANISMS; PROTEINASE-INHIBITOR-9	Estrogen receptor alpha(ER alpha) plays an important role in several human cancers. Most current ER alpha antagonists bind in the receptor ligand binding pocket and compete for binding with estrogenic ligands. Instead of the traditional approach of targeting estrogen binding to ER, we describe a strategy using a high throughput fluorescence anisotropy microplate assay to identify small molecule inhibitors of ER alpha binding to consensus estrogen response element (cERE) DNA. We identified small molecule inhibitors of ER alpha binding to the fluorescein-labeled (fl)cERE and evaluated their specificity, potency, and efficacy. One small molecule, theophylline, 8-[(benzylthio) methyl]-(7CI, 8CI) (TPBM), inhibited ER alpha binding to the flcERE (IC50 similar to 3 mu M) and inhibited ER alpha-mediated transcription of a stably transfected ERE-containing reporter gene. Inhibition by TPBM was ER-specific, because progesterone and glucocorticoid receptor transcriptional activity were not significantly inhibited. In tamoxifen resistant breast cancer cells that overexpress ER alpha, TPBM inhibited 17 beta-estradiol (E-2)-ER alpha (IC50 9 mu M) and 4-hydroxytamoxifen ER alpha-mediated gene expression. Chromatin immunoprecipitation showed TPBM reduced E-2.ER alpha recruitment to an endogenous estrogen-responsive gene. TPBM inhibited E-2-dependent growth of ER alpha-positive cancer cells (IC50 of 5 mu M). TPBM is not toxic to cells and does not affect estrogen-independent cell growth. TPBM acts outside of the ER ligand binding pocket, does not act by chelating the zinc in ER zinc fingers, and differs from known ER alpha inhibitors. Using a simple high throughput screen for inhibitors of ER alpha binding to the cERE, a small molecule inhibitor has been identified that selectively inhibits ER alpha-mediated gene expression and estrogen-dependent growth of cancer cells.	[Mao, Chengjian; Patterson, Nicole M.; Zhang, Chen; Cheng, Jingwei; Shapiro, David J.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cherian, Milu T.; Aninye, Irene O.; Montoya, Jamie Boney; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Putt, Karson S.; Hergenrother, Paul J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	djshapir@uiuc.edu	Zhang, Chen/K-3978-2014	Aninye, Irene/0000-0002-1747-9148	NICHD NIH HHS [HD16910] Funding Source: Medline; NIDDK NIH HHS [R01 DK053884-11, R01 DK053884, R01 DK-071909, R01 DK 53884, R01 DK071909] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909, R01DK053884] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Baldwin WS, 1998, IN VITRO CELL DEV-AN, V34, P649; BOCCARDO F, 2004, CLIN BREAST CANC  S1, V1, P13; Boonyaratanakornkit V, 2004, ESSAYS BIOCHEM, V40, P105, DOI 10.1042/bse0400105; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cheng JW, 2007, J BIOL CHEM, V282, P30535, DOI 10.1074/jbc.M704829200; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cunningham TD, 2007, CELL IMMUNOL, V245, P32, DOI 10.1016/j.cellimm.2007.03.004; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; DIETZ AJ, 1966, J MED CHEM, V9, P500, DOI 10.1021/jm00322a013; DIETZ AJ, 1966, J MED CHEM, V9, P160, DOI 10.1021/jm00319a044; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gradishar WJ, 2006, JAMA-J AM MED ASSOC, V295, P2784, DOI 10.1001/jama.295.23.jed60037; Hergenrother PJ, 2006, CURR OPIN CHEM BIOL, V10, P213, DOI 10.1016/j.cbpa.2006.04.005; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Jiang XG, 2006, ENDOCRINOLOGY, V147, P1419, DOI 10.1210/en.2005-0996; Jordan VC, 2001, ANN NY ACAD SCI, V949, P72; Katzenellenbogen BS, 2000, J SOC GYNECOL INVEST, V7, pS33, DOI 10.1177/1071557600007001S10; Katzenellenbogen BS, 1997, BREAST CANCER RES TR, V44, P23, DOI 10.1023/A:1005835428423; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Krieg SA, 2001, MOL ENDOCRINOL, V15, P1971, DOI 10.1210/me.15.11.1971; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Mao CJ, 2006, ANAL BIOCHEM, V350, P222, DOI 10.1016/j.ab.2005.12.010; Mattick S, 1997, J STEROID BIOCHEM, V60, P285, DOI 10.1016/S0960-0760(96)00198-7; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Melvin VS, 2001, METH MOL B, V176, P39; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Pandey Kaushal Raj, 2007, BMJ, V334, P925, DOI 10.1136/bmj.39202.548588.DB; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Rishi V, 2005, ANAL BIOCHEM, V340, P259, DOI 10.1016/j.ab.2005.02.012; Schultz-Norton JR, 2007, MOL ENDOCRINOL, V21, P1569, DOI 10.1210/me.2006-0519; Schultz-Norton JR, 2006, MOL ENDOCRINOL, V20, P1982, DOI 10.1210/me.2006-0006; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; ten Berge RL, 2002, BLOOD, V99, P4540, DOI 10.1182/blood.V99.12.4540; van Houdt IS, 2005, CLIN CANCER RES, V11, P6400, DOI 10.1158/1078-0432.CCR-05-0306; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Wang LH, 2004, NAT MED, V10, P40, DOI 10.1038/nm969; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; Wang S, 2007, J BIOL CHEM, V282, P2765, DOI 10.1074/jbc.M607531200; Wang SY, 2004, BIOTECHNIQUES, V37, P807, DOI 10.2144/04375RR01; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Winer EP, 2005, J CLIN ONCOL, V23, P1609, DOI 10.1200/JCO.2005.01.005; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	60	46	49	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12819	12830		10.1074/jbc.M709936200	http://dx.doi.org/10.1074/jbc.M709936200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337247	Green Published, hybrid			2022-12-27	WOS:000255499800018
J	Ogo, Y; Kobayashi, T; Itai, RN; Nakanishi, H; Kakei, Y; Takahashi, M; Toki, S; Mori, S; Nishizawa, NK				Ogo, Yuko; Kobayashi, Takanori; Itai, Reiko Nakanishi; Nakanishi, Hiromi; Kakei, Yusuke; Takahashi, Michiko; Toki, Seiichi; Mori, Satoshi; Nishizawa, Naoko K.			A novel NAC transcription factor, IDEF2, that recognizes the iron deficiency-responsive element 2 regulates the genes involved in iron homeostasis in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTIANAMINE SYNTHASE GENES; MOLECULAR CHARACTERIZATION; RICE; PROTEIN; EXPRESSION; CLONING; ROOT; PHYTOSIDEROPHORES; ACQUISITION; BARLEY	Iron is essential for most living organisms, and thus iron deficiency poses a major abiotic stress in crop production. Plants induce iron utilization systems under conditions of low iron availability, but the molecular mechanisms of gene regulation under iron deficiency remain largely unknown. We identified a novel transcription factor of rice and barley, IDEF2, which specifically binds to the iron deficiency-responsive cis-acting element 2 (IDE2) by yeast one-hybrid screening. IDEF2 belongs to an uncharacterized branch of the NAC transcription factor family and exhibits novel properties of sequence recognition. An electrophoretic mobility shift assay and cyclic amplification and selection of targets experiment revealed that IDEF2 predominantly recognized CA(A/C) G(T/C)(T/C/A)(T/C/A) within IDE2 as the core-binding site. IDEF2 transcripts are constitutively present in rice roots and leaves. Repression of the function of IDEF2 by the RNA interference (RNAi) technique and chimeric repressor gene-silencing technology (CRES-T) caused aberrant iron homeostasis in rice. Several genes up-regulated by iron deficiency, including the Fe(II)-nicotianamine transporter gene OsYSL2, were less induced by iron deficiency in the RNAi rice of IDEF2, suggesting that IDEF2 is involved in the regulation of these genes. Many genes with repressed expression in IDEF2 RNAi rice possessed the IDEF2-binding core sites in their promoters, and the flanking sequences were also highly homologous to IDE2. IDEF2 bound to OsYSL2 promoter region containing the binding core site, suggesting direct regulation of OsYSL2 expression. These results reveal novel cis-element/trans-factor interactions functionally associated with iron homeostasis.	[Ogo, Yuko; Kobayashi, Takanori; Itai, Reiko Nakanishi; Kakei, Yusuke; Takahashi, Michiko; Nishizawa, Naoko K.] Univ Tokyo, Plant Biotechnol Lab, Bunkyo Ku, Tokyo 1138657, Japan; [Mori, Satoshi] Univ Tokyo, Lab Plant Physiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Toki, Seiichi] Natl Inst Agrobiol Sci, Plant Genet Engn Res Unit, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan	University of Tokyo; University of Tokyo; National Institute of Agrobiological Sciences - Japan	Nishizawa, NK (corresponding author), Univ Tokyo, Plant Biotechnol Lab, Bunkyo Ku, 1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Kakei, Yusuke/AAF-7408-2020; Toki, Seiichi/AAR-1889-2021; Nakanishi, Hiromi/C-6461-2015	Nakanishi, Hiromi/0000-0001-5556-5058				Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; BECKER R, 1995, PLANT PHYSIOL, V108, P269, DOI 10.1104/pp.108.1.269; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Inoue H, 2006, PLANT CELL PHYSIOL, V47, pS231; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; IZAWA T, 1993, J MOL BIOL, V230, P1131, DOI 10.1006/jmbi.1993.1230; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; KATAGIRI F, 1989, NATURE, V340, P727, DOI 10.1038/340727a0; Kobayashi T, 2004, SOIL SCI PLANT NUTR, V50, P1167, DOI 10.1080/00380768.2004.10408590; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Ling HQ, 2002, P NATL ACAD SCI USA, V99, P13938, DOI 10.1073/pnas.212448699; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; NAKANISHI H, 1993, PLANT CELL PHYSIOL, V34, P401; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; OKUMURA N, 1994, PLANT MOL BIOL, V25, P705, DOI 10.1007/BF00029608; Olsen AN, 2005, PLANT SCI, V169, P785, DOI 10.1016/j.plantsci.2005.05.035; Pich A, 1996, J EXP BOT, V47, P41, DOI 10.1093/jxb/47.1.41; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; STEPHAN UW, 1994, PLANT SOIL, V165, P181, DOI 10.1007/BF00008060; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vorwieger A, 2007, PLANTA, V226, P147, DOI 10.1007/s00425-006-0476-9; Yi Y, 1996, PLANT J, V10, P835, DOI 10.1046/j.1365-313X.1996.10050835.x	47	156	171	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13407	13417		10.1074/jbc.M708732200	http://dx.doi.org/10.1074/jbc.M708732200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308732	hybrid			2022-12-27	WOS:000255499800080
J	Martin, AM; Kuhlmann, C; Trossbach, S; Jaeger, S; Waldron, E; Roebroek, A; Luhmann, HJ; Laatsch, A; Weggen, S; Lessmann, V; Pietrzik, CU				Martin, Anne M.; Kuhlmann, Christoph; Trossbach, Svenja; Jaeger, Sebastian; Waldron, Elaine; Roebroek, Anton; Luhmann, Heiko J.; Laatsch, Alexander; Weggen, Sascha; Lessmann, Volkmar; Pietrzik, Claus U.			The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CYTOPLASMIC DOMAIN; ALZHEIMERS; MODULATION; CLEARANCE; FAMILY	The low density lipoprotein receptor-related protein 1 (LRP1) emerges to play fundamental roles in cellular signaling pathways in the brain. One of its prominent ligands is the serine proteinase tissue-type plasminogen activator (tPA), which has been shown to act as a key activator of neuronal mitogen-activated protein kinase pathways via the N-methyl-D-aspartate (NMDA) receptor. However, here we set out to examine whether LRP1 and the NMDA receptor might eventually act in a combined fashion to mediate tPA downstream signaling. By blocking tPA from binding to LRP1 using the receptor-associated protein, we were able to completely inhibit NMDA receptor activation. Additionally, inhibition of NMDA receptor calcium influx with MK-801 resulted in dramatic reduction of tPA-mediated downstream signaling. This indicates a functional interaction between the two receptors, since both experimental approaches resulted in strongly reduced calcium influx and Erk1/2 phosphorylation. Additionally, we were able to inhibit Erk1/2 activation by competing for the LRP1 C-terminal binding motif with a truncated PSD95 construct resembling its PDZ III domain. Furthermore, we identified the distal NPXY amino acid motif in the C terminus of LRP1 as the crucial element for LRP1-NMDA receptor interaction via the adaptor protein PSD95. These results provide new insights into the mechanism of a tPA-induced, LRP1-mediated gating mechanism for NMDA receptors.	[Martin, Anne M.; Trossbach, Svenja; Jaeger, Sebastian; Waldron, Elaine; Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany; [Kuhlmann, Christoph; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Inst Physiol, D-55099 Mainz, Germany; [Roebroek, Anton] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Roebroek, Anton] Flanders Inst Biotechnol, B-3000 Louvain, Belgium; [Laatsch, Alexander] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Weggen, Sascha] Univ Med Ctr Heinrich Heine Univ, Dept Mol Neuropathol, Inst Neuropathol, D-40225 Dusseldorf, Germany; [Lessmann, Volkmar] Otto Von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Otto von Guericke University	Pietrzik, CU (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, Duesbergweg 6, D-55099 Mainz, Germany.	pietrzik@uni-mainz.de	Luhmann, Heiko J./N-8797-2019; Leßmann, Volkmar/E-8125-2013	Luhmann, Heiko J./0000-0002-7934-8661; Leßmann, Volkmar/0000-0002-6863-323X				Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Cao J, 2005, J CELL BIOL, V168, P117, DOI 10.1083/jcb.200407024; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Harris-White M. E., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P469, DOI 10.2174/156800705774322102; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kanterewicz BI, 1998, J NEUROCHEM, V70, P1009; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Laatsch A, 2004, EUR J CELL BIOL, V83, P113, DOI 10.1078/0171-9335-00364; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Roebroek AJM, 2006, MOL CELL BIOL, V26, P605, DOI 10.1128/MCB.26.2.605-616.2006; Sambrook J., 2001, MOL CLONING LAB MANU; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Waldron E, 2006, NEURODEGENER DIS, V3, P233, DOI 10.1159/000095261; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	35	83	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12004	12013		10.1074/jbc.M707607200	http://dx.doi.org/10.1074/jbc.M707607200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321860	hybrid			2022-12-27	WOS:000255340000016
J	Atkins, KM; Thomas, L; Youker, RT; Harriff, MJ; Pissani, F; You, HH; Thomas, G				Atkins, Katelyn M.; Thomas, Laurel; Youker, Robert T.; Harriff, Melanie J.; Pissani, Franco; You, Huihong; Thomas, Gary			HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation - Analysis using short interfering RNA and knock-out mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; TRANS-GOLGI NETWORK; CELL-SURFACE; SH3 DOMAIN; PHOSPHOINOSITIDE 3-KINASE; CYTOPLASMIC TAIL; ACIDIC CLUSTER; AMINO-ACID; C-SRC; PROTEIN	Human immunodeficiency virus, type 1, negative factor (Nef) initiates down-regulation of cell-surface major histocompatibility complex-I (MHC-I) by assembling an Src family kinase (SFK)-ZAP70/Syk-phosphoinositide 3-kinase (PI3K) cascade through the sequential actions of two sites, Nef EEEE65 and PXXP75. The internalized MHC-I molecules are then sequestered in endosomal compartments by a process requiring Nef Met(20). How Nef assembles the multikinase cascade to trigger the MHC-I down-regulation pathway is unknown. Here we report that EEEE65-dependent binding to the sorting protein PACS-2 targets Nef to the paranuclear region, enabling PXXP75 to bind and activate a trans-Golgi network (TGN)-localized SFK. This SFK then phosphorylates ZAP-70 to recruit class I PI3K by interaction with the p85 C-terminal Src homology 2 domain. Using splenocytes and embryonic fibroblasts from PACS-2(-/-) mice, we confirm genetically that Nef requires PACS-2 to localize to the paranuclear region and assemble the multikinase cascade. Moreover, genetic loss of PACS-2 or inhibition of class I PI3K prevents Nef-mediated MHC-I down-regulation, demonstrating that short interfering RNA knockdown of PACS-2 phenocopies the gene knock-out. This PACS-2-dependent targeting pathway is not restricted to Nef, because PACS-2 is also required for trafficking of an endocytosed cation-independent mannose 6-phosphate receptor reporter from early endosomes to the TGN. Together, these results demonstrate PACS-2 is required for Nef action and sorting of itinerant membrane cargo in the TGN/endosomal system.	[Atkins, Katelyn M.; Thomas, Laurel; Youker, Robert T.; Harriff, Melanie J.; Pissani, Franco; You, Huihong; Thomas, Gary] Vollum Inst, Portland, OR 97239 USA		Thomas, G (corresponding author), Vollum Inst, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.	thomasg@ohsu.edu	Youker, Robert/AAP-8725-2021	Pissani, Franco/0000-0001-8869-8455; Youker, Robert/0000-0002-3986-1655	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037274, F32DK076343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007381] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI49793] Funding Source: Medline; NIDDK NIH HHS [R01 DK37274, DK076343] Funding Source: Medline; NIGMS NIH HHS [T32 GM71338] Funding Source: Medline; NINDS NIH HHS [T32 NS007381] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agopian K, 2007, VIROLOGY, V358, P119, DOI 10.1016/j.virol.2006.07.053; Akari H, 2000, J VIROL, V74, P2907, DOI 10.1128/JVI.74.6.2907-2912.2000; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bard F, 2002, EUR J CELL BIOL, V81, P26, DOI 10.1078/0171-9335-00217; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bouard D, 2007, TRAFFIC, V8, P835, DOI 10.1111/j.1600-0854.2007.00581.x; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Coleman SH, 2006, J VIROL, V80, P1837, DOI 10.1128/JVI.80.4.1837-1849.2006; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Crump CM, 2003, J VIROL, V77, P11105, DOI 10.1128/JVI.77.20.11105-11113.2003; Das SR, 2005, INDIAN J MED RES, V121, P315; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Foster JL, 2007, ADV PHARMACOL, V55, P389, DOI 10.1016/S1054-3589(07)55011-8; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Hinners I, 2003, EMBO REP, V4, P1182, DOI 10.1038/sj.embor.7400018; Hiyoshi M, 2008, BLOOD, V111, P243, DOI 10.1182/blood-2007-04-086017; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Kasper MR, 2003, J VIROL, V77, P3041, DOI 10.1128/JVI.77.5.3041-3049.2003; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Larsen JE, 2004, MOL BIOL CELL, V15, P323, DOI 10.1091/mbc.E03-08-0578; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Marsh JW, 1999, ARCH BIOCHEM BIOPHYS, V365, P192, DOI 10.1006/abbi.1999.1208; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Scott GK, 2003, EMBO J, V22, P6234, DOI 10.1093/emboj/cdg596; Scott GK, 2006, EMBO J, V25, P4423, DOI 10.1038/sj.emboj.7601336; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Simmen T, 2005, EMBO J, V24, P717, DOI 10.1038/sj.emboj.7600559; Simmen T, 1999, MOL CELL BIOL, V19, P3136; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Stove V, 2003, BLOOD, V102, P2925, DOI 10.1182/blood-2003-03-0833; Stumptner-Cuvelette P, 2003, MOL BIOL CELL, V14, P4857, DOI 10.1091/mbc.E03-04-0211; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Ward S, 2003, CHEM BIOL, V10, P207, DOI 10.1016/S1074-5521(03)00048-6; Zauli G, 1999, BLOOD, V93, P1000, DOI 10.1182/blood.V93.3.1000.403a12_1000_1010	58	62	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11772	11784		10.1074/jbc.M707572200	http://dx.doi.org/10.1074/jbc.M707572200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18296443	Green Published, hybrid			2022-12-27	WOS:000255067400077
J	Liu, X; Spicarova, Z; Rydholm, S; Li, J; Brismar, H; Aperia, A				Liu, Xiao; Spicarova, Zuzana; Rydholm, Susanna; Li, Juan; Brismar, Hjalmar; Aperia, Anita			Ankyrin B modulates the function of Na, K-ATPase/inositol 1,4,5-trisphosphate receptor signaling microdomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM OSCILLATIONS; CARDIAC-ARRHYTHMIA; CATALYTIC SUBUNIT; SERUM DEPRIVATION; BINDING DOMAIN; IP3 RECEPTOR; NA,K-ATPASE; ATPASE; IDENTIFICATION; HOMEOSTASIS	Na, K-ATPase and inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) can form a signaling microdomain that in the presence of ouabain triggers highly regular calcium oscillations. Downstream effects include NF-kappa B activation. Here we report that ankyrin B (Ank-B), expressed in most mammalian cells, plays a pivotal role in the function of the Na, K-ATPase/ IP3R signaling microdomain. In studies performed on a monkey kidney cell line, we show that Ank-B co-precipitates with both Na, K-ATPase and IP3R. We identify the N terminus tail of the Na, K-ATPase catalytic subunit and the N-terminal portion 1-604 of the IP3R as novel binding sites for Ank-B. Knockdown of Ank-B with small interfering RNA reduced the expression of Ank-B to 15-30%. This down-regulation of Ank-B attenuated the interaction between Na, K-ATPase and IP3R, reduced the number of cells responding to pM doses of ouabain with calcium oscillations, altered the calcium oscillatory pattern, and abolished the ouabain effect on NF-kappa B. In contrast, Ank-B down-regulation had no effect on the ion transporting function of Na, K-ATPase and no effect on the distribution and apparent mobility of Na, K-ATPase in the plasma membrane.	[Liu, Xiao; Spicarova, Zuzana; Li, Juan; Brismar, Hjalmar; Aperia, Anita] Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, SE-17176 Stockholm, Sweden; [Rydholm, Susanna; Brismar, Hjalmar] AlbaNova Univ Ctr, Royal Inst Technol, Dept Cell Phys, S-10691 Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Aperia, A (corresponding author), Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, Q2 09, SE-17176 Stockholm, Sweden.	anita.aperia@ki.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003				Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Haas M, 2000, J BIOL CHEM, V275, P27832; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liu XL, 2007, NEUROREPORT, V18, P597, DOI 10.1097/WNR.0b013e3280b07bc9; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J CELL SCI, V115, P1565; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Pressley TA, 1996, AM J PHYSIOL-CELL PH, V271, pC825, DOI 10.1152/ajpcell.1996.271.3.C825; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Scott L, 2006, P NATL ACAD SCI USA, V103, P762, DOI 10.1073/pnas.0505557103; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Woroniecki R, 2003, AM J PHYSIOL-RENAL, V284, pF358, DOI 10.1152/ajprenal.00100.2002; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; Zhang ZS, 1998, J BIOL CHEM, V273, P18681, DOI 10.1074/jbc.273.30.18681	33	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11461	11468		10.1074/jbc.M706942200	http://dx.doi.org/10.1074/jbc.M706942200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303017	hybrid			2022-12-27	WOS:000255067400044
J	Whiteson, KL; Rice, PA				Whiteson, Katrine L.; Rice, Phoebe A.			Binding and catalytic contributions to site recognition by Flp recombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION COMPLEX; DNA-SEQUENCE RECOGNITION; MUTATIONAL ANALYSIS; INDIRECT READOUT; CRE RECOMBINASE; SPECIFICITY; EVOLUTION; PROTEIN; ENZYME; MECHANISMS	Flp catalyzes site-specific recombination in a highly sequence-specific manner despite making few direct contacts to the bases within its binding site. Sequence discrimination could take place in the binding and/or the catalytic steps. In this study, we independently measure the binding affinity and initial cleavage rate of Flp recombinase with similar to 20 designed alternate target DNA sequences. Our results show that Flp specificity is largely, although not entirely, imparted at the binding step and is the result of a combination of direct and indirect readout. The Flp binding site includes an A/T-rich region that displays a characteristically narrow minor groove. We find that many A --> T changes are tolerated at the binding step, whereas C or G substitutions tend to decrease binding affinity. The effects of the latter can be alleviated by replacing guanine with inosine, which removes the N2 amino group that protrudes into the minor groove. Some A --> T changes reduce binding affinity, due to clashing with nearby residues, reinforcing that specificity requires avoiding negative contacts as well as creating positive ones. A tracts, which can lead to unusually rigid DNA structure, are tolerated during the binding step when placed within the region where the minor groove is already narrow. However, most A tracts slow catalysis more than C or G substitutions. Understanding what kind of sequence variation is tolerated in the binding and catalytic steps helps us understand how the target DNA is recognized by Flp and will be useful in guiding the design of Flp variants with altered specificities.	[Whiteson, Katrine L.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Rice, PA (corresponding author), 929 E 57th St,GCIS W136, Chicago, IL 60637 USA.	price@uchicago.edu		Whiteson, Katrine/0000-0002-5423-6014	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058827] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM058827] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akopian A, 2003, P NATL ACAD SCI USA, V100, P8688, DOI 10.1073/pnas.1533177100; Barbic A, 2003, P NATL ACAD SCI USA, V100, P2369, DOI 10.1073/pnas.0437877100; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, J BIOL CHEM, V278, P24800, DOI 10.1074/jbc.M300853200; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; DeLano W.L, PYMOL MOL GRAPHICS S; Fersht A., 1999, STRUCTURE MECH PROTE; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; Goldhaber-Gordon I, 2003, BIOCHEMISTRY-US, V42, P14633, DOI 10.1021/bi035360o; Gordley RM, 2007, J MOL BIOL, V367, P802, DOI 10.1016/j.jmb.2007.01.017; GORIN AA, 1995, J MOL BIOL, V247, P34, DOI 10.1006/jmbi.1994.0120; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Krohn KA, 2003, NUCL MED BIOL, V30, P819, DOI 10.1016/S0969-8051(03)00132-X; Kurpiewski MR, 2004, STRUCTURE, V12, P1775, DOI 10.1016/j.str.2004.07.016; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lynch TW, 2003, J MOL BIOL, V330, P493, DOI 10.1016/S0022-2836(03)00529-1; Mauro SA, 2003, J BIOL CHEM, V278, P12955, DOI 10.1074/jbc.M212667200; MUNSON PJ, 1988, J RECEPTOR RES, V8, P533, DOI 10.3109/10799898809049010; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; SENECOFF JF, 1988, J MOL BIOL, V201, P405, DOI 10.1016/0022-2836(88)90147-7; Swinger KK, 2007, J MOL BIOL, V365, P1005, DOI 10.1016/j.jmb.2006.10.024; Voziyanov Y, 2003, J MOL BIOL, V326, P65, DOI 10.1016/S0022-2836(02)01364-5; Voziyanov Y, 2002, NUCLEIC ACIDS RES, V30, P1656, DOI 10.1093/nar/30.7.1656; Wenz C, 1996, J BIOL CHEM, V271, P5565, DOI 10.1074/jbc.271.10.5565	29	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11414	11423		10.1074/jbc.M800106200	http://dx.doi.org/10.1074/jbc.M800106200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18276592	hybrid, Green Published			2022-12-27	WOS:000255067400039
J	Gusdon, AM; Votyakova, TV; Mathews, CE				Gusdon, Aaron M.; Votyakova, Tatyana V.; Mathews, Clayton E.			Mt-Nd2(a) suppresses reactive oxygen species production by mitochondrial complexes I and III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; DNA MUTATIONS; SUPEROXIDE-PRODUCTION; ANTIOXIDANT DEFENSE; ELECTRON-TRANSPORT; A/C POLYMORPHISM; HEART; NADH; GENERATION	Reactive oxygen species (ROS) play a critical role in the pathogenesis of human diseases. A cytosine to adenine transversion in the mitochondrially encoded NADH dehydrogenase subunit 2 (mt-ND2, human; mt-Nd2, mouse) gene results in resistance against type 1 diabetes and several additional ROS-associated conditions. Our previous studies have demonstrated that the adenine-containing allele (mt-Nd2(a)) is also strongly associated with resistance against type 1 diabetes in mice. In this report we have confirmed that the cytosine-containing allele (mt-Nd2(c)) results in elevated mitochondrial ROS production. Using inhibitors of the electron transport chain, we show that when in combination with nuclear genes from the alloxan-resistant (ALR) strain, mt-Nd2c increases ROS from complex III. Furthermore, by using alamethicin-permeabilized mitochondria, we measured a significant increase in electron transport chain-dependent ROS production from all mt-Nd2(c)-encoding strains including ALR. mt(NOD), non-obese diabetic (NOD), and C57BL/6 (B6). Studies employing alamethicin and inhibitors were able to again localize the heightened ROS production in ALR. mtNOD to complex III and identified complex I as the site of elevated ROS production from NOD and B6 mitochondria. Using submitochondrial particles, we confirmed that in the context of the NOD or B6 nuclear genomes, mt-Nd2(c) elevates complex I-specific ROS production. In all assays mitochondria from mt-Nd2(a)-encoding strains exhibited low ROS production. Our data suggest that lowering overall mitochondrial ROS production is a key mechanism of disease protection provided by mt-Nd2(a).	[Gusdon, Aaron M.; Mathews, Clayton E.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Gusdon, Aaron M.; Votyakova, Tatyana V.; Mathews, Clayton E.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA	State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mathews, CE (corresponding author), 1600 SW Archer Rd,POB 100275, Gainesville, FL 32610 USA.	clayton.mathews@pathology.ufl.edu			NIAID NIH HHS [U19 AI056374] Funding Source: Medline; NIDDK NIH HHS [R01 DK074656, R01 DK74656] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074656] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMED I, 1992, FEBS LETT, V300, P275, DOI 10.1016/0014-5793(92)80862-B; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; Briehl M M, 1995, Cell Death Differ, V2, P41; Briehl MM, 1996, CELL DEATH DIFFER, V3, P63; Butterfield DA, 1999, LIFE SCI, V65, P1883, DOI 10.1016/S0024-3205(99)00442-7; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Genova MW, 2003, EXP BIOL MED, V228, P506, DOI 10.1177/15353702-0322805-14; GONDAL JA, 1985, J BIOL CHEM, V260, P2690; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Gusdon AM, 2007, J BIOL CHEM, V282, P5171, DOI 10.1074/jbc.M609367200; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; Kokaze A, 2004, J HUM HYPERTENS, V18, P41, DOI 10.1038/sj.jhh.1001632; Kokaze A, 2001, HUM GENET, V109, P521, DOI 10.1007/s004390100602; Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; Lee C., 1967, METHOD ENZYMOL, V10, P543; Liochev SI, 2002, FREE RADICAL BIO MED, V33, P137, DOI 10.1016/S0891-5849(02)00864-X; Mathews CE, 2005, DIABETOLOGIA, V48, P261, DOI 10.1007/s00125-004-1644-8; Mathews CE, 2003, IMMUNOGENETICS, V55, P491, DOI 10.1007/s00251-003-0603-8; Matsunaga H, 2001, DIABETES CARE, V24, P500, DOI 10.2337/diacare.24.3.500; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Mukae S, 2003, CIRC J, V67, P16, DOI 10.1253/circj.67.16; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; NICOLLE MM, 2001, NEUROSCIENCE, V12, P345; Ohta S, 2006, ONCOGENE, V25, P4768, DOI 10.1038/sj.onc.1209602; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; Pandya Dipak P., 2001, Comprehensive Therapy, V27, P284, DOI 10.1007/s12019-001-0026-0; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Peterson JR, 2006, CURR HYPERTENS REP, V8, P232, DOI 10.1007/s11906-006-0056-1; Reyes-Toso CF, 2006, AMINO ACIDS, V31, P299, DOI 10.1007/s00726-005-0280-z; Schonfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Singhal SK, 2006, INDIAN J ENG MATER S, V13, P129; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Surekha R. H., 2007, SMJ Singapore Medical Journal, V48, P137; Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008; Tanaka M, 2000, MECH AGEING DEV, V116, P65, DOI 10.1016/S0047-6374(00)00149-4; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b; Uchigata Y, 2002, DIABETES CARE, V25, P2106, DOI 10.2337/diacare.25.11.2106; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zhang HF, 2007, AM J PATHOL, V170, P1108, DOI 10.2353/ajpath.2007.060960; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA	62	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10690	10697		10.1074/jbc.M708801200	http://dx.doi.org/10.1074/jbc.M708801200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281288	hybrid, Green Published			2022-12-27	WOS:000254894700051
J	Inoue, K; Negishi, M				Inoue, Kaoru; Negishi, Masahiko			Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P4502B6 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; SYNERGISTIC ACTIVATION; FACTOR 4-ALPHA; TARGET GENES; HEPG2 CELLS; CROSS-TALK; P450 GENE; EXPRESSION; FACTOR-4-ALPHA	The nuclear receptor CAR (constitutive active/androstane receptor) is a drug-sensing transcription factor, regulating the hepatic genes that encode various drug-metabolizing enzymes. We have now characterized the novel regulatory mechanism by which the signal molecule EGR1 (early growth response 1) determines CAR-mediated activation of the human CYP2B6 (cytochrome P450 2B6) gene. The CYP2B6 enzyme metabolizes commonly used therapeutics and also activates pro-drugs. The CAR directly binds to the distal enhancer element of the CYP2B6 promoter, which is essential in converging to its drug-sensing function onto promoter activity. However, this binding alone is not sufficient to activate the CYP2B6 promoter; the promoter requires EGR1 to enable CAR to activate the CYP2B6 promoter. Upon stimulation by protein kinase C, EGR1 directly binds to the proximal promoter and coordinates the nearby HNF4 alpha (hepatocyte-enriched nuclear factor 4 alpha) with CAR at the distal enhancer element to activate the promoter. Thus, synergy of drug activation and the stimulation of cellular signal are necessary for CAR to activate the CYP2B6 gene.	[Inoue, Kaoru; Negishi, Masahiko] NIEHS, NIH, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, Z01ES080040] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barbier O, 2005, MOL PHARMACOL, V67, P241, DOI 10.1124/mol.104.003863; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; CAO XM, 1993, J BIOL CHEM, V268, P16949; CAO XM, 1992, J BIOL CHEM, V267, P12991; Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hosseinpour F, 2007, FEBS LETT, V581, P4937, DOI 10.1016/j.febslet.2007.09.024; Hung HL, 1996, J BIOL CHEM, V271, P2323, DOI 10.1074/jbc.271.4.2323; Inoue K, 2006, BIOCHEM J, V398, P125, DOI 10.1042/BJ20060109; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Saborowski M, 2006, J PHARMACOL EXP THER, V317, P778, DOI 10.1124/jpet.105.099929; Schwartz PS, 2003, CANCER GENE THER, V10, P571, DOI 10.1038/sj.cgt.7700601; Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Tarumi T, 2002, J BIOL CHEM, V277, P18510, DOI 10.1074/jbc.M201886200; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; Wong WK, 2002, J BIOL CHEM, V277, P22222, DOI 10.1074/jbc.M202844200; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989	30	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10425	10432		10.1074/jbc.M800729200	http://dx.doi.org/10.1074/jbc.M800729200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18303024	hybrid, Green Published			2022-12-27	WOS:000254894700023
J	Boulanger, P; Jacquot, P; Plancon, L; Chami, M; Engel, A; Parquet, C; Herbeuval, C; Letellier, L				Boulanger, Pascale; Jacquot, Pierre; Plancon, Laure; Chami, Mohamed; Engel, Andreas; Parquet, Claudine; Herbeuval, Chantal; Letellier, Lucienne			Phage T5 straight tail fiber is a multifunctional protein acting as a tape measure and carrying fusogenic and muralytic activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; OUTER-MEMBRANE PROTEIN; BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; IRREVERSIBLE BINDING; LENGTH DETERMINATION; SECONDARY STRUCTURE; DNA; FHUA; INJECTION	We report a bioinformatic and functional characterization of Pb2, a 121-kDa multimeric protein that forms phage T5 straight fiber and is implicated in DNA transfer into the host. Pb2 was predicted to consist of three domains. Region I ( residues 1-1030) was mainly organized in coiled coil and shared features of tape measure proteins. Region II ( residues 1030-1076) contained two alpha-helical transmembrane segments. Region III ( residues 1135-1148) included a metallopeptidase motif. A truncated version of Pb2 (Pb2-Cterm, residues 964-1148) was expressed and purified. Pb2-Cterm shared common features with fusogenic membrane polypeptides. It formed oligomeric structures and inserted into liposomes triggering their fusion. Pb2-Cterm caused beta-galactosidase release from Escherichia coli cells and in vitro peptidoglycan hydrolysis. Based on these multifunctional properties, we propose that binding of phage T5 to its receptor triggers large conformational changes in Pb2. The coiled coil region would serve as a sensor for triggering the opening of the head-tail connector. The C-terminal region would gain access to the host envelope, permitting the local degradation of the peptidoglycan and the formation of the DNA pore by fusion of the two membranes.	[Boulanger, Pascale; Jacquot, Pierre; Plancon, Laure; Parquet, Claudine; Herbeuval, Chantal; Letellier, Lucienne] Univ Paris Sud, IBBMC, F-91405 Orsay, France; [Boulanger, Pascale; Jacquot, Pierre; Plancon, Laure; Parquet, Claudine; Herbeuval, Chantal; Letellier, Lucienne] CNRS, UMR 8619, F-91405 Orsay, France; [Chami, Mohamed; Engel, Andreas] Univ Basel, ME Muller Inst, CH-4056 Basel, Switzerland	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Basel	Letellier, L (corresponding author), Univ Paris Sud, IBBMC, Bat 430, F-91405 Orsay, France.	lucienne.letellier@u-psud.fr						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; BOULANGER P, 1992, J BIOL CHEM, V267, P3168; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Del Angel VD, 2002, BIOCHEM BIOPH RES CO, V293, P1153; Edmonds L, 2007, J MOL BIOL, V365, P175, DOI 10.1016/j.jmb.2006.09.068; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; FEUCHT A, 1989, FEBS LETT, V255, P435, DOI 10.1016/0014-5793(89)81140-8; FEUCHT A, 1990, J BIOL CHEM, V265, P18561; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Goldberg Edward, 1994, P347; Gonzalez-Huici V, 2004, MOL MICROBIOL, V52, P529, DOI 10.1111/j.1365-2958.2004.03993.x; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; GUIHARD G, 1992, J BIOL CHEM, V267, P3173; HELLER KJ, 1992, ARCH MICROBIOL, V158, P235, DOI 10.1007/BF00245239; HELLER KJ, 1985, J BACTERIOL, V162, P621, DOI 10.1128/JB.162.2.621-625.1985; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; HENDRIX RW, 1988, CURR TOP MICROBIOL, V136, P21; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HEUSTERSPREUTE M, 1987, GENE, V52, P155, DOI 10.1016/0378-1119(87)90042-4; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Inamdar MM, 2006, BIOPHYS J, V91, P411, DOI 10.1529/biophysj.105.070532; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D; KATSURA I, 1975, J MOL BIOL, V91, P257, DOI 10.1016/0022-2836(75)90379-4; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; LABEDAN B, 1979, P NATL ACAD SCI USA, V76, P4669, DOI 10.1073/pnas.76.9.4669; Lambert O, 1998, MOL MICROBIOL, V30, P761, DOI 10.1046/j.1365-2958.1998.01107.x; Lambert O, 2000, P NATL ACAD SCI USA, V97, P7248, DOI 10.1073/pnas.130187297; LANNI YT, 1960, VIROLOGY, V10, P501, DOI 10.1016/0042-6822(60)90132-X; LANNI YT, 1968, BACTERIOL REV, V32, P227, DOI 10.1128/MMBR.32.3.227-242.1968; LEMAIRE M, 1989, ANAL BIOCHEM, V177, P50, DOI 10.1016/0003-2697(89)90012-2; Letellier L, 2004, FRONT BIOSCI-LANDMRK, V9, P1228, DOI 10.2741/1333; Letellier L, 2003, RES MICROBIOL, V154, P283, DOI 10.1016/S0923-2508(03)00072-X; LETELLIER L, 1998, LIPID PROTEIN TRAFFI, V106, P267; Letellier Lucienne, 2007, P209; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; MCCORQUODALE DJ, 1977, J VIROL, V22, P480, DOI 10.1128/JVI.22.2.480-488.1977; MCCORQUODALE JD, 1988, VIRUSES, V1, P439; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plancon L, 1997, J BIOL CHEM, V272, P16868, DOI 10.1074/jbc.272.27.16868; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; RHOADES M, 1972, J MOL BIOL, V69, P187, DOI 10.1016/0022-2836(72)90224-0; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; ROESSNER CA, 1983, J BACTERIOL, V153, P1528, DOI 10.1128/JB.153.3.1528-1534.1983; ROESSNER CA, 1983, J BIOL CHEM, V258, P643; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SNYDER CE, 1981, J VIROL, V40, P248, DOI 10.1128/JVI.40.1.248-257.1981; Stojkovic EA, 2007, J MOL BIOL, V366, P406, DOI 10.1016/j.jmb.2006.11.028; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049; ZWEIG M, 1973, J MOL BIOL, V80, P505, DOI 10.1016/0022-2836(73)90418-X; ZWEIG M, 1973, VIROLOGY, V51, P443, DOI 10.1016/0042-6822(73)90443-1	64	61	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13556	13564		10.1074/jbc.M800052200	http://dx.doi.org/10.1074/jbc.M800052200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348984	hybrid			2022-12-27	WOS:000255728200009
J	Nabavi, S; Nazar, RN				Nabavi, Sadeq; Nazar, Ross N.			Nonpolyadenylated RNA polymerase II termination is induced by transcript cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; 3'-END FORMATION; PAC1 RIBONUCLEASE; YEAST SNORNA; PROTEIN; PLASMIDS; SNRNA; DNA	Although the termination of transcription and 3' RNA processing of the eukaryotic mRNA has been linked to a polyadenylation signal and a transcript cleavage process, much less is known about the termination or processing of nonpolyadenylated RNA polymerase II transcripts. An efficiently expressed plasmid-based expression system was used to study the termination and processing of Schizosaccharomyces pombe U3 small nucleolar RNA ( snoRNA) transcripts in vivo. The termination assay was linked to cell transformation, and restriction fragment length polymorphism was used to determine levels of plasmid-derived U3 snoRNA. Mutation analyses in vivo indicate that the maturation of the 3' end is not directly dependent on an external cis-acting sequence or structure; rather, it is dependent on a transcript cleavage that can occur hundreds or even thousands of nucleotides downstream of the mature U3 snoRNA sequence. Similarly, termination is dependent on the same transcript cleavage that is localized in a hairpin structure that normally follows the 3' end of the U3 snoRNA but that also can be moved hundreds or thousands of nucleotides downstream. Both processes, however, can be induced simultaneously and equally efficiently with a single unrelated Pac1 endonuclease-labile structure. The results support a "reversed torpedoes" model in which a single cleavage allows exonucleases and/or other protein factors access to the transcript leading to transcription termination in one direction and RNA maturation in the other direction.	[Nabavi, Sadeq; Nazar, Ross N.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rnnazar@uoguelph.ca		Nabavi, Sadegh/0000-0002-3940-1210				ABOUELELA S, 1998, EMBO J, V13, P3738; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; CHACONAS G, 1980, METHOD ENZYMOL, V1, P75; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; Hitchcock RA, 2004, FEMS MICROBIOL LETT, V236, P73, DOI 10.1016/j.femsle.2004.05.020; Hitchen J, 1997, J MOL BIOL, V274, P481, DOI 10.1006/jmbi.1997.1376; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ivakine E, 2003, NUCLEIC ACIDS RES, V31, P7110, DOI 10.1093/nar/gkg932; Kessler MM, 1996, J BIOL CHEM, V271, P27167, DOI 10.1074/jbc.271.43.27167; Kienzle N, 1996, BIOTECHNIQUES, V20, P612; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; Lalev AI, 1999, NUCLEIC ACIDS RES, V27, P3071, DOI 10.1093/nar/27.15.3071; LANG WH, 1993, MOL CELL BIOL, V13, P649, DOI 10.1128/MCB.13.1.649; Lee Y, 1997, J BIOL CHEM, V272, P15206, DOI 10.1074/jbc.272.24.15206; LOSSON R, 1983, CELL, V32, P371, DOI 10.1016/0092-8674(83)90456-7; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Nabavi S, 2005, ANAL BIOCHEM, V345, P346, DOI 10.1016/j.ab.2005.06.033; NAZAR RN, 1991, J BIOL CHEM, V266, P4562; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Reeder RH, 1997, TRENDS BIOCHEM SCI, V22, P473, DOI 10.1016/S0968-0004(97)01133-X; Reeder RH, 1999, MOL CELL BIOL, V19, P7369; Rose M. D., 1990, METHODS YEAST GENETI, P140; Rotondo G, 1996, NUCLEIC ACIDS RES, V24, P2377, DOI 10.1093/nar/24.12.2377; Rotondo G, 1997, RNA, V3, P1182; Sambrook J., 2001, MOL CLONING LAB MANU; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SELINGER DA, 1992, MOL BIOL EVOL, V9, P297; Spasov K, 2002, MOL CELL, V9, P433, DOI 10.1016/S1097-2765(02)00461-6; STEELE WJ, 1965, J BIOL CHEM, V240, P1742; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Steinmetz EJ, 2006, MOL CELL BIOL, V26, P2688, DOI 10.1128/MCB.26.7.2688-2696.2006; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Zhou DW, 1999, RNA, V5, P1083, DOI 10.1017/S1355838299990726	53	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13601	13610		10.1074/jbc.M710125200	http://dx.doi.org/10.1074/jbc.M710125200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18321857	hybrid			2022-12-27	WOS:000255728200013
J	Sjostrand, D; Ibanez, CF				Sjostrand, Dan; Ibanez, Carlos F.			Insights into GFR alpha 1 regulation of neural cell adhesion molecule (NCAM) function from structure-function analysis of the NCAM/GFR alpha 1 receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; HOMOPHILIC ADHESION; LIGAND-BINDING; NGF BINDING; GDNF; ACTIVATION; DOMAINS; TRK; PROTOONCOGENE	The neural cell adhesion molecule NCAM binds glial cell line-derived neurotrophic factor (GDNF) through specific determinants located in its third immunoglobulin (Ig) domain. However, high affinity GDNF binding and downstream signaling depend upon NCAM co-expression with the GDNF co-receptor GFR alpha 1. GFR alpha 1 promotes high affinity GDNF binding to NCAM and down-regulates NCAM-mediated homophilic cell adhesion, but the mechanisms underlying these effects are unknown. NCAM and GFR alpha 1 interact at the plasma membrane, but the molecular determinants involved have not been characterized nor is it clear whether their interaction is required for GFR alpha 1 regulation of NCAM function. We have investigated the structure-function relationships underlying GFR alpha 1 binding to NCAM in intact cells. The fourth Ig domain of NCAM was both necessary and sufficient for the interaction of NCAM with GFR alpha 1. Moreover, although the N-terminal domain of GFR alpha 1 had previously been shown to be dispensable for GDNF binding, we found that it was both necessary and sufficient for the efficient interaction of this receptor with NCAM. GFR alpha 1 lacking its N-terminal domain was still able to potentiate GDNF binding to NCAM and assemble into a tripartite receptor complex but showed a reduced capacity to attenuate NCAM-mediated cell adhesion. On its own, the GFR alpha 1 N-terminal domain was sufficient to decrease NCAM-mediated cell adhesion. These results indicate that direct receptor-receptor interactions are not required for high affinity GDNF binding to NCAM but play an important role in the regulation of NCAM-mediated cell adhesion by GFR alpha 1.	[Sjostrand, Dan; Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	carlos.ibanez@ki.se						Atkins AR, 2004, J BIOL CHEM, V279, P49633, DOI 10.1074/jbc.M409159200; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Cik M, 2000, J BIOL CHEM, V275, P27505; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Sjostrand D, 2007, J BIOL CHEM, V282, P12734, DOI 10.1074/jbc.M701588200; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wieland JA, 2005, J BIOL CHEM, V280, P41037, DOI 10.1074/jbc.M503975200	24	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13792	13798		10.1074/jbc.M800283200	http://dx.doi.org/10.1074/jbc.M800283200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353777	hybrid			2022-12-27	WOS:000255728200031
J	Abu-Hamad, S; Zaid, H; Israelson, A; Nahon, E; Shoshan-Barmatz, V				Abu-Hamad, Salah; Zaid, Hilal; Israelson, Adrian; Nahon, Edna; Shoshan-Barmatz, Varda			Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1 - Mapping the site of binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; RAT-BRAIN HEXOKINASE; SARCOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; HEPATOMA MITOCHONDRIA; MAMMALIAN HEXOKINASE; GLUCOSE CATABOLISM; BOUND HEXOKINASE; CANCER-CELLS; VDAC	In brain and tumor cells, the hexokinase isoforms HK-I and HK-II bind to the voltage-dependent anion channel ( VDAC) in the outer mitochondrial membrane. We have previously shown that HK-I decreases murine VDAC1 (mVDAC1) channel conductance, inhibits cytochrome c release, and protects against apoptotic cell death. Now, we define mVDAC1 residues, found in two cytoplasmic domains, involved in the interaction with HK-I. Protection against cell death by HK-I, as induced by overexpression of native or mutated mVDAC1, served to identify the mVDAC1 amino acids required for interaction with HK-I. HK-I binding to mVDAC1 either in isolated mitochondria or reconstituted in a bilayer was inhibited upon mutation of specific VDAC1 residues. HK-I anti-apoptotic activity was also diminished upon mutation of these amino acids. HK-I-mediated inhibition of cytochrome c release induced by staurosporine was also diminished in cells expressing VDAC1 mutants. Our results thus offer new insights into the mechanism by which HK-I promotes tumor cell survival via inhibition of cytochrome c release through HK-I binding to VDAC1. These results, moreover, point to VDAC1 as a key player in mitochondrially mediated apoptosis and implicate an HK-I-VDAC1 interaction in the regulation of apoptosis. Finally, these findings suggest that interference with the binding of HK-I to mitochondria by VDAC1-derived peptides may offer a novel strategy by which to potentiate the efficacy of conventional chemotherapeutic agents.	[Abu-Hamad, Salah; Nahon, Edna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zaid, Hilal] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Israelson, Adrian] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ben Gurion University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il		Israelson, Adrian/0000-0002-8289-7653				Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; AUBERTFOUCHER E, 1984, ARCH BIOCHEM BIOPHYS, V232, P391, DOI 10.1016/0003-9861(84)90554-X; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Cullen KJ, 2007, J BIOENERG BIOMEMBR, V39, P43, DOI 10.1007/s10863-006-9059-5; De Pinto Vito, 2003, Ital J Biochem, V52, P17; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; DEPINTO V, 1993, J BIOL CHEM, V268, P12977; FANCIULLI M, 1994, ONCOL RES, V6, P405; FELGNER PL, 1977, ARCH BIOCHEM BIOPHYS, V182, P282, DOI 10.1016/0003-9861(77)90309-5; Gardner Colin R, 2004, Expert Rev Anticancer Ther, V4, P1157, DOI 10.1586/14737140.4.6.1157; GELB BD, 1992, P NATL ACAD SCI USA, V89, P202, DOI 10.1073/pnas.89.1.202; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hashimoto M, 2000, ARCH BIOCHEM BIOPHYS, V384, P163, DOI 10.1006/abbi.2000.2085; Israelson A, 2008, CELL CALCIUM, V43, P196, DOI 10.1016/j.ceca.2007.05.006; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MATHUPALA SP, 1995, J BIOL CHEM, V270, P16918, DOI 10.1074/jbc.270.28.16918; MCENERY MW, 1992, J BIOENERG BIOMEMBR, V24, P63, DOI 10.1007/BF00769532; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; NAKASHIMA RA, 1988, CANCER RES, V48, P913; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Oudard Stephane, 2004, Bull Cancer, V91, pE184; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; POLAKIS PG, 1985, ARCH BIOCHEM BIOPHYS, V236, P328, DOI 10.1016/0003-9861(85)90633-2; Preston TJ, 2001, ADV DRUG DELIVER REV, V49, P45, DOI 10.1016/S0169-409X(01)00127-2; Rempel A, 1996, CANCER RES, V56, P2468; REMPEL A, 1994, BBA-GENE STRUCT EXPR, V1219, P660, DOI 10.1016/0167-4781(94)90225-9; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Roman I, 2006, BBA-BIOMEMBRANES, V1758, P479, DOI 10.1016/j.bbamem.2006.03.019; Sade H, 2004, EUR J IMMUNOL, V34, P119, DOI 10.1002/eji.200324650; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Shafir I, 1998, EUR J BIOCHEM, V253, P627, DOI 10.1046/j.1432-1327.1998.2530627.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; ShoshanBarmatz V, 1996, FEBS LETT, V386, P205, DOI 10.1016/0014-5793(96)00442-5; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wilson JE, 1997, J BIOENERG BIOMEMBR, V29, P97, DOI 10.1023/A:1022472124746; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599	50	197	202	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13482	13490		10.1074/jbc.M708216200	http://dx.doi.org/10.1074/jbc.M708216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308720	hybrid			2022-12-27	WOS:000255499800087
J	Matitau, AE; Scheid, MP				Matitau, Adi E.; Scheid, Michael P.			Phosphorylation of MEKK3 at threonine 294 promotes 14-3-3 association to inhibit nuclear factor kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; KINASE-ACTIVITY; IN-VIVO; RAF-1; PROTEINS; 14-3-3-PROTEINS; DOMAIN	The protein kinase MEKK3 is essential for tumor necrosis factor alpha(TNF alpha)- and lipopolysaccharide-induced activation of nuclear factor kappa B, although the mechanism by which TNF receptor 1 and Toll-like receptors regulate MEKK3 is largely unknown. In this study we have identified MEKK3 Thr(294) as a novel site of phosphorylation that regulates MEKK3 binding with 14-3-3. Phosphorylation of MEKK3 at Thr(294) was observed for both endogenous and ectopically expressed MEKK3. Mutation of Thr(294) to alanine abolished 14-3-3-MEKK3 association and incubation with phosphorylated peptides mimicking Thr(P)(294) competed for 14-3-3 binding. Mutation of Thr(294) did not alter Ser(526) phosphorylation within the activation loop. However, expression of T294A MEKK3 elevated TNF alpha-stimulated NF-kappa B transcriptional activity, suggesting that Thr(294) phosphorylation and 14-3-3 binding negatively regulate MEKK3. Stimulation with TNF alpha or lipopolysaccharide caused a rapid decrease in Thr(294) phosphorylation of endogenous MEKK3 and subsequent loss of 14-3-3 association. Thus, this study identifies a potentially important regulatory step in MEKK3 signaling via dephosphorylation of Thr(294), which reduces 14-3-3 binding correlating with MEKK3 pathway activation.	[Matitau, Adi E.; Scheid, Michael P.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Scheid, MP (corresponding author), York Univ, Dept Biol, Farquharson Bldg,Rm 236, Toronto, ON M3J 1P3, Canada.	mscheid@yorku.ca						Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	18	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13261	13268		10.1074/jbc.M801474200	http://dx.doi.org/10.1074/jbc.M801474200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308725	hybrid			2022-12-27	WOS:000255499800066
J	Winton, MJ; Igaz, LM; Wong, MM; Kwong, LK; Trojanowski, JQ; Lee, VMY				Winton, Matthew J.; Igaz, Lionel M.; Wong, Margaret M.; Kwong, Linda K.; Trojanowski, John Q.; Lee, Virginia M. -Y.			Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; UBIQUITIN-POSITIVE INCLUSIONS; DEMENTIA; EXPORT; LOCALIZATION; MUTATIONS; PATHOLOGY; SIGNAL; RCC1	TAR DNA-binding protein 43 (TDP- 43) is the disease protein in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS). Although normal TDP- 43 is a nuclear protein, pathological TDP- 43 is redistributed and sequestered as insoluble aggregates in neuronal nuclei, perikarya, and neurites. Here we recapitulate these pathological phenotypes in cultured cells by altering endogenous TDP-43 nuclear trafficking and by expressing mutants with defective nuclear localization (TDP-43-Delta NLS) or nuclear export signals (TDP-43-Delta NES). Restricting endogenous cytoplasmic TDP- 43 from entering the nucleus or preventing its exit out of the nucleus resulted in TDP- 43 aggregate formation. TDP-43-Delta NLS accumulates as insoluble cytoplasmic aggregates and sequesters endogenous TDP-43, thereby depleting normal nuclear TDP-43, whereas TDP-43-Delta NES forms insoluble nuclear aggregates with endogenous TDP-43. Mutant forms of TDP-43 also replicate the biochemical profile of pathological TDP-43 in FTLD-U/ALS. Thus, FTLD-U/ALS pathogenesis may be linked mechanistically to deleterious perturbations of nuclear trafficking and solubility of TDP-43.	[Winton, Matthew J.; Igaz, Lionel M.; Wong, Margaret M.; Kwong, Linda K.; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res,HUP, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res,HUP, Maloney Bldg,3rd Floor,3600 Spruce St, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Igaz, Lionel/AAP-3059-2020	Igaz, Lionel Muller/0000-0001-9988-3242	NIA NIH HHS [AG17586, AG10124] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG010124, P01AG017586] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; BANKER G, 1998, CULTURING NERVE CELL, P398; Boche I, 1997, J CELL BIOL, V139, P313, DOI 10.1083/jcb.139.2.313; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; DREYFUSS G, 1984, J CELL BIOL, V99, pA233, DOI 10.1083/jcb.99.6.1997; GEISERT EE, 1990, P NATL ACAD SCI USA, V87, P3967, DOI 10.1073/pnas.87.10.3967; Grossman M, 2002, J INT NEUROPSYCH SOC, V8, P566, DOI 10.1017/S1355617702814357; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; PEEPLES ME, 1988, VIROLOGY, V162, P255, DOI 10.1016/0042-6822(88)90418-7; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3	22	416	427	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13302	13309		10.1074/jbc.M800342200	http://dx.doi.org/10.1074/jbc.M800342200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18305110	Green Published, hybrid			2022-12-27	WOS:000255499800070
J	Zheng, J; Shen, WH; Lu, TJ; Zhou, Y; Chen, Q; Wang, Z; Xiang, T; Zhu, YC; Zhang, C; Duan, SM; Xiong, ZQ				Zheng, Jing; Shen, Wan-Hua; Lu, Ting-Jia; Zhou, Yang; Chen, Qian; Wang, Zi; Xiang, Ting; Zhu, Yong-Chuan; Zhang, Chi; Duan, Shumin; Xiong, Zhi-Qi			Clathrin-dependent endocytosis is required for TrkB-dependent Akt-mediated neuronal protection and dendritic growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; RECEPTOR INTERNALIZATION; IN-VITRO; SURVIVAL; EXPRESSION; KINASE; CELLS; BDNF; NGF	Endocytosis of Trk ((t) under bar ropomyosin-(r) under bar elated (k) under bar inase) receptors is critical for neurotrophin signal transduction and biological functions. However, the mechanism governing endocytosis of TrkB ((t) under bar ropomyosin-(r) under bar elated (k) under bar inase (B) under bar) and the specific contributions of TrkB endocytosis to downstream signaling are unknown. In this study, we report that blocking clathrin, dynamin, or AP2 in cultured neurons of the central nervous system inhibited brain-derived neurotrophic factor (BDNF)-induced activation of Akt but not ERK. Treating neurons with the clathrin inhibitor monodansylcadaverine or a peptide that blocks dynamin function specifically abrogated Akt pathway activation in response to BDNF but did not affect the response of other downstream effectors or the up-regulation of immediate early genes neuropeptide Y and activity-regulated cytoskeleton-associated protein. Similar effects were found in neurons expressing small interfering RNA to silence AP2 or a dominant negative form of dynamin that inhibits clathrin-mediated endocytosis. In PC12 cells, ERK but not Akt activation required TrkA endocytosis following stimulation with nerve growth factor, whereas the opposite was true when TrkA-expressing neurons were stimulated with nerve growth factor in the central nervous system. Thus, the specific effects of internalized Trk receptors probably depend on the presence of cell type-specific modulators of neurotrophin signaling and not on differences inherent to Trk receptors themselves. Endocytosis-dependent activation of Akt in neurons was found to be critical for BDNF-supported survival and dendrite outgrowth. Together, these results demonstrate the functional requirement of clathrin-and dynamin-dependent endocytosis in generating the full intracellular response of neurons to BDNF in the central nervous system.	[Xiong, Zhi-Qi] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiong, ZQ (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	xiongzhiqi@ion.ac.cn	Chen, Qian/B-7405-2013; Zhang, Chi/ABB-1176-2021; Shen, Wanhua/B-5554-2011	Zhang, Chi/0000-0003-4866-1441; Shen, Wanhua/0000-0002-5178-9561				Alder J, 2003, J NEUROSCI, V23, P10800; Alderson RF, 2000, BRAIN RES, V871, P210, DOI 10.1016/S0006-8993(00)02428-8; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Baxter GT, 1997, J NEUROSCI, V17, P2683; Beattie EC, 2000, J NEUROSCI, V20, P7325; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Eide FF, 1996, J NEUROSCI, V16, P3123; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Grimes ML, 1996, J NEUROSCI, V16, P7950; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IP NY, 1993, J NEUROSCI, V13, P3394; Je HS, 2005, J NEUROSCI, V25, P11719, DOI 10.1523/JNEUROSCI.4087-05.2005; KAHLE P, 1994, J NEUROSCI RES, V38, P599, DOI 10.1002/jnr.490380512; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; SOTRONIEW MV, 2001, ANNU REV NEUROSCI, V24, P1217; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	37	89	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13280	13288		10.1074/jbc.M709930200	http://dx.doi.org/10.1074/jbc.M709930200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18353779	hybrid			2022-12-27	WOS:000255499800068
J	Dominy, JE; Hwang, J; Guo, S; Hirschberger, LL; Zhang, S; Stipanuk, MH				Dominy, John E.; Hwang, Jesse; Guo, Stephanie; Hirschberger, Lawrence L.; Zhang, Sheng; Stipanuk, Martha H.			Synthesis of amino acid cofactor in cysteine dioxygenase is regulated by substrate and represents a novel post-translational regulation of activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSE-OXIDASE; INTRACELLULAR CYSTEINE; PROTEASOME SYSTEM; CRYSTAL-STRUCTURE; GLYOXAL OXIDASE; RAT; PURIFICATION; BIOGENESIS; EXPRESSION; MECHANISM	Cysteine dioxygenase (CDO) catalyzes the conversion of cysteine to cysteinesulfinic acid and is important in the regulation of intracellular cysteine levels in mammals and in the provision of oxidized cysteine metabolites such as sulfate and taurine. Several crystal structure studies of mammalian CDO have shown that there is a cross-linked cofactor present in the active site of the enzyme. The cofactor consists of a thioether bond between the gamma-sulfur of residue cysteine 93 and the aromatic side chain of residue tyrosine 157. The exact requirements for cofactor synthesis and the contribution of the cofactor to the catalytic activity of the enzyme have yet to be fully described. In this study, therefore, we explored the factors necessary for cofactor biogenesis in vitro and in vivo and examined what effect cofactor formation had on activity in vitro. Like other cross-linked cofactor-containing enzymes, formation of the Cys-Tyr cofactor in CDO required a transition metal cofactor (Fe2+) and O-2. Unlike other enzymes, however, biogenesis was also strictly dependent upon the presence of substrate. Cofactor formation was also appreciably slower than the rates reported for other enzymes and, indeed, took hundreds of catalytic turnover cycles to occur. In the absence of the Cys-Tyr cofactor, CDO possessed appreciable catalytic activity, suggesting that the cofactor was not essential for catalysis. Nevertheless, at physiologically relevant cysteine concentrations, cofactor formation increased CDO catalytic efficiency by similar to 10-fold. Overall, the regulation of Cys-Tyr cofactor formation in CDO by ambient cysteine levels represents an unusual form of substrate-mediated feed-forward activation of enzyme activity with important physiological consequences.	[Dominy, John E.; Hwang, Jesse; Guo, Stephanie; Hirschberger, Lawrence L.; Stipanuk, Martha H.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Zhang, Sheng] Cornell Univ, Life Sci Core Labs Ctr, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stipanuk, MH (corresponding author), Cornell Univ, Div Nutr Sci, 227 Savage Hall, Ithaca, NY 14853 USA.	mhs6@cornell.edu						BAGLEY PJ, 1994, J NUTR, V124, P2410, DOI 10.1093/jn/124.12.2410; BAGLEY PJ, 1995, J NUTR, V125, P933; Bella DL, 1999, AM J PHYSIOL-ENDOC M, V277, pE144, DOI 10.1152/ajpendo.1999.277.1.E144; Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200; Chai SC, 2006, J BIOL CHEM, V281, P15774, DOI 10.1074/jbc.M601269200; Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t; DEVILLEBONNE D, 1991, BIOCHEMISTRY-US, V30, P5750, DOI 10.1021/bi00237a017; Dominy JE, 2006, BIOCHEM J, V394, P267, DOI 10.1042/BJ20051510; Dominy JE, 2007, AM J PHYSIOL-ENDOC M, V293, pE62, DOI 10.1152/ajpendo.00053.2007; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Dooley DM, 1999, J BIOL INORG CHEM, V4, P1, DOI 10.1007/s007750050283; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Klinman JP, 2001, P NATL ACAD SCI USA, V98, P14766, DOI 10.1073/pnas.011602498; Lee JI, 2004, J NUTR BIOCHEM, V15, P112, DOI 10.1016/j.jnutbio.2003.10.005; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Okeley NM, 2000, CHEM BIOL, V7, pR159, DOI 10.1016/S1074-5521(00)00140-X; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; PRATT ML, 1979, J BIOL CHEM, V254, P7191; Rogers MS, 2000, J AM CHEM SOC, V122, P990, DOI 10.1021/ja993385y; Ruggiero CE, 1997, BIOCHEMISTRY-US, V36, P1953, DOI 10.1021/bi9628836; Schnell R, 2005, J BIOL CHEM, V280, P27319, DOI 10.1074/jbc.M502560200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Simmons CR, 2006, PROTEIN EXPRES PURIF, V47, P74, DOI 10.1016/j.pep.2005.10.025; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Stipanuk MH, 2004, AM J PHYSIOL-ENDOC M, V286, pE439, DOI 10.1152/ajpendo.00336.2003; Stipanuk MH, 2004, AMINO ACIDS, V26, P99, DOI 10.1007/s00726-003-0001-4; Whittaker MM, 1999, J BIOL CHEM, V274, P36226, DOI 10.1074/jbc.274.51.36226; Whittaker MM, 2003, J BIOL CHEM, V278, P22090, DOI 10.1074/jbc.M300112200; Whittaker MM, 1996, J BIOL CHEM, V271, P681, DOI 10.1074/jbc.271.2.681; YAMAGUCHI K, 1978, J BIOCHEM-TOKYO, V83, P479, DOI 10.1093/oxfordjournals.jbchem.a131935; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200	32	87	90	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12188	12201		10.1074/jbc.M800044200	http://dx.doi.org/10.1074/jbc.M800044200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18308719	Green Published, hybrid			2022-12-27	WOS:000255340000035
J	Luo, DH; He, Y; Zhang, HF; Yu, LY; Chen, H; Xu, Z; Tang, SB; Urano, F; Min, W				Luo, Dianhong; He, Yun; Zhang, Haifeng; Yu, Luyang; Chen, Hong; Xu, Zhe; Tang, Shibo; Urano, Fumihiko; Min, Wang			AIP1 is critical in transducing IRE1-mediated endoplasmic reticulum stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-MEDIATED ARTERIOGENESIS; UNFOLDED-PROTEIN RESPONSE; REGULATING KINASE 1; INDUCED ACTIVATION; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; CELL-DEATH; ER STRESS; TUMOR; ASK1	We have previously shown that ASK1-interacting protein 1 (AIP1) transduces tumor necrosis factor-induced ASK1-JNK signaling. Because endoplasmic reticulum (ER) stress activates ASK1-JNK signaling cascade, we investigated the role of AIP1 in ER stress-induced signaling. We created AIP1-deficient mice (AIP1-KO) from which mouse embryonic fibroblasts and vascular endothelial cells were isolated. AIP1-KO cells show dramatic reductions in ER stress-induced, but not oxidative stress-induced, ASK1-JNK activation and cell apoptosis. The ER stress-induced IRE1-JNK/XBP-1 axis, but not the PERK-CHOP1 axis, is blunted in AIP1-KO cells. ER stress induced formation of an AIP1-IRE1 complex, and the PH domain of AIP1 is critical for the IRE1 interaction. Furthermore, reconstitution of AIP1-KO cells with AIP1 wild type, not an AIP1 mutant with a deletion of the PH domain (AIP1-Delta PH), restores ER stress-induced IRE1-JNK/XBP-1 signaling. AIP1-IRE1 association facilitates IRE1 dimerization, a critical step for activation of IRE1 signaling. More importantly, AIP1-KO mice show impaired ER stress-induced IRE1-dependent signaling in vivo. We conclude that AIP1 is essential for transducing the IRE1-mediated ER stress response.	[Luo, Dianhong; He, Yun; Zhang, Haifeng; Yu, Luyang; Chen, Hong; Min, Wang] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, Dept Pathol, New Haven, CT 06520 USA; [Xu, Zhe; Tang, Shibo] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Peoples R China; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	Yale University; Sun Yat Sen University; University of Massachusetts System; University of Massachusetts Worcester	Tang, SB (corresponding author), Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.	tangsb@mail.sysu.edu.cn; wang.min@yale.edu	Longo, Kenneth A/A-5631-2010; TANG, Shi/GXH-5719-2022; Urano, Fumihiko/AAF-4492-2020	Yu, Luyang/0000-0002-1301-6285	NHLBI NIH HHS [R01 HL077357-1, R01 HL65978-05, P01 HL070295-6] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070295, R01HL065978, R01HL077357] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Mauro C, 2006, J BIOL CHEM, V281, P2631, DOI 10.1074/jbc.M502181200; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Pan S, 2002, MOL CELL BIOL, V22, P7512, DOI 10.1128/MCB.22.21.7512-7523.2002; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yang QF, 2006, EMBO REP, V7, P622, DOI 10.1038/sj.embor.7400687; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang HF, 2007, AM J PATHOL, V170, P1108, DOI 10.2353/ajpath.2007.060960; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	30	84	96	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11905	11912		10.1074/jbc.M710557200	http://dx.doi.org/10.1074/jbc.M710557200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18281285	Green Published, hybrid			2022-12-27	WOS:000255340000006
J	Wang, XJ; Liu, B; Li, N; Li, HZ; Qiu, JM; Zhang, YY; Cao, XT				Wang, Xiaojian; Liu, Bin; Li, Nan; Li, Hongzhe; Qiu, Jianming; Zhang, Yuanyuan; Cao, Xuetao			IPP5, a novel protein inhibitor of protein phosphatase 1, promotes G(1)/S progression in a Thr-40-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; ALPHA-INDUCED APOPTOSIS; BREAST-CANCER CELLS; RETINOBLASTOMA PROTEIN; OKADAIC ACID; ACTIVATION; DEPHOSPHORYLATION; GROWTH; PP1; PHOSPHORYLATION	Protein phosphatase 1 (PP1) is a major serine/threonine phosphatase that controls gene expression and cell cycle progression. Here we describe the characterization of a novel inhibitory molecule for PP1, human inhibitor-5 of protein phosphatase 1 (IPP5). We find that IPP5, containing the PP1 inhibitory subunits, specifically interacts with the PP1 catalytic subunit and inhibits PP1 phosphatase activity. Furthermore, the mutation of Thr-40 within the inhibitory subunit of IPP5 into Ala eliminates the phosphorylation of IPP5 by protein kinase A and its inhibitor activity to PP1, whereas the mutation of Thr-40 within a truncated form of IPP5 into Asp can serve as a dominant active form of IPP5 in inhibiting PP1 activity. In IPP5-negative SW480 and IPP5-highly positive SW620 human colon cancer cells, we find that overexpression of IPP5 promotes the growth and accelerates the G(1)-S transition of SW480 cells in a Thr-40-dependent manner, which could be reversed by down-regulation of the PP1 expression. Moreover, silencing of IPP5 inhibits the growth of SW620 cells both in vitro and in nude mice possibly by inducing G(0)/G(1) arrest but not by promoting apoptosis. According to its role in the promotion of cell cycle progression and cell growth, IPP5 up-regulates the expression of cyclin E and the phosphorylated form of retinoblastoma protein. Our findings suggest that IPP5, by acting as an inhibitory molecule for PP1, can promote tumor cell growth and cell cycle progression, and may be a promising target in cancer therapeutics in IPP5-highly expressing tumor cells.	[Wang, Xiaojian; Liu, Bin; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Wang, Xiaojian; Liu, Bin; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Wang, Xiaojian; Li, Hongzhe; Qiu, Jianming; Zhang, Yuanyuan; Cao, Xuetao] Zhejiang Univ, Inst Immunol, Hangzhou 310058, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University	Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	caoxt@public3.sta.net.cn	zhang, yuanyuan/GYA-4428-2022					Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Cohen PTW, 2002, J CELL SCI, V115, P241; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Corsino P, 2007, CANCER RES, V67, P3135, DOI 10.1158/0008-5472.CAN-06-3815; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Huang HB, 1999, J BIOL CHEM, V274, P7870, DOI 10.1074/jbc.274.12.7870; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P3536, DOI 10.1073/pnas.94.8.3536; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Li N, 2001, J BIOL CHEM, V276, P28106, DOI 10.1074/jbc.M100467200; Liu CWY, 2006, MOL CARCINOGEN, V45, P648, DOI 10.1002/mc.20191; MacKintosh C, 1996, FEBS LETT, V397, P235, DOI 10.1016/S0014-5793(96)01175-1; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Pasder O, 2006, ONCOGENE, V25, P4194, DOI 10.1038/sj.onc.1209695; Rubin E, 2001, ONCOGENE, V20, P3776, DOI 10.1038/sj.onc.1204518; Shirato H, 2000, BIOCHEMISTRY-US, V39, P13848, DOI 10.1021/bi001326n; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; ULEMANS H, 2004, PHYSIOL REV, V84, P1; Van Eynde A, 2003, METHOD ENZYMOL, V366, P144; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wakula P, 2006, BIOCHEM J, V400, P377, DOI 10.1042/BJ20060758; Wang RH, 2001, ONCOGENE, V20, P6111, DOI 10.1038/sj.onc.1204829; Wang T, 2005, J BIOL CHEM, V280, P4374, DOI 10.1074/jbc.M408708200; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; Yamasaki Lili, 2003, Cancer Treat Res, V115, P209; Yan Q, 2007, J BIOL CHEM, V282, P13954, DOI 10.1074/jbc.M611476200; Yang LJ, 2004, J BIOL CHEM, V279, P11639, DOI 10.1074/jbc.M312895200; Yu Y, 2002, J CANCER RES CLIN, V128, P283, DOI 10.1007/s00432-002-0325-6; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang J, 1998, BIOCHEMISTRY-US, V37, P16728, DOI 10.1021/bi981169g	38	15	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12076	12084		10.1074/jbc.M801571200	http://dx.doi.org/10.1074/jbc.M801571200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310074	hybrid			2022-12-27	WOS:000255340000023
J	Yan, G; Huang, J; Jarbadan, NR; Jiang, YX; Cheng, H				Yan, Guang; Huang, Jiannan; Jarbadan, Nancy Ruth; Jiang, Yixing; Cheng, Hua			Sequestration of NF-kappa B signaling complexes in lipid rafts contributes to repression of NF-kappa B in T lymphocytes under hyperthermia stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-THETA; RECEPTOR-MEDIATED APOPTOSIS; HUMAN DNAJ PROTEIN; INHIBITS APOPTOSIS; APAF-1 APOPTOSOME; SENSITIZES CELLS; MEMBRANE RAFTS; PKC-THETA; ACTIVATION; RECRUITMENT	Sepsis causes extensive apoptosis of lymphocytes, a pathological condition that is frequently associated with hyperthermia. Heat stress has been implicated to repress the activation of an inflammatory mediator, nuclear factor of kappa B (NF-kappa B), which sensitizes cells to apoptosis mediated by inflammatory cytokine, tumor necrosis factor alpha. However, the molecular mechanism of hyperthermia-associated loss of T cells remains unclear. We show that hyperthermia causes rapid translocation of I kappa B kinase (IKK) and NF-kappa B complexes into the plasma membrane-associated lipid rafts in T cells. Heat stress induces aggregation of Carma1 in lipid rafts, which in turn recruits protein kinase C theta (PKC theta) and Bcl10 to the microdomains, causing subsequent membrane translocation of the IKK and NF-kappa B signalosomes. Depletion of Carma1 and inhibition of PKC theta impair accumulation of NF-kappa B complexes in lipid rafts. Heat stress prohibits I kappa B kinase activity by sequestrating the IKK and NF-kappa B complexes in lipid rafts and by segregating the chaperone protein Hsp90, an essential cofactor for IKK, from the IKK complex. This process ultimately results in functional deficiency of NF-kappa B and renders T cells resistant to tumor necrosis factor alpha-induced activation of IKK, thereby contributing to the apoptotic loss of T lymphocytes in sepsis-associated hyperthermia.	[Yan, Guang; Huang, Jiannan; Jarbadan, Nancy Ruth; Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA 17033 USA; [Yan, Guang; Huang, Jiannan; Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), Penn State Univ, Coll Med, Penn State Canc Inst, Oncol Room 6818,500 Univ Dr, Hershey, PA 17033 USA.	hcheng@hmc.psu.edu						Abboushi N, 2004, J IMMUNOL, V173, P3193, DOI 10.4049/jimmunol.173.5.3193; Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cheng H, 2005, NEOPLASIA, V7, P1065, DOI 10.1593/neo.05553; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2001, CURR BIOL, V11, P1771, DOI 10.1016/S0960-9822(01)00540-1; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clemons NJ, 2006, CELL STRESS CHAPERON, V11, P343, DOI 10.1379/CSC-206.1; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Feng XL, 2006, MOL CELL BIOL, V26, P9244, DOI 10.1128/MCB.01538-06; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Guzhova I, 2006, INT REV CYTOL, V254, P101, DOI 10.1016/S0074-7696(06)54003-3; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Jiang YX, 2007, LEUKEMIA RES, V31, P541, DOI 10.1016/j.leukres.2006.07.010; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; LAIRMORE MD, 1992, INT J CANCER, V50, P124, DOI 10.1002/ijc.2910500125; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sebald A, 2005, EUR J IMMUNOL, V35, P318, DOI 10.1002/eji.200425024; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Tani-ichi S, 2005, INT IMMUNOL, V17, P749, DOI 10.1093/intimm/dxh257; Tran SEF, 2003, CELL DEATH DIFFER, V10, P1137, DOI 10.1038/sj.cdd.4401278; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; WANG SD, 1994, J IMMUNOL, V152, P5014; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	52	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12489	12500		10.1074/jbc.M707988200	http://dx.doi.org/10.1074/jbc.M707988200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316375	hybrid			2022-12-27	WOS:000255340000065
J	Lee, JY; Retamal, C; Cuitino, L; Caruano-Yzermans, A; Shin, JE; van Kerkhof, P; Marzolo, MP; Bu, GJ				Lee, Jiyeon; Retamal, Claudio; Cuitino, Loreto; Caruano-Yzermans, Amy; Shin, Jung-Eun; van Kerkhof, Peter; Marzolo, Maria-Paz; Bu, Guojun			Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; CELL-SURFACE; LDL RECEPTOR; ALZHEIMERS-DISEASE; COATED PITS; P-SELECTIN; ENDOCYTOSIS; DISABLED-2; DOMAIN; FE65	Accumulation of extracellular amyloid beta peptide (A beta), generated from amyloid precursor protein (APP) processing by beta- and gamma-secretases, is toxic to neurons and is central to the pathogenesis of Alzheimer disease. Production of A beta from APP is greatly affected by the subcellular localization and trafficking of APP. Here we have identified a novel intracellular adaptor protein, sorting nexin 17 (SNX17), that binds specifically to the APP cytoplasmic domain via the YXNPXY motif that has been shown previously to bind several cell surface adaptors, including Fe65 and X11. Overexpression of a dominant-negative mutant of SNX17 and RNA interference knockdown of endogenous SNX17 expression both reduced steady-state levels of APP with a concomitant increase in A beta production. RNA interference knockdown of SNX17 also decreased APP half-life, which led to the decreased steady-state levels of APP. Immunofluorescence staining confirmed a colocalization of SNX17 and APP in the early endosomes. We also showed that a cell surface adaptor protein, Dab2, binds to the same YXNPXY motif and regulates APP endocytosis at the cell surface. Our results thus provide strong evidence that both cell surface and intracellular adaptor proteins regulate APP endocytic trafficking and processing to A beta. The identification of SNX17 as a novel APP intracellular adaptor protein highly expressed in neurons should facilitate the understanding of the relationship between APP intracellular trafficking and processing to A beta.	[Lee, Jiyeon; Caruano-Yzermans, Amy; Shin, Jung-Eun; Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Lee, Jiyeon; Caruano-Yzermans, Amy; Shin, Jung-Eun; Bu, Guojun] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Retamal, Claudio; Cuitino, Loreto; Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol,Ctr Regulac Celular & Pat, Millennium Inst Fundamental & Appl Biol, Santiago 340, Chile; [van Kerkhof, Peter] Univ Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [van Kerkhof, Peter] Univ Med Ctr, Biomembrane Inst, NL-3584 CX Utrecht, Netherlands	Washington University (WUSTL); Washington University (WUSTL); Pontificia Universidad Catolica de Chile; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	bu@wustl.edu		Lee, Jiyeon/0000-0002-8952-7938; Shin, Jung Eun/0000-0002-8502-7979; Retamal, Claudio/0000-0001-8618-2260; van Kerkhof, Peter/0000-0002-8954-2230; Cuitino, Loreto/0000-0003-2330-9732	FOGARTY INTERNATIONAL CENTER [R03TW006456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027924] Funding Source: NIH RePORTER; FIC NIH HHS [TW006456] Funding Source: Medline; NIA NIH HHS [R01 AG027924] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; BU GJ, 1994, J BIOL CHEM, V269, P29874; Burden JJ, 2004, J BIOL CHEM, V279, P16237, DOI 10.1074/jbc.M313689200; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; Florian V, 2001, BIOCHEM BIOPH RES CO, V281, P1045, DOI 10.1006/bbrc.2001.4467; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Gallagher H, 2004, BIOCHIMIE, V86, P179, DOI 10.1016/j.biochi.2004.03.001; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Koo EH, 1996, J CELL SCI, V109, P991; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Melman L, 2002, MOL BIOL CELL, V13, P3325, DOI 10.1091/mbc.E02-03-0152; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2006, MOL INTERV, V6, P74, DOI 10.1124/mi.6.2.4; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Williams R, 2004, MOL BIOL CELL, V15, P3095, DOI 10.1091/mbc.E04-02-0143; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Xie ZC, 2007, J BIOL CHEM, V282, P4318, DOI 10.1074/jbc.M609293200; Yamazaki T, 1996, J CELL SCI, V109, P999; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	38	117	122	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11501	11508		10.1074/jbc.M800642200	http://dx.doi.org/10.1074/jbc.M800642200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18276590	Green Published, hybrid			2022-12-27	WOS:000255067400049
J	Lee, KG; Xu, S; Wong, ET; Tergaonkar, V; Lam, KP				Lee, Koon-Guan; Xu, Shengli; Wong, Ee-Tsin; Tergaonkar, Vinay; Lam, Kong-Peng			Bruton's tyrosine kinase separately regulates NF kappa B p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG OLIGODEOXYNUCLEOTIDES; MOLECULAR-MECHANISMS; DENDRITIC CELLS; RECEPTOR; RESPONSES; LIPOPOLYSACCHARIDE; EXPRESSION; IL-10; DNA; AGAMMAGLOBULINEMIA	B lymphocytes express both B cell receptor and Toll-like receptors (TLR). We show here that Bruton's tyrosine kinase (Btk), a critical component in B cell receptor signaling, is also involved in TLR9 signaling in B cells. Stimulation of B cells with TLR9 ligand CpG oligodeoxynucleotide (ODN) leads to transient phosphorylation of Btk, and in the absence of Btk, TLR9-induced proliferation of B cells is impaired. Interestingly, Btk(-/-) B cells secrete significantly more interleukin (IL)-12 but much less IL-10 compared with wild type B cells upon TLR9 stimulation. Immunization of Btk(-/-) mice with CpG ODN also leads to elevated levels of IL-12 in vivo and consequently, a greater-fold increment in the production of Th1 type IgG2b and IgG3 antibodies in these mice compared with wild type controls. The addition of exogenous recombinant IL-10 could suppress IL-12 production by TLR9-activated Btk(-/-) B cells, suggesting that in B cells, Btk negatively regulates IL-12 through the induction of autocrine IL-10 production. TLR9 signaling also leads to the activation of NF kappa B, including the p65RelA subunit in wild type B cells. The lack of Btk signaling affects the activation of NF kappa B and impairs the translocation of the p65RelA subunit to the nucleus of B cells upon TLR9 stimulation. However, p65RelA(-/-) B cells could respond similarly to wild type B cells in terms of IL-10 and IL-12 secretion when stimulated with CpG ODN, suggesting that the defect in NF kappa B p65RelA activation is additional to the impairment in cytokine production in TLR9-activated Btk(-/-) B cells. Thus, Btk plays an important role in TLR9 signaling and acts separately to regulate NF kappa B RelA activation as well as IL-10 and IL-12 production in B cells.	[Lee, Koon-Guan; Xu, Shengli; Lam, Kong-Peng] Agcy Sci Technol & Res, Lab Immunol, Bioproc Technol Inst, Singapore 138648, Singapore; [Wong, Ee-Tsin; Tergaonkar, Vinay] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Lam, KP (corresponding author), Agcy Sci Technol & Res, Lab Immunol, Bioproc Technol Inst, Singapore 138648, Singapore.	lam_kong_peng@immunol.a-star.edu.sg	Lam, Kong-Peng/G-5374-2012	Lam, Kong-Peng/0000-0002-1316-4333				Akdis CA, 2001, IMMUNOLOGY, V103, P131, DOI 10.1046/j.1365-2567.2001.01235.x; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amedei A, 2001, EUR J IMMUNOL, V31, P1927, DOI 10.1002/1521-4141(200106)31:6<1927::AID-IMMU1927>3.0.CO;2-D; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Bajpai UD, 2000, J EXP MED, V191, P1735, DOI 10.1084/jem.191.10.1735; Chaung HC, 2006, INT IMMUNOPHARMACOL, V6, P1586, DOI 10.1016/j.intimp.2006.06.001; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1081, DOI 10.1016/j.bcp.2006.06.017; Hasan M, 2008, IMMUNOLOGY, V123, P239, DOI 10.1111/j.1365-2567.2007.02693.x; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Klinman DM, 2006, INT REV IMMUNOL, V25, P135, DOI 10.1080/08830180600743057; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lamphier MS, 2006, ANN NY ACAD SCI, V1082, P31, DOI 10.1196/annals.1348.005; Lijeroos M, 2007, CELL SIGNAL, V19, P625, DOI 10.1016/j.cellsig.2006.08.013; MATSUDA T, 1995, BLOOD, V85, P627, DOI 10.1182/blood.V85.3.627.bloodjournal853627; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sabet M, 2006, FEMS IMMUNOL MED MIC, V47, P369, DOI 10.1111/j.1574-695X.2006.00096.x; SATO S, 1994, J EXP MED, V180, P2101, DOI 10.1084/jem.180.6.2101; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Schmidt NW, 2006, J IMMUNOL, V177, P7203, DOI 10.4049/jimmunol.177.10.7203; Snijders A, 1996, J IMMUNOL, V156, P1207; Sochorova K, 2007, BLOOD, V109, P2553, DOI 10.1182/blood-2006-07-037960; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Verthelyi Daniela, 2006, V127, P139; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777	41	66	69	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11189	11198		10.1074/jbc.M708516200	http://dx.doi.org/10.1074/jbc.M708516200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18276597	hybrid			2022-12-27	WOS:000255067400014
J	Navaratnarajah, CK; Vongpunsawad, S; Oezguen, N; Stehle, T; Braun, W; Hashiguchi, T; Maenaka, K; Yanagi, Y; Cattaneo, R				Navaratnarajah, Chanakha K.; Vongpunsawad, Sompong; Oezguen, Numan; Stehle, Thilo; Braun, Werner; Hashiguchi, Takao; Maenaka, Katsumi; Yanagi, Yusuke; Cattaneo, Roberto			Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CD46 DOWN-REGULATION; CELLULAR RECEPTOR; RECOMBINANT VIRUS; CRYSTAL-STRUCTURE; AMINO-ACIDS; FUSION; STRAIN; SITES; CELLS	The interaction of measles virus with its receptor signaling lymphocytic activation molecule (SLAM) controls cell entry and governs tropism. We predicted potential interface areas of the measles virus attachment protein hemagglutinin to begin the investigation. We then assessed the relevance of individual amino acids located in these areas for SLAM-binding and SLAM-dependent membrane fusion, as measured by surface plasmon resonance and receptor-specific fusion assays, respectively. These studies identified one hemagglutinin protein residue, isoleucine 194, which is essential for primary binding. The crystal structure of the hemagglutinin-protein localizes Ile-194 at the interface of propeller blades 5 and 6, and our data indicate that a small aliphatic side chain of residue 194 stabilizes a protein conformation conducive to binding. In contrast, a quartet of residues previously shown to sustain SLAM-dependent fusion is not involved in binding. Instead, our data prove that after binding, this quartet of residues on propeller blade 5 conducts conformational changes that are receptor-specific. Our study sets a structure-based stage for understanding how the SLAM-elicited conformational changes travel through the H-protein ectodomain before triggering fusion protein unfolding and membrane fusion.	[Navaratnarajah, Chanakha K.; Vongpunsawad, Sompong; Cattaneo, Roberto] Mayo Clin, Dept Mol Med & Virol, Rochester, MN 55905 USA; [Oezguen, Numan; Braun, Werner] Univ Texas Galveston, Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Nashville, TN 37240 USA; [Maenaka, Katsumi] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Fukuoka 8128582, Japan; [Hashiguchi, Takao; Yanagi, Yusuke] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan	Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston; Eberhard Karls University of Tubingen; Vanderbilt University; Kyushu University; Kyushu University	Cattaneo, R (corresponding author), 200 1st St SW,Guggenheim 1838, Rochester, MN 55905 USA.	cattaneo.roberto@mayo.edu	Braun, Werner/A-6642-2012; Navaratnarajah, Chanakha/AAB-6171-2019; Oezguen, Numan/C-9267-2009	Navaratnarajah, Chanakha/0000-0002-4513-8412; Oezguen, Numan/0000-0002-3175-2382; vongpunsawad, sompong/0000-0001-7520-8728; Hashiguchi, Takao/0000-0001-7578-7571; Yanagi, Yusuke/0000-0001-7815-1667	NCI NIH HHS [R01 CA090363] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartz R, 1996, VIROLOGY, V224, P334, DOI 10.1006/viro.1996.0538; BORROW P, 1995, CURR TOP MICROBIOL, V191, P85; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; CATTANEO R, 1993, J VIROL, V67, P1493, DOI 10.1128/JVI.67.3.1493-1502.1993; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Duclos P, 1998, DRUG SAFETY, V19, P435, DOI 10.2165/00002018-199819060-00002; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashimoto K, 2002, J VIROL, V76, P6743, DOI 10.1128/JVI.76.13.6743-6749.2002; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Holmen SL, 1999, J VIROL, V73, P10051, DOI 10.1128/JVI.73.12.10051-10060.1999; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; Hsu EC, 1998, J VIROL, V72, P2905, DOI 10.1128/JVI.72.4.2905-2916.1998; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713; Lecouturier V, 1996, J VIROL, V70, P4200, DOI 10.1128/JVI.70.7.4200-4204.1996; Masse N, 2004, J VIROL, V78, P9051, DOI 10.1128/JVI.78.17.9051-9063.2004; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Negi SS, 2007, BIOINFORMATICS, V23, P3397, DOI 10.1093/bioinformatics/btm474; Negi SS, 2007, J MOL MODEL, V13, P1157, DOI 10.1007/s00894-007-0237-0; Negi SS, 2006, J MOL MODEL, V12, P921, DOI 10.1007/s00894-006-0101-7; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Plemper RK, 2000, J VIROL, V74, P6485, DOI 10.1128/JVI.74.14.6485-6493.2000; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Rager M, 2002, EMBO J, V21, P2364, DOI 10.1093/emboj/21.10.2364; Santiago C, 2002, J BIOL CHEM, V277, P32294, DOI 10.1074/jbc.M202973200; Schein CH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-40; Schneider U, 2000, J VIROL, V74, P9928, DOI 10.1128/JVI.74.21.9928-9936.2000; Schneider U, 2002, J VIROL, V76, P7460, DOI 10.1128/JVI.76.15.7460-7467.2002; Seki F, 2006, J GEN VIROL, V87, P1643, DOI 10.1099/vir.0.81682-0; Simonis D, 2007, SEMIN THROMB HEMOST, V33, P534, DOI 10.1055/s-2007-982085; STREBEL PM, 2004, VACCINES, P389; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Ungerechts G, 2007, CANCER RES, V67, P10939, DOI 10.1158/0008-5472.CAN-07-1252; Vongpunsawad S, 2004, J VIROL, V78, P302, DOI 10.1128/JVI.78.1.302-313.2004; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	38	55	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11763	11771		10.1074/jbc.M800896200	http://dx.doi.org/10.1074/jbc.M800896200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18292085	Green Published, hybrid			2022-12-27	WOS:000255067400076
J	Wang, CM; Li, N; Liu, XG; Zheng, YY; Cao, XT				Wang, Chunmei; Li, Nan; Liu, Xingguang; Zheng, Yuanyuan; Cao, Xuetao			A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization (Publication with Expression of Concern. See vol. 295, pg. 8878, 2020) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							KINASE-II INHIBITOR; DEPENDENT DEGRADATION; APOPTOSIS; CANCER; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; P27(KIP1); INTEGRIN; KN-93	Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates numerous physiological functions. Inhibition of CaMKII activity, mostly by synthetic reagents, has been proved to suppress cell growth in many cases. So far there are no reports about the physiological functions and underlying mechanisms of endogenous CaMKII inhibitory proteins in cell cycle progression. Here we report the characterization of a novel human endogenous CaMKII inhibitor, human CaMKII inhibitory protein alpha(hCaMKIIN alpha), which directly interacts with activated CaMKII and effectively inhibits CaMKII activity. hCaMKIIN alpha expression is negatively correlated with the severity of human colon adenocarcinoma. Overexpression of hCaMKIIN alpha inhibits colon adenocarcinoma growth in vitro and in vivo by arresting the cell cycle at the S phase through its conserved inhibitory region (27CIR), whereas silencing the hCaMKIIN alpha expression accelerates tumor growth and cell cycle progression. We found that the effect of hCaMKIIN alpha on cell cycle is correlated with up-regulation of p27 expression, which may be due to the inhibition of proteasome degradation, but not transcriptional regulation, of p27. Moreover, hCaMKIIN alpha deactivated MEK/ERK, which is prerequisite to the inhibition of Thr-187 phosphorylation and subsequent proteasomal degradation of p27, causing the inhibition of S-phase progression of cell cycle. The findings underscore a link between hCaMKIIN alpha-mediated inhibition of CaMKII activity and p27-dependent pathways in controlling tumor cell growth and cell cycle and imply a potential application of hCaMKIIN alpha in the therapeutics of colon cancers.	[Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Cao, XT (corresponding author), Second Mil Med Univ, Inst Immunol, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.	caoxt@public3.sta.net.cn						Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Illario M, 2005, J CLIN ENDOCR METAB, V90, P2865, DOI 10.1210/jc.2004-1520; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; ISHIDA A, 1995, J BIOL CHEM, V270, P2163, DOI 10.1074/jbc.270.5.2163; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; LORCA T, 1991, EMBO J, V10, P2087, DOI 10.1002/j.1460-2075.1991.tb07741.x; MINAMI H, 1994, BIOCHEM BIOPH RES CO, V199, P241, DOI 10.1006/bbrc.1994.1220; Moore HG, 2004, ANN SURG ONCOL, V11, P955, DOI 10.1245/ASO.2004.03.095; Morris TA, 1998, EXP CELL RES, V240, P218, DOI 10.1006/excr.1997.3925; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; PINOL MR, 1988, FEBS LETT, V231, P445, DOI 10.1016/0014-5793(88)80868-8; RASMUSSEN G, 1995, BIOCHEM CELL BIOL, V73, P201, DOI 10.1139/o95-024; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; TERASAWA M, 1991, J BIOCHEM-TOKYO, V110, P417, DOI 10.1093/oxfordjournals.jbchem.a123596; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wen Y, 2001, CANCER RES, V61, P7142; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yang LJ, 2004, J BIOL CHEM, V279, P11639, DOI 10.1074/jbc.M312895200; Zhang J, 2001, BIOCHEM BIOPH RES CO, V285, P229, DOI 10.1006/bbrc.2001.5175	30	62	68	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11565	11574		10.1074/jbc.M800436200	http://dx.doi.org/10.1074/jbc.M800436200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305109	Green Published, hybrid			2022-12-27	WOS:000255067400057
J	Jorgensen, R; Purdy, AE; Fieldhouse, RJ; Kimber, MS; Bartlett, DH; Merrill, AR				Jorgensen, Rene; Purdy, Alexandra E.; Fieldhouse, Robert J.; Kimber, Matthew S.; Bartlett, Douglas H.; Merrill, A. Rod			Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA EXOTOXIN; VIRULENCE FACTORS; CRYSTAL-STRUCTURE; ENVIRONMENTAL STRAINS; INFECTIOUS-DISEASE; CATALYTIC DOMAIN; DIPHTHERIA-TOXIN; SECRETION SYSTEM; IN-VITRO; NON-O1	The ADP-ribosyltransferases are a class of enzymes that display activity in a variety of bacterial pathogens responsible for causing diseases in plants and animals, including those affecting mankind, such as diphtheria, cholera, and whooping cough. We report the characterization of a novel toxin from Vibrio cholerae, which we call cholix toxin. The toxin is active against mammalian cells (IC50 = 4.6 +/- 0.4 ng/ml) and crustaceans (Artemia nauplii LD50 = 10 +/- 2 mu g/ml). Here we show that this toxin is the third member of the diphthamide-specific class of ADP-ribose transferases and that it possesses specific ADP-ribose transferase activity against ribosomal eukaryotic elongation factor 2. We also describe the high resolution crystal structures of the multidomain toxin and its catalytic domain at 2.1- and 1.25-angstrom resolution, respectively. The new structural data show that cholix toxin possesses the necessary molecular features required for infection of eukaryotes by receptor-mediated endocytosis, translocation to the host cytoplasm, and inhibition of protein synthesis by specific modification of elongation factor 2. The crystal structures also provide important insight into the structural basis for activation of toxin ADP-ribosyltransferase activity. These results indicate that cholix toxin may be an important virulence factor of Vibrio cholerae that likely plays a significant role in the survival of the organism in an aquatic environment.	[Purdy, Alexandra E.; Bartlett, Douglas H.] Univ Calif San Diego, Marine Biol Res Div, Ctr Marine Biotechnol & Biomed, Biol Grade Scripps Inst Oceanog 8750, La Jolla, CA 92093 USA; [Jorgensen, Rene; Fieldhouse, Robert J.; Kimber, Matthew S.; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Guelph	Bartlett, DH (corresponding author), Univ Calif San Diego, Marine Biol Res Div, Ctr Marine Biotechnol & Biomed, Biol Grade Scripps Inst Oceanog 8750, La Jolla, CA 92093 USA.	dbartlett@ucsd.edu	Jørgensen, René/P-5619-2014; Merrill, Rod/M-8313-2014; Kimber, Matthew/Q-8144-2019	Jørgensen, René/0000-0003-0672-466X; Kimber, Matthew/0000-0001-9454-5586	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI46600-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046600] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alam M, 2006, APPL ENVIRON MICROB, V72, P4096, DOI 10.1128/AEM.00066-06; Alouf J. E, 1999, COMPREHENSIVE SOURCE, V2nd; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P9042, DOI 10.1021/bi960396k; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns D., 2003, BACTERIAL PROTEIN TO; Chen Y, 2007, INFECT IMMUN, V75, P2645, DOI 10.1128/IAI.01317-06; CHIRON MF, 1994, J BIOL CHEM, V269, P18167; Chow KH, 2001, J CLIN MICROBIOL, V39, P2594, DOI 10.1128/JCM.39.7.2594-2597.2001; CHUNG DW, 1977, INFECT IMMUN, V16, P832, DOI 10.1128/IAI.16.3.832-841.1977; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Dalsgaard A, 2000, CLIN MICROBIOL INFEC, V6, P625, DOI 10.1046/j.1469-0691.2000.00174.x; DALSGAARD A, 1995, J CLIN MICROBIOL, V33, P2715, DOI 10.1128/JCM.33.10.2715-2722.1995; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; GALLOWAY DR, 1989, J BIOL CHEM, V264, P14869; Halpern M, 2003, APPL ENVIRON MICROB, V69, P4200, DOI 10.1128/AEM.69.7.4200-4204.2003; Hessler JL, 1997, BIOCHEMISTRY-US, V36, P14577, DOI 10.1021/bi971447w; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; INOCENCIO NM, 1994, J BIOL CHEM, V269, P31831; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jorgensen R, 2006, BIOCHEM SOC T, V34, P1; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; KONDO T, 1988, J BIOL CHEM, V263, P9470; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPPLA SH, 1978, BIOCHEM BIOPH RES CO, V81, P532, DOI 10.1016/0006-291X(78)91567-X; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; LI M, 1995, P NATL ACAD SCI USA, V92, P9308, DOI 10.1073/pnas.92.20.9308; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; LORY S, 1980, INFECT IMMUN, V28, P494; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Makri S, 2007, MICROBES INFECT, V9, P1351, DOI 10.1016/j.micinf.2007.06.011; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MIDDLEBROOK JL, 1977, CAN J MICROBIOL, V23, P183, DOI 10.1139/m77-026; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OGATA M, 1990, J BIOL CHEM, V265, P20678; PERENTESIS JP, 1992, BIOFACTORS, V3, P173; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Purdy A, 2005, J BACTERIOL, V187, P2992, DOI 10.1128/JB.187.9.2992-3001.2005; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Ruby EG, 2005, P NATL ACAD SCI USA, V102, P3004, DOI 10.1073/pnas.0409900102; Sarkar B, 2002, EPIDEMIOL INFECT, V129, P245, DOI 10.1017/S0950268802007392; Sharma C, 1998, J CLIN MICROBIOL, V36, P756, DOI 10.1128/JCM.36.3.756-763.1998; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WILSON BA, 1992, CURR TOP MICROBIOL, V175, P27; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480	61	100	107	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10671	10678		10.1074/jbc.M710008200	http://dx.doi.org/10.1074/jbc.M710008200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18276581	hybrid			2022-12-27	WOS:000254894700049
J	Thiaville, MM; Pan, YX; Gjymishka, A; Zhong, C; Kaufman, RJ; Kilberg, MS				Thiaville, Michelle M.; Pan, Yuan-Xiang; Gjymishka, Altin; Zhong, Can; Kaufman, Randal J.; Kilberg, Michael S.			MEK signaling is required for phosphorylation of eIF2 alpha following amino acid limitation of HepG2 human hepatoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INDUCED GENE-EXPRESSION; TRANSLATIONAL CONTROL; TRANSPORT SYSTEM; TRANSFER-RNA; DEPRIVATION; BINDING; KINASE; DEPHOSPHORYLATION; REINITIATION	The mammalian amino acid response (AAR) pathway is upregulated by protein or amino acid depletion. This pathway involves detection of uncharged tRNA by the GCN2 kinase, phosphorylation of the translation initiation factor eIF2 alpha (eukaryotic initiation factor 2 alpha), and, through subsequent translational control, enhanced de novo synthesis of the transcription factor ATF4. The present studies demonstrate that inhibition of MEK activation in HepG2 human hepatoma cells by PD98059 or U0126 blocked the increased phosphorylation of eIF2 alpha and ATF4 synthesis triggered by amino acid limitation, showing that the AAR requires activation of the MEK-ERK pathway. Inhibitors of the JNK or p38 MAPK pathways were ineffective. Consequently, inhibition of MEK activation blocked transcriptional induction of ATF4 target genes, but the induction was rescued by overexpression of ATF4 protein. Furthermore, the enhanced ERK phosphorylation following amino acid deprivation required GCN2 kinase activity and eIF2 alpha phosphorylation. Inhibition of protein phosphatase 1 action on phospho-eIF2 alpha by knockdown of GADD34 did not block the sensitivity to PD98059, suggesting that MEK functions to enhance GCN2-dependent eIF2 alpha phosphorylation rather than suppressing dephosphorylation. Collectively, these results document a critical interdependence between the MEK-ERK MAPK signaling pathway and the amino acid stress-activated pathway.	[Thiaville, Michelle M.; Pan, Yuan-Xiang; Gjymishka, Altin; Zhong, Can; Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Genet Inst,Shands Canc Ctr, Gainesville, FL 32610 USA; [Thiaville, Michelle M.; Pan, Yuan-Xiang; Gjymishka, Altin; Zhong, Can; Kilberg, Michael S.] Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA; [Kaufman, Randal J.] Univ Michigan, Ctr Med, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Ctr Med, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Genet Inst,Shands Canc Ctr, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Pan, Yuan-Xiang/C-6576-2019	Pan, Yuan-Xiang/0000-0003-3219-4367	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052064, R01DK042394, R01DK070647, R37DK042394] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL-52173] Funding Source: Medline; NIDDK NIH HHS [DK-42394, R01 DK052064, R01 DK070647, DK70647, DK-52064] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Bain PJ, 2002, J NUTR, V132, P3023, DOI 10.1093/jn/131.10.3023; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Gazzola RF, 2001, FEBS LETT, V490, P11; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KILBERG MS, 1989, METHOD ENZYMOL, V173, P564; Leung-Pineda V, 2004, BIOCHEM J, V379, P79, DOI 10.1042/BJ20031383; Leung-Pineda V, 2002, J BIOL CHEM, V277, P16585, DOI 10.1074/jbc.M110972200; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Monick MM, 2006, J IMMUNOL, V177, P1636, DOI 10.4049/jimmunol.177.3.1636; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharp JW, 2006, J COMP NEUROL, V494, P485, DOI 10.1002/cne.20817; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; STRAUS DS, 1993, ENDOCRINOLOGY, V132, P1090, DOI 10.1210/en.132.3.1090; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Zykova TA, 2007, CARCINOGENESIS, V28, P1543, DOI 10.1093/carcin/bgm070	35	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10848	10857		10.1074/jbc.M708320200	http://dx.doi.org/10.1074/jbc.M708320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18287093	Green Published, hybrid			2022-12-27	WOS:000254894700067
J	Zhao, YM; Zhang, JF; Li, HY; Li, YY; Ren, J; Luo, M; Zheng, X				Zhao, Yanmei; Zhang, Jinfang; Li, Huiying; Li, Yiyu; Ren, Jie; Luo, Ming; Zheng, Xiaofeng			An NADPH sensor protein (HSCARG) down-regulates nitric oxide synthesis by association with argininosuccinate synthetase and is essential for epithelial cell viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CANCER BIOLOGY; L-ARGININE; APOPTOSIS; EXPRESSION; SYNTHASE; BINDING; NO; BIOSYNTHESIS; REGENERATION	NADPH is an important cofactor in many biosynthesis pathways that control fundamental cellular processes. We recently determined the crystal structure of HSCARG, with functions previously unknown, and demonstrated it is an NADPH sensor, which undergoes restructuring and redistribution in response to changes of intracellular NADPH/NADP levels. In this study, we identified argininosuccinate synthetase (AS), a rate-limiting enzyme in nitric oxide synthesis, as capable of associating with HSCARG and demonstrated further that HSCARG decreased nitric oxide synthesis by down-regulating AS activity, whereas AS overexpression up-regulated hscarg mRNA transcription, suggesting a negative feedback mechanism. A decrease in the NADPH/NADP(+) ratio, induced by dehydroepiandrosterone treatment, enhanced the interaction between HSCARG and AS, which resulted in stronger inhibition of AS activity and nitric oxide production. The dimerization region of HSCARG, amino acids 153-189, was identified to undergo critical interactions with AS. Furthermore, the viability of HSCARG RNA interference-treated epithelial cells decreased significantly, accompanied by an increase of the activity of caspase-3, which suggested that the loss of viability was because of apoptosis. These results indicate that HSCARG regulation of AS activity is crucial for maintaining the intracellular balance between redox state and nitric oxide levels.	[Zhao, Yanmei; Zhang, Jinfang; Li, Huiying; Luo, Ming; Zheng, Xiaofeng] Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China; [Zhao, Yanmei; Zhang, Jinfang; Li, Huiying; Li, Yiyu; Ren, Jie; Zheng, Xiaofeng] Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Luo, Ming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Peking University; University of Alabama System; University of Alabama Birmingham	Zheng, X (corresponding author), Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn						Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Brasse-Lagnel C, 2006, BIOCHIMIE, V88, P607, DOI 10.1016/j.biochi.2005.11.005; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BURCH HB, 1967, J BIOL CHEM, V242, P4546; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S; Dai XY, 2006, PROTEIN PEPTIDE LETT, V13, P955, DOI 10.2174/092986606778256135; Dimmeler S, 1997, NITRIC OXIDE-BIOL CH, V1, P275, DOI 10.1006/niox.1997.0133; El Omari K, 2005, J BIOL CHEM, V280, P18229, DOI 10.1074/jbc.M501113200; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Filomeni G, 2002, BIOCHEM PHARMACOL, V64, P1057, DOI 10.1016/S0006-2952(02)01176-0; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Goodwin BL, 2004, J BIOL CHEM, V279, P18353, DOI 10.1074/jbc.M308160200; Gow AJ, 2001, J CELL PHYSIOL, V187, P277, DOI 10.1002/jcp.1085; Haendeler J, 1997, NITRIC OXIDE-BIOL CH, V1, P282, DOI 10.1006/niox.1997.0134; Haendeler J, 1999, VITAM HORM, V57, P49; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751; HATTORI Y, 1994, J BIOL CHEM, V269, P9405; HECKER M, 1990, P NATL ACAD SCI USA, V87, P8612, DOI 10.1073/pnas.87.21.8612; Kim HM, 2007, DIABETES RES CLIN PR, V75, P111, DOI 10.1016/j.diabres.2006.04.009; Lamb HK, 2004, PROTEIN SCI, V13, P3127, DOI 10.1110/ps.04958904; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Melino G, 2000, CELL MOL LIFE SCI, V57, P612, DOI 10.1007/PL00000723; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Shen YH, 1998, FEBS LETT, V433, P125, DOI 10.1016/S0014-5793(98)00844-8; Solomonson LP, 2003, J EXP BIOL, V206, P2083, DOI 10.1242/jeb.00361; Stammers DK, 2001, EMBO J, V20, P6619, DOI 10.1093/emboj/20.23.6619; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vallance P, 2001, HEART, V85, P342, DOI 10.1136/heart.85.3.342; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wang CCC, 2008, CANCER LETT, V259, P82, DOI 10.1016/j.canlet.2007.10.005; Wiley JW, 2007, NEUROGASTROENT MOTIL, V19, P541, DOI 10.1111/j.1365-2982.2007.00958.x; Xie LJ, 1997, J BIOL CHEM, V272, P16624, DOI 10.1074/jbc.272.26.16624; Ying WH, 2006, FRONT BIOSCI-LANDMRK, V11, P3129, DOI 10.2741/2038; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	50	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					11004	11013		10.1074/jbc.M708697200	http://dx.doi.org/10.1074/jbc.M708697200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18263583	hybrid			2022-12-27	WOS:000254894700081
J	Heine, GF; Horwitz, AA; Parvin, JD				Heine, George F.; Horwitz, Andrew A.; Parvin, Jeffrey D.			Multiple mechanisms contribute to inhibit transcription in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; UBIQUITIN-PROTEIN LIGASE; LARGE SUBUNIT; IN-VITRO; INDUCED DEGRADATION; FACTOR TFIIH; BRCA1; PHOSPHORYLATION; COMPLEX	Cellular DNA damage elicits the phosphorylation and ubiquitination of RNA polymerase II (RNAPII), leading to the global repression of transcription. In this report we show that there are at least two different pathways to transcriptional repression, depending on the type of DNA damage. After H2O2 treatment, transcription was rapidly inhibited and rapidly restored. On the other hand, UV irradiation caused a much slower transcriptional inhibition, with a corresponding depletion of unphosphorylated RNAPII. We found that after UV treatment, but not treatment with H2O2, the inhibition of transcription was dependent on both the proteasome and new protein synthesis. In addition, RNAPII activity and ubiquitination were regulated through the phosphorylation of RNAPII by the P-TEFb kinase. These results highlight that multiple cellular pathways exist to globally repress transcriptional processes that might interfere with the repair of DNA damage.	[Heine, George F.; Parvin, Jeffrey D.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Heine, George F.; Parvin, Jeffrey D.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Heine, George F.; Horwitz, Andrew A.; Parvin, Jeffrey D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Heine, George F.; Horwitz, Andrew A.; Parvin, Jeffrey D.] Brigham & Womens Hosp, Boston, MA 02115 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Parvin, JD (corresponding author), 960 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Jeffrey.Parvin@OSUMC.edu	Parvin, Jeffrey D/C-8955-2009		NATIONAL CANCER INSTITUTE [R01CA090281, F32CA130302] Funding Source: NIH RePORTER; NCI NIH HHS [CA 130302, CA 90281] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; BURATOWSKI S, 1988, NATURE, V334, P37, DOI 10.1038/334037a0; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Horwitz AA, 2006, J BIOL CHEM, V281, P8317, DOI 10.1074/jbc.C500475200; Horwitz AA, 2007, P NATL ACAD SCI USA, V104, P6614, DOI 10.1073/pnas.0610481104; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Jung Y, 2006, J BIOL CHEM, V281, P1361, DOI 10.1074/jbc.M509688200; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Ljungman M, 1996, ONCOGENE, V13, P823; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; McKay BC, 2001, MUTAT RES-DNA REPAIR, V485, P93, DOI 10.1016/S0921-8777(00)00064-1; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Schlegel BP, 2000, P NATL ACAD SCI USA, V97, P3148, DOI 10.1073/pnas.070452397; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Starita LM, 2005, J BIOL CHEM, V280, P24498, DOI 10.1074/jbc.M414020200; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Wu WW, 2007, CANCER RES, V67, P951, DOI 10.1158/0008-5472.CAN-06-3187; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	39	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9555	9561		10.1074/jbc.M707700200	http://dx.doi.org/10.1074/jbc.M707700200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18281289	Green Published, hybrid			2022-12-27	WOS:000254671600008
J	Taylor, EB; An, D; Kramer, HF; Yu, H; Fujii, NL; Roeckl, KSC; Bowles, N; Hirshman, MF; Xie, JX; Feener, EP; Goodyear, LJ				Taylor, Eric B.; An, Ding; Kramer, Henning F.; Yu, Haiyan; Fujii, Nobuharu L.; Roeckl, Katja S. C.; Bowles, Nicole; Hirshman, Michael F.; Xie, Jianxin; Feener, Edward P.; Goodyear, Laurie J.			Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; GLUT4 TRANSLOCATION; AKT SUBSTRATE; PHOSPHORYLATION ANALYSIS; GLUCOSE-TRANSPORT; AS160 PHOSPHORYLATION; KINASE; BINDING; DOMAIN; JAK2	The Akt substrate of 160 kDa (AS160) is phosphorylated on Akt substrate (PAS) motifs in response to insulin and contraction in skeletal muscle, regulating glucose uptake. Here we discovered a dissociation between AS160 protein expression and apparent AS160 PAS phosphorylation among soleus, tibialis anterior, and extensor digitorum longus muscles. Immuno-depletion of AS160 in tibialis anterior muscle lysates resulted in minimal depletion of the PAS band at 160 kDa, suggesting the presence of an additional PAS immunoreactive protein. By immunoprecipitation and mass spectrometry, we identified this protein as the AS160 paralog TBC1D1, an obesity candidate gene regulating GLUT4 translocation in adipocytes. TBC1D1 expression was severalfold higher in skeletal muscles compared with all other tissues and was the dominant protein detected by the anti-PAS antibody at 160 kDa in tibialis anterior and extensor digitorum longus but not soleus muscles. In vivo stimulation by insulin, contraction, and the AMP-activated protein kinase (AMPK) activator AICAR increased TBC1D1 PAS phosphorylation. Using mass spectrometry on TBC1D1 from mouse skeletal muscle, we identified several novel phosphorylation sites on TBC1D1 and found the majority were consensus or near consensus sites for AMPK. Semiquantitative analysis of spectra suggested that AICAR caused greater overall phosphorylation of TBC1D1 sites compared with insulin. Purified Akt and AMPK phosphorylated TBC1D1 in vitro, and AMPK, but not Akt, reduced TBC1D1 electrophoretic mobility. TBC1D1 is a major PAS immunoreactive protein in skeletal muscle that is phosphorylated in vivo by insulin, AICAR, and contraction. Both Akt and AMPK phosphorylate TBC1D1, but AMPK may be the more robust regulator.	[Taylor, Eric B.; An, Ding; Kramer, Henning F.; Yu, Haiyan; Fujii, Nobuharu L.; Roeckl, Katja S. C.; Bowles, Nicole; Hirshman, Michael F.; Goodyear, Laurie J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Metab Sect, Boston, MA 02215 USA; [Feener, Edward P.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Proteom Core, Boston, MA 02215 USA; [Xie, Jianxin] Cell Signaling Technol Inc, Danvers, MA 01923 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Goodyear, LJ (corresponding author), 1 Joslin Pl, Boston, MA 02215 USA.	laurie.goodyear@joslin.harvard.edu	Fujii, Nobuharu/J-2724-2014	Fujii, Nobuharu/0000-0002-0974-3033; Taylor, Eric/0000-0003-4549-6567	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045670, R01AR042238, R29AR042238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK075851, P30DK036836] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR045670, AR 42238, R01 AR042238, AR 45670] Funding Source: Medline; NIDDK NIH HHS [F32 DK075851, F32 DK 075851, DK 36836] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bamman MM, 1999, ELECTROPHORESIS, V20, P466, DOI 10.1002/(SICI)1522-2683(19990301)20:3<466::AID-ELPS466>3.0.CO;2-7; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bouzakri K, 2006, DIABETES, V55, P785, DOI 10.2337/diabetes.55.03.06.db05-0796; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Deshmukh A, 2006, DIABETES, V55, P1776, DOI 10.2337/db05-1419; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Feener EP, 2004, MOL CELL BIOL, V24, P4968, DOI 10.1128/MCB.24.11.4968-4978.2004; Gao BB, 2006, BIOCHEM J, V397, P337, DOI 10.1042/BJ20060095; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Ishida-Takahashi R, 2006, MOL CELL BIOL, V26, P4063, DOI 10.1128/MCB.01589-05; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Karlsson HKR, 2005, DIABETES, V54, P1459, DOI 10.2337/diabetes.54.5.1459; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Kramer HF, 2007, DIABETES, V56, P2854, DOI 10.2337/db07-0681; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Richter EA, 2004, P NUTR SOC, V63, P211, DOI 10.1079/PNS2004343; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treebak JT, 2007, AM J PHYSIOL-ENDOC M, V292, pE715, DOI 10.1152/ajpendo.00380.2006; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	41	190	194	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9787	9796		10.1074/jbc.M708839200	http://dx.doi.org/10.1074/jbc.M708839200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18276596	Green Published, hybrid			2022-12-27	WOS:000254671600033
J	Beck, BD; Park, SJ; Lee, YJ; Roman, Y; Hromas, RA; Lee, SH				Beck, Brian D.; Park, Su-Jung; Lee, Young-Ju; Roman, Yaritzabel; Hromas, Robert A.; Lee, Suk-Hee			Human pso4 is a metnase (SETMAR)-binding partner that regulates metnase function in DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; REPLICATION PROTEIN-A; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; U-BOX; MRE11 COMPLEX; DAMAGE; TRANSPOSASE; GENE; BINDING	Metnase, also known as SETMAR, is a SET and transposase fusion protein with an undefined role in mammalian DNA repair. The SET domain is responsible for histone lysine methyltransferase activity at histone 3K4 and K36, whereas the transposase domain possesses 5'-terminal inverted repeat (TIR)-specific DNA binding, DNA looping, and DNA cleavage activities. Although the transposase domain is essential for Metnase function in DNA repair, it is not clear how a protein with sequence-specific DNA binding activity plays a role in DNA repair. Here, we show that human homolog of the ScPSO4/PRP19 (hPso4) forms a stable complex with Metnase on both TIR and non-TIR DNA. The transposase domain essential for Metnase-TIR interaction is not sufficient for its interaction with non-TIRDNA in the presence of hPso4. In vivo, hPso4 is induced and co-localized with Metnase following ionizing radiation treatment. Cells treated with hPso4-siRNA failed to show Metnase localization at DSB sites and Metnase-mediated stimulation of DNA end joining coupled to genomic integration, suggesting that hPso4 is necessary to bring Metnase to the DSB sites for its function(s) in DNA repair.	[Beck, Brian D.; Park, Su-Jung; Lee, Young-Ju; Roman, Yaritzabel; Lee, Suk-Hee] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Beck, Brian D.; Lee, Young-Ju; Lee, Suk-Hee] Indiana Univ, Sch Med, Walther Canc Inst, Indianapolis, IN 46202 USA; [Hromas, Robert A.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Hromas, Robert A.] Univ New Mexico, Canc Treatment Res Ctr, Albuquerque, NM 87131 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; University of New Mexico; University of New Mexico	Lee, SH (corresponding author), IU Canc Res Inst, 1044 W Walnut St,Rm 153, Indianapolis, IN 46202 USA.	slee@iupui.edu			NATIONAL CANCER INSTITUTE [T32CA111198] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA 111198-01, CA 92111] Funding Source: Medline; NIDDK NIH HHS [T32 DK 0075-20] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Brendel M, 2003, MUTAT RES-REV MUTAT, V544, P179, DOI 10.1016/j.mrrev.2003.06.018; Brendel M, 2001, MUTAT RES-REV MUTAT, V489, P79, DOI 10.1016/S1383-5742(01)00066-7; Chen Jake Y, 2006, Comput Syst Bioinformatics Conf, P389; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; DASILVA KVCL, 1995, CURR GENET, V27, P207, DOI 10.1007/BF00326150; DEANDRADE HHR, 1989, MOL GEN GENET, V217, P419; Gerner C, 1999, J CELL BIOCHEM, V72, P470, DOI 10.1002/(SICI)1097-4644(19990315)72:4<470::AID-JCB3>3.0.CO;2-V; Gotzmann J, 2000, EXP CELL RES, V261, P166, DOI 10.1006/excr.2000.5025; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; HENRIQUES JAP, 1989, MUTAT RES, V218, P111, DOI 10.1016/0921-8777(89)90017-7; Jordan IK, 2006, P NATL ACAD SCI USA, V103, P7941, DOI 10.1073/pnas.0602656103; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Leschziner AE, 1998, P NATL ACAD SCI USA, V95, P7345, DOI 10.1073/pnas.95.13.7345; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Loscher M, 2005, BIOCHEM J, V388, P593, DOI 10.1042/BJ20041517; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mahajan KN, 1999, P NATL ACAD SCI USA, V96, P13926, DOI 10.1073/pnas.96.24.13926; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; MEIRA LB, 1992, MOL GEN GENET, V235, P311, DOI 10.1007/BF00279375; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Murti KG, 1996, EXP CELL RES, V223, P279, DOI 10.1006/excr.1996.0083; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Park JS, 1999, J BIOL CHEM, V274, P29075, DOI 10.1074/jbc.274.41.29075; Park SJ, 2004, J BIOL CHEM, V279, P6046, DOI 10.1074/jbc.M311054200; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; ROMAN Y, 2007, BIOCHEMISTRY; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Skalka AM, 2005, CELL DEATH DIFFER, V12, P971, DOI 10.1038/sj.cdd.4401573; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; VOS JC, 1994, EMBO J, V13, P6125, DOI 10.1002/j.1460-2075.1994.tb06959.x; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	42	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9023	9030		10.1074/jbc.M800150200	http://dx.doi.org/10.1074/jbc.M800150200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18263876	Green Published, hybrid			2022-12-27	WOS:000254465800032
J	Dhawan, P; Su, YJ; Thu, YM; Yu, YC; Baugher, P; Ellis, DL; Sobolik-Delmaire, T; Kelley, M; Cheung, TC; Ware, CF; Richmond, A				Dhawan, Punita; Su, Yingjun; Thu, Yee Mon; Yu, Yingchun; Baugher, Paige; Ellis, Darrel L.; Sobolik-Delmaire, Tammy; Kelley, Mark; Cheung, Timothy C.; Ware, Carl F.; Richmond, Ann			The lymphotoxin-beta receptor is an upstream activator of NF-kappa B-mediated transcription in melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IN-VIVO; KINASE; NUCLEAR; ALPHA; ALYMPHOPLASIA; INHIBITOR; PATHWAY; TNF; PHOSPHORYLATION	The pleiotropic transcription factor nuclear factor-kappa B (NF-kappa B (p50/p65)) regulates the transcription of genes involved in the modulation of cell proliferation, apoptosis, and oncogenesis. Furthermore, a host of solid and hematopoietic tumor types exhibit constitutive activation of NF-kappa B (Basseres, D. S., and Baldwin, A. S. (2006) 25,6817-6830). However, the mechanism for this constitutive activation of NF-kappa B has not been elucidated in the tumors. We have previously shown that NF-kappa B-inducing kinase (NIK) protein and its association with Inhibitor of kappa B kinase alpha beta are elevated in melanoma cells compared with their normal counterpart, leading to constitutive activation of NF-kappa B. Moreover, expression of dominant negative NIK blocked this base-line NF-kappa B activity in melanoma cells. Of the three receptors that require NIK for activation of NF-kappa B only the lymphotoxin-beta receptor (LT beta-R) is expressed in melanoma. We show in this manuscript that for melanoma there is a strong relationship between expression of the LT beta-R and constitutive NF-kappa B transcriptional activity. Moreover, we show that activation of the LT beta-R can drive NF-kappa B. activity to regulate gene expression that leads to enhanced cell growth. The inhibition by LT beta-R shRNA resulted in decreased NF-kappa B promoter activity, decreased growth, and decreased invasiveness as compared with control. These results indicate that the LT beta-R constitutively induces NF-kappa B activation, and this event maybe associated with autonomous growth of melanoma cells.	[Richmond, Ann] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Dhawan, Punita; Su, Yingjun; Thu, Yee Mon; Yu, Yingchun; Baugher, Paige; Sobolik-Delmaire, Tammy; Richmond, Ann] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Dhawan, Punita; Kelley, Mark] Vanderbilt Univ, Med Ctr, Surg Oncol Res Labs, Dept Surg, Nashville, TN 37232 USA; [Ellis, Darrel L.] Vanderbilt Univ, Med Ctr, Div Dermatol, Dept Med, Nashville, TN 37232 USA; [Cheung, Timothy C.; Ware, Carl F.] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; La Jolla Institute for Immunology	Richmond, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 23rd Ave S Pierce,PRB 432, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	NATIONAL CANCER INSTITUTE [P30CA068485, R01CA098807, R01CA056704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001943] Funding Source: NIH RePORTER; NCI NIH HHS [CA 56704, P30 CA068485, CA 098807, R01 CA098807, R01 CA098807-03, CA 68485] Funding Source: Medline; NHLBI NIH HHS [T30 HL 07751, T32 HL007751] Funding Source: Medline; NIAMS NIH HHS [SP30 AR 1943] Funding Source: Medline; BLRD VA [IK6 BX005225] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); BLRD VA		Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Dhawan P, 2002, CANCER RES, V62, P7335; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karrer U, 2000, EUR J IMMUNOL, V30, P2799, DOI 10.1002/1521-4141(200010)30:10<2799::AID-IMMU2799>3.0.CO;2-2; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Lukashev M, 2006, CANCER RES, V66, P9617, DOI 10.1158/0008-5472.CAN-06-0217; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mortarini R, 2005, CANCER RES, V65, P3428, DOI 10.1158/0008-5472.CAN-04-3239; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stahl JM, 2003, CANCER RES, V63, P2881; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yang JM, 2007, CANCER RES, V67, P3127, DOI 10.1158/0008-5472.CAN-06-3547; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220; Yang JM, 2001, CANCER RES, V61, P4901; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	36	33	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15399	15408		10.1074/jbc.M708272200	http://dx.doi.org/10.1074/jbc.M708272200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18347013	hybrid, Green Published			2022-12-27	WOS:000256232000058
J	Ito, K; Nakanishi, M; Lee, WC; Zhi, Y; Sasaki, H; Zenno, S; Saigo, K; Kitade, Y; Tanokura, M				Ito, Kosuke; Nakanishi, Masayuki; Lee, Woo-Cheol; Zhi, Yuehua; Sasaki, Hiroshi; Zenno, Shuhei; Saigo, Kaoru; Kitade, Yukio; Tanokura, Masaru			Expansion of substrate specificity and catalytic mechanism of azoreductase by X-ray crystallography and site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENOME SEQUENCE; REDUCTASE; FLAVIN; ENZYME; PURIFICATION; DEGRADATION; NAD(P)H; PROGRAM; BINDING	AzoR is an FMN-dependent NADH-azoreductase isolated from Escherichia coli as a protein responsible for the degradation of azo compounds. We previously reported the crystal structure of the enzyme in the oxidized form. In the present study, different structures of AzoR were determined under several conditions to obtain clues to the reaction mechanism of the enzyme. AzoR in its reduced form revealed a twisted butterfly bend of the isoalloxazine ring of the FMN cofactor and a rearrangement of solvent molecules. The crystal structure of oxidized AzoR in a different space group and the structure of the enzyme in complex with the inhibitor dicoumarol were also determined. These structures indicate that the formation of a hydrophobic part around the isoalloxazine ring is important for substrate binding and an electrostatic interaction between Arg-59 and the carboxyl group of the azo compound causes a substrate preference for methyl red over p-methyl red. The substitution of Arg-59 with Ala enhanced the V-max value for p-methyl red 27-fold with a 3.8-fold increase of the K-m value. This result indicates that Arg-59 decides the substrate specificity of AzoR. The V-max value for the p-methyl red reduction of the R59A mutant is comparable with that for the methyl red reduction of the wild-type enzyme, whereas the activity toward methyl red was retained. These findings indicate the expansion of AzoR substrate specificity by a single amino acid substitution. Furthermore, we built an authentic model of the AzoR-methyl red complex based on the results of the study.	[Ito, Kosuke; Lee, Woo-Cheol; Zhi, Yuehua; Sasaki, Hiroshi; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Nakanishi, Masayuki; Kitade, Yukio] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan; [Zenno, Shuhei; Saigo, Kaoru] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan	University of Tokyo; Gifu University; University of Tokyo	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Tanokura, Masaru/0000-0001-5072-2480				Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEINERT WD, 1985, EUR J BIOCHEM, V152, P573, DOI 10.1111/j.1432-1033.1985.tb09234.x; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; DeLano W.L, PYMOL MOL GRAPHICS S; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; DIXON DA, 1979, BIOCHEMISTRY-US, V18, P5770, DOI 10.1021/bi00593a004; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Faig M, 2000, P NATL ACAD SCI USA, V97, P3177, DOI 10.1073/pnas.050585797; Foster CE, 1999, BIOCHEMISTRY-US, V38, P9881, DOI 10.1021/bi990799v; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Ghosh Dilip K., 1993, Indian Journal of Experimental Biology, V31, P951; GHOSH DK, 1992, FEMS MICROBIOL LETT, V98, P229, DOI 10.1016/0378-1097(92)90161-G; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; HUANG MT, 1979, J BIOL CHEM, V254, P3930; Ito K, 2005, ACTA CRYSTALLOGR F, V61, P399, DOI 10.1107/S1744309105007918; Ito K, 2006, J BIOL CHEM, V281, P20567, DOI 10.1074/jbc.M513345200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khan H, 2002, J BIOL CHEM, V277, P21906, DOI 10.1074/jbc.M200637200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; Liger D, 2004, J BIOL CHEM, V279, P34890, DOI 10.1074/jbc.M405404200; Maier J, 2004, APPL ENVIRON MICROB, V70, P837, DOI 10.1128/AEM.70.2.837-844.2004; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moutaouakkil A, 2003, ARCH BIOCHEM BIOPHYS, V413, P139, DOI 10.1016/S0003-9861(03)00096-1; Muller F, 1991, CHEM BIOCH FLAVOENZY, V1, P1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai S, 1999, THEOR CHEM ACC, V103, P109, DOI 10.1007/s002140050521; Nakanishi M, 2001, J BIOL CHEM, V276, P46394, DOI 10.1074/jbc.M104483200; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; RAFII F, 1993, APPL ENVIRON MICROB, V59, P1731, DOI 10.1128/AEM.59.6.1731-1734.1993; Ramalho PA, 2005, APPL ENVIRON MICROB, V71, P3882, DOI 10.1128/AEM.71.7.3882-3888.2005; Suzuki Y, 2001, J BIOL CHEM, V276, P9059, DOI 10.1074/jbc.M008083200; TRUS BL, 1969, ACTA CRYSTALL B-STRU, VB 25, P1911, DOI 10.1107/S0567740869004900; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zheng YJ, 1996, J AM CHEM SOC, V118, P9402, DOI 10.1021/ja9608151; ZIMMERMANN T, 1984, ARCH MICROBIOL, V138, P37, DOI 10.1007/BF00425404; ZIMMERMANN T, 1982, EUR J BIOCHEM, V129, P197, DOI 10.1111/j.1432-1033.1982.tb07040.x	43	45	50	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13889	13896		10.1074/jbc.M710070200	http://dx.doi.org/10.1074/jbc.M710070200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337254	hybrid			2022-12-27	WOS:000255728200042
J	Papakostas, K; Georgopoulou, E; Frillingos, S				Papakostas, Konstantinos; Georgopoulou, Ekaterini; Frillingos, Stathis			Cysteine-scanning analysis of putative helix XII in the YgfO xanthine permease - Ile-432 and Asn-430 are important	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ASPERGILLUS-NIDULANS; PURINE TRANSPORTERS; LACTOSE PERMEASE; FUNCTIONAL-CHARACTERIZATION; NUCLEOBASE TRANSPORTERS; MEMBRANE-PROTEINS; CARRIER PROTEIN; SIGNATURE MOTIF; NAT/NCS2 FAMILY	Transmembrane helix XII of UapA, the major fungal homolog of the nucleobase-ascorbate transporter (NAT/NCS2) family, has been proposed to contain an aromatic residue acting as a purine-selectivity filter, distinct from the binding site. To analyze the role of helix XII more systematically, we employed Cys-scanning mutagenesis of the Escherichia coli xanthine-specific homolog YgfO. Using a functional mutant devoid of Cys residues (C-less), each amino acid residue in sequence (419)ILPASIYVLVENPICAGGLTAILLNIILPGGY(450) ( the putative helix XII is underlined) was replaced individually with Cys. Of the 32 single-Cys mutants, 25 accumulate xanthine to 80-130% of the steady state observed with C-less YgfO, six (P421C, S423C, I424C, Y425C, L427C, G436C) accumulate to low levels (15-40%), and I432C is inactive. Immunoblot analysis shows that P421C and I432C display low expression in the membrane. Extensive mutagenesis reveals that replacement of Ile-432 with equally or more bulky side chains abolishes active transport without affecting expression, whereas replacement with smaller side chains allows activity but impairs affinity for the analogues 1-methyl and 6-thioxanthine. Only three of the single-Cys mutants of helix XII (V426C, N430C, and N443C) are sensitive to inactivation by N-ethylmaleimide. N430C is highly sensitive, with an IC50 of 10 mu M, and is completely protected against inactivation in the presence of 2-thioxanthine, a high affinity substrate analogue. Other xanthine analogues are poorly bound by N430C, whereas replacement of Asn-430 with Thr inactivates the permease. The findings suggest that Ile-432 and Asn-430 of helix XII are crucial for purine uptake and affinity, and Asn-430 is probably at the vicinity of the binding site.	[Papakostas, Konstantinos; Georgopoulou, Ekaterini; Frillingos, Stathis] Univ Loannina Med Sch, Biol Chem Lab, Loannina 45110, Greece		Frillingos, S (corresponding author), Univ Loannina Med Sch, Biol Chem Lab, Loannina 45110, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021					Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Amillis S, 2001, J MOL BIOL, V313, P765, DOI 10.1006/jmbi.2001.5087; Argyrou E, 2001, PLANT CELL, V13, P953, DOI 10.1105/tpc.13.4.953; CARRASCO N, 1984, P NATL ACAD SCI-BIOL, V81, P4672, DOI 10.1073/pnas.81.15.4672; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; DIALLINAS G, 1989, GENETICS, V122, P341; FRILLINGOS S, 1994, BIOCHEMISTRY-US, V33, P8074, DOI 10.1021/bi00192a012; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Goudela S, 2005, MOL MEMBR BIOL, V22, P263, DOI 10.1080/09687860500093016; Goudela S, 2008, FUNGAL GENET BIOL, V45, P459, DOI 10.1016/j.fgb.2007.08.001; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; Meintanis C, 2000, MOL MEMBR BIOL, V17, P47; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070	24	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13666	13678		10.1074/jbc.M800261200	http://dx.doi.org/10.1074/jbc.M800261200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359771	hybrid			2022-12-27	WOS:000255728200018
J	Pavon, LR; Lundh, F; Lundin, B; Mishra, A; Persson, BL; Spetea, C				Pavon, Lorena Ruiz; Lundh, Fredrik; Lundin, Bjoern; Mishra, Arti; Persson, Bengt L.; Spetea, Cornelia			Arabidopsis ANTR1 is a thylakoid Na+-dependent phosphate transporter - Functional characterization in escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED-CHLOROPLASTS; INORGANIC-PHOSPHATE; IN-VIVO; EXPRESSION; MEMBRANE; ENVELOPE; PROTEIN; CARRIER; CDNA; COTRANSPORTERS	In this study, the putative anion transporter 1 (ANTR1) from Arabidopsis thaliana was shown to be localized to the chloroplast thylakoid membrane by Western blotting with two different peptide-specific antibodies. ANTR1 is homologous to the type I of mammalian Na+-dependent inorganic phosphate ( Pi) transporters. The function of ANTR1 as a Na+-dependent Pi transporter was demonstrated by heterologous expression and uptake of radioactive Pi into Escherichia coli cells. The expression of ANTR1 conferred increased growth rates to the transformed cells and stimulated Pi uptake in a pH- and Na+-dependent manner as compared with the control cells. Among various tested effectors, Pi was the preferred substrate. Although it competed with the uptake of Pi, glutamate was not transported by ANTR1 into E. coli. In relation to its function as a Pi transporter, several physiological roles for ANTR1 in the thylakoid membrane are proposed, such as export of Pi produced during nucleotide metabolism in the thylakoid lumen back to the chloroplast stroma and balance of the trans-thylakoid H+ electrochemical gradient storage.	[Pavon, Lorena Ruiz; Lundin, Bjoern; Mishra, Arti; Spetea, Cornelia] Linkoping Univ, Dept Phys Chem & Biol, Div Mol Genet, SE-58183 Linkoping, Sweden; [Lundh, Fredrik; Persson, Bengt L.] Kalmar Univ, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden	Linkoping University; Linnaeus University; University of Kalmar	Persson, BL (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Mol Genet, SE-58183 Linkoping, Sweden.	corsp@ifm.liu.se	Wiklund, Cornelia Spetea/S-3635-2019	Mishra, Arti/0000-0002-5214-0676				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; DEGUCHI Y, 1990, J BIOL CHEM, V265, P21704; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Flugge UI, 1999, ANNU REV PLANT PHYS, V50, P27, DOI 10.1146/annurev.arplant.50.1.27; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Lebens M, 2002, J BACTERIOL, V184, P4466, DOI 10.1128/JB.184.16.4466-4474.2002; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; LOLKEMA JS, 1994, BBA-BIOENERGETICS, V1187, P211, DOI 10.1016/0005-2728(94)90113-9; MIYAMOTO KI, 1995, BIOCHEM J, V305, P81, DOI 10.1042/bj3050081; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Reid RJ, 2000, PLANT CELL ENVIRON, V23, P223, DOI 10.1046/j.1365-3040.2000.00524.x; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; ROBINSON SP, 1987, AUST J PLANT PHYSIOL, V14, P451, DOI 10.1071/PP9870451; ROBINSON SP, 1983, PLANT PHYSIOL, V73, P238, DOI 10.1104/pp.73.2.238; Rolland N, 2003, PHOTOSYNTH RES, V78, P205, DOI 10.1023/B:PRES.0000006891.12416.6c; Roth C, 2004, PLANTA, V218, P406, DOI 10.1007/s00425-003-1121-5; Rubio L, 2005, J EXP BOT, V56, P613, DOI 10.1093/jxb/eri053; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; SHARKEY TD, 1989, PLANT PHYSIOL, V91, P679, DOI 10.1104/pp.91.2.679; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; Takizawa K, 2008, PLANT CELL ENVIRON, V31, P235, DOI 10.1111/j.1365-3040.2007.01753.x; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Weber APM, 2005, ANNU REV PLANT BIOL, V56, P133, DOI 10.1146/annurev.arplant.56.032604.144228; Werner A, 1998, J EXP BIOL, V201, P3135; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003	35	47	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13520	13527		10.1074/jbc.M709371200	http://dx.doi.org/10.1074/jbc.M709371200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353780	hybrid			2022-12-27	WOS:000255728200005
J	Delagoutte, E; Goellner, GM; Guo, J; Baldacci, G; McMurray, CT				Delagoutte, Emmanuelle; Goellner, Geoffrey M.; Guo, Jie; Baldacci, Giuseppe; McMurray, Cynthia T.			Single-stranded DNA-binding protein in vitro eliminates the orientation-dependent impediment to polymerase passage on CAG/CTG repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY-DISEASE GENES; TRIPLET REPEATS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; TRINUCLEOTIDE REPEAT; CTG REPEATS; REPLICATION PROTEINS; SECONDARY STRUCTURE; DYNAMIC MUTATIONS; LEADING-STRAND	Small insertions and deletions of trinucleotide repeats (TNRs) can occur by polymerase slippage and hairpin formation on either template or newly synthesized strands during replication. Although not predicted by a slippage model, deletions occur preferentially when 5 '-CTG is in the lagging strand template and are highly favored over insertion events in rapidly replicating cells. The mechanism for the deletion bias and the orientation dependence of TNR instability is poorly understood. We report here that there is an orientation-dependent impediment to polymerase progression on 5 '-CAG and 5 '-CTG repeats that can be relieved by the binding of single-stranded DNA-binding protein. The block depends on the primary sequence of the TNR but does not correlate with the thermodynamic stability of hairpins. The orientation-dependent block of polymerase passage is the strongest when 5 '-CAG is the template. We propose a "template-push" model in which the slow speed of DNA polymerase across the 5 '-CAG leading strand template creates a threat to helicase-polymerase coupling. To prevent uncoupling, the TNR template is pushed out and by-passed. Hairpins do not cause the block, but appear to occur as a consequence of polymerase pass-over.	[Delagoutte, Emmanuelle; Guo, Jie; Baldacci, Giuseppe] Univ Paris 11, CNRS, Inst Curie, F-91405 Orsay, France; [Goellner, Geoffrey M.; McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Goellner, Geoffrey M.; McMurray, Cynthia T.] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Mayo Clinic; Mayo Clinic	Delagoutte, E (corresponding author), Univ Paris 11, CNRS, Inst Curie, F-91405 Orsay, France.	emmanuelle.delagoutte@curie.u-psud.fr; mcmurray.cynthia@mayo.edu			NIGMS NIH HHS [GM066359] Funding Source: Medline; NINDS NIH HHS [NS40738] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bowater RP, 1997, NUCLEIC ACIDS RES, V25, P2861, DOI 10.1093/nar/25.14.2861; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Dixon MJ, 2004, NUCLEIC ACIDS RES, V32, P1289, DOI 10.1093/nar/gkh292; EliasArnanz M, 1997, EMBO J, V16, P5775, DOI 10.1093/emboj/16.18.5775; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; GACY AM, 1995, CELL, V81, P533; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Goellner GM, 1997, AM J HUM GENET, V60, P879; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Iyer RR, 1999, J BIOL CHEM, V274, P3865, DOI 10.1074/jbc.274.6.3865; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kovtun Irina V., 2004, V277, P309; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Minetti CASA, 2003, P NATL ACAD SCI USA, V100, P14719, DOI 10.1073/pnas.2336142100; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Nossal NG, 1995, METHOD ENZYMOL, V262, P560; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Paiva AM, 2004, BIOCHEMISTRY-US, V43, P14218, DOI 10.1021/bi0494368; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; RICHETTI M, 1990, EMBO J, V9, P1583; Rolfsmeier ML, 2001, GENETICS, V157, P1569; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; Schumacher S, 1998, J MOL BIOL, V279, P1101, DOI 10.1006/jmbi.1998.1827; SMITH GK, 1995, NUCLEIC ACIDS RES, V23, P4303; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Zahra R, 2007, GENETICS, V176, P27, DOI 10.1534/genetics.106.069724; Zheng MX, 1996, J MOL BIOL, V264, P323, DOI 10.1006/jmbi.1996.0643; Zhuang P, 2001, BIOCHEMISTRY-US, V40, P6660, DOI 10.1021/bi010005o	45	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13341	13356		10.1074/jbc.M800153200	http://dx.doi.org/10.1074/jbc.M800153200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18263578	Green Published, hybrid			2022-12-27	WOS:000255499800074
J	Drew, ME; Banerjee, R; Uffman, EW; Gilbertson, S; Rosenthal, PJ; Goldberg, DE				Drew, Mark E.; Banerjee, Ritu; Uffman, Eric W.; Gilbertson, Scott; Rosenthal, Philip J.; Goldberg, Daniel E.			Plasmodium food vacuole plasmepsins are activated by falcipains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASES; HEMOGLOBIN DEGRADATION; ASPARTIC PROTEASES; EXPRESSION; ROLES; BIOSYNTHESIS; TRAFFICKING; PROTEINASE; INVASION	Intraerythrocytic malaria parasites use host hemoglobin as a major nutrient source. Aspartic proteases (plasmepsins) and cysteine proteases (falcipains) function in the early steps of the hemoglobin degradation pathway. There is extensive functional redundancy within and between these protease families. Plasmepsins are synthesized as integral membrane proenzymes that are activated by cleavage from the membrane. This cleavage is mediated by a maturase activity whose identity has been elusive. We have used a combination of cell biology, chemical biology, and enzymology approaches to analyze this processing event. These studies reveal that plasmepsin processing occurs primarily via the falcipains; however, if falcipain activity is blocked, autoprocessing can take place, serving as an alternate activation system. These results establish a further level of redundancy between the protease families involved in Plasmodium hemoglobin degradation.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA; [Drew, Mark E.; Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA; [Banerjee, Ritu] Univ Calif San Francisco, Div Infect Dis, Dept Pediat, San Francisco, CA 94143 USA; [Uffman, Eric W.] Chemir Anal Serv, St Louis, MO 63043 USA; [Gilbertson, Scott] Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA; [Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of California System; University of California San Francisco; University of Texas System; University of Texas Medical Branch Galveston; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	goldberg@borcim.wustl.edu	Drew, Mark/E-2993-2011		Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI-035800, AI-47798] Funding Source: Medline; NICHD NIH HHS [T32 HD044331] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035800, R56AI035800, R01AI047798, R29AI035800] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banerjee R, 2003, MOL BIOCHEM PARASIT, V129, P157, DOI 10.1016/S0166-6851(03)00119-1; Bonilla JA, 2007, INT J PARASITOL, V37, P317, DOI 10.1016/j.ijpara.2006.11.008; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dahl EL, 2005, MOL BIOCHEM PARASIT, V139, P205, DOI 10.1016/j.molbiopara.2004.11.009; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HILL J, 1994, FEBS LETT, V352, P155, DOI 10.1016/0014-5793(94)00940-6; Kim YM, 2006, J BIOCHEM, V139, P189, DOI 10.1093/jb/mvj018; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Luker KE, 1996, MOL BIOCHEM PARASIT, V79, P71, DOI 10.1016/0166-6851(96)02651-5; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Ramjee MK, 2006, BIOCHEM J, V399, P47, DOI 10.1042/BJ20060422; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Singh N, 2006, EXP PARASITOL, V112, P187, DOI 10.1016/j.exppara.2005.10.007; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200	27	90	91	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12870	12876		10.1074/jbc.M708949200	http://dx.doi.org/10.1074/jbc.M708949200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308731	Green Published, hybrid			2022-12-27	WOS:000255499800023
J	Liu, L; Srikakulam, R; Winkelmann, DA				Liu, Li; Srikakulam, Rajani; Winkelmann, Donald A.			Unc45 activates hsp90-dependent folding of the myosin motor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONE; RETICULOCYTE LYSATE; STRIATED-MUSCLE; UNC-45; PROTEIN; HSP90; SKELETAL; RNG3P; COLOCALIZES	Myosin folding and assembly in striated muscle are mediated by the general chaperones Hsc70 and Hsp90 and involve a myosin-specific co-chaperone related to the Caenorhabditis elegans gene unc-45. Two unc-45 genes are found in vertebrates, a general cell isoform, unc45a, and a striated muscle-specific isoform, unc45b. We have investigated the role of both isoforms of mouse Unc45 in myosin folding using an in vitro synthesis and folding assay. A smooth muscle myosin motor domain ( MD) fused to green fluorescent protein (GFP) ( MD:: GFP) was used as substrate, and folding was measured by native gel electrophoresis and functional assays. In the absence of Unc45, the MD:: GFP chimera folds poorly. Addition of either Unc45a or Unc45b dramatically enhances the folding in a reaction that is dependent on Hsp90 ATPase activity. Unc45a is more effective than Unc45b with a higher apparent affinity and greater extent of folding. The Unc45- Hsp90 chaperone complex acts late in the folding pathway and promotes motor domain maturation after release from the ribosome. Unc45a behaves kinetically as an activator of the folding reaction by stimulating the rate of the Hsp90-dependent folding by > 20-fold with an apparent K-act of 33 nM. This analysis of vertebrate Unc45 isoforms clearly demonstrates a direct role for Unc45 in Hsp90-mediated myosin motor domain folding and highlights major differences between the isoforms in substrate specificity and mechanism.	[Liu, Li; Srikakulam, Rajani; Winkelmann, Donald A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Winkelmann, DA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA.	daw@pleiad.umdnj.edu			NIAMS NIH HHS [AR38454] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038454, R29AR038454] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chow D, 2002, J BIOL CHEM, V277, P36799, DOI 10.1074/jbc.M204101200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Mishra M, 2005, EUKARYOT CELL, V4, P567, DOI 10.1128/EC.4.3.567-576.2005; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; SRIKAKULAM R, 2008, IN PTRDD PLOS ONE; VENOLIA L, 1990, GENETICS, V126, P345; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; WINKELMANN DA, 1986, J MOL BIOL, V188, P595, DOI 10.1016/S0022-2836(86)80009-2; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wong KCY, 2000, J CELL SCI, V113, P2421; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	33	59	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13185	13193		10.1074/jbc.M800757200	http://dx.doi.org/10.1074/jbc.M800757200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326487	Green Published, hybrid			2022-12-27	WOS:000255499800058
J	Son, M; Leary, SC; Romain, N; Pierrel, F; Winge, DR; Haller, RG; Elliott, JL				Son, Marjatta; Leary, Scot C.; Romain, Nadine; Pierrel, Fabien; Winge, Dennis R.; Haller, Ronald G.; Elliott, Jeffrey L.			Isolated cytochrome C oxidase deficiency in G93A SOD1 mice overexpressing CCS protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; OXIDATIVE-PHOSPHORYLATION; TRANSGENIC MICE; CELL-DEATH; HEME-A; HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRIAL DYSFUNCTION; NATIVE-ELECTROPHORESIS; BIOSYNTHETIC-PATHWAY	G93A SOD1 transgenic mice overexpressing CCS protein develop an accelerated disease course that is associated with enhanced mitochondrial pathology and increased mitochondrial localization of mutant SOD1. Because these results suggest an effect of mutant SOD1 on mitochondrial function, we assessed the enzymatic activities of mitochondrial respiratory chain complexes in the spinal cords of CCS/G93A SOD1 and control mice. CCS/G93A SOD1 mouse spinal cord demonstrates a 55% loss of complex IV (cytochrome c oxidase) activity compared with spinal cord from age-matched non-transgenic or G93A SOD1 mice. In contrast, CCS/G93A SOD1 spinal cord shows no reduction in the activities of complex I, II, or III. Blue native gel analysis further demonstrates a marked reduction in the levels of complex IV but not of complex I, II, III, or V in spinal cords of CCS/G93A SOD1 mice compared with non-transgenic, G93A SOD1, or CCS/WT SOD1 controls. With SDS-PAGE analysis, spinal cords from CCS/G93A SOD1 mice showed significant decreases in the levels of two structural subunits of cytochrome c oxidase, COX1 and COX5b, relative to controls. In contrast, CCS/G93A SOD1 mouse spinal cord showed no reduction in levels of selected subunits from complexes I, II, III, or V. Heme A analyses of spinal cord further support the existence of cytochrome c oxidase deficiency in CCS/G93A SOD1 mice. Collectively, these results establish that CCS/G93A SOD1 mice manifest an isolated complex IV deficiency which may underlie a substantial part of mutant SOD1-induced mitochondrial cytopathy.	[Son, Marjatta; Haller, Ronald G.; Elliott, Jeffrey L.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Leary, Scot C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Haller, Ronald G.] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA; [Romain, Nadine; Haller, Ronald G.] Inst Exercise & Environm Med, Dallas, TX 75232 USA; [Pierrel, Fabien; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Pierrel, Fabien; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; McGill University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Elliott, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	elliott@utsouthwestern.edu	PIERREL, Fabien/M-6016-2014; Winge, Dennis/G-3611-2010; Leary, Scot/B-3036-2012	PIERREL, Fabien/0000-0003-2083-3002; Romain, Nadine/0000-0003-2492-549X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055315] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM083292] Funding Source: Medline; NINDS NIH HHS [NS055315] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bertamini M, 2002, EUR J NEUROSCI, V16, P2291, DOI 10.1046/j.1460-9568.2002.02299.x; Borisov VB, 2002, MOL ASPECTS MED, V23, P385, DOI 10.1016/S0098-2997(02)00013-4; Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1; Browne SE, 1998, J NEUROCHEM, V71, P281; Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546; Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926; Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Papadopoulou LC, 1999, NAT GENET, V23, P333; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rubio-Gozalbo ME, 1999, NEUROLOGY, V52, P383, DOI 10.1212/WNL.52.2.383; Sasaki S, 2004, ACTA NEUROPATHOL, V107, P461, DOI 10.1007/s00401-004-0837-z; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Son M, 2003, J BIOL CHEM, V278, P14331, DOI 10.1074/jbc.M211698200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Valnot I, 2000, AM J HUM GENET, V67, P1104; Vesela K, 2004, ACTA PAEDIATR, V93, P1312, DOI 10.1080/08035250410031341; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	57	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12267	12275		10.1074/jbc.M708523200	http://dx.doi.org/10.1074/jbc.M708523200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18334481	Green Published, hybrid			2022-12-27	WOS:000255340000043
J	Chen, YC; Siems, WF; Pearce, G; Ryan, CA				Chen, Yu-Chi; Siems, William F.; Pearce, Gregory; Ryan, Clarence A.			Six peptide wound signals derived from a single precursor protein in Ipomoea batatas leaves activate the expression of the Defense gene sporamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOMATO LEAVES; ARABIDOPSIS; PLANTS; BIOSYNTHESIS; POLYPEPTIDE; RESISTANCE; RECEPTOR; HORMONES; SURFACE	A mixture of three homologous bioactive hydroxyproline-rich glycopeptides (HypSys peptides) of 18 amino acids in length, differing only at two residues, was isolated from leaves of Ipomoea batatas, the common sweet potato. One of the peptides represented over 95% of the isolated isopeptides, which, at 2.5 nM concentration, induced the expression of sporamin, a major defense protein of I. batatas. The sequence of the major isoform was used to synthesize a primer that identified a cDNA encoding a precursor protein. The protein contained six proline-rich regions whose sequences suggested that they might be HypSys defense signals. One of the encoded peptides, called IbHypSys IV, was identical to one of two minor components of the isolated isopeptides, but neither the major isopeptide nor the other minor isoform was found within the precursor. The six peptides encoded by the precursor gene were synthesized but with hydroxyproline residues at positions found in the native isoforms and lacking carbohydrate moieties. All of the peptides were biologically active when supplied to leaves of sweet potato plants. The gene is the first ortholog of the preproHypSys gene family to be found outside of the Solanaceae family, and its encoded peptide precursor is the first example in plants of a precursor protein with six potential peptide defense signals, a scenario only found previously in animals. The data indicate that multiple copies of the HypSys peptides in a single precursor may have an important role in amplifying wound signaling in leaves in response to herbivore attacks.	[Chen, Yu-Chi; Pearce, Gregory; Ryan, Clarence A.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Siems, William F.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Chen, YC (corresponding author), Chinese Culture Univ, Dept Hort & Biotechnol, 55 Hwa Kang Rd, Taipei 111, Taiwan.	cyq12@faculty.pccu.edu.tw; pearce@wsu.edu			NCRR NIH HHS [1S10RR022538] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022538] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Cai DG, 2003, PLANT MOL BIOL, V51, P839, DOI 10.1023/A:1023089017906; Conconi A, 1996, PLANT PHYSIOL, V111, P797, DOI 10.1104/pp.111.3.797; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1995, PLANT J, V7, P381, DOI 10.1046/j.1365-313X.1995.7030381.x; HORTON N, 2007, PLANT CELL, V19, P1709; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; McLaughlin PJ, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P1313, DOI 10.1016/B978-012369442-3/50185-9; Narvaez-Vasquez J, 2005, P NATL ACAD SCI USA, V102, P12974, DOI 10.1073/pnas.0505248102; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Pearce G, 2001, NATURE, V411, P817, DOI 10.1038/35081107; Pearce G, 2007, J BIOL CHEM, V282, P17777, DOI 10.1074/jbc.M701543200; Ren F, 2006, PLANT SCI, V171, P286, DOI 10.1016/j.plantsci.2006.04.001; Ryan CA, 2002, PLANT CELL, V14, pS251, DOI 10.1105/tpc.010484; Ryan CA, 2007, CELL MICROBIOL, V9, P1902, DOI 10.1111/j.1462-5822.2007.00991.x; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Scheer JM, 1999, PLANT CELL, V11, P1525, DOI 10.1105/tpc.11.8.1525; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Wang SJ, 2002, PLANT MOL BIOL, V48, P223, DOI 10.1023/A:1013359227041; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yeh KW, 1997, PLANT CELL REP, V16, P696, DOI 10.1007/s002990050304; Yeh KW, 1997, PLANT MOL BIOL, V33, P565, DOI 10.1023/A:1005764702510	24	49	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11469	11476		10.1074/jbc.M709002200	http://dx.doi.org/10.1074/jbc.M709002200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299332	hybrid, Green Published			2022-12-27	WOS:000255067400045
J	Fan, CG; Bobik, TA				Fan, Chenguang; Bobik, Thomas A.			The PduX enzyme of Salmonella enterica is an L-threonine kinase used for coenzyme B-12 synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; VITAMIN-B12 BIOSYNTHETIC GENES; SEROVAR TYPHIMURIUM LT2; ESCHERICHIA-COLI; COBALAMIN BIOSYNTHESIS; PROTEIN; INTERMEDIATE; TRANSPORT	Here, the PduX enzyme of Salmonella enterica is shown to be an L-threonine kinase used for the de novo synthesis of coenzyme B-12 and the assimilation of cobyric acid (Cby). PduX with a C-terminal His tag (PduX-His(6)) was produced at high levels in Escherichia coli, purified by nickel affinity chromatography, and partially characterized. P-31 NMR spectroscopy established that purified PduX-His(6) catalyzed the conversion of L-threonine and ATP to L-threonine-O-3-phosphate and ADP. Enzyme assays showed that ATP was the preferred substrate compared with GTP, CTP, or UTP. PduX displayed Michaelis-Menten kinetics with respect to both ATP and L-threonine and nonlinear regression was used to determine the following kinetic constants: V-max = 62.1 +/- 3.6 nmol min(-1) mg of protein(-1); K-m,K-ATP = 54.7 +/- 5.7 mu M and K-m,K-Thr = 146.1 +/- 8.4 mu M. Growth studies showed that pduX mutants were impaired for the synthesis of coenzyme B-12 de novo and from Cby, but not from cobinamide, which was the expected phenotype for an L-threonine kinase mutant. The defect in Cby assimilation was corrected by ectopic expression of pduX or by supplementation of growth medium with L-threonine-O-3-phosphate, providing further support that PduX is an L-threonine kinase. In addition, a bioassay showed that a pduX mutant was impaired for the de novo synthesis of coenzyme B-12 as expected. Collectively, the genetic and biochemical studies presented here show that PduX is an L-threonine kinase used for AdoCbl synthesis. To our knowledge, PduX is the first enzyme shown to phosphorylate free L-threonine and the first L-threonine kinase shown to function in coenzyme B-12 synthesis.	[Fan, Chenguang; Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Iowa City, IA 50011 USA	Iowa State University	Bobik, TA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Iowa City, IA 50011 USA.	bobik@iastate.edu	Fan, Cheguang/O-9709-2016	Fan, Cheguang/0000-0003-0662-1185				AILION M, 1993, J BACTERIOL, V175, P7200, DOI 10.1128/JB.175.22.7200-7208.1993; Banerjee R., 1999, CHEM BIOCH B 12; BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; BORK P, 1993, PROTEIN SCI, V2, P31; Brushaber KR, 1998, J BIOL CHEM, V273, P2684, DOI 10.1074/jbc.273.5.2684; CAUTHEN SE, 1966, BIOCHEM J, V98, P630, DOI 10.1042/bj0980630; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Escalante-Semerena JC, 2007, J BACTERIOL, V189, P4555, DOI 10.1128/JB.00503-07; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; FUJII K, 1974, J BIOL CHEM, V249, P6745; GRABAU C, 1992, J BACTERIOL, V174, P2138, DOI 10.1128/JB.174.7.2138-2144.1992; HELLER K, 1985, J BACTERIOL, V161, P904, DOI 10.1128/JB.161.3.904-908.1985; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; JETER RM, 1987, J BACTERIOL, V169, P3189, DOI 10.1128/jb.169.7.3189-3198.1987; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Krautler B, 2005, BIOCHEM SOC T, V33, P806; Liu Y, 2007, J BACTERIOL, V189, P1589, DOI 10.1128/JB.01151-06; Matthews R. G., 1999, Chemistry and biochemistry of B12., P681; NEUHARD J, 1987, ESCHERICHIA COLI SAL, P447; OTOOLE GA, 1995, J BIOL CHEM, V270, P23560, DOI 10.1074/jbc.270.40.23560; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roessner CA, 2006, J BACTERIOL, V188, P7331, DOI 10.1128/JB.00918-06; RONDON MR, 1992, J BACTERIOL, V174, P2267, DOI 10.1128/JB.174.7.2267-2272.1992; ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/jb.170.9.3855-3863.1988; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider Z., 1987, COMPREHENSIVE B12 CH; Scott AI, 2003, J ORG CHEM, V68, P2529, DOI 10.1021/jo020728t; Van Bibber M, 1999, J BACTERIOL, V181, P5539, DOI 10.1128/JB.181.17.5539-5541.1999; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06	36	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11322	11329		10.1074/jbc.M800287200	http://dx.doi.org/10.1074/jbc.M800287200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308727	hybrid			2022-12-27	WOS:000255067400028
J	Mariappan, M; Gande, SL; Radhakrishnan, K; Schmidt, B; Dierks, T; von Figura, K				Mariappan, Malaiyalam; Gande, Santosh Lakshmi; Radhakrishnan, Karthikeyan; Schmidt, Bernhard; Dierks, Thomas; von Figura, Kurt			The non-catalytic N-terminal extension of formylglycine-generating enzyme is required for its biological activity and retention in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SULFATASE DEFICIENCY; PROTEIN MODIFICATION; MODIFYING FACTOR-1; OXIDASE ERV2P; MUTATIONS; CYSTEINE; PARALOG; ERP44; GENE; DETERMINANTS	Formylglycine-generating enzyme (FGE) catalyzes the oxidation of a specific cysteine residue in nascent sulfatase polypeptides to formylglycine (FGly). This FGly is part of the active site of all sulfatases and is required for their catalytic activity. Here we demonstrate that residues 34-68 constitute an N-terminal extension of the FGE catalytic core that is dispensable for in vitro enzymatic activity of FGE but is required for its in vivo activity in the endoplasmic reticulum (ER), i.e. for generation of FGly residues in nascent sulfatases. In addition, this extension is needed for the retention of FGE in the ER. Fusing a KDEL retention signal to the C terminus of FGE is sufficient to mediate retention of an N-terminally truncated FGE but not sufficient to restore its biological activity. Fusion of FGE residues 1-88 to secretory proteins resulted in ER retention of the fusion protein. Moreover, when fused to the paralog of FGE (pFGE), which itself lacks FGly-generating activity, the FGE extension ( residues 34-88) of this hybrid construct led to partial restoration of the biological activity of co-expressed N-terminally truncated FGE. Within the FGE N-terminal extension cysteine 52 is critical for the biological activity. We postulate that this N-terminal region of FGE mediates the interaction with an ER component to be identified and that this interaction is required for both the generation of FGly residues in nascent sulfatase polypeptides and for retention of FGE in the ER.	[Mariappan, Malaiyalam; Gande, Santosh Lakshmi; Schmidt, Bernhard; von Figura, Kurt] Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany; [Radhakrishnan, Karthikeyan; Dierks, Thomas] Univ Bielefeld, Fac Chem, D-33615 Bielefeld, Germany	University of Gottingen; University of Bielefeld	von Figura, K (corresponding author), Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.	kurt.figura@zvw.uni-goettingen.de	mariappan, malaiyalam/K-9024-2012; Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Radhakrishnan, Karthikeyan/0000-0003-1731-7410				Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Annunziata Ida, 2007, Hum Mutat, V28, P928, DOI 10.1002/humu.9504; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dickmanns A, 2005, J BIOL CHEM, V280, P15180, DOI 10.1074/jbc.M414317200; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Gande SL, 2008, FEBS J, V275, P1118, DOI 10.1111/j.1742-4658.2008.06271.x; GIESELMANN V, 1992, J BIOL CHEM, V267, P13262; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Mariappan M, 2005, J BIOL CHEM, V280, P15173, DOI 10.1074/jbc.M413698200; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; ROMMERSKIRCH W, 1992, P NATL ACAD SCI USA, V89, P2561, DOI 10.1073/pnas.89.7.2561; Schlotawa Lars, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9515; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vala A, 2005, J MOL BIOL, V354, P952, DOI 10.1016/j.jmb.2005.09.076; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; ZHANG RM, 1989, J BIOL CHEM, V264, P18472; Zito E, 2005, EMBO REP, V6, P655, DOI 10.1038/sj.embor.7400454; Zito E, 2007, EMBO J, V26, P2443, DOI 10.1038/sj.emboj.7601695	32	14	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11556	11564		10.1074/jbc.M707858200	http://dx.doi.org/10.1074/jbc.M707858200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305113	hybrid			2022-12-27	WOS:000255067400056
J	Payandeh, J; Li, CH; Ramjeesingh, M; Poduch, E; Bear, CE; Pai, EF				Payandeh, Jian; Li, Canhui; Ramjeesingh, Mohabir; Poduch, Ewa; Bear, Christine E.; Pai, Emil F.			Probing structure-function relationships and gating mechanisms in the CorA Mg2+ transport system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; ENTERICA SEROVAR TYPHIMURIUM; YEAST PLASMA-MEMBRANE; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; SALMONELLA-ENTERICA; POTASSIUM-CHANNEL; SELECTIVITY FILTER; ESCHERICHIA-COLI; MAGNESIUM UPTAKE	Recent crystal structures of the CorA Mg2+ transport protein from Thermotoga maritima (TmCorA) revealed an unusually long ion pore putatively gated by hydrophobic residues near the intracellular end and by universally conserved asparagine residues at the periplasmic entrance. A conformational change observed in an isolated funnel domain structure also led to a proposal for the structural basis of gating. Because understanding the molecular mechanisms underlying ion channel and transporter gating remains an important challenge, we have undertaken a structure-guided engineering approach to probe structure-function relationships in TmCorA. The intracellular funnel domain is shown to constitute an allosteric regulatory module that can be engineered to promote an activated or closed state. A periplasmic gate centered about a proline-induced kink of the pore-lining helix is described where "helix-straightening" mutations produce a dramatic gain-of-function. Mutation to the narrowest constriction along the pore demonstrates that a hydrophobic gate is operational within this Mg2+-selective transport protein and likely forms an energetic barrier to ion flux. We also provide evidence that highly conserved acidic residues found in the short periplasmic loop are not essential for TmCorA function or Mg2+ selectivity but may be required for proper protein folding and stability. This work extends our gating model for the CorA-Alr1-Mrs2 superfamily and reveals features that are characteristic of an ion channel. Aspects of these results that have broader implications for a range of channel and transporter families are highlighted.	[Payandeh, Jian; Pai, Emil F.] Ontario Canc Inst, Med & Related Sci Ctr, Div Canc Genom & Proteom, Toronto, ON M5G 1L7, Canada; [Payandeh, Jian; Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Li, Canhui; Ramjeesingh, Mohabir; Bear, Christine E.; Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1L7, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Li, Canhui; Bear, Christine E.] Hosp Sick Children, Mol Struct & Funct Programme, Toronto, ON M5G 1X8, Canada; [Li, Canhui; Ramjeesingh, Mohabir; Bear, Christine E.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Poduch, Ewa] Toronto Gen Res Inst, Ctr Mol Design & Preformulat, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Payandeh, J (corresponding author), Ontario Canc Inst, Med & Related Sci Ctr, Div Canc Genom & Proteom, 101 Coll St, Toronto, ON M5G 1L7, Canada.	payandeh@uhnres.utoronto.ca; pai@hera.med.utoronto.ca	Pai, Emil/R-8908-2019; Pai, Emil F/D-2526-2013	Pai, Emil/0000-0002-1162-7242; 				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Chamnongpol S, 2002, MOL MICROBIOL, V44, P561, DOI 10.1046/j.1365-2958.2002.02917.x; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; DeLano WL, 2002, PYMOL USERS MANUAL; Doyle DA, 2004, EUR BIOPHYS J BIOPHY, V33, P175, DOI 10.1007/s00249-003-0382-z; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Gregan J, 2001, GENE DEV, V15, P2229, DOI 10.1101/gad.201301; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Ivanov I, 2007, J AM CHEM SOC, V129, P8217, DOI 10.1021/ja070778l; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lee JM, 2006, CURR GENET, V49, P7, DOI 10.1007/s00294-005-0037-y; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Liu GJ, 2002, FEMS MICROBIOL LETT, V213, P231; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Maguire ME, 2006, CURR OPIN STRUC BIOL, V16, P432, DOI 10.1016/j.sbi.2006.06.006; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Papp KM, 2004, J BACTERIOL, V186, P7653, DOI 10.1128/JB.186.22.7653-7658.2004; Papp-Wallace KM, 2007, MOL MEMBR BIOL, V24, P351, DOI 10.1080/09687680701441883; Payandeh J, 2006, ACTA CRYSTALLOGR F, V62, P148, DOI 10.1107/S1744309106000996; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Perozo E, 2006, NAT REV MOL CELL BIO, V7, P109, DOI 10.1038/nrm1833; Pfeiffer J, 2002, INFECT IMMUN, V70, P3930, DOI 10.1128/IAI.70.7.3930-3934.2002; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Schmitz C, 2007, MAGNESIUM RES, V20, P6; Sermon J, 2005, APPL ENVIRON MICROB, V71, P6515, DOI 10.1128/AEM.71.11.6515-6523.2005; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Szegedy MA, 1999, J BIOL CHEM, V274, P36973, DOI 10.1074/jbc.274.52.36973; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi VN, 2006, J BIOSCIENCES, V31, P61, DOI 10.1007/BF02705236; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Wachek M, 2006, FEBS J, V273, P4236, DOI 10.1111/j.1742-4658.2006.05424.x; Weghuber J, 2006, FEBS J, V273, P1198, DOI 10.1111/j.1742-4658.2006.05157.x; Worlock AJ, 2002, J BACTERIOL, V184, P4369, DOI 10.1128/JB.184.16.4369-4373.2002; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022	67	52	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11721	11733		10.1074/jbc.M707889200	http://dx.doi.org/10.1074/jbc.M707889200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18276588	hybrid			2022-12-27	WOS:000255067400072
J	Schuetz, A; Min, J; Allali-Hassani, A; Schapira, M; Shuen, M; Loppnau, P; Mazitschek, R; Kwiatkowski, NP; Lewis, TA; Maglathin, RL; McLean, TH; Bochkarev, A; Plotnikov, AN; Vedadi, M; Arrowsmith, CH				Schuetz, Anja; Min, Jinrong; Allali-Hassani, Abdellah; Schapira, Matthieu; Shuen, Michael; Loppnau, Peter; Mazitschek, Ralph; Kwiatkowski, Nick P.; Lewis, Timothy A.; Maglathin, Rebecca L.; McLean, Thomas H.; Bochkarev, Alexey; Plotnikov, Alexander N.; Vedadi, Masoud; Arrowsmith, Cheryl H.			Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CLASS-I; SUBSTRATE-SPECIFICITY; NUCLEAR EXPORT; INHIBITORS; HOMOLOG; COMPLEX; DIFFERENTIATION; AMIDOHYDROLASE; HYPERTROPHY	Histone deacetylases (HDACs) are protein deacetylases that play a role in repression of gene transcription and are emerging targets in cancer therapy. Here, we characterize the structure and enzymatic activity of the catalytic domain of human HDAC7(cdHDAC7). Although HDAC7 normally exists as part of a multiprotein complex, we show that cdHDAC7 has a low level of deacetylase activity which can be inhibited by known HDAC inhibitors. The crystal structures of human cdHDAC7 and its complexes with two hydroxamate inhibitors are the first structures of the catalytic domain of class IIa HDACs and demonstrate significant differences with previously reported class I and class IIb-like HDAC structures. We show that cdHDAC7 has an additional class IIa HDAC-specific zinc binding motif adjacent to the active site which is likely to participate in substrate recognition and protein-protein interaction and may provide a site for modulation of activity. Furthermore, a different active site topology results in modified catalytic properties and in an enlarged active site pocket. Our studies provide mechanistic insights into class IIa HDACs and facilitate the design of specific modulators.	[Schuetz, Anja; Min, Jinrong; Allali-Hassani, Abdellah; Schapira, Matthieu; Shuen, Michael; Loppnau, Peter; Bochkarev, Alexey; Plotnikov, Alexander N.; Vedadi, Masoud; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Mazitschek, Ralph; Kwiatkowski, Nick P.; Lewis, Timothy A.; Maglathin, Rebecca L.] MIT, Cambridge, MA 02142 USA; [Mazitschek, Ralph; Kwiatkowski, Nick P.; Lewis, Timothy A.; Maglathin, Rebecca L.; McLean, Thomas H.] Broad Inst Harvard, Chem Biol Program, Cambridge, MA 02142 USA; [Bochkarev, Alexey; Arrowsmith, Cheryl H.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L5, Canada; [Bochkarev, Alexey; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5G 1L5, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L5, Canada; [Min, Jinrong; Plotnikov, Alexander N.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L5, Canada	University of Toronto; Structural Genomics Consortium; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Arrowsmith, CH (corresponding author), 100 Coll St, Toronto, ON M5G 1L5, Canada.	carrow@uhnresearch.ca	Mazitschek, Ralph/E-3741-2013; Min, Jinrong/G-3449-2011	Mazitschek, Ralph/0000-0002-1105-689X; Min, Jinrong/0000-0001-5210-3130; Lewis, Timothy/0000-0001-9748-9575; Schutz, Anja/0000-0002-0606-2574; Arrowsmith, Cheryl/0000-0002-4971-3250	NCI NIH HHS [N01-CO-12400] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Clemente S, 2001, BIOCHEMISTRY-US, V40, P10671, DOI 10.1021/bi0100844; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hildmann C, 2004, J BACTERIOL, V186, P2328, DOI 10.1128/JB.186.8.2328-2339.2004; Hildmann C, 2006, J BIOTECHNOL, V124, P258, DOI 10.1016/j.jbiotec.2006.01.030; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kao HY, 2000, GENE DEV, V14, P55; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moreth K, 2007, BIOCHEM J, V401, P659, DOI 10.1042/BJ20061239; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen TK, 2007, ACTA CRYSTALLOGR F, V63, P270, DOI 10.1107/S1744309107012377; Nielsen TK, 2005, J MOL BIOL, V354, P107, DOI 10.1016/j.jmb.2005.09.065; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Riester D, 2004, BIOCHEM BIOPH RES CO, V324, P1116, DOI 10.1016/j.bbrc.2004.09.155; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	47	214	225	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11355	11363		10.1074/jbc.M707362200	http://dx.doi.org/10.1074/jbc.M707362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18285338	Green Published, hybrid			2022-12-27	WOS:000255067400032
J	Kathrein, KL; Chari, S; Winandy, S				Kathrein, Katie L.; Chari, Sheila; Winandy, Susan			Ikaros directly represses the notch target gene Hes1 in a leukemia T cell line - Implications for CD4 regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOCYTE DEVELOPMENT; SIGNALING PATHWAY; MAMMALIAN NOTCH; RUNX PROTEINS; EXPRESSION; DIFFERENTIATION; ACTIVATION; MICE; MUTATIONS	Ikaros and Notch1, two regulators of gene transcription, are critically important at many stages of T cell development. Deregulation of Ikaros and Notch activities cooperate to promote T cell leukemogenesis, providing evidence that they function in converging pathways in developing T cells. In this report, a mechanism for Ikaros: Notch cooperativity is described, revealing a non-redundant role for Ikaros in regulating expression of the Notch target gene Hes1 in a leukemia T cell line. We provide evidence that Ikaros directly represses Hes1 in concert with the transcriptional repressor, RBP-J kappa, allowing for crosstalk between Notch and Ikaros that impacts regulation of CD4 expression. Taken together, these data describe a potential mechanism for Ikaros' function during T cell development and define Ikaros as an obligate repressor of Hes1.	[Kathrein, Katie L.; Chari, Sheila; Winandy, Susan] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Winandy, S (corresponding author), Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	s-winandy@northwestern.edu			NATIONAL CANCER INSTITUTE [R01CA104962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA104962-01A1] Funding Source: Medline; NIGMS NIH HHS [T32 GM08061] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen RD, 2001, MOL CELL BIOL, V21, P3071, DOI 10.1128/MCB.21.9.3071-3082.2001; Anderson AC, 2001, CURR OPIN GENET DEV, V11, P554, DOI 10.1016/S0959-437X(00)00232-X; Aster JC, 2001, CURR OPIN HEMATOL, V8, P237, DOI 10.1097/00062752-200107000-00010; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Beverly LJ, 2004, TRENDS MOL MED, V10, P591, DOI 10.1016/j.molmed.2004.10.001; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Camos Mireia, 2006, Clin Transl Oncol, V8, P550, DOI 10.1007/s12094-006-0060-6; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hruban RH, 1999, CURR OPIN GASTROEN, V15, P404, DOI 10.1097/00001574-199909000-00006; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kim HK, 1998, MOL CELL BIOL, V18, P7166, DOI 10.1128/MCB.18.12.7166; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Lopez-Nieva P, 2004, CARCINOGENESIS, V25, P1299, DOI 10.1093/carcin/bgh124; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Pear WS, 2004, CURR OPIN HEMATOL, V11, P426, DOI 10.1097/01.moh.0000143965.90813.70; Pons M, 2006, Clin Transl Oncol, V8, P466, DOI 10.1007/s12094-006-0046-4; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shattuck-Brandt RL, 1999, CURR OPIN GASTROEN, V15, P3, DOI 10.1097/00001574-199901000-00002; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Urban JA, 2004, J IMMUNOL, V173, P4470, DOI 10.4049/jimmunol.173.7.4470; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Zweidler-McKay PA, 2004, SEMIN CANCER BIOL, V14, P329, DOI 10.1016/j.semcancer.2004.04.012	46	45	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10476	10484		10.1074/jbc.M709643200	http://dx.doi.org/10.1074/jbc.M709643200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18287091	hybrid, Green Published			2022-12-27	WOS:000254894700029
J	Smyth, VA; Di Lorenzo, D; Kennedy, BN				Smyth, Vincent A.; Di Lorenzo, David; Kennedy, Breandan N.			A novel, evolutionarily conserved enhancer of cone photoreceptor-specific expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPORTER GENE-EXPRESSION; TRANSGENE EXPRESSION; OPSIN PROMOTER; ALPHA-SUBUNIT; ROD PHOTORECEPTORS; NR2E3 FUNCTIONS; MOUSE RETINA; CIS-ELEMENTS; IN-VIVO; ZEBRAFISH	The alpha subunit of cone transducin (T alpha C) is expressed exclusively in cone photoreceptors of the eye and pineal. T alpha C is a key phototransduction protein, and inherited mutations in T alpha C cause total color blindness in humans. We use transgenic zebrafish to identify and characterize cone photoreceptor regulatory element 1 (CPRE-1) a novel 20-bp enhancer element in the T alpha C promoter (T alpha CP). CPRE-1 is located similar to 2.5 kb upstream of the translation start site and is necessary for strong cone photoreceptor-specific expression in vivo. CPRE-1 comprises of a modular arrangement of two 10-bp elements that have separate, but co-dependent transcriptional activities. In vitro, CPRE-1 specifically binds nuclear factors that are enriched in ocular tissue. Bioinformatic alignments reveal that CPRE-1 sites are evolutionarily conserved in the promoter regions of fish, rodent, and mammalian T alpha C orthologues and identify a 5'-CTGGAGTG(A/T) TGGA(G/A) GCAGGG(G/C) T-3' consensus sequence.	[Smyth, Vincent A.; Di Lorenzo, David; Kennedy, Breandan N.] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin	Kennedy, BN (corresponding author), Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689				Babu S, 2006, FEBS LETT, V580, P1479, DOI 10.1016/j.febslet.2006.01.080; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Boatright J H, 1997, Mol Vis, V3, P15; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; CHEN J, 1994, P NATL ACAD SCI USA, V91, P2611, DOI 10.1073/pnas.91.7.2611; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Collery RE, 2006, ADV EXP MED BIOL, V572, P201; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Forrester JVDA., 2002, EYE BASIC SCI PRACTI; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Glushakova LG, 2006, INVEST OPHTH VIS SCI, V47, P3505, DOI 10.1167/iovs.05-1670; Goldsmith P, 2003, SEMIN CELL DEV BIOL, V14, P11, DOI 10.1016/S1084-9521(02)00167-2; GOURAS P, 1994, VISUAL NEUROSCI, V11, P1227, DOI 10.1017/S0952523800007021; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Kennedy BN, 2007, INVEST OPHTH VIS SCI, V48, P522, DOI 10.1167/iovs.06-0975; Kimble TDH, 2000, ANAT EMBRYOL, V201, P305, DOI 10.1007/s004290050319; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luo WQ, 2004, J BIOL CHEM, V279, P19286, DOI 10.1074/jbc.M400161200; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Michaelides M, 2003, BRIT J OPHTHALMOL, V87, P1317, DOI 10.1136/bjo.87.11.1317; Morris TA, 1997, INVEST OPHTH VIS SCI, V38, P196; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pickrell SW, 2004, INVEST OPHTH VIS SCI, V45, P3877, DOI 10.1167/iovs.04-0663; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; Riu ER, 2007, MOL THER, V15, P1348, DOI 10.1038/sj.mt.6300177; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Silva E, 2000, INVEST OPHTH VIS SCI, V41, P2076; Tsujimura T, 2007, P NATL ACAD SCI USA, V104, P12813, DOI 10.1073/pnas.0704061104; Vihtelic TS, 1999, VISUAL NEUROSCI, V16, P571, DOI 10.1017/S0952523899163168; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Ying SX, 1998, CURR EYE RES, V17, P777, DOI 10.1076/ceyr.17.8.777.5158	40	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10881	10891		10.1074/jbc.M710454200	http://dx.doi.org/10.1074/jbc.M710454200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18272521	hybrid			2022-12-27	WOS:000254894700070
J	Kol, S; Nouwen, N; Driessen, AJM				Kol, Stefan; Nouwen, Nico; Driessen, Arnold J. M.			The charge distribution in the cytoplasmic loop of subunit C of the F1F0 ATPase is a determinant for YidC targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN INSERTION; ESCHERICHIA-COLI YIDC; INNER MEMBRANE; M13 PROCOAT; F-0 COMPLEX; SYNTHASE; BIOGENESIS; PATHWAY; SRP; BACTERIOPHAGE-M13	YidC is a member of the Oxa1 family of proteins that facilitates the membrane insertion of a subset of inner membrane proteins in Escherichia coli. YidC acts as an insertase for membrane insertion of subunit c of the F1F0 ATP synthase (F(0)c), but the requirements for substrate recognition have remained unclear. Here, we have analyzed the role of the charged aminoacyl residues in F(0)c in YidC targeting and membrane insertion. Binding experiments demonstrate that F(0)c is targeted directly to YidC without the presence of a stable lipid surface-bound intermediate. Positive charges in the cytoplasmic loop of F(0)c are important determinants for YidC binding and subsequent membrane insertion. These data support a model in which F(0)c binds directly to YidC prior to its membrane insertion.	[Kol, Stefan; Nouwen, Nico; Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands; [Kol, Stefan; Nouwen, Nico; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, NL-9751 NN Haren, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Kol, Stefan/0000-0002-1992-8242				BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; CAO GQ, 1994, J BIOL CHEM, V269, P26898; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Chen MY, 2003, J BIOL CHEM, V278, P23295, DOI 10.1074/jbc.M301008200; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; CLARK AJ, 1963, GENETICS, V48, P105; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; GALLUSSER A, 1990, EMBO J, V9, P2723, DOI 10.1002/j.1460-2075.1990.tb07459.x; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kol S, 2006, J BIOL CHEM, V281, P29762, DOI 10.1074/jbc.M605317200; KUHN A, 1990, EMBO J, V9, P2385, DOI 10.1002/j.1460-2075.1990.tb07413.x; KUHN A, 1986, NATURE, V322, P335, DOI 10.1038/322335a0; KUHN A, 1995, FEMS MICROBIOL REV, V17, P185; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; STEFFENS K, 1984, EUR J BIOCHEM, V138, P617, DOI 10.1111/j.1432-1033.1984.tb07959.x; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2005, CURR OPIN MICROBIOL, V8, P182, DOI 10.1016/j.mib.2005.02.004; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6	33	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9871	9877		10.1074/jbc.M709408200	http://dx.doi.org/10.1074/jbc.M709408200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18276587	Green Published, hybrid			2022-12-27	WOS:000254671600043
J	Takagi, S; Nakajima, M; Mohri, T; Yokoi, T				Takagi, Shingo; Nakajima, Miki; Mohri, Takuya; Yokoi, Tsuyoshi			Post-transcriptional regulation of human pregnane x receptor by micro-RNA affects the expression of cytochrome P450 3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; TRANSCRIPTIONAL REGULATION; DRUG-INTERACTIONS; MESSENGER-RNA; HUMAN TISSUES; HUMAN LIVER; CYP3A4; PXR; METABOLISM; IDENTIFICATION	Pregnane X receptor (PXR) is a major transcription factor regulating the inducible expression of a variety of transporters and drug-metabolizing enzymes, including CYP3A4 (cytochrome P450 3A4). We first found that the PXR mRNA level was not correlated with the PXR protein level in a panel of 25 human livers, indicating the involvement of post-transcriptional regulation. Notably, a potential miR-148a recognition element was identified in the 3'-untranslated region of human PXR mRNA. We investigated whether PXR might be regulated by miR-148a. A reporter assay revealed that miR-148a could recognize the miR-148a recognition element of PXR mRNA. The PXR protein level was decreased by the overexpression of miR-148a, whereas it was increased by inhibition of miR-148a. The miR-148a-dependent decrease of PXR protein attenuated the induction CYP3A4 mRNA. Furthermore, the translational efficiency of PXR (PXR protein/PXR mRNA ratio) was inversely correlated with the expression levels of miR-148a in a panel of 25 human livers, supporting the miR-148a-dependent regulation of PXR in human livers. Eventually, the PXR protein level was significantly correlated with the CYP3A4 mRNA and protein levels. In conclusion, we found that miR-148a post-transcriptionally regulated human PXR, resulting in the modulation of the inducible and/or constitutive levels of CYP3A4 in human liver. This study will provide new insight into the unsolved mechanism of the large interindividual variability of CYP3A4 expression.	[Takagi, Shingo; Nakajima, Miki; Mohri, Takuya; Yokoi, Tsuyoshi] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yokoi, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tyokoi@kenroku.kanazawa-u.ac.jp	Nakajima, Miki/C-3990-2015; yokoi, tsuyoshi/I-7115-2014	Yokoi, Tsuyoshi/0000-0002-3239-2817				Aouabdi S, 2006, DRUG METAB DISPOS, V34, P138, DOI 10.1124/dmd.105.006064; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Dotzlaw H, 1999, CLIN CANCER RES, V5, P2103; Floyd MD, 2003, PHARMACOGENETICS, V13, P595, DOI 10.1097/00008571-200310000-00003; Goodwin B, 2001, MOL PHARMACOL, V60, P427; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003; Lamba JK, 2002, PHARMACOGENETICS, V12, P121, DOI 10.1097/00008571-200203000-00006; Lamba V, 2004, TOXICOL APPL PHARM, V199, P251, DOI 10.1016/j.taap.2003.12.027; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Martinez-Jimenez CP, 2007, CURR DRUG METAB, V8, P185, DOI 10.2174/138920007779815986; Meijerman I, 2006, ONCOLOGIST, V11, P742, DOI 10.1634/theoncologist.11-7-742; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Takada Tomonari, 2004, Drug Metab Pharmacokinet, V19, P103, DOI 10.2133/dmpk.19.103; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Watanabe M, 2004, J PHARMACOL SCI, V94, P459, DOI 10.1254/jphs.94.459; Westlind-Johnsson A, 2003, DRUG METAB DISPOS, V31, P755, DOI 10.1124/dmd.31.6.755; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	30	231	255	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9674	9680		10.1074/jbc.M709382200	http://dx.doi.org/10.1074/jbc.M709382200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18268015	hybrid, Green Submitted			2022-12-27	WOS:000254671600022
J	Zhao, JF; Gao, FQ; Zhang, YD; Wei, K; Liu, YH; Deng, XM				Zhao, Jinfeng; Gao, Fengqin; Zhang, Yangde; Wei, Kun; Liu, Yunhai; Deng, Xingming			Bcl2 inhibits abasic site repair by down-regulating APE1 endonuclease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; TRANSCRIPTIONAL ACTIVITY; INTERPHASE NUCLEI; MISMATCH REPAIR; APOPTOSIS; PROTEIN; CELLS; LOCALIZATION; SPECIFICITY; SUPPRESSION	Bcl2 not only prolongs cell survival but also suppresses the repair of abasic (AP) sites of DNA lesions. Apurinic/apyrimidinic endonuclease 1 (APE1) plays a central role in the repair of AP sites via the base excision repair pathway. Here we found that Bcl2 down-regulates APE1 endonuclease activity in association with inhibition of AP site repair. Exposure of cells to nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone results in accumulation of Bcl2 in the nucleus and interaction with APE1, which requires all of the BH domains of Bcl2. Deletion of any of the BH domains from Bcl2 abrogates the ability of Bcl2 to interact with APE1 as well as the inhibitory effects of Bcl2 on APE1 activity and AP site repair. Overexpression of Bcl2 in cells reduces formation of the APE1 center dot XRCC1 complex, and purified Bcl2 protein directly disrupts the APE1 center dot XRCC1 complex with suppression of APE1 endonuclease activity in vitro. Importantly, specific knockdown of endogenous Bcl2 by RNA interference enhances APE1 endonuclease activity with accelerated AP site repair. Thus, Bcl2 inhibition of AP site repair may occur in a novel mechanism by down-regulating APE1 endonuclease activity, which may promote genetic instability and tumorigenesis.	[Zhao, Jinfeng; Gao, Fengqin; Deng, Xingming] Univ Florida, Univ Florida Shands Canc Ctr, Dept Med, Gainesville, FL 32610 USA; [Zhao, Jinfeng; Gao, Fengqin; Deng, Xingming] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Zhao, Jinfeng; Gao, Fengqin; Zhang, Yangde] Cent S Univ, Xiangya Hosp, Dept Surg, Natl Hepatobillary & Enter Surg Res Ctr, Changsha 4100080, Peoples R China; [Wei, Kun] Coll Mat Sci & Engn, Guangzhou 510640, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Central South University	Deng, XM (corresponding author), Univ Florida, Univ Florida Shands Canc Ctr, Dept Med, 1376 Mowry Rd,Canc Genet Res Complex,Rm 262, Gainesville, FL 32610 USA.	xdeng@ufl.edu			NATIONAL CANCER INSTITUTE [R01CA112183] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 112183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Castelli M, 2004, CELL DEATH DIFFER, V11, P906, DOI 10.1038/sj.cdd.4401433; CHEBONNELLASSER.C, 1996, ONCOGENE, V13, P1489; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hoetelmans RWM, 2000, CELL DEATH DIFFER, V7, P384, DOI 10.1038/sj.cdd.4400664; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Jin ZH, 2006, J BIOL CHEM, V281, P14446, DOI 10.1074/jbc.M511914200; JORQUERA R, 1994, CARCINOGENESIS, V15, P389, DOI 10.1093/carcin/15.2.389; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; Kuo ML, 1999, MOL PHARMACOL, V55, P894; Lau JP, 2004, BRIT J CANCER, V91, P1166, DOI 10.1038/sj.bjc.6602080; LINETTE GP, 1995, BLOOD, V86, P1255, DOI 10.1182/blood.V86.4.1255.bloodjournal8641255; Liu YF, 1997, CANCER RES, V57, P1650; LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6; Mijal RS, 2004, CHEM RES TOXICOL, V17, P424, DOI 10.1021/tx0342417; Saintigny Y, 2001, EMBO J, V20, P2596, DOI 10.1093/emboj/20.10.2596; Schandl CA, 1999, J HISTOCHEM CYTOCHEM, V47, P151, DOI 10.1177/002215549904700204; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	27	24	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9925	9932		10.1074/jbc.M708345200	http://dx.doi.org/10.1074/jbc.M708345200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18263880	Green Published, hybrid			2022-12-27	WOS:000254671600049
J	Harita, Y; Kurihara, H; Kosako, H; Tezuka, T; Sekine, T; Igarashi, T; Hattori, S				Harita, Yutaka; Kurihara, Hidetake; Kosako, Hidetaka; Tezuka, Tohru; Sekine, Takashi; Igarashi, Takashi; Hattori, Seisuke			Neph1, a component of the kidney slit diaphragm, is tyrosine-phosphorylated by the Src family tyrosine kinase and modulates intracellular signaling by binding to Grb2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL NEPHROTIC SYNDROME; MICE LACKING; ACTIN POLYMERIZATION; GLOMERULAR PODOCYTE; ADAPTER PROTEINS; EGF RECEPTOR; DOMAIN; ACTIVATION; JUNCTION; RECRUITMENT	There are several lines of evidence that the podocyte slit diaphragm ( SD), which serves as a structural framework for the filtration barrier in kidney glomerulus, also plays an essential role as a signaling platform. Several SD components including nephrin and TRPC6 are known to be phosphorylated by a Src family tyrosine kinase ( SFK), Fyn. Here we have characterized Neph1, another SD component, as a novel substrate of SFK. Fyn interacts with and phosphorylates the cytoplasmic domain of Neph1 in vitro and in intact cells. Peptide mass fingerprinting and site-directed mutagenesis identified several tyrosine phosphorylation sites. In pull-down assays using rat glomerular lysates, Neph1 but not nephrin specifically binds to adaptor protein Grb2 and tyrosine kinase Csk in a phosphorylation-dependent manner. Both tyrosine 637 and 638 of Neph1 are crucial for Neph1-Grb2 binding. Phosphorylation of tyrosine 637 is significantly up-regulated in in vivo models of podocyte injury. Furthermore, Neph1 attenuates ERK activation elicited by Fyn, and this inhibitory effect requires the intact binding motif for the Grb2 SH2 domain. Our results shown here demonstrate that Neph1 is a novel in vivo substrate of SFK and suggest that Neph1 modulates ERK signaling through phosphorylation-dependent interaction with Grb2. Thus, SFK orchestrates a wide spectrum of protein-protein interactions and intracellular signaling networks at SD through tyrosine phosphorylation.	[Harita, Yutaka; Kosako, Hidetaka; Hattori, Seisuke] Univ Tokyo, Inst Med Sci, Div Cellular Prote BML, Minato Ku, Tokyo 1088639, Japan; [Tezuka, Tohru] Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan; [Harita, Yutaka; Sekine, Takashi; Igarashi, Takashi] Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Kurihara, Hidetake] Juntendo Univ, Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 1138421, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Minato Ku, Tokyo 1088641, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Juntendo University; Kitasato University	Hattori, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Prote BML, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hattoris@ims.u-tokyo.ac.jp						Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Durvasula RV, 2006, CURR OPIN NEPHROL HY, V15, P1, DOI 10.1097/01.mnh.0000199012.79670.0b; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerard A, 2004, ONCOGENE, V23, P1594, DOI 10.1038/sj.onc.1207283; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Honma M, 2006, GENES CELLS, V11, P143, DOI 10.1111/j.1365-2443.2006.00926.x; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 1999, CURR BIOL, V9, P1057, DOI 10.1016/S0960-9822(99)80458-8; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; KURIHARA H, 1995, AM J PHYSIOL-RENAL, V268, pF514, DOI 10.1152/ajprenal.1995.268.3.F514; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Maekawa M, 2002, J BIOL CHEM, V277, P37783, DOI 10.1074/jbc.M204506200; Matsui I, 2007, LAB INVEST, V87, P273, DOI 10.1038/labinvest.3700518; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Zhou J, 2001, J BIOL CHEM, V276, P27793, DOI 10.1074/jbc.M102803200	52	59	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9177	9186		10.1074/jbc.M707247200	http://dx.doi.org/10.1074/jbc.M707247200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18258597	hybrid, Green Published			2022-12-27	WOS:000254465800047
J	Murphy, RC; Johnson, KM				Murphy, Robert C.; Johnson, Kyle M.			Cholesterol, reactive oxygen species, and the formation of biologically active mediators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STEROL-REGULATED TRANSPORT; LOW-DENSITY-LIPOPROTEIN; OXIDATION-PRODUCTS; ENDOPLASMIC-RETICULUM; LIPID-PEROXIDATION; MASS-SPECTROMETRY; FATTY-ACIDS; IN-VIVO; OXYSTEROLS; MEMBRANE		[Murphy, Robert C.; Johnson, Kyle M.] Univ Colorado Denver, Dept Pharmacol, Hlth Sci Ctr, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Murphy, RC (corresponding author), Univ Colorado Denver, Dept Pharmacol, Hlth Sci Ctr, Aurora, CO 80045 USA.	robert.murphy@uchsc.edu	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL034303] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKWITH ALJ, 1989, J CHEM SOC P2, V2, P815; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chang YH, 1997, FREE RADICAL BIO MED, V23, P202, DOI 10.1016/S0891-5849(96)00626-0; Colles SM, 2001, TRENDS CARDIOVAS MED, V11, P131, DOI 10.1016/S1050-1738(01)00106-2; Ferderbar S, 2007, DIABETES-METAB RES, V23, P35, DOI 10.1002/dmrr.645; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; Girotti AW, 1998, J LIPID RES, V39, P1529; Girotti AW, 2000, METHOD ENZYMOL, V319, P85; Hazen SL, 1996, J BIOL CHEM, V271, P23080, DOI 10.1074/jbc.271.38.23080; HODIS HN, 1991, ATHEROSCLEROSIS, V89, P117, DOI 10.1016/0021-9150(91)90051-4; HOWARD JA, 1968, J AM CHEM SOC, V90, P1056, DOI 10.1021/ja01006a037; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Korytowski W, 1999, PHOTOCHEM PHOTOBIOL, V70, P484; Koumanov KS, 2005, ARCH BIOCHEM BIOPHYS, V434, P150, DOI 10.1016/j.abb.2004.10.025; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Leonarduzzi Gabriella, 2004, Molecular Aspects of Medicine, V25, P155, DOI 10.1016/j.mam.2004.02.016; Lizard G, 1997, FEBS LETT, V419, P276, DOI 10.1016/S0014-5793(97)01473-7; Maeba R, 2003, J LIPID RES, V44, P164, DOI 10.1194/jlr.M200340-JLR200; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Panini SR, 2001, CURR OPIN LIPIDOL, V12, P529, DOI 10.1097/00041433-200110000-00008; Pulfer MK, 2005, J PHARMACOL EXP THER, V312, P256, DOI 10.1124/jpet.104.073437; Pulfer MK, 2004, J BIOL CHEM, V279, P26331, DOI 10.1074/jbc.M403581200; Pulfer MK, 2004, J AM SOC MASS SPECTR, V15, P194, DOI 10.1016/j.jasms.2003.10.011; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Saito Y, 2007, FEBS LETT, V581, P4349, DOI 10.1016/j.febslet.2007.08.010; Selley ML, 1996, THROMB RES, V83, P449, DOI 10.1016/0049-3848(96)00154-5; Smith, 1981, CHOLESTEROL AUTOXIDA; Smith LL, 2004, FREE RADICAL BIO MED, V37, P318, DOI 10.1016/j.freeradbiomed.2004.04.024; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; SMITH LL, 1987, CHEM PHYS LIPIDS, V44, P87, DOI 10.1016/0009-3084(87)90046-6; Spiteller G, 2006, FREE RADICAL BIO MED, V41, P362, DOI 10.1016/j.freeradbiomed.2006.03.013; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Takeuchi C, 2006, BIOCHEMISTRY-US, V45, P7162, DOI 10.1021/bi0604330; VANDENBERG JJM, 1993, J LIPID RES, V34, P2005; Vila A, 2004, BIOCHEMISTRY-US, V43, P12592, DOI 10.1021/bi0491200; Vine DF, 1997, LIPIDS, V32, P887, DOI 10.1007/s11745-997-0114-0; WANG KY, 1993, STEROIDS, V58, P225, DOI 10.1016/0039-128X(93)90023-G; WATABE T, 1984, BIOCHIM BIOPHYS ACTA, V795, P60; Wentworth P, 2003, SCIENCE, V302, P1053, DOI 10.1126/science.1089525; Wu QZ, 2006, BBA-MOL CELL BIOL L, V1761, P350, DOI 10.1016/j.bbalip.2006.02.017; Yoshida Y, 2004, FREE RADICAL RES, V38, P787, DOI 10.1080/10715760410001700460; Yoshioka N, 2005, FREE RADICAL RES, V39, P299, DOI 10.1080/10715760400023002	49	135	137	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15521	15525		10.1074/jbc.R700049200	http://dx.doi.org/10.1074/jbc.R700049200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18285330	hybrid, Green Published			2022-12-27	WOS:000256332500003
J	Ha, BH; Ahn, HC; Kang, SH; Tanaka, K; Chung, CH; Kim, EE				Ha, Byung Hak; Ahn, Hee-Chul; Kang, Sung Hwan; Tanaka, Keiji; Chung, Chin Ha; Kim, Eunice EunKyeong			Structural basis for Ufm1 processing by UfSP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; CONJUGATING ENZYME; CRYSTAL-STRUCTURE; HUMAN ATG4B; UBIQUITIN; SYSTEM; PROTEINS; PATHWAY; COMPLEX; UCH-L3	Ubiquitin-fold modifier 1 (Ufm1) is a newly identified ubiquitin-like protein. Like ubiquitin and other ubiquitin-like proteins, Ufm1 is synthesized as a precursor that needs to be processed to expose the conserved C-terminal glycine prior to its conjugation to target proteins. Two novel proteases, named UfSP1 and UfSP2, have been shown to be responsible for the release of Ufm1 from Ufm1-conjugated cellular proteins as well as for the processing of its precursor. They show no sequence homology with known proteases. Here, we describe the 1.7 angstrom resolution crystal structure of mouse UfSP1, consisting of 217 amino acids. The structure reveals that it is a novel cysteine protease having a papain-like fold, with Cys(53), Asp(175), and His(177) that form a catalytic triad, and Tyr(41) that participates in the formation of the oxyanion hole. This differs from the canonical catalytic triad of papain-like proteases in that the aspartate and the histidine residues are from the "Asp-Pro-His" box. The Asp-Pro-His configuration seen in UfSP1, together with Atg4B and M48(USP), seem to form a new subfamily of the cysteine protease superfamily. The mutagenesis study of the active site residues confirms structural basis for catalysis. The interaction between UfSP1 and Ufm1 appears quite substantial, since the K-D value was estimated to be 1.6 mu M by the isothermal titration calorimetry analysis. Furthermore, the NMR data shows that the loop between beta 3 and alpha 2 in addition to the C-terminal region of Ufm1 plays a role in binding to UfSP1.	[Ha, Byung Hak; Kang, Sung Hwan; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Ha, Byung Hak; Ahn, Hee-Chul; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Tokyo Metropolitan Institute of Medical Science	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	chchung@snu.ac.kr; eunice@kist.re.kr						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; VIJAYKUMAR S, 1987, J BIOL CHEM, V262, P6396; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	36	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14893	14900		10.1074/jbc.M708756200	http://dx.doi.org/10.1074/jbc.M708756200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18321862	hybrid			2022-12-27	WOS:000255941400076
J	Navarro, MVAS; Oliveira, CC; Zanchin, NIT; Guimaraes, BG				Navarro, Marcos V. A. S.; Oliveira, Carla C.; Zanchin, Nilson I. T.; Guimaraes, Beatriz G.			Insights into the mechanism of progressive RNA degradation by the archaeal exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST EXOSOME; RIBOSOMAL-RNA; NUCLEAR SURVEILLANCE; STRUCTURAL BASIS; QUALITY CONTROL; MESSENGER-RNAS; COMPLEX; PROTEIN; PATHWAY; POLYMERASE	Initially identified in yeast, the exosome has emerged as a central component of the RNA maturation and degradation machinery both in Archaea and eukaryotes. Here we describe a series of high-resolution structures of the RNase PH ring from the Pyrococcus abyssi exosome, one of them containing three 10-mer RNA strands within the exosome catalytic chamber, and report additional nucleotide interactions involving positions N5 and N7. Residues from all three Rrp41-Rrp42 heterodimers interact with a single RNA molecule, providing evidence for the functional relevance of exosome ring-like assembly in RNA processivity. Furthermore, an ADP-bound structure showed a rearrangement of nucleotide interactions at site N1, suggesting a rationale for the elimination of nucleoside diphosphate after catalysis. In combination with RNA degradation assays performed with mutants of key amino acid residues, the structural data presented here provide support for a model of exosome-mediated RNA degradation that integrates the events involving catalytic cleavage, product elimination, and RNA translocation. Finally, comparisons between the archaeal and human exosome structures provide a possible explanation for the eukaryotic exosome inability to catalyze phosphate-dependent RNA degradation.	[Navarro, Marcos V. A. S.; Zanchin, Nilson I. T.; Guimaraes, Beatriz G.] Brazilian Synchrotron Light Lab, BR-13083970 Campinas, SP, Brazil; [Oliveira, Carla C.] Univ Sao Paulo, Dept Biochem, Inst Chem, BR-05508900 Sao Paulo, Brazil	Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade de Sao Paulo	Navarro, MVAS (corresponding author), Cornell Univ, Vet Med Ctr C4 173, Ithaca, NY 14853 USA.	mn372@cornell.edu; beatriz@lnls.br	Oliveira, Carla C/F-2323-2011; Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Navarro, Marcos VAS/C-9141-2013; Guimarães, Beatriz G/D-3858-2014; Guimarães, Beatriz Gomes/Z-6242-2019	Oliveira, Carla C/0000-0002-1098-9241; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; Guimarães, Beatriz Gomes/0000-0002-8546-2460; Navarro, Marcos/0000-0002-2461-0431				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brakoulias A, 2004, PROTEINS, V56, P250, DOI 10.1002/prot.20123; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jiang TJ, 2002, P NATL ACAD SCI USA, V99, P5295, DOI 10.1073/pnas.072083699; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LANDAU M, 2003, BIOINFORMATICS, V19, P163; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu QS, 2007, CELL, V131, P188, DOI 10.1016/j.cell.2007.09.019; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Ramos CRR, 2006, J BIOL CHEM, V281, P6751, DOI 10.1074/jbc.M512495200; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Wahle E, 2007, NAT STRUCT MOL BIOL, V14, P5, DOI 10.1038/nsmb0107-5; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	45	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14120	14131		10.1074/jbc.M801005200	http://dx.doi.org/10.1074/jbc.M801005200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353775	hybrid			2022-12-27	WOS:000255728200066
J	Qian, P; Bullough, PA; Hunter, CN				Qian, Pu; Bullough, Per A.; Hunter, C. Neil			Three-dimensional reconstruction of a membrane-bending complex - The RC-LH1-PufX core dimer of Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PIGMENT PROTEIN COMPLEXES; RHODOSPIRILLUM-RUBRUM; PHOTOSYNTHETIC APPARATUS; CRYSTAL-STRUCTURE; PROJECTION STRUCTURE; STRUCTURAL-ANALYSIS; CHARGE SEPARATION; REACTION CENTERS; ANTENNA COMPLEX	A three-dimensional model of the dimeric reaction center-light harvesting I-PufX (RC-LH1-PufX) complex from Rhodobacter sphaeroides, calculated from electron microscope single particle analysis of negatively stained complexes, shows that the two halves of the dimer molecule incline toward each other on the periplasmic side, creating a remarkable V-shaped structure. The distribution of negative stain is consistent with loose packing of the LH1 ring near the 14th LH1 alpha/beta pair, which could facilitate the migration of quinone and quinol molecules across the LH1 boundary. The three-dimensional model encloses a space near the reaction center Q(B) site and the 14th LH1 alpha/beta pair, which is similar to 20 angstrom in diameter, sufficient to sequester a quinone pool. Helical arrays of dimers were used to construct a three-dimensional membrane model, which matches the packing lattice deduced from electron microscope analysis of the tubular dimer-only membranes found in mutants of Rba. sphaeroides lacking the LH2 complex. The intrinsic curvature of the dimer explains the shape and similar to 70-nm diameter of these membrane tubules, and at least partially accounts for the spherical membrane invaginations found in wild-type Rba. sphaeroides. A model of dimer aggregation and membrane curvature in these spherical membrane invaginations is presented.	[Qian, Pu; Bullough, Per A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biochem, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biochem, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac.uk	Qian, Pu/GZM-2400-2022	Bullough, Per/0000-0001-8147-1127	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abresch EC, 2005, PHOTOSYNTH RES, V86, P61, DOI 10.1007/s11120-005-5106-z; [Anonymous], 2002, PHOTOSYNTHETICA; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; Busselez J, 2007, STRUCTURE, V15, P1674, DOI 10.1016/j.str.2007.09.026; Chaban Y, 2002, EMBO REP, V3, P982, DOI 10.1093/embo-reports/kvf196; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cogdell R. J., 1995, ANOXYGENIC PHOTOSYNT, P315; Comayras R, 2005, J BIOL CHEM, V280, P11203, DOI 10.1074/jbc.M412088200; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Darrouzet E, 2004, PHOTOSYNTH RES, V79, P25, DOI 10.1023/B:PRES.0000011926.47778.4e; Dezi M, 2007, BBA-BIOENERGETICS, V1767, P1041, DOI 10.1016/j.bbabio.2007.05.006; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; FARCHAUS JW, 1990, J BACTERIOL, V172, P977, DOI 10.1128/jb.172.2.977-985.1990; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Francia F, 1999, BIOCHEMISTRY-US, V38, P6834, DOI 10.1021/bi982891h; Francia F, 2004, BIOCHEMISTRY-US, V43, P14199, DOI 10.1021/bi048629s; Francia F, 2002, EUR J BIOCHEM, V269, P1877, DOI 10.1046/j.1432-1033.2002.02834.x; Frese RN, 2008, BIOPHYS J, V94, P640, DOI 10.1529/biophysj.107.116913; Frese RN, 2004, P NATL ACAD SCI USA, V101, P17994, DOI 10.1073/pnas.0407295102; HUNTER CN, 1988, BIOCHEMISTRY-US, V27, P3459, DOI 10.1021/bi00409a050; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7; Jones MR, 2007, PROG LIPID RES, V46, P56, DOI 10.1016/j.plipres.2006.06.001; JONES MR, 1992, MOL MICROBIOL, V6, P1173, DOI 10.1111/j.1365-2958.1992.tb01556.x; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; KILEY PJ, 1988, J BACTERIOL, V170, P1103, DOI 10.1128/jb.170.3.1103-1115.1988; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Loach P. A., 1995, ANOXYGENIC PHOTOSYNT, P437; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MILLER KR, 1982, NATURE, V300, P53, DOI 10.1038/300053a0; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; OELZE J, 1972, BIOCHIM BIOPHYS ACTA, V265, P209, DOI 10.1016/0304-4157(72)90003-2; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Qian P, 2003, J BIOL CHEM, V278, P23678, DOI 10.1074/jbc.M302753200; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2004, P NATL ACAD SCI USA, V101, P11293, DOI 10.1073/pnas.0404350101; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Sener MK, 2007, P NATL ACAD SCI USA, V104, P15723, DOI 10.1073/pnas.0706861104; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; STARK W, 1984, EMBO J, V3, P777, DOI 10.1002/j.1460-2075.1984.tb01884.x; Tunnicliffe RB, 2006, FEBS LETT, V580, P6967, DOI 10.1016/j.febslet.2006.11.065; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V7, P113, DOI 10.1016/0304-3991(81)90001-2; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; Westerhuis WHJ, 2002, BIOCHEMISTRY-US, V41, P8698, DOI 10.1021/bi011663b	65	82	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14002	14011		10.1074/jbc.M800625200	http://dx.doi.org/10.1074/jbc.M800625200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326046	hybrid			2022-12-27	WOS:000255728200054
J	Taghbalout, A; Rothfield, L				Taghbalout, Aziz; Rothfield, Lawrence			RNaseE and RNA helicase B play central roles in the cytoskeletal organization of the RNA degradosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; RIBONUCLEASE-E; BACTERIAL CYTOSKELETON; CHROMOSOMAL GENES; CELL-SHAPE; COMPLEXES; PROTEINS; MINE; MREB	The RNA degradosome of Escherichia coli is a multiprotein complex that plays an essential role in normal RNA processing and decay. It was recently shown that the major degradosome constituents are organized in a coiled cytoskeletal-like structure that extends along the length of the cell. Here we show that the endoribonuclease E (RNaseE) and RNA helicase B (RhlB) components of the degradosome can each independently form coiled structures in the absence of the other degradosome proteins. In contrast, the cytoskeletal organization of the other degradosome proteins required the presence of the RNaseE or RhlB coiled elements. Although the RNaseE and RhlB structures were equally competent to support the helical organization of polynucleotide phosphorylase, the cytoskeletal-like organization of enolase occurred only in the presence of the RNaseE coiled structure. The results indicate that the RNA degradosome proteins are components of the bacterial cytoskeleton rather than existing as randomly distributed multiprotein complexes within the cell and suggest a model for the cellular organization of the components within the helical degradosomal structure.	[Taghbalout, Aziz; Rothfield, Lawrence] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06032 USA	University of Connecticut	Taghbalout, A (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 263 Farmington Ave, Farmington, CT 06032 USA.	taghbalout@neuron.uchc.edu	Taghbalout, Aziz/A-7516-2009		NIGMS NIH HHS [GM R37-06032] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Divakaruni AV, 2005, P NATL ACAD SCI USA, V102, P18602, DOI 10.1073/pnas.0507937102; Dye NA, 2005, P NATL ACAD SCI USA, V102, P18608, DOI 10.1073/pnas.0507708102; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Maniatis T., 1982, MOL CLONING; MICZAK A, 1991, MOL MICROBIOL, V5, P1801, DOI 10.1111/j.1365-2958.1991.tb01929.x; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Miller J. H., 1992, SHORT COURSE BACTERI, P263; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770	36	43	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13850	13855		10.1074/jbc.M709118200	http://dx.doi.org/10.1074/jbc.M709118200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337249	hybrid, Green Published			2022-12-27	WOS:000255728200038
J	Bhamidi, S; Scherman, MS; Rithner, CD; Prenni, JE; Chatterjee, D; Khoo, KH; McNeil, MR				Bhamidi, Suresh; Scherman, Michael S.; Rithner, Christopher D.; Prenni, Jessica E.; Chatterjee, Delphi; Khoo, Kay-Hooi; McNeil, Michael R.			The identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL ARABINOGALACTAN; MASS-SPECTROMETRY; LIPOARABINOMANNAN; BIOSYNTHESIS; SMEGMATIS; CORYNEBACTERIANEAE; PEPTIDOGLYCAN; SPECTROSCOPY; FRAGMENTS; FEATURES	The complex cell wall of Mycobacterium tuberculosis is the hallmark of acid fast bacteria and is responsible for much of its physiological characteristics. Hence, much effort has been made to determine its primary structure. Such studies have been hampered by its extreme complexity. Also, its insolubility leads to difficulties determining the presence or absence of base labile groups. We have used an endogenous arabinase to solubilize the arabinan region of the cell wall and have shown using mass spectrometry and NMR that succinyl esters are present on O2 of the inner-branched 1,3,5-alpha-D-arabinofuranosyl residues. In addition, an inner arabinan region of 14 linear alpha-1,5 arabinofuranosyl residues has been identified. These and earlier results now allow the presentation of a model of the entire primary structure of the mycobacterial mycolyl arabinogalactan highlighted by three arabinan chains of 31 residues each.	[Bhamidi, Suresh; Scherman, Michael S.; Chatterjee, Delphi; McNeil, Michael R.] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; [Rithner, Christopher D.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Prenni, Jessica E.] Colorado State Univ, Proteom & Metab Facil, Ft Collins, CO 80523 USA; [Khoo, Kay-Hooi] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; [Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Colorado State University; Colorado State University; Colorado State University; National Taiwan University; Academia Sinica - Taiwan	McNeil, MR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mmcneil@colostate.edu	Khoo, Kay-Hooi/E-1989-2019; McNeil, Michael/G-3325-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Prenni, Jessica/0000-0002-0337-8450	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI037139, R01AI033706, R01AI037139] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-37139, AI-33706] Funding Source: Medline; PHS HHS [NSC96-2628-B-001-014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; AMARNACASCH C, 1970, B SOC CHIM BIOL, V52, P145; AZUMA I, 1969, J BACTERIOL, V98, P331, DOI 10.1128/JB.98.1.331-333.1969; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BESRA GS, 1995, BIOCHEMISTRY-US, V34, P4257, DOI 10.1021/bi00013a015; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Dmitriev BA, 2000, INT J MED MICROBIOL, V290, P251; Dong X, 2006, APPL ENVIRON MICROB, V72, P2601, DOI 10.1128/AEM.72.4.2601-2605.2006; Draper P, 1997, BIOCHEM J, V327, P519, DOI 10.1042/bj3270519; Escuyer VE, 2001, J BIOL CHEM, V276, P48854, DOI 10.1074/jbc.M102272200; KANETSUN.F, 1968, BIOCHIM BIOPHYS ACTA, V158, P130, DOI 10.1016/0304-4165(68)90080-9; KOTANI S, 1971, BIKEN J, V14, P379; Lee A, 2006, BIOCHEMISTRY-US, V45, P15817, DOI 10.1021/bi060688d; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Mahapatra S, 2005, J BACTERIOL, V187, P2747, DOI 10.1128/JB.187.8.2747-2757.2005; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; McNeil M, 1999, GENETICS OF BACTERIALS POLYSACCHARIDES, P207; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; McNeil M., 1996, TUBERCULOSIS, P171; MCNEIL MR, 1994, GLYCOBIOLOGY, V4, P165, DOI 10.1093/glycob/4.2.165; MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y; MINNIKIN DE, 1982, BIOL MYCOBACTERIA, V1, P95; MISAKI A, 1974, J BIOCHEM-TOKYO, V76, P15, DOI 10.1093/oxfordjournals.jbchem.a130540; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; VILKAS E, 1973, BIOCHIM BIOPHYS ACTA, V297, P423, DOI 10.1016/0304-4165(73)90089-5; WIETZERBIN J, 1974, BIOCHEMISTRY-US, V13, P3471, DOI 10.1021/bi00714a008; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	34	72	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12992	13000		10.1074/jbc.M800222200	http://dx.doi.org/10.1074/jbc.M800222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18303028	Green Published, hybrid			2022-12-27	WOS:000255499800036
J	Ferber, EC; Kajita, M; Wadlow, A; Tobiansky, L; Niessen, C; Ariga, H; Daniel, J; Fujita, Y				Ferber, Emma C.; Kajita, Mihoko; Wadlow, Anthony; Tobiansky, Lara; Niessen, Carien; Ariga, Hiroyoshi; Daniel, Juliet; Fujita, Yasuyuki			A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSCRIPTIONAL REPRESSION; C-TERMINAL FRAGMENT; CELL-CELL CONTACTS; BETA-CATENIN; P120 CATENIN; INTRACELLULAR DOMAIN; ADHERENS JUNCTIONS; N-CADHERIN; GAMMA-PROTOCADHERINS; PROTEOLYTIC RELEASE	Cell-cell contacts play a vital role in intracellular signaling, although the molecular mechanisms of these signaling pathways are not fully understood. E-cadherin, an important mediator of cell-cell adhesions, has been shown to be cleaved by gamma-secretase. This cleavage releases a fragment of E-cadherin, E-cadherin C-terminal fragment 2 (E-cad/CTF2), into the cytosol. Here, we study the fate and function of this fragment. First, we show that coexpression of the cadherin-binding protein, p120 catenin (p120), enhances the nuclear translocation of E-cad/CTF2. By knocking down p120 with short interfering RNA, we also demonstrate that p120 is necessary for the nuclear localization of E-cad/CTF2. Furthermore, p120 enhances and is required for the specific binding of E-cad/CTF2 to DNA. Finally, we show that E-cad/CTF2 can regulate the p120-Kaiso-mediated signaling pathway in the nucleus. These data indicate a novel role for cleaved E-cadherin in the nucleus.	[Ferber, Emma C.; Kajita, Mihoko; Wadlow, Anthony; Tobiansky, Lara; Fujita, Yasuyuki] UCL, MRC Cell Biol Unit, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Fujita, Yasuyuki] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Niessen, Carien] Univ Cologne, Dept Dermatol, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Daniel, Juliet] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Cologne; Hokkaido University; McMaster University	Fujita, Y (corresponding author), UCL, MRC Cell Biol Unit, MRC Lab Mol Cell Biol, London WC1E 6BT, England.	y.fujita@ucl.ac.uk	Ariga, Hiroyoshi/B-5895-2013; Fujita, Yasuyuki/A-4324-2012	Ariga, Hiroyoshi/0000-0001-7384-2143; Niessen, Carien M./0000-0002-4892-9391	Medical Research Council [MC_U122669938] Funding Source: Medline; MRC [MC_U122669938] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Larue L, 1996, DEVELOPMENT, V122, P3185; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shcherbik N, 2004, J CELL BIOCHEM, V93, P11, DOI 10.1002/jcb.20130; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tricaud N, 2005, J NEUROSCI, V25, P3259, DOI 10.1523/JNEUROSCI.5168-04.2005; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455; Yagi T, 2000, GENE DEV, V14, P1169; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200	52	113	117	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12691	12700		10.1074/jbc.M708887200	http://dx.doi.org/10.1074/jbc.M708887200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18356166	Green Published, hybrid			2022-12-27	WOS:000255499800004
J	Ishida, N; Sugiura, M; Rappaport, F; Lai, TL; Rutherford, AW; Boussac, A				Ishida, Naoko; Sugiura, Miwa; Rappaport, Fabrice; Lai, Thanh-Lan; Rutherford, A. William; Boussac, Alain			Biosynthetic exchange of bromide for chloride and strontium for calcium in the photosystem II oxygen-evolving enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC WATER OXIDATION; S-STATE TRANSITION; THERMOSYNECHOCOCCUS-ELONGATUS; THERMOPHILIC CYANOBACTERIUM; SYNECHOCOCCUS-ELONGATUS; TEMPERATURE-DEPENDENCE; CA2+/SR2+ EXCHANGE; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; PSII MEMBRANES	The active site for water oxidation in photosystem II goes through five sequential oxidation states (S-0 to S-4) before O-2 is evolved. It consists of a Mn4Ca cluster close to a redox-active tyrosine residue (Tyr(Z)). Cl- is also required for enzyme activity. To study the role of Ca2+ and Cl- in PSII, these ions were biosynthetically substituted by Sr2+ and Br-, respectively, in the thermophilic cyanobacterium Thermosynechococcus elongatus. Irrespective of the combination of the non-native ions used (Ca/Br, Sr/Cl, Sr/Br), the enzyme could be isolated in a state that was fully intact but kinetically limited. The electron transfer steps affected by the exchanges were identified and then investigated by using time-resolved UV-visible absorption spectroscopy, time-resolved O-2 polarography, and thermoluminescence spectroscopy. The effect of the Ca2+/Sr2+ and Cl-/Br- exchanges was additive, and the magnitude of the effect varied in the following order: Ca/Cl < Ca/Br < Sr/Cl < Sr/Br. In all cases, the rate of O-2 release was similar to that of the S(3)Tyr(Z)(center dot) to S(0)Tyr(Z) transition, with the slowest kinetics (i.e. the Sr/Br enzyme) being approximate to 6-7 slower than in the native Ca/Cl enzyme. This slowdown in the kinetics was reflected in a decrease in the free energy level of the S-3 state as manifest by thermoluminescence. These observations indicate that Cl- is involved in the water oxidation mechanism. The possibility that Cl- is close to the active site is discussed in terms of recent structural models.	[Ishida, Naoko; Lai, Thanh-Lan; Rutherford, A. William; Boussac, Alain] Inst Biol & Technol Saclay, Commissariat Energie Atom Saclay, CNRS, URA 2096, F-91191 Gif Sur Yvette, France; [Sugiura, Miwa] Osaka Prefecture Univ, Sch Life Sci & Environm Sci, Dept Plant Biosci, Naka Ku, Sakai, Osaka 5998531, Japan; [Rappaport, Fabrice] Univ Paris 06, CNRS, UMR7141, Inst Biol Physicochim, F-75005 Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); Osaka Metropolitan University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Boussac, A (corresponding author), Inst Biol & Technol Saclay, Commissariat Energie Atom Saclay, CNRS, URA 2096, F-91191 Gif Sur Yvette, France.	alain.boussac@cea.fr	Rutherford, Alfred W/A-7831-2019	Rutherford, Alfred W/0000-0002-3124-154X; Rappaport, Fabrice/0000-0001-9377-4934				Ananyev GM, 2001, BBA-BIOENERGETICS, V1503, P52, DOI 10.1016/S0005-2728(00)00215-2; Barber J, 2004, PHYS CHEM CHEM PHYS, V6, P4737, DOI 10.1039/b407981g; BAUMGARTEN M, 1990, BIOCHEMISTRY-US, V29, P10814, DOI 10.1021/bi00500a014; Betley TA, 2008, PHILOS T R SOC B, V363, P1293, DOI 10.1098/rstb.2007.2226; Boussac A, 2000, BIOCHEMISTRY-US, V39, P13788, DOI 10.1021/bi001159r; BOUSSAC A, 1992, BIOCHEMISTRY-US, V31, P1224, DOI 10.1021/bi00119a036; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; BOUSSAC A, 1988, BIOCHEMISTRY-US, V27, P3476, DOI 10.1021/bi00409a052; BOUSSAC A, 1988, FEBS LETT, V236, P432, DOI 10.1016/0014-5793(88)80071-1; BOUSSAC A, 1995, CHEM PHYS, V194, P409, DOI 10.1016/0301-0104(94)00419-B; Boussac A, 2008, PHILOS T R SOC B, V363, P1203, DOI 10.1098/rstb.2007.2216; CHEN CG, 1995, BIOCHEMISTRY-US, V34, P13511, DOI 10.1021/bi00041a031; Christen G, 1999, BIOCHEMISTRY-US, V38, P2068, DOI 10.1021/bi982188t; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Clausen J, 2005, BIOCHEMISTRY-US, V44, P12775, DOI 10.1021/bi051183a; Clausen J, 2004, NATURE, V430, P480, DOI 10.1038/nature02676; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEVAULT D, 1990, PHOTOSYNTH RES, V24, P175, DOI 10.1007/BF00032597; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; DUCRUET JM, 1992, PHOTOSYNTH RES, V33, P15, DOI 10.1007/BF00032979; Fernandez C, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P1399; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fufezan C, 2005, BIOCHEMISTRY-US, V44, P12780, DOI 10.1021/bi051000k; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Groot ML, 2005, P NATL ACAD SCI USA, V102, P13087, DOI 10.1073/pnas.0503483102; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13839, DOI 10.1021/bi026595n; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2006, BIOCHEMISTRY-US, V45, P13101, DOI 10.1021/bi061308r; Hendry G, 2003, BIOCHEMISTRY-US, V42, P6209, DOI 10.1021/bi034279i; Hillier W, 2004, PHYS CHEM CHEM PHYS, V6, P4882, DOI 10.1039/b407269c; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; Homann PH, 2002, PHOTOSYNTH RES, V73, P169, DOI 10.1023/A:1020486729283; HOMANN PH, 1986, ION INTERACTIONS ENE, P291; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kargul J, 2007, BBA-BIOENERGETICS, V1767, P404, DOI 10.1016/j.bbabio.2007.01.007; Kimura Y, 2005, PHOTOSYNTH RES, V84, P245, DOI 10.1007/s11120-005-0412-z; KOIKE H, 1987, BIOCHIM BIOPHYS ACTA, V893, P524, DOI 10.1016/0005-2728(87)90104-6; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175, DOI 10.1016/S0005-2728(09)91005-2; LAVOREL J, 1992, BIOCHIM BIOPHYS ACTA, V1101, P33, DOI 10.1016/0167-4838(92)90463-N; LINDBERG K, 1993, PHOTOSYNTH RES, V38, P401, DOI 10.1007/BF00046767; Lindberg K, 1996, BIOCHEMISTRY-US, V35, P14259, DOI 10.1021/bi961244s; LINDBERG K, 1990, FEBS LETT, V264, P153, DOI 10.1016/0014-5793(90)80788-K; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; McEvoy JP, 2004, PHYS CHEM CHEM PHYS, V6, P4754, DOI 10.1039/b407500e; Meelich K, 2008, PHILOS T R SOC B, V363, P1271, DOI 10.1098/rstb.2007.2224; Messinger J, 2004, PHYS CHEM CHEM PHYS, V6, P4764, DOI 10.1039/b406437b; MIYAO M, 1991, BIOCHEMISTRY-US, V30, P5379, DOI 10.1021/bi00236a008; Olesen K, 2003, BIOCHEMISTRY-US, V42, P2025, DOI 10.1021/bi026175y; ONO T, 1986, BIOCHIM BIOPHYS ACTA, V851, P193, DOI 10.1016/0005-2728(86)90125-8; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Rappaport F, 2005, BIOPHYS J, V88, P1948, DOI 10.1529/biophysj.104.050237; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Razeghifard MR, 1999, BIOCHEMISTRY-US, V38, P1252, DOI 10.1021/bi9811765; Renger G, 2007, PHOTOSYNTH RES, V92, P407, DOI 10.1007/s11120-007-9185-x; RUTHERFORD AW, 1984, BIOCHIM BIOPHYS ACTA, V767, P548, DOI 10.1016/0005-2728(84)90054-9; Rutherford AW, 2004, SCIENCE, V303, P1782, DOI 10.1126/science.1096767; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; Schilstra MJ, 1998, BIOCHEMISTRY-US, V37, P3974, DOI 10.1021/bi9713815; Siegbahn PEM, 2008, PHILOS T R SOC B, V363, P1221, DOI 10.1098/rstb.2007.2218; Sproviero EM, 2008, PHILOS T R SOC B, V363, P1149, DOI 10.1098/rstb.2007.2210; Sproviero EM, 2007, CURR OPIN STRUC BIOL, V17, P173, DOI 10.1016/j.sbi.2007.03.015; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2004, BIOCHEMISTRY-US, V43, P13549, DOI 10.1021/bi048732h; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Suzuki H, 2006, BIOCHEMISTRY-US, V45, P13454, DOI 10.1021/bi061232z; Tang XS, 1996, J AM CHEM SOC, V118, P7638, DOI 10.1021/ja9610592; Un S, 2007, BIOCHEMISTRY-US, V46, P3138, DOI 10.1021/bi062084f; vanVliet P, 1996, BIOCHEMISTRY-US, V35, P1829, DOI 10.1021/bi9514471; Vass I, 2003, PHOTOSYNTH RES, V76, P303, DOI 10.1023/A:1024989519054; VOS MH, 1991, BIOCHIM BIOPHYS ACTA, V1056, P27, DOI 10.1016/S0005-2728(05)80069-6; Vrettos JS, 2002, PHILOS T R SOC B, V357, P1395, DOI 10.1098/rstb.2002.1136; Westphal KL, 2000, BIOCHEMISTRY-US, V39, P16220, DOI 10.1021/bi0018077; Wincencjusz H, 1998, BIOCHEMISTRY-US, V37, P8595, DOI 10.1021/bi972660v; Wincencjusz H, 1999, BIOCHEMISTRY-US, V38, P3719, DOI 10.1021/bi982295n; Wincencjusz H, 1997, BIOCHEMISTRY-US, V36, P3663, DOI 10.1021/bi9626719; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	90	56	56	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13330	13340		10.1074/jbc.M710583200	http://dx.doi.org/10.1074/jbc.M710583200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332136	hybrid			2022-12-27	WOS:000255499800073
J	Potapova, IA; Brink, PR; Cohen, IS; Doronin, SV				Potapova, Irina A.; Brink, Peter R.; Cohen, Ira S.; Doronin, Sergey V.			Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; CHEMOKINE RECEPTORS; IN-VITRO; PROMOTING MIGRATION; HIV-1 ENTRY; TRANSPLANTATION; INDUCTION; MATRIX; BLOOD; MICE	Culture-expanded human mesenchymal stem cells (hMSCs) are increasingly used in a variety of preclinical and clinical studies. However, these cells have a low rate of engraftment to bone marrow or damaged tissues. Several laboratories have shown that during isolation and subculturing mesenchymal stem cells quickly lose the expression of CXCR4, the key receptor responsible for lymphocytes and hematopoietic stem cell homing. Here we show that culturing of hMSCs as three-dimensional aggregates (hMSC spheroids) restores CXCR4 functional expression. Expression of CXCR4 inversely correlates with the secretion of SDF-1 by hMSCs. Cells from hMSC spheroids up-regulate expression of CD49b, the alpha 2 integrin subunit, and suppress the expression of CD49d, the alpha 4 integrin subunit. Transfer of cells from the spheroids back to a monolayer suppresses the expression of CXCR4 and CD49b and restores the expression of CD49d. Treatment of cells from the spheroids with SDF-1 leads to CXCR4 internalization and activation of ERK-1,2. Adhesion of hMSCs to human umbilical vein endothelial cells ( HUVECs) was investigated. SDF-1, AMD-3100, or exposure of HUVECs to hypoxia did not affect adhesion of hMSCs from a monolayer to HUVECs. Adhesion of cells from hMSC spheroids to HUVECs was stimulated by SDF-1, AMD-3100, or by exposure of HUVECs to hypoxia. Stimulatory effects of hypoxia and addition of SDF-1 or AMD- 3100 were not additive. Overall, our data indicate that the expression of CXCR4 by hMSCs regulates hMSC adhesion to endothelial cells.	[Potapova, Irina A.; Brink, Peter R.; Cohen, Ira S.; Doronin, Sergey V.] SUNY Stony Brook, Dept Physiol & Biophys, Inst Mol Cardiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Doronin, SV (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Inst Mol Cardiol, BST-6,Rm 124, Stony Brook, NY 11794 USA.	sdoronin@notes.cc.sunysb.edu			NHLBI NIH HHS [HL67101, HL28958] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067101, P01HL028958] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; BHAKTA S, 2006, J INTERFERON CYTOKIN, V27, P53; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2006.0037; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Feil C, 1998, BIOCHEM BIOPH RES CO, V247, P38, DOI 10.1006/bbrc.1998.8499; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; FRIEDL P, 1995, J IMMUNOL, V154, P4973; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Le Y, 2005, J IMMUNOL, V174, P2582, DOI 10.4049/jimmunol.174.5.2582; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Lisignoli G, 2006, J CELL PHYSIOL, V207, P364, DOI 10.1002/jcp.20572; Lisignoli G, 2003, Chir Organi Mov, V88, P363; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shield Kristy, 2007, J Carcinog, V6, P11, DOI 10.1186/1477-3163-6-11; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wang Lei, 2002, Hematology, V7, P113; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	140	146	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13100	13107		10.1074/jbc.M800184200	http://dx.doi.org/10.1074/jbc.M800184200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334485	Green Published, hybrid			2022-12-27	WOS:000255499800048
J	Rand, KD; Andersen, MD; Olsen, OH; Jorgensen, TJD; Ostergaard, H; Jensen, ON; Stennicke, HR; Persson, E				Rand, Kasper D.; Andersen, Mette D.; Olsen, Ole H.; Jorgensen, Thomas J. D.; Ostergaard, Henrik; Jensen, Ole N.; Stennicke, Henning R.; Persson, Egon			The origins of enhanced activity in factor VIIa analogs and the interplay between key allosteric sites revealed by hydrogen exchange mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VIIA; RECOMBINANT FACTOR VIIA; TISSUE FACTOR-BINDING; BLOOD-COAGULATION; PROTEASE DOMAIN; CRYSTAL-STRUCTURE; INTRINSIC ACTIVITY; CATALYTIC-ACTIVITY; AFFINITY; IDENTIFICATION	Factor VIIa (FVIIa) circulates in the blood in a zymogen-like state. Only upon association with membrane-bound tissue factor (TF) at the site of vascular injury does FVIIa become active and able to initiate blood coagulation. Here we used hydrogen exchange monitored by mass spectrometry to investigate the conformational effects of site-directed mutagenesis at key positions in FVIIa and the origins of enhanced intrinsic activity of FVIIa analogs. The differences in hydrogen exchange of two highly active variants, FVIIa(DVQ) and FVIIa(VEAY), imply that enhanced catalytic efficiency was attained by two different mechanisms. Regions protected from exchange in FVIIaDVQ include the N-terminal tail and the activation pocket, which is a subset of the regions of FVIIa protected from exchange upon TF binding. FVIIaDVQ appeared to adopt an intermediate conformation between the free (zymogen-like) and TF-bound ( active) form of FVIIa and to attain enhanced activity by partial mimicry of TF-induced activation. In contrast, exchange-protected regions in FVIIaVEAY were confined to the vicinity of the active site of FVIIa. Thus, the changes in FVIIaVEAY appeared to optimize the active site region rather than imitate the TF-induced effect. Hydrogen exchange analysis of the FVIIa(M306D) variant, which was unresponsive to stimulation by TF, correlated widespread reductions in exchange to the single mutation in the TF-binding region. These results reveal the delicate interplay between key allosteric sites necessary to achieve the transition of FVIIa into the active form.	[Rand, Kasper D.; Andersen, Mette D.; Olsen, Ole H.; Ostergaard, Henrik; Stennicke, Henning R.; Persson, Egon] Novo Nordisk AS, Dept Haemostasis Biochem, DK-2760 Malov, Denmark; [Rand, Kasper D.; Jorgensen, Thomas J. D.; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Novo Nordisk; University of Southern Denmark	Rand, KD (corresponding author), Novo Nordisk AS, Dept Haemostasis Biochem, Novo Nordisk Pk, DK-2760 Malov, Denmark.	kasperd@bmb.sdu.dk; egpe@novonordisk.com	Rand, Kasper/ABG-7446-2021; Jensen, Ole N/J-1763-2012	Jensen, Ole N/0000-0003-1862-8528; Jorgensen, Thomas J.D./0000-0002-7149-316X; Rand, Kasper/0000-0002-6337-5489				Allen GA, 2007, ARTERIOSCL THROM VAS, V27, P683, DOI 10.1161/01.ATV.0000257204.82396.2b; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dickinson CD, 1997, J BIOL CHEM, V272, P19875, DOI 10.1074/jbc.272.32.19875; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Kemball-Cook G, 1999, J STRUCT BIOL, V127, P213, DOI 10.1006/jsbi.1999.4158; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; Persson E, 2006, BIOCHEM BIOPH RES CO, V341, P28, DOI 10.1016/j.bbrc.2005.12.146; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Petersen LC, 2000, PROTEIN SCI, V9, P859, DOI 10.1110/ps.9.5.859; Petrovan RJ, 2000, BIOCHEMISTRY-US, V39, P14457, DOI 10.1021/bi0009486; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; Roberts HR, 2004, BLOOD, V104, P3858, DOI 10.1182/blood-2004-06-2223; Ruf W, 1998, TRENDS CARDIOVAS MED, V8, P350, DOI 10.1016/S1050-1738(98)00031-0; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Soejima K, 2002, J BIOL CHEM, V277, P49027, DOI 10.1074/jbc.M203091200; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; Sorensen B, 2007, BRIT J HAEMATOL, V137, P158, DOI 10.1111/j.1365-2141.2007.06534.x; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; WILDGOOSE P, 1993, BIOCHEMISTRY-US, V32, P114, DOI 10.1021/bi00052a016	37	29	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13378	13387		10.1074/jbc.M709716200	http://dx.doi.org/10.1074/jbc.M709716200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343822	hybrid			2022-12-27	WOS:000255499800077
J	Sheoran, A; First, EA				Sheoran, Anita; First, Eric A.			Activation of D-tyrosine by Bacillus stearothermophilus tyrosyl-tRNA synthetase - 2. Cooperative binding of atp is limited to the initial turnover of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						6	SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; CATALYSIS; KINETICS; SEQUENCE; BACTERIORHODOPSIN; DISSOCIATION; SUBUNITS; MUTATION; MUTANTS	The activation of D-tyrosine by tyrosyl-tRNA synthetase has been investigated using single and multiple turnover kinetic methods. In the presence of saturating concentrations of D-tyrosine, the activation reaction displays sigmoidal kinetics with respect to ATP concentration under single turnover conditions. In contrast, when the kinetics for the activation reaction are monitored using a steady-state ( multiple turnover) pyrophosphate exchange assay, Michaelis-Menten kinetics are observed. Previous investigations indicated that activation of L-tyrosine by the K233A variant of Bacillus stearothermophilus tyrosyl-tRNA synthetase displays sigmoidal kinetics similar to those observed for activation of D-tyrosine by the wild-type enzyme. Kinetic analyses indicate that the sigmoidal behavior of the D-tyrosine activation reaction is not enhanced when Lys-233 is replaced by alanine. This supports the hypothesis that the mechanistic basis for the sigmoidal behavior is the same for both D-tyrosine activation by wild-type tyrosyl-tRNA synthetase and activation of L-tyrosine by the K233A variant. The observed sigmoidal behavior presents a paradox, as tyrosyl-tRNA synthetase displays an extreme form of negative cooperativity, known as "half-of-the-sites reactivity," with respect to tyrosine binding and tyrosyl-adenylate formation. We propose that the binding of D-tyrosine weakens the affinity with which ATP binds to the functional subunit in tyrosyl-tRNA synthetase. This allows ATP to bind initially to the nonfunctional subunit, inducing a conformational change in the enzyme that enhances the affinity of the functional subunit for ATP. The observation that sigmoidal kinetics are observed only under single turnover conditions suggests that this conformational change is stable over multiple rounds of catalysis.	[Sheoran, Anita; First, Eric A.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	First, EA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	efirst@lsuhsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068070] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68070, R01 GM068070] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adair GS, 1925, J BIOL CHEM, V63, P529; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Austin J, 2002, J BIOL CHEM, V277, P20243, DOI 10.1074/jbc.M201923200; Austin J, 2002, J BIOL CHEM, V277, P14812, DOI 10.1074/jbc.M103396200; AVIS JM, 1993, BIOCHEMISTRY-US, V32, P5312, DOI 10.1021/bi00071a005; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1967, J MOL BIOL, V26, P39, DOI 10.1016/0022-2836(67)90259-8; CLARKE AR, 1996, ENZYMOLOGY LABFAX, P201; Eadie GS, 1942, J BIOL CHEM, V146, P85; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; HO CK, 1986, BIOCHEMISTRY-US, V25, P1891, DOI 10.1021/bi00356a009; HOFSTEE BHJ, 1959, NATURE, V184, P1296, DOI 10.1038/1841296b0; JONES DH, 1985, BIOCHEMISTRY-US, V24, P5852, DOI 10.1021/bi00342a024; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Kollbach G, 1998, BIOCHEMISTRY-US, V37, P8227, DOI 10.1021/bi972268h; LLOYD AJ, 1995, NUCLEIC ACIDS RES, V23, P2886, DOI 10.1093/nar/23.15.2886; MATSUOKA I, 1982, J BIOCHEM-TOKYO, V92, P1383, DOI 10.1093/oxfordjournals.jbchem.a134062; Michaelis L, 1913, BIOCHEM Z, V49, P333; Prigent V, 2005, BIOINFORMATICS, V21, P1437, DOI 10.1093/bioinformatics/bti218; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sheoran A, 2008, J BIOL CHEM, V283, P12960, DOI 10.1074/jbc.M801649200; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Xin Y, 2000, BIOCHEMISTRY-US, V39, P340, DOI 10.1021/bi991675l; Yamaguchi S, 2000, J BIOCHEM-TOKYO, V127, P861, DOI 10.1093/oxfordjournals.jbchem.a022680	32	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12971	12980		10.1074/jbc.M801650200	http://dx.doi.org/10.1074/jbc.M801650200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319246	hybrid, Green Published			2022-12-27	WOS:000255499800034
J	Shim, SY; Samuels, BA; Wang, J; Neumayer, G; Belzil, C; Ayala, R; Shi, Y; Shi, YJ; Tsai, LH; Nguyen, MD				Shim, Su Yeon; Samuels, Benjamin Adam; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Ayala, Ramses; Shi, Yang; Shi, Yujiang; Tsai, Li-Huei; Nguyen, Minh Dang			Ndel1 controls the dynein-mediated transport of vimentin during neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT NETWORKS; AMYOTROPHIC-LATERAL-SCLEROSIS; MARIE-TOOTH-DISEASE; CYTOPLASMIC DYNEIN; NEURONAL MIGRATION; VESICLE-TRAFFICKING; MOTILE PROPERTIES; CEREBRAL-CORTEX; LIS1; NUDEL	Ndel1, the mammalian homologue of the Aspergillus nidulans NudE, is emergently viewed as an integrator of the cytoskeleton. By regulating the dynamics of microtubules and assembly of neuronal intermediate filaments (IFs), Ndel1 promotes neurite outgrowth, neuronal migration, and cell integrity (1-6). To further understand the roles of Ndel1 in cytoskeletal dynamics, we performed a tandem affinity purification of Ndel1-interacting proteins. We isolated a novel Ndel1 molecular complex composed of the IF vimentin, the molecular motor dynein, the lissencephaly protein Lis1, and the cis-Golgi-associated protein alpha COP. Ndel1 promotes the interaction between Lis1, alpha COP, and the vimentin-dynein complex. The functional result of this complex is activation of dynein-mediated transport of vimentin. A loss of Ndel1 functions by RNA interference fails to incorporate Lis1/alpha COP in the complex, reduces the transport of vimentin, and culminates in IF accumulations and altered neuritogenesis. Our findings reveal a novel regulatory mechanism of vimentin transport during neurite extension that may have implications in diseases featuring transport/trafficking defects and impaired regeneration.	[Shim, Su Yeon; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Wang, Jian; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Samuels, Benjamin Adam; Ayala, Ramses; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Shi, Yang; Shi, Yujiang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Calgary; University of Calgary; University of Calgary; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School	Nguyen, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, 3330 Hosp Dr NW,Heritage Med Res Bldg,Room 151, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Boyne LJ, 1996, INT J DEV NEUROSCI, V14, P739, DOI 10.1016/S0736-5748(96)00053-6; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007; Dubey M, 2004, J NEUROSCI RES, V78, P245, DOI 10.1002/jnr.20146; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; LO NC, 1997, HUM MOL GENET, V6, P157; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2001, Prog Brain Res, V132, P23; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perrin FE, 2005, HUM MOL GENET, V14, P3309, DOI 10.1093/hmg/ddi357; Perrin FE, 2006, J NEUROCHEM, V98, P1959, DOI 10.1111/j.1471-4159.2006.04024.x; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Qi YP, 1997, J NEUROSCI, V17, P1217; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; SHEA TB, 1993, J NEUROSCI RES, V36, P66, DOI 10.1002/jnr.490360108; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; Wang L, 2001, MOL BIOL CELL, V12, P3257, DOI 10.1091/mbc.12.10.3257; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yan YP, 2005, J NEUROSCI, V25, P7014, DOI 10.1523/JNEUROSCI.2001-05.2005; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	61	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12232	12240		10.1074/jbc.M710200200	http://dx.doi.org/10.1074/jbc.M710200200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303022	hybrid			2022-12-27	WOS:000255340000039
J	Tanemoto, M; Toyohara, T; Abe, T; Ito, S				Tanemoto, Masayuki; Toyohara, Takafumi; Abe, Takaaki; Ito, Sadayoshi			MAGI-1a functions as a scaffolding protein for the distal renal tubular basolateral K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PHOSPHORYLATION; HUMAN HYPERTENSION; BETA-CATENIN; PDZ-BINDING; RAT-KIDNEY; MEMBRANE; CELLS; KIR4.1; PREVALENCE; KINASE	As the K+ recycling pathway for renal Na+ reabsorption, renal tubular K+ channels participate in the fluid and electrolyte homeostasis. Previously, we showed that the Kir5.1/Kir4.1 heteromer, which is a heteromeric assembly of two inwardly rectifying K+ channels, composes the principal basolateral K+ channels in distal renal tubules and that two motifs in the carboxyl-terminal portion of the Kir4.1 subunit regulate its functional expression. In this study, by using yeast two-hybrid screening, we identified a new isoform of membrane-associated guanylate kinase with inverted domain structure 1 (MAGI-1a-long) as a scaffolding protein for the basolateral K+ channels. MAGI-1a-long interacted with the PSD-95/Dlg/ZO-1 (PDZ)binding motif of Kir4.1 by its fifth PDZ domain, and a high salt diet, which could suppress mineralocorticoid secretion, facilitated the interaction. The phosphorylation of serine 377 in the PDZ-binding motif disrupted the interaction, and the disruption of the interaction altered the intracellular localization of the channels from the basolateral side to perinuclear components. These results demonstrate that the phosphorylation-dependent scaffolding of the basolateral K+ channels by MAGI-1a-long participates in the renal regulation of the fluid and electrolyte homeostasis.	[Tanemoto, Masayuki; Toyohara, Takafumi; Abe, Takaaki; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol,Aoba Ku, Sendai, Miyagi 9808574, Japan	Tohoku University	Tanemoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol,Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	mtanemoto-tky@umin.ac.jp	Ito, Sadayoshi/A-3933-2015	Ito, Sadayoshi/0000-0002-5092-3626				Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Brown D, 2000, KIDNEY INT, V57, P816, DOI 10.1046/j.1523-1755.2000.00920.x; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; de la Rosa DA, 2003, J PHYSIOL-LONDON, V551, P455, DOI 10.1113/jphysiol.2003.042903; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Giebisch G, 2001, KIDNEY INT, V60, P436, DOI 10.1046/j.1523-1755.2001.060002436.x; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hou JH, 2002, J AM SOC NEPHROL, V13, P1190, DOI 10.1097/01.ASN.0000013702.73570.3B; Ito M, 1996, FEBS LETT, V388, P11, DOI 10.1016/0014-5793(96)00502-9; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Loh NY, 2000, J CELL SCI, V113, P2715; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Meneton P, 2004, AM J PHYSIOL-RENAL, V287, pF593, DOI 10.1152/ajprenal.00454.2003; Nishimura W, 2000, J CELL PHYSIOL, V185, P358, DOI 10.1002/1097-4652(200012)185:3<358::AID-JCP6>3.3.CO;2-R; Patrie KM, 2001, J AM SOC NEPHROL, V12, P667, DOI 10.1681/ASN.V124667; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Psaltopoulou T, 2004, INT J EPIDEMIOL, V33, P1345, DOI 10.1093/ije/dyh249; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tanemoto M, 2005, J AM SOC NEPHROL, V16, P2608, DOI 10.1681/ASN.2005030266; Tanemoto M, 2004, AM J PHYSIOL-RENAL, V287, pF1148, DOI 10.1152/ajprenal.00203.2004; Tanemoto M, 2002, NEURON, V34, P387, DOI 10.1016/S0896-6273(02)00675-X; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844	34	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12241	12247		10.1074/jbc.M707738200	http://dx.doi.org/10.1074/jbc.M707738200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303016	hybrid			2022-12-27	WOS:000255340000040
J	Cordle, J; Redfield, C; Stacey, M; van der Merwe, PA; Willis, AC; Champion, BR; Hambleton, S; Handford, PA				Cordle, Jemima; Redfield, Christina; Stacey, Martin; van der Merwe, P. Anton; Willis, Antony C.; Champion, Brian R.; Hambleton, Sophie; Handford, Penny A.			Localization of the delta-like-1-binding site in human notch-1 and its modulation by calcium affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; HUMAN FIBRILLIN-1; MARFAN-SYNDROME; O-FUCOSE; DOMAIN; RECEPTORS; DISEASE; REPEATS; PROTEOLYSIS; DROSOPHILA	The Notch signaling pathway plays a key role in a myriad of cellular processes, including cell fate determination. Despite extensive study of the downstream consequences of receptor activation, very little molecular data are available for the initial binding event between the Notch receptor and its ligands. In this study, we have expressed and purified a natively folded wildtype epidermal growth factor-like domain (EGF) 11-14 construct from human Notch-1 and have used flow cytometry and surface plasmon resonance analysis to demonstrate a calcium-dependent interaction with the human ligand Delta-like-1. Site-directed mutagenesis of three of the calcium-binding sites within the Notch-(11-14) fragment indicated that only loss of calcium binding to EGF12, and not EGF11 or EGF13, abrogates ligand binding. Further mapping of the ligand-binding site within this region by limited proteolysis of Notch wild-type and mutant fragments suggested that EGF12 rather than EGF11 contains the major Delta-like-1-binding site. Analysis of an extended fragment EGF-(10-14), where EGF11 is placed in a native context, surprisingly demonstrated a reduction in ligand binding, suggesting that EGF10 modulates binding by limiting access of ligand. This inhibition could be overcome by the introduction of a calcium binding mutation in EGF11, which decouples the EGF-(10-11) module interface. This study therefore demonstrates that long range calcium-dependent structural perturbations can influence the affinity of Notch for its ligand, in the absence of any post-translational modifications.	[Willis, Antony C.; Handford, Penny A.] Univ Oxford, Dept Biochem, Immunochem Unit, MRC, Oxford OX1 3QU, England; [Stacey, Martin; van der Merwe, P. Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Champion, Brian R.] Celldex Therapeut Ltd, Cambridge CB4 0PE, England; [Hambleton, Sophie] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Human Immunol Unit,MRC, Oxford OX3 9DS, England	University of Oxford; University of Oxford; University of Oxford	Handford, PA (corresponding author), Univ Oxford, Dept Biochem, Immunochem Unit, MRC, S Parks Rd, Oxford OX1 3QU, England.	penny.handford@bioch.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011		Medical Research Council [G9722488] Funding Source: Medline; Wellcome Trust [079440] Funding Source: Medline; MRC [G9722488] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbott RJM, 2004, ACTA CRYSTALLOGR D, V60, P936, DOI 10.1107/S0907444904005098; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CORDLE JD, 2005, THESIS U OXFORD; Davis JA, 2007, J BIOL CHEM, V282, P28807, DOI 10.1074/jbc.M704015200; DE SB, 1999, NATURE, V398, P518; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Joutel A, 1998, SEMIN CELL DEV BIOL, V9, P619, DOI 10.1006/scdb.1998.0261; Kettle S, 1999, J MOL BIOL, V285, P1277, DOI 10.1006/jmbi.1998.2368; Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; vanderMerwe PA, 1996, CURR OPIN IMMUNOL, V8, P257, DOI 10.1016/S0952-7915(96)80065-3; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Whiteman P, 2001, J BIOL CHEM, V276, P17156, DOI 10.1074/jbc.M006547200; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200	35	71	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11785	11793		10.1074/jbc.M708424200	http://dx.doi.org/10.1074/jbc.M708424200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18296446	hybrid			2022-12-27	WOS:000255067400078
J	Cossette, C; Patel, P; Anumolu, JR; Sivendran, S; Lee, GJ; Gravel, S; Graham, FD; Lesimple, A; Mamer, OA; Rokach, J; Powell, WS				Cossette, Chantal; Patel, Pranav; Anumolu, Jaganmohan R.; Sivendran, Sashikala; Lee, Gue Jae; Gravel, Sylvie; Graham, Francois D.; Lesimple, Alain; Mamer, Orval A.; Rokach, Joshua; Powell, William S.			Human neutrophils convert the sebum-derived polyunsaturated fatty acid sebaleic acid to a potent granulocyte chemoattractant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SEBACEOUS GLAND; POLYMORPHONUCLEAR LEUKOCYTES; 5-OXO-6,8,11,14-EICOSATETRAENOIC ACID; LIQUID-CHROMATOGRAPHY; HUMAN EOSINOPHILS; ARACHIDONIC-ACID; LEPIDIUM-MEYENII; LEUKOTRIENE B-4; METABOLISM; 5-OXO-ETE	Sebaleic acid (5,8-octadecadienoic acid) is the major polyunsaturated fatty acid in human sebum and skin surface lipids. The objective of the present study was to investigate the metabolism of this fatty acid by human neutrophils and to determine whether its metabolites are biologically active. Neutrophils converted sebaleic acid to four major products, which were identified by their chromatographic properties, UV absorbance, and mass spectra as 5-hydroxy-(6E, 8Z)-octadecadienoic acid (5-HODE), 5-oxo-(6E, 8Z)-octadecadienoic acid (5-oxo-ODE), 5S, 18-dihydroxy-(6E, 8Z)-octadecadienoic acid, and 5-oxo-18-hydroxy-(6E, 8Z)-octadecadienoic acid. The identities of these metabolites were confirmed by comparison of their properties with those of authentic chemically synthesized standards. Both neutrophils and human keratinocytes converted 5-HODE to 5-oxo- ODE. This reaction was stimulated in neutrophils by phorbol myristate acetate and in keratinocytes by oxidative stress (t-butyl-hydroperoxide). Both treatments dramatically elevated intracellular levels of NADP(+), the cofactor required by 5-hydroxyeicosanoid dehydrogenase. In keratinocytes, this was accompanied by a rapid increase in intracellular GSSG levels, consistent with the involvement of glutathione peroxidase. 5-Oxo-ODE stimulated calcium mobilization in human neutrophils and induced desensitization to 5-oxo- 6,8,11,14-eicosatetraenoic acid but not leukotriene B-4, indicating that this effect was mediated by the OXE receptor. 5-Oxo-ODE and its 8-trans isomer were equipotent with 5-oxo- 6,8,11,14-eicosatetraenoic acid in stimulating actin polymerization and chemotaxis in human neutrophils, whereas 5-HODE, 5-oxo- 18-hydroxy(6E, 8Z)-octadecadienoic acid, and 5S, 18-dihydroxy-(6E, 8Z)-octadecadienoic acid were much less active. We conclude that neutrophil 5-lipoxygenase converts sebaleic acid to 5-HODE, which can be further metabolized to 5-oxo-ODE by 5-hydroxyeicosanoid dehydrogenase in neutrophils and keratinocytes. Because of its chemoattractant properties, sebum-derived 5-oxo-ODE could be involved in neutrophil infiltration in inflammatory skin diseases.	[Cossette, Chantal; Gravel, Sylvie; Graham, Francois D.; Powell, William S.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ H2X 2P2, Canada; [Lesimple, Alain; Mamer, Orval A.] McGill Univ, Mass Spectrometry Unit, Montreal, PQ H3A 1A4, Canada; [Patel, Pranav; Anumolu, Jaganmohan R.; Sivendran, Sashikala; Lee, Gue Jae; Rokach, Joshua] Florida Inst Technol, Claude Pepper Inst, Melbourne, FL 32901 USA; [Patel, Pranav; Anumolu, Jaganmohan R.; Sivendran, Sashikala; Lee, Gue Jae; Rokach, Joshua] Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA	McGill University; McGill University; Florida Institute of Technology; Florida Institute of Technology	Powell, WS (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, 3626 St Urbain St, Montreal, PQ H2X 2P2, Canada.	William.Powell@McGill.ca	Graham, François/AAP-2630-2020; Powell, William/AAE-9000-2020	Powell, William/0000-0002-8507-4038; Rokach, Joshu/0000-0003-1814-7505	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081873] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL81873] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alestas T, 2006, J MOL MED, V84, P75, DOI 10.1007/s00109-005-0715-8; BIANCHI A, 2003, B LATINOAM CARIBE PL, V2, P30; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P3213, DOI 10.1073/pnas.76.7.3213; Brink C, 2004, PHARMACOL REV, V56, P149, DOI 10.1124/pr.56.1.4; Erlemann KR, 2007, BIOCHEM J, V403, P157, DOI 10.1042/BJ20061617; Erlemann KR, 2007, FREE RADICAL BIO MED, V42, P654, DOI 10.1016/j.freeradbiomed.2006.12.006; Erlemann KR, 2006, BIOCHEM BIOPH RES CO, V350, P151, DOI 10.1016/j.bbrc.2006.09.011; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ge L, 2003, J INVEST DERMATOL, V120, P707, DOI 10.1046/j.1523-1747.2003.12123.x; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; HANSSON G, 1981, FEBS LETT, V130, P107, DOI 10.1016/0014-5793(81)80676-X; Hosoi T, 2005, BIOCHEM BIOPH RES CO, V334, P987, DOI 10.1016/j.bbrc.2005.06.191; Jones CE, 2003, MOL PHARMACOL, V63, P471, DOI 10.1124/mol.63.3.471; Khanapure SP, 1998, J ORG CHEM, V63, P337, DOI 10.1021/jo9716993; KOBAYASHI Y, 1994, BBA-LIPID LIPID MET, V1215, P280, DOI 10.1016/0005-2760(94)90054-X; LUDWIG SA, 1979, ARCH BIOCHEM BIOPHYS, V197, P333, DOI 10.1016/0003-9861(79)90253-4; MARPLES RR, 1971, J INVEST DERMATOL, V56, P127, DOI 10.1111/1523-1747.ep12260695; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; Muhammad I, 2002, PHYTOCHEMISTRY, V59, P105, DOI 10.1016/S0031-9422(01)00395-8; NICOLAIDES N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; O'Flaherty JT, 2000, J IMMUNOL, V164, P3345, DOI 10.4049/jimmunol.164.6.3345; OFLAHERTY JT, 1986, J IMMUNOL, V137, P3277; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; Parmentier C, 1998, J CHROMATOGR B, V719, P37, DOI 10.1016/S0378-4347(98)00414-9; POWELL WS, 1994, J BIOL CHEM, V269, P25373; Powell WS, 1996, J PHARMACOL EXP THER, V276, P728; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; POWELL WS, 1980, PROSTAGLANDINS, V20, P947, DOI 10.1016/0090-6980(80)90144-6; POWELL WS, 1993, J BIOL CHEM, V268, P9280; Powell WS, 1996, J IMMUNOL, V156, P336; POWELL WS, 1992, J BIOL CHEM, V267, P19233; POWELL WS, 1987, BIOCHEM BIOPH RES CO, V145, P991, DOI 10.1016/0006-291X(87)91533-6; POWELL WS, 1987, ANAL BIOCHEM, V164, P117, DOI 10.1016/0003-2697(87)90375-7; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; STEWART ME, 1978, BIOCHIM BIOPHYS ACTA, V529, P380, DOI 10.1016/0005-2760(78)90082-6; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002; Valentova Katerina, 2003, Biomedical Papers (Olomouc), V147, P119; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; ZAMBONI R, 1982, TETRAHEDRON LETT, V23, P2631, DOI 10.1016/S0040-4039(00)87415-8; Zheng BL, 2000, UROLOGY, V55, P598, DOI 10.1016/S0090-4295(99)00549-X	42	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11234	11243		10.1074/jbc.M709531200	http://dx.doi.org/10.1074/jbc.M709531200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18287092	Green Published, hybrid			2022-12-27	WOS:000255067400019
J	Nishimura, S; Takahashi, S; Kamikatahira, H; Kuroki, Y; Jaalouk, DE; O'Brien, S; Koivunen, E; Arap, W; Pasqualini, R; Nakayama, H; Kuniyasu, A				Nishimura, Shinpei; Takahashi, Shunsuke; Kamikatahira, Hiromi; Kuroki, Yuko; Jaalouk, Diana E.; O'Brien, Susan; Koivunen, Erkki; Arap, Wadih; Pasqualini, Renata; Nakayama, Hitoshi; Kuniyasu, Akihiko			Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH PEPTIDES; ACUTE MYELOID-LEUKEMIA; CELLULAR UPTAKE; DRUG-DELIVERY; INTRACELLULAR TRAFFICKING; PENETRATING PEPTIDES; BLOOD-VESSELS; GENE DELIVERY; PHAGE DISPLAY; TAT PEPTIDE	Ligand-directed delivery of agents to leukemia and lymphoma cells has the potential to yield new mechanistic disease insights and targeted therapies. Here we set out to target the macropinocytotic pathway with a combinatorial approach. From the screening of acute T-lymphoblastic leukemia Molt-4 cells with a random phage-display peptide library, we isolated a phage displaying the sequence CAYHRLRRC. This peptide contains a lymph node-homing motif (Cys-Ala-Tyr) and a cell-penetrating motif (Arg-Leu-Arg-Arg). Binding of this ligand-directed phage to a large panel of leukemia/lymphoma cells and to patient-derived samples was much higher than to non-leukemia control cells. CAYHRLRRC phage internalization into Molt-4 cells is both energy- and temperature-dependent. Flow cytometry with fluorescein-labeled peptide and endocytosis blocking with specific inhibitors revealed that CAYHRLRRC is indeed taken up through macropinocytosis in Molt-4 and K562 human leukemia cells. Unexpectedly, the cell surface receptor for the CAYHRLRRC peptide is not a heparan sulfate proteoglycan as it would be predicted for other cell-penetrating peptides. Confirming this interpretation, a CAYHRLRRC-directed peptidomimetic-induced cell death in all the leukemia and lymphoma cells was evaluated, whereas a control transactivator of transcription protein (tat)-directed proapoptotic peptidomimetic was non-selective. In summary, the targeting peptide CAYHRLRRC is selectively internalized through macropinocytosis in leukemia and lymphoma cells and has potential as a drug lead for ligand-directed anti-leukemia therapies.	[Jaalouk, Diana E.; O'Brien, Susan; Koivunen, Erkki; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Nishimura, Shinpei; Takahashi, Shunsuke; Kamikatahira, Hiromi; Kuroki, Yuko; Nakayama, Hitoshi; Kuniyasu, Akihiko] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol Cell Funct, Kumamoto 8620973, Japan	University of Texas System; UTMD Anderson Cancer Center; Kumamoto University	Arap, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	warap@mdanderson.org; rpasqual@mdanderson.org; kuniyasu@gpo.kumamoto-u.ac.jp		Koivunen, Erkki/0000-0002-6443-9595				Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Ardelt PU, 2003, J UROLOGY, V169, P1535, DOI 10.1097/01.ju.0000055477.37115.66; Zhao B, 2006, J BIOL CHEM, V281, P15757, DOI 10.1074/jbc.M510714200; Christianson Dawn R, 2007, Methods Mol Biol, V357, P385; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Curnis F, 2002, CANCER RES, V62, P867; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; FRA AM, 1994, J BIOL CHEM, V269, P30745; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; GOLDMACHER VS, 1986, J CELL BIOL, V102, P1312, DOI 10.1083/jcb.102.4.1312; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grimmer S, 2002, J CELL SCI, V115, P2953; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2006, TRENDS CARDIOVAS MED, V16, P80, DOI 10.1016/j.tcm.2006.01.003; HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689; Hong FD, 2000, CANCER RES, V60, P6551; Jager S, 2007, LEUKEMIA, V21, P411, DOI 10.1038/sj.leu.2404548; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kawamura KS, 2006, BIOCHEMISTRY-US, V45, P1116, DOI 10.1021/bi051338e; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; Koivunen E, 2001, J CELL BIOL, V153, P905, DOI 10.1083/jcb.153.5.905; Kolonin M, 2001, CURR OPIN CHEM BIOL, V5, P308, DOI 10.1016/S1367-5931(00)00207-6; Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5472.CAN-05-2748; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kolonin MG, 2002, P NATL ACAD SCI USA, V99, P13055, DOI 10.1073/pnas.162468499; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; McGuire MJ, 2006, EXP HEMATOL, V34, P443, DOI 10.1016/j.exphem.2005.12.013; Meade BR, 2007, ADV DRUG DELIVER REV, V59, P134, DOI 10.1016/j.addr.2007.03.004; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Snyder EL, 2003, J CONTROL RELEASE, V91, P45, DOI 10.1016/S0168-3659(03)00212-8; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Takahashi S, 2003, CANCER RES, V63, P5213; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Trepel M, 2001, CANCER RES, V61, P8110; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Zurita AJ, 2004, CANCER RES, V64, P435, DOI 10.1158/0008-5472.CAN-03-2675	61	44	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11752	11762		10.1074/jbc.M708849200	http://dx.doi.org/10.1074/jbc.M708849200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18292083	Green Published, hybrid			2022-12-27	WOS:000255067400075
J	Strathdee, D; Whitelaw, CBA; Clark, AJ				Strathdee, Douglas; Whitelaw, C. Bruce A.; Clark, A. John			Distal transgene insertion affects CpG island maintenance during differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC GENE INACTIVATION; EMBRYONIC STEM-CELLS; BETA-ACTIN LOCUS; DNA METHYLATION; EXPRESSION; PROMOTER; SP1; EVOLUTION; METHYLTRANSFERASES; SEQUENCES	About half of all genes have a CpG island surrounding the promoter and transcription start site. Most promoter CpG islands are normally unmethylated in all tissues, irrespective of the expression level of the associated gene. Establishment of the appropriate patterns of DNA methylation in the genome is essential for normal development and patterns of gene expression. Aberrant methylation of CpG islands and silencing of the associated genes is frequently observed in cancer. One gene with a 5'-CpG island is cytoplasmic beta-actin, which is an abundantly expressed protein and a major component of microfilaments. Inserting a beta geo cassette into the 3'-untranslated region of beta-actin gene led to widespread but not ubiquitous lacZ expression in mice heterozygous for the modified beta-actin allele. Surprisingly, embryos homozygous for this insertion died at mid-gestation. The modified beta-actin allele was expressed in undifferentiated embryonic stem cells but was turned off as these cells differentiate in vitro and in vivo. We demonstrate that the insertion affects the maintenance of the methylation status of the CpG island of the modified beta-actin allele in differentiated but not in undifferentiated embryonic cells. These data suggest that there is a two-step process to defining a CpG island, requiring both embryonic establishment and a signal that maintains the CpG island in differentiated cells. Furthermore, they indicate that features built into the CpG island are not sufficient to direct CpG island maintenance during differentiation.	[Strathdee, Douglas; Whitelaw, C. Bruce A.; Clark, A. John] Roslin Inst, Div Gene Funct & Dev, Roslin EH25 9PS, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Strathdee, D (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton Cambridge CB10 1SA, Cambs, England.	ds10@sanger.ac.uk		Whitelaw, Bruce/0000-0002-2918-1605	BBSRC [BBS/E/D/05251442, BBS/E/D/05251445, BBS/E/D/05251443, BBS/E/D/05251444] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05251444, BBS/E/D/05251445, Cad04943, BBS/E/D/05251443, BBS/E/D/05251442] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; ELDER PK, 1988, MOL CELL BIOL, V8, P480, DOI 10.1128/MCB.8.1.480; ERBA HP, 1988, MOL CELL BIOL, V8, P1775, DOI 10.1128/MCB.8.4.1775; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5; Hattori N, 2004, GENOME RES, V14, P1733, DOI 10.1101/gr.2431504; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lei H, 1996, DEVELOPMENT, V122, P3195; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Macleod D, 1998, MOL CELL BIOL, V18, P4433, DOI 10.1128/MCB.18.8.4433; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; MUMMANENI P, 1995, J BIOL CHEM, V270, P788, DOI 10.1074/jbc.270.2.788; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Wallace H, 2000, NUCLEIC ACIDS RES, V28, P1455, DOI 10.1093/nar/28.6.1455; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yates PA, 1999, J BIOL CHEM, V274, P36357, DOI 10.1074/jbc.274.51.36357	37	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11509	11515		10.1074/jbc.M709805200	http://dx.doi.org/10.1074/jbc.M709805200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308728	hybrid			2022-12-27	WOS:000255067400050
J	Kim, HJ; Kirsch, T				Kim, Hyon Jong; Kirsch, Thorsten			Collagen/annexin V interactions regulate chondrocyte mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN OSTEOARTHRITIC CARTILAGE; LARGE UNILAMELLAR VESICLES; GROWTH-PLATE CHONDROCYTES; CHICK-EMBRYO CHONDROCYTES; ANNEXIN-V; ASCORBIC-ACID; EXTRACELLULAR-MATRIX; II COLLAGEN; X-COLLAGEN; ANCHORIN-CII	Physiological mineralization in growth plate cartilage is highly regulated and restricted to terminally differentiated chondrocytes. Because mineralization occurs in the extracellular matrix, we asked whether major extracellular matrix components (collagens) of growth plate cartilage are directly involved in regulating the mineralization process. Our findings show that types II and X collagen interacted with cell surfaceexpressed annexin V. These interactions led to a stimulation of annexin Vmediated Ca2+ influx resulting in an increased intracellular Ca2+ concentration, [Ca2+](i), and ultimately increased alkaline phosphatase activity and mineralization of growth plate chondrocytes. Consequently, stimulation of these interactions (ascorbate to stimulate collagen synthesis, culturing cells on type II collagencoated dishes, or overexpression of fulllength annexin V) resulted in increase of [Ca2+](i), alkaline phosphatase activity, and mineralization of growth plate chondrocytes, whereas inhibition of these interactions (3,4dehydroLproline to inhibit collagen secretion, K201, a specific annexin channel blocker, overexpression of N terminusdeleted mutant annexin V that does not bind to type II collagen and shows reduced Ca2+ channel activities) decreased [Ca2+](i), alkaline phosphatase activity, and mineralization. In conclusion, the interactions between collagen and annexin V regulate mineralization of growth plate cartilage. Because annexin V is upregulated during pathological mineralization events of articular cartilage, it is possible that these interactions also regulate pathological mineralization.	[Kim, Hyon Jong; Kirsch, Thorsten] Univ Maryland, Sch Med, Dept Orthopaed, Musculoskeletal Res Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kirsch, T (corresponding author), NYU, Hosp Joint Dis, Musculoskeletal Res Ctr, Dept Orthopaed Surg, 301 E 17th St,Suite 1500, New York, NY 10003 USA.	Thorsten.Kirsch@nyumc.org	Kirsch, Thorsten/GQP-1157-2022	Kim, Hyon Jong/0000-0002-3106-4977	NIAMS NIH HHS [R01AR046245, R01AR049074] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049074, R01AR046245] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abe T, 2001, J CELL PHYSIOL, V189, P144, DOI 10.1002/jcp.10011; AIGNER T, 1993, J CLIN INVEST, V91, P829, DOI 10.1172/JCI116303; ALINI M, 1992, CALCIFIED TISSUE INT, V50, P327, DOI 10.1007/BF00301630; Aurich M, 2002, ARTHRITIS RHEUM, V46, P2903, DOI 10.1002/art.10611; Baran DT, 2000, J CELL BIOCHEM, V78, P34, DOI 10.1002/(SICI)1097-4644(20000701)78:1<34::AID-JCB4>3.3.CO;2-Q; BERENDES R, 1993, FEBS LETT, V317, P131, DOI 10.1016/0014-5793(93)81507-V; Castro-Caldas M, 2002, MOL CELL BIOCHEM, V237, P31, DOI 10.1023/A:1016502120139; Chen NX, 2007, AM J PHYSIOL-RENAL, V292, pF599, DOI 10.1152/ajprenal.00303.2006; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAJEK AS, 1977, J EXP ZOOL, V200, P377, DOI 10.1002/jez.1402000308; HARADA S, 1991, J BONE MINER RES, V6, P903; Hausler G, 2002, CALCIFIED TISSUE INT, V71, P212, DOI 10.1007/s00223-001-2083-x; IANNOTTI JP, 1989, J ORTHOPAED RES, V7, P511, DOI 10.1002/jor.1100070408; Kaneko N, 1997, BBA-BIOMEMBRANES, V1330, P1, DOI 10.1016/S0005-2736(97)00132-6; Kaneko N, 1997, J MOL BIOL, V274, P16, DOI 10.1006/jmbi.1997.1375; KERWAR SS, 1976, J BIOL CHEM, V251, P503; KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x; KIRSCH T, 1992, BONE MINER, V18, P107, DOI 10.1016/0169-6009(92)90851-4; Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867; KIRSCH T, 1992, FEBS LETT, V310, P143, DOI 10.1016/0014-5793(92)81316-E; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; KIVIRIKKO KI, 1987, METHOD ENZYMOL, V144, P96; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; Lucic D, 2003, CONNECT TISSUE RES, V44, P225, DOI 10.1080/03008200390248632; MEIER S, 1978, J ULTRA MOL STRUCT R, V65, P48, DOI 10.1016/S0022-5320(78)90021-7; MILLS DK, 1993, CONNECT TISSUE RES, V30, P37, DOI 10.3109/03008209309032929; Mollenhauer J, 1999, J HISTOCHEM CYTOCHEM, V47, P209, DOI 10.1177/002215549904700209; MOLLENHAUER J, 1984, J CELL BIOL, V98, P1572, DOI 10.1083/jcb.98.4.1572; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; Reid DL, 2000, J ORTHOPAED RES, V18, P364, DOI 10.1002/jor.1100180307; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; Siever DA, 1997, INT J BIOCHEM CELL B, V29, P1219, DOI 10.1016/S1357-2725(97)00057-5; SULLIVAN TA, 1994, J BIOL CHEM, V269, P22500; Takagi H, 2002, J CELL SCI, V115, P3309; Wang W, 2003, J BIOL CHEM, V278, P3762, DOI 10.1074/jbc.M208868200; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Wang W, 2005, EXP CELL RES, V305, P156, DOI 10.1016/j.yexcr.2004.12.022; Wang W, 2006, J BIOL CHEM, V281, P30848, DOI 10.1074/jbc.M605937200; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Zuscik MJ, 2002, EXP CELL RES, V276, P310, DOI 10.1006/excr.2002.5527	45	21	22	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10310	10317		10.1074/jbc.M708456200	http://dx.doi.org/10.1074/jbc.M708456200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281278	Green Published, hybrid			2022-12-27	WOS:000254894700011
J	Smrz, D; Lebduska, P; Draberova, L; Korb, J; Draber, P				Smrz, Daniel; Lebduska, Pavel; Draberova, L'ubica; Korb, Jan; Draber, Petr			Engagement of phospholipid scramblase 1 in activated cells - Implication for phosphatidylserine externalization and exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; MEMBRANE PHOSPHOLIPID SCRAMBLASE-1; PLASMA-MEMBRANE; LIPID RAFTS; MAST-CELLS; HIGH-AFFINITY; GENE-EXPRESSION; IGE RECEPTOR; TYROSINE PHOSPHORYLATION; IMMUNOGLOBULIN-E	Phosphatidylserine (PS) in quiescent cells is predominantly confined to the inner leaflet of the plasma membrane. Externalization of PS is a marker of apoptosis, exocytosis, and some nonapoptotic activation events. It has been proposed that PS externalization is regulated by the activity of PLSCR1 (phospholipid scramblase 1), a Ca2+-dependent endofacial plasma membrane protein, which is tyrosine-phosphorylated in activated cells. It is, however, unclear how the phosphorylation of PLSCR1 is related to its membrane topography, PS externalization, and exocytosis. Using rat basophilic leukemia cells as a model, we show that nonapoptotic PS externalization induced through the high affinity IgE receptor(Fc epsilon RI) or the glycosylphosphatidylinositol-anchored protein Thy-1 does not correlate with enhanced tyrosine phosphorylation of PLSCR1. In addition, PS externalization in Fc epsilon RI-or Thy-1-activated cells is not associated with alterations of PLSCR1 fine topography as detected by electron microscopy on isolated plasma membrane sheets. In contrast, activation by calcium ionophore A23187 induces changes in the cellular distribution of PLSCR1. We also show for the first time that in pervanadate-activated cells, exocytosis occurs even in the absence of PS externalization. Finally, we document here that tyrosine-phosphorylated PLSCR1 is preferentially located in detergent-insoluble membranes, suggesting its involvement in the formation of membrane-bound signaling assemblies. The combined data indicate that changes in the topography of PLSCR1 and its tyrosine phosphorylation, PS externalization, and exocytosis are independent phenomena that could be distinguished by employing specific conditions of activation.	[Smrz, Daniel; Lebduska, Pavel; Draberova, L'ubica; Korb, Jan; Draber, Petr] Acad Sci Czech Republ, Inst Genet Mol, Dept Signal Transduct, CZ-14220 Prague 4, Czech Republic	Czech Academy of Sciences	Draber, P (corresponding author), Acad Sci Czech Republ, Inst Genet Mol, Dept Signal Transduct, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	draberpe@img.cas.cz	Draber, Petr/E-1119-2018; Smrz, Daniel/D-4853-2014; Draberova, Lubica/G-3505-2014; Draber, Petr/G-3412-2014	Draber, Petr/0000-0002-3986-2025; Smrz, Daniel/0000-0003-0143-8744; Draberova, Lubica/0000-0002-2459-4435; Draber, Petr/0000-0002-3986-2025	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Amoui M, 1997, EUR J IMMUNOL, V27, P1881, DOI 10.1002/eji.1830270810; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; BANIYASH M, 1987, J IMMUNOL, V138, P2999; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Bobek J, 2004, PROTEOMICS, V4, P3864, DOI 10.1002/pmic.200400818; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; DRABER P, 1980, J IMMUNOGENET, V7, P455; Draber P, 2002, MOL IMMUNOL, V38, P1247, DOI 10.1016/S0161-5890(02)00071-8; DRABEROVA L, 1991, EUR J IMMUNOL, V21, P1583, DOI 10.1002/eji.1830210703; Draberova L, 2004, EUR J IMMUNOL, V34, P2209, DOI 10.1002/eji.200322663; DRABEROVA L, 1989, EUR J IMMUNOL, V19, P1715, DOI 10.1002/eji.1830190928; DRABEROVA L, 1993, IMMUNOLOGY, V80, P103; Draberova L, 2007, J IMMUNOL, V179, P5169, DOI 10.4049/jimmunol.179.8.5169; Ehring GR, 2000, J IMMUNOL, V164, P679, DOI 10.4049/jimmunol.164.2.679; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; Field KA, 1999, J BIOL CHEM, V274, P1753, DOI 10.1074/jbc.274.3.1753; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Frasch SC, 2004, J BIOL CHEM, V279, P17625, DOI 10.1074/jbc.M313414200; Frigeri L, 1999, J IMMUNOL, V162, P2243; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Goth SR, 2001, INFECT IMMUN, V69, P1109, DOI 10.1128/IAI.69.2.1109-1119.2001; Hehner SP, 1999, CELL DEATH DIFFER, V6, P833, DOI 10.1038/sj.cdd.4400559; Heneberg P, 2006, EUR J IMMUNOL, V36, P2795, DOI 10.1002/eji.200636159; Holowka D, 2000, J CELL SCI, V113, P1009; Huang Y, 2006, ONCOGENE, V25, P6618, DOI 10.1038/sj.onc.1209677; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Kametaka S, 2003, J BIOL CHEM, V278, P15239, DOI 10.1074/jbc.M208611200; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; KONVALINKA J, 1995, EUR J BIOCHEM, V228, P191, DOI 10.1111/j.1432-1033.1995.tb20249.x; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kunzelmann-Marche C, 2001, J BIOL CHEM, V276, P5134, DOI 10.1074/jbc.M007924200; Lebduska P, 2007, J IMMUNOL METHODS, V328, P139, DOI 10.1016/j.jim.2007.08.015; LIU FT, 1980, J IMMUNOL, V124, P2728; Loo DT, 1998, METHOD CELL BIOL, V57, P251; Luciano F, 2001, ONCOGENE, V20, P4935, DOI 10.1038/sj.onc.1204661; Martin S, 2000, INT ARCH ALLERGY IMM, V123, P249, DOI 10.1159/000024451; MASON DW, 1980, BIOCHEM J, V187, P1; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; Nanjundan M, 2003, J BIOL CHEM, V278, P37413, DOI 10.1074/jbc.M306182200; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pastorelli C, 2002, MOL IMMUNOL, V38, P1235, DOI 10.1016/S0161-5890(02)00069-X; Pastorelli C, 2001, J BIOL CHEM, V276, P20407, DOI 10.1074/jbc.M100790200; Patton WF, 2002, J CHROMATOGR B, V771, P3, DOI 10.1016/S1570-0232(02)00043-0; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; SANAN DA, 1991, J HISTOCHEM CYTOCHEM, V39, P1017, DOI 10.1177/39.8.1906908; SCHRAVEN B, 1994, J EXP MED, V180, P897, DOI 10.1084/jem.180.3.897; SEAGRAVE J, 1991, J CELL PHYSIOL, V148, P139, DOI 10.1002/jcp.1041480117; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SIRAGANIAN RP, 1982, FED PROC, V41, P30; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; Stout JG, 1998, BIOCHEMISTRY-US, V37, P14860, DOI 10.1021/bi9812930; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Sun J, 2001, J BIOL CHEM, V276, P28984, DOI 10.1074/jbc.M102505200; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; TESHIMA R, 1994, BIOCHEM J, V302, P867, DOI 10.1042/bj3020867; Tolarova H, 2004, EUR J IMMUNOL, V34, P1627, DOI 10.1002/eji.200424991; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; Vettermann C, 2002, ANAL BIOCHEM, V308, P381, DOI 10.1016/S0003-2697(02)00269-5; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Windmiller DA, 2003, J BIOL CHEM, V278, P11874, DOI 10.1074/jbc.M211787200; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Wurth GA, 2002, BIOCHEM J, V362, P701, DOI 10.1042/bj3620701; Yokoyama A, 2004, LEUKEMIA RES, V28, P149, DOI 10.1016/S0145-2126(03)00189-9; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhou QS, 2005, J BIOL CHEM, V280, P35062, DOI 10.1074/jbc.M504821200; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; ZICK Y, 1990, BIOCHEMISTRY-US, V29, P10240, DOI 10.1021/bi00496a013; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	85	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10904	10918		10.1074/jbc.M710386200	http://dx.doi.org/10.1074/jbc.M710386200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281686	hybrid			2022-12-27	WOS:000254894700072
J	Chadli, A; Felts, SJ; Toft, DO				Chadli, Ahmed; Felts, Sara J.; Toft, David O.			GCUNC45 is the first Hsp90 co-chaperone to show alpha/beta isoform specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; PROTEIN; EXPRESSION; RECEPTORS; UNC-45; MYOSIN; FAMILY	Hsp90 is an essential molecular chaperone required for the normal functioning of many key regulatory proteins in eukaryotic cells. Vertebrates have two closely related isoforms of cytosolic Hsp90 (Hsp90 alpha and Hsp90 beta). However, specific functions for each isoform are largely unknown, and no Hsp90 co-chaper-one has been reported to distinguish between the two isoforms. In this study, we show that the Hsp90 co-chaperone GCUNC45 bound preferentially to the beta isoform of Hsp90 in vitro. GCUNC45 efficiently blocked the progression of progesterone receptor chaperoning in an in vitro functional system when Hsp90 beta was used, but did so with much less efficacy when Hsp90 alpha was used. Knockdown experiments in HeLa cells showed that GCUNC45 is required for the normal cellular distribution of Hsp90 beta, but not Hsp90 alpha. This is the first example of a co-chaperone with isoform selectivity, and this approach may open novel avenues to understanding the functional differences between Hsp90 isoforms.	[Chadli, Ahmed; Felts, Sara J.; Toft, David O.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Chadli, A (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	chadli.ahmed@mayo.edu			NIDDK NIH HHS [R01 DK 4624] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chadli A, 2008, BIOCHEMISTRY-US, V47, P2850, DOI 10.1021/bi7023332; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; MENDEL DB, 1988, J BIOL CHEM, V263, P6695; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; MINAMI Y, 1991, J BIOL CHEM, V266, P10099; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; PERDEW GH, 1993, EXP CELL RES, V209, P350, DOI 10.1006/excr.1993.1320; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Sreedhar AS, 2004, FEBS LETT, V562, P11; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Te JN, 2007, J PROTEOME RES, V6, P1963, DOI 10.1021/pr060595i; Vanmuylder N, 2002, ANAT EMBRYOL, V205, P301, DOI 10.1007/s00429-002-0258-5; Voss AK, 2000, DEVELOPMENT, V127, P1; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033	24	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9509	9512		10.1074/jbc.C800017200	http://dx.doi.org/10.1074/jbc.C800017200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18285346	Green Published, hybrid			2022-12-27	WOS:000254671600003
J	Koide, K; Ito, K; Akiyama, Y				Koide, Kayo; Ito, Koreaki; Akiyama, Yoshinori			Substrate recognition and binding by RseP, an Escherichia coli intramembrane protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE-STRESS-RESPONSE; ANTI-SIGMA FACTOR; GAMMA-SECRETASE; SITE-2 PROTEASE; ACTIVE-SITE; PDZ DOMAIN; TRANSMEMBRANE DOMAIN; RHOMBOID PROTEASE; PROTEOLYSIS; MEMBRANE	Escherichia coli RseP belongs to the S2P family of intramembrane cleaving proteases. RseP catalyzes proteolytic cleavage of the membrane-bound anti-sigma(E) E protein RseA as an essential step in transmembrane signal transduction in the sigma(E) extracytoplasmic stress response pathway. RseP cleaves transmembrane segments of membrane proteins, but the molecular mechanisms of its substrate recognition and proteolytic action remain largely unknown. Here we analyzed interaction between RseP and substrate membrane proteins. Co-immunoprecipitation assays showed that helix-destabilizing residues in a substrate transmembrane segment, which were previously shown to be required for efficient proteolysis of the substrate by RseP, stabilize the substrate-RseP interaction. Substitutions of certain amino acid residues, including those evolutionarily conserved, in the third transmembrane region (TM3) of RseP weakened the RseP-substrate interaction. Specific combinations of Cys substitutions in RseP TM3 and in the RseA transmembrane segment led to the formation of disulfide bonds upon oxidation, suggesting that TM3 of RseP directly binds the substrate. These results provide insights into the mechanism of membrane protein proteolysis by RseP.	[Koide, Kayo; Ito, Koreaki; Akiyama, Yoshinori] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Kyoto University	Akiyama, Y (corresponding author), Kyoto Univ, Inst Virus Res, Kawara Chu, Kyoto 6068507, Japan.	yakiyama@virus.kyoto-u.ac.jp			Grants-in-Aid for Scientific Research [20247020] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ades SE, 2004, CURR OPIN MICROBIOL, V7, P157, DOI 10.1016/j.mib.2004.02.010; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; AKIYAMA Y, 1995, J BIOL CHEM, V270, P23485, DOI 10.1074/jbc.270.40.23485; AKIYAMA Y, 1985, EMBO J, V4, P3351, DOI 10.1002/j.1460-2075.1985.tb04088.x; Akiyama Y, 2007, MOL MICROBIOL, V64, P1028, DOI 10.1111/j.1365-2958.2007.05715.x; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Bohn C, 2004, MOL MICROBIOL, V52, P427, DOI 10.1111/j.1365-2958.2004.03985.x; Bramkamp M, 2006, MOL MICROBIOL, V62, P580, DOI 10.1111/j.1365-2958.2006.05402.x; Chaba R, 2007, GENE DEV, V21, P124, DOI 10.1101/gad.1496707; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Davis R., 1980, ADV BACTERIAL GENETI; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Grigorova IL, 2004, GENE DEV, V18, P2686, DOI 10.1101/gad.1238604; Ha Y, 2007, CURR OPIN STRUC BIOL, V17, P405, DOI 10.1016/j.sbi.2007.06.010; Kanehara K, 2003, EMBO J, V22, P6389, DOI 10.1093/emboj/cdg602; Kanehara K, 2001, GENE, V281, P71, DOI 10.1016/S0378-1119(01)00823-X; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kinch LN, 2006, PROTEIN SCI, V15, P84, DOI 10.1110/ps.051766506; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	45	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9562	9570		10.1074/jbc.M709984200	http://dx.doi.org/10.1074/jbc.M709984200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18268014	hybrid			2022-12-27	WOS:000254671600009
J	Leclercq, TM; Moretti, PAB; Vadas, MA; Pitson, SM				Leclercq, Tamara M.; Moretti, Paul A. B.; Vadas, Mathew A.; Pitson, Stuart M.			Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4-KINASE; PHOSPHOLIPASE C-GAMMA-1; MOLECULAR-CLONING; CANCER CELLS; FACTOR-I; PROTEIN; PHOSPHORYLATION; FACTOR-1-ALPHA; ACTIVATION; BINDING	Sphingosine 1-phosphate (S1P) has many important roles in mammalian cells, including contributing to the control of cell survival and proliferation. S1P is generated by sphingosine kinases (SKs), of which two mammalian isoforms have been identified (SK1 and SK2). To gain a better understanding of SK regulation, we have used a yeast two-hybrid screen to identify SK1-interacting proteins and established elongation factor 1A (eEF1A) as one such protein that associates with both SK1 and SK2. We show the direct interaction of eEF1A with the SKs in vitro, whereas the physiological relevance of this association was demonstrated by co-immunoprecipitation of the endogenous proteins from cell lysates. Although the canonical role of eEF1A resides in protein synthesis, it has also been implicated in other roles, including regulating the activity of some signaling enzymes. Thus, we examined the potential role of eEF1A in regulation of the SKs and show that eEF1A is able to directly increase the activity of SK1 and SK2 similar to 3-fold in vitro. Substrate kinetics demonstrated that eEF1A increased the catalytic rate of both SKs, while having no observable effect on substrate affinities of these enzymes for either ATP or sphingosine. Overexpression of eEF1A in quiescent Chinese hamster ovary cells increased cellular SK activity, whereas a small interfering RNA-mediated decrease in eEF1A levels in MCF7 cells substantially reduced cellular SK activity and S1P levels, supporting the in vivo physiological relevance of this interaction. Thus, this study has established a novel mechanism of regulation of both SK1 and SK2 that is mediated by their interaction with eEF1A.	[Leclercq, Tamara M.; Moretti, Paul A. B.; Vadas, Mathew A.; Pitson, Stuart M.] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Adelaide, SA 5000, Australia; [Leclercq, Tamara M.; Pitson, Stuart M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Hanson Institute; Institute Medical & Veterinary Science Australia; University of Adelaide	Pitson, SM (corresponding author), Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@imvs.sa.gov.au	Pitson, Stuart/B-9342-2009; Vadas, Mathew/R-1378-2019	Pitson, Stuart/0000-0002-9527-2740; 				Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Baumruker T, 2005, IMMUNOL LETT, V96, P175, DOI 10.1016/j.imlet.2004.09.001; BRANDS JHGM, 1986, EUR J BIOCHEM, V155, P167, DOI 10.1111/j.1432-1033.1986.tb09472.x; CAVALLIUS J, 1986, EXP GERONTOL, V21, P149, DOI 10.1016/0531-5565(86)90068-9; Chang JS, 2002, J BIOL CHEM, V277, P19697, DOI 10.1074/jbc.M111206200; Dapas B, 2003, EUR J BIOCHEM, V270, P3251, DOI 10.1046/j.1432-1033.2003.03713.x; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; French KJ, 2003, CANCER RES, V63, P5962; Fujita T, 2004, BIOCHEM J, V382, P717, DOI 10.1042/BJ20040141; Fukuda Y, 2004, BBA-MOL CELL BIOL L, V1636, P12, DOI 10.1016/j.bbalip.2003.11.006; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Hong GY, 1999, FEBS LETT, V460, P513, DOI 10.1016/S0014-5793(99)01400-3; Izawa T, 2000, BIOCHEM BIOPH RES CO, V278, P72, DOI 10.1006/bbrc.2000.3772; Jeganathan S, 2007, J BIOL CHEM, V282, P372, DOI 10.1074/jbc.M602955200; KIELBASSA K, 1995, J BIOL CHEM, V270, P6156, DOI 10.1074/jbc.270.11.6156; Kim MJ, 1999, MOL CELLS, V9, P631; Lacana E, 2002, J BIOL CHEM, V277, P32947, DOI 10.1074/jbc.M202841200; LEE S, 1994, BIOCHEM BIOPH RES CO, V203, P1371, DOI 10.1006/bbrc.1994.2336; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Ma YF, 2005, J BIOL CHEM, V280, P26011, DOI 10.1074/jbc.M409081200; Maceyka M, 2004, FEBS LETT, V568, P30, DOI 10.1016/j.febslet.2004.04.093; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Roberts JL, 2004, ANAL BIOCHEM, V331, P122, DOI 10.1016/j.ab.2004.03.030; Ruwisch L, 2001, N-S ARCH PHARMACOL, V363, P358, DOI 10.1007/s002100000365; SANDERS J, 1992, NUCLEIC ACIDS RES, V109, P1113; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Sun JX, 2006, CIRC RES, V99, P468, DOI 10.1161/01.RES.0000239410.65551.b3; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Urtz N, 2004, MOL CELL BIOL, V24, P8765, DOI 10.1128/MCB.24.19.8765-8777.2004; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; YANG W, 1994, J BIOL CHEM, V269, P3852; YANG WN, 1993, J BIOL CHEM, V268, P392	46	42	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9606	9614		10.1074/jbc.M708782200	http://dx.doi.org/10.1074/jbc.M708782200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18263879	Green Published, hybrid			2022-12-27	WOS:000254671600014
J	Minami, M; Shimizu, K; Okamoto, Y; Folco, E; Ilasaca, ML; Feinberg, MW; Aikawa, M; Libby, P				Minami, Manabu; Shimizu, Koichi; Okamoto, Yoshihisa; Folco, Eduardo; Ilasaca, Marco-Lopez; Feinberg, Mark W.; Aikawa, Masanori; Libby, Peter			Prostaglandin e receptor type 4-associated protein interacts directly with NF-kappa B1 and attenuates macrophage activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TNF-ALPHA; MATRIX METALLOPROTEINASE-1; ANKYRIN REPEAT; GENE; EXPRESSION; KINASE; SIGNAL; INFLAMMATION; P105	Macrophage activation participates pivotally in the pathophysiology of chronic inflammatory diseases, including atherosclerosis. Through the receptor EP4, prostaglandin E-2 (PGE(2)) exerts an anti-inflammatory action in macrophages, suppressing stimulus-induced expression of certain proinflammatory genes, including chemokines. We recently identified a novel EP4 receptor-associated protein (EPRAP), whose function in PGE(2)-mediated anti-inflammation remains undefined. Here we demonstrate that PGE(2) pretreatment selectively inhibits lipopolysaccharide (LPS)-induced nuclear factor kappa B1 (NF-kappa B1) p105 phosphorylation and degradation in mouse bone marrow-derived macrophages through EP4-dependent mechanisms. Similarly, directed EPRAP expression in RAW264.7 cells suppresses LPS-induced p105 phosphorylation and degradation, and subsequent activation of mitogen-activated protein kinase kinase 1/2. Forced expression of EPRAP also inhibits NF-kappa B activation induced by various proinflammatory stimuli in a concentration-dependent manner. In co-transfected cells, EPRAP, which contains multiple ankyrin repeat motifs, directly interacts with NF-kappa B1 p105/p50 and forms a complex with EP4. In EP4-overexpressing cells, PGE2 enhances the protective action of EPRAP against stimulus-induced p105 phosphorylation, whereas EPRAP silencing in RAW264.7 cells impairs the inhibitory effect of PGE(2)-EP4 signaling on LPS-induced p105 phosphorylation. Additionally, EPRAP knockdown as well as deficiency of NF-kappa B1 in macrophages attenuates the inhibitory effect of PGE2 on LPS-induced MIP-1 beta production. Thus, PGE2-EP4 signaling augments NF-kappa B1 p105 protein stability through EPRAP after proinflammatory stimulation, limiting macrophage activation.	[Minami, Manabu; Shimizu, Koichi; Okamoto, Yoshihisa; Folco, Eduardo; Ilasaca, Marco-Lopez; Feinberg, Mark W.; Aikawa, Masanori; Libby, Peter] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Libby, P (corresponding author), 75 Ave Louis Pasture, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021; Minami, Manabu/ABA-4357-2020	Libby, Peter/0000-0002-1502-502X; Minami, Manabu/0000-0003-0052-398X; Aikawa, Masanori/0000-0002-9275-2079; Feinberg, Mark/0000-0001-9523-3859	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034636, R37HL034636] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 34636] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aikawa M, 2004, CARDIOVASC PATHOL, V13, P125, DOI 10.1016/S1054-8807(04)00004-3; Andersohn F, 2006, CIRCULATION, V113, P1950, DOI 10.1161/CIRCULATIONAHA.105.602425; AOKI M, 1993, J BIOL CHEM, V268, P22723; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Cheon H, 2006, J IMMUNOL, V177, P1092, DOI 10.4049/jimmunol.177.2.1092; Colombo MP, 2005, CANCER RES, V65, P9113, DOI 10.1158/0008-5472.CAN-05-2714; D'Acquisto F, 1998, FEBS LETT, V440, P76, DOI 10.1016/S0014-5793(98)01407-0; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Ferrier R, 1999, ONCOGENE, V18, P995, DOI 10.1038/sj.onc.1202374; Fushimi K, 2007, J CELL BIOCHEM, V100, P783, DOI 10.1002/jcb.21099; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hubbard NE, 2001, PROSTAG LEUKOTR ESS, V65, P287, DOI 10.1054/plef.2001.0327; Ishikawa H, 1998, J EXP MED, V187, P985, DOI 10.1084/jem.187.7.985; Jiang BB, 2001, ARTERIOSCL THROM VAS, V21, P1915, DOI 10.1161/hq1201.099424; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kamimura M, 2005, CIRC RES, V97, P305, DOI 10.1161/01.RES.0000177893.24574.13; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Largo R, 2004, ANN RHEUM DIS, V63, P1197, DOI 10.1136/ard.2003.011163; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li ZQ, 2003, BIOCHEM BIOPH RES CO, V309, P980, DOI 10.1016/j.bbrc.2003.08.104; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2007, AM J CARDIOL, V99, p27B, DOI 10.1016/j.amjcard.2006.11.004; Lu DY, 2005, MOL CELL BIOL, V25, P6570, DOI 10.1128/MCB.25.15.6570-6577.2005; Maher JF, 2005, GYNECOL ENDOCRINOL, V21, P330, DOI 10.1080/09513590500431458; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Murakami M, 2006, CURR PHARM DESIGN, V12, P943, DOI 10.2174/138161206776055912; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Pillinger MH, 2003, J IMMUNOL, V171, P6080, DOI 10.4049/jimmunol.171.11.6080; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; STRASSMANN G, 1994, J EXP MED, V180, P2365, DOI 10.1084/jem.180.6.2365; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2006, CIRC RES, V98, P499, DOI 10.1161/01.RES.0000204451.88147.96; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Ventura-Holman T, 2005, TUMOR BIOL, V26, P294, DOI 10.1159/000089261; Ventura-Holman T, 1998, GENOMICS, V54, P221, DOI 10.1006/geno.1998.5569; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; WARREN MK, 1985, J IMMUNOL, V134, P982; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399	65	72	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9692	9703		10.1074/jbc.M709663200	http://dx.doi.org/10.1074/jbc.M709663200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18270204	Green Published, hybrid			2022-12-27	WOS:000254671600024
J	Belenky, PA; Moga, TG; Brenner, C				Belenky, Peter A.; Moga, Tiberiu G.; Brenner, Charles			Saccharomyces cerevisiae YOR071C encodes the high affinity nicotinamide riboside transporter Nrt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NAD(+) SALVAGE PATHWAY; URACIL PERMEASE GENE; YEAST; IDENTIFICATION; BIOSYNTHESIS; DEACETYLASE; EXPRESSION; SEQUENCE; DELETION; NRK	NAD(+) is an essential coenzyme for hydride transfer enzymes and a substrate of sirtuins and other NAD(+)-consuming enzymes. Nicotinamide riboside is a recently discovered eukaryotic NAD(+) precursor converted to NAD(+) via the nicotinamide riboside kinase pathway and by nucleosidase activity and nicotinamide salvage. Nicotinamide riboside supplementation of yeast extends replicative life span on high glucose medium. The molecular basis for nicotinamide riboside uptake was unknown in any eukaryote. Here, we show that deletion of a single gene, YOR071C, abrogates nicotinamide riboside uptake without altering nicotinic acid or nicotinamide import. The gene, which is negatively regulated by Sum1, Hst1, and Rfm1, fully restores nicotinamide riboside import and utilization when resupplied to mutant yeast cells. The encoded polypeptide, Nrt1, is a predicted deca-spanning membrane protein related to the thiamine transporter, which functions as a pH-dependent facilitator with a Km for nicotinamide riboside of 22 mu M. Nrt1-related molecules are conserved in particular fungi, suggesting a similar basis for nicotinamide riboside uptake.	[Brenner, Charles] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Biochem, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Brenner, C (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA.	charles.brenner@dartmouth.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226				Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Brachmann CB, 1998, YEAST, V14, P115; CHEVALLIER MR, 1982, EMBO J, V1, P375, DOI 10.1002/j.1460-2075.1982.tb01177.x; Damaraju VL, 2005, MOL PHARMACOL, V67, P273, DOI 10.1124/mol.104.004408; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; Elvehjem CA, 1938, J BIOL CHEM, V123, P137; Enjo F, 1997, J BIOL CHEM, V272, P19165, DOI 10.1074/jbc.272.31.19165; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Herbert M, 2003, INFECT IMMUN, V71, P5398, DOI 10.1128/IAI.71.9.5398-5401.2003; HOPKINS P, 1988, FEMS MICROBIOL LETT, V49, P173; IWASHIMA A, 1973, BIOCHIM BIOPHYS ACTA, V330, P222, DOI 10.1016/0005-2736(73)90227-7; Kahsay RY, 2005, BIOINFORMATICS, V21, P1853, DOI 10.1093/bioinformatics/bti303; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Ma B, 2007, MOL MICROBIOL, V66, P14, DOI 10.1111/j.1365-2958.2007.05886.x; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; McCord R, 2003, MOL CELL BIOL, V23, P2009, DOI 10.1128/MCB.23.6.2009-2016.2003; Paluszynski JP, 2006, YEAST, V23, P707, DOI 10.1002/yea.1387; PREISS J, 1958, J BIOL CHEM, V233, P493; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; ROWEN JW, 1951, A J BIOL CHEM, V193, P497; Sandmeier JJ, 2002, GENETICS, V160, P877; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; TEMPEL W, 2007, C PLOS BIOL, V5, pE263; Vickers MF, 2000, J BIOL CHEM, V275, P25931, DOI 10.1074/jbc.M000239200; WEBER E, 1990, MOL MICROBIOL, V4, P585, DOI 10.1111/j.1365-2958.1990.tb00627.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YOO HS, 1992, YEAST, V8, P997, DOI 10.1002/yea.320081202	32	53	59	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8075	8079		10.1074/jbc.C800021200	http://dx.doi.org/10.1074/jbc.C800021200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18258590	hybrid			2022-12-27	WOS:000254288000003
J	Fukuhara, N; Howitt, JA; Hussain, SA; Hohenester, E				Fukuhara, Noemi; Howitt, Jason A.; Hussain, Sadaf-Ahmahni; Hohenester, Erhard			Structural and functional analysis of Slit and heparin binding to immunoglobulin-like domains 1 and 2 of Drosophila Robo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; REPELLENT SLIT; GUIDANCE; SULFATE; LIGAND; INDUCTION; MOLECULES; MECHANISM; NETRIN-1; COMPLEX	Recognition of the secreted protein Slit by transmembrane receptors of the Robo family provides important signals in the development of the nervous system and other organs, as well as in tumor metastasis and angiogenesis. Heparan sulfate (HS) proteoglycans serve as essential co-receptors in Slit-Robo signaling. Previous studies have shown that the second leucine-rich repeat domain of Slit, D2, binds to the N-terminal immunoglobulin-like domains of Robo, IG1-2. Here we present two crystal structures of Drosophila Robo IG1-2, one of which contains a bound heparin-derived oligosaccharide. Using structure-based mutagenesis of a Robo IG1-5 construct we identified key Slit binding residues (Thr-74, Phe-114, Arg-117) forming a conserved patch on the surface of IG1; mutation of similarly conserved residues in IG2 had no effect on Slit binding. Mutation of conserved basic residues in IG1 (Lys-69, Arg-117, Lys-122, Lys-123), but not in IG2, reduced binding of Robo IG1-5 to heparin, in full agreement with the Robo-heparin co-crystal structure. Our collective results, together with a recent crystal structure of a minimal human Slit-Robo complex (Morlot, C., Thielens, N. M., Ravelli, R. B., Hemrika, W., Romijn, R. A., Gros, P., Cusack, S., and McCarthy, A. A. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 14923 -14928), reveal a contiguous HS/ heparin binding surface extending across the Slit-Robo interface. Based on the size of this composite binding site, we predict that at least five HS disaccharide units are required to support Slit-Robo signaling.	[Fukuhara, Noemi; Howitt, Jason A.; Hussain, Sadaf-Ahmahni; Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Biophys Sect, Blackett Lab, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Biophys Sect, Blackett Lab, Dept Life Sci, London SW7 2AZ, England.	e.hohenester@imperial.ac.uk	Xiao, Yang/B-5668-2012	Howitt, Jason/0000-0001-9922-7931	BBSRC [BB/D524840/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBD5248401, BB/D524840/1] Funding Source: Medline; Wellcome Trust [054334] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098	40	62	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16226	16234		10.1074/jbc.M800688200	http://dx.doi.org/10.1074/jbc.M800688200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18359766	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000256332500081
J	Schneider, C; Porter, NA; Brash, AR				Schneider, Claus; Porter, Ned A.; Brash, Alan R.			Routes to 4-hydroxynonenal: Fundamental issues in the mechanisms of lipid peroxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							METHYL LINOLEATE HYDROPEROXIDES; DECOMPOSITION PRODUCTS; UNSATURATED COMPOUNDS; HYDROXY-ALKENALS; INITIAL-STAGE; AUTOXIDATION; OXIDATION; DIMERS; ACID; DIHYDROPEROXIDES	Although investigation of the toxicological and physiological actions of alpha/beta-unsaturated 4-hydroxyalkenals has made great progress over the last 2 decades, understanding of the chemical mechanism of formation of 4-hydroxynonenal and related aldehydes has advanced much less. The aim of this review is to discuss mechanistic evidence for these non-enzymatic routes, especially of the underappreciated intermolecular pathways that involve dimerized and oligomerized fatty acid derivatives as key intermediates. These cross-molecular reactions of fatty acid peroxyls have also important implications for understanding of the basic initiation and propagation steps during lipid peroxidation and the nature of the products that arise.	[Schneider, Claus; Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Porter, Ned A.] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Porter, Ned A.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, 221 Kirkland Hall, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			NIGMS NIH HHS [GM076592, GM15431] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592, P01GM015431, P50GM015431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATEMAN L, 1954, Q REV CHEM SOC, V8, P147, DOI 10.1039/qr9540800147; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; BOLLAND JL, 1949, Q REV CHEM SOC, V3, P1, DOI 10.1039/qr9490300001; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Dwivedi S, 2007, REDOX REP, V12, P4, DOI 10.1179/135100007X162211; FRANKEL EN, 1988, LIPIDS, V23, P295, DOI 10.1007/BF02537336; FRANKEL EN, 1987, CHEM PHYS LIPIDS, V44, P73, DOI 10.1016/0009-3084(87)90045-4; GARDNER HW, 1993, J BIOL CHEM, V268, P6971; Grechkin AN, 2006, BBA-MOL CELL BIOL L, V1761, P1419, DOI 10.1016/j.bbalip.2006.09.002; Gu XD, 2007, J AM CHEM SOC, V129, P6088, DOI 10.1021/ja0689785; Guichardant M, 2006, PROSTAG LEUKOTR ESS, V75, P179, DOI 10.1016/j.plefa.2006.05.006; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Honzatko A, 2007, J CHROMATOGR B, V857, P115, DOI 10.1016/j.jchromb.2007.07.004; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Leonarduzzi G, 2005, MOL NUTR FOOD RES, V49, P1044, DOI 10.1002/mnfr.200500090; Liu Quan, 2003, Molecular Aspects of Medicine, V24, P305, DOI 10.1016/S0098-2997(03)00025-6; Matsumoto A, 2006, J AM CHEM SOC, V128, P4566, DOI 10.1021/ja0580385; MAYO FR, 1958, J AM CHEM SOC, V80, P2465, DOI 10.1021/ja01543a030; MAYO FR, 1956, J AM CHEM SOC, V78, P1023, DOI 10.1021/ja01586a043; MIYASHITA K, 1982, AGR BIOL CHEM TOKYO, V46, P751, DOI 10.1080/00021369.1982.10865133; MIYASHITA K, 1985, LIPIDS, V20, P578, DOI 10.1007/BF02534283; MIYASHITA K, 1985, AGR BIOL CHEM TOKYO, V49, P2633, DOI 10.1080/00021369.1985.10867146; MIYASHITA K, 1982, AGR BIOL CHEM TOKYO, V46, P2293, DOI 10.1080/00021369.1982.10865425; MIYASHITA K, 1984, AGR BIOL CHEM TOKYO, V48, P2511, DOI 10.1080/00021369.1984.10866533; MORITA M, 1990, CHEM PHYS LIPIDS, V56, P209, DOI 10.1016/0009-3084(90)90104-Y; MORITA M, 1993, CHEM PHYS LIPIDS, V66, P13, DOI 10.1016/0009-3084(93)90026-Y; MORITA M, 1973, J AGR FOOD CHEM, V21, P860, DOI 10.1021/jf60189a035; MORITA M, 1973, AGR BIOL CHEM TOKYO, V37, P1213, DOI 10.1080/00021369.1973.10860819; Morita M, 2006, LIPIDS, V41, P91, DOI 10.1007/s11745-006-5075-9; Nakashima Izumi, 2003, Molecular Aspects of Medicine, V24, P231, DOI 10.1016/S0098-2997(03)00018-9; NEFF WE, 1988, J AM OIL CHEM SOC, V65, P616, DOI 10.1007/BF02540690; Noordermeer MA, 2000, BIOCHEM BIOPH RES CO, V277, P112, DOI 10.1006/bbrc.2000.3641; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; PORTER NA, 1990, FREE RADIC BIOL MED, V8, P541; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Schneider C, 2005, LIPIDS, V40, P1155, DOI 10.1007/s11745-005-1480-3; Schneider C, 2004, CHEM RES TOXICOL, V17, P937, DOI 10.1021/tx049913n; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; SCHNEIDER C, 2008, CHEM RES TO IN PRESS; SEVANIAN A, 1979, LIPIDS, V14, P634, DOI 10.1007/BF02533449; Sugimoto Y, 2006, MACROMOLECULES, V39, P9112, DOI 10.1021/ma061823x; Weichert H, 2000, BIOCHEM SOC T, V28, P850, DOI 10.1042/BST0280850; West JD, 2006, CHEM RES TOXICOL, V19, P173, DOI 10.1021/tx050321u; WU GS, 1977, LIPIDS, V12, P971, DOI 10.1007/BF02533320; Yin HY, 2004, J BIOL CHEM, V279, P3766, DOI 10.1074/jbc.M307137200; Zhang WJ, 2006, J ORG CHEM, V71, P5607, DOI 10.1021/jo0605795	48	194	202	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15539	15543		10.1074/jbc.R800001200	http://dx.doi.org/10.1074/jbc.R800001200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18285327	Green Published, hybrid			2022-12-27	WOS:000256332500006
J	Marchand, A; Winther, AML; Holm, PJ; Olesen, C; Montigny, C; Arnou, B; Champeil, P; Clausen, JD; Vilsen, B; Andersen, JP; Nissen, P; Jaxel, C; Moller, JV; Le Maire, M				Marchand, Alexandre; Winther, Anne-Marie Lund; Holm, Peter Joakim; Olesen, Claus; Montigny, Cedric; Arnou, Bertrand; Champeil, Philippe; Clausen, Johannes D.; Vilsen, Bente; Andersen, Jens Peter; Nissen, Poul; Jaxel, Christine; Moller, Jesper Vuust; Le Maire, Marc			Crystal structure of D351A and P312A mutant forms of the mammalian sarcoplasmic reticulum Ca2+-ATPase reveals key events in phosphorylation and Ca2+ release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; CALCIUM-PUMP; ATP-BINDING; CONFORMATIONAL-CHANGES; FUNCTIONAL CONSEQUENCES; SERCA1A CA2+-ATPASE; INORGANIC-PHOSPHATE; MEMBRANE-PROTEINS; SITE; TRANSPORT	In recent years crystal structures of the sarcoplasmic reticulum Ca2+-ATPase (SERCA1a), stabilized in various conformations with nucleotide and phosphate analogs, have been obtained. However, structural analysis of mutant forms would also be valuable to address key mechanistic aspects. We have worked out a procedure for affinity purification of SERCA1a heterologously expressed in yeast cells, producing sufficient amounts for crystallization and biophysical studies. We present here the crystal structures of two mutant forms, D351A and P312A, to address the issue whether the profound functional changes seen for these mutants are caused by major structural changes. We find that the structure of P312A with ADP and AlF4- bound (3.5-angstrom resolution) and D351A with AMPPCP or ATP bound (3.4- and 3.7-angstrom resolution, respectively) deviate only slightly from the complexes formed with that of wild-type ATPase. ATP affinity of the D351A mutant was very high, whereas the affinity for cytosolic Ca2+ was similar to that of the wild type. We conclude from an analysis of data that the extraordinary affinity of the D351A mutant for ATP is caused by the electrostatic effects of charge removal and not by a conformational change. P312A exhibits a profound slowing of the Ca2+-translocating Ca(2)E1P -> E2P transition, which seems to be due to a stabilization of Ca(2)E1P rather than a destabilization of E2P. This can be accounted for by the strain that the Pro residue induces in the straight M4 helix of the wild type, which is removed upon the replacement of Pro(312) with alanine in P312A.	[Winther, Anne-Marie Lund; Holm, Peter Joakim; Nissen, Poul] Univ Aarhus, Dept Mol Biol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-2800 Aarhus, Denmark; [Olesen, Claus; Clausen, Johannes D.; Andersen, Jens Peter; Moller, Jesper Vuust] Univ Aarhus, Inst Physiol & Biophys, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-2800 Aarhus, Denmark; [Marchand, Alexandre; Olesen, Claus; Montigny, Cedric; Arnou, Bertrand; Jaxel, Christine; Le Maire, Marc] 17V Univ Paris Sud, Lab Rech Assoc, URA CNRS 2096, Inst Biol & Technol Saclay,SB SM 2,CEA, F-91191 Gif Sur Yvette, France	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Nissen, P (corresponding author), Univ Aarhus, Dept Mol Biol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-2800 Aarhus, Denmark.	pn@mb.au.dk; chrisstine.jaxel@cea.fr; jvm@biophys.au.dk; marc.lemaire@cea.fr	Nissen, Poul/D-5774-2014	Nissen, Poul/0000-0003-0948-6628; Vilsen, Bente/0000-0002-4727-9382; Andersen, Jens Peter/0000-0003-0654-4300; Olesen, Claus/0000-0002-0462-1686; Lund Winther, Anne-Marie/0000-0002-5776-0989; JAXEL, CHRISTINE/0000-0002-1387-4458				Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; ANDERSEN JP, 1983, EUR J BIOCHEM, V134, P205, DOI 10.1111/j.1432-1033.1983.tb07552.x; BEIL FU, 1977, EUR J BIOCHEM, V81, P151, DOI 10.1111/j.1432-1033.1977.tb11936.x; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; CHAMPEIL P, 1983, J BIOL CHEM, V258, P4453; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; COMBETTES L, 1993, CELL CALCIUM, V14, P279, DOI 10.1016/0143-4160(93)90049-C; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; DEFORESTA B, 1994, EUR J BIOCHEM, V223, P359; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DUPONT Y, 1980, FEBS LETT, V115, P247, DOI 10.1016/0014-5793(80)81179-3; EBASHI F, 1962, NATURE, V194, P378, DOI 10.1038/194378a0; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GUILLAIN F, 1982, J BIOL CHEM, V257, P7366; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LACAPERE JJ, 1993, EUR J BIOCHEM, V211, P117, DOI 10.1111/j.1432-1033.1993.tb19877.x; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lenoir G, 2006, BIOCHEMISTRY-US, V45, P5261, DOI 10.1021/bi0522091; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Soulie S, 1999, BIOCHEMISTRY-US, V38, P5813, DOI 10.1021/bi983039d; Stokes DL, 2003, ANNU REV BIOPH BIOM, V32, P445, DOI 10.1146/annurev.biophys.32.110601.142433; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Touret N, 2001, BIOCHEMISTRY-US, V40, P5095, DOI 10.1021/bi0025464; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VILSEN B, 1991, J BIOL CHEM, V266, P16157; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; VILSEN B, 1989, J BIOL CHEM, V264, P21024; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; ZHANG Z, 1995, J BIOL CHEM, V270, P16283	70	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14867	14882		10.1074/jbc.M710165200	http://dx.doi.org/10.1074/jbc.M710165200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356161	hybrid, Green Published			2022-12-27	WOS:000255941400074
J	Briggs, LC; Baldwin, GS; Miyata, N; Kondo, HS; Zhang, XD; Freemont, PS				Briggs, Louise C.; Baldwin, Geoff S.; Miyata, Non; Kondo, Hisao; Zhang, Xiaodong; Freemont, Paul S.			Analysis of nucleotide binding to p97 reveals the properties of a tandem AAA hexameric ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE FUSION PROTEIN; CONFORMATIONAL-CHANGES; P97/VALOSIN-CONTAINING PROTEIN; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; DOMAIN; P97/VCP; HYDROLYSIS; HSP104; CYCLE	p97, an essential chaperone in endoplasmic reticulum-associated degradation and organelle biogenesis, contains two AAA domains (D1 and D2) and assembles as a stable hexamer. We present a quantitative analysis of nucleotide binding to both D1 and D2 domains of p97, the first detailed study of nucleotide binding to both AAA domains for this type of AAA+ ATPase. We report that adenosine 5'-O-(thiotriphosphate) (ATP gamma S) binds with similar affinity to D1 and D2, but ADP binds with higher affinity to D1 than D2, offering an explanation for the higher ATPase activity in D2. Stoichiometric measurements suggest that although both ADP and ATP gamma S can saturate all 6 nucleotide binding sites in D1, only 3-4 of the 6 D2 sites can bind ATP gamma S simultaneously. ATP gamma S binding triggers a downstream cooperative conformational change of at least three monomers, which involves conserved arginine fingers and is necessary for ATP hydrolysis.	[Briggs, Louise C.; Baldwin, Geoff S.; Zhang, Xiaodong; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Miyata, Non; Kondo, Hisao] Kyushi Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Imperial College London; Kyushu University	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Rm 502, London SW7 2AZ, England.	p.freemont@imperial.ac.uk		Baldwin, Geoffrey/0000-0003-4800-023X; Zhang, Xiaodong/0000-0001-9786-7038; Freemont, Paul/0000-0002-5658-8486	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Smith GR, 2004, J STRUCT BIOL, V146, P189, DOI 10.1016/j.jsb.2003.11.022; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	41	63	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13745	13752		10.1074/jbc.M709632200	http://dx.doi.org/10.1074/jbc.M709632200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332143	Green Published, hybrid			2022-12-27	WOS:000255728200026
J	Chen, C; Lewis, RE; White, MA				Chen, Chiyuan; Lewis, Robert E.; White, Michael A.			IMP modulates KSR1-dependent multivalent complex formation to specify ERK1/2 pathway activation and response thresholds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MAP KINASE; B-RAF; SIGNAL PROPAGATION; SCAFFOLD; KSR; HETERODIMERIZATION; ERK/MAPK; MECHANISMS; CANCER; CELLS	The Ras effector and ubiquitin-protein isopeptide ligase family member IMP acts as a steady-state resistor within the Raf-MEK- ERK kinase module. IMP concentrations are regulated by Ras through induction of autodegradation and can modulate signal/response thresholds by directly limiting the assembly of functional KSR1-dependent Raf.MEK complexes. Here, we show that the capacity of IMP to inhibit signal propagation through Raf to MEK is a consequence of disrupting KSR1 homo-oligomerization and B-Raf/c-Raf hetero-oligomerization. This impairs both the recruitment of MEK to activated Raf family members and the contribution of Raf oligomers to c-Raf kinase activation. Our observations indicate that human KSR1 proteins promote assembly of multivalent Raf.MEK complexes that are required for c-Raf kinase activation and functional coupling of active kinases to downstream substrates. This property is engaged by IMP for modulation of signal amplitude.	[Chen, Chiyuan; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lewis, Robert E.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Pathol, Omaha, NE 68198 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Nebraska System; University of Nebraska Medical Center	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Lewis, Robert E./H-3404-2019		NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER; NCI NIH HHS [CA71443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anselmo AN, 2002, J BIOL CHEM, V277, P5940, DOI 10.1074/jbc.M110498200; Bumeister R, 2004, CURR BIOL, V14, P439, DOI 10.1016/j.cub.2004.02.037; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Ory S, 2004, CURR BIOL, V14, pR277, DOI 10.1016/j.cub.2004.03.023; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	26	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12789	12796		10.1074/jbc.M709305200	http://dx.doi.org/10.1074/jbc.M709305200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332145	Green Published, hybrid			2022-12-27	WOS:000255499800015
J	Eckford, PDW; Sharom, FJ				Eckford, Paul D. W.; Sharom, Frances J.			Functional characterization of Escherichia coli MsbA - Interaction with nucleotides and substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN MULTIDRUG TRANSPORTER; TEMPERATURE REQUIREMENT GENE; P-GLYCOPROTEIN; ABC TRANSPORTER; HTRB GENE; NULL MUTATIONS; MULTICOPY SUPPRESSOR; ATP BINDING; FLIPPASE; PROTEIN	The Escherichia coli MsbA protein is a 65-kDa member of the ATP-binding cassette superfamily. It is thought to function as an ATP-dependent lipid translocase that transports lipid A from the inner to the outer leaflet of the cytoplasmic membrane. MsbA with high ATPase activity was isolated and found to be homodimeric in detergent solution. The protein ATPase activity was inhibited by vanadate and showed variable patterns of stimulation and inhibition by lipid A and other compounds. The intrinsic tryptophan fluorescence of the protein was characterized, and dynamic quenching using acrylamide showed that a conformational change took place on binding of lipid A. Fluorescence quenching was used to characterize the interactions of MsbA with nucleotides and various putative substrates, including lipids, lipid-like compounds, and drugs. MsbA had an apparent binding affinity for ATP of similar to 2 mM and also bound nonhydrolyzable ATP analogs and fluorescent ATP derivatives. The putative substrate lipid A interacted with the protein with an affinity of 6.4 mu M. Drugs that are known to be substrates for ABC multidrug transporters also interacted with MsbA with affinities in the range 0.25-50 mu M. This study represents the first use of fluorescence approaches to estimate MsbA binding affinities for nucleotides and putative transport substrates.	[Eckford, Paul D. W.; Sharom, Frances J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Eckford, Paul/ABE-9189-2021; Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367				Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Eckford PDW, 2006, BIOCHEM CELL BIOL, V84, P1022, DOI 10.1139/O06-196; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Huang ZH, 2004, BBA-BIOMEMBRANES, V1660, P155, DOI 10.1016/j.bbamem.2003.11.010; Huijbregts RPH, 2000, BBA-REV BIOMEMBRANES, V1469, P43, DOI 10.1016/S0304-4157(99)00014-3; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; KAROW M, 1991, MOL MICROBIOL, V5, P2285, DOI 10.1111/j.1365-2958.1991.tb02159.x; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; KAROW M, 1992, J BACTERIOL, V174, P7407, DOI 10.1128/jb.174.22.7407-7418.1992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005	31	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12840	12850		10.1074/jbc.M708274200	http://dx.doi.org/10.1074/jbc.M708274200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18344567	hybrid			2022-12-27	WOS:000255499800020
J	Lee, SG; Su, ZZ; Emdad, L; Gupta, P; Sarkar, D; Borjabad, A; Volsky, DJ; Fisher, PB				Lee, Seok-Geun; Su, Zhao-Zhong; Emdad, Luni; Gupta, Pankaj; Sarkar, Devanand; Borjabad, Alejandra; Volsky, David J.; Fisher, Paul B.			Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NF-KAPPA-B; ELEVATED GENE-1; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; CEREBROSPINAL-FLUID; EAAT2; PATHWAYS; DISEASE; NEUROTRANSMITTER	Glutamate is an essential neurotransmitter regulating brain functions. Excitatory amino acid transporter ( EAAT)-2 is one of the major glutamate transporters primarily expressed in astroglial cells. Dysfunction of EAAT2 is implicated in acute and chronic neurological disorders, including stroke/ischemia, temporal lobe epilepsy, amyotrophic lateral sclerosis, Alzheimer disease, human immunodeficiency virus 1-associated dementia, and growth of malignant gliomas. Ceftriaxone, one of the beta-lactam antibiotics, is a stimulator of EAAT2 expression with neuroprotective effects in both in vitro and in vivo models based in part on its ability to inhibit neuronal cell death by glutamate excitotoxicity. Based on this consideration and its lack of toxicity, ceftriaxone has potential to manipulate glutamate transmission and ameliorate neurotoxicity. We investigated the mechanism by which ceftriaxone enhances EAAT2 expression in primary human fetal astrocytes (PHFA). Ceftriaxone elevated EAAT2 transcription in PHFA through the nuclear factor-kappa B (NF-kappa B) signaling pathway. The antibiotic promoted nuclear translocation of p65 and activation of NF-kappa B. The specific NF-kappa B binding site at the -272 position of the EAAT2 promoter was responsible for ceftriaxone-mediated EAAT2 induction. In addition, ceftriaxone increased glutamate uptake, a primary function of EAAT2, and EAAT2 small interference RNA completely inhibited ceftriaxone-induced glutamate uptake activity in PHFA. Taken together, our data indicate that ceftriaxone is a potent modulator of glutamate transport in PHFA through NF-kappa-Bmediated EAAT2 promoter activation. These findings suggest a mechanism for ceftriaxone modulation of glutamate transport and for its potential effects on ameliorating specific neurodegenerative diseases through modulation of extracellular glutamate.	[Lee, Seok-Geun; Su, Zhao-Zhong; Emdad, Luni; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Inst Mol Med, Massey Canc Ctr, Dept Human & Mol Genet,Sch Med, Richmond, VA 23298 USA; [Lee, Seok-Geun; Su, Zhao-Zhong; Emdad, Luni; Gupta, Pankaj; Sarkar, Devanand; Fisher, Paul B.] Columbia Univ, Coll Phys & Surg, Med Ctr, Herbert Irving Comprehens Canc Ctr,Dept Urol, New York, NY 10032 USA; [Emdad, Luni; Fisher, Paul B.] Columbia Univ, Coll Phys & Surg, Med Ctr, Herbert Irving Comprehens Canc Ctr,Dept Neurosurg, New York, NY 10032 USA; [Borjabad, Alejandra; Volsky, David J.; Fisher, Paul B.] Columbia Univ, Coll Phys & Surg, Med Ctr, Herbert Irving Comprehens Canc Ctr,Dept Pathol, New York, NY 10032 USA; [Borjabad, Alejandra; Volsky, David J.] St Lukes Roosevelt Hosp, Div Mol Virol, New York, NY 10019 USA	Virginia Commonwealth University; Columbia University; Columbia University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Fisher, PB (corresponding author), Virginia Commonwealth Univ, VCU Inst Mol Med, Massey Canc Ctr, Dept Human & Mol Genet,Sch Med, 1101 E Marshall St,Sanger Hall Bldg, Richmond, VA 23298 USA.	pbfisher@vcu.edu	Lee, Seok-Geun/B-3408-2011	Lee, Seok-Geun/0000-0002-0060-5777	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031492] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS031492, P01 NS31492] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson CM, 2000, GLIA, V32, P1; Blei AT, 1999, J HEPATOL, V31, P771, DOI 10.1016/S0168-8278(99)80361-4; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Brown J.H., 2001, GOODMAN GILMANS PHAR, V10th ed., P10; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Chan H, 1999, NEUROCHEM RES, V24, P1397, DOI 10.1023/A:1022532623281; CHANDRASEKAR PH, 1984, J ANTIMICROB CHEMOTH, V14, P427, DOI 10.1093/jac/14.4.427; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; COURATIER P, 1993, LANCET, V341, P265, DOI 10.1016/0140-6736(93)92615-Z; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; HEADLEY PM, 1990, TRENDS PHARMACOL SCI, V11, P205, DOI 10.1016/0165-6147(90)90116-P; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Massa PT, 2006, J NEUROCHEM, V97, P607, DOI 10.1111/j.1471-4159.2006.03810.x; Mathern GW, 1999, NEUROLOGY, V52, P453, DOI 10.1212/WNL.52.3.453; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; NAU R, 1993, ANTIMICROB AGENTS CH, V37, P1518, DOI 10.1128/AAC.37.7.1518; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pappas TC, 1998, J NEUROVIROL, V4, P69, DOI 10.3109/13550289809113483; PLAITAKIS A, 1987, ANN NEUROL, V22, P575, DOI 10.1002/ana.410220503; Rawls SM, 2007, BRIT J PHARMACOL, V151, P1095, DOI 10.1038/sj.bjp.0707309; Robinson MB, 1998, NEUROCHEM INT, V33, P479, DOI 10.1016/S0197-0186(98)00055-2; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rumbaugh JA, 2007, J NEUROVIROL, V13, P168, DOI 10.1080/13550280601178218; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; TORP R, 1995, EXP BRAIN RES, V103, P51; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Waxman EA, 2007, J BIOL CHEM, V282, P17594, DOI 10.1074/jbc.M702278200; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667	50	234	245	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13116	13123		10.1074/jbc.M707697200	http://dx.doi.org/10.1074/jbc.M707697200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326497	Green Published, hybrid			2022-12-27	WOS:000255499800050
J	Vercauteren, K; Gleyzer, N; Scarpulla, RC				Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.			PGC-1-related coactivator complexes with HCF-1 and NRF-2 beta in mediating NRF-2(GABP)-dependent respiratory gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; CYTOCHROME-C PROMOTER; DNA COPY NUMBER; INDUCIBLE COACTIVATOR; PGC-1 FAMILY; FACTOR GABP; BIOGENESIS; ACTIVATION; GROWTH; ALPHA	The PGC-1 family of regulated coactivators (PGC-1 alpha, PGC-1 beta, and PRC) plays an important role in directing respiratory gene expression in response to environmental signals. Here, we show that PRC and PGC-1 alpha differ in their interactions with nuclear hormone receptors but are highly similar in their direct binding to several nuclear transcription factors implicated in the expression of the respiratory chain. Surprisingly, neither coactivator binds NRF-2(GABP), a multisubunit transcriptional activator associated with the expression of many respiratory genes. However, the NRF-2 subunits and PRC are co-immuno-precipitated from cell extracts indicating that the two proteins exist in a complex in vivo. Several lines of evidence indicate that HCF-1(host cell factor 1), a major chromatin component, mediates the association between PRC and NRF-2. Both PRC and NRF-2 beta bind HCF-1 in vitro, and the molecular determinants required for the interactions of each with HCF-1 are also required for PRC trans-activation through promoter-bound NRF-2. These determinants include a consensus HCF-1 binding site on PRC and the NRF-2 activation domain. In addition, PRC and NRF-2 beta can complex with HCF-1 in vivo, and all three associate with NRF-2-dependent nuclear genes that direct the expression of the mitochondrial transcription factors, TFB1M and TFB2M. Finally, short hairpin RNA-mediated knock down of PRC protein levels leads to reduced expression of TFB2M mRNA and mitochondrial transcripts for cytochrome oxidase II (COXII) and cytochrome b. These changes in gene expression coincide with a marked reduction in cytochrome oxidase activity. The results are consistent with a pathway whereby PRC regulates NRF-2-dependent genes through a multiprotein complex involving HCF-1.	[Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM032525, R01GM032525] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32525-25] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321; SCARPULLA RC, 2004, MED INTELL UNIT, P28; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Vogel JL, 2000, P NATL ACAD SCI USA, V97, P9425, DOI 10.1073/pnas.160266697; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	47	57	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12102	12111		10.1074/jbc.M710150200	http://dx.doi.org/10.1074/jbc.M710150200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18343819	Green Published, hybrid			2022-12-27	WOS:000255340000026
J	Yang, HB; Pesavento, JJ; Starnes, TW; Cryderman, DE; Wallrath, LL; Kelleher, NL; Mizzen, CA				Yang, Hongbo; Pesavento, James J.; Starnes, Taylor W.; Cryderman, Diane E.; Wallrath, Lori L.; Kelleher, Neil L.; Mizzen, Craig A.			Preferential dimethylation of histone H4 lysine 20 by Suv4-20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITHORAX-GROUP PROTEIN; H4 LYS-20; METHYLATION; METHYLTRANSFERASE; EXPRESSION; SET8; TRIMETHYLATION; ASH1; H3; MONOMETHYLATION	Post-translational modifications of histone tails direct nuclear processes including transcription, DNA repair, and chromatin packaging. Lysine 20 of histone H4 is mono-, di-, or trimethylated in vivo, but the regulation and significance of these methylations is poorly understood. The SET domain proteins PR-Set7 and Suv4-20 have been implicated in mono- and trimethylation, respectively; however, enzymes that dimethylate lysine 20 have not been identified. Here were port that Drosophila Suv4-20 is a mixed product specificity methyltransferase that dimethylates similar to 90% and trimethylates less than 5% of total H4 at lysine 20 in S2 cells. Trimethylation, but not dimethylation, is reduced in Drosophila larvae lacking HP1, suggesting that an interaction with HP1 regulates the product specificity of Suv4-20 and enrichment of trimethyllysine 20 within heterochromatin. Similar to the Drosophila enzyme, human Suv4-20h1/h2 enzymes generate di- and trimethyllysine 20. PR-Set7 and Suv4-20 are both required for normal levels of methylation, suggesting they have non-redundant functions. Alterations in the level of lysine 20 methylation following knock-down or overexpression of Suv4- 20 did not affect lysine 16 acetylation, revealing that these two modifications are not competitive in vivo. Depletion of Suv4-20 h1/h2 in HeLa cells impaired the formation of 53BP1 foci, suggesting dimethyllysine 20 is required for a proper DNA damage response. Collectively, the data indicate that Suv4-20 generates nearly ubiquitous dimethylation that facilitates the DNA damage response and selective trimethylation that is involved in heterochromatin formation.	[Yang, Hongbo; Starnes, Taylor W.; Mizzen, Craig A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Pesavento, James J.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Kelleher, Neil L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Kelleher, Neil L.; Mizzen, Craig A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cryderman, Diane E.; Wallrath, Lori L.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa	Mizzen, CA (corresponding author), B107 CLSL,MC123,601 S Goodwin Ave, Urbana, IL 61801 USA.	cmizzen@life.uiuc.edu		Wallrath, Lori/0000-0002-4391-7199; Pesavento, James/0000-0001-6107-3666	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008276, R01GM061513, R01GM067193] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067193-05S1, GM067193-06, R01 GM067193, 5T32 GM 08276, GM61513] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; DELANGE RJ, 1969, J BIOL CHEM, V244, P319; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Juan G, 1998, METH MOL B, V91, P67; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pesavento JJ, 2007, MOL CELL PROTEOMICS, V6, P1510, DOI 10.1074/mcp.M600404-MCP200; Pesavento JJ, 2006, ANAL CHEM, V78, P4271, DOI 10.1021/ac0600050; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tryndyak VP, 2006, CANCER BIOL THER, V5, P65, DOI 10.4161/cbt.5.1.2288; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200	47	102	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12085	12092		10.1074/jbc.M707974200	http://dx.doi.org/10.1074/jbc.M707974200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18296440	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000255340000024
J	Pan, MR; Hou, MF; Chang, HC; Hung, WC				Pan, Mei-Ren; Hou, Ming-Feng; Chang, Hui-Chiu; Hung, Wen-Chun			Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGNOSTIC-SIGNIFICANCE; LUNG ADENOCARCINOMA; NODE METASTASIS; DENDRITIC CELLS; EXPRESSION; MECHANISM; GROWTH; ANGIOGENESIS; INVOLVEMENT; ACTIVATION	Recent studies demonstrate that cyclooxygenase-2 (COX-2) expression is frequently associated with lymph node metastasis. However, the mechanism by which COX-2 increases the invasion of cancer cells to lymph node is unclear. CCR7 is a chemokine receptor that plays important roles in the mediation of migration of leukocytes and dendritic cells toward lymphatic endothelial cells (LECs) that express receptor ligand CCL21. We found that treatment of prostaglandin E-2 or ectopic expression of COX-2 in MCF-7 cells up-regulated CCR7 expression. On the contrary, knockdown of COX-2 by small hairpin RNA reduced CCR7 in COX-2-overexpressing MDA-MB-231 cells. Interaction of CCR7 and CCL21 was important for the migration of breast cancer cells toward LECs because antibodies against these two molecules inhibited the migration. We also found that COX-2 increased CCR7 expression via the EP2 and EP4 receptor in breast cancer cells. EP2 and EP4 agonists stimulated CCR7 in MCF- 7 cells, whereas antagonists or small hairpin RNA of EP2 and EP4 attenuated CCR7 in MDA-MB-231 cells. Protein kinase A and AKT kinase were involved in COX-2-induced CCR7. Pathological analysis demonstrated that COX-2 overexpression was associated with CCR7, EP2, and EP4 expressions in breast tumor tissues. In addition, CCR7 expression in COX-2 overexpressing tumors was significantly correlated with lymph node metastasis. Collectively, we suggest that CCR7 is a downstream target for COX-2 to enhance the migration of breast cancer cells toward LECs and to promote lymphatic invasion.	[Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan; [Pan, Mei-Ren; Chang, Hui-Chiu] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Dept Surg, Kaohsiung 807, Taiwan; [Hou, Ming-Feng; Chang, Hui-Chiu; Hung, Wen-Chun] Kaohsiung Med Univ Joint Res Ctr, Natl Sun Yat Sen Univ, Fukuoka 804, Taiwan; [Hung, Wen-Chun] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Cheng Kung University	Hung, WC (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 804, Taiwan.	hung1228@ms10.hinet.net	Pan, Mei-Ren/I-2021-2013; Hou, Ming-Feng/D-5506-2009; Hung, Wen-Chun/F-4846-2011	Hou, Ming-Feng/0000-0001-6030-9702				Achiwa H, 1999, CLIN CANCER RES, V5, P1001; Barnes NLP, 2007, BRIT J CANCER, V96, P575, DOI 10.1038/sj.bjc.6603593; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chan G, 1999, CANCER RES, V59, P991; Chang HC, 2001, ONCOL REP, V8, P1321; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Costa C, 2002, J CLIN PATHOL, V55, P429, DOI 10.1136/jcp.55.6.429; Denkert C, 2003, CANCER-AM CANCER SOC, V97, P2978, DOI 10.1002/cncr.11437; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gately S, 2000, CANCER METAST REV, V19, P19, DOI 10.1023/A:1026575610124; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Hida T, 1998, CANCER RES, V58, P3761; Huang M, 1996, J IMMUNOL, V157, P5512; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Lin MT, 2001, J BIOL CHEM, V276, P48997, DOI 10.1074/jbc.M107829200; Liu LT, 2003, CANCER RES, V63, P3069; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mutoh M, 2002, CANCER RES, V62, P28; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Ristimaki A, 2002, CANCER RES, V62, P632; Saeki H, 1999, J IMMUNOL, V162, P2472; SANO H, 1995, CANCER RES, V55, P3785; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sorokin A, 2004, CURR PHARM DESIGN, V10, P647, DOI 10.2174/1381612043453117; Su JL, 2004, CANCER RES, V64, P554, DOI 10.1158/0008-5472.CAN-03-1301; Taichman RS, 2002, CANCER RES, V62, P1832; Timoshenko AV, 2006, BRIT J CANCER, V94, P1154, DOI 10.1038/sj.bjc.6603067; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Tucker ON, 1999, CANCER RES, V59, P987; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev	36	86	98	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11155	11163		10.1074/jbc.M710038200	http://dx.doi.org/10.1074/jbc.M710038200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18319253	hybrid			2022-12-27	WOS:000255067400011
J	To, C; Kulkarni, S; Pawson, T; Honda, T; Gribble, GW; Sporn, MB; Wrana, JL; Di Guglielmo, GM				To, Ciric; Kulkarni, Sarang; Pawson, Tony; Honda, Tadashi; Gribble, Gordon W.; Sporn, Michael B.; Wrana, Jeffrey L.; Di Guglielmo, Gianni M.			The synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid-imidazolide alters transforming growth factor beta-dependent signaling and cell migration by affecting the cytoskeleton and the polarity complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACTIVATION SARA; FYVE DOMAIN PROTEIN; BREAST-CANCER CELLS; TGF-BETA; UBIQUITIN LIGASE; EPITHELIAL-CELLS; EARLY ENDOSOMES; MICROTUBULE DYNAMICS; ENDOTHELIAL-CELLS; CDDO-IMIDAZOLIDE	The anti-tumor synthetic triterpenoid 2-cyano-3,12-dioxooleana1,9-dien-28-oic acid (CDDO)-imidazolide (CDDO-Im) ectopically activates the transforming growth factor beta (TGF beta)-Smad pathway and extends the duration of signaling by an undefined mechanism. Here we show that CDDO-Im-dependent persistence of Smad2 phosphorylation is independent of Smad2 phosphatase activity and correlates with delayed TGF beta receptor degradation and trafficking. Altered TGF beta trafficking parallels the dispersal of EEA1-positive endosomes from the perinuclear region of CDDO-Im-treated cells. The effect of CDDO-Im on the EEA1 compartment led to an analysis of the cytoskeleton, and we observed that CDDO-Im alters microtubule dynamics by disrupting the microtubule-capping protein, Clip-170. Interestingly, biotinylated triterpenoid was found to localize to the polarity complex at the leading edge of migrating cells. Furthermore, CDDO-Im disrupted the localization of IQGAP1, PKC zeta, Par6, and TGF beta receptors from the leading edge of migrating cells and inhibited TGF beta-dependent cell migration. Thus, the synthetic triterpenoid CDDO-Im interferes with TGF beta receptor trafficking and turnover and disrupts cell migration by severing the link between members of the polarity complex and the microtubule network.	[To, Ciric; Di Guglielmo, Gianni M.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Kulkarni, Sarang; Pawson, Tony; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; [Honda, Tadashi; Gribble, Gordon W.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Sporn, Michael B.] Dartmouth Med Sch, Dept Pharmacol, Hanover, NH 03755 USA	Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Dartmouth College; Dartmouth College	Di Guglielmo, GM (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Med Sci Bldg, London, ON N6A 5C1, Canada.	john.diguglielmo@schulich.uwo.ca	Pawson, Tony J/E-4578-2013; Wrana, Jeffrey/F-8857-2013; To, Ciric/AAE-7406-2019		NATIONAL CANCER INSTITUTE [P30CA023108, R01CA078814] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA078814, R01 CA78814, P30 CA023108] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bose R, 2006, CURR OPIN CELL BIOL, V18, P206, DOI 10.1016/j.ceb.2006.02.005; Burkhardt JK, 1998, BBA-MOL CELL RES, V1404, P113, DOI 10.1016/S0167-4889(98)00052-4; Chen CL, 2006, J BIOL CHEM, V281, P11506, DOI 10.1074/jbc.M512821200; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Contin MA, 1999, BIOCHEM J, V339, P463, DOI 10.1042/0264-6021:3390463; Couch RD, 2006, MOL PHARMACOL, V69, P1158, DOI 10.1124/mol.105.018572; DArrigo A, 1997, EUR J CELL BIOL, V72, P95; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Ji Y, 2006, MOL CANCER THER, V5, P1452, DOI 10.1158/1535-7163.MCT-06-0136; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Lapillonne H, 2003, CANCER RES, V63, P5926; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Mix KS, 2004, MOL PHARMACOL, V65, P309, DOI 10.1124/mol.65.2.309; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Murray JW, 2003, ADV DRUG DELIVER REV, V55, P1385, DOI 10.1016/j.addr.2003.07.008; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Place AE, 2003, CLIN CANCER RES, V9, P2798; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Schwartz EA, 2005, BIOCHEM J, V390, P199, DOI 10.1042/BJ20041182; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Sporn MB, 2006, CYTOKINE GROWTH F R, V17, P3, DOI 10.1016/j.cytogfr.2005.09.012; Suh N, 2003, CANCER RES, V63, P1371; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Verrills NM, 2005, CURR PHARM DESIGN, V11, P1719, DOI 10.2174/1381612053764706; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Xu Z, 2003, CELL RES, V13, P343, DOI 10.1038/sj.cr.7290179; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yore MM, 2006, MOL CANCER THER, V5, P3232, DOI 10.1158/1535-7163.MCT-06-0444; Zhang XL, 2005, J BIOL CHEM, V280, P12239, DOI 10.1074/jbc.M413284200; Zhang Y, 2004, CELL CYCLE, V3, P391	63	28	43	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11700	11713		10.1074/jbc.M704064200	http://dx.doi.org/10.1074/jbc.M704064200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18283107	Green Published, hybrid			2022-12-27	WOS:000255067400070
J	Zhao, S; Ammanamanchi, S; Brattain, M; Cao, L; Thangasamy, A; Wang, J; Freeman, JW				Zhao, Shujie; Ammanamanchi, Sudhakar; Brattain, Michael; Cao, Lin; Thangasamy, Amalraj; Wang, Jing; Freeman, James W.			Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MACROPHAGE-STIMULATING PROTEIN; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; BONE METASTASIS; EXPRESSION; PROGRESSION; GENE; DPC4	Transforming growth factor beta(TGF-beta) signals through Smad-dependent and Smad-independent pathways. However, Smad signaling is altered by allelic deletion or intragenic mutation of the Smad4 gene in more than half of pancreatic ductal adenocarcinomas. We show here that loss of Smad4-dependent signaling leads to aberrant expression of RON, a phosphotyrosine kinase receptor, and that signaling by RON cooperates with Smad4-independent TGF-beta signaling to promote cell motility and invasion. Restoring Smad4 expression in a pancreatic ductal adenocarcinoma cell line that is deficient in Smad4 repressed RON expression. Conversely, small interference RNA knock down of Smad4 or blocking TGF-beta signaling with a TGF-beta type I receptor kinase inhibitor in Smad4-intact cell lines induced RON expression. TGF-beta-induced motility and invasion were inhibited in cells that express Smad4 and that have low levels of RON compared with isogenically matched cells that were deficient in Smad4. Furthermore, knocking down RON expression in Smad4-deficient cells suppressed TGF-beta-mediated motility and invasion. We further determined that Smad4-dependent signaling regulated RON expression at the transcriptional level by real-time reverse transcription PCR and RON promoter luciferase reporter assays. Functional inactivation by site-directed mutations of two Smad binding sites on the RON promoter inhibited TGF-beta-mediated repression of RON promoter activity. These studies indicate that loss of Smad4 contributes to aberrant RON expression and that cross-talk of Smad4-independent TGF-beta signaling and the RON pathway promotes an invasive phenotype.	[Zhao, Shujie; Ammanamanchi, Sudhakar; Cao, Lin; Thangasamy, Amalraj; Freeman, James W.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Med Oncol, San Antonio, TX 78229 USA; [Brattain, Michael; Wang, Jing] Univ Nebraska, Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Freeman, James W.] Audie Murphy Vet Adm Hosop, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Nebraska System; University of Nebraska Medical Center	Freeman, JW (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Med Oncol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	freemanjw@uthscsa.edu			NCI NIH HHS [CA96122] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed MM, 2002, J BIOL CHEM, V277, P2234, DOI 10.1074/jbc.M110168200; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Camp ER, 2007, CANCER-AM CANCER SOC, V109, P1030, DOI 10.1002/cncr.22490; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DELGATTO F, 1995, BBA-GENE STRUCT EXPR, V1263, P93, DOI 10.1016/0167-4781(95)00082-R; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fralix KD, 2000, CANCER, V88, P2010, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2010::AID-CNCR5>3.0.CO;2-5; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Freeman JW, 2004, FRONT BIOSCI-LANDMRK, V9, P1889, DOI 10.2741/1388; Germano S, 2006, J BIOL CHEM, V281, P21710, DOI 10.1074/jbc.M602014200; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hua Z, 2003, WORLD J GASTROENTERO, V9, P2764; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuzaki S, 2005, FERTIL STERIL, V84, P1180, DOI 10.1016/j.fertnstert.2005.04.041; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; RONSIN C, 1993, ONCOGENE, V8, P1195; Schutte M, 1996, CANCER RES, V56, P2527; SENTONROGERS SE, 2004, P NATL ACAD SCI USA, V101, P1257; Sieg DJ, 1999, J CELL SCI, V112, P2677; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Tian F, 2003, CANCER RES, V63, P8284; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Venkatasubbarao K, 2005, CANCER RES, V65, P2861, DOI 10.1158/0008-5472.CAN-04-2396; Venkatasubbarao K, 1998, GENE CHROMOSOME CANC, V22, P138, DOI 10.1002/(SICI)1098-2264(199806)22:2<138::AID-GCC8>3.0.CO;2-Y; Wang D, 2005, CARCINOGENESIS, V26, P27, DOI 10.1093/carcin/bgh284; Wang D, 2004, ONCOGENE, V23, P1668, DOI 10.1038/sj.onc.1207282; Wilentz RE, 2000, CANCER RES, V60, P2002; Wilkins-Port C. E., 2007, J BIOMED BIOTECHNOL, V2007, P1, DOI DOI 10.1155/2007/85208; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhao SJ, 2003, CANCER RES, V63, P2624; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075	45	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11293	11301		10.1074/jbc.M800154200	http://dx.doi.org/10.1074/jbc.M800154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18310076	hybrid, Green Published			2022-12-27	WOS:000255067400025
J	Katsoulidis, E; Sassano, A; Majchrzak-Kita, B; Carayol, N; Yoon, P; Jordan, A; Druker, BJ; Fish, EN; Platanias, LC				Katsoulidis, Efstratios; Sassano, Antonella; Majchrzak-Kita, Beata; Carayol, Nathalie; Yoon, Patrick; Jordan, Alison; Druker, Brian J.; Fish, Eleanor N.; Platanias, Leonidas C.			Suppression of interferon (IFN)-inducible genes and IFN-mediated functional responses in BCR-ABL-expressing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MYELOGENOUS LEUKEMIA-CELLS; CHRONIC MYELOID-LEUKEMIA; ALPHA/BETA-RECEPTOR INTERACTIONS; IMATINIB MESYLATE STI571; P70 S6 KINASE; I INTERFERONS; TYROSINE PHOSPHORYLATION; JAK-STAT; PHOSPHATIDYLINOSITOL 3-KINASE	The interferons (IFNs) are cytokines that play key roles in host defense against viral infections and immune surveillance against cancer. We report that BCR-ABL transformation of hematopoietic cells results in suppression of IFN-dependent responses, including transcription of IFN-inducible genes and generation of IFN-mediated antiviral effects. BCR-ABL transformation suppresses expression of several IFN-regulated genes containing IFN-sensitive response element (ISRE) or GAS elements in their promoters, including Isg15, Irf1, Irf9, and Ifit2 (interferon-induced protein with tetratricopeptide repeats 2). Suppression of transcription of ISRE-containing genes is also seen in cells expressing various BCR-ABL kinase domain mutants, including T315I, H396P, Y253F, and E255K, but not kinase-defective BCR-ABL. Such effects are associated with impaired IFN-dependent phosphorylation of Stat1 on Tyr(701) and Stat3 on Tyr(705) and defective binding of Stat complexes to ISRE or GAS elements. Beyond suppression of Stat activities, BCR-ABL inhibits IFN-inducible phosphorylation/activation of the p38 MAPK, suggesting a dual mechanism by which this abnormal fusion protein blocks IFN transcriptional responses. The inhibitory activities of BCR-ABL ultimately result in impaired IFN alpha-mediated protection against encephalomyocarditis virus infection and reversal of IFN-dependent growth suppression. Altogether, our data provide evidence for a novel mechanism by which BCR-ABL impairs host defenses and promotes malignant transformation, involving dual suppression of IFN-activated signaling pathways.	[Katsoulidis, Efstratios; Sassano, Antonella; Carayol, Nathalie; Yoon, Patrick; Jordan, Alison; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Katsoulidis, Efstratios; Sassano, Antonella; Carayol, Nathalie; Yoon, Patrick; Jordan, Alison; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Katsoulidis, Efstratios; Sassano, Antonella; Carayol, Nathalie; Yoon, Patrick; Jordan, Alison; Platanias, Leonidas C.] Lakeside Vet Adm Med Ctr, Chicago, IL 60611 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Hlth Network, Toronto Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M1, Canada; [Druker, Brian J.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Oregon Health & Science University	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 710 N Fairbanks St,Olson 8250, Chicago, IL 60611 USA.	l-platanias@northwestern.edu		Druker, Brian/0000-0001-8331-8206	NCI NIH HHS [CA100579, CA77816, CA121192] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121192, R01CA077816, R01CA100579] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; BEN NY, 1986, SCIENCE, V233, P212; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Lavallade H, 2007, BLOOD, V110, P2779, DOI 10.1182/blood-2007-06-094508; Deonarain R, 2002, CURR PHARM DESIGN, V8, P2131, DOI 10.2174/1381612023393288; Dorn A, 2005, J VIROL, V79, P2404, DOI 10.1128/JVI.79.4.2404-2412.2005; DRUKER B, 1992, BLOOD, V79, P2215; Fish EN, 1999, J BIOL CHEM, V274, P571, DOI 10.1074/jbc.274.2.571; Galligan CL, 2006, IMMUNOL RES, V35, P27, DOI 10.1385/IR:35:1:27; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Grandvaux N, 2002, CURR OPIN INFECT DIS, V15, P259, DOI 10.1097/00001432-200206000-00008; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Grumbach IM, 2001, BRIT J HAEMATOL, V112, P327, DOI 10.1046/j.1365-2141.2001.02556.x; Hochhaus A, 1997, LEUKEMIA, V11, P933, DOI 10.1038/sj.leu.2400723; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaur S, 2005, J INTERF CYTOK RES, V25, P780, DOI 10.1089/jir.2005.25.780; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Landolfo S, 2000, Hematol J, V1, P7, DOI 10.1038/sj.thj.6200004; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Ly C, 2003, CANCER RES, V63, P5716; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Martensen PM, 2004, J INTERF CYTOK RES, V24, P1, DOI 10.1089/107999004772719864; MATSUGUCHI T, 1994, J BIOL CHEM, V269, P5016; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; Paun A, 2007, ADV VIRUS RES, V69, P1, DOI 10.1016/S0065-3527(06)69001-5; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 1996, J BIOL CHEM, V271, P278, DOI 10.1074/jbc.271.1.278; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramaraj P, 2004, CANCER RES, V64, P5322, DOI 10.1158/0008-5472.CAN-03-3656; Rhodes J, 2000, EXP HEMATOL, V28, P305, DOI 10.1016/S0301-472X(99)00148-4; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Sattler M, 1997, ONCOGENE, V15, P2379, DOI 10.1038/sj.onc.1201422; Sattler M, 1996, ONCOGENE, V12, P839; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tzoanopoulos D, 2002, BRIT J HAEMATOL, V119, P46, DOI 10.1046/j.1365-2141.2002.03829.x; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1997, J IMMUNOL, V158, P2390; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Verma A, 2002, LEUKEMIA LYMPHOMA, V43, P703, DOI 10.1080/10428190290016782; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Wong S, 2003, BLOOD, V101, P4088, DOI 10.1182/blood-2002-11-3376; Yan M, 2007, BLOOD, V110, P305, DOI 10.1182/blood-2006-07-033209	73	20	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10793	10803		10.1074/jbc.M706816200	http://dx.doi.org/10.1074/jbc.M706816200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18287094	hybrid, Green Published			2022-12-27	WOS:000254894700062
J	Lawrence, AD; Deery, E; McLean, KJ; Munro, AW; Pickersgill, RW; Rigby, SEJ; Warren, MJ				Lawrence, Andrew D.; Deery, Evelyne; McLean, Kirsty J.; Munro, Andrew W.; Pickersgill, Richard W.; Rigby, Stephen E. J.; Warren, Martin J.			Identification, characterization, and structure/function analysis of a corrin reductase involved in adenosylcobalamin biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-PROTEIN COMPONENT ENZYME; PSEUDOMONAS-DENITRIFICANS; ESCHERICHIA-COLI; COB(I)ALAMIN ADENOSYLTRANSFERASE; RESONANCE SPECTROSCOPY; SALMONELLA-TYPHIMURIUM; COBALAMIN; REFINEMENT; 3-MONOOXYGENASE; VITAMIN-B-12	Vitamin B-12, the antipernicious anemia factor, is the cyano derivative of adenosylcobalamin, which is one of nature's most complex coenzymes. Adenosylcobalamin is made along one of two similar yet distinct metabolic pathways, which are referred to as the aerobic and anaerobic routes. The aerobic pathway for cobalamin biosynthesis proceeds via cobalt insertion into a ring-contracted macrocycle, which is closely followed by adenosylation of the cobalt ion. An important prerequisite for adenosylation is the reduction of the centrally chelated metal from Co(II) to a highly nucleophilic Co(I) form. We have cloned a gene, cobR, encoding a biosynthetic enzyme with this co(II)rrin reductase activity from Brucella melitensis. The protein has been overproduced, and the resulting flavoprotein has been purified, characterized, and crystallized and its structure determined to 1.6 angstrom resolution. Kinetic and EPR analysis reveals that the enzyme proceeds via a semiquinone form. It is proposed that CobR may interact with the adenosyltransferase to overcome the large thermodynamic barrier required for co(II)rrin reduction.	[Pickersgill, Richard W.; Rigby, Stephen E. J.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Lawrence, Andrew D.; Deery, Evelyne; Warren, Martin J.] Univ Kent, Dept Biosci, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England; [McLean, Kirsty J.; Munro, Andrew W.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England	University of London; University of Kent; University of Manchester	Pickersgill, RW (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	r.w.pickersgill@qmul.ac.uk; m.j.warren@kent.ac.uk	McLean, Kirsty J/GXI-2853-2022; Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Warren, Martin/0000-0002-6028-6456	BBSRC [BB/E002137/1, BB/E002889/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002889/1, BB/E002137/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Bauer CB, 2001, BIOCHEMISTRY-US, V40, P361, DOI 10.1021/bi002145o; BLANCHE F, 1995, ANGEW CHEM INT EDIT, V34, P383, DOI 10.1002/anie.199503831; BLANCHE F, 1992, J BACTERIOL, V174, P7452, DOI 10.1128/jb.174.22.7452-7454.1992; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; CROUZET J, 1991, J BACTERIOL, V173, P6074, DOI 10.1128/jb.173.19.6074-6087.1991; DEBUSSCHE L, 1993, J BACTERIOL, V175, P7430, DOI 10.1128/JB.175.22.7430-7440.1993; DEBUSSCHE L, 1991, J BACTERIOL, V173, P6300, DOI 10.1128/jb.173.19.6300-6302.1991; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELANO WL, 2002, PYMOL MOL GRAPHICS; Dutton P L, 1978, Methods Enzymol, V54, P411; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; Fonseca MV, 2001, J BIOL CHEM, V276, P32101, DOI 10.1074/jbc.M102510200; Fonseca MV, 2000, J BACTERIOL, V182, P4304, DOI 10.1128/JB.182.15.4304-4309.2000; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kay CWM, 1999, BIOCHEMISTRY-US, V38, P16740, DOI 10.1021/bi991442u; Kim SH, 2003, ACTA CRYSTALLOGR D, V59, P2275, DOI 10.1107/S0907444903020821; KURRECK H, 1984, J AM CHEM SOC, V106, P737, DOI 10.1021/ja00315a048; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o; MCCONNELL HM, 1956, J CHEM PHYS, V24, P764, DOI 10.1063/1.1742605; MULLER F, 1970, EUR J BIOCHEM, V14, P185, DOI 10.1111/j.1432-1033.1970.tb00277.x; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Palmer G., 1971, FLAVINS FLAVOPROTEIN, P123; Pratt J. M., 1999, Chemistry and biochemistry of B12., P113; PRIETO MA, 1994, J BIOL CHEM, V269, P22823; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Thomas MG, 2000, J BACTERIOL, V182, P4227, DOI 10.1128/JB.182.15.4227-4233.2000; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WEILBACHER E, 1988, MAGN RESON CHEM, V26, P64, DOI 10.1002/mrc.1260260115	40	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10813	10821		10.1074/jbc.M710431200	http://dx.doi.org/10.1074/jbc.M710431200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18263579	hybrid			2022-12-27	WOS:000254894700064
J	Robins, RJ; Petavy, F; Nemmaoui, Y; Ayadi, F; Silvestre, V; Zhang, BL				Robins, Richard J.; Petavy, Francois; Nemmaoui, Youssef; Ayadi, Farouk; Silvestre, Virginie; Zhang, Ben-Li			Non-equivalence of hydrogen transfer from glucose to the pro-R and pro-S methylene positions of ethanol during fermentation by Leuconostoc mesenteroides quantified by H-2 NMR at natural abundance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOL-DEHYDROGENASE; LACTOCOCCUS-LACTIS; ALDEHYDE DEHYDROGENASE; IN-VIVO; PATHWAY; REGENERATION; SUBSTRATE; KINETICS; BACTERIA; NAD(P)H	The anaerobic fermentation of glucose by Leuconostoc mesenteroides via the reductive pentose phosphate pathway leads to the accumulation of lactic acid and ethanol. The isotope redistribution coefficients (a(ij)) that characterize the specific derivation of each hydrogen atom in ethanol in relation to the non-exchangeable hydrogen atoms in glucose and the medium water have been determined using quantitative H-2 NMR. First, it is confirmed that the hydrogens of the methylene group are related only to the 1 and 3 positions of glucose via the NAD(P)H pool and not to the 4 position, in contrast to ethanol produced by Saccharomyces cerevisiae. Second, it is found that the conversion factors (C-f) for the transfer of hydrogen to the pro-S and pro-R positions of the methylene group are not equivalent: the C-f- 1-R: C-f-1-S ratio is 2.1, whereas the Cf-3-R: Cf-3-S ratio is 0.8. It is shown that this non-equivalence is not determined by the stereochemistry of the terminal NADH- and NADPH-dependent alcohol dehydrogenases, but is dependent on the cofactor selectivities of the reductive and oxidative steps of the reduced nucleotide cycle.	[Robins, Richard J.; Petavy, Francois; Nemmaoui, Youssef; Ayadi, Farouk; Silvestre, Virginie; Zhang, Ben-Li] Univ Nantes, CNRS, UMR 6230, CEISAM,Elucidat Biosynth Isotop Spectrometry Grp, F-44322 Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite	Robins, RJ (corresponding author), Univ Nantes, CNRS, UMR 6230, CEISAM,Elucidat Biosynth Isotop Spectrometry Grp, 2 Rue Houssiniere,BP 92208, F-44322 Nantes, France.	richard.robins@univ-nantes.fr	; Ayadi, Farouk/N-6260-2015	Robins, Richard/0000-0002-5325-8983; Ayadi, Farouk/0000-0003-4904-2917				BRADSHAW CW, 1992, J ORG CHEM, V57, P1532, DOI 10.1021/jo00031a037; COGAN TM, 1994, J DAIRY SCI, V77, P2704, DOI 10.3168/jds.S0022-0302(94)77213-1; CRANS DC, 1990, BIOCHEMISTRY-US, V29, P6698, DOI 10.1021/bi00480a020; DARTOIS V, 1995, RES MICROBIOL, V146, P291, DOI 10.1016/0923-2508(96)81052-7; DEMOSS RD, 1954, J BACTERIOL, V68, P252, DOI 10.1128/JB.68.2.252-257.1954; DEMOSS RD, 1955, METHOD ENZYMOL, V1, P504, DOI 10.1016/0076-6879(55)01085-9; DEMOSS RD, 1955, METHOD ENZYMOL, V1, P328, DOI 10.1016/0076-6879(55)01047-1; Hirakawa H, 2004, J BIOSCI BIOENG, V97, P202, DOI 10.1263/jbb.97.202; KAZAHAYA T, 1972, J GEN APPL MICROBIOL, V18, P43, DOI 10.2323/jgam.18.43; Koebmann BJ, 2002, ANTON LEEUW INT J G, V82, P237, DOI 10.1023/A:1020643918089; MAHMOUD M, 2004, THESIS U NANTES NANT; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; Pionnier S, 2003, J AGR FOOD CHEM, V51, P2076, DOI 10.1021/jf0259617; Pionnier S, 2002, ANAL BIOCHEM, V307, P138, DOI 10.1016/S0003-2697(02)00005-2; RABILLER C, 1990, CHIRALITY, V2, P85, DOI 10.1002/chir.530020205; Robins Richard J., 2003, Phytochemistry Reviews, V2, P87, DOI 10.1023/B:PHYT.0000004301.52646.a8; Roger O, 2004, J BIOL CHEM, V279, P24923, DOI 10.1074/jbc.M401232200; Silvestre V, 2001, ANAL CHEM, V73, P1862, DOI 10.1021/ac0013204; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; VEIGADACUNHA M, 1993, J BACTERIOL, V175, P3941, DOI 10.1128/JB.175.13.3941-3948.1993; WONG CH, 1982, J ORG CHEM, V47, P2816, DOI 10.1021/jo00135a037; WONG CH, 1985, J AM CHEM SOC, V107, P4028, DOI 10.1021/ja00299a044; Zhang BL, 2002, J AGR FOOD CHEM, V50, P1574, DOI 10.1021/jf010776z; ZHANG HL, 1995, J BIOL CHEM, V270, P16023, DOI 10.1074/jbc.270.27.16023	25	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9704	9712		10.1074/jbc.M710272200	http://dx.doi.org/10.1074/jbc.M710272200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18258593	hybrid			2022-12-27	WOS:000254671600025
J	Cheng, GZ; Zhang, W; Sun, M; Wang, Q; Coppola, D; Mansour, M; Xu, L; Costanzo, C; Cheng, JQ; Wang, LH				Cheng, George Z.; Zhang, WeiZhou; Sun, Mei; Wang, Qi; Coppola, Domenico; Mansour, Mena; Xu, Limei; Costanzo, Carliann; Cheng, Jin Q.; Wang, Lu-Hai			Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EPIDERMAL-GROWTH-FACTOR; CANCER-CELLS; CONSTITUTIVE ACTIVATION; SIGNALING PATHWAY; UP-REGULATION; E-CADHERIN; EXPRESSION; PROTEIN; GENE	To explore the basis of metastasis, we compared the human breast cancer lines MCF-7 and MDA-MB453, which have low invasive ability, with their sublines MCF7-I4 and MDA-MB453-I4 with high invasive ability for gene expression and signaling pathways. We previously showed that the I4 lines had dramatically elevated levels of Twist compared with their parental lines. In this study, we observed significantly increased STAT3 Tyr(705) phosphorylation, but not the STAT3 protein levels, in the I4 lines. Activation of STAT3 by interleukin-6 or expression of activated Src induced Twist expression at protein and mRNA levels. Inhibiting STAT3 by a small molecule inhibitor, JSI-124, STAT3 small hairpin RNAs, or dominant negative STAT3 resulted in significant reduction of Twist protein and mRNA expression. STAT3 directly bound to the second proximal STAT3-binding site on the human Twist promoter and activated its transcriptional activity. Inhibition of STAT3 reduced migration, invasion, and colony formation of the I4 cells. Ectopic expression of Twist significantly rescued those phenotypes. Ten normal and 46 tumor specimens of breast tissues were examined for activation of STAT3 and expression of Twist. There was a strong correlation between Tyr(705) p-STAT3 and Twist level in the late stage tumor tissues. Our results indicate that activated STAT3 transcriptionally induces Twist, which plays an important role in promoting migration, invasion, and anchorage-independent growth. Together with our previous observation that Twist transcriptionally induces AKT2 to mediate Twist-promoted oncogenic functions, we conclude that STAT3, Twist, and AKT2 form a functional signaling axis to regulate pivotal oncogenic properties of cancer cells.	[Cheng, George Z.; Zhang, WeiZhou; Mansour, Mena; Xu, Limei; Costanzo, Carliann; Wang, Lu-Hai] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Sun, Mei; Wang, Qi; Coppola, Domenico; Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA	Icahn School of Medicine at Mount Sinai; H Lee Moffitt Cancer Center & Research Institute	Wang, LH (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	lu-hai.wang@mssm.edu	Mansour, Mena/K-6632-2019; Wang, Lu-Hai/E-3986-2010	Mansour, Mena/0000-0003-1358-1062; 	NCI NIH HHS [CA 29339] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA029339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Buettner R, 2002, CLIN CANCER RES, V8, P945; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Castanon I, 2001, DEVELOPMENT, V128, P3145; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; Fernandes A, 1999, INT J CANCER, V83, P564, DOI 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mitchell TJ, 2005, IMMUNOLOGY, V114, P301, DOI 10.1111/j.1365-2567.2005.02091.x; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Pedranzini L, 2004, J CLIN INVEST, V114, P619, DOI 10.1172/JCI200422800; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Spiekermann K, 2002, EXP HEMATOL, V30, P262, DOI 10.1016/S0301-472X(01)00787-1; Wang SM, 1997, GENE, V187, P83, DOI 10.1016/S0378-1119(96)00727-5; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004; Zong CS, 1998, J BIOL CHEM, V273, P28065, DOI 10.1074/jbc.273.43.28065	44	221	236	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14665	14673		10.1074/jbc.M707429200	http://dx.doi.org/10.1074/jbc.M707429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353781	Green Published, hybrid			2022-12-27	WOS:000255941400055
J	Hanawa, N; Shinohara, M; Saberi, B; Gaarde, WA; Han, D; Kaplowitz, N				Hanawa, Naoko; Shinohara, Mie; Saberi, Behnam; Gaarde, William A.; Han, Derick; Kaplowitz, Neil			Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-INDUCED APOPTOSIS; N-TERMINAL KINASE; C-JUN; CELL-DEATH; GLUTATHIONE DEPLETION; HYDROGEN-PEROXIDE; SUPEROXIDE ANION; PERMEABILITY TRANSITION; INTERMEMBRANE SPACE; MOUSE HEPATOCYTES	Previously, we demonstrated JNK plays a central role in acetaminophen (APAP)-induced liver injury (Gunawan, B. K., Liu, Z. X., Han, D., Hanawa, N., Gaarde, W. A., and Kaplowitz, N. ( 2006) Gastroenterology 131, 165-178). In this study, we examine the mechanism involved in activating JNK and explore the downstream targets of JNK important in promoting APAP-induced liver injury in vivo. JNK inhibitor (SP600125) was observed to significantly protect against APAP-induced liver injury. Increased mitochondria-derived reactive oxygen species were implicated in APAP-induced JNK activation based on the following: 1) mitochondrial GSH depletion (maximal at 2 h) caused increased H2O2 release from mitochondria, which preceded JNK activation ( maximal at 4 h); 2) treatment of isolated hepatocytes with H2O2 or inhibitors ( e. g. antimycin) that cause increased H2O2 release from mitochondria-activated JNK. An important downstream target of JNK following activation was mitochondria based on the following: 1) JNK translocated to mitochondria following activation; 2) JNK inhibitor treatment partially protected against a decline in mitochondria respiration caused by APAP treatment; and 3) addition of purified active JNK to mitochondria isolated from mice treated with APAP plus JNK inhibitor ( mitochondria with severe GSH depletion, covalent binding) directly inhibited respiration. Cyclosporin A blocked the inhibitory effect of JNK on mitochondria respiration, suggesting JNK was directly inducing mitochondrial permeability transition in isolated mitochondria from mice treated with APAP plus JNK inhibitor. Addition of JNK to mitochondria isolated from control mice did not affect respiration. Our results suggests that APAP-induced liver injury involves JNK activation, due to increased reactive oxygen species generated by GSH-depleted mitochondria, and translocation of activated JNK to mitochondria where JNK induces mitochondrial permeability transition and inhibits mitochondria bioenergetics.	[Hanawa, Naoko; Shinohara, Mie; Saberi, Behnam; Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA; [Gaarde, William A.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	University of Southern California; Isis Pharmaceuticals Inc	Kaplowitz, N (corresponding author), Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, 2011 Zonol Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215, P30DK048522] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK048522, R01 DK067215, DK48522, DK067215] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445; Bradham CA, 1997, HEPATOLOGY, V25, P1128, DOI 10.1002/hep.510250514; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; BURCHAM PC, 1991, J BIOL CHEM, V266, P5049; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Dorion S, 2002, J BIOL CHEM, V277, P30792, DOI 10.1074/jbc.M203642200; El-Hassan H, 2003, TOXICOL APPL PHARM, V191, P118, DOI 10.1016/S0041-008X(03)00240-0; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Han D, 2002, METHOD ENZYMOL, V349, P271, DOI 10.1016/S0076-6879(02)49341-X; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Jaeschke H, 2006, LIFE SCI, V78, P1670, DOI 10.1016/j.lfs.2005.07.003; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; JEFFERY EH, 1988, TOXICOL APPL PHARM, V93, P452, DOI 10.1016/0041-008X(88)90048-8; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kaplowitz N, 2002, SEMIN LIVER DIS, V22, P137, DOI 10.1055/s-2002-30100; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; Meyer S, 1999, ANAL BIOCHEM, V271, P43, DOI 10.1006/abio.1999.4119; MEYERS LL, 1988, TOXICOL APPL PHARM, V93, P378, DOI 10.1016/0041-008X(88)90040-3; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; PARK YJ, 1988, TOXICOLOGY, V52, P165, DOI 10.1016/0300-483X(88)90202-8; Pumford NR, 1997, ANNU REV PHARMACOL, V37, P91, DOI 10.1146/annurev.pharmtox.37.1.91; RASHED MS, 1990, DRUG METAB DISPOS, V18, P765; RASHED MS, 1989, CHEM RES TOXICOL, V2, P41, DOI 10.1021/tx00007a007; Reilly TP, 2001, CHEM RES TOXICOL, V14, P1620, DOI 10.1021/tx0155505; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2006, GASTROENTEROLOGY, V131, P314, DOI 10.1053/j.gastro.2006.05.029; Singh R, 2007, J GASTROEN HEPATOL, V22, pS45, DOI 10.1111/j.1440-1746.2006.04646.x; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wicovsky A, 2007, J BIOL CHEM, V282, P2174, DOI 10.1074/jbc.M606167200; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	57	373	376	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13565	13577		10.1074/jbc.M708916200	http://dx.doi.org/10.1074/jbc.M708916200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337250	Green Published, hybrid			2022-12-27	WOS:000255728200010
J	Phillips, MJ; Calero, G; Chan, B; Ramachandran, S; Cerione, RA				Phillips, Matthew J.; Calero, Guillermo; Chan, Britton; Ramachandran, Sekar; Cerione, Richard A.			Effector proteins exert an important influence on the signaling-active state of the small GTPase Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; ACTIVATING PROTEIN; NUCLEOTIDE-BINDING; H-RAS; FAMILY; RHO; COMPLEX; SWITCH	GTP-binding (G) proteins regulate the flow of information in cellular signaling pathways by alternating between a GTP-bound "active" state and a GDP-bound "inactive" state. Cdc42, a member of the Rho family of Ras-related small G-proteins, plays key roles in the regulation of cell shape, motility, and growth. Here we describe the high resolution x-ray crystal structure for Cdc42 bound to the GTP analog guanylyl beta,gamma-methylene-diphosphonate (GMP-PCP) (i.e. the presumed signaling-active state) and show that it is virtually identical to the structures for the signaling-inactive, GDP-bound form of the protein, contrary to what has been reported for Ras and other G-proteins. Especially surprising was that the GMP-PCP- and GDP-bound forms of Cdc42 did not show detectable differences in their Switch I and Switch II loops. Fluorescence studies using a Cdc42 mutant in which a tryptophan residue was introduced at position 32 of Switch I also showed that there was little difference in the Switch I conformation between the GDP- and GMP-PCP-bound states (i.e. < 10%), which again differed from Ras where much larger changes in Trp-32 fluorescence were observed when comparing these two nucleotide-bound states (> 30%). However, the binding of an effector protein induced significant changes in the Trp-32 emission specifically from GMP-PCP-bound Cdc42, as well as in the phosphate resonances for GTP bound to this G-protein as indicated in NMR studies. An examination of the available structures for Cdc42 complexed to different effector proteins, versus the x-ray crystal structure for GMP-PCP-bound Cdc42, provides a possible explanation for how effectors can distinguish between the GTP- and GDP-bound forms of this G-protein and ensure that the necessary conformational changes for signal propagation occur.	[Phillips, Matthew J.; Chan, Britton; Ramachandran, Sekar; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Calero, Guillermo] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Cornell University; Cornell University; Stanford University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020	Ramachandran, Sekar/0000-0002-2243-1368	NIGMS NIH HHS [GM40654, GM47458, R01 GM047458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM047458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DeLano W.L, PYMOL MOL GRAPHICS S; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; Dias SMG, 2007, BIOCHEMISTRY-US, V46, P6547, DOI 10.1021/bi700035p; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Gladfelter AS, 2001, MOL BIOL CELL, V12, P1239, DOI 10.1091/mbc.12.5.1239; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HART MJ, 1991, J BIOL CHEM, V266, P20840; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Loh AP, 1999, BIOCHEMISTRY-US, V38, P12547, DOI 10.1021/bi9913707; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; RESLAND H, 1995, BIOCHEMISTRY-US, V34, P593; Rudolph MG, 1999, PROTEIN SCI, V8, P778; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stumber M, 2002, J MOL BIOL, V323, P899, DOI 10.1016/S0022-2836(02)01010-0; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Wilson KF, 2000, J BIOL CHEM, V275, P37307, DOI 10.1074/jbc.C000482200; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	50	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14153	14164		10.1074/jbc.M706271200	http://dx.doi.org/10.1074/jbc.M706271200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348980	Green Published, hybrid			2022-12-27	WOS:000255728200069
J	Trapasso, F; Pichiorri, F; Gaspari, M; Palumbo, T; Aqeilan, RI; Gaudio, E; Okumura, H; Iuliano, R; Di Leva, G; Fabbri, M; Birk, DE; Raso, C; Green-Church, K; Spagnoli, LG; Venuta, S; Huebner, K; Croce, CM				Trapasso, Francesco; Pichiorri, Flavia; Gaspari, Marco; Palumbo, Tiziana; Aqeilan, Rami I.; Gaudio, Eugenio; Okumura, Hiroshi; Iuliano, Rodolfo; Di Leva, Giampiero; Fabbri, Muller; Birk, David E.; Raso, Cinzia; Green-Church, Kari; Spagnoli, Luigi G.; Venuta, Salvatore; Huebner, Kay; Croce, Carlo M.			RETRACTED: Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells (Retracted article. See vol. 292, pg. 14279, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							FRAGILE HISTIDINE TRIAD; DNA-DAMAGE CHECKPOINT; DEFICIENT MICE; SUPPRESSES TUMORIGENICITY; FORMER SMOKERS; LUNG-CANCER; GENE; PROTEIN; EXPRESSION; ADRENODOXIN	Fhit protein is lost in most cancers, its restoration suppresses tumorigenicity, and virus-mediated FHIT gene therapy induces apoptosis and suppresses tumors in preclinical models. We have used protein cross-linking and proteomics methods to characterize a Fhit protein complex involved in triggering Fhit-mediated apoptosis. The complex includes Hsp60 and Hsp10 that mediate Fhit stability and may affect import into mitochondria, where it interacts with ferredoxin reductase, responsible for transferring electrons from NADPH to cytochrome P450 via ferredoxin. Viral-mediated Fhit restoration increases production of intracellular reactive oxygen species, followed by increased apoptosis of lung cancer cells under oxidative stress conditions; conversely, Fhit-negative cells escape apoptosis, carrying serious oxidative DNA damage that may contribute to an increased mutation rate. Characterization of Fhit interacting proteins has identified direct effectors of the Fhit- mediated apoptotic pathway that is lost in most cancers through loss of Fhit.	[Trapasso, Francesco; Pichiorri, Flavia; Palumbo, Tiziana; Aqeilan, Rami I.; Gaudio, Eugenio; Okumura, Hiroshi; Iuliano, Rodolfo; Di Leva, Giampiero; Fabbri, Muller; Green-Church, Kari; Huebner, Kay] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Trapasso, Francesco; Gaspari, Marco; Gaudio, Eugenio; Iuliano, Rodolfo; Raso, Cinzia; Venuta, Salvatore] Magna Graecia Univ Catanzaro, Dipartimento Med Sperimentale & Clin, I-88100 Catanzaro, Italy; [Pichiorri, Flavia; Spagnoli, Luigi G.] Univ Roma Tor Vergata, Inst Anat Patol, I-00173 Rome, Italy; [Palumbo, Tiziana] Univ Catania, Dipartimento Farmacol Spreimentale Preclin & Clin, I-95123 Catania, Italy; [Birk, David E.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Magna Graecia University of Catanzaro; University of Rome Tor Vergata; University of Catania; Jefferson University	Croce, CM (corresponding author), BRT Rm 1082,460 W 12th Ave, Columbus, OH 43210 USA.	Carlo.Croce@osumc.edu	Gaspari, Marco/C-2756-2009; Birk, David/I-4072-2012; Gaspari, Marco/HGB-2399-2022; Young, Richard A/F-6495-2012; Gaspari, Marco/ABE-1539-2020; Aqeilan, Rami/R-4443-2016; Green, Kari B/H-3541-2011; Aqeilan, Rami/AAT-7785-2020	Gaspari, Marco/0000-0002-5411-8800; Birk, David/0000-0002-4865-9088; Young, Richard A/0000-0001-8855-8647; Gaspari, Marco/0000-0002-5411-8800; Aqeilan, Rami/0000-0002-6034-023X; Di Leva, Gianpiero/0000-0001-6759-8682; Spagnoli, Luigi Giusto/0000-0002-0684-5501	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NCI NIH HHS [CA78890, P01 CA078890, P01 CA077738, CA77738] Funding Source: Medline; NCRR NIH HHS [S10 RR023647] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077738, P01CA078890] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Chaudhuri AR, 1999, J BIOL CHEM, V274, P24378, DOI 10.1074/jbc.274.34.24378; Daheron L, 2001, NUCLEIC ACIDS RES, V29, P1308, DOI 10.1093/nar/29.6.1308; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Fong LYY, 2000, P NATL ACAD SCI USA, V97, P4742, DOI 10.1073/pnas.080063497; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gupta S, 2005, J CELL MOL MED, V9, P51, DOI 10.1111/j.1582-4934.2005.tb00336.x; HANUKOGLU I, 1993, ARCH BIOCHEM BIOPHYS, V305, P489, DOI 10.1006/abbi.1993.1452; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Ichikawa W, 2006, CANCER CHEMOTH PHARM, V58, P794, DOI 10.1007/s00280-006-0217-6; Ishii H, 2003, FASEB J, V17, P1768, DOI 10.1096/fj.03-0241fje; Ishii H, 2001, CANCER RES, V61, P1578; Ishii H, 2006, CANCER RES, V66, P11287, DOI 10.1158/0008-5472.CAN-06-2503; Ji L, 1999, CANCER RES, V59, P3333; Kerley-Hamilton JS, 2005, ONCOGENE, V24, P6090, DOI 10.1038/sj.onc.1208755; KIMURA T, 1967, J BIOL CHEM, V242, P485; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Mao L, 1997, J NATL CANCER I, V89, P857, DOI 10.1093/jnci/89.12.857; Matsuyama A, 2003, P NATL ACAD SCI USA, V100, P14988, DOI 10.1073/pnas.2336256100; Nishizaki M, 2004, CANCER RES, V64, P5745, DOI 10.1158/0008-5472.CAN-04-0195; Ohashi M, 1999, GUT, V44, P366, DOI 10.1136/gut.44.3.366; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Ottey M, 2004, BRIT J CANCER, V91, P1669, DOI 10.1038/sj.bjc.6602058; Roz L, 2002, P NATL ACAD SCI USA, V99, P3615, DOI 10.1073/pnas.062030799; Shi YF, 2000, BIOCHEM J, V352, P443, DOI 10.1042/0264-6021:3520443; Siprashvili Z, 1997, P NATL ACAD SCI USA, V94, P13771, DOI 10.1073/pnas.94.25.13771; Sozzi G, 1998, CANCER RES, V58, P5032; Thavathiru E, 2005, MOL CARCINOGEN, V44, P174, DOI 10.1002/mc.20122; Trapasso F, 2003, P NATL ACAD SCI USA, V100, P1592, DOI 10.1073/pnas.0437915100; Wistuba II, 1997, JNCI-J NATL CANCER I, V89, P1366, DOI 10.1093/jnci/89.18.1366; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898	37	57	81	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13736	13744		10.1074/jbc.M709062200	http://dx.doi.org/10.1074/jbc.M709062200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18319262	Green Published, hybrid			2022-12-27	WOS:000255728200025
J	Paulsen, FP; Woon, CW; Varoga, D; Jansen, A; Garreis, F; Jager, K; Amm, M; Podolsky, DK; Steven, P; Barker, NP; Sel, S				Paulsen, Friedrich P.; Woon, Chee-Wai; Varoga, Deike; Jansen, Anne; Garreis, Fabian; Jaeger, Kristin; Amm, Marita; Podolsky, Daniel K.; Steven, Philipp; Barker, Nicholas P.; Sel, Saadettin			Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; EPITHELIAL-CELLS; TFF PEPTIDES; IMMUNE-RESPONSE; MIGRATION; MAINTENANCE; RESTITUTION	Disorders of wound healing characterized by impaired or delayed re-epithelialization are a serious medical problem. These conditions affect many tissues, are painful, and are difficult to treat. In this study using cornea as a model, we demonstrate the importance of trefoil factor 3 (TFF3, also known as intestinal trefoil factor) in re-epithelialization of wounds. In two different models of corneal wound healing, alkali- and laser-induced corneal wounding, we analyzed the wound healing process in in vivo as well as in combined in vivo/in vitro model in wild type (Tff3(+/+)) and Tff3-deficient (Tff3(-/-)) mice. Furthermore, we topically applied different concentrations of recombinant human TFF3 (rTFF3) peptide on the wounded cornea to determine the efficacy of rTFF3 on corneal wound healing. We found that Tff3 peptide is not expressed in intact corneal epithelium, but its expression is extensively up-regulated after epithelial injury. Re-epithelialization of corneal wounds in Tff3(-/-) mice is significantly prolonged in comparison to Tff3(-/-) mice. In addition, exogenous application of rTFF3 to the alkali- induced corneal wounds accelerates significantly in in vivo and in combined in vivo/in vitro model wound healing in Tff3(+/+) and Tff3(-/-) mice. These findings reveal a pivotal role for Tff3 in corneal wound healing mechanism and have broad implications for developing novel therapeutic strategies for treating nonhealing wounds.	[Paulsen, Friedrich P.; Garreis, Fabian; Jaeger, Kristin] Univ Halle Wittenberg, Dept Anat & Cell Biol, D-06097 Halle, Germany; [Varoga, Deike; Jansen, Anne] Univ Kiel, Inst Anat, D-24098 Kiel, Germany; [Woon, Chee-Wai; Barker, Nicholas P.] Gl Co Inc, Framingham, MA 01701 USA; [Podolsky, Daniel K.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Steven, Philipp] Med Univ Lubeck, Dept Ophthalmol, D-23538 Lubeck, Germany	Martin Luther University Halle Wittenberg; University of Kiel; Harvard University; Massachusetts General Hospital; University of Lubeck	Paulsen, FP (corresponding author), Univ Halle Wittenberg, Dept Anat & Cell Biol, Grosse Steinstr 52, D-06097 Halle, Germany.	friedrich.paulsen@medizin.uni-halle.de		Steven, Philipp/0000-0001-6892-3619; Paulsen, Friedrich/0000-0002-0527-0953; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305	NIDDK NIH HHS [DK46906] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046906] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2947, DOI 10.1007/s00018-005-5483-7; Blin N, 2005, CELL MOL LIFE SCI, V62, P2907, DOI 10.1007/s00018-005-5477-5; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Chwieralski CE, 2004, AM J RESP CELL MOL, V31, P528, DOI 10.1165/rcmb.2003-0433OC; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Emami S, 2001, FASEB J, V15, P351, DOI 10.1096/fj.00-0355com; Goke MN, 2001, EXP CELL RES, V264, P337, DOI 10.1006/excr.2000.5116; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Krachmer JH, 1997, CORNEA; Kuo Irene C, 2004, Curr Opin Ophthalmol, V15, P311, DOI 10.1097/00055735-200408000-00006; Lalani EN, 1999, LAB INVEST, V79, P537; Langer G, 1999, INVEST OPHTH VIS SCI, V40, P2220; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Matsumoto K, 2005, CORNEA, V24, pS43, DOI 10.1097/01.ico.0000178737.35297.d4; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Otto W, 2005, CELL MOL LIFE SCI, V62, P2939, DOI 10.1007/s00018-005-5482-8; Paulsen FP, 2002, INVEST OPHTH VIS SCI, V43, P3359; Paulsen FP, 2006, PROG HISTOCHEM CYTO, V41, P1, DOI 10.1016/j.proghi.2006.03.001; Steven P, 2004, PEPTIDES, V25, P819, DOI 10.1016/j.peptides.2004.01.023; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Williams GR, 1997, VIRCHOWS ARCH, V431, P299, DOI 10.1007/s004280050102; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8	31	54	57	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13418	13427		10.1074/jbc.M800177200	http://dx.doi.org/10.1074/jbc.M800177200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326859	Green Published, hybrid			2022-12-27	WOS:000255499800081
J	Zhang, Y; Yuan, F; Wang, D; Gu, L; Li, GM				Zhang, Yanbin; Yuan, Fenghua; Wang, Daojing; Gu, Liya; Li, Guo-Min			Identification of regulatory factor X as a novel mismatch repair stimulatory factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARE LYMPHOCYTE SYNDROME; HUMAN EXONUCLEASE-I; SYSTEM; DEFICIENCY; COMPLEX; RECONSTITUTION; RECOMBINATION; EXPRESSION; EXCISION; CELLS	This report describes the identification and purification of a novel mismatch repair stimulatory factor from HeLa cell extracts. This activity copurifies with a proliferating cell nuclear antigen-dependent 5' --> 33' DNA excision activity during several purification steps but is resolved from the excision activity during gel filtration chromatography using Sephacryl S-300. After purification to near homogeneity, the stimulatory factor is associated with three polypeptides with apparent molecular masses of 68, 36, and 30 kDa. Peptide sequencing analysis by tandem mass spectrometry identified the stimulatory factor as the heterotrimeric regulatory factor X (RFX) complex, which regulates transcription of the class II major histocompatibility complex by facilitating histone acetylation and is defective in the human hereditary immunodeficiency syndrome called bare lymphocyte syndrome. This conclusion was confirmed by the facts that purified recombinant RFX stimulates mismatch repair in an in vitro reconstituted mismatch repair system and that depletion of RFX from nuclear extracts or RFX knockdown in cells reduces mismatch repair activity. As expected, RFX knockdown cells display instability in microsatellite sequences. The possible role of RFX in human MMR repair is discussed.	[Zhang, Yanbin; Yuan, Fenghua; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Dept Toxicol, Lexington, KY 40536 USA; [Wang, Daojing] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	University of Kentucky; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Li, GM (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol, 1095 VA Dr, Lexington, KY 40536 USA.	gmli@uky.edu	Zhang, Yanbin/F-2998-2011; Yuan, Fenghua/F-8736-2011; Li, Guo-Min/I-5016-2014	Zhang, Yanbin/0000-0002-7263-5510; Li, Guo-Min/0000-0002-9842-4578	NATIONAL CANCER INSTITUTE [R01CA115942, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER; NCI NIH HHS [CA115942, CA104333] Funding Source: Medline; NIGMS NIH HHS [GM072756] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Carmell MA, 2003, NAT STRUCT BIOL, V10, P91, DOI 10.1038/nsb896; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; DeSandro A, 1999, AM J HUM GENET, V65, P279, DOI 10.1086/302519; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Elhasid R, 1996, BLOOD REV, V10, P242, DOI 10.1016/S0268-960X(96)90008-9; Garvie CW, 2007, BIOCHEMISTRY-US, V46, P1597, DOI 10.1021/bi6023868; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Gu LY, 2002, NUCLEIC ACIDS RES, V30, P2758, DOI 10.1093/nar/gkf410; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mudhasani R, 2005, MOL IMMUNOL, V42, P673, DOI 10.1016/j.molimm.2004.09.021; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Schmutte C, 1998, CANCER RES, V58, P4537; Tishkoff DX, 1998, CANCER RES, V58, P5027; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	27	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12730	12735		10.1074/jbc.M800460200	http://dx.doi.org/10.1074/jbc.M800460200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319249	Green Published, hybrid			2022-12-27	WOS:000255499800008
J	Jeon, D; Song, I; Guido, W; Kim, K; Kim, E; Oh, U; Shin, HS				Jeon, Daejong; Song, Inseon; Guido, William; Kim, Karam; Kim, Eunjoon; Oh, Uhtaek; Shin, Hee-Sup			Ablation of Ca2+ channel beta 3 subunit leads to enhanced N-methyl-D-aspartate receptor-dependent long term potentiation and improved long term memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; SYNAPTIC PLASTICITY; MICE LACKING; SIGNAL-TRANSDUCTION; SPATIAL MEMORY; MUTANT MICE; RAT-BRAIN; EXPRESSION; PROTEIN; DOMAIN	The beta subunits of voltage-dependent Ca2+ channels (VDCCs) have marked effects on the properties of the pore-forming alpha(1) subunits of VDCCs, including surface expression of channel complexes and modification of voltage-dependent kinetics. Among the four different beta subunits, the beta 3 subunit (Ca-v beta 3) is abundantly expressed in the hippocampus. However, the role of Ca-v beta 3 in hippocampal physiology and function in vivo has never been examined. Here, we investigated Ca-v beta 3-deficient mice for hippocampus-dependent learning and memory and synaptic plasticity at hippocampal CA3-CA1 synapses. Interestingly, the mutant mice exhibited enhanced performance in several hippocampus-dependent learning and memory tasks. However, electrophysiological studies revealed no alteration in the Ca2+ current density, the frequency and amplitude of miniature excitatory postsynaptic currents, and the basal synaptic transmission in the mutant hippocampus. On the other hand, however, N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic currents and NMDAR-dependent long term potentiation were significantly increased in the mutant. Protein blot analysis showed a slight increase in the level of NMDAR-2B in the mutant hippocampus. Our results suggest a possibility that, unrelated to VDCCs regulation, Ca-v beta 3 negatively regulates the NMDAR activity in the hippocampus and thus activity-dependent synaptic plasticity and cognitive behaviors in the mouse.	[Jeon, Daejong; Oh, Uhtaek] Seoul Natl Univ, Natl Creat Res Initiat Ctr Sensory Res, Coll Pharm, Seoul 151742, South Korea; [Jeon, Daejong; Song, Inseon; Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Guido, William] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Kim, Karam; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Virginia Commonwealth University; Korea Advanced Institute of Science & Technology (KAIST)	Oh, U (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Sensory Res, Coll Pharm, Seoul 151742, South Korea.	utoh@plaza.snu.ac.kr; shin@kist.re.kr	Jeon, Daejong/C-1814-2011; Kim, Eunjoon/C-1566-2011; Kim, Karam/K-1412-2018	Kim, Karam/0000-0002-1886-5163; Jeon, Daejong/0000-0002-6998-7603	NATIONAL EYE INSTITUTE [R01EY012716] Funding Source: NIH RePORTER; NEI NIH HHS [EY12716, R01 EY012716] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Bichet D, 2000, BIOCHEM BIOPH RES CO, V277, P729, DOI 10.1006/bbrc.2000.3750; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cavus I, 1996, J NEUROPHYSIOL, V76, P3038, DOI 10.1152/jn.1996.76.5.3038; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Jeon D, 2007, GENES BRAIN BEHAV, V6, P375, DOI 10.1111/j.1601-183X.2006.00267.x; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; JEON D, 2007, IN PRESS CELL CALCIU; Kang YS, 2002, MOL CELLS, V14, P361; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Lu YM, 1997, J NEUROSCI, V17, P5196; Ludwig A, 1997, J NEUROSCI, V17, P1339; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; REGEHR WG, 1994, J NEUROSCI, V14, P523; Restituito S, 2001, BIOPHYS J, V81, P89, DOI 10.1016/S0006-3495(01)75682-2; ROUSSET M, 2005, SCI STKE 2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Sheng M, 2000, J CELL SCI, V113, P1851; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shiraiwa T, 2007, BIOCHEM BIOPH RES CO, V355, P1019, DOI 10.1016/j.bbrc.2007.02.063; Song I, 2004, J NEUROSCI, V24, P5249, DOI 10.1523/JNEUROSCI.5546-03.2004; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Vnek N, 1996, J NEUROSCI, V16, P2780; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	57	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12093	12101		10.1074/jbc.M800816200	http://dx.doi.org/10.1074/jbc.M800816200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18339621	Green Published, hybrid			2022-12-27	WOS:000255340000025
J	Courel, M; Vasquez, MS; Hook, VY; Mahata, SK; Taupenot, L				Courel, Maite; Vasquez, Michael S.; Hook, Vivian Y.; Mahata, Sushil K.; Taupenot, Laurent			Sorting of the neuroendocrine secretory protein secretogranin II into the regulated secretory pathway - Role of N- and C-terminal alpha-helical domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BONDED LOOP; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; TRANS-GOLGI NETWORK; CHROMOGRANIN-A; GRANULE BIOGENESIS; CARBOXYPEPTIDASE-E; MEMBRANE-BINDING; NEUROPEPTIDE SECRETONEURIN; PROHORMONE CONVERTASES; CONFORMATIONAL-CHANGE	Secretogranin II (SgII) belongs to the granin family of prohormones widely distributed in dense-core secretory granules (DCGs) of endocrine, neuroendocrine, and neuronal cells, including sympathoadrenal chromaffin cells. The mechanisms by which secretory proteins, and granins in particular, are sorted into the regulated secretory pathway are unsettled. We designed a strategy based on novel chimeric forms of human SgII fused to fluorescent (green fluorescent protein) or chemiluminescent (embryonic alkaline phosphatase) reporters to identify trafficking determinants mediating DCG targeting of SgII in sympathoadrenal cells. Three-dimensional deconvolution fluorescence microscopy and secretagogue-stimulated release studies demonstrate that SgII chimeras are correctly targeted to DCGs and released by exocytosis in PC12 and primary chromaffin cells. Results from a Golgi-retained mutant form of SgII suggest that sorting of SgII into DCGs depends on a saturable sorting machinery at the trans-Golgi/trans-Golgi network. Truncation analyses reveal the presence of DCG-targeting signals within both the N- and C-terminal regions of SgII, with the putative alpha-helix-containing SgII-(25-41) and SgII-(334-348) acting as sufficient, independent sorting domains. This study defines sequence features of SgII mediating vesicular targeting in sympathoadrenal cells and suggests a mechanism by which discrete domains of the molecule function in sorting, perhaps by virtue of a particular arrangement in tertiary structure and/or interaction with a specific component of the DCG membrane.	[Courel, Maite; Mahata, Sushil K.; Taupenot, Laurent] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Vasquez, Michael S.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; [Hook, Vivian Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Mahata, Sushil K.; Taupenot, Laurent] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Taupenot, L (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,0838, La Jolla, CA 92093 USA.	ltaupenot@ucsd.edu	Mahata, Sushil/AAF-8781-2021	Taupenot, Laurent/0000-0003-2316-3825	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK059628] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK59628] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Blazquez M, 2000, BIOCHEM CELL BIOL, V78, P181, DOI 10.1139/bcb-78-3-181; CHANAT E, 1993, EMBO J, V12, P2159, DOI 10.1002/j.1460-2075.1993.tb05864.x; Choe CU, 2004, J BIOL CHEM, V279, P35551, DOI 10.1074/jbc.M311261200; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cool DR, 1998, MOL CELL ENDOCRINOL, V139, P7, DOI 10.1016/S0303-7207(98)00081-1; COOL DR, 1995, J BIOL CHEM, V270, P8723, DOI 10.1074/jbc.270.15.8723; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200; Cowley DJ, 2000, J BIOL CHEM, V275, P7743, DOI 10.1074/jbc.275.11.7743; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Eskeland NL, 1996, J CLIN INVEST, V98, P148, DOI 10.1172/JCI118760; FISCHERCOLBRIE R, 1995, PROG NEUROBIOL, V46, P49, DOI 10.1016/0301-0082(94)00060-U; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; GORR SU, 1995, FEBS LETT, V361, P8, DOI 10.1016/0014-5793(95)00142-V; Gorr SU, 2001, MOL CELL ENDOCRINOL, V172, P1, DOI 10.1016/S0303-7207(00)00342-7; Hosaka M, 2005, J CELL SCI, V118, P4785, DOI 10.1242/jcs.02608; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.02-03-0040; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; JUNG LJ, 1991, SCIENCE, V251, P1330, DOI 10.1126/science.2003219; Jutras I, 2000, J BIOL CHEM, V275, P40337, DOI 10.1074/jbc.M004757200; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Kim MK, 1999, PROTEIN SCI, V8, P1492, DOI 10.1110/ps.8.7.1492; Kim T, 2006, MOL BIOL CELL, V17, P789, DOI 10.1091/mbc.E05-08-0755; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; Kromer A, 1998, J CELL BIOL, V140, P1331, DOI 10.1083/jcb.140.6.1331; Kuliawat R, 2000, MOL BIOL CELL, V11, P1959, DOI 10.1091/mbc.11.6.1959; Lacombe MJ, 2005, J BIOL CHEM, V280, P4803, DOI 10.1074/jbc.M408658200; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Laslop A, 1998, J NEUROCHEM, V70, P374; Lin CC, 2007, J CELL PHYSIOL, V211, P316, DOI 10.1002/jcp.20938; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mouchantaf R, 2001, J BIOL CHEM, V276, P26308, DOI 10.1074/jbc.M102514200; Ng YK, 2002, J NEUROSCI, V22, P3890, DOI 10.1523/JNEUROSCI.22-10-03890.2002; Normant E, 1998, ENDOCRINOLOGY, V139, P2137, DOI 10.1210/en.139.4.2137; O'Connor DT, 2007, NAT PROTOC, V2, P1248, DOI 10.1038/nprot.2007.136; Park HY, 2002, BIOCHEMISTRY-US, V41, P1259, DOI 10.1021/bi0156963; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; Taupenot L, 1999, HYPERTENSION, V34, P1152, DOI 10.1161/01.HYP.34.5.1152; Thiele C, 1998, J BIOL CHEM, V273, P1223, DOI 10.1074/jbc.273.2.1223; Urbe S, 1997, BIOCHEM J, V321, P65, DOI 10.1042/bj3210065; Yoo SH, 2000, J BIOL CHEM, V275, P12553, DOI 10.1074/jbc.275.17.12553; Yoo SH, 1996, J BIOL CHEM, V271, P1558; YOO SH, 1995, J BIOL CHEM, V270, P12578, DOI 10.1074/jbc.270.21.12578; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8213, DOI 10.1021/bi00083a023; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	53	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11807	11822		10.1074/jbc.M709832200	http://dx.doi.org/10.1074/jbc.M709832200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299326	Green Published, hybrid			2022-12-27	WOS:000255067400080
J	Shtraizent, N; Eliyahu, E; Park, JH; He, X; Shalgi, R; Schuchman, EH				Shtraizent, Nataly; Eliyahu, Efrat; Park, Jae-Ho; He, Xingxuan; Shalgi, Ruth; Schuchman, Edward H.			Autoproteolytic cleavage and activation of human acid ceramidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL NUCLEOPHILE; TUMOR-GROWTH; OVEREXPRESSION; PURIFICATION; APOPTOSIS; CELLS	Herein we report the mechanism of human acid ceramidase (AC; N-acylsphingosine deacylase) cleavage and activation. A highly purified, recombinant human AC precursor underwent self-cleavage into alpha and beta subunits, similar to other members of the N-terminal nucleophile hydrolase superfamily. This reaction proceeded with first order kinetics, characteristic of self-cleavage. AC self-cleavage occurred most rapidly at acidic pH, but also at neutral pH. Site-directed mutagenesis and expression studies demonstrated that Cys-143 was an essential nucleophile that was required at the cleavage site. Other amino acids participating in AC cleavage included Arg-159 and Asp-162. Mutations at these three amino acids prevented AC cleavage and activity, the latter assessed using BODIPY-conjugated ceramide. We propose the following mechanism for AC self-cleavage and activation. Asp-162 likely forms a hydrogen bond with Cys-143, initiating a conformational change that allows Arg-159 to act as a proton acceptor. This, in turn, facilitates an intermediate thioether bond between Cys-143 and Ile-142, the site of AC cleavage. Hydrolysis of this bond is catalyzed by water. Treatment of recombinant AC with the cysteine protease inhibitor, methyl methanethiosulfonate, inhibited both cleavage and enzymatic activity, further indicating that cysteine-mediated self-cleavage is required for ceramide hydrolysis.	[Shtraizent, Nataly; Eliyahu, Efrat; Park, Jae-Ho; He, Xingxuan; Schuchman, Edward H.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Shtraizent, Nataly; Shalgi, Ruth] Tel Aviv Univ, Fac Med, Dept Cell & Dev Biol, IL-66978 Tel Aviv, Israel	Icahn School of Medicine at Mount Sinai; Tel Aviv University	Schuchman, EH (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, 1425 Madison Ave, New York, NY 10029 USA.	Edward.Schuchman@mssm.edu			NIDDK NIH HHS [DK54830] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054830, R56DK054830] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auge N, 1999, J BIOL CHEM, V274, P21533, DOI 10.1074/jbc.274.31.21533; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; Bielawska AE, 1997, AM J PATHOL, V151, P1257; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Elojeimy S, 2007, MOL THER, V15, P1259, DOI 10.1038/sj.mt.6300167; Ferlinz K, 2001, J BIOL CHEM, V276, P35352, DOI 10.1074/jbc.M103066200; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Huang Y, 2004, EUR J NEUROSCI, V20, P3489, DOI 10.1111/j.1460-9568.2004.03852.x; Lemansky P, 1998, EUR J CELL BIOL, V76, P53, DOI 10.1016/S0171-9335(98)80017-4; Linke, 2001, METABOLIC MOL BASES, P3573; Mallat Z, 2001, CIRC RES, V88, P998, DOI 10.1161/hh1001.090571; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Pei JM, 2003, PROTEIN SCI, V12, P1131, DOI 10.1110/ps.0240803; Romiti E, 2000, BIOCHEM BIOPH RES CO, V275, P746, DOI 10.1006/bbrc.2000.3370; SAVTCHOUK IA, 2007, SCI STKE, V394, pJC1; Schulze H, 2007, BIOL CHEM, V388, P1333, DOI 10.1515/BC.2007.152; Seelan RS, 2000, GENE CHROMOSOME CANC, V29, P137, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1018>3.0.CO;2-E; Selzner M, 2001, CANCER RES, V61, P1233; Strelow A, 2000, J EXP MED, V192, P601, DOI 10.1084/jem.192.5.601; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97	25	58	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11253	11259		10.1074/jbc.M709166200	http://dx.doi.org/10.1074/jbc.M709166200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18281275	Green Published, hybrid			2022-12-27	WOS:000255067400021
J	Vogel, JT; Tan, BC; McCarty, DR; Klee, HJ				Vogel, Jonathan T.; Tan, Bao-Cai; McCarty, Donald R.; Klee, Harry J.			The carotenoid cleavage dioxygenase 1 enzyme has broad substrate specificity, cleaving multiple carotenoids at two different bond positions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID BIOSYNTHESIS; 9-CIS-EPOXYCAROTENOID DIOXYGENASE; BETA-CAROTENE; FUNCTIONAL-CHARACTERIZATION; DROUGHT TOLERANCE; ORGANIC-SOLVENTS; LYCOPENE CYCLASE; GENE FAMILY; VITAMIN-A; IDENTIFICATION	In many organisms, various enzymes mediate site-specific carotenoid cleavage to generate biologically active apocarotenoids. These carotenoid-derived products include provitamin A, hormones, and flavor and fragrance molecules. In plants, the CCD1 enzyme cleaves carotenoids at 9,10 (9', 10')bonds to generate multiple apocarotenoid products. Here we systematically analyzed volatile apocarotenoids generated by maize CCD1 (ZmCCD1) from multiple carotenoid substrates. ZmCCD1 did not cleave geranylgeranyl diphosphate or phytoene but did cleave other linear and cyclic carotenoids, producing volatiles derived from 9,10 (9', 10') bond cleavage. Additionally the Arabidopsis, maize, and tomato CCD1 enzymes all cleaved lycopene to generate 6-methyl-5-hepten-2-one. 6-Methyl-5-hepten-2-one, an important flavor volatile in tomato, was produced by cleavage of the 5,6 or 5',6' bond positions of lycopene but not geranylgeranyl diphosphate, zeta-carotene, or phytoene. In vitro, ZmCCD1 cleaved linear and cyclic carotenoids with equal efficiency. Based on the pattern of apocarotenoid volatiles produced, we propose that CCD1 recognizes its cleavage site based on the saturation status between carbons 7 and 8 (7' and 8') and carbons 11 and 12 (11' and 12') as well as the methyl groups on carbons 5, 9, and 13 (5', 9', and 13').	[Vogel, Jonathan T.; Tan, Bao-Cai; McCarty, Donald R.; Klee, Harry J.] Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Klee, HJ (corresponding author), Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, POB 110690, Gainesville, FL 32611 USA.	hjklee@ifas.ufl.edu	Klee, Harry/A-7912-2008; Vogel, Jonathan/AAO-4748-2020	Vogel, Jonathan/0000-0001-8550-3923	Direct For Biological Sciences [0749266] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Ansari M S, 2005, Future Oncol, V1, P425, DOI 10.1517/14796694.1.3.425; Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x; Baldwin EA, 1998, J AM SOC HORTIC SCI, V123, P906, DOI 10.21273/JASHS.123.5.906; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bouvier F, 2003, PLANT CELL, V15, P47, DOI 10.1105/tpc.006536; Bouwmeester HJ, 2007, TRENDS PLANT SCI, V12, P224, DOI 10.1016/j.tplants.2007.03.009; BRITTON G, 1998, CAROTENOIDS A, V1; CAMARA B, 1986, PLANT PHYSIOL, V80, P172, DOI 10.1104/pp.80.1.172; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Cunningham FX, 2001, P NATL ACAD SCI USA, V98, P2905, DOI 10.1073/pnas.051618398; Du YJ, 1998, J CHEM ECOL, V24, P1355, DOI 10.1023/A:1021278816970; Fraser PD, 2000, PLANT J, V24, P551, DOI 10.1111/j.1365-313X.2000.00896.x; FRENCH RC, 1992, MYCOLOGIA, V84, P277, DOI 10.2307/3760180; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Gooday Graham W., 1997, Mycologist, V11, P126; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Ibdah M, 2006, PHYTOCHEMISTRY, V67, P1579, DOI 10.1016/j.phytochem.2006.02.009; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Kato M, 2006, J EXP BOT, V57, P2153, DOI 10.1093/jxb/erj172; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; KLINGNER A, 1995, PHYTOCHEMISTRY, V38, P53, DOI 10.1016/0031-9422(94)00538-5; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; MAIER W, 1995, PLANT PHYSIOL, V109, P465, DOI 10.1104/pp.109.2.465; Marasco EK, 2006, J BIOL CHEM, V281, P31583, DOI 10.1074/jbc.M606299200; Mathieu S, 2005, J EXP BOT, V56, P2721, DOI 10.1093/jxb/eri265; Mathieu S, 2007, BIOTECHNOL LETT, V29, P837, DOI 10.1007/s10529-007-9315-8; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; OLSON JA, 1989, J NUTR, V119, P105, DOI 10.1093/jn/119.1.105; Qin XQ, 2002, PLANT PHYSIOL, V128, P544, DOI 10.1104/pp.010663; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Quiroz A, 1997, J CHEM ECOL, V23, P2599, DOI 10.1023/B:JOEC.0000006669.34845.0d; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Schilling M, 2007, APPL MICROBIOL BIOT, V75, P829, DOI 10.1007/s00253-007-0878-z; Schmelz EA, 2001, PLANTA, V214, P171, DOI 10.1007/s004250100603; Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Simkin AJ, 2004, PLANT J, V40, P882, DOI 10.1111/j.1365-313X.2004.02263.x; Simkin AJ, 2004, PLANT PHYSIOL, V136, P3504, DOI 10.1104/pp.104.049718; SIMKIN AJ, 2008, IN PRESS J PLANT PHY; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Stoeffler M, 2007, J CHEM ECOL, V33, P1382, DOI 10.1007/s10886-007-9315-0; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Thompson AJ, 2000, PLANT J, V23, P363, DOI 10.1046/j.1365-313x.2000.00789.x; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Wahlberg I., 1998, CAROTENOIDS, P195; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.arplant.39.1.439	51	193	210	5	76	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11364	11373		10.1074/jbc.M710106200	http://dx.doi.org/10.1074/jbc.M710106200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18285342	hybrid			2022-12-27	WOS:000255067400033
J	Yakovenko, O; Sharma, S; Forero, M; Tchesnokova, V; Aprikian, P; Kidd, B; Mach, A; Vogel, V; Sokurenko, E; Thomas, WE				Yakovenko, Olga; Sharma, Shivani; Forero, Manu; Tchesnokova, Veronika; Aprikian, Pavel; Kidd, Brian; Mach, Albert; Vogel, Viola; Sokurenko, Evgeni; Thomas, Wendy E.			FimH forms catch bonds that are enhanced by mechanical force due to allosteric regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; P-SELECTIN; RECEPTOR-BINDING; PHYSICAL MODELS; ADHESION; CELLS; PILI; FLOW; COLONIZATION; INFECTION	The bacterial adhesive protein, FimH, is the most common adhesin of Escherichia coli and mediates weak adhesion at low flow but strong adhesion at high flow. There is evidence that this occurs because FimH forms catch bonds, defined as bonds that are strengthened by tensile mechanical force. Here, we applied force to single isolated FimH bonds with an atomic force microscope in order to test this directly. If force was loaded slowly, most of the bonds broke up at low force (< 60 piconewtons of rupture force). However, when force was loaded rapidly, all bonds survived until much higher force (140-180 piconewtons of rupture force), behavior that indicates a catch bond. Structural mutations or pretreatment with a monoclonal antibody, both of which allosterically stabilize a high affinity conformation of FimH, cause all bonds to survive until high forces regardless of the rate at which force is applied. Pretreatment of FimH bonds with intermediate force has the same strengthening effect on the bonds. This demonstrates that FimH forms catch bonds and that tensile force induces an allosteric switch to the high affinity, strong binding conformation of the adhesin. The catch bond behavior of FimH, the amount of force needed to regulate FimH, and the allosteric mechanism all provide insight into how bacteria bind and form biofilms in fluid flow. Additionally, these observations may provide a means for designing antiadhesive mechanisms.	[Yakovenko, Olga; Sharma, Shivani; Kidd, Brian; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Tchesnokova, Veronika; Aprikian, Pavel; Sokurenko, Evgeni] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Forero, Manu; Vogel, Viola] ETH, Dept Mat, CH-8093 Zurich, Switzerland; [Mach, Albert] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley	Thomas, WE (corresponding author), 1705 NE Pacific St,Suite N430P, Seattle, WA 98195 USA.	wendyt@u.washington.edu	Vogel, Viola/O-8025-2015	Vogel, Viola/0000-0003-2898-7671; Thomas, Wendy/0000-0001-8602-0819; Kidd, Brian/0000-0003-2110-1145; Forero-Shelton, Manu/0000-0002-7989-0311	NIAID NIH HHS [1R01 AI50940] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050940] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Arya M, 2005, BIOPHYS J, V88, P4391, DOI 10.1529/biophysj.104.046318; Bartolo D, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051910; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; COSTERTON JW, 1983, PROG FOOD NUTR SCI, V7, P91; DALNOGARE AR, 1990, AM J RESP CELL MOL, V2, P433, DOI 10.1165/ajrcmb/2.5.433; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; Forero M, 2004, NANO LETT, V4, P1593, DOI 10.1021/nl049329z; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; ISAACSON RE, 1978, INFECT IMMUN, V21, P392, DOI 10.1128/IAI.21.2.392-397.1978; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; IWAHI T, 1983, INFECT IMMUN, V39, P1307, DOI 10.1128/IAI.39.3.1307-1315.1983; JACKSON MB, 2006, MOL CELLULAR BIOPHYS, P121; Jeffrey B, 2003, AM J PHYSIOL-GASTR L, V285, pG907, DOI 10.1152/ajpgi.00062.2003; KEITH BR, 1986, INFECT IMMUN, V53, P693, DOI 10.1128/IAI.53.3.693-696.1986; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; OFEK I, 1977, NATURE, V265, P623, DOI 10.1038/265623a0; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Saterbak A, 1996, BIOTECHNOL PROGR, V12, P682, DOI 10.1021/bp960061u; Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001; Shapiro BE, 1997, BIOPHYS CHEM, V67, P211, DOI 10.1016/S0301-4622(97)00045-8; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; STOWELL CP, 1980, BIOCHEMISTRY-US, V19, P4899, DOI 10.1021/bi00562a030; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Zhu C, 2005, BIORHEOLOGY, V42, P443; Zhu Cheng, 2005, Molecular & Cellular Biomechanics, V2, P91	54	160	163	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11596	11605		10.1074/jbc.M707815200	http://dx.doi.org/10.1074/jbc.M707815200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18292092	Green Published, hybrid			2022-12-27	WOS:000255067400060
J	Xu, Y; Ravid, K; Smith, BD				Xu, Yong; Ravid, Katya; Smith, Barbara D.			Major histocompatibility class II transactivator expression in smooth muscle cells from A2b adenosine receptor knock-out mice - Cross-talk between the adenosine and interferon-gamma signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN COL1A2 TRANSCRIPTION; CYCLIC-AMP; PROTEIN-KINASE; GENE-EXPRESSION; IFN-GAMMA; REGULATORY FACTOR; A(2B) ADENOSINE; BLOOD-PRESSURE; CIITA; INFLAMMATION	Atherosclerosis characterized by sustained inflammation and aberrant extracellular matrix alterations. Our previous investigation has defined major histocompatibility class II transactivator ( CIITA) as a key factor in mediating these two processes in smooth muscle cells. Here, we demonstrate that CIITA and major histocompatibility class II expression are elevated in interferon-gamma (IFN-gamma)-treated smooth muscle cells from A2b adenosine receptor ( A2bAR(-/-)) knock- out mice, as compared with wild type cells. An A2-type adenosine receptor agonist suppresses these effects of IFN-gamma in wild type cells, which can be blocked by an A2bAR-specific antagonist. We further identify that increased cellular cAMP levels are responsible for the down-regulation of CIITA expression and, hence, reduced IFN-gamma response as evidenced by the following data: 1) direct activation of adenylyl cyclase activity is both necessary and sufficient to suppress the IFN-gamma response; 2) inhibition of phosphodiesterase activity attenuates IFN-gamma induced transcription events; and 3) direct treatment with cAMP analog abrogates CIITA activation and IFN-gamma response. Therefore, our data establish possible crosstalk between the adenosine signaling through cAMP and IFN-gamma during regulation of CIITA expression.	[Xu, Yong; Ravid, Katya; Smith, Barbara D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Smith, BD (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	smith@biochem.bumc.bu.edu		Ravid, Katya/0000-0002-9918-3024; Smith, Barbara/0000-0002-5375-7627	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068094, P01HL013262] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 68094, HL 013262-31] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKUTAGAWA H, 1994, HEMATOL PATHOL, V8, P85; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; BOUILLON M, 1992, INT J CANCER, V50, P281, DOI 10.1002/ijc.2910500219; Braun M, 1997, ARTERIOSCL THROM VAS, V17, P2568, DOI 10.1161/01.ATV.17.11.2568; Buttice G, 2006, CIRC RES, V98, P472, DOI 10.1161/01.RES.0000204725.46332.97; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999; Day YJ, 2005, J IMMUNOL, V174, P5040, DOI 10.4049/jimmunol.174.8.5040; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dubey RK, 2000, HYPERTENSION, V35, P267, DOI 10.1161/01.HYP.35.1.267; Emala CW, 1997, AM J PHYSIOL-LUNG C, V272, pL644, DOI 10.1152/ajplung.1997.272.4.L644; Fozard JR, 2002, EUR J PHARMACOL, V438, P183, DOI 10.1016/S0014-2999(02)01305-5; Gao ZH, 1999, J BIOL CHEM, V274, P5972, DOI 10.1074/jbc.274.9.5972; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Hilaire CS, 2008, J CELL BIOCHEM, V103, P1962, DOI 10.1002/jcb.21586; Hofmann CS, 2005, J BIOL CHEM, V280, P7694, DOI 10.1074/jbc.M412501200; Hofmann CS, 2004, ARTERIOSCL THROM VAS, V24, P1608, DOI 10.1161/01.ATV.0000139010.71779.f3; Ivashkiv LB, 1996, J IMMUNOL, V157, P1415; Kalk P, 2007, BRIT J PHARMACOL, V151, P1025, DOI 10.1038/sj.bjp.0707319; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Lange-Sperandio B, 2005, NEPHRON EXP NEPHROL, V100, pE113, DOI 10.1159/000085057; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Lin HY, 1998, J IMMUNOL, V161, P843; Lochamy J, 2007, MOL IMMUNOL, V44, P837, DOI 10.1016/j.molimm.2006.04.004; LONDOS C, 1980, P NATL ACAD SCI-BIOL, V77, P2551, DOI 10.1073/pnas.77.5.2551; McPherson JA, 2001, ARTERIOSCL THROM VAS, V21, P791, DOI 10.1161/01.ATV.21.5.791; Mead JR, 2003, J BIOL CHEM, V278, P17741, DOI 10.1074/jbc.M301602200; Mohsenin A, 2007, AM J PHYSIOL-LUNG C, V293, pL753, DOI 10.1152/ajplung.00187.2007; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; Peirce SM, 2001, AM J PHYSIOL-HEART C, V281, pH67, DOI 10.1152/ajpheart.2001.281.1.H67; Ravid K, 1999, J CELL BIOCHEM, V75, P177, DOI 10.1002/(SICI)1097-4644(19991001)75:1<177::AID-JCB18>3.3.CO;2-N; Schulte G, 2003, EXP CELL RES, V290, P168, DOI 10.1016/S0014-4827(03)00324-0; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Xu Y, 2004, J BIOL CHEM, V279, P41319, DOI 10.1074/jbc.M404174200; Xu Y, 2003, J BIOL CHEM, V278, P49134, DOI 10.1074/jbc.M309003200; Xu Y, 2008, J BIOL CHEM, V283, P1243, DOI 10.1074/jbc.M707180200; Xu Y, 2007, J BIOL CHEM, V282, P26046, DOI 10.1074/jbc.M703652200; Xu Y, 2007, MOL IMMUNOL, V44, P1709, DOI 10.1016/j.molimm.2006.07.294; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zhao ZH, 2000, BBA-MOL BASIS DIS, V1500, P280, DOI 10.1016/S0925-4439(99)00111-8; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001	48	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14213	14220		10.1074/jbc.M708657200	http://dx.doi.org/10.1074/jbc.M708657200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18359773	Green Published, hybrid			2022-12-27	WOS:000255941400007
J	Helland, R; Fjellbirkeland, A; Karlsen, OA; Ve, T; Lillehaug, JR; Jensen, HB				Helland, Ronny; Fjellbirkeland, Anne; Karlsen, Odd Andre; Ve, Thomas; Lillehaug, Johan R.; Jensen, Harald B.			An oxidized tryptophan facilitates copper binding in Methylococcus capsulatus-secreted protein MopE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; METAL SITES; RESIDUES; BATH; TRYPTOPHYLQUINONE; IDENTIFICATION; METHANOTROPH; HOMEOSTASIS; REFINEMENT; COMPLEXES	Proteins can coordinate metal ions with endogenous nitrogen and oxygen ligands through backbone amino and carbonyl groups, but the amino acid side chains coordinating metals do not include tryptophan. Here we show for the first time the involvement of the tryptophan metabolite kynurenine in a protein metal-binding site. The crystal structure to 1.35 angstrom of MopE* from the methane-oxidizing Methylococcus capsulatus (Bath) provided detailed information about its structure and mononuclear copper-binding site. MopE* contains a novel protein fold of which only one-third of the structure displays similarities to other known folds. The geometry around the copper ion is distorted tetrahedral with one oxygen ligand from a water molecule, two histidine imidazoles (His-132 and His-203), and at the fourth distorted tetrahedral position, the N1 atom of the kynurenine, an oxidation product of Trp-130. Trp-130 was not oxidized to kynurenine in MopE* heterologously expressed in Escherichia coli, nor did this protein bind copper. Our findings indicate that the modification of tryptophan to kynurenine and its involvement in copper binding is an innate property of M. capsulatus MopE*.	[Fjellbirkeland, Anne; Karlsen, Odd Andre; Ve, Thomas; Lillehaug, Johan R.; Jensen, Harald B.] Univ Bergen, Dept Mol Biol, HIB, N-5020 Bergen, Norway; [Helland, Ronny] Univ Tromso, Fac Sci, Norwegian Struct Biol Ctr, N-9073 Tromso, Norway	University of Bergen; UiT The Arctic University of Tromso	Jensen, HB (corresponding author), Univ Bergen, Dept Mol Biol, HIB, Thormohlensgate 55, N-5020 Bergen, Norway.	jensen@mbi.uib.no	Ve, Thomas/AEK-1006-2022; Ve, Thomas/F-9820-2011	Ve, Thomas/0000-0002-0113-1905; 				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball LJ, 2004, ORG BIOMOL CHEM, V2, P1872, DOI 10.1039/b402722a; Berson O, 1997, FEMS MICROBIOL LETT, V148, P169, DOI 10.1016/S0378-1097(97)00029-3; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Fjellbirkeland A, 1997, ARCH MICROBIOL, V168, P128, DOI 10.1007/s002030050478; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung D, 2004, CHEM BIOL, V11, P949, DOI 10.1016/j.chembiol.2004.04.020; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaminskaia NV, 2001, INORG CHEM, V40, P2368, DOI 10.1021/ic0014033; Karlsen OA, 2005, FEBS J, V272, P6324, DOI 10.1111/j.1742-4658.2005.05020.x; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Manzanares D, 2007, BIOCHEMISTRY-US, V46, P5604, DOI 10.1021/bi062304p; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Moller IM, 2006, FREE RADICAL BIO MED, V40, P430, DOI 10.1016/j.freeradbiomed.2005.08.036; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pearson AR, 2004, BIOCHEMISTRY-US, V43, P5494, DOI 10.1021/bi049863l; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Takani M, 2006, INORG CHEM, V45, P5938, DOI 10.1021/ic060595k; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang ZM, 2000, ACTA CRYSTALLOGR C, V56, P786, DOI 10.1107/S0108270100004984; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Yang CY, 1999, BIOCHEMISTRY-US, V38, P15903, DOI 10.1021/bi991464g; Zhang H, 2004, FREE RADICAL BIO MED, V37, P2018, DOI 10.1016/j.freeradbiomed.2004.08.026	45	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13897	13904		10.1074/jbc.M800340200	http://dx.doi.org/10.1074/jbc.M800340200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348978	hybrid			2022-12-27	WOS:000255728200043
J	Lindemann, MJ; Hu, ZH; Benczik, M; Liu, KD; Gaffen, SL				Lindemann, Matthew J.; Hu, Zihua; Benczik, Marta; Liu, Kathleen D.; Gaffen, Sarah L.			Differential regulation of the IL-17 receptor by gamma c cytokines - Inhibitory signaling by the phosphatidylinositol 3-kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; BETA-CHAIN; INTERLEUKIN-2 RECEPTOR; PROTEIN-KINASE; TYROSINE RESIDUES; ALPHA SUBUNIT; TARGET GENES; TRANSDUCTION; FAMILY; PROLIFERATION	The gamma c-family cytokine IL-2 activates signaling events that contribute to cell survival and proliferation, the best-studied of which are the STAT-5 and phosphatidylinositol 3-kinase (PI3K) pathways. The starting point of this study was to define genes regulated by the IL-2R-mediated PI3K pathway in T cells. Accordingly, we used an erythropoietin (EPO) receptor chimeric receptor system in which IL-2-dependent HT-2 T cells expressed a mutant EPO-IL-2R beta construct where Tyr-338 is mutated to Phe. Cells expressing this mutant IL-2R beta chain fail to induce phosphorylation of PI3K-p85 alpha/beta or activate Akt, but mediate normal IL-2-dependent proliferation and activation of JAK1 and STAT-5A/B. Microarray analyses revealed differential regulation of numerous genes compared with cells expressing a wild-type IL-2R beta, including up-regulation of the IL-17 receptor subunit IL-17RA. Blockade of the PI3K pathway but not p70(S6K) led to up-regulation of IL-17RA, and constitutive Akt activation was associated with suppressed IL-17RA expression. Moreover, similar to the mutant EPO-IL-2R beta chimera, IL-15 and IL-21 induced IL-17RA preferentially compared with IL-2, and IL-2 but not IL-15 or IL-21 mediated prolonged activation of the PI3K p85 regulatory subunit. Thus, there are intrinsic signaling differences between IL-2 and IL-15 that can be attributed to differences in activation of the PI3K pathway.	[Lindemann, Matthew J.; Benczik, Marta; Gaffen, Sarah L.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA; [Gaffen, Sarah L.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Hu, Zihua] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA; [Hu, Zihua] SUNY Buffalo, Ctr Excellence Bioinformat, Buffalo, NY 14214 USA; [Liu, Kathleen D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California San Francisco	Gaffen, SL (corresponding author), 36 Foster Hall,3435 Main St, Buffalo, NY 14214 USA.	sgaffen@buffalo.edu	Gaffen, Sarah L/B-1560-2009	Gaffen, Sarah L/0000-0001-8511-2041; Liu, Kathleen/0000-0003-4891-8649	NIAID NIH HHS [AI05439] Funding Source: Medline; NIAMS NIH HHS [AR050458] Funding Source: Medline; NIDCR NIH HHS [DE007034] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR050458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R43DE007034] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Bauer JH, 1998, J BIOL CHEM, V273, P9255, DOI 10.1074/jbc.273.15.9255; Chu CL, 1999, J IMMUNOL, V162, P1896; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Cua DJ, 2006, NAT IMMUNOL, V7, P557, DOI 10.1038/ni0606-557; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Gaffen SL, 2006, VITAM HORM, V74, P255, DOI 10.1016/S0083-6729(06)74010-9; Gaffen Sarah L., 1998, P73; Gaffen SL, 1999, BLOOD, V94, P74, DOI 10.1182/blood.V94.1.74.413k36_74_86; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gaffen SL, 1996, J BIOL CHEM, V271, P21381, DOI 10.1074/jbc.271.35.21381; GAFFEN SL, 1995, P NATL ACAD SCI USA, V92, P7192, DOI 10.1073/pnas.92.16.7192; GOLDSMITH MA, 1995, J BIOL CHEM, V270, P21729, DOI 10.1074/jbc.270.37.21729; Ha CT, 2005, J LEUKOCYTE BIOL, V77, P948, DOI 10.1189/jlb.0804453; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HATAKEYAMA M, 1992, P NATL ACAD SCI USA, V89, P2022, DOI 10.1073/pnas.89.6.2022; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; Hur EM, 2003, J EXP MED, V198, P1463, DOI 10.1084/jem.20030232; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Lai SY, 1996, EMBO J, V15, P4506, DOI 10.1002/j.1460-2075.1996.tb00828.x; Lai SY, 1997, J CLIN INVEST, V99, P169, DOI 10.1172/JCI119144; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lindemann MJ, 2003, J BIOL CHEM, V278, P10239, DOI 10.1074/jbc.M209471200; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Lord JD, 1998, J IMMUNOL, V161, P4627; MA A, 2000, MOD ASP IMMUNOBIOL, V1, P102; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nelson BH, 1996, MOL CELL BIOL, V16, P309; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shindoh M, 2004, CANCER LETT, V216, P1, DOI 10.1016/j.canlet.2004.07.020; Tagaya Y, 2006, BLOOD, V108, P409, DOI 10.1182/blood-2006-05-019463; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	60	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14100	14108		10.1074/jbc.M801357200	http://dx.doi.org/10.1074/jbc.M801357200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348982	hybrid, Green Published			2022-12-27	WOS:000255728200064
J	Ozturk, Y; Lee, DW; Mandaci, S; Osyczka, A; Prince, RC; Daldal, F				Ozturk, Yavuz; Lee, Dong-Woo; Mandaci, Sevnur; Osyczka, Artur; Prince, Roger C.; Daldal, Fevzi			Soluble variants of Rhodobacter capsulatus membrane-anchored cytochrome c(y) are efficient photosynthetic electron carriers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHAEROIDES REACTION-CENTER; RHODOPSEUDOMONAS-CAPSULATA; BC(1) COMPLEX; PARACOCCUS-DENITRIFICANS; C-OXIDASE; C(2); GROWTH; RESPIRATION; DOMAIN; EXPRESSION	Photosynthetic (Ps) electron transport pathways often contain multiple electron carriers with overlapping functions. Here we focus on two c-type cytochromes (cyt) in facultative phototrophic bacteria of the Rhodobacter genus: the diffusible cyt c(2) and the membrane-anchored cyt c(y). In species like R. capsulatus, cyt c(y) functions in both Ps and respiratory electron transport chains, whereas in other species like R. sphaeroides, it does so only in respiration. The molecular bases of this difference was investigated by producing a soluble variant of cyt c(y) (S-c(y)), by fusing genetically the cyt c(2) signal sequence to the cyt c domain of cyt c(y). This novel electron carrier was unable to support the Ps growth of R. capsulatus. However, strains harboring cyt S-c(y) regained Ps growth ability by acquiring mutations in its cyt c domain. They produced cyt S-c(y) variants at amounts comparable with that of cyt c(2), and conferred Ps growth. Chemical titration indicated that the redox midpoint potential of cyt S-c(y) was about 340 mV, similar to that of cyts c(2) or c(y). Remarkably, electron transfer kinetics from the cyt bc(1) complex to the photochemical reaction center (RC) mediated by cyt S-c(y) was distinct from those seen with the cyt c(2) or cyt c(y). The kinetics exhibited a pronounced slow phase, suggesting that cyt S-c(y) interacted with the RC less tightly than cyt c(2). Comparison of structural models of cyts c(2) and S-c(y) revealed that several of the amino acid residues implicated in long-range electrostatic interactions promoting binding of cyt c(2) to the RC are not conserved in cyt c(y), whereas those supporting short-range hydrophobic interactions are conserved. These findings indicated that attaching electron carrier cytochromes to the membrane allowed them to weaken their interactions with their partners so that they could accommodate more rapid multiple turnovers.	[Ozturk, Yavuz; Lee, Dong-Woo; Daldal, Fevzi] Univ Penn, Johnson Res Fdn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; [Osyczka, Artur] Univ Penn, Johnson Res Fdn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ozturk, Yavuz; Mandaci, Sevnur] TUBITAK Marmara Res Ctr, Genet Engn & Biotechnol Inst, TR-41470 Kocaeli, Turkey; [Prince, Roger C.] Exxon Mobil Biomed Sci Inc, Annandale, NJ 08801 USA	University of Pennsylvania; University of Pennsylvania; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Exxon Mobil Corporation	Daldal, F (corresponding author), Univ Penn, Johnson Res Fdn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu		Osyczka, Artur/0000-0002-1637-2365	NIGMS NIH HHS [R01 GM038237, GM 38237] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelrod HL, 2002, J MOL BIOL, V319, P501, DOI 10.1016/S0022-2836(02)00168-7; Baymann F, 2003, FEBS LETT, V539, P91, DOI 10.1016/S0014-5793(03)00206-0; BLANKENSHIP R, 1995, ANOXYGENIC PHOTOSYNT, P747; CAFFREY MS, 1992, J BIOL CHEM, V267, P6317; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; DALDAL F, 1988, J BACTERIOL, V170, P2388, DOI 10.1128/jb.170.5.2388-2391.1988; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; DONOHUE TJ, 1986, J BACTERIOL, V168, P962, DOI 10.1128/jb.168.2.962-972.1986; Drepper F, 1997, BIOCHEMISTRY-US, V36, P1418, DOI 10.1021/bi961350u; Drepper F, 1997, BIOCHEMISTRY-US, V36, P1428, DOI 10.1021/bi961351m; Dutton P L, 1978, Methods Enzymol, V54, P411; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; Harrenga A, 2000, J MOL BIOL, V295, P667, DOI 10.1006/jmbi.1999.3382; HOCHKOEPPLER A, 1995, J BACTERIOL, V177, P608, DOI 10.1128/jb.177.3.608-613.1995; Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9; HUNTER N, 2008, PURPLE PHOTOSYNTHETI; JENNEY FE, 1994, BIOCHEMISTRY-US, V33, P2496, DOI 10.1021/bi00175a019; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Jenney FE, 1996, BBA-BIOENERGETICS, V1273, P159, DOI 10.1016/0005-2728(95)00137-9; LAMONICA RF, 1976, BIOCHIM BIOPHYS ACTA, V423, P431, DOI 10.1016/0005-2728(76)90198-5; Lee DW, 2008, J BIOL CHEM, V283, P13973, DOI 10.1074/jbc.M800091200; Lee DW, 2006, BBA-BIOENERGETICS, V1757, P346, DOI 10.1016/j.bbabio.2006.04.025; LONG JE, 1989, BIOCHEMISTRY-US, V28, P6970, DOI 10.1021/bi00443a029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; MOSER CC, 1988, BIOCHEMISTRY-US, V27, P2450, DOI 10.1021/bi00407a031; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Myllykallio H, 1998, BIOCHEMISTRY-US, V37, P5501, DOI 10.1021/bi973123d; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P493, DOI 10.1016/S0966-842X(00)01831-X; Myllykallio H, 1997, J BACTERIOL, V179, P2623, DOI 10.1128/jb.179.8.2623-2631.1997; OVERFIELD RE, 1979, FEBS LETT, V105, P137, DOI 10.1016/0014-5793(79)80903-5; PRINCE RC, 1975, BIOCHIM BIOPHYS ACTA, V387, P212, DOI 10.1016/0005-2728(75)90104-8; PRINCE RC, 1986, BIOCHEMISTRY-US, V25, P5208, DOI 10.1021/bi00366a034; PRINCE RC, 1990, BACTERIA, V12, P111; Reincke B, 2001, BIOCHEMISTRY-US, V40, P12312, DOI 10.1021/bi010615o; ROBERTSON DE, 1986, J BIOL CHEM, V261, P584; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; Tetreault M, 2002, BIOCHEMISTRY-US, V41, P5807, DOI 10.1021/bi012053e; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; TIEDE DM, 1993, BIOCHEMISTRY-US, V32, P4515, DOI 10.1021/bi00068a006; Vermeglio A, 2002, BBA-BIOENERGETICS, V1555, P60, DOI 10.1016/S0005-2728(02)00255-4; ZANNONI D, 1993, ARCH MICROBIOL, V160, P413, DOI 10.1007/BF00245301; ZANNONI D, 1976, BIOCHIM BIOPHYS ACTA, V423, P413, DOI 10.1016/0005-2728(76)90197-3	47	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13964	13972		10.1074/jbc.M800090200	http://dx.doi.org/10.1074/jbc.M800090200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343817	Green Published, hybrid			2022-12-27	WOS:000255728200050
J	Sengle, G; Charbonneau, NL; Ono, RN; Sasaki, T; Alvarez, J; Keene, DR; Bachinger, HP; Sakai, LY				Sengle, Gerhard; Charbonneau, Noe L.; Ono, Robert N.; Sasaki, Takako; Alvarez, Jennifer; Keene, Douglas R.; Bachinger, Hans Peter; Sakai, Lynn Y.			Targeting of bone morphogenetic protein growth factor complexes to fibrillin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BINDING PROTEIN-1; TGF-BETA; PRODOMAIN; CALCIUM; IDENTIFICATION; PURIFICATION; MICROFIBRILS; DEGRADATION; EXPRESSION; PROPEPTIDE	Both latent transforming growth factor-beta (TGF-beta)-binding proteins fibrillins are components of microfibril networks, and both interact with members of the TGF-beta family of growth factors. Interactions between latent TGF-beta-binding protein-1 and TGF-beta and between fibrillin-1 and bone morphogenetic protein-7 (BMP-7) are mediated by the prodomain of growth factor complexes. To extend this information, investigations were performed to test whether stable complexes are formed by additional selected TGF-beta family members. Using velocity sedimentation in sucrose gradients as an assay, complex formation was demonstrated for BMP-7 and growth and differentiation factor-8 (GDF-8), which are known to exist in prodomain/growth factor complexes. Comparison of these results with complex formation by BMP-2, BMP-4 (full-length and shortened propeptides), BMP-10, and GDF-5 allowed us to conclude that all, except for BMP-2 and the short BMP-4 propeptides, formed complexes with their growth factors. Using surface plasmon resonance, binding affinities between fibrillin and all propeptides were determined. Binding studies revealed that the N-terminal end of fibrillin-1 serves as a universal high affinity docking site for the propeptides of BMP-2, -4, -7, and -10 and GDF-5, but not GDF-8, and located the BMP/GDF binding site within the N-terminal domain in fibrillin-1. Rotary shadowing electron microscopy of molecules of BMP-7 complex bound to fibrillin-1 confirmed these findings and also showed that prodomain binding targets the growth factor to fibrillin. Immunolocalization of BMP-4 demonstrated fibrillar staining limited to certain tissues, indicating tissue-specific targeting of BMP-4. These data implicate the fibrillin microfibril network in the extracellular control of BMP signaling and demonstrate differences in how prodomains target their growth factors to the extracellular space.	[Sengle, Gerhard; Charbonneau, Noe L.; Ono, Robert N.; Sasaki, Takako; Alvarez, Jennifer; Keene, Douglas R.; Bachinger, Hans Peter; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Sasaki, Takako; Bachinger, Hans Peter; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Sakai, LY (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR046811] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01AR46811, P01 AR049698] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Cui YZ, 2001, GENE DEV, V15, P2797; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Israel DI, 1992, GROWTH FACTORS, V7, P139, DOI 10.3109/08977199209046403; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; MAYER U, 1995, FEBS LETT, V365, P129, DOI 10.1016/0014-5793(95)00438-F; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Schmid B, 2000, DEVELOPMENT, V127, P957; Thies RS, 2001, GROWTH FACTORS, V18, P251; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659	33	168	172	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13874	13888		10.1074/jbc.M707820200	http://dx.doi.org/10.1074/jbc.M707820200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339631	hybrid, Green Published			2022-12-27	WOS:000255728200041
J	Snider, JL; Allison, C; Bellaire, BH; Ferrero, RL; Cardelli, JA				Snider, Jared L.; Allison, Cody; Bellaire, Bryan H.; Ferrero, Richard L.; Cardelli, James A.			The beta(1) integrin activates JNK independent of CagA, and JNK activation is required for Helicobacter pylori CagA(+)-induced motility of gastric cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; N-TERMINAL KINASE; JUN NH2-TERMINAL KINASE; TYROSINE PHOSPHORYLATION; IV SECRETION; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; UP-REGULATION; IN-VITRO; KAPPA-B	The Helicobacter pylori CagA protein is translocated into gastric epithelial cells through a type IV secretion system (TFSS), and published studies suggest CagA is critical for H. pylori-associated carcinogenesis. CagA is thought to be necessary and sufficient to induce the motogenic response observed in response to CagA(+) strains, as CagA interacts with proteins involved in adhesion and motility. We report that H. pylori strain 60190 stimulated AGS cell motility through a CagA- and TFSS-dependent mechanism, because strains 60190 Delta cagA or 60190 Delta cagE (TFSS-defective) did not increase motility. The JNK pathway is critical for H. pylori-dependent cell motility, as inhibition using SP600125 (JNK1/2/3 inhibitor) or a JNK2/3-specific inhibitor blocked motility. JNK mediates H. pylori-induced cell motility by activating paxillin, because JNK inhibition blocked paxillin(Tyr-118) phosphorylation, and paxillin expression knockdown completely abrogated bacteria-induced motility. Furthermore, JNK and paxillinTyr-118 were activated by 60190 Delta cagA but not 60190 Delta cagE, demonstrating CagA-independent signaling critical for cell motility. A beta(1) integrin-blocking antibody significantly inhibited JNK and paxillinTyr-118 phosphorylation and cell scattering, demonstrating that CagA-independent signaling required for cell motility occurs through beta(1). The requirement of both Src and focal adhesion kinase for signaling and motility further suggests the importance of integrin signaling in H. pylori-induced cell motility. Finally, we show that JNK activation occurs independent of known upstream kinases and signaling molecules, including Nod1, Cdc42, Rac1, MKK4, and MKK7, which demonstrates novel signaling leading to JNK activation. We report for the first time that H. pylori mediates CagA-independent signaling that promotes cell motility through the beta(1) integrin pathway.	[Snider, Jared L.; Cardelli, James A.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71130 USA; [Snider, Jared L.; Cardelli, James A.] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA; [Allison, Cody; Ferrero, Richard L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Bellaire, Bryan H.] Iowa State Univ Sci & Technol, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Monash University; Iowa State University	Cardelli, JA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, 1501 Kings Highway, Shreveport, LA 71130 USA.	jcarde@lsuhsc.edu	Bellaire, Bryan/GNP-5200-2022; Ferrero, Richard/U-1332-2017	Bellaire, Bryan/0000-0002-4034-6482; Ferrero, Richard/0000-0001-6817-6211	NCI NIH HHS [CA104242] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104242] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Ghoul L, 2004, BIOCHEM BIOPH RES CO, V322, P860, DOI 10.1016/j.bbrc.2004.07.199; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Amagasaki K, 2006, J BIOL CHEM, V281, P22173, DOI 10.1074/jbc.M513307200; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Backert S, 2001, PROTEOMICS, V1, P608, DOI 10.1002/1615-9861(200104)1:4<608::AID-PROT608>3.3.CO;2-7; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Churin Y, 2001, MOL MICROBIOL, V40, P815, DOI 10.1046/j.1365-2958.2001.02443.x; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; FORMAN D, 1993, LANCET, V341, P1359; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirata Y, 2001, INFECT IMMUN, V69, P3965, DOI 10.1128/IAI.69.6.3965-3971.2001; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moese S, 2004, INFECT IMMUN, V72, P3646, DOI 10.1128/IAI.72.6.3646-3649.2004; Moese S, 2002, INFECT IMMUN, V70, P4687, DOI 10.1128/IAI.70.8.4687-4691.2002; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Scott WN, 2000, ANAL BIOCHEM, V287, P343, DOI 10.1006/abio.2000.4866; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Yamauchi J, 2000, J BIOL CHEM, V275, P7633, DOI 10.1074/jbc.275.11.7633; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004	64	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13952	13963		10.1074/jbc.M800289200	http://dx.doi.org/10.1074/jbc.M800289200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18356158	Green Published, hybrid			2022-12-27	WOS:000255728200049
J	Gusarov, I; Starodubtseva, M; Wang, ZQ; McQuade, L; Lippard, SJ; Stuehr, DJ; Nudler, E				Gusarov, Ivan; Starodubtseva, Marina; Wang, Zhi-Qiang; McQuade, Lindsey; Lippard, Stephen J.; Stuehr, Dennis J.; Nudler, Evgeny			Bacterial nitric-oxide Synthases operate without a dedicated redox partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; NITROSATIVE STRESS; SIGNALING MOLECULE; OXIDATIVE STRESS; GENE-EXPRESSION; PROTEIN; ADAPTATION; MECHANISM	Bacterial nitric-oxide (NO) synthases (bNOSs) are smaller than their mammalian counterparts. They lack an essential reductase domain that supplies electrons during NO biosynthesis. This and other structural peculiarities have raised doubts about whether bNOSs were capable of producing NO in vivo. Here we demonstrate that bNOS enzymes from Bacillus subtilis and Bacillus anthracis do indeed produce NO in living cells and accomplish this task by hijacking available cellular redox partners that are not normally committed to NO production. These "promiscuous" bacterial reductases also support NO synthesis by the oxygenase domain of mammalian NOS expressed in Escherichia coli. Our results suggest that bNOS is an early precursor of eukaryotic NOS and that it acquired its dedicated reductase domain later in evolution. This work also suggests that alternatively spliced forms of mammalian NOSs lacking their reductase domains could still be functional in vivo. On a practical side, bNOS-containing probiotic bacteria offer a unique advantage over conventional chemical NO donors in generating continuous, readily controllable physiological levels of NO, suggesting a possibility of utilizing such live NO donors for research and clinical needs.	[Gusarov, Ivan; Starodubtseva, Marina; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Wang, Zhi-Qiang] Kent State Univ Tuscarawas, Dept Chem, New Philadelphia, PA USA; [McQuade, Lindsey; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	New York University; Massachusetts Institute of Technology (MIT); Cleveland Clinic Foundation	Nudler, E (corresponding author), 550 1st Ave,MSB359, New York, NY 10016 USA.	evgeny.nudler@med.nyu.edu	Gusarov, Ivan/AAJ-6282-2020	Nudler, Evgeny/0000-0002-8811-3071	NIH HHS [DP1 OD000799] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000799] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; CHEN YJ, 1994, BIOCHEM BIOPH RES CO, V203, P1251, DOI 10.1006/bbrc.1994.2317; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Fang F.C., 1999, NITRIC OXIDE INFECT; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gautier C, 2006, NITRIC OXIDE-BIOL CH, V15, P312, DOI 10.1016/j.niox.2006.03.010; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; KERWIN JF, 1995, J MED CHEM, V38, P4343, DOI 10.1021/jm00022a001; Korneev S, 2002, MOL BIOL EVOL, V19, P1228, DOI 10.1093/oxfordjournals.molbev.a004183; Larsson B, 1998, BIOCHEM BIOPH RES CO, V251, P898, DOI 10.1006/bbrc.1998.9578; Lei L, 2004, P NATL ACAD SCI USA, V101, P494, DOI 10.1073/pnas.2435922100; Lim MH, 2006, J AM CHEM SOC, V128, P14364, DOI 10.1021/ja064955e; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Miller J. H, 1972, EXPT MOL GENETICS; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Nakano MM, 2002, J BACTERIOL, V184, P1783, DOI 10.1128/JB.184.6.1783-1787.2002; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Okuda S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-48; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Rafikova O, 2002, P NATL ACAD SCI USA, V99, P5913, DOI 10.1073/pnas.092048999; Rogstam A, 2007, J BACTERIOL, V189, P3063, DOI 10.1128/JB.01782-06; Salard I, 2006, J INORG BIOCHEM, V100, P2024, DOI 10.1016/j.jinorgbio.2006.09.017; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Stasiv Y, 2004, GENE DEV, V18, P1812, DOI 10.1101/gad.298004; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8	45	117	121	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13140	13147		10.1074/jbc.M710178200	http://dx.doi.org/10.1074/jbc.M710178200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316370	hybrid, Green Published			2022-12-27	WOS:000255499800053
J	Rabionet, M; van der Spoel, AC; Chuang, CC; von Tumpling-Radosta, B; Litjens, M; Bouwmeester, D; Hellbusch, CC; Korner, C; Wiegandt, H; Gorgas, K; Platt, FM; Grone, HJ; Sandhoff, R				Rabionet, Mariona; van der Spoel, Aarnoud C.; Chuang, Chia-Chen; von Tuempling-Radosta, Benita; Litjens, Manja; Bouwmeester, Diane; Hellbusch, Christina C.; Koerner, Christian; Wiegandt, Herbert; Gorgas, Karin; Platt, Frances M.; Groene, Hermann Josef; Sandhoff, Roger			Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis - A link to ceramide synthase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SEMINIFEROUS EPITHELIUM; DEFICIENT MICE; FAMILY-MEMBERS; SPERMATOGENESIS; TESTIS; MOUSE; GENE; GLUCOSYLCERAMIDE; GANGLIOSIDES	Previously, it was found that a novel class of neutral fucosylated glycosphingolipids (GSLs) is required for male fertility. These lipids contain very long-chain (C26-C32) polyunsaturated (4-6 double bonds) fatty acid residues (VLC-PUFAs). To assess the role of these complex GSLs in spermatogenesis, we have now investigated with which of the testicular cell types these lipids are associated. During postnatal development, complex glycosylated and simple VLC-PUFA sphingolipids were first detectable at day 15, when the most advanced germ cells are pachytene spermatocytes. Their synthesis is most likely driven by ceramide synthase-3. This enzyme is encoded by the Cers3/Lass3 gene (longevity assurance genes), and out of six members of this gene family, only Cers3 mRNA expression was limited to germ cells, where it was up-regulated more than 700-fold during postnatal testicular maturation. Increasing levels of neutral complex VLC-PUFA GSLs also correlated with the progression of spermatogenesis in a series of male sterile mutants with arrests at different stages of spermatogenesis. Remarkably, fucosylation of the complex VLC-PUFA GSLs was not essential for spermatogenesis, as fucosylation- deficient mice produced nonfucosylated versions of the complex testicular VLC-PUFA GSLs, had complete spermatogenesis, and were fertile. Nevertheless, sterile Galgt1(-/-) mice, with a defective meiotic cytokinesis and a subsequent block in spermiogenesis, lacked complex but contained simple VLC-PUFA GSLs, as well as VLC-PUFA ceramides and sphingomyelins, indicating that the latter lipids are not sufficient for completion of spermatogenesis. Thus, our data imply that both glycans and the particular acyl chains of germinal sphingolipids are relevant for proper completion of meiosis.	[van der Spoel, Aarnoud C.; Chuang, Chia-Chen; Litjens, Manja; Bouwmeester, Diane; Wiegandt, Herbert; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Rabionet, Mariona; von Tuempling-Radosta, Benita; Wiegandt, Herbert; Groene, Hermann Josef; Sandhoff, Roger] German Canc Res Ctr, Dept Cellular & Mol Pathol, INF 280, D-69120 Heidelberg, Germany; [Hellbusch, Christina C.; Koerner, Christian] Univ Childrens Hosp, Div Inborn Metab Dis, Dept Pediat, INF 153, D-69120 Heidelberg, Germany; [Gorgas, Karin] Heidelberg Univ, Dept Anat & Cell Biol 2, INF 307, D-69120 Heidelberg, Germany	University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	van der Spoel, AC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	aarnoud.vanderspoel@pharm.ox.ac.uk; r.sandhoff@dkfz-heidelberg.de	Platt, Frances/G-1004-2010	Platt, Frances/0000-0001-7614-0403; van der Spoel, Aarnoud/0000-0002-2338-5316	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045861] Funding Source: NIH RePORTER; NICHD NIH HHS [1 U01 HD45861] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams J, 2005, AM J PATHOL, V167, P285, DOI 10.1016/S0002-9440(10)62973-2; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BURGOS MH, 1970, TESTIS, P551; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fujimoto H, 2000, J BIOL CHEM, V275, P22623, DOI 10.1074/jbc.C000200200; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; Furland NE, 2007, J BIOL CHEM, V282, P18141, DOI 10.1074/jbc.M700708200; GORGAS K, 1989, J LIPID RES, V30, P1859; GROGAN WM, 1982, LIPIDS, V17, P605, DOI 10.1007/BF02535366; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; ISHIZUKA I, 1973, J BIOCHEM-TOKYO, V73, P77; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lee NPY, 2007, J ENDOCRINOL, V192, P17, DOI 10.1677/JOE-06-0002; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Ohta H, 2000, DEVELOPMENT, V127, P2125; Popko B, 2000, GLIA, V29, P149, DOI 10.1002/(SICI)1098-1136(20000115)29:2<149::AID-GLIA8>3.0.CO;2-4; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; RUSSELL LD, 1980, GAMETE RES, V3, P179, DOI 10.1002/mrd.1120030209; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Sandhoff R, 2005, J BIOL CHEM, V280, P27310, DOI 10.1074/jbc.M502775200; Sandhoff R, 2002, J BIOL CHEM, V277, P20386, DOI 10.1074/jbc.M110641200; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; SUZUKI A, 1973, JPN J EXP MED, V43, P435; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR11; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; WardBailey PF, 1996, MAMM GENOME, V7, P793, DOI 10.1007/s003359900239; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhang YL, 2005, GLYCOBIOLOGY, V15, P649, DOI 10.1093/glycob/cwi043	46	79	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13357	13369		10.1074/jbc.M800870200	http://dx.doi.org/10.1074/jbc.M800870200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308723	hybrid, Green Published			2022-12-27	WOS:000255499800075
J	Havasi, A; Li, ZJ; Wang, ZY; Martin, JL; Botla, V; Ruchalski, K; Schwartz, JH; Borkan, SC				Havasi, Andrea; Li, Zhijian; Wang, Zhiyong; Martin, Jody L.; Botla, Venugopal; Ruchalski, Kathleen; Schwartz, John H.; Borkan, Steven C.			Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; CELL-DEATH; POTENTIAL ROLE; ATP DEPLETION; BETA-CATENIN; PHOSPHORYLATION; TRANSLOCATION; STRESS; HEAT-SHOCK-PROTEIN-27; KINASE	Hsp27 inhibits mitochondrial injury and apoptosis in both normal and cancer cells by an unknown mechanism. To test the hypothesis that Hsp27 decreases apoptosis by inhibiting Bax, Hsp27 expression was manipulated in renal epithelial cells before transient metabolic stress, an insult that activates Bax, induces mitochondrial injury, and causes apoptosis. Compared with control, enhanced Hsp27 expression inhibited conformational Bax activation, oligomerization, and translocation to mitochondria, reduced the leakage of both cytochrome c and apoptosis-inducing factor, and significantly improved cell survival by > 50% after stress. In contrast, Hsp27 down-regulation using RNA-mediated interference promoted Bax activation, increased Bax translocation, and reduced cell survival after stress. Immunoprecipitation did not detect Hsp27-Bax interaction before, during, or after stress, suggesting that Hsp27 indirectly inhibits Bax. During stress, Hsp27 expression prevented the inactivation of Akt, a pro-survival kinase, and increased the interaction between Akt and Bax, an Akt substrate. In contrast, Hsp27 RNA-mediated interference promoted Akt inactivation during stress. Hsp27 up-or down-regulation markedly altered the activity of phosphatidylinositol 3-kinase (PI3-kinase), a major regulator of Akt. Furthermore, distinct PI3-kinase inhibitors completely abrogated the protective effect of Hsp27 expression on Akt activation, Bax inactivation, and cell survival. These data show that Hsp27 antagonizes Bax-mediated mitochondrial injury and apoptosis by promoting Akt activation via a PI3-kinase-dependent mechanism.	[Havasi, Andrea; Wang, Zhiyong; Botla, Venugopal; Ruchalski, Kathleen; Schwartz, John H.; Borkan, Steven C.] Boston Med Ctr, Boston, MA 02118 USA; [Li, Zhijian] Zhongshan Univ, Affiliated Hosp 1, Guangzhou 510080, Peoples R China; [Martin, Jody L.] Loyola Univ, Cardiovasc Inst, Maywood, IL 60153 USA	Boston Medical Center; Sun Yat Sen University; Loyola University Chicago	Borkan, SC (corresponding author), Boston Med Ctr, 650 Albany St,EBRC Rm 546, Boston, MA 02118 USA.	sborkan@bu.edu	Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681; Wang, Zhiyon/0000-0002-6471-266X; Borkan, Steven/0000-0003-3062-9486; Havasi, Andrea/0000-0002-8758-0823	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052898, R01DK053387] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-52898, DK-53387] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Adachi M, 2004, AM J PHYSIOL-GASTR L, V287, pG695, DOI 10.1152/ajpgi.00415.2003; Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; BORKAN SC, 1993, AM J PHYSIOL, V265, pF333, DOI 10.1152/ajprenal.1993.265.3.F333; Brar BK, 1999, J MOL CELL CARDIOL, V31, P135, DOI 10.1006/jmcc.1998.0857; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bush KT, 2000, AM J PHYSIOL-RENAL, V278, pF847, DOI 10.1152/ajprenal.2000.278.5.F847; Chiang GJ, 2005, BJU INT, V96, P416, DOI 10.1111/j.1464-410X.2005.05642.x; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Ferns G, 2006, INT J EXP PATHOL, V87, P253, DOI 10.1111/j.1365-2613.2006.00484.x; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Garrido C, 1997, CANCER RES, V57, P2661; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Grzesiak JJ, 2005, INT J CANCER, V114, P522, DOI 10.1002/ijc.20748; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hollander JM, 2004, CIRCULATION, V110, P3544, DOI 10.1161/01.CIR.0000148825.99184.50; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Huang JH, 2005, CIRCULATION, V112, P76, DOI 10.1161/CIRCULATIONAHA.105.535740; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Li F, 2002, AM J PHYSIOL-CELL PH, V283, pC917, DOI 10.1152/ajpcell.00517.2001; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V275, pF691, DOI 10.1152/ajprenal.1998.275.5.F691; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V271, pF477, DOI 10.1152/ajprenal.1996.271.3.F477; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Martin JL, 1999, GENE EXPRESSION, V7, P349; Martin JL, 1997, CIRCULATION, V96, P4343; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Munshi HG, 2002, J BIOL CHEM, V277, P38159, DOI 10.1074/jbc.M202384200; OESTERREICH S, 1993, CANCER RES, V53, P4443; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Price VR, 2002, J AM SOC NEPHROL, V13, P1152, DOI 10.1097/01.ASN.0000012609.22035.44; Ruchalski K, 2006, J BIOL CHEM, V281, P7873, DOI 10.1074/jbc.M513728200; Ruchalski K, 2003, AM J PHYSIOL-CELL PH, V285, pC1483, DOI 10.1152/ajpcell.00049.2003; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Schwartz JH, 1999, J AM SOC NEPHROL, V10, P2297; Sinha D, 2003, AM J PHYSIOL-RENAL, V284, pF488, DOI 10.1152/ajprenal.00172.2002; Somasiri A, 2000, DIFFERENTIATION, V66, P116, DOI 10.1046/j.1432-0436.2000.660206.x; Suga H, 2005, ARCH BIOCHEM BIOPHYS, V438, P137, DOI 10.1016/j.abb.2005.04.002; Ueda N, 2000, AM J MED, V108, P403, DOI 10.1016/S0002-9343(00)00311-9; Wang YH, 1999, KIDNEY INT, V55, P2224, DOI 10.1046/j.1523-1755.1999.00476.x; Wang YH, 1996, AM J PHYSIOL-RENAL, V270, pF1057, DOI 10.1152/ajprenal.1996.270.6.F1057; Wolfs TGAM, 2005, AM J TRANSPLANT, V5, P68, DOI 10.1111/j.1600-6143.2004.00657.x; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200	49	174	191	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12305	12313		10.1074/jbc.M801291200	http://dx.doi.org/10.1074/jbc.M801291200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18299320	hybrid, Green Published			2022-12-27	WOS:000255340000047
J	Koga, T; Lim, JH; Jono, H; Ha, UH; Xu, HD; Ishinaga, H; Morino, S; Xu, XB; Yan, C; Kai, H; Li, JD				Koga, Tomoaki; Lim, Jae Hyang; Jono, Hirofumi; Ha, Un Hwan; Xu, Haidong; Ishinaga, Hajime; Morino, Saori; Xu, Xiangbin; Yan, Chen; Kai, Hirofumi; Li, Jian-Dong			Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; DEUBIQUITINATING ENZYME CYLD; KAPPA-B ACTIVATION; T-CELL DEVELOPMENT; EPITHELIAL-CELLS; NUCLEAR-FACTOR; IKK-BETA; PNEUMOLYSIN; KINASE; EXPRESSION	Gram-positive bacterium Streptococcus pneumoniae is an important human pathogen that colonizes the upper respiratory tract and is also the major cause of morbidity and mortality worldwide. S. pneumoniae causes invasive diseases such as pneumonia, meningitis, and otitis media. Despite the importance of pneumococcal diseases, little is known about the molecular mechanisms by which S. pneumoniae-induced inflammation is regulated, especially the negative regulatory mechanisms. Here we show that S. pneumoniae activates nuclear factor of activated T cells ( NFAT) signaling pathway and the subsequent up-regulation of inflammatory mediators via a key pneumococcal virulence factor, pneumolysin. We also demonstrate that S. pneumoniae activates NFAT transcription factor independently of Toll-like receptors 2 and 4. Moreover, S. pneumoniae induces NFAT activation via both Ca2(+)-calcineurin and transforming growth factor-beta-activated kinase 1 (TAK1)-mitogen-activated protein kinase kinase (MKK) 3/6-p38 alpha/beta-dependent signaling pathways. Interestingly, we found for the first time that tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for S. pneumoniae-induced NFAT signaling pathway via a deubiquitination-dependent mechanism. Finally, we showed that CYLD interacts with and deubiquitinates TAK1 to negatively regulate the activation of the downstream MKK3/6p38 alpha/beta pathway. Our studies thus bring new insights into the molecular pathogenesis of S. pneumoniae infections through the NFAT-dependent mechanism and further identify CYLD as a negative regulator for NFAT signaling, thereby opening up new therapeutic targets for these diseases.	[Koga, Tomoaki; Lim, Jae Hyang; Jono, Hirofumi; Ha, Un Hwan; Xu, Haidong; Ishinaga, Hajime; Xu, Xiangbin; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Yan, Chen] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA; [Morino, Saori; Kai, Hirofumi] Kumamoto Univ, Dept Mol Med, Kumamoto 8620973, Japan	University of Rochester; University of Rochester; Kumamoto University	Li, JD (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Box 672,601 Elmwood Ave, Rochester, NY 14642 USA.	Jian-Dong_Li@URMC.Rochester.edu	Ha, Un-Hwan/ABH-8017-2020	Yan, Chen/0000-0002-1397-6358; Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077789, R01HL088400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL088400, P01 HL077789] Funding Source: Medline; NIDCD NIH HHS [DC004562, DC005843] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Amory-Rivier CF, 2000, CRIT CARE MED, V28, P3249, DOI 10.1097/00003246-200009000-00021; Arnold KE, 1996, J PEDIATR-US, V128, P757, DOI 10.1016/S0022-3476(96)70326-8; BENTON KA, 1995, INFECT IMMUN, V63, P448, DOI 10.1128/IAI.63.2.448-455.1995; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Braun JS, 2002, J CLIN INVEST, V109, P19; COURTOIS G, 2008, CELL MOL LIFE SCI; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Klugman KP, 2001, CURR OPIN INFECT DIS, V14, P173, DOI 10.1097/00001432-200104000-00011; Koga T, 2005, BIOCHEM BIOPH RES CO, V337, P1319, DOI 10.1016/j.bbrc.2005.09.184; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koga T, 2005, FEBS LETT, V579, P2811, DOI 10.1016/j.febslet.2005.04.015; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krutzik SR, 2001, CURR OPIN IMMUNOL, V13, P104, DOI 10.1016/S0952-7915(00)00189-8; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kweon SM, 2006, BIOCHEM BIOPH RES CO, V351, P368, DOI 10.1016/j.bbrc.2006.10.052; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Sakai A, 2007, FEBS J, V274, P3655, DOI 10.1111/j.1742-4658.2007.05899.x; Schmeck B, 2006, AM J PHYSIOL-LUNG C, V290, pL730, DOI 10.1152/ajplung.00271.2005; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Wheeler J, 1999, J MED MICROBIOL, V48, P863, DOI 10.1099/00222615-48-9-863; Xia Y, 2002, J BIOL CHEM, V277, P24601, DOI 10.1074/jbc.M201369200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	44	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12546	12554		10.1074/jbc.M710518200	http://dx.doi.org/10.1074/jbc.M710518200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332137	hybrid, Green Published			2022-12-27	WOS:000255340000071
J	Sam, KA; Fairhurst, SA; Thorneley, RNF; Allen, JWA; Ferguson, SJ				Sam, Katharine A.; Fairhurst, Shirley A.; Thorneley, Roger N. F.; Allen, James W. A.; Ferguson, Stuart J.			Pseudoazurin dramatically enhances the reaction profile of nitrite reduction by Paracoccus pantotrophus cytochrome cd(1) and facilitates release of product nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; THIOSPHAERA-PANTOTROPHA; ELECTRON-TRANSFER; D(1) HEME; INTERMEDIATE; SPECTROSCOPY; BINDING; ENZYME; DENITRIFICANS; REDUCTASES	Cytochrome cd(1) is a respiratory nitrite reductase found in the periplasm of denitrifying bacteria. When fully reduced Paracoccus pantotrophus cytochrome cd1 is mixed with nitrite in a stopped-flow apparatus in the absence of excess reductant, a kinetically stable complex of enzyme and product forms, assigned as a mixture of cFe(II) d(1)Fe(II)-NO+ and cFe(III)d1Fe(II)-NO (cd(1)-X). However, in order for the enzyme to achieve steady-state turnover, product (NO) release must occur. In this work, we have investigated the effect of a physiological electron donor to cytochrome cd(1), the copper protein pseudoazurin, on the mechanism of nitrite reduction by the enzyme. Our data clearly show that initially oxidized pseudoazurin causes rapid further turnover by the enzyme to give a final product that we assign as all-ferric cytochrome cd(1) with nitrite bound to the d(1) heme (i.e. from which NO had dissociated). Pseudoazurin catalyzed this effect even when present at only one-tenth the stoichiometry of cytochrome cd(1). In contrast, redox-inert zinc pseudoazurin did not affect cd(1)-X, indicating a crucial role for electron movement between monomers or individual enzyme dimers rather than simply a protein-protein interaction. Furthermore, formation of cd(1)-X was, remarkably, accelerated by the presence of pseudoazurin, such that it occurred at a rate consistent with cd(1)-X being an intermediate in the catalytic cycle. It is clear that cytochrome cd1 functions significantly differently in the presence of its two substrates, nitrite and electron donor protein, than in the presence of nitrite alone.	[Sam, Katharine A.; Allen, James W. A.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Fairhurst, Shirley A.; Thorneley, Roger N. F.] John Innes Inst, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk			Biotechnology and Biological Sciences Research Council [C19430, BB/D019753/1] Funding Source: Medline; BBSRC [BB/D019753/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Allen JWA, 2000, NAT STRUCT BIOL, V7, P885; Allen JWA, 2003, PHILOS T ROY SOC B, V358, P255, DOI 10.1098/rstb.2002.1192; Allen JWA, 2002, BIOCHEM J, V366, P883, DOI 10.1042/BJ20020795; Allen JWA, 2000, BIOCHEM BIOPH RES CO, V279, P674, DOI 10.1006/bbrc.2000.4009; Allen JWA, 2001, HDB METALLOPROTEINS; Capaldi AP, 1999, J MOL BIOL, V286, P1621, DOI 10.1006/jmbi.1998.2588; Cheesman MR, 1997, BIOCHEMISTRY-US, V36, P16267, DOI 10.1021/bi971677a; COYNE MS, 1990, J BACTERIOL, V172, P2558, DOI 10.1128/jb.172.5.2558-2562.1990; Cutruzzola F, 2001, P NATL ACAD SCI USA, V98, P2232, DOI 10.1073/pnas.041365298; Fry HC, 2003, J AM CHEM SOC, V125, P11866, DOI 10.1021/ja034911v; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; George SJ, 2000, J BIOL CHEM, V275, P33231, DOI 10.1074/jbc.M005033200; Gordon EHJ, 2003, J BIOL CHEM, V278, P11773, DOI 10.1074/jbc.M211886200; Jafferji A, 2000, J BIOL CHEM, V275, P25089, DOI 10.1074/jbc.M001377200; JOHNSON MK, 1980, BIOCHEM J, V189, P285, DOI 10.1042/bj1890285; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4028, DOI 10.1021/bi991912k; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4243, DOI 10.1021/bi000192a; Leung YC, 1997, BIOCHEM J, V321, P699, DOI 10.1042/bj3210699; MOIR JWB, 1993, EUR J BIOCHEM, V212, P377, DOI 10.1111/j.1432-1033.1993.tb17672.x; Pearson IV, 2003, J BACTERIOL, V185, P6308, DOI 10.1128/JB.185.21.6308-6315.2003; Richter CD, 2002, J BIOL CHEM, V277, P3093, DOI 10.1074/jbc.M108944200; Rinaldo S, 2007, BIOCHEM BIOPH RES CO, V363, P662, DOI 10.1016/j.bbrc.2007.09.036; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; SAM KA, 2007, THESIS U OXFORD; SILVESTRINI MC, 1992, BIOCHEM J, V285, P661, DOI 10.1042/bj2850661; Stevens JM, 2004, ACCOUNTS CHEM RES, V37, P999, DOI 10.1021/ar030266l; TIMKOVICH R, 1982, ARCH BIOCHEM BIOPHYS, V215, P47, DOI 10.1016/0003-9861(82)90277-6; Wang YN, 1996, J AM CHEM SOC, V118, P3972, DOI 10.1021/ja9538647; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; WILLIAMS PA, 1995, NAT STRUCT BIOL, V2, P975, DOI 10.1038/nsb1195-975; WU WS, 1987, J AM CHEM SOC, V109, P3149, DOI 10.1021/ja00244a050; Zajicek RS, 2005, J BIOL CHEM, V280, P26073, DOI 10.1074/jbc.M501890200; ZENNARO E, 1993, FEMS MICROBIOL LETT, V109, P243, DOI 10.1016/0378-1097(93)90027-Y; ZUMFT WG, 1988, ARCH MICROBIOL, V149, P492, DOI 10.1007/BF00446750	36	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12555	12563		10.1074/jbc.M800954200	http://dx.doi.org/10.1074/jbc.M800954200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310770	hybrid			2022-12-27	WOS:000255340000072
J	Boyle, JG; Logan, PJ; Ewart, MA; Reihill, JA; Ritchie, SA; Connell, JMC; Cleland, SJ; Salt, IP				Boyle, James G.; Logan, Pamela J.; Ewart, Marie-Ann; Reihill, James A.; Ritchie, Stuart A.; Connell, John M. C.; Cleland, Stephen J.; Salt, Ian P.			Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; UPSTREAM KINASE; SKELETAL-MUSCLE; PPAR-GAMMA; RAT-LIVER; PHOSPHORYLATION; LKB1; SYNTHASE; GLUCOSE; BETA	The thiazolidinedione anti-diabetic drugs increase activation of endothelial nitric-oxide (NO) synthase by phosphorylation at Ser-1177 and increase NO bioavailability, yet the molecular mechanisms that underlie this remain poorly characterized. Several protein kinases, including AMP-activated protein kinase, have been demonstrated to phosphorylate endothelial NO synthase at Ser-1177. In the current study we determined the role of AMP-activated protein kinase in rosiglitazone-stimulated NO synthesis. Stimulation of human aortic endothelial cells with rosiglitazone resulted in the time- and dose-dependent stimulation of AMP-activated protein kinase activity and NO production with concomitant phosphorylation of endothelial NO synthase at Ser-1177. Rosiglitazone stimulated an increase in the ADP/ATP ratio in endothelial cells, and LKB1 was essential for rosiglitazone-stimulated AMPK activity in HeLa cells. Infection of endothelial cells with a virus encoding a dominant negative AMP-activated protein kinase mutant abrogated rosiglitazone-stimulated Ser-1177 phosphorylation and NO production. Furthermore, the stimulation of AMP-activated protein kinase and NO synthesis by rosiglitazone was unaffected by the peroxisome proliferator-activated receptor-gamma inhibitor GW9662. These studies demonstrate that rosiglitazone is able to acutely stimulate NO synthesis in cultured endothelial cells by an AMP-activated protein kinase-dependent mechanism, likely to be mediated by LKB1.	[Boyle, James G.; Logan, Pamela J.; Ewart, Marie-Ann; Reihill, James A.; Ritchie, Stuart A.; Salt, Ian P.] Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Boyle, James G.; Ritchie, Stuart A.; Connell, John M. C.; Cleland, Stephen J.] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Salt, IP (corresponding author), Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	i.salt@bio.gla.ac.uk		Salt, Ian/0000-0003-0055-3724; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Reihill, James/0000-0001-8599-5198; s, hema/0000-0002-3440-9475	MRC [G84/6589, G0400874] Funding Source: UKRI; British Heart Foundation Funding Source: Medline; Medical Research Council [G84/6589, G0400874] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altarejos JY, 2005, J BIOL CHEM, V280, P183, DOI 10.1074/jbc.M411810200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calnek DS, 2003, ARTERIOSCL THROM VAS, V23, P52, DOI 10.1161/01.ATV.0000044461.01844.C9; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cho DH, 2004, J BIOL CHEM, V279, P2499, DOI 10.1074/jbc.M309451200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hetzel J, 2005, ARTERIOSCL THROM VAS, V25, P1804, DOI 10.1161/01.ATV.0000176192.16951.9a; Ignarro Louis J, 2005, Curr Diab Rep, V5, P17, DOI 10.1007/s11892-005-0062-8; Kim KA, 2004, BIOMED CHROMATOGR, V18, P613, DOI 10.1002/bmc.410; Kim KY, 2006, J BIOL CHEM, V281, P13503, DOI 10.1074/jbc.M510357200; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Kurebayashi S, 2005, ATHEROSCLEROSIS, V182, P71, DOI 10.1016/j.atherosclerosis.2005.02.004; Laight DW, 2000, CARDIOVASC RES, V47, P457, DOI 10.1016/S0008-6363(00)00054-7; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Natali A, 2004, DIABETES CARE, V27, P1349, DOI 10.2337/diacare.27.6.1349; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pistrosch F, 2004, DIABETES CARE, V27, P484, DOI 10.2337/diacare.27.2.484; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; REDDY KG, 1994, J AM COLL CARDIOL, V23, P833, DOI 10.1016/0735-1097(94)90627-0; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V368, P507, DOI 10.1042/BJ20021284; Satoh N, 2003, DIABETES CARE, V26, P2493, DOI 10.2337/diacare.26.9.2493; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; Uesugi T, 1997, J CHROMATOGR B, V703, P63, DOI 10.1016/S0378-4347(97)00430-1; Wang TD, 2004, AM J CARDIOL, V93, P362, DOI 10.1016/j.amjcard.2003.10.022; WILLIAMS SB, 1996, J AM COLL CARDIOL, V27, P564; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	46	77	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11210	11217		10.1074/jbc.M710048200	http://dx.doi.org/10.1074/jbc.M710048200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303014	hybrid			2022-12-27	WOS:000255067400016
J	Clemencon, B; Rey, M; Dianoux, AC; Trezeguet, R; Lauquin, GJM; Brandolin, G; Pelosi, L				Clemencon, Benjamin; Rey, Martial; Dianoux, Anne-Christine; Trezeguet, Ronique; Lauquin, Guy J. -M.; Brandolin, Gerard; Pelosi, Ludovic			Structure-function relationships of the C-terminal end of the Saccharomyces cerevisiae ADP/ATP carrier isoform 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-ATP CARRIER; ADENINE-NUCLEOTIDE CARRIER; CONFORMATIONAL-CHANGES; N-ETHYLMALEIMIDE; MATRIX LOOP; YEAST; MITOCHONDRIA; PROTEIN; MEMBRANE; RESIDUES	The adenine nucleotide carrier (Ancp) catalyzes the transport of ADP and ATP across the mitochondrial inner membrane, thus playing an essential role in the cellular energy metabolism. Two regions of Anc2p from Saccharomyces cerevisiae are specifically photolabeled using a photoactivable ADP derivative; they are the central matrix loop, m2, and the C-terminal end. To get more insights into the structure-function relationships of the C-terminal region during nucleotide transport, we have developed two independent approaches. In the first we have deleted the last eight amino acids of Anc2p (Anc2p Delta Cter) and demonstrated that the C-terminal end of Anc2p plays an essential role in yeast growth on a non-fermentable carbon source. This resulted from impaired nucleotide binding properties of the Anc2p Delta Cter variant in line with conversion of ADP binding sites from high to low affinity. In the second we probed the ligand-induced conformational changes of Anc2p C-terminal end (i) by assessing its accessibility to anti-C-terminal antibodies and (ii) by measuring intrinsic fluorescence changes of an Anc2p mutant containing only one tryptophan residue located at its C-terminal end (Anc2p3Y-u). We show that the C- terminal region is no further accessible to antibodies when Anc2p binds nontransportable analogues of ADP. Besides, Trp-316 fluorescence is highly increased upon ligand binding, suggesting large conformational changes. Taken together, our results highlight the involvement of the Anc2p C- terminal region in nucleotide recognition, binding, and transport.	[Clemencon, Benjamin; Rey, Martial; Dianoux, Anne-Christine; Brandolin, Gerard; Pelosi, Ludovic] Univ Grenoble 1, CNRS Commissariat Energie Atom, UMR 5092, Lab Biochem & Biophys Syst Integres,Inst Rech Tec, F-38054 Grenoble 9, France; [Trezeguet, Ronique; Lauquin, Guy J. -M.] Univ Bordeaux 2, Inst Biochim & Genet Cellulaires, CNRS, UMR 5095,Lab Physiol Mol & Cellulaire, F-33077 Bordeaux, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Pelosi, L (corresponding author), Univ Grenoble 1, CNRS Commissariat Energie Atom, UMR 5092, Lab Biochem & Biophys Syst Integres,Inst Rech Tec, F-38054 Grenoble 9, France.	ludovic.pelosi@cea.fr	Pelosi, Ludovic/AAB-9832-2020; Pelosi, Ludovic/M-6406-2014	Pelosi, Ludovic/0000-0002-4198-5681; Trezeguet, Veronique/0000-0003-2487-7571; Rey, Martial/0000-0002-7378-1106				Bamber L, 2007, J MOL BIOL, V371, P388, DOI 10.1016/j.jmb.2007.05.072; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; BLOCK MR, 1982, BIOCHEMISTRY-US, V21, P5451, DOI 10.1021/bi00265a011; BLOCK MR, 1984, BIOCHIM BIOPHYS ACTA, V767, P369, DOI 10.1016/0005-2728(84)90207-X; BLOCK MR, 1980, FEBS LETT, V117, P335, DOI 10.1016/0014-5793(80)80975-6; BOULAY F, 1984, BIOCHEMISTRY-US, V23, P4807, DOI 10.1021/bi00315a042; BRANDOLIN G, 1974, FEBS LETT, V46, P149, DOI 10.1016/0014-5793(74)80356-X; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Dahout-Gonzalez C, 2005, BIOCHEMISTRY-US, V44, P16310, DOI 10.1021/bi0514820; DALBON P, 1988, BIOCHEMISTRY-US, V27, P5141, DOI 10.1021/bi00414a029; DEMARCOS L, 2002, THESIS U  BORDEAUX 2; Dianoux AC, 2000, BIOCHEMISTRY-US, V39, P11477, DOI 10.1021/bi000618l; DRGON T, 1991, FEBS LETT, V289, P159, DOI 10.1016/0014-5793(91)81059-H; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hatanaka T, 2001, BIOCHEM BIOPH RES CO, V286, P936, DOI 10.1006/bbrc.2001.5498; Iwahashi A, 2006, MITOCHONDRION, V6, P245, DOI 10.1016/j.mito.2006.07.007; Kihira Y, 2005, BIOCHEMISTRY-US, V44, P184, DOI 10.1021/bi0488653; Kihira Y, 2004, BIOCHEMISTRY-US, V43, P15204, DOI 10.1021/bi0494222; Kihira Y, 2007, BIOL PHARM BULL, V30, P885, DOI 10.1248/bpb.30.885; KLINGENBERG M, 1978, BIOCHIM BIOPHYS ACTA, V503, P193, DOI 10.1016/0005-2728(78)90182-2; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2316, DOI 10.1021/bi00656a011; LeSaux A, 1996, BIOCHEMISTRY-US, V35, P16116, DOI 10.1021/bi961714i; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; MAYER I, 1984, BIOCHEMISTRY-US, V23, P2436, DOI 10.1021/bi00306a018; PASSARELLA S, 1988, BIOCHEM BIOPH RES CO, V156, P978, DOI 10.1016/S0006-291X(88)80940-9; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; SCHLIMME E, 1983, FEBS LETT, V155, P6, DOI 10.1016/0014-5793(83)80197-5; WEIDEMAN.MJ, 1970, EUR J BIOCHEM, V16, P313, DOI 10.1111/j.1432-1033.1970.tb01086.x	33	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11218	11225		10.1074/jbc.M709565200	http://dx.doi.org/10.1074/jbc.M709565200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299327	hybrid			2022-12-27	WOS:000255067400017
J	Gorshkova, I; He, D; Berdyshev, E; Usatuyk, P; Burns, M; Kalari, S; Zhao, Y; Pendyala, S; Garcia, JGN; Pyne, NJ; Brindley, DN; Natarajan, V				Gorshkova, Irina; He, Donghong; Berdyshev, Evgeny; Usatuyk, Peter; Burns, Michael; Kalari, Satish; Zhao, Yutong; Pendyala, Srikanth; Garcia, Joe G. N.; Pyne, Nigel J.; Brindley, David N.; Natarajan, Viswanathan			Protein kinase C-epsilon regulates sphingosine 1-phosphate-mediated migration of human lung endothelial cells through activation of phospholipase D2, protein kinase C-zeta, and Rac1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATE PHOSPHATASE-1; BRONCHIAL EPITHELIAL-CELLS; FOCAL ADHESION KINASE; SMOOTH-MUSCLE CELLS; HAMSTER OVARY CELLS; GROWTH-FACTOR; INTERLEUKIN-8 SECRETION; LYSOPHOSPHATIDIC ACID; SIGNALING PATHWAYS; MAMMALIAN-CELLS	The signaling pathways by which sphingosine 1-phosphate (S1P) potently stimulates endothelial cell migration and angiogenesis are not yet fully defined. We, therefore, investigated the role of protein kinaseC(PKC) isoforms, phospholipase D(PLD), and Rac in S1P-induced migration of human pulmonary artery endothelial cells (HPAECs). S1P-induced migration was sensitive to S1P(1) small interfering RNA (siRNA) and pertussis toxin, demonstrating coupling of S1P(1) to G(i). Overexpression of dominant negative (dn) PKC-epsilon or -zeta, but not PKC-alpha or -delta, blocked S1P-induced migration. Although S1P activated both PLD1 and PLD2, S1P-induced migration was attenuated by knocking down PLD2 or expressing dnPLD2 but not PLD1. Blocking PKC-epsilon, but not PKC-zeta, activity attenuated S1P-mediated PLD stimulation, demonstrating that PKC-epsilon, but not PKC-zeta, was upstream of PLD. Transfection of HPAECs with dnRac1 or Rac1 siRNA attenuated S1P-induced migration. Furthermore, transfection with PLD2 siRNA, infection of HPAECs with dnPKC-zeta, or treatment with myristoylated PKC-zeta peptide inhibitor abrogated S1P-induced Rac1 activation. These results establish that S1P signals through S1P1 and Gi to activate PKC-epsilon and, subsequently, a PLD2-PKC-zeta-Rac1 cascade. Activation of this pathway is necessary to stimulate the migration of lung endothelial cells, a key component of the angiogenic process.	[Gorshkova, Irina; He, Donghong; Berdyshev, Evgeny; Usatuyk, Peter; Burns, Michael; Kalari, Satish; Zhao, Yutong; Pendyala, Srikanth; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Pyne, Nigel J.] Univ Strathclyde, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland; [Brindley, David N.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Chicago; University of Strathclyde; University of Alberta	Natarajan, V (corresponding author), Univ Chicago, Dept Med, CIS Bldg,Rm W408B,929 E 57th St, Chicago, IL 60637 USA.	vnataraj@medicine.bsd.uchicago.edu	Kalari, Satish/C-6967-2012; Garcia, Joe GN/E-8862-2010	Pyne, Nigel/0000-0002-5657-4578	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079396] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL R01 79396] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; Boguslawski G, 2002, EXP CELL RES, V274, P264, DOI 10.1006/excr.2002.5472; Chaudhuri P, 2005, CIRC RES, V97, P674, DOI 10.1161/01.RES.0000184667.82354.b1; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Cross MJ, 1996, CURR BIOL, V6, P588, DOI 10.1016/S0960-9822(02)00545-6; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Donati C, 2006, BBA-BIOMEMBRANES, V1758, P2037, DOI 10.1016/j.bbamem.2006.06.015; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; English D, 1999, J HEMATOTH STEM CELL, V8, P627, DOI 10.1089/152581699319795; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; GORSHKOVA IA, 2005, FASEB J, V19; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Jaillard C, 2005, J NEUROSCI, V25, P1459, DOI 10.1523/JNEUROSCI.4645-04.2005; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; JONES GA, 1993, J BIOL CHEM, V268, P20845; Kanaho Y, 2007, METHOD ENZYMOL, V434, P155, DOI 10.1016/S0076-6879(07)34009-3; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Kishikawa K, 1999, J BIOL CHEM, V274, P21335, DOI 10.1074/jbc.274.30.21335; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lee OH, 2000, BIOCHEM BIOPH RES CO, V268, P47, DOI 10.1006/bbrc.2000.2087; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Li YS, 2004, EXP CELL RES, V298, P107, DOI 10.1016/j.yexcr.2004.03.023; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Long JS, 2006, PROSTAG OTH LIPID M, V80, P74, DOI 10.1016/j.prostaglandins.2006.05.001; Michel MC, 2007, ACTA PAEDIATR, V96, P44, DOI 10.1111/j.1651-2227.2007.00207.x; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OVERBECK AF, 1995, MOL REPROD DEV, V42, P468, DOI 10.1002/mrd.1080420415; Ozaki Harunobu, 2003, J Atheroscler Thromb, V10, P125; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Panetti TS, 2000, ARTERIOSCL THROM VAS, V20, P1013, DOI 10.1161/01.ATV.20.4.1013; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Porcelli AM, 2002, CELL SIGNAL, V14, P75, DOI 10.1016/S0898-6568(01)00222-4; Powner DJ, 2002, MOL BIOL CELL, V13, P1252, DOI 10.1091/mbc.01-05-0235; Pyne NJ, 2003, BIOCHEM SOC T, V31, P1220; Pyne S, 2000, PHARMACOL THERAPEUT, V88, P115, DOI 10.1016/S0163-7258(00)00084-X; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Shizukuda Y, 1999, CIRC RES, V85, P247, DOI 10.1161/01.RES.85.3.247; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; STASEK JE, 1993, BIOCHEM BIOPH RES CO, V191, P134, DOI 10.1006/bbrc.1993.1194; Thompson B, 2006, PROSTAG OTH LIPID M, V80, P15, DOI 10.1016/j.prostaglandins.2006.03.002; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; Usatyuk PV, 2006, J BIOL CHEM, V281, P35554, DOI 10.1074/jbc.M607305200; Wang F, 1999, EXP CELL RES, V247, P17, DOI 10.1006/excr.1998.4327; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Waters D, 2006, FASEB J, V20, pA1058; Yasui H, 2001, J BIOL CHEM, V276, P15298, DOI 10.1074/jbc.M008546200; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	76	45	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11794	11806		10.1074/jbc.M800250200	http://dx.doi.org/10.1074/jbc.M800250200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18296444	Green Published, hybrid			2022-12-27	WOS:000255067400079
J	Harayama, T; Shindou, H; Ogasawara, R; Suwabe, A; Shimizu, T				Harayama, Takeshi; Shindou, Hideo; Ogasawara, Rie; Suwabe, Akira; Shimizu, Takao			Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); FACTOR RECEPTOR; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; II CELLS; PAF; ACID; COA; ACETYLTRANSFERASE; PHOSPHORYLATION; INFLAMMATION	Platelet-activating factor (PAF) is a potent lipid mediator playing various inflammatory and physiological roles. PAF is biosynthesized through two independent pathways called the de novo and remodeling pathways. Lyso-PAF acetyltransferase (lyso-PAF AT) was believed to biosynthesize PAF under inflammatory conditions, through the remodeling pathway. The first isolated lyso-PAF AT (LysoPAFAT/LPCAT2) had consistent properties. However, we show in this study the finding of a second lyso-PAF AT working under noninflammatory conditions. We partially purified a Ca2+-independent lyso-PAF AT from mouse lung. Immunoreactivity for lysophosphatidylcholine acyltransferase 1 (LPCAT1) was detected in the active fraction. Lpcat1-transfected Chinese hamster ovary cells exhibited both LPCAT and lyso-PAF AT activities. We confirmed that LPCAT1 transfers acetate from acetyl-CoA to lyso-PAF by the identification of an acetyl-CoA (and other acyl-CoAs) interacting site in LPCAT1. We further showed that LPCAT1 activity and expression are independent of inflammatory signals. Therefore, these results suggest the molecular diversity of lyso-PAF ATs is as follows: one (LysoPAFAT/LPCAT2) is inducible and activated by inflammatory stimulation, and the other (LPCAT1) is constitutively expressed. Each lyso-PAF AT biosynthesizes inflammatory and physiological amounts of PAF, depending on the cell type. These findings provide important knowledge for the understanding of the diverse pathological and physiological roles of PAF.	[Harayama, Takeshi; Shindou, Hideo; Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Ogasawara, Rie; Suwabe, Akira] Iwate Med Univ, Sch Med, Dept Lab Med, Morioka, Iwate 0208505, Japan	University of Tokyo; Iwate Medical University	Shimizu, T (corresponding author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tshimizu@m.u-tokyo.ac.jp	Harayama, Takeshi/AAD-8852-2022; Shimizu, Takao/AAV-7052-2021	Harayama, Takeshi/0000-0003-2255-4197; 				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; AMMIT AJ, 1992, HUM REPROD, V7, P865, DOI 10.1093/oxfordjournals.humrep.a137751; BILLAH MM, 1983, BIOCHEM BIOPH RES CO, V113, P51, DOI 10.1016/0006-291X(83)90430-8; Chen C, 2001, J NEUROPHYSIOL, V85, P384, DOI 10.1152/jn.2001.85.1.384; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Dircks LK, 1999, J BIOL CHEM, V274, P34728, DOI 10.1074/jbc.274.49.34728; DOBBS LG, 1979, J CLIN INVEST, V63, P378, DOI 10.1172/JCI109313; DOMENECH C, 1987, J BIOL CHEM, V262, P5671; GOMEZCAMBRONERO J, 1985, BIOCHIM BIOPHYS ACTA, V845, P511, DOI 10.1016/0167-4889(85)90218-6; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Harrison KA, 1999, J MASS SPECTROM, V34, P330, DOI 10.1002/(SICI)1096-9888(199904)34:4<330::AID-JMS798>3.0.CO;2-#; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMAN DR, 1988, J BIOL CHEM, V263, P9316; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; Ishii S, 2004, J IMMUNOL, V172, P7095, DOI 10.4049/jimmunol.172.11.7095; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Iyer PP, 2001, J BACTERIOL, V183, P4244, DOI 10.1128/JB.183.14.4244-4250.2001; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kihara Y, 2005, J EXP MED, V202, P853, DOI 10.1084/jem.20050660; KING MT, 1985, ANAL BIOCHEM, V146, P173, DOI 10.1016/0003-2697(85)90412-9; KRAUSZ C, 1994, HUM REPROD, V9, P471, DOI 10.1093/oxfordjournals.humrep.a138529; Kume K, 1997, ANAL BIOCHEM, V246, P118, DOI 10.1006/abio.1996.9959; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; MONTRUCCHIO G, 1986, PROSTAGLANDINS, V32, P539, DOI 10.1016/0090-6980(86)90036-5; Nagase T, 1999, J CLIN INVEST, V104, P1071, DOI 10.1172/JCI7727; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; O'Neill C, 2005, HUM REPROD UPDATE, V11, P215, DOI 10.1093/humupd/dmi003; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Schmitz F, 2004, EUR J IMMUNOL, V34, P2863, DOI 10.1002/eji.200425228; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; SNYDER F, 1995, BBA-LIPID LIPID MET, V1254, P231, DOI 10.1016/0005-2760(94)00192-2; Syrbu SI, 1999, J IMMUNOL, V162, P2334; WYKLE RL, 1980, J BIOL CHEM, V255, P256; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; ZHU YP, 1991, BIOL REPROD, V44, P39, DOI 10.1095/biolreprod44.1.39; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	43	95	99	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11097	11106		10.1074/jbc.M708909200	http://dx.doi.org/10.1074/jbc.M708909200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18285344	hybrid			2022-12-27	WOS:000255067400005
J	Sotillo, E; Garriga, J; Kurimchak, A; Grana, X				Sotillo, Elena; Garriga, Judit; Kurimchak, Alison; Grana, Xavier			Cyclin E and SV40 small t antigen cooperate to bypass quiescence and contribute to transformation by activating CDK2 in human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR TFIIH; HUMAN CELL-TRANSFORMATION; SMALL TUMOR-ANTIGEN; DEPENDENT KINASE; MODULATES PHOSPHORYLATION; PHASE-TRANSITION; UBIQUITIN LIGASE; GENE-EXPRESSION; S-PHASE; MYC	Cyclin E overexpression is observed in multiple human tumors and linked to poor prognosis. We have previously shown that ectopic expression of cyclin E is sufficient to induce mitogen independent cell cycle entry in a variety of tumor/immortal cell lines. Here we have investigated the rate-limiting step leading to cell cycle entry in quiescent normal human fibroblasts (NHF) ectopically expressing cyclin E. We found that in serum-starved NHF, cyclin E forms inactive complexes with CDK2 and fails to induce DNA synthesis. Coexpression of SV40 small t antigen (st), but not other tested oncogenes, efficiently induces mitogen-independent CDK2 phosphorylation on Thr-160, CDK2 activation, and DNA synthesis. Additionally, in contact-inhibited NHF ectopically expressing cyclin E, st induces cell cycle entry, continued proliferation, and foci formation. Coexpression of cyclin E and st also bypasses G(0)/G(1) arrests induced by CDK inhibitors. Although CDK2 is dispensable for G(0)/G(1) cell cycle entry and normal proliferation in mammals, CDK2 activity is an essential rate-limiting step in NHF with deregulated cyclin E expression and altered PP2A activity, which endows primary cells with transformed features. Consequently, CDK2 could be targeted therapeutically in tumors that involve these alterations. These data also suggest that alterations prior to cyclin E deregulation facilitate proliferation of tumor cells by bypassing mitogenic requirements and negative regulation by adjacent cells.	[Sotillo, Elena; Garriga, Judit; Kurimchak, Alison; Grana, Xavier] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Kurimchak, Alison; Grana, Xavier] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Grana, X (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, AHP Bldg Rm 308,3307 N Broad St, Philadelphia, PA 19140 USA.	xavier@temple.edu		Grana, Xavier/0000-0001-7134-0473; Sotillo, Elena/0000-0002-3993-1932	NCI NIH HHS [R24 CA88261-01, CA095569] Funding Source: Medline; NIAID NIH HHS [KO2 AI01823] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095569, R24CA088261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI001823] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; APRELIKOVA O, 1995, J BIOL CHEM, V270, P18195, DOI 10.1074/jbc.270.31.18195; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Calbo J, 2002, J BIOL CHEM, V277, P50263, DOI 10.1074/jbc.M209181200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; DEVAULT A, 1995, EMBO J, V14, P5027, DOI 10.1002/j.1460-2075.1995.tb00185.x; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; FISHER RP, 1995, CELL, V83, P47, DOI 10.1016/0092-8674(95)90233-3; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Garriga J, 2004, CELL CYCLE, V3, P1320, DOI 10.4161/cc.3.10.1183; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Haas K, 1997, ONCOGENE, V15, P2615, DOI 10.1038/sj.onc.1201434; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; Karsunky H, 1999, ONCOGENE, V18, P7816, DOI 10.1038/sj.onc.1203205; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Macias E, 2007, CANCER RES, V67, P9713, DOI 10.1158/0008-5472.CAN-07-2119; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Moreno CS, 2004, CANCER RES, V64, P6978, DOI 10.1158/0008-5472.CAN-04-1150; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1996, CURR OPIN CELL BIOL, V8, P767, DOI 10.1016/S0955-0674(96)80076-7; MUNGRE S, 1994, J VIROL, V68, P1675, DOI 10.1128/JVI.68.3.1675-1681.1994; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parreno M, 2001, ONCOGENE, V20, P4793, DOI 10.1038/sj.onc.1204644; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; Rank KB, 2000, BIOCHEM BIOPH RES CO, V271, P469, DOI 10.1006/bbrc.2000.2648; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; Spruck C, 2006, CANCER RES, V66, P7355, DOI 10.1158/0008-5472.CAN-05-3240; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; YU DH, 1994, CELL GROWTH DIFFER, V5, P431	55	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11280	11292		10.1074/jbc.M709055200	http://dx.doi.org/10.1074/jbc.M709055200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18276582	hybrid, Green Published			2022-12-27	WOS:000255067400024
J	Merkouropoulos, G; Andreasson, E; Hess, D; Boller, T; Peck, SC				Merkouropoulos, Georgios; Andreasson, Erik; Hess, Daniel; Boller, Thomas; Peck, Scott C.			An Arabidopsis protein phosphorylated in response to microbial elicitation, AtPHOS32, is a substrate of MAP kinases 3 and 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNIVERSAL STRESS-PROTEIN; BACTERIAL ELICITOR FLAGELLIN; PLASMA-MEMBRANE; INNATE IMMUNITY; KINASE; PLANTS; THALIANA; PERCEPTION; CASCADES; ANIMALS	Although mitogen-activated protein kinases (MAPKs) have been shown to be activated by a wide range of biotic and abiotic stimuli in diverse plant species, few in vivo substrates for these kinases have been identified. While studying proteins that are differentially phosphorylated upon treatment of Arabidopsis suspension cultures with the general bacterial elicitor peptide flagellin-22 (flg22), we identified two proteins with endogenous nickel binding properties that become phosphorylated after flg22 elicitation. These highly related proteins, AtPHOS32 and AtPHOS34, show similarity to bacterial universal stress protein A. We identified one of the phosphorylation sites on AtPHOS32 by nanoelectrospray ionization tandem mass spectrometry. Phosphorylation in a phosphoSer-Pro motif indicated that this protein may be a substrate of MAPKs. Using in vitro kinase assays, we confirmed that AtPHOS32 is a substrate of both AtMPK3 and AtMPK6. Specificity of phosphorylation was demonstrated by site-directed mutagenesis of the first phosphorylation site. In addition, immunosubtraction of both MAPKs from protein extracts removed detectable kinase activity toward AtPHOS32, indicating that the two MAPKs were the predominate kinases recognizing the motif in this protein. Finally, the target phosphorylation site in AtPHOS32 is conserved in AtPHOS34 and among apparent orthologues from many plant species, indicating that phosphorylation of these proteins by AtMPK3 and AtMPK6 orthologues has been conserved throughout evolution.	[Merkouropoulos, Georgios; Andreasson, Erik; Peck, Scott C.] John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Hess, Daniel] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Boller, Thomas] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Friedrich Miescher Institute for Biomedical Research; University of Basel	Peck, SC (corresponding author), Univ Missouri, 271H Bond Life Sci Ctr, Columbia, MO 65211 USA.	pecks@missouri.edu	Boller, Thomas/G-3500-2012	Boller, Thomas/0000-0001-6768-7503; Andreasson, Erik/0000-0003-0666-7204	Biotechnology and Biological Sciences Research Council [p15616] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Kerk D, 2003, PLANT PHYSIOL, V131, P1209, DOI 10.1104/pp.102.016006; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Nuhse TS, 2003, J BIOL CHEM, V278, P45248, DOI 10.1074/jbc.M307443200; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Peck SC, 2003, CURR OPIN PLANT BIOL, V6, P334, DOI 10.1016/S1369-5266(03)00056-6; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sousa MC, 2001, STRUCTURE, V9, P1135, DOI 10.1016/S0969-2126(01)00680-3; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	24	57	63	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10493	10499		10.1074/jbc.M800735200	http://dx.doi.org/10.1074/jbc.M800735200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18285339	hybrid			2022-12-27	WOS:000254894700031
J	Wang, Z; Zhang, BC; Yang, LQ; Ding, J; Ding, HF				Wang, Zhe; Zhang, Baochun; Yang, Liqun; Ding, Jane; Ding, Han-Fei			Constitutive production of NF-kappa B2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing bim expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN BREAST-CANCER; FAMILY-MEMBER BIM; TRANSCRIPTION FACTOR; CELL-DEATH; APOPTOSIS; GENE; ACTIVATION; RESPONSES; PATHWAYS	Normal development of the immune system requires regulated processing of NF-kappa B2 p100 to p52, which activates NF-kappa B2 signaling. Constitutive production of p52 has been suggested as a major mechanism underlying lymphomagenesis induced by NF-kappa B2 mutations, which occur recurrently in a variety of human lymphoid malignancies. To test the hypothesis, we generated transgenic mice with targeted expression of p52 in lymphocytes. In contrast to their counterparts expressing the tumor-derived NF-kappa B2 mutant p80HT, which develop predominantly B cell tumors, p52 transgenic mice are not prone to lymphomagenesis. However, they are predisposed to inflammatory autoimmune disease characterized by multiorgan infiltration of activated lymphocytes, high levels of autoantibodies in the serum, and immune complex glomerulonephritis. p52, but not p80HT, represses Bim expression, leading to defects in apoptotic processes critical for elimination of autoreactive lymphocytes and control of immune response. These findings reveal distinct signaling pathways for actions of NF-kappa B2 mutants and p52 and suggest a causal role for sustained NF-kappa B2 activation in the pathogenesis of autoimmunity.	[Wang, Zhe; Zhang, Baochun; Yang, Liqun; Ding, Jane; Ding, Han-Fei] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA	University System of Ohio; University of Toledo	Ding, HF (corresponding author), Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Hlth Sci Campus,BHSB 461,3035 Arlington Ave, Toledo, OH 43614 USA.	han-fei.ding@utoledo.edu		Ding, Han-Fei/0000-0001-5702-3439; Zhang, Baochun/0000-0003-1759-1161	NATIONAL CANCER INSTITUTE [R01CA106550] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106550] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; BOURS V, 1994, BIOCHEM PHARMACOL, V47, P145, DOI 10.1016/0006-2952(94)90448-0; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; CHANG CC, 1995, MOL CELL BIOL, V15, P5180; CHANG CC, 1994, ONCOGENE, V9, P923; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DEJARDIN E, 1995, ONCOGENE, V11, P1835; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, BIOCHEM BIOPH RES CO, V308, P744, DOI 10.1016/S0006-291X(03)01474-8; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Epinat JC, 2000, ONCOGENE, V19, P599, DOI 10.1038/sj.onc.1203376; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; HASBOLD J, 1990, EUR J IMMUNOL, V20, P1685, DOI 10.1002/eji.1830200810; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim KE, 2000, ONCOGENE, V19, P1334, DOI 10.1038/sj.onc.1203432; MIGLIAZZA A, 1994, BLOOD, V84, P3850, DOI 10.1182/blood.V84.11.3850.bloodjournal84113850; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; Qing GL, 2007, P NATL ACAD SCI USA, V104, P5324, DOI 10.1073/pnas.0609914104; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; THAKUR S, 1994, ONCOGENE, V9, P2335; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang YQ, 2002, NAT CELL BIOL, V4, P888, DOI 10.1038/ncb872; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zapata JM, 2007, ADV EXP MED BIOL, V597, P188; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446; Zhang BC, 2006, J BIOL CHEM, V281, P38617, DOI 10.1074/jbc.M606705200; ZHANG JD, 1994, ONCOGENE, V9, P1931	50	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10698	10706		10.1074/jbc.M800806200	http://dx.doi.org/10.1074/jbc.M800806200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281283	Green Published, hybrid			2022-12-27	WOS:000254894700052
J	Zhang, HF; Bosch-Marce, M; Shimoda, LA; Tan, YS; Baek, JH; Wesley, JB; Gonzalez, FJ; Semenza, GL				Zhang, Huafeng; Bosch-Marce, Marta; Shimoda, Larissa A.; Tan, Yee Sun; Baek, Jin Hyen; Wesley, Jacob B.; Gonzalez, Frank J.; Semenza, Gregg L.			Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; BH3-ONLY PROTEIN; GENE-EXPRESSION; COMPLEX-III; HIF-1; OXYGEN; TRANSCRIPTION; PATHWAY; FACTOR-1-ALPHA; HIF-1-ALPHA	Autophagy is a process by which cytoplasmic organelles can be catabolized either to remove defective structures or as a means of providing macromolecules for energy generation under conditions of nutrient starvation. In this study we demonstrate that mitochondrial autophagy is induced by hypoxia, that this process requires the hypoxia-dependent factor-1-dependent expression of BNIP3 and the constitutive expression of Beclin-1 and Atg5, and that in cells subjected to prolonged hypoxia, mitochondrial autophagy is an adaptive metabolic response which is necessary to prevent increased levels of reactive oxygen species and cell death.	[Zhang, Huafeng; Bosch-Marce, Marta; Tan, Yee Sun; Baek, Jin Hyen; Wesley, Jacob B.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Zhang, Huafeng; Bosch-Marce, Marta; Tan, Yee Sun; Baek, Jin Hyen; Wesley, Jacob B.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Shimoda, Larissa A.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Natl Inst Hlth, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Semenza, GL (corresponding author), Broadway Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Zhang, Huafeng/A-7188-2012		NATIONAL CANCER INSTITUTE [P50CA103175, ZIABC005708] Funding Source: NIH RePORTER; NCI NIH HHS [P50-CA103175] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bohensky J, 2007, AUTOPHAGY, V3, P207, DOI 10.4161/auto.3708; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Dann CE, 2005, BIOCHEM BIOPH RES CO, V338, P639, DOI 10.1016/j.bbrc.2005.08.140; DECKER RS, 1980, AM J PATHOL, V98, P425; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Feldser D, 1999, CANCER RES, V59, P3915; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Lee MJ, 2004, MOL CELL BIOL, V24, P3918, DOI 10.1128/MCB.24.9.3918-3927.2004; LEHNIGER AL, 1975, BIOCHEMISTRY; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melillo G, 2004, CELL CYCLE, V3, P154; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Sowter HM, 2001, CANCER RES, V61, P6669; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yim SH, 2006, HEPATOLOGY, V44, P550, DOI 10.1002/hep.21284; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	45	1213	1268	7	116	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10892	10903		10.1074/jbc.M800102200	http://dx.doi.org/10.1074/jbc.M800102200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281291	hybrid, Green Published			2022-12-27	WOS:000254894700071
J	Pasic, L; Kotova, T; Schafer, DA				Pasic, Lejla; Kotova, Tatyana; Schafer, Dorothy A.			Ena/VASP proteins capture actin filament barbed ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; CAPPING PROTEIN; ADP-ACTIN; F-ACTIN; BINDING; PROFILIN; POLYMERIZATION; MONOMERS; FORMIN; LOCALIZATION	Ena/VASP (vasodialator-stimulated protein) proteins regulate many actin-dependent events, including formation of protrusive structures, fibroblast migration, neurite extension, cell-cell adhesion, and Listeria pathogenesis. In vitro, Ena/VASP activities on actin are complex and varied. They promote actin assembly, protect filaments from cappers, bundle filaments, and inhibit filament branching. To determine the mechanisms by which Ena/VASP proteins regulate actin dynamics at barbed ends, we monitored individual actin filaments growing in the presence of VASP and profilin using total internal reflection fluorescence microscopy. Filament growth was unchanged by VASP, but filaments grew faster in profilin-actin and VASP than with profilin-actin alone. Actin filaments were captured directly by VASP-coated surfaces via interactions with growing barbed ends. End-attached filaments transiently paused but resumed growth after becoming bound to the surface via a filament side attachment. Thus, Ena/VASP proteins promote actin assembly by interacting directly with actin filament barbed ends, recruiting profilin-actin, and blocking capping.	[Pasic, Lejla; Kotova, Tatyana; Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia	Schafer, DA (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall,McCormick Rd, Charlottesville, VA 22901 USA.	das9w@virginia.edu			NIGMS NIH HHS [R01 GM 067222] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067222] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Chereau D, 2006, J STRUCT BIOL, V155, P195, DOI 10.1016/j.jsb.2006.01.012; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Kang F, 1997, BIOCHEMISTRY-US, V36, P8384, DOI 10.1021/bi970065n; Kim K, 2007, J BIOL CHEM, V282, P5871, DOI 10.1074/jbc.M609850200; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Kuhn JR, 2007, J BIOL CHEM, V282, P28014, DOI 10.1074/jbc.M705287200; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191; Schirenbeck A, 2005, BIOCHEM SOC T, V33, P1256, DOI 10.1042/BST0331256; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417	38	70	72	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9814	9819		10.1074/jbc.M710475200	http://dx.doi.org/10.1074/jbc.M710475200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18283104	hybrid, Green Published			2022-12-27	WOS:000254671600036
J	Smith, AE; Hurd, PJ; Bannister, AJ; Kouzarides, T; Ford, KG				Smith, Alexander E.; Hurd, Paul J.; Bannister, Andrew J.; Kouzarides, Tony; Ford, Kevin G.			Heritable gene repression through the action of a directed DNA methyltransferase at a chromosomal locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE METHYLATION; EXPRESSION; CELLS; REPLICATION; SEQUENCES; PROMOTER; SETDB1	The ability to exogenously impose targeted epigenetic changes in the genome represents an attractive route for the simulation of genomic de novo epigenetic events characteristic of some diseases and for the study of their downstream effects and also provides a potential therapeutic approach for the heritable repression of selected genes. Here we demonstrate for the first time the ability of zinc finger peptides to deliver DNA cytosine methylation in vivo to a genomic integrated target promoter when expressed as fusions with a mutant prokaryotic DNA cytosine methyltransferase enzyme, thus mimicking cellular genomic de novo methylation events and allowing a direct analysis of the mechanics of de novo DNA methylation-mediated gene silencing at a genomic locus. We show that targeted methylation leads to gene silencing via the initiation of a repressive chromatin signature at the targeted genomic locus. This repression is maintained after the loss of targeted methyltransferase enzyme from the cell, confirming epigenetic maintenance purely through the action of cellular enzymes. The inherited DNA methylation pattern is restricted only to targeted sites, suggesting that the establishment of repressive chromatin structure does not drive further de novo DNA methylation in this system. As well as demonstrating the potential of these enzymes as tools for the exogenous, heritable control of cellular gene expression, this work also provides the most definitive confirmation to date for a transcriptionally repressive role for de novo DNA methylation in the cell and lends some weight to the hypothesis that the aberrant methylation associated with certain diseases may well be a cause rather than a consequence of transcriptional gene repression.	[Smith, Alexander E.; Ford, Kevin G.] Kings Coll London, Rayne Inst, Dept Haematol Med, London SE5 9NU, England; [Smith, Alexander E.; Ford, Kevin G.] St Thomas Sch Med, London SE5 9NU, England; [Hurd, Paul J.; Bannister, Andrew J.; Kouzarides, Tony] Univ Cambridge, Wellcome Trust & Canc Res UK Gardon Inst Canc & D, Cambridge CB2 1QN, England; [Hurd, Paul J.; Bannister, Andrew J.; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England	University of London; King's College London; University of London; King's College London; University of Cambridge; University of Cambridge	Ford, KG (corresponding author), Kings Coll London, Rayne Inst, Dept Haematol Med, 123 Coldharbour Lane, London SE5 9NU, England.	kevin.ford@kcl.ac.uk		Kouzarides, Tony/0000-0002-8918-4162; Hurd, Paul/0000-0003-1112-9347; Bannister, Andrew/0000-0002-6312-4436	Biotechnology and Biological Sciences Research Council [47/GTH12521] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Choo Y, 1997, J MOL BIOL, V273, P525, DOI 10.1006/jmbi.1997.1339; CHOO Y, 1994, NATURE, V372, P642, DOI 10.1038/372642a0; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Ishii T, 2004, CANCER LETT, V212, P211, DOI 10.1016/j.canlet.2004.03.001; Jamieson AC, 2003, NAT REV DRUG DISCOV, V2, P361, DOI 10.1038/nrd1087; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Liang GG, 2002, METHODS, V27, P150, DOI 10.1016/S1046-2023(02)00068-3; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; McNamara AR, 2000, NUCLEIC ACIDS RES, V28, P4865, DOI 10.1093/nar/28.24.4865; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Park CW, 2004, BIOCHEM BIOPH RES CO, V323, P275, DOI 10.1016/j.bbrc.2004.08.096; Quesnel B, 1998, BLOOD, V91, P2985, DOI 10.1182/blood.V91.8.2985.2985_2985_2990; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith AEF, 2005, BIOL CHEM, V386, P95, DOI 10.1515/BC.2005.012; Smith AE, 2007, NUCLEIC ACIDS RES, V35, P740, DOI 10.1093/nar/gkl1053; Spada F, 2006, ADV ENZYME REGUL, V46, P224, DOI 10.1016/j.advenzreg.2006.01.011; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Svoboda P, 2004, NUCLEIC ACIDS RES, V32, P3601, DOI 10.1093/nar/gkh697; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Yao XM, 2003, J CLIN INVEST, V111, P265, DOI 10.1172/JCI200315109; ZION M, 1994, P NATL ACAD SCI USA, V91, P10722, DOI 10.1073/pnas.91.22.10722	40	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9878	9885		10.1074/jbc.M710393200	http://dx.doi.org/10.1074/jbc.M710393200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18272522	hybrid			2022-12-27	WOS:000254671600044
J	Malakhova, OA; Zhang, DE				Malakhova, Oxana A.; Zhang, Dong-Er			ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GENE-15; IN-VIVO; PROTEIN; RELEASE; IDENTIFICATION; UBIQUITYLATION; INTERFERONS; CONJUGATION; EXPRESSION; INFLUENZA	Interferons regulate diverse immune functions through the transcriptional activation of hundreds of genes involved in antiviral responses. The interferon-inducible ubiquitin-like protein ISG15 is expressed in cells in response to a variety of stress conditions like viral or bacterial infection and is present in its free form or is conjugated to cellular proteins. In addition, protein ubiquitination plays a regulatory role in the immune system. Many viruses modulate the ubiquitin (Ub) pathway to alter cellular signaling and the antiviral response. Ubiquitination of retroviral group-specific antigen precursors and matrix proteins of the Ebola, vesicular stomatitis, and rabies viruses by Nedd4 family HECT domain E3 ligases is an important step in facilitating viral release. We found that Nedd4 is negatively regulated by ISG15. Free ISG15 specifically bound to Nedd4 and blocked its interaction with Ub-E2 molecules, thus preventing further Ub transfer from E2 to E3. Furthermore, overexpression of ISG15 diminished the ability of Nedd4 to ubiquitinate viral matrix proteins and led to a decrease in the release of Ebola VP40 virus-like particles from the cells. These results point to a mechanistically novel function of ISG15 in the enhancement of the innate antiviral response through specific inhibition of Nedd4 Ub-E3 activity. To our knowledge, this is the first example of a Ub-like protein with the ability to interfere with Ub-E2 and E3 interaction to inhibit protein ubiquitination.	[Zhang, Dong-Er] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Malakhova, Oxana A.; Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute	Zhang, DE (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, Rm 5328,Mail Stop 0815,3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	d7zhang@ucsd.edu			NATIONAL CANCER INSTITUTE [R01CA079849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066955] Funding Source: NIH RePORTER; NCI NIH HHS [CA 079849] Funding Source: Medline; NIGMS NIH HHS [GM 066955] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; DCunha J, 1996, J IMMUNOL, V157, P4100; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Narasimhan J, 1996, J BIOL CHEM, V271, P324, DOI 10.1074/jbc.271.1.324; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Timmins J, 2001, VIROLOGY, V283, P1, DOI 10.1006/viro.2001.0860; WARD CL, 1995, CELL, V83, P12; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	27	144	153	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8783	8787		10.1074/jbc.C800030200	http://dx.doi.org/10.1074/jbc.C800030200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18287095	Green Published, hybrid			2022-12-27	WOS:000254465800003
J	Khan, AA; Hanada, T; Mohseni, M; Jeong, JJ; Zeng, LX; Gaetani, M; Li, DH; Reed, BC; Speicher, DW; Chishti, AH				Khan, Anwar A.; Hanada, Toshihiko; Mohseni, Morvarid; Jeong, Jong-Jin; Zeng, Lixiao; Gaetani, Massimiliano; Li, Donghai; Reed, Brent C.; Speicher, David W.; Chishti, Athar H.			Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELL; GLUCOSE-TRANSPORTER GLUT1; ACTIN-BINDING DOMAIN; GLYCOPHORIN-C; BETA-ADDUCIN; PROTEIN 4.1; SKELETAL PROTEIN-4.1; DEFICIENCY SYNDROME; STABILITY; COMPLEX	Dematin and adducin are actin-binding proteins located at the spectrin-actin junctions, also called the junctional complex, in the erythrocyte membrane. Here we propose a new model whereby dematin and adducin link the junctional complex to human erythrocyte plasma membrane. Using a combination of surface labeling, immunoprecipitation, and vesicle proteomics approaches, we have identified glucose transporter-1 as the receptor for dematin and adducin in the human erythrocyte membrane. This finding is the first description of a transmembrane protein that binds to dematin and adducin, thus providing a rationale for the attachment of the junctional complex to the lipid bilayer. Because homologues of dematin, adducin, and glucose transporter-1 exist in many non-erythroid cells, we propose that a conserved mechanism may exist that couples sugar and other related transporters to the actin cytoskeleton.	[Khan, Anwar A.; Hanada, Toshihiko; Mohseni, Morvarid; Jeong, Jong-Jin; Zeng, Lixiao; Chishti, Athar H.] Univ Illinois, Ctr Canc, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Gaetani, Massimiliano; Li, Donghai; Speicher, David W.] Wistar Inst Anat & Biol, Syst Biol Div, Philadelphia, PA 19104 USA; [Reed, Brent C.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; The Wistar Institute; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Chishti, AH (corresponding author), Univ Illinois, Ctr Canc, Dept Pharmacol, Coll Med, MC-704,909 S Wolcott Ave, Chicago, IL 60612 USA.	chishti@uic.edu	Gaetani, Massimiliano/Z-1252-2019	Gaetani, Massimiliano/0000-0001-5610-0797	NHLBI NIH HHS [HL 38794, HL 051445, R01 HL038794] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL051445, R01HL051445, R01HL038794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; BALDWIN SA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P17, DOI 10.1016/0304-4157(93)90015-G; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Boukharov AA, 1998, BIOCHEM J, V330, P1391, DOI 10.1042/bj3301391; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Chang SH, 2001, J BIOL CHEM, V276, P22223, DOI 10.1074/jbc.M100604200; CHASIS JA, 1992, BLOOD, V80, P1869; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; Chishti A H, 1998, Curr Opin Hematol, V5, P116; CHISHTI AH, 1988, NATURE, V334, P718; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; DAS AK, 1994, EUR J BIOCHEM, V224, P575, DOI 10.1111/j.1432-1033.1994.00575.x; DERICK LH, 1992, EUR J CELL BIOL, V57, P317; DISCHER D, 1993, J BIOL CHEM, V268, P7186; DISCHER DE, 1995, J CELL BIOL, V130, P897, DOI 10.1083/jcb.130.4.897; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; GILLIGAN DM, 1993, SEMIN HEMATOL, V30, P74; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Heilig C, 2003, AM J PATHOL, V163, P1873, DOI 10.1016/S0002-9440(10)63546-8; HEMMING NJ, 1994, BIOCHEM J, V299, P191, DOI 10.1042/bj2990191; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Huang S, 2001, EUR J CLIN INVEST, V31, P907, DOI 10.1046/j.1365-2362.2001.00892.x; IZUMO A, 1989, PARASITOLOGY, V98, P371, DOI 10.1017/S0031182000061448; JARVIS SM, 1988, BIOCHEM J, V249, P383, DOI 10.1042/bj2490383; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Klepper J, 2005, BIOCHEMISTRY-US, V44, P12621, DOI 10.1021/bi051079t; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Klepper J, 1999, J CLIN LAB ANAL, V13, P116, DOI 10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C; Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707, DOI 10.1111/j.1469-8749.2007.00707.x; KONDO T, 1980, J CLIN INVEST, V65, P1, DOI 10.1172/JCI109638; LARIS PC, 1958, J CELL COMPAR PHYSL, V51, P273, DOI 10.1002/jcp.1030510212; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Muro AF, 2000, BLOOD, V95, P3978; OHANIAN V, 1984, BIOCHEMISTRY-US, V23, P4416, DOI 10.1021/bi00314a027; Pascual JM, 2004, REV NEUROLOGIA, V38, P860, DOI 10.33588/rn.3809.2003609; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; PINDER JC, 1993, BLOOD, V82, P3482; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; STAUFENBIEL M, 1986, P NATL ACAD SCI USA, V83, P318, DOI 10.1073/pnas.83.2.318; Steck T L, 1974, Methods Enzymol, V31, P172; TAKAKUWA Y, 1990, BIORHEOLOGY, V27, P357; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; Wang D, 2006, HUM MOL GENET, V15, P1169, DOI 10.1093/hmg/ddl032; WIDDAS WF, 1955, J PHYSIOL-LONDON, V127, P318, DOI 10.1113/jphysiol.1955.sp005259; WINARDI R, 1993, BLOOD, V81, P2799; Zhang JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P173, DOI 10.1006/abbi.1999.1489; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277	55	68	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14600	14609		10.1074/jbc.M707818200	http://dx.doi.org/10.1074/jbc.M707818200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347014	hybrid, Green Published			2022-12-27	WOS:000255941400048
J	Litherland, GJ; Dixon, C; Lakey, RL; Robson, T; Jones, D; Young, DA; Cawston, TE; Rowan, AD				Litherland, Gary J.; Dixon, Craig; Lakey, Rachel L.; Robson, Timothy; Jones, Debra; Young, David A.; Cawston, Tim E.; Rowan, Andrew D.			Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ARTHRITIS SYNOVIAL FIBROBLASTS; MATRIX METALLOPROTEINASE-13 EXPRESSION; HUMAN ARTICULAR CHONDROCYTES; LINKED-IMMUNOSORBENT-ASSAY; ACTIVATED PROTEIN-KINASE; BOVINE NASAL CARTILAGE; T-CELL-ACTIVATION; ONCOSTATIN-M; RHEUMATOID-ARTHRITIS	The phosphatidylinositol 3-kinase (PI3K) signaling pathway has emerged as a major regulator of cellular functions and has been implicated in several pathologies involving remodeling of extracellular matrix ( ECM). The end stage of inflammatory joint diseases is characterized by excessive ECM catabolism, and in this study we assess the role of PI3K signaling in the induction of collagenolytic matrix metalloproteinases ( MMPs) in human chondrocytes. We used the most potent cytokine stimulus reported to promote cartilage ECM catabolism, namely interleu-kin-1 ( IL-1) in combination with oncostatin M( OSM). Both OSM and IL-6 ( in the presence of its soluble receptor), but not IL-1 nor leukemia inhibitory factor, induced Akt phosphorylation in human chondrocytes. Inhibition of PI3K signaling using LY294002 blocked IL-1 + OSM-mediated Akt phosphorylation, induction of MMP-1 and MMP-13, and cartilage collagenolysis. To further explore the role of downstream substrates within the PI3K pathway, complementary use of small molecule inhibitors and specific small interfering RNAs demonstrated that the PI3K subunit p110 alpha and Akt1 were required for MMP-1 mRNA induction. MMP-13 induction was also reduced by loss of function of these molecules and by a lack of p110 delta, 3-phosphoinositide-dependent kinase-1 or Akt3. We therefore propose that the activities of specific elements of the PI3K signaling pathway, including Akt, are necessary for the synergistic induction of MMP-1 and MMP- 13 and the cartilage breakdown stimulated by IL-1 + OSM. Our data provide new insight into the mechanism of synergy between IL-1 and OSM and highlight new therapeutic targets for inflammatory joint diseases that aim to repress the expression of collagenases.	[Litherland, Gary J.; Dixon, Craig; Lakey, Rachel L.; Robson, Timothy; Jones, Debra; Young, David A.; Cawston, Tim E.; Rowan, Andrew D.] Univ Newcastle, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Rowan, AD (corresponding author), Univ Newcastle, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	a.d.rowan@ncl.ac.uk	Young, David/H-2023-2014; Litherland, Gary J/K-9755-2015; Young, David/GOV-5677-2022	Young, David/0000-0002-7547-3246; Young, David/0000-0002-7078-6745; Litherland, Gary/0000-0001-5264-0219	Arthritis Research UK Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Catterall JB, 2006, RHEUMATOLOGY, V45, P1101, DOI 10.1093/rheumatology/kel060; Catterall JB, 2001, ARTHRITIS RHEUM-US, V44, P2296, DOI 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; CLARK IM, 1992, MATRIX, V12, P475, DOI 10.1016/S0934-8832(11)80092-2; CLARK IM, 1991, MATRIX, V11, P76, DOI 10.1016/S0934-8832(11)80211-8; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; El Mabrouk M, 2007, BBA-MOL CELL RES, V1773, P309, DOI 10.1016/j.bbamcr.2006.11.018; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Fukaya Y, 2005, ONCOL REP, V14, P847; Godoy-Tundidor S, 2005, PROSTATE, V64, P209, DOI 10.1002/pros.20235; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; GUERNE PA, 1990, J IMMUNOL, V144, P499; GUERNE PA, 1989, J CLIN INVEST, V83, P585, DOI 10.1172/JCI113921; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hsieh YS, 2007, J RHEUMATOL, V34, P785; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jacques C, 2007, OSTEOARTHR CARTILAGE, V15, P138, DOI 10.1016/j.joca.2006.07.003; Johansen JS, 1999, RHEUMATOLOGY, V38, P618, DOI 10.1093/rheumatology/38.7.618; JUBB RW, 1980, J PATHOL, V130, P159, DOI 10.1002/path.1711300304; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim G, 2002, ARTHRITIS RHEUM-US, V46, P1504, DOI 10.1002/art.10314; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 1999, ANAL BIOCHEM, V275, P202, DOI 10.1006/abio.1999.4310; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Kumar R, 2005, CANCER RES, V65, P2511, DOI 10.1158/0008-5472.CAN-05-0189; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Morgan TG, 2006, ANN RHEUM DIS, V65, P184, DOI 10.1136/ard.2004.033480; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; Reuveni H, 2002, BIOCHEMISTRY-US, V41, P10304, DOI 10.1021/bi0202530; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Scrivo R, 2007, ANN NY ACAD SCI, V1108, P312, DOI 10.1196/annals.1422.033; Shingleton WD, 2006, RHEUMATOLOGY, V45, P958, DOI 10.1093/rheumatology/kel024; Shingleton WD, 2000, J CELL BIOCHEM, V79, P519, DOI 10.1002/1097-4644(20001215)79:4<519::AID-JCB10>3.0.CO;2-U; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Tetlow LC, 1998, BRIT J RHEUMATOL, V37, P64; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Volck B, 1999, SCAND J RHEUMATOL, V28, P171; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Zhang HG, 2001, ARTHRITIS RHEUM-US, V44, P1555, DOI 10.1002/1529-0131(200107)44:7<1555::AID-ART279>3.0.CO;2-M	66	43	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14221	14229		10.1074/jbc.M710136200	http://dx.doi.org/10.1074/jbc.M710136200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332138	hybrid			2022-12-27	WOS:000255941400008
J	Paun, A; Reinert, JT; Jiang, Z; Medin, C; Balkhi, MY; Fitzgerald, KA; Pitha, PM				Paun, Andrea; Reinert, Jorgen T.; Jiang, Zhaozhao; Medin, Carey; Balkhi, Mumtaz Yaseen; Fitzgerald, Katherine A.; Pitha, Paula M.			Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; GENE INDUCTION-PROGRAM; RIG-I; VIRAL-INFECTION; ALPHA GENES; TRANSCRIPTIONAL ACTIVITY; VIRUS-INFECTION	Although the role of human IRF-5 in antiviral and inflammatory responses in vitro has been well characterized, much remains to be elucidated about murine IRF-5. Murine IRF-5, unlike the heavily spliced human gene, is primarily expressed as a full-length transcript, with only a single splice variant that was detected in very low levels in the bone marrow of C57BL/6J mice. This bone marrow variant contains a 288-nucleotide deletion from exons 4-6 and exhibits impaired transcriptional activity. The murine IRF-5 can be activated by both TBK1 and MyD88 to form homodimers and bind to and activate transcription of type I interferon and inflammatory cytokine genes. The importance of IRF-5 in the antiviral and inflammatory response in vivo is highlighted by marked reductions in serum levels of type I interferon and tumor necrosis factor alpha (TNF alpha) in Newcastle disease virus-infected Irf5(-/-) mice. IRF- 5 is critical for TLR3-, TLR4-, and TLR9-dependent induction of TNF alpha in CD11c(+) dendritic cells. In contrast, TLR9, but not TLR3/4-mediated induction of type I IFN transcription, is dependent on IRF- 5 in these cells. In addition, IRF- 5 regulates TNF alpha but not type I interferon gene transcription in Newcastle disease virus-infected peritoneal macrophages. Altogether, these data reveal the cell type-specific importance of IRF- 5 in MyD88-mediated antiviral pathways and the widespread role of IRF- 5 in the regulation of inflammatory cytokines.	[Paun, Andrea; Reinert, Jorgen T.; Balkhi, Mumtaz Yaseen; Pitha, Paula M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Pitha, Paula M.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; [Pitha, Paula M.] Johns Hopkins Univ, Sch Med, Dept Biol, Baltimore, MD 21231 USA; [Jiang, Zhaozhao; Fitzgerald, Katherine A.] Univ Massachusetts, Med Ctr, Div Infect Dis & Immunol, Worcester, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Pitha, PM (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	parowe@jhmi.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; Medin, Carey/0000-0002-9346-6760; Reinert, Thomas/0000-0003-4835-4804	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067497, R37AI067497, R01AI067497, R01AI067632] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 067632, AI 067497] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; CHEUNG SC, 1991, J IMMUNOL, V146, P121; COUZINET A, 2008, NATL ACAD SCI US, V105, P2556; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dragan AI, 2007, NUCLEIC ACIDS RES, V35, P3525, DOI 10.1093/nar/gkm142; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; HARADA H, 1994, ONCOGENE, V9, P3313; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Paun A, 2007, ADV VIRUS RES, V69, P1, DOI 10.1016/S0065-3527(06)69001-5; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; YANAI H, 2007, NATL ACAD SCI US, V104, P3402; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yeow WS, 2000, J BIOL CHEM, V275, P6313, DOI 10.1074/jbc.275.9.6313; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748	64	98	99	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14295	14308		10.1074/jbc.M800501200	http://dx.doi.org/10.1074/jbc.M800501200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332133	hybrid, Green Published			2022-12-27	WOS:000255941400016
J	Bandyopadhyay, S; Naik, SG; O'Carroll, IP; Huynh, BH; Dean, DR; Johnson, MK; Dos Santos, PC				Bandyopadhyay, Sibali; Naik, Sunil G.; O'Carroll, Ina P.; Huynh, Boi-Hanh; Dean, Dennis R.; Johnson, Michael K.; Dos Santos, Patricia C.			A proposed role for the Azotobacter vinelandii NfuA protein as an intermediate iron-sulfur cluster carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAFFOLD PROTEIN; ESCHERICHIA-COLI; 4FE-4S CLUSTERS; CONTROLLED EXPRESSION; GENE-CLUSTER; NIFU; FERREDOXIN; ISCA; NITROGENASE; ACONITASE	Iron-sulfur clusters ([Fe-S] clusters) are assembled on molecular scaffolds and subsequently used for maturation of proteins that require [Fe-S] clusters for their functions. Previous studies have shown that Azotobacter vinelandii produces at least two [Fe-S] cluster assembly scaffolds: NifU, required for the maturation of nitrogenase, and IscU, required for the general maturation of other [Fe-S] proteins. A. vinelandii also encodes a protein designated NfuA, which shares amino acid sequence similarity with the C-terminal region of NifU. The activity of aconitase, a [4Fe-4S] cluster-containing enzyme, is markedly diminished in a strain containing an inactivated nfuA gene. This inactivation also results in a null-growth phenotype when the strain is cultivated under elevated oxygen concentrations. NifU has a limited ability to serve the function of NfuA, as its expression at high levels corrects the defect of the nfuA-disrupted strain. Spectroscopic and analytical studies indicate that one [4Fe-4S] cluster can be assembled in vitro within a dimeric form of NfuA. The resultant [4Fe-4S] cluster-loaded form of NfuA is competent for rapid in vitro activation of apo-aconitase. Based on these results a model is proposed where NfuA could represent a class of intermediate [Fe-S] cluster carriers involved in [Fe-S] protein maturation.	[O'Carroll, Ina P.; Dean, Dennis R.; Dos Santos, Patricia C.] Virginia Tech, Fralin Biotech Ctr 108, Dept Biochem, Blacksburg, VA 24061 USA; [Bandyopadhyay, Sibali; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Naik, Sunil G.; Huynh, Boi-Hanh] Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia; Emory University	Dos Santos, PC (corresponding author), Virginia Tech, Fralin Biotech Ctr 108, Dept Biochem, W Campus Dr, Blacksburg, VA 24061 USA.	pdossant@vt.edu	O'Carroll, Ina Puleri/GZH-1001-2022	O'Carroll, Ina Puleri/0000-0002-1331-9155; Dos Santos, Patricia/0000-0002-3364-0931	NIGMS NIH HHS [GM62524, GM47295, R01 GM062524, R01 GM062524-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062524, R37GM062524, R01GM047295] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Cosper MM, 2004, BIOCHEMISTRY-US, V43, P2007, DOI 10.1021/bi0356653; CRIBBS R, 1964, GENETICS, V49, P95; CZERNUSZEWICZ RS, 1987, J AM CHEM SOC, V109, P7178, DOI 10.1021/ja00257a045; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, BIOCHEM SOC T, V33, P90, DOI 10.1042/BST0330090; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; ONATE YA, 1993, BIOCHIM BIOPHYS ACTA, V1164, P113, DOI 10.1016/0167-4838(93)90237-L; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Que Jr L., 2000, PHYS METHODS BIOINOR, P233; RAVI N, 1994, J AM CHEM SOC, V116, P8007, DOI 10.1021/ja00097a007; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Sen S, 2004, BIOCHEMISTRY-US, V43, P1787, DOI 10.1021/bi0358465; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Spiro T. G., 1988, BIOL APPLICATIONS RA, P523; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P25, DOI 10.1139/m68-005; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	45	88	91	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14092	14099		10.1074/jbc.M709161200	http://dx.doi.org/10.1074/jbc.M709161200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339629	Green Published, hybrid			2022-12-27	WOS:000255728200063
J	Ammar, H; Closset, JL				Ammar, Hayet; Closset, Jean L.			Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; NECROSIS-FACTOR-ALPHA; CLUSTERIN/APOLIPOPROTEIN-J; EPITHELIAL-CELLS; APOLIPOPROTEIN-J; SULFATED GLYCOPROTEIN-2; ANDROGEN-ABLATION; NUCLEAR CLUSTERIN; OXIDATIVE STRESS; MESSENGER-RNA	Clusterin is, in its major form, a secreted heterodimeric disulfide-linked glycoprotein (75-80 kDa). It was first linked to cell death in the rat ventral prostate after androgen deprivation. Recent studies have demonstrated that overexpression of clusterin in prostatic cells protects them against tumor necrosis factor alpha (TNF alpha)-induced apoptosis. However the details of this survival mechanism remain undefined. Here, we investigate how clusterin prevents cells from undergoing TNF alpha-induced apoptosis. We established a double-stable prostatic cell line for inducible clusterin by using the Tet-On gene expression system. We demonstrated that 50% of the cells overexpressing clusterin escaped from TNF alpha- and actinomycin D-induced cell death. Moreover we demonstrated that the incubation of MLL cells with conditioned medium containing the secreted clusterin or the supplementation of purified clusterin in the extracellular medium decreased the TNF alpha-induced apoptosis significantly. This extracellular action implicates megalin, the putative membrane receptor for clusterin to mediate survival. Indeed clusterin overexpression up-regulated the expression of megalin and induced its phosphorylation in a dose-dependent manner. We interestingly showed that clusterin overexpression is associated with the up-regulation of the phosphorylation of Akt. Activated Akt induced the phosphorylation of Bad and caused a decrease of cytochrome c release. These results enable us to pinpoint one mechanism by which secreted clusterin favors survival in androgen-independent prostate cancer cells, implicating its receptor megalin and Akt survival pathway.	[Ammar, Hayet; Closset, Jean L.] Univ Liege, Dept Biochem, Inst Pathol B23, Liege 4000, Belgium	University of Liege	Closset, JL (corresponding author), Univ Liege, Dept Biochem, Inst Pathol B23, Ave Hop 3, Liege 4000, Belgium.	jclosset@ulg.ac.be						Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; BETTUZZI S, 1989, BIOCHEM J, V257, P293, DOI 10.1042/bj2570293; BURSCH W, 1995, ARCH TOXICOL, V69, P253, DOI 10.1007/s002040050167; Caccamo AE, 2006, J CELL PHYSIOL, V207, P208, DOI 10.1002/jcp.20561; Caccamo AE, 2003, ANN NY ACAD SCI, V1010, P514, DOI 10.1196/annals.1299.095; Carnevali S, 2006, AM J RESP CRIT CARE, V174, P393, DOI 10.1164/rccm.200512-1835OC; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; FRENCH LE, 1992, J CLIN INVEST, V90, P1919, DOI 10.1172/JCI116069; Gasparian AV, 2002, J CELL SCI, V115, P141; Girton RA, 2002, AM J PHYSIOL-RENAL, V282, pF703, DOI 10.1152/ajprenal.00060.2001; Gleave M, 2005, ANN NY ACAD SCI, V1058, P1, DOI 10.1196/annals.1359.001; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hammad SM, 1997, J BIOL CHEM, V272, P18644, DOI 10.1074/jbc.272.30.18644; Hermo L, 1999, MOL REPROD DEV, V53, P282, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;282::AID-MRD4&gt;3.0.CO;2-A; Herz J, 2000, CURR OPIN LIPIDOL, V11, P161, DOI 10.1097/00041433-200004000-00009; Ho SM, 1998, AM J PATHOL, V153, P131, DOI 10.1016/S0002-9440(10)65553-8; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; Kurahashi T, 2005, BJU INT, V96, P895, DOI 10.1111/j.1464-410X.2005.05733.x; KYPRIANOU N, 1990, CANCER RES, V50, P3748; KYPRIANOU N, 1991, CANCER RES, V51, P162; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lourda M, 2007, INT J CANCER, V120, P611, DOI 10.1002/ijc.22327; May Petra, 2003, Sci STKE, V2003, pPE12, DOI 10.1126/stke.2003.176.pe12; Miyake H, 2000, CLIN CANCER RES, V6, P1655; Miyake H, 2000, CANCER RES, V60, P2547; Miyake H, 2000, CANCER RES, V60, P170; Miyake H, 2005, ONCOL REP, V14, P1371; Morales CR, 1996, BIOL REPROD, V55, P676, DOI 10.1095/biolreprod55.3.676; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Scaltriti M, 2004, CANCER RES, V64, P6174, DOI 10.1158/0008-5472.CAN-04-0920; SCUDIERO DA, 1988, CANCER RES, V48, P4827; SENSIBAR JA, 1995, CANCER RES, V55, P2431; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; SHUKLA S, 2005, PROSTATE; Sintich SM, 1999, PROSTATE, V39, P87; Trougakos IP, 2005, FREE RADICAL BIO MED, V38, P436, DOI 10.1016/j.freeradbiomed.2004.10.038; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Yang CC, 2003, J BIOL CHEM, V278, P25872, DOI 10.1074/jbc.M301744200; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; You KH, 2003, Z NATURFORSCH C, V58, P148; Zellweger T, 2002, CLIN CANCER RES, V8, P3276; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	51	104	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12851	12861		10.1074/jbc.M800403200	http://dx.doi.org/10.1074/jbc.M800403200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321852	hybrid			2022-12-27	WOS:000255499800021
J	Goodger, SJ; Robinson, CJ; Murphy, KJ; Gasiunas, N; Harmer, NJ; Blundell, TL; Pye, DA; Gallagher, JT				Goodger, Sarah J.; Robinson, Christopher J.; Murphy, Kevin J.; Gasiunas, Nijole; Harmer, Nicholas J.; Blundell, Tom L.; Pye, David A.; Gallagher, John T.			Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; FLAVOBACTERIUM-HEPARINUM; SULFATE OLIGOSACCHARIDES; CRYSTAL-STRUCTURE; BASIC FGF; RECEPTOR; BINDING; SPECIFICITY; ANGIOGENESIS; COMPLEX	Heparin-like saccharides play an essential role in binding to both fibroblast growth factors (FGF) and their receptors at the cell surface. In this study we prepared a series of heparin oligosaccharides according to their size and sulfation level. We then investigated their affinity for FGF2 and their ability to support FGF2 mitogenesis of heparan sulfate-deficient cells expressing FGFR1c. Tetra- and hexasaccharides bound FGF2, but failed to dimerize the growth factor. Nevertheless, these saccharides promoted FGF2-mediated cell growth. Furthermore, whereas enzymatic removal of the non-reducing end 2-O-sulfate group had little effect on the 1: 1 interaction with FGF2, it eliminated the mitogenic activity of these saccharides. This evidence supports the symmetric two-end model of ternary complex formation. In contrast, even at very low concentrations, octasaccharide and larger heparin fragments conferred a potent mitogenic activity that was independent of terminal 2-O-sulfation. This correlated with the ability to dimerize FGF2 in an apparently cooperative manner. This data suggests that potent mitogenic signaling results from heparin-mediated trans-dimerization of FGF2, consistent with the asymmetric model of ternary complex formation. We propose that, depending on saccharide structure, there are different architectures and modes of ternary complex assembly that differ in stability and/or efficiency of transmembrane signaling.	[Goodger, Sarah J.; Robinson, Christopher J.; Gasiunas, Nijole; Gallagher, John T.] Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Canc Res UK Glycooncol Grp, Manchester M20 4BX, Lancs, England; [Murphy, Kevin J.; Pye, David A.] Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Harmer, Nicholas J.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Harmer, Nicholas J.] Univ Exeter, Exeter EX4 4QD, Devon, England	Paterson Institute for Cancer Research; University of Manchester; University of Huddersfield; University of Cambridge; University of Exeter	Robinson, CJ (corresponding author), Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Canc Res UK Glycooncol Grp, Manchester M20 4BX, Lancs, England.	christopher.robinson@manchester.ac.uk		Robinson, Christopher/0000-0001-6146-566X	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		BIELICKI J, 1993, BIOCHEM J, V289, P241, DOI 10.1042/bj2890241; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; DELL KR, 1992, J BIOL CHEM, V267, P21225; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; DUAN DSR, 1992, J BIOL CHEM, V267, P16076; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Harmer NJ, 2006, BIOCHEM J, V393, P741, DOI 10.1042/BJ20050985; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Manetti F, 2000, CURR PHARM DESIGN, V6, P1897, DOI 10.2174/1381612003398528; Ornitz DM, 2001, GENOME BIOL, V2; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Scotet E, 1998, ONCOGENE, V17, P67, DOI 10.1038/sj.onc.1201908; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	35	69	71	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13001	13008		10.1074/jbc.M704531200	http://dx.doi.org/10.1074/jbc.M704531200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18281281	hybrid			2022-12-27	WOS:000255499800037
J	Itoh, Y; Ito, N; Nagase, H; Seiki, M				Itoh, Yoshifumi; Ito, Noriko; Nagase, Hideaki; Seiki, Motoharu			The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; 3-DIMENSIONAL EXTRACELLULAR-MATRIX; GELATINASE-A; TISSUE INHIBITOR; TUMOR-GROWTH; MEMBRANE; MIGRATION; INVASION; EXPRESSION; HEMOPEXIN	Activation of proMMP-2 and cell surface collagenolysis are important activities of membrane-type 1 matrix metalloproteinase (MT1-MMP) to promote cell migration in tissue, and these activities are regulated by homodimerization of MT1-MMP on the cell surface. In this study, we have identified the transmembrane domain as a second dimer interface of MT1-MMP in addition to the previously identified hemopexin domain. Our analyses indicate that these two modes of dimerization have different roles; transmembrane-dependent dimerization is critical forproMMP-2activation, whereas hemopexin-dependent dimerization is important for degradation of collagen on the cell surface. Our finding provides new insight into the potential molecular arrangement of MT1-MMP contributing to its function on the cell surface.	[Itoh, Yoshifumi; Ito, Noriko; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst,Dept Matrix Biol, London W6 8LH, England; [Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Tokyo 1088639, Japan	Imperial College London; University of Oxford; University of Tokyo	Itoh, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst,Dept Matrix Biol, 65 Aspenlea Rd, London W6 8LH, England.	y.itoh@imperial.ac.uk	Seiki, Motoharu/K-9443-2015	Itoh, Yoshifumi/0000-0002-2128-2823	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Arthritis Research UK Funding Source: Medline; Cancer Research UK [C1507/A5541] Funding Source: Medline; NIAMS NIH HHS [AR40994, R01 AR040994, R01 AR040994-15A1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Research UK(Versus Arthritis); Cancer Research UK(Cancer Research UK); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fosang AJ, 1998, FEBS LETT, V430, P186, DOI 10.1016/S0014-5793(98)00667-X; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Honda S, 2001, CLIN EXP IMMUNOL, V126, P131, DOI 10.1046/j.1365-2249.2001.01624.x; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huber O, 1999, J CELL SCI, V112, P4415; Itoh Y, 2004, TRENDS BIOCHEM SCI, V29, P285, DOI 10.1016/j.tibs.2004.04.001; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; KANUPER V, 1996, J BIOL CHEM, V271, P17124; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; Nakada M, 2003, CANCER RES, V63, P3364; Nakada M, 2001, CANCER RES, V61, P8896; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Sato T, 1997, J CELL SCI, V110, P589; Stanton H, 1998, J CELL SCI, V111, P2789; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	62	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13053	13062		10.1074/jbc.M709327200	http://dx.doi.org/10.1074/jbc.M709327200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337248	Green Published, hybrid			2022-12-27	WOS:000255499800043
J	Sarker, KP; Kataoka, H; Chan, A; Netherton, SJ; Pot, I; Huynh, MA; Feng, XL; Bonni, A; Riabowol, K; Bonni, S				Sarker, Krishna P.; Kataoka, Hiromi; Chan, Angela; Netherton, Stuart J.; Pot, Isabelle; Huynh, Mai Anh; Feng, Xiaolan; Bonni, Azad; Riabowol, Karl; Bonni, Shirin			ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDATE TUMOR-SUPPRESSOR; REPRESSES TRANSCRIPTION; AXONAL MORPHOGENESIS; PLANT HOMEODOMAIN; RECEPTOR COMPLEX; PHD FINGER; PROTEINS; CANCER; FAMILY; SNON	Members of the ING(inhibitor of growth) family of chromatin modifying proteins (ING1-ING5) have emerged as critical regulators of gene expression and cellular responses, suggesting that the ING proteins may impinge on specific signal transduction pathways and their mediated effects. Here, we demonstrate a role for the protein ING2 in mediating responses by the transforming growth factor (TGF)-beta-Smad signaling pathway. We show that ING2 promotes TGF-beta-induced transcription. Both gain-of-function and RNA interference-mediated knockdown of endogenous ING2 reveal that ING2 couples TGF-beta signals to the induction of transcription and cell cycle arrest. We also find that the Smad-interacting transcriptional modulator SnoN interacts with ING2 and promotes the assembly of a protein complex containing SnoN, ING2, and Smad2. Knockdown of endogenous SnoN blocks the ability of ING2 to promote TGF beta-dependent transcription, and conversely expression of SnoN augments ING2 enhancement of the TGF-beta response. Collectively, our data suggest that ING2 collaborates with SnoN to mediate TGF-beta-induced Smad-dependent transcription and cellular responses.	[Sarker, Krishna P.; Kataoka, Hiromi; Chan, Angela; Netherton, Stuart J.; Pot, Isabelle; Feng, Xiaolan; Riabowol, Karl; Bonni, Shirin] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 1N4, Canada; [Sarker, Krishna P.; Kataoka, Hiromi; Chan, Angela; Netherton, Stuart J.; Pot, Isabelle; Feng, Xiaolan; Riabowol, Karl; Bonni, Shirin] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Riabowol, Karl] Univ Calgary, Fac Med, Dept Oncol, Calgary, AB T2N 1N4, Canada; [Huynh, Mai Anh; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Calgary; University of Calgary; University of Calgary; Harvard University; Harvard Medical School	Bonni, S (corresponding author), Univ Calgary, So Alberta Canc Res Inst, 3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada.	sbonni@ucalgary.ca	Feng, Xiaolan/J-9997-2019	Feng, Xiaolan/0000-0002-7333-8198	NIGMS NIH HHS [GM077226, T32 GM007753] Funding Source: Medline; NINDS NIH HHS [NS051255] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM077226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chen LS, 2001, CANCER RES, V61, P4345; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Feng XL, 2006, MOL CELL BIOL, V26, P9244, DOI 10.1128/MCB.01538-06; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gasparri F, 2004, J BIOMOL SCREEN, V9, P232, DOI 10.1177/1087057103262836; Gong W, 2005, INT J BIOCHEM CELL B, V37, P1054, DOI 10.1016/j.biocel.2004.09.008; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helbing CC, 1997, CANCER RES, V57, P1255; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Kaadige MR, 2006, J BIOL CHEM, V281, P28831, DOI 10.1074/jbc.M605624200; Kameyama K, 2003, CLIN CANCER RES, V9, P4926; Kataoka H, 2003, CANCER RES, V63, P5785; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; POT I, 2008, IN PRESS CURR MOL ME; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; STROSCHEIN SL, 2001, GENES DEV, V15; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Toyama T, 1999, ONCOGENE, V18, P5187, DOI 10.1038/sj.onc.1202905; Vieyra D, 2002, J BIOL CHEM, V277, P29832, DOI 10.1074/jbc.M200197200; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	51	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13269	13279		10.1074/jbc.M708834200	http://dx.doi.org/10.1074/jbc.M708834200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334480	hybrid, Green Published			2022-12-27	WOS:000255499800067
J	Gordon, AR; Outram, SV; Keramatipour, M; Goddard, CA; Colledge, WH; Metcalfe, JC; Hager-Theodorides, AL; Crompton, T; Kemp, PR				Gordon, Adele R.; Outram, Susan V.; Keramatipour, Mohammad; Goddard, Catherine A.; Colledge, William H.; Metcalfe, James C.; Hager-Theodorides, Ariadne L.; Crompton, Tessa; Kemp, Paul R.			Splenomegaly and modified erythropoiesis in KLF13(-/-) mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR KLF13; T-LYMPHOCYTES; IN-VIVO; EXPRESSION; GLOBIN; GATA-1; DIFFERENTIATION; PRECURSORS; ELEMENTS; RFLAT-1	To study the function of the Kruppel-like transcription factor KLF13 in vivo, we generated mice with a disrupted Klf13 allele. Although Klf13(-/-) mice are viable, fewer mice were present at 3 weeks than predicted by Mendelian inheritance. Viable Klf13(-/-) mice had reduced numbers of circulating erythrocytes and a larger spleen. The spleen contained an increased number of Ter119(med)CD71(hi), Ter119(hi)CD71(hi), and Ter119(hi)CD71(med) cells but not Ter119(hi)CD71(-) cells, indicating an increase in less mature erythroblasts. A higher proportion of the Ter119(med)CD71(hi) cells were proliferating, indicating that the mice were under a degree of erythropoietic stress. These data indicate that KLF13 is involved in the normal control of erythropoiesis.	[Kemp, Paul R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Gordon, Adele R.; Keramatipour, Mohammad; Goddard, Catherine A.; Metcalfe, James C.] Univ Cambridge, Dept Biochem, Sect Cardiovasc Biol, Cambridge CB2 1QW, England; [Outram, Susan V.; Hager-Theodorides, Ariadne L.; Crompton, Tessa] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Colledge, William H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England	Imperial College London; University of Cambridge; Imperial College London; University of Cambridge	Kemp, PR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, S Kensington Campus, London SW7 2AZ, England.	p.kemp@imperial.ac.uk	Colledge, William/X-4976-2019; Hager-Theodorides, Ariande/AAM-1160-2021; Hager-Theodorides, Ariadne L./AAM-4671-2021	Colledge, William/0000-0002-9603-4429; Hager-Theodorides, Ariadne L./0000-0002-8480-3200; Crompton, Tessa/0000-0002-8973-4021; Kemp, Paul/0000-0001-8975-7293	Biotechnology and Biological Sciences Research Council [BB/D522770/1] Funding Source: Medline; British Heart Foundation [PG/02/135/14620] Funding Source: Medline; Medical Research Council [G0000121] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000121] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Ellis PD, 2004, J BIOL CHEM, V279, P36660, DOI 10.1074/jbc.M405380200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; HARA H, 1976, AM J HEMATOL, V1, P453, DOI 10.1002/ajh.2830010410; Ingley E, 2005, ONCOGENE, V24, P336, DOI 10.1038/sj.onc.1208199; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kam HY, 1999, J APPL PHYSIOL, V87, P1901, DOI 10.1152/jappl.1999.87.5.1901; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; Martin KM, 2001, MECH DEVELOP, V103, P149, DOI 10.1016/S0925-4773(01)00343-4; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; Perkins A, 1999, INT J BIOCHEM CELL B, V31, P1175, DOI 10.1016/S1357-2725(99)00083-7; PERKINS AC, 1995, NATURE, V375, P318; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; Rhodes MM, 2005, BLOOD, V106, P1857, DOI 10.1182/blood-2004-11-4344; Song A, 1999, IMMUNITY, V10, P93, DOI 10.1016/S1074-7613(00)80010-2; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang P, 2005, BLOOD CELL MOL DIS, V35, P227, DOI 10.1016/j.bcmd.2005.04.009; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496	29	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11897	11904		10.1074/jbc.M709569200	http://dx.doi.org/10.1074/jbc.M709569200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18285334	hybrid			2022-12-27	WOS:000255340000005
J	Romantsov, T; Stalker, L; Culham, DE; Wood, JM				Romantsov, Tatyana; Stalker, Leanne; Culham, Doreen E.; Wood, Janet M.			Cardiolipin controls the osmotic stress response and the subcellular location of transporter ProP in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; LISTERIA-MONOCYTOGENES; BETAINE TRANSPORTER; MEMBRANE-PROTEINS; DOMAIN FORMATION; OSMOSENSOR PROP; ACRIDINE-ORANGE; IN-VIVO; ANTIPARALLEL; MODEL	The phospholipid composition of the membrane and transporter structure control the subcellular location and function of osmosensory transporter ProP in Escherichia coli. Growth in media of increasing osmolality increases, and entry to stationary phase decreases, the proportion of phosphatidate in anionic lipids (phosphatidylglycerol (PG) plus cardiolipin (CL)). Both treatments increase the CL: PG ratio. Transporters ProP and LacY are concentrated with CL (and not PG) near cell poles and septa. The polar concentration of ProP is CL-dependent. Here we show that the polar concentration of LacY is CL-independent. The osmotic activation threshold of ProP was directly proportional to the CL content of wild type bacteria, the PG content of CL-deficient bacteria, and the anionic lipid content of cells and proteoliposomes. CL was effective at a lower concentration in cells than in proteoliposomes, and at a much lower concentration than PG in either system. Thus, in wild type bacteria, osmotic induction of CL synthesis and concentration of ProP with CL at the cell poles adjust the osmotic activation threshold of ProP to match ambient conditions. ProP proteins linked by homodimeric, C-terminal coiled-coils are known to activate at lower osmolalities than those without such structures and coiled-coil disrupting mutations raise the osmotic activation threshold. Here we show that these mutations also prevent polar concentration of ProP. Stabilization of the C-terminal coiled-coil by covalent cross-linking of introduced Cys reverses the impact of increasing CL on the osmotic activation of ProP. Association of ProP C termini with the CL-rich membrane at cell poles may raise the osmotic activation threshold by blocking coiled-coil formation. Mutations that block coiled-coil formation may also block association of the C termini with the CL-rich membrane.	[Romantsov, Tatyana; Stalker, Leanne; Culham, Doreen E.; Wood, Janet M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Wood, JM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jwood@uoguelph.ca						Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Binenbaum Z, 1999, MOL MICROBIOL, V32, P1173, DOI 10.1046/j.1365-2958.1999.01426.x; Bolen D W, 2001, Methods Mol Biol, V168, P17; BROWN ED, 1992, J BIOL CHEM, V267, P13086; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Culham DE, 2000, J MOL RECOGNIT, V13, P309, DOI 10.1002/1099-1352(200009/10)13:5<309::AID-JMR505>3.3.CO;2-I; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Fiske CH, 1925, J BIOL CHEM, V66, P375; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harold FM, 2002, FUNGAL GENET BIOL, V37, P271, DOI 10.1016/S1087-1845(02)00528-5; Hillar A, 2005, BIOCHEMISTRY-US, V44, P10170, DOI 10.1021/bi050774y; Hillar A, 2003, BIOCHEMISTRY-US, V42, P15170, DOI 10.1021/bi035122t; HOUSSIN C, 1991, BIOCHIM BIOPHYS ACTA, V1056, P76, DOI 10.1016/S0005-2728(05)80075-1; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lai EM, 2004, MOL MICROBIOL, V52, P1029, DOI 10.1111/j.1365-2958.2004.04040.x; Liu F, 2007, BIOCHEMISTRY-US, V46, P5647, DOI 10.1021/bi062198r; MacMillan SV, 1999, BBA-BIOMEMBRANES, V1420, P30, DOI 10.1016/S0005-2736(99)00085-1; MANGOLD HK, 1961, J AM OIL CHEM SOC, V38, P708, DOI 10.1007/BF02633061; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; MORGAN, 1967, J BACTERIOL, V93, P1987, DOI 10.1128/JB.93.6.1987-2002.1967; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NORRIS V, 1995, MOL MICROBIOL, V16, P1051, DOI 10.1111/j.1365-2958.1995.tb02330.x; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Sambrook J., 2001, MOL CLONING LAB MANU; Sleator RD, 2003, J BACTERIOL, V185, P7140, DOI 10.1128/JB.185.24.7140-7144.2003; Sleator RD, 2003, APPL ENVIRON MICROB, V69, P1, DOI 10.1128/AEM.69.1.1-9.2003; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thiem S, 2007, EMBO J, V26, P1615, DOI 10.1038/sj.emboj.7601610; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; Tsatskis Y, 2008, BIOCHEMISTRY-US, V47, P60, DOI 10.1021/bi7018173; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Wood JM, 2005, BIOCHEMISTRY-US, V44, P5634, DOI 10.1021/bi047383o; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zakharyan E, 2001, FEMS MICROBIOL LETT, V204, P61, DOI 10.1111/j.1574-6968.2001.tb10863.x; Zoetewey DL, 2003, J MOL BIOL, V334, P1063, DOI 10.1016/j.jmb.2003.10.020	53	59	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12314	12323		10.1074/jbc.M709871200	http://dx.doi.org/10.1074/jbc.M709871200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326496	hybrid			2022-12-27	WOS:000255340000048
J	Song, XM; Hresko, RC; Mueckler, M				Song, Xiao Mei; Hresko, Richard C.; Mueckler, Mike			Identification of amino acid residues within the C terminus of the glut4 glucose transporter that are essential for insulin-stimulated redistribution to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; INTRACELLULAR SEQUESTRATION; TARGETING MOTIF; ADIPOSE-CELLS; REGULATED TRANSPORT; NH2 TERMINUS; TRANSLOCATION; VESICLES; PROTEIN; SIGNAL	The Glut4 glucose transporter undergoes complex insulinregulated subcellular trafficking in adipocytes. Much effort has been expended in an attempt to identify targeting motifs within Glut4 that direct its subcellular trafficking, but an amino acid motif responsible for the targeting of the transporter to insulin-responsive intracellular compartments in the basal state or that is directly responsible for its insulin-stimulated redistribution to the plasma membrane has not yet been delineated. In this study we define amino acid residues within the C-terminal cytoplasmic tail of Glut4 that are essential for its insulin-stimulated translocation to the plasma membrane. The residues were identified based on sequence similarity (LXXLXPDEXD) between cytoplasmic domains of Glut4 and the insulin-responsive aminopeptidase ( IRAP). Alteration of this putative targeting motif (IRM, insulin-responsive motif) resulted in the targeting of the bulk of the mutant Glut4 molecules to dispersed membrane vesicles that lacked detectable levels of wild-type Glut4 in either the basal or insulin-stimulated states and completely abolished the insulin-stimulated translocation of the mutant Glut4 to the plasma membrane in 3T3L1 adipocytes. The bulk of the dispersed membrane vesicles containing the IRM mutant did not contain detectable levels of any subcellular marker tested. A fraction of the total IRM mutant was also detected in a wild-type Glut4/Syntaxin 6-containing perinuclear compartment. Interestingly, mutation of the IRM sequence did not appreciably alter the subcellular trafficking of IRAP. We conclude that residues within the IRM are critical for the targeting of Glut4, but not of IRAP, to insulin-responsive intracellular membrane compartments in 3T3-L1 adipocytes.	[Song, Xiao Mei; Hresko, Richard C.; Mueckler, Mike] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mueckler, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol, 660 Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	mmueckler@wustl.edu	Mueckler, Mike M/F-6115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043695, R01DK067229, P30DK056341] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK043695, P30 DK056341-08, R01 DK067229, P30 DK056341, P30 DK056341-07] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Hasani H, 2002, J CELL SCI, V115, P131; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Cope DL, 2000, FEBS LETT, V481, P261, DOI 10.1016/S0014-5793(00)02021-4; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1993, J CELL BIOL, V123, P127, DOI 10.1083/jcb.123.1.127; DUDEK RW, 1994, FEBS LETT, V339, P205, DOI 10.1016/0014-5793(94)80416-8; GARIPPA RJ, 1994, J CELL BIOL, V124, P705, DOI 10.1083/jcb.124.5.705; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HANEY PM, 1995, J CELL BIOL, V129, P641, DOI 10.1083/jcb.129.3.641; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holman GD, 2001, TRENDS CELL BIOL, V11, P173, DOI 10.1016/S0962-8924(01)01953-5; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; Malide D, 2000, J CELL SCI, V113, P4203; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; MARSH BJ, 1995, J CELL BIOL, V130, P1081, DOI 10.1083/jcb.130.5.1081; MARSHALL BA, 1993, J BIOL CHEM, V268, P26193; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Martinez-Arca S, 2000, J CELL SCI, V113, P1705; MUECKLER MM, 1995, NEWS PHYSIOL SCI, V10, P22; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; PIPER RC, 1993, J CELL BIOL, V121, P1221, DOI 10.1083/jcb.121.6.1221; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; ROTHMAN DL, 1992, J CLIN INVEST, V89, P1069, DOI 10.1172/JCI115686; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; VERHEY KJ, 1995, J CELL BIOL, V130, P1071, DOI 10.1083/jcb.130.5.1071; VERHEY KJ, 1994, J BIOL CHEM, V269, P2353; Wang WC, 1996, J CELL BIOL, V135, P415, DOI 10.1083/jcb.135.2.415; Xu Z, 2006, MOL ENDOCRINOL, V20, P2890, DOI 10.1210/me.2006-0193; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071	48	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12571	12585		10.1074/jbc.M800838200	http://dx.doi.org/10.1074/jbc.M800838200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18305115	Green Published, hybrid			2022-12-27	WOS:000255340000074
J	Lee, SH; Kim, T; Jeong, D; Kim, N; Choi, YW				Lee, Seoung Hoon; Kim, Taesoo; Jeong, Daewon; Kim, Nacksung; Choi, Yongwon			The Tec family tyrosine kinase Btk regulates RANKL-induced osteoclast maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; CELL ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; ADAPTER PROTEINS; BONE HOMEOSTASIS; DC-STAMP; T-CELL; DIFFERENTIATION; MICE; FUSION	A spontaneous mutation in Bruton's tyrosine kinase (Btk) induces a defect in B-cell development that results in the immunodeficiency diseases X-linked agammaglobulinemia in humans and X-linked immunodeficiency (Xid) in mice. Here we show an unexpected role of Btk in osteoclast formation. When bone marrow cells derived from Xid mice were stimulated with receptor activator of NF-kappa B ligand, an osteoclast differentiation factor, they did not completely differentiate into mature multinucleated osteoclasts. Moreover, we found that the defects appeared to occur at the stage in which mononuclear preosteoclasts fuse to generate multinucleated cells. Supporting this notion, macrophages from Xid mice also failed to form multinucleated foreign body giant cells. The fusion defect of the Xid mutant osteoclasts was caused by decreased expression of nuclear factor of activated T cells c1 (NFATc1), a master regulator of osteoclast differentiation, as well as reduced expression of various osteoclast fusion-related molecules, such as the d2 isoform of vacuolar H+-ATPase V0 domain and the dendritic cell-specific transmembrane protein. This deficiency was completely rescued by the introduction of a constitutively active form of NFATc1 into bone marrow-derived macrophages. Our data provide strong evidence that Btk plays a critical role in osteoclast multinucleation by modulating the activity of NFATc1.	[Lee, Seoung Hoon; Kim, Taesoo; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Lee, Seoung Hoon; Kim, Taesoo; Choi, Yongwon] Univ Penn, Sch Med, Dept Lab Med, Philadelphia, PA 19104 USA; [Jeong, Daewon] Yeungnam Univ, Coll Med, Dept Microbiol, Taegu 705717, South Korea; [Jeong, Daewon] Yeungnam Univ, Coll Med, Aging Associated Dis Res Ctr, Taegu 705717, South Korea; [Kim, Nacksung] Chonnam Natl Univ, Sch Med, Natl Res Lab Regulat Bone Metab & Dis, Kwangju 501746, South Korea	University of Pennsylvania; University of Pennsylvania; Yeungnam University; Yeungnam University; Chonnam National University	Choi, YW (corresponding author), Rm 308,BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	ychoi3@mail.med.upenn.edu						Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CAMPANA D, 1990, J IMMUNOL, V145, P1675; Conley ME, 1998, CURR OPIN IMMUNOL, V10, P399, DOI 10.1016/S0952-7915(98)80112-X; Felices M, 2007, ADV IMMUNOL, V93, P145, DOI 10.1016/S0065-2776(06)93004-1; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Komarova SV, 2005, P NATL ACAD SCI USA, V102, P2643, DOI 10.1073/pnas.0406874102; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; Kurosaki T, 2000, IMMUNITY, V12, P1, DOI 10.1016/S1074-7613(00)80153-3; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; RETH M, 1995, IMMUNOL TODAY, V16, P310; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schmidt U, 2004, INT ARCH ALLERGY IMM, V134, P65, DOI 10.1159/000078339; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	36	88	100	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11526	11534		10.1074/jbc.M708935200	http://dx.doi.org/10.1074/jbc.M708935200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18281276	Green Published, hybrid			2022-12-27	WOS:000255067400052
J	Su, NY; Ouni, I; Papagiannis, CV; Kaiser, P				Su, Ning-Yuan; Ouni, Ikram; Papagiannis, Christie V.; Kaiser, Peter			A dominant suppressor mutation of the met30 cell cycle defect suggests regulation of the Saccharomyces cerevisiae Met4-Cbf1 transcription complex by Met32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR MET4; POLYUBIQUITINATED MET4; SULFUR METABOLISM; UBIQUITIN LIGASES; YEAST; DEGRADATION; BINDING; PROTEIN; SCFMET30; CADMIUM	Met30 is the substrate recognition subunit of the essential ubiquitin ligase SCFMet30. The essential function of Met30 is the inactivation of the Saccharomyces cerevisiae transcription factor Met4, because fully activated Met4 induces a cell cycle arrest. Met4 regulates expression of genes involved in the sulfur assimilation pathway and coordinates the transcriptional program and cell cycle progression in response to cadmium and arsenic stress. Met4 lacks DNA binding activity and requires either Cbf1 or one of the two homologous proteins Met31 and Met32 for promoter association. Accordingly, met4 mutants, cbf1 mutants, and met31 met32 double mutants are methionine auxotroph. We isolated a truncated version of Met32 (Met32(Delta 145-192)) as a dominant suppressor of the cell cycle defect of met30 mutants. Expression of Met32(Delta 145-192) significantly reduced induction of Met4-regulated genes. Interestingly, both Cbf1- and Met31/32-dependent genes were affected by Met32(Delta 145-192). Mechanistically, Met32(Delta 145-192) prevented recruitment of Met4 to both Cbf1 and Met31/32-dependent promoters. We further demonstrated that Met32 is part of the Cbf1-Met4 complex bound to Cbf1- recruiting promoter elements and that Met31/32 are required for formation of a stable Met4-Cbf1 transcription complex. These results suggest a regulatory role of Met32 as part of the Cbf1-Met4 complex and provide molecular insight into coordination of cell cycle response and modulation of gene expression programs.	[Su, Ning-Yuan; Ouni, Ikram; Papagiannis, Christie V.; Kaiser, Peter] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Kaiser, P (corresponding author), 240D Med Sci 1, Irvine, CA 92697 USA.	pkaiser@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066164, R01GM066164] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066164, GM66164] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Blaiseau PL, 1998, EMBO J, V17, P6327, DOI 10.1093/emboj/17.21.6327; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Chandrasekaran S, 2006, MOL CELL, V24, P689, DOI 10.1016/j.molcel.2006.10.028; Dormer UH, 2000, J BIOL CHEM, V275, P32611, DOI 10.1074/jbc.M004167200; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Guthrie C, 1991, GUIDE YEAST GENETICS; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Kuras L, 1997, EMBO J, V16, P2441, DOI 10.1093/emboj/16.9.2441; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; Menant A, 2006, J BIOL CHEM, V281, P11744, DOI 10.1074/jbc.M600037200; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Su NY, 2005, MOL CELL BIOL, V25, P3875, DOI 10.1128/MCB.25.10.3875-3885.2005; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1995, MOL CELL BIOL, V15, P6526; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Yen JL, 2005, MOL BIOL CELL, V16, P1872, DOI 10.1091/mbc.E04-12-1130	27	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11615	11624		10.1074/jbc.M708230200	http://dx.doi.org/10.1074/jbc.M708230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308733	Green Published, hybrid			2022-12-27	WOS:000255067400062
J	Waraich, RS; Weigert, C; Kalbacher, H; Hennige, AM; Lutz, SZ; Haring, HU; Schleicher, ED; Voelter, W; Lehmann, R				Waraich, Rizwana Sanaullah; Weigert, Cora; Kalbacher, Hubert; Hennige, Anita M.; Lutz, Stefan Z.; Haering, Hans-Ulrich; Schleicher, Erwin D.; Voelter, Wolfgang; Lehmann, Rainer			Phosphorylation of Ser(357) of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-delta on insulin action in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; GLUCOSE-TRANSPORT; ISOFORMS ALPHA; IRS PROTEINS; RESISTANCE; ACTIVATION; THETA; INHIBITION	The activation of the protein kinase C (PKC) family of serine/threonine kinases contributes to the modulation of insulin signaling, and the PKC-dependent phosphorylation of insulin receptor substrate (IRS)-1 has been implicated in the development of insulin resistance. Here we demonstrate Ser(357) of rat IRS-1 as a novel PKC-delta-dependent phosphorylation site in skeletal muscle cells upon stimulation with insulin and phorbol ester using Ser(P)(357) antibodies and active and kinase dead mutants of PKC-delta. Phosphorylation of this site was simulated using IRS-1 Glu(357) and shown to reduce insulin-induced tyrosine phosphorylation of IRS-1, to decrease activation of Akt, and to subsequently diminish phosphorylation of glycogen synthase kinase-3. When the phosphorylation was prevented by mutation of Ser(357) to alanine, these effects of insulin were enhanced. When the adjacent Ser(358), present in mouse and rat IRS-1, was mutated to alanine, which is homologous to the human sequence, the insulin-induced phosphorylation of glycogen synthase kinase-3 or tyrosine phosphorylation of IRS-1 was not increased. Moreover, both active PKC-delta and phosphorylation of Ser357 were shown to be necessary for the attenuation of insulin-stimulated Akt phosphorylation. The phosphorylation of Ser357 could lead to increased association of PKC-delta to IRS-1 upon insulin stimulation, which was demonstrated with IRS-1 Glu(357). Together, these data suggest that phosphorylation of Ser(357) mediates at least in part the adverse effects of PKC-delta activation on insulin action.	[Waraich, Rizwana Sanaullah; Weigert, Cora; Schleicher, Erwin D.; Lehmann, Rainer] Univ Tubingen, Dept Internal Med 4, Div Clin Chem & Pathobiochem, D-72076 Tubingen, Germany; [Kalbacher, Hubert; Voelter, Wolfgang] Univ Tubingen, Dept Internal Med 4, Interfacultary Inst Biochem, D-72076 Tubingen, Germany; [Kalbacher, Hubert] Univ Tubingen, Dept Internal Med 4, Med & Nat Sci Res Ctr, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Weigert, C (corresponding author), Univ Tubingen, Dept Internal Med 4, Div Clin Chem & Pathobiochem, Otfried Mueller Str 10, D-72076 Tubingen, Germany.	Cora.Weigert@med.uni-tuebingen.de	waraich, rizwana/A-8470-2012	waraich, rizwana/0000-0002-5560-5053				Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Bandyopadhyay G, 1997, ENDOCRINOLOGY, V138, P4721, DOI 10.1210/en.138.11.4721; Beck A, 2003, J AM SOC MASS SPECTR, V14, P401, DOI 10.1016/S1044-0305(03)00122-3; BERTI L, 1994, J BIOL CHEM, V269, P3381; Bouzakri K, 2006, CELL METAB, V4, P89, DOI 10.1016/j.cmet.2006.04.008; Braiman L, 1999, MOL ENDOCRINOL, V13, P2002, DOI 10.1210/me.13.12.2002; Braiman L, 2001, MOL ENDOCRINOL, V15, P565, DOI 10.1210/me.15.4.565; Brand C, 2006, BIOCHEM BIOPH RES CO, V349, P954, DOI 10.1016/j.bbrc.2006.08.100; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; CHIN JE, 1993, J BIOL CHEM, V268, P6338; Ciaraldi TP, 2007, ENDOCRINOLOGY, V148, P4393, DOI 10.1210/en.2006-0932; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Heled Y, 2003, METABOLISM, V52, P1028, DOI 10.1016/S0026-0495(03)00154-9; Hennige AM, 2006, FASEB J, V20, P1206, DOI 10.1096/fj.05-4635fje; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Laybutt DR, 1999, AM J PHYSIOL-ENDOC M, V277, pE1070, DOI 10.1152/ajpendo.1999.277.6.E1070; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liu YF, 2004, MOL CELL BIOL, V24, P9668, DOI 10.1128/MCB.24.21.9668-9681.2004; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Rosenzweig T, 2002, DIABETES, V51, P1921, DOI 10.2337/diabetes.51.6.1921; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200; Weigert C, 2005, J BIOL CHEM, V280, P37393, DOI 10.1074/jbc.M506134200; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	49	33	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11226	11233		10.1074/jbc.M708588200	http://dx.doi.org/10.1074/jbc.M708588200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18285345	hybrid			2022-12-27	WOS:000255067400018
J	Li, QX; Zhang, N; Zhang, DW; Wang, YQ; Lin, TW; Wang, YH; Zhou, HM; Ye, ZY; Zhang, FM; Lin, SC; Han, J				Li, Qinxi; Zhang, Na; Zhang, Duanwu; Wang, Yuqian; Lin, Tianwei; Wang, Yanhai; Zhou, Huamin; Ye, Zhiyun; Zhang, Faming; Lin, Sheng-Cai; Han, Jiahuai			Determinants that control the distinct subcellular localization of p38 alpha-PRAK and p38 beta-PRAK complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; NUCLEAR IMPORT; CRYSTALLOGRAPHIC ANALYSIS; KARYOPHERIN ALPHA; TUMOR SUPPRESSION; PHOSPHORYLATION; RECOGNITION; EXPORT; MNK1	p38 alpha and p38 beta MAPKs (mitogen-activated protein kinases) share about 80% of their protein sequence identity, but have quite different biological functions. One such difference is in regulating the subcellular localization of their downstream kinases, such as PRAK (p38-regulated/activated protein kinase or MK5). The p38 alpha-PRAK complex is found in the nucleus, whereas the p38 beta-PRAK complex is exclusively localized to the cytosol. By generating a series of chimeric and point mutants of p38 alpha and p38 beta, we found two amino acid residues (Asp(145) and Leu(156) in p38 alpha, Gly(145) and Val(156) in p38 beta) that determine the distinct subcellular locations of p38 alpha-PRAK and p38 beta-PRAK. The subcellular localization of MK2 (MAPK-activated protein kinase 2), another downstream kinase of p38, was regulated in the same manner as that of PRAK. We found that nuclear import, but not export, determines the subcellular localization of p38 alpha-PRAK and p38 beta-PRAK. The published structure of the p38 alpha-MK2 complex suggests Leu(156) of p38 alpha is involved in the interaction with the nuclear localization signal in PRAK. The difference at this residue between p38 alpha and p38 beta may affect the nuclear localization signal in PRAK differently, and thereby influence the import of the complexes. Asp(145) in p38 alpha (or Gly(145) in p38 beta) is located on a different surface patch, and further random mutagenesis revealed that mutation of Asp(145), Thr(123), and Gln(325), the residues that can directly interact with importin alpha as predicted by modeling, but not mutation of the other 7 amino acid residues that cannot reach importin alpha, re-locate p38 alpha-PRAK to the cytosol, suggesting that interaction with import machinery is involved in determining the subcellular localization of the p38 alpha-PRAK and p38 beta-PRAK complexes. Last, we show that nuclear localization of PRAK is required for its role in inhibiting the proliferation of NIH3T3 cells. In conclusion, multiple determinants control the distinct subcellular localization of p38 alpha-PRAK and p38 beta-PRAK complexes, and the location of PRAK plays a role in its function.	[Li, Qinxi; Zhang, Na; Zhang, Duanwu; Wang, Yuqian; Lin, Tianwei; Wang, Yanhai; Zhou, Huamin; Ye, Zhiyun; Lin, Sheng-Cai; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Zhang, Faming] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	Xiamen University; Indiana University System; Indiana University Bloomington	Han, J (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China.	jhan@xmu.edu.cn	Lin, SC/G-4666-2010; Li, QX/G-4669-2010; Han, J/G-4671-2010; Zhang, Duanwu/AAH-1627-2020	Zhang, Duanwu/0000-0003-2946-846X				Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; BEN LR, 1998, CURR BIOL, V8, P1049; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; HAAR ET, 2007, J BIOL CHEM, V282, P9733; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; LA BS, 1999, EMBO J, V18, P480; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Moroianu J, 1998, J CELL BIOCHEM, V70, P231; Natale DR, 2004, DEV BIOL, V268, P76, DOI 10.1016/j.ydbio.2003.12.011; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; O'Loghlen A, 2004, EXP CELL RES, V299, P343, DOI 10.1016/j.yexcr.2004.06.006; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Smith S, 1999, J CELL SCI, V112, P3649; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	29	26	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					11014	11023		10.1074/jbc.M709682200	http://dx.doi.org/10.1074/jbc.M709682200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18268017	hybrid			2022-12-27	WOS:000254894700082
J	Chen, D; Yu, ZY; Zhu, ZY; Lopez, CD				Chen, Dexi; Yu, Zhiyong; Zhu, Zhiyi; Lopez, Charles D.			E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; TRANSCRIPTION FACTOR; DIFFERENTIAL REGULATION; IONIZING-RADIATION; PROSTATE CARCINOMA; PROTEIN-KINASE; DAMAGE REPAIR; TARGET GENES; P53; EXPRESSION	The E2F1 transcription factor activates S-phase-promoting genes, mediates apoptosis, and stimulates DNA repair through incompletely understood mechanisms. XRCC1 (x-ray repair cross-complementing group 1) protein is important for efficient single strand break/base excision repair. Although both damage and proliferative signals increase XRCC1 levels, the mechanisms regulating XRCC1 transcription remain unclear. To study these upstream mechanisms, the XRCC1 promoter was cloned into a luciferase reporter. Ectopic expression of wild-type E2F1, but not an inactive mutant E2F1(132E), activated the XRCC1 promoter-luciferase reporter, and deletion of predicted E2F1 binding sites in the promoter attenuated E2F1-induced activation. Endogenous XRCC1 expression increased in cells conditionally expressing wild-type, but not mutant E2F1, and methyl methanesulfonate-induced DNA damage stimulated XRCC1 expression in E2F1(+/+) but not E2F1(-/-) mouse embryo fibroblasts (MEFs). Additionally, E2F1(-/-) MEFs displayed attenuated DNA repair after methyl methanesulfonate-induced damage compared with E2F1(+/+) MEFs. Moreover, Chinese hamster ovary cells with mutant XRCC1 (EM9) were more sensitive to E2F1-induced apoptosis compared with Chinese hamster ovary cells with wild-type XRCC1 (AA8). These results provide new mechanistic insight into the role of the E2F pathway in maintaining genomic stability.	[Chen, Dexi; Yu, Zhiyong; Zhu, Zhiyi; Lopez, Charles D.] Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97239 USA	Oregon Health & Science University	Lopez, CD (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lopezc@ohsu.edu			NCI NIH HHS [CA 104997] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104997] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brem R, 2005, NUCLEIC ACIDS RES, V33, P2512, DOI 10.1093/nar/gki543; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; CANTONI O, 1987, CHEM-BIOL INTERACT, V63, P29, DOI 10.1016/0009-2797(87)90102-5; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen J, 1997, J NEUROCHEM, V69, P232; CHURCHILL ME, 1991, PHOTOCHEM PHOTOBIOL, V53, P229, DOI 10.1111/j.1751-1097.1991.tb03927.x; Collis SJ, 2003, CANCER RES, V63, P1550; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dong ZW, 2006, NUCLEIC ACIDS RES, V34, P5721, DOI 10.1093/nar/gkl705; Dynlacht BD, 2005, CELL DEATH DIFFER, V12, P313, DOI 10.1038/sj.cdd.4401612; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Ladiges WC, 2006, ONCOGENE, V25, P1612, DOI 10.1038/sj.onc.1209370; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Levy N, 2006, NUCLEIC ACIDS RES, V34, P32, DOI 10.1093/nar/gkj409; Lin WC, 2001, GENE DEV, V15, P1833; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; Nakada D, 2003, NUCLEIC ACIDS RES, V31, P1715, DOI 10.1093/nar/gkg252; Offer H, 1999, FEBS LETT, V450, P197, DOI 10.1016/S0014-5793(99)00505-0; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Prost S, 2007, ONCOGENE, V26, P3572, DOI 10.1038/sj.onc.1210151; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Seo YR, 2002, ONCOGENE, V21, P731, DOI 10.1038/sj.onc.1205129; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; SHUNG B, 1994, MUTAT RES, V307, P43, DOI 10.1016/0027-5107(94)90276-3; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Speit G, 1999, METH MOL B, V113, P203; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1982, MUTAT RES, V95, P427, DOI 10.1016/0027-5107(82)90276-7; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; TIMARCHI JM, 2002, NAT REV MOL CELL BIO, V3, P11; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; WALSH MJ, 1995, J BIOL CHEM, V270, P5289, DOI 10.1074/jbc.270.10.5289; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WINKONKAL N, 2003, NAT CELL BIOL, V5, P655; Yacoub A, 2003, RADIAT RES, V159, P439, DOI 10.1667/0033-7587(2003)159[0439:EGFAIR]2.0.CO;2; Yacoub A, 2001, INT J RADIAT BIOL, V77, P1067, DOI 10.1080/09553000110069317; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215; ZDZIENICKA MZ, 1992, MUTAGENESIS, V7, P265, DOI 10.1093/mutage/7.4.265; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914; Zhu ZY, 2005, J BIOL CHEM, V280, P34473, DOI 10.1074/jbc.M503736200	75	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15381	15389		10.1074/jbc.M710296200	http://dx.doi.org/10.1074/jbc.M710296200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18348985	hybrid, Green Published			2022-12-27	WOS:000256232000056
J	Nie, C; Tian, CH; Zhao, LX; Petit, PX; Mehrpour, M; Chen, Q				Nie, Chunlai; Tian, Changhai; Zhao, Lixia; Petit, Patrice Xavier; Mehrpour, Maryam; Chen, Quan			Cysteine 62 of Bax is critical for its conformational activation and its proapoptotic activity in response to H2O2-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; CASPASE ACTIVATION; HYDROGEN-PEROXIDE; ARSENIC TRIOXIDE; NITRIC-OXIDE; TRANSLOCATION; PHOSPHORYLATION; DIMERIZATION	Bax is activated and translocated onto mitochondria to mediate cytochrome c release and apoptosis. The molecular mechanisms of Bax activation during apoptosis remain a subject of debate. We addressed the question of whether reactive oxygen species could directly activate Bax for its subsequent translocation and apoptosis. Using the SW480 human colon adenocarcinoma cell line stably expressing Bax fused to GFP, we showed that H2O2 induces Bax conformational change, mitochondrial translocation, and subsequent oligomerization at mitochondria. We found that H2O2-induced Bax activation is dependent on the conserved cysteine residue 62 of Bax. Mutation of cysteine 6, but not cysteine 126, to serine or alanine abolished its activation by H2O2 but not other death stimuli, both in SW480 and Bax-deficient HCT116 cells, whereas wild type Bax sensitizes these cells to apoptosis. Cysteines of Bax could chemically react with H2O2. Mutation of Bax BH3 domain in the presence of cysteine 62 also abolished Bax proapoptotic activity. We conclude that reactive oxygen species could be a direct signal for Bax activation by reacting with cysteine residues. Our results identify a critical role of cysteine 62 in oxidative stress-induced Bax activation and subsequent apoptosis.	[Nie, Chunlai; Tian, Changhai; Zhao, Lixia; Mehrpour, Maryam; Chen, Quan] Chinese Acad Med Sci, Joint Lab Apoptosis & Canc Biol, State Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Tianjin 300071, Peoples R China; [Nie, Chunlai; Tian, Changhai; Zhao, Lixia; Mehrpour, Maryam; Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Petit, Patrice Xavier] Univ Paris 05, Inst Cochin, CNRS UMR 8104,INSERM U567, Dept Genet & Dev,Team Canc Apoptosis & Mitochondr, F-75014 Paris, France; [Mehrpour, Maryam] Univ Paris 11, Fac Pharm, INSERM U756, F-92296 Chatenay Malabry, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Nankai University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Mehrpour, M (corresponding author), Chinese Acad Sci, Lab Apoptosis & Canc Biol, IOZ, Beijing 100101, Peoples R China.	mehrpour@ioz.ac.cn	Mehrpour, Maryam/D-8640-2017; Petit, Patrice X./A-3692-2009; Tian, Changhai/AAD-4856-2019; Petit, patrice/AAF-6774-2020	Petit, Patrice X./0000-0002-5038-9101; Chen, Quan/0000-0001-7539-8728				Ahmad KA, 2004, CANCER RES, V64, P7867, DOI 10.1158/0008-5472.CAN-04-0648; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chen Q, 1997, J BIOL CHEM, V272, P14532, DOI 10.1074/jbc.272.23.14532; Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338; D'Alessio M, 2005, FASEB J, V19, P1504, DOI 10.1096/fj.04-3329fje; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Trojan J, 2004, INT J COLORECTAL DIS, V19, P538, DOI 10.1007/s00384-004-0597-1; Wang XD, 2001, GENE DEV, V15, P2922; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zheng YH, 2005, ONCOGENE, V24, P3339, DOI 10.1038/sj.onc.1208484; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205; Zhou H, 2007, ONCOGENE, V26, P7092, DOI 10.1038/sj.onc.1210517	36	85	92	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15359	15369		10.1074/jbc.M800847200	http://dx.doi.org/10.1074/jbc.M800847200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18344566	Green Published, hybrid			2022-12-27	WOS:000256232000054
J	Ishida, H; Huang, H; Yamniuk, AP; Takaya, Y; Vogel, HJ				Ishida, Hiroaki; Huang, Hao; Yamniuk, Aaron P.; Takaya, Yoshiaki; Vogel, Hans J.			The solution structures of two soybean calmodulin isoforms provide a structural basis for their selective target activation properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; PLANT CALMODULIN; NITRIC-OXIDE; BACKBONE DYNAMICS; BINDING PROTEINS; CHEMICAL-SHIFT; NMR; CALCIUM; DOMAIN; RELAXATION	The intracellular calcium ion is one of the most important secondary messengers in eukaryotic cells. Ca2+ signals are translated into physiological responses by EF-hand calcium-binding proteins such as calmodulin (CaM). Multiple CaM isoforms occur in plant cells, whereas only a single CaM protein is found in animals. Soybean CaM isoform 1 (sCaM1) shares 90% amino acid sequence identity with animal CaM (aCaM), whereas sCaM4 is only 78% identical. These two sCaM isoforms have distinct target-enzyme activation properties and physiological functions. sCaM4 is highly expressed during the self-defense reaction of the plant and activates the enzyme nitric-oxide synthase (NOS), whereas sCaM1 is incapable of activating NOS. The mechanism of selective target activation by plant CaM isoforms is poorly understood. We have determined high resolution NMR solution structures of Ca2+-sCaM1 and -sCaM4. These were compared with previously determined Ca2+-aCaM structures. For the N-lobe of the protein, the solution structures of Ca2+-sCaM1, -sCaM4, and -aCaM all closely resemble each other. However, despite the high sequence identity with aCaM, the C-lobe of Ca2+-sCaM1 has a more open conformation and consequently a larger hydrophobic target-protein binding pocket than Ca2+-aCaM or -sCaM4, the presence of which was further confirmed through biophysical measurements. The single Val-144 -> Met substitution in the C-lobe of Ca2+-sCaM1, which restores its ability to activate NOS, alters the structure of the C-lobe to a more closed conformation resembling Ca2+-aCaM and -sCaM4. The relationships between the structural differences in the two Ca2+-sCaM isoforms and their selective target activation properties are discussed.	[Ishida, Hiroaki; Huang, Hao; Yamniuk, Aaron P.; Takaya, Yoshiaki; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca						BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kondo R, 1999, J BIOL CHEM, V274, P36213, DOI 10.1074/jbc.274.51.36213; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Yamniuk AP, 2005, BIOCHEMISTRY-US, V44, P3101, DOI 10.1021/bi047770y; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yuan T, 1999, PROTEIN SCI, V8, P113; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	46	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14619	14628		10.1074/jbc.M801398200	http://dx.doi.org/10.1074/jbc.M801398200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347016	hybrid			2022-12-27	WOS:000255941400050
J	van der Weerden, NL; Lay, FT; Anderson, MA				van der Weerden, Nicole L.; Lay, Fung T.; Anderson, Marilyn A.			The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAHLIA DAHLIA-MERCKII; ANTIMICROBIAL PEPTIDES; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; ANTIFUNGAL ACTIVITY; GAMMA-PUROTHIONINS; PROTEIN; ARABIDOPSIS; MEMBRANE; MECHANISMS	The plant defensin, NaD1, from the flowers of Nicotiana alata displays potent antifungal activity against a variety of agronomically important filamentous fungi including Fusarium oxysporum f. sp. vasinfectum (Fov). To understand the mechanism of this antifungal activity, the effect of NaD1 on Fov fungal membranes and the location of NaD1 in treated hyphae was examined using various fluorescence techniques. NaD1 permeabilized fungal plasma membranes via the formation of an aperture with an internal diameter of between 14 and 22 A. NaD1 bound to the cell walls of all treated hyphae and entered several hyphae, resulting in granulation of the cytoplasm and cell death. These results suggest that the activity of antifungal plant defensins may not be restricted to the hyphal membrane and that they enter cells and affect intracellular targets.	[van der Weerden, Nicole L.; Lay, Fung T.; Anderson, Marilyn A.] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia	La Trobe University	Anderson, MA (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.	M.Anderson@latrobe.edu.Au	van der Weerden, Nicole L/C-3705-2014; Anderson, Marilyn A/A-4259-2012; Lay, Fung T/A-9043-2010	Anderson, Marilyn A/0000-0002-8257-5128; Lay, Fung T/0000-0002-3101-3782				Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753; BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P; Dickinson H G, 1998, Symp Soc Exp Biol, V51, P51; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Ibeas JI, 2000, PLANT J, V23, P375, DOI 10.1046/j.1365-313x.2000.00792.x; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Ladokhin AS, 1997, BIOPHYS J, V72, P1762, DOI 10.1016/S0006-3495(97)78822-2; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; McPhee JB, 2005, J PEPT SCI, V11, P677, DOI 10.1002/psc.704; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Salzman RA, 2004, MOL PLANT MICROBE IN, V17, P780, DOI 10.1094/MPMI.2004.17.7.780; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2006, CURR OPIN PLANT BIOL, V9, P142, DOI 10.1016/j.pbi.2006.01.002; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thevissen K, 2003, FEMS MICROBIOL LETT, V226, P169, DOI 10.1016/S0378-1097(03)00590-1; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Vylkova S, 2006, ANTIMICROB AGENTS CH, V50, P324, DOI 10.1128/AAC.50.1.324-331.2006; Wilson IW, 2005, PLANT CELL PHYSIOL, V46, P1190, DOI 10.1093/pcp/pci128; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	33	142	155	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14445	14452		10.1074/jbc.M709867200	http://dx.doi.org/10.1074/jbc.M709867200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18339623	hybrid			2022-12-27	WOS:000255941400031
J	Shah, C; Yang, G; Lee, I; Bielawski, J; Hannun, YA; Samad, F				Shah, Charmi; Yang, Guang; Lee, Ian; Bielawski, Jacek; Hannun, Yusuf A.; Samad, Fahumiya			Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PLASMA SPHINGOLIPID METABOLISM; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; OBESITY; RAT; INDUCTION; INFLAMMATION; EXPRESSION	Obesity increases the risk for metabolic and cardiovascular disease, and adipose tissue plays a central role in this process. Ceramide, the key intermediate of sphingolipid metabolism, also contributes to obesity-related disorders. We show that a high fat diet increased ceramide levels in the adipose tissues and plasma in C57BL/6J mice via a mechanism that involves an increase in gene expression of enzymes mediating ceramide generation through the de novo pathway (e. g. serine palmitoyltransferase) and via the hydrolysis of sphingomyelin (acid sphingomyelinase and neutral sphingomyelinase). Although the induction of total ceramide in response to the high fat diet was modest, dramatic increases were observed for C16, C18, and C18:1 ceramides. Next, we investigated the relationship of ceramide to plasminogen activator inhibitor-1 (PAI-1), the primary inhibitor of plasminogen activation and another key player in obesity. PAI-1 is consistently elevated in obesity and thought to contribute to increased artherothrombotic events and more recently to obesity-mediated insulin resistance. Interestingly, the changes in ceramide were attenuated in mice lacking PAI-1. Mechanistically, mice lacking PAI-1 were protected from dietinduced increase in serine palmitoyltransferase, acid sphingomyelinase, and neutral sphingomyelinase mRNA, providing a mechanistic link for decreased ceramide in PAI-1(-/-) mice. The decreases in plasma free fatty acids and adipose tumor necrosis factor-alpha in PAI-1(-/-) mice may have additionally contributed indirectly to improvements in ceramide profile in these mice. This study has identified a novel link between sphingolipid metabolism and PAI-1 and also suggests that ceramide may be an intermediary molecule linking elevated PAI-1 to insulin resistance.	[Shah, Charmi; Yang, Guang; Lee, Ian; Samad, Fahumiya] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Bielawski, Jacek; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Torrey Pines Institute for Molecular Studies, California; Medical University of South Carolina	Samad, F (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA.	fsamad@tpims.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071146] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL071146] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Auge N, 2004, CIRCULATION, V110, P571, DOI 10.1161/01.CIR.0000136995.83451.1D; Auge N, 2000, PROG LIPID RES, V39, P207, DOI 10.1016/S0163-7827(00)00007-2; Axelsson J, 2005, J RENAL NUTR, V15, P131, DOI 10.1053/j.jrn.2004.09.034; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007; Deng G, 2001, J CELL PHYSIOL, V189, P23, DOI 10.1002/jcp.1133; Dobrzyn A, 2002, AM J PHYSIOL-ENDOC M, V282, pE277, DOI 10.1152/ajpendo.00151.2001; FEARNS C, 1995, VASCULAR CONTROL HEM, P207; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P1575, DOI 10.1046/j.1538-7836.2003.00279.x; Kimura M, 2000, J NEUROSCI RES, V62, P781, DOI 10.1002/1097-4547(20001215)62:6<781::AID-JNR4>3.3.CO;2-N; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Li HG, 2002, CIRCULATION, V106, P2250, DOI 10.1161/01.CIR.0000035650.05921.50; Li ZQ, 2005, BBA-MOL CELL BIOL L, V1735, P130, DOI 10.1016/j.bbalip.2005.05.004; Lijnen HR, 2003, ARTERIOSCL THROM VAS, V23, P78, DOI 10.1161/01.ATV.0000044457.60665.DD; Lopez-Alemany R, 2003, EUR J BIOCHEM, V270, P814, DOI 10.1046/j.1432-1033.2003.03453.x; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Marathe S, 2000, ARTERIOSCL THROM VAS, V20, P2607, DOI 10.1161/01.ATV.20.12.2607; MEGIDISH T, 1995, BIOCHEM BIOPH RES CO, V216, P739, DOI 10.1006/bbrc.1995.2684; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mitchinson MJ, 1996, CURR OPIN LIPIDOL, V7, P324, DOI 10.1097/00041433-199610000-00011; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Morange PE, 2000, ARTERIOSCL THROM VAS, V20, P1150, DOI 10.1161/01.ATV.20.4.1150; Pandey M, 2005, FASEB J, V19, P1317, DOI 10.1096/fj.04-3459fje; Pandey M, 2003, AM J PATHOL, V162, P933, DOI 10.1016/S0002-9440(10)63888-6; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Samad F, 1997, THROMB HAEMOSTASIS, V78, P652; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Samad F, 1996, MOL MED, V2, P568, DOI 10.1007/BF03401641; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zendzian-Piotrowska M, 2006, J PHYSIOL PHARMACOL, V57, P101	53	110	111	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13538	13548		10.1074/jbc.M709950200	http://dx.doi.org/10.1074/jbc.M709950200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359942	Green Published, hybrid			2022-12-27	WOS:000255728200007
J	Drover, VA; Nguyen, DV; Bastie, CC; Darlington, YF; Abumrad, NA; Pessin, JE; London, E; Sahoo, D; Phillips, MC				Drover, Victor A.; Nguyen, David V.; Bastie, Claire C.; Darlington, Yolanda F.; Abumrad, Nada A.; Pessin, Jeffrey E.; London, Erwin; Sahoo, Daisy; Phillips, Michael C.			CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; B SCAVENGER RECEPTOR; SR-BI; CHOLESTEROL ABSORPTION; LIPID ABSORPTION; SERUM-ALBUMIN; TRANSPORT; LOCALIZATION; CELLS; ADRENOLEUKODYSTROPHY	The intestine has an extraordinary capacity for fatty acid ( FA) absorption. Numerous candidates for a protein-mediated mechanism of dietary FA absorption have been proposed, but firm evidence for this process has remained elusive. Here we show that the scavenger receptor CD36 is required both for the uptake of very long chain FAs (VLCFAs) in cultured cells and the absorption of dietary VLCFAs in mice. We found that the fraction of CD36-dependent saturated fatty acid association/ absorption in these model systems is proportional to the FA chain length and specific for fatty acids and fatty alcohols containing very long saturated acyl chains. Moreover, intestinal VLCFA absorption is completely abolished in CD36-null mice fed a high fat diet, illustrating that the predominant mechanism for VLCFA absorption is CD36-dependent. Together, these findings represent the first direct evidence for protein-facilitated FA absorption in the intestine and identify a novel therapeutic target for the treatment of diseases characterized by elevated VLCFA levels.	[Drover, Victor A.; Bastie, Claire C.; Darlington, Yolanda F.; Pessin, Jeffrey E.; Sahoo, Daisy] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Nguyen, David V.; Phillips, Michael C.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, GI Nutr Div, Philadelphia, PA 19104 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Washington University (WUSTL)	Drover, VA (corresponding author), H4880 Hlth Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53089 USA.	victor.drover@mcw.edu		Bastie, Claire/0000-0001-8178-4748; Phillips, Michael/0000-0002-7147-8007	NHLBI NIH HHS [HL63768, HL22633] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-08, DK060022, P30 DK056341, P30 DK056341-07] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, R01HL063768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK060022] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Calvo D, 1998, J LIPID RES, V39, P777; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916, DOI 10.1152/ajpendo.2001.281.5.E916; Choi JK, 2002, J LIPID RES, V43, P1000, DOI 10.1194/jlr.M200041-JLR200; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; FIELDS M, 1963, NATURE, V198, P994, DOI 10.1038/198994b0; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; Hamilton JA, 1998, J LIPID RES, V39, P467; HO JK, 1995, J CLIN INVEST, V96, P1455, DOI 10.1172/JCI118182; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; Kamp F, 2006, PROSTAG LEUKOTR ESS, V75, P149, DOI 10.1016/j.plefa.2006.05.003; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; Werder M, 2001, BIOCHEMISTRY-US, V40, P11643, DOI 10.1021/bi0109820; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b; Zhang XQ, 2003, LAB INVEST, V83, P317, DOI 10.1097/01.LAB.0000059923.67198.BA	30	104	108	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13108	13115		10.1074/jbc.M708086200	http://dx.doi.org/10.1074/jbc.M708086200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332148	hybrid, Green Published			2022-12-27	WOS:000255499800049
J	Gushiken, FC; Patel, V; Liu, Y; Pradhan, S; Bergeron, AL; Peng, Y; Vijayan, KV				Gushiken, Francisca C.; Patel, Vimal; Liu, Yan; Pradhan, Subhashree; Bergeron, Angela L.; Peng, Yuandong; Vijayan, K. Vinod			Protein phosphatase 2A negatively regulates integrin alpha(IIb)beta(3) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CYTOPLASMIC DOMAIN; CELL-MIGRATION; OKADAIC ACID; ACTIVATION; KINASE; PHOSPHORYLATION; PLATELETS; ADHESION; GROWTH	Integrin alpha(IIb)beta(3) activation is critical for platelet physiology and is controlled by signal transduction through kinases and phosphatases. Compared with kinases, a role for phosphatases in platelet integrin alpha(IIb)beta(3) signaling is less understood. We report that the catalytic subunit of protein phosphatase 2A (PP2Ac) associates constitutively with the integrin alpha(IIb)beta(3) in resting platelets and in human embryonal kidney 293 cells expressing alpha(IIb)beta(3). The membrane proximal KVGFFKR sequence within the cytoplasmic domain of integrin alpha(IIb) is sufficient to support a direct interaction with PP2Ac. Fibrinogen binding to alpha(IIb)beta(3) during platelet adhesion decreased integrin-associated PP2A activity and increased the phosphorylation of a PP2A substrate, vasodilator associated phosphoprotein. Overexpression of PP2Ac(alpha) in 293 cells decreased alpha(IIb)beta(3)-mediated adhesion to immobilized fibrinogen. Conversely, small interference RNA mediated knockdown of endogenous PP2Ac alpha expression in 293 cells, enhanced extracellular signal-regulated kinase (ERK1/2) and p38 activation, and accelerated alpha(IIb)beta(3) adhesion to fibrinogen and von Willebrand factor. Inhibition of ERK1/2, but not p38 activation, abolished the increased adhesiveness of PP2Ac(alpha)-depleted 293 cells to fibrinogen. Furthermore, knockdown of PP2Ac(alpha) expression in bone marrow-derived murine megakaryocytes increased soluble fibrinogen binding induced by protease-activated receptor 4-activating peptide. These studies demonstrate that PP2Ac(alpha) can negatively regulate integrin alpha(IIb)beta(3) signaling by suppressing the ERK1/2 signaling pathway.	[Gushiken, Francisca C.; Patel, Vimal; Liu, Yan; Pradhan, Subhashree; Bergeron, Angela L.; Peng, Yuandong; Vijayan, K. Vinod] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Vijayan, KV (corresponding author), Baylor Coll Med, Thrombosis Res Sect, Dept Med, 1 Baylor Plaza,BCM 286,N1319, Houston, TX 77030 USA.	vvijayan@bcm.tmc.edu			NHLBI NIH HHS [R01 HL081613, R01 HL081613-02, HL0816013, T-32HL072754] Funding Source: Medline; PHS HHS [0435017N] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, T32HL072754] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Brunton VG, 2001, NEOPLASIA, V3, P215, DOI 10.1038/sj.neo.7900149; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; HIGASHIHARA M, 1992, FEBS LETT, V307, P206, DOI 10.1016/0014-5793(92)80768-C; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KHEWGOODALL Y, 1988, FEBS LETT, V238, P265, DOI 10.1016/0014-5793(88)80493-9; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Larkin D, 2004, J BIOL CHEM, V279, P27286, DOI 10.1074/jbc.M402159200; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; LEREA KM, 2006, BIOCHIM BIOPHYS ACTA, V1773, P185; Li ZY, 2006, BLOOD, V107, P965, DOI 10.1182/blood-2005-03-1308; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Mutz D, 2006, J NEUROSCI RES, V84, P1759, DOI 10.1002/jnr.21078; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Rita M, 2003, INT J CANCER, V103, P38, DOI 10.1002/ijc.10772; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shiraga M, 1999, J CELL BIOL, V147, P1419, DOI 10.1083/jcb.147.7.1419; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Vijayan KV, 2003, J BIOL CHEM, V278, P3860, DOI 10.1074/jbc.M208680200; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Young MRI, 2002, INT J CANCER, V100, P276, DOI 10.1002/ijc.10491; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	36	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12862	12869		10.1074/jbc.M708804200	http://dx.doi.org/10.1074/jbc.M708804200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334487	hybrid, Green Published			2022-12-27	WOS:000255499800022
J	Lane, DJR; Lawen, A				Lane, Darius J. R.; Lawen, Alfons			Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRIC CITRATE UPTAKE; VITAMIN-C TRANSPORT; BOUND IRON; FERRIREDUCTASE ACTIVITY; DEHYDROASCORBIC ACID; STEAP PROTEINS; HEPATOMA-CELLS; NONHEME-IRON; METABOLISM; PLASMA	K562 erythroleukemia cells import non-transferrin-bound iron (NTBI) by an incompletely understood process that requires initial iron reduction. The mechanism of NTBI ferrir-eduction remains unknown but probably involves transplasma membrane electron transport. We here provide evidence for a novel mechanism of NTBI reduction and uptake by K562 cells that utilizes transplasma membrane ascorbate cycling. Incubation of cells with dehydroascorbic acid, but not ascorbate, resulted in (i) accumulation of intracellular ascorbate that was blocked by the glucose transporter inhibitor, cytochalasin B, and (ii) subsequent release of micromolar concentrations of ascorbate into the externalmedium via a route that was sensitive to the anion channel inhibitor, 4,4'-diisothiocyanatostilbene-2,2'-disulfonate. Ascorbate-deficient control cells demonstrated low levels of ferric citrate reduction. However, incubation of the cells with dehydroascorbic acid resulted in a dose-dependent stimulation of both iron reduction and uptake from radiolabeled [Fe-55] ferric citrate. This stimulation was abrogated by ascorbate oxidase treatment, suggesting dependence on direct chemical reduction by ascorbate. These results support a novel model of NTBI reduction and uptake by K562 cells in which uptake is preceded by reduction of iron by extracellular ascorbate, the latter of which is subsequently regenerated by transplasma membrane ascorbate cycling.	[Lane, Darius J. R.; Lawen, Alfons] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Melbourne, Vic 3800, Australia	Monash University	Lawen, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Bldg 13D,100 Wellington Rd, Melbourne, Vic 3800, Australia.	alfons.lawen@med.monash.edu.au	Lawen, Alfons/A-6598-2008	Lawen, Alfons/0000-0001-6553-9945; Lane, Darius/0000-0001-8725-6903				AKOMPONG T, 1995, J BIOL CHEM, V270, P20937, DOI 10.1074/jbc.270.36.20937; Anderson GJ, 2001, IUBMB LIFE, V51, P11, DOI 10.1080/15216540152035000; Baker E, 1998, BBA-GEN SUBJECTS, V1380, P21, DOI 10.1016/S0304-4165(97)00120-7; Breuer W, 2000, TRANSFUS SCI, V23, P185, DOI 10.1016/S0955-3886(00)00087-4; Brunner-Dopper L, 1998, ANAL BIOCHEM, V261, P128, DOI 10.1006/abio.1998.2712; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; CRANE FL, 1985, BIOCHIM BIOPHYS ACTA, V811, P233, DOI 10.1016/0304-4173(85)90013-8; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Davis KA, 2006, BRIT J PHARMACOL, V147, P131, DOI 10.1038/sj.bjp.0706492; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; DOREY C, 1993, BRIT J NUTR, V70, P157, DOI 10.1079/BJN19930113; Dringen R, 2007, NEUROCHEM RES, V32, P1884, DOI 10.1007/s11064-007-9375-0; Duarte TL, 2007, FREE RADICAL BIO MED, V43, P1165, DOI 10.1016/j.freeradbiomed.2007.07.017; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Fidler MC, 2004, AM J CLIN NUTR, V79, P99; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Ghio AJ, 2003, AM J RESP CELL MOL, V29, P653, DOI 10.1165/rcmb.2003-0070OC; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gutierrez JA, 1998, J CELL PHYSIOL, V177, P585, DOI 10.1002/(SICI)1097-4652(199812)177:4<585::AID-JCP9>3.3.CO;2-P; HAN O, 1995, J NUTR, V125, P1291; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HOFFMAN KE, 1991, AM J CLIN NUTR, V54, pS1188, DOI 10.1093/ajcn/54.6.1188s; INMAN RS, 1993, J BIOL CHEM, V268, P8521; INMAN RS, 1994, BIOCHEMISTRY-US, V33, P11850, DOI 10.1021/bi00205a022; JORDAN I, 1994, BIOCHEM J, V302, P875, DOI 10.1042/bj3020875; Jung CH, 1998, ARCH BIOCHEM BIOPHYS, V355, P9, DOI 10.1006/abbi.1998.0713; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Konigsberger LC, 2000, J INORG BIOCHEM, V78, P175, DOI 10.1016/S0162-0134(99)00222-6; Konya C, 2006, BRIT J PHARMACOL, V147, P125, DOI 10.1038/sj.bjp.0706494; Kovar J, 2006, BLOOD CELL MOL DIS, V37, P95, DOI 10.1016/j.bcmd.2006.06.004; Laggner H, 1999, EUR J BIOCHEM, V262, P659, DOI 10.1046/j.1432-1327.1999.00403.x; Lane DJR, 2008, ANAL BIOCHEM, V373, P287, DOI 10.1016/j.ab.2007.09.009; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; May JM, 2006, NEUROCHEM RES, V31, P785, DOI 10.1007/s11064-006-9077-z; May JM, 1999, BIOCHEM PHARMACOL, V57, P1275, DOI 10.1016/S0006-2952(99)00040-4; Musilkova J, 2001, BBA-BIOMEMBRANES, V1514, P117, DOI 10.1016/S0005-2736(01)00367-4; Ngkeekwong FC, 1997, BIOCHEM J, V324, P225, DOI 10.1042/bj3240225; Nualart FJ, 2003, J BIOL CHEM, V278, P10128, DOI 10.1074/jbc.M210686200; Oakhill JS, 2008, BBA-BIOENERGETICS, V1777, P260, DOI 10.1016/j.bbabio.2007.12.001; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Rumsey SC, 1998, J NUTR BIOCHEM, V9, P116, DOI 10.1016/S0955-2863(98)00002-3; SAVINI I, 2007, IN PRESS AMINO ACIDS; Schweinzer E, 1996, CELL BIOCHEM FUNCT, V14, P27, DOI 10.1002/(SICI)1099-0844(199603)14:1<27::AID-CBF635>3.3.CO;2-P; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Su D, 2006, FEBS J, V273, P3722, DOI 10.1111/j.1742-4658.2006.05381.x; Su D, 2006, J BIOL CHEM, V281, P39852, DOI 10.1074/jbc.M606543200; Takeda A, 2002, NEUROCHEM INT, V41, P223, DOI 10.1016/S0197-0186(02)00023-2; TOTH I, 1995, J BIOL CHEM, V270, P2846, DOI 10.1074/jbc.270.6.2846; Trinder D, 1998, AM J PHYSIOL-GASTR L, V275, pG279, DOI 10.1152/ajpgi.1998.275.2.G279; Upston JM, 1999, BIOCHEM J, V342, P49, DOI 10.1042/0264-6021:3420049; Van Duijn MM, 1998, J BIOL CHEM, V273, P13415, DOI 10.1074/jbc.273.22.13415; Verrijt CEH, 1998, PLACENTA, V19, P525, DOI 10.1016/S0143-4004(98)91046-3; WATKINS D, 1983, BIOCHEM J, V214, P465, DOI 10.1042/bj2140465; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Wilson JX, 2000, BRAIN RES, V858, P61, DOI 10.1016/S0006-8993(99)02433-6	59	44	47	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12701	12708		10.1074/jbc.M800713200	http://dx.doi.org/10.1074/jbc.M800713200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18347019	hybrid			2022-12-27	WOS:000255499800005
J	Palazuelos, J; Davoust, N; Julien, B; Hatterer, E; Aguado, T; Mechoulam, R; Benito, C; Romero, J; Silva, A; Guzman, M; Nataf, S; Galve-Roperh, I				Palazuelos, Javier; Davoust, Nathalie; Julien, Boris; Hatterer, Eric; Aguado, Tania; Mechoulam, Raphael; Benito, Cristina; Romero, Julian; Silva, Augusto; Guzman, Manuel; Nataf, Serge; Galve-Roperh, Ismael			The CB2 cannabinoid receptor controls myeloid progenitor trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; ENDOCANNABINOID SYSTEM; MICROGLIAL CELLS; MURINE MODEL; SPASTICITY; BRAIN; INFLAMMATION; DIFFERENTIATION; INVOLVEMENT; MODULATION	Cannabinoids are potential agents for the development of therapeutic strategies against multiple sclerosis. Here we analyzed the role of the peripheral CB2 cannabinoid receptor in the control of myeloid progenitor cell trafficking toward the inflamed spinal cord and their contribution to microglial activation in an animal model of multiple sclerosis ( experimental autoimmune encephalomyelitis, EAE). CB2 receptor knock-out mice showed an exacerbated clinical score of the disease when compared with their wild-type littermates, and this occurred in concert with extended axonal loss, T-lymphocyte (CD4(+)) infiltration, and microglial ( CD11b(+)) activation. Immature bone marrow-derived CD34(+) myeloid progenitor cells, which play a role in neuroinflammatory pathologies, were shown to express CB2 receptors and to be abundantly recruited toward the spinal cords of CB2 knock-out EAE mice. Bone marrow-derived cell transfer experiments further evidenced the increased contribution of these cells to microglial replenishment in the spinal cords of CB2-deficient animals. In line with these observations, selective pharmacological CB2 activation markedly reduced EAE symptoms, axonal loss, and microglial activation. CB2 receptor manipulation altered the expression pattern of different chemokines (CCL2, CCL3, CCL5) and their receptors (CCR1, CCR2), thus providing a mechanistic explanation for its role in myeloid progenitor recruitment during neuroinflammation. These findings demonstrate the protective role of CB2 receptors in EAE pathology; provide evidence for a new site of CB2 receptor action, namely the targeting of myeloid progenitor trafficking and its contribution to microglial activation; and support the potential use of non-psychoactive CB2 agonists in therapeutic strategies for multiple sclerosis and other neuroinflammatory disorders.	[Palazuelos, Javier; Julien, Boris; Aguado, Tania; Guzman, Manuel; Galve-Roperh, Ismael] Univ Complutense, Dept Biochem & Mol Biol 1, Sch Biol, E-28040 Madrid, Spain; [Palazuelos, Javier; Julien, Boris; Aguado, Tania; Guzman, Manuel; Galve-Roperh, Ismael] Univ Complutense, CIBERNED, E-28040 Madrid, Spain; [Davoust, Nathalie; Hatterer, Eric; Nataf, Serge] Fac Med Laennec, Inst Federatif Rech Neurosci Lyon, INSERM, U433, F-69372 Lyon, France; [Mechoulam, Raphael] Hebrew Univ Jerusalem, Sch Pharm, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel; [Benito, Cristina; Romero, Julian] Fdn Hosp Alcorcon, Lab Apoyo Invest, Madrid 28922, Spain; [Silva, Augusto] CSIC, CIB, Madrid 28040, Spain	Complutense University of Madrid; CIBERNED; Complutense University of Madrid; Institut National de la Sante et de la Recherche Medicale (Inserm); Hebrew University of Jerusalem; Alcorcon Foundation University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Galve-Roperh, I (corresponding author), Univ Complutense, Dept Biochem & Mol Biol 1, Sch Biol, E-28040 Madrid, Spain.	igr@quim.ucm.es	PAREDES, JULIAN ROMERO/F-4772-2016; Galve-Roperh, Ismael/AAG-2369-2020; Davoust, Nathalie/S-5676-2017; Aguado, Tania/AAE-3972-2019; AGUADO SANCHEZ, TANIA/ABD-6975-2021; PALAZUELOS, JAVIER/AAD-7313-2020; Julien, Boris/E-2374-2012; PALAZUELOS, JAVIER/D-1211-2013	PAREDES, JULIAN ROMERO/0000-0002-2897-606X; AGUADO SANCHEZ, TANIA/0000-0003-4339-0443; PALAZUELOS, JAVIER/0000-0002-0409-1398; Guzman, Manuel/0000-0001-7475-118X				Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Babcock AA, 2003, J NEUROSCI, V23, P7922; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabranes A, 2005, NEUROBIOL DIS, V20, P207, DOI 10.1016/j.nbd.2005.03.002; Carayon P, 1998, BLOOD, V92, P3605, DOI 10.1182/blood.V92.10.3605.422k05_3605_3615; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Davoust N, 2006, FASEB J, V20, P2081, DOI 10.1096/fj.05-5593com; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Docagne F, 2007, MOL CELL NEUROSCI, V34, P551, DOI 10.1016/j.mcn.2006.12.005; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Jorda MA, 2004, BLOOD, V104, P526, DOI 10.1182/blood-2003-12-4257; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MECHOULAM R, 2002, SCI STKE, V129, pE5; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; Nataf S, 2000, J IMMUNOL, V165, P5867, DOI 10.4049/jimmunol.165.10.5867; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Pryce G, 2005, TRENDS NEUROSCI, V28, P272, DOI 10.1016/j.tins.2005.03.006; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Vallieres L, 2003, J NEUROSCI, V23, P5197; Wade DT, 2006, MULT SCLER J, V12, P639, DOI 10.1177/1352458505070618; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Zajicek JP, 2005, J NEUROL NEUROSUR PS, V76, P1664, DOI 10.1136/jnnp.2005.070136; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	46	132	139	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13320	13329		10.1074/jbc.M707960200	http://dx.doi.org/10.1074/jbc.M707960200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334483	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000255499800072
J	Gonzales, ML; Mellman, DL; Anderson, RA				Gonzales, Michael L.; Mellman, David L.; Anderson, Richard A.			CKI alpha is associated with and phosphorylates Star-PAP and is also required for expression of select Star-PAP target messenger RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; PHOSPHATIDYLINOSITOL PHOSPHATE KINASES; POLY(A) POLYMERASE; HEME OXYGENASE-1; FAMILY; POLYADENYLATION; EUKARYOTES; MECHANISM	We have recently identified Star-PAP, a nuclear poly( A) polymerase that associates with phosphatidylinositol-4-phosphate 5-kinase I alpha (PIPKI alpha) and is required for the expression of a specific subset of mRNAs. Star-PAP activity is directly modulated by the PIPKI alpha product phosphatidylinositol 4,5-bisphosphate (PI-4,5-P-2), linking nuclear phosphoinositide signaling to gene expression. Here, we show that PI-4,5-P-2-dependent protein kinase activity is also a part of the Star-PAP protein complex. We identify the PI-4,5- P-2-sensitive casein kinase I alpha (CKI alpha) as a protein kinase responsible for this activity and further show that CKI alpha is capable of directly phosphorylating Star-PAP. Both CKI alpha and PIPKI alpha are required for the synthesis of some but not all Star-PAP target mRNA, and like Star-PAP, CKI alpha is associated with these messages in vivo. Taken together, these data indicate that CKI alpha, PIPKI alpha, and Star-PAP function together to modulate the production of specific Star-PAP messages. The Star-PAP complex therefore represents a location where multiple signaling pathways converge to regulate the expression of specific mRNAs.	[Gonzales, Michael L.; Mellman, David L.; Anderson, Richard A.] Univ Wisconsin, Dept Pharmacol, Mol & Cellular Pharmacol Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Dept Pharmacol, Mol & Cellular Pharmacol Training Program, 1300 Univ Ave,Rm 3750 MSC, Madison, WI 53706 USA.	raanders@wisc.edu		Anderson, Richard/0000-0001-6265-8359	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051968, R01GM114386] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051968, R01 GM114386] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; BAZENET CE, 1990, J BIOL CHEM, V265, P7369; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; Gross SD, 1999, J CELL SCI, V112, P2647; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; HUMPHREY T, 1987, EMBO J, V6, P4159, DOI 10.1002/j.1460-2075.1987.tb02762.x; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Takahashi T, 2004, CURR MED CHEM, V11, P1545, DOI 10.2174/0929867043365080; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao WQ, 1998, MOL CELL BIOL, V18, P5010, DOI 10.1128/MCB.18.9.5010	26	39	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12665	12673		10.1074/jbc.M800656200	http://dx.doi.org/10.1074/jbc.M800656200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18305108	Green Published, hybrid			2022-12-27	WOS:000255340000083
J	Hazelbaker, D; Azaro, MA; Landy, A				Hazelbaker, Dane; Azaro, Marco A.; Landy, Arthur			A biotin interference assay highlights two different asymmetric interaction profiles for lambda integrase arm-type binding sites in integrative versus excisive recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA; DNA-BINDING; ATT-SITE; CRYSTAL-STRUCTURE; SINGLE-BASE; HOST FACTOR; PROTEIN; DIRECTIONALITY; COMPLEX; XIS	The site-specific recombinase integrase encoded by bacteriophage lambda promotes integration and excision of the viral chromosome into and out of its Escherichia coli host chromosome through a Holliday junction recombination intermediate. This intermediate contains an integrase tetramer bound via its catalytic carboxyl-terminal domains to the four "core-type" sites of the Holliday junction DNA and via its amino-terminal domains to distal "arm-type" sites. The two classes of integrase binding sites are brought into close proximity by an ensemble of accessory proteins that bind and bend the intervening DNA. We have used a biotin interference assay that probes the requirement for major groove protein binding at specified DNA loci in conjunction with DNA protection, gel mobility shift, and genetic experiments to test several predictions of the models derived from the x-ray crystal structures of minimized and symmetrized surrogates of recombination intermediates lacking the accessory proteins and their cognate DNA targets. Our data do not support the predictions of "non-canonical" DNA targets for the N-domain of integrase, and they indicate that the complexes used for x-ray crystallography are more appropriate for modeling excisive rather than integrative recombination intermediates. We suggest that the difference in the asymmetric interaction profiles of the N-domains and arm-type sites in integrative versus excisive recombinogenic complexes reflects the regulation of recombination, whereas the asymmetry of these patterns within each reaction contributes to directionality.	[Hazelbaker, Dane; Landy, Arthur] Brown Univ, Dept Biochem Mol Biol & Cellular Biol, Providence, RI 02912 USA; [Azaro, Marco A.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Brown University; Rutgers State University New Brunswick	Landy, A (corresponding author), 185 Meeting St, Providence, RI 02912 USA.	Arthur_Landy@brown.edu			NIGMS NIH HHS [R01 GM033928, R01 GM062723, GM62723, R01 GM033928-23, R01 GM062723-31, GM33928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062723, R01GM033928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbani MA, 2007, P NATL ACAD SCI USA, V104, P2109, DOI 10.1073/pnas.0607820104; ABREMSKI K, 1982, J BIOL CHEM, V257, P9658; Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; Azaro MA., 2002, MOBILE DNA-UK, P118, DOI DOI 10.1128/9781555817954.CH7; BAUER CE, 1986, J MOL BIOL, V192, P513, DOI 10.1016/0022-2836(86)90273-1; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Boldt JL, 2007, NUCLEIC ACIDS RES, V35, P716, DOI 10.1093/nar/gkl1078; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; BUSHMAN W, 1984, CELL, V39, P699, DOI 10.1016/0092-8674(84)90477-X; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; CAMPBELL AM, 1962, ADV GENET, V11, P101; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DEVARGAS LM, 1991, P NATL ACAD SCI USA, V88, P588, DOI 10.1073/pnas.88.2.588; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; GOPALAKRISHNAN V, 1994, J BIOL CHEM, V269, P21123; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HSU PL, 1984, NATURE, V311, P721, DOI 10.1038/311721a0; KIM S, 1992, SCIENCE, V256, P198, DOI 10.1126/science.1533056; KIM SH, 1990, CELL, V63, P773, DOI 10.1016/0092-8674(90)90143-3; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; KOSTREWA D, 1991, NATURE, V349, P178, DOI 10.1038/349178a0; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LANDY A, 1977, SCIENCE, V197, P1147, DOI 10.1126/science.331474; Lynch TW, 2003, J MOL BIOL, V330, P493, DOI 10.1016/S0022-2836(03)00529-1; Maxam A M, 1980, Methods Enzymol, V65, P499; MIZUUCHI K, 1980, COLD SPRING HARB SYM, V45, P429; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; NASH HA, 1981, J BIOL CHEM, V256, P9246; NASH HA, 1974, NATURE, V247, P543, DOI 10.1038/247543a0; NUMRYCH TE, 1992, EMBO J, V11, P3797, DOI 10.1002/j.1460-2075.1992.tb05465.x; NUMRYCH TE, 1990, NUCLEIC ACIDS RES, V18, P3953, DOI 10.1093/nar/18.13.3953; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; NUNESDUBY SE, 1995, J MOL BIOL, V253, P228, DOI 10.1006/jmbi.1995.0548; NUNESDUBY SE, 1989, CELL, V59, P197, DOI 10.1016/0092-8674(89)90881-7; Pan CQ, 1996, J MOL BIOL, V264, P675, DOI 10.1006/jmbi.1996.0669; Papagiannis CV, 2007, J MOL BIOL, V367, P328, DOI 10.1016/j.jmb.2006.12.071; Radman-Livaja M, 2006, CURR OPIN STRUC BIOL, V16, P42, DOI 10.1016/j.sbi.2005.12.003; Radman-Livaja M, 2005, P NATL ACAD SCI USA, V102, P3913, DOI 10.1073/pnas.0500844102; Radman-Livaja M, 2003, MOL CELL, V11, P783, DOI 10.1016/S1097-2765(03)00111-4; RADMANLIVAJA M, 2003, THESIS BROWN U; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; RICHET E, 1986, CELL, V46, P1011, DOI 10.1016/0092-8674(86)90700-2; ROSS W, 1982, P NATL ACAD SCI-BIOL, V79, P7724, DOI 10.1073/pnas.79.24.7724; Sam MD, 2004, J MOL BIOL, V338, P229, DOI 10.1016/j.jmb.2004.02.053; Sam MD, 2002, J MOL BIOL, V324, P791, DOI 10.1016/S0022-2836(02)01150-6; Sarkar D, 2002, J MOL BIOL, V324, P775, DOI 10.1016/S0022-2836(02)01199-3; Sarkar D, 2001, EMBO J, V20, P1203, DOI 10.1093/emboj/20.5.1203; Sun XM, 2006, MOL CELL, V24, P569, DOI 10.1016/j.molcel.2006.10.006; TELSER J, 1989, J AM CHEM SOC, V111, P6966, DOI 10.1021/ja00200a011; THOMPSON JF, 1987, J MOL BIOL, V195, P481, DOI 10.1016/0022-2836(87)90177-X; THOMPSON JF, 1987, CELL, V50, P901, DOI 10.1016/0092-8674(87)90516-2; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; THOMPSON JF, 1986, J BACTERIOL, V168, P1343, DOI 10.1128/jb.168.3.1343-1351.1986; Tirumalai RS, 1997, P NATL ACAD SCI USA, V94, P6104, DOI 10.1073/pnas.94.12.6104; TULLIUS TD, 1989, ANNU REV BIOPHYS BIO, V18, P213, DOI 10.1146/annurev.bb.18.060189.001241; Van Duyne G.D., 2002, MOBILE DNA, VII, P93; Van Duyne GD, 2005, CURR BIOL, V15, pR658, DOI 10.1016/j.cub.2005.08.031; Warren D, 2005, MOL MICROBIOL, V55, P1104, DOI 10.1111/j.1365-2958.2004.04447.x; WINOTO A, 1986, J MOL BIOL, V192, P677, DOI 10.1016/0022-2836(86)90286-X; Wojciak JM, 2002, P NATL ACAD SCI USA, V99, P3434, DOI 10.1073/pnas.052017999	63	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12402	12414		10.1074/jbc.M800544200	http://dx.doi.org/10.1074/jbc.M800544200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319248	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000255340000057
J	Kayama, H; Ramirez-Carrozzi, VR; Yamamoto, M; Mizutani, T; Kuwata, H; Iba, H; Matsumoto, M; Honda, K; Smale, ST; Takeda, K				Kayama, Hisako; Ramirez-Carrozzi, Vladimir R.; Yamamoto, Masahiro; Mizutani, Taketoshi; Kuwata, Hirotaka; Iba, Hideo; Matsumoto, Makoto; Honda, Kenya; Smale, Stephen T.; Takeda, Kiyoshi			Class-specific regulation of pro-inflammatory genes by MyD88 pathways and I kappa B zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE NUCLEAR-PROTEIN; NEGATIVE REGULATION; REMODELING COMPLEXES; IMMUNE-RESPONSES; ACTIVE GENES; HISTONE H3; T-CELLS; CHROMATIN; TRANSCRIPTION; INDUCTION	Toll-like receptors trigger the induction of primary response genes via MyD88-mediated activation of NF-kappa B and other transcription factors. These factors then act in concert with primary response gene products to induce secondary response genes. Although the MyD88 pathway is important for the expression of both primary and secondary response genes, we show that the recruitment of NF-kappa B, RNA polymerase, and the TATA-binding protein is MyD88-dependent only at secondary response genes. This selective dependence correlates with the fact that MyD88 is required for nucleosome remodeling and histone H3K4 trimethylation at secondary response promoters, whereas rapidly induced primary response promoters are assembled into poised MyD88-independent chromatin structures. At a subset of secondary response promoters, I kappa B zeta was identified as a selective regulator of H3K4 trimethylation and preinitiation complex assembly after nucleosome remodeling. These mechanistic distinctions advance our understanding of the diverse molecular cascades that underlie the differential regulation of pro-inflammatory genes.	[Ramirez-Carrozzi, Vladimir R.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, HHMI, Los Angeles, CA 90095 USA; [Kayama, Hisako; Yamamoto, Masahiro; Honda, Kenya; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Kayama, Hisako; Kuwata, Hirotaka; Matsumoto, Makoto; Takeda, Kiyoshi] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 8128582, Japan; [Mizutani, Taketoshi; Iba, Hideo] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Host Parasite Interact, Tokyo 1088639, Japan	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Osaka University; Kyushu University; University of Tokyo	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, HHMI, 6525 MRL,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu; ktakeda@ongene.med.osaka-u.ac.jp	Kuwata, Hiro/N-2023-2019; Takeda, Kiyoshi/C-9331-2009	Kuwata, Hiro/0000-0002-5023-1777; Takeda, Kiyoshi/0000-0002-1778-6332	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DINARELLO CA, 1991, J INFECT DIS, V163, P1177, DOI 10.1093/infdis/163.6.1177; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mostoslavsky R, 2003, NAT IMMUNOL, V4, P603, DOI 10.1038/ni0703-603; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Natoli G, 2006, FEBS LETT, V580, P2843, DOI 10.1016/j.febslet.2006.02.072; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Zhang XW, 2001, BRIT J PHARMACOL, V133, P413, DOI 10.1038/sj.bjp.0704087; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004	41	76	77	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12468	12477		10.1074/jbc.M709965200	http://dx.doi.org/10.1074/jbc.M709965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319258	hybrid			2022-12-27	WOS:000255340000063
J	Maghzal, GJ; Thomas, SR; Hunt, NH; Stocker, R				Maghzal, Ghassan J.; Thomas, Shane R.; Hunt, Nicholas H.; Stocker, Roland			Cytochrome b(5), not superoxide anion radical, is a major reductant of indoleamine 2,3-dioxygenase in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN-METABOLISM; INTERFERON-GAMMA; DIHYDROFLAVIN MONONUCLEOTIDE; POSTTRANSLATIONAL REGULATION; KYNURENINE PATHWAY; METHYLENE-BLUE; NITRIC-OXIDE; IN-VIVO; ENZYME; HYDROETHIDINE	The heme protein indoleamine 2,3-dioxygenase (IDO) initiates oxidative metabolism of tryptophan along the kynurenine pathway, and this requires reductive activation of Fe3+-IDO. The current dogma is that superoxide anion radical (O-2(radical anion)) is responsible for this activation, based largely on previous work employing purified rabbit IDO and rabbit enterocytes. We have re-investigated this role of O-2(radical anion). using purified recombinant human IDO (rhIDO), rabbit enterocytes that constitutively express IDO, human endothelial cells, and monocyte-derived macrophages treated with interferon-gamma to induce IDO expression, and two cell lines transfected with the human IDO gene. Both potassium superoxide and O-2(radical anion) generated by xanthine oxidase modestly activated rhIDO, in reactions thatwerepreventedcompletelybysuperoxidedismutase(SOD). In contrast, SOD mimetics had no effect on IDO activity in enterocytes and interferon-gamma-treated human cells, despite significantly decreasing cellular O-2(radical anion). Similarly, cellular IDO activity was unaffected by increasing SOD activity via co-expression of Cu, Zn-SOD or by increasing cellular O-2(radical anion) via treatment of cells with menadione. Other reductants, such as tetrahydrobiopterin, ascorbate, and cytochrome P450 reductase, were ineffective in activating cellular IDO. However, recombinant human cytochrome b(5) plus cytochrome P450 reductase and NADPH reduced Fe3+-IDO to Fe2+-IDO and activated rhIDO in a reconstituted system, a reaction inhibited marginally by SOD. Additionally, short interfering RNA-mediated knockdown of microsomal cytochrome b(5) significantly decreased IDO activityin IDO-transfected cells. Together, our data show that cytochrome b(5) rather than O-2(radical anion) plays a major role in the activation of IDO in human cells.	[Maghzal, Ghassan J.; Stocker, Roland] Univ Sydney, Sch Med Sci, Ctr Vasc Res, Sydney, NSW 2006, Australia; [Hunt, Nicholas H.] Univ Sydney, Sch Med Sci, Bosch Inst, Mol Immunopathol Unit, Sydney, NSW 2006, Australia; [Hunt, Nicholas H.] Univ Sydney, Sch Med Sci, Discipline Pathol, Sydney, NSW 2006, Australia; [Maghzal, Ghassan J.; Thomas, Shane R.; Stocker, Roland] Univ New S Wales, Fac Med, Ctr Vasc Res, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney	Stocker, R (corresponding author), Univ Sydney, Sch Med Sci, Ctr Vasc Res, Bosch Inst, Med Fdn Bldg,92-94 Parramatta Rd, Camperdown, NSW 2006, Australia.	rstocker@med.usyd.edu.au	maghzal, ghassan/A-9692-2015; Stocker, Roland/AAV-4489-2021; Hunt, Nick H/A-3636-2011					BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; CHRISTEN S, 1994, J CLIN INVEST, V93, P2149, DOI 10.1172/JCI117211; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; HALLIWELL B, 2007, FREE RADICAL BIO MED, P82; Hansen AM, 2004, INT J PARASITOL, V34, P1309, DOI 10.1016/j.ijpara.2004.07.008; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; HAYAISHI O, 1977, J BIOL CHEM, V252, P3548; HIRATA F, 1977, J BIOL CHEM, V252, P4637; HIRATA F, 1975, J BIOL CHEM, V250, P5960; Hultquist D E, 1981, Prog Clin Biol Res, V55, P291; Iwamoto Y, 1996, ADV EXP MED BIOL, V398, P441; KUMA F, 1981, J BIOL CHEM, V256, P5518; Littlejohn TK, 2000, PROTEIN EXPRES PURIF, V19, P22, DOI 10.1006/prep.2000.1214; LIVINGSTON DJ, 1985, J BIOL CHEM, V260, P5699; Maghzal GJ, 2007, FREE RADICAL BIO MED, V43, P1095, DOI 10.1016/j.freeradbiomed.2007.06.023; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; ODONNELL VB, 1994, MOL PHARMACOL, V46, P778; OHNISHI T, 1977, J BIOL CHEM, V252, P4643; OZAKI Y, 1986, BIOCHEM BIOPH RES CO, V137, P1106, DOI 10.1016/0006-291X(86)90339-6; OZAKI Y, 1987, ARCH BIOCHEM BIOPHYS, V257, P207, DOI 10.1016/0003-9861(87)90560-1; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Pyatt DW, 2000, BIOCHEM BIOPH RES CO, V274, P513, DOI 10.1006/bbrc.2000.3149; SAKAI N, 1993, BIOCHEM J, V295, P543, DOI 10.1042/bj2950543; Salvemini D, 2002, PULM PHARMACOL THER, V15, P439, DOI 10.1006/pupt.2002.0374; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SONO M, 1980, J BIOL CHEM, V255, P1339; SONO M, 1989, J BIOL CHEM, V264, P1616; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Suzuki T, 1998, J PROTEIN CHEM, V17, P817, DOI 10.1023/A:1020782403070; Suzuki T, 1998, COMP BIOCHEM PHYS B, V121, P117, DOI 10.1016/S0305-0491(98)10086-X; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; TANIGUCHI T, 1979, J BIOL CHEM, V254, P3288; TANIGUCHI T, 1977, J BIOL CHEM, V252, P2774; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; TEW DG, 1993, BIOCHEMISTRY-US, V32, P10209, DOI 10.1021/bi00089a042; Thomas SR, 2007, J BIOL CHEM, V282, P23778, DOI 10.1074/jbc.M700669200; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Vottero E, 2006, FEBS LETT, V580, P2265, DOI 10.1016/j.febslet.2006.03.034; Warburg O, 1930, BIOCHEM Z, V227, P245; WERNER ER, 1989, BIOCHEM J, V262, P861, DOI 10.1042/bj2620861; Werner ER, 2007, CURR DRUG METAB, V8, P201, DOI 10.2174/138920007780362482; Xue LL, 1999, BIOCHEMISTRY-US, V38, P11961, DOI 10.1021/bi990893b; YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031; Zielonka J, 2006, FREE RADICAL BIO MED, V41, P1050, DOI 10.1016/j.freeradbiomed.2006.04.017	54	66	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12014	12025		10.1074/jbc.M710266200	http://dx.doi.org/10.1074/jbc.M710266200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18299324	hybrid			2022-12-27	WOS:000255340000017
J	Song, P; Xie, ZL; Wu, Y; Xu, J; Dong, YZ; Zou, MH				Song, Ping; Xie, Zhonglin; Wu, Yong; Xu, Jian; Dong, Yunzhou; Zou, Ming-Hui			Protein kinase C zeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells (Publication with Expression of Concern. See vol. 294, pg. 10026, 2019) (Withdrawn Publication. See vol. 294, pg. 13831, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							TUMOR-NECROSIS-FACTOR; PKC-ZETA; NITRIC-OXIDE; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATASE-ACTIVITY; GLUCOSE-HOMEOSTASIS; SKELETAL-MUSCLE; IN-VIVO; PEROXYNITRITE; ACTIVATION	LKB1 is a serine-threonine protein kinase that, when inhibited, may result in unregulated cell growth and tumor formation. However, how LKB1 is regulated remains poorly understood. The aim of the present study was to define the upstream signaling events responsible for peroxynitrite (ONOO-)-induced LKB1 activation. Exposure of cultured human umbilical vein endothelial cells to a low concentration of ONOO- (5 mu M) significantly increased the phosphorylation of LKB1 at Ser(428) and protein kinase C zeta (PKC zeta) at Thr(410). These effects were accompanied by increased activity of the lipid phosphatase PTEN, decreased activity and phosphorylation (Ser(473)) of Akt, and induction of apoptosis. ONOO- enhanced Akt-Ser(473) phosphorylation in LKB1-deficient HeLa S3 cells or in HeLa S3 cells transfected with kinase-dead LKB1. Conversely, ONOO- inhibited Akt Ser(473) phosphorylation when wild type LKB1 were reintroduced in HeLa S3 cells. Further analysis revealed that PKC zeta directly phosphorylated LKB1 at Ser(428) in vitro and in intact cells, resulting in increased PTEN phosphorylation at Ser(380)/Thr(382)/ (383). Finally, ONOO- enhanced PKC zeta nuclear import and LKB1 nuclear export. We conclude that PKC zeta mediates LKB1-dependent Akt inhibition in response to ONOO-, resulting in endothelial apoptosis.	[Song, Ping; Xie, Zhonglin; Wu, Yong; Xu, Jian; Dong, Yunzhou; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Endocrinol & Diabet, BSEB 325, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	Song, Ping/N-8456-2018; Song, Ping/D-6972-2011	Song, Ping/0000-0002-6143-4270; Song, Ping/0000-0002-2654-6162	NHLBI NIH HHS [HL089920, HL080499, HL079584, HL074399] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080499, R01HL089920, R01HL079584, R01HL074399] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Alvarez MN, 2004, ARCH BIOCHEM BIOPHYS, V432, P222, DOI 10.1016/j.abb.2004.09.015; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Boudeau J, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9112; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; de Kozak Y, 2007, AM J PATHOL, V170, P1241, DOI 10.2353/ajpath.2007.060236; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Ferdinandy P, 2000, CIRC RES, V87, P241, DOI 10.1161/01.RES.87.3.241; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Garin G, 2007, CIRC RES, V101, P97, DOI 10.1161/CIRCRESAHA.107.148270; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Javaid K, 2003, CIRC RES, V92, P1089, DOI 10.1161/01.RES.0000072971.88704.CB; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jimenez AI, 2003, CANCER RES, V63, P1382; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Katori T, 2006, FREE RADICAL BIO MED, V41, P1606, DOI 10.1016/j.freeradbiomed.2006.08.023; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Knapp LT, 2001, BIOCHEM BIOPH RES CO, V286, P764, DOI 10.1006/bbrc.2001.5448; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leroy I, 2005, CELL SIGNAL, V17, P1149, DOI 10.1016/j.cellsig.2004.12.013; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu LZ, 2006, MOL BIOL CELL, V17, P2322, DOI 10.1091/mbc.E05-10-0969; Lorenzo M, 2002, EXP CELL RES, V278, P146, DOI 10.1006/excr.2002.5570; Magid R, 2005, CIRC RES, V97, P443, DOI 10.1161/01.RES.0000179767.37838.60; Mehenni H, 2005, HUM MOL GENET, V14, P2209, DOI 10.1093/hmg/ddi225; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Rahman A, 2000, AM J PHYSIOL-CELL PH, V279, pC906, DOI 10.1152/ajpcell.2000.279.4.C906; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schulz R, 1997, AM J PHYSIOL-HEART C, V272, pH1212, DOI 10.1152/ajpheart.1997.272.3.H1212; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1506, DOI 10.1038/sj.cdd.4401831; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Smith L, 2003, BIOCHEM J, V375, P663, DOI 10.1042/BJ20030926; Smith L, 2000, J BIOL CHEM, V275, P40620, DOI 10.1074/jbc.M908517199; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Xu J, 2006, ARTERIOSCL THROM VAS, V26, P2688, DOI 10.1161/01.ATV.0000249394.94588.82; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	59	59	63	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12446	12455		10.1074/jbc.M708208200	http://dx.doi.org/10.1074/jbc.M708208200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321849	hybrid, Green Published			2022-12-27	WOS:000255340000061
J	Wang, T; Craig, EA				Wang, Tao; Craig, Elizabeth A.			Binding of yeast frataxin to the scaffold for Fe-S cluster biogenesis, Isu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-BINDING; FRIEDREICHS-ATAXIA; 2FE-2S CLUSTERS; PROTEIN; HOMOLOG; ISD11; BIOSYNTHESIS; DONOR; YFH1P	Friedreich ataxia is caused by reduced activity of frataxin, a conserved iron-binding protein of the mitochondrial matrix, thought to supply iron for formation of Fe-S clusters on the scaffold protein Isu. Frataxin binds Isu in an iron-dependent manner in vitro. However, the biological relevance of this interaction and whether in vivo the interaction between frataxin and Isu is mediated by adaptor proteins is a matter of debate. Here, we report that alterations of conserved, surface-exposed residues of yeast frataxin, which have deleterious effects on cell growth, impair Fe-S cluster biogenesis and interaction with Isu while altering neither iron binding nor oligomerization. Our results support the idea that the surface of the beta-sheet, adjacent to the acidic, iron binding ridge, is important for interaction of Yfh1 with the Fe-S cluster scaffold and point to a critical role for frataxin in Fe-S cluster biogenesis.	[Wang, Tao; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27870] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; DeLano W.L, PYMOL MOL GRAPHICS S; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Parvin R, 1969, METHODS ENZYMOL, P16; Puccio H, 2000, HUM MOL GENET, V9, P887, DOI 10.1093/hmg/9.6.887; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zuhlke CH, 2004, EUR J HUM GENET, V12, P979, DOI 10.1038/sj.ejhg.5201257	29	77	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12674	12679		10.1074/jbc.M800399200	http://dx.doi.org/10.1074/jbc.M800399200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319250	hybrid, Green Published			2022-12-27	WOS:000255340000084
J	Tatematsu, K; Yoshimoto, N; Okajima, T; Tanizawa, K; Kuroda, S				Tatematsu, Kenji; Yoshimoto, Nobuo; Okajima, Toshihide; Tanizawa, Katsuyuki; Kuroda, Shun'ichi			Identification of ubiquitin ligase activity of RBCK1 and its inhibition by splice variant RBCK2 and protein kinase C beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE REGULATOR PROTEIN; RING-FINGER; PARKINSONS-DISEASE; MOLECULAR-CLONING; BINDING; PHOSPHORYLATION; INTERACTS; FAMILY; DEGRADATION; ACTIVATION	We previously identified a RING-IBR protein, RBCK1, as a protein kinase C (PKC) beta- and zeta-interacting protein, and its splice variant, RBCK2, lacking the C-terminal half including the RING-IBR domain. RBCK1 has been shown to function as a transcriptional activator whose nuclear translocation is prevented by interaction with the cytoplasmic RBCK2. We here demonstrate that RBCK1, like many other RING proteins, also possesses a ubiquitin ligase (E3) activity and that its E3 activity is inhibited by interaction with RBCK2. Moreover, RBCK1 has been found to undergo efficient phosphorylation by PKC beta. The phosphorylated RBCK1 shows no self-ubiquitination activity in vitro. Overexpression of PKC beta leads to significant increases in the amounts of intracellular RBCK1, presumably suppressing the proteasomal degradation of RBCK1 through self-ubiquitination, whereas coexpression with PKC beta, PKC epsilon, and PKC zeta shows no or little effect on the intracellular amount of RBCK1. Taken together, the E3 activity of RBCK1 is controlled by two distinct manners, interaction with RBCK2 and phosphorylation by PKC beta. It is possible that other RING proteins, such as Parkin, BRCA1, and RNF8, having the E3 activity, are also down-regulated by interaction with their RING-lacking splice variants and/or phosphorylation by protein kinases.	[Tatematsu, Kenji; Yoshimoto, Nobuo; Okajima, Toshihide; Tanizawa, Katsuyuki; Kuroda, Shun'ichi] Osaka Univ, Inst Sci & Ind Res, Dept Struct Mol Biol, Osaka 5670047, Japan	Osaka University	Tatematsu, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Struct Mol Biol, Osaka 5670047, Japan.	kenji44@sanken.osaka-u.ac.jp		Okajima, Toshihide/0000-0003-1733-9580				Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; CIECHANOVER A, 1994, J BIOL CHEM, V269, P9582; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Iwata M, 2005, BIOCHEM BIOPH RES CO, V327, P1105, DOI 10.1016/j.bbrc.2004.12.128; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Los GV, 2007, METH MOL B, V356, P195; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tatematsu K, 1998, BIOCHEM BIOPH RES CO, V247, P392, DOI 10.1006/bbrc.1998.8795; Tatematsu K, 2005, J BIOL CHEM, V280, P22937, DOI 10.1074/jbc.M413476200; Thomson AM, 2000, J BIOL CHEM, V275, P31609, DOI 10.1074/jbc.M002354200; Tokunaga C, 1998, BIOCHEM BIOPH RES CO, V244, P353, DOI 10.1006/bbrc.1998.8270; Tokunaga C, 1998, FEBS LETT, V435, P11, DOI 10.1016/S0014-5793(98)01029-1; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Yoshimoto N, 2005, BIOCHEM BIOPH RES CO, V335, P550, DOI 10.1016/j.bbrc.2005.07.104; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	48	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11575	11585		10.1074/jbc.M706961200	http://dx.doi.org/10.1074/jbc.M706961200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303026	hybrid			2022-12-27	WOS:000255067400058
J	Choi, RCY; Simon, J; Tsim, KWK; Barnard, EA				Choi, Roy C. Y.; Simon, Joseph; Tsim, Karl W. K.; Barnard, Eric A.			Constitutive and agonist-induced dimerizations of the P2Y(1) receptor - Relationship to internalization and scaffolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; GREEN-FLUORESCENT PROTEIN; NUCLEOTIDE RECEPTOR; DIFFERENTIAL REGULATION; LIVING CELLS; INTERNATIONAL UNION; ATP RELEASE; OLIGOMERIZATION; ACTIVATION; MECHANISMS	In living cells, P2Y(1) receptor dimerization was quantitated by an improved version of fluorescence resonance energy transfer donor photobleaching analysis. 44% of the P2Y(1) receptors expressed in HEK293 cell membranes exist as dimers in the resting state, inducible by agonist exposure to give 85-100% dimerization. Monomer and constitutive dimers are fully active. Agonist-induced dimerization follows desensitization and is fully reversible upon withdrawal of agonist. Receptor dimers are required for internalization at 37 degrees C but are not sufficient; at 20 degrees C dimerization also occurs, but endocytosis is abolished. Removal of the C-terminal 19 amino acids abolished both dimerization and internalization, whereas full activation by agonists was retained up to a loss of 39 amino acids, confirming active monomers. This receptor is known to bind through its last four amino acids (DTSL) to a scaffolding protein, Na/H exchanger regulatory factor-2, which was endogenous here, and DTSL removal blocked constitutive dimerization specifically. Distinction should therefore be made between the following: 1) constitutive dimers tethered to a scaffolding protein, together with effector proteins, within a signaling micro-domain, and 2) free dimers in the cell membrane, which here are inducible by agonist exposure. For the class A G-protein-coupled receptors, we suggest that the percentages of free monomers, and in many cases of induced free dimers, commonly become artifactually increased; this would arise from an excess there of the receptor over its specific scaffold and from a lack of the native targeting of the receptor to that site.	[Choi, Roy C. Y.; Simon, Joseph; Barnard, Eric A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Tsim, Karl W. K.] Univ Sci & Technol, Dept Biol, Hong Hom, Hong Kong, Peoples R China	University of Cambridge; Hong Kong University of Science & Technology	Barnard, EA (corresponding author), Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England.	eb247@cam.ac.uk		Tsim, Karl/0000-0003-4808-1674	Wellcome Trust [081706, 076139] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayyanathan K, 1996, BIOCHEM BIOPH RES CO, V218, P783, DOI 10.1006/bbrc.1996.0139; Barnard EA, 1997, MOL NEUROBIOL, V15, P103, DOI 10.1007/BF02740631; Baurand A, 2005, MOL PHARMACOL, V67, P721, DOI 10.1124/mol.104.004846; Brinson AE, 2001, J BIOL CHEM, V276, P11939, DOI 10.1074/jbc.M009909200; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Choi RCY, 2003, J NEUROSCI, V23, P4445; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; Ding ZG, 2005, AM J PHYSIOL-CELL PH, V288, pC559, DOI 10.1152/ajpcell.00401.2004; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fam SR, 2003, J NEUROSCI, V23, P4437; Filippov AK, 2006, J NEUROSCI, V26, P9340, DOI 10.1523/JNEUROSCI.2635-06.2006; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; Grant M, 2004, J BIOL CHEM, V279, P38636, DOI 10.1074/jbc.M406276200; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Joseph SM, 2003, J BIOL CHEM, V278, P23331, DOI 10.1074/jbc.M302680200; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; MEADOWS DL, 1991, J IMMUNOL METHODS, V143, P263, DOI 10.1016/0022-1759(91)90051-G; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; MILLIGAN G, 2007, BIOCHIM BIOPHYS ACTA, V68, P825; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Nandanan E, 2000, J MED CHEM, V43, P829, DOI 10.1021/jm990249v; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Otero M, 2000, MOL CELL BIOCHEM, V205, P115, DOI 10.1023/A:1007018001735; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; Sellers LK, 2001, J BIOL CHEM, V276, P16379, DOI 10.1074/jbc.M006617200; Simon J, 2002, J BIOL CHEM, V277, P31390, DOI 10.1074/jbc.M110714200; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; van Rijn RM, 2006, MOL PHARMACOL, V70, P604, DOI 10.1124/mol.105.020818; Vohringer C, 2000, BIOCHEM PHARMACOL, V59, P791, DOI 10.1016/S0006-2952(99)00390-1; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; Yoshioka K, 2002, FEBS LETT, V523, P147, DOI 10.1016/S0014-5793(02)02965-4; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	51	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					11050	11063		10.1074/jbc.M709266200	http://dx.doi.org/10.1074/jbc.M709266200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18270199	hybrid			2022-12-27	WOS:000254894700085
J	Hall, MC; Jeong, DE; Henderson, JT; Choi, E; Bremmer, SC; Iliuk, AB; Charbonneau, H				Hall, Mark C.; Jeong, Dah-Eun; Henderson, James T.; Choi, Eunyoung; Bremmer, Steven C.; Iliuk, Anton B.; Charbonneau, Harry			Cdc28 and Cdc14 control stability of the anaphase-promoting complex inhibitor Acm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; S-PHASE; YEAST; APC/C; PHOSPHORYLATION; PROTEINS; COMPLEX/CYCLOSOME; 14-3-3-PROTEINS	The anaphase-promoting complex (APC) regulates the eukaryotic cell cycle by targeting specific proteins for proteasomal degradation. Its activity must be strictly controlled to ensure proper cell cycle progression. The co-activator proteins Cdc20 and Cdh1 are required for APC activity and are important regulatory targets. Recently, budding yeast Acm1 was identified as a Cdh1 binding partner and APC(Cdh1) inhibitor. Acm1 disappears in late mitosis when APC(Cdh1) becomes active and contains conserved degron-like sequences common to APC substrates, suggesting it could be both an inhibitor and substrate. Surprisingly, we found that Acm1 proteolysis is independent of APC. A major determinant of Acm1 stability is phosphorylation at consensus cyclin-dependent kinase sites. Acm1 is a substrate of Cdc28 cyclin-dependent kinase and Cdc14 phosphatase both in vivo and in vitro. Mutation of Cdc28 phosphorylation sites or conditional inactivation of Cdc28 destabilizes Acm1. In contrast, inactivation of Cdc14 prevents Acm1 dephosphorylation and proteolysis. Cdc28 stabilizes Acm1 in part by promoting binding of the 14-3-3 proteins Bmh1 and Bmh2. We conclude that the opposing actions of Cdc28 and Cdc14 are primary factors limiting Acm1 to the interval from G(1)/S to late mitosis and are capable of establishing APC-independent expression patterns similar to APC substrates.	[Hall, Mark C.; Jeong, Dah-Eun; Henderson, James T.; Choi, Eunyoung; Bremmer, Steven C.; Iliuk, Anton B.; Charbonneau, Harry] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Hall, Mark C.; Charbonneau, Harry] Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA; [Hall, Mark C.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hall, MC (corresponding author), 175 S Univ St, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Hall, Mark C./D-1698-2011	Iliuk, Anton/0000-0002-2914-1363; Hall, Mark/0000-0001-6429-2506	NATIONAL CANCER INSTITUTE [R29CA059935, R01CA059935] Funding Source: NIH RePORTER; NCI NIH HHS [CA59935] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Amon A, 2002, METHOD ENZYMOL, V351, P457; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FLINT AJ, 2003, HDB CELL SIGNALING, P671; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; HARTWELL LH, 1973, GENETICS, V74, P267; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	60	30	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10396	10407		10.1074/jbc.M710011200	http://dx.doi.org/10.1074/jbc.M710011200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18287090	Green Published, hybrid			2022-12-27	WOS:000254894700020
J	Shirai, A; Matsuyama, A; Yashiroda, Y; Hashimoto, A; Kawamura, Y; Arai, R; Komatsu, Y; Horinouchi, S; Yoshida, M				Shirai, Atsuko; Matsuyama, Akihisa; Yashiroda, Yoko; Hashimoto, Atsushi; Kawamura, Yumi; Arai, Ritsuko; Komatsu, Yasuhiko; Horinouchi, Sueharu; Yoshida, Minoru			Global analysis of gel mobility of proteins and its use in target identification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; SODIUM DODECYL-SULFATE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; POSTTRANSLATIONAL MODIFICATIONS; MONOCLONAL-ANTIBODIES; DISC ELECTROPHORESIS; RIBOSOMAL-PROTEINS; LYSINE-ACETYLATION; ANTI-ACETYLLYSINE	SDS-PAGE is a basic method that has long been used for separation of proteins according to their molecular sizes. Despite its simplicity, it provides information on characteristics of proteins beyond their molecular masses because gel mobility of proteins often reflects their physicochemical properties and post-translational modifications. Here we report on a global analysis of gel mobility of the proteome, which we term the "mobilitome," covering 93.4% of the fission yeast proteome. To our surprise, more than 40% of proteins did not migrate to their calculated positions. Statistical analyses revealed that the discrepancy was largely dependent on the hydrophobicity of proteins. This experimental data set, with a high coverage rate of real mobility, made it feasible to identify proteins detected on the gel without using any specialized techniques. This approach enabled us to detect previously unknown post-translational modifications of a protein; for example, we revealed that eIF5A is novel substrate of a Sir2-related deacetylase Hst2. Furthermore, we concomitantly identified twelve acetylated and eight methylated proteins using specific anti-acetylated and anti-methylated lysine antibodies, most of which had not been known to be subject to the modifications. Thus, we propose the general usefulness of the mobilitome and electrophoresis-based methodology for the identification and characterization of proteins detected on the gel.	[Shirai, Atsuko; Matsuyama, Akihisa; Yashiroda, Yoko; Hashimoto, Atsushi; Kawamura, Yumi; Arai, Ritsuko; Yoshida, Minoru] RIKEN, Chem Genet Lab, Wako, Saitama 4621336, Japan; [Shirai, Atsuko; Horinouchi, Sueharu; Yoshida, Minoru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Shirai, Atsuko; Matsuyama, Akihisa; Yashiroda, Yoko; Hashimoto, Atsushi; Kawamura, Yumi; Arai, Ritsuko; Yoshida, Minoru] Japan Sci & Technol Agcy, CREST Res Project, Kawaguchi, Saitama 3320012, Japan; [Komatsu, Yasuhiko] Adv Life Sci Inst Inc, Wako, Saitama 3510012, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST)	Matsuyama, A (corresponding author), RIKEN, Chem Genet Lab, Wako, Saitama 4621336, Japan.	akihisa@riken.jp	Matsuyama, Akihisa/P-7805-2016; shirai, atsuko/C-5406-2017; Yashiroda, Yoko/C-8769-2014; Yoshida, Minoru/C-8049-2014	Matsuyama, Akihisa/0000-0002-6135-6276; shirai, atsuko/0000-0003-1344-4746; Yoshida, Minoru/0000-0002-4376-5674; Komatsu, Yasuhiko/0000-0003-1739-8222				CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KLIER H, 1995, BIOCHEMISTRY-US, V34, P14693, DOI 10.1021/bi00045a010; Komatsu Y, 2003, J IMMUNOL METHODS, V272, P161, DOI 10.1016/S0022-1759(02)00500-8; KRUISWIJK T, 1978, BIOCHEM J, V175, P221, DOI 10.1042/bj1750221; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Linder P, 1999, YEAST, V15, P865; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Matsuyama A, 2000, GENETICS, V155, P539; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; PITTRIVE.R, 1968, BIOCHEM J, V109, P825, DOI 10.1042/bj1090825; Poly WJ, 1997, COMP BIOCHEM PHYS A, V118, P551, DOI 10.1016/S0300-9629(96)00041-2; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; RADHA K, 1993, ADV ENZYMOL RELAT AR, V67, P265; REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161; ROBINSON NC, 1975, BIOCHEMISTRY-US, V14, P369, DOI 10.1021/bi00673a025; SHAPIRO AL, 1967, BIOCHEM BIOPH RES CO, V28, P815, DOI 10.1016/0006-291X(67)90391-9; Sherman F., 1986, METHODS YEAST GENETI; SHIRAI A, 2006, NAT PROTOCOLS; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; WEBER K, 1969, J BIOL CHEM, V244, P4406; Williamson NA, 1997, EUR J BIOCHEM, V246, P786, DOI 10.1111/j.1432-1033.1997.00786.x; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Zhu CC, 2002, J BIOL CHEM, V277, P28228, DOI 10.1074/jbc.M204221200	40	95	98	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10745	10752		10.1074/jbc.M709211200	http://dx.doi.org/10.1074/jbc.M709211200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18292091	hybrid			2022-12-27	WOS:000254894700057
J	Wollers, S; Heidenreich, T; Zarepour, M; Zachmann, D; Kraft, C; Zhao, YD; Mendel, RR; Bittner, F				Wollers, Silke; Heidenreich, Torsten; Zarepour, Maryam; Zachmann, Dieter; Kraft, Claudia; Zhao, Yunde; Mendel, Ralf R.; Bittner, Florian			Binding of sulfurated molybdenum cofactor to the C-terminal domain of ABA3 from Arabidopsis thaliana provides insight into the mechanism of molybdenum cofactor sulfuration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACIDOVORANS XANTHINE DEHYDROGENASE; NITRATE REDUCTASE; ALDEHYDE OXIDASE; BIOCHEMICAL-CHARACTERIZATION; RHODOBACTER-CAPSULATUS; MOLYBDOPTERIN COFACTOR; CLASSICAL XANTHINURIA; ESCHERICHIA-COLI; SULFITE OXIDASE; GENE	The molybdenum cofactor sulfurase ABA3 from Arabidopsis thaliana is needed for post-translational activation of aldehyde oxidase and xanthine dehydrogenase by transferring a sulfur atom to the desulfo-molybdenum cofactor of these enzymes. ABA3 is a two-domain protein consisting of an NH2-terminal NifS-like cysteine desulfurase domain and a C-terminal domain of yet undescribed function. The NH2-terminal domain of ABA3 decomposes L-cysteine to yield elemental sulfur, which subsequently is bound as persulfide to a conserved protein cysteinyl residue within this domain. In vivo, activation of aldehyde oxidase and xanthine dehydrogenase also depends on the function of the C-terminal domain, as can be concluded from the A. thaliana aba3/sir3-3 mutant. sir3-3 plants are strongly reduced in aldehyde oxidase and xanthine dehydrogenase activities due to a substitution of arginine 723 by a lysine within the C-terminal domain of the ABA3 protein. Here we present first evidence for the function of the C-terminal domain and show that molybdenum cofactor is bound to this domain with high affinity. Furthermore, cyanide-treated ABA3 C terminus was shown to release thiocyanate, indicating that the molybdenum cofactor bound to the C-terminal domain is present in the sulfurated form. Co-incubation of partially active aldehyde oxidase and xanthine dehydrogenase with ABA3 C terminus carrying sulfurated molybdenum cofactor resulted in stimulation of aldehyde oxidase and xanthine dehydrogenase activity. The data of this work suggest that the C-terminal domain of ABA3 might act as a scaffold protein where prebound desulfo-molybdenum cofactor is converted into sulfurated cofactor prior to activation of aldehyde oxidase and xanthine dehydrogenase.	[Wollers, Silke; Heidenreich, Torsten; Zarepour, Maryam; Mendel, Ralf R.; Bittner, Florian] Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38023 Braunschweig, Germany; [Zachmann, Dieter; Kraft, Claudia] Tech Univ Carolo Wilhelmina Braunschweig, Dept Environm Geol, D-38023 Braunschweig, Germany; [Zhao, Yunde] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	Braunschweig University of Technology; Braunschweig University of Technology; University of California System; University of California San Diego	Mendel, RR (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, Humboldtstr 1, D-38023 Braunschweig, Germany.	r.mendel@tu-bs.de	Zhao, Yunde/AAC-5360-2019		NIGMS NIH HHS [R01 GM068631] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani L, 2000, MOL MICROBIOL, V38, P114, DOI 10.1046/j.1365-2958.2000.02119.x; Anantharaman V, 2002, FEMS MICROBIOL LETT, V207, P55, DOI 10.1016/S0378-1097(01)00515-8; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dai XH, 2005, P NATL ACAD SCI USA, V102, P3129, DOI 10.1073/pnas.0500185102; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Hesberg C, 2004, J BIOL CHEM, V279, P13547, DOI 10.1074/jbc.M312929200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Ichida K, 2001, BIOCHEM BIOPH RES CO, V282, P1194, DOI 10.1006/bbrc.2001.4719; Ivanov NV, 2004, PROTEIN EXPRES PURIF, V37, P72, DOI 10.1016/j.pep.2004.05.002; Ivanov NV, 2003, EUR J BIOCHEM, V270, P4744, DOI 10.1046/j.1432-1033.2003.03875.x; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Koiwai H, 2000, J BIOCHEM-TOKYO, V127, P659, DOI 10.1093/oxfordjournals.jbchem.a022654; Komoto N, 2003, INSECT BIOCHEM MOLEC, V33, P417, DOI 10.1016/S0965-1748(03)00006-7; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; Leimkuhler S, 1999, J BACTERIOL, V181, P2745; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; Peretz H, 2007, MOL GENET METAB, V91, P23, DOI 10.1016/j.ymgme.2007.02.005; Sagi M, 1999, PLANT PHYSIOL, V120, P571, DOI 10.1104/pp.120.2.571; Sagi M, 2002, PLANT J, V31, P305, DOI 10.1046/j.1365-313X.2002.01363.x; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; WAHL RC, 1982, J BIOL CHEM, V257, P3958; Watanabe T, 2000, J BIOL CHEM, V275, P21789, DOI 10.1074/jbc.C000230200	33	58	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9642	9650		10.1074/jbc.M708549200	http://dx.doi.org/10.1074/jbc.M708549200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18258600	hybrid			2022-12-27	WOS:000254671600018
J	Bright, NJ; Carling, D; Thornton, C				Bright, Nicola J.; Carling, David; Thornton, Claire			Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR; NEURONAL POLARIZATION; UPSTREAM KINASE; SAD KINASES; LKB1; UBIQUITIN; BETA; STIMULATION; INTERACT	Brain-specific kinases 1 and 2 (BRSK1/2) are AMP-activated protein kinase (AMPK)-related kinases that are highly expressed in mammalian forebrain. Studies using transgenic animal models have implicated a role for these kinases in the establishment of neuronal polarity. BRSK1 and BRSK2 are activated by phosphorylation of a threonine residue in the T-loop activation segment of the kinase domain. In vitro studies have demonstrated that LKB1, an upstream kinase in the AMPK cascade, can catalyze this phosphorylation. However, to date, a detailed comparative analysis of the molecular regulation of BRSK1/2 has not been undertaken. Here we present evidence that excludes another upstream kinase in the AMPK cascade, Ca2+/calmodulin-dependent protein kinase kinase beta, from a role in activating BRSK1/2. We show that equivalent mutations in the ubiquitin-associated domains of the BRSK isoforms produce differential effects on the activation of BRSK1 and BRSK2. Contrary to previous reports, activation of cAMP-dependent protein kinase does not affect BRSK1 or BRSK2 activity in mammalian cells. Furthermore, stimuli that activate AMPK had no effect on BRSK1/2. Finally, we provide evidence suggesting that protein phosphatase 2C is a likely candidate for catalyzing the dephosphorylation and inactivation of BRSK1/2.	[Bright, Nicola J.; Carling, David; Thornton, Claire] MRC, Ctr Clin Sci, Cellular Stress Grp, London W12 0NN, England		Carling, D (corresponding author), MRC, Ctr Clin Sci, Cellular Stress Grp, Du Cane Rd, London W12 0NN, England.	dcarling@imperial.ac.uk; claire.thornton@imperial.ac.uk	Thornton, Claire/AAF-7481-2019; Carling, David/F-1943-2014	Thornton, Claire/0000-0001-7676-3272; Carling, David/0000-0002-2316-1830	Medical Research Council [MC_U120027537] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Guo ZK, 2006, BIOCHEM BIOPH RES CO, V347, P867, DOI 10.1016/j.bbrc.2006.06.178; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Ross H, 2002, BIOCHEM J, V366, P977, DOI 10.1042/BJ20020786; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Wang JW, 2007, J NEUROSCI, V27, P574, DOI 10.1523/JNEUROSCI.5094-06.2007; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	36	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					14946	14954		10.1074/jbc.M710381200	http://dx.doi.org/10.1074/jbc.M710381200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18339622	Green Published, hybrid			2022-12-27	WOS:000256232000006
J	Klutts, JS; Doering, TL				Klutts, J. Stacey; Doering, Tamara L.			Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT STRAINS; O-ACETYLATION; GLUCURONOXYLOMANNAN; GALACTOXYLOMANNAN; ABSENCE; FAMILY	The opportunistic yeast Cryptococcus neoformans causes serious disease in humans and expresses a prominent polysaccharide capsule that is required for its virulence. Little is known about how this capsule is synthesized. We previously identified a beta 1,2-xylosyltransferase (Cxt1p) with in vitro enzymatic activity appropriate for involvement in capsule synthesis. Here, we investigate C. neoformans strains in which the corresponding gene has been deleted (cxt1 Delta). Loss of CXT1 does not affect in vitro growth of the mutant cells or the general morphology of their capsules. However, NMR structural analysis of the two main capsule polysaccharides, glucuronoxylomannan (GXM) and galactoxylomannan (GalXM), showed that both were missing beta 1,2-xylose residues. There was an similar to 30% reduction in the abundance of this residue in GXM in mutant compared with wild-type strains, and mutant GalXM was almost completely devoid of beta 1,2-linked xylose. The GalXM from the mutant strain was also missing a beta 1,3- linked xylose residue. Furthermore, deletion of CXT1 led to attenuation of cryptococcal growth in a mouse model of infection, suggesting that the affected xylose residues are important for normal host-pathogen interactions. Cxt1p is the first glycosyltransferase with a defined role in C. neoformans capsule biosynthesis, and cxt1 Delta is the only strain identified to date with structural alterations of the capsule polysaccharide GalXM.	[Klutts, J. Stacey; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Klutts, J. Stacey] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Doering, TL (corresponding author), 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	doering@wustl.edu		Klutts, James/0000-0003-3788-1940	NIGMS NIH HHS [R01 GM071007, R01 GM 071007, F32 GM072341, F32 GM 072341] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071007, F32GM072341] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2004, CURRENT PROTOCOLS MO; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Brandt S, 2003, CLIN DIAGN LAB IMMUN, V10, P903, DOI 10.1128/CDLI.10.5.903-909.2003; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; ECKERT TF, 1987, INFECT IMMUN, V55, P1895, DOI 10.1128/IAI.55.8.1895-1899.1987; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Gutierrez ALS, 2007, GLYCOBIOLOGY, V17, p1C, DOI 10.1093/glycob/cwm030; Heise N, 2002, GLYCOBIOLOGY, V12, P409, DOI 10.1093/glycob/cwf053; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; KWONCHUNG KJ, 1986, EUKARYOT CELL, V2, P655; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Nelson RT, 2001, GENETICS, V157, P935; OWUOR E, 2007, GLYCOBIOLOGY, V17, P1183; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pierini LM, 2001, MOL MICROBIOL, V41, P105, DOI 10.1046/j.1365-2958.2001.02504.x; Sheng SQ, 1997, CARBOHYD RES, V301, P33, DOI 10.1016/S0008-6215(97)00084-0; Sommer U, 2003, J BIOL CHEM, V278, P47724, DOI 10.1074/jbc.M307223200; SPIROPULU C, 1989, INFECT IMMUN, V57, P3240, DOI 10.1128/IAI.57.10.3240-3242.1989; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Vecchiarelli A, 2005, CURR MOL MED, V5, P413, DOI 10.2174/1566524054022585; Yan Z, 2002, J CLIN MICROBIOL, V40, P965, DOI 10.1128/JCM.40.3.965-972.2002; YORK WS, 1986, METHOD ENZYMOL, V118, P3	32	43	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14327	14334		10.1074/jbc.M708927200	http://dx.doi.org/10.1074/jbc.M708927200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347023	Green Published, hybrid			2022-12-27	WOS:000255941400019
J	Nahle, Z; Hsieh, M; Pietka, T; Coburn, CT; Grimaldi, PA; Zhang, MQ; Das, D; Abumrad, NA				Nahle, Zaher; Hsieh, Michael; Pietka, Terri; Coburn, Chris T.; Grimaldi, Paul A.; Zhang, Michael Q.; Das, Debopriya; Abumrad, Nada A.			CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-DELTA; FATTY-ACID UPTAKE; TRANSCRIPTION FACTOR FOXO1; PYRUVATE-DEHYDROGENASE COMPLEX; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; CELL-CYCLE; INSULIN-RESISTANCE; LIPID-METABOLISM; PROTEIN-KINASE	The transcription factor FoxO1 contributes to the metabolic adaptation to fasting by suppressing muscle oxidation of glucose, sparing it for glucose-dependent tissues. Previously, we reported that FoxO1 activation in C2C12 muscle cells recruits the fatty acid translocase CD36 to the plasma membrane and increases fatty acid uptake and oxidation. This, together with FoxO1 induction of lipoprotein lipase, would promote the reliance on fatty acid utilization characteristic of the fasted muscle. Here, we show that CD36-mediated fatty acid uptake, in turn, up-regulates protein levels and activity of FoxO1 as well as its target PDK4, the negative regulator of glucose oxidation. Increased fatty acid flux or enforced CD36 expression in C2C12 cells is sufficient to induce FoxO1 and PDK4, whereas CD36 knockdown has opposite effects. In vivo, CD36 loss blunts fasting induction of FoxO1 and PDK4 and the associated suppression of glucose oxidation. Importantly, CD36-dependent regulation of FoxO1 is mediated by the nuclear receptor PPAR delta/beta. Loss of PPAR delta/beta phenocopies CD36 deficiency in blunting fasting induction of muscle FoxO1 and PDK4 in vivo. Expression of PPAR delta/beta in C2C12 cells, like that of CD36, robustly induces FoxO1 and suppresses glucose oxidation, whereas co-expression of a dominant negative PPAR delta/beta compromises FoxO1 induction. Finally, several PPRE sites were identified in the FoxO1 promoter, which was responsive to PPAR delta/beta. Agonists of PPAR delta/beta were sufficient to confer responsiveness and transactivate the heterologous FoxO1 promoter but not in the presence of dominant negative PPAR delta/beta. Taken together, our findings suggest that CD36-dependent FA activation of PPAR delta/beta results in the transcriptional regulation of FoxO1 as well as PDK4, recently shown to be a direct PPAR delta/beta target. FoxO1 in turn can regulate CD36, lipoprotein lipase, and PDK4, reinforcing the action of PPAR delta/beta to increase muscle reliance on FA. The findings could have implications in the chronic abnormalities of fatty acid metabolism associated with obesity and diabetes.	[Nahle, Zaher; Hsieh, Michael; Pietka, Terri; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Coburn, Chris T.] Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA; [Grimaldi, Paul A.] Univ Nice Sophia Antipolis, INSERM, Ctr Biochim, U636,UFR Sci, F-06108 Nice, France; [Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Das, Debopriya] Ernest O Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94270 USA	Washington University (WUSTL); University of North Carolina; Western Carolina University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Cold Spring Harbor Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Nahle, Z (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8031, St Louis, MO 63110 USA.	znahle@im.wustl.edu			NIDDK NIH HHS [P30 DK056341, P30 DK056341-07, P30 DK056341-08, DK 56351, DK 33301] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bonen A, 2003, ACTA PHYSIOL SCAND, V178, P347, DOI 10.1046/j.1365-201X.2003.01157.x; Bonen A, 2006, ESSAYS BIOCHEM, V42, P47, DOI 10.1042/bse0420047; Chabowski A, 2006, AM J PHYSIOL-ENDOC M, V291, pE675, DOI 10.1152/ajpendo.00096.2006; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Constantin D, 2007, J PHYSIOL-LONDON, V583, P381, DOI 10.1113/jphysiol.2007.135459; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dyck DJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE600, DOI 10.1152/ajpendo.2001.281.3.E600; Farmer SR, 2003, MOL CELL, V11, P6, DOI 10.1016/S1097-2765(03)00003-0; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Furnsinn C, 2007, DIABETOLOGIA, V50, P8, DOI 10.1007/s00125-006-0492-0; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Grimaldi PA, 2007, BBA-MOL CELL BIOL L, V1771, P983, DOI 10.1016/j.bbalip.2007.02.006; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Holst D, 2003, EXP CELL RES, V288, P168, DOI 10.1016/S0014-4827(03)00179-4; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Matsumoto M, 2005, CELL METAB, V1, P215, DOI 10.1016/j.cmet.2005.03.008; Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nahle Z, 2004, CURR OPIN CLIN NUTR, V7, P397, DOI 10.1097/01.mco.0000134360.30911.bb; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nakae J, 2001, BIOCHEMISTRY-US, V40, P11768, DOI 10.1021/bi015532m; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Puig O, 2006, CELL CYCLE, V5, P503, DOI 10.4161/cc.5.5.2501; Puigserver P, 2005, INT J OBESITY, V29, P5; Sidossis LS, 1996, J CLIN INVEST, V98, P2244, DOI 10.1172/JCI119034; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Thewke D, 2000, BIOCHEM BIOPH RES CO, V273, P1, DOI 10.1006/bbrc.2000.2826; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Voss MD, 2005, DIABETOLOGIA, V48, P2622, DOI 10.1007/s00125-005-0025-2; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wolkenhauer O, 2005, FEBS LETT, V579, P1846, DOI 10.1016/j.febslet.2005.02.008; Xuan ZY, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r72; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	79	88	91	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14317	14326		10.1074/jbc.M706478200	http://dx.doi.org/10.1074/jbc.M706478200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18308721	hybrid, Green Published			2022-12-27	WOS:000255941400018
J	Desai, B; Ma, T; Chellaiah, MA				Desai, Bhavik; Ma, Tao; Chellaiah, Meenakshi A.			Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; BONE-RESORPTION; EXTRACELLULAR-MATRIX; BREAST-CANCER; TRANSFORMED FIBROBLASTS; ACTIN POLYMERIZATION; PODOSOME FORMATION; ENDOTHELIAL-CELLS; MMP-9 EXPRESSION; IN-VITRO	The present study demonstrated that invadopodia are associated with invasion by degradation of matrix in prostate cancer cells PC3. To find out the presence of invadopodia in PC3 cells, we performed a few comparative analyses with osteoclasts, which utilize podosomes for migration. Our investigations indeed demonstrated that invadopodia are comparable to podosomes in the localization of Wiskott-Aldrich syndrome protein (WASP)/matrix metalloproteinase-9 and the degradation of matrix. Invadopodia are different from podosomes in the localization of actin/vinculin, distribution during migration, and the mode of degradation of extracellular matrix. Invadopodia enable polarized invasion of PC3 cells into the gelatin matrix in a time-dependent manner. Gelatin degradation was confined within the periphery of the cell. Osteoclasts demonstrated directional migration with extensive degradation of matrix underneath and around the osteoclasts. A pathway of degradation of matrix representing a migratory track was observed due to the rearrangement of podosomes as rosettes or clusters at the leading edge. Reducing the matrix metalloproteinase-9 levels by RNA interference inhibited the degradation of matrix but not the formation of podosomes or invadopodia. Competition experiments with TAT-fused WASP peptides suggest that actin polymerization and formation of invadopodia involve the WASP-Arp2/3 complex pathway. Moreover, PC3 cells overexpressing osteopontin (OPN) displayed an increase in the number of invadopodia and gelatinolytic activity as compared with PC3 cells and PC3 cells expressing mutant OPN in integrin-binding domain and null for OPN. Thus, we conclude that OPN/integrin alpha v beta 3 signaling participates in the process of migration and invasion of PC3 cells through regulating processes essential for the formation and function of invadopodia.	[Desai, Bhavik; Ma, Tao; Chellaiah, Meenakshi A.] Univ Maryland, Sch Dent, Dept Biomed Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chellaiah, MA (corresponding author), Univ Maryland, Sch Dent, Dept Biomed Sci, 7th Floor, S,650 W Baltimore St, Baltimore, MD 21201 USA.	mchellaiah@umaryland.edu			NIAMS NIH HHS [AR46292] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046292, R56AR046292] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Biswas RS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-19; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chellaiah MA, 2007, J BIOL CHEM, V282, P10104, DOI 10.1074/jbc.M608957200; Chen WT, 1996, ENZYME PROTEIN, V49, P59, DOI 10.1159/000468616; Collin O, 2006, J CELL SCI, V119, P1914, DOI 10.1242/jcs.02838; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; Festuccia C, 1998, INT J CANCER, V75, P418, DOI 10.1002/(SICI)1097-0215(19980130)75:3<418::AID-IJC16>3.0.CO;2-4; Gimona M, 2008, SEMIN CANCER BIOL, V18, P23, DOI 10.1016/j.semcancer.2007.08.005; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Goto T, 2002, J BONE MINER METAB, V20, P98, DOI 10.1007/s007740200013; Incorvaia L, 2007, ANTICANCER RES, V27, P1519; Ishibashi O, 2006, LIFE SCI, V79, P1657, DOI 10.1016/j.lfs.2006.05.024; KANEHISA J, 1990, BONE, V11, P287, DOI 10.1016/8756-3282(90)90082-A; Kelly T, 1998, CLIN EXP METASTAS, V16, P501, DOI 10.1023/A:1006538200886; KIEFER MC, 1989, NUCLEIC ACIDS RES, V17, P3306, DOI 10.1093/nar/17.8.3306; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Low JA, 1996, CLIN CANCER RES, V2, P1207; MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2; Mizutani K, 2002, CANCER RES, V62, P669; Moreau V, 2006, EUR J CELL BIOL, V85, P319, DOI 10.1016/j.ejcb.2005.09.009; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Thalmann GN, 1999, CLIN CANCER RES, V5, P2271; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zambonin Z.A., 1989, CONNECT TISSUE RES, V20, P143	44	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13856	13866		10.1074/jbc.M709401200	http://dx.doi.org/10.1074/jbc.M709401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337256	Green Published, hybrid			2022-12-27	WOS:000255728200039
J	Esquerra, RM; Jensen, RA; Bhaskaran, S; Pillsbury, ML; Mendoza, JL; Lintner, BW; Kliger, DS; Goldbeck, RA				Esquerra, Raymond M.; Jensen, Russell A.; Bhaskaran, Shyam; Pillsbury, Marlisa L.; Mendoza, Juan L.; Lintner, Benjamin W.; Kliger, David S.; Goldbeck, Robert A.			The pH dependence of heme pocket hydration and ligand rebinding kinetics in photodissociated carbonmonoxymyoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM-WHALE MYOGLOBIN; DISTAL HISTIDINE; RESONANCE RAMAN; CARBON-MONOXIDE; CRYSTAL-STRUCTURES; BINDING; CO; RELAXATION; HEMOGLOBIN; RESOLUTION	We monitored the occupancy of a functionally important non-coordinated water molecule in the distal heme pocket of sperm whale myoglobin over the pH range 4.3-9.4. Water occupancy was assessed by using time-resolved spectroscopy to detect the perturbation of the heme visible band absorption spectrum caused by water entry after CO photodissociation (Goldbeck, R. A., Bhaskaran, S., Ortega, C., Mendoza, J. L., Olson, J. S., Soman, J., Kliger, D. S., and Esquerra, R. M. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 1254-1259). We found that the water occupancy observed during the time interval between ligand photolysis and diffusive recombination decreased by nearly 20% as the pH was lowered below 6. This decrease accounted for most of the concomitant increase in the observed CO bimolecular recombination rate constant, as the lower water occupancy presented a smaller kinetic barrier to CO entry into the pocket at lower pH. These results were consistent with a model in which the distal histidine, which stabilizes the water molecule within the distal pocket by accepting a hydrogen bond, tends to swing out of the pocket upon protonation and destabilize the water occupancy at low pH. Extrapolation of this model to lower pH suggests that the additional increase in ligand association rate constant observed previously in stopped-flow studies at pH 3 may also be due in part to reduced distal water occupancy concomitant with further His(64) protonation and coupled protein conformational change.	[Esquerra, Raymond M.; Jensen, Russell A.; Bhaskaran, Shyam; Pillsbury, Marlisa L.; Mendoza, Juan L.; Lintner, Benjamin W.] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Kliger, David S.; Goldbeck, Robert A.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	California State University System; San Francisco State University; University of California System; University of California Santa Cruz	Esquerra, RM (corresponding author), San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA.	esquerra@sfsu.edu; goldbeck@chemistry.ucsc.edu		Mendoza, Juan/0000-0001-6972-7476	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM052588, T34GM008574] Funding Source: NIH RePORTER; NIBIB NIH HHS [EB02056] Funding Source: Medline; NIGMS NIH HHS [GM52588, 5T34 GM08574] Funding Source: Medline; NIMHD NIH HHS [P20 MD000262] Funding Source: Medline	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		ANSARI A, 1987, BIOPHYS CHEM, V26, P337, DOI 10.1016/0301-4622(87)80034-0; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; BARBOY N, 1987, BIOCHEMISTRY-US, V26, P3240, DOI 10.1021/bi00385a046; BASHFORD D, 1993, BIOCHEMISTRY-US, V32, P8045, DOI 10.1021/bi00082a027; Bonaventura C, 1999, J BIOL CHEM, V274, P8686, DOI 10.1074/jbc.274.13.8686; BONAVENTURA C, 1991, J BIOL CHEM, V266, P23033; CANNON J, 1976, J AM CHEM SOC, V98, P3395, DOI 10.1021/ja00427a069; Cao WX, 2001, BIOCHEMISTRY-US, V40, P5728, DOI 10.1021/bi010067e; CARVER TE, 1992, J BIOL CHEM, V267, P14443; CASE DA, 1979, J MOL BIOL, V132, P343, DOI 10.1016/0022-2836(79)90265-1; CHANCE B, 1966, J MOL BIOL, V17, P525, DOI 10.1016/S0022-2836(66)80162-6; COCCO MJ, 1992, BIOCHEMISTRY-US, V31, P6481, DOI 10.1021/bi00143a018; COLETTA M, 1985, J BIOL CHEM, V260, P4151; Dantsker D, 2004, J BIOL CHEM, V279, P38844, DOI 10.1074/jbc.M401513200; Dantsker D, 2005, BBA-PROTEINS PROTEOM, V1749, P234, DOI 10.1016/j.bbapap.2005.04.002; De Angelis F, 2005, J PHYS CHEM B, V109, P3065, DOI 10.1021/jp0451851; DOSTER W, 1982, BIOCHEMISTRY-US, V21, P4831, DOI 10.1021/bi00263a001; EGEBERG KD, 1990, J BIOL CHEM, V265, P11788; Esquerra RM, 1998, BIOCHEMISTRY-US, V37, P17527, DOI 10.1021/bi9814437; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; FUCHSMAN WH, 1979, BIOCHEMISTRY-US, V18, P1309, DOI 10.1021/bi00574a030; GEIBEL J, 1975, J AM CHEM SOC, V97, P5924, DOI 10.1021/ja00853a053; GIACOMETTI GM, 1977, J BIOL CHEM, V252, P7447; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Goldbeck R. A., 2001, ENCY CHEM PHYS PHYS, P2637; GOLDBECK RA, 1993, METHOD ENZYMOL, V226, P147, DOI 10.1016/0076-6879(93)26009-X; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; JOHNSON KA, 1989, J MOL BIOL, V207, P459, DOI 10.1016/0022-2836(89)90269-6; KURIYAN J, 1986, J MOL BIOL, V192, P133, DOI 10.1016/0022-2836(86)90470-5; LAMBRIGHT DG, 1989, J MOL BIOL, V207, P289, DOI 10.1016/0022-2836(89)90456-7; MORIKIS D, 1989, BIOCHEMISTRY-US, V28, P4791, DOI 10.1021/bi00437a041; Muller JD, 1999, BIOPHYS J, V77, P1036, DOI 10.1016/S0006-3495(99)76954-7; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PERUTZ MF, 1989, TRENDS BIOCHEM SCI, V14, P42, DOI 10.1016/0968-0004(89)90039-X; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; RAMSDEN J, 1989, BIOCHEMISTRY-US, V28, P3125, DOI 10.1021/bi00434a001; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1227, DOI 10.1021/bi00219a010; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1237, DOI 10.1021/bi00219a011; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Spiro TG, 2001, ACCOUNTS CHEM RES, V34, P137, DOI 10.1021/ar000108j; Spiro TG, 2001, CURR OPIN CHEM BIOL, V5, P715, DOI 10.1016/S1367-5931(01)00271-X; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; Tang Q, 1997, BIOSPECTROSCOPY, V3, P17, DOI 10.1002/(SICI)1520-6343(1997)3:1<17::AID-BSPY2>3.3.CO;2-P; TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491; TIAN WD, 1992, PHYS REV LETT, V68, P408, DOI 10.1103/PhysRevLett.68.408; TRAYLOR TG, 1983, J BIOL CHEM, V258, P2147; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	55	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14165	14175		10.1074/jbc.M709710200	http://dx.doi.org/10.1074/jbc.M709710200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359768	Green Published, hybrid			2022-12-27	WOS:000255728200070
J	Malki, A; Le, HT; Milles, S; Kern, R; Caldas, T; Abdallah, J; Richarme, G				Malki, Abderrahim; Le, Hai-Tuong; Milles, Sigrid; Kern, Renee; Caldas, Teresa; Abdallah, Jad; Richarme, Gilbert			Solubilization of protein aggregates by the acid stress chaperones HdeA and HdeB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; PERIPLASMIC PROTEIN; HELICOBACTER-PYLORI; COMPETENT STATE; DNAK CHAPERONE; PH; DISAGGREGATION; RESISTANCE; HSP26	The acid stress chaperones HdeA and HdeB of Escherichia coli prevent the aggregation of periplasmic proteins at acidic pH. We show in this report that they also form mixed aggregates with proteins that have failed to be solubilized at acidic pH and allow their subsequent solubilization at neutral pH. HdeA, HdeB, and HdeA and HdeB together display an increasing efficiency for the solubilization of protein aggregates at pH 3. They are less efficient for the solubilization of aggregates at pH 2, whereas HdeB is the most efficient. Increasing amounts of periplasmic proteins draw increasing amounts of chaperone into pellets, suggesting that chaperones co-aggregate with their substrate proteins. We observed a decrease in the size of protein aggregates in the presence of HdeA and HdeB, from very high molecular mass aggregates to 100-5000-kDa species. Moreover, a marked decrease in the exposed hydrophobicity of aggregated proteins in the presence of HdeA and HdeB was revealed by 1,1'-bis(4-anilino) naphtalene-5,5'-disulfonic acid binding experiments. In vivo, during the recovery at neutral pH of acid stressed bacterial cells, HdeA and HdeB allow the solubilization and renaturation of protein aggregates, including those formed by the maltose receptor MalE, the oligopeptide receptor OppA, and the histidine receptor HisJ. Thus, HdeA and HdeB not only help to maintain proteins in a soluble state during acid treatment, as previously reported, but also assist, both in vitro and in vivo, in the solubilization at neutral pH of mixed protein-chaperone aggregates formed at acidic pH, by decreasing the size of protein aggregates and the exposed hydrophobicity of aggregated proteins.	[Malki, Abderrahim; Le, Hai-Tuong; Milles, Sigrid; Kern, Renee; Caldas, Teresa; Abdallah, Jad; Richarme, Gilbert] Univ Paris 07, Inst Jacques Monod, Stress Mol Lab, F-75005 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, Stress Mol Lab, 2 Pl Jussieu, F-75005 Paris, France.	richarme@ccr.jussieu.fr	Abdallah, Jad/AAD-3595-2020	Abdallah, Jad/0000-0001-5267-4953				Arie JP, 2006, MOL MICROBIOL, V62, P427, DOI 10.1111/j.1365-2958.2006.05394.x; Booth IR, 2002, ANTON LEEUW INT J G, V81, P33, DOI 10.1023/A:1020565206835; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; DUGAY AR, 2004, BIOCHIM BIOPHYS ACTA, V1694, P121; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Jiao WW, 2005, BIOCHEM BIOPH RES CO, V335, P227, DOI 10.1016/j.bbrc.2005.07.065; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; LAEMMLI UK, 1972, NATURE, V227, P680; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Lim EM, 2000, ELECTROPHORESIS, V21, P2557, DOI 10.1002/1522-2683(20000701)21:12&lt;2557::AID-ELPS2557&gt;3.0.CO;2-B; Liu Y, 2004, BIOCHEM BIOPH RES CO, V316, P795, DOI 10.1016/j.bbrc.2004.02.125; Malki A, 2003, BIOCHEM BIOPH RES CO, V301, P430, DOI 10.1016/S0006-291X(02)03053-X; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; SEALE JW, 1995, BIOCHEMISTRY-US, V34, P7443, DOI 10.1021/bi00022a018; Small PLC, 1998, TRENDS MICROBIOL, V6, P214, DOI 10.1016/S0966-842X(98)01285-2; THOMPSON SA, 1995, INFECT IMMUN, V63, P2185, DOI 10.1128/IAI.63.6.2185-2193.1995; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Yohannes E, 2004, J BACTERIOL, V186, P192, DOI 10.1128/JB.186.1.192-199.2004	34	55	61	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13679	13687		10.1074/jbc.M800869200	http://dx.doi.org/10.1074/jbc.M800869200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359765	hybrid			2022-12-27	WOS:000255728200019
J	Bachhuber, T; Almaca, J; Aldehni, F; Mehta, A; Amaral, MD; Schreiber, R; Kunzelmann, K				Bachhuber, Tanja; Almaca, Joana; Aldehni, Fadi; Mehta, Anil; Amaral, Margarida D.; Schreiber, Rainer; Kunzelmann, Karl			Regulation of the epithelial Na+ channel by the protein kinase CK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CELL-SURFACE EXPRESSION; SODIUM-CHANNEL; OPEN PROBABILITY; DOWN-REGULATION; ALPHA-SUBUNIT; BETA-SUBUNIT; PHOSPHORYLATION; ENAC; SERUM	CK2 is a ubiquitous, pleiotropic, and constitutively active Ser/Thr protein kinase that controls protein expression, cell signaling, and ion channel activity. Phosphorylation sites for CK2 are located in the C terminus of both beta- and gamma- subunits of the epithelial Na+ channel ( ENaC). We examined the role of CK2 on the regulation of both endogenous ENaC in native murine epithelia and in Xenopus oocytes expressing rENaC. In Ussing chamber experiments with mouse airways, colon, and cultured M1-collecting duct cells, amiloride-sensitive Na+ transport was inhibited dose-dependently by the selective CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB). In oocytes, ENaC currents were also inhibited by TBB and by the structurally unrelated inhibitors heparin and poly(E:Y). Expression of a trimeric channel lacking both CK2 sites (alpha beta(S631A)gamma(T599A)) produced a largely attenuated amiloride-sensitive whole cell conductance and rendered the mutant channel insensitive to CK2. In Xenopus oocytes, CK2 was translocated to the cell membrane upon expression of wt-ENaC but not of (alpha beta(S631A)gamma(T599A)-ENaC. Phosphorylation by CK2 is essential for ENaC activation, and to a lesser degree, it also controls membrane expression of alpha beta gamma-ENaC. Channels lacking the Nedd4-2 binding motif in beta-ENaC(R561X, Y618A) no longer required the CK2 site for channel activity and siRNA-knockdown of Nedd4-2 eliminated the effects of TBB. This implies a role for CK2 in inhibiting the Nedd4-2 pathway. We propose that the C terminus of beta-ENaC is targeted by this essential, conserved pleiotropic kinase that directs its constitutive activity toward many cellular protein complexes.	[Bachhuber, Tanja; Almaca, Joana; Aldehni, Fadi; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Mehta, Anil; Amaral, Margarida D.] Univ Dundee, Ninewells Hosp, Dept Maternal & Child Hlth Sci, Dundee DD1 9SY, Scotland; [Almaca, Joana] Univ Lisbon, Fac Ciencias, P-1749016 Lisbon, Portugal; [Amaral, Margarida D.] Natl Inst Hlth, Ctr Human Genet, P-1649016 Lisbon, Portugal	University of Regensburg; University of Dundee; Universidade de Lisboa	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	uqkkunze@mailbox.uq.edu.au	Amaral, Margarida D/E-5748-2012	Amaral, Margarida D/0000-0002-0828-8630; Kunzelmann, Karl/0000-0002-4583-7037; Almaca, Joana/0000-0002-9316-712X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; Bachhuber T, 2005, J BIOL CHEM, V280, P31587, DOI 10.1074/jbc.M504347200; Becchetti A, 2002, AM J PHYSIOL-RENAL, V283, pF1030, DOI 10.1152/ajprenal.00011.2002; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Feldman RD, 2002, MOL PHARMACOL, V61, P707, DOI 10.1124/mol.61.4.707; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Kimura T, 2003, NEUROSCI RES, V46, P105, DOI 10.1016/S0168-0102(03)00038-5; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Rajamanickam J, 2007, J NEUROCHEM, V102, P858, DOI 10.1111/j.1471-4159.2007.04585.x; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Treharne KJ, 2007, J BIOL CHEM, V282, P10804, DOI 10.1074/jbc.M610956200; Yan WS, 2007, AM J PHYSIOL-RENAL, V293, pF868, DOI 10.1152/ajprenal.00194.2007; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200	26	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13225	13232		10.1074/jbc.M704532200	http://dx.doi.org/10.1074/jbc.M704532200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308722	Green Published, hybrid			2022-12-27	WOS:000255499800062
J	He, DY; Ron, D				He, Dao-Yao; Ron, Dorit			Glial cell line-derived neurotrophic factor reverses ethanol-mediated increases in tyrosine hydroxylase immunoreactivity via altering the activity of heat shock protein 90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK-PROTEIN 90; GLUCOCORTICOID-RESPONSIVE ELEMENT; NIGROSTRIATAL DOPAMINE SYSTEM; HSP90 MOLECULAR CHAPERONE; ANTI-ADDICTION DRUG; GENE-EXPRESSION; NOREPINEPHRINE BIOSYNTHESIS; PROMOTER REGION; BINDING-SITE; GDNF	We previously found that glial cell line-derived neurotrophic factor (GDNF) in the midbrain ventral tegmental area (VTA) negatively regulates alcohol drinking (He, D. Y., McGough, N. N., Ravindranathan, A., Jeanblanc, J., Logrip, M. L., Phamluong, K., Janak, P. H., and Ron, D. (2005) J. Neurosci. 25, 619 628). Several studies suggest a role for GDNF in the regulation of tyrosine hydroxylase (TH) levels in the midbrain (Georgievska, B., Kirik, D., and Bjorklund, A. (2004) J. Neurosci. 24, 6437 6445). Up-regulation of TH levels has been reported as a hallmark of biochemical adaptations to in vivo chronic exposure to drugs of abuse, including ethanol (Ortiz, J., Fitzgerald, L. W., Charlton, M., Lane, S., Trevisan, L., Guitart, X., Shoemaker, W., Duman, R. S., and Nestler, E. J. (1995) Synapse 21, 289 -298). We hypothesized that GDNF plays an important role in regulating prolonged ethanol-mediated increases in TH protein levels. Using the SH-SY5Y dopaminergic-like cell line, we found that the increase in TH levels in the presence of ethanol required the activation of the cAMP/PKA pathway and was reversed by GDNF. Ethanol treatment did not alter the mRNA level or protein translation of TH, but enhanced the stability of the protein that was decreased by GDNF. Interestingly, we observed that ethanol treatment resulted in an increase in TH association with the chaperone heat shock protein (HSP90) that was mediated by the cAMP/PKA pathway and inhibited by GDNF. Taken together, these data suggest that prolonged ethanol exposure leads to increased association of TH and HSP90 via the cAMP/ PKA pathway, resulting in the stabilization and subsequent accumulation of TH. GDNF reverses this ethanol-mediated adaptation by inhibiting the interaction of TH with HSP90.	[He, Dao-Yao] Univ Calif San Francisco, Ernest Gallo Res Ctr, Emeryville, CA 94608 USA; [Ron, Dorit] Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Ron, D (corresponding author), 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	dorit.ron@ucsf.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014366] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA014366-02] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BEITNERJOHNSON D, 1991, J NEUROCHEM, V57, P344, DOI 10.1111/j.1471-4159.1991.tb02133.x; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bobrovskaya L, 2007, CELL SIGNAL, V19, P1141, DOI 10.1016/j.cellsig.2006.12.006; Borba JC, 2005, DEV BRAIN RES, V156, P193, DOI 10.1016/j.devbrainres.2005.02.016; CAPPENDIJK SLT, 1993, EUR J PHARMACOL, V241, P261, DOI 10.1016/0014-2999(93)90212-Z; Cass WA, 1996, J NEUROSCI, V16, P8132; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; GAHN LG, 1995, BIOCHEMISTRY-US, V34, P252, DOI 10.1021/bi00001a030; Georgievska B, 2004, J NEUROSCI, V24, P6437, DOI 10.1523/JNEUROSCI.1122-04.2004; Green-Sadan T, 2005, EXP NEUROL, V194, P97, DOI 10.1016/j.expneurol.2005.01.020; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hadden MK, 2006, CURR TOP MED CHEM, V6, P1173; Hagerty T, 2001, J NEUROCHEM, V78, P1379, DOI 10.1046/j.1471-4159.2001.00521.x; Hagerty T, 2001, J NEUROCHEM, V76, P825, DOI 10.1046/j.1471-4159.2001.00072.x; Haile CN, 2001, SYNAPSE, V41, P179, DOI 10.1002/syn.1073; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; He DY, 2005, J NEUROSCI, V25, P619, DOI 10.1523/JNEUROSCI.3959-04.2005; Jeong H, 2006, J NEUROCHEM, V98, P386, DOI 10.1111/j.1471-4159.2006.03866.x; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kumer SC, 1996, J NEUROCHEM, V67, P443; LAZAR MA, 1981, J NEUROCHEM, V36, P677, DOI 10.1111/j.1471-4159.1981.tb01641.x; Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Mailliard WS, 2004, PHARMACOL THERAPEUT, V101, P39, DOI 10.1016/j.pharmthera.2003.10.002; Mash DC, 1998, ANN NY ACAD SCI, V844, P274, DOI 10.1111/j.1749-6632.1998.tb08242.x; Messer CJ, 2000, NEURON, V26, P247, DOI 10.1016/S0896-6273(00)81154-X; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; ORTIZ J, 1995, SYNAPSE, V21, P289, DOI 10.1002/syn.890210403; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Piech-Dumas KM, 2001, J NEUROCHEM, V76, P1376, DOI 10.1046/j.1471-4159.2001.00127.x; POPIK P, 1995, PHARMACOL REV, V47, P235; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REZVANI AH, 1995, PHARMACOL BIOCHEM BE, V52, P615, DOI 10.1016/0091-3057(95)00152-M; Roe DF, 2004, MOL BRAIN RES, V120, P91, DOI 10.1016/j.molbrainres.2003.09.019; RON D, 2005, SCI STKE, pRE14; Ronca F, 1999, J BIOL CHEM, V274, P18128, DOI 10.1074/jbc.274.25.18128; Rosenblad C, 2003, EUR J NEUROSCI, V17, P260, DOI 10.1046/j.1460-9568.2003.02456.x; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Sajadi A, 2005, J NEUROCHEM, V93, P1482, DOI 10.1111/j.1471-4159.2005.03139.x; Schmidt EF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-07-j0003.2001; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; SERSHEN H, 1994, PHARMACOL BIOCHEM BE, V47, P13, DOI 10.1016/0091-3057(94)90105-8; SORG BA, 1993, J PHARMACOL EXP THER, V266, P424; Suzuki T, 2004, BIOCHEM BIOPH RES CO, V315, P389, DOI 10.1016/j.bbrc.2004.01.068; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Vanhoose AM, 2006, J NEUROSCI, V26, P1138, DOI 10.1523/JNEUROSCI.3572-05.2006; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Xiao L, 2007, CURR MED CHEM, V14, P223, DOI 10.2174/092986707779313372; Xu RY, 1998, J NEUROCHEM, V70, P1383, DOI 10.1046/j.1471-4159.1998.70041383.x; Yoshimura R, 2004, MOL BRAIN RES, V126, P188, DOI 10.1016/j.molbrainres.2004.04.007; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9	63	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12811	12818		10.1074/jbc.M706216200	http://dx.doi.org/10.1074/jbc.M706216200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343820	Green Published, hybrid			2022-12-27	WOS:000255499800017
J	Reid, BN; Ables, GP; Otlivanchik, OA; Schoiswohl, G; Zechner, R; Blaner, WS; Goldberg, IJ; Schwabe, RF; Chua, SC; Huang, LS				Reid, Brendan N.; Ables, Gene P.; Otlivanchik, Oleg A.; Schoiswohl, Gabriele; Zechner, Rudolf; Blaner, William S.; Goldberg, Ira J.; Schwabe, Robert F.; Chua, Streamson C., Jr.; Huang, Li-Shin			Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE STRAINS; LIVER-DISEASE; OB/OB MICE; GENE-EXPRESSION; DIABETIC MICE; PPAR-ALPHA; APO-B; TISSUE; OBESE; METABOLISM	Hepatic steatosis is often associated with insulin resistance and obesity and can lead to steatohepatitis and cirrhosis. In this study, we have demonstrated that hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), two enzymes critical for lipolysis in adipose tissues, also contribute to lipolysis in the liver and can mobilize hepatic triglycerides in vivo and in vitro. Adenoviral overexpression of HSL and/or ATGL reduced liver triglycerides by 40 - 60% in both ob/ob mice and mice with high fat diet-induced obesity. However, these enzymes did not affect fasting plasma triglyceride and free fatty acid levels or triglyceride and apolipoprotein B secretion rates. Plasma 3-beta-hydroxybutyrate levels were increased 3 - 5 days after infection in both HSL- and ATGL-overexpressing male mice, suggesting an increase in beta-oxidation. Expression of genes involved in fatty acid transport and synthesis, lipid storage, and mitochondrial bioenergetics was unchanged. Mechanistic studies in oleate-supplemented McA-RH7777 cells with adenoviral overexpression of HSL or ATGL showed that reduced cellular triglycerides could be attributed to increases in beta-oxidation as well as direct release of free fatty acids into the medium. In summary, hepatic overexpression of HSL or ATGL can promote fatty acid oxidation, stimulate direct release of free fatty acid, and ameliorate hepatic steatosis. This study suggests a direct functional role for both HSL and ATGL in hepatic lipid homeostasis and identifies these enzymes as potential therapeutic targets for ameliorating hepatic steatosis associated with insulin resistance and obesity.	[Reid, Brendan N.; Ables, Gene P.; Otlivanchik, Oleg A.; Blaner, William S.; Goldberg, Ira J.; Schwabe, Robert F.; Huang, Li-Shin] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Schoiswohl, Gabriele; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Chua, Streamson C., Jr.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Columbia University; University of Graz; Yeshiva University; Albert Einstein College of Medicine	Huang, LS (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, 630 W 168th St,P&S 9-503, New York, NY 10032 USA.	lh99@columbia.edu	Schwabe, Robert/AAY-6506-2021	Zechner, Rudolf/0000-0001-5483-1182; Schoiswohl, Gabriele/0000-0002-7346-2834	NHLBI NIH HHS [R01 HL062583, HL45095, HL007343, HL73029, R01 HL045095, HL62583, R01 HL073029] Funding Source: Medline; NIDDK NIH HHS [DK063306, DK079221] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062583, R37HL045095, R01HL045095, R01HL073029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063306, R01DK079221] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Baffy G, 2005, FRONT BIOSCI-LANDMRK, V10, P2082, DOI 10.2741/1683; Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chua S, 2002, DIABETOLOGIA, V45, P976, DOI 10.1007/s00125-002-0880-z; Ferrante AW, 2001, DIABETES, V50, P2268, DOI 10.2337/diabetes.50.10.2268; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goldberg IJ, 2006, GASTROENTEROLOGY, V130, P1343, DOI 10.1053/j.gastro.2006.02.040; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Ko C, 2003, J LIPID RES, V44, P1946, DOI 10.1194/jlr.M300172-JLR200; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Lutchman G, 2006, CLIN GASTROENTEROL H, V4, P1048, DOI 10.1016/j.cgh.2006.05.005; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; MEMON RA, 1994, HORM METAB RES, V26, P85, DOI 10.1055/s-2007-1000778; Memon RA, 1999, DIABETES, V48, P121, DOI 10.2337/diabetes.48.1.121; Pease RJ, 1999, BIOCHEM J, V341, P453, DOI 10.1042/0264-6021:3410453; Portincasa P, 2006, CURR MED CHEM, V13, P2889, DOI 10.2174/092986706778521878; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Suzuki J, 2001, AM J PHYSIOL-ENDOC M, V281, pE857, DOI 10.1152/ajpendo.2001.281.4.E857; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Voyiaziakis E, 1999, J LIPID RES, V40, P2004; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; Wiegman CH, 2003, DIABETES, V52, P1081, DOI 10.2337/diabetes.52.5.1081; YEAMAN SJ, 1994, ADV ENZYME REGUL, V34, P355, DOI 10.1016/0065-2571(94)90022-1; Youssef Wael, 2002, Semin Gastrointest Dis, V13, P17; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	43	232	246	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13087	13099		10.1074/jbc.M800533200	http://dx.doi.org/10.1074/jbc.M800533200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337240	Green Published, hybrid			2022-12-27	WOS:000255499800047
J	Bi, S; Earl, LA; Jacobs, L; Baum, LG				Bi, Shuguang; Earl, Lesley A.; Jacobs, Linsey; Baum, Linda G.			Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; GALACTOSIDE-BINDING LECTIN; THYMIC EPITHELIAL-CELLS; CORE-2 O-GLYCANS; ENDOGENOUS LECTIN; MURINE MODEL; APOPTOSIS; EXPRESSION; ADHESION; GROWTH	The galectin family of lectins regulates multiple biologic functions, such as development, inflammation, immunity, and cancer. One common function of several galectins is the ability to trigger T cell death. However, differences among the death pathways triggered by various galectins with regard to glycoprotein receptors, intracellular death pathways, and target cell specificity are not well understood. Specifically, galectin-9 and galectin-1 both kill thymocytes, peripheral T cells, and T cell lines; however, we have found that galectin-9 and galectin-1 require different glycan ligands and glycoprotein receptors to trigger T cell death. The two galectins also utilize different intracellular death pathways, as galectin-9, but not galectin-1, T cell death was blocked by intracellular Bcl-2, whereas galectin-1, but not galectin-9, T cell death was blocked by intracellular galectin-3. Target cell susceptibility also differed between the two galectins, as galectin-9 and galectin-1 killed different subsets of murine thymocytes. To define structural features responsible for distinct activities of the tandem repeat galectin-9 and dimeric galectin-1, we created a series of bivalent constructs with galectin-9 and galectin-1 carbohydrate recognition domains connected by different peptide linkers. We found that the N-terminal carbohydrate recognition domain and linker peptide contributed to the potency of these constructs. However, we found that the C-terminal carbohydrate recognition domain was the primary determinant of receptor recognition, death pathway signaling, and target cell susceptibility. Thus, carbohydrate recognition domain specificity, presentation, and valency make distinct contributions to the specific effects of different galectins in initiating T cell death.	[Bi, Shuguang; Earl, Lesley A.; Jacobs, Linsey; Baum, Linda G.] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Baum, LG (corresponding author), 10833 LeConte Ave, Los Angeles, CA 90095 USA.	lbaum@mednet.ucla.edu			NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063281] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16042] Funding Source: Medline; NIAID NIH HHS [AI28697] Funding Source: Medline; NIGMS NIH HHS [R01 GM63281] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bao Q, 1999, GLYCOBIOLOGY, V9, P489, DOI 10.1093/glycob/9.5.489; Battig P, 2004, MOL IMMUNOL, V41, P9, DOI 10.1016/j.molimm.2004.02.004; BAUM LG, 1995, J EXP MED, V181, P877, DOI 10.1084/jem.181.3.877; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Fukumori T, 2003, CANCER RES, V63, P8302; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Galvan M, 2000, J BIOL CHEM, V275, P16730, DOI 10.1074/jbc.M001117200; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Hadari YR, 2000, J CELL SCI, V113, P2385; Hahn HP, 2004, CELL DEATH DIFFER, V11, P1277, DOI 10.1038/sj.cdd.4401485; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Hotta K, 2001, J BIOL CHEM, V276, P34089, DOI 10.1074/jbc.M105097200; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; LEFFLER H, 1986, J BIOL CHEM, V261, P119; LIAO DI, 1994, P NATL ACAD SCI USA, V91, P1428, DOI 10.1073/pnas.91.4.1428; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lopez E, 2006, J IMMUNOL, V176, P1943, DOI 10.4049/jimmunol.176.3.1943; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Miyanishi N, 2007, GLYCOBIOLOGY, V17, P423, DOI 10.1093/glycob/cwm001; Nagae M, 2008, J MOL BIOL, V375, P119, DOI 10.1016/j.jmb.2007.09.060; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Okudaira T, 2007, INT J CANCER, V120, P2251, DOI 10.1002/ijc.22534; Opferman JT, 2008, CELL DEATH DIFFER, V15, P234, DOI 10.1038/sj.cdd.4402182; Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331; Pace KE, 2003, METHOD ENZYMOL, V363, P499; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Rabinovich GA, 2002, GLYCOCONJUGATE J, V19, P565, DOI 10.1023/B:GLYC.0000014087.41914.72; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Spitzenberger F, 2001, BIOCHIMIE, V83, P851, DOI 10.1016/S0300-9084(01)01335-9; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Tsuchiyama Y, 2000, KIDNEY INT, V58, P1941, DOI 10.1111/j.1523-1755.2000.00366.x; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011; Vespa GNR, 1999, J IMMUNOL, V162, P799; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Walzel H, 2000, GLYCOBIOLOGY, V10, P131, DOI 10.1093/glycob/10.2.131; Walzel H, 2006, GLYCOBIOLOGY, V16, P1262, DOI 10.1093/glycob/cwl037; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	61	105	114	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12248	12258		10.1074/jbc.M800523200	http://dx.doi.org/10.1074/jbc.M800523200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18258591	Green Published, hybrid			2022-12-27	WOS:000255340000041
J	Blasiole, DA; Oler, AT; Attie, AD				Blasiole, Daniel A.; Oler, Angie T.; Attie, Alan D.			Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN-B; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN-FIBROBLASTS; IN-VIVO; MICE; VLDL; DEGRADATION; PROTEIN	Apolipoprotein B (apoB) is required for the hepatic assembly and secretion of very low density lipoprotein (VLDL). The LDL receptor (LDLR) promotes post-translational degradation of apoB and thereby reduces VLDL particle secretion. We investigated the trafficking pathways and ligand requirements for the LDLR to promote degradation of apoB. We first tested whether the LDLR drives apoB degradation in an endoplasmic reticulum (ER)-associated pathway. Primary mouse hepatocytes harboring an ethyl-nitrosourea-induced, ER-retained mutant LDLR secreted comparable levels of apoB with LDLR-null hepatocytes, despite reduced secretion from cells expressing the wild-type LDLR. Additionally, treatment of cells with brefeldin A inhibited LDLR-dependent degradation. However, this rescue was reversible, and degradation of apoB occurred upon removal of brefeldin A. To characterize the lipoprotein reuptake pathway of degradation, we employed an LDLR mutant defective in constitutive endocytosis and internalization of apoB. This mutant was as effective in reducing apoB secretion as the wild-type LDLR. However, the effect was dependent on apolipoprotein E (apoE) as only the wild-type LDLR, and not the endocytic mutant, reduced apoB secretion in apoE-null cells. Treatment with heparin rescued a pool of apoB in cells expressing the endocytic mutant, indicating that reuptake of VLDL via apoE still occurs with this mutant. Finally, an LDLR mutant defective in binding apoB but not apoE reduced apoB secretion in an apoE-dependent manner. Together, these data suggest that the LDLR directs apoB to degradation in a post-ER compartment. Furthermore, the reuptake mechanism of degradation occurs via internalization of apoB through a constitutive endocytic pathway and apoE through a ligand-dependent pathway.	[Blasiole, Daniel A.; Oler, Angie T.; Attie, Alan D.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Attie, AD (corresponding author), 433 Babcock Dr, Madison, WI 53706 USA.	adattie@wisc.edu			NHLBI NIH HHS [HL56593, T32 HL07936] Funding Source: Medline; NIA NIH HHS [T32 AG20013] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056593, T32HL007936] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON RGW, 1982, J CELL BIOL, V93, P523, DOI 10.1083/jcb.93.3.523; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; Boren J, 1998, J CLIN INVEST, V101, P1084, DOI 10.1172/JCI1847; BROWN MS, 1976, CELL, V9, P663, DOI 10.1016/0092-8674(76)90130-6; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; Davis RA, 1999, BBA-MOL CELL BIOL L, V1440, P1, DOI 10.1016/S1388-1981(99)00083-9; Dirlam KA, 1996, PROTEIN EXPRES PURIF, V8, P489, DOI 10.1016/S1046-5928(96)90129-1; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Gillian-Daniel DL, 2002, P NATL ACAD SCI USA, V99, P4337, DOI 10.1073/pnas.072557199; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; HOPKINS CR, 1985, J CELL SCI, P173; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Huang YD, 1999, ARTERIOSCL THROM VAS, V19, P2952, DOI 10.1161/01.ATV.19.12.2952; JAMES RW, 1989, J LIPID RES, V30, P159; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Jones C, 2007, J CLIN INVEST, V117, P165, DOI 10.1172/JCI29415; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Larsson SL, 2004, J BIOL CHEM, V279, P831, DOI 10.1074/jbc.M303057200; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maugeais C, 2000, J LIPID RES, V41, P1673; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Mensenkamp AR, 2004, J HEPATOL, V40, P599, DOI 10.1016/j.jhep.2003.12.011; Mensenkamp AR, 2001, ARTERIOSCL THROM VAS, V21, P1366, DOI 10.1161/hq0801.093864; Michaely P, 2007, EMBO J, V26, P3273, DOI 10.1038/sj.emboj.7601769; Millar JS, 2005, ARTERIOSCL THROM VAS, V25, P560, DOI 10.1161/01.ATV.0000155323.18856.a2; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Nassir F, 2004, J LIPID RES, V45, P1649, DOI 10.1194/jlr.M300505-JLR200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SATO R, 1990, J BIOL CHEM, V265, P11880; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Teusink B, 2001, J BIOL CHEM, V276, P40693, DOI 10.1074/jbc.M106396200; Tremblay AJ, 2004, J LIPID RES, V45, P866, DOI 10.1194/jlr.M300448-JLR200; Twisk J, 2000, J CLIN INVEST, V105, P521, DOI 10.1172/JCI8623; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P16741; Wu XJ, 1997, J BIOL CHEM, V272, P11575	50	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11374	11381		10.1074/jbc.M710457200	http://dx.doi.org/10.1074/jbc.M710457200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18272520	hybrid, Green Published			2022-12-27	WOS:000255067400034
J	Majumdar, A; Muniandy, PA; Liu, J; Liu, JI; Liu, ST; Cuenoud, B; Seidman, MM				Majumdar, Alokes; Muniandy, Parameswary A.; Liu, Jia; Liu, Ji-Ian; Liu, Su-ting; Cuenoud, Bernard; Seidman, Michael M.			Targeted gene knock in and sequence modulation mediated by a psoralen-linked triplex-forming oligonucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; NUCLEOTIDE EXCISION-REPAIR; INTERSTRAND CROSS-LINK; INDUCED HOMOLOGOUS RECOMBINATION; SISTER-CHROMATID EXCHANGE; MAMMALIAN-CELLS; 2'-O-(2-AMINOETHYL) RESIDUES; DIRECTED REPAIR; HELIX FORMATION; UV-RADIATION	Information from exogenous donor DNA can be introduced into the genome via homology-directed repair (HDR) pathways. These pathways are stimulated by double strand breaks and by DNA damage such as interstrand cross-links. We have employed triple helix-forming oligonucleotides linked to psoralen (pso-TFO) to introduce a DNA interstrand cross-link at a specific site in the genome of living mammalian cells. Co-introduction of duplex DNA with target region homology resulted in precise knock in of the donor at frequencies 2-3 orders of magnitude greater than with donor alone. Knock-in was eliminated in cells deficient in ERCC1-XPF, which is involved in recombinational pathways as well as cross-link repair. Separately, single strand oligonucleotide donors (SSO) were co-introduced with the pso-TFO. These were 10-fold more active than the duplex knock-in donor. SSO efficacy was further elevated in cells deficient in ERCC1-XPF, in contrast to the duplex donor. Resected single strand ends have been implicated as critical intermediates in sequence modulation by SSO, as well as duplex donor knock in. We asked whether there would be a competition between the donor species for these ends if both were present with the pso-TFO. The frequency of duplex donor knock in was unaffected by a 100-fold molar excess of the SSO. The same result was obtained when the homing endonuclease I-SceI was used to initiate HDR at the target site. We conclude that the entry of double strand breaks into distinct HDR pathways is controlled by factors other than the nucleic acid partners in those pathways.	[Majumdar, Alokes; Muniandy, Parameswary A.; Liu, Jia; Liu, Ji-Ian; Liu, Su-ting; Seidman, Michael M.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Cuenoud, Bernard] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Novartis	Seidman, MM (corresponding author), NIA, Lab Mol Gerontol, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	seidmanm@grc.nia.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000747, ZIAAG000747] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aarts M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl896; Adair GM, 1998, SOMAT CELL MOLEC GEN, V24, P91, DOI 10.1023/B:SCAM.0000007112.62928.d8; Adair GR, 2000, EMBO J, V19, P5552, DOI 10.1093/emboj/19.20.5552; Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Becker NA, 1999, ANTISENSE NUCLEIC A, V9, P313, DOI 10.1089/oli.1.1999.9.313; Bessho T, 2003, J BIOL CHEM, V278, P5250, DOI 10.1074/jbc.M212323200; Cao J, 1997, MUTAT RES-FUND MOL M, V374, P233, DOI 10.1016/S0027-5107(96)00237-0; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chin JY, 2007, FRONT BIOSCI-LANDMRK, V12, P4288, DOI 10.2741/2388; CORTES F, 1991, EXP CELL RES, V196, P127, DOI 10.1016/0014-4827(91)90464-6; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Cuenoud B, 1998, ANGEW CHEM INT EDIT, V37, P1288, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1288::AID-ANIE1288>3.0.CO;2-U; De Semir D, 2003, OLIGONUCLEOTIDES, V13, P261, DOI 10.1089/154545703322460630; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; Durant ST, 2006, MOL CELL BIOL, V26, P6047, DOI 10.1128/MCB.00444-06; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Faruqi AF, 1996, MOL CELL BIOL, V16, P6820; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Jonnalagadda VS, 2005, DNA REPAIR, V4, P594, DOI 10.1016/j.dnarep.2005.02.002; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lin YF, 1999, MOL CELL BIOL, V19, P8353; Lin YF, 2001, GENETICS, V158, P1665; Ma YM, 2005, CELL CYCLE, V4, P1193, DOI 10.4161/cc.4.9.1977; Majumdar A, 2003, J BIOL CHEM, V278, P11072, DOI 10.1074/jbc.M211837200; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; Maurisse R, 2006, OLIGONUCLEOTIDES, V16, P375, DOI 10.1089/oli.2006.16.375; Motycka TA, 2004, J BIOL CHEM, V279, P13634, DOI 10.1074/jbc.M313779200; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Olsen PA, 2003, GENE THER, V10, P1830, DOI 10.1038/sj.gt.3302079; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Puri N, 2004, BIOCHEMISTRY-US, V43, P1343, DOI 10.1021/bi035808l; Puri N, 2002, BIOCHEMISTRY-US, V41, P7716, DOI 10.1021/bi025734y; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Richards S, 2005, NUCLEIC ACIDS RES, V33, P5382, DOI 10.1093/nar/gki851; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Richardson C, 1999, METH MOL B, V113, P453; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Rolig RL, 1997, MUTAGENESIS, V12, P277, DOI 10.1093/mutage/12.4.277; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Saffran WA, 2004, J BIOL CHEM, V279, P36462, DOI 10.1074/jbc.M402323200; Sargent RG, 2000, NUCLEIC ACIDS RES, V28, P3771, DOI 10.1093/nar/28.19.3771; Sargent RG, 1997, P NATL ACAD SCI USA, V94, P13122, DOI 10.1073/pnas.94.24.13122; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Seidman MM, 2003, J CLIN INVEST, V112, P487, DOI 10.1172/JCI200319552; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; TSUJIMURA T, 1990, P NATL ACAD SCI USA, V87, P1566, DOI 10.1073/pnas.87.4.1566; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varga T, 2005, DNA REPAIR, V4, P1038, DOI 10.1016/j.dnarep.2005.05.004; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2	63	31	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11244	11252		10.1074/jbc.M800607200	http://dx.doi.org/10.1074/jbc.M800607200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303025	Green Published, hybrid			2022-12-27	WOS:000255067400020
J	Yoshitake, F; Itoh, S; Narita, H; Ishihara, K; Ebisu, S				Yoshitake, Fumio; Itoh, Shousaku; Narita, Hiroko; Ishihara, Katsuhiko; Ebisu, Shigeyuki			Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappa B signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLASTIC CELLS; STAT3 ACTIVATION; PROTEIN-KINASE; FAMILY; IL-6; CYTOKINE; SPECIFICITY; EXPRESSION; INDUCTION; NUCLEAR	Interleukin-6 (IL-6) is a multifunctional cytokine produced by various cells to regulate hematopoiesis, inflammation, immune responses, and bone homeostasis. IL-6 is also known to modulate the differentiation of osteoblasts and osteoclasts. IL-6 is believed to play a positive regulatory role in osteoclast differentiation by inducing the expression of receptor activator of NF-kappa B ligand ( RANKL) on the surface of osteoblasts: RANKL then interacts with RANK expressed on osteoclast progenitors, inducing osteoclast differentiation via the RANK signaling pathway, which involves NF-kappa B, JNK, and p38. In this report, we demonstrate that IL-6 can also directly act on osteoclast progenitors to suppress their differentiation via an inhibition of RANK signaling pathways. IL-6 specifically suppressed RANK-mediated I kappa B degradation and JNK activation. Microarray analysis revealed that costimulation with IL-6 and RANKL up-regulates the transcription of MKP1 and MKP7, which encode enzymes that dephosphorylate JNK, and down-regulates the transcription of Senp2 and Cul4A, which are related to the ubiquitin pathway. Thus, IL-6 directly acts on osteoclast progenitors and suppresses their differentiation by regulating the transcription of specific genes related to MAPK phosphatases and the ubiquitin pathway.	[Yoshitake, Fumio; Itoh, Shousaku; Narita, Hiroko; Ebisu, Shigeyuki] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Suita, Osaka 5650871, Japan; [Ishihara, Katsuhiko] Kawasaki Med Sch, Dept Immunol & Mol Genet, Okayama, Japan	Osaka University; Kawasaki Medical School	Itoh, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ito@dent.osaka-u.ac.jp	Ishihara, Katsuhiko/AAL-8175-2021					Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Ishihara K, 2002, BBA-MOL CELL RES, V1592, P281, DOI 10.1016/S0167-4889(02)00321-X; Itoh S, 2002, J IMMUNOL, V168, P5110, DOI 10.4049/jimmunol.168.10.5110; Itoh S, 2007, J BONE MINER METAB, V25, P81, DOI 10.1007/s00774-006-0731-y; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kawasaki K, 1997, ENDOCRINOLOGY, V138, P4959, DOI 10.1210/en.138.11.4959; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; KITAMURA H, 1995, AM J PATHOL, V147, P1682; Kotake S, 1996, J BONE MINER RES, V11, P88; MANOLAGAS SC, 1995, BONE, V17, pS63, DOI 10.1016/8756-3282(95)00180-L; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; UDAGAWA N, 1995, J EXP MED, V182, P1461, DOI 10.1084/jem.182.5.1461; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Yamamoto A, 2002, J BONE MINER RES, V17, P612, DOI 10.1359/jbmr.2002.17.4.612; Zhang ZY, 2005, BIOCHEM BIOPH RES CO, V328, P800, DOI 10.1016/j.bbrc.2005.01.019	28	195	212	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11535	11540		10.1074/jbc.M607999200	http://dx.doi.org/10.1074/jbc.M607999200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18296709	hybrid			2022-12-27	WOS:000255067400053
J	Kim, SI; Kwak, JH; Wang, L; Choi, ME				Kim, Sung Il; Kwak, Joon Hyeok; Wang, Lin; Choi, Mary E.			Protein phosphatase 2A is a negative regulator of transforming growth factor-beta 1-induced TAK1 activation in mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE KINASE KINASE; I-KAPPA-B; FACTOR-BETA; CATALYTIC SUBUNIT; FIBRONECTIN SYNTHESIS; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; SMAD; IL-1; PATHWAYS	TAK1 (transforming growth factor (TGF)-beta-activated kinase 1) is a serine/threonine kinase that is rapidly activated by TGF-beta 1 and plays a vital function in its signal transduction. Once TAK1 is activated, efficient down-regulation of TAK1 activity is important to prevent excessive TGF-beta 1 responses. The regulatory mechanism of TAK1 inactivation following TGF-beta 1 stimulation has not been elucidated. Here we demonstrate that protein phosphatase 2A (PP2A) plays a pivotal role as a negative regulator of TAK1 activation in response to TGF-beta 1 in mesangial cells. Treatment with okadaic acid (OA) induces autophosphorylation of Thr-187 in the activation loop of TAK1. In vitro dephosphorylation assay suggests that Thr-187 in TAK1 is a major dephosphorylation target of PP2A. TGF-beta 1 stimulation rapidly activates TAK1 in a biphasic manner, indicating that TGF-beta 1-induced TAK1 activation is tightly regulated. The association of PP2A(C) with TAK1 is enhanced in response to TGF-beta 1 stimulation and closely parallels TGF-beta 1-induced TAK1 activity. Attenuation of PP2A activity by OA treatment or targeted knockdown of PP2AC with small interfering RNA enhances TGF-beta 1-induced phosphorylation of TAK1 at Thr-187 and MKK3 (MAPK kinase 3). Endogenous TAK1 co-precipitates with PP2AC but not PP6(C), another OA-sensitive protein phosphatase, and knockdown of PP6C by small interfering RNA does not affect TGF-beta 1-induced phosphorylation of TAK1 at Thr-187 and MKK3. Moreover, ectopic expression of phosphatase-deficient PP2AC enhances TAK1-mediated MKK3 phosphorylation by TGF-beta 1 stimulation, whereas the expression of wild-type PP2AC suppresses the MKK3 phosphorylation. Taken together, our data indicate that PP2A functions as a negative regulator in TGF-beta 1-induced TAK1 activation.	[Kim, Sung Il; Kwak, Joon Hyeok; Choi, Mary E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Renal,Dept Med, 4 Blackfan Circle,HIM-5, Boston, MA 02115 USA; [Kim, Sung Il; Kwak, Joon Hyeok; Wang, Lin; Choi, Mary E.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15213 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Choi, ME (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Renal,Dept Med, 4 Blackfan Circle,HIM-5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu			NIDDK NIH HHS [R01 DK57661] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecassis L, 2004, J BIOL CHEM, V279, P30474, DOI 10.1074/jbc.M403294200; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Chung HY, 1999, CELL SIGNAL, V11, P575, DOI 10.1016/S0898-6568(99)00033-9; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 2005, J BIOL CHEM, V280, P25920, DOI 10.1074/jbc.M501150200; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi Y, 2005, J BIOL CHEM, V280, P11395, DOI 10.1074/jbc.M411189200; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mucsi I, 1996, J BIOL CHEM, V271, P16567, DOI 10.1074/jbc.271.28.16567; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oliver Carey J., 1998, Frontiers in Bioscience, V3, pD961; Ono K, 2003, BIOCHEM BIOPH RES CO, V307, P332, DOI 10.1016/S0006-291X(03)01207-5; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sano Y, 1999, J BIOL CHEM, V274, P8949, DOI 10.1074/jbc.274.13.8949; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Terada Y, 1999, KIDNEY INT, V56, P1378, DOI 10.1046/j.1523-1755.1999.00665.x; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	67	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10753	10763		10.1074/jbc.M801263200	http://dx.doi.org/10.1074/jbc.M801263200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18299321	hybrid, Green Published			2022-12-27	WOS:000254894700058
J	Neco, P; Fernandez-Peruchena, C; Navas, S; Gutierrez, LM; de Toledo, GA; Ales, E				Neco, Patricia; Fernandez-Peruchena, Carlos; Navas, Sergio; Gutierrez, Luis M.; de Toledo, Guillermo Alvarez; Ales, Eva			Myosin II contributes to fusion pore expansion during exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-C; MEMBRANE-FUSION; CATECHOLAMINE RELEASE; NEUROENDOCRINE CELLS; ACTIN CYTOSKELETON; PATCH AMPEROMETRY; VESICLE MEMBRANE; DYNAMICS; SECRETION	During exocytosis, the fusion pore expands to allow release of neurotransmitters and hormones to the extracellular space. To understand the process of synaptic transmission, it is of outstanding importance to know the properties of the fusion pore and how these properties affect the release process. Many proteins have been implicated in vesicle fusion; however, there is little evidence for proteins involved in fusion pore expansion. Myosin II has been shown to participate in the transport of vesicles and, surprisingly, in the final phases of exocytosis, affecting the kinetics of catecholamine release in adrenal chromaffin cells as measured by amperometry. Here, we have studied single vesicle exocytosis in chromaffin cells overexpressing an unphosphorylatable form (T18AS19A RLC-GFP) of myosin II that produces an inactive protein by patch amperometry. This method allows direct determination of fusion pore expansion by measuring its conductance, whereas the release of catecholamines is recorded simultaneously by amperometry. Here we demonstrated that the fusion pore is of critical importance to control the release of catecholamines during single vesicle secretion in chromaffin cells. We proved that myosin II acts as a molecular motor on the fusion pore expansion by hindering its dilation when it lacks the phosphorylation sites.	[Fernandez-Peruchena, Carlos; Navas, Sergio; de Toledo, Guillermo Alvarez; Ales, Eva] Univ Seville, Dpto Fisiol Med & Biofis, E-41009 Seville, Spain; [Neco, Patricia; Gutierrez, Luis M.] CSIC, Ctr Mixto Univ Miguel Hernandez, Inst Neurociencias, Alicante 03550, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Ales, E (corresponding author), Univ Seville, Dpto Fisiol Med & Biofis, E-41009 Seville, Spain.	eales@us.es	Peruchena, Carlos M. Fernández/ABF-2123-2020; Gutierrez, Luis/K-8633-2014; Ales, Eva/E-6315-2010; Alvarez de Toledo, Guillermo/I-2888-2015	Peruchena, Carlos M. Fernández/0000-0003-4801-4375; Gutierrez, Luis/0000-0002-0512-7858; Ales, Eva/0000-0002-5536-4616; Alvarez de Toledo, Guillermo/0000-0001-7193-2663				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Amatore C, 1999, CHEM-EUR J, V5, P2151, DOI 10.1002/(SICI)1521-3765(19990702)5:7<2151::AID-CHEM2151>3.3.CO;2-I; Amatore C, 2007, BIOPHYS CHEM, V129, P181, DOI 10.1016/j.bpc.2007.05.018; An S, 2004, CURR OPIN NEUROBIOL, V14, P522, DOI 10.1016/j.conb.2004.08.008; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; Burgoyne RD, 2001, BIOCHEM SOC T, V29, P467, DOI 10.1042/BST0290467; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHEEK TR, 1986, FEBS LETT, V207, P110, DOI 10.1016/0014-5793(86)80022-9; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Dernick G, 2003, NAT CELL BIOL, V5, P358, DOI 10.1038/ncb956; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Fernandez-Peruchena C, 2005, BRAIN RES REV, V49, P406, DOI 10.1016/j.brainresrev.2004.12.037; GERHARDT G, 1982, ANAL CHEM, V54, P2618, DOI 10.1021/ac00251a054; Giner D, 2007, NEUROSCIENCE, V146, P659, DOI 10.1016/j.neuroscience.2007.02.039; Giner D, 2005, J CELL SCI, V118, P2871, DOI 10.1242/jcs.02419; Gong LW, 2007, NAT CELL BIOL, V9, P915, DOI 10.1038/ncb1617; Gullo F, 2002, FASEB J, V16, P330, DOI 10.1096/fj.02-0200fje; Haller M, 1998, BIOPHYS J, V74, P2100, DOI 10.1016/S0006-3495(98)77917-2; LESZCZYSZYN DJ, 1991, J NEUROCHEM, V56, P1855, DOI 10.1111/j.1471-4159.1991.tb03441.x; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; LOLLIKE K, 1995, J CELL BIOL, V129, P99, DOI 10.1083/jcb.129.1.99; MONCK JR, 1992, J CELL BIOL, V119, P1395, DOI 10.1083/jcb.119.6.1395; Monck JR, 1996, CURR OPIN CELL BIOL, V8, P524, DOI 10.1016/S0955-0674(96)80031-7; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; ORNBERG RL, 1981, J CELL BIOL, V90, P40, DOI 10.1083/jcb.90.1.40; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Schneider SW, 1997, P NATL ACAD SCI USA, V94, P316, DOI 10.1073/pnas.94.1.316; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Tabares L, 2003, BIOCHEM SOC T, V31, P837, DOI 10.1042/bst0310837; Tabares L, 2001, J BIOL CHEM, V276, P39974, DOI 10.1074/jbc.M106498200; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Xu JH, 1999, J BIOL CHEM, V274, P19095, DOI 10.1074/jbc.274.27.19095	43	75	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10949	10957		10.1074/jbc.M709058200	http://dx.doi.org/10.1074/jbc.M709058200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18283106	hybrid			2022-12-27	WOS:000254894700076
J	Blair, IA				Blair, Ian A.			DNA adducts with lipid peroxidation products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHROMATOGRAPHY/MASS SPECTROMETRY ANALYSIS; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; MEDIATED DECOMPOSITION; HYDROPEROXIDE; ACID; QUANTIFICATION; GLUTATHIONE; 2'-DEOXYGUANOSINE; ELECTROPHILES		[Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Blair, Ian A.] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Blair, Ian A.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Blair, IA (corresponding author), Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA.	ian@spirit.gcrc.upenn.edu	Blair, Ian A/B-3320-2010		NCI NIH HHS [R01CA091016, R01 CA091016] Funding Source: Medline; NIEHS NIH HHS [U01ES016004, P30ES013508, U01 ES016004, P30 ES013508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA091016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, U01ES016004] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BARBIN A, 1986, CHEM-BIOL INTERACT, V59, P43, DOI 10.1016/S0009-2797(86)80054-0; Blair IA, 2001, EXP GERONTOL, V36, P1473, DOI 10.1016/S0531-5565(01)00133-4; BLAIR IA, 2005, ENCY MASS SPECTROMET, V3, P283; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; CHANDHARY AK, 1994, BIOL MASS SPECTROM, V23, P457, DOI 10.1002/bms.1200230802; Chaudhary AK, 1996, CARCINOGENESIS, V17, P1167, DOI 10.1093/carcin/17.5.1167; CHAUDHARY AK, 1995, J MASS SPECTROM, V30, P1157, DOI 10.1002/jms.1190300813; CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; Chen HJC, 2004, CHEM RES TOXICOL, V17, P963, DOI 10.1021/tx0341963; Chen HJC, 1999, CHEM RES TOXICOL, V12, P1119, DOI 10.1021/tx990074s; Churchwell MI, 2002, CHEM RES TOXICOL, V15, P1295, DOI 10.1021/tx0101595; Doerge DR, 2000, CHEM RES TOXICOL, V13, P1259, DOI 10.1021/tx0001575; Douki T, 2004, FREE RADICAL BIO MED, V37, P62, DOI 10.1016/j.freeradbiomed.2004.04.013; Ham AJL, 1999, CHEM RES TOXICOL, V12, P1240, DOI 10.1021/tx990150r; Hoberg AM, 2004, J MASS SPECTROM, V39, P38, DOI 10.1002/jms.547; Jian WY, 2007, CHEM RES TOXICOL, V20, P1008, DOI 10.1021/tx700001t; Jian WY, 2005, FREE RADICAL BIO MED, V39, P1162, DOI 10.1016/j.freeradbiomed.2005.06.008; Jian WY, 2005, CHEM RES TOXICOL, V18, P599, DOI 10.1021/tx049693d; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Knutson CG, 2007, J BIOL CHEM, V282, P36257, DOI 10.1074/jbc.M706814200; Lee SH, 2007, CHEM RES TOXICOL, V20, P1665, DOI 10.1021/tx700130p; Lee SH, 2007, METHOD ENZYMOL, V433, P159, DOI 10.1016/S0076-6879(07)33009-7; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SH, 2000, CHEM RES TOXICOL, V13, P565, DOI 10.1021/tx000057z; Lee SH, 2005, J MASS SPECTROM, V40, P661, DOI 10.1002/jms.838; Lee SH, 2005, J BIOL CHEM, V280, P28337, DOI 10.1074/jbc.M504178200; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; Lee SH, 2005, CHEM RES TOXICOL, V18, P566, DOI 10.1021/tx049716o; Lee SH, 2003, RAPID COMMUN MASS SP, V17, P2168, DOI 10.1002/rcm.1170; Lee SH, 2002, CHEM RES TOXICOL, V15, P300, DOI 10.1021/tx010147j; Lee SH, 2001, TRENDS CARDIOVAS MED, V11, P148, DOI 10.1016/S1050-1738(01)00094-9; Loureiro APM, 2000, CHEM RES TOXICOL, V13, P601, DOI 10.1021/tx000004h; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Muller M, 1997, CHEM RES TOXICOL, V10, P242, DOI 10.1021/tx960124i; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Rindgen D, 2000, CHEM RES TOXICOL, V13, P846, DOI 10.1021/tx0000771; Roberts DW, 2001, ANAL CHEM, V73, P303, DOI 10.1021/ac000866n; Rouzer CA, 1997, CHEM RES TOXICOL, V10, P181, DOI 10.1021/tx9601216; Sharma RA, 2004, CLIN CANCER RES, V10, P4901, DOI 10.1158/1078-0432.CCR-04-0098; Singh G, 2000, ANAL CHEM, V72, P3007, DOI 10.1021/ac000374a; SODUM RS, 1991, CANCER RES, V51, P137; Swenberg JA, 1999, IARC SCI PUBL, P29; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Williams MV, 2006, J BIOL CHEM, V281, P10127, DOI 10.1074/jbc.M600178200; Williams MV, 2005, RAPID COMMUN MASS SP, V19, P849, DOI 10.1002/rcm.1854; Zhou XF, 2005, J BIOL CHEM, V280, P25377, DOI 10.1074/jbc.M503079200; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	55	172	180	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15545	15549		10.1074/jbc.R700051200	http://dx.doi.org/10.1074/jbc.R700051200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18285329	hybrid, Green Published			2022-12-27	WOS:000256332500007
J	Gangloff, M; Murali, A; Xiong, J; Arnot, CJ; Weber, AN; Sandercock, AM; Robinson, CV; Sarisky, R; Holzenburg, A; Kao, C; Gay, NJ				Gangloff, Monique; Murali, Ayaluru; Xiong, Jin; Arnot, Christopher J.; Weber, Alexander N.; Sandercock, Alan M.; Robinson, Carol V.; Sarisky, Robert; Holzenburg, Andreas; Kao, Cheng; Gay, Nicholas J.			Structural insight into the mechanism of activation of the Toll receptor by the dimeric ligand Spatzle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CRYSTAL-STRUCTURE; PROTEIN; COMPLEX; BINDING; ORIGIN; DOMAIN; IONS	The Drosophila Toll receptor, which functions in both embryonic patterning and innate immunity to fungi and Gram-positive bacteria, is activated by a dimeric cytokine ligand, Spatzle (Spz). Previous studies have suggested that one Spz cross-links two Toll receptor molecules to form an activated complex. Here we report electron microscopy structures of the Toll ectodomain in the absence and presence of Spz. Contrary to expectations, Spz does not directly cross-link two Toll ectodomains. Instead, Spz binding at the N-terminal end of Toll predominantly induces the formation of a 2: 2 complex, with two sites of interaction between the ectodomain chains, one located near to the N terminus of the solenoid and the other between the C-terminal juxtamembrane sequences. Moreover, Toll undergoes a ligand-induced conformational change, becoming more tightly curved than in the apo form. The unexpected 2: 2 complex was confirmed by mass spectrometry under native conditions. These results suggest that activation of Toll is an allosteric mechanism induced by an end-on binding mode of its ligand Spz.	[Kao, Cheng] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Xiong, Jin] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Holzenburg, Andreas] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX 77843 USA; [Gangloff, Monique; Arnot, Christopher J.; Weber, Alexander N.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Sandercock, Alan M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Sarisky, Robert] Centocor Res & Dev Inc, Discovery Res, Radnor, PA 19087 USA; [Weber, Alexander N.] Deutsches Krebsforschungzentrum, Angewandte Tumovirrol, Div F120, Lab 2 206, D-69120 Heidelberg, Germany	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Cambridge; University of Cambridge; Johnson & Johnson; Johnson & Johnson USA	Kao, C (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ckao@tamu.edu; njg11@mole.bio.cam.ac.uk	Murali, Ayaluru/G-3401-2014	Murali, Ayaluru/0000-0001-6406-6840; Gangloff, Monique/0000-0001-6131-0115; robinson, carol/0000-0001-7829-5505; Weber, Alexander/0000-0002-8627-7056	Medical Research Council [G0400007, G1000133] Funding Source: Medline; MRC [G0400007] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; Felitsyn N, 2002, INT J MASS SPECTROM, V219, P39, DOI 10.1016/S1387-3806(02)00588-2; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jurchen JC, 2003, J AM CHEM SOC, V125, P2817, DOI 10.1021/ja0211508; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; VAKSER IA, 1995, PROTEIN ENG, V8, P371, DOI 10.1093/protein/8.4.371; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732	40	52	54	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14629	14635		10.1074/jbc.M800112200	http://dx.doi.org/10.1074/jbc.M800112200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347020	hybrid			2022-12-27	WOS:000255941400051
J	Misra, S; Obeid, LM; Hannun, YA; Minamisawa, S; Berger, FG; Markwald, RR; Toole, BP; Ghatak, S				Misra, Suniti; Obeid, Lina M.; Hannun, Yusuf A.; Minamisawa, Susumu; Berger, Franklin G.; Markwald, Roger R.; Toole, Bryan P.; Ghatak, Shibnath			Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; COLORECTAL-CANCER; BETA-CATENIN; MESENCHYMAL-TRANSITION; PROSTATE-CANCER; CYCLOOXYGENASE-2 EXPRESSION; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; CD44 EXPRESSION; IN-VITRO	Hyaluronan is a major component of the pericellular matrix surrounding tumor cells, including colon carcinomas. Elevated cycooxygenase-2 levels have been implicated in several malignant properties of colon cancer. We now show for the first time a strong link between hyaluronan-CD44 interaction and cyclooxygenase-2 in colon cancer cells. First, we have shown that increased expression of hyaluronan synthase-2 induces malignant cell properties, including increased proliferation, anchorage-independent growth, and epithelial-mesenchymal transition in HIEC6 cells. Second, constitutive hyaluronan-CD44 interaction stimulates a signaling pathway involving ErbB2, phosphoinositide 3-kinase/AKT, beta-catenin, and cyclooxygenase-2/prostaglandin E-2 in HCA7 colon carcinoma cells. Third, the HA/CD44-activated ErbB2 --> phosphoinositide 3-kinase/ AKT --> beta-catenin pathway stimulates cell survival/cell proliferation through COX-2 induction in hyaluronan-overexpressing HIEC6 cells and in HCA7 cells. Fourth, perturbation of hyaluronan-CD44 interaction by hyaluronan oligomers or CD44-silencing RNA decreases cyclooxygenase-2 expression and enzyme activity, and inhibition of cyclooxygenase-2 decreases hyaluronan production suggesting the possibility of an amplifying positive feedback loop between hyaluronan and cyclooxygenase-2. We conclude that hyaluronan is an important endogenous regulator of colon cancer cell survival properties and that cyclooxygenase-2 is a major mediator of these hyaluronan-induced effects. Defining hyaluronan-dependent cyclooxygenase-2/prostaglandin E-2-associated signaling pathways will provide a platform for developing novel therapeutic approaches for colon cancer.	[Misra, Suniti; Markwald, Roger R.; Toole, Bryan P.; Ghatak, Shibnath] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Hosp, Div Gen Internal Med, Charleston, SC 29401 USA; [Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Berger, Franklin G.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Minamisawa, Susumu] Yokohama City Univ, Dept Physiol, Yokohama, Kanagawa 2360004, Japan	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Yokohama City University	Misra, S (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, 171 Ashley Ave, Charleston, SC 29425 USA.	misra@musc.edu		obeid, lina/0000-0002-0734-0847; Minamisawa, Susumu/0000-0003-4728-2116	NCI NIH HHS [CA 082867, R01 CA 87584, CA 073839] Funding Source: Medline; NCRR NIH HHS [P20 RR 017698, P20 RR 016434] Funding Source: Medline; NIGMS NIH HHS [GM 062887] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073839, R01CA087584, R01CA082867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434, P20RR017698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anttila MA, 2000, CANCER RES, V60, P150; Bates RC, 2005, CELL CYCLE, V4, P1350, DOI 10.4161/cc.4.10.2053; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chen QZ, 2004, J UROLOGY, V172, P2153, DOI 10.1097/01.ju.0000143440.08760.3a; Crew TE, 2000, CARCINOGENESIS, V21, P69, DOI 10.1093/carcin/21.1.69; Dale TC, 1998, BIOCHEM J, V329, P209; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; Du JG, 2005, NEOPLASIA, V7, P761, DOI 10.1593/neo.04652; Edward M, 2005, CARCINOGENESIS, V26, P1215, DOI 10.1093/carcin/bgi064; Edward M, 2001, BRIT J DERMATOL, V144, P465, DOI 10.1046/j.1365-2133.2001.04069.x; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V332, P433, DOI 10.1016/j.bbrc.2005.04.143; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kosunen A, 2004, ORAL ONCOL, V40, P257, DOI 10.1016/j.oraloncology.2003.08.004; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Laurich C, 2004, J SURG RES, V122, P70, DOI 10.1016/j.jss.2004.05.018; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lesley J, 2000, J BIOL CHEM, V275, P26967; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; MARKWALD RR, 1978, DEV BIOL, V62, P292, DOI 10.1016/0012-1606(78)90218-X; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; OSHEROV N, 1993, J BIOL CHEM, V268, P11134; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Ropponen KM, 1998, SCAND J GASTROENTERO, V33, P301; SCHAEFFER WI, 1976, CANCER LETT, V1, P259; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Takahashi K, 1995, ONCOGENE, V11, P2223; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UNDERHILL CB, 1983, J BIOL CHEM, V258, P8086; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wu R, 2005, CLIN CANCER RES, V11, P6155, DOI 10.1158/1078-0432.CCR-04-2664; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	73	78	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14335	14344		10.1074/jbc.M703811200	http://dx.doi.org/10.1074/jbc.M703811200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18326857	hybrid, Green Published			2022-12-27	WOS:000255941400020
J	Smith, J; Su, X; El-Maghrabi, R; Stahl, PD; Abumrad, NA				Smith, Jill; Su, Xiong; El-Maghrabi, Raafat; Stahl, Philip D.; Abumrad, Nada A.			Opposite regulation of CD36 ubiquitination by fatty acids and insulin - Effects on fatty acid uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE MEMBRANE-PROTEIN; SKELETAL-MUSCLE; CELLULAR REDISTRIBUTION; RECEPTOR; TRANSPORT; DEGRADATION; HEART; METABOLISM; EXPRESSION; OXIDATION	FAT/CD36 is a membrane scavenger receptor that facilitates long chain fatty acid uptake by muscle. Acute increases in membrane CD36 and fatty acid uptake have been reported in response to insulin and contraction. In this study we have explored protein ubiquitination as one potential mechanism for the regulation of CD36 level. CD36 expressed in Chinese hamster ovary (CHO) or HEK 293 cells was found to be polyubiquitinated via a process involving both lysines 48 and 63 of ubiquitin. Using CHO cells expressing the insulin receptor (CHO/hIR) and CD36, it is shown that addition of insulin (100 nM, 10 and 30 min) significantly reduced CD36 ubiquitination. In contrast, ubiquitination was strongly enhanced by fatty acids (200 mu M palmitate or oleate, 2 h). Similarly, endogenous CD36 in C2C12 myotubes was ubiquitinated, and this was enhanced by oleic acid treatment, which also reduced total CD36 protein in cell lysates. Insulin reduced CD36 ubiquitination, increased CD36 protein, and inhibited the opposite effects of fatty acids on both parameters. These changes were paralleled by changes in fatty acid uptake, which could be blocked by the CD36 inhibitor sulfosuccinimidyl oleate. Mutation of the two lysine residues in the carboxyl-terminal tail of CD36 markedly attenuated ubiquitination of the protein expressed in CHO cells and was associated with increased CD36 level and enhanced oleate uptake and incorporation into triglycerides. In conclusion, fatty acids and insulin induce opposite alterations in CD36 ubiquitination, modulating CD36 level and fatty acid uptake. Altered CD36 turnover may contribute to abnormal fatty acid uptake in the insulin-resistant muscle.	[Smith, Jill; Su, Xiong; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Su, Xiong; Stahl, Philip D.; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [El-Maghrabi, Raafat] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Washington University (WUSTL); Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Abumrad, NA (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA.	nabumrad@im.wustl.edu	Stahl, Philip/D-6315-2012		NHLBI NIH HHS [T32 HL-007275] Funding Source: Medline; NIDDK NIH HHS [R01DK 33301, P30 DK056341, P30 DK056341-07, DK56351, P30 DK056341-08] Funding Source: Medline; NIGMS NIH HHS [2R01GM42259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2003, ACTA PHYSIOL SCAND, V178, P347, DOI 10.1046/j.1365-201X.2003.01157.x; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Glatz JFC, 2006, CARDIOVASC DRUG THER, V20, P471, DOI 10.1007/s10557-006-0582-8; Glatz JFC, 2001, J MOL NEUROSCI, V16, P123, DOI 10.1385/JMN:16:2-3:123; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Grimaldi PA, 2001, CURR OPIN CLIN NUTR, V4, P433, DOI 10.1097/00075197-200109000-00015; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; HARMON CM, 1992, BIOCHEM SOC T, V20, P811, DOI 10.1042/bst0200811; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Irie H, 2003, P NATL ACAD SCI USA, V100, P6819, DOI 10.1073/pnas.1132094100; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; LOVEGREGORY L, 2008, IN PRESS HUM MOL GEN; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Muoio DM, 2007, APPL PHYSIOL NUTR ME, V32, P874, DOI 10.1139/H07-083; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Nicholson AC, 2004, VASC PHARMACOL, V41, P139, DOI 10.1016/j.vph.2004.08.003; Osanai T, 2007, CIRC RES, V100, P1106, DOI 10.1161/01.RES.0000266975.34924.b1; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Steinberg GR, 2002, J BIOL CHEM, V277, P8854, DOI 10.1074/jbc.M107683200; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Xia XF, 2004, J BIOL CHEM, V279, P44931, DOI 10.1074/jbc.M400969200; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zhang ZG, 2004, MOL PHARMACOL, V66, P395, DOI 10.1124/mol.104.001966; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	48	73	76	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13578	13585		10.1074/jbc.M800008200	http://dx.doi.org/10.1074/jbc.M800008200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353783	hybrid, Green Published			2022-12-27	WOS:000255728200011
J	Barbas, A; Matos, RG; Amblar, M; Lopez-Vinas, E; Gomez-Puertas, P; Arraiano, CM				Barbas, Ana; Matos, Rute G.; Amblar, Monica; Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino; Arraiano, Cecilia M.			New insights into the mechanism of RNA degradation by ribonuclease II - Identification of the residue responsible for setting the RNase II end product	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; EXOSOME; COMPLEX; EXPRESSION; DECAY; SPECIFICITY; SUBUNIT; CELLS	RNase II is a key exoribonuclease involved in the maturation, turnover, and quality control of RNA. RNase II homologues are components of the exosome, a complex of exoribonucleases. The structure of RNase II unraveled crucial aspects of the mechanism of RNA degradation. Here we show that mutations in highly conserved residues at the active site affect the activity of the enzyme. Moreover, we have identified the residue that is responsible for setting the end product of RNase II. In addition, we present for the first time the models of two members of the RNase II family, RNase R from Escherichia coli and human Rrp44, also called Dis3. Our findings improve the present model for RNA degradation by the RNase II family of enzymes.	[Barbas, Ana; Matos, Rute G.; Amblar, Monica; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino] Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino] Inst Salud Carlos III, CIBER Obn, Madrid 28049, Spain	Universidade Nova de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Arraiano, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Apartado 127, P-2781901 Oeiras, Portugal.	cecilia@itqb.unl.pt	Amblar, 2405/C-3941-2011; Amblar, Monica/E-2366-2016; López-Viñas, Eduardo/AAT-1124-2021; Gomez-Puertas, Paulino/G-8821-2014; Matos, Rute/J-4983-2013	Amblar, Monica/0000-0003-3530-615X; Gomez-Puertas, Paulino/0000-0003-3131-729X; Barbas, Ana/0000-0002-6245-8549; Matos Luis, Rute/0000-0002-9788-7562; Arraiano, Cecilia/0000-0003-1934-9301				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Cairrao F, 2006, BIOCHEM BIOPH RES CO, V343, P731, DOI 10.1016/j.bbrc.2006.03.040; Cairrao F, 2005, DEV DYNAM, V232, P733, DOI 10.1002/dvdy.20269; Cairrao F, 2001, MOL MICROBIOL, V276, P19172; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 2004, AMBER, V8; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Grossman D, 2006, NAT STRUCT MOL BIOL, V13, P760, DOI 10.1038/nsmb0906-760; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lim JT, 1997, CANCER RES, V57, P921; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; McVey CE, 2006, ACTA CRYSTALLOGR F, V62, P684, DOI 10.1107/S1744309106021506; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Zilhao R, 1996, MOL MICROBIOL, V20, P1033, DOI 10.1111/j.1365-2958.1996.tb02544.x; ZILHAO R, 1995, FEMS MICROBIOL LETT, V130, P237; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	32	39	41	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13070	13076		10.1074/jbc.M709989200	http://dx.doi.org/10.1074/jbc.M709989200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337246	hybrid			2022-12-27	WOS:000255499800045
J	Callejas-Valera, JL; Guinea-Viniegra, J; Ramirez-Castillejo, C; Recio, JA; Galan-Moya, E; Martinez, N; Rojas, JM; Cajal, SR; Sanchez-Prieto, R				Callejas-Valera, Juan L.; Guinea-Viniegra, Juan; Ramirez-Castillejo, Carmen; Recio, Juan A.; Galan-Moya, Eva; Martinez, Natalia; Rojas, Jose M.; Ramon y Cajal, Santiago; Sanchez-Prieto, Ricardo			E1a gene expression blocks the ERK1/2 signaling pathway by promoting nuclear localization and MKP up-regulation - Implication in v-H-Ras-induced senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED PREMATURE SENESCENCE; ONCOGENE-INDUCED SENESCENCE; MAP KINASE; CYTOPLASMIC SEQUESTRATION; PHYSIOLOGICAL FUNCTIONS; ADENOVIRAL E1A; PHOSPHATASE 2A; PEA-15; PROLIFERATION	In response to oncogenic signals, cells have developed safe mechanisms to avoid transformation through activation of a senescence program. Upon v-H-Ras overexpression, normal cells undergo senescence through several cellular processes, including activation of the ERK1/2 pathway. Interestingly, the E1a gene from adenovirus 5 has been shown to rescue cells from senescence by a yet unknown mechanism. We investigated whether E1a was able to interfere with the ERK1/ 2 signaling pathway to rescue cells from v-H-Ras-mediated senescence. Our results show that, E1a overexpression blocks v-H-Ras-mediated ERK1/ 2 activation by two different and concomitant mechanisms. E1a through its ability to interfere with PKB/Akt activation induces the down-regulation of the PEA15 protein, an ERK1/ 2 nuclear export factor, leading to nuclear accumulation of ERK1/2. In addition to this, we show that E1a increases the expression of the inducible ERK1/ 2 nuclear phosphatases (MAPK phosphatases) MKP1/DUSP1 and DUSP5, which leads to ERK1/ 2 dephosphorylation. We confirmed our observations in the human normal diploid fibroblasts IMR90, in which we could also show that an E1a mutant, unable to bind retinoblastoma protein (pRb), cannot rescue cells from v-H-Ras-induced senescence. In conclusion, E1a is able to rescue from Ras-induced senescence by affecting ERK1/ 2 localization and phosphorylation.	[Callejas-Valera, Juan L.; Guinea-Viniegra, Juan; Ramirez-Castillejo, Carmen; Galan-Moya, Eva; Sanchez-Prieto, Ricardo] Univ Castilla La Mancha, Fac Med, Ctr Reg Invest Biomed, Albacete 02006, Spain; [Recio, Juan A.; Martinez, Natalia; Rojas, Jose M.] Univ Vall Hebron, Inst Recerca Vall Hebron Hosp, Programa Oncol Med, Barcelona 08035, Spain; [Martinez, Natalia; Rojas, Jose M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol Celular, Madrid 28220, Spain; [Ramon y Cajal, Santiago] Hosp Univ Vall Hebron, Serv Anat Patol, Barcelona 08035, Spain	Universidad de Castilla-La Mancha; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Universitari Vall d'Hebron	Sanchez-Prieto, R (corresponding author), Univ Castilla La Mancha, Fac Med, Ctr Reg Invest Biomed, Albacete 02006, Spain.	ricardo.sanchez@uclm.es	Galan-Moya, Eva M/I-2912-2015; Rojas, José M/D-3718-2018; Ramirez-Castillejo, Carmen/S-7276-2019; Sanchez-Prieto, Ricardo/B-6877-2008; Ramon y Cajal, Santiago/H-4955-2016; Sanchez-Prieto, Ricardo/AAY-4271-2021; Prieto, Ricardo/AAZ-7221-2021; Rojas, José M./AAA-3354-2021	Galan-Moya, Eva M/0000-0001-5758-7592; Rojas, José M/0000-0002-5383-3482; Ramirez-Castillejo, Carmen/0000-0002-1877-3381; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Ramon y Cajal, Santiago/0000-0002-3867-1390; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Rojas, José M./0000-0002-7547-2825; Recio, Juan Angel/0000-0002-7320-3832				Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Bartholomeusz C, 2006, ONCOGENE, V25, P79, DOI 10.1038/sj.onc.1209014; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Ferbeyre G, 2000, GENE DEV, V14, P2015; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gaumont-Leclerc MF, 2004, J BIOL CHEM, V279, P46802, DOI 10.1074/jbc.M403893200; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Liao Y, 2004, CANCER RES, V64, P5938, DOI 10.1158/0008-5472.CAN-04-1533; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mason DX, 2006, CARCINOGENESIS, V27, P350, DOI 10.1093/carcin/bgi264; Minamino T, 2004, CELL CYCLE, V3, P449; MYMRYK JS, 1994, ONCOGENE, V9, P1187; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Renault-Mihara F, 2006, MOL BIOL CELL, V17, P5141, DOI 10.1091/mbc.E05-11-1072; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; SANCHEZPRIETO R, 1995, INT J CANCER, V60, P235; Sang NL, 2002, FRONT BIOSCI, V7, pD407, DOI 10.2741/sang; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Viniegra JG, 2002, ONCOGENE, V21, P7131, DOI 10.1038/sj.onc.1205934; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002	37	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13450	13458		10.1074/jbc.M709230200	http://dx.doi.org/10.1074/jbc.M709230200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316372	hybrid			2022-12-27	WOS:000255499800084
J	Dusa, A; Staerk, J; Elliott, J; Pecquet, C; Poirel, HA; Johnston, JA; Constantinescu, SN				Dusa, Alexandra; Staerk, Judith; Elliott, Joanne; Pecquet, Christian; Poirel, Helene A.; Johnston, James A.; Constantinescu, Stefan N.			Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SURFACE EXPRESSION; PROTEIN-TYROSINE KINASES; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; ERYTHROPOIETIN RECEPTOR; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; SOCS3 DEGRADATION; CYTOKINE RECEPTOR; MUTATION	Explaining the uniqueness of the acquired somatic JAK2 V617F mutation, which is present in more than 95% of polycythemia vera patients, has been a challenge. The V617F mutation in the pseudokinase domain of JAK2 renders the unmutated kinase domain constitutively active. We have performed random mutagenesis at position 617 of JAK2 and tested each of the 20 possible amino acids for ability to induce constitutive signaling in Ba/F3 cells expressing the erythropoietin receptor. Four JAK2 mutants, V617W, V617M, V617I, and V617L, were able to induce cytokine independence and constitutive downstream signaling. Only V617W induced a level of constitutive activation comparable with V617F. Also, only V617W stabilized tyrosine-phosphorylated suppressor of cytokine signaling 3 ( SOCS3), a mechanism by which JAK2 V617F overcomes inhibition by SOCS3. The V617W mutant induced a myeloproliferative disease in mice, mainly characterized by erythrocytosis and megakaryocytic proliferation. Although JAK2 V617W would predictably be pathogenic in humans, the substitution of the Val codon, GTC, by TTG, the codon for Trp, would require three base pair changes, and thus it is unlikely to occur. We discuss how the predicted conformations of the activated JAK2 mutants can lead to better screening assays for novel small molecule inhibitors.	[Dusa, Alexandra; Staerk, Judith; Pecquet, Christian; Constantinescu, Stefan N.] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Dusa, Alexandra; Staerk, Judith; Pecquet, Christian; Constantinescu, Stefan N.] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium; [Elliott, Joanne; Johnston, James A.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Infect & Immun Grp, Belfast BT7 1NN, Antrim, North Ireland; [Poirel, Helene A.] Univ Catholique Louvain, Ctr Human Genet, Clin Univ St Luc, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Queens University Belfast; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Constantinescu, SN (corresponding author), Ave Hippocrate 74,UCL 75-4, B-1200 Brussels, Belgium.	stefan.constantinescu@bru.licr.org	Constantinescu, Stefan N/E-5277-2012	Staerk, Judith/0000-0001-8698-6998; Constantinescu, Stefan N./0000-0002-8599-2699; Christian, Pecquet/0000-0002-8623-3483				Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Eyckerman S, 1999, EUR CYTOKINE NETW, V10, P549; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Gordon H, 1936, AM J PATHOL, V12, P545; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; HARPUR AG, 1992, ONCOGENE, V7, P1347; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	32	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12941	12948		10.1074/jbc.M709302200	http://dx.doi.org/10.1074/jbc.M709302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326042	hybrid			2022-12-27	WOS:000255499800031
J	Masuda, J; Usui, R; Maru, Y				Masuda, Junko; Usui, Ryosuke; Maru, Yoshiro			Fibronectin type I repeat is a nonactivating ligand for EphA1 and inhibits ATF3-dependent angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; PROTEIN; ATF3; INTEGRIN; ADHESION; FAMILY; VIVO; PROGRESSION	ATF3 stimulated promoter activity of EphA1 by 3.4-fold in ATF3-dependent angiogenesis in vitro. Although tyrosine kinase activation of EphA1 was dispensable, binding of EphA1 to fibronectin through its type I repeat played an essential role in the angiogenesis. Recombinant proteins containing fibronectin 10th to 12th type I repeat (I10-12) but not I 12 could inhibit the angiogenesis in vitro by competitively targeting EphA1 with the full-length fibronectin. However, I 12 acquired a higher affinity toward EphA2 with K-d 18 nM and inhibited vascular endothelial growth factor-dependent angiogenic invasion in a Matrigel plug assay.	[Masuda, Junko; Usui, Ryosuke; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan	Tokyo Women's Medical University	Maru, Y (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ymaru@research.twmu.ac.jp						Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Ambesi A, 2005, CANCER RES, V65, P148; Ameri K, 2007, ONCOGENE, V26, P284, DOI 10.1038/sj.onc.1209781; Baldwin C, 2006, AM J PHYSIOL-RENAL, V291, pF960, DOI 10.1152/ajprenal.00020.2006; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Cheng N, 2002, MOL CANCER RES, V1, P2; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gurniak CB, 1996, ONCOGENE, V13, P777; Halloran MC, 2006, CURR OPIN CELL BIOL, V18, P533, DOI 10.1016/j.ceb.2006.08.010; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Ingham KC, 2004, J BIOL CHEM, V279, P42945, DOI 10.1074/jbc.M406984200; Ivanov AI, 2005, PHYSIOL GENOMICS, V21, P152, DOI 10.1152/physiolgenomics.00043.2004; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Makogonenko E, 2007, BIOCHEMISTRY-US, V46, P5418, DOI 10.1021/bi7001373; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maru Y, 1998, J CELL PHYSIOL, V176, P223, DOI 10.1002/(SICI)1097-4652(199808)176:2<223::AID-JCP1>3.0.CO;2-Q; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Ojima T, 2006, AM J PATHOL, V168, P331, DOI 10.2353/ajpath.2006.050435; Okamoto A, 2006, MOL CELL BIOL, V26, P1087, DOI 10.1128/MCB.26.3.1087-1097.2006; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Rostagno AA, 1999, BIOCHEM J, V338, P375, DOI 10.1042/0264-6021:3380375; Takeda N, 1999, P NATL ACAD SCI USA, V96, P203, DOI 10.1073/pnas.96.1.203; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	38	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13148	13155		10.1074/jbc.M702164200	http://dx.doi.org/10.1074/jbc.M702164200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308734	hybrid			2022-12-27	WOS:000255499800054
J	Fusco, AJ; Savinova, OV; Talwar, R; Kearns, JD; Hoffmann, A; Ghosh, G				Fusco, Amanda J.; Savinova, Olga V.; Talwar, Rashmi; Kearns, Jeffrey D.; Hoffmann, Alexander; Ghosh, Gourisankar			Stabilization of RelB requires multidomain interactions with p100/p52	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IKK-ALPHA; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; NF-KAPPA-B2 P100; SIGNALING MODULE; ACTIVATION; MICE; PHOSPHORYLATION; RESPONSES	The NF-kappa B family member RelB has many properties not shared by other family members such as restricted subunit association and lack of regulation by the classical I kappa B proteins. We show that the protein level of RelB is significantly reduced in the absence of p100 and reduced even more when both p100 and p105 are absent. RelB stabilizes itself by directly interacting with p100, p105, and their processed products. However, RelB forms complexes with its partners using different interaction modes. Although the C-terminal ankyrin repeat domain of p105 is not involved in the RelB-p105 complex formation, all domains and flexible regions of each protein are engaged in the RelB-p100 complex. In several respects the RelB-p52 and RelB-p100 complexes are unique in the NF-kappa B family. The N-terminal domain of p100/p52 interacts with RelB but not RelA. The transcriptional activation domain of RelB, but not RelA, directly interacts with the processing region of p100. These unique protein-protein contacts explain why RelB prefers p52 as its dimeric partner for transcriptional activity and is retained in the cytoplasm as an inhibited complex by p100. This association-mediated stabilization of RelB implies a possible role for RelB in the processing of p100 into p52.	[Fusco, Amanda J.; Savinova, Olga V.; Talwar, Rashmi; Kearns, Jeffrey D.; Hoffmann, Alexander; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Kearns, Jeffrey D.; Hoffmann, Alexander] Univ Calif San Diego, Signaling Syst Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gghosh@ucsd.edu						Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang DB, 2005, STRUCTURE, V13, P1365, DOI 10.1016/j.str.2005.06.018; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; MOORTHY AK, 2007, J MOL BIOL; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; TOLEDANO MB, 1993, MOL CELL BIOL, V13, P852, DOI 10.1128/MCB.13.2.852; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	33	52	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12324	12332		10.1074/jbc.M707898200	http://dx.doi.org/10.1074/jbc.M707898200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321863	Green Published, hybrid			2022-12-27	WOS:000255340000049
J	Zaun, HC; Shrier, A; Orlowski, J				Zaun, Hans C.; Shrier, Alvin; Orlowski, John			Calcineurin B homologous protein 3 promotes the Biosynthetic maturation, cell surface stability, and optimal transport of the Na+/H+ exchanger NHE1 isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND CA2+-BINDING PROTEIN; NA-H EXCHANGE; EVOLUTIONARY ORIGINS; DEPENDENT ACTIVATION; ESSENTIAL COFACTOR; PH REGULATION; BINDING-SITE; KINASE; TESCALCIN; GENE	Calcineurin B homologous protein (CHP) 1 and 2 are Ca2+-binding proteins that modulate several cellular processes, including cytoplasmic pH by positively regulating plasma membranetype Na+/H+ exchangers ( NHEs). Recently another CHP-related protein, termed tescalcin or CHP3, was also shown to interact with the ubiquitous NHE1 isoform, but seemingly suppressed its activity. However, the precise physical and functional nature of this association was not examined in detail. In this study, biochemical and cellular studies were undertaken to further delineate this relationship. Glutathione S-transferase NHE1 fusion protein pulldown assays revealed that full-length CHP3 binds directly to the proximal juxtamembrane C-terminal region (amino acids 505-571) of rat NHE1 in the same region that binds CHP1 and CHP2. The interaction was further validated by coimmunoprecipitation and coimmunolocalization experiments using full-length CHP3 and wild-type NHE1 in transfected Chinese hamster ovary AP-1 cells. Simultaneous mutation of four hydrophobic residues within this region ((FLDHLL535)-F-530) to either Ala, Gln, or Arg (FL-A, FL-Q,or FL-R)abrogated this interaction both in vitro and in intact cells. The NHE1 mutants were sorted properly to the cell surface but showed markedly reduced (FL-A) or minimal (FL-R and FL-Q) activity. Interestingly, and contrary to an earlier finding, ectopic coexpression of CHP3 up-regulated the cell surface activity of wild-type NHE1. This stimulation was not observed with the CHP3 binding-defective mutants. Mechanistically, overexpression of CHP3 did not alter the H+ sensitivity of wild-type NHE1 but rather promoted its biosynthetic maturation and half-life at the cell surface, thereby increasing the steady-state abundance of functional NHE1 protein.	[Zaun, Hans C.; Shrier, Alvin; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X				Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bobulescu IA, 2005, CURR OPIN NEPHROL HY, V14, P485, DOI 10.1097/01.mnh.0000174146.52915.5d; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; Jin Q, 2007, IN VIVO, V21, P593; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Konstantinidis D, 2006, CELL PHYSIOL BIOCHEM, V18, P211, DOI 10.1159/000097668; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Li XJ, 2003, BIOCHEMISTRY-US, V42, P7448, DOI 10.1021/bi027143d; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Matsushita M, 2007, AM J PHYSIOL-CELL PH, V293, pC246, DOI 10.1152/ajpcell.00464.2006; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Misik AJ, 2005, BIOCHEMISTRY-US, V44, P5842, DOI 10.1021/bi047659s; Nakamura N, 2002, J BIOCHEM, V132, P483, DOI 10.1093/oxfordjournals.jbchem.a003246; Naoe Y, 2005, J BIOL CHEM, V280, P32372, DOI 10.1074/jbc.M503390200; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Perera EM, 2001, ENDOCRINOLOGY, V142, P455, DOI 10.1210/en.142.1.455; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Snabaitis AK, 2006, J BIOL CHEM, V281, P20252, DOI 10.1074/jbc.M600268200; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Sun HY, 2004, EUR J PHARMACOL, V486, P121, DOI 10.1016/j.ejphar.2003.12.016; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200	54	47	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12456	12467		10.1074/jbc.M800267200	http://dx.doi.org/10.1074/jbc.M800267200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321853	hybrid, Green Published			2022-12-27	WOS:000255340000062
J	Canals, M; Milligan, G				Canals, Meritxell; Milligan, Graeme			Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed mu opioid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; INVERSE AGONISM; CROSS-TALK; CONCURRENT STIMULATION; BETA-ARRESTINS; ACTIVATION; LOCALIZATION; ENDOCYTOSIS; INHIBITION; IDENTIFICATION	The human mu opioid receptor was expressed stably in Flp-In T-REx HEK293 cells. Occupancy by the agonist DAMGO (Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol) resulted in phosphorylation of the ERK1/2 MAP kinases, which was blocked by the opioid antagonist naloxone but not the cannabinoid CB1 receptor inverse agonist SR141716A. Expression of the human cannabinoid CB1 receptor in these cells from the inducible Flp-In T-REx locus did not alter expression levels of the mu opioid receptor. This allowed the cannabinoid CB1 agonist WIN55212-2 to stimulate ERK1/2 phosphorylation but resulted in a large reduction in the capacity of DAMGO to activate these kinases. Although lacking affinity for the mu opioid receptor, co-addition of SR141716A caused recovery of the effectiveness of DAMGO. In contrast co-addition of the CB1 receptor neutral antagonist O-2050 did not. Induction of the CB1 receptor also resulted in an increase of basal [S-35] guanosine 5'-3-O-(thio) triphosphate (GTP gamma S) binding and thereby a greatly reduced capacity of DAMGO to further stimulate [S-35] GTP gamma S binding. CB1 inverse agonists attenuated basal [S-35] GTP gamma S binding and restored the capacity of DAMGO to stimulate. Flp-In T-REx HEK293 cells were generated, which express the human mu opioid receptor constitutively and harbor a modified D163N cannabinoid CB1 receptor that lacks constitutive activity. Induction of expression of the modified cannabinoid CB1 receptor did not limit DAMGO-mediated ERK1/2 MAP kinase phosphorylation and did not allow SR141716A to enhance the function of DAMGO. These data indicate that it is the constitutive activity inherent in the cannabinoid CB1 receptor that reduces the capacity of co-expressed mu opioid receptor to function.	[Canals, Meritxell; Milligan, Graeme] Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Canals, Meritxell/0000-0002-7942-5006	MRC [G9811527] Funding Source: UKRI; Medical Research Council [G9811527] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; ADIE EJ, 1992, BIOCHEM J, V285, P529, DOI 10.1042/bj2850529; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Bidlack Jean M., 2003, V237, P135; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; CHILDERS SR, 1992, ANN NY ACAD SCI, V654, P33, DOI 10.1111/j.1749-6632.1992.tb25954.x; Christie MJ, 2006, BRIT J PHARMACOL, V148, P385, DOI 10.1038/sj.bjp.0706756; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gardner A, 2006, EUR J PHARMACOL, V530, P103, DOI 10.1016/j.ejphar.2005.11.032; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Glass M, 1997, J NEUROSCI, V17, P5327, DOI 10.1523/jneurosci.17-14-05327.1997; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; HOWLETT AC, 1995, ANNU REV PHARMACOL, V35, P607, DOI 10.1146/annurev.pharmtox.35.1.607; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Kearn CS, 2005, MOL PHARMACOL, V67, P1697, DOI 10.1124/mol.104.006882; Kenakin T, 2004, MOL PHARMACOL, V65, P2, DOI 10.1124/mol.65.1.2; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; LANE JR, 2008, IN PRESS FASEB J; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; MacLennan SJ, 1998, BRIT J PHARMACOL, V124, P619, DOI 10.1038/sj.bjp.0701915; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Merkouris M, 1997, J NEUROCHEM, V69, P2115; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; MILLIGAN G, 1994, METHOD ENZYMOL, V237, P268; Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; MULLANEY I, 1990, J NEUROCHEM, V55, P1890, DOI 10.1111/j.1471-4159.1990.tb05773.x; Navarro M, 2001, J NEUROSCI, V21, P5344, DOI 10.1523/JNEUROSCI.21-14-05344.2001; Nie JJ, 2001, J NEUROSCI, V21, P8758, DOI 10.1523/JNEUROSCI.21-22-08758.2001; Parra S, 2007, CURR OPIN PHARMACOL, V7, P146, DOI 10.1016/j.coph.2006.10.005; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Reisine T, 1996, ANN NY ACAD SCI, V780, P168, DOI 10.1111/j.1749-6632.1996.tb15121.x; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Roche JP, 1999, MOL PHARMACOL, V56, P611, DOI 10.1124/mol.56.3.611; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Rosenkilde MM, 2001, ONCOGENE, V20, P1582, DOI 10.1038/sj.onc.1204191; Salim S, 2007, J PHARMACOL EXP THER, V321, P51, DOI 10.1124/jpet.106.116921; Salio C, 2001, NEUROREPORT, V12, P3689, DOI 10.1097/00001756-200112040-00017; Schoffelmeer ANM, 2006, NEUROPHARMACOLOGY, V51, P773, DOI 10.1016/j.neuropharm.2006.05.019; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Solinas M, 2005, NEUROPSYCHOPHARMACOL, V30, P2035, DOI 10.1038/sj.npp.1300720; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vischer HF, 2007, ERNST SCHERING FOUND, V2, P187, DOI 10.1007/2789_2006_009; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940	63	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11424	11434		10.1074/jbc.M710300200	http://dx.doi.org/10.1074/jbc.M710300200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18319252	hybrid			2022-12-27	WOS:000255067400040
J	Geisler, C; Aumiller, JJ; Jarvis, DL				Geisler, Christoph; Aumiller, Jared J.; Jarvis, Donald L.			A fused lobes gene encodes the processing beta-N-acetylglucosaminidase in Sf9 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; INSECT CELLS; MOLECULAR-CLONING; HEXOSAMINIDASE; EXPRESSION; SEQUENCE; GLYCOSYLTRANSFERASES; GLYCOSYLATION; PREDICTION; DROSOPHILA	Man alpha 6( Man alpha 3) Man beta 4GlcNAc beta 4GlcNAc-R is the core structure of the major processed protein N-glycans produced by insect cells. Ultimately, this paucimannose type structure is produced by an unusual beta-N-acetylglucosaminidase, which removes the terminal N-acetylglucosamine residue from the upstream intermediate, Man alpha 6(GlcNAc beta 2Man alpha 3) Man beta 4GlcNAc beta 4GlcNAc-R. Because the N-glycan processing pathways leading to the production of this intermediate are probably identical in insects and higher eukaryotes, the presence or absence of this specific, processing beta-N-acetylglucosaminidase is a key factor distinguishing the processing pathways in these two different types of organisms. Recent studies have shown that the fused lobes (fdl) gene encodes the specific, processing beta-N-acetylglucosaminidase of Drosophila melanogaster. However, there are conflicting reports on the identity of the gene encoding this enzyme in the lepidopteran insect, Spodoptera frugiperda. One has suggested that a gene alternatively designated SfGlcNAcase-3 or SfHex encodes this function, whereas another has suggested that this gene encodes a broad-spectrum beta-N-acetylglucosaminidase that functions in glycan and chitin degradation. In this study we resolved this conflict by molecularly cloning an S. frugiperda fdl ortholog (Sf-fdl) and demonstrating that it encodes a product with the substrate specificity expected of the processing beta-N-acetylglucosaminidase. Moreover, we showed that the endogenous levels of specific, processing beta-N-acetylglucosaminidase activity were significantly reduced in S. frugiperda cells engineered to express a double-stranded RNA derived from the Sf-fdl gene. These results indicate that Sf-fdl encodes the specific, processing beta-N-acetylglucosaminidase of S. frugiperda and validate our previous suggestion that the broad-spectrum beta-N-acetylglucosaminidase encoded by the SfGlcNAcase-3/SfHex gene is more likely to be involved in N-glycan and/or chitin degradation.	[Geisler, Christoph; Aumiller, Jared J.; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Jarvis, DL (corresponding author), Univ Wyoming, Dept Mol Biol, Mol Biol Dept 3944,1000 E Univ Ave, Laramie, WY 82071 USA.	DLJarvis@uwyo.edu		Jarvis, Donald/0000-0002-8104-7155	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049734] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM049734, R01 GM49734] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Aumiller JJ, 2006, PROTEIN EXPRES PURIF, V47, P571, DOI 10.1016/j.pep.2005.11.026; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; FIELD MC, 1995, GLYCOBIOLOGY, V5, P463, DOI 10.1093/glycob/5.5.463; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Harrison Robert L., 2007, V388, P299; Jarvis DL, 1996, PROTEIN EXPRES PURIF, V8, P191, DOI 10.1006/prep.1996.0092; JARVIS DL, 1997, BACULOVIRUSES, P389; KITTS PA, 1993, BIOTECHNIQUES, V14, P810; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Marz L., 1995, GLYCOPROTEINS, P543; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Summers MD, 1987, TEXAS AGR EXPT STATI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomiya N, 2006, J BIOL CHEM, V281, P19545, DOI 10.1074/jbc.M603312200; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wagner R, 1996, J VIROL, V70, P4103, DOI 10.1128/JVI.70.6.4103-4109.1996; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931	32	64	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11330	11339		10.1074/jbc.M710279200	http://dx.doi.org/10.1074/jbc.M710279200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303021	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000255067400029
J	Nagao, K; Taniyama, Y; Kietzmann, T; Doi, T; Komuro, I; Morishita, R				Nagao, Kaori; Taniyama, Yoshiaki; Kietzmann, Thomas; Doi, Takefumi; Komuro, Issei; Morishita, Ryuichi			HIF-1 alpha signaling upstream of NKX2.5 is required for cardiac development in xenopus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; HEART DEVELOPMENT; FACTOR 1-ALPHA; EMBRYOS LACKING; SMOOTH-MUSCLE; CARDIOVASCULAR-SYSTEM; PROGENITOR CELLS; VERTEBRATE HEART; HIF-ALPHA; PROTEIN	HIF-1 alpha is originally identified as a transcription factor that activates gene expression in response to hypoxia. In metazoans, HIF-1 alpha functions as a master regulator of oxygen homeostasis and regulates adaptive responses to change in oxygen tension during embryogenesis, tissue ischemia, and tumorigenesis. Because Hif-1 alpha-deficient mice exhibit a number of developmental defects, the precise role of HIF-1 alpha in early cardiac morphogenesis has been uncertain. Therefore, to clarify the role of HIF-1 alpha in heart development, we investigated the effect of knockdown of HIF-1 alpha in Xenopus embryos using antisense morpholino oligonucleotide microinjection techniques. Knockdown of HIF-1 alpha resulted in defects of cardiogenesis. Whole mount in situ hybridization for cardiac troponin I (cTnI) showed the two separated populations of cardiomyocytes, which is indicative of cardia bifida, in HIF-1 alpha-depleted embryos. Furthermore, the depletion of HIF-1 alpha led to the reduction in cTnI expression, suggesting the correlation between HIF-1 alpha and cardiac differentiation. We further examined the expression of several heart markers, nkx2.5, gata4, tbx5, bmp4, hand1, and hand2 in HIF-1 alpha-depleted embryos. Among them, the expression of nkx2.5 was significantly reduced. Luciferase reporter assay using the Nkx2.5 promoter showed that knockdown of HIF-1 alpha decreased its promoter activity. The cardiac abnormality in the HIF-1 alpha-depleted embryo was restored with co-injection of nkx2.5 mRNA. Collectively, these findings reveal that HIF-1 alpha-regulated nkx2.5 expression is required for heart development in Xenopus.	[Nagao, Kaori; Taniyama, Yoshiaki; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan; [Doi, Takefumi; Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan; [Kietzmann, Thomas; Komuro, Issei] Univ Kaiserslautern, Dept Biochem, D-67663 Kaiserslautern, Germany; [Doi, Takefumi; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan	Osaka University; Osaka University; University of Kaiserslautern; Chiba University	Morishita, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	morishit@cgt.med.osaka-u.ac.jp		Kietzmann, Thomas/0000-0003-0242-8636				Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1993, DEVELOPMENT, V118, P719; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; DALE L, 1987, DEVELOPMENT, V99, P527; Fu YC, 1998, DEVELOPMENT, V125, P4439; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grow MW, 1998, DEV BIOL, V204, P187, DOI 10.1006/dbio.1998.9080; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iraha F, 2002, DEV GROWTH DIFFER, V44, P395; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Koibuchi N, 2006, BIOCHEM BIOPH RES CO, V344, P339, DOI 10.1016/j.bbrc.2006.03.140; Lacaud G, 2001, ANN NY ACAD SCI, V938, P96; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 1999, DEVELOPMENT, V126, P75; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mohun T, 1997, CURR OPIN GENET DEV, V7, P628, DOI 10.1016/S0959-437X(97)80010-X; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pereira T, 2003, J BIOL CHEM, V278, P6816, DOI 10.1074/jbc.M209297200; Peterkin T, 2003, EMBO J, V22, P4260, DOI 10.1093/emboj/cdg400; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saga Y, 1999, DEVELOPMENT, V126, P3437; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schoenwolf GC, 1995, CELL MOL BIOL RES, V41, P233; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Searcy RD, 1998, DEVELOPMENT, V125, P4461; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Sparrow DB, 2000, DEV BIOL, V227, P65, DOI 10.1006/dbio.2000.9891; Takahashi T, 2001, BIOCHEM BIOPH RES CO, V281, P1057, DOI 10.1006/bbrc.2001.4463; Tanaka M, 1999, DEVELOPMENT, V126, P1269; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Walters MJ, 2001, MECH DEVELOP, V100, P263, DOI 10.1016/S0925-4773(00)00535-9; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	53	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11841	11849		10.1074/jbc.M702563200	http://dx.doi.org/10.1074/jbc.M702563200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303027	hybrid			2022-12-27	WOS:000255067400083
J	Wooldridge, AA; Fortner, CN; Lontay, B; Akimoto, T; Neppl, RL; Facemire, C; Datto, MB; Kwon, A; McCook, E; Li, P; Wang, S; Thresher, RJ; Miller, SE; Perriard, JC; Gavin, TP; Hickner, RC; Coffman, TM; Somlyo, AV; Yan, Z; Haystead, TAJ				Wooldridge, Anne A.; Fortner, Christopher N.; Lontay, Beata; Akimoto, Takayuki; Neppl, Ronald L.; Facemire, Carie; Datto, Michael B.; Kwon, Ashley; McCook, Everett; Li, Ping; Wang, Shiliang; Thresher, Randy J.; Miller, Sara E.; Perriard, Jean-Claude; Gavin, Timothy P.; Hickner, Robert C.; Coffman, Thomas M.; Somlyo, Avril V.; Yan, Zhen; Haystead, Timothy A. J.			Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; DEFICIENT MICE; CGMP KINASE; MYOSIN; PHOSPHORYLATION; PHOSPHATASE; CONTRACTILITY; ADAPTATION; STRESS	In vivo protein kinases A and G (PKA and PKG) coordinately phosphorylate a broad range of substrates to mediate their various physiological effects. The functions of many of these substrates have yet to be defined genetically. Herein we show a role for smoothelin-like protein 1 (SMTNL1), a novel in vivo target of PKG/PKA, in mediating vascular adaptations to exercise. Aortas from smtnl1(-/-) mice exhibited strikingly enhanced vasorelaxation before exercise, similar in extent to that achieved after endurance training of wild-type littermates. Additionally, contractile responses to alpha-adrenergic agonists were greatly attenuated. Immunological studies showed SMTNL1 is expressed in smooth muscle and type 2a striated muscle fibers. Consistent with a role in adaptations to exercise, smtnl1(-/-) mice also exhibited increased type 2a fibers before training and better performance after forced endurance training compared smtnl1(-/-) mice. Furthermore, exercise was found to reduce expression of SMTNL1, particularly in female mice. In both muscle types, SMTNL1 is phosphorylated at Ser-301 in response to adrenergic signals. In vitro SMTNL1 suppresses myosin phosphatase activity through a substrate-directed effect, which is relieved by Ser-301 phosphorylation. Our findings suggest roles for SMTNL1 in cGMP/cAMP-mediated adaptations to exercise through mechanisms involving direct modulation of contractile activity.	[Wooldridge, Anne A.; Fortner, Christopher N.; Lontay, Beata; Kwon, Ashley; McCook, Everett; Haystead, Timothy A. J.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Akimoto, Takayuki; Facemire, Carie; Li, Ping; Coffman, Thomas M.; Yan, Zhen] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Datto, Michael B.; Miller, Sara E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Neppl, Ronald L.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol, Charlottesville, VA 22908 USA; [Wang, Shiliang; Thresher, Randy J.] Univ N Carolina, Anim Models Core Facil, Chapel Hill, NC 27599 USA; [Perriard, Jean-Claude] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Gavin, Timothy P.; Hickner, Robert C.] E Carolina Univ, Dept Exercise & Sport Sci, Greenville, NC 27878 USA	Duke University; Duke University; Duke University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of North Carolina; East Carolina University	Haystead, TAJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol, Med Ctr Box 3813,C11P LSRC Res Dr, Durham, NC 27710 USA.	hayst001@mc.duke.edu	Neppl, Ronald L/AAW-1257-2020; Akimoto, Takayuki/H-6704-2012	Neppl, Ronald L/0000-0003-1497-6058; Akimoto, Takayuki/0000-0002-8874-7779; hickner, Robert/0000-0002-2683-1617; Yan, Zhen/0000-0002-4826-9813	NHLBI NIH HHS [5 R01 HL078795-04] Funding Source: Medline; NIAMS NIH HHS [R01 AR050429] Funding Source: Medline; NIDDK NIH HHS [DK065954-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065954, R56DK065954] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Boo YC, 2006, EXP MOL MED, V38, P453, DOI 10.1038/emm.2006.53; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Haubold KW, 2003, J APPL PHYSIOL, V95, P1617, DOI 10.1152/japplphysiol.00408.2003; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Pannirselvam M, 2003, BRIT J PHARMACOL, V140, P701, DOI 10.1038/sj.bjp.0705476; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; PLOURDE G, 1993, J APPL PHYSIOL, V74, P1641, DOI 10.1152/jappl.1993.74.4.1641; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Sakamoto K, 2002, J APPL PHYSIOL, V93, P369, DOI 10.1152/japplphysiol.00167.2002; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200	21	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11850	11859		10.1074/jbc.M708628200	http://dx.doi.org/10.1074/jbc.M708628200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18310078	hybrid, Green Published			2022-12-27	WOS:000255067400084
J	Alibin, CP; Kopilas, MA; Anderson, HDI				Alibin, Caroline P.; Kopilas, Melanie A.; Anderson, Hope D. I.			Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid - Role of peroxisome proliferator-activated receptors alpha and gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C ISOFORMS; PPAR-GAMMA; DIACYLGLYCEROL-KINASE; PLASMA-LIPOPROTEINS; FATTY-ACIDS; IN-VITRO; INHIBITION; EXPRESSION; AGONIST; HEART	Conjugated linoleic acid (CLA) refers to a naturally occurring mixture of positional and geometric isomers of linoleic acid. Evidence suggests that CLA is a dietary constituent and nutraceutical with anti-cancer, insulin-sensitizing, immunomodulatory, weight-partitioning, and cardioprotective properties. The aim of this study was to evaluate the effects of intervention with CLA on cardiac hypertrophy. In vitro, CLA prevented indicators of cardiomyocyte hypertrophy elicited by endothelin-1, including cell size augmentation, protein synthesis, and fetal gene activation. Similar anti-hypertrophic effects of CLA were observed in hypertrophy induced by angiotensin II, fibroblast growth factor, and mechanical strain. CLA may inhibit hypertrophy through activation of peroxisome proliferator-activated receptors (PPARs). CLA stimulated PPAR activity in cardiomyocytes, and the anti-hypertrophic effects of CLA were blocked by genetic and pharmacological inhibitors of PPAR isoforms alpha and gamma. CLA may disrupt hypertrophic signaling by stimulating diacylglycerol kinase zeta, which decreases availability of diacylglycerol and thereby inhibits the protein kinase C epsilon pathway. In vivo, dietary CLA supplementation significantly reduced blood pressure and cardiac hypertrophy in spontaneously hypertensive heart failure rats. These data suggest that dietary supplementation with CLA may be a viable strategy to prevent pathological cardiac hypertrophy, a major risk factor for heart failure.	St Boniface Gen Hosp, Res Ctr, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB R2H 2A6, Canada; Univ Manitoba, Fac Pharm, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Anderson, HDI (corresponding author), St Boniface Gen Hosp, Res Ctr, Canadian Ctr Agri Food Res Hlth & Med, 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	handerson@sbrc.ca		Anderson, Hope/0000-0001-6570-6678				Anderson HDI, 2004, J BIOL CHEM, V279, P9287, DOI 10.1074/jbc.M309227200; Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771; Asakawa M, 2002, CIRCULATION, V105, P1240, DOI 10.1161/hc1002.105225; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; BENES AJ, 1985, J CELL SCI, V75, P35; Benito P, 2001, LIPIDS, V36, P229, DOI 10.1007/s11745-001-0712-x; Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Cimini AM, 2005, INT J CANCER, V117, P923, DOI 10.1002/ijc.21272; Clerk A, 1996, BIOCHEM J, V317, P109, DOI 10.1042/bj3170109; CLERK A, 1994, J BIOL CHEM, V269, P32848; De Caterina R, 2006, AM J CLIN NUTR, V83, p421S; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Doyle L, 2005, EUR J CLIN NUTR, V59, P432, DOI 10.1038/sj.ejcn.1602093; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Herbel BK, 1998, AM J CLIN NUTR, V67, P332, DOI 10.1093/ajcn/67.2.332; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Houseknecht KL, 1998, BIOCHEM BIOPH RES CO, V244, P678, DOI 10.1006/bbrc.1998.8303; Ichihara S, 2006, J MOL CELL CARDIOL, V41, P318, DOI 10.1016/j.yjmcc.2006.05.013; Inoue N, 2004, BIOCHEM BIOPH RES CO, V323, P679, DOI 10.1016/j.bbrc.2004.08.139; Irukayama-Tomobe Y, 2004, CIRCULATION, V109, P904, DOI 10.1161/01.CIR.0000112596.06954.00; Kamlage B, 2000, J NUTR, V130, P2036, DOI 10.1093/jn/130.8.2036; Kehrer JP, 2001, BIOCHEM J, V356, P899, DOI 10.1042/0264-6021:3560899; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kritchevsky D, 2000, J AM COLL NUTR, V19, p472S, DOI 10.1080/07315724.2000.10718950; Lai KL, 2005, LIPIDS, V40, P1107, DOI 10.1007/s11745-005-1474-1; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lee KC, 2001, TRENDS ENDOCRIN MET, V12, P191, DOI 10.1016/S1043-2760(01)00392-7; LEVY D, 1990, NEW ENGL J MED, V0322; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; LITWIN SE, 1991, CIRCULATION, V83, P1028, DOI 10.1161/01.CIR.83.3.1028; Lockhart LK, 1999, J PHARMACOL EXP THER, V289, P721; MEERSON F Z, 1961, Cor Vasa, V3, P161; Miller A, 2002, ANTICANCER RES, V22, P3879; Moya-Camarena SY, 1999, BBA-MOL CELL BIOL L, V1436, P331, DOI 10.1016/S0005-2760(98)00121-0; Moya-Camarena SY, 1999, J LIPID RES, V40, P1426; Nagao K, 2003, BIOCHEM BIOPH RES CO, V310, P562, DOI 10.1016/j.bbrc.2003.09.044; Nicolosi RJ, 1997, ARTERY, V22, P266; OSLER WO, 1892, PRINCIPLES PRACTICE, P735; Pariza MW, 2004, AM J CLIN NUTR, V79, p1132S, DOI 10.1093/ajcn/79.6.1132S; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; PUCEAT M, 1994, J BIOL CHEM, V269, P16938; Reffelmann T, 2003, BASIC RES CARDIOL, V98, P275, DOI 10.1007/s00395-003-0401-3; SAKAI S, 2002, CLIN SCI LOND S48, V103, P16; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Takahashi H, 2005, CIRCULATION, V111, P1510, DOI 10.1161/01.CIR.0000159339.00703.22; Takano H, 2000, CIRC RES, V87, P596, DOI 10.1161/01.RES.87.7.596; Takeishi Y, 2007, PHARMACOL THERAPEUT, V115, P352, DOI 10.1016/j.pharmthera.2007.04.010; Toomey S, 2003, BIOCHEM SOC T, V31, P1075, DOI 10.1042/BST0311075; Verrier E, 2004, CIRC RES, V94, P1515, DOI 10.1161/01.RES.0000130527.92537.06; Wargent Ed, 2005, Lipids Health Dis, V4, P3, DOI 10.1186/1476-511X-4-3; Wayman NS, 2002, FASEB J, V16, P1027, DOI 10.1096/fj.01-0793com; WU JP, 1989, J BIOL CHEM, V264, P6472; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182; Xiao YF, 1998, P NATL ACAD SCI USA, V95, P2680, DOI 10.1073/pnas.95.5.2680; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Yu Y, 2002, BBA-MOL CELL BIOL L, V1581, P89, DOI 10.1016/S1388-1981(02)00126-9	60	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10707	10715		10.1074/jbc.M800035200	http://dx.doi.org/10.1074/jbc.M800035200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18283099	hybrid			2022-12-27	WOS:000254894700053
J	Karpichev, IV; Durand-Heredia, JM; Luo, Y; Small, GM				Karpichev, Igor V.; Durand-Heredia, Jorge M.; Luo, Yi; Small, Gillian M.			Binding characteristics and regulatory mechanisms of the transcription factors controlling oleate-responsive genes in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODING PEROXISOMAL PROTEINS; BETA-OXIDATION; ACID INDUCTION; IDENTIFY GENES; FATTY-ACIDS; PROLIFERATION; ADR1; ACTIVATION; PIP2P; DNA	Transcriptional activation of many genes involved in peroxisome-related functions is regulated by the Oaf1p, Pip2p, and Adr1p transcription factors in Saccharomyces cerevisiae. We have analyzed the in vivo binding characteristics of Oaf1p-Pip2p and found that this complex is recruited to its target oleate-response element (ORE) under all growth conditions tested. In addition, this complex also binds to ORE-containing genes that do not appear to be regulated by these proteins, as well as to some genes lacking conventional OREs. The recruitment of the Oaf1p-Pip2p complex was greatly increased upon glucose derepression, possibly due to Oaf1p phosphorylation with only moderate increases upon oleate induction. Thus, this complex may receive a nutritional cue while it is already bound to DNA, suggesting that, in addition to the increase in Oaf1p-Pip2p binding, other mechanism(s) such as enhanced Adr1p association may drive the expression of highly inducible fatty acid-responsive genes. Adr1p binds to target genes in an oleate-dependent fashion and is involved in Oaf1p-Pip2p binding. In turn, the Oaf1p-Pip2p complex appears to be important for Adr1p binding to a subset of oleate-responsive genes. Adr1p is a positive regulator of ORE-containing genes, but it also acts as a negative factor in expression of some of these genes. Finally, we have also shown that Adr1p is directly involved in mediating oleate induction of Oaf1p-Pip2p target genes.	[Karpichev, Igor V.; Durand-Heredia, Jorge M.; Luo, Yi; Small, Gillian M.] CUNY City Coll, Dept Biol, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Small, GM (corresponding author), 535 E 80th St, New York, NY 10075 USA.	Gillian.small@mail.cuny.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008168] Funding Source: NIH RePORTER; NCRR NIH HHS [RCMI RR 03060] Funding Source: Medline; NIGMS NIH HHS [S06 GM-08168] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agricola E, 2004, BIOCHEMISTRY-US, V43, P8878, DOI 10.1021/bi049577+; APARICIO O, 2005, CURRENT PROTOCOLS MO; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; CHENG C, 1994, MOL CELL BIOL, V14, P3842, DOI 10.1128/MCB.14.6.3842; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; DENIS CL, 1983, MOL CELL BIOL, V3, P360, DOI 10.1128/MCB.3.3.360; EINERHAND AWC, 1993, EUR J BIOCHEM, V214, P323, DOI 10.1111/j.1432-1033.1993.tb17927.x; FILIPITS M, 1993, GENE, V132, P49, DOI 10.1016/0378-1119(93)90513-3; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Geisberg J. V., 2005, CURR PROTOC MOL BIOL, P8; Gunji L, 2004, DNA RES, V11, P163, DOI 10.1093/dnares/11.3.163; Gurvitz A, 2001, J BIOL CHEM, V276, P31825, DOI 10.1074/jbc.M105989200; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Gurvitz Aner, 2000, Molecular Cell Biology Research Communications, V4, P81, DOI 10.1006/mcbr.2000.0261; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Karpichev IV, 1997, MOL CELL BIOL, V17, P69, DOI 10.1128/MCB.17.1.69; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Karpichev IV, 2002, J BIOL CHEM, V277, P19609, DOI 10.1074/jbc.M202045200; KIRKPATRICK CR, 1995, MOL CELL BIOL, V15, P4021; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Luo Y, 1996, J BIOL CHEM, V271, P12068, DOI 10.1074/jbc.271.20.12068; LUO Y, 1997, THESIS MOUNT SINAI S; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Rottensteiner H, 2003, J BIOL CHEM, V278, P27605, DOI 10.1074/jbc.M304097200; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Sellick CA, 2003, EMBO J, V22, P5147, DOI 10.1093/emboj/cdg480; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON M, 1991, MOL CELL BIOL, V11, P699, DOI 10.1128/MCB.11.2.699; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; SIMON MM, 1995, MOL GEN GENET, V249, P289, DOI 10.1007/BF00290529; SKONECZNY M, 1988, EUR J BIOCHEM, V174, P297, DOI 10.1111/j.1432-1033.1988.tb14097.x; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	51	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10264	10275		10.1074/jbc.M708215200	http://dx.doi.org/10.1074/jbc.M708215200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18285336	Green Published, hybrid			2022-12-27	WOS:000254894700007
J	Yoshida, KI; Yamaguchi, M; Morinaga, T; Kinehara, M; Ikeuchi, M; Ashida, H; Fujita, Y				Yoshida, Ken-Ichi; Yamaguchi, Masanori; Morinaga, Tetsuro; Kinehara, Masaki; Ikeuchi, Maya; Ashida, Hitoshi; Fujita, Yasutaro			myo-inositol catabolism in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYO-INOSITOL DEGRADATION; AEROBACTER-AEROGENES; ESCHERICHIA-COLI; 2-DEOXY-5-KETO-D-GLUCONIC ACID; MOLECULAR-CLONING; GENE; IDENTIFICATION; PATHWAY; DEHYDROGENASE; EXPRESSION	The iolABCDEFGHIJ operon of Bacillus subtilis is responsible for myo-inositol catabolism involving multiple and stepwise reactions. Previous studies demonstrated that IolG and IolE are the enzymes for the first and second reactions, namely dehydrogenation of myo-inositol to give 2-keto-myo-inositol and the subsequent dehydration to 3D-(3,5/4)-trihydroxycyclohexane1,2- dione. In the present studies the third reaction was shown to be the hydrolysis of 3D-(3,5/4)-trihydroxycyclohexane-1,2-dione catalyzed by IolD to yield 5-deoxy-D-glucuronic acid. The fourth reaction was the isomerization of 5-deoxy-D-glucuronic acid by IolB to produce 2-deoxy-5-keto-D-gluconic acid. Next, in the fifth reaction 2-deoxy-5-keto-D-gluconic acid was phosphorylated by IolC kinase to yield 2-deoxy-5-keto-D-gluconic acid 6-phosphate. IolR is known as the repressor controlling transcription of the iol operon. In this reaction 2-deoxy-5-keto-D-gluconic acid 6-phosphate appeared to be the intermediate acting as inducer by antagonizing DNA binding of IolR. Finally, IolJ turned out to be the specific aldolase for the sixth reaction, the cleavage of 2-deoxy-5-keto-D-gluconic acid 6-phosphate into dihydroxyacetone phosphate and malonic semialdehyde. The former is a known glycolytic intermediate, and the latter was previously shown to be converted to acetyl-CoA and CO2 by a reaction catalyzed by IolA. The net result of the inositol catabolic pathway in B. subtilis is, thus, the conversion of myo-inositol to an equimolar mixture of dihydroxyacetone phosphate, acetyl-CoA, and CO2.	[Yoshida, Ken-Ichi; Morinaga, Tetsuro; Kinehara, Masaki; Ikeuchi, Maya; Ashida, Hitoshi] Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Yamaguchi, Masanori] Hokko Chem Ind Co Ltd, Cent Res Labs, Atsugi, Kanagawa 2430023, Japan; [Fujita, Yasutaro] Fukuyama Univ, Dept Biotechnol, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima 7290292, Japan	Kobe University; Fukuyama University	Yoshida, KI (corresponding author), Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	kenyoshi@kobe-u.ac.jp	Yoshida, Ken-ichi/R-8863-2016	Yoshida, Ken-ichi/0000-0002-3383-4664				ANDERSON WA, 1971, J BIOL CHEM, V246, P5653; ANDERSON WA, 1971, J BIOL CHEM, V246, P5662; BERMAN T, 1966, J BIOL CHEM, V241, P807; BERMAN T, 1966, J BIOL CHEM, V241, P800; FUJITA Y, 1981, J BACTERIOL, V145, P760, DOI 10.1128/JB.145.2.760-767.1981; Fujita Y, 1998, J BACTERIOL, V180, P4309, DOI 10.1128/JB.180.16.4309-4313.1998; FUJITA Y, 1983, J BACTERIOL, V154, P864, DOI 10.1128/JB.154.2.864-869.1983; FUJITA Y, 1991, GENE, V108, P121; Galbraith MP, 1998, MICROBIOL-SGM, V144, P2915, DOI 10.1099/00221287-144-10-2915; Jiang GQ, 2001, J BACTERIOL, V183, P2595, DOI 10.1128/JB.183.8.2595-2604.2001; KAEMPFER RO, 1967, J MOL BIOL, V27, P453, DOI 10.1016/0022-2836(67)90051-4; Krings E, 2006, J BACTERIOL, V188, P8054, DOI 10.1128/JB.00935-06; Morinaga T, 2006, BIOSCI BIOTECH BIOCH, V70, P1913, DOI 10.1271/bbb.60084; Nakano M, 1999, J BIOL CHEM, V274, P23185, DOI 10.1074/jbc.274.33.23185; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; Sambrook J., 2001, MOL CLONING LAB MANU; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; VANROOIJEN RJ, 1990, J BIOL CHEM, V265, P18499; VIDALLEI.M, 1973, BIOCHIM BIOPHYS ACTA, V293, P295, DOI 10.1016/0005-2744(73)90337-9; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yebra MJ, 2007, APPL ENVIRON MICROB, V73, P3850, DOI 10.1128/AEM.00243-07; Yoshida K, 2006, APPL ENVIRON MICROB, V72, P1310, DOI 10.1128/AEM.72.2.1310-1315.2006; Yoshida KI, 2004, MICROBIOL-SGM, V150, P571, DOI 10.1099/mic.0.26768-0; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997; Yoshida KI, 2002, J BACTERIOL, V184, P983, DOI 10.1128/jb.184.4.983-991.2002; Yoshida KI, 1999, J MOL BIOL, V285, P917, DOI 10.1006/jmbi.1998.2398	28	87	94	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10415	10424		10.1074/jbc.M708043200	http://dx.doi.org/10.1074/jbc.M708043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18310071	hybrid			2022-12-27	WOS:000254894700022
J	Chung, MC; Popova, TG; Jorgensen, SC; Dong, L; Chandhoke, V; Bailey, CL; Popov, SG				Chung, Myung-Chul; Popova, Taissia G.; Jorgensen, Shelley C.; Dong, Li; Chandhoke, Vikas; Bailey, Charles L.; Popov, Serguei G.			Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; HEMOLYTIC-UREMIC SYNDROME; RICKETTSIA-RICKETTSII INFECTION; VONWILLEBRAND-FACTOR MULTIMERS; INHALATIONAL ANTHRAX; LETHAL TOXIN; GLYCOPROTEIN-IB; PLATELET-AGGREGATION; VACCINE CANDIDATES; IN-VITRO	Pathology data from the anthrax animal models show evidence of significant increases in vascular permeability coincident with hemostatic imbalances manifested by thrombocytopenia, transient leucopenia, and aggressive disseminated intravascular coagulation. In this study we hypothesized that anthrax infection modulates the activity of von Willebrand factor (VWF) and its endogenous regulator ADAMTS13, which play important roles in hemostasis and thrombosis, including interaction of endothelial cells with platelets. We previously demonstrated that purified anthrax neutral metalloproteases Npr599 and InhA are capable of cleaving a variety of host structural and regulatory proteins. Incubation of human plasma with these proteases at 37 C in the presence of urea as a mild denaturant results in proteolysis of VWF. Also in these conditions, InhA directly cleaves plasma ADAMTS13 protein. Npr599 and InhA digest synthetic VWF substrate FRETS-VWF73. Amino acid sequencing of VWF fragments produced by InhA suggests that one of the cleavage sites of VWF is located at domain A2, the target domain of ADAMTS13. Proteolysis of VWF by InhA impairs its collagen binding activity (VWF: CBA) and ristocetin-induced platelet aggregation activity. In plasma from anthrax spore-challenged DBA/2 mice, VWF antigen levels increase up to 2-fold at day 3 post-infection with toxigenic Sterne 34F(2) strain, whereas VWF: CBA levels drop in a time-dependent manner, suggesting dysfunction of VWF instead of its quantitative deficiency. This conclusion is further supported by significant reduction in the amount of VWF circulating in blood in the ultra-large forms. In addition, Western blot analysis shows proteolytic depletion of ADAMTS13 from plasma of spore-challenged mice despite its increased expression in the liver. Our results suggest a new mechanism of anthrax coagulopathy affecting the levels and functional activities of both VWF and its natural regulator ADAMTS13. This mechanism may contribute to hemorrhage and thrombosis typical in anthrax.	[Chung, Myung-Chul; Popova, Taissia G.; Jorgensen, Shelley C.; Dong, Li; Chandhoke, Vikas; Bailey, Charles L.; Popov, Serguei G.] George Mason Univ, Coll Sci, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA	George Mason University	Popov, SG (corresponding author), George Mason Univ, Coll Sci, Natl Ctr Biodefense & Infect Dis, 10900 Univ Blvd, Manassas, VA 20110 USA.	spopov@gmu.edu						ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Alam S, 2006, BIOCHEM BIOPH RES CO, V339, P107, DOI 10.1016/j.bbrc.2005.11.008; Ariel N, 2003, INFECT IMMUN, V71, P4563, DOI 10.1128/IAI.71.8.4563-4579.2003; Banno F, 2006, BLOOD, V107, P3161, DOI 10.1182/blood-2005-07-2765; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chitlaru T, 2006, J BACTERIOL, V188, P3551, DOI 10.1128/JB.188.10.3551-3571.2006; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Crawley JTB, 2005, BLOOD, V105, P1085, DOI 10.1182/blood-2004-03-1101; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; DALLDORF FG, 1967, ARCH PATHOL, V83, P154; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; DENT JA, 1991, J CLIN INVEST, V88, P774, DOI 10.1172/JCI115376; Donadelli R, 2006, BLOOD, V107, P1943, DOI 10.1182/blood-2005-07-2972; FEDERICI AB, 1989, BRIT J HAEMATOL, V73, P93, DOI 10.1111/j.1365-2141.1989.tb00226.x; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Galbusera M, 1999, J AM SOC NEPHROL, V10, P1234; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Groot E, 2007, CURR OPIN HEMATOL, V14, P284, DOI 10.1097/MOH.0b013e3280dce531; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Heffernan BJ, 2007, FEMS MICROBIOL LETT, V271, P98, DOI 10.1111/j.1574-6968.2007.00713.x; Hollestelle MJ, 2006, BRIT J HAEMATOL, V133, P562, DOI 10.1111/j.1365-2141.2006.06067.x; Jy W, 1998, AM J HEMATOL, V57, P33, DOI 10.1002/(SICI)1096-8652(199801)57:1<33::AID-AJH6>3.3.CO;2-1; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Klichko VI, 2003, BIOCHEM BIOPH RES CO, V303, P855, DOI 10.1016/S0006-291X(03)00440-6; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; MANNUCCI PM, 1989, BLOOD, V74, P978; Mina B, 2002, JAMA-J AM MED ASSOC, V287, P858, DOI 10.1001/jama.287.7.858; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Neugebauer BM, 2002, SEMIN THROMB HEMOST, V28, P139, DOI 10.1055/s-2002-27816; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Nolasco LH, 2005, BLOOD, V106, P4199, DOI 10.1182/blood-2005-05-2111; Ono T, 2006, BLOOD, V107, P528, DOI 10.1182/blood-2005-03-1087; Perutelli P, 2005, BLOOD COAGUL FIBRIN, V16, P607, DOI 10.1097/01.mbc.0000187251.32630.1f; Popov SG, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-25; Popov SG, 2004, CELL MICROBIOL, V6, P225, DOI 10.1046/j.1462-5822.2003.00358.x; Popova TG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-8; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sejvar JJ, 2005, LANCET INFECT DIS, V5, P287, DOI 10.1016/S1473-3099(05)70113-4; SMITH H, 1967, FED PROC, V26, P1554; SPORN LA, 1991, BLOOD, V78, P2595; SPORN LA, 1994, BLOOD, V83, P1527; Stearns-Kurosawa DJ, 2006, AM J PATHOL, V169, P433, DOI 10.2353/ajpath.2006.051330; Tsai HM, 2006, ANNU REV MED, V57, P419, DOI 10.1146/annurev.med.57.061804.084505; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; WARKENTIN TE, 1992, LANCET, V340, P35, DOI 10.1016/0140-6736(92)92434-H; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Wu YP, 2000, ARTERIOSCL THROM VAS, V20, P1661, DOI 10.1161/01.ATV.20.6.1661; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x	59	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9531	9542		10.1074/jbc.M705871200	http://dx.doi.org/10.1074/jbc.M705871200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18263586	hybrid			2022-12-27	WOS:000254671600006
J	Hejna, J; Holtorf, M; Hines, J; Mathewson, L; Hemphill, A; Al-Dhalimy, M; Olson, SB; Moses, RE				Hejna, James; Holtorf, Megan; Hines, Jennie; Mathewson, Lauren; Hemphill, Aaron; Al-Dhalimy, Muhsen; Olson, Susan B.; Moses, Robb E.			Tip60 is required for DNA interstrand cross-link repair in the Fanconi anemia pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; DAMAGE RESPONSE; COMPLEX; PROTEIN; CHROMATIN; IDENTIFICATION; FANCD2; BRCA1; H2AX; LOCALIZATION	The disease Fanconi anemia is a genome instability syndrome characterized by cellular sensitivity to DNA interstrand cross-linking agents, manifest by decreased cellular survival and chromosomal aberrations after such treatment. There are at least 13 proteins acting in the pathway, with the FANCD2 protein apparently functioning as a late term effecter in the maintenance of genome stability. We find that the chromatin remodeling protein, Tip60, interacts directly with the FANCD2 protein in a yeast two-hybrid system. This interaction has been confirmed by co-immunoprecipitation and co-localization using both endogenous and epitope-tagged FANCD2 and Tip60 from human cells. The observation of decreased cellular survival after exposure to mitomycin C in normal fibroblasts depleted for Tip60 indicates a direct function in interstrand cross-link repair. The coincident function of Tip60 and FANCD2 in one pathway is supported by the finding that depletion of Tip60 in Fanconi anemia cells does not increase sensitivity to DNA cross-links. However, depletion of Tip60 did not reduce monoubiquitination of FANCD2 or its localization to nuclear foci following DNA damage. The observations indicate that Fanconi anemia proteins act in concert with chromatin remodeling functions to maintain genome stability after DNA cross-link damage.	[Hejna, James; Holtorf, Megan; Hines, Jennie; Mathewson, Lauren; Hemphill, Aaron; Al-Dhalimy, Muhsen; Olson, Susan B.; Moses, Robb E.] OHSU, Dept Mol & Med Genet, Portland, OR 97239 USA	Oregon Health & Science University	Moses, RE (corresponding author), OHSU, Dept Mol & Med Genet, 3181 Sam Jackson Pkway, Portland, OR 97239 USA.	mosesr@ohsu.edu			NHLBI NIH HHS [1P01 HL 48546, P01 HL048546-130001] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048546] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; D'Andrea A, 2003, CURR BIOL, V13, pR546, DOI 10.1016/S0960-9822(03)00467-6; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Folias A, 2002, HUM MOL GENET, V11, P2591, DOI 10.1093/hmg/11.21.2591; FRANGIONI JV, 1993, J CELL SCI, V105, P481; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Godthelp BC, 2006, MUTAT RES-FUND MOL M, V594, P39, DOI 10.1016/j.mrfmmm.2005.07.008; Grossmann KF, 2001, MUTAT RES-DNA REPAIR, V487, P73, DOI 10.1016/S0921-8777(01)00106-9; Hejna JA, 2000, AM J HUM GENET, V66, P1540, DOI 10.1086/302896; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; KUSHCH T, 2004, SCIENCE, V306, P2084; Logan IR, 2004, J BIOL CHEM, V279, P11696, DOI 10.1074/jbc.M312712200; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mi J, 2005, BLOOD, V105, P759, DOI 10.1182/blood-2004-01-0001; Miller John, 2004, Methods Mol Biol, V261, P247; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Thomashevski A, 2004, J BIOL CHEM, V279, P26201, DOI 10.1074/jbc.M400091200; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wang Y, 2000, GENE DEV, V14, P927; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595	37	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9844	9851		10.1074/jbc.M709076200	http://dx.doi.org/10.1074/jbc.M709076200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18263878	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000254671600040
J	Simonsen, SM; Sando, L; Rosengren, KJ; Wang, CK; Colgrave, ML; Daly, NL; Craik, DJ				Simonsen, Shane M.; Sando, Lillian; Rosengren, K. Johan; Wang, Conan K.; Colgrave, Michelle L.; Daly, Norelle L.; Craik, David J.			Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE CALCULATION; POLYPEPTIDE KALATA B1; CYCLIC CYSTINE-KNOT; TORSION ANGLE DYNAMICS; MACROCYCLIC PEPTIDES; OLDENLANDIA-AFFINIS; STRUCTURAL MOTIF; PLANT CYCLOTIDES; CYCLOVIOLACIN O2; ACYCLIC PERMUTANTS	The cyclotides are stable plant-derived mini-proteins with a topologically circular peptide backbone and a knotted arrangement of three disulfide bonds that form a cyclic cystine knot structural framework. They display a wide range of pharmaceutically important bioactivities, but their natural function is in plant defense as insecticidal agents. To determine the influence of individual residues on structure and activity in the prototypic cyclotide kalata B1, all 23 non-cysteine residues were successively replaced with alanine. The structure was generally tolerant of modification, indicating that the framework is a viable candidate for the stabilization of bioactive peptide epitopes. Remarkably, insecticidal and hemolytic activities were both dependent on a common, well defined cluster of hydrophilic residues on one face of the cyclotide. Interestingly, this cluster is separate from the membrane binding face of the cyclotides. Overall, the mutagenesis data provide an important insight into cyclotide biological activity and suggest that specific self-association, in combination with membrane binding mediates cyclotide bioactivities.	[Simonsen, Shane M.; Sando, Lillian; Rosengren, K. Johan; Wang, Conan K.; Colgrave, Michelle L.; Daly, Norelle L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Daly, Norelle L/D-4302-2013; Rosengren, K. Johan/P-4450-2016; Wang, Conan K/D-1481-2010; Colgrave, Michelle/A-5710-2012; Craik, David/B-1695-2010	Daly, Norelle L/0000-0002-4697-6602; Rosengren, K. Johan/0000-0002-5007-8434; Wang, Conan K/0000-0002-7973-7632; Colgrave, Michelle/0000-0001-8463-805X; Craik, David/0000-0003-0007-6796				Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Craik DJ, 2002, CURR OPIN DRUG DI DE, V5, P251; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Ghirardi ML, 1998, BIOCHEMISTRY-US, V37, P13559, DOI 10.1021/bi980358w; Goransson U, 2004, J NAT PROD, V67, P1287, DOI 10.1021/np0499719; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gran L., 1970, MEDDELELSER NORSK FA, V12, P173; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Kimura RH, 2006, ANGEW CHEM INT EDIT, V45, P973, DOI 10.1002/anie.200503882; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lindholm P, 2002, MOL CANCER THER, V1, P365; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; McIntosh JM, 2000, EUR J PHARMACOL, V393, P205, DOI 10.1016/S0014-2999(99)00887-0; Millard EL, 2004, EUR J BIOCHEM, V271, P2320, DOI 10.1111/j.1432-1033.2004.04148.x; Mulvenna JP, 2006, NUCLEIC ACIDS RES, V34, pD192, DOI 10.1093/nar/gkj005; Nair SS, 2006, BBA-PROTEINS PROTEOM, V1764, P1568, DOI 10.1016/j.bbapap.2006.07.009; Nourse A, 2004, J BIOL CHEM, V279, P562, DOI 10.1074/jbc.M306826200; OJCIUS DM, 1991, TRENDS BIOCHEM SCI, V16, P225, DOI 10.1016/0968-0004(91)90090-I; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schoepke T., 1993, SCI PHARM, V61, P145; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Simonsen SM, 2004, FEBS LETT, V577, P399, DOI 10.1016/j.febslet.2004.10.034; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tam JP, 1998, PROTEIN SCI, V7, P1583, DOI 10.1002/pro.5560070712; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 1997, TETRAHEDRON LETT, V38, P5599, DOI 10.1016/S0040-4039(97)01271-9; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Trabi M, 2004, PLANT CELL, V16, P2204, DOI 10.1105/tpc.104.021790; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	52	136	141	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9805	9813		10.1074/jbc.M709303200	http://dx.doi.org/10.1074/jbc.M709303200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18258598	hybrid, Green Published			2022-12-27	WOS:000254671600035
J	Bailey, KM; Liu, J				Bailey, Kelly M.; Liu, Jun			Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; RESISTANT CANCER-CELLS; ROUS-SARCOMA VIRUS; GROWTH-FACTOR-BETA; TYROSINE PHOSPHORYLATION; DOWN-REGULATION; BREAST-CANCER; E-CADHERIN; TGF-BETA; SIGNAL-TRANSDUCTION	Emerging evidence has shown that caveolin-1 is up-regulated in a number of metastatic cancers and can influence various aspects of cell migration. However, in general, the role of caveolin-1 in cancer progression is poorly understood. In the present study, we examined alterations in caveolin-1 expression during epithelial-to-mesenchymal transition (EMT) and the ability of caveolin-1 to alter cancer cell adhesion, an aspect of cell motility. We employed two EMT cell models, the human embryonic carcinoma cell line NT2/D1, and TGF-beta 1-treated NMuMG cells, which are derived from normal mouse mammary epithelia. Caveolin-1 expression was substantially upregulated in both cell lines following the induction of EMT and was preceded by increased activation of focal adhesion kinase (FAK) and Src, two known tyrosine kinases involved in EMT. We hypothesized that caveolin-1 expression could be influenced by increased FAK phosphorylation, to which Src is a known contributor. Examination of FAK(+/+) and FAK(+/+) mouse embryonic fibroblasts revealed that in cells devoid of FAK, caveolin-1 expression is strikingly diminished. Using FAK and superFAK constructs and the novel FAK inhibitor PF-228, we were able to demonstrate that indeed, FAK can regulate caveolin-1 expression. We also found that Src can contribute to increases in caveolin-1 expression, however, only in the presence of FAK. From the culmination of this data and our functional analyses, we conclude that caveolin-1 expression can be up-regulated during EMT, and further, once expressed, caveolin-1 can greatly influence cancer cell adhesion.	[Liu, Jun] W Virginia Univ, Hlth Sci Ctr, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA	West Virginia University	Liu, J (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Physiol & Pharmacol, POB 9229, Morgantown, WV 26506 USA.	junliu@hsc.wvu.edu		Bailey, Kelly/0000-0003-3925-3243	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NCRR NIH HHS [RR016440] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1984, LAB INVEST, V50, P147; [Anonymous], MEMBRANE MICRODOMAIN; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Duran C, 2001, INT J CANCER, V93, P324, DOI 10.1002/ijc.1355; Earley S, 2006, BIOCHEM BIOPH RES CO, V350, P405, DOI 10.1016/j.bbrc.2006.09.056; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Fielding CJ, 1997, P NATL ACAD SCI USA, V94, P3753, DOI 10.1073/pnas.94.8.3753; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hayashi K, 2001, CANCER RES, V61, P2361; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Lavie Y, 2001, ADV DRUG DELIVER REV, V49, P317, DOI 10.1016/S0169-409X(01)00144-2; Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEE VMY, 1986, J NEUROSCI, V6, P514; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Podar K, 2004, CANCER RES, V64, P7500, DOI 10.1158/0008-5472.CAN-04-0124; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; Ravid D, 2006, ADV ENZYME REGUL, V46, P163, DOI 10.1016/j.advenzreg.2006.01.022; Razani B, 2001, BIOCHEM SOC T, V29, P494, DOI 10.1042/BST0290494; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Salatino M, 2006, ONCOGENE, V25, P7723, DOI 10.1038/sj.onc.1209757; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; Sun XH, 2007, J BIOL CHEM, V282, P7232, DOI 10.1074/jbc.M607396200; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	75	82	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13714	13724		10.1074/jbc.M709329200	http://dx.doi.org/10.1074/jbc.M709329200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332144	Green Published, hybrid			2022-12-27	WOS:000255728200023
J	Kim, KJ; Park, MC; Choi, SJ; Oh, YS; Choi, EC; Cho, HJ; Kim, MH; Kim, SH; Kim, DW; Kim, S; Kang, BS				Kim, Kyung-Jin; Park, Min Chul; Choi, So Jung; Oh, Young Sun; Choi, Eung-Chil; Cho, Hyo Je; Kim, Myung Hee; Kim, Soo-Hyun; Kim, Dong Wook; Kim, Sunghoon; Kang, Beom Sik			Determination of three-dimensional structure and residues of the novel tumor suppressor AIMP3/p18 required for the interaction with ATM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; PROTEIN; DOMAIN; P43; COFACTOR; IDENTIFICATION; TRANSLATION; ACTIVATION	Although AIMP3/p18 is normally associated with the multi-tRNA synthetase complex via its specific interaction with methionyl-tRNA synthetase, it also works as a tumor suppressor by interacting with ATM, the upstream kinase of p53. To understand the molecular interactions of AIMP3 and the mechanisms involved, we determined the crystal structure of AIMP3 at 2.0-angstrom resolution and identified its potential sites of interaction with ATM. AIMP3 contains two distinct domains linked by a 7-amino acid (Lys(57)-Ser(63)) peptide, which contains a 310 helix. The 56-amino acid N-terminal domain consists of two helices into which three antiparallel beta strands are inserted, and the 111-amino acid C-terminal domain contains a bundle of five helices (Thr(64)-Tyr(152)) followed by a coiled region (Pro(153)-Leu(169)). Structural analyses revealed homologous proteins such as yeast glutamyl-tRNA synthetase, Arc1p, EF1B gamma, and glutathione S-transferase and suggested two potential molecular binding sites. Moreover, mutations at the C-terminal putative binding site abolished the interaction between AIMP3 and ATM and the ability of AIMP3 to activate p53. Thus, this work identified the two potential molecular interaction sites of AIMP3 and determined the residues critical for its tumor-suppressive activity through the interaction with ATM.	[Park, Min Chul; Choi, So Jung; Oh, Young Sun; Choi, Eung-Chil; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Seoul 151742, South Korea; [Kim, Kyung-Jin] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, South Korea; [Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Kim, Soo-Hyun; Kim, Dong Wook] Catholic Univ, Coll Med, St Marys Hosp, Div Hematol, Seoul 150713, South Korea; [Cho, Hyo Je; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Kyungpook National University	Kim, S (corresponding author), Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Kwanak Ro 599, Seoul 151742, South Korea.	sungkim@snu.ac.kr; bskang2@knu.ac.kr	Kim, Sunghoon/AAE-8314-2020					Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Cheong HK, 2003, INT J BIOCHEM CELL B, V35, P1548, DOI 10.1016/S1357-2725(03)00070-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Hansen AM, 2005, J BIOL CHEM, V280, P17380, DOI 10.1074/jbc.M501444200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kim E, 2006, J IMMUNOL, V176, P256, DOI 10.4049/jimmunol.176.1.256; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kim Y, 2000, J BIOL CHEM, V275, P27062; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Neuefeind T, 1997, J MOL BIOL, V274, P446, DOI 10.1006/jmbi.1997.1402; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park BJ, 2006, CANCER RES, V66, P6913, DOI 10.1158/0008-5472.CAN-05-3740; Park SG, 2006, P NATL ACAD SCI USA, V103, P14913, DOI 10.1073/pnas.0602045103; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Simader H, 2006, ACTA CRYSTALLOGR D, V62, P1510, DOI 10.1107/S0907444906039850; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898	39	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14032	14040		10.1074/jbc.M800859200	http://dx.doi.org/10.1074/jbc.M800859200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343821	hybrid			2022-12-27	WOS:000255728200057
J	Lopez-Pajares, V; Kim, MM; Yuan, ZM				Lopez-Pajares, Vanessa; Kim, Mihee M.; Yuan, Zhi-Min			Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; LIGASE ACTIVITY; P53 UBIQUITINATION; CANCER-THERAPY; DEGRADATION; HDMX; PROTEIN; AMPLIFICATION; ATM; CONTRIBUTES	The critical tumor suppressor p53 is mutated or functionally inactivated in nearly all cancers. We have shown previously that the MDM2-MDMX complex functions as an integral unit in targeting p53 for degradation. Here we identify the small protein 14-3-3 as a binding partner of MDMX, which binds at the C terminus (Ser367) in a phosphorylation-dependent manner. Importantly, we demonstrate that the serine/threonine kinase Akt mediates phosphorylation of MDMX at Ser367. This phosphorylation leads to stabilization of MDMX and consequent stabilization of MDM2. Previous studies have shown that Akt phosphorylates and stabilizes MDM2. Our data suggest that stabilization of MDMX by Akt may be an alternative mechanism by which Akt up-regulates MDM2 protein levels and exerts its oncogenic effects on p53 in tumor cells.	[Lopez-Pajares, Vanessa; Kim, Mihee M.; Yuan, Zhi-Min] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), 665 Huntington Ave Bldg 1-507, Boston, MA 02215 USA.	zyuan@hsph.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA085679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007155] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA85679-02] Funding Source: Medline; NIEHS NIH HHS [T32ES07155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Basu S, 2003, CELL CYCLE, V2, P69, DOI 10.4161/cc.2.2.303; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Finch RA, 2002, CANCER RES, V62, P3221; Gentiletti F, 2002, ONCOGENE, V21, P867, DOI 10.1038/sj.onc.1205137; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Milne D, 2004, FEBS LETT, V577, P270, DOI 10.1016/j.febslet.2004.09.081; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Ramos YFM, 2001, CANCER RES, V61, P1839; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Singh RK, 2007, J BIOL CHEM, V282, P10901, DOI 10.1074/jbc.M610879200; Stad R, 2000, J BIOL CHEM, V275, P28039; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	48	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13707	13713		10.1074/jbc.M710030200	http://dx.doi.org/10.1074/jbc.M710030200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18356162	hybrid, Green Published			2022-12-27	WOS:000255728200022
J	Malla, N; Berg, E; Uhlin-Hansen, L; Winberg, JO				Malla, Nabin; Berg, Eli; Uhlin-Hansen, Lars; Winberg, Jan-Olof			Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; EPIDERMOLYSIS-BULLOSA SIMPLEX; HUMAN NEUTROPHIL GELATINASE; FIBRONECTIN-LIKE DOMAIN; IV COLLAGENASE; EXTRACELLULAR-MATRIX; FUNCTIONAL-ANALYSIS; BINDING-PROPERTIES; ENDOTHELIAL-CELLS; COMPLEX-FORMATION	Previously we have shown that THP-1 cells synthesize matrix metalloproteinase-9 (MMP-9) where a fraction of the enzyme is strongly linked to a proteoglycan ( PG) core protein. In the present work we show that these pro-MMP-9 center dot PG heteromers have different biochemical properties compared with the monomeric form of pro-MMP-9. In these heteromers, the fibronectin II-like domain in the catalytic site of the enzyme is hidden, and the fibronectin II-like-mediated binding to gelatin and collagen is prevented. However, a fraction of the pro-MMP-9 center dot PG heteromers interacted with gelatin and collagen. This interaction was not through the chondroitin sulfate (CS) part of the PG molecule but, rather, through a region in the PG core protein, a new site induced by the interaction of pro-MMP-9 and the PG core protein, or a non-CS glycosaminoglycan part of the PG molecule. The interaction between pro-MMP-9 center dot PG heteromers and gelatin was weaker than the interaction between pro-MMP-9 and gelatin. In contrast, collagen I bound to pro-MMP-9 center dot PG heteromers and pro-MMP-9 with approximately the same affinity. Removal of CS chains from the PG part of the heteromers did not affect the binding to gelatin and collagen. Although the identity of the PG core protein is not known, this does not have any impact on the described biochemical properties of the heteromer or its pro-MMP-9 component. It is also shown that a small fraction of the PG, which is not a part of the pro-MMP-9 center dot PG heteromer, can bind gelatin. As for the pro-MMP-9 center dot PG heteromers, this was independent of the CS chains. The structure that mediates the binding of free PG to gelatin is different from the corresponding structure in the pro-MMP-9 center dot PG heteromer, because they were eluted from gelatin-Sepharose columns under totally different conditions. Although only a small amount of pro-MMP-9 center dot PG heteromer is formed, the heteromer may have fundamental physiological importance, because only catalytic amounts of the enzyme are required to digest physiological targets.	[Malla, Nabin; Berg, Eli; Winberg, Jan-Olof] Univ Tromso, Inst Med Biol, Dept Med Biochem, N-9037 Tromso, Norway; [Uhlin-Hansen, Lars] Univ Tromso, Inst Med Biol, Dept Pathol, N-9037 Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Winberg, JO (corresponding author), Univ Tromso, Inst Med Biol, Dept Med Biochem, MH Bldg, N-9037 Tromso, Norway.	janow@fagmed.uit.no						ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; CARRINO DA, 1991, BIOCHEM INT, V24, P485; CARSON DD, 1992, DEV BIOL, V149, P307, DOI 10.1016/0012-1606(92)90286-P; Cattaruzza S, 2006, MACROMOL BIOSCI, V6, P667, DOI 10.1002/mabi.200600100; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Flannery CR, 2006, FRONT BIOSCI-LANDMRK, V11, P544, DOI 10.2741/1818; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kolkenbrock H, 1996, BIOL CHEM, V377, P529, DOI 10.1515/bchm3.1996.377.7-8.529; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; LYON M, 1991, BIOCHEM J, V273, P415, DOI 10.1042/bj2730415; LYONS JG, 1991, BIOCHEMISTRY-US, V30, P1449, DOI 10.1021/bi00220a001; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; MURPHY G, 1994, J BIOL CHEM, V269, P6632; MURPHY G, 1995, METHOD ENZYMOL, V248, P470; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; POURMOTABBED T, 1994, ANN NY ACAD SCI, V732, P372, DOI 10.1111/j.1749-6632.1994.tb24757.x; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; RUOSLAHTI E, 1980, BIOCHIM BIOPHYS ACTA, V631, P350, DOI 10.1016/0304-4165(80)90308-6; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Shipley JM, 1996, J BIOL CHEM, V271, P4335; SMITH RL, 1988, ARCH BIOCHEM BIOPHYS, V266, P181, DOI 10.1016/0003-9861(88)90248-2; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; STRONGIN AY, 1993, KIDNEY INT, V43, P158, DOI 10.1038/ki.1993.26; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; UHLINHANSEN L, 1993, BLOOD, V82, P2880; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; WINBERG JO, 1992, BIOCHEM GENET, V30, P401, DOI 10.1007/BF00569330; WINBERG JO, 1986, J INVEST DERMATOL, V87, P326, DOI 10.1111/1523-1747.ep12524396; Winberg JO, 2003, EUR J BIOCHEM, V270, P3996, DOI 10.1046/j.1432-1033.2003.03788.x; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Xu XP, 2004, MATRIX BIOL, V23, P171, DOI 10.1016/j.matbio.2004.05.002; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Zhou J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-25	54	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13652	13665		10.1074/jbc.M709140200	http://dx.doi.org/10.1074/jbc.M709140200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359769	hybrid			2022-12-27	WOS:000255728200017
J	Singh, P; Wang, BL; Maeda, T; Palczewski, K; Tesmer, JJG				Singh, Puja; Wang, Benlian; Maeda, Tadao; Palczewski, Krzysztof; Tesmer, John J. G.			Structures of rhodopsin kinase in different ligand states reveal key elements involved in G protein-coupled receptor kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; TERMINAL TAIL; OGUCHI FORM; PHOSPHORYLATION; SITES; ROD; IDENTIFICATION; PEPTIDE; GENE; ISOPRENYLATION	G protein-coupled receptor (GPCR) kinases (GRKs) phosphorylate activated heptahelical receptors, leading to their uncoupling from G proteins. Here we report six crystal structures of rhodopsin kinase (GRK1), revealing not only three distinct nucleotide-binding states of a GRK but also two key structural elements believed to be involved in the recognition of activated GPCRs. The first is the C-terminal extension of the kinase domain, which was observed in all nucleotide-bound GRK1 structures. The second is residues 5-30 of the N terminus, observed in one of the GRK1 center dot(Mg2+)(2)center dot ATP structures. The N terminus was also clearly phosphorylated, leading to the identification of two novel phosphorylation sites by mass spectral analysis. Co-localization of the N terminus and the C-terminal extension near the hinge of the kinase domain suggests that activated GPCRs stimulate kinase activity by binding to this region to facilitate full closure of the kinase domain.	[Singh, Puja; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Singh, Puja] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Maeda, Tadao; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Sch Med, Ctr Prote & Mass Spectrometry, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; Case Western Reserve University; Case Western Reserve University	Tesmer, JJG (corresponding author), Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu	Singh, Puja/M-9548-2014	Tesmer, John/0000-0003-1125-3727	NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NEI NIH HHS [P30 EY011373, P30-EY11373, R01 EY008061-22, R01 EY008061, EY 08061, P30 EY011373-129005] Funding Source: Medline; NHLBI NIH HHS [HL071818] Funding Source: Medline; NIGMS NIH HHS [Y1-GM-1104] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY011373, R29EY008061, R01EY008061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; BINDER BM, 1990, J BIOL CHEM, V265, P15333; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; Hayashi T, 2007, OPHTHALMOLOGY, V114, P134, DOI 10.1016/j.ophtha.2006.05.069; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Higgins MK, 2006, J BIOL CHEM, V281, P19426, DOI 10.1074/jbc.M602203200; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; Khani SC, 1998, P NATL ACAD SCI USA, V95, P2824, DOI 10.1073/pnas.95.6.2824; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levay K, 1998, BIOCHEMISTRY-US, V37, P13650, DOI 10.1021/bi980998z; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; OTWINOSKI Z, 1993, P CCP4 STUD WEEK DAT; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P8764, DOI 10.1021/bi00448a013; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; SHI W, 1995, J BIOL CHEM, V270, P2112, DOI 10.1074/jbc.270.5.2112; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	50	80	82	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14053	14062		10.1074/jbc.M708974200	http://dx.doi.org/10.1074/jbc.M708974200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339619	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000255728200059
J	Yan, WX; Armishaw, C; Goyette, J; Yang, Z; Cai, H; Alewood, P; Geczy, CL				Yan, Wei Xing; Armishaw, Chris; Goyette, Jesse; Yang, Zheng; Cai, Hong; Alewood, Paul; Geczy, Carolyn L.			Mast cell and monocyte recruitment by S100A12 and its hinge domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY SMOOTH-MUSCLE; IMMUNE-RESPONSE; PROTEIN S100A12; BONE-MARROW; EN-RAGE; RECEPTOR; MIGRATION; ACTIVATION; EXPRESSION; FAMILY	S100A12 is expressed at sites of acute, chronic, and allergic inflammation. S100 proteins have regions of high sequence homology, but the "hinge" region between the conserved calcium binding domains is structurally and functionally divergent. Because the murine S100A8 hinge domain ( mS100A8(42-55)) is a monocyte chemoattractant whereas the human sequence ( hS100A8(43-56)) is inactive, we postulated that common hydrophobic amino acids within the S100A12 hinge sequence may be functional. The hinge domain, S100A12(38-53), was chemotactic for human monocytes and murine mast cells in vitro. S100A12(38-53) provoked an acute inflammatory response similar to that elicited by S100A12 in vivo and caused edema and leukocyte and mast cell recruitment. Circular dichroism studies showed that S100A12(38-53) had increased helical structure in hydrophobic environments. Mutations in S100A12(38-53) produced using an alanine scan confirmed that specific hydrophobic residues ( I44A, I47A, and I53A) on the same face of the helix were critical for monocyte chemotaxis in vitro and generation of edema in vivo. In a hydrophobic environment such as the cell membrane, these critical residues would likely align on one face of an alpha-helix to facilitate receptor interaction. Interaction is unlikely to occur via the receptor for advanced glycation end products but, rather, via a G- protein- coupled mechanism.	[Yan, Wei Xing; Goyette, Jesse; Yang, Zheng; Cai, Hong; Geczy, Carolyn L.] Univ New S Wales, Inflammatory Dis Res Unit, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [Armishaw, Chris; Alewood, Paul] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of New South Wales Sydney; University of Queensland	Geczy, CL (corresponding author), Univ New S Wales, Inflammatory Dis Res Unit, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia.	geczy@unsw.edu.au	Goyette, Jesse/AAW-4701-2021; Alewood, Paul F/J-2412-2014	Goyette, Jesse/0000-0002-1008-1890; Yang, Zheng/0000-0003-4275-0590				Berger P, 2003, FASEB J, V17, P2139, DOI 10.1096/fj.03-0041fje; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2003, THORAX, V58, P613, DOI 10.1136/thorax.58.7.613; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gordon JR, 2000, J ALLERGY CLIN IMMUN, V106, P110; Hasegawa T, 2003, ATHEROSCLEROSIS, V171, P211, DOI 10.1016/j.atherosclerosis.2003.08.021; HE D, 1990, J INVEST DERMATOL, V95, P178, DOI 10.1111/1523-1747.ep12477951; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Jackson NE, 2005, EUR J IMMUNOL, V35, P2376, DOI 10.1002/eji.200526154; Kitaura J, 2005, BLOOD, V105, P3222, DOI 10.1182/blood-2004-11-4205; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; LACKMANN M, 1993, J IMMUNOL, V150, P2981; LAU W, 1995, J CLIN INVEST, V95, P1957, DOI 10.1172/JCI117879; Lazoura E, 2000, J PEPT RES, V55, P411, DOI 10.1034/j.1399-3011.2000.00690.x; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Markowitz J, 2004, J MED CHEM, V47, P5085, DOI 10.1021/jm0497038; Meyers HV, 1995, MOL DIVERS, V1, P13, DOI 10.1007/BF01715805; Moroz OV, 2002, ACTA CRYSTALLOGR D, V58, P407, DOI 10.1107/S0907444901021278; Moroz OV, 2003, MICROSC RES TECHNIQ, V60, P581, DOI 10.1002/jemt.10300; MURAKAMI M, 1995, J EXP MED, V182, P197, DOI 10.1084/jem.182.1.197; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Nilsson G, 1999, BLOOD, V93, P2791; Pozdnyakov N, 1998, BIOCHEMISTRY-US, V37, P10701, DOI 10.1021/bi9802115; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Robinson MJ, 2000, BIOCHEM BIOPH RES CO, V275, P865, DOI 10.1006/bbrc.2000.3407; Rouleau P, 2003, CLIN IMMUNOL, V107, P46, DOI 10.1016/S1521-6616(02)00043-8; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Vogl T, 1999, J BIOL CHEM, V274, P25291, DOI 10.1074/jbc.274.36.25291; Wang HW, 1998, J CLIN INVEST, V102, P1617, DOI 10.1172/JCI3704; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Yang Z, 2001, J LEUKOCYTE BIOL, V69, P986; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Yokomizo T, 2001, LIFE SCI, V68, P2207, DOI 10.1016/S0024-3205(01)01007-4	44	55	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13035	13043		10.1074/jbc.M710388200	http://dx.doi.org/10.1074/jbc.M710388200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18292089	hybrid			2022-12-27	WOS:000255499800041
J	Das, A; Base, C; Manna, D; Cho, W; Dubreuil, RR				Das, Amlan; Base, Christine; Manna, Debasis; Cho, Wonhwa; Dubreuil, Ronald R.			Unexpected complexity in the mechanisms that target assembly of the spectrin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BRONCHIAL EPITHELIAL-CELLS; DROSOPHILA BETA-SPECTRIN; AXON INITIAL SEGMENTS; ALPHA-SPECTRIN; PLASMA-MEMBRANE; LATERAL MEMBRANE; EMBRYONIC CNS; II-SPECTRIN; ANKYRIN-G	The spectrin cytoskeleton assembles within discrete regions of the plasma membrane in a wide range of animal cell types. Although recent studies carried out in vertebrate systems indicate that spectrin assembly occurs indirectly through the adapter protein ankyrin, recent studies in Drosophila have established that spectrin can also assemble through a direct ankyrin-independent mechanism. Here we tested specific regions of the spectrin molecule for a role in polarized assembly and function. First, we tested mutant beta-spectrins lacking ankyrin binding activity and/or the COOH-terminal pleckstrin homology (PH) domain for their assembly competence in midgut, salivary gland, and larval brain. Remarkably, three different assembly mechanisms operate in these three cell types: 1) neither site was required for assembly in salivary gland; 2) only the PH domain was required in midgut copper cells; and 3) either one of the two sites was sufficient for spectrin assembly in larval brain. Further characterization of the PH domain revealed that it binds strongly to lipid mixtures containing phosphatidylinositol 4,5-bisphosphate (PIP2) but not phosphatidylinositol 3,4,5-trisphosphate. A K8Q mutation in the lipid binding region of the PH domain eliminated the PIP2 interaction in vitro, yet the mutant protein retained full biological function in vivo. Reporter gene studies revealed that PIP2 and the spectrin PH domain codistribute with one another in cells but not with authentic wild type alpha beta-spectrin. Thus, it appears that the PH domain imparts membrane targeting activity through a second mechanism that takes precedence over its PIP2 binding activity.	Univ Illinois, Mol Biol Lab, Chicago, IL 60607 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Manna, Debasis; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dubreuil, RR (corresponding author), 900 S Ashland Ave,Rm 4152 MBRB,MC 567, Chicago, IL 60607 USA.	ron@uic.edu		Manna, Debasis/0000-0002-6920-9000	NIGMS NIH HHS [GM68849, GM49301] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849, R01GM049301] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; DUBREUIL R, 1987, J CELL BIOL, V105, P2095, DOI 10.1083/jcb.105.5.2095; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; DUBREUIL RR, 1994, P NATL ACAD SCI USA, V91, P10285, DOI 10.1073/pnas.91.22.10285; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Dubreuil RR, 1997, MOL BIOL CELL, V8, P1933, DOI 10.1091/mbc.8.10.1933; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Garbe DS, 2007, DEVELOPMENT, V134, P273, DOI 10.1242/dev.02653; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; GUMBINER B, 1985, TRENDS BIOCHEM SCI, V10, P435, DOI 10.1016/0968-0004(85)90026-X; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LOMBARDO CR, 1994, J BIOL CHEM, V269, P29212; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Salomao M, 2006, P NATL ACAD SCI USA, V103, P643, DOI 10.1073/pnas.0507661103; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Stahelin RV, 2006, J BIOL CHEM, V281, P39396, DOI 10.1074/jbc.M607079200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TSE WT, 1990, J CLIN INVEST, V86, P909, DOI 10.1172/JCI114792; Tse WT, 2001, J BIOL CHEM, V276, P23974, DOI 10.1074/jbc.M009307200; Wang DS, 1996, BIOCHEM BIOPH RES CO, V225, P420, DOI 10.1006/bbrc.1996.1189; Williams JA, 2004, J CELL SCI, V117, P771, DOI 10.1242/jcs.00922; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; ZHANG P, 1995, STRUCTURE, V3, P1185, DOI 10.1016/S0969-2126(01)00254-4	43	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12643	12653		10.1074/jbc.M800094200	http://dx.doi.org/10.1074/jbc.M800094200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18287096	Green Published, hybrid			2022-12-27	WOS:000255340000081
J	Hsu, HJ; Tsai, KC; Sun, YK; Chang, HJ; Huang, YJ; Yu, HM; Lin, CH; Mao, SS; Yang, AS				Hsu, Hung-Ju; Tsai, Keng-Chang; Sun, Yi-Kun; Chang, Hung-Ju; Huang, Yi-Jen; Yu, Hui-Ming; Lin, Chun-Hung; Mao, Shi-Shan; Yang, An-Suei			Factor Xa active site substrate specificity with substrate phage display and computational molecular modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR SUBSTRATE; PROTHROMBINASE COMPLEX; PROTEASE SPECIFICITY; GENETIC ALGORITHM; SERINE PROTEASES; INHIBITORS; RECOGNITION; LIBRARIES; CLEAVAGE; IDENTIFICATION	Structural origin of substrate-enzyme recognition remains incompletely understood. In the model enzyme system of serine protease, canonical anti-parallel beta-structure substrate-enzyme complex is the predominant hypothesis for the substrate-enzyme interaction at the atomic level. We used factor Xa (fXa), a key serine protease of the coagulation system, as a model enzyme to test the canonical conformation hypothesis. More than 160 fXa-cleavable substrate phage variants were experimentally selected from three designed substrate phage display libraries. These substrate phage variants were sequenced and their specificities to the model enzyme were quantified with quantitative enzyme-linked immunosorbent assay for substrate phage- enzyme reaction kinetics. At least three substrate-enzyme recognition modes emerged from the experimental data as necessary to account for the sequence-dependent specificity of the model enzyme. Computational molecular models were constructed, with both energetics and pharmacophore criteria, for the substrate-enzyme complexes of several of the representative substrate peptide sequences. In contrast to the canonical conformation hypothesis, the binding modes of the substrates to the model enzyme varied according to the substrate peptide sequence, indicating that an ensemble of binding modes underlay the observed specificity of the model serine protease.	[Hsu, Hung-Ju; Tsai, Keng-Chang; Sun, Yi-Kun; Chang, Hung-Ju; Huang, Yi-Jen; Yu, Hui-Ming; Mao, Shi-Shan; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Chun-Hung] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Huang, Yi-Jen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsu, Hung-Ju] Natl Def Med Univ, Grad Inst Life Sci, Taipei 114, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Defense Medical Center	Yang, AS (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	yangas@gate.sinica.edu.tw		Tsai, Keng-Chang/0000-0001-8277-9174; Chang, Hung-Ju/0000-0003-2062-9212; Yang, An-Suei/0000-0002-4699-873X				Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; Bromfield KM, 2006, CHEM BIOL DRUG DES, V68, P11, DOI 10.1111/j.1747-0285.2006.00404.x; Coombs GS, 1999, J BIOL CHEM, V274, P24074, DOI 10.1074/jbc.274.34.24074; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Deperthes D, 2002, BIOL CHEM, V383, P1107, DOI 10.1515/BC.2002.119; Ding XC, 2006, BIOORG CHEM, V34, P410, DOI 10.1016/j.bioorg.2006.10.002; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HERTZBERG M, 1994, BLOOD REV, V8, P56, DOI 10.1016/0268-960X(94)90007-8; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kontogiorgis CA, 2004, MED RES REV, V24, P687, DOI 10.1002/med.20006; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Li H., 1999, PHARMACOPHORE PERCEP, P173; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Maignan Sebastien, 2001, Current Topics in Medicinal Chemistry, V1, P161, DOI 10.2174/1568026013395461; Marlowe CK, 2000, BIOORG MED CHEM LETT, V10, P13, DOI 10.1016/S0960-894X(99)00582-X; Marnett AB, 2005, TRENDS BIOTECHNOL, V23, P59, DOI 10.1016/j.tibtech.2004.12.010; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; Ohkubo S, 2001, COMB CHEM HIGH T SCR, V4, P573; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Rodi DJ, 2002, J MOL BIOL, V322, P1039, DOI 10.1016/S0022-2836(02)00844-6; Sharkov NA, 2001, J BIOL CHEM, V276, P10788, DOI 10.1074/jbc.M011772200; Sidhu SS, 2004, PHAGE DISPLAY, V1st, P27; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e	39	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12343	12353		10.1074/jbc.M708843200	http://dx.doi.org/10.1074/jbc.M708843200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18296445	hybrid, Green Published			2022-12-27	WOS:000255340000051
J	Humphries, SM; Lu, YH; Canty, EG; Kadler, KE				Humphries, Sally M.; Lu, Yinhui; Canty, Elizabeth G.; Kadler, Karl E.			Active negative control of collagen fibrillogenesis in vivo - Intracellular cleavage of the type I procollagen propeptides in tendon fibroblasts without intracellular fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; CELL-SURFACE; FIBRONECTIN; PROTEINASE; POLYMERIZATION; PURIFICATION	It is established fact that type I collagen spontaneously self-assembles in vitro in the absence of cells or other macromolecules. Whether or not this is the situation in vivo was unknown. Recent evidence shows that intracellular cleavage of procollagen (the soluble precursor of collagen) to collagen can occur in embryonic tendon cells in vivo, and when this occurs, intracellular collagen fibrils are observed. A cause-and-effect relationship between intracellular collagen and intracellular fibrils was not established. Here we show that intracellular cleavage of procollagen to collagen occurs in postnatal murine tendon cells in situ. Pulse-chase analyses showed cleavage of procollagen to collagen via its two propeptide-retained intermediates. Furthermore, immunoelectron microscopy, using an antibody that recognizes the triple helical domain of collagen, shows collagen molecules in large-diameter transport compartments close to the plasma membrane. However, neither intracellular fibrils nor fibripositors (collagen fibril-containing plasma membrane protrusions) were observed. The results show that intracellular collagen occurs in murine tendon in the absence of intracellular fibrillogenesis and fibripositor formation. Furthermore, the results show that murine postnatal tendon cells have a high capacity to prevent intracellular collagen fibrillogenesis.	[Humphries, Sally M.; Lu, Yinhui; Canty, Elizabeth G.; Kadler, Karl E.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Kadler, KE (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	karl.kadler@manchester.ac.uk	Laird, Elizabeth/AAX-7280-2020; KADLER, KARL/ABI-2403-2020	Laird, Elizabeth/0000-0001-5041-1316; KADLER, KARL/0000-0003-4977-4683	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		BELLAMY G, 1971, P NATL ACAD SCI USA, V68, P1138, DOI 10.1073/pnas.68.6.1138; BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Canty EG, 2006, J BIOL CHEM, V281, P38592, DOI 10.1074/jbc.M607581200; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; FESSLER JH, 1978, ANNU REV BIOCHEM, V47, P129, DOI 10.1146/annurev.bi.47.070178.001021; Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; HOJIMA Y, 1994, J BIOL CHEM, V269, P11381; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; Kadler KE, 1996, BIOCHEM J, V316, P1; KADLER KE, 1987, J BIOL CHEM, V262, P15696; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; NAKAGAWA Y, 1994, ACTA PHYSIOL SCAND, V152, P307, DOI 10.1111/j.1748-1716.1994.tb09810.x; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07; Starkuviene V, 2007, TRAFFIC, V8, P1035, DOI 10.1111/j.1600-0854.2007.00582.x; TRELSTAD RL, 1979, DEV BIOL, V71, P228, DOI 10.1016/0012-1606(79)90166-0; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200	23	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12129	12135		10.1074/jbc.M708198200	http://dx.doi.org/10.1074/jbc.M708198200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18285337	hybrid			2022-12-27	WOS:000255340000029
J	Valentine, WJ; Fells, JI; Perygin, DH; Mujahid, S; Yokoyama, K; Fujiwara, Y; Tsukahara, R; Van Brocklyn, JR; Parrill, AL; Tigyi, G				Valentine, William J.; Fells, James I.; Perygin, Donna H.; Mujahid, Sana; Yokoyama, Kazuaki; Fujiwara, Yuko; Tsukahara, Ryoko; Van Brocklyn, James R.; Parrill, Abby L.; Tigyi, Gabor			Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHOLIPID RECEPTORS; CELLULAR-RESPONSES; MOLECULAR-CLONING; PPAR-GAMMA; IDENTIFICATION; OVARIAN; PROLIFERATION; SPHINGOSINE-1-PHOSPHATE; RECOGNITION	Lysophosphatidic acid (LPA) is a ligand for three endothelial differentiation gene family G protein-coupled receptors, LPA(1-3). We performed computational modeling-guided mutagenesis of conserved residues in transmembrane domains 3, 4, 5, and 7 of LPA(1-3) predicted to interact with the glycerophosphate motif of LPA C18:1. The mutants were expressed in RH7777 cells, and the efficacy (E-max) and potency (EC50) of LPA-elicited Ca2+ transients were measured. Mutation to alanine of R3.28 universally decreased both the efficacy and potency in LPA(1-3) and eliminated strong ionic interactions in the modeled LPA complexes. The alanine mutation at Q3.29 decreased modeled interactions and activation in LPA(1) and LPA(2) more than in LPA(3). The mutation W4.64A had no effect on activation and modeled LPA interaction of LPA(1) and LPA(2) but reduced the activation and modeled interactions of LPA(3). The R5.38A mutant of LPA(2) and R5.38N mutant of LPA(3) showed diminished activation by LPA; however, in LPA(1) the D5.38A mutation did not, and mutation to arginine enhanced receptor activation. In LPA(2), K7.36A decreased the potency of LPA; in LPA(1) this same mutation increased the E-max. In LPA(3), R7.36A had almost no effect on receptor activation; however, the mutation K7.35A increased the EC50 in response to LPA 10-fold. In LPA(1-3), the mutation Q3.29E caused a modest increase in EC50 in response to LPA but caused the LPA receptors to become more responsive to sphingosine 1-phosphate (S1P). Surprisingly micromolar concentrations of S1P activated the wild type LPA(2) and LPA(3) receptors, indicating that S1P may function as a weak agonist of endothelial differentiation gene family LPA receptors.	[Valentine, William J.; Mujahid, Sana; Yokoyama, Kazuaki; Fujiwara, Yuko; Tsukahara, Ryoko; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA; [Van Brocklyn, James R.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis; University System of Ohio; Ohio State University	Tigyi, G (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	gtigyi@physio1.utmem.edu	Van Brocklyn, Jim/A-9733-2010	Parrill, Abby/0000-0003-1658-8497	NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061469, T32HL007641, R01HL084007] Funding Source: NIH RePORTER; NCI NIH HHS [CA921160, R01 CA092160] Funding Source: Medline; NHLBI NIH HHS [R01 HL061469, R01 HL084007, HL61469, HL07641-19, T32 HL007641, HL084007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		An SZ, 1998, MOL PHARMACOL, V54, P881, DOI 10.1124/mol.54.5.881; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1999, MOL PHARMACOL, V55, P787; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Durgam GG, 2005, J MED CHEM, V48, P4919, DOI 10.1021/jm049609r; Fischer DJ, 1998, MOL PHARMACOL, V54, P979, DOI 10.1124/mol.54.6.979; Fischer DJ, 2001, MOL PHARMACOL, V60, P776; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Goetzl EJ, 1999, CANCER RES, V59, P4732; Gueguen G, 1999, BIOCHEMISTRY-US, V38, P8440, DOI 10.1021/bi9816756; Guo R, 2006, ENDOCRINOLOGY, V147, P4883, DOI 10.1210/en.2005-1635; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Hama K, 2002, FEBS LETT, V523, P187, DOI 10.1016/S0014-5793(02)02976-9; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Heringdorf DMZ, 2004, J CELL BIOCHEM, V92, P937, DOI 10.1002/jcb.20107; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Holdsworth Gill, 2004, BMC Biochemistry, V5, P1, DOI 10.1186/1471-2091-5-12; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jiang XT, 2006, J LIPID RES, V47, P1865, DOI 10.1194/jlr.D600012-JLR200; Karliner JS, 2002, BBA-MOL CELL BIOL L, V1582, P216, DOI 10.1016/S1388-1981(02)00174-9; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motohashi K, 2000, FEBS LETT, V468, P189, DOI 10.1016/S0014-5793(00)01222-9; Naor MM, 2007, J MOL GRAPH MODEL, V26, P519, DOI 10.1016/j.jmgm.2007.03.004; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Parrill AL, 2000, ANN NY ACAD SCI, V905, P330; Qi C, 1998, J CELL PHYSIOL, V174, P261, DOI 10.1002/(SICI)1097-4652(199802)174:2<261::AID-JCP13>3.0.CO;2-F; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Rhee MH, 2000, J NEUROCHEM, V75, P2485, DOI 10.1046/j.1471-4159.2000.0752485.x; Sardar VM, 2002, BBA-MOL CELL BIOL L, V1582, P309, DOI 10.1016/S1388-1981(02)00185-3; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Sliva D, 2000, BIOCHEM BIOPH RES CO, V268, P471, DOI 10.1006/bbrc.2000.2111; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	51	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12175	12187		10.1074/jbc.M708847200	http://dx.doi.org/10.1074/jbc.M708847200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316373	Green Published, hybrid			2022-12-27	WOS:000255340000034
J	de Pina, MZ; Vazquez-Meza, H; Pardo, JP; Rendon, JL; Villalobos-Molina, R; Riveros-Rosas, H; Pina, E				Zentella de Pina, Martha; Vazquez-Meza, Hector; Pardo, Juan Pablo; Rendon, Juan Luis; Villalobos-Molina, Rafael; Riveros-Rosas, Hector; Pina, Enrique			Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; DISULFIDE BOND FORMATION; RII-BETA-SUBUNIT; II REGULATORY SUBUNITS; HYDROGEN-PEROXIDE; CATALYTIC SUBUNIT; RAT ADIPOCYTES; SEQUENCE ALIGNMENT; INDUCED ACTIVATION; 3T3-L1 ADIPOCYTES	Catecholamines in adipose tissue promote lipolysis via cAMP, whereas insulin stimulates lipogenesis. Here we show that H2O2 generated by insulin in rat adipocytes impaired cAMP- mediated amplification cascade of lipolysis. These micromolar concentrations of H2O2 added before cAMP suppressed cAMP activation of type II beta cyclic AMP-dependent protein kinase (PKA) holoenzyme, prevented hormone-sensitive lipase translocation from cytosol to storage droplets, and inhibited lipolysis. Similarly, H2O2 impaired activation of type II alpha PKA holoenzyme from bovine heart and from that reconstituted with regulatory II alpha and catalytic alpha subunits. H2O2 was ineffective (a) if these PKA holoenzymes were preincubated with cAMP, (b) if added to the catalytic alpha subunit, which is active independently of cAMP activation, and (c) if the catalytic alpha subunit was substituted by its C199A mutant in the reconstituted holoenzyme. H2O2 inhibition of PKA activation remained after H2O2 elimination by gel filtration but was reverted with dithiothreitol or with thioredoxin reductase plus thioredoxin. Electrophoresis of holoenzyme in SDS gels showed separation of catalytic and regulatory subunits after cAMP incubation but a single band after H2O2 incubation. These data strongly suggest that H2O2 promotes the formation of an intersubunit disulfide bond, impairing cAMP-dependent PKA activation. Phylogenetic analysis showed that Cys-97 is conserved only in type II regulatory subunits and not in type I regulatory subunits; hence, the redox regulation mechanism described is restricted to type II PKA-expressing tissues. In conclusion, phylogenetic analysis results, selective chemical behavior, and the privileged position in holoenzyme lead us to suggest that Cys-97 in regulatory II alpha or II beta subunits is the residue forming the disulfide bond with Cys- 199 in the PKA catalytic alpha subunit. A new molecular point for cross-talk among heterologous signal transduction pathways is demonstrated.	[Zentella de Pina, Martha; Vazquez-Meza, Hector; Pardo, Juan Pablo; Rendon, Juan Luis; Riveros-Rosas, Hector; Pina, Enrique] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Villalobos-Molina, Rafael] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Pina, E (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Apartado Postal 70159, Mexico City 04510, DF, Mexico.	epgarza@servidor.unam.mx	Riveros-Rosas, Hector/B-6607-2008; Riveros-Rosas, Hector/ABD-6638-2020	Riveros-Rosas, Hector/0000-0003-0194-2537; Riveros-Rosas, Hector/0000-0003-0194-2537; Pina, Enrique/0000-0003-2436-9956; Vazquez-Meza, Hector/0000-0002-8312-3115				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Blaschke RJ, 2000, GENOMICS, V64, P187, DOI 10.1006/geno.2000.6116; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Burns LL, 2003, BIOCHEMISTRY-US, V42, P5754, DOI 10.1021/bi0265729; Burton KA, 1997, P NATL ACAD SCI USA, V94, P11067, DOI 10.1073/pnas.94.20.11067; Burton KA, 1999, J BIOL CHEM, V274, P24131, DOI 10.1074/jbc.274.34.24131; Chaudhry A, 2002, AM J PHYSIOL-CELL PH, V282, pC205, DOI 10.1152/ajpcell.2002.282.1.C205; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DAME JB, 1980, BIOCHEMISTRY-US, V19, P2931, DOI 10.1021/bi00554a018; Dwivedi Y, 2002, J PHARMACOL EXP THER, V301, P197, DOI 10.1124/jpet.301.1.197; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FIRST EA, 1984, J BIOL CHEM, V259, P4011; FIRST EA, 1988, J BIOL CHEM, V263, P5176; GAGELMANN M, 1980, P NATL ACAD SCI-BIOL, V77, P2492, DOI 10.1073/pnas.77.5.2492; Gaudiot N, 2000, AM J PHYSIOL-CELL PH, V279, pC1603, DOI 10.1152/ajpcell.2000.279.5.C1603; HOLM C, 1988, NUCLEIC ACIDS RES, V16, P9879, DOI 10.1093/nar/16.20.9879; Holm C, 1997, METHOD ENZYMOL, V286, P45; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Humphries KM, 2002, J BIOL CHEM, V277, P43505, DOI 10.1074/jbc.M207088200; Hupfeld CJ, 2003, P NATL ACAD SCI USA, V100, P161, DOI 10.1073/pnas.0235674100; KRIEGERBRAUER HI, 1992, J CLIN INVEST, V89, P1006, DOI 10.1172/JCI115641; KriegerBrauer HI, 1997, J BIOL CHEM, V272, P10135; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; MARGOLIASH E, 1960, BIOCHEM J, V74, P349, DOI 10.1042/bj0740349; Mueller S, 2002, BIOCHEM J, V363, P483, DOI 10.1042/0264-6021:3630483; MUKHERJEE SP, 1980, BIOCHEM PHARMACOL, V29, P1239; NELSON NC, 1983, J BIOL CHEM, V258, P981; Newhall KJ, 2005, MOL ENDOCRINOL, V19, P982, DOI 10.1210/me.2004-0343; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Raynaud F, 1997, FREE RADICAL BIO MED, V22, P623, DOI 10.1016/S0891-5849(96)00353-X; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; SLICE LW, 1989, J BIOL CHEM, V264, P20940; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; TAKIO K, 1982, P NATL ACAD SCI-BIOL, V79, P2544, DOI 10.1073/pnas.79.8.2544; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; TAYLOR WM, 1979, BIOCHEM J, V178, P381, DOI 10.1042/bj1780381; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Visentin V, 2003, EUR J PHARMACOL, V466, P235, DOI 10.1016/S0014-2999(03)01562-0; Warnick G R, 1986, Methods Enzymol, V129, P101; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zentella de Pina M., 2007, Autonomic & Autacoid Pharmacology, V27, P85; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; ZHAO J, 1988, J BIOL CHEM, V273, P30448; Zmuda-Trzebiatowska E, 2007, CELL SIGNAL, V19, P81, DOI 10.1016/j.cellsig.2006.05.024	69	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12373	12386		10.1074/jbc.M706832200	http://dx.doi.org/10.1074/jbc.M706832200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326045	hybrid			2022-12-27	WOS:000255340000054
J	Azam, L; Yoshikami, D; McIntosh, JM				Azam, Layla; Yoshikami, Doju; McIntosh, J. Michael			Amino acid residues that confer high selectivity of the alpha 6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A, E11A, L15A]	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; NIGROSTRIATAL DAMAGE; CRYSTAL-STRUCTURE; MII BINDING; DETERMINANTS; RELEASE; ACHBP; SENSITIVITY; DECREASES; TARGETS	Nicotinic acetylcholine receptors (nAChRs) containing alpha 3 and beta 2 subunits are found in autonomic ganglia and mediate ganglionic transmission. The closely related alpha 6 nAChR subtype is found in the central nervous system where changes in its level of expression are observed in Parkinson's disease. To obtain a ligand that discriminates between these two receptors, we designed and synthesized a novel analog of alpha-conotoxin MII, MII[ S4A, E11A, L15A], and tested it on nAChRs expressed in Xenopus oocytes. The peptide blocked chimeric alpha 6/alpha 3 beta 2 beta 3 nAChRs with an IC50 of 1.2 nM; in contrast, its IC50 on the closely related alpha 3 beta 2 as well as non-alpha 6 nAChRs was three orders of magnitude higher. We identified the residues in the receptors that are responsible for their differential sensitivity to the peptide. We constructed chimeras with increasingly longer fragments of the N-terminal ligand binding domain of the alpha 3 subunit inserted into the homologous positions of the alpha 6 subunit, and these were used to determine that the region downstream of the first 140 amino acids was involved. Further mutagenesis of this region revealed that the alpha 6 subunit residues Glu-152, Asp-184, and Thr-195 were critical, and replacement of these three residues with their homologs from the alpha 3 subunit increased the IC(5)0 of the peptide by> 1000-fold. Conversely, when these key residues in alpha 3 were replaced with those from alpha 6, the IC50 decreased by almost 150-fold. Similar effects were seen with other alpha 6- selective conotoxins, suggesting the general importance of these alpha 6 residues in conferring selective binding.	[Azam, Layla; Yoshikami, Doju; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Azam, L (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	layla_azam@yahoo.com			NIDA NIH HHS [F32 DA016835, F32 DA016835-03, DA 016835, F32 DA016835-02, F32 DA016835-01] Funding Source: Medline; NIGMS NIH HHS [P01 GM048677, P01 GM048677-160012, GM48677] Funding Source: Medline; NIMH NIH HHS [R01 MH053631, R01 MH053631-13, MH53631, R01 MH053631-11S1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053631, R29MH053631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA016835] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Azam L, 2005, J PHARMACOL EXP THER, V312, P231, DOI 10.1124/jpet.104.071456; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2006, MOL PHARMACOL, V70, P967, DOI 10.1124/mol.106.024513; Bordia T, 2007, MOL PHARMACOL, V72, P52, DOI 10.1124/mol.107.035998; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; De Biasi M, 2002, J NEUROBIOL, V53, P568, DOI 10.1002/neu.10145; De Biasi M, 2002, CNS NEUROL DISORD-DR, V1, P331, DOI 10.2174/1568007023339148; Dowell C, 2003, J NEUROSCI, V23, P8445; Everhart D, 2003, J PHARMACOL EXP THER, V306, P664, DOI 10.1124/jpet.103.051656; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Luetje CW, 1998, MOL PHARMACOL, V53, P1112; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Mugnaini M, 2006, NEUROSCIENCE, V137, P565, DOI 10.1016/j.neuroscience.2005.09.008; Perry DC, 2007, J PHARMACOL EXP THER, V322, P306, DOI 10.1124/jpet.107.121228; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; Quik M, 2001, J NEUROSCI, V21, P5494, DOI 10.1523/JNEUROSCI.21-15-05494.2001; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Shi JX, 2006, J BIOL CHEM, V281, P12170, DOI 10.1074/jbc.M600154200; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031	29	36	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11625	11632		10.1074/jbc.M710288200	http://dx.doi.org/10.1074/jbc.M710288200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18299323	Green Published, hybrid			2022-12-27	WOS:000255067400063
J	Dewire, SM; Kim, J; Whalen, EJ; Ahn, S; Chen, M; Lefkowitz, RJ				Dewire, Scott M.; Kim, Jihee; Whalen, Erin J.; Ahn, Seungkirl; Chen, Minyong; Lefkowitz, Robert J.			beta-arrestin-mediated signaling regulates protein synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR TRANSACTIVATION; CARDIAC MYOCYTES; ERK ACTIVATION; MESSENGER-RNA; MNK1; PHOSPHORYLATION	Seven transmembrane receptors (7TMRs) exert strong regulatory influences on virtually all physiological processes. Although it is historically assumed that heterotrimeric G proteins mediate these actions, there is a newer appreciation that beta-arrestins, originally thought only to desensitize G protein signaling, also serve as independent receptor signal transducers. Recently, we found that activation of ERK1/2 by the angiotensin receptor occurs via both of these distinct pathways. In this work, we explore the physiological consequences of beta-arrestin ERK1/2 signaling and delineate a pathway that regulates mRNA translation and protein synthesis via Mnk1, a protein that both physically interacts with and is activated by beta-arrestins. We show that beta-arrestin-dependent activation of ERK1/2, Mnk1, and eIF4E are responsible for increasing translation rates in both human embryonic kidney 293 and rat vascular smooth muscle cells. This novel demonstration that beta-arrestins regulate protein synthesis reveals that the spectrum of beta-arrestin-mediated signaling events is broader than previously imagined.	[Dewire, Scott M.; Ahn, Seungkirl; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Kim, Jihee; Whalen, Erin J.; Chen, Minyong; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021	DeWire, Scott/0000-0002-1357-4543	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL070631, R01HL016037] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL16037, HL70631] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Chrestensen CA, 2007, J BIOL CHEM, V282, P4243, DOI 10.1074/jbc.M607368200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gesty-Palmer D, 2005, J BIOL CHEM, V280, P32157, DOI 10.1074/jbc.M507460200; Ishida M, 2003, CIRC RES, V93, P1218, DOI 10.1161/01.RES.0000105570.34585.F2; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mendez M, 2005, AM J PHYSIOL-HEART C, V288, pH2111, DOI 10.1152/ajpheart.00838.2004; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Miura S, 2004, HYPERTENS RES, V27, P765, DOI 10.1291/hypres.27.765; O'Loghlen A, 2004, FEBS LETT, V578, P31, DOI 10.1016/j.febslet.2004.10.063; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Spruill LS, 2006, FASEB J, V20, P2133, DOI 10.1096/fj.06-6245fje; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Tuxworth WJ, 2004, BIOCHEM J, V378, P73, DOI 10.1042/BJ20031027; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Violin JD, 2006, J BIOL CHEM, V281, P36411, DOI 10.1074/jbc.M607956200; Voisin L, 2002, AM J PHYSIOL-CELL PH, V283, pC446, DOI 10.1152/ajpcell.00261.2001; Wada H, 1996, J BIOL CHEM, V271, P8359, DOI 10.1074/jbc.271.14.8359; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; WISLER JW, 2007, P NATL ACAD SCI US; Yamakawa T, 2003, EUR J PHARMACOL, V478, P39, DOI 10.1016/j.ejphar.2003.08.044; Yee DK, 2006, MOL ENDOCRINOL, V20, P1924, DOI 10.1210/me.2006-0018	40	74	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10611	10620		10.1074/jbc.M710515200	http://dx.doi.org/10.1074/jbc.M710515200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18276584	hybrid, Green Published			2022-12-27	WOS:000254894700043
J	Erlandson, KJ; Or, E; Osborne, AR; Rapoport, TA				Erlandson, Karl J.; Or, Eran; Osborne, Andrew R.; Rapoport, Tom A.			Analysis of polypeptide movement in the SecY channel during SecA-mediated protein translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPROTEIN TRANSLOCASE; ESCHERICHIA-COLI; CYTOPLASMIC MEMBRANE; STEPWISE MOVEMENT; DISULFIDE BRIDGE; ER MEMBRANE; DOMAIN; CYCLE	In bacteria most secretory proteins are transported across the plasma membrane by the interplay of the ATPase SecA with the translocation channel formed by the SecY complex; SecA uses cycles of ATP hydrolysis to "push" consecutive segments of a polypeptide substrate through the channel. Here we have addressed the mechanism of this process by following the fate of stalled translocation intermediates. These were generated by using a polypeptide substrate containing a bulky disulfide-bonded loop, thus preventing the final residues from passing through the channel. Protease protection experiments showed that the intermediates were stable in the presence of ATP and could complete translocation once the block was removed. The translocation intermediate was also stable when SecA associated with ATP gamma S, a poorly hydrolyzable ATP analog, or ADP plus AlF4, which mimics the transition state during ATP hydrolysis. In contrast, when SecA was in its ADP-bound state, the translocating polypeptide moved back into the cytosol, as indicated by the disappearance of the protected fragment. Backsliding was not significantly altered by deletion of the plug domain, a short helix in the center of the SecY channel, but it was slowed down when changes were introduced into the pore ring, the constriction of the hourglass-shaped channel. In all cases, backsliding was significantly slower than forward translocation. Together, these data suggest that SecA binds the polypeptide chain in its ATP state and releases it in the ADP state. The channel itself does not bind the polypeptide chain but provides "friction" that minimizes backsliding when ADP-bound SecA resets to "grab" the next segment of the substrate.	[Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM052586, R01 GM052586-13] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Gumbart J, 2006, BIOPHYS J, V90, P2356, DOI 10.1529/biophysj.105.075291; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Sato K, 1997, J BIOL CHEM, V272, P5880, DOI 10.1074/jbc.272.9.5880; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Tomkiewicz D, 2007, FEBS LETT, V581, P2820, DOI 10.1016/j.febslet.2007.04.015; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van Voorst F, 2000, FEBS LETT, V486, P57, DOI 10.1016/S0014-5793(00)02209-2	26	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15709	15715		10.1074/jbc.M710356200	http://dx.doi.org/10.1074/jbc.M710356200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18359943	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000256332500026
J	Congdon, EE; Kim, S; Bonchak, J; Songrug, T; Matzavinos, A; Kuret, J				Congdon, Erin E.; Kim, Sohee; Bonchak, Jonathan; Songrug, Tanakorn; Matzavinos, Anastasios; Kuret, Jeff			Nucleation-dependent tau filament formation - The importance of dimerization and an estimation of elementary rate constants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; FULL-LENGTH TAU; ALZHEIMERS-DISEASE; PROTEIN-TAU; IN-VITRO; ELECTRON-MICROSCOPY; AGGREGATION; KINETICS; ACTIN; PHOSPHORYLATION	Filamentous inclusions composed of the microtubule-associated protein tau are found in Alzheimer disease and other tauopathic neurodegenerative diseases, but the mechanisms underlying their formation from full-length protein monomer under physiological conditions are unclear. To address this issue, the fibrillization of recombinant full-length four-repeat human tau was examined in vitro as a function of time and submicromolar tau concentrations using electron microscopy assay methods and a small-molecule inducer of aggregation, thiazine red. Data were then fit to a simple homogeneous nucleation model with rate constant constraints established from filament dissociation rate, critical concentration, and mass-per-unit length measurements. The model was then tested by comparing the predicted time-dependent evolution of length distributions to experimental data. Results indicated that once assembly-competent conformations were attained, the rate-limiting step in the fibrillization pathway was tau dimer formation. Filament elongation then proceeded by addition of tau monomers to nascent filament ends. Filaments isolated at reaction plateau contained similar to 2 tau protomers/beta-strand spacing on the basis of mass-per-unit length measurements. The model suggests four key steps in the aggregation pathway that must be surmounted for tau filaments to form in disease.	[Congdon, Erin E.; Kim, Sohee; Bonchak, Jonathan; Songrug, Tanakorn; Kuret, Jeff] Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Matzavinos, Anastasios] Ohio State Univ, Dept Math, Math Biosci Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kuret, J (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu		Congdon, Erin/0000-0001-8322-6176; Matzavinos, Anastasios/0000-0003-0491-7329	NIA NIH HHS [AG14452] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Ahn JS, 2005, CHEM BIOL, V12, P811, DOI 10.1016/j.chembiol.2005.05.011; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRIEHL RW, 1990, J MOL BIOL, V211, P693, DOI 10.1016/0022-2836(90)90070-3; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chang E, 2008, ANAL BIOCHEM, V373, P330, DOI 10.1016/j.ab.2007.09.015; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Dehmelt L, 2005, GENOME BIOL, V6; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Flyvbjerg H, 1997, PHYS REV E, V56, P7083, DOI 10.1103/PhysRevE.56.7083; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Galvan M, 2001, J ALZHEIMERS DIS, V3, P417, DOI 10.3233/JAD-2001-3409; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; GOLDSTEIN RF, 1986, BIOPHYS J, V50, P583, DOI 10.1016/S0006-3495(86)83498-1; GomezIsla T, 1996, J NEUROSCI, V16, P4491; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hu JF, 2007, J STAT PHYS, V128, P111, DOI 10.1007/s10955-006-9204-x; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ignatova Z, 2005, BIOCHEMISTRY-US, V44, P7266, DOI 10.1021/bi047404e; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; Kim YS, 2003, J BIOL CHEM, V278, P10842, DOI 10.1074/jbc.M212540200; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; King ME, 2001, AM J PATHOL, V158, P1481, DOI 10.1016/S0002-9440(10)64099-0; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Ko LW, 2002, J MOL NEUROSCI, V19, P311; KRISTOFFERSON D, 1980, J BIOL CHEM, V255, P8567; Ksiezak-Reding H, 2005, MICROSC RES TECHNIQ, V67, P126, DOI 10.1002/jemt.20188; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Kuret Jeff, 2008, P289; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Necula M, 2005, BIOCHEMISTRY-US, V44, P10227, DOI 10.1021/bi050387o; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Necula M, 2004, ANAL BIOCHEM, V329, P238, DOI 10.1016/j.ab.2004.02.023; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; OOSAWA F, 1975, THERMODYNAMICS POLYM, P51; Paudel HK, 1997, J BIOL CHEM, V272, P1777; Perez M, 1996, J NEUROCHEM, V67, P1183; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sept D, 1999, BIOPHYS J, V77, P2911, DOI 10.1016/S0006-3495(99)77124-9; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Timasheff S. N., 1981, PROTEIN PROTEIN INTE, P315; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; Xu SH, 2007, AMYLOID, V14, P119, DOI 10.1080/13506120701260059; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	82	87	90	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13806	13816		10.1074/jbc.M800247200	http://dx.doi.org/10.1074/jbc.M800247200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359772	Green Published, hybrid			2022-12-27	WOS:000255728200033
J	Schulze, H; Dose, M; Korpal, M; Meyer, I; Italiano, JE; Shivdasani, RA				Schulze, Harald; Dose, Marei; Korpal, Manav; Meyer, Imke; Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.			RanBP10 is a cytoplasmic guanine nucleotide exchange factor that modulates noncentrosomal microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NF-E2; GAMMA-TUBULIN COMPLEXES; XENOPUS EGG EXTRACTS; NUCLEAR-PORE COMPLEX; SMALL GTPASE RAN; STRUCTURAL INSIGHTS; BLOOD-PLATELETS; BINDING PROTEIN; BETA-1 TUBULIN; IMPORTIN-BETA	Microtubule spindle assembly in mitosis is stimulated by Ran.GTP, which is generated along condensed chromosomes by the guanine nucleotide exchange factor (GEF) RCC1. This relationship suggests that similar activities might modulate other microtubule structures. Interphase microtubules usually extend from the centrosome, although noncentrosomal microtubules function in some differentiated cells, including megakaryocytes. In these cells, platelet biogenesis requires massive mobilization of microtubules in the cell periphery, where they form proplatelets, the immediate precursors of platelets, in the apparent absence of centrioles. Here we identify a cytoplasmic Ran-binding protein, RanBP10, as a factor that binds beta-tubulin and associates with megakaryocyte microtubules. Unexpectedly, RanBP10 harbors GEF activity toward Ran. A point mutation in the candidate GEF domain abolishes exchange activity, and our results implicate RanBP10 as a localized cytoplasmic Ran-GEF. RNA interference-mediated loss of RanBP10 in cultured megakaryocytes disrupts microtubule organization. These results lead us to propose that spatiotemporally restricted generation of cytoplasmic Ran.GTP may influence organization of the specialized microtubules required in thrombopoiesis and that RanBP10 might serve as a molecular link between Ran and noncentrosomal microtubules.	[Schulze, Harald; Dose, Marei; Korpal, Manav; Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Schulze, Harald; Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Meyer, Imke] Charite Univ Med Berlin, Dept Pediat, D-10017 Berlin, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulze, H (corresponding author), Labor Padiatr Mol Biol, Ziegelstr 5-9, D-10098 Berlin, Germany.	harald.schulze@charite.de; ramesh_shivdasani@dfci.harvard.edu		Dose, Marei/0000-0001-5394-9779	NHLBI NIH HHS [R01HL63143] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063143] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cheng L, 2002, MOL CELL BIOL, V22, P6895, DOI 10.1128/MCB.22.19.6895-6905.2002; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; KIRKPATRICK D, 1994, GENETICS, V137, P381; KLEBE C, 1993, BIOCHEMISTRY-US, V32, P11923, DOI 10.1021/bi00095a023; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lecine P, 2000, BLOOD, V96, P1366, DOI 10.1182/blood.V96.4.1366.h8001366_1366_1373; Lecine P, 1998, J BIOL CHEM, V273, P7572, DOI 10.1074/jbc.273.13.7572; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; MOSKWINTARKHANOV MI, 1978, TSITOLOGIYA+, V20, P1436; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nicolas FJ, 2001, J CELL SCI, V114, P3013; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; RADLEY JM, 1980, BLOOD, V56, P996; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Schulze H, 2004, BLOOD, V104, P3949, DOI 10.1182/blood-2004-03-1179; Schwer HD, 2001, CURR BIOL, V11, P579, DOI 10.1016/S0960-9822(01)00153-1; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Steggerda SM, 2000, J BIOL CHEM, V275, P23175, DOI 10.1074/jbc.C000252200; Urbani L, 1999, CURR BIOL, V9, pR315, DOI 10.1016/S0960-9822(99)80201-2; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Wang DK, 2004, BIOCHEM BIOPH RES CO, V313, P320, DOI 10.1016/j.bbrc.2003.11.124; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	55	44	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14109	14119		10.1074/jbc.M709397200	http://dx.doi.org/10.1074/jbc.M709397200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347012	hybrid, Green Published			2022-12-27	WOS:000255728200065
J	Townsend, TA; Wrana, JL; Davis, GE; Barnett, JV				Townsend, Todd A.; Wrana, Jeffrey L.; Davis, George E.; Barnett, Joey V.			Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on Par6c regulation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSFORMATION; CONGENITAL HEART-DISEASE; CARDIAC-VALVE FORMATION; VASCULAR HOMEOSTASIS; ENDOTHELIAL-CELLS; RECEPTOR SYSTEM; EXPRESSION; ACTIVATION; MIGRATION; GTPASES	Valvular heart disease due to congenital abnormalities or pathology is a major cause of mortality and morbidity. Understanding the cellular processes and molecules that regulate valve formation and remodeling is required to develop effective therapies. In the developing heart, epithelial-mesenchymal transformation (EMT) in a subpopulation of endocardial cells in the atrioventricular cushion (AVC) is an important step in valve formation. Transforming growth factor-beta(TGF beta) has been shown to be an important regulator of AVC endocardial cell EMT in vitro and mesenchymal cell differentiation in vivo. Recently Par6c (Par6) has been shown to function downstream of TGF beta to recruit Smurf1, an E3 ubiquitin ligase, which targets RhoA for degradation to control apical-basal polarity and tight junction dissolution. We tested the hypothesis that Par6 functions in a pathway that regulates endocardial cell EMT. Here we show that the Type I TGF beta receptor ALK5 is required for endocardial cell EMT. Overexpression of dominant negative Par6 inhibits EMT in AVC endocardial cells, whereas overexpression of wild-type Par6 in normally non-transforming ventricular endocardial cells results in EMT. Overexpression of Smurf1 in ventricular endocardial cells induces EMT. Decreasing RhoA activity using dominant negative RhoA or small interfering RNA in ventricular endocardial cells also increases EMT, whereas overexpression of constitutively active RhoA in AVC endothelial cells blocks EMT. Manipulation of Rac1 or Cdc42 activity is without effect. These data demonstrate a functional role for Par6/Smurf1/RhoA in regulating EMT in endocardial cells.	[Townsend, Todd A.; Barnett, Joey V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Wrana, Jeffrey L.] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M56 1X5, Canada; [Davis, George E.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA	Vanderbilt University; University of Toronto; University of Missouri System; University of Missouri Columbia	Barnett, JV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Rm 476 RRB,220 Pierce Ave, Nashville, TN 37232 USA.	joey.barnett@vanderbilt.edu	Wrana, Jeffrey/F-8857-2013		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52922, R01 HL052922-10, R01 HL052922] Funding Source: Medline; NIGMS NIH HHS [GM007628] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		American Heart Association, 2008, HEART STROK STAT UPD; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BERNANKE DH, 1982, DEV BIOL, V91, P235, DOI 10.1016/0012-1606(82)90030-6; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bose R, 2006, CURR OPIN CELL BIOL, V18, P206, DOI 10.1016/j.ceb.2006.02.005; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Compton LA, 2007, CIRC RES, V101, P784, DOI 10.1161/CIRCRESAHA.107.152082; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; GALLOWAY AC, 1999, SCHWARTZS PRINCIPLES, P845; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HOFFMAN JIE, 1990, PEDIATR CLIN N AM, V37, P25; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaarbo M, 2003, DEV DYNAM, V227, P35, DOI 10.1002/dvdy.10283; KELLER BRADLY B, 1998, HURSTS HEART ARTERIE, P195; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; ROBIOLIO PA, 1995, CIRCULATION, V92, P790, DOI 10.1161/01.CIR.92.4.790; Sadler TW, 1985, LANGMANS MED EMBRYOL, P168; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakabe M, 2006, DEV DYNAM, V235, P94, DOI 10.1002/dvdy.20648; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Tavares ALP, 2006, DEV DYNAM, V235, P1589, DOI 10.1002/dvdy.20771; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Ward SM, 2002, J MOL CELL CARDIOL, V34, P1217, DOI 10.1006/jmcc.2002.7023; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Zhao ZY, 2004, DEV BIOL, V275, P183, DOI 10.1016/j.ydbio.2004.08.002	62	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13834	13841		10.1074/jbc.M710607200	http://dx.doi.org/10.1074/jbc.M710607200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343818	hybrid, Green Published			2022-12-27	WOS:000255728200036
J	Jacob, E; Hod-Dvorai, R; Schif-Zuck, S; Avni, O				Jacob, Eyal; Hod-Dvorai, Reut; Schif-Zuck, Sagie; Avni, Orly			Unconventional association of the polycomb group proteins with cytokine genes in differentiated T helper cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TRANSCRIPTION FACTOR YY1; LOCUS-CONTROL REGION; RANGE INTRACHROMOSOMAL INTERACTIONS; HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; INTERFERON-GAMMA; TH2 CELLS; DROSOPHILA-MELANOGASTER; RESPONSE ELEMENTS; DEVELOPMENTAL REGULATORS	The cytokine transcription profiles of developing T helper 1 and T helper 2 cells are imprinted and induced appropriately following stimulation of differentiated cells. Epigenetic regulation combines several mechanisms to ensure the inheritance of transcriptional programs. We found that the expression of the polycomb group proteins, whose role in maintaining gene silencing is well documented, was induced during development in both T helper lineages. Nevertheless, the polycomb proteins, YY1, Mel-18, Ring1A, Ezh2, and Eed, bound to the Il4 and Ifng loci in a differential pattern. In contrast to the prevailing dogma, the binding activity of the polycomb proteins in differentiated T helper cells was associated with cytokine transcription. The polycomb proteins bound to the cytokine genes under resting conditions, and their binding was induced dynamically following stimulation. The recruitment of the polycomb proteins Mel-18 and Ezh2 to the cytokine promoters was inhibited in the presence of cyclosporine A, suggesting the involvement of NFAT. Considering their binding pattern at the cytokine genes and their known function in higher order folding of regulatory elements, we propose a model whereby the polycomb proteins, in some contexts, positively regulate gene expression by mediating long-distance chromosomal interactions.	[Jacob, Eyal; Hod-Dvorai, Reut; Schif-Zuck, Sagie; Avni, Orly] Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Avni, O (corresponding author), Efron 1 St, IL-31096 Haifa, Israel.	oavni@tx.technion.ac.il	Hod-Dvorai, Reut/H-9791-2019	Hod-Dvorai, Reut/0000-0001-6748-5733; Schif-Zuck, Sagie/0000-0001-5415-9488				Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Akasaka T, 1996, DEVELOPMENT, V122, P1513; Akasaka T, 1997, IMMUNITY, V7, P135, DOI 10.1016/S1074-7613(00)80516-6; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bantignies F, 2006, CURR OPIN CELL BIOL, V18, P275, DOI 10.1016/j.ceb.2006.04.003; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brock HW, 2005, DEV DYNAM, V232, P633, DOI 10.1002/dvdy.20298; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chang SJ, 2007, NAT IMMUNOL, V8, P723, DOI 10.1038/ni1473; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietzel S, 1999, CHROMOSOMA, V108, P83, DOI 10.1007/s004120050355; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Eivazova ER, 2007, GENES IMMUN, V8, P35, DOI 10.1038/sj.gene.6364349; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Fujimura Y, 2006, DEVELOPMENT, V133, P2371, DOI 10.1242/dev.02405; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Guo J, 2001, J BIOL CHEM, V276, P48871, DOI 10.1074/jbc.M101592200; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Miyagishima H, 2003, HISTOCHEM CELL BIOL, V120, P111, DOI 10.1007/s00418-003-0551-2; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Mullen AC, 2002, NAT IMMUNOL, V3, P652, DOI 10.1038/ni807; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Ogawa M, 2003, IMMUNOL LETT, V86, P57, DOI 10.1016/S0165-2478(02)00293-6; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Razin SV, 2007, J MOL BIOL, V369, P597, DOI 10.1016/j.jmb.2007.04.003; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rincon-Arano H, 2005, J MOL BIOL, V349, P961, DOI 10.1016/j.jmb.2005.04.040; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Soutto M, 2002, J IMMUNOL, V169, P4205, DOI 10.4049/jimmunol.169.8.4205; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yamashita M, 2004, J BIOL CHEM, V279, P39454, DOI 10.1074/jbc.M405989200; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Ye JP, 1996, MOL CELL BIOL, V16, P4744; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	107	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13471	13481		10.1074/jbc.M709886200	http://dx.doi.org/10.1074/jbc.M709886200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18285333	hybrid			2022-12-27	WOS:000255499800086
J	Lu, ZL; Liu, W; Huang, HZ; He, Y; Han, Y; Rui, YN; Wang, YH; Li, QX; Ruan, K; Ye, ZY; Low, BC; Meng, AM; Lin, SC				Lu, Zailian; Liu, Wei; Huang, Huizhe; He, Ying; Han, Ying; Rui, Yanning; Wang, Yanhai; Li, Qinxi; Ruan, Ka; Ye, Zhiyun; Low, Boon Chuan; Meng, Anming; Lin, Sheng-Cai			Protein encoded by the Axin(Fu) allele effectively down-regulates wnt signaling but exerts a dominant negative effect on c-jun n-terminal kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; AXIS FORMATION; FUSED LOCUS; PATHWAY; MOUSE; JNK; DOMAINS; COMPLEX; GENE; NEURECTODERM	Axin plays an architectural role in many important signaling pathways that control various aspects of development and tumorigenesis, including the Wnt, transforming growth factor-beta, MAP kinase pathways, as well as p53 activation cascades. It is encoded by the mouse Fused (Fu) locus; the Axin(Fu) allele is caused by insertion of an IAP transposon. Axin(Fu/Fu) mice display varying phenotypes ranging from embryonic lethality to relatively normal adulthood with kinky tails. However, the protein product(s) has not been identified or characterized. In the present study, we conducted immunoprecipitation using brain extracts from the Axin(Fu) mice with specific antibodies against different regions of Axin and found that a truncated Axin containing amino acids 1-596 (designated as Axin(Fu-NT)) and the full-length complement of Axin (Axin(WT)) can both be generated from the AxinFu allele. When tested for functionality changes, Axin(Fu-NT) was found to abolish Axin-mediated activation of JNK, which plays a critical role in dorsoventral patterning. Together with a proteomics approach, we found that Axin(Fu-NT) contains a previously uncharacterized dimerization domain and can form a heterodimeric interaction with Axin(WT). TheAxin(Fu-NT)/Axin(WT) is not conducive to JNK activation, providing a molecular explanation for the dominant negative effect of Axin(Fu-NT) on JNK activation by wild-type Axin. Importantly, Axin(Fu-NT) exhibits no difference in the inhibition of Wnt signaling compared with Axin(WT) as determined by reporter gene assays, interaction with key Wnt regulators, and expression of Wnt marker genes in zebrafish embryos, suggesting that altered JNK signaling contributes, at least in part, to the developmental defects seen in Axin(Fu) mice.	[Lu, Zailian; Huang, Huizhe; He, Ying; Han, Ying; Rui, Yanning; Wang, Yanhai; Li, Qinxi; Ruan, Ka; Ye, Zhiyun; Lin, Sheng-Cai] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Liu, Wei] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Meng, Anming] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117609, Singapore	Xiamen University; Hong Kong University of Science & Technology; Tsinghua University; National University of Singapore	Lin, SC (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China.	linsc@xmu.edu.cn	Li, QX/G-4669-2010; Lin, SC/G-4666-2010; Low, Boon Chuan/AAU-7685-2021; Low, Boon Chuan/H-8049-2012; Meng, Anming/A-4785-2012	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Rui, Yanning/0000-0002-4482-5579				Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; DUNN LC, 1956, GENETICS, V41, P344; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Fekany K, 1999, DEVELOPMENT, V126, P1427; Flood WD, 2001, HEREDITY, V87, P146, DOI 10.1046/j.1365-2540.2001.00868.x; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; GLUECKSOHNSCHOENHEIMER S, 1949, J EXP ZOOL, V110, P47, DOI 10.1002/jez.1401100105; GREENSPAN RJ, 1986, P NATL ACAD SCI USA, V83, P4413, DOI 10.1073/pnas.83.12.4413; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JACOBSCOHEN RJ, 1984, GENET RES, V43, P43, DOI 10.1017/S0016672300025702; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRY WL, 1995, GENETICS, V141, P321; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Reed SC, 1937, GENETICS, V22, P1; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Vasicek TJ, 1997, GENETICS, V147, P777; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; WEAVER CR, 2002, CURR OPIN GENE DEV, V12, P14; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhang Y, 2001, J BIOL CHEM, V276, P32152, DOI 10.1074/jbc.M104451200; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593	41	5	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13132	13139		10.1074/jbc.M710595200	http://dx.doi.org/10.1074/jbc.M710595200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316368	hybrid			2022-12-27	WOS:000255499800052
J	Bartoszewski, R; Rab, A; Twitty, G; Stevenson, L; Fortenberry, J; Piotrowski, A; Dumanski, JP; Bebok, Z				Bartoszewski, Rafal; Rab, Andras; Twitty, George; Stevenson, Lauren; Fortenberry, James; Piotrowski, Arkadiusz; Dumanski, Jan P.; Bebok, Zsuzsa			The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SMALL-MOLECULE CORRECTORS; AIRWAY EPITHELIAL-CELLS; ER STRESS; MESSENGER-RNA; INHIBITORS INDUCE; CHLORIDE CHANNEL; DELTA-F508 CFTR; GENE-EXPRESSION; CPG ISLANDS	The unfolded protein response (UPR) aids cellular recovery by increasing the capacity and decreasing the protein load of the endoplasmic reticulum (ER). Although the main pathways of the UPR are known, the mechanisms of UPR-associated transcriptional repression have not been explored in mammalian cells. Previous studies indicate that endogenous cystic fibrosis transmembrane conductance regulator (CFTR) mRNA levels and protein maturation efficiency decrease when the UPR is activated. In the present study, we demonstrate that inhibition of CFTR expression under ER stress leads to reduced cAMP-activated chloride secretion in epithelial monolayers, an indication of diminished CFTR function. Moreover, ER stress and the UPR obliterate endogenous Delta F508 CFTR mRNA expression in CFPAC-1 cells without affecting recombinant Delta F508 CFTR mRNA levels or mRNA half-life. These results emphasize that transcriptional repression of CFTR under ER stress, in concert with decreased CFTR maturation efficiency, leads to diminished function. Using human CFTR promoter reporter constructs, we confined the ER stress-associated CFTR transcriptional repression to the minimal promoter. Chromatin immunoprecipitation assays established the binding of the UPR-activated ATF6 transcription factor to this region during ER stress, which links the repression to the UPR. Methylation-specific PCR (MSP) revealed hypermethylation of CpG sites inside and in the vicinity of the MAZ transcription factor binding region of CFTR, demonstrating methylation-dependent repression. Using pharmacological inhibitors, we show that both DNA methylation and histone deacetylation contribute to CFTR transcriptional inhibition. These studies provide novel insight into the mechanism of gene repression during the mammalian UPR.	[Bartoszewski, Rafal; Rab, Andras; Twitty, George; Stevenson, Lauren; Bebok, Zsuzsa] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Piotrowski, Arkadiusz; Dumanski, Jan P.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Fortenberry, James] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bebok, Z (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 760, Birmingham, AL 35294 USA.	bebok@uab.edu	Rab, András/AAR-7804-2021; Bartoszewski, Rafal A/D-6311-2011; Rab, Andras/AAI-9402-2021; Piotrowski, Arkadiusz/A-5484-2010	Rab, András/0000-0003-2154-0017; Bartoszewski, Rafal A/0000-0002-2864-6757; Piotrowski, Arkadiusz/0000-0002-0823-0607; Dumanski, Jan Piotr/0000-0002-1489-1452				AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; Akiba Y, 2005, AM J PHYSIOL-GASTR L, V289, pG753, DOI 10.1152/ajpgi.00130.2005; Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bates E, 2007, J CYST FIBROS, V6, P351, DOI 10.1016/j.jcf.2007.01.001; Baudouin-Legros M, 2005, AM J PHYSIOL-CELL PH, V289, pC1240, DOI 10.1152/ajpcell.00595.2004; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, AM J PHYSIOL-CELL PH, V275, pC599, DOI 10.1152/ajpcell.1998.275.2.C599; Bebok Z, 2002, J BIOL CHEM, V277, P43041, DOI 10.1074/jbc.M203154200; Bebok Z, 2001, AM J PHYSIOL-CELL PH, V280, pC135, DOI 10.1152/ajpcell.2001.280.1.C135; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; BRAUN ME, 2006, PEDIATR PULM, V29, P236; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chaabane C, 2006, BIOCHEM BIOPH RES CO, V345, P1377, DOI 10.1016/j.bbrc.2006.05.054; Chen L, 2006, J BIOL CHEM, V281, P9190, DOI 10.1074/jbc.M513231200; CHOU JL, 1991, J BIOL CHEM, V266, P24471; CLIFF WH, 1992, AM J PHYSIOL, V262, pC1154, DOI 10.1152/ajpcell.1992.262.5.C1154; DOERFLER W, 1989, CELL BIOPHYS, V15, P21, DOI 10.1007/BF02991576; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hong M, 2004, J CELL BIOCHEM, V92, P723, DOI 10.1002/jcb.20118; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kawane T, 2001, BIOCHEM BIOPH RES CO, V287, P313, DOI 10.1006/bbrc.2001.5586; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Kimata Y, 2006, GENES CELLS, V11, P59, DOI 10.1111/j.1365-2443.2005.00921.x; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Latchman DS, 1996, INT J BIOCHEM CELL B, V28, P965, DOI 10.1016/1357-2725(96)00039-8; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Matthews RP, 1996, J BIOL CHEM, V271, P31869, DOI 10.1074/jbc.271.50.31869; McCarthy VA, 2005, PEDIATR PULM, V40, P1, DOI 10.1002/ppul.20199; MEEHAN R, 1992, J CELL SCI, P9; Mehta A, 2005, PEDIATR PULM, V39, P292, DOI 10.1002/ppul.20147; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Quivy V, 2004, CLONING STEM CELLS, V6, P140, DOI 10.1089/1536230041372454; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ratjen F, 2006, PAEDIATR RESPIR REV, V7, pS70, DOI 10.1016/j.prrv.2006.04.170; Rene C, 2005, NUCLEIC ACIDS RES, V33, P5271, DOI 10.1093/nar/gki837; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Rodriguez BAT, 2005, BIOCHEM CELL BIOL, V83, P525, DOI 10.1139/O05-055; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Rowe SM, 2006, CURR OPIN PEDIATR, V18, P604, DOI 10.1097/MOP.0b013e3280109b90; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Verkman AS, 2004, CURR OPIN NEPHROL HY, V13, P563, DOI 10.1097/00041552-200409000-00013; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	84	59	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12154	12165		10.1074/jbc.M707610200	http://dx.doi.org/10.1074/jbc.M707610200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319256	hybrid			2022-12-27	WOS:000255340000032
J	Moya-Garcia, AA; Ruiz-Pernia, J; Marti, S; Sanchez-Jimenez, F; Tunon, I				Moya-Garcia, Aurelio A.; Ruiz-Pernia, Javier; Marti, Sergio; Sanchez-Jimenez, Francisca; Tunon, Inaki			Analysis of the decarboxylation step in mammalian histidine decarboxylase - A computational study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DECARBOXYLASE; CATECHOL O-METHYLTRANSFERASE; SITE-DIRECTED MUTAGENESIS; POTENTIAL-ENERGY SURFACE; TRANSITION-STATE; HISTAMINE; ENZYMES; CATALYSIS; STABILIZATION; CONFORMATION	We report a hybrid quantum mechanics/molecular mechanics theoretical study on the reaction mechanism of mammalian histidine decarboxylase that allows us to obtain valuable insights on the structure of the cofactor-substrate adduct ( external aldimine) in the active site of rat histidine decarboxylase. By means of molecular dynamics simulations, we traced the potential of mean force corresponding to the decarboxylation reaction of the adduct both in the active site of the enzyme and in aqueous solution. By comparing this process in both media, we have identified the key electrostatic interactions that explain the lowering of the free energy barrier in the enzyme. Our analysis also offers a validation of Dunathan's hypothesis (Dunathan, H. (1966) Proc. Natl. Acad. Sci. U. S. A. 55, 712-716) regarding the role of stereoelectronic effects in the enzymatic decarboxylation process.	[Ruiz-Pernia, Javier; Tunon, Inaki] Univ Valencia, Dept Quim Fis, E-46100 Valencia, Spain; [Moya-Garcia, Aurelio A.; Sanchez-Jimenez, Francisca] Univ Malaga, Dept Biol Mol & Bioquim, Procel Lab, E-29071 Malaga, Spain; [Marti, Sergio] Univ Jaume 1, Dept Quim Fis & Analit, Castellon de La Plana 12071, Spain	University of Valencia; Universidad de Malaga; Universitat Jaume I	Tunon, I (corresponding author), Univ Valencia, Dept Quim Fis, E-46100 Valencia, Spain.	Tunon@uv.es	Martí, Sergio/G-7844-2015; Pernia, Jose Javier Ruiz/L-9863-2014; Tunon, Inaki/F-7973-2012; Ruiz-Pernía, José Javier/AAT-2917-2021; Moya-García, Aurelio/AAA-3429-2020; Jiménez, Francisca María Sánchez/H-2513-2015	Martí, Sergio/0000-0002-1087-7143; Tunon, Inaki/0000-0002-6995-1838; Ruiz-Pernía, José Javier/0000-0002-4640-0419; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Moya Garcia, Aurelio/0000-0002-0567-0949				AULD DS, 1967, J AM CHEM SOC, V89, P2098, DOI 10.1021/ja00985a022; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Chiu W, 2005, STRUCTURE, V13, P363, DOI 10.1016/j.str.2004.12.016; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ferrer S, 2005, J CHEM THEORY COMPUT, V1, P750, DOI 10.1021/ct050016l; Fitzpatrick LA, 2003, P NATL ACAD SCI USA, V100, P6027, DOI 10.1073/pnas.0934373100; Fleming JV, 2004, BIOCHEM J, V381, P769, DOI 10.1042/BJ20031553; Fleming JV, 2004, BIOCHEM J, V379, P253, DOI 10.1042/BJ20031525; Furuta K, 2007, J BIOL CHEM, V282, P13438, DOI 10.1074/jbc.M609943200; Gao JL, 2002, ANNU REV PHYS CHEM, V53, P467, DOI 10.1146/annurev.physchem.53.091301.150114; GAO JL, 1991, J AM CHEM SOC, V113, P7796, DOI 10.1021/ja00020a070; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ishii S, 1998, PROTEIN SCI, V7, P1802, DOI 10.1002/pro.5560070816; JANSONIUS JN, 1984, BIOCHEM SOC T, V12, P424, DOI 10.1042/bst0120424; KAMATH AV, 1991, J BIOL CHEM, V266, P9432; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez-de-Albeniz FJ, 2004, INT J GAME THEORY, V33, P107, DOI 10.1007/s001820400188; Matsuda N, 2004, J BIOCHEM, V135, P33, DOI 10.1093/jb/mvh004; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Moya-Garcia AA, 2005, BIOESSAYS, V27, P57, DOI 10.1002/bies.20174; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Olmo M, 2002, J BIOCHEM, V132, P433, DOI 10.1093/oxfordjournals.jbchem.a003240; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Panula P, 2000, SEMIN CANCER BIOL, V10, P11, DOI 10.1006/scbi.2000.0302; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Pos Z, 2005, CANCER RES, V65, P4458, DOI 10.1158/0008-5472.CAN-05-0011; Poulsen TD, 2003, J PHYS CHEM B, V107, P9567, DOI 10.1021/jp030107j; Poupon A, 1999, PROTEINS, V37, P191, DOI 10.1002/(SICI)1097-0134(19991101)37:2<191::AID-PROT5>3.0.CO;2-4; Roca M, 2006, J PHYS CHEM A, V110, P503, DOI 10.1021/jp0520953; Roca M, 2005, J AM CHEM SOC, V127, P10648, DOI 10.1021/ja051503d; Rodriguez-Caso C, 2003, EUR J BIOCHEM, V270, P4376, DOI 10.1046/j.1432-1033.2003.03834.x; Rodriguez-Caso C, 2003, CELL MOL LIFE SCI, V60, P1760, DOI 10.1007/s00018-003-3135-3; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Schneider E, 2002, TRENDS IMMUNOL, V23, P255, DOI 10.1016/S1471-4906(02)02215-9; Schubert ML, 2005, CURR OPIN GASTROEN, V21, P636, DOI 10.1097/01.mog.0000181713.89281.14; Siaterli MZ, 2003, NEUROCHEM RES, V28, P797, DOI 10.1023/A:1023246620276; TANASE S, 1985, J BIOL CHEM, V260, P6738; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; Warshel A, 2000, BIOCHEMISTRY-US, V39, P14728, DOI 10.1021/bi000987h; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	51	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12393	12401		10.1074/jbc.M707434200	http://dx.doi.org/10.1074/jbc.M707434200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310073	hybrid			2022-12-27	WOS:000255340000056
J	Fukushima, T; Kitajima, T; Yamaguchi, H; Ouyang, Q; Furuhata, K; Yamamoto, H; Shida, T; Sekiguchi, J				Fukushima, Tatsuya; Kitajima, Toshihiko; Yamaguchi, Hiroyuki; Ouyang, Qin; Furuhata, Kazumi; Yamamoto, Hiroki; Shida, Toshio; Sekiguchi, Junichi			Identification and characterization of novel cell wall hydrolase CwIT - A two-domain autolysin exhibiting N-acetylmuramidase and DL-endopeptidase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE LYTIC TRANSGLYCOSYLASE; BACILLUS-SUBTILIS 168; EGG-WHITE LYSOZYME; GOOSE LYSOZYME; GENE-PRODUCT; PEPTIDOGLYCAN; ELEMENT; PLAYS; SEPARATION; SEQUENCE	A cell wall hydrolase homologue, Bacillus subtilis YddH (renamed CwlT), was determined to be a novel cell wall lytic enzyme. The cwlT gene is located in the region of an integrative and conjugative element (ICEBs1), and a cwlT-lacZ fusion experiment revealed the significant expression when mitomycin C was added to the culture. Judging from the Pfam data base, CwlT (cell wall lytic enzyme T (Two-catalytic domains)) has two hydrolase domains that exhibit high amino acid sequence similarity to DL-endopeptidases and relatively low similarity to lytic transglycosylases at the C and N termini, respectively. The purified C-terminal domain of CwlT (CwlT-C-His) could hydrolyze the linkage of D-gamma-glutamyl-meso-diaminopimelic acid in B. subtilis peptidoglycan, suggesting that the C-terminal domain acts as a DL-endopeptidase. On the other hand, the purified N-terminal domain (CwlT-N-His) could also hydrolyze the peptidoglycan of B. subtilis. However, on reverse-phase HPLC and mass spectrometry (MS) and MS-MS analyses of the reaction products by CwlT-N-His, this domain was determined to act as an N-acetylmuramidase and not a lytic transglycosylase. Moreover, the site-directed mutagenesis analysis revealed that Glu-87 and Asp-94 are sites related with the cell wall lytic activity. Because the amino acid sequence of the N-terminal domain of CwlT exhibits low similarity compared with those of the soluble lytic transglycosylase and muramidase (goose lysozyme), this domain represents "a new category of cell wall hydrolases.".	[Fukushima, Tatsuya; Kitajima, Toshihiko; Yamaguchi, Hiroyuki; Ouyang, Qin; Furuhata, Kazumi; Yamamoto, Hiroki; Shida, Toshio; Sekiguchi, Junichi] Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, Nagano 3868567, Japan; [Sekiguchi, Junichi] Shinshu Univ, Div Gene Res, Dept Life Sci, Res Ctr Human & Environm Sci, Nagano 3868567, Japan	Shinshu University; Shinshu University	Sekiguchi, J (corresponding author), Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, 3-15-1 Tokida, Nagano 3868567, Japan.	jsekigu@shinshu-u.ac.jp	Sekiguchi, Junichi/F-9963-2010; Kitajima, Toshihiko/K-2894-2013; Kitajima, Toshihiko/D-2463-2016	Kitajima, Toshihiko/0000-0002-0202-5282; Kitajima, Toshihiko/0000-0001-9677-5086				ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Auchtung JM, 2005, P NATL ACAD SCI USA, V102, P12554, DOI 10.1073/pnas.0505835102; Beaber JW, 2002, J BACTERIOL, V184, P4259, DOI 10.1128/JB.184.15.4259-4269.2002; Boltner D, 2002, J BACTERIOL, V184, P5158, DOI 10.1128/JB.184.18.5158-5169.2002; Burrus V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6; DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475, DOI 10.1128/AEM.61.4.1475-1479.1995; ENGEL H, 1991, J BACTERIOL, V173, P6773, DOI 10.1128/jb.173.21.6773-6782.1991; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Foster S.J., 2002, BACILLUS SUBTILIS IT, P21; FRANKE AE, 1981, J BACTERIOL, V145, P494, DOI 10.1128/JB.145.1.494-502.1981; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Fukushima T, 2007, MOL GENET GENOMICS, V278, P371, DOI 10.1007/s00438-007-0255-8; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; GREEN F, 1989, ANAL BIOCHEM, V182, P197, DOI 10.1016/0003-2697(89)90578-2; GRUTTER MG, 1983, NATURE, V303, P828, DOI 10.1038/303828a0; Kawamura S, 2006, J BIOCHEM, V140, P75, DOI 10.1093/jb/mvj125; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; LECLERC D, 1989, CAN J MICROBIOL, V35, P749, DOI 10.1139/m89-125; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1881, DOI 10.1021/bi951671q; Nugroho FA, 1999, J BACTERIOL, V181, P6230, DOI 10.1128/JB.181.20.6230-6237.1999; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Roberts AP, 2001, MICROBIOL-SGM, V147, P1243, DOI 10.1099/00221287-147-5-1243; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Shida T, 2001, J BIOL CHEM, V276, P28140, DOI 10.1074/jbc.M103903200; SHIMOTSU H, 1986, J BACTERIOL, V168, P380, DOI 10.1128/jb.168.1.380-388.1986; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Yamaguchi H, 2004, J BIOSCI BIOENG, V98, P174, DOI 10.1263/jbb.98.174	39	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11117	11125		10.1074/jbc.M706626200	http://dx.doi.org/10.1074/jbc.M706626200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305117	hybrid			2022-12-27	WOS:000255067400007
J	Furukohri, A; Goodman, MF; Maki, H				Furukohri, Asako; Goodman, Myron F.; Maki, Hisaji			A dynamic polymerase exchange with Escherichia coli DNA polymerase IV replacing DNA polymerase III on the sliding clamp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK; BETA-CLAMP; LEADING-STRAND; IN-VIVO; POL-IV; PROCESSIVITY; HOLOENZYME; MUTAGENESIS; MECHANISM; MUTATIONS	An assay that measures synchronized, processive DNA replication by Escherichia coli DNA polymerase III holoenzyme was used to reveal replacement of pol III by the specialized lesion bypass DNA polymerase IV when the replicative polymerase is stalled. When idled replication is restarted, a rapid burst of pol III-catalyzed synthesis accompanied by similar to 7-kb full-length products is strongly inhibited by the presence of pol IV. The production of slower-forming, shorter length DNA reflects a rapid takeover of DNA synthesis by pol IV. Here we demonstrate that pol IV rapidly (<15s) obstructs the stable interaction between pol III* and the beta clamp (the lifetime of the complex is > 5 min), causing the removal of pol III* from template DNA. We propose that the rapid replacement of pol III* on the beta clamp with pol IV is mediated by two processes, an interaction between pol IV and the beta clamp and a separate interaction between pol IV and pol III*. This newly discovered property of pol IV facilitates a dynamic exchange between the two free polymerases at the primer terminus. Our study suggests a model in which the interaction between pol III* and the beta clamp is mediated by pol IV to ensure that DNA replication proceeds with minimal interruption.	[Furukohri, Asako; Maki, Hisaji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Mol Biol, Nara 6300192, Japan; [Goodman, Myron F.] Univ So Calif, Dept Biol Sci & Chem, Los Angeles, CA 90089 USA	Nara Institute of Science & Technology; University of Southern California	Maki, H (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Mol Biol, Nara 6300192, Japan.	maki@bs.naist.jp			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES012259] Funding Source: Medline; NIGMS NIH HHS [R37GM21422] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Lenne-Samuel N, 2002, EMBO REP, V3, P45, DOI 10.1093/embo-reports/kvf007; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; MAKI S, 1988, J BIOL CHEM, V263, P6561; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; NORRIS D, 1990, BIOCHEMISTRY-US, V29, P7911, DOI 10.1021/bi00486a019; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Sugaya Y, 2002, GENES CELLS, V7, P385, DOI 10.1046/j.1365-2443.2002.00527.x; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wagner J, 2000, EMBO REP, V1, P484; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101	32	66	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11260	11269		10.1074/jbc.M709689200	http://dx.doi.org/10.1074/jbc.M709689200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308729	Green Published, hybrid			2022-12-27	WOS:000255067400022
J	He, YX; Xiao, YH; Song, HF; Liang, Q; Ju, D; Chen, X; Lu, H; Jing, WG; Jiang, SB; Zhang, LQ				He, Yuxian; Xiao, Yonghong; Song, Haifeng; Liang, Qing; Ju, Dan; Chen, Xin; Lu, Hong; Jing, Weiguo; Jiang, Shibo; Zhang, Linqi			Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INFECTION; GCN4 LEUCINE-ZIPPER; ENTRY INHIBITORS; MEMBRANE-FUSION; COILED-COIL; GP41 CORE; ENVELOPE GLYCOPROTEINS; ATOMIC-STRUCTURE; SALT BRIDGES; PEPTIDES	Enfuvirtide (T20) is the first and only HIV-1 fusion inhibitor approved for clinical use, but it can easily induce drug resistance limiting its practical application. A novel anti-HIV peptide, termed sifuvirtide, was designed based on the three-dimensional structure of the HIV-1 gp41 fusogenic core conformation. Here we report its in vitro anti-HIV potency, its mechanism of action, as well as the results from Phase Ia clinical studies. We demonstrated that sifuvirtide inhibited HIV-1-mediated cell-cell fusion in a dose-dependent manner and exhibited high potency against infections by a wide range of primary and laboratory-adapted HIV-1 isolates from multiple genotypes with R5 or X4 phenotypes. Notably, sifuvirtide was also highly effective against T20-resistant strains. Unlike T20, sifuvirtide could efficiently block six-helix bundle formation in a dominant negative fashion. These results suggest that sifuvirtide has a different mechanism of action from that of T20. Phase Ia clinical studies of sifuvirtide (FS0101) in 60 healthy individuals demonstrated good safety, tolerability, and pharmacokinetic profiles. A single dose regimen( 5,10,20,30, and 40 mg) by subcutaneous injection once daily at abdominal sites was well tolerated without serious adverse events. Pharmacokinetic studies of single and multiple administration of sifuvirtide showed that its decay half-lives were 20.0 +/- 8.6 h and 26.0 +/- 7.9h, respectively. In summary, sifuvirtide has potential to become an ideal fusion inhibitor for treatment of HIV/AIDS patients, including those with HIV-1 strains resistant to T20.	[He, Yuxian; Lu, Hong; Jing, Weiguo; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [He, Yuxian; Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100730, Peoples R China; [He, Yuxian; Zhang, Linqi] Peking Union Med Coll, Beijing 100730, Peoples R China; [Xiao, Yonghong] Peking Univ, Inst Clin Pharmacol, Beijing 100083, Peoples R China; [Song, Haifeng] Acad Mil Med Sci, Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Liang, Qing; Ju, Dan; Chen, Xin] FusoGen Pharmaceut Inc, Beijing 100016, Peoples R China; [Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China	New York Blood Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Academy of Military Medical Sciences - China; Fuso Pharmaceutical Industries, Ltd.; Tsinghua University	Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	sjiang@nybloodcenter.org; LZhang07@hotmail.com	Jiang, Shibo/L-4500-2014; ZHANG, LIN/GYD-9123-2022	Jiang, Shibo/0000-0001-8283-7135; 				Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Debnath AK, 2006, EXPERT OPIN INV DRUG, V15, P465, DOI 10.1517/13543784.15.5.465; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Gustchina E, 2006, J MOL BIOL, V364, P283, DOI 10.1016/j.jmb.2006.09.017; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; HUNTER E, 1990, CURR TOP MICROBIOL, V157, P187; JIANG S, 1991, J EXP MED, V174, P1557, DOI 10.1084/jem.174.6.1557; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Kammerer RA, 2001, J BIOL CHEM, V276, P13685, DOI 10.1074/jbc.M010492200; Kilby JM, 2003, NEW ENGL J MED, V348, P2228, DOI 10.1056/NEJMra022812; Kliger Y, 2000, J MOL BIOL, V295, P163, DOI 10.1006/jmbi.1999.3368; Leonard JT, 2006, CURR MED CHEM, V13, P911, DOI 10.2174/092986706776361030; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Liu SW, 2003, PEPTIDES, V24, P1303, DOI 10.1016/j.peptides.2003.07.013; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moore JP, 2000, NAT REV MOL CELL BIO, V1, P40, DOI 10.1038/35036060; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pillay D, 2000, REV MED VIROL, V10, P231, DOI 10.1002/1099-1654(200007/08)10:4&lt;231::AID-RMV290&gt;3.0.CO;2-P; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Shu W, 2000, J BIOL CHEM, V275, P1839, DOI 10.1074/jbc.275.3.1839; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	42	184	195	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11126	11134		10.1074/jbc.M800200200	http://dx.doi.org/10.1074/jbc.M800200200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303020				2022-12-27	WOS:000255067400008
J	Zhang, Y; Mckay, SE; Bewley, B; Kaczmarek, LK				Zhang, Yalan; Mckay, Sharen E.; Bewley, Benoit; Kaczmarek, Leonard K.			Repetitive firing triggers clustering of kv2.1 potassium channels in aplysia neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAG CELL NEURONS; DELAYED-RECTIFIER PROPERTIES; K+ CHANNEL; HIPPOCAMPAL-NEURONS; PEPTIDERGIC NEURONS; ABDOMINAL-GANGLION; EXPRESSION; AFTERDISCHARGE; LOCALIZATION; MODULATION	The Kv2.1 gene encodes a highly conserved delayed rectifier potassium channel that is widely expressed in neurons of the central nervous system. In the bag cell neurons of Aplysia, Kv2.1 channels contribute to the repolarization of action potentials during a prolonged after discharge that triggers a series of reproductive behaviors. Partial inactivation of Aplysia Kv2.1 during repetitive firing produces frequency-dependent broadening of action potentials during the after discharge. We have now found that, as in mammalian neurons, Kv2.1 channels in bag cell neurons are localized to ring-like clusters in the plasma membrane of the soma and proximal dendrites. Either elevation of cyclic AMP levels or direct electrical stimulation of after discharge rapidly enhanced formation of these clusters on the somata of these neurons. In contrast, injection of a 13-amino acid peptide corresponding to a region in the C terminus that is required for clustering of Kv2.1 channels produced disassociation of the clusters, resulting in a more uniform distribution over the somata. Voltage clamp recordings demonstrated that peptide-induced dissociation of the Kv2.1 clusters is associated with an increase in the amplitude of delayed rectifier current and a shift of activation toward more negative potentials. In current clamp recording, injection of the unclustering peptide reduced the width of action potentials and reduced frequency-dependent broadening of action potentials. Our results suggest that rapid redistribution of Kv2.1 channels occurs during physiological changes in neuronal excitability.	[Zhang, Yalan; Bewley, Benoit; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Mckay, Sharen E.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University; Yale University	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu						Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; ARCH S, 1989, BRAIN RES REV, V14, P181, DOI 10.1016/0165-0173(89)90014-3; AZHDERIAN EM, 1994, NEURON, V12, P1223, DOI 10.1016/0896-6273(94)90439-1; Blaine JT, 2001, J NEUROSCI, V21, P1473, DOI 10.1523/JNEUROSCI.21-05-01473.2001; CHIU AY, 1981, J NEUROSCI, V1, P812; CHUN JY, 1994, NEURON, V12, P831, DOI 10.1016/0896-6273(94)90336-0; CONN PJ, 1989, MOL NEUROBIOL, V3, P237, DOI 10.1007/BF02740607; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; DUDEK FE, 1976, SCIENCE, V192, P1009, DOI 10.1126/science.1273581; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Jonas EA, 1996, J NEUROSCI, V16, P1645; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; KACZMAREK LK, 1981, J NEUROSCI, V1, P626; KACZMAREK LK, 1978, P NATL ACAD SCI USA, V75, P5200, DOI 10.1073/pnas.75.10.5200; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KACZMAREK LK, 1979, J NEUROBIOL, V10, P535, DOI 10.1002/neu.480100604; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; KUPFERMANN I, 1970, J NEUROPHYSIOL, V33, P865, DOI 10.1152/jn.1970.33.6.865; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; LOECHNER KJ, 1990, BRAIN RES, V532, P1, DOI 10.1016/0006-8993(90)91733-W; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; NAGLE GT, 1990, J BIOL CHEM, V265, P22329; PAK MD, 1991, J NEUROSCI, V11, P869; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; QUATTROCKI EA, 1994, NEURON, V12, P73, DOI 10.1016/0896-6273(94)90153-8; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; TRIMMER JS, 1990, DEV BIOL, V142, P360, DOI 10.1016/0012-1606(90)90356-N; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Wayne NL, 1998, GEN COMP ENDOCR, V109, P356, DOI 10.1006/gcen.1997.7040; White BH, 1997, J NEUROSCI, V17, P1582; WILSON WA, 1975, J NEUROBIOL, V6, P411, DOI 10.1002/neu.480060406	36	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10632	10641		10.1074/jbc.M800253200	http://dx.doi.org/10.1074/jbc.M800253200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18276591	hybrid			2022-12-27	WOS:000254894700045
J	Wong, CF; Tellam, RL				Wong, Chung Fai; Tellam, Ross L.			MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DEVELOPMENT; GROUP PROTEIN EZH2; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; DIFFERENTIATION; EXPRESSION; GENE; TRANSCRIPTION; MIR-206; CANCER	MicroRNA ( miRNA) are important regulators of many biological processes, but the targets for most miRNA are still poorly defined. In this study, we profiled the expression of miRNA during myogenesis, from proliferating myoblasts through to terminally differentiated myotubes. Microarray results identified six significantly differentially expressed miRNA that were more than 2-fold different in myotubes. From this list, miRNA-26a (miR-26a), an up-regulated miRNA, was further examined. Overexpression of miR-26a in murine myogenic C2C12 cells induced creatine kinase activity, an enzyme that markedly increases during myogenesis. Further, myoD and myogenin mRNA expression levels were also up-regulated. These results suggest that increased expression of miR-26a promotes myogenesis. Through a bioinformatics approach, we identified the histone methyltransferase, Enhancer of Zeste homolog 2 (Ezh2), as a potential target of miR-26a. Overexpression of miR-26a suppressed the activity of a luciferase reporter construct fused with the 3'-untranslated region of Ezh2. In addition, miR-26a overexpression decreased Ezh2 mRNA expression. These results reveal a model of regulation during myogenesis whereby the up-regulation of miR-26a acts to post-transcriptionally repress Ezh2, a known suppressor of skeletal muscle cell differentiation.	[Wong, Chung Fai; Tellam, Ross L.] Queensland Biosci Precinct, CSIRO Liverstock Ind, St Lucia, Qld 4067, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tellam, RL (corresponding author), Queensland Biosci Precinct, CSIRO Liverstock Ind, 306 Carmody Rd,St, St Lucia, Qld 4067, Australia.	Ross.Tellam@csiro.Au	Tellam, Ross/H-2798-2013; Tellam, Ross/T-2423-2019	Tellam, Ross/0000-0003-2353-1640; 				Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; EULALI A, 2007, GENE DEV, V20, P2258; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KHANNA KK, 1995, ONCOGENE, V11, P609; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nakajima N, 2006, BIOCHEM BIOPH RES CO, V350, P1006, DOI 10.1016/j.bbrc.2006.09.153; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Tonini T, 2004, ONCOGENE, V23, P4930, DOI 10.1038/sj.onc.1207608; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wilson DL, 2003, BIOINFORMATICS, V19, P1325, DOI 10.1093/bioinformatics/btg146; Wong CF, 2004, BIOCHEM BIOPH RES CO, V324, P497, DOI 10.1016/j.bbrc.2004.09.084; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	63	259	279	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9836	9843		10.1074/jbc.M709614200	http://dx.doi.org/10.1074/jbc.M709614200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18281287	hybrid			2022-12-27	WOS:000254671600039
J	Chavez, JA; Roach, WG; Keller, SR; Lane, WS; Lienhard, GE				Chavez, Jose A.; Roach, William G.; Keller, Susanna R.; Lane, William S.; Lienhard, Gustav E.			Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-STIMULATED PHOSPHORYLATION; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; AS160 PHOSPHORYLATION; AKT SUBSTRATE; CONTRACTION; DIFFERENTIATION; EXPRESSION; MEMBRANE; VESICLES	Insulin increases glucose transport by stimulating the trafficking of intracellular GLUT4 to the cell surface, a process known as GLUT4 translocation. A key protein in signaling this process is AS160, a Rab GTPase-activating protein ( GAP) whose activity appears to be suppressed by Akt phosphorylation. Tbc1d1 is a Rab GAP with a sequence highly similar to that of AS160 and with the same Rab specificity as that of AS160. The role of Tbc1d1 in regulating GLUT4 trafficking has been unclear. Our previous study showed that overexpressed Tbc1d1 inhibited insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes, even though insulin caused phosphorylation on its single canonical Akt motif. In the present study, we show in 3T3-L1 adipocytes that Tbc1d1 is only 1/20 as abundant as AS160, that knockdown of Tbc1d1 has no effect on insulin-stimulated GLUT4 translocation, and that overexpressed Tbc1d1 also inhibits GLUT4 translocation elicited by activated Akt expression. These results indicate that endogenous Tbc1d1 does not participate in insulin-regulated GLUT4 translocation in adipocytes and suggest that the GAP activity of Tbc1d1 is not suppressed by Akt phosphorylation. In addition, we discovered that Tbc1d1 is much more highly expressed in skeletal muscle than fat and that the AMP-activated protein kinase ( AMPK) activator 5'-aminoimidazole-4-carboxamide ribonucleoside partially reversed the inhibition of insulin-stimulated GLUT4 translocation by overexpressed Tbc1d1 in 3T3-L1 adipocytes. 5'-Aminoimidazole-4-carboxamide ribonucleoside activation of the kinase AMPK is known to cause GLUT4 translocation in muscle. The above findings strongly suggest that Tbc1d1 is a component in the signal transduction pathway leading to AMPK-stimulated GLUT4 translocation in muscle.	[Chavez, Jose A.; Roach, William G.; Lienhard, Gustav E.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Keller, Susanna R.] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA; [Lane, William S.] Harvard Univ, Ctr Syst Biol, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA	Dartmouth College; University of Virginia; Harvard University	Lienhard, GE (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	gustav.e.lienhard@dartmouth.edu			NCI NIH HHS [P30 CA023108] Funding Source: Medline; NIDDK NIH HHS [DK 42816, DK 25336, R56 DK025336, R01 DK042816, R01 DK025336] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK025336, R56DK042816, R01DK025336, R56DK025336, R01DK042816] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; El-Jack AK, 1999, MOL BIOL CELL, V10, P1581, DOI 10.1091/mbc.10.5.1581; FROST SC, 1985, J BIOL CHEM, V260, P2646; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Guo XM, 2000, GENE, V251, P45, DOI 10.1016/S0378-1119(00)00192-X; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kramer HF, 2007, DIABETES, V56, P2854, DOI 10.2337/db07-0681; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; LAMPHERE L, 1992, ENDOCRINOLOGY, V131, P2196, DOI 10.1210/en.131.5.2196; Mitra P, 2004, J BIOL CHEM, V279, P37431, DOI 10.1074/jbc.C400180200; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Salt IP, 2000, DIABETES, V49, P1649, DOI 10.2337/diabetes.49.10.1649; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	30	124	126	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					9187	9195		10.1074/jbc.M708934200	http://dx.doi.org/10.1074/jbc.M708934200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18258599	Green Published, hybrid			2022-12-27	WOS:000254465800048
J	Freeman, BA; Baker, PRS; Schopfer, FJ; Woodcock, SR; Napolitano, A; d'Ischia, M				Freeman, Bruce A.; Baker, Paul R. S.; Schopfer, Francisco J.; Woodcock, Steven R.; Napolitano, Alessandra; d'Ischia, Marco			Nitro-fatty acid formation and signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DEPENDENT PROTEIN NITRATION; LIPID PEROXYL RADICALS; NITROLINOLEIC ACID; HEME OXYGENASE-1; ETHYL LINOLEATE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ANTIINFLAMMATORY PROPERTIES; STRUCTURAL-CHARACTERIZATION; HUMAN NEUTROPHILS; PROMOTED REACTION		[Freeman, Bruce A.; Baker, Paul R. S.; Schopfer, Francisco J.; Woodcock, Steven R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Napolitano, Alessandra; d'Ischia, Marco] Univ Naples Federico 2, Dept Organ Chem & Biochem, I-80126 Naples, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Naples Federico II	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	freerad@pitt.edu; dischia@unina.it	Freeman, Bruce A/H-9342-2012; d'Ischia, Marco/C-9837-2011; Schopfer, Francisco Jose/AAE-8125-2020; Schopfer, Francisco/AAW-6505-2021; Napolitano, Alessandra/E-9761-2011; Woodcock, Steven/AAE-9199-2020	d'Ischia, Marco/0000-0002-7184-0029; Schopfer, Francisco Jose/0000-0001-9526-695X; Napolitano, Alessandra/0000-0003-0507-5370; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, R01HL064937] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL64937, R01 HL58115] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Balazy M, 2001, J PHARMACOL EXP THER, V299, P611; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Castro L, 2004, ARCH BIOCHEM BIOPHYS, V421, P99, DOI 10.1016/j.abb.2003.08.033; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Crabb JW, 2002, PROTEIN SCI, V11, P831, DOI 10.1110/ps.4400102; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; d'Ischia M, 1999, TETRAHEDRON, V55, P9297, DOI 10.1016/S0040-4020(99)00491-3; dIschia M, 1996, TETRAHEDRON LETT, V37, P5773, DOI 10.1016/0040-4039(96)01182-3; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Gorczynski MJ, 2006, ORG LETT, V8, P2305, DOI 10.1021/ol060548w; HILLACORTA L, 2007, AM J PHYSIOL, V293, pH770; Ishii T, 2003, BIOCHEMISTRY-US, V42, P3474, DOI 10.1021/bi027172o; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; Lim DG, 2002, P NATL ACAD SCI USA, V99, P15941, DOI 10.1073/pnas.232409599; Lima ES, 2005, FREE RADICAL BIO MED, V39, P532, DOI 10.1016/j.freeradbiomed.2005.04.005; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1; Moller M, 2005, J BIOL CHEM, V280, P8850, DOI 10.1074/jbc.M413699200; Napolitano A, 2004, CHEM RES TOXICOL, V17, P1329, DOI 10.1021/tx049880b; Napolitano A, 2002, J ORG CHEM, V67, P803, DOI 10.1021/jo015965v; Napolitano A, 2002, TETRAHEDRON, V58, P5061, DOI 10.1016/S0040-4020(02)00460-X; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; O'Donnell VB, 2000, J BIOL CHEM, V275, P38239, DOI 10.1074/jbc.M001802200; O'Donnell VB, 1999, J BIOL CHEM, V274, P20083, DOI 10.1074/jbc.274.29.20083; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; PRYOR WA, 1982, J AM CHEM SOC, V104, P6685, DOI 10.1021/ja00388a035; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 1999, METHOD ENZYMOL, V301, P353; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rubbo H, 2000, J BIOL CHEM, V275, P10812, DOI 10.1074/jbc.275.15.10812; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Serhan CN, 2001, J CLIN INVEST, V107, P1481, DOI 10.1172/JCI13375; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Trostchansky A, 2007, BIOCHEMISTRY-US, V46, P4645, DOI 10.1021/bi602652j; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wanikiat P, 1997, BRIT J PHARMACOL, V122, P1135, DOI 10.1038/sj.bjp.0701477; Wright MM, 2007, FREE RADICAL BIO MED, V43, pS161; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103	55	207	219	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15515	15519		10.1074/jbc.R800004200	http://dx.doi.org/10.1074/jbc.R800004200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18285326	Green Published, hybrid			2022-12-27	WOS:000256332500002
J	Stahl, M; Uemura, K; Ge, CH; Shi, SL; Tashima, Y; Stanley, P				Stahl, Mark; Uemura, Kazuhide; Ge, Changhui; Shi, Shaolin; Tashima, Yuko; Stanley, Pamela			Roles of Pofut1 and O-fucose in mammalian notch signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-MANNOSE 4,6-DEHYDRATASE; LIGAND-BINDING DOMAIN; FACTOR-LIKE REPEATS; PROTEIN O-FUCOSYL-TRANSFERASE-1; CONGENITAL DISORDER; MOLECULAR-CLONING; DROSOPHILA-MELANOGASTER; GLYCOSYLATION MUTANTS; LINKED GLYCOSYLATION; RECEPTOR ACTIVATION	Mammalian Notch receptors contain 29-36 epidermal growth factor (EGF)-like repeats that may be modified by protein O-fucosyltransferase 1 (Pofut1), an essential component of the canonical Notch signaling pathway. The Drosophila orthologue Ofut1 is proposed to function as both a chaperone required for stable cell surface expression of Notch and a protein O-fucosyltransferase. Here we investigate these dual roles of Pofut1 in relation to endogenous Notch receptors of Chinese hamster ovary and murine embryonic stem (ES) cells. We show that fucosylation-deficient Lec13 Chinese hamster ovary cells have wild type levels of Pofut1 and cell surface Notch receptors. Nevertheless, they have reduced binding of Notch ligands and low levels of Delta1- and Jagged1-induced Notch signaling. Exogenous fucose but not galactose rescues both ligand binding and Notch signaling. Murine ES cells lacking Pofut1 also have wild type levels of cell surface Notch receptors. However, Pofut1(-/-) ES cells do not bind Notch ligands or exhibit Notch signaling. Although overexpression of fucosyltransferase-defective Pofut1 R245A in Pofut1(-/-) cells partially rescues ligand binding and Notch signaling, this effect is not specific. The same rescue is achieved by an unrelated, inactive, endoplasmic reticulum glucosidase. Therefore, mammalian Notch receptors require Pofut1 for the generation of optimally functional Notch receptors, but, in contrast to Drosophila, Pofut1 is not required for stable cell surface expression of Notch. Importantly, we also show that, under certain circumstances, mammalian Notch receptors are capable of signaling in the absence of Pofut1 and O-fucose.	[Stahl, Mark; Uemura, Kazuhide; Ge, Changhui; Shi, Shaolin; Tashima, Yuko; Stanley, Pamela] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stanley@aecom.yu.edu		Shi, Shaolin/0000-0003-2297-6496; Stahl, Mark/0000-0002-6885-1106; Stanley, Pamela/0000-0001-5704-3747	NATIONAL CANCER INSTITUTE [R01CA095022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCI NIH HHS [CA 95022] Funding Source: Medline; NIGMS NIH HHS [T32 GM07288] Funding Source: Medline; PHS HHS [P01 13330] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ACAR M, 2008, J CELL, V132, P247; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Arboleda-Velasquez JF, 2005, HUM MOL GENET, V14, P1631, DOI 10.1093/hmg/ddi171; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hong Y, 2004, J BIOL CHEM, V279, P49894, DOI 10.1074/jbc.M410121200; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Kopan R, 2002, J CELL SCI, V115, P1095; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Loriol C, 2006, GLYCOBIOLOGY, V16, P736, DOI 10.1093/glycob/cwj124; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; OKAJIMA T, 2008, IN PRESS J BIOCH TOK; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Oyama T, 2007, P NATL ACAD SCI USA, V104, P9764, DOI 10.1073/pnas.0700240104; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Tsukamoto H, 2002, ANAT REC, V267, P7, DOI 10.1002/ar.10070; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vodovar Nicolas, 2008, J Biol, V7, P7, DOI 10.1186/jbiol68; Walker BK, 1998, BIOCHEM BIOPH RES CO, V250, P264, DOI 10.1006/bbrc.1998.9304; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wu LZ, 2004, SEMIN CANCER BIOL, V14, P348, DOI 10.1016/j.semcancer.2004.04.014; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	69	133	138	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13638	13651		10.1074/jbc.M802027200	http://dx.doi.org/10.1074/jbc.M802027200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347015	Green Published, hybrid			2022-12-27	WOS:000255728200016
J	Wang, SY; Assmann, SM; Fedoroff, NV				Wang, Shiyu; Assmann, Sarah M.; Fedoroff, Nina V.			Characterization of the Arabidopsis heterotrimeric G protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING PLANT-CELLS; ALPHA-SUBUNIT GPA1; G-BETA-GAMMA; PLASMA-MEMBRANE; SEED-GERMINATION; BINDING PROTEIN; FLUORESCENT PROTEINS; DISEASE RESISTANCE; ACTIVATION; INTERACTS	We have used fluorescence resonance energy transfer and co-immunoprecipitation to analyze the interactions among the alpha, beta, and gamma 1 subunits of the Arabidopsis heterotrimeric G protein. Using cyan and yellow fluorescent protein fusion constructs, we show that overexpressed G(gamma 1) localizes to protoplast membranes, but G beta exhibits membrane localization only when the G gamma(1) protein is co-overexpressed. Overexpressed G alpha shows membrane localization unaccompanied by overexpression of either G beta or G gamma(1). We detect fluorescence resonance energy transfer between G beta and G gamma(1) in the absence of G alpha overexpression and between G alpha and G gamma(1) but only when all three subunits are co-overexpressed. Both G alpha and G beta are associated with large macromolecular complexes of similar to 700 kDa in the plasma membrane. G alpha is present in both large complexes and as free G alpha in plasma membranes from wild type plants. In plants homozygous for a null allele of the G beta gene, G alpha is associated with smaller complexes in the 200-400-kDa range, indicating that its presence in the large complex depends on association with G beta gamma. Activation of the G alpha subunit with guanosine 5'-3-O-(thio)triphosphate (GTP gamma S) results in partial dissociation of G alpha from the complex. Hydrogen peroxide (H2O2) promotes extensive dissociation of the G alpha complex but does not interfere with binding of GTP gamma S to purified recombinant G alpha, suggesting that reactive oxygen species affect the stability of the large complex but not the activity of G alpha itself.	[Wang, Shiyu; Assmann, Sarah M.; Fedoroff, Nina V.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wang, Shiyu; Fedoroff, Nina V.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Fedoroff, Nina V.] Santa Fe Inst, Santa Fe, NM 87501 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; The Santa Fe Institute	Fedoroff, NV (corresponding author), Penn State Univ, Dept Biol, 219 Wartik Lab, University Pk, PA 16802 USA.	nvf1@psu.edu						Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; BASBOA O, 1987, INDIAN J BIOCHEM BIO, V24, P24; BOWLER C, 1994, GENE DEV, V8, P2188, DOI 10.1101/gad.8.18.2188; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129; Fedoroff N, 2006, ANN BOT-LONDON, V98, P289, DOI 10.1093/aob/mcl128; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Gadella TWJ, 1999, TRENDS PLANT SCI, V4, P287, DOI 10.1016/S1360-1385(99)01426-0; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kato C, 2004, PLANT J, V38, P320, DOI 10.1111/j.1365-313X.2004.02046.x; Kato N, 2002, PLANT PHYSIOL, V129, P931, DOI 10.1104/pp.005496; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2002, J BIOL CHEM, V277, P9036, DOI 10.1074/jbc.M107392200; Obrdlik P, 2000, FEBS LETT, V476, P208, DOI 10.1016/S0014-5793(00)01706-3; Okamoto H, 2001, PLANT CELL, V13, P1639, DOI 10.1105/tpc.13.7.1639; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Rivas S, 2002, PLANT CELL, V14, P689, DOI [10.1105/tpc.010357, 10.​1105/​tpc.​010357]; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SERRANO R, 1984, BIOCHEM BIOPH RES CO, V121, P735, DOI 10.1016/0006-291X(84)90243-2; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; THOMSON LJ, 1993, PLANT PHYSIOL, V102, P553, DOI 10.1104/pp.102.2.553; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Wang SY, 2007, P NATL ACAD SCI USA, V104, P3817, DOI 10.1073/pnas.0611735104; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WARPEHA KMF, 1991, P NATL ACAD SCI USA, V88, P8925, DOI 10.1073/pnas.88.20.8925; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5; WU WH, 1994, P NATL ACAD SCI USA, V91, P6310, DOI 10.1073/pnas.91.14.6310; Xu XH, 2005, MOL BIOL CELL, V16, P676, DOI 10.1091/mbc.E04-07-0544; Yan F, 1998, PLANT PHYSIOL, V117, P311, DOI 10.1104/pp.117.1.311; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200	64	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13913	13922		10.1074/jbc.M801376200	http://dx.doi.org/10.1074/jbc.M801376200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326491	hybrid			2022-12-27	WOS:000255728200045
J	Dang, Y; Siew, LM; Zheng, YH				Dang, Ying; Siew, Lai Mun; Zheng, Yong-Hui			APOBEC3G is degraded by the proteasomal pathway in a vif-dependent manner without being polyubiquitylated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; HIV-1 VIF; INDEPENDENT DEGRADATION; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; SOCS-BOX; PROTEIN; RESIDUES; COMPLEX	Although the covalent attachment of a polyubiquitin is the prevailing paradigm for entry into proteasomes, accumulating evidence suggests that poorly defined ubiquitin-free pathways also degrade proteins. The cytidine deaminase APOBEC3G (A3G) potently inhibits human immunodeficiency virus type 1 replication by disrupting viral reverse transcription. However, human immunodeficiency virus type 1 produces a viral infectivity factor (Vif) to destroy this antiretroviral protein. It was shown that Vif binds to both A3G and a Cullin 5 ubiquitin-protein isopeptide ligase. It is currently accepted that this enzyme polyubiquitylates A3G on lysine residues, resulting in its degradation by proteasomes. Here, we find that A3G without ubiquitylation is still degraded by proteasomes in a Vif-dependent manner. We further show that Vif is polyubiquitylated and that this event could be critical for A3G proteasomal degradation. Thus, A3G is degraded by a novel pathway that might involve ubiquitylation of one protein and then targets a second binding partner for proteasomal entry and degradation. We propose that instead of triggering A3G polyubiquitylation, polyubiquitylated Vif might serve as a vehicle to transport A3G into proteasomes for degradation.	[Dang, Ying; Siew, Lai Mun; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 2215 Biomed & Phys Sci, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385	NIAID NIH HHS [AI063344, R01 AI063944-02, R01 AI063944, K02 AI080225] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063944, K02AI080225] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akari H, 2004, J BIOL CHEM, V279, P12355, DOI 10.1074/jbc.M312426200; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; GONCALVES J, 1995, J VIROL, V69, P7196, DOI 10.1128/JVI.69.11.7196-7204.1995; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; HOYT MA, 2007, PROTEIN DEGRADATIO, V4, P107; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kao Sandra, 2004, Retrovirology, V1, P27, DOI 10.1186/1742-4690-1-27; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	33	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13124	13131		10.1074/jbc.M708728200	http://dx.doi.org/10.1074/jbc.M708728200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326044	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000255499800051
J	Hwang, SO; Boswell, SA; Seo, JS; Lee, SW				Hwang, Sun Ok; Boswell, Sarah A.; Seo, Jeong-Sun; Lee, Sam W.			Novel oxidative stress-responsive gene ERS25 functions as a regulator of the heat-shock and cell death response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; COPII-COATED VESICLES; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; QUALITY-CONTROL; TARGETED GENE; P24 PROTEINS; FACTOR-I; TRANSPORT	Members of the yeast p24 family, including Emp24p and Erv25p, exist as heteromeric complexes that have been proposed to cycle between the endoplasmic reticulum ( ER) and Golgi compartments. The specific functions and sites of action of p24 proteins are still unknown. Here we identified a human homolog of the yeast p24 family of proteins, named ERS25 ( endoplasmic reticulum stress-response protein 25), and investigated its role in stress response. ERS25 is predicted to have an ER localization signal peptide, a GOLD ( Golgi dynamics) domain, which is found in several eukaryotic Golgi and lipid-trafficking proteins, a coiled- coil region, and a transmembrane domain. We demonstrate that ERS25 is localized to the ER and is induced by ER-specific stress, heat shock, and oxidative stress. The selective induction of ERS25 by brefeldin A, but not tunicamycin, implicates the involvement of ERS25 in protein trafficking between the ER and the Golgi. Small interfering RNA-mediated inhibition of ERS25 results in a significant decrease in apoptosis as well as a reduction of reactive oxygen species induced by oxidative stress. Moreover, ERS25 depletion results in a significant increase in the levels of the ER chaperone HSP70 in response to heat-shock stress through increased levels of HSF-1. We also found that inhibition of ERS25 induction in response to heat shock enhanced the binding of HSP70 to Apaf-1, which is likely to interfere in stress-mediated apoptosis. Together, the data presented here demonstrate that ERS25 may play a critical role in regulation of heat-shock response and apoptosis.	[Hwang, Sun Ok; Boswell, Sarah A.; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Hwang, Sun Ok; Boswell, Sarah A.; Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Seo, Jeong-Sun] Seoul Natl Univ, Coll Med, Inst Med Res Council, ILCHUN Mol Med,Dept Biochem & Mol Biol, Seoul 110799, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Seoul National University (SNU)	Lee, SW (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	sam.lee@cbrc2.mgh.harvard.edu	Seo, Jeong-Sun/J-2763-2012	Boswell, Sarah/0000-0002-3118-3378	NATIONAL CANCER INSTITUTE [R01CA127247, R01CA097216, R01CA078356] Funding Source: NIH RePORTER; NCI NIH HHS [CA80058, CA078356, CA127247, CA097216] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anantharaman V, 2002, GENOME BIOL, V3; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Blum R, 1999, J CELL SCI, V112, P537; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Carney GE, 2004, BIOL CELL, V96, P271, DOI 10.1016/j.biolcel.2004.01.004; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; HAND JW, 1979, INT J RADIAT BIOL, V35, P521, DOI 10.1080/09553007914550631; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; KING IA, 1981, BIOCHEM J, V198, P331, DOI 10.1042/bj1980331; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; LANDRY J, 1982, CANCER RES, V42, P2457; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; Li WX, 1996, RADIAT RES, V145, P324, DOI 10.2307/3578988; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samali A, 1998, CELL STRESS CHAPERON, V3, P228, DOI 10.1379/1466-1268(1998)003<0228:HSPROS>2.3.CO;2; Samali A, 1996, EXP CELL RES, V223, P163, DOI 10.1006/excr.1996.0070; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Stavridi ES, 2004, GENE DEV, V18, P241, DOI 10.1101/gad.1181704; Strating JRPM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000704; STROUS GJ, 1993, J BIOL CHEM, V268, P2341; SUBJECK JR, 1982, BRIT J CANCER, V45, P127; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165	46	13	16	6	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13063	13069		10.1074/jbc.M709656200	http://dx.doi.org/10.1074/jbc.M709656200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326488	hybrid, Green Published			2022-12-27	WOS:000255499800044
J	Iyer, RR; Pohlhaus, TJ; Chen, S; Hura, GL; Dzantiev, L; Beese, LS; Modrich, P				Iyer, Ravi R.; Pohlhaus, Timothy J.; Chen, Sihong; Hura, Gregory L.; Dzantiev, Leonid; Beese, Lorena S.; Modrich, Paul			The MutS alpha-proliferating cell nuclear antigen interaction in human DNA mismatch repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; RAY SOLUTION SCATTERING; BIOLOGICAL MACROMOLECULES; RECOGNITION COMPLEX; PCNA; PROTEINS; SYSTEM; ASSOCIATION; EXPRESSION; RESOLUTION	We have examined the interaction parameters, conformation, and functional significance of the human MutS alpha center dot proliferating cell nuclear antigen ( PCNA) complex in mismatch repair. The two proteins associate with a 1: 1 stoichiometry and a K-D of 0.7 mu M in the absence or presence of heteroduplex DNA. PCNA does not influence the affinity of MutS alpha for a mismatch, and mismatch-bound MutS alpha binds PCNA. Small angle x-ray scattering studies have established the molecular parameters of the complex, which are consistent with an elongated conformation in which the two proteins associate in an end-to-end fashion in a manner that does not involve an extended unstructured tether, as has been proposed for yeast MutS alpha and PCNA ( Shell, S. S., Putnam, C. D., and Kolodner, R. D. (2007) Mol. Cell 26, 565 578). MutS alpha variants lacking the PCNA interaction motif are functional in 3 '- or 5 '- directed mismatch- provoked excision, but display a partial defect in 5 '- directed mismatch repair. This finding is consistent with the modest mutability conferred by inactivation of the MutS alpha PCNA interaction motif and suggests that interaction of the replication clamp with other repair protein(s) accounts for the essential role of PCNA in MutS alpha-dependent mismatch repair.	[Iyer, Ravi R.; Pohlhaus, Timothy J.; Chen, Sihong; Dzantiev, Leonid; Beese, Lorena S.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Iyer, Ravi R.; Chen, Sihong; Dzantiev, Leonid; Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Hura, Gregory L.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Duke University; Duke University; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu	beese, lorena/G-4993-2010; Classen, Scott/AAY-8176-2020	Modrich, Paul/0000-0001-8708-9885; Hura, Greg/0000-0003-0501-8464	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA092584-070005, P01 CA092584, P01 CA92584] Funding Source: Medline; NIGMS NIH HHS [R01 GM45190, R01 GM045190, R01 GM045190-18] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackers G K, 1973, Methods Enzymol, V27, P441; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Dynlacht BD, 1997, METHOD ENZYMOL, V283, P230; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guinier A., 1955, SMALL ANGLE SCATTERI; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KELMAN Z, 1995, GENE, V166, P177, DOI 10.1016/0378-1119(95)00556-7; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRATKY O, 1963, PROG BIOPHYS MOL BIO, V13, P105, DOI 10.1016/S0079-6107(63)80015-2; Lau PJ, 2003, J BIOL CHEM, V278, P14, DOI 10.1074/jbc.C200627200; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2005, STRUCTURE, V13, P169, DOI 10.1016/j.str.2005.01.001; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002	44	35	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13310	13319		10.1074/jbc.M800606200	http://dx.doi.org/10.1074/jbc.M800606200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326858	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000255499800071
J	Ramsay, AJ; Dong, Y; Hunt, ML; Linn, M; Samaratunga, H; Clements, JA; Hooper, JD				Ramsay, Andrew J.; Dong, Ying; Hunt, Melanie L.; Linn, Mayla; Samaratunga, Hemamali; Clements, Judith A.; Hooper, John D.			Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; HUMAN PROSTATIC-CARCINOMA; HUMAN TISSUE KALLIKREIN-4; BREAST-CANCER CELLS; THROMBIN RECEPTOR; SERINE-PROTEASE; MOLECULAR-CLONING; PLASMINOGEN-ACTIVATOR; EPITHELIAL-CELLS; GENE FAMILY	Kallikrein-related peptidase 4 (KLK4) is one of the 15 members of the human KLK family and a trypsin-like, prostate cancer-associated serine protease. Signaling initiated by trypsin-like serine proteases are transduced across the plasma membrane primarily by members of the protease-activated receptor (PAR) family of G protein-coupled receptors. Here we show, using Ca2+ flux assays, that KLK4 signals via both PAR-1 and PAR-2 but not via PAR-4. Dose-response analysis over the enzyme concentration range 0.1-1000 nM indicated that KLK4-induced Ca2+ mobilization via PAR-1 is more potent than via PAR-2, whereas KLK4 displayed greater efficacy via the latter PAR. We confirmed the specificity of KLK4 signaling via PAR-2 using in vitro protease cleavage assays and anti-phospho-ERK1/2/total ERK1/2 Western blot analysis of PAR-2-overexpressing and small interfering RNA-mediated receptor knockdown cell lines. Consistently, confocal microscopy analyses indicated that KLK4 initiates loss of PAR-2 from the cell surface and receptor internalization. Immunohistochemical analysis indicated the co-expression of agonist and PAR-2 in primary prostate cancer and bone metastases, suggesting that KLK4 signaling via this receptor will have pathological relevance. These data provide insight into KLK4-mediated cell signaling and suggest that signals induced by this enzyme via PARs may be important in prostate cancer.	[Ramsay, Andrew J.; Dong, Ying; Hunt, Melanie L.; Linn, Mayla; Clements, Judith A.; Hooper, John D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Samaratunga, Hemamali] Dept Anat Pathol, Taringa, Qld 4068, Australia	Queensland University of Technology (QUT)	Hooper, JD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Corner Musk Ave & Blamey St, Kelvin Grove, Qld 4059, Australia.	jd.hooper@qut.edu.au	Hooper, John/C-1481-2016; Dong, Ying/C-3511-2012; Hooper, John/B-4153-2011; Samaratunga, Hemamali M L/D-1559-2013	Hooper, John/0000-0003-1054-8486; Samaratunga, Hemamali M L/0000-0001-5796-1791; Clements, Judith/0000-0001-6026-1964				Abraham LA, 2000, BONE, V26, P7, DOI 10.1016/S8756-3282(99)00237-9; Abraham LA, 1999, J BONE MINER RES, V14, P1320, DOI 10.1359/jbmr.1999.14.8.1320; Abraham LA, 1998, J BONE MINER RES, V13, P818, DOI 10.1359/jbmr.1998.13.5.818; Afar DEH, 2001, CANCER RES, V61, P1686; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Beaufort N, 2006, BIOL CHEM, V387, P217, DOI 10.1515/BC.2006.029; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Davidson B, 2005, AM J CLIN PATHOL, V123, P360, DOI 10.1309/PTBB5BPCKX8K9V69; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Day CH, 2002, ONCOGENE, V21, P7114, DOI 10.1038/sj.onc.1205786; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Harvey TJ, 2000, J BIOL CHEM, V275, P37397, DOI 10.1074/jbc.M004525200; Harvey Tracey J, 2003, Methods Mol Med, V81, P241; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2001, GENOMICS, V73, P117, DOI 10.1006/geno.2000.6490; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Jenkins Alison L., 1993, Journal of Biological Chemistry, V268, P21432; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kaushal V, 2006, PROSTATE, V66, P273, DOI 10.1002/pros.20326; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Matsumura M, 2005, PROSTATE, V62, P1, DOI 10.1002/pros.20101; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Obiezu CV, 2006, BIOL CHEM, V387, P749, DOI 10.1515/BC.2006.094; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shaffer DR, 2003, LANCET ONCOL, V4, P407, DOI 10.1016/S1470-2045(03)01138-0; Smith R, 2004, J BONE MINER RES, V19, P507, DOI 10.1359/JBMR.0301248; Smith R, 2000, FEBS LETT, V484, P285, DOI 10.1016/S0014-5793(00)02146-3; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Stephenson SA, 1999, J BIOL CHEM, V274, P23210, DOI 10.1074/jbc.274.33.23210; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sun J, 2003, BIOCHEMISTRY-US, V42, P892, DOI 10.1021/bi026878f; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Titus B, 2005, CRIT REV EUKAR GENE, V15, P103, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i2.20; Vesey DA, 2007, NEPHROLOGY, V12, P36, DOI 10.1111/j.1440-1797.2006.00746.x; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Webber MM, 1996, PROSTATE, V29, P386, DOI 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; WILSON S, 2004, PROSTATE, V9999, P1; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Ye XC, 2007, FRONT BIOSCI, V12, P3273, DOI 10.2741/2311; Yousef GM, 1999, CANCER RES, V59, P4252; Zaichick V. Ye., 1997, International Urology and Nephrology, V29, P565, DOI 10.1007/BF02552202; Zaichick V. Ye, 1996, International Urology and Nephrology, V28, P687, DOI 10.1007/BF02552165	86	121	121	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12293	12304		10.1074/jbc.M709493200	http://dx.doi.org/10.1074/jbc.M709493200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18308730	hybrid, Green Published			2022-12-27	WOS:000255340000046
J	Huang, Y; Wu, M; Li, HY				Huang, Yafen; Wu, Mian; Li, Hoi-Yeung			Tumor suppressor ARF promotes non-classic proteasome-independent polyubiquitination of COMMD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-INDEPENDENT FUNCTIONS; NUCLEOLAR LOCALIZATION; UBIQUITIN LIGASE; HUMAN P14(ARF); GENE; DEGRADATION; PATHWAYS; MURR1; MDM2; P53	Although the tumor suppressor ARF is generally accepted for its essential role in activating the p53 pathway, its p53-independent function has also been proposed. Here, we report that ARF associates with COMMD1 and promotes Lys(63)-mediated polyubiquitination of COMMD1 in a p53-independent manner. We found that ARF interacts with COMMD1 in vivo. Deletion analysis of ARF suggested that the N-terminal amino acids 15-45 are important for its interaction with COMMD1. In addition, we found that endogenous ARF redistributes from the nucleolus to the nucleoplasm and interacts with COMMD1 when DNA is damaged by actinomycin D. Interestingly, we found that ARF promotes the polyubiquitination of COMMD1 through Lys(63) of ubiquitin but not the polyubiquitination of Lys(48), which does not target COMMD1 for proteasome-dependent proteolysis. Moreover, ARF mutants lacking the domain interacting with COMMD1 did not promote COMMD1 polyubiquitination, indicating that physical association is a prerequisite condition for the polyubiquitination process. Together, these data suggest that the ability to promote Lys(63)-mediated polyubiquitination of COMMD1 is a novel property of ARF independent of p53.	[Huang, Yafen; Li, Hoi-Yeung] Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Mol & Cell Biol, Singapore 637551, Singapore; [Wu, Mian] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, HY (corresponding author), Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Mol & Cell Biol, Singapore 637551, Singapore.	hyli@ntu.edu.sg		Wu, Mian/0000-0002-2714-0500; Li, Hoi Yeung/0000-0002-8603-1953				Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Karayan L, 2001, ONCOGENE, V20, P836, DOI 10.1038/sj.onc.1204170; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lindstrom MS, 2000, EXP CELL RES, V256, P400, DOI 10.1006/excr.2000.4854; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; QUELLE DE, 1995, CELL, V83, P993; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Rizos H, 2005, CELL CYCLE, V4, P597, DOI 10.4161/cc.4.4.1588; Rizos H, 2007, CELL CYCLE, V6, P1741, DOI 10.4161/cc.6.14.4428; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Woods YL, 2004, J BIOL CHEM, V279, P50157, DOI 10.1074/jbc.M405414200; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	33	17	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11453	11460		10.1074/jbc.M708544200	http://dx.doi.org/10.1074/jbc.M708544200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305112	hybrid			2022-12-27	WOS:000255067400043
J	Jablonka-Shariff, A; Pearl, CA; Comstock, A; Boime, I				Jablonka-Shariff, Albina; Pearl, Christopher A.; Comstock, Anna; Boime, Irving			A carboxyl-terminal sequence in the lutropin beta subunit contributes to the sorting of lutropin to the regulated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; HAMSTER OVARY CELLS; HUMAN LUTEINIZING-HORMONE; SECRETORY GRANULES; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN HORMONES; MOLECULAR-CLONING; ALPHA-SUBUNIT; SINGLE-CHAIN; GH(3) CELLS	Although synthesized in the same pituitary gonadotropes, the secretion profiles of lutropin (LH) and follitropin (FSH) differ. LH is secreted through a regulated pathway and associated with a bolus release at mid-estrous cycle. In contrast, the majority of FSH is secreted constitutively with an incremental increase until ovulation. Both share an identical alpha subunit, and thus the beta subunit contains determinants for sorting into the regulated pathway. Previously, we demonstrated that a hydrophobic carboxyl-terminal heptapeptide of the LH beta subunit (Leu-Ser-Gly-Leu-Leu-Phe-Leu), not found in the FSH beta subunit, influences the intracellular behavior of the LH dimer. To test the hypothesis that the peptide contributes to differential sorting, we monitored the fates of LH and LH Delta T (LH beta subunit lacking the carboxyl-terminal seven amino acids) dimers in the rat somatotrope-derived GH(3) cell line in which both the regulated and constitutive secretory pathways operate. Pulse-chase labeling demonstrated that the LH Delta T dimer was diverted to the constitutive pathway, resulting in a significant decrease in the corresponding intracellular pool. Forskolin stimulated LH dimer release 3-fold, which was accompanied by a parallel decrease of intracellular LH; only marginal forskolin stimulation of LH Delta T was seen. Immunofluorescence after cycloheximide treatment demonstrated decreased retention of LH Delta T compared with LH, consistent with increased constitutive secretion of LH Delta T. We also demonstrated that fusing the heptapeptide to the carboxyl terminus of the FSH beta subunit resulted in an increased regulated secretion of this FSH analog compared with wild-type FSH. These data are the first to identify a novel structural determinant responsible for the sorting of a member of the glycoprotein hormone family into the regulated secretory pathway.	[Jablonka-Shariff, Albina; Pearl, Christopher A.; Comstock, Anna; Boime, Irving] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Boime, I (corresponding author), 660 S Euclid Ave,Box 8103, St Louis, MO 63110 USA.	iboime@wustl.edu			NICHD NIH HHS [T32HD049305-03] Funding Source: Medline; NINDS NIH HHS [NS057105] Funding Source: Medline; PHS HHS [DR065155] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvan P, 2002, CURR OPIN CELL BIOL, V14, P448, DOI 10.1016/S0955-0674(02)00344-7; Assadi M, 2004, BIOCHEMISTRY-US, V43, P7798, DOI 10.1021/bi036331g; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1994, FASEB J, V8, P1019, DOI 10.1096/fasebj.8.13.7926366; BIELINSKA M, 1994, MOL ENDOCRINOL, V8, P919, DOI 10.1210/me.8.7.919; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brechler V, 1996, J BIOL CHEM, V271, P20636, DOI 10.1074/jbc.271.34.20636; Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199; CHILDS GV, 1985, ENDOCRINOLOGY, P499; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; CORLESS CL, 1987, J CELL BIOL, V104, P1173, DOI 10.1083/jcb.104.5.1173; CURRIE RJW, 1995, J ENDOCRINOL, V147, P259, DOI 10.1677/joe.0.1470259; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; Dannies PS, 2001, MOL CELL ENDOCRINOL, V177, P87, DOI 10.1016/S0303-7207(01)00437-3; Dikeakos JD, 2007, J BIOL CHEM, V282, P1136, DOI 10.1074/jbc.M605718200; FARNWORTH PG, 1995, J ENDOCRINOL, V145, P387, DOI 10.1677/joe.0.1450387; Garcia-Campayo V, 2004, J BIOL CHEM, V279, P44286, DOI 10.1074/jbc.M408386200; GREEN ED, 1986, MOL CELL BIOCHEM, V72, P81; Griffiths G, 1996, PROTOPLASMA, V195, P37, DOI 10.1007/BF01279185; HAYASHIZAKI Y, 1985, FEBS LETT, V188, P394, DOI 10.1016/0014-5793(85)80409-9; HO MK, 1983, J BIOL CHEM, V258, P2766; Jablonka-Shariff A, 2006, MOL ENDOCRINOL, V20, P1437, DOI 10.1210/me.2005-0537; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAETZEL DM, 1989, MOL ENDOCRINOL, V3, P1765, DOI 10.1210/mend-3-11-1765; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; KEENE JL, 1989, J BIOL CHEM, V264, P4769; KESSLER MJ, 1979, J BIOL CHEM, V254, P7909; KEUTMANN HT, 1979, BIOCHEM BIOPH RES CO, V90, P842, DOI 10.1016/0006-291X(79)91904-1; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; Luderer U., 1992, SER S FSH REG SECR M, P1; MATZUK MM, 1989, J CELL BIOL, V109, P1429, DOI 10.1083/jcb.109.4.1429; MATZUK MM, 1987, P NATL ACAD SCI USA, V84, P6354, DOI 10.1073/pnas.84.18.6354; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MUYAN M, 1994, MOL ENDOCRINOL, V8, P1789, DOI 10.1210/me.8.12.1789; Muyan M, 1996, MOL ENDOCRINOL, V10, P1678, DOI 10.1210/me.10.12.1678; Nakatsu F, 2003, CELL STRUCT FUNCT, V28, P419, DOI 10.1247/csf.28.419; Pantel J, 1998, ENDOCRINOLOGY, V139, P527, DOI 10.1210/en.139.2.527; PARSONS TF, 1980, P NATL ACAD SCI-BIOL, V77, P7089, DOI 10.1073/pnas.77.12.7089; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; SAIRAM MR, 1983, HORMONAL PROTEINS PE, P1; Shimizu Y, 2007, ADV EXP MED BIOL, V594, P37; SITIA R, 1992, MOL BIOL CELL, V3, P1067, DOI 10.1091/mbc.3.10.1067; TALMADGE K, 1984, NATURE, V307, P37, DOI 10.1038/307037a0; TARTAKOFF A, 1979, J CELL BIOL, V83, P284, DOI 10.1083/jcb.83.2.284; Thomas SG, 1997, ENDOCRINOLOGY, V138, P1347, DOI 10.1210/en.138.3.1347; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Watanabe N, 2007, COMP BIOCHEM PHYS A, V146, P105, DOI 10.1016/j.cbpa.2006.09.011	49	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11485	11492		10.1074/jbc.M800654200	http://dx.doi.org/10.1074/jbc.M800654200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18292086	hybrid, Green Published			2022-12-27	WOS:000255067400047
J	Shen, XR; Li, HM; Ou, Y; Tao, WB; Dong, A; Kong, JL; Ji, CN; Yu, SN				Shen, Xianrong; Li, Huiming; Ou, Yan; Tao, Wenbing; Dong, Aichun; Kong, Jilie; Ji, Chaoneng; Yu, Shaoning			The secondary structure of calcineurin regulatory region and conformational change induced by calcium/calmodulin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP RECEPTOR PROTEIN; AUTOINHIBITORY DOMAIN; PHOSPHATASE-ACTIVITY; ESCHERICHIA-COLI; CALMODULIN; CALCIUM; NFAT; COMPLEX; FAMILY	The protein serine/threonine phosphatase calcineurin (CN) is activated by calmodulin (CaM) in response to intracellular calcium mobilization. A widely accepted model for CN activation involves displacement of the CN autoinhibitory peptide (CN467-486) from the active site upon binding of CaM. However, CN activation requires calcium binding both to the low affinity sites of CNB and to CaM, and previous studies did not dissect the individual contributions of CNB and CaM to displacement of the autoinhibitory peptide from the active site. In this work we have produced separate CN fragments corresponding to the CNA regulatory region (CNRR381-521, residues 381-521), the CNA catalytic domain truncated at residue 341, and the CNA-CNB heterodimer with CNA truncated at residue 380 immediately after the CNB binding helix. We show that the separately expressed regulatory region retains its ability to inhibit CN phosphatase activity of the truncated CN341 and CN380 and that the inhibition can be reversed by calcium/CaM binding. Tryptophan fluorescence quenching measurements further indicate that the isolated regulatory region inhibits CN activity by occluding the catalytic site and that CaM binding exposes the catalytic site. The results provide new support for a model in which calcium binding to CNB enables CaM binding to the CNA regulatory region, and CaM binding then instructs an activating conformational change of the regulatory region that does not depend further on CNB. Moreover, the secondary structural content of the CNRR381-521 was tentatively addressed by Fourier transform infrared spectroscopy. The results indicate that the secondary structure of CNRR381-521 fragment is predominantly random coil, but with significant amount of beta-strand and alpha-helix structures.	[Shen, Xianrong; Ou, Yan; Tao, Wenbing; Kong, Jilie; Yu, Shaoning] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Shen, Xianrong; Ou, Yan; Tao, Wenbing; Kong, Jilie; Yu, Shaoning] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Ji, Chaoneng] Fudan Univ, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China; [Li, Huiming] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Dong, Aichun] Univ No Colorado, Dept Chem & Biochem, Greeley, CO 80639 USA	Fudan University; Fudan University; Fudan University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Northern Colorado	Yu, SN (corresponding author), Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China.	yushaoning@fudan.edu.cn						Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Chen R, 2003, J BIOL CHEM, V278, P13235, DOI 10.1074/jbc.M211551200; Cohen P T, 1996, Adv Pharmacol, V36, P67; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Dong AC, 2002, BIOCHEMISTRY-US, V41, P6660, DOI 10.1021/bi020036z; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KINCAID R, 1993, ADV SEC MESS PHOSPH, V27, P1; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Perrino BA, 1999, ARCH BIOCHEM BIOPHYS, V372, P159, DOI 10.1006/abbi.1999.1485; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q	21	32	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11407	11413		10.1074/jbc.M708513200	http://dx.doi.org/10.1074/jbc.M708513200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18296442	hybrid			2022-12-27	WOS:000255067400038
J	Liang, F; Luo, Y; Dong, YS; Walls, CD; Liang, J; Jiang, HY; Sanford, JR; Wek, RC; Zhang, ZY				Liang, Fubo; Luo, Yong; Dong, Yuanshu; Walls, Chad D.; Liang, Jiao; Jiang, Hao-Yuan; Sanford, Jeremy R.; Wek, Ronald C.; Zhang, Zhong-Yin			Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MESSENGER-RNA TRANSLATION; MOUSE MELANOMA-CELLS; MALIGNANT-TRANSFORMATION; COLORECTAL-CANCER; IN-VIVO; METASTASIS; CARCINOMA; GENE; MIGRATION	Phosphatase of regenerating liver 3 (PRL3) is up-regulated in cancer metastases. However, little is known of PRL3-mediated cellular signaling pathways. We previously reported that elevated PRL3 expression increases Src kinase activity, which likely contributes to the increased tumorigenesis and metastasis potential of PRL3. PRL3-induced Src activation is proposed to be indirect through down-regulation of Csk, a negative regulator of Src. Given the importance of PRL3 in tumor metastasis and the role of Csk in controlling Src activity, we addressed the mechanism by which PRL3 mediates Csk down-regulation. PRL3 is shown to exert a negative effect on Csk protein synthesis, rather than regulation of Csk mRNA levels or protein turnover. Interestingly, the preferential decrease in Csk protein synthesis is a consequence of increased eIF2 phosphorylation resulting from PRL3 expression. Reduced Csk synthesis also occurs in response to cellular stress that induces eIF2 phosphorylation, indicating that this regulatory mechanism may occur in response to a wider spectrum of cellular conditions known to direct translational control. Thus, we have uncovered a previously uncharacterized role for PRL3 in the gene-specific translational control of Csk expression.	[Liang, Fubo; Luo, Yong; Dong, Yuanshu; Walls, Chad D.; Liang, Jiao; Jiang, Hao-Yuan; Sanford, Jeremy R.; Wek, Ronald C.; Zhang, Zhong-Yin] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Zhang, ZY (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	zyzhang@iupui.edu			NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM049164] Funding Source: NIH RePORTER; NCI NIH HHS [CA69202] Funding Source: Medline; NIGMS NIH HHS [GM49164] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Cam WR, 2001, CANCER, V92, P61, DOI 10.1002/1097-0142(20010701)92:1<61::AID-CNCR1292>3.0.CO;2-D; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Glaser T, 2001, ONCOGENE, V20, P4757, DOI 10.1038/sj.onc.1204498; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; Kubens BS, 1998, CANCER LETT, V131, P55, DOI 10.1016/S0304-3835(98)00201-8; Kwok JC, 2004, MOL PHARMACOL, V65, P181, DOI 10.1124/mol.65.1.181; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Miskad UA, 2004, PATHOBIOLOGY, V71, P176, DOI 10.1159/000078671; Nakagawa T, 2000, INT J CANCER, V88, P384, DOI 10.1002/1097-0215(20001101)88:3<384::AID-IJC10>3.3.CO;2-2; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Rengifo-Cam W, 2004, ONCOGENE, V23, P289, DOI 10.1038/sj.onc.1207041; Rouleau C, 2006, MOL CANCER THER, V5, P219, DOI 10.1158/1535-7163.MCT-05-0289; Sager JA, 2004, CANCER BIOL THER, V3, P952, DOI 10.4161/cbt.3.10.1115; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Schwering I, 2003, MOL MED, V9, P85, DOI 10.1007/BF03402041; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; SU Q, 2004, P NATL ACAD SCI USA, V103, P63; Tan M, 2005, CANCER RES, V65, P1858, DOI 10.1158/0008-5472.CAN-04-2353; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wu XP, 2004, AM J PATHOL, V164, P2039, DOI 10.1016/S0002-9440(10)63763-7; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zeng Q, 2003, CANCER RES, V63, P2716	47	29	30	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10339	10346		10.1074/jbc.M708285200	http://dx.doi.org/10.1074/jbc.M708285200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18268019	Green Published, hybrid			2022-12-27	WOS:000254894700014
J	Song, JK; Bettendorff, L; Tonelli, M; Markley, JL				Song, Jikui; Bettendorff, Lucien; Tonelli, Marco; Markley, John L.			Structural basis for the catalytic mechanism of mammalian 25-kDa thiamine triphosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUNNEL METALLOENZYME SUPERFAMILY; YEAST RNA TRIPHOSPHATASE; TORSION ANGLE DYNAMICS; RAT-BRAIN; NMR; PROTEIN; PURIFICATION; TISSUES; PHOSPHATE; SYSTEM	Mammalian soluble thiamine triphosphatase (ThTPase) is a 25-kDa cytosolic enzyme that specifically catalyzes the conversion of thiamine triphosphate (ThTP) to thiamine diphosphate and has an absolute requirement for divalent cations. We have investigated the kinetic properties of recombinant mouse thiamine triphosphatase (mThTPase) and determined its solution structure by NMR spectroscopy. Residues responsible for binding Mg2+ and ThTP were determined from NMR titration experiments. The binding of Mg2+ induced only a minor local conformational change, whereas ThTP binding was found to cause a more global conformational change. We derived a structural model for the mThTPase.ThTP.Mg2+ ternary complex and concluded from this that whereas free mThTPase has an open cleft fold, the enzyme in the ternary complex adopts a tunnel fold. Our results provide a functional rationale for a number of conserved residues and suggest an essential role for Mg2+ in catalysis. We propose a mechanism underlying the high substrate specificity of mThTPase and discuss the possible role of water molecules in enzymatic catalysis.	[Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Song, Jikui; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Bettendorff, Lucien] Univ Liege, Ctr Cellular & Mol Neurobiol, B-4000 Liege, Belgium	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Liege	Markley, JL (corresponding author), Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, 433 Babcock Dr, Madison, WI 53706 USA.	markley@nmrfam.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064598, U54GM074901] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM64598, U54 GM074901] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARCHI RL, 1976, J BIOL CHEM, V251, P193; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; BETTENDORFF L, 1993, J NEUROCHEM, V60, P423, DOI 10.1111/j.1471-4159.1993.tb03168.x; Bisaillon M, 2003, J BIOL CHEM, V278, P33963, DOI 10.1074/jbc.M303007200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HASHITANI Y, 1972, J BIOL CHEM, V247, P2117; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; IWATA H, 1985, NEUROCHEM RES, V10, P779, DOI 10.1007/BF00964535; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jeon Won Bae, 2005, Journal of Structural and Functional Genomics, V6, P143, DOI 10.1007/s10969-005-1908-7; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Lakaye B, 2004, INT J BIOCHEM CELL B, V36, P1348, DOI 10.1016/j.biocel.2003.11.013; Lakaye B, 2004, J BIOL CHEM, V279, P17142, DOI 10.1074/jbc.M313569200; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; MAKARCHIKOV AF, 1992, BIOCHIM BIOPHYS ACTA, V1117, P326, DOI 10.1016/0304-4165(92)90032-P; Nghiem HO, 2000, FASEB J, V14, P543, DOI 10.1096/fasebj.14.3.543; PENTTINEN HK, 1981, MED BIOL, V59, P177; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sousa MC, 1998, BIOCHEMISTRY-US, V37, P15392, DOI 10.1021/bi981510x; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Szyniarowski P, 2005, BBA-GEN SUBJECTS, V1725, P93, DOI 10.1016/j.bbagen.2005.05.026; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Zolnai Zsolt, 2003, Journal of Structural and Functional Genomics, V4, P11, DOI 10.1023/A:1024684404761; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	32	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10939	10948		10.1074/jbc.M709675200	http://dx.doi.org/10.1074/jbc.M709675200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18276586	Green Published, hybrid			2022-12-27	WOS:000254894700075
J	Liu, XY; Pavlovsky, AG; Viola, RE				Liu, Xuying; Pavlovsky, Alexander G.; Viola, Ronald E.			The structural basis for allosteric inhibition of a threonine-sensitive aspartokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOSERINE DEHYDROGENASE-I; COMPLETE GENOME SEQUENCE; AMINO-ACID BIOSYNTHESIS; ESCHERICHIA-COLI K12; ASPARTATE KINASE; IDENTIFICATION; EQUILIBRIUM; PROTEINS; ENZYMES	The commitment step to the aspartate pathway of amino acid biosynthesis is the phosphorylation of aspartic acid catalyzed by aspartokinase (AK). Most microorganisms and plants have multiple forms of this enzyme, and many of these isofunctional enzymes are subject to feedback regulation by the end products of the pathway. However, the archeal species Methanococcus jannaschii has only a single, monofunctional form of AK. The substrate L-aspartate binds to this recombinant enzyme in two different orientations, providing the first structural evidence supporting the relaxed regiospecificity previously observed with several alternative substrates of Escherichia coli AK (Angeles, T. S., Hunsley, J. R., and Viola, R. E. (1992) Biochemistry 31, 799-805). Binding of the nucleotide substrate triggers significant domain movements that result in a more compact quaternary structure. In contrast, the highly cooperative binding of the allosteric regulator L-threonine to multiple sites on this dimer of dimers leads to an open enzyme structure. A comparison of these structures supports a mechanism for allosteric regulation in which the domain movements induced by threonine binding causes displacement of the substrates from the enzyme, resulting in a relaxed, inactive conformation.	[Liu, Xuying; Pavlovsky, Alexander G.] Univ Toledo, Dept Chem, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Viola, RE (corresponding author), Univ Toledo, Dept Chem, 2801 W Bancroft St, Toledo, OH 43606 USA.	ron.viola@utoledo.edu	Viola, Ronald/C-5904-2011; liu, xuying/G-7258-2012					ANGELES TS, 1992, BIOCHEMISTRY-US, V31, P799, DOI 10.1021/bi00118a023; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; BEARER CF, 1978, BIOCHEMISTRY-US, V17, P3523, DOI 10.1021/bi00610a016; BEARER CF, 1978, BIOCHEMISTRY-US, V17, P3512, DOI 10.1021/bi00610a014; Bono H, 1998, GENOME RES, V8, P203, DOI 10.1101/gr.8.3.203; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faehnle CR, 2006, ACTA CRYSTALLOGR F, V62, P962, DOI 10.1107/S1744309106038279; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HECK HD, 1972, BIOCHEMISTRY-US, V11, P4421, DOI 10.1021/bi00774a001; JANIN J, 1969, EUR J BIOCHEM, V11, P520, DOI 10.1111/j.1432-1033.1969.tb00804.x; JANIN J, 1969, EUR J BIOCHEM, V11, P530, DOI 10.1111/j.1432-1033.1969.tb00805.x; JANIN J, 1974, FEBS LETT, V45, P318, DOI 10.1016/0014-5793(74)80870-7; Keng YF, 1996, ARCH BIOCHEM BIOPHYS, V335, P73, DOI 10.1006/abbi.1996.0483; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paris S, 2003, J BIOL CHEM, V278, P5361, DOI 10.1074/jbc.M207379200; Ragkousi K, 2003, J BACTERIOL, V185, P2315, DOI 10.1128/JB.185.7.2315-2329.2003; Roberts CJ, 1995, NUCLEIC ACIDS RES, V23, P4818, DOI 10.1093/nar/23.23.4818; Somerville R. L., 1983, AMINO ACIDS BIOSYNTH, P147; TILAK A, 1976, EUR J BIOCHEM, V69, P249, DOI 10.1111/j.1432-1033.1976.tb10880.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; VICKERS LP, 1978, J BIOL CHEM, V253, P2155; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q	30	21	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16216	16225		10.1074/jbc.M800760200	http://dx.doi.org/10.1074/jbc.M800760200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18334478	Green Published, hybrid			2022-12-27	WOS:000256332500080
J	Younes, A; Lyashkov, AE; Graham, D; Sheydina, A; Volkova, MV; Mitsak, M; Vinogradova, TM; Lukyanenko, YO; Li, Y; Ruknudin, AM; Boheler, KR; van Eyk, J; Lakatta, EG				Younes, Antoine; Lyashkov, Alexey E.; Graham, David; Sheydina, Anna; Volkova, Maria V.; Mitsak, Megan; Vinogradova, Tatiana M.; Lukyanenko, Yevgeniya O.; Li, Yue; Ruknudin, Abdul M.; Boheler, Kenneth R.; van Eyk, Jennifer; Lakatta, Edward G.			Ca2+-stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHODIESTERASE ACTIVITY; DIASTOLIC DEPOLARIZATION; RYANODINE RECEPTOR; TRANSGENIC MICE; SIGNALING COMPONENTS; DIRECTED EXPRESSION; PLASMA-MEMBRANE; CA2+ RELEASES; BEATING RATE; CYCLIC-AMP	Spontaneous, rhythmic subsarcolemmal local Ca2+ releases driven by cAMP- mediated, protein kinase A (PKA)- dependent phosphorylation are crucial for normal pacemaker function of sinoatrial nodal cells (SANC). Because local Ca2+ releases occur beneath the cell surface membrane, near to where adenylyl cyclases (ACs) reside, we hypothesized that the dual Ca2+ and cAMP/ PKA regulatory components of automaticity are coupled via Ca2+ activation of AC activity within membrane microdomains. Here we show by quantitative reverse transcriptase PCR that SANC express Ca2+-activated AC isoforms 1 and 8, in addition to AC type 2, 5, and 6 transcripts. Immunolabeling of cell fractions, isolated by sucrose gradient ultracentrifugation, confirmed that ACs localize to membrane lipid microdomains. AC activity within these lipid microdomains is activated by Ca2+ over the entire physiological Ca2+ range. In intact SANC, the high basal AC activity produces a high level of cAMP that is further elevated by phosphodiesterase inhibition. cAMP and cAMP- mediated PKA- dependent activation of ion channels and Ca2+ cycling proteins drive sarcoplasmic reticulum Ca2+ releases, which, in turn, activate ACs. This feed forward "fail safe" system, kept in check by a high basal phosphodiesterase activity, is central to the generation of normal rhythmic, spontaneous action potentials by pacemaker cells.	[Younes, Antoine; Lyashkov, Alexey E.; Sheydina, Anna; Volkova, Maria V.; Vinogradova, Tatiana M.; Lukyanenko, Yevgeniya O.; Li, Yue; Ruknudin, Abdul M.; Boheler, Kenneth R.; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Graham, David; Mitsak, Megan; van Eyk, Jennifer] Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Lakatta, EG (corresponding author), NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	lakattae@mail.nih.gov	Lakatta, Edward G/AAL-1447-2020; Vinogradova, Tatiana/AAU-5793-2020	Lakatta, Edward/0000-0002-4772-0035	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [P01 HL077180-040001, P01 HL077180-030001, P01 HL077180, P01 HL077180-010001, P01 HL077180-020001] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000258, ZIAAG000259, ZIAAG000260] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Barbuti A, 2004, CIRC RES, V94, P1325, DOI 10.1161/01.RES.0000127621.54132.AE; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bogdanov KY, 2006, CIRC RES, V99, P979, DOI 10.1161/01.RES.0000247933.66532.0b; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; CALI JJ, 1994, J BIOL CHEM, V269, P12190; DiFrancesco D, 2005, CURR MED RES OPIN, V21, P1115, DOI 10.1185/030079905X50543; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Georget M, 2003, FASEB J, V17, P1380, DOI 10.1096/fj.02-0784com; Georget M, 2002, FASEB J, V16, P1636, DOI 10.1096/fj.02-0292fje; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Ilangumaran S, 1996, ANAL BIOCHEM, V235, P49, DOI 10.1006/abio.1996.0090; Ju YK, 2007, CIRC RES, V100, P1605, DOI 10.1161/CIRCRESAHA.107.152181; Lipskaia L, 2000, CIRC RES, V86, P795, DOI 10.1161/01.RES.86.7.795; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Lyashkov AE, 2007, CIRC RES, V100, P1723, DOI 10.1161/CIRCRESAHA.107.153676; Maltsev VA, 2004, BIOPHYS J, V86, P2596, DOI 10.1016/S0006-3495(04)74314-3; Maltsev VA, 2006, J PHARMACOL SCI, V100, P338, DOI 10.1254/jphs.CR0060018; MASSONPEVET M, 1979, CIRC RES, V45, P621, DOI 10.1161/01.RES.45.5.621; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Sanders L, 2006, J PHYSIOL-LONDON, V571, P639, DOI 10.1113/jphysiol.2005.100305; Schwencke C, 1999, MOL ENDOCRINOL, V13, P1061, DOI 10.1210/me.13.7.1061; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Stieber J, 2006, MOL PHARMACOL, V69, P1328, DOI 10.1124/mol.105.020701; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Swaney JS, 2006, J BIOL CHEM, V281, P17173, DOI 10.1074/jbc.M513097200; TARASOVA YS, 2006, EMBRYONIC STEM CELLS; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TOBISE K, 1994, CIRC RES, V74, P596, DOI 10.1161/01.RES.74.4.596; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2004, CIRC RES, V94, P802, DOI 10.1161/01.RES.0000122045.55331.0F; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271; VINOGRADOVA TM, 2006, BIOPHYS J, V90, pA155; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6	45	77	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14461	14468		10.1074/jbc.M707540200	http://dx.doi.org/10.1074/jbc.M707540200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356168	hybrid, Green Published			2022-12-27	WOS:000255941400033
J	Joly, N; Burrows, PC; Buck, M				Joly, Nicolas; Burrows, Patricia C.; Buck, Martin			An intramolecular route for coupling ATPase activity in AAA(+) proteins for transcription activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEINS; PROMOTER DNA COMPLEX; ESCHERICHIA-COLI; FUNCTIONAL DOMAINS; ALUMINUM FLUORIDE; PLUS ATPASES; MECHANISM; PSPF; SIGMA(54); SIGMA-54	AAA(+) proteins ( ATPases associated with various cellular activities) contribute to many cellular processes and typically function as higher order oligomers permitting the coordination of nucleotide hydrolysis for functional output, which leads to substrate remodeling. The precise mechanisms that enable the relay of nucleotide hydrolysis to their specific functional outputs are largely unknown. Here we use PspF, a specialized AAA(+) protein required for enhancer-dependent transcription activation in Escherichia coli, as a model system to address this question. We demonstrate that a conserved asparagine is involved in internal organization of the oligomeric ring, regulation of ATPase activity by "trans" factors, and optimizing substrate remodeling. We provide evidence that the spatial relationship between the asparagine residue and the Walker B motif is one key element in the conformational signaling pathway that leads to substrate remodeling. Such functional organization most likely applies to other AAA(+) proteins, including Ltag ( simian virus 40), Rep40 (Adeno-associated virus-2), and p97 (Mus musculus) in which the asparagine to Walker B motif relationship is conserved.	[Joly, Nicolas; Burrows, Patricia C.; Buck, Martin] Imperial Coll London, Div Biol, London SW7 2AZ, England	Imperial College London	Buck, M (corresponding author), Imperial Coll London, Div Biol, London SW7 2AZ, England.	m.buck@imperial.ac.uk	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827	BBSRC [BB/G001278/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001278/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bordes P, 2004, MOL MICROBIOL, V54, P489, DOI 10.1111/j.1365-2958.2004.04280.x; Burrows PC, 2008, J MOL BIOL, V375, P43, DOI 10.1016/j.jmb.2007.10.045; Burrows PC, 2004, EMBO J, V23, P4253, DOI 10.1038/sj.emboj.7600406; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Joly N, 2008, J MOL BIOL, V375, P1206, DOI 10.1016/j.jmb.2007.11.050; Joly N, 2007, MOL MICROBIOL, V66, P583, DOI 10.1111/j.1365-2958.2007.05901.x; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; Jovanovic G, 1999, J MOL BIOL, V285, P469, DOI 10.1006/jmbi.1998.2263; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Lin YC, 2005, NAT STRUCT MOL BIOL, V12, P603, DOI 10.1038/nsmb949; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; MAYER AN, 1995, GENE, V153, P1, DOI 10.1016/0378-1119(94)00752-E; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; Schumacher J, 2004, J MOL BIOL, V338, P863, DOI 10.1016/j.jmb.2004.02.071; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	37	27	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13725	13735		10.1074/jbc.M800801200	http://dx.doi.org/10.1074/jbc.M800801200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326037	hybrid			2022-12-27	WOS:000255728200024
J	Brazier, MW; Davies, P; Player, E; Marken, F; Viles, JH; Brown, DR				Brazier, Marcus W.; Davies, Paul; Player, Esmie; Marken, Frank; Viles, John H.; Brown, David R.			Manganese binding to the prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION BINDING; FULL-LENGTH; COPPER-BINDING; RESISTANT PRION; HIGH-AFFINITY; SCRAPIE; COORDINATION; RECOMBINANT; GENERATION; CONVERSION	There is considerable evidence that the prion protein binds copper. However, there have also been suggestions that prion protein (PrP) binds manganese. We used isothermal titration calorimetry to identify the manganese binding sites in wild-type mouse PrP. The protein showed two manganese binding sites with affinities that would bind manganese at concentrations of 63 and 200 mu M at pH 5.5. This indicates that PrP binds manganese with affinity similar to other known manganese-binding proteins. Further study indicated that the main manganese binding site is associated with His-95 in the so-called "fifth site" normally associated with copper binding. Additionally, it was shown that occupancy by copper does not prevent manganese binding. Under these conditions, manganese binding resulted in an altered conformation of PrP, displacement of copper, and altered redox chemistry of the metal-protein complex. Cyclic voltammetric measurements suggested a complex redox chemistry involving manganese bound to PrP, whereas copper-bound PrP was able to undergo fully reversible electron cycling. Additionally, manganese binding to PrP converted it to a form able to catalyze aggregation of metal-free PrP. These results further support the notion that manganese binding could cause a conformation change in PrP and trigger changes in the protein similar to those associated with prion disease.	[Brazier, Marcus W.; Davies, Paul; Player, Esmie; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Marken, Frank] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England; [Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Bath; University of Bath; University of London	Brown, DR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk	Marken, Frank/H-7674-2014; Marken, Frank/AAG-3210-2020	Marken, Frank/0000-0003-3177-4562; Marken, Frank/0000-0003-3177-4562; Davies, Paul/0000-0001-8022-2719	Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: Medline; BBSRC [BB/D005027/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Bellini P, 2006, BIOCHEMISTRY-US, V45, P2686, DOI 10.1021/bi052081n; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 2004, J INORG BIOCHEM, V98, P133, DOI 10.1016/j.jinorgbio.2003.09.006; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Cui T, 2003, EUR J BIOCHEM, V270, P3368, DOI 10.1046/j.1432-1033.2003.03717.x; del Pino P, 2007, EUR BIOPHYS J BIOPHY, V36, P239, DOI 10.1007/s00249-006-0124-0; Deloncle R, 2006, NEUROTOXICOLOGY, V27, P437, DOI 10.1016/j.neuro.2006.01.003; DESMET J, 1988, BIOCHIM BIOPHYS ACTA, V957, P411, DOI 10.1016/0167-4838(88)90232-4; Erikson KM, 2006, NEUROTOXICOLOGY, V27, P125, DOI 10.1016/j.neuro.2005.07.003; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Giese A, 2004, BIOCHEM BIOPH RES CO, V320, P1240, DOI 10.1016/j.bbrc.2004.06.075; Hesketh S, 2007, J ANIM SCI, V85, P1596, DOI 10.2527/jas.2006-714; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Horton TE, 1998, BIOCHEMISTRY-US, V37, P18094, DOI 10.1021/bi981425p; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jones CE, 2005, J MOL BIOL, V346, P1393, DOI 10.1016/j.jmb.2004.12.043; Jose TJ, 1999, J BIOL INORG CHEM, V4, P814, DOI 10.1007/s007750050355; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; Kramer ML, 2001, J BIOL CHEM, V276, P16711, DOI 10.1074/jbc.M006554200; Lekishvili T, 2004, EXP NEUROL, V190, P233, DOI 10.1016/j.expneurol.2004.07.002; Mauk MR, 1998, BIOCHEMISTRY-US, V37, P6767, DOI 10.1021/bi972932u; McKenzie D, 1998, J BIOL CHEM, V273, P25545, DOI 10.1074/jbc.273.40.25545; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Ragnarsdottir KV, 2006, J GEOCHEM EXPLOR, V88, P228, DOI 10.1016/j.gexplo.2005.08.046; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Semin BK, 2006, BBA-BIOENERGETICS, V1757, P189, DOI 10.1016/j.bbabio.2006.02.001; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Treiber C, 2007, J BIOL INORG CHEM, V12, P711, DOI 10.1007/s00775-007-0220-3; Treiber C, 2006, BIOCHEMISTRY-US, V45, P6674, DOI 10.1021/bi060244h; Tsenkova RN, 2004, BIOCHEM BIOPH RES CO, V325, P1005, DOI 10.1016/j.bbrc.2004.10.135; UPPINGTON KM, 2008, IN PRESS J NEUROCHEM; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Zhu F, 2008, BIOCHEMISTRY-US, V47, P2510, DOI 10.1021/bi7022893	51	84	84	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12831	12839		10.1074/jbc.M709820200	http://dx.doi.org/10.1074/jbc.M709820200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332141	hybrid			2022-12-27	WOS:000255499800019
J	Suzuki, R; Wada, J; Katayama, T; Fushinobu, S; Wakagi, T; Shoun, H; Sugimoto, H; Tanaka, A; Kumagai, H; Ashida, H; Kitaoka, M; Yamamoto, K				Suzuki, Ryuichiro; Wada, Jun; Katayama, Takane; Fushinobu, Shinya; Wakagi, Takayoshi; Shoun, Hirofumi; Sugimoto, Hayuki; Tanaka, Akiyoshi; Kumagai, Hidehiko; Ashida, Hisashi; Kitaoka, Motomitsu; Yamamoto, Kenji			Structural and thermodynamic analyses of solute-binding protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; GLYCOSIDE HYDROLASE FAMILY; T-ANTIGEN DISACCHARIDE; X-RAY-ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HUMAN-MILK; ACTIVE-TRANSPORT; PEANUT LECTIN; L-ARABINOSE	Recently, a gene cluster involving a phosphorylase specific for lacto-N-biose I (LNB; Gal beta 1-3GlcNAc) and galacto-N-biose (GNB; Gal beta 1-3GalNAc) has been found in Bifidobacterium longum. We showed that the solute-binding protein of a putative ATP-binding cassette-type transporter encoded in the cluster crystallizes only in the presence of LNB or GNB, and therefore we named it GNB/LNB-binding protein (GL-BP). Isothermal titration calorimetry measurements revealed that GL-BP specifically binds LNB and GNB with K-d values of 0.087 and 0.010 mu M, respectively, and the binding process is enthalpy-driven. The crystal structures of GL-BP complexed with LNB, GNB, and lacto-N-tetraose ( Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc) were determined. The interactions between GL-BP and the disaccharide ligands mainly occurred through water-mediated hydrogen bonds. In comparison with the LNB complex, one additional hydrogen bond was found in the GNB complex. These structural characteristics of ligand binding are in agreement with the thermodynamic properties. The overall structure of GL-BP was similar to that of maltose-binding protein; however, the mode of ligand binding and the thermodynamic properties of these proteins were significantly different.	[Suzuki, Ryuichiro; Fushinobu, Shinya; Wakagi, Takayoshi; Shoun, Hirofumi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Wada, Jun; Ashida, Hisashi; Yamamoto, Kenji] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Wada, Jun; Katayama, Takane; Kumagai, Hidehiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Sugimoto, Hayuki; Tanaka, Akiyoshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Kitaoka, Motomitsu] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; Kyoto University; Ishikawa Prefecture University; Mie University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Wada, J (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Kitaoka, Motomitsu/R-1536-2019; Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021; Ashida, Hisashi/HCI-0293-2022	Kitaoka, Motomitsu/0000-0002-0083-1838; Fushinobu, Shinya/0000-0003-1346-6435; Ashida, Hisashi/0000-0001-5844-4075; Katayama, Takane/0000-0003-4009-7874; Sugimoto, Hayuki/0000-0002-0171-7631				Adhikari P, 2001, J BIOL CHEM, V276, P40734, DOI 10.1074/jbc.M103040200; [Anonymous], BIOCH PHYSL BIFIDOBA; BENNO Y, 1984, MICROBIOL IMMUNOL, V28, P975, DOI 10.1111/j.1348-0421.1984.tb00754.x; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; Campobasso N, 1998, BIOCHEMISTRY-US, V37, P15981, DOI 10.1021/bi981673l; Carrizo ME, 2005, J BIOL CHEM, V280, P10614, DOI 10.1074/jbc.M411989200; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Daranas AH, 2004, J AM CHEM SOC, V126, P11870, DOI 10.1021/ja048054m; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; FUKADA H, 1983, J BIOL CHEM, V258, P3193; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; HAEUWFIEVRE S, 1993, EUR J BIOCHEM, V215, P361, DOI 10.1111/j.1432-1033.1993.tb18042.x; HE JJ, 1993, PROTEIN SCI, V2, P1643, DOI 10.1002/pro.5560021010; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Hu YL, 1997, NAT STRUCT BIOL, V4, P703, DOI 10.1038/nsb0997-703; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jeyaprakash AA, 2002, J MOL BIOL, V321, P637, DOI 10.1016/S0022-2836(02)00674-5; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kobata A, 1978, Methods Enzymol, V50, P216, DOI 10.1016/0076-6879(78)50023-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; LANDICK R, 1982, MEMBRANES TRANSPORT, P81; LARSON G, 1988, J BIOL CHEM, V263, P10790; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; MacRaild CA, 2007, J MOL BIOL, V368, P822, DOI 10.1016/j.jmb.2007.02.055; MAGNANI JL, 1983, CANCER RES, V43, P5489; Martin-Pastor M, 2000, BIOCHEMISTRY-US, V39, P4674, DOI 10.1021/bi992050q; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natchiar SK, 2004, ACTA CRYSTALLOGR D, V60, P211, DOI 10.1107/S090744490302849X; Newburg D, 1995, HDB MILK COMPOSITION, P273; NEWMAN RA, 1979, J NATL CANCER I, V63, P1339; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; QUIOCHO FA, 1977, J BIOL CHEM, V252, P5142; Ravishankar R, 1997, CURR SCI INDIA, V72, P855; ROTIMI VO, 1981, J MED MICROBIOL, V14, P51, DOI 10.1099/00222615-14-1-51; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Schafer K, 2004, J MOL BIOL, V335, P261, DOI 10.1016/j.jmb.2003.10.042; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; SHARFF AJ, 1993, BIOCHEMISTRY-US, V32, P10553, DOI 10.1021/bi00091a004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Springer G F, 1990, Immunol Ser, V53, P587; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sugiyama S, 1996, PROTEIN SCI, V5, P1984, DOI 10.1002/pro.5560051004; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Tonozuka T, 2007, FEBS J, V274, P2109, DOI 10.1111/j.1742-4658.2007.05753.x; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; VandenAkker F, 1996, PROTEIN SCI, V5, P1184; Wada J, 2007, ACTA CRYSTALLOGR F, V63, P751, DOI 10.1107/S1744309107036263; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Wu HC, 1996, ESCHERICHIA COLI SAL, V1, P1005	76	88	90	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13165	13173		10.1074/jbc.M709777200	http://dx.doi.org/10.1074/jbc.M709777200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332142	hybrid			2022-12-27	WOS:000255499800056
J	Liu, HY; Collins, QF; Moukdar, F; Zhuo, DG; Han, JM; Hong, T; Collins, S; Cao, WH				Liu, Hui-Yu; Collins, Qu Fan; Moukdar, Fatiha; Zhuo, Degen; Han, Jianmin; Hong, Tao; Collins, Sheila; Cao, Wenhong			Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR FOXO1; METABOLIC CONTROL; SKELETAL-MUSCLE; MAP KINASE; C-SRC; GLUCONEOGENESIS; RESISTANCE; EXPRESSION; HEPATOCYTES	In this study, we tested the hypothesis that human neutrophil alpha-defensins (HNPs) inhibit hepatic glucose production through a signaling pathway distinct from insulin. The effect of HNP-1 on fasting blood glucose levels and the expression of hepatic gluconeogenic genes was first examined. Using hyperinsuline-miceuglycemic clamps, we determined the effect of HNP-1 on endogenous glucose production, hepatic expression of key gluconeogenic genes and glucose uptake in skeletal muscle in Zucker diabetic fatty rats. In isolated primary hepatocytes, we studied the effect of HNP-1 and -2 on glucose production, expression of gluconeogenic genes, and phosphorylation of Akt, c-Src, and FoxO1. Our results show that HNP-1 reduced blood glucose levels of both normal mice and Zucker diabetic fatty rats predominantly through suppression of hepatic glucose production. HNPs inhibited glycogenolysis and gluconeogenesis in isolated hepatocytes. HNPs also suppressed expression of key gluconeogenic genes including phosphoenoylpyruvate carboxyl kinase and glucose-6-phosphatase. To investigate the mechanism, we found that HNPs stimulated phosphorylation of Akt and FoxO1 without activating IRS1. Nevertheless, HNPs activated c-Src. Blockade of c-Src activity with either a chemical inhibitor PP2 or an alternative inhibitor CSK prevented the inhibitory effect of HNPs on gluconeogenesis. Together, our results support the hypothesis that HNPs can suppress hepatic glucose production through an intracellular mechanism distinct from the classical insulin signaling pathway.	[Liu, Hui-Yu; Collins, Qu Fan; Moukdar, Fatiha; Zhuo, Degen; Han, Jianmin; Hong, Tao; Collins, Sheila; Cao, Wenhong] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Collins, Sheila] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Collins, Sheila; Cao, Wenhong] Duke Univ, Med Ctr, Dept Med Endocrinol, Durham, NC 27710 USA	The Hamner Institutes for Health Sciences; Duke University; Duke University	Cao, WH (corresponding author), Hamner Inst Hlth Sci, Div Translat Biol, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK076039-01A2, R01 DK076039, R01DK076039] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; ARDAWI MSM, 1989, J LAB CLIN MED, V114, P579; Berasi SP, 2006, J BIOL CHEM, V281, P27167, DOI 10.1074/jbc.M602416200; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chakravarty K, 2007, NUTR REV, V65, pS47, DOI [10.1111/j.1753-4887.2007.tb00328.x, 10.1301/nr.2007.jun.S47-S56]; Chavakis T, 2004, FASEB J, V18, P1306, DOI 10.1096/fj.03-1009fje; Cherrington AD, 2002, DIABETES, V51, pS103, DOI 10.2337/diabetes.51.2007.S103; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; DEVASCONCELOS PRL, 1987, CLIN SCI, V72, P683, DOI 10.1042/cs0720683; Diaz B, 2001, LIFE SCI, V68, P2925, DOI 10.1016/S0024-3205(01)01087-6; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Froy O, 2007, MOL IMMUNOL, V44, P796, DOI 10.1016/j.molimm.2006.04.009; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Giovambattista A, 2000, NEUROIMMUNOMODULAT, V7, P92, DOI 10.1159/000026426; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hiratsuka T, 2001, NEPHRON, V88, P65, DOI 10.1159/000045961; Jin CJ, 2007, J NUTR, V137, P339, DOI 10.1093/jn/137.2.339; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; KENISON DC, 1991, AM J VET RES, V52, P1320; Kim JK, 2003, DIABETES, V52, P1311, DOI 10.2337/diabetes.52.6.1311; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu YJ, 2005, DIABETES, V54, P32, DOI 10.2337/diabetes.54.1.32; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; ROMIJN JA, 1990, J ENDOCRINOL INVEST, V13, P743, DOI 10.1007/BF03349613; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SHIOMI K, 1993, BIOCHEM BIOPH RES CO, V195, P1336, DOI 10.1006/bbrc.1993.2190; Syeda F, 2008, J CELL PHYSIOL, V214, P820, DOI 10.1002/jcp.21279; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65	48	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12056	12063		10.1074/jbc.M801033200	http://dx.doi.org/10.1074/jbc.M801033200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18347011	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000255340000021
J	Narayana, Y; Balaji, KN				Narayana, Yeddula; Balaji, Kithiganahalli Narayanaswamy			NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 expression in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; KAPPA-B ACTIVITY; IFN-GAMMA; NONPATHOGENIC MYCOBACTERIA; MAMMALIAN TARGET; TNF-ALPHA; T-CELLS; TUBERCULOSIS; PATHWAY; SUPPRESSOR	Suppressor of cytokine signaling ( SOCS) 3 is a critical negative regulator of cytokine signaling and is induced by Mycobacterium bovis Bacille Calmette-Guerin ( M. bovis BCG) in mouse macrophages. However, little is known about the early receptor proximal signaling mechanisms underlying mycobacteria-mediated induction of SOCS3. We demonstrate here for the first time that M. bovis BCG up-regulates NOTCH1 and activates the NOTCH1 signaling pathway, leading to the expression of SOCS3. We show that perturbing Notch signaling in infected macrophages results in the marked reduction in the expression of SOCS3. Furthermore, enforced expression of the Notch1 intracellular domain in RAW 264.7 macrophages induces the expression of SOCS3, which can be further potentiated by M. bovis BCG. The perturbation of Toll-like receptor (TLR) 2 signaling resulted in marked reduction in SOCS3 levels and expression of the NOTCH1 target gene, Hes1. The down-regulation of MyD88 resulted in a significant decrease in SOCS3 expression, implicating the role of the TLR2-MyD88 axis in M. bovis BCG-triggered signaling. However, the SOCS3 inducing ability of M. bovis BCG remains unaltered also upon infection of macrophages from TLR4-defective C3H/HeJ mice. More importantly, signaling perturbation data suggest the involvement of crosstalk among members of the phosphoinositide 3-kinase and mitogen-activated protein kinase cascades with NOTCH1 signaling in SOCS3 expression. Furthermore, SOCS3 expression requires the NOTCH1-mediated recruitment of Suppressor of Hairless (CSL) and nuclear factor-kappa B to the Socs3 promoter. Overall, these results implicate NOTCH1 signaling during inducible expression of SOCS3 following infection of macrophages with an intracellular bacillus-like M. bovis BCG.	[Narayana, Yeddula; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	Yeddula, Narayana/H-4893-2011					Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; FALCONE V, 1994, FEMS IMMUNOL MED MIC, V8, P225, DOI 10.1111/j.1574-695X.1994.tb00447.x; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jonsson JI, 2001, EUR J IMMUNOL, V31, P3240, DOI 10.1002/1521-4141(200111)31:11<3240::AID-IMMU3240>3.0.CO;2-E; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kaufmann SHE, 2005, NEW ENGL J MED, V353, P2423, DOI 10.1056/NEJMp058131; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Sommer U, 2005, J BIOL CHEM, V280, P31478, DOI 10.1074/jbc.M506008200; Stoiber D, 1999, J IMMUNOL, V163, P2640; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; WHO, 2007, WHOHTMTB2007376; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zlobin A., 2000, Current Pharmaceutical Biotechnology, V1, P83, DOI 10.2174/1389201003379013	59	77	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12501	12511		10.1074/jbc.M709960200	http://dx.doi.org/10.1074/jbc.M709960200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332140	hybrid			2022-12-27	WOS:000255340000066
J	Hu, J; Hu, K; Williams, DC; Komlosh, ME; Cai, M; Clore, GM				Hu, Jun; Hu, Kaifeng; Williams, David C., Jr.; Komlosh, Michal E.; Cai, Mengli; Clore, G. Marius			Solution NMR structures of productive and non-productive complexes between the A and B domains of the cytoplasmic subunit of the mannose transporter of the Escherichia coli phosphotransferase system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYL TRANSFER COMPLEX; BACTERIAL PHOSPHOENOLPYRUVATE; 3-DIMENSIONAL STRUCTURES; DIPOLAR COUPLINGS; STEREOCHEMICAL COURSE; DISTANCE GEOMETRY; PROTEIN COMPLEXES; IIAB(MAN) SUBUNIT; MACROMOLECULES; REFINEMENT	Solution structures of complexes between the isolated A (IIA(Man)) and B (IIBMan) domains of the cytoplasmic component of the mannose transporter of Escherichia coli have been solved by NMR. The complex of wild-type IIA(Man) and IIBMan is a mixture of two species comprising a productive, phosphoryl transfer competent complex and a non-productive complex with the two active site histidines, His-10 of IIA(Man) and His-175 of IIBMan, separated by similar to 25 angstrom. Mutation of the active site histidine, His-10, of IIA(Man) to a glutamate, to mimic phosphorylation, results in the formation of a single productive complex. The apparent equilibrium dissociation constants for the binding of both wild-type and H10E IIA(Man) to IIBMan are approximately the same (K-D similar to 0.5mM). The productive complex can readily accommodate a transition state involving a pentacoordinate phosphoryl group with trigonal bipyramidal geometry bonded to the N epsilon 2 atom of His-10 of IIA(Man) and the N delta 1 atom of His-175 of IIBMan with negligible (< 0.2 angstrom) local backbone conformational changes in the immediate vicinity of the active site. The non-productive complex is related to the productive one by a similar to 90 rotation and similar to 37 angstrom translation of IIBMan relative to IIA(Man), leaving the active site His-175 of IIBMan fully exposed to solvent in the non-productive complex. The interaction surface on IIA(Man) for the non-productive complex comprises a subset of residues used in the productive complex and in both cases involves both subunits of IIA(Man). The selection of the productive complex by IIA(Man)(H10E) can be attributed to neutralization of the positively charged Arg-172 of IIBMan at the center of the interface. The non-productive IIA(Man)-IIBMan complex may possibly be relevant to subsequent phosphoryl transfer from His-175 of IIBMan to the incoming sugar located on the transmembrane IICMan-IIDMan complex.	[Hu, Jun; Hu, Kaifeng; Williams, David C., Jr.; Komlosh, Michal E.; Cai, Mengli; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,B1-301, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029043, ZIADK029023, Z01DK029023] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; BAX A, 1994, METHOD ENZYMOL, V239, P79; BEGLEY GS, 1982, BIOCHEMISTRY-US, V21, P5552, DOI 10.1021/bi00265a026; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P979; Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 2002, J MAGN RESON, V154, P329, DOI 10.1006/jmre.2001.2489; Clore GM, 2002, J AM CHEM SOC, V124, P2866, DOI 10.1021/ja017712p; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; CLORE GM, 1987, EMBO J, V6, P529, DOI 10.1002/j.1460-2075.1987.tb04785.x; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; ERNI B, 1989, J BIOL CHEM, V264, P18733; ERNI B, 1987, J BIOL CHEM, V262, P5238; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Gutknecht R, 1999, J BIOL CHEM, V274, P6091, DOI 10.1074/jbc.274.10.6091; Gutknecht R, 1998, J BIOL CHEM, V273, P12234, DOI 10.1074/jbc.273.20.12234; HOLLFELDER F, 1995, BIOCHEMISTRY-US, V34, P12255, DOI 10.1021/bi00038a021; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kay LE, 2005, J MAGN RESON, V173, P193, DOI 10.1016/j.jmr.2004.11.021; KUSZEWSKI J, 1995, J MAGN RESON SER B, V106, P92, DOI 10.1006/jmrb.1995.1017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; MAO QC, 1995, J BIOL CHEM, V270, P5258, DOI 10.1074/jbc.270.10.5258; MARKOVICHOUSLEY Z, 1994, BIOCHEMISTRY-US, V33, P10977, DOI 10.1021/bi00202a017; MARTINVERSTRAETE I, 1990, J MOL BIOL, V214, P657, DOI 10.1016/0022-2836(90)90284-S; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; MUELLER EG, 1990, BIOCHEMISTRY-US, V29, P6892, DOI 10.1021/bi00481a019; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; RHIEL E, 1994, BIOL CHEM H-S, V375, P551, DOI 10.1515/bchm3.1994.375.8.551; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Schwieters CD, 2008, J PHYS CHEM B, V112, P6070, DOI 10.1021/jp076244o; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; Suh JY, 2007, P NATL ACAD SCI USA, V104, P3153, DOI 10.1073/pnas.0609103104; Suh JY, 2006, J BIOL CHEM, V281, P8939, DOI 10.1074/jbc.M513466200; vanMontfort RLM, 1997, STRUCTURE, V5, P217, DOI 10.1016/S0969-2126(97)00180-9; VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; WEHMEIER UF, 1994, BBA-PROTEIN STRUCT M, V1208, P348, DOI 10.1016/0167-4838(94)90124-4; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; WILLIAMS N, 1986, P NATL ACAD SCI USA, V83, P8934, DOI 10.1073/pnas.83.23.8934	63	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					11024	11037		10.1074/jbc.M800312200	http://dx.doi.org/10.1074/jbc.M800312200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18270202	Green Published, hybrid			2022-12-27	WOS:000254894700083
J	Kumanovics, A; Chen, OS; Li, LT; Bagley, D; Adkins, EM; Lin, HL; Dingra, NN; Outten, CE; Keller, G; Winge, D; Ward, DM; Kaplan, J				Kumanovics, Attila; Chen, Opal S.; Li, Liangtao; Bagley, Dustin; Adkins, Erika M.; Lin, Huilan; Dingra, Nin N.; Outten, Caryn E.; Keller, Greg; Winge, Dennis; Ward, Diane M.; Kaplan, Jerry			Identification of FRA1 and FRA2 as genes involved in regulating the yeast iron regulon in response to decreased mitochondrial iron-sulfur cluster synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN BIOGENESIS; OXIDATIVE STRESS; ACTIVE-SITE; TRANSCRIPTION; AFT1P; LOCALIZATION; EXPRESSION; MEDIATOR; SYSTEM	The nature of the connection between mitochondrial Fe-S cluster synthesis and the iron-sensitive transcription factor Aft1 in regulating the expression of the iron transport system in Saccharomyces cerevisiae is not known. Using a genetic screen, we identified two novel cytosolic proteins, Fra1 and Fra2, that are part of a complex that interprets the signal derived from mitochondrial Fe-S synthesis. We found that mutations in FRA1 (YLL029W) and FRA2 (YGL220W) led to an increase in transcription of the iron regulon. In cells incubated in high iron medium, deletion of either FRA gene results in the translocation of the low iron-sensing transcription factor Aft1 into the nucleus, where it occupies the FET3 promoter. Deletion of either FRA gene has the same effect on transcription as deletion of both genes and is not additive with activation of the iron regulon due to loss of mitochondrial Fe-S cluster synthesis. These observations suggest that the FRA proteins are in the same signal transduction pathway as Fe-S cluster synthesis. We show that Fra1 and Fra2 interact in the cytosol in an iron-independent fashion. The Fra1-Fra2 complex binds to Grx3 and Grx4, two cytosolic monothiol glutaredoxins, in an iron-independent fashion. These results show that the Fra-Grx complex is an intermediate between the production of mitochondrial Fe-S clusters and transcription of the iron regulon.	[Kumanovics, Attila; Chen, Opal S.; Li, Liangtao; Bagley, Dustin; Adkins, Erika M.; Lin, Huilan; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA; [Keller, Greg; Winge, Dennis] Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; [Keller, Greg; Winge, Dennis] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; [Dingra, Nin N.; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Kaplan, J (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu	Outten, Caryn E./I-9433-2019; Winge, Dennis/G-3611-2010; Lin, Huilan/B-7671-2013	Outten, Caryn E./0000-0003-0335-6531; 	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052380, R37DK030534, R01DK030534, T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES013780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA 42014] Funding Source: Medline; NIDDK NIH HHS [DK30534, DK52380, T32 DK07115-29] Funding Source: Medline; NIEHS NIH HHS [K22 ES013780, ES13780] Funding Source: Medline; NIGMS NIH HHS [GM083292] Funding Source: Medline; PHS HHS [5P30KD72437] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P16922, DOI 10.1073/pnas.232392299; Crisp RJ, 2006, EMBO J, V25, P512, DOI 10.1038/sj.emboj.7600961; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lesuisse E, 2005, GENETICS, V169, P107, DOI 10.1534/genetics.104.035873; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200	34	172	187	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10276	10286		10.1074/jbc.M801160200	http://dx.doi.org/10.1074/jbc.M801160200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281282	Green Published, hybrid			2022-12-27	WOS:000254894700008
J	Shank, LC; Kelley, JB; Gioeli, D; Yang, CS; Spencer, A; Allison, LA; Paschal, BM				Shank, Leonard C.; Kelley, Joshua B.; Gioeli, Daniel; Yang, Chun-Song; Spencer, Adam; Allison, Lizabeth A.; Paschal, Bryce M.			Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; GLUCOCORTICOID-RECEPTOR; PROSTATE-CANCER; PROGESTERONE-RECEPTORS; BINDING DOMAIN; MOLECULAR CHAPERONES; ESTROGEN-RECEPTOR; RESPONSE ELEMENT; LIGAND-BINDING; LIVING CELLS	The androgen receptor undergoes nuclear import in response to ligand, but the mechanism by which it undergoes nuclear export is poorly understood. We developed a permeabilized cell assay to characterize nuclear export of the androgen receptor in LNCaP prostate cancer cells. We found that nuclear export of endogenous androgen receptor can be stimulated by short double-stranded DNA oligonucleotides. This androgen receptor export pathway is dependent on ATP hydrolysis and is enhanced by phosphatase inhibition with okadaic acid. Fluorescence recovery after photobleaching in permeabilized cells, under the conditions that stimulate androgen receptor export, suggested that double-stranded DNA-dependent export does not simply reflect the relief of a nuclear retention mechanism. A radiolabeled androgen was used to show that the androgen receptor remains ligand-bound during translocation through the nuclear pore complex. A specific inhibitor to the DNA-dependent protein kinase, NU7026, inhibits androgen receptor export and phosphorylation. In living cells, NU7026 treatment increases androgen-dependent transcription from endogenous genes that are regulated by androgen receptor. We suggest that DNA-dependent protein kinase phosphorylation of the androgen receptor, or an interacting component, helps target the androgen receptor for export from the nucleus.	Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Gioeli, Daniel; Paschal, Bryce M.] Univ Virginia, Hlth Sci Ctr, Ctr Canc, Charlottesville, VA 22908 USA; [Allison, Lizabeth A.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA	University of Virginia; University of Virginia; William & Mary	Paschal, BM (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	paschal@virginia.edu	Kelley, Joshua Brian/S-1031-2019	Kelley, Joshua Brian/0000-0002-5700-1173	NATIONAL CANCER INSTITUTE [R01CA124706] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA124706] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; ARNOLD SF, 1995, J STEROID BIOCHEM, V52, P159, DOI 10.1016/0960-0760(94)00166-J; BAGCHI MK, 1992, P NATL ACAD SCI USA, V89, P2664, DOI 10.1073/pnas.89.7.2664; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; BANNISTER AJ, 1993, NUCLEIC ACIDS RES, V21, P1289, DOI 10.1093/nar/21.5.1289; Bentel JM, 1996, J ENDOCRINOL, V151, P1, DOI 10.1677/joe.0.1510001; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Brinkmann AO, 2000, NAT MED, V6, P628, DOI 10.1038/76194; Brinkmann AO, 2001, MOL CELL ENDOCRINOL, V179, P105, DOI 10.1016/S0303-7207(01)00466-X; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; CARTER TH, 1988, BIOCHEM BIOPH RES CO, V157, P535, DOI 10.1016/S0006-291X(88)80282-1; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; CLAESSENS F, 1989, BIOCHEM BIOPH RES CO, V164, P833, DOI 10.1016/0006-291X(89)91534-9; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; Daniel R, 1999, SCIENCE, V284, P644, DOI 10.1126/science.284.5414.644; DEFRANCO DB, 1991, MOL ENDOCRINOL, V5, P1215, DOI 10.1210/mend-5-9-1215; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Hammarsten O, 2000, J BIOL CHEM, V275, P1541, DOI 10.1074/jbc.275.3.1541; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kesler CT, 2007, MOL ENDOCRINOL, V21, P2071, DOI 10.1210/me.2007-0240; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Liu JM, 2000, MOL ENDOCRINOL, V14, P40, DOI 10.1210/me.14.1.40; Love DC, 1998, P NATL ACAD SCI USA, V95, P10608, DOI 10.1073/pnas.95.18.10608; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Martensson S, 2002, J BIOL CHEM, V277, P3020, DOI 10.1074/jbc.M106711200; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V304, P632, DOI 10.1016/S0006-291X(03)00651-X; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; PETERSON SR, 1995, J BIOL CHEM, V270, P1449, DOI 10.1074/jbc.270.3.1449; Prescott J, 2006, CANCER LETT, V231, P12, DOI 10.1016/j.canlet.2004.12.037; Qiu M, 2003, MOL ENDOCRINOL, V17, P628, DOI 10.1210/me.2002-0378; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Sackey FNA, 1996, MOL ENDOCRINOL, V10, P1191, DOI 10.1210/me.10.10.1191; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Savory JGA, 1999, MOL CELL BIOL, V19, P1025; Schoenmakers E, 2000, J BIOL CHEM, V275, P12290, DOI 10.1074/jbc.275.16.12290; Shank LC, 2005, CRIT REV EUKAR GENE, V15, P49, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.40; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Veuger SJ, 2003, CANCER RES, V63, P6008; Walther RF, 2003, J BIOL CHEM, V278, P37858, DOI 10.1074/jbc.M306356200; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Yang CS, 2007, MOL CELL BIOL, V27, P3390, DOI 10.1128/MCB.02411-06; Yang J, 1997, J CELL BIOL, V137, P523, DOI 10.1083/jcb.137.3.523; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x; Zhang LQ, 2003, CANCER RES, V63, P4552; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	70	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10568	10580		10.1074/jbc.M800810200	http://dx.doi.org/10.1074/jbc.M800810200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18270197	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000254894700039
J	Hazen, SL				Hazen, Stanley L.			Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LOW-DENSITY-LIPOPROTEIN; PLATELET-ACTIVATING-FACTOR; SCAVENGER RECEPTOR CD36; MACROPHAGE FOAM CELL; MOUSE PERITONEAL-MACROPHAGES; APOPTOTIC CELLS; FACTOR ACETYLHYDROLASE; PROTEIN MOIETIES; OXIDANT STRESS; LDL		[Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021		NHLBI NIH HHS [P01 HL077107, P01 HL076491, HL70621] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, R01HL070621, P50HL077107] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Boullier A, 2000, J BIOL CHEM, V275, P9163, DOI 10.1074/jbc.275.13.9163; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; de Assis EF, 2003, J IMMUNOL, V171, P2090, DOI 10.4049/jimmunol.171.4.2090; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; FABISIAK JP, 2004, METH MOL B, V291, P449; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gao SQ, 2006, J BIOL CHEM, V281, P31298, DOI 10.1074/jbc.M604039200; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Gillotte KL, 2000, J LIPID RES, V41, P824; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hazen SL, 2002, P NATL ACAD SCI USA, V99, P12515, DOI 10.1073/pnas.212532799; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; Marathe GK, 2001, TRENDS CARDIOVAS MED, V11, P139, DOI 10.1016/S1050-1738(01)00100-1; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Terpstra V, 1998, P NATL ACAD SCI USA, V95, P1806, DOI 10.1073/pnas.95.4.1806	49	139	146	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15527	15531		10.1074/jbc.R700054200	http://dx.doi.org/10.1074/jbc.R700054200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18285328	Green Published, hybrid			2022-12-27	WOS:000256332500004
J	Bazirgan, OA; Hampton, RY				Bazirgan, Omar A.; Hampton, Randolph Y.			Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; ENDOPLASMIC-RETICULUM DEGRADATION; ER-ASSOCIATED DEGRADATION; HMG-COA REDUCTASE; MEMBRANE-PROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; LIGASE COMPLEX; REGULATED DEGRADATION; POLYUBIQUITIN CHAINS; OVERLAP EXTENSION	Ubc7p is a ubiquitin-conjugating enzyme (E2) that functions with endoplasmic reticulum (ER)-resident ubiquitin ligases (E3s) to promote endoplasmic reticulum-associated degradation (ERAD). Ubc7p only functions in ERAD if bound to the ER surface by Cue1p, a membrane-anchored ER protein. The role of Cue1p was thought to involve passive concentration of Ubc7p at the surface of the ER. However, our biochemical studies of Ubc7p suggested that Cue1p may, in addition, stimulate Ubc7p E2 activity. We have tested this idea and found it to be true both in vitro and in vivo. Ubc7p bound to the soluble domain of Cue1p showed strongly enhanced in vitro ubiquitination activity, both in the presence and absence of E3. Cue1p also enhanced Ubc7p function in vivo, and this activation was separable from the established ER-anchoring role of Cue1p. Finally, we tested in vivo activation of Ubc7p by Cue1p in an assay independent of the ER membrane and ERAD. A chimeric E2 linking Ubc7p to the Cdc34p/Ubc3p localization domain complemented the cdc34-2 TS phenotype, and co-expression of the soluble Cue1p domain enhanced complementation by this chimeric Ubc7p E2. These studies reveal a previously unobserved stimulation of Ubc7p E2 activity by Cue1p that is critical for full ERAD and that functions independently of the well known Cue1p anchoring function. Moreover, it suggests a previously unappreciated mode for regulation of E2s by Cue1p-like interacting partners.	[Bazirgan, Omar A.; Hampton, Randolph Y.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@biomail.ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051996] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07240, GM51996-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bazirgan OA, 2006, J BIOL CHEM, V281, P38989, DOI 10.1074/jbc.M608174200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOSINK MM, 1995, P NATL ACAD SCI USA, V92, P9117, DOI 10.1073/pnas.92.20.9117; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JONES RB, 2002, INT J COMP PSYCHOL, V15, P1; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Mori S, 1997, EUR J BIOCHEM, V247, P1190, DOI 10.1111/j.1432-1033.1997.01190.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ptak C, 2001, MOL CELL BIOL, V21, P6537, DOI 10.1128/MCB.21.19.6537-6548.2001; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697	56	50	50	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12797	12810		10.1074/jbc.M801122200	http://dx.doi.org/10.1074/jbc.M801122200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321851	Green Published, hybrid			2022-12-27	WOS:000255499800016
J	Moore, KJ; Angevine, CM; Vincent, OD; Schwem, BE; Fillingame, RH				Moore, Kyle J.; Angevine, Christine M.; Vincent, Owen D.; Schwem, Brian E.; Fillingame, Robert H.			The cytoplasmic loops of subunit a of Escherichia coli ATP synthase may participate in the proton translocating mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; AQUEOUS ACCESS PATHWAYS; CROSS-LINKING; POTASSIUM CHANNEL; ROTARY MOTOR; C-SUBUNITS; MEMBRANE; RING; F-0; TRANSPORTER	Subunit a plays a key role in promoting H+ transport and the coupled rotary motion of the subunit c ring in F1F0-ATP synthase. H+ binding and release occur at Asp-61 in the middle of the second transmembrane helix (TMH) of F-0 subunit c. H+ are thought to reach Asp-61 via aqueous pathways mapping to the surfaces of TMHs 2 - 5 of subunit a based upon the chemical reactivity of Cys substituted into these helices. Here we substituted Cys into loops connecting TMHs 1 and 2 ( loop 1 - 2) and TMHs 3 and 4 ( loop 3 - 4). A large segment of loop 3 - 4 extending from loop residue 192 loop to residue 203 in TMH4 at the lipid bilayer surface proved to be very sensitive to inhibition by Ag+. Cys-161 and - 165 at the other end of the loop bordering TMH3 were also sensitive to inhibition by Ag+. Further Cys substitutions in residues 86 and 93 in the middle of the 1 - 2 loop proved to be Ag+-sensitive. We next asked whether the regions of Ag+-sensitive residues clustered together near the surface of the membrane by combining Cys substitutions from two domains and testing for cross-linking. Cys-161 and - 165 in loop 3 - 4 were found to cross-link with Cys-202, - 203, or - 205, which extend into TMH4 from the cytoplasm. Further Cys at residues 86 and 93 in loop 1 - 2 were found to cross-link with Cys-195 in loop 3 - 4. We conclude that the Ag+-sensitive regions of loops 1 - 2 and 3 - 4 may pack in a single domain that packs at the ends of TMHs 3 and 4. We suggest that the Ag+- sensitive domain may be involved in gating H+ release at the cytoplasmic side of the aqueous access channel extending through F-0.	[Moore, Kyle J.; Angevine, Christine M.; Vincent, Owen D.; Schwem, Brian E.; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREEN GAM, 1986, J BIOL CHEM, V261, P1680; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; COX GB, 1986, BIOCHIM BIOPHYS ACTA, V849, P62, DOI 10.1016/0005-2728(86)90096-4; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 2004, J BIOMOL NMR, V29, P439, DOI 10.1023/B:JNMR.0000032519.14221.20; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fillingame RH, 2000, BBA-BIOENERGETICS, V1458, P387, DOI 10.1016/S0005-2728(00)00089-X; FILLINGAME RH, 1991, J BIOL CHEM, V266, P20934; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FRAGA D, 1994, J BIOL CHEM, V269, P2562; GALINIS M, 1989, FEBS LETT, V249, P333; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; NAGLEY P, 1986, FEBS LETT, V195, P159, DOI 10.1016/0014-5793(86)80152-1; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; RAY MK, 1988, BIOCHIM BIOPHYS ACTA, V951, P213, DOI 10.1016/0167-4781(88)90042-5; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; von Glehn M, 1972, FEBS Lett, V20, P267, DOI 10.1016/0014-5793(72)80083-8; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang D, 2003, J BIOL CHEM, V278, P12319, DOI 10.1074/jbc.M212413200	53	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13044	13052		10.1074/jbc.M800900200	http://dx.doi.org/10.1074/jbc.M800900200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337242	Green Published, hybrid			2022-12-27	WOS:000255499800042
J	Pratt, G; Rechsteiner, M				Pratt, Gregory; Rechsteiner, Martin			Proteasomes cleave at multiple sites within polyglutamine tracts - Activation by PA28 gamma(K188E)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTONS-DISEASE; REG-GAMMA; NEURODEGENERATIVE DISEASES; TRINUCLEOTIDE REPEAT; PROTEIN AGGREGATION; MOUSE MODEL; CELL-DEATH; SYSTEM; IMPAIRMENT; TOXICITY	Eukaryotic proteasomes have been reported to cleave only once within polyglutamine tracts and then only after the N-terminal glutamine ( Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N., and Goldberg, A. L. ( 2004) Mol. Cell 14, 95-104). We have obtained results that directly conflict with that report. In the presence of the proteasome activator PA28 gamma(K188E) human red cell proteasomes progressively degraded fluorescein-GGQ(10)RR or fluorescein-HPHQ(10)RR into small fragments as shown by size exclusion chromatography and mass spectrometry. MALDI-TOF mass spectrometry revealed that proteolytic products arose from cleavage after every glutamine in fluorescein-HPHQ(10)RR, and mass accuracy rules out deamidation of glutamine to glutamic acid as an explanation for peptide degradation. Moreover, degradation cannot be attributed to a contaminating protease because peptide hydrolysis was completely blocked by the proteasome-specific inhibitors, lactacystin and epoxomicin. We conclude that proteasomes cleave repetitively anywhere within a stretch of ten glutamine residues. Thus our results cast doubt on the idea that mammalian proteasomes cannot degrade glutamine-expanded regions within pathogenic polyQ-expanded proteins, such as Huntingtin.	[Pratt, Gregory; Rechsteiner, Martin] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Rechsteiner, M (corresponding author), 15 N Med Dr E Rm 4100, Salt Lake City, UT 84112 USA.	marty@biochem.utah.edu			NINDS NIH HHS [NS042892] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042892] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; de Cristofaro T, 2000, BIOCHEM BIOPH RES CO, V272, P816, DOI 10.1006/bbrc.2000.2843; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Goellner GM, 2003, INT J BIOCHEM CELL B, V35, P562, DOI 10.1016/S1357-2725(02)00388-6; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Morfini G, 2005, TRENDS MOL MED, V11, P64, DOI 10.1016/j.molmed.2004.12.002; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Weydt P, 2006, EXPERT OPIN THER TAR, V10, P505, DOI 10.1517/14728222.10.4.505; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076	41	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12919	12925		10.1074/jbc.M709347200	http://dx.doi.org/10.1074/jbc.M709347200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343811	hybrid, Green Published			2022-12-27	WOS:000255499800028
J	Chiaverini, C; Beuret, L; Flori, E; Busca, R; Abbe, P; Bille, K; Bahadoran, P; Ortonne, JP; Bertolotto, C; Ballotti, R				Chiaverini, Christine; Beuret, Laurent; Flori, Enrica; Busca, Roser; Abbe, Patricia; Bille, Karine; Bahadoran, Philippe; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert			Microphthalmia-associated transcription factor regulates RAB27A gene expression and controls melanosome transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; MASTER REGULATOR; MET EXPRESSION; FACTOR MITF; MELANOCYTE; ELEMENTS; DEFECTS; CELLS; RAB8; CAMP	Melanosomes are lysosome-related organelles specialized in melanin synthesis and transport. In this study, we show that microphthalmia-associated transcription factor ( MITF) silencing induces melanosome gathering around the nucleus and causes the relocalization of Rab27A, Slac2a-Mlph, and Myo5a that control the transport of melanosomes on the actin network. In an attempt to elucidate the mechanism by which MITF controls melanosome distribution, we identify RAB27A as a new MITF target gene. Indeed, MITF silencing leads to a dramatic decrease in Rab27A expression and blocks the stimulation of Rab27A expression evoked by cAMP. Further, forced expression of MITF increases Rab27A expression, indicating that MITF is required and sufficient for Rab27A expression in melanoma cells. MITF binds to two E-boxes in the proximal region of the Rab27A promoter and stimulates its transcriptional activity. Finally, re-expression of Rab27A, in MITF-depleted cells, restores the transport of melanosomes to the cell periphery. These results show that RAB27A is a new direct transcriptional target of MITF and link MITF to melanosome transport, another key parameter of melanocyte differentiation and skin pigmentation. Interestingly, Rab27A is involved in other fundamental physiological functions, such as the transport of lytic granules and insulin secretion. Thus our results, deciphering the mechanism of Rab27A transcriptional regulation, have an interest that goes beyond the skin pigmentation field.	[Chiaverini, Christine; Beuret, Laurent; Busca, Roser; Abbe, Patricia; Bille, Karine; Bahadoran, Philippe; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert] INSERM, U895, F-06107 Nice 2, France; [Chiaverini, Christine; Beuret, Laurent; Abbe, Patricia; Bille, Karine; Bahadoran, Philippe; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert] Univ Nice Sophia Antipolis, UFR Med, F-06107 Nice, France; [Chiaverini, Christine; Bahadoran, Philippe; Ortonne, Jean-Paul; Bertolotto, Corine; Ballotti, Robert] CHU Nice, Dept Dermatol, F-06200 Nice, France; [Flori, Enrica] IRCCS, Ist Dermatol San Gallicano, Lab Fisiopatol Cutanea, I-00153 Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG)	Ballotti, R (corresponding author), INSERM, U895, 28 Ave Valombrose, F-06107 Nice 2, France.	ballotti@unice.fr	BALLOTTI, Robert/F-8825-2013; Bertolotto, Corine/AAF-6634-2021; Flori, Enrica/H-4417-2014; Bertolotto-Ballotti, Corine/O-2155-2016	Bertolotto, Corine/0000-0001-6971-7753; Flori, Enrica/0000-0002-9275-1041; BALLOTTI, Robert/0000-0002-7322-4908; Bahadoran, Philippe/0000-0002-2481-0556				Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Barral DC, 2004, PIGM CELL RES, V17, P111, DOI 10.1111/j.1600-0749.2004.00138.x; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Beuret L, 2007, J BIOL CHEM, V282, P14140, DOI 10.1074/jbc.M611563200; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chabrillat ML, 2005, MOL BIOL CELL, V16, P1640, DOI 10.1091/mbc.e04-09-0770; Chakraborty AK, 2003, CELL TISSUE RES, V314, P381, DOI 10.1007/s00441-003-0773-6; Chen YR, 2002, J INVEST DERMATOL, V118, P933, DOI 10.1046/j.1523-1747.2002.01754.x; Chu K, 2001, RECENT PROG HORM RES, V56, P23, DOI 10.1210/rp.56.1.23; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Gaggioli C, 2003, PIGM CELL RES, V16, P374, DOI 10.1034/j.1600-0749.2003.00057.x; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Goding CR, 2007, INT J BIOCHEM CELL B, V39, P275, DOI 10.1016/j.biocel.2006.10.003; Huan CM, 2006, NAT IMMUNOL, V7, P1082, DOI 10.1038/ni1378; Hume AN, 2007, J CELL SCI, V120, P3111, DOI 10.1242/jcs.010207; Jordens I, 2006, PIGM CELL RES, V19, P412, DOI 10.1111/j.1600-0749.2006.00329.x; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Menasche G, 2002, AM J HUM GENET, V71, P1237, DOI 10.1086/344140; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; Passeron T, 2004, FASEB J, V18, P989, DOI 10.1096/fj.03-1240fje; Scott G, 2001, J INVEST DERMATOL, V116, P296, DOI 10.1046/j.1523-1747.2001.01221.x; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Tolmachova T, 1999, GENE, V239, P109, DOI 10.1016/S0378-1119(99)00371-6; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002	38	81	85	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12635	12642		10.1074/jbc.M800130200	http://dx.doi.org/10.1074/jbc.M800130200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18281284	hybrid			2022-12-27	WOS:000255340000080
J	Dadsetan, S; Zakharova, L; Molinski, TF; Fomina, AF				Dadsetan, Sepehr; Zakharova, Liudmila; Molinski, Tadeusz F.; Fomina, Alla F.			Store-operated Ca2(+) influx causes Ca2(+) release from the intracellular Ca2(+) channels that is required for T cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CAPACITATIVE CALCIUM-ENTRY; SARCOPLASMIC-RETICULUM VESICLES; TYPE-3 RYANODINE RECEPTOR; CYCLIC ADP-RIBOSE; CA2+ ENTRY; PLASMA-MEMBRANE; LYMPHOCYTE-ACTIVATION; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION	The precise control of many T cell functions relies on cytosolic Ca2(+) dynamics that is shaped by the Ca2(+) release from the intracellular store and extracellular Ca2(+) influx. The Ca2(+) influx activated following T cell receptor (TCR)-mediated store depletion is considered to be a major mechanism for sustained elevation in cytosolic Ca2(+) concentration ([ Ca2(+)](i)) necessary for T cell activation, whereas the role of intracellular Ca2(+) release channels is believed to be minor. We found, however, that in Jurkat T cells [Ca2(+)] i elevation observed upon activation of the store-operated Ca2(+) entry (SOCE) by passive store depletion with cyclopiazonic acid, a reversible blocker of sarco-endoplasmic reticulum Ca2(+)-ATPase, inversely correlated with store refilling. This indicated that intracellular Ca2(+) release channels were activated in parallel with SOCE and contributed to global [ Ca2(+)] i elevation. Pretreating cells with (-)- xestospongin C (10 mu M) or ryanodine (400 mu M), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca2(+)] i elevation evoked by the passive store depletion or TCR ligation. Although the Ca2(+) release from the IP3R can be activated by TCR stimulation, the Ca2(+) release from the RyR was not inducible via TCR engagement and was exclusively activated by the SOCE. We also established that inhibition of IP3R or RyR down-regulated T cell proliferation and T-cell growth factor interleukin 2 production. These studies revealed a new aspect of [Ca2(+)]i signaling in T cells, that is SOCE-dependent Ca2(+) release via IP3R and/or RyR, and identified the IP3R and RyR as potential targets for manipulation of Ca2+-dependent functions of T lymphocytes.	[Dadsetan, Sepehr; Zakharova, Liudmila; Fomina, Alla F.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California Davis; University of California System; University of California San Diego	Fomina, AF (corresponding author), 4138 Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.	affomina@ucdavis.edu	Molinski, Tadeusz F/P-2125-2018					Bergling S, 1998, CELL CALCIUM, V23, P251, DOI 10.1016/S0143-4160(98)90123-3; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; BYRON KL, 1992, J BIOL CHEM, V267, P108; CHIESI M, 1981, ARCH BIOCHEM BIOPHYS, V208, P586, DOI 10.1016/0003-9861(81)90547-6; CHIESI M, 1980, BIOCHEMISTRY-US, V19, P2912, DOI 10.1021/bi00554a015; Conrad DM, 2004, J CELL BIOCHEM, V92, P387, DOI 10.1002/jcb.20064; Dadsetan S, 2005, J BIOL CHEM, V280, P16377, DOI 10.1074/jbc.M501202200; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DUPUIS G, 1988, J LEUKOCYTE BIOL, V43, P238, DOI 10.1002/jlb.43.3.238; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; HAKAMATA Y, 1994, FEBS LETT, V352, P206, DOI 10.1016/0014-5793(94)00955-4; HARNICK DJ, 1995, J BIOL CHEM, V270, P2833, DOI 10.1074/jbc.270.6.2833; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Kunerth S, 2004, J CELL SCI, V117, P2141, DOI 10.1242/jcs.01063; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma JJ, 2003, CELL CALCIUM, V33, P375, DOI 10.1016/S0143-4160(03)00050-2; Ma JJ, 2003, FRONT BIOSCI-LANDMRK, V8, pD242, DOI 10.2741/977; MISSIAEN L, 1990, J PHYSIOL-LONDON, V427, P171, DOI 10.1113/jphysiol.1990.sp018166; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Moon SS, 2002, J NAT PROD, V65, P249, DOI 10.1021/np010427z; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, BIOESSAYS, V21, P38; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yao J, 2004, J BIOL CHEM, V279, P21511, DOI 10.1074/jbc.M314028200; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; Zucchi R, 1997, PHARMACOL REV, V49, P1	47	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12512	12519		10.1074/jbc.M709330200	http://dx.doi.org/10.1074/jbc.M709330200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316371	hybrid			2022-12-27	WOS:000255340000067
J	Gregg, KJ; Finn, R; Abbott, DW; Boraston, AB				Gregg, Katie J.; Finn, Ron; Abbott, D. Wade; Boraston, Alisdair B.			Divergent modes of glycan recognition by a new family of carbohydrate-binding modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-PERFRINGENS; STRUCTURAL BASIS; OLIGOSACCHARIDE RECOGNITION; GLYCOSIDE HYDROLASE; REPLACEMENT; SPECIFICITY; REFINEMENT; ALIGNMENT; SEQUENCE	The genomes of myonecrotic Clostridium perfringens isolates contain genes encoding a large and fascinating array of highly modular glycoside hydrolase enzymes. Although the catalytic activities of many of these enzymes are somewhat predictable based on their amino acid sequences, the functions of their abundant ancillary modules are not and remain poorly studied. Here, we present the structural and functional analysis of a new family of ancillary carbohydrate-binding modules (CBMs), CBM51, which was previously annotated in data bases as the novel putative CBM domain. The high resolution crystal structures of two CBM51 members, GH95CBM51 and GH98CBM51, from a putative family 95 alpha-fucosidase and from a family 98 blood group A/B antigen-specific endo-beta-galactosidase, respectively, showed them to have highly similar beta-sandwich folds. However, GH95CBM51 was shown by glycan microarray screening, isothermal titration calorimetry, and x-ray crystallography to bind galactose residues, whereas the same analyses of GH98CBM51 revealed specificity for the blood group A/B antigens through non-conserved interactions. Overall, this work identifies a new family of CBMs with many members having apparent specificity for eukaryotic glycans, in keeping with the glycan-rich environment C. perfringens would experience in its host. However, a wider bioinformatic analysis of this CBM family also indicated a large number of members in non-pathogenic environmental bacteria, suggesting a role in the recognition of environmental glycans.	[Gregg, Katie J.; Finn, Ron; Abbott, D. Wade; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Boraston, Alisdair/0000-0001-6417-0592; Abbott, Wade/0000-0003-4893-5799	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62116] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Chitayat S, 2008, J MOL BIOL, V375, P20, DOI 10.1016/j.jmb.2007.10.031; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2002, ACTA CRYSTALLOGR D, V58, P976, DOI 10.1107/S0907444902005486; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kulkarni KA, 2007, PROTEINS, V68, P762, DOI 10.1002/prot.21428; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rigden DJ, 2005, FEBS LETT, V579, P5466, DOI 10.1016/j.febslet.2005.09.011; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van Bueren AL, 2004, J MOL BIOL, V340, P869, DOI 10.1016/j.jbm.2004.05.038; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	35	35	35	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12604	12613		10.1074/jbc.M709865200	http://dx.doi.org/10.1074/jbc.M709865200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18292090	Green Published, hybrid			2022-12-27	WOS:000255340000077
J	Mardones, P; Medina, JF; Elferink, RPJO				Mardones, Pablo; Medina, Juan F.; Elferink, Ronald P. J. Oude			Activation of cyclic AMP signaling in Ae2-deficient mouse fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; AE2 ANION-EXCHANGER; CYTOPLASMIC DOMAIN; GENETIC-DISEASES; INTRACELLULAR PH; SPLICE VARIANTS; C-FOS; CAMP; TRANSCRIPTION; EXPRESSION	Anion exchanger 2 (AE2, SLC4A2) is a ubiquitously expressed membrane solute carrier that regulates intracellular pH (pH(i)) by exchanging cytosolic bicarbonate for extracellular chloride. We used fibroblasts from Ae2-deficient (Ae2(a,b)(-/-)) mice to study the effects of an alkaline shift in resting intracellular pH (pH(i)) on the activation of cAMP signaling and gene expression. Ae2(a,b)(-/-) fibroblasts show increased pH(i) (by 0.22 +/- 0.03 unit) compared with wild type cells at extracellular pH (pH(o)) 7.4 and 37 degrees C. This shift in resting pHi is associated with an up-regulation of bicarbonate-activated soluble adenylyl cyclase expression, increased cAMP production, Creb phosphorylation, inducible cAMP early repressor 1 mRNA expression, and impaired activation of c-Fos transcription by forskolin. These results highlight the importance of bicarbonate transport via Ae2 in maintaining pHi homeostasis in cultured mouse fibroblasts and unveil the role of cAMP in the cellular response to chronic alkalization, which putatively includes an inducible cAMP early repressor 1-mediated attenuation of phosphorylated Creb activity.	[Mardones, Pablo; Elferink, Ronald P. J. Oude] Univ Amsterdam, Acad Med Ctr, Ctr Liver, NL-1105 BK Amsterdam, Netherlands; [Medina, Juan F.] Univ Navarra, Univ Hosp, Sch Med, Ctr Appl Med Res,Div Gene Therapy & Hepatol, E-31008 Pamplona, Spain	University of Amsterdam; Academic Medical Center Amsterdam; University of Navarra	Elferink, RPJO (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Liver, S1-162,Meibergdreef 69-71, NL-1105 BK Amsterdam, Netherlands.	r.p.oude-elferink@amc.uva.nl	Mardones Hiche, Pablo/B-8544-2009; Mardones, Pablo/ABG-3418-2021					Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; Baker JG, 2004, MOL PHARMACOL, V65, P986, DOI 10.1124/mol.65.4.986; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Behr R, 2001, INT J ANDROL, V24, P126, DOI 10.1046/j.1365-2605.2001.00277.x; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Bumke MA, 2003, PROTEOMICS, V3, P675, DOI 10.1002/pmic.200300395; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Foulkes NS, 1997, BIOL CELL, V89, P487, DOI 10.1016/S0248-4900(98)80004-X; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Kurschat CE, 2006, J BIOL CHEM, V281, P1885, DOI 10.1074/jbc.M509734200; Lamas M, 1996, PHILOS T R SOC B, V351, P561, DOI 10.1098/rstb.1996.0055; Lecanda J, 2000, BIOCHEM BIOPH RES CO, V276, P117, DOI 10.1006/bbrc.2000.3439; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medina JF, 2003, P NATL ACAD SCI USA, V100, P15847, DOI 10.1073/pnas.2536127100; Medina JF, 2000, BIOCHEM BIOPH RES CO, V267, P228, DOI 10.1006/bbrc.1999.1951; Misund K, 2007, J CELL BIOCHEM, V101, P1532, DOI 10.1002/jcb.21267; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; PETRONINI PG, 1995, J CELL PHYSIOL, V162, P322, DOI 10.1002/jcp.1041620304; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Recalde S, 2006, AM J PATHOL, V169, P165, DOI 10.2353/ajpath.2006.051096; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Steigedal TS, 2007, AM J PHYSIOL-GASTR L, V292, pG1062, DOI 10.1152/ajpgi.00287.2006; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; Sun Xing Cai, 2004, BMC Physiol, V4, P8, DOI 10.1186/1472-6793-4-8; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4	44	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12146	12153		10.1074/jbc.M710590200	http://dx.doi.org/10.1074/jbc.M710590200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319251	hybrid			2022-12-27	WOS:000255340000031
J	Tsumoto, K; Yokota, A; Tanaka, Y; Ui, M; Tsumuraya, T; Fujii, I; Kumagai, I; Nagumo, Y; Oguri, H; Inoue, M; Hirama, M				Tsumoto, Kouhei; Yokota, Akiko; Tanaka, Yoshikazu; Ui, Mihoko; Tsumuraya, Takeshi; Fujii, Ikuo; Kumagai, Izumi; Nagumo, Yoko; Oguri, Hiroki; Inoue, Masayuki; Hirama, Masahiro			Critical contribution of aromatic rings to specific recognition of polyether rings - The case of ciguatoxin CTX3C-ABC and its specific antibody 1C49	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTODEXTRIN-BINDING PROTEIN; ALANINE-SCANNING MUTAGENESIS; CATION-PI INTERACTIONS; CHAIN FV FRAGMENT; SANDWICH IMMUNOASSAY; PTYCHODISCUS-BREVIS; STEPWISE DIALYSIS; MASS-SPECTROMETRY; INCLUSION-BODIES; MARINE TOXINS	To address how proteins recognize polyether toxin compounds, we focused on the interaction between the ABC ring compound of ciguatoxin 3C and its specific antibody, 1C49. Surface plasmon resonance analyses indicated that Escherichia coli-expressed variable domain fragments (Fv) of 1C49 had the high affinity constants and slow dissociation constants typical of antigen-antibody interactions. Linear van't Hoff analyses suggested that the interaction is enthalpy-driven. We resolved the crystal structure of 1C49 Fv bound to ABC ring compound of ciguatoxin 3C at a resolution of 1.7 angstrom. The binding pocket of the antibody had many aromatic rings and bound the antigen by shape complementarity typical of hapten-antibody interactions. Three hydrogen bonds and many van der Waals interactions were present. We mutated several residues of the antibody to Ala, and we used surface plasmon resonance to analyze the interactions between the mutated antibodies and the antigen. This analysis identified Tyr-91 and Trp-96 in the light chain as hot spots for the interaction, and other residues made incremental contributions by conferring enthalpic advantages and reducing the dissociation rate constant. Systematic mutation of Tyr-91 indicated that CH-pi and pi-pi interactions between the aromatic ring at this site and the antigen made substantial contributions to the association, and van der Waals interactions inhibited dissociation, suggesting that aromaticity and bulkiness are critical for the specific recognition of polyether compounds by proteins.	[Tsumoto, Kouhei; Tanaka, Yoshikazu; Ui, Mihoko] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Yokota, Akiko; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Tsumuraya, Takeshi; Fujii, Ikuo] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5998570, Japan; [Nagumo, Yoko; Oguri, Hiroki; Inoue, Masayuki; Hirama, Masahiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Nagumo, Yoko; Oguri, Hiroki; Inoue, Masayuki; Hirama, Masahiro] Japan Sci & Technol Agcy, SORST, Sendai, Miyagi 9808578, Japan	University of Tokyo; Tohoku University; Osaka Metropolitan University; Tohoku University; Japan Science & Technology Agency (JST)	Tsumoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan.	tsumoto@k.u-tokyo.ac.jp	Oguri, Hiroki/F-9541-2015; Oguri, Hiroki/AAV-2045-2020; Oguri, Hiroki/B-7366-2014; Tsumuraya, Takeshi/W-1080-2019	Oguri, Hiroki/0000-0001-8007-1631; Oguri, Hiroki/0000-0001-8007-1631; Tsumuraya, Takeshi/0000-0001-8979-2160				Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchbinder JL, 1998, J MOL BIOL, V282, P1033, DOI 10.1006/jmbi.1998.2025; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Daranas AH, 2004, CHEM REC, V4, P1, DOI 10.1002/tcr.10072; Dechraoui MY, 1999, TOXICON, V37, P125, DOI 10.1016/S0041-0101(98)00169-X; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Fields BA, 1996, BIOCHEMISTRY-US, V35, P15494, DOI 10.1021/bi961709e; Heine A, 1998, SCIENCE, V279, P1934, DOI 10.1126/science.279.5358.1934; Hirama M, 2005, CHEM REC, V5, P240, DOI 10.1002/tcr.20049; JEFFREY PD, 1993, P NATL ACAD SCI USA, V90, P10310, DOI 10.1073/pnas.90.21.10310; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kabat EA, 1991, SEQUENCES PROTEINS I; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lang S, 2000, BIOCHEMISTRY-US, V39, P15674, DOI 10.1021/bi000838z; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS RJ, 1993, TOXICON, V31, P1333, DOI 10.1016/0041-0101(93)90407-A; Lewis RJ, 1997, TOXICON, V35, P159, DOI 10.1016/S0041-0101(96)00132-8; Lewis RJ, 1999, ANAL CHEM, V71, P247, DOI 10.1021/ac980598h; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lim K, 1998, J BIOL CHEM, V273, P28576, DOI 10.1074/jbc.273.44.28576; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Makabe K, 2005, BIOCHEM BIOPH RES CO, V328, P98, DOI 10.1016/j.bbrc.2004.12.141; MANGER RL, 1995, J AOAC INT, V78, P521; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; MURATA M, 1989, J AM CHEM SOC, V111, P8929, DOI 10.1021/ja00206a032; Nagumo Y, 2004, J IMMUNOL METHODS, V289, P137, DOI 10.1016/j.jim.2004.04.003; Oguri H, 2003, J AM CHEM SOC, V125, P7608, DOI 10.1021/ja034990a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; SCHEUER PJ, 1967, SCIENCE, V155, P1267, DOI 10.1126/science.155.3767.1267; SCHEUER PJ, 1994, TETRAHEDRON, V50, P3, DOI 10.1016/S0040-4020(01)80733-X; SHIMIZU Y, 1983, NATURE, V302, P212, DOI 10.1038/302212a0; SHIMIZU Y, 1986, J AM CHEM SOC, V108, P514, DOI 10.1021/ja00263a031; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l; Takahashi H, 1996, TETRAHEDRON LETT, V37, P7087, DOI 10.1016/0040-4039(96)01580-8; TRONRUD DE, 1987, SCIENCE, V235, P571, DOI 10.1126/science.3810156; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Tsumuraya T, 2006, TOXICON, V48, P287, DOI 10.1016/j.toxicon.2006.05.014; Ulrich HD, 1997, NATURE, V389, P271, DOI 10.1038/38470; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; YASUMOTO T, 1995, J AOAC INT, V78, P574; Yasumoto T, 2001, CHEM REC, V1, P228, DOI 10.1002/tcr.1010; Yasumoto T, 2000, J AM CHEM SOC, V122, P4988, DOI 10.1021/ja9944204	59	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12259	12266		10.1074/jbc.M710553200	http://dx.doi.org/10.1074/jbc.M710553200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326040	hybrid			2022-12-27	WOS:000255340000042
J	Xiao, ZS; Zhang, SQ; Magenheimer, BS; Luo, JM; Quarles, LD				Xiao, Zhousheng; Zhang, Shiqin; Magenheimer, Brenda S.; Luo, Junming; Quarles, L. Darryl			Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; NUCLEAR-FACTOR; INTRAFLAGELLAR TRANSPORT; GROWTH-PLATE; CLEIDOCRANIAL DYSPLASIA; TARGETED DISRUPTION; EPITHELIAL-CELLS; BONE-FORMATION; C-TERMINUS; GENE	Polycystin-1 (PC1) may play an important role in skeletogenesis through regulation of the bone-specific transcription factor Runx2-II. In the current study we found that PC1 co-localizes with the calcium channel polycystin-2 (PC2) in primary cilia of MC3T3-E1 osteoblasts. To establish the role of Runx2-II in mediating PC1 effects on bone, we crossed heterozygous Pkd1(m1Bei) and Runx2-II mice to create double heterozygous mice (Pkd1(+/m1Bei)/Runx2-II+/-) deficient in both PC1 and Runx2-II. Pkd1(+/m1Bei)/Runx2-II+/- mice exhibited additive reductions in Runx2-II expression that was associated with impaired endochondral bone development, defective osteoblast-mediated bone formation, and osteopenia. In addition, we found that basal intracellular calcium levels were reduced in homozygous Pkd1m1Bei osteoblasts. In contrast, overexpression of a PC1 C-tail construct increased intracellular calcium and selectively stimulated Runx2-II P1 promoter activity in osteoblasts through a calcium-dependent mechanism. Site-directed mutagenesis of critical amino acids in the coiled-coil domain of PC1 required for coupling to PC2 abolished PC1-mediated Runx2-II P1 promoter activity. Additional promoter analysis mapped the PC1-responsive region to the "osteoblast-specific" enhancer element between -420 and -350 bp that contains NFI and AP-1 binding sites. Chromatin immunoprecipitation assays confirmed the calcium-dependent binding of NFI to this region. These findings indicate that PC1 regulates osteoblast function through intracellular calcium-dependent control of Runx2-II expression. The overall function of the primary cilium-polycystin complex may be to sense and transduce environmental clues into signals regulating osteoblast differentiation and bone development.	[Xiao, Zhousheng; Zhang, Shiqin; Magenheimer, Brenda S.; Luo, Junming; Quarles, L. Darryl] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Quarles, LD (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, MS 3018,3901 Rainbow Blvd,6018 Wahl Hall E, Kansas City, KS 66160 USA.	dquarles@kumc.edu		Quarles, L. Darryl/0000-0002-5082-7896	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, R01DK083303] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01-AR049712] Funding Source: Medline; NIDDK NIH HHS [P50-DK057301, R01 DK083303] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Christensen ST, 2007, SCIENCE, V317, P330, DOI 10.1126/science.1146180; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FEDERMAN M, 1974, CALC TISS RES, V17, P81, DOI 10.1007/BF02547216; Ferrari S, 2004, J BIOL CHEM, V279, P55520, DOI 10.1074/jbc.M410346200; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Le NH, 2004, J BIOL CHEM, V279, P27472, DOI 10.1074/jbc.M312183200; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Manzati E, 2005, EXP CELL RES, V304, P391, DOI 10.1016/j.yexcr.2004.10.023; Mukhopadhyay SS, 2001, MOL CELL BIOL, V21, P6859, DOI 10.1128/MCB.21.20.6859-6869.2001; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Takaoki Muneo, 2004, Biol Sci Space, V18, P181; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Uchihashi T, 2007, BONE, V41, P1025, DOI 10.1016/j.bone.2007.08.028; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vandorpe DH, 2001, J BIOL CHEM, V276, P4093, DOI 10.1074/jbc.M006252200; Wang W, 2007, J NEUROSCI, V27, P6115, DOI 10.1523/JNEUROSCI.0180-07.2007; Whitfield JF, 2003, J CELL BIOCHEM, V89, P233, DOI 10.1002/jcb.10509; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xiao ZS, 1999, J CELL BIOCHEM, V74, P596, DOI 10.1002/(SICI)1097-4644(19990915)74:4<596::AID-JCB9>3.0.CO;2-F; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	59	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12624	12634		10.1074/jbc.M710407200	http://dx.doi.org/10.1074/jbc.M710407200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321855	Green Published, hybrid			2022-12-27	WOS:000255340000079
J	Ashraf, MZ; Kar, NS; Chen, X; Choi, J; Salomon, RG; Febbraio, M; Podrez, EA				Ashraf, Mohammad Z.; Kar, Niladri S.; Chen, Xi; Choi, Jaewoo; Salomon, Robert G.; Febbraio, Maria; Podrez, Eugene A.			Specific oxidized phospholipids inhibit scavenger receptor BI-mediated selective uptake of cholesteryl esters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SR-BI; ATHEROSCLEROTIC LESIONS; DEFICIENT MICE; CD36; BINDING; LDL; EXPRESSION; IDENTIFICATION; MACROPHAGES	We have recently demonstrated that specific oxidized phospholipids (oxPC(CD36)) accumulate at sites of oxidative stress in vivo such as within atherosclerotic lesions, hyperlipidemic plasma, and plasma with low high-density lipoprotein levels. oxPC(CD36) serve as high affinity ligands for the scavenger receptor CD36, mediate uptake of oxidized low density lipoprotein by macrophages, and promote a pro-thrombotic state via platelet scavenger receptor CD36. We now report that oxPC(CD36) represent ligands for another member of the scavenger receptor class B, type I (SR-BI). oxPC(CD36) prevent binding to SR-BI of its physiological ligand, high density lipoprotein, because of the close proximity of the binding sites for these two ligands on SR-BI. Furthermore, oxPC(CD36) interfere with SR-BI-mediated selective uptake of cholesteryl esters in hepatocytes. Thus, oxidative stress and accumulation of specific oxidized phospholipids in plasma may have an inhibitory effect on reverse cholesterol transport.	[Ashraf, Mohammad Z.; Kar, Niladri S.; Podrez, Eugene A.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Febbraio, Maria] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Chen, Xi; Choi, Jaewoo; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Podrez, EA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.	podreze@ccf.org	Salomon, Robert G/C-3463-2008	Salomon, Robert/0000-0001-9456-3557	NHLBI NIH HHS [R01 HL077213, HL077213, R01 HL070083, HL053315, HL70083, HL53315] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077213, R01HL070083, R01HL053315] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; ASHKENAS J, 1993, J LIPID RES, V34, P983; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Calvo D, 1998, J LIPID RES, V39, P777; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Connelly MA, 2004, CURR OPIN LIPIDOL, V15, P287, DOI 10.1097/00041433-200406000-00008; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Greene DJ, 2001, J BIOL CHEM, V276, P4804, DOI 10.1074/jbc.M008725200; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Han JH, 2001, J BIOL CHEM, V276, P16567, DOI 10.1074/jbc.M011302200; Hoff HF, 2003, ARTERIOSCL THROM VAS, V23, P275, DOI 10.1161/01.ATV.0000051407.42536.73; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD	32	47	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10408	10414		10.1074/jbc.M710474200	http://dx.doi.org/10.1074/jbc.M710474200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18285332	Green Published, hybrid			2022-12-27	WOS:000254894700021
J	Dou, ZC; Heinhorst, S; Williams, EB; Murin, CD; Shively, JM; Cannon, GC				Dou, Zhicheng; Heinhorst, Sabine; Williams, Eric B.; Murin, C. Daniel; Shively, Jessup M.; Cannon, Gordon C.			CO2 fixation kinetics of Halothiobacillus neapolitanus mutant carboxysomes lacking carbonic anhydrase suggest the shell acts as a diffusional barrier for CO2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC CARBON; CONCENTRATING MECHANISMS; SYNECHOCOCCUS PCC7942; THIOBACILLUS; GENE; CARBOXYLASE; PHOTOSYNTHESIS; PROKARYOTES; ORGANELLES; DIVERSITY	The widely accepted models for the role of carboxysomes in the carbon-concentrating mechanism of autotrophic bacteria predict the carboxysomal carbonic anhydrase to be a crucial component. The enzyme is thought to dehydrate abundant cytosolic bicarbonate and provide ribulose 1.5-bisphosphate carboxylase/ oxygenase (RubisCO) sequestered within the carboxysome with sufficiently high concentrations of its substrate, CO2, to permit its efficient fixation onto ribulose 1,5-bisphosphate. In this study, structure and function of carboxysomes purified from wild type Halothiobacillus neapolitanus and from a high CO2-requiring mutant that is devoid of carboxysomal carbonic anhydrase were compared. The kinetic constants for the carbon fixation reaction confirmed the importance of a functional carboxysomal carbonic anhydrase for efficient catalysis by RubisCO. Furthermore, comparisons of the reaction in intact and broken microcompartments and by purified carboxysomal RubisCO implicated the protein shell of the microcompartment as impeding diffusion of CO2 into and out of the carboxysome interior.	[Dou, Zhicheng; Heinhorst, Sabine; Williams, Eric B.; Murin, C. Daniel; Shively, Jessup M.; Cannon, Gordon C.] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Shively, Jessup M.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA	University of Southern Mississippi; Clemson University	Cannon, GC (corresponding author), Univ So Mississippi, Dept Chem & Biochem, 118 Coll Dr 5043, Hattiesburg, MS 39406 USA.	gordon.cannon@usm.edu	Murin, Charles Daniel/ABA-2861-2020					Ausubel FM, 1998, CURRENT PROTOCOLS MO; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Baker SH, 2000, ARCH MICROBIOL, V173, P278, DOI 10.1007/s002030000141; Baker SH, 1999, ARCH MICROBIOL, V172, P233, DOI 10.1007/s002030050765; BAKER SH, 1998, GENETICS, P102; BEUDEKER RF, 1980, ARCH MICROBIOL, V124, P185, DOI 10.1007/BF00427725; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cai F, 2008, ARCH MICROBIOL, V189, P141, DOI 10.1007/s00203-007-0305-y; CANNON GC, 1983, ARCH MICROBIOL, V134, P52, DOI 10.1007/BF00429407; Cannon GC, 2003, CURR MICROBIOL, V46, P115, DOI 10.1007/s00284-002-3825-3; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Dean J. A., 1999, LANGES HDB CHEM; Dobrinski KP, 2005, J BACTERIOL, V187, P5761, DOI 10.1128/JB.187.16.5761-5766.2005; ENGLISH RS, 1995, APPL ENVIRON MICROB, V61, P3256, DOI 10.1128/AEM.61.9.3256-3260.1995; FUKUZAWA H, 1992, P NATL ACAD SCI USA, V89, P4437, DOI 10.1073/pnas.89.10.4437; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141, DOI [10.1007/7171_023, DOI 10.1007/7171_023]; Heinhorst S, 2006, J BACTERIOL, V188, P8087, DOI 10.1128/JB.00990-06; HOLTHUIJZEN YA, 1987, ARCH MICROBIOL, V147, P285, DOI 10.1007/BF00463489; HOLTHUIJZEN YA, 1987, FEMS MICROBIOL LETT, V42, P121; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; PRICE GD, 1989, PLANT PHYSIOL, V91, P514, DOI 10.1104/pp.91.2.514; PRICE GD, 1992, PLANT PHYSIOL, V100, P784, DOI 10.1104/pp.100.2.784; PRICE GD, 1991, CAN J BOT, V69, P963, DOI 10.1139/b91-124; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; PRICE GD, 2007, J EXP BOT; REINHOLD L, 1991, CAN J BOT, V69, P984, DOI 10.1139/b91-126; REINHOLD L, 1989, PLANT PHYSIOL BIOCH, V27, P945; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; SHIVELY JM, 1973, J BACTERIOL, V116, P1405, DOI 10.1128/JB.116.3.1405-1411.1973; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; STONER MT, 1993, FEMS MICROBIOL LETT, V107, P287, DOI 10.1016/0378-1097(93)90324-U; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; TAYLOR LA, 1988, NUCLEIC ACIDS RES, V16, P358, DOI 10.1093/nar/16.1.358; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; YU JW, 1992, PLANT PHYSIOL, V100, P794, DOI 10.1104/pp.100.2.794	40	123	126	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10377	10384		10.1074/jbc.M709285200	http://dx.doi.org/10.1074/jbc.M709285200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18258595	hybrid, Green Published			2022-12-27	WOS:000254894700018
J	Jewell, JL; Luo, W; Oh, EJ; Wang, ZX; Thurmond, DC				Jewell, Jenna L.; Luo, Wei; Oh, Eunjin; Wang, Zhanxiang; Thurmond, Debbie C.			Filamentous actin regulates insulin exocytosis through direct interaction with syntaxin 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; LIPID RAFTS; BETA-CELLS; GLUCOSE; SECRETION; PROTEIN; GRANULES; RELEASE; CDC42; MICROTUBULES	Glucose-induced insulin exocytosis is coupled to associations between F-actin and SNARE proteins, although the nature and function of these interactions remains unknown. Toward this end we show here that both Syntaxin 1A and Syntaxin 4 associated with F-actin in MIN6 cells and that each interaction was rapidly and transiently diminished by stimulation of cells with D-glucose. Of the two isoforms, only Syntaxin 4 was capable of interacting directly with F-actin in an in vitro sedimentation assay, conferred by the N-terminal 39-112 residues of Syntaxin 4. The 39-112 fragment was capable of selective competitive inhibitory action, disrupting endogenous F-actin-Syntaxin 4 binding in MIN6 cells. Disruption of F-actin-Syntaxin 4 binding correlated with enhanced glucose-stimulated insulin secretion, mediated by increased granule accumulation at the plasma membrane and increased Syntaxin 4 accessibility under basal conditions. However, no increase in basal level Syntaxin 4-VAMP2 association occurred with either latrunculin treatment or expression of the 39-112 fragment. Taken together, these data disclose a new underlying mechanism by which F-actin negatively regulates exocytosis via binding and blocking Syntaxin 4 accessibility, but they also reveal the existence of additional signals and/or steps required to trigger the subsequent docking and fusion steps of exocytosis.	[Jewell, Jenna L.; Oh, Eunjin; Wang, Zhanxiang; Thurmond, Debbie C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Diabet Res Ctr, Indianapolis, IN 46202 USA; [Luo, Wei] GebScript Corp, Piscataway, NJ 08854 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Thurmond, DC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Diabet Res Ctr, 635 Barnhill Dr,MS4053, Indianapolis, IN 46202 USA.	dthurmon@iupui.edu			NIDDK NIH HHS [R01 DK076614, R01 DK067912, DK-067912, R01 DK076614-01A2, DK-76614, R01 DK067912-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067912, R01DK076614] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUNIS D, 1988, J EXP BIOL, V139, P253; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Barg S, 2002, DIABETES, V51, pS74, DOI 10.2337/diabetes.51.2007.S74; BEEST MB, 2005, MOL BIOL CELL, V16, P5784; Betz A, 1997, J BIOL CHEM, V272, P2520; Bruun TZ, 2000, EUR J PHARMACOL, V403, P221, DOI 10.1016/S0014-2999(00)00602-6; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HOWELL SL, 1979, BIOCHEM J, V178, P367, DOI 10.1042/bj1780367; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Isgandarova S, 2007, J BIOL CHEM, V282, P30466, DOI 10.1074/jbc.M704117200; Ivarsson R, 2005, TRAFFIC, V6, P1027, DOI 10.1111/j.1600-0854.2005.00342.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kang Y, 2002, DIABETOLOGIA, V45, P231, DOI 10.1007/s00125-001-0718-0; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; KELLY RB, 1990, CELL, V61, P5, DOI 10.1016/0092-8674(90)90206-T; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LACY PE, 1972, DIABETES, V21, P987, DOI 10.2337/diab.21.10.987; LACY PE, 1968, NATURE, V219, P1177, DOI 10.1038/2191177a0; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Li GD, 1996, BIOCHEM J, V316, P345, DOI 10.1042/bj3160345; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; MALAISSE WJ, 1975, ANN NY ACAD SCI, V253, P630, DOI 10.1111/j.1749-6632.1975.tb19234.x; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Nakano M, 2001, BIOCHEM BIOPH RES CO, V288, P468, DOI 10.1006/bbrc.2001.5795; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; SNABES MC, 1982, BIOCHEM BIOPH RES CO, V104, P207, DOI 10.1016/0006-291X(82)91960-X; SOMERS G, 1979, ENDOCRINOLOGY, V104, P255, DOI 10.1210/endo-104-1-255; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Spurlin BA, 2003, DIABETES, V52, P1910, DOI 10.2337/diabetes.52.8.1910; Straub SG, 2004, DIABETES, V53, P3179, DOI 10.2337/diabetes.53.12.3179; SWANSTONFLATT SK, 1980, FEBS LETT, V117, P299, DOI 10.1016/0014-5793(80)80966-5; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Varadi A, 2005, MOL BIOL CELL, V16, P2670, DOI 10.1091/mbc.e04-11-1001; Vikman J, 2006, J MOL ENDOCRINOL, V36, P503, DOI 10.1677/jme.1.01978; WANG JL, 1990, BIOCHEM BIOPH RES CO, V171, P424, DOI 10.1016/0006-291X(90)91410-T; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Yang XF, 2006, J BIOL CHEM, V281, P15457, DOI 10.1074/jbc.M513246200	56	87	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10716	10726		10.1074/jbc.M709876200	http://dx.doi.org/10.1074/jbc.M709876200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18285343	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000254894700054
J	Kwon, YH; Seong, C; Chi, P; Greene, EC; Klein, H; Sung, P				Kwon, YoungHo; Seong, Changhyun; Chi, Peter; Greene, Eric C.; Klein, Hannah; Sung, Patrick			ATP-dependent chromatin remodeling by the Saccharomyces cerevisiae homologous recombination factor Rdh54	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; RAD51 RECOMBINASE; NUCLEOPROTEIN FILAMENT; NUCLEOSOME CORE; HISTONE OCTAMER; SNF2 FAMILY; YEAST RAD51; PROTEINS; COMPLEX; REPAIR	Saccharomyces cerevisiae RDH54 is a key member of the evolutionarily conserved RAD52 epistasis group of genes needed for homologous recombination and DNA double strand break repair. The RDH54-encoded protein possesses a DNA translocase activity and functions together with the Rad51 recombinase in the D-loop reaction. By chromatin immunoprecipitation (ChIP), we show that Rdh54 is recruited, in a manner that is dependent on Rad51 and Rad52, to a site-specific DNA double strand break induced by the HO endonuclease. Because of its relatedness to Swi2/ Snf2 chromatin remodelers, we have asked whether highly purified Rdh54 possesses chromatin-remodeling activity. Importantly, our results show that Rdh54 can mobilize a mononucleosome along DNA and render nucleosomal DNA accessible to a restriction enzyme, indicative of a chromatin-remodeling function. Moreover, Rdh54 co-operates with Rad51 in the utilization of naked or chromatinized DNA as template for D-loop formation. We also provide evidence for a strict dependence of the chromatin-remodeling attributes of Rdh54 on its ATPase activity and N-terminal domain. Interestingly, an N-terminal deletion mutant (rdh54 Delta 102) is unable to promote Rad51-mediated D-loop formation with a chromatinized template, while retaining substantial activity with naked DNA. These features of Rdh54 suggest a role of this protein factor in chromatin rearrangement during DNA recombination and repair.	[Kwon, YoungHo; Seong, Changhyun; Chi, Peter; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Klein, Hannah] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Klein, Hannah] NYU, Sch Med, Kaplan Canc Ctr, New York, NY 10016 USA	Yale University; Columbia University; New York University; New York University	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St,SHM-C130, New Haven, CT 06520 USA.	Patrick.Sung@yale.edu	Chi, Peter/AAI-1580-2019; Huang, Wenchi/F-3981-2010	Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; Klein, Hannah/0000-0003-4228-8535	NIEHS NIH HHS [ES07061] Funding Source: Medline; NIGMS NIH HHS [GM53738, GM57814, GM074739] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074739, R01GM057814, R01GM053738] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alexiadis V, 2004, J BIOL CHEM, V279, P27824, DOI 10.1074/jbc.M402648200; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Eberharter A, 2004, METHOD ENZYMOL, V377, P344; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2003, BIOPOLYMERS, V68, P563, DOI 10.1002/bip.10323; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Holzen TM, 2006, GENE DEV, V20, P2593, DOI 10.1101/gad.1447106; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kwon Y, 2007, DNA REPAIR, V6, P1496, DOI 10.1016/j.dnarep.2007.04.012; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nimonkar AV, 2007, J BIOL CHEM, V282, P30776, DOI 10.1074/jbc.M704767200; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Shinohara M, 1997, GENETICS, V147, P1545; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; STEIN A, 1989, METHOD ENZYMOL, V170, P585; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 2000, MUTAT RES-FUND MOL M, V451, P257, DOI 10.1016/S0027-5107(00)00054-3; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tanaka K, 2002, NUCLEIC ACIDS RES, V30, P1346, DOI 10.1093/nar/30.6.1346; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223	43	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10445	10452		10.1074/jbc.M800082200	http://dx.doi.org/10.1074/jbc.M800082200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18292093	Green Published, hybrid			2022-12-27	WOS:000254894700025
J	Saras, A; Gisselmann, G; Vogt-Eisele, AK; Erlkamp, KS; Kletke, O; Pusch, H; Hatt, H				Saras, Arunesh; Gisselmann, Guenter; Vogt-Eisele, Angela K.; Erlkamp, Katja S.; Kletke, Olaf; Pusch, Hermann; Hatt, Hanns			Histamine action on vertebrate GABA(A) receptors - Direct channel gating and potentiation of GABA responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; DROSOPHILA-MELANOGASTER; CHLORIDE CHANNEL; XENOPUS-OOCYTES; SUBUNITS; EXPRESSION; PROPOFOL; IDENTIFICATION; TRANSMISSION; ANESTHETICS	Histamine is not only a crucial cytokine in the periphery but also an important neurotransmitter and neuromodulator in the brain. It is known to act on metabotropic H1-H4 receptors, but the existence of directly histamine-gated chloride channels in mammals has been suspected for many years. However, the molecular basis of such mammalian channels remained elusive, whereas in invertebrates, genes for histamine-gated channels have been already identified. In this report, we demonstrated that histamine can directly open vertebrate ion channels and identified beta subunits of GABA(A) receptors as potential candidates for histamine-gated channels. In Xenopus oocytes expressing homomultimeric beta channels, histamine evoked currents with an EC50 of 212 mu M (beta(2)) and 174 mu M (beta(3)), whereas GABA is only a very weak partial agonist. We tested several known agonists and antagonists for the histamine-binding site of H1-H4 receptors and described for beta channels a unique pharmacological profile distinct from either of these receptors. In heteromultimeric channels composed of alpha(1)beta(2) or alpha(1)beta(2)gamma(2) subunits, we found that histamine is a modulator of the GABA response rather than an agonist as it potentiates GABA-evoked currents in a gamma(2) subunit-controlled manner. Despite the vast number of synthetic modulators of GABAA receptors widely used in medicine, which act on several distinct sites, only a few endogenous modulators have yet been identified. We show here for the first time that histamine modulates heteromultimeric GABAA receptors and may thus represent an endogenous ligand for an allosteric site.	[Saras, Arunesh; Gisselmann, Guenter; Vogt-Eisele, Angela K.; Erlkamp, Katja S.; Kletke, Olaf; Pusch, Hermann; Hatt, Hanns] Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany	Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Univ Str 150, D-44780 Bochum, Germany.	guenter.gisselmann@rub.de		Kletke, Olaf/0000-0002-7825-1278				Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; Borycz JA, 2005, J NEUROPHYSIOL, V93, P1611, DOI 10.1152/jn.00894.2004; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Cannon KE, 2004, LIFE SCI, V75, P2551, DOI 10.1016/j.lfs.2004.05.020; Cestari IN, 1996, NEUROREPORT, V7, P943, DOI 10.1097/00001756-199603220-00023; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gisselmann G, 2004, NEUROSCI LETT, V372, P151, DOI 10.1016/j.neulet.2004.09.031; Gisselmann G, 2004, BRIT J PHARMACOL, V142, P409, DOI 10.1038/sj.bjp.0705818; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Hatton GI, 2001, J NEUROSCI, V21, P2974, DOI 10.1523/JNEUROSCI.21-09-02974.2001; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Korpi ER, 2002, PROG NEUROBIOL, V67, P113, DOI 10.1016/S0301-0082(02)00013-8; Koutsoviti-Papadopoulou M, 2003, PHARMACOL RES, V48, P279, DOI 10.1016/S1043-6618(03)00148-8; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Lam DW, 1998, BRAIN RES, V784, P179, DOI 10.1016/S0006-8993(97)01334-6; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Martinez-Torres A, 2004, P NATL ACAD SCI USA, V101, P3220, DOI 10.1073/pnas.0308682101; Miko A, 2004, J BIOL CHEM, V279, P22833, DOI 10.1074/jbc.M402577200; Olsen RW, 2004, BIOCHEM PHARMACOL, V68, P1675, DOI 10.1016/j.bcp.2004.07.026; Olsen RW, 1998, TOXICOL LETT, V101, P193, DOI 10.1016/S0378-4274(98)00185-4; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; SANNA E, 1995, MOL PHARMACOL, V47, P213; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Sharonova IN, 1998, EUR J NEUROSCI, V10, P522, DOI 10.1046/j.1460-9568.1998.00057.x; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Taylor PM, 1999, J NEUROSCI, V19, P6360; van der Goot H, 2000, EUR J MED CHEM, V35, P5, DOI 10.1016/S0223-5234(00)00101-X; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; WILLIAMS K, 1994, MOL PHARMACOL, V46, P531; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	37	57	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10470	10475		10.1074/jbc.M709993200	http://dx.doi.org/10.1074/jbc.M709993200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281286	hybrid			2022-12-27	WOS:000254894700028
J	Sugaya, N; Habuchi, H; Nagai, N; Ashikari-Hada, S; Kimata, K				Sugaya, Noriko; Habuchi, Hiroko; Nagai, Naoko; Ashikari-Hada, Satoko; Kimata, Koji			6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SPECIFICITY; EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; BINDING SITES; FGF; 6-O-SULFOTRANSFERASE; OLIGOSACCHARIDES; PROTEOGLYCANS; PROTEINS; QSULF1	Heparan sulfate (HS) interacts with diverse heparin-binding growth factors and thereby regulates their bioactivities. These interactions depend on the structures characterized by the sulfation pattern and isomer of uronic acid residues. One of the biosynthetic modifications of HS, namely 6-O-sulfation, is catalyzed by three isoforms of HS6-O-sulfotransferase. We generated HS6ST-1- and/ or HS6ST-2-deficient mice (6ST1-KO, 6ST2-KO, and double knock-out (dKO)) that exhibited different phenotypes. We examined the effects of HS 6-O-sulfation in heparin-binding growth factor signaling using fibroblasts derived from these mutant mice. Mouse embryonic fibroblasts (MEF) prepared from E14.5 dKO mice produced HS with little 6-O-sulfate, whereas 2-O-sulfation in HS from dKO-MEF(dKOHS) was increased by 1.9-fold. HS6-O-sulfotransferase activity in the dKO-MEF was hardly detected, and HS2-O-sulfotransferase activity was 1.5-fold higher than that in wild type (WT)MEFs. The response of dKO-MEFs to fibroblast growth factors (FGFs) was distinct from that of WT-MEFs; in dKO-MEFs, FGF-4-and FGF-2-dependent signalings were reduced to similar to 30 and 60% of WT-MEFs, respectively, and FGF-1-dependent signaling was moderately reduced compared with that of WT-MEFs but only at the lower FGF-1 concentrations. Analysis with a surface plasmon resonance biosensor demonstrated that the apparent affinity of dKO-HS for FGF-4 was markedly reduced and was also reduced for FGF-1. In contrast, the affinity of dKO-HS for FGF-2 was 2.5-fold higher than that of HS from WT-MEFs. Thus, 6-O-sulfate in HS may regulate the signalings of some of HB-GFs, including FGFs, by inducing different interactions between ligands and their receptors.	[Sugaya, Noriko; Habuchi, Hiroko; Nagai, Naoko; Ashikari-Hada, Satoko; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	Aichi Medical University	Kimata, K (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan.	kimata@aichi-med-u.ac.jp						Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Aviezer D, 1999, BIOCHEM BIOPH RES CO, V263, P621, DOI 10.1006/bbrc.1999.1434; Bellosta P, 2001, MOL CELL BIOL, V21, P5946, DOI 10.1128/MCB.21.17.5946-5957.2001; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P817, DOI 10.1093/glycob/4.6.817; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kobayashi T, 2007, J BIOL CHEM, V282, P19589, DOI 10.1074/jbc.M610707200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Nogami K, 2004, J BIOL CHEM, V279, P8219, DOI 10.1074/jbc.M307304200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Pratt T, 2006, J NEUROSCI, V26, P6911, DOI 10.1523/JNEUROSCI.0505-06.2006; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sedita J, 2004, DEV DYNAM, V231, P782, DOI 10.1002/dvdy.20173; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	55	78	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10366	10376		10.1074/jbc.M705948200	http://dx.doi.org/10.1074/jbc.M705948200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18281280	hybrid			2022-12-27	WOS:000254894700017
J	Cohen, L; Lipstein, N; Karbat, I; Ilan, N; Gilles, N; Kahn, R; Gordon, D; Gurevitz, M				Cohen, Lior; Lipstein, Noa; Karbat, Izhar; Ilan, Nitza; Gilles, Nicolas; Kahn, Roy; Gordon, Dalia; Gurevitz, Michael			Miniaturization of scorpion beta-toxins uncovers a putative ancestral surface of interaction with voltage-gated sodium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; ALLOSTERIC INTERACTIONS; FUNCTIONAL SURFACE; RECEPTOR-SITES; INSECT CONTROL; NA+ CHANNELS; ION CHANNELS; BINDING; BREVETOXIN; NEUROTOXINS	The bioactive surface of scorpion beta-toxins that interact with receptor site-4 at voltage-gated sodium channels is constituted of residues of the conserved beta alpha beta beta core and the C-tail. In an attempt to evaluate the extent by which residues of the toxin core contribute to bioactivity, the anti-insect and anti-mammalian beta-toxins Bj-xtrIT and Css4 were truncated at their N and C termini, resulting in miniature peptides composed essentially of the core secondary structure motives. The truncated beta-toxins (Delta Delta Bj-xtrIT and Delta Delta Css4) were non-toxic and did not compete with the parental toxins on binding at receptor site-4. Surprisingly, Delta Delta Bj-xtrIT and Delta Delta Css4 were capable of modulating in an allosteric manner the binding and effects of site-3 scorpion alpha-toxins in a way reminiscent of that of brevetoxins, which bind at receptor site-5. While reducing the binding and effect of the scorpion alpha-toxin Lqh2 at mammalian sodium channels, they enhanced the binding and effect of Lqh alpha IT at insect sodium channels. Co-application of Delta Delta Bj-xtrIT or Delta Delta Css4 with brevetoxin abolished the brevetoxin effect, although they did not compete in binding. These results denote a novel surface at Delta Delta Bj-xtrIT and Delta Delta Css4 capable of interaction with sodium channels at a site other than sites 3,4, or 5, which prior to the truncation was masked by the bioactive surface that interacts with receptor site-4. The disclosure of this hidden surface at both beta-toxins may be viewed as an exercise in "reverse evolution," providing a clue as to their evolution from a smaller ancestor of similar scaffold.	[Cohen, Lior; Lipstein, Noa; Karbat, Izhar; Ilan, Nitza; Kahn, Roy; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Gilles, Nicolas] CE Saclay, Dept Ingn & Etud Prot, Commissariat Energie Atom, F-91191 Gif Sur Yvette, France	Tel Aviv University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Gordon, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	dgordon@post.tau.ac.il; mamgur@post.tau.ac.il		Lipstein, Noa/0000-0002-0755-5899	NINDS NIH HHS [1U01 NS 058039-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Baden DG, 2005, ENVIRON HEALTH PERSP, V113, P621, DOI 10.1289/ehp.7499; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bourdelais AJ, 2004, CELL MOL NEUROBIOL, V24, P553, DOI 10.1023/B:CEMN.0000023629.81595.09; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 1998, J NEUROCHEM, V70, P1217; Cestele S, 1996, J BIOL CHEM, V271, P18329, DOI 10.1074/jbc.271.31.18329; CESTELE S, 1995, J BIOL CHEM, V270, P15153, DOI 10.1074/jbc.270.25.15153; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2004, J BIOL CHEM, V279, P8206, DOI 10.1074/jbc.M307531200; Cohen L, 2007, MOL PHARMACOL, V72, P1220, DOI 10.1124/mol.107.039057; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Cohen L, 2006, FASEB J, V20, P1933, DOI 10.1096/fj.05-5545fje; Froy O, 1998, FASEB J, V12, P1793, DOI 10.1096/fasebj.12.15.1793; Froy O, 1999, J BIOL CHEM, V274, P5769, DOI 10.1074/jbc.274.9.5769; Gilles N, 2003, FEBS LETT, V540, P81, DOI 10.1016/S0014-5793(03)00226-6; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Gilles N, 2000, J NEUROCHEM, V75, P1735, DOI 10.1046/j.1471-4159.2000.0751735.x; GORDON D, 1993, FEBS LETT, V315, P125, DOI 10.1016/0014-5793(93)81147-R; Gordon D, 1996, J BIOL CHEM, V271, P8034, DOI 10.1074/jbc.271.14.8034; Gordon D, 1997, TOXINS SIGNAL TRANSD, P119; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2001, FASEB J, V15, P1201, DOI 10.1096/fj.00-0571hyp; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Martin-Eauclaire M. F., 1995, Handbook of neurotoxicology., P683; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Oren DA, 1998, STRUCTURE, V6, P1095, DOI 10.1016/S0969-2126(98)00111-7; Pimenta AMC, 2001, RAPID COMMUN MASS SP, V15, P1562, DOI 10.1002/rcm.415; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Purkerson-Parker SL, 2000, CHEM BIOL, V7, P385, DOI 10.1016/S1074-5521(00)00119-8; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; TRAINER VL, 1994, J BIOL CHEM, V269, P19904	39	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15169	15176		10.1074/jbc.M801229200	http://dx.doi.org/10.1074/jbc.M801229200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18339620	hybrid, Green Published			2022-12-27	WOS:000256232000033
J	Shanmugam, M; Hernandez, N				Shanmugam, Mayilvahanan; Hernandez, Nouria			Mitotic functions for SNAP45, a subunit of the small nuclear RNA-activating protein complex SNAP(c)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; POLYMERASES II; BRCA1-DEPENDENT UBIQUITINATION; SNRNA TRANSCRIPTION; DNA-REPLICATION; CELL-CYCLE; CENTROSOME; PROMOTER; GENES; BRCA1	The small nuclear RNA-activating protein complex SNAP(c) is required for transcription of small nuclear RNA genes and binds to a proximal sequence element in their promoters. SNAP(c) contains five types of subunits stably associated with each other. Here we show that one of these polypeptides, SNAP45, also known as PTF delta, localizes to centrosomes during parts of mitosis, as well as to the spindle midzone during anaphase and the mid-body during telophase. Consistent with localization to these mitotic structures, both down- and up-regulation of SNAP45 lead to a G(2)/M arrest with cells displaying abnormal mitotic structures. In contrast, down- regulation of SNAP190, another SNAPc subunit, leads to an accumulation of cells with a G(0)/G(1) DNA content. These results are consistent with the proposal that SNAP45 plays two roles in the cell, one as a subunit of the transcription factor SNAPc and another as a factor required for proper mitotic progression.	[Hernandez, Nouria] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, CH-1015 Lausanne, Switzerland; [Shanmugam, Mayilvahanan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Lausanne; Cold Spring Harbor Laboratory	Hernandez, N (corresponding author), Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Genopode Bldg,Quartier Sorge, CH-1015 Lausanne, Switzerland.	Nouria.Hernandez@unil.ch		Hernandez, Nouria/0000-0003-1465-4585	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM 38810] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038810] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Emran F, 2006, GENE, V377, P96, DOI 10.1016/j.gene.2006.03.012; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Henry RW, 1998, COLD SPRING HARB SYM, V63, P111, DOI 10.1101/sqb.1998.63.111; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Li C, 2004, MOL CELL BIOL, V24, P1897, DOI 10.1128/MCB.24.5.1897-1906.2004; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Ma B, 2001, J BIOL CHEM, V276, P5027, DOI 10.1074/jbc.M009301200; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Pombo A, 1998, EMBO J, V17, P1768, DOI 10.1093/emboj/17.6.1768; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; Sankaran S, 2006, CANCER RES, V66, P4100, DOI 10.1158/0008-5472.CAN-05-4430; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; YANG CH, 1992, J CELL BIOL, V116, P1303, DOI 10.1083/jcb.116.6.1303; Yoon JB, 1996, MOL CELL BIOL, V16, P1; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	37	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14845	14856		10.1074/jbc.M800833200	http://dx.doi.org/10.1074/jbc.M800833200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356157	Green Published, hybrid			2022-12-27	WOS:000255941400072
J	Angelini, S; Gerez, C; Ollagnier-de Choudens, S; Sanakis, Y; Fontecave, M; Barras, F; Py, B				Angelini, Sandra; Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Sanakis, Yiannis; Fontecave, Marc; Barras, Frederic; Py, Beatrice			NfuA, a new factor required for maturing Fe/S proteins in Escherichia coli under oxidative stress and iron starvation conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER; CYSTEINE DESULFURASE; SCAFFOLD PROTEIN; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; AZOTOBACTER-VINELANDII; CRYSTAL-STRUCTURE; 2FE-2S CLUSTER; NIFU PROTEIN; BIOGENESIS	Iron/sulfur (Fe/S) proteins are central to the functioning of cells in both prokaryotes and eukaryotes. Here, we show that the yhgI gene, which we renamed nfuA, encodes a two-domain protein that is required for Fe/S biogenesis in Escherichia coli. The N-terminal domain resembles the so-called Fe/S A-type scaffold but, curiously, has lost the functionally important Cys residues. The C-terminal domain shares sequence identity with Nfu proteins. Mossbauer and UV-visible spectroscopic analyses revealed that, upon reconstitution, NfuA binds a [4Fe-4S] cluster. Moreover, NfuA can transfer this cluster to apo-aconitase. Mutagenesis studies indicated that the N-and C-terminal domains are important for NfuA function in vivo. Similarly, the functional importance of Cys residues present in the Nfu-like domain was demonstrated in vivo by introducing Cys-->Ser mutations. In vivo investigations revealed that the nfuA gene is important for E. coli to sustain oxidative stress and iron starvation. Also, combining nfuA with either isc or suf mutations led to additive phenotypic deficiencies, indicating that NfuA is a bona fide new player in Isc-and Suf-dependent Fe/S biogenesis pathways. Taken together, these data demonstrate that NfuA intervenes in the maturation of apoproteins in E. coli, allowing them to acquire Fe/S clusters. By taking into account results from numerous previous transcriptomic studies that had suggested a link between NfuA and protein misfolding, we discuss the possibility that NfuA could act as a scaffold/chaperone for damaged Fe/S proteins.	[Angelini, Sandra; Barras, Frederic; Py, Beatrice] CNRS, Chim Bacterienne Lab, UPR 9043, F-13402 Marseille 20, France; [Barras, Frederic; Py, Beatrice] Univ Aix Marseille 2, F-13009 Marseille, France; [Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Fontecave, Marc] CNRS, UMR 5249, Lab Chim & Biol Met, F-38054 Grenoble, France; [Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Fontecave, Marc] CEA, Lab Chim & Biol Met, F-38054 Grenoble, France; [Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Fontecave, Marc] Univ Grenoble 1, F-38054 Grenoble, France; [Sanakis, Yiannis] NCSR Demokritos, Inst Mat Sci, Athens 15310, Greece	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Centre of Scientific Research "Demokritos"	Py, B (corresponding author), CNRS, Chim Bacterienne Lab, UPR 9043, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	py@ibsm.cnrs-mrs.fr		Barras, Frederic/0000-0003-3458-2574; Angelini, Sandra/0000-0002-8671-8018; Ollagnier de Choudens, Sandrine/0000-0002-0080-6659				Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Hwang DM, 1996, J MOL EVOL, V43, P536, DOI 10.1007/PL00006114; IUCHI S, 2004, ZINC FINGER PROTEINS; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Lesley SA, 2002, PROTEIN ENG, V15, P153, DOI 10.1093/protein/15.2.153; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Porco A, 1998, J BASIC MICROB, V38, P395, DOI 10.1002/(SICI)1521-4028(199811)38:5/6<395::AID-JOBM395>3.3.CO;2-Z; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Saio T, 2007, J BIOCHEM, V142, P113, DOI 10.1093/jb/mvm120; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Tamarit J, 2000, J BIOL CHEM, V275, P15669, DOI 10.1074/jbc.275.21.15669; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	44	109	111	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14084	14091		10.1074/jbc.M709405200	http://dx.doi.org/10.1074/jbc.M709405200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339628	hybrid			2022-12-27	WOS:000255728200062
J	Cheung, J; Bingman, CA; Reyngold, M; Hendrickson, WA; Waldburger, CD				Cheung, Jonah; Bingman, Craig A.; Reyngold, Marsha; Hendrickson, Wayne A.; Waldburger, Carey D.			Crystal structure of a functional dimer of the PhoQ sensor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; PROTEIN STRUCTURES; DISTANCE MATRICES; HISTIDINE KINASES; SIGNAL-DETECTION; PAS DOMAIN; MG2+; CRYSTALLOGRAPHY	The PhoP-PhoQ two-component system is a well studied bacterial signaling system that regulates virulence and stress response. Catalytic activity of the histidine kinase sensor protein PhoQ is activated by low extracellular concentrations of divalent cations such as Mg2+, and subsequently the response regulator PhoP is activated in turn through a classic phosphotransfer pathway that is typical in such systems. The PhoQ sensor domains of enteric bacteria contain an acidic cluster of residues (EDDDDAE) that has been implicated in direct binding to divalent cations. We have determined crystal structures of the wildtype Escherichia coli PhoQ periplasmic sensor domain and of a mutant variant in which the acidic cluster was neutralized to conservative uncharged residues (QNNNNAQ). The PhoQ domain structure is similar to that of DcuS and CitA sensor domains, and this PhoQ-DcuS-CitA (PDC) sensor fold is seen to be distinct from the superficially similar PAS domain fold. Analysis of the wild-type structure reveals a dimer that allows for the formation of a salt bridge across the dimer interface between Arg-50' and Asp-179 and with nickel ions bound to aspartate residues in the acidic cluster. The physiological importance of the salt bridge to in vivo PhoQ function has been confirmed by mutagenesis. The mutant structure has an alternative, non-physiological dimeric association.	[Cheung, Jonah; Bingman, Craig A.; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Reyngold, Marsha; Waldburger, Carey D.] Columbia Univ, Dept Microbiol, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Waldburger, CD (corresponding author), William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA.	WaldburgerC@wpunj.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI41566] Funding Source: Medline; NIGMS NIH HHS [GM34102] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; HENDRICKSON WA, 1979, ACTA CRYSTALLOGR A, V35, P158, DOI 10.1107/S0567739479000279; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaspar S, 1999, MOL MICROBIOL, V33, P858, DOI 10.1046/j.1365-2958.1999.01536.x; KLEYWEGT GJ, 1994, CCP4 ESF EACBM NEWSL, V31, P9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lesley JA, 2001, J BIOL CHEM, V276, P30827, DOI 10.1074/jbc.M104262200; Minagawa S, 2005, BIOSCI BIOTECH BIOCH, V69, P1281, DOI 10.1271/bbb.69.1281; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Razeto A, 2004, J MOL BIOL, V336, P319, DOI 10.1016/j.jmb.2003.12.057; Regelmann AG, 2002, J BACTERIOL, V184, P5468, DOI 10.1128/JB.184.19.5468-5478.2002; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sanowar S, 2005, BIOCHEM J, V390, P769, DOI 10.1042/BJ20050060; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Vescovi EG, 1997, J BIOL CHEM, V272, P1440, DOI 10.1074/jbc.272.3.1440; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WOLANIN PM, 2002, GENOME BIOL; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	44	71	73	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13762	13770		10.1074/jbc.M710592200	http://dx.doi.org/10.1074/jbc.M710592200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348979	hybrid, Green Published			2022-12-27	WOS:000255728200028
J	Lu, XD; Kovalev, GI; Chang, H; Kallin, E; Knudsen, G; Xia, L; Mishra, N; Ruiz, P; Li, E; Su, LS; Zhang, Y				Lu, Xiangdong; Kovalev, Grigoriy I.; Chang, Hua; Kallin, Eric; Knudsen, Geoffrey; Xia, Li; Mishra, Nilamadhab; Ruiz, Phillip; Li, En; Su, Lishan; Zhang, Yi			Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; COMPLEX; DIFFERENTIATION; MBD3; OVEREXPRESSION; METHYLATION; METASTASIS; CARCINOMAS; MI-2/NURD	Dynamic changes in chromatin structure through ATP-dependent remodeling and covalent modifications on histones play important roles in transcription regulation. Among the many chromatin modifiers identified, the NuRD (nucleosome remodeling histone deacetylase) complex is unique because it possesses both nucleosome remodeling and histone deacetylase activities. To understand the biological function of the NuRD complex, we generated a knock-out mouse model of the Mta2 (metastasis-associated protein 2) gene, which encodes a NuRD-specific component. Mta2 null mice exhibited partial embryonic lethality. The surviving mice developed lupus-like autoimmune symptoms including skin lesions, bodyweight loss, glomerulonephritis, liver inflammation, and production of autoantibodies. Transplantation of bone marrow cells from Mta2 null mice recapitulated some of the symptoms including skin lesion and bodyweight loss in the recipient mice. Mta2 null T lymphocytes showed normal development but hyperproliferation upon stimulation, which correlates with hyperinduction of interleukin (IL)-2, IL-4, and interferon (IFN)-gamma. T cell hyperproliferation, but not other autoimmune symptoms, was observed in T cell-specific Mta2 knock-out mice. Mta2 null T cells produced more IL-4 and IFN-gamma under Th2 activation conditions, but normal levels of IL-4 and IFN-gamma under Th1 activation conditions. Furthermore, we found that IL-4 is a direct target gene of Mta2. Our study suggests that Mta2/NuRD is involved in modulating IL-4 and IFN-gamma expression in T cell immune responses, and gene expression in non-T cells plays an important role in controlling autoimmunity.	[Kovalev, Grigoriy I.; Knudsen, Geoffrey; Su, Lishan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lu, Xiangdong; Kallin, Eric; Xia, Li; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Lu, Xiangdong; Kallin, Eric; Xia, Li; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chang, Hua; Li, En] Novartis Inst Biomed Res Inc, Models Dis Ctr, Cambridge, MA 02139 USA; [Mishra, Nilamadhab] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Ruiz, Phillip] Univ Miami, Dept Pathol, Miami, FL 33136 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Novartis; Wake Forest University; University of Miami	Su, LS (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	lsu@med.unc.edu	Kovalev, Grigoriy/V-8768-2018	Zhang, Yi/0000-0002-2789-0811; Kovalev, Grigoriy/0000-0003-4346-3585	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL072240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048407, R01AI077454, R01AI048407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063067] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL72240] Funding Source: Medline; NIAID NIH HHS [R01 AI077454, AI48407] Funding Source: Medline; NIGMS NIH HHS [GM63067] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Feng Q, 2001, GENE DEV, V15, P827; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; KANAUCHI H, 1991, J INVEST DERMATOL, V96, P478, DOI 10.1111/1523-1747.ep12470176; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	37	43	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13825	13833		10.1074/jbc.M801275200	http://dx.doi.org/10.1074/jbc.M801275200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353770	Green Published, hybrid			2022-12-27	WOS:000255728200035
J	Gou, DM; Mishra, A; Weng, TT; Su, LJ; Chintagari, NR; Wang, ZX; Zhang, HH; Gao, L; Wang, PC; Stricker, HM; Liu, L				Gou, Deming; Mishra, Amarjit; Weng, Tingting; Su, Lijing; Chintagari, Narendranath Reddy; Wang, Zhixin; Zhang, Honghao; Gao, Li; Wang, Pengcheng; Stricker, Heidi M.; Liu, Lin			Annexin A2 interactions with Rab14 in alveolar type II cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG SURFACTANT SECRETION; BINDING PROTEIN; LAMELLAR BODY; ENDOTHELIAL-CELLS; MEMBRANE-FUSION; PLASMA-MEMBRANE; IN-VITRO; RAT LUNG; EXOCYTOSIS; TETRAMER	Annexin A2, a calcium-dependent phospholipid-binding protein, is abundantly expressed in alveolar type II cells where it plays a role in lung surfactant secretion. Nevertheless, little is known about the details of its cellular pathways. To identify annexin A2-regulated or associated proteins, we silenced endogenous annexin A2 expression in rat alveolar type II cells by RNA interference and assessed the change of the cellular transcriptome by DNA microarray analysis. The loss of annexin A2 resulted in the change of 61 genes. Thirteen of the selected genes (11 down- regulated and 2 up-regulated genes) were validated by real time quantitative PCR. When the loss of rat annexin A2 was rescued by overexpressing EGFP-tagged human annexin A2, six of seven selected targets returned to their normal expression level, indicating that these genes are indeed annexin A2-associated targets. One of the targets, Rab14, co-immunoprecipitated with annexin A2. Rab14 also co-localized in part with annexin A2 and lamellar bodies in alveolar type II cells. The silencing of Rab14 resulted in a decrease in surfactant secretion, suggesting that Rab14 may play a role in surfactant secretion.	[Gou, Deming; Mishra, Amarjit; Weng, Tingting; Su, Lijing; Chintagari, Narendranath Reddy; Wang, Zhixin; Zhang, Honghao; Gao, Li; Wang, Pengcheng; Stricker, Heidi M.; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), Oklahoma State Univ, Dept Physiol Sci, 264 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	wang, zhixin/GZH-2500-2022; MISHRA, AMARJIT/I-4928-2019; MISHRA, AMARJIT/D-7504-2016	MISHRA, AMARJIT/0000-0002-3777-0338; MISHRA, AMARJIT/0000-0002-3777-0338; Zhang, Honghao/0000-0002-2338-6992	NHLBI NIH HHS [R01 HL-083188, R01 HL083188, R01 HL-071628, R01 HL052146, R01 HL-052146, R01 HL071628] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083188, R01HL052146, R01HL071628] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Benli M, 1996, EMBO J, V15, P6460, DOI 10.1002/j.1460-2075.1996.tb01037.x; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Chattopadhyay S, 2003, J BIOL CHEM, V278, P39675, DOI 10.1074/jbc.M212594200; Chen ZM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-47; Chen ZM, 2005, PHYSIOL GENOMICS, V21, P284, DOI 10.1152/physiolgenomics.00236.2004; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Eberhard DA, 2001, J CELL SCI, V114, P3155; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gou D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh129; GOU D, 2004, ANNEXINS, V1, P31; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; Ichimura H, 2006, AM J PHYSIOL-LUNG C, V291, pL596, DOI 10.1152/ajplung.00036.2006; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; KARASIK A, 1988, J BIOL CHEM, V263, P11862; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Liu L, 1996, AM J PHYSIOL-LUNG C, V270, pL668, DOI 10.1152/ajplung.1996.270.4.L668; Liu L, 1999, CELL SIGNAL, V11, P317, DOI 10.1016/S0898-6568(98)00047-3; Liu L, 2002, EUR J BIOCHEM, V269, P4277, DOI 10.1046/j.1432-1033.2002.03118.x; Liu L, 1997, ARCH BIOCHEM BIOPHYS, V342, P322, DOI 10.1006/abbi.1997.0140; Mason RJ, 2002, AM J PHYSIOL-LUNG C, V282, pL249, DOI 10.1152/ajplung.00027.2001; Nilius B, 1996, J BIOL CHEM, V271, P30631, DOI 10.1074/jbc.271.48.30631; Osanai K, 2005, BIOL CHEM, V386, P143, DOI 10.1515/BC.2005.018; Osanai K, 2001, AM J PATHOL, V158, P1665, DOI 10.1016/S0002-9440(10)64122-3; Ren MD, 1996, P NATL ACAD SCI USA, V93, P5151, DOI 10.1073/pnas.93.10.5151; Rowan WH, 2002, BIOCHEMISTRY-US, V41, P1409, DOI 10.1021/bi0119767; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; van Weeren L, 2004, AM J RESP CELL MOL, V30, P288, DOI 10.1165/rcmb.2003-0264OC; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	22	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13156	13164		10.1074/jbc.M801532200	http://dx.doi.org/10.1074/jbc.M801532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332131	Green Published, hybrid			2022-12-27	WOS:000255499800055
J	Yoshida, Y; Yang, J; Peaker, PE; Kato, H; Bush, CA; Cisar, JO				Yoshida, Yasuo; Yang, Jinghua; Peaker, Paule-Esther; Kato, Hirohisa; Bush, C. Allen; Cisar, John O.			Molecular and antigenic characterization of a Streptococcus oralis coaggregation receptor polysaccharide by carbohydrate engineering in Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE POLYSACCHARIDE; VIRIDANS GROUP STREPTOCOCCI; CAPSULAR POLYSACCHARIDE; GENETIC-TRANSFORMATION; ACTINOMYCES-VISCOSUS; WALL POLYSACCHARIDES; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; COMPETENCE; IDENTIFICATION	The coaggregation receptor polysaccharides (RPS) of Streptococcus oralis and related species are recognized by lectin-like adhesins on other members of the oral biofilm community and by RPS-specific antibodies. The former interactions involve beta-GalNAc or beta-Gal containing host-like motifs in the oligosaccharide repeating units of these polysaccharides, whereas the latter involves features of these molecules that are immunogenic. In the present investigation, the molecular and corresponding structural basis for the serotype specificity of S. oralis ATCC 10557 RPS was determined by engineering the production of this polysaccharide in transformable Streptococcus gordonii 38. This involved the systematic replacement of genes in the rps cluster of strain 38 with different but related genes from S. oralis 10557 and structural characterization of the resulting polysaccharides. The results identify four unique genes in the rps cluster of strain 10557. These include wefI for an alpha-Gal transferase, wefJ for a GalNAc-1-phosphotransferase that has a unique acceptor specificity, wefK for an acetyl transferase that acts at two positions in the hexasaccharide repeating unit, and a novel wzy associated with the beta 1-3 linkage between these units. The serotype specificity of engineered polysaccharides correlated with the wefI-dependent presence of alpha-Gal in these molecules rather than with partial O-acetylation or with the linkage between repeating units. The findings illustrate a direct approach for defining the molecular basis of polysaccharide structure and antigenicity.	[Yoshida, Yasuo; Yang, Jinghua; Cisar, John O.] NIH, NIDCR, Oral Infect & Immun Branch, Bethesda, MD 20892 USA; [Yoshida, Yasuo; Kato, Hirohisa] Iwate Med Univ, Sch Dent, Dept Dent Pharmacol, Morioka, Iwate 0208505, Japan; [Peaker, Paule-Esther; Bush, C. Allen] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Iwate Medical University; University System of Maryland; University of Maryland Baltimore County	Cisar, JO (corresponding author), NIH, NIDCR, Oral Infect & Immun Branch, Bldg 30,Rm 3A-301,30 Convent Dr, Bethesda, MD 20892 USA.	john.cisar@nih.gov			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000672] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABEYGUNAWARDANA C, 1990, BIOCHEMISTRY-US, V29, P234, DOI 10.1021/bi00453a032; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P8568, DOI 10.1021/bi00099a012; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P6528, DOI 10.1021/bi00240a025; ABEYGUNAWARDANA C, 1989, CARBOHYD RES, V191, P279, DOI 10.1016/0008-6215(89)85071-2; Abeygunawardana C, 1993, ADV BIOPHYSICAL CHEM, V3, P199; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BRIDGE PD, 1983, J GEN MICROBIOL, V129, P565; CASSELS FJ, 1995, J IND MICROBIOL, V15, P176, DOI 10.1007/BF01569823; Cisar JO, 1997, INFECT IMMUN, V65, P5035, DOI 10.1128/IAI.65.12.5035-5041.1997; CISAR JO, 1995, GLYCOBIOLOGY, V5, P655, DOI 10.1093/glycob/5.7.655; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GLUSHKA J, 1992, BIOCHEMISTRY-US, V31, P10741, DOI 10.1021/bi00159a014; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAWLEY RJ, 1980, ANTIMICROB AGENTS CH, V17, P372, DOI 10.1128/AAC.17.3.372; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HSU SD, 1994, MICROB ECOL HEALTH D, V7, P125, DOI 10.3109/08910609409141342; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kolkman MAB, 1997, J BIOL CHEM, V272, P19502, DOI 10.1074/jbc.272.31.19502; LEBLANC DJ, 1992, PLASMID, V28, P130, DOI 10.1016/0147-619X(92)90044-B; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Lunsford RD, 1996, J BACTERIOL, V178, P5831, DOI 10.1128/jb.178.19.5831-5835.1996; MCINTIRE FC, 1988, J BACTERIOL, V170, P2229, DOI 10.1128/jb.170.5.2229-2235.1988; Morona JK, 1999, J BACTERIOL, V181, P5355, DOI 10.1128/JB.181.17.5355-5364.1999; OCHMAN H, 1988, GENETICS, V120, P621; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; REDDY GP, 1994, GLYCOBIOLOGY, V4, P183, DOI 10.1093/glycob/4.2.183; SLAUCH JM, 1995, INFECT IMMUN, V63, P437, DOI 10.1128/IAI.63.2.437-441.1995; Takahashi Y, 2002, ORAL MICROBIOL IMMUN, V17, P257, DOI 10.1034/j.1399-302X.2002.170409.x; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; WHITE JC, 1946, J BACTERIOL, V51, P717, DOI 10.1128/JB.51.6.717-722.1946; Xu DQ, 2003, J BACTERIOL, V185, P5419, DOI 10.1128/JB.185.18.5419-5430.2003; Yoshida Y, 2005, MOL MICROBIOL, V58, P244, DOI 10.1111/j.1365-2958.2005.04820.x; Yoshida Y, 2006, J BACTERIOL, V188, P4125, DOI 10.1128/JB.01843-05	39	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12654	12664		10.1074/jbc.M801412200	http://dx.doi.org/10.1074/jbc.M801412200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303023	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000255340000082
J	Huen, MSY; Sy, SMH; van Deursen, JM; Chen, JJ				Huen, Michael S. Y.; Sy, Shirley M. -H.; van Deursen, Jan M.; Chen, Junjie			Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4; STRUCTURAL BASIS; GENE-EXPRESSION; S-PHASE; METHYLTRANSFERASE; CHROMATIN; TRIMETHYLATION; PR-SET7; L3MBTL1; HETEROCHROMATIN	Chromatin endowed by histone modifications governs chromatin structure, which in turn represents a means to regulate cellular processes, including transcription and heterochromatin formation. Recent evidence revealed a plethora of enzymes that catalyze specific histone modifications for epigenetic maintenance, and dysregulation of which contributes to tumorigenesis and developmental defects. The histone methyltransferase SET8 (also known as Pr-Set7) was previously reported to monomethylate Lys(20) of histone H4. However, the temporal and spatial control of SET8 activity remains elusive. Here, we provide evidence to support that SET8 monomethylates Lys(20) of histone H4 during S phase by tethering to proliferating cell nuclear antigen via a putative proliferating cell nuclear antigen-interacting protein box. In addition, we show that SET8 function is required for S phase progression. Finally, deletion of SET8 in mice causes embryonic lethality, suggesting that SET8 plays an important role in mammalian embryogenesis.	[Huen, Michael S. Y.; Sy, Shirley M. -H.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA	Yale University; Mayo Clinic	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	junjie.chen@yale.edu	Huen, Michael Shing Yan/E-9862-2010	Huen, Michael Shing-Yan/0000-0003-1774-2425; Sy, Ming Hui/0000-0002-2731-6692	NATIONAL CANCER INSTITUTE [R01CA100109, P50CA116201] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100109, R01 CA100109-07, CA100109] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200	33	104	106	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11073	11077		10.1074/jbc.C700242200	http://dx.doi.org/10.1074/jbc.C700242200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18319261	Green Published, hybrid			2022-12-27	WOS:000255067400002
J	Caramelo, JJ; Parodi, AJ				Caramelo, Julio J.; Parodi, Armando J.			Getting in and out from calnexin/calreticulin cycles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; GLC-GLYCOPROTEIN GLUCOSYLTRANSFERASE; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; GLUCOSIDASE-II; ALPHA-MANNOSIDASE; UDP-GLC; MISFOLDED GLYCOPROTEINS	The N-glycan-dependent quality control mechanism of glycoprotein folding was proposed initially by Helenius and coworkers several years ago; with a few minor modifications, it is still valid today (Fig. 1) (1-3).(2) Glycan processing starts immediately after its transfer from a dolichol-P-P derivative to Asn residues in nascent polypeptide chains entering the lumen of the ER. 3 Removal of the outermost and following glucoses by the successive action of GI and GII exposes the Glc(1)Man(9)GlcNAc(2) epitope (Fig. 2). This structure is then recognized by two ER resident lectins (CNX and CRT) that specifically bind monoglucosylated polymannose glycans. This is followed by removal of the innermost glucose by GII, thus liberating the glycoprotein from the lectin anchor. The protein-linked glycan is then reglucosylated by the soluble ER enzyme GT only if the protein moiety displays non-native three-dimensional structures, as this enzyme behaves as a conformational sensor. Cycles of CNX/CRT-glycoprotein binding and liberation, catalyzed by the opposing activities of GT and GII, are terminated once glycoproteins attain their native structures. Glucose-free glycoproteins then continue their transit through the secretory pathway. Alternatively, permanently misfolded glycoproteins may be then transported to the cytosol for proteasomal degradation. Lectin-glycoprotein association not only thwarts Golgi exit of folding intermediates and irreparably misfolded glycoproteins but also enhances folding efficiency by preventing aggregation and promoting proper disulfide bonding. The latter is catalyzed by an oxidoreductase of the protein-disulfide isomerase family (ERp57) that acts exclusively on glycoproteins, as it is loosely associated with CNX/CRT. GT is the only component of the quality control mechanism that senses protein conformations, as it recognizes hydrophobic amino acid patches exposed in molten globule-like conformers (4, 5). GT may also glucosylate glycoproteins in not fully assembled oligomeric complexes because it also recognizes hydrophobic surfaces exposed as a consequence of the absence of subunit components (6). The aim of this review is to give an overview of recent reports dealing with the entrance and exit of glycoproteins from CNX/CRT cycles.	[Caramelo, Julio J.; Parodi, Armando J.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Caramelo, Julio J.; Parodi, Armando J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Caramelo, JJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Ave Patriclas Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.				Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM44500] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; BISCHOFF J, 1986, J BIOL CHEM, V261, P4766; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Cacan R, 2001, J BIOL CHEM, V276, P22307, DOI 10.1074/jbc.M101077200; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Ermonval M, 2001, GLYCOBIOLOGY, V11, P565, DOI 10.1093/glycob/11.7.565; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez F, 1996, EMBO J, V15, P705, DOI 10.1002/j.1460-2075.1996.tb00406.x; Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 2002, GLYCOBIOLOGY, V12, p14G; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jakob CA, 2001, EMBO REP, V2, P423; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Keith N, 2005, J BIOL CHEM, V280, P18138, DOI 10.1074/jbc.M501710200; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Labunskyy VM, 2007, IUBMB LIFE, V59, P1, DOI 10.1080/15216540601126694; Lal A, 1998, GLYCOBIOLOGY, V8, P981, DOI 10.1093/glycob/8.10.981; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Molinari M, 2005, MOL CELL, V20, P503, DOI 10.1016/j.molcel.2005.09.027; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Movsichoff F, 2005, MOL BIOL CELL, V16, P4714, DOI 10.1091/mbc.E05-03-0246; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Pieren M, 2005, J BIOL CHEM, V280, P28265, DOI 10.1074/jbc.M501020200; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Wanamaker CP, 2005, J BIOL CHEM, V280, P33800, DOI 10.1074/jbc.M501813200; WENG SA, 1993, J BIOL CHEM, V268, P25656; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Zuber C, 2007, P NATL ACAD SCI USA, V104, P4407, DOI 10.1073/pnas.0700154104	62	231	236	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10221	10225		10.1074/jbc.R700048200	http://dx.doi.org/10.1074/jbc.R700048200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18303019	Green Published, hybrid			2022-12-27	WOS:000254894700002
J	Luo, GZ; Gruhler, A; Liu, Y; Jensen, ON; Dickson, RC				Luo, Guangzuo; Gruhler, Albrecht; Liu, Ying; Jensen, Ole N.; Dickson, Robert C.			The sphingolipid long-chain base-Pkh1/2-Ypk1/2 signaling pathway regulates eisosome assembly and turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEINS SLM1; SACCHAROMYCES-CEREVISIAE; PKH-KINASES; YEAST; ENDOCYTOSIS; PHOSPHORYLATION; PHOSPHOPEPTIDES; IDENTIFICATION; DOWNSTREAM; EXTRACTION	Eisosomes are recently described fungal structures that play roles in the organization of the plasma membrane and endocytosis. Their major protein components are Pil1 and Lsp1, and previous studies showed that these proteins are phosphorylated by the sphingolipid long-chain base-activated Pkh1 and Pkh2 protein kinases in vitro. We show that Pkh1 and Pkh2 phosphorylate Pil1 and Lsp1 in vivo to produce species B, and that heat stress, which activates Pkh1 and Pkh2, generates a more highly phosphorylated species, C. Cells with low Pkh activity lack species B and C and contain abnormally organized eisosomes. To verify that Pil1 phosphorylation is essential for correct eisosome organization, phosphorylated serine and threonine residues were identified and changed to alanines. A variant Pil1 protein lacking five phosphorylation sites did not form eisosomes during log phase growth, indicating that phosphorylation is critical for eisosome organization. We also found that eisosomes are dynamic structures and disassemble when the Ypk protein kinases, which are activated by the sphingolipid-Pkh signaling pathway, are inactivated or when the sphingolipid signal is pharmacologically blocked with myriocin. We conclude that eisosome formation and turnover are regulated by the sphingolipid-Pkh1/2-Ypk1/2 signaling pathway. These data and previous data showing that endocytosis is regulated by the sphingolipid-Pkh1/2-Ypk1/2 signaling pathway suggest that Pkh1 and -2 respond to changes in membrane sphingolipids and transmit this information to eisosomes via Pil1 phosphorylation. Eisosomes then control endocytosis to align the composition and function of the plasma membrane to match demand.	[Luo, Guangzuo; Liu, Ying; Dickson, Robert C.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Gruhler, Albrecht; Jensen, Ole N.] Univ So Denmark, Protein Res Grp, Dept Biochem & Mol Biol, Odense, Denmark	University of Kentucky; University of Southern Denmark	Dickson, RC (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	bobd@uky.edu	Jensen, Ole N/J-1763-2012	Jensen, Ole N/0000-0003-1862-8528; Luo, Guangzuo/0000-0002-8518-5766	NCRR NIH HHS [P20-RR020171] Funding Source: Medline; NIGMS NIH HHS [GM41302] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041302] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brachmann CB, 1998, YEAST, V14, P115; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HUGHES TR, 2006, NATURE, V440, P637; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kjellstrom S, 2004, ANAL CHEM, V76, P5109, DOI 10.1021/ac0400257; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Neville DCA, 1997, PROTEIN SCI, V6, P2436; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; SIKORSKI RS, 1989, GENETICS, V122, P19; Stensballe A, 2001, PROTEOMICS, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.3.CO;2-V; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; YU W, 1993, ANAL CHEM, V65, P3015, DOI 10.1021/ac00069a014; Zhang XP, 2004, J BIOL CHEM, V279, P22030, DOI 10.1074/jbc.M400299200	43	90	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10433	10444		10.1074/jbc.M709972200	http://dx.doi.org/10.1074/jbc.M709972200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18296441	Green Published, hybrid			2022-12-27	WOS:000254894700024
J	Blakaj, A; Lin, HF				Blakaj, Adriana; Lin, Haifan			Piecing together the mosaic of early mammalian development through microRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; ZEBRAFISH; DICER; RNAS; DIFFERENTIATION; RENEWAL; PATHWAY; MURINE; ROLES	The microRNA (miRNA) pathway represents an integral component of the gene regulation circuitry that controls development. In recent years, the role of miRNAs in embryonic stem (ES) cells and mammalian embryogenesis has begun to be explored. A few dozens of miRNAs expressed in mammalian ES cells, either exclusively or nonexclusively, have been cloned. The overall role of miRNAs in ES cells and embryonic development has been assessed by examining the effect of knocking out Dicer, an RNase III enzyme required for miRNA and small interfering RNA biogenesis, as well as DGCR8, a nuclear protein specifically involved in miRNA biogenesis. In addition, the role of a cluster of miRNAs specifically expressed in ES cells, the miR-290-295 group, has been investigated by the knock-out approach. These analyses have revealed the crucial role of miRNAs in ES cell differentiation, lineage specification, and organogenesis, especially neurogenesis and cardiogenesis. Systematic investigation of the role of miRNAs in ES cells and embryos will allow us to find missing pieces of the mosaic of early development.	Yale Univ, Sch Med, Yal Stem Cell Ctr, New Haven, CT 06509 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06509 USA	Yale University; Yale University	Lin, HF (corresponding author), Yale Univ, Sch Med, Yal Stem Cell Ctr, 333 Cedar St, New Haven, CT 06509 USA.	haifan.lin@yale.edu			NIAID NIH HHS [AI 067798] Funding Source: Medline; NICHD NIH HHS [HD 42042, HD 33760, HD 37760-S1] Funding Source: Medline; NIGMS NIH HHS [T32 GM007205] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD042042, R01HD033760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; COOPER HM, 1991, J CELL BIOL, V115, P843, DOI 10.1083/jcb.115.3.843; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Seitz H, 2006, CELL, V125, P827, DOI 10.1016/j.cell.2006.05.018; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wang Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2316, DOI 10.2741/2234; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	25	65	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9505	9508		10.1074/jbc.R800002200	http://dx.doi.org/10.1074/jbc.R800002200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18272516	Green Published, hybrid			2022-12-27	WOS:000254671600002
